Citrus Sinensis ID: 001152
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1137 | 2.2.26 [Sep-21-2011] | |||||||
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.197 | 0.237 | 0.277 | 3e-19 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.188 | 0.160 | 0.299 | 1e-17 | |
| Q39008 | 608 | Mitogen-activated protein | no | no | 0.217 | 0.406 | 0.314 | 1e-17 | |
| P38692 | 1080 | Serine/threonine-protein | yes | no | 0.180 | 0.189 | 0.307 | 2e-17 | |
| Q54XJ4 | 1495 | Probable serine/threonine | no | no | 0.141 | 0.107 | 0.330 | 2e-17 | |
| Q9NQU5 | 681 | Serine/threonine-protein | yes | no | 0.180 | 0.301 | 0.269 | 2e-17 | |
| Q5R8Z4 | 681 | Serine/threonine-protein | yes | no | 0.180 | 0.301 | 0.269 | 2e-17 | |
| Q55EC7 | 960 | RasGEF domain-containing | no | no | 0.175 | 0.208 | 0.336 | 2e-17 | |
| Q8BTW9 | 593 | Serine/threonine-protein | yes | no | 0.151 | 0.290 | 0.305 | 3e-17 | |
| Q3ULB5 | 682 | Serine/threonine-protein | no | no | 0.153 | 0.255 | 0.293 | 3e-17 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 98.2 bits (243), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 68/292 (23%)
Query: 832 VRTLKVCGSSAD-EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 890
V+ L++ ++D +++N S E+ ++ +LRH IV G + +L
Sbjct: 198 VKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVRYLGTSLDQSFL---------- 247
Query: 891 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 950
++F+EY+ GGS+ + + K E + V + + L LH+ I+HRDI
Sbjct: 248 ----SVFLEYIPGGSISSLLGKFGAFSENVIKV-----YTKQILQGLSFLHANSIIHRDI 298
Query: 951 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV-GTPRWMA 1009
K NILID K +VKL DF C + GI + + GTP WMA
Sbjct: 299 KGANILIDT-------KGIVKLSDFG-----------CSKSFSGIVSQFKSMQGTPYWMA 340
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 1069
PEV+ K +G DIWS GC+++E+ T Q P+ ++EL
Sbjct: 341 PEVI----KQTGHGRSSDIWSLGCVIVEMATAQPPWSNITEL------------------ 378
Query: 1070 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
+ + +A S S P + + +F D C + +P ERP A L
Sbjct: 379 ----AAVMYHIASSNSIPNIP-SHMSQEAF--DFLNLCFKRDPKERPDANQL 423
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 79/264 (29%), Positives = 121/264 (45%), Gaps = 50/264 (18%)
Query: 809 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 868
E GK S + + + D A K + + I+ F+ EV +LG+L+H +V
Sbjct: 1078 EIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQEFK----AEVELLGSLQHPNLV 1133
Query: 869 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL--- 925
YG+ + NP I ME++ G++ I S+ E+ S+KL
Sbjct: 1134 TCYGYSL----------NP------MCIVMEFLPSGNLFELIH--SKPSEQQQSIKLDST 1175
Query: 926 -ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF 984
L IA D+A + LH+++I+HRD+KS N+L+D +K+ D A SF
Sbjct: 1176 LILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMDKHFN-------IKIADLGIARE-TSF 1227
Query: 985 LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044
T +GT W APE+LR H+ Y + D++SY +L ELLT + P
Sbjct: 1228 TQTMT-----------TIGTVAWTAPEILR--HES--YNQKADVYSYAIVLYELLTGEEP 1272
Query: 1045 YMGLSELEIHDLI-QMGKRPRLTD 1067
Y G+ + L+ G RP L D
Sbjct: 1273 YQGIPPMNAGILVASKGLRPELPD 1296
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 101/321 (31%), Positives = 139/321 (43%), Gaps = 74/321 (23%)
Query: 811 GKSVSSSLFRCKFGSADA-AAKVRTLKVCGSSADE-IRNFEYSCLGEVRMLGALRHSCIV 868
G+ S++ G D A K +L GS A E I+ E GE+++L L+H IV
Sbjct: 340 GRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLE----GEIKLLSQLQHQNIV 395
Query: 869 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 928
G + DG+ + IF+E V GS + KL + + SV ++L+
Sbjct: 396 RYRGT--------AKDGSNLY------IFLELVTQGS----LLKLYQRYQLRDSV-VSLY 436
Query: 929 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 988
Q + L LH K +HRDIK NIL+D A+G VKL DF A + F
Sbjct: 437 TRQ-ILDGLKYLHDKGFIHRDIKCANILVD-----ANG--AVKLADFGLA-KVSKFNDIK 487
Query: 989 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1048
C GTP WMAPEV+ + YG DIWS GC +LE+ T Q+PY L
Sbjct: 488 S-----------CKGTPFWMAPEVINRKDS-DGYGSPADIWSLGCTVLEMCTGQIPYSDL 535
Query: 1049 SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1108
++ I G P + D L L+ F++ +C
Sbjct: 536 EPVQALFRIGRGTLPEVPDTL-----------------------SLDARLFIL----KCL 568
Query: 1109 EENPTERPTAGDLYEM-FVAR 1128
+ NP ERPTA +L FV R
Sbjct: 569 KVNPEERPTAAELLNHPFVRR 589
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P38692|KIC1_YEAST Serine/threonine-protein kinase KIC1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=KIC1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 83/270 (30%), Positives = 120/270 (44%), Gaps = 65/270 (24%)
Query: 816 SSLF-------RCKFGSADAAAKVRTLKVCG-------SSADEIRNFEYSCLGEVRMLGA 861
SSLF R KFG V+T +V S +DE+ + + E++ L +
Sbjct: 20 SSLFKRTEVIGRGKFGVVYKGYNVKTGRVYAIKVLNLDSDSDEVEDVQR----EIQFLAS 75
Query: 862 LRH-SCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 918
L+ S I YG K +S W I ME+ GGS+++ + + + E
Sbjct: 76 LKQISNITRYYGSYLKDTSLW----------------IIMEHCAGGSLRSLL-RPGKIDE 118
Query: 919 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 978
K++ V I +++ AL +H +++HRDIK+ N+LI E VKLCDF A
Sbjct: 119 KYIGV-----IMRELLVALKCIHKDNVIHRDIKAANVLITNEGN-------VKLCDFGVA 166
Query: 979 VPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037
+ ++ L +A GTP WMAPEV+ Y +VDIWS G E
Sbjct: 167 AQVNQTSLRRQTMA-----------GTPYWMAPEVIMEGV---YYDTKVDIWSLGITTYE 212
Query: 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1067
+ T PY + L LI K PRL D
Sbjct: 213 IATGNPPYCDVEALRAMQLIIKSKPPRLED 242
|
Protein kinase involved in morphogenesis and cell integrity. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XJ4|Y8901_DICDI Probable serine/threonine-protein kinase DDB_G0278901 OS=Dictyostelium discoideum GN=DDB_G0278901 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 67/203 (33%), Positives = 97/203 (47%), Gaps = 42/203 (20%)
Query: 849 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 908
+ S + E+ +L L H IV Y H +PS+ S I ME+++ GS++
Sbjct: 66 QISLMAEINLLKVLSHHNIVRYYEH------IPSSS--------HSYIVMEFIENGSLEK 111
Query: 909 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968
I++ E V+V +IAQ V L LH + ++HRDIK+ N+LI DG
Sbjct: 112 IIKRHGLLPESLVTV----YIAQ-VLNGLEYLHRQGVIHRDIKAANLLIS-----TDGS- 160
Query: 969 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV-- 1026
+KL DF A + D GTP WMAPEV++ + G+
Sbjct: 161 -IKLADFGVATKVSDL--------SSDNPDDTFAGTPYWMAPEVIQ------MQGISTAC 205
Query: 1027 DIWSYGCLLLELLTLQVPYMGLS 1049
D+WS GC ++ELLT PY GL+
Sbjct: 206 DVWSLGCTIIELLTGTPPYFGLA 228
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NQU5|PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 1093 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8Z4|PAK6_PONAB Serine/threonine-protein kinase PAK 6 OS=Pongo abelii GN=PAK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 92.4 bits (228), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 66/271 (24%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 450 FNEVVIMRDYQHFNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQ 495
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 496 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 542
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 543 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 588
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
+++E++ + PY S ++ ++ P+L + H+V+
Sbjct: 589 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------SHKVS----------- 628
Query: 1093 ELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
L D R +P ER TA +L +
Sbjct: 629 -----PVLRDFLERMLVRDPQERATAQELLD 654
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55EC7|GEFX_DICDI RasGEF domain-containing serine/threonine-protein kinase X OS=Dictyostelium discoideum GN=gefX PE=2 SV=1 | Back alignment and function description |
|---|
Score = 92.0 bits (227), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 84/250 (33%), Positives = 117/250 (46%), Gaps = 50/250 (20%)
Query: 801 FPSLSSCDEAGKSVSSSLFR-CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML 859
F SL ++ GK S+FR C G A K+ AD+ +Y EV ML
Sbjct: 18 FESLEFNEKIGKGSFGSVFRGCYLGLDVAIKKIE-------KADDPEYLKY-IDREVSML 69
Query: 860 GALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG-E 918
+LRH IV G + S L I E+V GG V+ ++K G +
Sbjct: 70 QSLRHPFIVNFSGICVHSSGL--------------YIVTEFVSGGDVRQLLKKTPPIGWD 115
Query: 919 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 978
K VS IA D+A A+V LH+K I+HRD+KS+NIL+D ++ ++LCDF A
Sbjct: 116 KRVS------IAVDLAKAMVFLHAKKIIHRDLKSKNILLDEFQR-------IRLCDFGFA 162
Query: 979 VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038
R T H + GT W+APE+L M Y D++SYG +L EL
Sbjct: 163 ---RMSEQTKKSRHMTM------CGTEGWVAPEILLGMS----YDTSCDVFSYGVVLAEL 209
Query: 1039 LTLQVPYMGL 1048
+T + P + L
Sbjct: 210 ITGRKPGVDL 219
|
Promotes the exchange of Ras-bound GDP by GTP. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8BTW9|PAK4_MOUSE Serine/threonine-protein kinase PAK 4 OS=Mus musculus GN=Pak4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 91.7 bits (226), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV ++ RH +VEMY + L + ME+++GG++ + +
Sbjct: 368 EVVIMRDYRHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVTHTR 413
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VKL D
Sbjct: 414 MNEEQIAAVCLA------VLQALAVLHAQGVIHRDIKSDSILL-----THDGR--VKLSD 460
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F C + +P VGTP WMAPE++ + YG EVDIWS G +
Sbjct: 461 FG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSLGVM 506
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1067
++E++ + PY L+ +I+ PRL +
Sbjct: 507 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKN 539
|
Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, growth, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3ULB5|PAK6_MOUSE Serine/threonine-protein kinase PAK 6 OS=Mus musculus GN=Pak6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 91.7 bits (226), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 41/215 (19%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
EV ++ +H +VEMY + + L + ME+++GG++ + I +
Sbjct: 451 FNEVVIMRDYQHLNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIISQ 496
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ E+ +V + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 497 VRLNEEQIATV------CEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 543
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF C + +P VGTP WMAPEV+ +LY EVDIWS G
Sbjct: 544 SDFG----------FCAQISKDVPKRKSLVGTPYWMAPEVISR----SLYATEVDIWSLG 589
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1067
+++E++ + PY S ++ ++ P+L +
Sbjct: 590 IMVIEMVDGEPPYFSDSPVQAMKRLRDSAPPKLKN 624
|
Serine/threonine protein kinase that plays a role in the regulation of gene transcription. The kinase activity is induced by various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the DNA-binding domain of androgen receptor/AR and thereby inhibits AR-mediated transcription. Inhibits also ESR1-mediated transcription. May play a role in cytoskeleton regulation by interacting with IQGAP1. May protect cells from apoptosis through phosphorylation of BAD. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1137 | ||||||
| 225432806 | 1117 | PREDICTED: uncharacterized protein LOC10 | 0.978 | 0.996 | 0.686 | 0.0 | |
| 255552033 | 1152 | ATP binding protein, putative [Ricinus c | 0.948 | 0.936 | 0.669 | 0.0 | |
| 449433293 | 1131 | PREDICTED: uncharacterized protein LOC10 | 0.977 | 0.982 | 0.603 | 0.0 | |
| 224099855 | 1214 | predicted protein [Populus trichocarpa] | 0.904 | 0.846 | 0.657 | 0.0 | |
| 356534187 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.968 | 0.992 | 0.612 | 0.0 | |
| 15219675 | 1112 | leucine-rich repeat protein kinase-like | 0.941 | 0.962 | 0.577 | 0.0 | |
| 297843232 | 1115 | leucine-rich repeat family protein [Arab | 0.941 | 0.960 | 0.571 | 0.0 | |
| 356574435 | 1021 | PREDICTED: uncharacterized protein LOC10 | 0.875 | 0.975 | 0.616 | 0.0 | |
| 449525764 | 970 | PREDICTED: uncharacterized protein LOC10 | 0.835 | 0.979 | 0.607 | 0.0 | |
| 218193736 | 1112 | hypothetical protein OsI_13471 [Oryza sa | 0.929 | 0.950 | 0.477 | 0.0 |
| >gi|225432806|ref|XP_002279386.1| PREDICTED: uncharacterized protein LOC100249467 [Vitis vinifera] gi|297737117|emb|CBI26318.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1540 bits (3988), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 783/1141 (68%), Positives = 921/1141 (80%), Gaps = 28/1141 (2%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E+ + E + + +K + + N+ DD S++DVSG+ ++F ++E+
Sbjct: 1 MQLPDSGEVVS------VTEPVKDDQSKPLDAASTGENNADDQSILDVSGRNLEFSVLEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
+++VEGLYLYKNV NLIP+ +G +L+ LKFF NEINLFP E NL+GLECLQ
Sbjct: 55 C-----ESTVEGLYLYKNVFNLIPQRLGELGRLKMLKFFANEINLFPPEFRNLVGLECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+K+SSPG+NG L+KL+GLKELEL KVPPRPS LLSEIAGLKCLTKLSVCHFSIRYLP
Sbjct: 110 VKLSSPGLNGLPLHKLRGLKELELCKVPPRPSAFPLLSEIAGLKCLTKLSVCHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL+NLE LDLSFNKMK LPTEI YL ALISLKVANNKLVELPSGL LQRLENLDL
Sbjct: 170 PEIGCLNNLEDLDLSFNKMKSLPTEISYLSALISLKVANNKLVELPSGLSSLQRLENLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MHNLQNLNLQYNKLLS CQ+PSWICCNLEGNGKD+ ND+FISSS
Sbjct: 230 SNNRLTSLGSLELVSMHNLQNLNLQYNKLLSCCQIPSWICCNLEGNGKDACNDEFISSSV 289
Query: 301 EMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQ 359
EMDV E E D ++ +GS +TSSS T SSNSR AR S K WKR ++LQQRARQ
Sbjct: 290 EMDVLETTNQEIDESICCNGSPNTSSSTLTGPSSNSRCFVARMSQKGWKRRYYLQQRARQ 349
Query: 360 ERLNNSRKWRGEGHAQT-SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSPE 418
ERLNNSRKW+ E HA+ ++K ++ + G L L E+ +E A DI+ LD+DDKQLLS E
Sbjct: 350 ERLNNSRKWKSEDHAEVLTIKAAEKCEHGKLAVLHPESLAEHAPDIVVLDNDDKQLLSEE 409
Query: 419 AESENLLFSVEDDKIRSGTGLHVENCSCAGLESTG--KEGNDECSKHDSSSLSTANGATE 476
AESENLL SVED + G SCA L+S + EC+ D+S S + GA+E
Sbjct: 410 AESENLLNSVEDAESGPRKG------SCAVLDSIAINQGSKSECNDDDASLSSLSKGASE 463
Query: 477 QDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPD 536
++EGSSSE SK+ K+KRHSDRDLDNPKPCK+R+ + E+SN S KYS +S+C+IEDRLPD
Sbjct: 464 KNEGSSSEVSKSTPKSKRHSDRDLDNPKPCKARRPVNEHSNLSCKYSKISYCNIEDRLPD 523
Query: 537 GFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLT 596
GFYDAGRDRPFM LT YEQ H DSREVIL+DR+ DEELDAI LSAQALV LKQLNGLT
Sbjct: 524 GFYDAGRDRPFMPLTVYEQNFHFDSREVILLDRERDEELDAITLSAQALVSQLKQLNGLT 583
Query: 597 KDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSD 656
K+ DNLQIA LLALFVSDHFGGSD+S ++ERTRK+VSGSNY+KPFVC+CSTGN +
Sbjct: 584 KERKQVTDDNLQIASLLALFVSDHFGGSDKSALIERTRKSVSGSNYQKPFVCSCSTGNRN 643
Query: 657 SANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCD 716
+ +TS KQ LD VEDIV+SDLCEKSLRSIK++RNS++VPIG++QFGVCRHRAVL+KYLCD
Sbjct: 644 NISTSNKQNLDTVEDIVVSDLCEKSLRSIKARRNSIIVPIGTLQFGVCRHRAVLMKYLCD 703
Query: 717 RVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIP 776
R+EPPVPCELVRGYLDF PHAWN + K+GDSW+RMIVDACRPHDIREE DPEYF RYIP
Sbjct: 704 RMEPPVPCELVRGYLDFLPHAWNVVHTKRGDSWVRMIVDACRPHDIREETDPEYFCRYIP 763
Query: 777 LYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLK 836
L R P ST+S +P +G GSFPSLS+CDE + SSSL +CKFGS +AAAKVR L+
Sbjct: 764 LSRINVPLSTQS--TPVTG---GSFPSLSACDEIANAPSSSLIQCKFGSVEAAAKVRILE 818
Query: 837 VCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAI 896
VCG S DE+RNFEY CLGEVR+LGAL+HSCIVE+YGH+ISSKW+P++DGN EH +LQSAI
Sbjct: 819 VCGDSVDEVRNFEYCCLGEVRILGALKHSCIVEIYGHQISSKWIPASDGNLEHRVLQSAI 878
Query: 897 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956
ME+VKGGS+K+Y+EKLSE GEKHV V+LAL IA+DVA+AL ELHSKHI+HRDIKSENIL
Sbjct: 879 LMEHVKGGSLKSYLEKLSEAGEKHVPVELALCIARDVASALAELHSKHIIHRDIKSENIL 938
Query: 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1016
IDL++K+ADG PVVKLCDFDRAVPLRSFLH+CCIAH GIP PDVCVGTPRWMAPEVLRAM
Sbjct: 939 IDLDKKRADGTPVVKLCDFDRAVPLRSFLHSCCIAHIGIPPPDVCVGTPRWMAPEVLRAM 998
Query: 1017 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1076
HK +YGLEVDIWSYGCLLLELLTLQVPY LSE + HD +QMGKRP+L +ELEALGS
Sbjct: 999 HKREIYGLEVDIWSYGCLLLELLTLQVPYFELSESQFHDQLQMGKRPQLPEELEALGS-Q 1057
Query: 1077 EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSR 1136
E E+AQSG E PE E+E L FLVD+ R CT+ NPT+RPTA +LY+M + +T + SSR
Sbjct: 1058 EPEMAQSGKE-EGPETEVEKLGFLVDLVRWCTKGNPTDRPTAENLYKMLLTQTRTFTSSR 1116
Query: 1137 S 1137
S
Sbjct: 1117 S 1117
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552033|ref|XP_002517061.1| ATP binding protein, putative [Ricinus communis] gi|223543696|gb|EEF45224.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1464 bits (3789), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 734/1096 (66%), Positives = 866/1096 (79%), Gaps = 17/1096 (1%)
Query: 49 SGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS 108
+GK++DF Y D+S++GLYLYKNV +L+PKSVG KLR KFFGNE+NLFP
Sbjct: 67 TGKSLDF----DYLLEKADDSLDGLYLYKNVFSLVPKSVGNLGKLRTFKFFGNEVNLFPI 122
Query: 109 EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168
E GNL+GLE LQ+K+SS G+NG LNKLKGLKELELSK P RPSV T+LSEIAGLKCLTK
Sbjct: 123 EFGNLVGLERLQVKVSSLGLNGLGLNKLKGLKELELSKAPSRPSVFTILSEIAGLKCLTK 182
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFSIRYLPPEIGCL+ LE LD+SFNK+K LP EI +L ALISLKVANN+L+ELPS
Sbjct: 183 LSVCHFSIRYLPPEIGCLNKLEYLDISFNKIKSLPIEISHLNALISLKVANNRLMELPSA 242
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK 288
L LLQRLENLDLSNNRLTSLGSL L LMHNLQNL+LQ+NKLLS C +P+WICCNLEGNG
Sbjct: 243 LSLLQRLENLDLSNNRLTSLGSLQLGLMHNLQNLDLQHNKLLSCCHIPAWICCNLEGNGL 302
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSLTARKSSKQW 348
D SNDD ISSS EMDVYE + + S +GS++ +SS+ T SNS+ AR+ +K+W
Sbjct: 303 DLSNDDSISSSVEMDVYETTIQSDHTKFSCNGSQNATSSLLTGPPSNSKCFAARRLNKRW 362
Query: 349 KR-HHLQQRARQERLNNSRKWRGEGHAQTSM-KEGQRYKSGNLDALASETPSEEASDIIG 406
KR H+LQQRARQERLNNSRKW+GEG A S KE + KS NLD L SET + SDIIG
Sbjct: 363 KRRHYLQQRARQERLNNSRKWKGEGRADLSTPKESKNCKSDNLDLLTSETCEDGTSDIIG 422
Query: 407 L-----DDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECS 461
L D +DK + S E E+ENLL S +DD++ S G ++++CS ES DEC
Sbjct: 423 LVDNNEDKEDKVVPSSEVEAENLLVSGKDDRMNSKKGFYIKSCS-HNPESVSNGEEDECC 481
Query: 462 KHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQK 521
H+ S T NG + +DEGSSSEN+K + K+KRH D LDNPKPCK R+ ++ + S K
Sbjct: 482 VHEKSLALTQNGVSGEDEGSSSENTKFILKSKRHFDGALDNPKPCKCRRPTEDSLSLSHK 541
Query: 522 YSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALS 581
YS +SFCS ED LPDGFYDAGRDRPFM L YEQ HLDSREVIL+DR+ DE+LDA LS
Sbjct: 542 YSDLSFCSTEDHLPDGFYDAGRDRPFMPLRRYEQILHLDSREVILLDREKDEKLDATVLS 601
Query: 582 AQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSN 641
AQALV LK+LNG ++G + VD LQIA LLALFVSDHFGGSDRS +ERTRK VSGSN
Sbjct: 602 AQALVCRLKRLNGFFEEGNKDAVDVLQIASLLALFVSDHFGGSDRSFTIERTRKAVSGSN 661
Query: 642 YRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQF 701
Y+KPFVCTCSTGN +S NTS KQIL + EDIV SDLCEKSLRS+K+KRNS++VP+G++QF
Sbjct: 662 YKKPFVCTCSTGNDESINTSTKQILGSAEDIVFSDLCEKSLRSVKAKRNSIIVPLGNLQF 721
Query: 702 GVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHD 761
GVCRHRA+L KYLCDR++PP+PCELVRGYLDF PHAWNTILVK+GDSW+RM+VDACRPHD
Sbjct: 722 GVCRHRALLFKYLCDRMDPPIPCELVRGYLDFIPHAWNTILVKRGDSWVRMLVDACRPHD 781
Query: 762 IREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRC 821
IREE DPEYF RY+PL T P STES HSP S S S+ DE K+V S++ +C
Sbjct: 782 IREETDPEYFCRYVPLSHTRVPLSTESIHSPGC-----SITSFSTHDELEKTVLSTVIQC 836
Query: 822 KFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881
KF S +AAAKVRTL++C + DEIRNFEYSC+GEVR+L ALRH CIVE+YGH+ISSKW+
Sbjct: 837 KFESVEAAAKVRTLEICETPVDEIRNFEYSCIGEVRILRALRHPCIVELYGHQISSKWIH 896
Query: 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 941
+ DG P H +L+S I ME+VKGGS+K+YIEK+S+T +KHV + AL IA+D++ A+ +LH
Sbjct: 897 AEDGKPPHQILRSTILMEHVKGGSLKSYIEKMSKTSKKHVPMDFALCIARDISCAMADLH 956
Query: 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1001
SKHI+HRD+KSENILIDL+ K+ADG PVVKLCDFDRAVPLRSFLHTCCIAH GIP PDVC
Sbjct: 957 SKHIIHRDVKSENILIDLDSKRADGMPVVKLCDFDRAVPLRSFLHTCCIAHNGIPPPDVC 1016
Query: 1002 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
VGTPRWMAPEVLRAMHK N YGLEVDIWS+GCLLLELLTLQ+PY GLSE I +L+QMG+
Sbjct: 1017 VGTPRWMAPEVLRAMHKRNPYGLEVDIWSFGCLLLELLTLQIPYSGLSEFHIKELLQMGE 1076
Query: 1062 RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
RP LTDELE L S +E QSGS PEAE ETL FLVD+FRRCTE NP RPTA ++
Sbjct: 1077 RPPLTDELETLVSMNEPVATQSGSDVAAPEAESETLRFLVDLFRRCTEANPASRPTAAEI 1136
Query: 1122 YEMFVARTSSSISSRS 1137
YE+ + +S+ SSRS
Sbjct: 1137 YELLLGCSSAFTSSRS 1152
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433293|ref|XP_004134432.1| PREDICTED: uncharacterized protein LOC101218031 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1337 bits (3459), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 687/1138 (60%), Positives = 877/1138 (77%), Gaps = 27/1138 (2%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL NS E S E + E +++++ + ++ + ND DD SV+DVSG+ +D +E
Sbjct: 1 MQLINSEETVADSSETGLVESRNLKSSELVSFEDDNGNDADD-SVLDVSGRNLDSNFLE- 58
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
G +SV+GLY+++N NLIPKSVG + +LR LKFFGNEINLFPSE+ N +GLECLQ
Sbjct: 59 ----GSSSSVKGLYVFRNAFNLIPKSVGDFRELRMLKFFGNEINLFPSELKNFVGLECLQ 114
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+K+SSPG G +L+KLKGLKELELSK+PP+PS +LSEIAGLKCLTKLSVCHFSIR+LP
Sbjct: 115 VKLSSPGFGGLSLHKLKGLKELELSKIPPKPSSFPILSEIAGLKCLTKLSVCHFSIRFLP 174
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL++LE LDLSFNK+K LP+EI YL +LISL+VANNKLVELP L LQ+LENLDL
Sbjct: 175 PEIGCLNSLEYLDLSFNKLKSLPSEIGYLNSLISLRVANNKLVELPPALSSLQKLENLDL 234
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK-DSSNDDFISSS 299
S+NRLTSLGSL+L MH+L+NLNLQYNKLL CQ+PSWICCN EGN + D++N+++ISS+
Sbjct: 235 SSNRLTSLGSLELVSMHSLRNLNLQYNKLLKSCQIPSWICCNFEGNLEYDTANEEWISST 294
Query: 300 AEMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSLTARKSSKQW-KRHHLQQRAR 358
EMDVYE +N+ + G R+ SS++ S+NSRS +++S K+W +RH+LQQ+AR
Sbjct: 295 VEMDVYEATDQDNENSFPLKGMRNISSNLLMGPSTNSRSFASKRSGKRWRRRHYLQQKAR 354
Query: 359 QERLNNSRKWRGEGHAQTSMKEGQRYKSGNLD-ALASETPSEEASDIIGLDDDDKQLLSP 417
QERLN+SRKW+G H T +K + + LD A SET ++S I L D K+
Sbjct: 355 QERLNSSRKWKGVDH-HTEVKIHENQEPERLDSASISETTVGDSSAIDEL-FDSKETCDV 412
Query: 418 EAESENLLFSVEDDKIRSGTGLHVENCS--CAGLESTGKEGNDECSKHDSSSLSTANGAT 475
AE EN + S E+D VE+CS C T +EC + + T NGA
Sbjct: 413 GAERENHIESHENDNFDPKKEFPVEDCSSICDAAAETMTRDENECCETSKTLPLTGNGAH 472
Query: 476 EQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLP 535
+Q EGSSS+ SK K KR S+++LDNPKPCKSRK + +S+ S KY+S SFC++ED LP
Sbjct: 473 DQ-EGSSSQVSKDNAKLKRCSEKELDNPKPCKSRKPVEYSSSLSCKYNSTSFCNVEDYLP 531
Query: 536 DGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGL 595
DGFYDAGRDRPFM L YEQ HLDSREVI+V+R+ DE LD+I ++A++LVL LKQ+N L
Sbjct: 532 DGFYDAGRDRPFMPLRNYEQNFHLDSREVIIVNREHDEVLDSITIAAKSLVLRLKQINQL 591
Query: 596 T--KDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTG 653
T +D VI D++ IA LLALFVSDHFGGSDRS +VE+TR+ VSGS Y+KPFVCTCSTG
Sbjct: 592 TQERDQVI---DDVYIAQLLALFVSDHFGGSDRSAMVEKTRRVVSGSKYQKPFVCTCSTG 648
Query: 654 NSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKY 713
+ D+ +S K +D EDI+ +D+CEKSLRSIK+ RNS++VP+G++QFGVCRHRA+LLKY
Sbjct: 649 DRDNLTSSTKLTVDNYEDILFTDICEKSLRSIKASRNSIIVPLGALQFGVCRHRALLLKY 708
Query: 714 LCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIR 773
LCDR+EPPVPCELVRGYLDF PHAWN ILV++G++ +RM+VDACRP+DIREEADPEYF R
Sbjct: 709 LCDRMEPPVPCELVRGYLDFLPHAWNVILVQRGNTLVRMVVDACRPNDIREEADPEYFCR 768
Query: 774 YIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVR 833
YIPL R P S SP G+ SFPSLS+CDE K+ SSS+ +CK S +AAAK+R
Sbjct: 769 YIPLSRAKLPISFGVTSSP--GI---SFPSLSNCDEIEKAPSSSVIKCKLASVEAAAKLR 823
Query: 834 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 893
+VC SS +EIRNFE+SCLGEVR+LGAL+HSCIV+MYGH+ISS+W+PS +G P+ LL+
Sbjct: 824 KREVCESSFEEIRNFEFSCLGEVRILGALKHSCIVQMYGHQISSEWIPSENGKPKRRLLR 883
Query: 894 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953
SAIF+E+VKGGS+K+Y++KL + G++HV + LAL +A+DVA+ALVELHSKHI+HRDIKSE
Sbjct: 884 SAIFLEHVKGGSLKSYMDKLYKAGKEHVPMDLALHVARDVASALVELHSKHIIHRDIKSE 943
Query: 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013
NIL+D + +K+DG P+VKLCDFDRAVPLRS LHTCCIAH GIP PDVCVGTPRWMAPEVL
Sbjct: 944 NILMDFD-EKSDGVPIVKLCDFDRAVPLRSLLHTCCIAHTGIPPPDVCVGTPRWMAPEVL 1002
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL-EAL 1072
RAMH P++YGLEVDIWS+GCLLLELLTLQ+P++GL+EL+I D +QMGKRP L +L E L
Sbjct: 1003 RAMHTPHVYGLEVDIWSFGCLLLELLTLQIPFLGLTELQIFDHLQMGKRPELAGDLEEEL 1062
Query: 1073 GSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129
G+ + ++QS E E + ET + L+D+FR+CT+ENP +RPTA +L+ + + T
Sbjct: 1063 GTIKQSTMSQSSVQESEGQEKDQETKALLIDLFRKCTQENPNDRPTAEELHRILLEHT 1120
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099855|ref|XP_002311646.1| predicted protein [Populus trichocarpa] gi|222851466|gb|EEE89013.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1319 bits (3413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 705/1072 (65%), Positives = 822/1072 (76%), Gaps = 44/1072 (4%)
Query: 1 MQLTNSVEITQKS---PEGPIKEKLPSEANKINNEKNGSVNDD---------DDDSVIDV 48
MQ +NS E KS PE P K PS + +D DD+ V+DV
Sbjct: 1 MQPSNSTESNSKSTDNPENPKSPKSPSTEFNATATTVTATSDSSFEKNSENVDDEVVLDV 60
Query: 49 SGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS 108
GK+++F L+E D+SVEGLYLYKN +L+PKSVG +KLR LKFFGNE+NLFP+
Sbjct: 61 IGKSLEFDLLEK-----ADDSVEGLYLYKNAFSLVPKSVGGLKKLRTLKFFGNEVNLFPA 115
Query: 109 EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168
E GNL+GLECLQ+K+SSPG+NG + NKLKGLKELELS+VPPRPSVLT+LSEI+G+KCLTK
Sbjct: 116 EFGNLVGLECLQVKVSSPGLNGLSFNKLKGLKELELSRVPPRPSVLTILSEISGIKCLTK 175
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFS+RYLPPEIGCLSNLE LDLSFNK+K LP EI YL ALISLKV+NNKLVELPS
Sbjct: 176 LSVCHFSVRYLPPEIGCLSNLEFLDLSFNKIKSLPNEITYLNALISLKVSNNKLVELPSS 235
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGK 288
L LQ LE+LDLSNNRLTSLGSL+L MHNLQ+LNLQYNKLLS CQ+PSWICCNLEGNGK
Sbjct: 236 LSSLQLLESLDLSNNRLTSLGSLELTSMHNLQHLNLQYNKLLSCCQIPSWICCNLEGNGK 295
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSLTARKSSKQW 348
D SND+FISSS EMDVYE E+D S +GS H+ SSI T SSN + R S +
Sbjct: 296 DLSNDEFISSSVEMDVYETSFQEDDRKFSCNGSNHSMSSIVTGPSSNRSFASRRSSKRWK 355
Query: 349 KRHHLQQRARQERLNNSRKWRGEGHAQT-SMKEGQRYKSGNLDALASETPSEEASDIIGL 407
+RH+LQQ+ARQERLNNSRKW+GEG A+ ++KE + +KS NLD L E SD++G+
Sbjct: 356 RRHYLQQKARQERLNNSRKWKGEGCAEALALKESESFKSNNLDVLTPEVHEGGTSDVVGV 415
Query: 408 DDDDKQL-LSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSS 466
DDD++++ LS EAE ENL SVEDDKI S VE+CSC L S K + C D
Sbjct: 416 DDDNEKVELSVEAEGENLHTSVEDDKISSKKVFSVESCSC-DLGSINKSEEEVCCVQDEP 474
Query: 467 SLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVS 526
ST + A QDE SSSE SK K+KRH DRD+DNPKPCK R+ ++SN S KYS +S
Sbjct: 475 LASTRDEAASQDESSSSEKSKITYKSKRHHDRDIDNPKPCKCRRPTEDSSNFSCKYSELS 534
Query: 527 FCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALV 586
FCSIEDRLPDGFYDAGRDRPFM L +EQ LDSREVIL+DR+ DE+LDA+ALSAQALV
Sbjct: 535 FCSIEDRLPDGFYDAGRDRPFMPLRRFEQILPLDSREVILLDREKDEQLDAVALSAQALV 594
Query: 587 LHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPF 646
K+ NG TK+ VDNLQIA LLALFVSDHFGGSDRSG VERTRK VSGSNYRKPF
Sbjct: 595 FRFKRSNGSTKERNKVAVDNLQIASLLALFVSDHFGGSDRSGAVERTRKAVSGSNYRKPF 654
Query: 647 VCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRH 706
VCTC TGN++S + + KQ L+ VEDI+ SDLCE+SLRSIK++R S+V+P+GS+QFGVCRH
Sbjct: 655 VCTCPTGNNESISLAGKQALETVEDIIFSDLCERSLRSIKARRGSIVIPLGSLQFGVCRH 714
Query: 707 RAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEA 766
RA+L+KYLCDR++PPVPCELVRGYLDF PHAWN IL ++GDS +RM+VDAC PHDIREE
Sbjct: 715 RALLMKYLCDRMDPPVPCELVRGYLDFMPHAWNVILRRRGDSLVRMVVDACHPHDIREET 774
Query: 767 DPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSA 826
DPEYF RYIPL RT P STES P SFP++S+ D+ K+ SS+L RCKFGS
Sbjct: 775 DPEYFCRYIPLSRTKVPLSTESVPGPGC-----SFPTMSTSDKIEKAGSSTLIRCKFGSV 829
Query: 827 DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 886
+AAAKVRTL+VC +SADEIRNFEY CLGE +SSKW+PS DGN
Sbjct: 830 EAAAKVRTLEVCEASADEIRNFEYICLGE-------------------LSSKWVPSEDGN 870
Query: 887 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 946
PE +LQS I MEYV GGS+KNY+E++S+TGEKHV V++AL IA+DVA AL E+HSK I+
Sbjct: 871 PERRILQSVILMEYVDGGSLKNYLEEVSKTGEKHVPVEMALCIARDVACALAEIHSKDII 930
Query: 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1006
HRDIKSENILIDL+ +ADG PVVKLCDFDRAVP +SFLHTCCIAHRGI PDVCVGTPR
Sbjct: 931 HRDIKSENILIDLDDTRADGMPVVKLCDFDRAVPRKSFLHTCCIAHRGIAPPDVCVGTPR 990
Query: 1007 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1058
WMAPEVLR M K N Y LEVDIWSYGCLLLELLTLQVPY GL E IH+L+Q
Sbjct: 991 WMAPEVLRTMDKRNTYALEVDIWSYGCLLLELLTLQVPYAGLPESRIHELLQ 1042
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534187|ref|XP_003535639.1| PREDICTED: uncharacterized protein LOC100819959 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1297 bits (3356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 693/1132 (61%), Positives = 839/1132 (74%), Gaps = 31/1132 (2%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E + + P K P N + + DD + +DV+GK+V+FP E+
Sbjct: 1 MQLLHSDEPAPERGDSPEKPDDP------NADTDSLDPGTDDGAALDVTGKSVEFPAAEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
G+ S E LY+YKNV +LIPKSV R +LR LKFFGNEINLF E GNL LECLQ
Sbjct: 55 AGD-----SAESLYVYKNVYSLIPKSVSRLARLRTLKFFGNEINLFAPEFGNLTALECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+KISSPG+ G L+ LKGLKELELSK PPRPS +L+EI+GLKCLTKLS+CHFSIRYLP
Sbjct: 110 MKISSPGIGGLQLHTLKGLKELELSKGPPRPSAFPILTEISGLKCLTKLSICHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL LE LDLSFNKMK LP EI YLK LIS+KVANNKLVELP+ + L RLE LDL
Sbjct: 170 PEIGCLKKLEYLDLSFNKMKTLPAEISYLKGLISMKVANNKLVELPAAMSSLSRLERLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MH LQ LNLQYNKLL Q+PSWICCN++GN K DD SSS
Sbjct: 230 SNNRLTSLGSLELASMHRLQELNLQYNKLLGIFQIPSWICCNMDGNDKARCKDD-CSSSV 288
Query: 301 EMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQ 359
EMD+YE END +S G +TSSS+ T SSS+SR +RKS K+WKR HHLQQ+ARQ
Sbjct: 289 EMDLYESNFQENDETLS-DGPHNTSSSMLTSSSSSSRCFASRKSGKRWKRRHHLQQKARQ 347
Query: 360 ERLNNSRKWRGEGHAQT--SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSP 417
ERLNNSRKW+ H S K + + N D+LASE+ +E S+ LDD++K++ S
Sbjct: 348 ERLNNSRKWKAVDHDDQLLSKKIHRISEPENHDSLASESCAEIVSENGSLDDNNKRISSE 407
Query: 418 EAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQ 477
A ++N + + +D++ + E+C E DE + S S +EQ
Sbjct: 408 RAVNDNAIDNDNNDEVITEKQFSGEDCCTT-------ESKDE---KEESLCSLDKRPSEQ 457
Query: 478 DEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDG 537
DE S E + V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC IED L DG
Sbjct: 458 DEASCLELLECVSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGIEDHLSDG 517
Query: 538 FYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTK 597
FYDAGRDR FM L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+LNGL++
Sbjct: 518 FYDAGRDRLFMPLECYEQNHCLASREVILLDRKIDEELDAVMLAAQALVYNLKKLNGLSR 577
Query: 598 DGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDS 657
G + VDNLQ+A LLALFVSDHFGGSDRSGIVERTRK+VSGSNY KPFVCTCS G+S S
Sbjct: 578 YGNQDGVDNLQMASLLALFVSDHFGGSDRSGIVERTRKSVSGSNYNKPFVCTCSAGSSTS 637
Query: 658 ANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDR 717
++ + + + +EDI LS + EKSL SIK +RNS+++PIGSVQ+GVCRHRA+L KYLCD
Sbjct: 638 ISSPTEPVANTIEDITLSKMSEKSLDSIKKRRNSIIIPIGSVQYGVCRHRALLFKYLCDH 697
Query: 718 VEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPL 777
+EPPVPCELVRGYLDF PHAWN IL+K+G +W+RM++DACRP DIREE DPEYF RYIPL
Sbjct: 698 MEPPVPCELVRGYLDFSPHAWNIILIKRGATWVRMLIDACRPLDIREEKDPEYFCRYIPL 757
Query: 778 YRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKV 837
RT P S+ P SFPSL++CDE S++L +CKFGS +AAAKVRTL+
Sbjct: 758 NRTTIPISSIGSPGP-----DYSFPSLTTCDELETKASTTLVKCKFGSVEAAAKVRTLEE 812
Query: 838 CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF 897
GSSAD+I+NFEY+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L+SAIF
Sbjct: 813 QGSSADKIKNFEYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVLRSAIF 872
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV+GGS+KNY+EKLSE GEKHV V+LAL IA+DV+ AL ELHSKHI+HRDIKSENIL
Sbjct: 873 MEYVEGGSLKNYLEKLSEAGEKHVPVELALHIAKDVSCALSELHSKHIIHRDIKSENILF 932
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
+L+RK+ DG P VKLCDFD AVPLRS LH CCIAH G P P +CVGTPRWMAPEV+R M+
Sbjct: 933 NLDRKRDDGTPTVKLCDFDSAVPLRSTLHVCCIAHAGTPPPCICVGTPRWMAPEVMRTMY 992
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 1077
K N YGLE DIWS+GCLLLE+LTLQ+PY GLS+ D +QMGKRP+LTDEL L S +
Sbjct: 993 KKNSYGLEADIWSFGCLLLEMLTLQIPYSGLSDSHFLDSLQMGKRPQLTDELRVLSSMNG 1052
Query: 1078 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129
+ SG EK +A ++ L FLVD+F +C EENP++RPTA ++++M +A T
Sbjct: 1053 PTMIPSGEELEKSDAGVDMLKFLVDLFHKCVEENPSKRPTAEEIHKMVLAHT 1104
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15219675|ref|NP_171917.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|3142291|gb|AAC16742.1| Contains similarity to adenylate cyclase gb|AF012921 from Magnaporthe grisae. EST gb|Z24512 comes from this gene [Arabidopsis thaliana] gi|20466532|gb|AAM20583.1| unknown protein [Arabidopsis thaliana] gi|34365545|gb|AAQ65084.1| At1g04210 [Arabidopsis thaliana] gi|332189549|gb|AEE27670.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1231 bits (3185), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/1093 (57%), Positives = 795/1093 (72%), Gaps = 23/1093 (2%)
Query: 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFG 100
+DDSV+DVSG+ ++F L+++ D+SV+GLY ++NV NLIPKS+G +LR LKFF
Sbjct: 34 EDDSVVDVSGQNLEFSLLDNV-----DDSVKGLYFFRNVFNLIPKSIGGLGRLRKLKFFS 88
Query: 101 NEINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE 159
NEI+LFP E+GNL+ LE LQ+KISSPG +G + +KLKGLKELEL+KVP R S LTLLSE
Sbjct: 89 NEIDLFPPELGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSALTLLSE 148
Query: 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
I+GLKCLT+LSVCHFSIRYLPPEIGCL +LE LDLSFNK+K LP EI YL +L LKVA+
Sbjct: 149 ISGLKCLTRLSVCHFSIRYLPPEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTFLKVAH 208
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
N+L+EL L LLQ LE+LD+SNNRLT+L LDL LM LQ LNL+YNKL SYC +P+WI
Sbjct: 209 NRLMELSPVLALLQNLESLDVSNNRLTTLHPLDLNLMPRLQILNLRYNKLPSYCWIPTWI 268
Query: 280 CCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSL 339
CN EGN ++ D SS EMDV+E P N V GS ++ST SS SR
Sbjct: 269 QCNFEGNYEEMGVDTCSSSMVEMDVFETPYENNVITVPHKGSHRNPLNMSTGISSISRCF 328
Query: 340 TARKSSKQWKR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALASETP 397
+ARKSSK+WKR ++ QQRARQERLNNSRKW+GE + + + ++G +
Sbjct: 329 SARKSSKRWKRRQYYFQQRARQERLNNSRKWKGEVPPEGLSLKMEVEETGKQGMKVPQNT 388
Query: 398 SEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGN 457
+ D D++DK E + + E+++ + +N C + T + N
Sbjct: 389 DRGSVDNSCSDENDKLF------EEASVITSEEEESSLKADVVSDNSQCVETQLTSERDN 442
Query: 458 DECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSN 517
E + +SS S+ + D SSSE K K+KR S++ LDNPK K K + +N
Sbjct: 443 YESCEIKTSSPSSGDAPGTVDYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHKLSTDITN 502
Query: 518 ASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDA 577
S+KYSS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE LDA
Sbjct: 503 LSRKYSSNSFCSTEDSLPDGFFDAGRDRPFMTLSKYEKVLPLDSREVILLDRAKDEVLDA 562
Query: 578 IALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTV 637
I LSA+ALV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+ I+ERTRK V
Sbjct: 563 ITLSARALVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERTRKAV 622
Query: 638 SGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIG 697
SG+NY+KPF+CTC TGN D KQ+ ED +LSD+CEKSLRSIKSKRNS+VVP+G
Sbjct: 623 SGTNYQKPFICTCLTGNQDDLAALNKQVSTTAEDAILSDVCEKSLRSIKSKRNSIVVPLG 682
Query: 698 SVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDAC 757
+QFG+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+VDAC
Sbjct: 683 KLQFGICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMVVDAC 742
Query: 758 RPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSS 817
RPHDIRE+ D EYF RYIPL R + L+PG S S + + +SS
Sbjct: 743 RPHDIREDTDQEYFCRYIPLNRLNESIRIKEK------LEPGCSVSSLSTGKGVERANSS 796
Query: 818 LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877
L RCK GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH+ISS
Sbjct: 797 LIRCKLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGHEISS 856
Query: 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 937
KW+ S +GN EH +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D++ AL
Sbjct: 857 KWITSENGN-EHRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDISGAL 915
Query: 938 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 997
+ELHSK I+HRDIKSEN+LIDL+ + A+G+P+VKLCDFDRAVPLRS LH CCIAH GIP
Sbjct: 916 MELHSKDIIHRDIKSENVLIDLDNQSANGEPIVKLCDFDRAVPLRSHLHGCCIAHVGIPP 975
Query: 998 PDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
P++CVGTPRWM+PEV RAMH+ N YGLEVDIWS+GCL+ ELLTLQ PY LSEL+IH+ +
Sbjct: 976 PNICVGTPRWMSPEVFRAMHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDLSELQIHESL 1035
Query: 1058 QMGKRPRLTDELEALGSCHEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115
Q GKRP+L +LE L S E E + + F+ E++L+T+ FL+DVF +CTEE+P++R
Sbjct: 1036 QNGKRPKLPKKLETLISETEEEESTNKLSEVFDLTESDLDTMRFLIDVFHQCTEESPSDR 1095
Query: 1116 PTAGDLYEMFVAR 1128
AGDL+EM ++R
Sbjct: 1096 LNAGDLHEMILSR 1108
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843232|ref|XP_002889497.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297335339|gb|EFH65756.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1224 bits (3168), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 627/1097 (57%), Positives = 791/1097 (72%), Gaps = 26/1097 (2%)
Query: 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFG 100
+D+SV+DVSG+ ++F L+++ D+SV+GLY ++NV NL+PKS+G +LR LKFF
Sbjct: 34 EDESVVDVSGQNLEFSLLDNV-----DDSVKGLYFFRNVFNLLPKSIGGLGRLRKLKFFS 88
Query: 101 NEINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE 159
NEI+LFP E+GNL+ LE LQ+KISSPG +G + +KLKGLKELEL+KVP R S LTLLSE
Sbjct: 89 NEIDLFPPELGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSALTLLSE 148
Query: 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
I+GLKCLT+LSVCHFSIRYLP EIGCL +LE LDLSFNK+K LP EI YL +L LKVA+
Sbjct: 149 ISGLKCLTRLSVCHFSIRYLPAEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTFLKVAH 208
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
N+L+EL L LLQ LE+LD+SNNRLT+L LDL LM LQ LNL+YNKL SYC +P+WI
Sbjct: 209 NRLMELSPALALLQNLESLDVSNNRLTNLHPLDLSLMPRLQILNLRYNKLPSYCWIPTWI 268
Query: 280 CCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSL 339
CNLEGN ++ D SS EMDV+E P N V GS ++ST SS SR
Sbjct: 269 HCNLEGNYEEMGVDTCSSSMVEMDVFETPYENNTITVPHKGSHRNPLNMSTGISSISRCF 328
Query: 340 TARKSSKQWKR--HHLQQRARQERLNNSRKWRGE---GHAQTSMKEGQRYKSGNLDALAS 394
+ARKSSK+WKR H+ QQRARQERLNNSRKW+GE G M+ + K G
Sbjct: 329 SARKSSKRWKRRQHYFQQRARQERLNNSRKWKGEVPPGGLSLKMEVEETGKQG---MKVP 385
Query: 395 ETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGK 454
E + D D+DK L E+ + E+++ +N + T +
Sbjct: 386 ENTDRGSVDSTYSGDNDKLL----EEASVITSEEEEEESSLKAKFASDNSRFVETQLTSE 441
Query: 455 EGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGE 514
N+E + +SS S+ + D SSSE K K+KR S++ LDNPK K + +
Sbjct: 442 RDNNESCEIKASSPSSGDAPGTADYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHRPSTD 501
Query: 515 NSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEE 574
+N S KYS SFCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE
Sbjct: 502 FANLSHKYSRNSFCSTEDSLPDGFFDAGRDRPFMSLSKYEEILPLDSREVILLDRAKDEV 561
Query: 575 LDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTR 634
LDAI LSA+ LV LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+ I+ERTR
Sbjct: 562 LDAITLSARTLVARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERTR 621
Query: 635 KTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVV 694
K VSG+NY+KPF+CTC TGN D KQ+ ED++LSD+CEKSLRSIKSKRNS+VV
Sbjct: 622 KAVSGTNYQKPFICTCLTGNQDDLAALNKQVSTTAEDVILSDVCEKSLRSIKSKRNSIVV 681
Query: 695 PIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIV 754
P+G +QFG+CRHRA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+V
Sbjct: 682 PLGKLQFGICRHRALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMVV 741
Query: 755 DACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSV 814
DACRPHDIRE+ D EYF RYIPL R T+ + L+PG S + +
Sbjct: 742 DACRPHDIREDTDQEYFCRYIPLNRLNESIRTKEN------LEPGCSVSSLLTGKGVERA 795
Query: 815 SSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874
+SSL RCK GS +A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH+
Sbjct: 796 NSSLIRCKLGSTEAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGHE 855
Query: 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVA 934
ISSKW+ S +G+ +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D++
Sbjct: 856 ISSKWITSENGDEHRRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDIS 915
Query: 935 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 994
AL+ELHSK I+HRDIKSEN+LIDL+ + A+G+ +VKLCDFDRAVPLRS LH CCIAH G
Sbjct: 916 GALMELHSKDIIHRDIKSENVLIDLDNQSANGEAIVKLCDFDRAVPLRSHLHGCCIAHVG 975
Query: 995 IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH 1054
IP P++CVGTPRWM+PEV RAMH+ N YGLEVDIWS+GCL+ ELLTLQ PY LSEL+IH
Sbjct: 976 IPPPNICVGTPRWMSPEVFRAMHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDLSELQIH 1035
Query: 1055 DLIQMGKRPRLTDELEALGSCHEHEVAQSG--SGFEKPEAELETLSFLVDVFRRCTEENP 1112
+ +Q GKRP+L +LE L S E + + + F+ E++L+T+ FL+DVF +CTEE+P
Sbjct: 1036 ESLQKGKRPKLPKKLETLSSETEEDESTNKLCEEFDLTESDLDTMRFLIDVFHQCTEESP 1095
Query: 1113 TERPTAGDLYEMFVART 1129
++R AGDL+EM ++RT
Sbjct: 1096 SDRLNAGDLHEMILSRT 1112
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574435|ref|XP_003555353.1| PREDICTED: uncharacterized protein LOC100811118 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1180 bits (3053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 633/1027 (61%), Positives = 768/1027 (74%), Gaps = 31/1027 (3%)
Query: 1 MQLTNSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIES 60
MQL +S E + + P K + P N ++ +G+ DD + +DV+GK+V+FP E+
Sbjct: 1 MQLVHSDEPAPERRDWPEKPEDPKADN--DSLDSGT----DDGAALDVTGKSVEFPAAEN 54
Query: 61 YGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120
++S E LY+YKNV +LIPKSV R +LR LKFFGNEINLF E GNL LECLQ
Sbjct: 55 -----AEDSAECLYVYKNVYSLIPKSVSRLARLRTLKFFGNEINLFAPEFGNLTTLECLQ 109
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+KISSPG+ G L+ LKGLKELELSK PPRPS +L+EI+GLKCLTKLS+CHFSIRYLP
Sbjct: 110 MKISSPGIGGLPLHTLKGLKELELSKGPPRPSAFPILTEISGLKCLTKLSICHFSIRYLP 169
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
PEIGCL LE LDLSFNKMK LP EI YLK LIS+KVANNKLVELP+ + L RLE+LDL
Sbjct: 170 PEIGCLKKLEYLDLSFNKMKTLPAEITYLKGLISMKVANNKLVELPAAMSSLSRLESLDL 229
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSA 300
SNNRLTSLGSL+L MH LQ LNLQYNKLL Q+PSW+CCN+EGN + DD SSS
Sbjct: 230 SNNRLTSLGSLELASMHRLQELNLQYNKLLRIFQIPSWMCCNMEGNDEARYKDD-CSSSV 288
Query: 301 EMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSLTARKSSKQWKR-HHLQQRARQ 359
EMD+YE END +S G +TSSS+ T SS+SR +RKS K+WKR ++LQQ+ARQ
Sbjct: 289 EMDLYESNFQENDETLS-DGPHNTSSSMLTSPSSSSRCFASRKSGKRWKRRYYLQQKARQ 347
Query: 360 ERLNNSRKWRGEGHAQT--SMKEGQRYKSGNLDALASETPSEEASDIIGLDDDDKQLLSP 417
ERLNNSRKW+ H S K + +SGN D+LASE+ +E S+ LDD++K++ S
Sbjct: 348 ERLNNSRKWKAVDHDDLLLSKKIHRISESGNHDSLASESCAEIESENGSLDDNNKRIFSE 407
Query: 418 EAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSSSLSTANGATEQ 477
A ++N + + +D++ + E+C E DE D+S S +EQ
Sbjct: 408 RAVNDNAIDNDNNDEVITEKQFSGEDCCTT-------ESKDE---KDASLCSLEKRQSEQ 457
Query: 478 DEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDG 537
+E S E ++V K+KRH DRDLDNPKPCKSRKS+ +S S KYS +SFC ED L DG
Sbjct: 458 EEASCLELLESVSKSKRHLDRDLDNPKPCKSRKSISSSSLLSCKYSKISFCGTEDHLSDG 517
Query: 538 FYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALVLHLKQLNGLTK 597
FYDAGRDRPFM L YEQ L SREVIL+DRK DEELDA+ L+AQALV +LK+LNGL +
Sbjct: 518 FYDAGRDRPFMPLESYEQNQCLASREVILLDRKRDEELDAVMLAAQALVYNLKKLNGLNR 577
Query: 598 DGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDS 657
G VDNLQ A LLALFVSDHFGGSDRS IVERTRK+VSGSNY KPFVCTCS G+S S
Sbjct: 578 HGNQVGVDNLQTASLLALFVSDHFGGSDRSAIVERTRKSVSGSNYNKPFVCTCSAGSSTS 637
Query: 658 ANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDR 717
++ + + + +EDI LS + EKSL S+K ++NS+++PIGSVQ+GVCRHRA+L KYLCD
Sbjct: 638 ISSPTEPVANTIEDITLSKMSEKSLDSMKKRQNSIIIPIGSVQYGVCRHRALLFKYLCDH 697
Query: 718 VEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPL 777
+EPPVPCELVRGYLDF PHAWN IL+K+G +W+RM++DAC+P DIREE DPEYF RYIPL
Sbjct: 698 MEPPVPCELVRGYLDFSPHAWNIILIKRGATWVRMLIDACQPLDIREEKDPEYFCRYIPL 757
Query: 778 YRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKV 837
RT P ST C G D SFPSL++CDE S+SL +CKFGS +AAAKVRTL+
Sbjct: 758 NRTTIPLSTIG----CPGPD-YSFPSLTTCDELETKASTSLVKCKFGSVEAAAKVRTLEE 812
Query: 838 CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF 897
GSSAD+I+NF+Y+CLGE+R+LGAL+H CIVEMYGH+IS +W SADGNPEH +L+SAIF
Sbjct: 813 QGSSADKIKNFKYNCLGEIRILGALKHPCIVEMYGHQISCQWSVSADGNPEHRVLRSAIF 872
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV+GGS+K+Y+EKLSE GEKHV V+LAL IA+DV+ AL ELHS+HI+HRDIKSENIL
Sbjct: 873 MEYVEGGSLKSYLEKLSEAGEKHVPVELALLIAKDVSCALSELHSRHIIHRDIKSENILF 932
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
DL+RK+ DG P VKLCDFD AVPLRS LH CCIAH G P P VCVGTPRWMAPEV+R M+
Sbjct: 933 DLDRKRDDGTPTVKLCDFDSAVPLRSTLHACCIAHAGTPPPCVCVGTPRWMAPEVMRTMY 992
Query: 1018 KPNLYGL 1024
K N YGL
Sbjct: 993 KKNSYGL 999
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525764|ref|XP_004169886.1| PREDICTED: uncharacterized protein LOC101227936, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1155 bits (2988), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/971 (60%), Positives = 751/971 (77%), Gaps = 21/971 (2%)
Query: 168 KLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227
K+ FS R+LPPEIGCL++LE LDLSFNK+K LP+EI YL +LISL+VANNKLVELP
Sbjct: 1 KICCVSFSFRFLPPEIGCLNSLEYLDLSFNKLKSLPSEIGYLNSLISLRVANNKLVELPP 60
Query: 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNG 287
L LQ+LENLDLS+NRLTSLGSL+L MH+L+NLNLQYNKLL CQ+PSWICCN EGN
Sbjct: 61 ALSSLQKLENLDLSSNRLTSLGSLELVSMHSLRNLNLQYNKLLKSCQIPSWICCNFEGNL 120
Query: 288 K-DSSNDDFISSSAEMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSLTARKSSK 346
+ D++N+++ISS+ EMDVYE + +N+ + G R+ SS++ S+NSRS +++S K
Sbjct: 121 EYDTANEEWISSTVEMDVYEATVQDNENSFPLKGMRNISSNLLMGPSTNSRSFASKRSGK 180
Query: 347 QWKR-HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLD-ALASETPSEEASDI 404
+W+R H+LQQ+ARQERLN+SRKW+G H T +K + + LD A SET ++S I
Sbjct: 181 RWRRRHYLQQKARQERLNSSRKWKGVDH-HTEVKIHENQEPERLDSASISETTVGDSSAI 239
Query: 405 IGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCS--CAGLESTGKEGNDECSK 462
L D K+ + AE EN + S E+D VE+CS C T +EC +
Sbjct: 240 DELFDS-KETCAVGAERENHIESHENDNFDPKKEFPVEDCSSICDAAAETMTRDENECCE 298
Query: 463 HDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKY 522
+ T NGA +Q EGSSS+ SK K KR S+R+LDNPKPCKSRK + +S+ S KY
Sbjct: 299 TSKTLPLTGNGAHDQ-EGSSSQVSKDNAKLKRCSERELDNPKPCKSRKPVEYSSSLSCKY 357
Query: 523 SSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSA 582
+S SFC++ED LPDGFYDAGRDRPFM L YEQ HLDSREVI+V+R+ DE LD+I ++A
Sbjct: 358 NSTSFCNVEDYLPDGFYDAGRDRPFMPLRNYEQNFHLDSREVIIVNREHDEVLDSITIAA 417
Query: 583 QALVLHLKQLNGLT--KDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGS 640
++LVL LKQ+N LT +D VI D++ IA LLALFVSDHFGGSDRS +VE+TR+ VSGS
Sbjct: 418 KSLVLRLKQINQLTQERDQVI---DDVYIAQLLALFVSDHFGGSDRSAMVEKTRRAVSGS 474
Query: 641 NYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQ 700
Y+KPFVCTCSTG+ D+ +S K +D EDI+ +D+CEKSLRSIK+ RNS++VP+G++Q
Sbjct: 475 KYQKPFVCTCSTGDRDNLTSSTKLTVDNYEDILFTDICEKSLRSIKASRNSIIVPLGALQ 534
Query: 701 FGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPH 760
FGVCRHRA+LLKYLCDR+EPPVPCELVRGYLDF PHAWN ILV++G++ +RM+VDACRP+
Sbjct: 535 FGVCRHRALLLKYLCDRMEPPVPCELVRGYLDFLPHAWNVILVQRGNTLVRMVVDACRPN 594
Query: 761 DIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFR 820
DIREEADPEYF RYIPL R P S SP G+ SFPSLS+CDE K+ SSS+ +
Sbjct: 595 DIREEADPEYFCRYIPLSRAKLPISFGVTSSP--GI---SFPSLSNCDEIEKAPSSSVIK 649
Query: 821 CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880
CK S +AAAK+R +VC SS +EIRNFE+SCLGEVR+LGAL+HSCIV+MYGH+ISS+W+
Sbjct: 650 CKLASVEAAAKLRKREVCESSFEEIRNFEFSCLGEVRILGALKHSCIVQMYGHQISSEWI 709
Query: 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVEL 940
PS +G P+ LL+SAIF+E+VKGGS+K+Y++KL + G++HV + LAL +A+DVA+ALVEL
Sbjct: 710 PSENGKPKRRLLRSAIFLEHVKGGSLKSYMDKLYKAGKEHVPMDLALHVARDVASALVEL 769
Query: 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1000
HSKHI+HRDIKSENIL+D + +K+DG P+VKLCDFDRAVPLRS LHTCCIAH GIP PDV
Sbjct: 770 HSKHIIHRDIKSENILMDFD-EKSDGVPIVKLCDFDRAVPLRSLLHTCCIAHTGIPPPDV 828
Query: 1001 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 1060
CVGTPRWMAPEVLRAMH PN+YGLEVDIWS+GCLLLELLTLQ+P++GL+EL+I D +QMG
Sbjct: 829 CVGTPRWMAPEVLRAMHTPNVYGLEVDIWSFGCLLLELLTLQIPFLGLTELQIFDHLQMG 888
Query: 1061 KRPRLTDEL-EALGSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118
KRP L +L E LG+ + ++QS E E + ET + L+D+FR+CT+ENP +RPTA
Sbjct: 889 KRPELAGDLEEELGTIKQSTMSQSSVQESEGQEKDQETKALLIDLFRKCTQENPNDRPTA 948
Query: 1119 GDLYEMFVART 1129
+L+ + + T
Sbjct: 949 EELHRILLEHT 959
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218193736|gb|EEC76163.1| hypothetical protein OsI_13471 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 950 bits (2455), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/1107 (47%), Positives = 706/1107 (63%), Gaps = 50/1107 (4%)
Query: 47 DVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYE-KLRNLKFFGNEINL 105
DV+G T D + E +Y+Y+N NL+P+S+G +R+LKFFGN++ +
Sbjct: 22 DVAGNTWDLAALPPPPPAARGGGGE-VYIYRNTYNLVPRSIGGCRGSVRSLKFFGNDVEV 80
Query: 106 FPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC 165
P E G L LE LQ+K+S+P V+G L +++ LKELELS VPPRPS ++L E+A LKC
Sbjct: 81 LPPEAGELDQLESLQVKVSAPRVSGAPLRRMRALKELELSIVPPRPSACSILVEVAALKC 140
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
LTKL++CHFSIRYLPPEIG L L++LDLSFNK+K LP I L AL LKV NNKLV+L
Sbjct: 141 LTKLTICHFSIRYLPPEIGSLRKLQELDLSFNKLKNLPNCITELGALKFLKVTNNKLVDL 200
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEG 285
PSG+ L+ LE+LDLSNNRLTSLGS+ L M LQ LNLQ+N++ + C +P+W+CC++ G
Sbjct: 201 PSGISSLRCLESLDLSNNRLTSLGSVKLISMLTLQYLNLQFNRISNSCVIPAWVCCDMRG 260
Query: 286 NGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSLTARKSS 345
NG+++ + S A V N + + SR S +S+N + +K+
Sbjct: 261 NGENNMKPGKLKSIAV--VSNTSAESRSMNHTCNASRLCSHP---EASANLKVHPTQKTK 315
Query: 346 KQWKRHH-LQQRARQERLNNSRKWRGEGHAQT-------------SMKEGQRYKSGNLDA 391
K WKR LQQ+ARQERL +SR + + M+ K + +A
Sbjct: 316 KGWKRRDCLQQQARQERLESSRSKLNDDYVDEMAVNMTEDESPLHDMENKSEMKGIDEEA 375
Query: 392 LASETPSEEAS---DIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVE-NCSC- 446
+ P E +S D+ + DDD + ++ +++ + G + NCSC
Sbjct: 376 SLQDLPKETSSISEDLSCIVDDDSY---GHIKDSGMMLQDHNEEEKPGLSMKSHGNCSCI 432
Query: 447 ---AGLESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNP 503
+ S + + E DS+ S+ + A E + SE SK K+KRH D D NP
Sbjct: 433 SGNTDILSRRRIRSVENELEDSA--SSVHDAAVVVEENPSETSKHSWKSKRHPDMDC-NP 489
Query: 504 KPCKSRKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSRE 563
KP K + E S S KYS SFCSI+D LPDGFYDAGRD PFM L YE++ L +RE
Sbjct: 490 KPSKCPRPFDECSKLSYKYSVQSFCSIDDHLPDGFYDAGRDMPFMPLEEYERSIGLYARE 549
Query: 564 VILVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGG 623
VIL+DR+ DEELDAIA SAQ L+ +LK + D + +L A +LALFVSD FGG
Sbjct: 550 VILLDREQDEELDAIASSAQILLSNLKMPSCFVADE--DAGQDLLRASVLALFVSDCFGG 607
Query: 624 SDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLR 683
DRS + RTR+ + +PFVCTCS G+ + + K+I + + LC+KS+
Sbjct: 608 CDRSASLSRTRRAIVSLRKEQPFVCTCSAGSICDSIEASKRINNLYGHFDFTGLCDKSIH 667
Query: 684 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILV 743
IK +RNS +VPIG++QFGVCRHRAVL+KYLCDR +PP+PCELVRG+LD+ PHAWN + V
Sbjct: 668 IIKERRNSGIVPIGALQFGVCRHRAVLMKYLCDRADPPIPCELVRGHLDYTPHAWNVVPV 727
Query: 744 KKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGS-FP 802
+KG++W+RMIVDAC P +I+EE DPEYF RY+PL R + G P S FP
Sbjct: 728 RKGNTWVRMIVDACYPTNIKEETDPEYFCRYVPLSRLQIILDDQ-------GYTPRSPFP 780
Query: 803 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 862
S+S C E + SSS++ CK G+ DAAAKVR L +S+DE++NFEY L EVRMLGAL
Sbjct: 781 SVSLCKEIETTASSSVYYCKIGAVDAAAKVRYLDTRCASSDEVKNFEYKLLAEVRMLGAL 840
Query: 863 R-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV 921
R H IVE+YGH++ SKW+ AD + E+ +LQS I MEYVKGGS+K Y+ KL + G+KH
Sbjct: 841 RKHQSIVEIYGHQLYSKWV-QADDDKEYKILQSTIMMEYVKGGSLKGYLTKLLKEGKKHA 899
Query: 922 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 981
+ LA +I ++VA AL+ELH K ++HRDIKSEN+L+DL+ +++DG PVVKL DFD A+PL
Sbjct: 900 PIDLAFYIVREVACALLELHKKLVIHRDIKSENVLVDLDLERSDGTPVVKLSDFDNAIPL 959
Query: 982 RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041
S HTCCIAH G P+VCVGTP WMAPEVLRAM N YGLEVDIWS+GC LLE+LTL
Sbjct: 960 HSLSHTCCIAHLGTYPPNVCVGTPCWMAPEVLRAMRDKNQYGLEVDIWSFGCFLLEMLTL 1019
Query: 1042 QVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1100
++PY GL + EI+DLI K RPRLT ELEA + + + + G +A E L L
Sbjct: 1020 RIPYQGLPDSEIYDLIMRKKQRPRLTQELEAFWTL-DKPITRLELGITS-DAHAEKLRLL 1077
Query: 1101 VDVFRRCTEENPTERPTAGDLYEMFVA 1127
+D+F +CT+ +ERP A +Y + +
Sbjct: 1078 IDLFYQCTKGIASERPKAEAVYNLLCS 1104
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1137 | ||||||
| TAIR|locus:2020220 | 1112 | AT1G04210 [Arabidopsis thalian | 0.933 | 0.954 | 0.546 | 5.7e-304 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.057 | 0.065 | 0.420 | 7.1e-19 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.057 | 0.063 | 0.420 | 5.2e-18 | |
| DICTYBASE|DDB_G0278509 | 1248 | DDB_G0278509 "MLK family prote | 0.078 | 0.071 | 0.426 | 7.3e-15 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.077 | 0.1 | 0.320 | 1.1e-14 | |
| DICTYBASE|DDB_G0269250 | 3184 | pats1 "LRRK family protein kin | 0.155 | 0.055 | 0.298 | 2.3e-14 | |
| DICTYBASE|DDB_G0279417 | 2147 | roco6 "LRRK family protein kin | 0.144 | 0.076 | 0.299 | 2.8e-14 | |
| DICTYBASE|DDB_G0286127 | 1867 | roco8 "LRRK family protein kin | 0.140 | 0.085 | 0.294 | 3.2e-14 | |
| TAIR|locus:2076416 | 809 | AT3G58640 [Arabidopsis thalian | 0.175 | 0.247 | 0.243 | 6.8e-14 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.062 | 0.076 | 0.448 | 1e-13 |
| TAIR|locus:2020220 AT1G04210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2917 (1031.9 bits), Expect = 5.7e-304, P = 5.7e-304
Identities = 592/1084 (54%), Positives = 747/1084 (68%)
Query: 50 GKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE 109
G+ ++F L+++ D+SV+GLY ++NV NLIPKS+G +LR LKFF NEI+LFP E
Sbjct: 43 GQNLEFSLLDNV-----DDSVKGLYFFRNVFNLIPKSIGGLGRLRKLKFFSNEIDLFPPE 97
Query: 110 VGNLLGLECLQIKISSPGV-NGFAXXXXXXXXXXXXXXVPPRPSVLTLLSEIAGLKCLTK 168
+GNL+ LE LQ+KISSPG +G + VP R S LTLLSEI+GLKCLT+
Sbjct: 98 LGNLVNLEYLQVKISSPGFGDGLSWDKLKGLKELELTKVPKRSSALTLLSEISGLKCLTR 157
Query: 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
LSVCHFSIRYLPPEIGCL +LE LDLSFNK+K LP EI YL +L LKVA+N+L+EL
Sbjct: 158 LSVCHFSIRYLPPEIGCLKSLEYLDLSFNKIKSLPNEIGYLSSLTFLKVAHNRLMELSPV 217
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDXXXXXXXXXXXXXXXXXXSYCQVPSWICCNLEGNGK 288
L LLQ LE+LD+SNNRLT+L LD SYC +P+WI CN EGN +
Sbjct: 218 LALLQNLESLDVSNNRLTTLHPLDLNLMPRLQILNLRYNKLPSYCWIPTWIQCNFEGNYE 277
Query: 289 DSSNDDFISSSAEMDVYEGPMLENDGNVXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKQW 348
+ D SS EMDV+E P N V K+W
Sbjct: 278 EMGVDTCSSSMVEMDVFETPYENNVITVPHKGSHRNPLNMSTGISSISRCFSARKSSKRW 337
Query: 349 KR--HHLQQRARQERLNNSRKWRGEGHAQTSMKEGQRYKSGNLDALASETPSEEASDIIG 406
KR ++ QQRARQERLNNSRKW+GE + + + ++G + + D
Sbjct: 338 KRRQYYFQQRARQERLNNSRKWKGEVPPEGLSLKMEVEETGKQGMKVPQNTDRGSVDNSC 397
Query: 407 LDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKEGNDECSKHDSS 466
D++DK L EA + + E+++ + +N C + T + N E + +S
Sbjct: 398 SDENDK--LFEEAS----VITSEEEESSLKADVVSDNSQCVETQLTSERDNYESCEIKTS 451
Query: 467 SLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKSRKSMGENSNASQKYSSVS 526
S S+ + D SSSE K K+KR S++ LDNPK K K + +N S+KYSS S
Sbjct: 452 SPSSGDAPGTVDYNSSSERKKPNNKSKRCSEKYLDNPKGSKCHKLSTDITNLSRKYSSNS 511
Query: 527 FCSIEDRLPDGFYDAGRDRPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSAQALV 586
FCS ED LPDGF+DAGRDRPFM L+ YE+ LDSREVIL+DR DE LDAI LSA+ALV
Sbjct: 512 FCSTEDSLPDGFFDAGRDRPFMTLSKYEKVLPLDSREVILLDRAKDEVLDAITLSARALV 571
Query: 587 LHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPF 646
LK+LN LT D +DNLQ+A LALFVSDHFGGSDR+ I+ERTRK VSG+NY+KPF
Sbjct: 572 ARLKKLNCLTPDVDQVSIDNLQVASFLALFVSDHFGGSDRTAIIERTRKAVSGTNYQKPF 631
Query: 647 VCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRH 706
+CTC TGN D KQ+ ED +LSD+CEKSLRSIKSKRNS+VVP+G +QFG+CRH
Sbjct: 632 ICTCLTGNQDDLAALNKQVSTTAEDAILSDVCEKSLRSIKSKRNSIVVPLGKLQFGICRH 691
Query: 707 RAVLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEA 766
RA+L+KYLCDR+EPPVPCELVRGYLDF PHAWN + VK+G SW+RM+VDACRPHDIRE+
Sbjct: 692 RALLMKYLCDRMEPPVPCELVRGYLDFMPHAWNIVPVKQGSSWVRMVVDACRPHDIREDT 751
Query: 767 DPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSA 826
D EYF RYIPL R ES L+PG S S + + +SSL RCK GS
Sbjct: 752 DQEYFCRYIPLNRL-----NESIRIK-EKLEPGCSVSSLSTGKGVERANSSLIRCKLGST 805
Query: 827 DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 886
+A K+RTL+V G+S D+IR FEY+CLGEVR+LGAL+H CIVE+YGH+ISSKW+ S +GN
Sbjct: 806 EAVVKMRTLEVSGASLDDIRTFEYTCLGEVRILGALKHDCIVELYGHEISSKWITSENGN 865
Query: 887 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 946
EH +LQS+I ME++KGGS+K +IEKLSE G+ HV + LAL IA+D++ AL+ELHSK I+
Sbjct: 866 -EHRVLQSSILMEHIKGGSLKGHIEKLSEAGKHHVPMDLALSIARDISGALMELHSKDII 924
Query: 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1006
HRDIKSEN+LIDL+ + A+G+P+VKLCDFDRAVPLRS LH CCIAH GIP P++CVGTPR
Sbjct: 925 HRDIKSENVLIDLDNQSANGEPIVKLCDFDRAVPLRSHLHGCCIAHVGIPPPNICVGTPR 984
Query: 1007 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 1066
WM+PEV RAMH+ N YGLEVDIWS+GCL+ ELLTLQ PY LSEL+IH+ +Q GKRP+L
Sbjct: 985 WMSPEVFRAMHEQNFYGLEVDIWSFGCLIFELLTLQNPYFDLSELQIHESLQNGKRPKLP 1044
Query: 1067 DELEALGSCHEHEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
+LE L S E E + + F+ E++L+T+ FL+DVF +CTEE+P++R AGDL+EM
Sbjct: 1045 KKLETLISETEEEESTNKLSEVFDLTESDLDTMRFLIDVFHQCTEESPSDRLNAGDLHEM 1104
Query: 1125 FVAR 1128
++R
Sbjct: 1105 ILSR 1108
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 127 (49.8 bits), Expect = 7.1e-19, Sum P(5) = 7.1e-19
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 684 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 741
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y A N+I
Sbjct: 282 SLKATLRSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSDDVAMNSI 339
Query: 742 LVKKGDSWI 750
G +I
Sbjct: 340 KTDDGREYI 348
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 5.2e-18, Sum P(4) = 5.2e-18
Identities = 29/69 (42%), Positives = 41/69 (59%)
Query: 684 SIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTI 741
S+K+ S+V+P+GS+ G+ RHRA+L K LCD V VPC +V+G Y + A N I
Sbjct: 306 SLKATLGSMVLPLGSLTIGLARHRALLFKVLCDSVG--VPCRIVKGQQYTGSEDVAMNFI 363
Query: 742 LVKKGDSWI 750
G +I
Sbjct: 364 KADDGREYI 372
|
|
| DICTYBASE|DDB_G0278509 DDB_G0278509 "MLK family protein kinase DDB_G0278509" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 163 (62.4 bits), Expect = 7.3e-15, Sum P(5) = 7.3e-15
Identities = 38/89 (42%), Positives = 55/89 (61%)
Query: 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
+A L L KL++ + I+ LP I LS+L +L+ S N ++ LP ICYL L L + N
Sbjct: 614 VASLSRLAKLTISNNKIKQLPFAINNLSSLIELNASNNVIELLPDSICYLSNLKKLNLNN 673
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSL 248
N L ELPS + L +L +L L NN+++SL
Sbjct: 674 NNLKELPSNIGFLTKLVDLQLYNNQISSL 702
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 123 (48.4 bits), Expect = 1.1e-14, Sum P(4) = 1.1e-14
Identities = 33/103 (32%), Positives = 56/103 (54%)
Query: 969 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028
VVK+CDF L H ++ + GTP WMAPEVLR ++P + D+
Sbjct: 745 VVKVCDFG----LSRMKHHTYLSSKST------AGTPEWMAPEVLR--NEPA--NEKCDV 790
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELE 1070
+S+G +L EL T +VP+ GL+ +++ + +R + D+++
Sbjct: 791 YSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDID 833
|
|
| DICTYBASE|DDB_G0269250 pats1 "LRRK family protein kinase Pats1" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 168 (64.2 bits), Expect = 2.3e-14, Sum P(2) = 2.3e-14
Identities = 55/184 (29%), Positives = 85/184 (46%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEK-LRNLKFFGNEINLFPSEVG---NLLGLECLQIKIS 124
S+ L L N L +P + K L+ L N + P +G NL+ L+ ++ +S
Sbjct: 1467 SLTELNLSSNQLIDLPIEFSMFSKSLKKLHLKNNRFSAIPEVLGMLENLIELDLSELDLS 1526
Query: 125 SPGVNGFAXXXXXXXXXXXXXXVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
S +G + ++ L E LK L KL + S+ LP
Sbjct: 1527 SSTNSGVGIPTKLSKLCILNLN---QTRIVELPKEFGDLKSLEKLYLDFNSLVTLPHSFR 1583
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+NLE+L LSFN M LP E+C+L L L + N++ LP+ + L +L L++ N+
Sbjct: 1584 QLTNLEELSLSFNSMTELPREVCFLINLKKLMIEGNQIQFLPNEISQLSKLMILNVCKNK 1643
Query: 245 LTSL 248
L SL
Sbjct: 1644 LDSL 1647
|
|
| DICTYBASE|DDB_G0279417 roco6 "LRRK family protein kinase Roco6" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 172 (65.6 bits), Expect = 2.8e-14, Sum P(3) = 2.8e-14
Identities = 56/187 (29%), Positives = 94/187 (50%)
Query: 898 MEYVKGGSVKNYIEKLSETGEK-HVSVKLALFIAQDVAAALVELHS--KHIMHRDIKSEN 954
MEY+ G + ++ S G++ + + L L +A D+A + LHS ++HRD+KS N
Sbjct: 1429 MEYIDCGDLHKFLH--SPIGDQLNGNWALILKLALDIAKGMEFLHSVTPPLLHRDLKSPN 1486
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
+L+ ++ DG K+ DF + R F+ R P VG W+APE+LR
Sbjct: 1487 VLLSMK----DGVYTAKVGDF--GLSSRMFIQALKHKLRNFP-----VGNITWVAPEILR 1535
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPY--MGLSELEIH-DLIQMGKRPRLTDELEA 1071
Y ++ D++++G +L ELLT + PY S + + D I+ G RP ++
Sbjct: 1536 EEE----YTVKSDVYAFGLILHELLTRKHPYREFNYSMVSLQEDAIKNGLRPTISPSYTQ 1591
Query: 1072 LGSCHEH 1078
+ HE+
Sbjct: 1592 TVTGHEY 1598
|
|
| DICTYBASE|DDB_G0286127 roco8 "LRRK family protein kinase Roco8" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 154 (59.3 bits), Expect = 3.2e-14, Sum P(3) = 3.2e-14
Identities = 55/187 (29%), Positives = 89/187 (47%)
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--KHIMHRDIKS 952
AI MEY+ GS+ ++++K E G+ + ++ L I D+A+ + LH+ ++HRD+KS
Sbjct: 1666 AIVMEYMDIGSLSSFLKKKKEDGQV-LDWQMLLKIVTDIASGMAFLHNITPPLVHRDLKS 1724
Query: 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1012
NIL+ + K+ DF + RS + V P W +PEV
Sbjct: 1725 PNILL-ASHPTNPNEISAKVSDFGLS---RSIVQNFS---------SKVVDNPTWQSPEV 1771
Query: 1013 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY-----MGLSELEIHDLIQMGKRPRLTD 1067
L+ M Y + DI+S+G +L E L++P+ +S LE D I G RP +
Sbjct: 1772 LKGME----YNEKSDIYSFGMILWECYHLELPFDEFDFKFMSTLE--DNILSGLRPSINQ 1825
Query: 1068 ELEALGS 1074
+ S
Sbjct: 1826 NCNRMYS 1832
|
|
| TAIR|locus:2076416 AT3G58640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 111 (44.1 bits), Expect = 6.8e-14, Sum P(4) = 6.8e-14
Identities = 54/222 (24%), Positives = 94/222 (42%)
Query: 643 RKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFG 702
+K + +G + T K+I V D+ + +S +S N + +G ++ G
Sbjct: 126 QKQLITKLVSGLNSKPATIIKKIAGLVADVYKQSTLQSPAKSTQSFENCGIQLLGQIKHG 185
Query: 703 VCRHRAVLLKYLCD------RVEPPVPCELVRGYLDFQPHAWNTILVKKGDSWIRMIVDA 756
CR RA+L K L D R+ +P + +D H T+L+ + M+VD
Sbjct: 186 SCRPRAILFKVLADTVGLQSRLVVGLPSDGAAESVDSYSHISVTVLLNS----VEMLVDL 241
Query: 757 CR-PHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPC-SGLDPGS----FPSLSSCDEA 810
R P + + F+ +I + A S +++ C S L+P S +P + A
Sbjct: 242 MRFPGQLIPLSTKAIFMSHI----SAAGESDSAENDSCDSPLEPNSPMFGYPEKFDHENA 297
Query: 811 GKSVSSSLFRCKFGSADAAAKV-RTLKVCGSSADEIRNFEYS 851
K + SL R GS + + R + + +SA E R +S
Sbjct: 298 EKDENLSLHRKLDGSPNTSGPPSRNMLLRSASALE-RKLSFS 338
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 126 (49.4 bits), Expect = 1.0e-13, Sum P(3) = 1.0e-13
Identities = 35/78 (44%), Positives = 45/78 (57%)
Query: 668 AVED--IVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCE 725
+ ED IVL+ EKS K+ N+ V PIG V+ G+ RHRA+L K L D V +PC
Sbjct: 233 SAEDSSIVLARWTEKS-SEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVR--LPCR 289
Query: 726 LVRG--YLDFQPHAWNTI 741
LV+G Y + A NTI
Sbjct: 290 LVKGSHYTGNEDDAVNTI 307
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1137 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-21 | |
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 1e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 8e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 83/282 (29%), Positives = 117/282 (41%), Gaps = 71/282 (25%)
Query: 843 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 902
+I+ L E+++L L+H IV +Y E L + MEY +
Sbjct: 35 KKIKKDRERILREIKILKKLKHPNIVRLYDV-----------FEDEDKLY---LVMEYCE 80
Query: 903 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962
GG + + ++K +S A F + + +AL LHSK I+HRD+K ENIL+
Sbjct: 81 GGDLFDLLKK-----RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILL----- 130
Query: 963 KADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1020
D VKL DF R + L T GTP +MAPEVL
Sbjct: 131 --DEDGHVKLADFGLARQLDPGEKLTTFV-------------GTPEYMAPEVLLGKG--- 172
Query: 1021 LYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHE 1079
YG VDIWS G +L ELLT + P+ G +L E+ I K P E +
Sbjct: 173 -YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI-------- 223
Query: 1080 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
PEA D+ R+ ++P +R TA +
Sbjct: 224 ---------SPEA--------KDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 60/281 (21%)
Query: 843 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 902
E + + E+R+L L H IV + A + +H + MEY +
Sbjct: 36 SEKSKKDQTARREIRILRRLSHPNIVRLID----------AFEDKDH----LYLVMEYCE 81
Query: 903 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962
GG + +Y+ + +S A IA + L LHS I+HRD+K ENIL+
Sbjct: 82 GGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILL----- 131
Query: 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022
D VVK+ DF A + + VGTP +MAPEVL N Y
Sbjct: 132 --DENGVVKIADFGLA----------KKLLKSSSSLTTFVGTPWYMAPEVLL---GGNGY 176
Query: 1023 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1082
G +VD+WS G +L ELLT + P+ G + L+ LI+ P L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL----------------- 219
Query: 1083 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
+ E + ++C ++P++RPTA ++ +
Sbjct: 220 EFDEPKWSSGSEEAKDLI----KKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 65/230 (28%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 811 GKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 868
G+ +++ + A K+ + S +E+ E+ +L L H IV
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLR-------EIEILKKLNHPNIV 54
Query: 869 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 928
++YG L + MEY +GGS+K+ +++ E +S L
Sbjct: 55 KLYGVFEDENHL--------------YLVMEYCEGGSLKDLLKEN----EGKLSEDEILR 96
Query: 929 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 988
I + L LHS I+HRD+K ENIL+D VKL DF + L S
Sbjct: 97 ILLQILEGLEYLHSNGIIHRDLKPENILLD------SDNGKVKLADFGLSKLLTSDKSLL 150
Query: 989 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038
VGTP +MAPEVL Y + DIWS G +L EL
Sbjct: 151 K----------TIVGTPAYMAPEVLLGKGY---YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 92/297 (30%), Positives = 131/297 (44%), Gaps = 79/297 (26%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+++++ G S +E+ + E+R+L +L+H IV YG + ++ L
Sbjct: 30 VKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYYGSERD---------EEKNTL 76
Query: 892 LQSAIFMEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948
IF+EYV GGS+ + ++K L E + + + L LHS I+HR
Sbjct: 77 N---IFLEYVSGGSLSSLLKKFGKLPEPVIRKY--------TRQILEGLAYLHSNGIVHR 125
Query: 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1008
DIK NIL+D +DG VVKL DF A L GTP WM
Sbjct: 126 DIKGANILVD-----SDG--VVKLADFGCAKRLGDIETGEGTGSV--------RGTPYWM 170
Query: 1009 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLT 1066
APEV+R YG DIWS GC ++E+ T GK P L
Sbjct: 171 APEVIRGE----EYGRAADIWSLGCTVIEMAT-------------------GKPPWSELG 207
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTAGDL 1121
+ + AL +++ SG E PE L E FL R+C +P +RPTA +L
Sbjct: 208 NPMAAL-----YKIGSSGEPPEIPE-HLSEEAKDFL----RKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 85/306 (27%), Positives = 126/306 (41%), Gaps = 81/306 (26%)
Query: 820 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 877
R K + A KV L+ I E+++L +H IV+ YG K
Sbjct: 20 RHKRTGKEVAIKVIKLESKEKKEKIIN--------EIQILKKCKHPNIVKYYGSYLKKDE 71
Query: 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAA 936
W I ME+ GGS+K+ ++ ++T E ++ ++ +++
Sbjct: 72 LW----------------IVMEFCSGGSLKDLLKSTNQTLTESQIA-----YVCKELLKG 110
Query: 937 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 996
L LHS I+HRDIK+ NIL+ +DG+ VKL DF + L
Sbjct: 111 LEYLHSNGIIHRDIKAANILL-----TSDGE--VKLIDFGLSAQLSD-----------TK 152
Query: 997 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1056
A + VGTP WMAPEV+ Y + DIWS G +EL + PY SEL
Sbjct: 153 ARNTMVGTPYWMAPEVINGKP----YDYKADIWSLGITAIELAEGKPPY---SELPPMKA 205
Query: 1057 IQMGKRPRLTDELEALGSCHEHEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENPTER 1115
+ +A +G G P E + F D ++C ++NP +R
Sbjct: 206 LFK--------------------IATNGPPGLRNP--EKWSDEF-KDFLKKCLQKNPEKR 242
Query: 1116 PTAGDL 1121
PTA L
Sbjct: 243 PTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TLK +S +I F L E R++ L H IV++ G + ++ E +
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNIVKLLG--VCTE--------EEPLM 77
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ MEY+ GG + +Y L + K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMPGGDLLDY---LRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLA 130
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1009
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 131 ARNCLVGENL-------VVKISDFGLSRDLYDDDYYKV---KGGKLPI--------RWMA 172
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 173 PESLKE----GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR------ 222
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L +C L + +C E+P +RPT +L E+
Sbjct: 223 LPKPPNCPPE---------------------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 9e-32
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 75/297 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TLK +S +I F L E R++ L H +V++ G + ++ E
Sbjct: 33 VKTLKE-DASEQQIEEF----LREARIMRKLDHPNVVKLLG--VCTE--------EEPLY 77
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ MEY++GG + +Y+ K +S+ L A +A + L SK+ +HRD+
Sbjct: 78 IV----MEYMEGGDLLSYLRKN----RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLA 129
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1009
+ N L+ VVK+ DF R + + +P RWMA
Sbjct: 130 ARNCLV-------GENLVVKISDFGLSRDLYDDDYYRK---RGGKLPI--------RWMA 171
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ + ++ G R
Sbjct: 172 PESLKEGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR------ 221
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L +C L D+ +C E+P +RPT +L E+
Sbjct: 222 LPQPPNCPPE---------------------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 74/297 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TLK G+S +E F L E ++ L H IV + G + ++ L
Sbjct: 33 VKTLK-EGASEEEREEF----LEEASIMKKLSHPNIVRLLG--VCTQ---------GEPL 76
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY+ GG + +++ K E +++K L +A +A + L SK+ +HRD+
Sbjct: 77 Y---IVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLESKNFVHRDLA 129
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1009
+ N L+ VVK+ DF R + + G P +WMA
Sbjct: 130 ARNCLV-------TENLVVKISDFGLSRDIYEDDYYR----KRGGGKLP------IKWMA 172
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE L+ + + D+WS+G LL E+ TL + PY G+S E+ +L++ G R
Sbjct: 173 PESLKDGK----FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR------ 222
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L +C + L ++ +C +P +RPT +L E
Sbjct: 223 LPRPENCPDE---------------------LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 67/286 (23%)
Query: 839 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 898
S E + L EV++L L H I++ Y L I M
Sbjct: 37 NMSEKERED----ALNEVKILKKLNHPNIIKYYESFEEKG-----------KLC---IVM 78
Query: 899 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958
EY GG + I+K + G K + L + AL LHS+ I+HRDIK +NI +
Sbjct: 79 EYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137
Query: 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1018
++G +VKL DF + + T +A VGTP +++PE+ + +K
Sbjct: 138 -----SNG--LVKLGDFGIS---KVLSSTVDLAK-------TVVGTPYYLSPELCQ--NK 178
Query: 1019 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1078
P Y + DIWS GC+L EL TL+ P+ G + LE+ I G+ P +
Sbjct: 179 P--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI------------- 223
Query: 1079 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
P L LV +++P ERP+ + +
Sbjct: 224 -----------PSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 78/274 (28%), Positives = 115/274 (41%), Gaps = 74/274 (27%)
Query: 854 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 913
E+ +L L+H IV+ G + L IF+E V GGS+ ++K
Sbjct: 51 QEIALLSKLQHPNIVQYLGTEREEDNL--------------YIFLELVPGGSLAKLLKKY 96
Query: 914 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 973
E + L+ Q + L LH ++ +HRDIK NIL+D +G VVKL
Sbjct: 97 GSFPEPVIR----LYTRQ-ILLGLEYLHDRNTVHRDIKGANILVD-----TNG--VVKLA 144
Query: 974 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033
DF A + F G+P WMAPEV+ + YGL DIWS GC
Sbjct: 145 DFGMAKQVVEFSFA-----------KSFKGSPYWMAPEVIA---QQGGYGLAADIWSLGC 190
Query: 1034 LLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1089
+LE+ T + P+ S+LE + + + + P + D L
Sbjct: 191 TVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHLS------------------- 228
Query: 1090 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
EA+ D +C + +P+ RPTA +L E
Sbjct: 229 DEAK--------DFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 70/299 (23%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TLK +S +E ++F L E R++ L H +V + G + ++ E L
Sbjct: 28 VKTLK-EDASEEERKDF----LKEARVMKKLGHPNVVRLLG--VCTE---------EEPL 71
Query: 892 LQSAIFMEYVKGGSVKNYIEK----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947
+ +EY++GG + +Y+ K + +S+K L A +A + L SK +H
Sbjct: 72 Y---LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVH 128
Query: 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
RD+ + N L+ VVK+ DF + + + +P RW
Sbjct: 129 RDLAARNCLV-------GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI--------RW 173
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1066
MAPE L K ++ + D+WS+G LL E+ TL PY GLS E+ + ++ G R
Sbjct: 174 MAPESL----KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL--- 226
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
KPE + L ++ C + +P +RPT +L E
Sbjct: 227 ---------------------PKPEYCPDELY---ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-28
Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 88/281 (31%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGS----V 906
+ E+ ++ +H IV+ Y + +L+ ++ MEY+ GGS +
Sbjct: 63 INEILIMKDCKHPNIVDYY----------------DSYLVGDELWVVMEYMDGGSLTDII 106
Query: 907 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 966
+++E ++ ++ ++V L LHS++++HRDIKS+NIL+ DG
Sbjct: 107 TQNFVRMNEP---QIA-----YVCREVLQGLEYLHSQNVIHRDIKSDNILLSK-----DG 153
Query: 967 KPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1020
VKL DF + R+ + VGTP WMAPEV++
Sbjct: 154 --SVKLADFGFAAQLTKEKSKRNSV----------------VGTPYWMAPEVIKR----K 191
Query: 1021 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV 1080
YG +VDIWS G + +E+ + PY+ L LI P L +
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP------------ 239
Query: 1081 AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
EK E FL +C ++P +RP+A +L
Sbjct: 240 -------EKWSPEF--KDFL----NKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 69/211 (32%), Positives = 92/211 (43%), Gaps = 52/211 (24%)
Query: 851 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 910
S + E+ +L L+H IV+ G +S L I +EY + GS++ I
Sbjct: 45 SIMQEIDLLKNLKHPNIVKYIGSIETSDSL--------------YIILEYAENGSLRQII 90
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
+K E V+V ++ Q V L LH + ++HRDIK+ NIL DG VV
Sbjct: 91 KKFGPFPESLVAV----YVYQ-VLQGLAYLHEQGVIHRDIKAANILT-----TKDG--VV 138
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 1028
KL DF A L VGTP WMAPEV+ + G DI
Sbjct: 139 KLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVI------EMSGASTASDI 182
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
WS GC ++ELLT PY +DL M
Sbjct: 183 WSLGCTVIELLTGNPPY--------YDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 59/164 (35%), Positives = 81/164 (49%), Gaps = 26/164 (15%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+EY GG + +++ K E S + A F A ++ AL LHS I++RD+K ENIL+
Sbjct: 72 LEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL 126
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D ADG +KL DF A L S + GTP ++APEVL +
Sbjct: 127 D-----ADGH--IKLTDFGLAKELSSEGSRT----------NTFCGTPEYLAPEVL--LG 167
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
K YG VD WS G LL E+LT + P+ EI++ I
Sbjct: 168 KG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP 209
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 81/269 (30%), Positives = 120/269 (44%), Gaps = 59/269 (21%)
Query: 854 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 913
E+++L L+H +V+ YG E H + IFMEY GG+ +E+L
Sbjct: 48 DEMKVLELLKHPNLVKYYG--------------VEVHREKVYIFMEYCSGGT----LEEL 89
Query: 914 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 973
E G + ++ Q + L LHS I+HRDIK NI +D +G V+KL
Sbjct: 90 LEHGRILDEHVIRVYTLQ-LLEGLAYLHSHGIVHRDIKPANIFLD-----HNG--VIKLG 141
Query: 974 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033
DF AV L++ +T + GTP +MAPEV+ K +G DIWS GC
Sbjct: 142 DFGCAVKLKN--NTTTMGEEV----QSLAGTPAYMAPEVITG-GKGKGHGRAADIWSLGC 194
Query: 1034 LLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
++LE+ T + P+ L +E +I + G +P + D L+
Sbjct: 195 VVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK---------------- 238
Query: 1093 ELETLSFLVDVFRRCTEENPTERPTAGDL 1121
D RC E +P +RPTA +L
Sbjct: 239 ---------DFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 69/271 (25%)
Query: 854 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 912
E+++L L+H IV+ YG + E +IFMEY+ GGSVK+ ++
Sbjct: 53 CEIQLLKNLQHERIVQYYG----------CLRDDET----LSIFMEYMPGGSVKDQLKAY 98
Query: 913 --LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
L+ET V+ K I + V LHS I+HRDIK NIL D V
Sbjct: 99 GALTET----VTRKYTRQILEGVEY----LHSNMIVHRDIKGANILRDSAGN-------V 143
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1030
KL DF + L T C + G+ + GTP WM+PEV+ YG + D+WS
Sbjct: 144 KLGDFGAS----KRLQTICSSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADVWS 192
Query: 1031 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 1090
GC ++E+LT + P+ + + ++ +P P
Sbjct: 193 VGCTVVEMLTEKPPWAEFEAMAA--IFKIATQP------------------------TNP 226
Query: 1091 EAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
+ + RR EN +RP+A +L
Sbjct: 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 78/269 (28%), Positives = 110/269 (40%), Gaps = 71/269 (26%)
Query: 855 EVRMLGALRHSCIVEMYGH--KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
E++ L R I + YG K S W I MEY GGS + + K
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLW----------------IIMEYCGGGSCLDLL-K 91
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ E +++ FI ++V L LH + +HRDIK+ NIL+ +G VKL
Sbjct: 92 PGKLDETYIA-----FILREVLLGLEYLHEEGKIHRDIKAANILLS-----EEGD--VKL 139
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF + L S ++ R + VGTP WMAPEV+ K + Y + DIWS G
Sbjct: 140 ADFGVSGQLTS-----TMSKR-----NTFVGTPFWMAPEVI----KQSGYDEKADIWSLG 185
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
+EL + P L + + LI P L G+ F KP
Sbjct: 186 ITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE-----------------GNKFSKP-- 226
Query: 1093 ELETLSFLVDVFRRCTEENPTERPTAGDL 1121
D C ++P ERP+A +L
Sbjct: 227 -------FKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 66/219 (30%), Positives = 93/219 (42%), Gaps = 45/219 (20%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV +L L+H IV Y I + + L I MEY +GG + I+K
Sbjct: 49 EVNILRELKHPNIVRYYDRII----------DRSNQTLY--IVMEYCEGGDLAQLIQKCK 96
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENILIDLERKKADGKPV 969
+ + + + I + AL E H ++HRD+K NI +D
Sbjct: 97 KERKY-IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-------ANNN 148
Query: 970 VKLCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1026
VKL DF A L SF T VGTP +M+PE L M Y +
Sbjct: 149 VKLGDFGLAKILGHDSSFAKTY-------------VGTPYYMSPEQLNHMS----YDEKS 191
Query: 1027 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1065
DIWS GCL+ EL L P+ ++L++ I+ GK R+
Sbjct: 192 DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 76/293 (25%), Positives = 108/293 (36%), Gaps = 43/293 (14%)
Query: 846 RNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 904
L E+++L +L H IV++Y + MEYV GG
Sbjct: 38 SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--------------SLYLVMEYVDGG 83
Query: 905 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964
S+++ ++K+ G +S ALFI + +AL LHSK I+HRDIK ENIL+D + +
Sbjct: 84 SLEDLLKKIGRKGP--LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV- 140
Query: 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1024
VKL DF L L P VGTP +MAPEVL +
Sbjct: 141 -----VKLIDF----GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY-ASS 190
Query: 1025 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1084
DIWS G L ELLT P+ G T L
Sbjct: 191 SSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL--------------- 235
Query: 1085 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSRS 1137
+ P D+ ++ ++P R ++ + S
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
|
Length = 384 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 71/229 (31%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I MEY +GGSV+ + K EK++SV I ++V AL +H ++HRDIK+ NI
Sbjct: 79 IIMEYAEGGSVRT-LMKAGPIAEKYISV-----IIREVLVALKYIHKVGVIHRDIKAANI 132
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+ VKLCDF A L VGTP WMAPEV+
Sbjct: 133 LVTNTGN-------VKLCDFGVAALLNQ----------NSSKRSTFVGTPYWMAPEVIT- 174
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1075
+ Y + DIWS G + E+ T PY + LI K PRL D
Sbjct: 175 --EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN------- 225
Query: 1076 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
G+ K L + C +E P ER +A +L +
Sbjct: 226 ----------GYSK---------LLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 43/210 (20%)
Query: 852 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 911
L E R+L ++RH +V +YG L +L+ MEYV GG + +++
Sbjct: 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNL---------YLV-----MEYVPGGELFSHLR 93
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
K E A F A V AL LHS I++RD+K EN+L+D +DG +K
Sbjct: 94 KSGRFPEPV-----ARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD-----SDGY--IK 141
Query: 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
+ DF A ++ +T C GTP ++APE++ K YG VD W+
Sbjct: 142 ITDFGFAKRVKGRTYTLC-------------GTPEYLAPEIIL--SKG--YGKAVDWWAL 184
Query: 1032 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
G L+ E+L P+ + ++I++ I GK
Sbjct: 185 GILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 76/272 (27%), Positives = 107/272 (39%), Gaps = 67/272 (24%)
Query: 854 GEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 913
E+ ML RH IV +G + L I MEY GGS+++ +
Sbjct: 49 QEISMLKECRHPNIVAYFGSYLRRDKL--------------WIVMEYCGGGSLQDIYQVT 94
Query: 914 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 973
+S ++ ++ L LH +HRDIK NIL+ DG VKL
Sbjct: 95 RG----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL-----TEDGD--VKLA 143
Query: 974 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033
DF + L T IA R +GTP WMAPEV A+ + Y + DIW+ G
Sbjct: 144 DFGVSAQL-----TATIAKR-----KSFIGTPYWMAPEVA-AVERKGGYDGKCDIWALGI 192
Query: 1034 LLLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEHEVAQSGSGFEK 1089
+EL LQ P L + L + K P+L D+
Sbjct: 193 TAIELAELQPPMFDLHPMRA--LFLISKSNFPPPKLKDK--------------------- 229
Query: 1090 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
E + F D ++C ++P +RPTA L
Sbjct: 230 ---EKWSPVF-HDFIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 76/269 (28%), Positives = 118/269 (43%), Gaps = 70/269 (26%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 912
EV ++ +H IVEMY +L+ ++ ME+++GG++ + +
Sbjct: 66 EVVIMRDYQHPNIVEMYSS----------------YLVGDELWVVMEFLEGGALTDIVTH 109
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
E+ +V LA V AL LH++ ++HRDIKS++IL+ +DG VKL
Sbjct: 110 TRMNEEQIATVCLA------VLKALSFLHAQGVIHRDIKSDSILL-----TSDG--RVKL 156
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF F C + +P VGTP WMAPEV+ P YG EVDIWS G
Sbjct: 157 SDF-------GF---CAQVSKEVPRRKSLVGTPYWMAPEVIS--RLP--YGTEVDIWSLG 202
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
+++E++ + PY L+ I+ P+L + H+V+ F
Sbjct: 203 IMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK---------NLHKVSPRLRSF----- 248
Query: 1093 ELETLSFLVDVFRRCTEENPTERPTAGDL 1121
R +P +R TA +L
Sbjct: 249 -----------LDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 75/302 (24%), Positives = 113/302 (37%), Gaps = 70/302 (23%)
Query: 828 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 886
A K+ + + +EI+ E +L H I YG I N
Sbjct: 34 VAIKI--MDIIEDEEEEIKE-------EYNILRKYSNHPNIATFYGAFIKK--------N 76
Query: 887 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHS 942
P + Q + ME GGSV + ++ L + G E+ ++ +I ++ L LH
Sbjct: 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-----YILRETLRGLAYLHE 131
Query: 943 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV 1002
++HRDIK +NIL+ K A+ VKL DF + L S L + +
Sbjct: 132 NKVIHRDIKGQNILLT---KNAE----VKLVDFGVSAQLDSTLG----------RRNTFI 174
Query: 1003 GTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
GTP WMAPEV+ +P+ Y D+WS G +EL + P + + I
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234
Query: 1062 RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
P L E + F D C +N +RP +L
Sbjct: 235 PPTLK------------------------SPENWSKKF-NDFISECLIKNYEQRPFMEEL 269
Query: 1122 YE 1123
E
Sbjct: 270 LE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 69/255 (27%), Positives = 93/255 (36%), Gaps = 75/255 (29%)
Query: 516 SNASQKYSSVSFCSIEDRLPDGFYD---------AGRDRPFMQLTGYEQTPHLD-SREVI 565
S +Y S +D++PDGFYD L + P D S EV+
Sbjct: 5 EALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSSFEVV 64
Query: 566 LVDRKSDEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSD 625
LVDR++D +L + A+ LV + + LA VSDH GG
Sbjct: 65 LVDRRTDPKLKELEQLARCLVSGC-------------GTNTAALVQKLAGLVSDHMGGP- 110
Query: 626 RSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSDLCEKSLRSI 685
V + S L S
Sbjct: 111 -----------VKDAE---------------------------------SMLARWKECSN 126
Query: 686 KSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRG--YLDFQPHAWNTILV 743
+ K NS VVP+GS++ G+CRHRA+L K L D + +PC LV+G Y A N LV
Sbjct: 127 ELKENSGVVPLGSLKIGLCRHRALLFKVLADSIG--LPCRLVKGCKYCGSDDDASN--LV 182
Query: 744 KKGDSWIRMIVDACR 758
K D +VD
Sbjct: 183 KFDDG-REYLVDLMG 196
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 82/308 (26%), Positives = 136/308 (44%), Gaps = 74/308 (24%)
Query: 828 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSK-WLPSADG 885
AAAK+ ++ S +E+ +F + E+ +L +H IV +Y + +K W
Sbjct: 33 AAAKIIQIE----SEEELEDF----MVEIDILSECKHPNIVGLYEAYFYENKLW------ 78
Query: 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 945
I +E+ GG++ + + +L E+ ++ ++ + + AL LHS +
Sbjct: 79 ----------ILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKV 124
Query: 946 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1005
+HRD+K+ NIL+ L+ VKL DF + +S L D +GTP
Sbjct: 125 IHRDLKAGNILLTLDGD-------VKLADFGVSAKNKSTLQK----------RDTFIGTP 167
Query: 1006 RWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1064
WMAPEV+ K N Y + DIWS G L+EL ++ P+ L+ + + I + P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT 227
Query: 1065 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
L Q S + SF D + C ++P +RPTA +L +
Sbjct: 228 L---------------DQP-SKWSS--------SF-NDFLKSCLVKDPDDRPTAAELLKH 262
Query: 1125 -FVARTSS 1131
FV+ S
Sbjct: 263 PFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 26/171 (15%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+EY G + YI K + K F A ++ AL LHSK I+HRD+K ENIL+
Sbjct: 81 LEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL 135
Query: 958 DLERKKADGKPVVKLCDFDRA-------VPLRSFLHTCCIAHRGIPAPDVC---VGTPRW 1007
D D +K+ DF A P + I + VGT +
Sbjct: 136 D-----KDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY 188
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1058
++PE+L KP G D+W+ GC++ ++LT + P+ G +E I
Sbjct: 189 VSPELLN--EKP--AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 3e-20
Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 57/217 (26%)
Query: 851 SCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSV 906
+ L E+ +L L+H IV++ H +L +F + +
Sbjct: 44 TALREISLLKELKHPNIVKLLDVIHTERKLYL---------------VFEYCDM----DL 84
Query: 907 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 966
K Y++K +S L I + L HS I+HRD+K +NILI +
Sbjct: 85 KKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI-------NR 133
Query: 967 KPVVKLCDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022
V+KL DF RA +PLR++ H V T + APE+L Y
Sbjct: 134 DGVLKLADFGLARAFGIPLRTYTHE--------------VVTLWYRAPEILLGSKH---Y 176
Query: 1023 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
VDIWS GC+ E++T + + G S EI L ++
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDS--EIDQLFKI 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 77/285 (27%), Positives = 117/285 (41%), Gaps = 90/285 (31%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ L L H IV+ G E +IF+EYV GGS+ + +
Sbjct: 58 EIETLKDLDHLNIVQYLGF--------------ETTEEYLSIFLEYVPGGSIGSCLRTYG 103
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E+ V F + V L LHSK I+HRD+K++N+L+D ADG + K+ D
Sbjct: 104 RFEEQLVR-----FFTEQVLEGLAYLHSKGILHRDLKADNLLVD-----ADG--ICKISD 151
Query: 975 F------------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022
F D+ + ++ G+ WMAPEV+ + + Y
Sbjct: 152 FGISKKSDDIYDNDQNMSMQ--------------------GSVFWMAPEVIHSYSQG--Y 189
Query: 1023 GLEVDIWSYGCLLLELLTLQVPYMGLSELE-IHDLIQMG---KRPRLTDELEALGSCHEH 1078
+VDIWS GC++LE+ + P+ S+ E I + ++G P + ++ S
Sbjct: 190 SAKVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFKLGNKRSAPPIPPDVSMNLS---- 242
Query: 1079 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
P A L FL C NP RPTA +L +
Sbjct: 243 -----------PVA----LDFL----NACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 76/321 (23%), Positives = 125/321 (38%), Gaps = 69/321 (21%)
Query: 808 DEAGKSVSSSLFR--CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS 865
+ G ++ ++ C + A K L+ C +S DE+R EV+ + H
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK-------EVQAMSQCNHP 59
Query: 866 CIVEMYGHKI--SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-KLSETGEKHVS 922
+V+ Y + W + M Y+ GGS+ + ++ G
Sbjct: 60 NVVKYYTSFVVGDELW----------------LVMPYLSGGSLLDIMKSSYPRGGLDEAI 103
Query: 923 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 982
+ + ++V L LHS +HRDIK+ NIL+ DG VK+ DF +
Sbjct: 104 IA---TVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-----EDGS--VKIADFGVSA--- 150
Query: 983 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042
S + VGTP WMAPEV M + + Y + DIWS+G +EL T
Sbjct: 151 SLADGGDRTRK---VRKTFVGTPCWMAPEV---MEQVHGYDFKADIWSFGITAIELATGA 204
Query: 1043 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 1102
PY +++ L P L + + F K ++
Sbjct: 205 APYSKYPPMKVLMLTLQNDPPSLE---------TGADYKKYSKSFRK----------MIS 245
Query: 1103 VFRRCTEENPTERPTAGDLYE 1123
C +++P++RPTA +L +
Sbjct: 246 ---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 75/278 (26%), Positives = 122/278 (43%), Gaps = 67/278 (24%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV ++ +H +VEMY + + L + ME+++GG++ + + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEEL--------------WVLMEFLQGGALTDIVSQTR 113
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E+ +V + V AL LHS+ ++HRDIKS++IL+ L DG+ VKL D
Sbjct: 114 LNEEQIATV------CESVLQALCYLHSQGVIHRDIKSDSILLTL-----DGR--VKLSD 160
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F C + +P VGTP WMAPEV+ YG EVDIWS G +
Sbjct: 161 FG----------FCAQISKDVPKRKSLVGTPYWMAPEVI----SRTPYGTEVDIWSLGIM 206
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
++E++ + PY S ++ ++ P+L + H+++
Sbjct: 207 VIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---------AHKIS------------- 244
Query: 1095 ETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 1131
L D R P ER TA +L + F+ +T
Sbjct: 245 ---PVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 68/268 (25%), Positives = 104/268 (38%), Gaps = 66/268 (24%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ +L IV+ YG + L I MEY GSV + ++ +
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNT-----------DLW---IVMEYCGAGSVSDIMKITN 93
Query: 915 ET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 973
+T E+ ++ I L LHS +HRDIK+ NIL++ +G KL
Sbjct: 94 KTLTEEEIAA-----ILYQTLKGLEYLHSNKKIHRDIKAGNILLN-----EEG--QAKLA 141
Query: 974 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033
DF + L + A R +GTP WMAPEV+ + Y + DIWS G
Sbjct: 142 DFGVSGQLTDTM-----AKRN-----TVIGTPFWMAPEVI----QEIGYNNKADIWSLGI 187
Query: 1034 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1093
+E+ + PY +IH + + P + PE
Sbjct: 188 TAIEMAEGKPPYS-----DIHPMRAIFMIPN-----------------KPPPTLSDPE-- 223
Query: 1094 LETLSFLVDVFRRCTEENPTERPTAGDL 1121
+ D ++C ++P ERP+A L
Sbjct: 224 -KWSPEFNDFVKKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 46/234 (19%)
Query: 838 CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF 897
++ E+ E C E+++L LRH IV+ YG +PE L +IF
Sbjct: 41 SQETSKEVNALE--C--EIQLLKNLRHDRIVQYYG----------CLRDPEEKKL--SIF 84
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+EY+ GGS+K+ ++ E V+ + I Q V+ LHS I+HRDIK NIL
Sbjct: 85 VEYMPGGSIKDQLKAYGALTEN-VTRRYTRQILQGVSY----LHSNMIVHRDIKGANIL- 138
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D VKL DF + + T C++ GI + GTP WM+PEV+
Sbjct: 139 ------RDSAGNVKLGDFGAS----KRIQTICMSGTGIKS---VTGTPYWMSPEVISG-- 183
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE----IHDLIQMGKRPRLTD 1067
YG + D+WS C ++E+LT + P+ +E E I + +P L D
Sbjct: 184 --EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 58/290 (20%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ + +++ E + E+R++ L H I+ M G A H
Sbjct: 30 VKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG----------ATCEDSHF- 78
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+F+E++ GGSV + + K E V + + + L LH I+HRD+K
Sbjct: 79 ---NLFVEWMAGGSVSHLLSKYGAFKEA-VIINYTEQLLR----GLSYLHENQIIHRDVK 130
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
N+LID + G+ +++ DF A L + T +G +GT +MAPE
Sbjct: 131 GANLLID-----STGQ-RLRIADFGAAARLAAKG-TGAGEFQG-----QLLGTIAFMAPE 178
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 1071
VLR YG D+WS GC+++E+ T K P ++
Sbjct: 179 VLRGEQ----YGRSCDVWSVGCVIIEMAT-------------------AKPPWNAEKH-- 213
Query: 1072 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
S H + + S P L DV RC E P +RP + +L
Sbjct: 214 --SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 61/207 (29%), Positives = 88/207 (42%), Gaps = 37/207 (17%)
Query: 852 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 911
CL E+ +L L H +++ I + L I +E G + I+
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNEL--------------NIVLELADAGDLSRMIK 94
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
+ + + Q + +AL +HSK IMHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPERTIWKYFVQ-LCSALEHMHSKRIMHRDIKPANVFIT-----ATG--VVK 146
Query: 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
L D R F AH VGTP +M+PE + N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPERIHE----NGYNFKSDIWSL 192
Query: 1032 GCLLLELLTLQVPYMGLSELEIHDLIQ 1058
GCLL E+ LQ P+ G ++ ++ L +
Sbjct: 193 GCLLYEMAALQSPFYG-DKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 71/227 (31%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 828 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887
A +V V SS D R+ + E+ +L L+H IV+ G + + L
Sbjct: 29 AVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL------- 81
Query: 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947
IF+EYV GGSV + E V F+ Q + L LH++ I+H
Sbjct: 82 -------NIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQ-ILKGLNYLHNRGIIH 129
Query: 948 RDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1005
RDIK NIL+D K +K+ DF + + S L T R P + G+
Sbjct: 130 RDIKGANILVD-------NKGGIKISDFGISKKLEANS-LSTKTNGAR----PSL-QGSV 176
Query: 1006 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1052
WMAPEV+ K Y + DIWS GCL++E+LT + P+ ++L+
Sbjct: 177 FWMAPEVV----KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 65/191 (34%), Positives = 93/191 (48%), Gaps = 35/191 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+++L L H IV+ YG E L +IFME++ GGS+K+ ++
Sbjct: 54 EIQLLKNLLHERIVQYYG---------CLRDPMERTL---SIFMEHMPGGSIKDQLKSYG 101
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E V+ K I + V+ LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTEN-VTRKYTRQILEGVSY----LHSNMIVHRDIKGANIL-------RDSVGNVKLGD 149
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F + L T C++ G+ + GTP WM+PEV+ YG + DIWS GC
Sbjct: 150 FGAS----KRLQTICLSGTGMKS---VTGTPYWMSPEVISG----EGYGRKADIWSVGCT 198
Query: 1035 LLELLTLQVPY 1045
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 65/191 (34%), Positives = 92/191 (48%), Gaps = 35/191 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+++L L+H IV+ YG E L IFMEY+ GGSVK+ ++
Sbjct: 54 EIQLLKNLQHERIVQYYG---------CLRDRAEKTL---TIFMEYMPGGSVKDQLKAYG 101
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E V+ K + + + LHS I+HRDIK NIL D VKL D
Sbjct: 102 ALTES-VTRKYT----RQILEGMSYLHSNMIVHRDIKGANIL-------RDSAGNVKLGD 149
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F + L T C++ GI + GTP WM+PEV+ YG + D+WS GC
Sbjct: 150 FGAS----KRLQTICMSGTGIRS---VTGTPYWMSPEVISG----EGYGRKADVWSLGCT 198
Query: 1035 LLELLTLQVPY 1045
++E+LT + P+
Sbjct: 199 VVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 66/267 (24%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV ++ +H +VEMY + L + ME+++GG++ + +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDEL--------------WVVMEFLEGGALTDIVTHTR 112
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E+ +V LA V AL LH++ ++HRDIKS++IL+ DG+ VKL D
Sbjct: 113 MNEEQIAAVCLA------VLKALSVLHAQGVIHRDIKSDSILL-----THDGR--VKLSD 159
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F C + +P VGTP WMAPE++ + YG EVDIWS G +
Sbjct: 160 FG----------FCAQVSKEVPRRKSLVGTPYWMAPELISRLP----YGPEVDIWSLGIM 205
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
++E++ + PY L+ +I+ P+L + H+V+ S GF
Sbjct: 206 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN---------LHKVSPSLKGF------- 249
Query: 1095 ETLSFLVDVFRRCTEENPTERPTAGDL 1121
R +P +R TA +L
Sbjct: 250 ---------LDRLLVRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 57/168 (33%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ MEY+ GG + + +E + E ++IA+ + AL LHS I+HRD+K +NI
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVA----RIYIAE-IVLALEYLHSNGIIHRDLKPDNI 124
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSF-LHTCCIAHRGIPAPDV-CVGTPRWMAPEVL 1013
LID ++G +KL DF L L I D VGTP ++APEV+
Sbjct: 125 LID-----SNGH--LKLTDFG----LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
+ VD WS GC+L E L P+ G + EI I GK
Sbjct: 174 LGQG----HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-18
Identities = 55/172 (31%), Positives = 89/172 (51%), Gaps = 27/172 (15%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ ME+++GG++ + + E+ +V L+ V AL LH++ ++HRDIKS++I
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLS------VLRALSYLHNQGVIHRDIKSDSI 149
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+ +DG+ +KL DF C + +P VGTP WMAPEV+
Sbjct: 150 LL-----TSDGR--IKLSDFG----------FCAQVSKEVPKRKSLVGTPYWMAPEVISR 192
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1067
+ YG EVDIWS G +++E++ + PY L+ I+ PR+ D
Sbjct: 193 LP----YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 78/293 (26%), Positives = 125/293 (42%), Gaps = 55/293 (18%)
Query: 841 SADEIRNFEYSCLGEVRMLGALRHSCIVEMY-GHKISSKWLPSADGNPEHHLLQSAIFME 899
++++ + L EV++L LRH IV + + + +L+ E
Sbjct: 39 DDEDVKK---TALREVKVLRQLRHENIVNLKEAFRRKGRL----------YLV-----FE 80
Query: 900 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959
YV ++ +E S G +V+ ++ + A+ HS +I+HRDIK ENIL+
Sbjct: 81 YV-ERTLLELLEA-SPGGLPPDAVRSYIW---QLLQAIAYCHSHNIIHRDIKPENILVSE 135
Query: 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHK 1018
V+KLCDF A LR+ R V T RW APE+L
Sbjct: 136 SG-------VLKLCDFGFARALRA---------RPASPLTDYVAT-RWYRAPELLV---G 175
Query: 1019 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1078
YG VD+W+ GC++ ELL + + G S+++ LIQ P L + L S +
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP-LPPSHQELFSSNPR 234
Query: 1079 -------EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
E +Q S + ++ S +D + C +P ER T +L +
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVS--SPALDFLKACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 67/276 (24%)
Query: 850 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 909
L E+ +L L+H I+ Y H + L I MEY GG
Sbjct: 44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTL--------------LIEMEYANGG---TL 86
Query: 910 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 969
+K+ + ++ L+ + +A+ +H I+HRDIK+ NI + KA +
Sbjct: 87 YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAG---L 139
Query: 970 VKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028
+KL DF + L S + + VGTP +M+PE+ + + Y + DI
Sbjct: 140 IKLGDFGISKILGSEYSMA-----------ETVVGTPYYMSPELCQGVK----YNFKSDI 184
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1088
W+ GC+L ELLTL+ + + L + I G + V+ S
Sbjct: 185 WALGCVLYELLTLKRTFDATNPLNLVVKIVQGN--------------YTPVVSVYSSE-- 228
Query: 1089 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
L+ + +++P +RPTA ++ +
Sbjct: 229 -----------LISLVHSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 59/184 (32%), Positives = 80/184 (43%), Gaps = 38/184 (20%)
Query: 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947
E HL + MEY+ GG + N + + E+ A F ++ AL +H +H
Sbjct: 73 EEHLY---LVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVHKLGFIH 124
Query: 948 RDIKSENILIDLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPA 997
RDIK +NILID ADG +KL DF DR L + + +
Sbjct: 125 RDIKPDNILID-----ADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 998 PD---------VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1048
D VGTP ++APEVLR YGLE D WS G +L E+L P+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTP----YGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 1049 SELE 1052
+ E
Sbjct: 234 TLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/217 (26%), Positives = 87/217 (40%), Gaps = 45/217 (20%)
Query: 843 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 902
+RN L E R+L L H +V ++ + + E+ L ++ +
Sbjct: 42 GSVRNV----LNERRILQELNHPFLVNLW----------YSFQDEENMYL----VVDLLL 83
Query: 903 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962
GG ++ ++ + + E+ V F ++ AL LHSK I+HRDIK +NIL+D
Sbjct: 84 GGDLRYHLSQKVKFSEEQVK-----FWICEIVLALEYLHSKGIIHRDIKPDNILLD---- 134
Query: 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022
G V + DF+ A GTP +MAPEVL Y
Sbjct: 135 -EQGH--VHITDFNIA----------TKVTPDTLTTSTS-GTPGYMAPEVLCR----QGY 176
Query: 1023 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
+ VD WS G E L + PY G S +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 43/207 (20%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E R+L + H I+ ++ + + L + MEYV GG + +Y+
Sbjct: 51 EKRVLKEVSHPFIIRLF-----------WTEHDQRFLY---MLMEYVPGGELFSYLR--- 93
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
S LF A ++ AL LHSK I++RD+K ENIL+D +G +KL D
Sbjct: 94 --NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD-----KEGH--IKLTD 144
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A LR T C GTP ++APEV+++ + VD W+ G L
Sbjct: 145 FGFAKKLRDRTWTLC-------------GTPEYLAPEVIQSKG----HNKAVDWWALGIL 187
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGK 1061
+ E+L P+ + I++ I GK
Sbjct: 188 IYEMLVGYPPFFDDNPFGIYEKILAGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 32/165 (19%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV GG + +I++ E A F A ++ L LH + I++RD+K +N+L+
Sbjct: 75 MEYVNGGDLMFHIQRSGRFDEPR-----ARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 958 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
D ++G +K+ DF + T C GTP ++APE+L
Sbjct: 130 D-----SEGH--IKIADFGMCKEGILGGVTTSTFC-------------GTPDYIAPEILS 169
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
YG VD W+ G LL E+L Q P+ G E E+ I
Sbjct: 170 YQ----PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 70/283 (24%), Positives = 106/283 (37%), Gaps = 77/283 (27%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 910
L E ++ +L H ++ +YG +L + M E GS+ +
Sbjct: 44 LKEAAIMHSLDHENLIRLYGV-----------------VLTHPLMMVTELAPLGSL---L 83
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
++L + H + A +A + L SK +HRD+ + NIL+ + K V
Sbjct: 84 DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-------V 136
Query: 971 KLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM---HKPNLYGLE 1025
K+ DF RA+P H H +P W APE LR H
Sbjct: 137 KIGDFGLMRALPQNE-DHYVMEEHLKVPFA--------WCAPESLRTRTFSHAS------ 181
Query: 1026 VDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1084
D+W +G L E+ T + P+ GLS +I I E E L
Sbjct: 182 -DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID--------KEGERL------------ 220
Query: 1085 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1127
E+PEA + + +V +C NP +RPT L E
Sbjct: 221 ---ERPEACPQD---IYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 29/162 (17%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEY GG + + E A F V A LH++ I++RD+K EN+L+
Sbjct: 72 MEYCLGGELWTILRDRGLFDEYT-----ARFYIACVVLAFEYLHNRGIIYRDLKPENLLL 126
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D ++G VKL DF A L+S T GTP ++APE++
Sbjct: 127 D-----SNG--YVKLVDFGFAKKLKSGQKTWTF-----------CGTPEYVAPEIILNKG 168
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE--LEIHDLI 1057
Y VD WS G LL ELLT + P+ E +EI++ I
Sbjct: 169 ----YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 54/158 (34%), Positives = 85/158 (53%), Gaps = 30/158 (18%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV GG + +I+++ + E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 1015
D A+G +K+ DF C + G C GTP ++APE++
Sbjct: 135 D-----AEGH--IKIADFGM-----------CKENIFGGKTTRTFC-GTPDYIAPEII-- 173
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 1053
++P YG VD W++G LL E+L Q P+ G E E+
Sbjct: 174 AYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 7e-17
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 42/204 (20%)
Query: 896 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 145
Query: 955 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 1069
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 186 VVTRKA----YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 1070 EA-----LGSCHEHEVAQSGSGFE 1088
A L C E +V + GS E
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 70/238 (29%)
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSE 953
+I +EY+ GGS+ + ++K+ + E ++ +IA+ + L LH+K HI+HRDIK
Sbjct: 75 SIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKRHIIHRDIKPS 129
Query: 954 NILIDLERKKADGKPVVKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1006
N+LI+ K VK+ DF + +F VGT
Sbjct: 130 NLLINS-------KGEVKIADFGISKVLENTLDQCNTF-----------------VGTVT 165
Query: 1007 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL---IQMGKRP 1063
+M+PE ++ Y DIWS G LLE + P++ + +L I G P
Sbjct: 166 YMSPERIQGES----YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP 221
Query: 1064 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
L E E E F+ C +++P +RP+A +L
Sbjct: 222 SLPAE----------------------EFSPEFRDFI----SACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 84/320 (26%), Positives = 127/320 (39%), Gaps = 67/320 (20%)
Query: 808 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYS--CLGEVRMLGALRHS 865
DE G+ V L + +G AA + T R+ Y E+ + L+H
Sbjct: 8 DENGERVV--LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 866 CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKL 925
IV+ G + + IFME V GGS+ + S+ G + +
Sbjct: 66 NIVQYLGSDSENGFF--------------KIFMEQVPGGSLSALLR--SKWGPLKDNEQT 109
Query: 926 ALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 985
+F + + L LH I+HRDIK +N+L++ VVK+ DF
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG------VVKISDFG--------- 154
Query: 986 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
T P + GT ++MAPEV+ P YG DIWS GC ++E+ T + P+
Sbjct: 155 -TSKRLAGINPCTETFTGTLQYMAPEVID--KGPRGYGAPADIWSLGCTIVEMATGKPPF 211
Query: 1046 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL-ETLSFLVDVF 1104
I++G E + A G K E+ E+LS F
Sbjct: 212 -----------IELG----------------EPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 1105 -RRCTEENPTERPTAGDLYE 1123
RC E +P +R +A DL +
Sbjct: 245 ILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 38/215 (17%)
Query: 851 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 910
+ E+R+L ++ H I+ + DGN + I MEY G + I
Sbjct: 45 DAVNEIRILASVNHPNIISYKEAFL--------DGN------KLCIVMEYAPFGDLSKAI 90
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
K + K + + I + L LH + I+HRD+KS NIL+ +V
Sbjct: 91 SKRKKKR-KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL------VAND-LV 142
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1030
K+ D + L+ + I GTP +MAPEV + +P Y + DIWS
Sbjct: 143 KIGDLGISKVLKKNMAKTQI------------GTPHYMAPEVWKG--RP--YSYKSDIWS 186
Query: 1031 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1065
GCLL E+ T P+ S ++ +Q GK P +
Sbjct: 187 LGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 72/235 (30%), Positives = 101/235 (42%), Gaps = 52/235 (22%)
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
I MEY +GGS+ + +K+ + G + + K+ IA+ V L LHS+ I+HRDIK N
Sbjct: 77 GIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013
IL+ K VKLCDF + L S T GT +MAPE
Sbjct: 136 ILLTR-------KGQVKLCDFGVSGELVNSLAGT-------------FTGTSFYMAPE-- 173
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY-----MGLSELEIHDLIQMGKRPRLTDE 1068
R KP Y + D+WS G LLE+ + P+ L +E+ I P L DE
Sbjct: 174 RIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
P ++ D ++C E++PT RPT D+ E
Sbjct: 232 ---------------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 55/174 (31%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV GG + + L E H A F ++ A+ LH +HRD+K EN LI
Sbjct: 80 MEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D A G +KL DF + + ++ ++ VG+P +MAPEVLR
Sbjct: 135 D-----ASGH--IKLTDFGLSKGIVTYANS-------------VVGSPDYMAPEVLRGKG 174
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI----QMGKRPRLTD 1067
Y VD WS GC+L E L P+ G + E + + + +RP D
Sbjct: 175 ----YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 52/227 (22%)
Query: 821 CKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880
C+ + ++ + V + DE + E ++L L H I+E Y + + K L
Sbjct: 19 CRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74
Query: 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-----LSETGEKHVSVKLALFIAQDVAA 935
I MEY GG++ YI+K L E H V++ L
Sbjct: 75 --------------MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL-------- 112
Query: 936 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 995
AL +H+K I+HRD+K++NIL+D + K VVK+ DF + L S
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLD--KHKM----VVKIGDFGISKILSS-----------K 155
Query: 996 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042
VGTP +++PE+ KP Y + DIW+ GC+L EL +L+
Sbjct: 156 SKAYTVVGTPCYISPELCEG--KP--YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-16
Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV GG + I+++ E H A+F A ++A L LHSK I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYQIQQVGRFKEPH-----AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 1015
D E +K+ DF C + G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKENMWDGVTTKTFC-GTPDYIAPEIIA- 174
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
++P YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 175 -YQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 59/235 (25%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 954
I MEY+ GGS ++K+ + + + ++ IA V L LH KH I+HRD+K N
Sbjct: 76 ICMEYMDGGS----LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
IL++ + G+ +KLCDF + L +A VGT +MAPE ++
Sbjct: 132 ILVN-----SRGQ--IKLCDFGVSGQL-----VNSLA-------KTFVGTSSYMAPERIQ 172
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-----LSELEIHDLIQMGKRPRLTDEL 1069
N Y ++ DIWS G L+EL T + PY E+ I PRL
Sbjct: 173 ----GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP--- 225
Query: 1070 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
F D C ++P ERP+ +L E
Sbjct: 226 --------------SGKFSPD---------FQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-16
Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 30/162 (18%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV GG + +I+++ + E A+F A +++ L LH + I++RD+K +N+++
Sbjct: 80 MEYVNGGDLMYHIQQVGKFKEPQ-----AVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRA 1015
D E +K+ DF C H G+ C GTP ++APE++
Sbjct: 135 DSEGH-------IKIADFGM-----------CKEHMVDGVTTRTFC-GTPDYIAPEII-- 173
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
++P YG VD W+YG LL E+L Q P+ G E E+ I
Sbjct: 174 AYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 63/297 (21%)
Query: 824 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883
GS V+TL+ G++ E + F L E ++ H IV++ G
Sbjct: 23 GSGPIRVAVKTLRK-GATDQEKKEF----LKEAHLMSNFNHPNIVKLLG--------VCL 69
Query: 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIE--KLSETGEKHVSVKLALFIAQDVAAALVELH 941
P++ I ME ++GG + +Y+ ++ G +++K L I DVA V L
Sbjct: 70 LNEPQY------IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123
Query: 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1001
H +HRD+ + N L+ K D VVK+ DF A + + +P
Sbjct: 124 QMHFIHRDLAARNCLV--SEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV---- 177
Query: 1002 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMG 1060
RWMAPE L + + D+WS+G L+ E+LTL Q PY L+ E+ + G
Sbjct: 178 ----RWMAPESL----LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229
Query: 1061 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117
R L+ +C + + + C ++P+ERPT
Sbjct: 230 GR------LQKPENCPDK---------------------IYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
L E +L H IV++ G P + I ME V GGS+ ++ K
Sbjct: 40 LQEAEILKQYDHPNIVKLIG--------VCVQKQPIY------IVMELVPGGSLLTFLRK 85
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ ++VK L ++ D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 ----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF + ++T + IP +W APE L Y E D+WSYG
Sbjct: 135 SDFGMSREEEGGIYTVSDGLKQIPI--------KWTAPEALNY----GRYTSESDVWSYG 182
Query: 1033 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDE 1068
LL E +L PY G+S + + I+ G R P+L E
Sbjct: 183 ILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE 222
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 51/245 (20%)
Query: 826 ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK------- 878
AA K+ L++ D I+ GEV+++ RH ++Y K+ SK
Sbjct: 29 EKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLV---RHKSSKQVYAMKLLSKFEMIKRS 85
Query: 879 -----WLPS---ADGNPE-----HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHV 921
W A N E H+ Q + MEY+ GG + N +
Sbjct: 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL------MSNYDI 139
Query: 922 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 981
K A F +V AL +HS +HRD+K +N+L+D G +KL DF
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH--LKLADFG----- 187
Query: 982 RSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
TC G+ D VGTP +++PEVL++ YG E D WS G L E+L
Sbjct: 188 -----TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
Query: 1041 LQVPY 1045
P+
Sbjct: 243 GDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 72/272 (26%), Positives = 104/272 (38%), Gaps = 69/272 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV +L +L+H IV+ G + + +IFME+V GGS+ + + +
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTI--------------SIFMEFVPGGSISSILNRFG 97
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E V K I VA LH+ ++HRDIK N+++ +G ++KL D
Sbjct: 98 PLPEP-VFCKYTKQILDGVAY----LHNNCVVHRDIKGNNVML-----MPNG--IIKLID 145
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
F A L ++ GTP WMAPEV+ YG + DIWS
Sbjct: 146 FGCARRL-------AWVGLHGTHSNMLKSMHGTPYWMAPEVINESG----YGRKSDIWSI 194
Query: 1032 GCLLLELLTLQVPYMGLSELEIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1089
GC + E+ T + P + L I G PRL D A
Sbjct: 195 GCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA---------------- 238
Query: 1090 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
+D C + ERP+A L
Sbjct: 239 -----------IDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEY+ GG + +I+ E A F A ++ L LH K I++RD+K +N+L+
Sbjct: 75 MEYLNGGDLMFHIQSSGRFDEAR-----ARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D DG +K+ DF C G GTP ++APE+L
Sbjct: 130 D-----KDGH--IKIADFG----------MCKENMNGEGKASTFCGTPDYIAPEIL---- 168
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
K Y VD WS+G LL E+L Q P+ G E E+ D I
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 30/162 (18%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
ME+V GG + +I+K E A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 75 MEFVNGGDLMFHIQKSRRFDEAR-----ARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRGIPAPDVCVGTPRWMAPEVLRA 1015
D E KL DF C G C GTP ++APE+L+
Sbjct: 130 DHEGH-------CKLADFGM-----------CKEGIFNGKTTSTFC-GTPDYIAPEILQE 170
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
M LYG VD W+ G LL E+L P+ +E ++ + I
Sbjct: 171 M----LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 73/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ M+ +H IV +G +S + L I MEY GGS+++
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKL--------------WICMEYCGGGSLQDIYHVTG 101
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E ++ ++ ++ L LHSK MHRDIK NIL+ D VKL D
Sbjct: 102 PLSELQIA-----YVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGD----VKLAD 149
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A + T IA R +GTP WMAPEV A+ K Y DIW+ G
Sbjct: 150 FGVAAKI-----TATIAKR-----KSFIGTPYWMAPEV-AAVEKNGGYNQLCDIWAVGIT 198
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 1089
+EL LQ P L + L M K P+L D+ + + H +++ + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256
Query: 1090 PEAE 1093
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 58/277 (20%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ +L L H IV+ G + G L+ MEY+ GS+++Y+++
Sbjct: 56 EIEILRTLDHENIVKYKG-------VCEKPGGRSLRLI-----MEYLPSGSLRDYLQRHR 103
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ +++K L + + + L S+ +HRD+ + NIL++ E VK+ D
Sbjct: 104 D----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL-------VKISD 152
Query: 975 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
F + +P + P W APE LR + + D+WS+G
Sbjct: 153 FGLAKVLPEDKDYYY-VKEPGESPI--------FWYAPECLRT----SKFSSASDVWSFG 199
Query: 1033 CLLLELLTL----QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1088
L EL T Q P + QM +T LE L + G
Sbjct: 200 VTLYELFTYGDPSQSPPAEFLRMIGIAQGQM----IVTRLLELL---------KEGERLP 246
Query: 1089 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+P + + D+ + C E P +RP+ DL +
Sbjct: 247 RPPS---CPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 5e-15
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 49/234 (20%)
Query: 896 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 955 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
IL+ + DG VKL DF + P +S VGTP WMAPE
Sbjct: 147 ILLGM-----DGS--VKLTDFGFCAQITPEQS-------------KRSTMVGTPYWMAPE 186
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 1069
V+ YG +VDIWS G + +E++ + PY+ + L LI P L ++L
Sbjct: 187 VVTR----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 1070 EA-----LGSCHEHEVAQSGSG-------FEKPEAELETLSFLVDVFRRCTEEN 1111
A L C + +V + GS F K L +L+ L+ + T+ N
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 5e-15
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 40/203 (19%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ MEY+ GGS+ + + +ET + + ++ AL LH+ ++HRDIKS+N+
Sbjct: 93 VVMEYLAGGSLTDVV---TETCMDEAQIAA---VCRECLQALEFLHANQVIHRDIKSDNV 146
Query: 956 LIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1012
L+ ++ VKL DF + P +S T VGTP WMAPEV
Sbjct: 147 LLGMDGS-------VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPEV 186
Query: 1013 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE---- 1068
+ YG +VDIWS G + +E++ + PY+ + L LI P L +
Sbjct: 187 VTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 1069 ---LEALGSCHEHEVAQSGSGFE 1088
+ L C E +V + GS E
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-15
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 42/204 (20%)
Query: 896 IFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
+ MEY+ GGS+ + + E + G+ + ++ AL LHS ++HRDIKS+N
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALDFLHSNQVIHRDIKSDN 145
Query: 955 ILIDLERKKADGKPVVKLCDFD---RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
IL+ + DG VKL DF + P +S T VGTP WMAPE
Sbjct: 146 ILLGM-----DGS--VKLTDFGFCAQITPEQSKRST-------------MVGTPYWMAPE 185
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT--DEL 1069
V+ YG +VDIWS G + +E++ + PY+ + L LI P L + L
Sbjct: 186 VVTR----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
Query: 1070 EA-----LGSCHEHEVAQSGSGFE 1088
A L C E +V + GS E
Sbjct: 242 SAVFRDFLNRCLEMDVDRRGSAKE 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-14
Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 59/270 (21%)
Query: 801 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG 860
FP+L K++ + L R K D K+R L++ + ++ GEV+++
Sbjct: 12 FPAL----RKNKNIDNFLNRYK----DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLV- 62
Query: 861 ALRHSCIVEMYGHKISSKW--LPSADGN---PEHHLLQSA-------------------I 896
RH ++Y K+ SK+ + +D E ++ A +
Sbjct: 63 --RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120
Query: 897 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956
MEY+ GG + N + V K A F +V AL +HS +HRD+K +N+L
Sbjct: 121 VMEYMPGGDLVNLMSNYD------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR-GIPAPDVCVGTPRWMAPEVLRA 1015
+D +KL DF TC ++ G+ D VGTP +++PEVL++
Sbjct: 175 LDKSGH-------LKLADFG----------TCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
YG E D WS G L E+L P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 63/311 (20%), Positives = 115/311 (36%), Gaps = 71/311 (22%)
Query: 820 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879
G + ++T+ S E F L E ++ +V + G + S
Sbjct: 29 GVVKGEPETRVAIKTVNENASM-RERIEF----LNEASVMKEFNCHHVVRLLG--VVST- 80
Query: 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-----VSVKLALFIAQDVA 934
G P + + ME + G +K+Y+ E + +++ + +A ++A
Sbjct: 81 -----GQP------TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 935 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 994
+ L +K +HRD+ + N ++ + VK+ DF + +
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDL-------TVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 995 IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEI 1053
+P RWMAPE L K ++ + D+WS+G +L E+ TL + PY GLS E+
Sbjct: 183 LPV--------RWMAPESL----KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230
Query: 1054 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113
+ G L + L+++ R C + NP
Sbjct: 231 LKFVIDGGHLDLPENCP---------------------------DKLLELMRMCWQYNPK 263
Query: 1114 ERPTAGDLYEM 1124
RPT ++
Sbjct: 264 MRPTFLEIVSS 274
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 65/240 (27%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 831 KVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW--LPSADGN-- 886
K+R L++ D ++ GEV+++ RH ++Y K+ SK+ + +D
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLV---RHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 887 -PEHHLLQSA-------------------IFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 926
E ++ A + MEY+ GG + N + V K A
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD------VPEKWA 144
Query: 927 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 986
F +V AL +HS ++HRD+K +N+L+D +KL DF
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-------LKLADFG---------- 187
Query: 987 TCC-IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
TC + G+ D VGTP +++PEVL++ YG E D WS G L E+L P+
Sbjct: 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 26/162 (16%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEY+ GG + +I+ + + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 75 MEYLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL 129
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D + +K+ DF C G GTP ++APE+L
Sbjct: 130 DTDGH-------IKIADFG----------MCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 173 ----YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 41/207 (19%)
Query: 929 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 988
I + L +H HRD+K EN+L+ G VVK+ DF A +RS
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLV-------SGPEVVKIADFGLAREIRS----- 151
Query: 989 CIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
P V T RW APE+L + + Y VDIW+ GC++ EL TL+ + G
Sbjct: 152 ------RPPYTDYVST-RWYRAPEIL--LRSTS-YSSPVDIWALGCIMAELYTLRPLFPG 201
Query: 1048 LSELEIHDLIQ--MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE---LETL----- 1097
SE++ I +G P D E +++A GF P+ L L
Sbjct: 202 SSEIDQLYKICSVLGT-PTKQDWPEG------YKLASK-LGFRFPQFAPTSLHQLIPNAS 253
Query: 1098 SFLVDVFRRCTEENPTERPTAGDLYEM 1124
+D+ + +P +RPTA +
Sbjct: 254 PEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-14
Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 54 DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGN 112
L + ++ L L N + IP +G L+ L N+I PS + N
Sbjct: 102 LNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRN 161
Query: 113 LLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172
L LK L+LS + L ++ L L L +
Sbjct: 162 L-----------------------PNLKNLDLSF----NDLSDLPKLLSNLSNLNNLDLS 194
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLL 232
I LPPEI LS LE+LDLS N + L + + LK L L+++NNKL +LP + L
Sbjct: 195 GNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNL 254
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LE LDLSNN+++S+ S L + NL+ L+L N L +
Sbjct: 255 SNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSN 291
|
Length = 394 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 68/285 (23%)
Query: 855 EVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 911
E+RML LRH +V E++ K + +L+ E+V +V + +E
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRK--KRL----------YLV-----FEFVDH-TVLDDLE 91
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
K G V+ LF + + HS +I+HRDIK ENIL+ VVK
Sbjct: 92 KY-PNGLDESRVRKYLF---QILRGIEFCHSHNIIHRDIKPENILVSQSG-------VVK 140
Query: 972 LCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029
LCDF A L + ++T +A R AP++ VG + YG VDIW
Sbjct: 141 LCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK---------------YGRAVDIW 185
Query: 1030 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--GSGF 1087
+ GCL+ E+LT + + G S++ D + + L L H+ ++ +G
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDI---DQLY-----HIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 1088 EKPEA-ELETL--------SFLVDVFRRCTEENPTERPTAGDLYE 1123
PE E+E L ++D+ ++C +P +RP++ L
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 66/206 (32%), Positives = 92/206 (44%), Gaps = 54/206 (26%)
Query: 936 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 995
L LHS I+HRD+K N+LI +DG V+KL DF A RSF
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA-----SDG--VLKLADFGLA---RSF----------- 152
Query: 996 PAPDVCVGTP----RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLS 1049
+P+ T RW APE+L YG+ VD+WS GC+ ELL L+VP++ G S
Sbjct: 153 GSPNR-KMTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELL-LRVPFLPGDS 207
Query: 1050 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-----SGSGFEK-PEAELETL-----S 1098
+++ Q+GK EALG+ E F+ P L+ +
Sbjct: 208 DID-----QLGKI------FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD 256
Query: 1099 FLVDVFRRCTEENPTERPTAGDLYEM 1124
+D+ +R NP +R TA E
Sbjct: 257 DALDLLQRLLTLNPNKRITARQALEH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 6e-14
Identities = 60/212 (28%), Positives = 86/212 (40%), Gaps = 54/212 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 911
E+++L LRH IV + S + +I+M V Y++
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKG--------------KGSIYM-------VFEYMDHDL 86
Query: 912 -KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
L ++ E + + + L LHS I+HRDIK NILI+ DG V+
Sbjct: 87 TGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN-----NDG--VL 139
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR----WM-APEVLRAMHKPNLYGLE 1025
KL DF A R + T R W PE+L + YG E
Sbjct: 140 KLADFGLA--------------RPYTKRNSADYTNRVITLWYRPPELL--LGATR-YGPE 182
Query: 1026 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
VD+WS GC+L EL + + G +ELE + I
Sbjct: 183 VDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 57/236 (24%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I ME V+GG ++ T + VK + + ++ AA + L SKH +HRD+ + N
Sbjct: 70 IVMELVQGGDFLTFLR----TEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC 125
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+ K V+K+ DF + ++ + IP +W APE L
Sbjct: 126 LV-------TEKNVLKISDFGMSREEEDGVYASTGGMKQIPV--------KWTAPEALNY 170
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1074
Y E D+WS+G LL E +L VPY LS + + I+ G R L
Sbjct: 171 ----GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR------LPCPEL 220
Query: 1075 CHEHEVAQSGSGFEKPEAELETLSFLVDVFR---RCTEENPTERPTAGDLYEMFVA 1127
C + V+R RC E +P +RP+ +++ +
Sbjct: 221 CPD------------------------AVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 73/278 (26%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
L E +++ LRH +V++Y + S + P + I EY+ GS+ ++++
Sbjct: 49 LQEAQIMKKLRHDKLVQLYA--VCS------EEEPIY------IVTEYMSKGSLLDFLK- 93
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
S G+K +L AQ +A + L S++ +HRD+ + NIL+ V K+
Sbjct: 94 -SGEGKKLRLPQLVDMAAQ-IAEGMAYLESRNYIHRDLAARNILV-------GENLVCKI 144
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1029
DF A R A G P +W APE YG ++ D+W
Sbjct: 145 ADFGLA---RLIEDDEYTAREGAKFP------IKWTAPEAA-------NYGRFTIKSDVW 188
Query: 1030 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGF 1087
S+G LL E++T +VPY G++ E+ + ++ G R PR + C
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN-------C------------ 229
Query: 1088 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
PE L D+ +C +++P ERPT L
Sbjct: 230 --PEE-------LYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-14
Identities = 82/311 (26%), Positives = 138/311 (44%), Gaps = 70/311 (22%)
Query: 828 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887
AAAKV K S +E+ ++ + E+ +L H IV++ G + W DG
Sbjct: 40 AAAKVIETK----SEEELEDY----MVEIEILATCNHPYIVKLLG---AFYW----DG-- 82
Query: 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947
+ I +E+ GG+V + +L + G +++ I + + AL LHS I+H
Sbjct: 83 -----KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQV---ICRQMLEALQYLHSMKIIH 133
Query: 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
RD+K+ N+L+ L DG +KL DF V ++ + + D +GTP W
Sbjct: 134 RDLKAGNVLLTL-----DGD--IKLADF--GVSAKNV--------KTLQRRDSFIGTPYW 176
Query: 1008 MAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 1066
MAPEV+ K Y + DIWS G L+E+ ++ P+ L+ + + I + P L+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-F 1125
+ + +E FL + +++P RP+A L E F
Sbjct: 237 ---------------------QPSKWSMEFRDFL----KTALDKHPETRPSAAQLLEHPF 271
Query: 1126 VARTSSSISSR 1136
V+ +S+ R
Sbjct: 272 VSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 35/256 (13%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G +++ + A ++ + V G +EI+ E+ ML H +
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-------EINMLKKYSHHRNIAT 67
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
Y K P D Q + ME+ GSV + I+ T + + +I
Sbjct: 68 YYGAFIKKNPPGMDD-------QLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYIC 117
Query: 931 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 990
+++ L LH ++HRDIK +N+L+ + VKL DF + L
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAE-------VKLVDFGVSAQL--------- 161
Query: 991 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLS 1049
R + + +GTP WMAPEV+ P+ Y + D+WS G +E+ P +
Sbjct: 162 -DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
Query: 1050 ELEIHDLIQMGKRPRL 1065
+ LI PRL
Sbjct: 221 PMRALFLIPRNPAPRL 236
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 23/152 (15%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I MEY GG + I + + G ++ + Q ++ L +H + I+HRDIKS+NI
Sbjct: 76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQ-ISLGLKHIHDRKILHRDIKSQNI 132
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
+ +G V KL DF A R + +A+ CVGTP +++PE+ +
Sbjct: 133 FL-----SKNGM-VAKLGDFGIA---RQLNDSMELAY-------TCVGTPYYLSPEICQ- 175
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
++P Y + DIWS GC+L EL TL+ P+ G
Sbjct: 176 -NRP--YNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 889 HHLLQSAIF----MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 944
H+ Q M+Y GG + + K E + +A F ++ A+ +H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1004
+HRDIK +N+L+D ++L DF + L + G +V VGT
Sbjct: 123 YVHRDIKPDNVLLDKNGH-------IRLADFGSCLRLLA---------DGTVQSNVAVGT 166
Query: 1005 PRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
P +++PE+L+AM YG E D WS G + E+L + P+ S +E + I
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 37/238 (15%)
Query: 830 AKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPE 888
A ++ + V +EI+ E+ ML H I YG I +P
Sbjct: 44 AAIKVMDVTEDEEEEIKL-------EINMLKKYSHHRNIATYYGAFIKK--------SPP 88
Query: 889 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948
H Q + ME+ GSV + ++ K + +I +++ L LH+ ++HR
Sbjct: 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA---YICREILRGLAHLHAHKVIHR 145
Query: 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1008
DIK +N+L+ + A+ VKL DF + L R + + +GTP WM
Sbjct: 146 DIKGQNVLLT---ENAE----VKLVDFGVSAQL----------DRTVGRRNTFIGTPYWM 188
Query: 1009 APEVLRAMHKPN-LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1065
APEV+ P+ Y DIWS G +E+ P + + LI P+L
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 71/244 (29%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ M+ +HS IV +G + L I ME+ GGS+++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKL--------------WICMEFCGGGSLQDIYHVTG 101
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E ++ +++++ L LHSK MHRDIK NIL+ VKL D
Sbjct: 102 PLSESQIA-----YVSRETLQGLYYLHSKGKMHRDIKGANILL-------TDNGHVKLAD 149
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F + + T IA R +GTP WMAPEV A+ + Y DIW+ G
Sbjct: 150 FGVSAQI-----TATIAKR-----KSFIGTPYWMAPEV-AAVERKGGYNQLCDIWAVGIT 198
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKR----PRLTDELEALGSCHEH-EVAQSGSGFEK 1089
+EL LQ P L + L M K P+L D+++ S H ++A + + ++
Sbjct: 199 AIELAELQPPMFDLHPMRA--LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR 256
Query: 1090 PEAE 1093
P AE
Sbjct: 257 PTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 50/231 (21%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 956
ME++ GS+ +K + V++ IA V L L++ H IMHRDIK NIL
Sbjct: 82 MEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136
Query: 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1016
+ + + +KLCDF + L + IA D VGT +M+PE ++
Sbjct: 137 V-------NSRGQIKLCDFGVSGELIN-----SIA-------DTFVGTSTYMSPERIQG- 176
Query: 1017 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1076
K Y ++ D+WS G ++EL + P+ + + MG L+ L
Sbjct: 177 GK---YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-------LDLL---- 222
Query: 1077 EHEVAQSGSGFEKPEAELETLSF---LVDVFRRCTEENPTERPTAGDLYEM 1124
++ Q +P L + F L D C ++PTERPT L M
Sbjct: 223 -QQIVQ------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 35/203 (17%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +NI
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+D+ ++L DF + L G V VGTP +++PE+L+A
Sbjct: 134 LMDMNGH-------IRLADFGSCLKL---------MEDGTVQSSVAVGTPDYISPEILQA 177
Query: 1016 MHK-PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL--------- 1065
M YG E D WS G + E+L + P+ S +E + I M + R
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-MNHKERFQFPAQVTDV 236
Query: 1066 ----TDELEALGSCHEHEVAQSG 1084
D + L EH + Q+G
Sbjct: 237 SEDAKDLIRRLICSREHRLGQNG 259
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 56/231 (24%), Positives = 107/231 (46%), Gaps = 51/231 (22%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I E++ G N ++ L E + V+ + L++A +++A+ L K+ +HRD+ + N
Sbjct: 79 IITEFMTYG---NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+ E +VK+ DF + + +T AH G P +W APE L
Sbjct: 136 LVG-ENH------LVKVADFGLSRLMTGDTYT---AHAGAKFP------IKWTAPESLAY 179
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 1074
N + ++ D+W++G LL E+ T + PY G+ ++++L++ G R
Sbjct: 180 ----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------ 223
Query: 1075 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
E+PE + ++ R C + NP++RP+ ++++ F
Sbjct: 224 ------------MERPEGCPPK---VYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 34/100 (34%), Positives = 45/100 (45%), Gaps = 19/100 (19%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
+H+ IMHRD+K N+LI ADG V+K+ DF A
Sbjct: 115 MHANGIMHRDLKPANLLIS-----ADG--VLKIADFGLARLFSE---------EEPRLYS 158
Query: 1000 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039
V T + APE+L K Y VD+W+ GC+ ELL
Sbjct: 159 HQVATRWYRAPELLYGARK---YDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 59/196 (30%), Positives = 84/196 (42%), Gaps = 36/196 (18%)
Query: 852 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 911
C+ E+ +L L H +++ Y I L I +E G + I+
Sbjct: 49 CIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMIK 94
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
+ + + Q + +AL +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 HFKKQKRLIPEKTVWKYFVQ-LCSALEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 1032 GCLLLELLTLQVPYMG 1047
GCLL E+ LQ P+ G
Sbjct: 193 GCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 67/248 (27%), Positives = 102/248 (41%), Gaps = 52/248 (20%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 954
I ME++ GGS+ ++K E + I+ V L L KH IMHRD+K N
Sbjct: 76 ICMEHMDGGSLDQVLKKAGRIPENILGK-----ISIAVLRGLTYLREKHKIMHRDVKPSN 130
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMA 1009
IL++ + G+ +KLCDF + L SF VGT +M+
Sbjct: 131 ILVN-----SRGE--IKLCDFGVSGQLIDSMANSF-----------------VGTRSYMS 166
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 1069
PE L+ H Y ++ DIWS G L+E+ + P E+ + E
Sbjct: 167 PERLQGTH----YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222
Query: 1070 EALGSCHEHEVAQSGSGFE-------KPEAELETLSF---LVDVFRRCTEENPTERPTAG 1119
S H + + + FE +P +L + +F D +C ++NP ER
Sbjct: 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA--- 279
Query: 1120 DLYEMFVA 1127
DL E+
Sbjct: 280 DLKELTKH 287
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 61/251 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TLK +S D ++FE E +L +H IV+ YG +G+P
Sbjct: 40 VKTLKE-TASNDARKDFER----EAELLTNFQHENIVKFYG--------VCTEGDPPI-- 84
Query: 892 LQSAIFMEYVKGGSVKNYIEK-------LSETGEKHVSVKLA--LFIAQDVAAALVELHS 942
+F EY++ G + ++ L + L+ L IA +A+ +V L S
Sbjct: 85 ---MVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140
Query: 943 KHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1000
+H +HRD+ + N L+ DL VVK+ DF + + + + H +P
Sbjct: 141 QHFVHRDLATRNCLVGYDL---------VVKIGDFGMSRDVYTTDYYRVGGHTMLPI--- 188
Query: 1001 CVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 1056
RWM PE + +Y E D+WS+G +L E+ T + P+ GLS E+ +
Sbjct: 189 -----RWMPPESI-------MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236
Query: 1057 IQMGK---RPR 1064
I G+ RPR
Sbjct: 237 ITQGRLLQRPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 50/163 (30%), Positives = 68/163 (41%), Gaps = 33/163 (20%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEY GG + +I S A+F A V L LH I++RD+K +N+L+
Sbjct: 81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134
Query: 958 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
D E VK+ DF + T C GTP ++APEVL
Sbjct: 135 DTE-------GFVKIADFGLCKEGMGFGDRTSTFC-------------GTPEFLAPEVLT 174
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
Y VD W G L+ E+L + P+ G E E+ D I
Sbjct: 175 ETS----YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 77/287 (26%), Positives = 113/287 (39%), Gaps = 80/287 (27%)
Query: 853 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 910
+ EVR L LRH +E G + + WL MEY G S + +
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWL----------------VMEYCLG-SASDIL 105
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
E + ++ V++A I L LHS +HRDIK+ NIL+ G V
Sbjct: 106 EVHKKPLQE---VEIAA-ICHGALQGLAYLHSHERIHRDIKAGNILL-----TEPG--TV 154
Query: 971 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1027
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 155 KLADFGSASLVSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 196
Query: 1028 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS-G 1086
+WS G +EL + P + + + AL + +AQ+ S
Sbjct: 197 VWSLGITCIELAERKPPLFNM------------------NAMSAL-----YHIAQNDSPT 233
Query: 1087 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSS 1132
+ +F+ C ++ P +RP++ +L + FV R
Sbjct: 234 LSSNDWSDYFRNFV----DSCLQKIPQDRPSSEELLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 47/148 (31%), Positives = 65/148 (43%), Gaps = 30/148 (20%)
Query: 910 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 969
+ KL + ++ + L + L HS I+HRD+K EN+LI +G V
Sbjct: 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI-----NTEG--V 136
Query: 970 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKPNLYGL 1024
+KL DF A RSF V T RW APE+L Y
Sbjct: 137 LKLADFGLA---RSF------------GSPVRPYTHYVVTRWYRAPELLLGD---KGYST 178
Query: 1025 EVDIWSYGCLLLELLTLQVPYMGLSELE 1052
VDIWS GC+ ELL+ + + G SE++
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEID 206
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 61/275 (22%), Positives = 97/275 (35%), Gaps = 75/275 (27%)
Query: 852 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 911
+ E R+L L S I+ Y + L I MEY + G + ++
Sbjct: 46 AIDEARVLAKLDSSYIIRYYESFLDKGKL--------------NIVMEYAENGDLHKLLK 91
Query: 912 K-----LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 966
L E +++ L L LHSK I+HRDIKS N+ +D D
Sbjct: 92 MQRGRPLPEDQVWRFFIQILL--------GLAHLHSKKILHRDIKSLNLFLD----AYDN 139
Query: 967 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1026
VK+ D A L I VGTP +++PE+ KP Y +
Sbjct: 140 ---VKIGDLGVA----KLLSDNTNFANTI------VGTPYYLSPELCE--DKP--YNEKS 182
Query: 1027 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1086
D+W+ G +L E T + P+ ++ + I G P +
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV------------------SQM 224
Query: 1087 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
+ + L + +C ++ +RP L
Sbjct: 225 YSQQ---------LAQLIDQCLTKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 7e-13
Identities = 57/192 (29%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 936 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 995
AL +HS +++HRD+K NIL++ + + VKL DF A RS + +
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCR-------VKLADFGLA---RSL--SELEENPEN 166
Query: 996 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIH 1054
P V T RW APE+L + Y VD+WS GC+L E+L + + G S L
Sbjct: 167 PVLTDYVAT-RWYRAPEILLGSTR---YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL 222
Query: 1055 DLIQMGKRPRLTDE-LEALGSCHEHEV-AQSGSGFEKPEAEL------ETLSFLVDVFRR 1106
+ I + + E +E++ S + S KP EL + L L ++
Sbjct: 223 EKI-IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLL----KK 277
Query: 1107 CTEENPTERPTA 1118
NP +R TA
Sbjct: 278 LLVFNPNKRLTA 289
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 68/240 (28%), Positives = 101/240 (42%), Gaps = 55/240 (22%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I MEY+ GGS + + K E +++ I +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-KPGPLEETYIAT-----ILREILKGLDYLHSERKIHRDIKAANV 132
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+ ++ D VKL DF A L T R + VGTP WMAPEV+
Sbjct: 133 LLS---EQGD----VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI-- 173
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1075
K + Y + DIWS G +EL + P L + + LI P L +
Sbjct: 174 --KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ------- 224
Query: 1076 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 1134
+ KP + C ++P RPTA +L + F+ R + S
Sbjct: 225 -----------YSKP---------FKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ M+Y GG + + K E + +A F ++ A+ +H H +HRDIK +N+
Sbjct: 78 LVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+D+ ++L DF + + G V VGTP +++PE+L+A
Sbjct: 134 LLDMNGH-------IRLADFGSCLKMNQ---------DGTVQSSVAVGTPDYISPEILQA 177
Query: 1016 MHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
M YG E D WS G + E+L + P+ S +E + I
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E +++ L H +V++YG + +K P I EY+ G + NY+ +
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIF------------IVTEYMANGCLLNYLRERK 94
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ L + DV A+ L S +HRD+ + N L+ + VVK+ D
Sbjct: 95 GKLGT----EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-------VVKVSD 143
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A R L + +G P +W PEV + + + + D+WS+G L
Sbjct: 144 FGLA---RYVLDDQYTSSQGTKFP------VKWAPPEVF--DY--SRFSSKSDVWSFGVL 190
Query: 1035 LLELLTL-QVPYMGLSELEIHDLIQMG---KRPRL--TDELEALGSCHEH 1078
+ E+ + ++PY S E+ + + G RP+L T+ + SC
Sbjct: 191 MWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 32/153 (20%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ +EYV GG + ++++ + E+H A F A ++ AL LH + I++RD+K +N+
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYAAEICIALNFLHERGIIYRDLKLDNV 127
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1012
L+D ADG +KL D+ + G+ D GTP ++APE+
Sbjct: 128 LLD-----ADGH--IKLTDYG-------------MCKEGLGPGDTTSTFCGTPNYIAPEI 167
Query: 1013 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
LR YG VD W+ G L+ E++ + P+
Sbjct: 168 LRGEE----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
ME++ GG + +I+ + + A F A ++ L LHSK I++RD+K +N+++
Sbjct: 75 MEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D DG +K+ DF C G GTP ++APE+L+ +
Sbjct: 130 D-----RDGH--IKIADFG----------MCKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
Y VD WS+G LL E+L Q P+ G E E+ + I++
Sbjct: 173 ----YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 81/353 (22%), Positives = 145/353 (41%), Gaps = 107/353 (30%)
Query: 809 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 868
E GK V ++ FR K + V+ LK +S+ E+R+ L E +L + H ++
Sbjct: 12 EFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDL----LSEFNLLKQVNHPHVI 66
Query: 869 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI------------------ 910
++YG S DG + +EY K GS+++++
Sbjct: 67 KLYG-------ACSQDGPL-------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 911 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 969
L E+ +++ + A ++ + L ++HRD+ + N+L+ A+G+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV------AEGR-K 165
Query: 970 VKLCDF--------DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAPEVLRAMHKPN 1020
+K+ DF + + RS +G IP +WMA E L H
Sbjct: 166 MKISDFGLSRDVYEEDSYVKRS---------KGRIPV--------KWMAIESL-FDH--- 204
Query: 1021 LYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 1079
+Y + D+WS+G LL E++TL PY G++ + +L++ G R
Sbjct: 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR----------------- 247
Query: 1080 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEMFVAR 1128
E+PE E + L+ C ++ P +RPT + +L +M V
Sbjct: 248 -------MERPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-12
Identities = 57/174 (32%), Positives = 90/174 (51%), Gaps = 28/174 (16%)
Query: 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 943
D ++L A+ ++Y G ++ I+ ++T + L Q V A+ +HSK
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ-VLLAVHHVHSK 162
Query: 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--- 1000
H++HRDIKS NIL+ ++G +VKL DF + + + T + DV
Sbjct: 163 HMIHRDIKSANILL-----CSNG--LVKLGDFGFS---KMYAATV--------SDDVGRT 204
Query: 1001 -CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEI 1053
C GTP ++APE+ R KP Y + D++S G LL ELLTL+ P+ G + E+
Sbjct: 205 FC-GTPYYVAPEIWR--RKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEV 253
|
Length = 496 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+E+V GG + ++ K +A F ++ A LHSK I++RD+K EN+
Sbjct: 95 FLLEFVVGGELFTHLRKAGRFPND-----VAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149
Query: 956 LIDLERKKADGKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013
L+ D K VK+ DF A VP R+F T C GTP ++APEV+
Sbjct: 150 LL-------DNKGHVKVTDFGFAKKVPDRTF--TLC-------------GTPEYLAPEVI 187
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
++ +G VD W+ G LL E + P+ + I++ I G+
Sbjct: 188 QSKG----HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV GG + I++ + E + F A +V AL+ LH +++RD+K +NIL+
Sbjct: 75 MEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV----GTPRWMAPEVL 1013
D A+G KL DF + GI V GTP ++APE+L
Sbjct: 130 D-----AEGH--CKLADFG-------------MCKEGI-LNGVTTTTFCGTPDYIAPEIL 168
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
+ + YG VD W+ G L+ E++ Q P+ +E ++ + I
Sbjct: 169 QELE----YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 876 SSKWLPSADG--NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 933
+S W+P + +L + MEY GG + + + + + ++ +A F ++
Sbjct: 59 NSPWIPQLQYAFQDKDNLY---LVMEYQPGGDLLSLLNRYEDQFDE----DMAQFYLAEL 111
Query: 934 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR 993
A+ +H +HRDIK EN+LID +KL DF A L +
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGH-------IKLADFGSAARLTANKMV------ 158
Query: 994 GIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
+ VGTP ++APEVL M+ YG+E D WS G + E++ + P+
Sbjct: 159 ---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 59/184 (32%), Positives = 86/184 (46%), Gaps = 37/184 (20%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ +EY+ GG + ++E+ E A F +++ AL LH + I++RD+K ENI
Sbjct: 77 LILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131
Query: 956 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1012
L+D A G VKL DF ++ + HT C GT +MAPE+
Sbjct: 132 LLD-----AQGH--VKLTDFGLCKESIHEGTVTHTFC-------------GTIEYMAPEI 171
Query: 1013 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK---RPRLTDE 1068
L R+ H G VD WS G L+ ++LT P+ + + D I GK P LT E
Sbjct: 172 LMRSGH-----GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPE 226
Query: 1069 LEAL 1072
L
Sbjct: 227 ARDL 230
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 72/287 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TLK + L E +++ LRH ++++Y P +
Sbjct: 35 VKTLKPGTMDPKDF-------LAEAQIMKKLRHPKLIQLYA--------VCTLEEPIY-- 77
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I E +K GS+ Y++ + + + + +A VA+ + L +++ +HRD+
Sbjct: 78 ----IVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+ N+L+ + + K+ DF A R A G P +W APE
Sbjct: 131 ARNVLV------GENN-ICKVADFGLA---RVIKEDIYEAREGAKFP------IKWTAPE 174
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
N + ++ D+WS+G LL E++T ++PY G++ E+ + G R +
Sbjct: 175 AALY----NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------MP 224
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117
C P+ L D+ C +E+P +RPT
Sbjct: 225 CPPGC--------------PKE-------LYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I +E+ GG+V + +L E+ ++ + + AL LH I+HRD+K+ NI
Sbjct: 79 ILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L L DG +KL DF + R I D +GTP WMAPEV+
Sbjct: 135 LFTL-----DGD--IKLADFGVSAK----------NTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 1016 -MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1065
K Y + D+WS G L+E+ ++ P+ L+ + + I + P L
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 55/226 (24%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ EY G + N++ + E+ ++++ L + VA + L SK+ +HRD+ + N+
Sbjct: 116 VITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG---IPAPDVCVGTPRWMAPEV 1012
L+ GK +VK+CDF A R ++ +G +P +WMAPE
Sbjct: 173 LL------THGK-IVKICDFGLA---RDIMNDSNYVVKGNARLPV--------KWMAPES 214
Query: 1013 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEA 1071
+ +Y E D+WSYG LL E+ +L PY G+ D
Sbjct: 215 IFN----CVYTFESDVWSYGILLWEIFSLGSNPYPGM----------------PVDSK-- 252
Query: 1072 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117
+++ + G +PE + D+ + C + +P +RPT
Sbjct: 253 -----FYKLIKEGYRMAQPEHAPAE---IYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 62/274 (22%)
Query: 852 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 911
C+ E+ +L L H ++ K+L S + E + I +E G + I+
Sbjct: 49 CVKEIDLLKQLNHPNVI---------KYLDSFIEDNELN-----IVLELADAGDLSQMIK 94
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
+ + + Q + +A+ +HS+ +MHRDIK N+ I A G VVK
Sbjct: 95 YFKKQKRLIPERTVWKYFVQ-LCSAVEHMHSRRVMHRDIKPANVFI-----TATG--VVK 146
Query: 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
L D R F AH VGTP +M+PE +H+ N Y + DIWS
Sbjct: 147 LGDLGLG---RFFSSKTTAAHS-------LVGTPYYMSPE---RIHE-NGYNFKSDIWSL 192
Query: 1032 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1091
GCLL E+ LQ P+ G D++ C + E + P
Sbjct: 193 GCLLYEMAALQSPFYG-------------------DKMNLFSLCQKIEQC------DYPP 227
Query: 1092 AELETLS-FLVDVFRRCTEENPTERPTAGDLYEM 1124
E S L ++ C +P +RP G ++++
Sbjct: 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 32/151 (21%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+E+V GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEFVSGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNFLHERGIIYRDLKLDNVLL 129
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLR 1014
D A+G +KL D+ + GI D GTP ++APE+LR
Sbjct: 130 D-----AEGH--IKLTDYG-------------MCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
YG VD W+ G L+ E++ + P+
Sbjct: 170 GED----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 71/319 (22%), Positives = 113/319 (35%), Gaps = 82/319 (25%)
Query: 813 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872
SV ++ K G A V+TLK + I + L E ++ L H CIV + G
Sbjct: 10 SVVKGVYLMKSGKEVEVA-VKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIVRLIG 63
Query: 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 932
+ + ME G + Y++K + + V +A
Sbjct: 64 VCKGEPLM---------------LVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQ 103
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCI 990
VA + L SKH +HRD+ + N+L L + K+ DF RA+ S +
Sbjct: 104 VAMGMAYLESKHFVHRDLAARNVL--LVNRHQ-----AKISDFGMSRALGAGSDYYR--- 153
Query: 991 AHRGIPAPDVCVGTPRWMAPEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYM 1046
A P +W APE + + K D+WSYG L E + PY
Sbjct: 154 ATTAGRWP------LKWYAPECINYGKFSSKS-------DVWSYGVTLWEAFSYGAKPYG 200
Query: 1047 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1106
+ E+ +++ G+R L C + + +
Sbjct: 201 EMKGAEVIAMLESGER------LPRPEECPQE---------------------IYSIMLS 233
Query: 1107 CTEENPTERPTAGDLYEMF 1125
C + P +RPT +L F
Sbjct: 234 CWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 67/267 (25%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
L E ++ L+H +V +Y + +K P I EY+ GS+ ++++
Sbjct: 49 LEEANLMKTLQHDKLVRLYA--VVTKEEPIY------------IITEYMAKGSLLDFLK- 93
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
S+ G K + KL F AQ +A + + K+ +HRD+++ N+L+ + K+
Sbjct: 94 -SDEGGKVLLPKLIDFSAQ-IAEGMAYIERKNYIHRDLRAANVLVS-------ESLMCKI 144
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF A + +T A G P +W APE + + ++ D+WS+G
Sbjct: 145 ADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAINF----GSFTIKSDVWSFG 191
Query: 1033 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKP 1090
LL E++T ++PY G+S ++ +Q G R PR+ + C +
Sbjct: 192 ILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN-------CPDE------------ 232
Query: 1091 EAELETLSFLVDVFRRCTEENPTERPT 1117
L D+ + C +E ERPT
Sbjct: 233 ---------LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 51/150 (34%), Positives = 72/150 (48%), Gaps = 23/150 (15%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ ++YV GG + ++ + E V V +A ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-----EIVLALDHLHQLGIIYRDIKLENI 136
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+D ++G V L DF + + FL A A C GT +MAPEV+R
Sbjct: 137 LLD-----SEGH--VVLTDFGLS---KEFL-----AEEEERAYSFC-GTIEYMAPEVIRG 180
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
+ VD WS G L ELLT P+
Sbjct: 181 --GSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 52/228 (22%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 910
E +L L+H IV+ YG DG+P + EY+K G + ++
Sbjct: 57 EAELLTNLQHEHIVKFYG--------VCGDGDP------LIMVFEYMKHGDLNKFLRAHG 102
Query: 911 ---------EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961
+ GE + + L IA +A+ +V L S+H +HRD+ + N L+
Sbjct: 103 PDAMILVDGQPRQAKGE--LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---- 156
Query: 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021
+VK+ DF + + S + H +P RWM PE + M++
Sbjct: 157 ---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI--------RWMPPESI--MYRK-- 201
Query: 1022 YGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK---RPRL 1065
+ E D+WS+G +L E+ T + P+ LS E+ + I G+ RPR+
Sbjct: 202 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 66/269 (24%), Positives = 117/269 (43%), Gaps = 72/269 (26%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
L E ++ L+H +V++ H + +K P + I E++ GS+ ++++
Sbjct: 49 LAEANVMKTLQHDKLVKL--HAVVTK-------EPIY------IITEFMAKGSLLDFLK- 92
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
S+ G K KL F AQ +A + + ++ +HRD+++ NIL+ V K+
Sbjct: 93 -SDEGSKQPLPKLIDFSAQ-IAEGMAFIEQRNYIHRDLRAANILVS-------ASLVCKI 143
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1029
DF A + +T A G P +W APE + +G ++ D+W
Sbjct: 144 ADFGLARVIEDNEYT---AREGAKFP------IKWTAPEAIN-------FGSFTIKSDVW 187
Query: 1030 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1088
S+G LL+E++T ++PY G+S E+ ++ G R + +C E
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE------NCPEE---------- 231
Query: 1089 KPEAELETLSFLVDVFRRCTEENPTERPT 1117
L ++ RC + P ERPT
Sbjct: 232 -----------LYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 64/214 (29%), Positives = 91/214 (42%), Gaps = 51/214 (23%)
Query: 851 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVK---GGS 905
S L E+ +L LRH IVE+ + K L S IF MEY +
Sbjct: 52 SSLREITLLLNLRHPNIVELK-EVVVGKHLDS-------------IFLVMEYCEQDLASL 97
Query: 906 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965
+ N SE+ VK + + L LH I+HRD+K N+L+
Sbjct: 98 LDNMPTPFSES-----QVKC---LMLQLLRGLQYLHENFIIHRDLKVSNLLL-------T 142
Query: 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAMHKPNLYG 1023
K +K+ DF A R++ G+PA + V T + APE+L Y
Sbjct: 143 DKGCLKIADFGLA---RTY---------GLPAKPMTPKVVTLWYRAPELLLGCTT---YT 187
Query: 1024 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
+D+W+ GC+L ELL + G SE+E DLI
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 34/206 (16%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I ME + G++ N+ L G VSV L + DVA + L SK ++HRD+ + NI
Sbjct: 75 IVMELMSKGNLVNF---LRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNI 131
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+ DG V K+ DF +A G D +W APE L
Sbjct: 132 LV-----SEDG--VAKVSDFG-------------LARVGSMGVDNSKLPVKWTAPEAL-- 169
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA--- 1071
K + + D+WSYG LL E+ + + PY +S E+ + ++ G R + A
Sbjct: 170 --KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227
Query: 1072 --LGSCHEHEVAQSGSGFEKPEAELE 1095
+ SC E E + S F K +LE
Sbjct: 228 VLMTSCWETEPKKRPS-FHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 37/191 (19%)
Query: 936 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 995
+L +H I HRDIK ENILI + ++KL DF +C +
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDD--------ILKLADFG----------SCRGIYSKP 153
Query: 996 PAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE-- 1052
P + + T RW APE L YG ++DIW+ GC+ E+L+L + G +EL+
Sbjct: 154 PYTEY-IST-RWYRAPECLLTD---GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208
Query: 1053 --IHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEK--PEAELETLSFLVDVFRRC 1107
IHD+ +G + + + + ++ G+G K P A E L D+ ++
Sbjct: 209 AKIHDV--LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGL----DLLKKL 262
Query: 1108 TEENPTERPTA 1118
+P ER TA
Sbjct: 263 LAYDPDERITA 273
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 51/154 (33%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I MEY GG + ++K+ K L + + +H K ++HRDIKS+NI
Sbjct: 75 IVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
+ +GK VKL DF A L S C VGTP ++ PE+
Sbjct: 132 FL-----TQNGK--VKLGDFGSARLLTSPGAYAC----------TYVGTPYYVPPEIWEN 174
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1049
M Y + DIWS GC+L EL TL+ P+ S
Sbjct: 175 MP----YNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
M + GG +K +I GE A+F A + L LH + I++RD+K EN+L+
Sbjct: 72 MTLMNGGDLKYHI---YNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D G V++ D AV L +G GTP +MAPEVL
Sbjct: 129 D-----DHGN--VRISDLGLAVEL-----------KGGKKIKGRAGTPGYMAPEVL---- 166
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQM 1059
+ +Y VD ++ GC L E++ + P+ E +E +L +
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-12
Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 35/181 (19%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128
Query: 958 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISDGATMKTFC-------------GTPEYLAPEVL- 167
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEA 1071
+ N YG VD W G ++ E++ ++P+ + +LI M + PR L+ E ++
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 224
Query: 1072 L 1072
L
Sbjct: 225 L 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 30/148 (20%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEY+ GG + I+ L E +A +V + +LH + I+HRDIK EN+LI
Sbjct: 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIA-----EVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D G +KL DF ++ G+ VGTP ++APE + +
Sbjct: 131 D-----QTGH--LKLTDFG-------------LSRNGLENKKF-VGTPDYLAPETI--LG 167
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
+ D WS GC++ E L P+
Sbjct: 168 VGDDK--MSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 33/152 (21%)
Query: 906 VKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964
+K +++ +G +K LF + Q +A HS ++HRD+K +N+LI+
Sbjct: 85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC----HSHRVLHRDLKPQNLLIN-----T 135
Query: 965 DGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1020
+G +KL DF A VP+R++ H V T + APE+L
Sbjct: 136 EGA--IKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGC---K 176
Query: 1021 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1052
Y VDIWS GC+ E++T + + G SE++
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 34/164 (20%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
++YV GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL 129
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 1013
D + G V L DF + GI C GTP ++APEVL
Sbjct: 130 D-----SQGH--VVLTDFG-------------LCKEGIEHSKTTSTFC-GTPEYLAPEVL 168
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
R +P Y VD W G +L E+L P+ E++D I
Sbjct: 169 R--KQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 26/148 (17%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 75 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 129
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D E +KL D+ C R GTP ++APE+LR
Sbjct: 130 DSEGH-------IKLTDYG----------MCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
YG VD W+ G L+ E++ + P+
Sbjct: 173 ----YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 74/311 (23%), Positives = 111/311 (35%), Gaps = 94/311 (30%)
Query: 848 FEYSCLGEVRMLGALRHSCIV---EMY--GHKISSKWLPS---------AD-----GNPE 888
F + L E+++L L+H +V +M S + S D NP
Sbjct: 50 FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS 109
Query: 889 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948
L +S I K Y+ +L E G + LH HI+HR
Sbjct: 110 VKLTESQI----------KCYMLQLLE-GINY-------------------LHENHILHR 139
Query: 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----CVG 1003
DIK+ NILI D + ++K+ DF A R + +G V
Sbjct: 140 DIKAANILI-------DNQGILKIADFGLA---RPY-DGPPPNPKGGGGGGTRKYTNLVV 188
Query: 1004 TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR 1062
T RW PE+L + + Y VDIW GC+ E+ T + G S+++ LI
Sbjct: 189 T-RWYRPPELL--LGERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI----- 239
Query: 1063 PRLTDELEALGSCHEHE--VAQSGSGFEKPEAELETLSFLVDVFRRCTEE---------- 1110
+ G+ E +S G E + L + F + E
Sbjct: 240 ------FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293
Query: 1111 -NPTERPTAGD 1120
+P +R TA D
Sbjct: 294 LDPYKRLTASD 304
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 33/161 (20%)
Query: 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 944
+ H+L M+Y+K G + + ++K E +S I + + AL +LH +
Sbjct: 79 TTLKGHVL----IMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1004
I+H DIK EN+L D + + + LCD+ C I P GT
Sbjct: 130 IIHNDIKLENVLYDRAKDR------IYLCDYG----------LCKIIG----TPSCYDGT 169
Query: 1005 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
+ +PE ++ Y + D W+ G L ELLT + P+
Sbjct: 170 LDYFSPEKIK--GHN--YDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 71/242 (29%), Positives = 103/242 (42%), Gaps = 59/242 (24%)
Query: 896 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953
I MEY+ GGS + +E L ET ++A I +++ L LHS+ +HRDIK+
Sbjct: 79 IIMEYLGGGSALDLLEPGPLDET-------QIAT-ILREILKGLDYLHSEKKIHRDIKAA 130
Query: 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013
N+L+ + VKL DF A L T R + VGTP WMAPEV+
Sbjct: 131 NVLLSEHGE-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVI 173
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1073
K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 174 ----KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE------- 222
Query: 1074 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSS 1132
+ KP L + C + P+ RPTA +L + F+ R +
Sbjct: 223 -----------GNYSKP---------LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
Query: 1133 IS 1134
S
Sbjct: 263 TS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 75/274 (27%), Positives = 103/274 (37%), Gaps = 77/274 (28%)
Query: 853 LGEVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 910
+ EV+ L L+H +E G K + WL MEY G +
Sbjct: 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWL----------------VMEYCLGSA----- 107
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
L E +K + I L LHS +++HRDIK+ NIL+ + V
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------V 160
Query: 971 KLCDFDRAV---PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1027
KL DF A P SF VGTP WMAPEV+ AM + Y +VD
Sbjct: 161 KLADFGSASKSSPANSF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVD 202
Query: 1028 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1087
+WS G +EL + P ++ + I P L +E S GF
Sbjct: 203 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL----------QSNEWTDSFRGF 252
Query: 1088 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
VD C ++ P ERP + +L
Sbjct: 253 -------------VDY---CLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 29/178 (16%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEY GG + ++ + E+ S A F ++ +AL LHS +++RD+K EN+++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D DG +K+ DF S G C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGISD---------GATMKTFC-GTPEYLAPEVL---- 167
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEAL 1072
+ N YG VD W G ++ E++ ++P+ ++ +LI M + PR L+ E ++L
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSL 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 58/298 (19%), Positives = 119/298 (39%), Gaps = 68/298 (22%)
Query: 832 VRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEH 889
V+T+K+ + EI F E +C+ + H ++++ G + S+
Sbjct: 32 VKTMKLDIHTYSEIEEFLSEAACMKD------FDHPNVMKLIGVCFEA----SSLQKIPK 81
Query: 890 HLLQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948
+ + + ++K G + +++ + + ++ L D+A + L +++ +HR
Sbjct: 82 PM----VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR 137
Query: 949 DIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1006
D+ + N ++ + V + DF + + + IA +P +
Sbjct: 138 DLAARNCMLREDMT-------VCVADFGLSKKIYSGDYYRQGRIAK--MPV--------K 180
Query: 1007 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1065
W+A E L +Y + D+W++G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 181 WIAIESL----ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--- 233
Query: 1066 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
++PE + L L D+ C +P +RPT L E
Sbjct: 234 ---------------------LKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 39/209 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV+ L LRH ++ + + S G P + I E ++ GS+ + L
Sbjct: 52 EVQALKRLRHKHLISL--FAVCSV------GEPVY------IITELMEKGSLLAF---LR 94
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ + V + +A VA + L ++ +HRD+ + NIL+ + V K+ D
Sbjct: 95 SPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-------VCKVAD 147
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A ++ ++ + + IP +W APE + + D+WS+G L
Sbjct: 148 FGLARLIKEDVYLS--SDKKIPY--------KWTAPEAASHGT----FSTKSDVWSFGIL 193
Query: 1035 LLELLTL-QVPYMGLSELEIHDLIQMGKR 1062
L E+ T QVPY G++ E++D I G R
Sbjct: 194 LYEMFTYGQVPYPGMNNHEVYDQITAGYR 222
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E +++ L H +V++YG + +K P I EY+ G + NY L
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIY------------IVTEYMSNGCLLNY---LR 91
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E G++ +L L + +DV + L SK +HRD+ + N L+D G VK+ D
Sbjct: 92 EHGKRFQPSQL-LEMCKDVCEGMAYLESKQFIHRDLAARNCLVD-----DQG--CVKVSD 143
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F + R L + G P RW PEVL + + D+W++G L
Sbjct: 144 FGLS---RYVLDDEYTSSVGSKFP------VRWSPPEVLLYSK----FSSKSDVWAFGVL 190
Query: 1035 LLELLTL-QVPYMGLSELEIHDLIQMGK---RPRLTDE--LEALGSCHEHEVAQSGSGFE 1088
+ E+ +L ++PY + E + + G RP L E + SC HE A+ F+
Sbjct: 191 MWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW-HEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-11
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 38/209 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ L A H IV+ + D + LL + MEY GG + I++
Sbjct: 115 ELHCLAACDHFGIVKHFD-----------DFKSDDKLL---LIMEYGSGGDLNKQIKQRL 160
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP--VVKL 972
+ ++ L Q + AL E+HS+ +MHRD+KS NI + P ++KL
Sbjct: 161 KEHLPFQEYEVGLLFYQ-IVLALDEVHSRKMMHRDLKSANIFL---------MPTGIIKL 210
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF + + + + + A C GTP ++APE+ Y + D+WS G
Sbjct: 211 GDFGFS---KQYSDSVSLD----VASSFC-GTPYYLAPELWERKR----YSKKADMWSLG 258
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
+L ELLTL P+ G S+ EI + GK
Sbjct: 259 VILYELLTLHRPFKGPSQREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 65/229 (28%), Positives = 97/229 (42%), Gaps = 62/229 (27%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ +++++GG + + K E+ V LA ++A AL LHS I++RD+K ENI
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALDHLHSLGIIYRDLKPENI 129
Query: 956 LIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1012
L+D +G +KL DF ++ ++ C GT +MAPEV
Sbjct: 130 LLD-----EEGH--IKLTDFGLSKESIDHEKKAYSFC-------------GTVEYMAPEV 169
Query: 1013 L-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 1071
+ R H D WS+G L+ E+LT +P+ G E +I K
Sbjct: 170 VNRRGHT-----QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------- 214
Query: 1072 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120
LG F PEA+ S L +F+R NP R AG
Sbjct: 215 LGMPQ----------FLSPEAQ----SLLRALFKR----NPANRLGAGP 245
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 92/301 (30%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ LK ++A + L E ++ LRH +V++ G GNP +
Sbjct: 34 VKCLKDDSTAAQ-------AFLAEASVMTTLRHPNLVQLLG--------VVLQGNPLY-- 76
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY+ GS+ +Y L G +++ L A DV + L K+ +HRD+
Sbjct: 77 ----IVTEYMAKGSLVDY---LRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1005
+ N+L+ + V K+ DF G+ A + G
Sbjct: 130 ARNVLVSEDL-------VAKVSDF------------------GL-AKEASQGQDSGKLPV 163
Query: 1006 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY--MGLSELEIHDLIQMGKR 1062
+W APE LR + + D+WS+G LL E+ + +VPY + L ++ H ++ G R
Sbjct: 164 KWTAPEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH--VEKGYR 217
Query: 1063 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1122
+EA C + V + C E +P +RPT L
Sbjct: 218 ------MEAPEGCPPE---------------------VYKVMKDCWELDPAKRPTFKQLR 250
Query: 1123 E 1123
E
Sbjct: 251 E 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 28/149 (18%)
Query: 896 IFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953
I M+Y +GG + I ++ E + L F+ + AL +H + I+HRDIKS+
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQI---LDWFV--QICLALKHVHDRKILHRDIKSQ 130
Query: 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013
NI + DG +KL DF A L S T +A C+GTP +++PE+
Sbjct: 131 NIFL-----TKDG--TIKLGDFGIARVLNS---TVELAR-------TCIGTPYYLSPEIC 173
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042
++P Y + DIW+ GC+L E+ TL+
Sbjct: 174 E--NRP--YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 47/212 (22%)
Query: 832 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 890
V+TLK CG E+ +L L H IV+ G ++ +
Sbjct: 38 VKTLKRECGQQNTS------GWKKEINILKTLYHENIVKYKG--------CCSEQGGKGL 83
Query: 891 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 950
L MEYV GS+++Y+ K +++ L AQ + + LHS+H +HRD+
Sbjct: 84 QL----IMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYLHSQHYIHRDL 133
Query: 951 KSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1008
+ N+L+D +R +VK+ DF +AVP +R D V W
Sbjct: 134 AARNVLLDNDR-------LVKIGDFGLAKAVP------EGHEYYRVREDGDSPV---FWY 177
Query: 1009 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
A E L K N + D+WS+G L ELLT
Sbjct: 178 AVECL----KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 87/298 (29%), Positives = 123/298 (41%), Gaps = 88/298 (29%)
Query: 853 LGEVRMLGALRHSCIV---EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 909
L E+RML L+H +V E++ K + L HL+ EY +V N
Sbjct: 48 LREIRMLKQLKHPNLVNLIEVFRRK---RKL---------HLV-----FEYCDH-TVLNE 89
Query: 910 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 969
+EK +H+ K+ Q V H + +HRD+K ENILI K
Sbjct: 90 LEKNPRGVPEHLIKKIIWQTLQAVNFC----HKHNCIHRDVKPENILI----TKQG---Q 138
Query: 970 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWM-APEVLRAMHKPNLYGL 1024
+KLCDF A R + P V T RW APE+L + YG
Sbjct: 139 IKLCDFGFA--------------RILTGPGDDYTDYVAT-RWYRAPELLVGDTQ---YGP 180
Query: 1025 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ--MGKR-PRLTDELEALGSCHEHEVA 1081
VD+W+ GC+ ELLT Q + G S+++ LI+ +G PR H+ +
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-----------HQQIFS 229
Query: 1082 QSG--SGFEKPEAE----LE---------TLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
+ G PE E LE LSFL + C + +PTER + +L E
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFL----KGCLQMDPTERLSCEELLEH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 50/234 (21%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV+GG ++ + + V +A + AL LH+ I+HRD+K +N+LI
Sbjct: 80 MEYVEGGDCATLLKNIGA-----LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI 134
Query: 958 DLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPE 1011
+ G +KL DF + + L + L+ I R VC GTP ++APE
Sbjct: 135 -----TSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIAPE 186
Query: 1012 V-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
V LR YG VD W+ G +L E L VP+ G + E+ + ++D++E
Sbjct: 187 VILRQG-----YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-------ISDDIE 234
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
G E A+ + D+ R +NP ER G +E+
Sbjct: 235 WPE------------GDEALPADAQ------DLISRLLRQNPLERLGTGGAFEV 270
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 64/247 (25%), Positives = 93/247 (37%), Gaps = 72/247 (29%)
Query: 896 IFMEYVKGGSVKNYI-------EKLS-----ETGEKHVSVKLALFIAQDVAAALVELHSK 943
+ +EY G++++++ E S E L F Q VA + L SK
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ-VARGMEFLASK 151
Query: 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1003
+HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 152 KCIHRDLAARNVLVTEDH-------VMKIADFGLA--------------RDIHHIDYYRK 190
Query: 1004 TPR------WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDL 1056
T WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L
Sbjct: 191 TTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 1057 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116
++ G R EKP L + R C E P++RP
Sbjct: 247 LKEGYR------------------------MEKP---QNCTQELYHLMRDCWHEVPSQRP 279
Query: 1117 TAGDLYE 1123
T L E
Sbjct: 280 TFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 51/245 (20%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TLK +S + ++F E +L L+H IV+ YG +G+P
Sbjct: 40 VKTLK--DASDNARKDFHR----EAELLTNLQHEHIVKFYG--------VCVEGDP---- 81
Query: 892 LQSAIFMEYVKGGSVKNYIEK------LSETGE--KHVSVKLALFIAQDVAAALVELHSK 943
+ EY+K G + ++ L G ++ L IAQ +AA +V L S+
Sbjct: 82 --LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139
Query: 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1003
H +HRD+ + N L+ +VK+ DF + + S + H +P
Sbjct: 140 HFVHRDLATRNCLV-------GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI------ 186
Query: 1004 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK- 1061
RWM PE + M++ + E D+WS G +L E+ T + P+ LS E+ + I G+
Sbjct: 187 --RWMPPESI--MYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240
Query: 1062 --RPR 1064
RPR
Sbjct: 241 LQRPR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 61/232 (26%), Positives = 87/232 (37%), Gaps = 47/232 (20%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
LKV RN L E +L L H + +Y + +L L+
Sbjct: 31 LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL---------CLV-- 79
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
M+Y GG L K +S ++A F A +V AL LH I++RD+K EN
Sbjct: 80 ---MDYCPGG---ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLH-TCCIAHRGIPAPDV------------- 1000
IL+ G + L DFD + +G V
Sbjct: 134 ILL-----HESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 1001 -----CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
VGT ++APEV+ + +G VD W+ G LL E+L P+ G
Sbjct: 187 FRSNSFVGTEEYIAPEVISG----DGHGSAVDWWTLGILLYEMLYGTTPFKG 234
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 67/249 (26%), Positives = 106/249 (42%), Gaps = 57/249 (22%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ LK SA + +F+ E +L L+H IV YG +G P
Sbjct: 40 VKALKEASESARQ--DFQR----EAELLTVLQHQHIVRFYG--------VCTEGRP---- 81
Query: 892 LQSAIFMEYVKGGSVKNYIE------KLSETGEKHVSVKLAL----FIAQDVAAALVELH 941
+ EY++ G + ++ K+ GE +L L IA +A+ +V L
Sbjct: 82 --LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA 139
Query: 942 SKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
S H +HRD+ + N L+ L VVK+ DF + + S + +P
Sbjct: 140 SLHFVHRDLATRNCLVGQGL---------VVKIGDFGMSRDIYSTDYYRVGGRTMLPI-- 188
Query: 1000 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 1058
RWM PE + +++ + E DIWS+G +L E+ T + P+ LS E + I
Sbjct: 189 ------RWMPPESI--LYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 1059 MGK---RPR 1064
G+ RPR
Sbjct: 239 QGRELERPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 34/172 (19%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV GG + ++ + E+ S F ++ +AL LHS I++RD+K EN+++
Sbjct: 74 MEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128
Query: 958 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 D-----KDGH--IKITDFGLCKEGITDAATMKTFC-------------GTPEYLAPEVL- 167
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG--KRPR 1064
+ N YG VD W G ++ E++ ++P+ ++ +LI M K PR
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR 216
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 74/309 (23%), Positives = 114/309 (36%), Gaps = 83/309 (26%)
Query: 829 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 888
V+TL S DE +F L E ++ H IV + G S + P
Sbjct: 38 QVAVKTLPESCSEQDES-DF----LMEALIMSKFNHQNIVRLIG--------VSFERLPR 84
Query: 889 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIM 946
I +E + GG +K+++ + E+ S+ + LF A+DVA L H +
Sbjct: 85 F------ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI 138
Query: 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-----C 1001
HRDI + N L+ K G+ V K+ DF A R I
Sbjct: 139 HRDIAARNCLLT---CKGPGR-VAKIADFGMA--------------RDIYRASYYRKGGR 180
Query: 1002 VGTP-RWMAPEVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 1056
P +WM PE L G+ + D+WS+G LL E+ +L +PY G + E+ +
Sbjct: 181 AMLPIKWMPPEAF-------LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 1057 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116
+ G R L+ C P + + C + P +RP
Sbjct: 234 VTGGGR------LDPPKGC--------------PGP-------VYRIMTDCWQHTPEDRP 266
Query: 1117 TAGDLYEMF 1125
+ E
Sbjct: 267 NFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 72/271 (26%), Positives = 108/271 (39%), Gaps = 45/271 (16%)
Query: 800 SFPSLSSCDEA----GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGE 855
SFP S E GK +F+ + A V+ L D I + + E
Sbjct: 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-------DPIHDIDEEIEAE 64
Query: 856 VRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
+L AL H +V+ YG K + + D Q + +E GGSV + ++
Sbjct: 65 YNILKALSDHPNVVKFYG-MYYKKDVKNGD--------QLWLVLELCNGGSVTDLVKGFL 115
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ GE+ + + +I + L LH +HRD+K NIL+ E VKL D
Sbjct: 116 KRGER-MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG-------VKLVD 167
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGC 1033
F + L S + VGTP WMAPEV+ + + Y D+WS G
Sbjct: 168 FGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217
Query: 1034 LLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1064
+EL P ++H + + K PR
Sbjct: 218 TAIELGDGDPPLA-----DLHPMRALFKIPR 243
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 9e-11
Identities = 53/226 (23%), Positives = 86/226 (38%), Gaps = 58/226 (25%)
Query: 909 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968
Y+ K + G + + + + + + LHS I+HRD+K +NIL+ + +
Sbjct: 95 YLSKCPKPG---LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ------ 145
Query: 969 VVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022
VK+ DF + L S V T + APEVL + Y
Sbjct: 146 -VKIADFGLARIYSFEMALTS-----------------VVVTLWYRAPEVL--LQSS--Y 183
Query: 1023 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE--- 1079
VD+WS GC+ EL + + G SE + D I + +G E E
Sbjct: 184 ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI-----------FDVIGLPSEEEWPR 232
Query: 1080 -VAQSGSGFE----KPEAEL--ETLSFLVDVFRRCTEENPTERPTA 1118
V+ S F + E +D+ ++ NP +R +A
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 41/115 (35%), Positives = 52/115 (45%), Gaps = 23/115 (20%)
Query: 936 ALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG 994
AL L KH ++HRD+K NIL+D A G VKLCDF I+ R
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLD-----ASG--NVKLCDFG-------------ISGRL 165
Query: 995 IP--APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
+ A G +MAPE + Y + D+WS G L+EL T Q PY
Sbjct: 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 46/198 (23%)
Query: 929 IAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 987
IA + AL LHSK ++HRD+K N+LI+ + VKLCDF + L +
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-------VKLCDFGISGYLVDSV-- 158
Query: 988 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
A + G +MAPE + Y ++ D+WS G ++EL T + PY
Sbjct: 159 ---------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-- 207
Query: 1048 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRR 1106
+ L +V + S P+ E S D +
Sbjct: 208 ---------------DSWKTPFQQL-----KQVVEEPS----PQLPAEKFSPEFQDFVNK 243
Query: 1107 CTEENPTERPTAGDLYEM 1124
C ++N ERP +L +
Sbjct: 244 CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 31/158 (19%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ + + GG +K +I + G + + ALF A ++ L +LH ++ ++RD+K ENI
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLHRENTVYRDLKPENI 133
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1012
L+D G +++ D AV IP + VGT +MAPEV
Sbjct: 134 LLD-----DYGH--IRISDLGLAVK--------------IPEGESIRGRVGTVGYMAPEV 172
Query: 1013 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1050
L Y L D W GCL+ E++ Q P+ G E
Sbjct: 173 L----NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 25/148 (16%)
Query: 903 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962
GG +K +I + G + A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 84 GGDLKFHIYNMGNPGFDE---ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---- 136
Query: 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022
+++ D AV + I R VGT +MAPEV+ K Y
Sbjct: 137 ---DYGHIRISDLGLAVEIPE---GETIRGR--------VGTVGYMAPEVV----KNERY 178
Query: 1023 GLEVDIWSYGCLLLELLTLQVPYMGLSE 1050
D W GCL+ E++ + P+ E
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 38/118 (32%), Positives = 57/118 (48%), Gaps = 29/118 (24%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRA--VPLRSFLHTCCIAHRGI 995
H +MHRD+K +N+L+D K ++K+ D RA +P++S+ H
Sbjct: 126 CHKHGVMHRDLKPQNLLVD------KQKGLLKIADLGLGRAFSIPVKSYTHE-------- 171
Query: 996 PAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1052
+ T + APEVL + H Y VDIWS GC+ E+ Q + G SEL+
Sbjct: 172 ------IVTLWYRAPEVLLGSTH----YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 88/324 (27%), Positives = 127/324 (39%), Gaps = 97/324 (29%)
Query: 823 FGSADAAAKVRTLKVCGSSADEIRNFEYS----------CLGEVRMLGALRHSCIVEMYG 872
FG+ A VRT +V I+ YS + EV+ L ++H +E G
Sbjct: 38 FGAVYFARDVRTNEVVA-----IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 932
+ EH + + MEY G + L E +K + I
Sbjct: 93 CYLR-----------EH---TAWLVMEYCLGSA-----SDLLEVHKKPLQEVEIAAITHG 133
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV---PLRSFLHTCC 989
L LHS +++HRDIK+ NIL+ + VKL DF A P SF
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-------VKLADFGSASIASPANSF----- 181
Query: 990 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1049
VGTP WMAPEV+ AM + Y +VD+WS G +EL + P +
Sbjct: 182 ------------VGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFNM- 227
Query: 1050 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR--- 1106
+ + AL + +AQ+ E P + S D FR
Sbjct: 228 -----------------NAMSAL-----YHIAQN----ESPTLQSNEWS---DYFRNFVD 258
Query: 1107 -CTEENPTERPTAGDLYE-MFVAR 1128
C ++ P +RPT+ +L + MFV R
Sbjct: 259 SCLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 58/240 (24%), Positives = 90/240 (37%), Gaps = 56/240 (23%)
Query: 892 LQSAIF--MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHR 948
++ A++ MEY+ GS+ T V L I V L L +H I+HR
Sbjct: 70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV-LR-RITYAVVKGLKFLKEEHNIIHR 127
Query: 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1008
D+K N+L+ +G VKLCDF + L + L I G +M
Sbjct: 128 DVKPTNVLV-------NGNGQVKLCDFGVSGNLVASLAKTNI------------GCQSYM 168
Query: 1009 APEVLRA--MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM---GKRP 1063
APE +++ ++ Y ++ D+WS G +LE+ + PY + I + G P
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP 228
Query: 1064 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
L +A+ D +C + P RPT L E
Sbjct: 229 TLPSGYS-------------------DDAQ--------DFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 59/203 (29%)
Query: 927 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 986
L IA+ VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLV-------GENMVVKIADFGLS-------- 177
Query: 987 TCCIAHRGIPAPDVCVGTP------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
R I + D + RWM PE + N Y E D+W+YG +L E+ +
Sbjct: 178 ------RNIYSADYYKASENDAIPIRWMPPESIFY----NRYTTESDVWAYGVVLWEIFS 227
Query: 1041 LQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1099
+ PY G++ E+ ++ G + SC ++
Sbjct: 228 YGMQPYYGMAHEEVIYYVRDGN----------VLSCPDN-----------------CPLE 260
Query: 1100 LVDVFRRCTEENPTERPTAGDLY 1122
L ++ R C + P++RP+ +
Sbjct: 261 LYNLMRLCWSKLPSDRPSFASIN 283
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 31/150 (20%)
Query: 907 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 966
K Y++ TG +K ++ Q + + HS ++HRD+K +N+LID E
Sbjct: 85 KKYMDSSPLTGLDPPLIKS--YLYQ-LLQGIAYCHSHRVLHRDLKPQNLLIDREG----- 136
Query: 967 KPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022
+KL DF A VP+R++ H V T + APE+L Y
Sbjct: 137 --ALKLADFGLARAFGVPVRTYTHE--------------VVTLWYRAPEILLGSR---QY 177
Query: 1023 GLEVDIWSYGCLLLELLTLQVPYMGLSELE 1052
VDIWS GC+ E++ + + G SE++
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 41/256 (16%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 869
GK +++ + A V+ L D I + + E +L +L H +V+
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 870 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI 929
YG + L Q + +E GGSV ++ L G++ ++ +I
Sbjct: 84 FYGMFYKADKLVGG---------QLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS-YI 133
Query: 930 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 989
L LH+ I+HRD+K NIL+ E VKL DF + L T
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG-------VKLVDFGVSAQL-----TST 181
Query: 990 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL 1048
R + VGTP WMAPEV+ + + Y D+WS G +EL P
Sbjct: 182 RLRR-----NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL--- 233
Query: 1049 SELEIHDLIQMGKRPR 1064
++H + + K PR
Sbjct: 234 --FDMHPVKTLFKIPR 247
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 64/267 (23%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E ++L L H IV+ + + I EY +G + +E+L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAF--------------CIITEYCEGRDLDCKLEELK 97
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
TG+ ++ + Q + + +H + I+HRD+K++NI + ++K+ D
Sbjct: 98 HTGKTLSENQVCEWFIQ-LLLGVHYMHQRRILHRDLKAKNIFLK--------NNLLKIGD 148
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F + R + +C +A GTP +M+PE L+ H+ Y + DIWS GC+
Sbjct: 149 FGVS---RLLMGSCDLA-------TTFTGTPYYMSPEALK--HQG--YDSKSDIWSLGCI 194
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
L E+ L + G + L + I G P L PE
Sbjct: 195 LYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL------------------------PETYS 230
Query: 1095 ETLSFLVDVFRRCTEENPTERPTAGDL 1121
L+ ++ ++P+ RP+A ++
Sbjct: 231 RQLNSIMQ---SMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-10
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 35/205 (17%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI-- 910
L E ++ L H IV +Y I S DG+P ++ M Y++G ++K+ +
Sbjct: 50 LREAKIAADLIHPGIVPVY--SICS------DGDPVYYT------MPYIEGYTLKSLLKS 95
Query: 911 ----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 966
E LS+ + SV L I + A + +HSK ++HRD+K +NIL+ L G
Sbjct: 96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-----G 150
Query: 967 KPVV------KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1020
+ V+ + L + I + + P VGTP +MAPE L
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----V 206
Query: 1021 LYGLEVDIWSYGCLLLELLTLQVPY 1045
DI++ G +L ++LTL PY
Sbjct: 207 PASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 30/117 (25%)
Query: 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLH-TCCIAHRGI 995
HS+ ++HRD+K +N+LI D K V+KL DF A +P+R + H + +R
Sbjct: 118 HSRRVLHRDLKPQNLLI-------DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR-- 168
Query: 996 PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1052
AP+V +G+PR+ P VDIWS G + E+ T + + G SE++
Sbjct: 169 -APEVLLGSPRYSTP---------------VDIWSIGTIFAEMATKKPLFHGDSEID 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 3e-10
Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 60/204 (29%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
LHS +++HRD+K NIL++ +K+CDF A RG+ +
Sbjct: 119 LHSANVIHRDLKPSNILVNSN-------CDLKICDFGLA--------------RGVDPDE 157
Query: 1000 VCVG------TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1052
G RW APE+L + + Y +DIWS GC+ ELLT + + G ++
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSR---YTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
Query: 1053 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-----LVDVFRRC 1107
+LI +E LG+ E ++ S EK L++L L +F
Sbjct: 215 QLNLI-----------VEVLGTPSEEDLKFITS--EKARNYLKSLPKKPKKPLSKLFPGA 261
Query: 1108 TEE-----------NPTERPTAGD 1120
+ E +P +R TA +
Sbjct: 262 SPEAIDLLEKMLVFDPKKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 85/304 (27%)
Query: 843 DEIRNFEYSCLGEVRMLGALRHSCIVEM----YGHKISSKWLPSADGNPEHHLLQSAIF- 897
E F + L E+ +L L+H IV + G + I+
Sbjct: 42 KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK------------------IYM 83
Query: 898 -MEYVKGGSVKNYIEKLSE---TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953
MEYV+ +K+ +E + + E VK + + + + LH I+HRD+K+
Sbjct: 84 VMEYVEH-DLKSLMETMKQPFLQSE----VK---CLMLQLLSGVAHLHDNWILHRDLKTS 135
Query: 954 NILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1009
N+L++ + ++K+CDF A PL+ + V T + A
Sbjct: 136 NLLLN-------NRGILKICDFGLAREYGSPLKPYTQL--------------VVTLWYRA 174
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL---- 1065
PE+L + Y +D+WS GC+ ELLT + + G SE++ Q+ K +L
Sbjct: 175 PELLLGAKE---YSTAIDMWSVGCIFAELLTKKPLFPGKSEID-----QLNKIFKLLGTP 226
Query: 1066 TDE-------LEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116
T++ L ++ Q F P L F D+ R +P +R
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKF--PALSLSDNGF--DLLNRLLTYDPAKRI 282
Query: 1117 TAGD 1120
+A D
Sbjct: 283 SAED 286
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 37/189 (19%)
Query: 900 YVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956
Y+ G++K ++++ + +S + + +A +A + LH + ++H+DI + N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT----P-RWMAPE 1011
ID E + VK+ D A+ F P C+G P +WMA E
Sbjct: 150 IDEELQ-------VKITD--NALSRDLF-----------PMDYHCLGDNENRPVKWMALE 189
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR----PRLT 1066
L Y D+WS+G LL EL+TL Q PY+ + E+ ++ G R
Sbjct: 190 SLVN----KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCP 245
Query: 1067 DELEALGSC 1075
DEL A+ +C
Sbjct: 246 DELFAVMAC 254
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 39/115 (33%), Positives = 53/115 (46%), Gaps = 27/115 (23%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKP--VVKLCDFDRA----VPLRSFLHTCCIAHR 993
LHS ++HRD+K NIL+ +G VVK+ D A PL+
Sbjct: 124 LHSNWVLHRDLKPANILV-----MGEGPERGVVKIGDLGLARLFNAPLKPLADL------ 172
Query: 994 GIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
D V T + APE+L A H Y +DIW+ GC+ ELLTL+ + G
Sbjct: 173 -----DPVVVTIWYRAPELLLGARH----YTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 61/217 (28%), Positives = 87/217 (40%), Gaps = 53/217 (24%)
Query: 855 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
EVR L LRH ++ G + + WL MEY G +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWL----------------VMEYCLGSA-----SD 103
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP-VVK 971
L E +K + + L LHS +++HRD+K+ NIL+ +P +VK
Sbjct: 104 LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--------EPGLVK 155
Query: 972 LCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028
L DF A P F VGTP WMAPEV+ AM + Y +VD+
Sbjct: 156 LGDFGSASIMAPANXF-----------------VGTPYWMAPEVILAMDEGQ-YDGKVDV 197
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1065
WS G +EL + P ++ + I + P L
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 851 SCLGEVRMLGALRHSCIVEMYGHKI--SSKWLPSADGNPEHHLLQSA-IFMEYVKGGSVK 907
L E++++ L H IV++Y + S L G+ L S I EY++ +
Sbjct: 48 HALREIKIIRRLDHDNIVKVY-EVLGPSGSDLTEDVGSLTE--LNSVYIVQEYMET-DLA 103
Query: 908 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 967
N +E+ E+H LF+ Q + L +HS +++HRD+K N+ I+ E
Sbjct: 104 NVLEQ-GPLSEEHAR----LFMYQ-LLRGLKYIHSANVLHRDLKPANVFINTE------D 151
Query: 968 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEV 1026
V+K+ DF A + +H+G + + +W +P +L + PN Y +
Sbjct: 152 LVLKIGDFGLARIVDPHY-----SHKGYLSEGL---VTKWYRSPRLLLS---PNNYTKAI 200
Query: 1027 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP--RLTDELEALGSCHEHEVAQSG 1084
D+W+ GC+ E+LT + + G ELE LI + P R D E L + V G
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLI-LESVPVVREEDRNELL-NVIPSFVRNDG 258
Query: 1085 SGFEKPEAEL--ETLSFLVDVFRRCTEENPTERPTA 1118
+P +L +D + NP +R TA
Sbjct: 259 GEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 899 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958
+Y+ GG + +++K E S A F ++ AL LH I++RD+K ENIL+D
Sbjct: 76 DYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 959 LERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
A G + LCDF + + +T C GT ++APEVL
Sbjct: 131 -----ATGH--IALCDFGLSKANLTDNKTTNTFC-------------GTTEYLAPEVLL- 169
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
Y VD WS G L+ E+ P+ +++ I GK
Sbjct: 170 --DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 56/178 (31%), Positives = 81/178 (45%), Gaps = 42/178 (23%)
Query: 889 HHLLQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 944
H+ Q+A ++YV GG + ++++ E+ A F A +VA+A+ LHS +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVC 1001
I++RD+K ENIL+D + V L DF V T C
Sbjct: 117 IIYRDLKPENILLDSQGH-------VVLTDFGLCKEGVEPEETTSTFC------------ 157
Query: 1002 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
GTP ++APEVLR +P Y VD W G +L E+L GL D+ QM
Sbjct: 158 -GTPEYLAPEVLR--KEP--YDRTVDWWCLGAVLYEML------YGLPPFYSRDVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-10
Identities = 54/195 (27%), Positives = 75/195 (38%), Gaps = 63/195 (32%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
M+Y+ GG + + + +L E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRLGIFEED-----LARFYIAELTCAIESVHKMGFIHRDIKPDNILI 134
Query: 958 DLERKKADGKPVVKLCDF-----------------------------------DRAVP-- 980
D DG +KL DF DR
Sbjct: 135 DR-----DGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP 187
Query: 981 ---LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037
R H C+AH VGTP ++APEVL Y D WS G +L E
Sbjct: 188 LERRRKRQHQRCLAHS-------LVGTPNYIAPEVLLRTG----YTQLCDWWSVGVILYE 236
Query: 1038 LLTLQVPYMGLSELE 1052
+L Q P++ + E
Sbjct: 237 MLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 57/226 (25%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I EY++ GS+ ++++ + G K KL AQ +A + + K+ +HRD+++ NI
Sbjct: 77 IITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQ-IAEGMAFIERKNYIHRDLRAANI 133
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+ K+ DF A R A G P +W APE +
Sbjct: 134 LVSETL-------CCKIADFGLA---RLIEDNEYTAREGAKFP------IKWTAPEAIN- 176
Query: 1016 MHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEA 1071
YG ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 177 ------YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD---- 226
Query: 1072 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117
+C PE L ++ R C +E P ERPT
Sbjct: 227 --NC--------------PEE-------LYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-10
Identities = 50/146 (34%), Positives = 71/146 (48%), Gaps = 23/146 (15%)
Query: 904 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963
VKN LS+ G + ++ L VA + L SK+ +HRD+ + N+L+
Sbjct: 220 SEVKNL---LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL------ 270
Query: 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1023
A GK +VK+CDF A R +H +G V +WMAPE + NLY
Sbjct: 271 AQGK-IVKICDFGLA---RDIMHDSNYVSKGSTFLPV-----KWMAPESIF----DNLYT 317
Query: 1024 LEVDIWSYGCLLLELLTL-QVPYMGL 1048
D+WSYG LL E+ +L PY G+
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 33/166 (19%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 956
MEY GG + ++ + E+ S A F ++ +AL LHS K++++RD+K EN++
Sbjct: 74 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128
Query: 957 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 129 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 168
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
+ N YG VD W G ++ E++ ++P+ ++ +LI M
Sbjct: 169 ----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 43/232 (18%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++TLK GSS + +F L E ++G H I+ + G S+ +
Sbjct: 37 IKTLKA-GSSDKQRLDF----LTEASIMGQFDHPNIIRLEGVVTKSRPV----------- 80
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY++ GS+ + L E K +L + + + +A+ + L + +HRD+
Sbjct: 81 ---MIITEYMENGSLDKF---LRENDGKFTVGQL-VGMLRGIASGMKYLSEMNYVHRDLA 133
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+ NIL++ V K+ DF + L T IP RW APE
Sbjct: 134 ARNILVNSNL-------VCKVSDFGLSRRLEDSEATYTTKGGKIPI--------RWTAPE 178
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1062
+ + D+WS+G ++ E+++ + PY +S ++ ++ G R
Sbjct: 179 AIAYRK----FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 28/128 (21%)
Query: 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIP 996
HS ++HRD+K +N+LID +KL DF A +P+R+F H
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTN------ALKLADFGLARAFGIPVRTFTHE--------- 163
Query: 997 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHD 1055
V T + APE+L Y VDIWS GC+ E++ + + G SE+ E+
Sbjct: 164 -----VVTLWYRAPEILLGSRH---YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
Query: 1056 LIQMGKRP 1063
+ ++ P
Sbjct: 216 IFRILGTP 223
|
Length = 294 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 70/276 (25%), Positives = 106/276 (38%), Gaps = 78/276 (28%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
L E R+L H IV++ G + ++ P I ME V GG +++ K
Sbjct: 40 LSEARILKQYDHPNIVKLIG--VCTQRQPIY------------IVMELVPGGDFLSFLRK 85
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ + VK AL D AA + L SK+ +HRD+ + N L+ V+K+
Sbjct: 86 KKDELKTKQLVKFAL----DAAAGMAYLESKNCIHRDLAARNCLVGENN-------VLKI 134
Query: 973 CDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1026
DF D + S L + IP +W APE L Y E
Sbjct: 135 SDFGMSRQEDDGIYSSSGL-------KQIPI--------KWTAPEALNY----GRYSSES 175
Query: 1027 DIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1085
D+WSYG LL E +L V PY G++ + + ++ G R + C +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR------MSCPQKCPDD------- 222
Query: 1086 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
+ V +RC + P RP +L
Sbjct: 223 --------------VYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 32/163 (19%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+++V GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL 129
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCV---GTPRWMAPEVLR 1014
D + G V L DF + GI D GTP ++APEV+R
Sbjct: 130 D-----SQGHVV--LTDFG-------------LCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
+P Y VD W G +L E+L P+ E++D I
Sbjct: 170 --KQP--YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 52/235 (22%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TLK G+ + E S L E +++ LRH +V++Y + S+ P +
Sbjct: 35 VKTLKP-GTMSPE------SFLEEAQIMKKLRHDKLVQLYA--VVSE-------EPIY-- 76
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY+ GS+ ++ L + + + + + +A VAA + + + +HRD++
Sbjct: 77 ----IVTEYMSKGSLLDF---LKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
S NIL+ DG V K+ DF A + +T A +G P +W APE
Sbjct: 130 SANILV------GDGL-VCKIADFGLARLIEDNEYT---ARQGAKFP------IKWTAPE 173
Query: 1012 VLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1062
LYG ++ D+WS+G LL EL+T +VPY G++ E+ + ++ G R
Sbjct: 174 AA-------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 72/269 (26%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
L E +++ LRH +V +Y P + I E++ GS+ ++
Sbjct: 49 LQEAQIMKKLRHDKLVPLYA---------VVSEEPIY------IVTEFMGKGSLLDF--- 90
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
L E K++ + + +A +A + + + +HRD+++ NIL+ D V K+
Sbjct: 91 LKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV------GDNL-VCKI 143
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1029
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 1030 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1088
S+G LL EL+T +VPY G+ E+ + ++ G R + C
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYR------MPCPQGC------------- 228
Query: 1089 KPEAELETLSFLVDVFRRCTEENPTERPT 1117
PE+ L ++ + C +++P ERPT
Sbjct: 229 -PES-------LHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 67/240 (27%), Positives = 100/240 (41%), Gaps = 55/240 (22%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I MEY+ GGS + + + E ++ L +++ L LHS+ +HRDIK+ N+
Sbjct: 79 IIMEYLGGGSALDLL-RAGPFDEFQIATML-----KEILKGLDYLHSEKKIHRDIKAANV 132
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+ + VKL DF A L T R + VGTP WMAPEV++
Sbjct: 133 LLSEQGD-------VKLADFGVAGQL-----TDTQIKR-----NTFVGTPFWMAPEVIQQ 175
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1075
+ Y + DIWS G +EL + P + + + LI P LT E
Sbjct: 176 ----SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE------- 224
Query: 1076 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSIS 1134
F KP E C ++P+ RPTA +L + F+ + + S
Sbjct: 225 -----------FSKPFKEF---------IDACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 69/292 (23%)
Query: 840 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 899
S+A+ +R+FE E+ +L +L+H IV+ G S+ G L+ ME
Sbjct: 44 STAEHLRDFER----EIEILKSLQHDNIVKYKGVCYSA-------GRRNLRLV-----ME 87
Query: 900 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959
Y+ GS+++Y++K E+ KL L+ +Q + + L SK +HRD+ + NIL++
Sbjct: 88 YLPYGSLRDYLQK---HRERLDHRKLLLYASQ-ICKGMEYLGSKRYVHRDLATRNILVES 143
Query: 960 ERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR-----WMAPEV 1012
E + VK+ DF + +P + V P W APE
Sbjct: 144 ENR-------VKIGDFGLTKVLPQDKEYYK--------------VREPGESPIFWYAPES 182
Query: 1013 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 1072
L + + + D+WS+G +L EL T + MG D+ +
Sbjct: 183 L----TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR---MMGN-----DKQGQM 230
Query: 1073 GSCHEHEVAQSGSGFEKPE---AELETLSFLVDVFRRCTEENPTERPTAGDL 1121
H E+ ++ P AE+ + + C +P++RP+ +L
Sbjct: 231 IVYHLIELLKNNGRLPAPPGCPAEIYAI------MKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 59/234 (25%), Positives = 88/234 (37%), Gaps = 65/234 (27%)
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
+I E++ GGS+ Y K+ E HV + IA V L L S I+HRD+K N
Sbjct: 75 SICTEFMDGGSLDVY-RKIPE----HVLGR----IAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
+L++ + VKLCDF + L + + VGT +MAPE +
Sbjct: 126 MLVNTRGQ-------VKLCDFGVSTQLVNSIAK------------TYVGTNAYMAPERIS 166
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-------GLSELEIHDLIQMGKRPRLTD 1067
YG+ D+WS G +EL + PY L L++ I P L
Sbjct: 167 GEQ----YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222
Query: 1068 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
+ ++ V +C + P ERP +L
Sbjct: 223 ----------GQFSEK----------------FVHFITQCMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 66/271 (24%), Positives = 99/271 (36%), Gaps = 78/271 (28%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMEVFPEV-----LARFYIAELTLAIESVHKMGFIHRDIKPDNILI 134
Query: 958 DLERKKADGKPVVKLCDF-----------------------------------------D 976
DL DG +KL DF D
Sbjct: 135 DL-----DGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD 187
Query: 977 RAVPLRSFL---HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033
R L H C+AH VGTP ++APEVL + K Y D WS G
Sbjct: 188 RLKTLEQRATKQHQRCLAHS-------LVGTPNYIAPEVL--LRKG--YTQLCDWWSVGV 236
Query: 1034 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1082
+L E+L Q P++ + E +H Q+ P D + L E + +
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296
Query: 1083 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113
+G+ K + F D+ + P
Sbjct: 297 NGADDIKAHPFFSEVDFSSDIRTQPAPYVPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 50/156 (32%), Positives = 71/156 (45%), Gaps = 28/156 (17%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
LHS I+HRDIK N+L+ + V+K+CDF A + + +
Sbjct: 119 LHSAGILHRDIKPGNLLV-------NSNCVLKICDFGLA-RVEEPDESKHMTQE------ 164
Query: 1000 VCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1058
V T + APE+L + H Y VDIWS GC+ ELL ++ + S ++ DLI
Sbjct: 165 --VVTQYYRAPEILMGSRH----YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
Query: 1059 --MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
+G T LEA+ S E A G KP +
Sbjct: 219 DLLG-----TPSLEAMRSACEGARAHILRGPHKPPS 249
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-09
Identities = 67/271 (24%), Positives = 102/271 (37%), Gaps = 78/271 (28%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
M+Y+ GG + + + ++ E LA F ++ A+ +H +HRDIK +NILI
Sbjct: 80 MDYIPGGDMMSLLIRMGIFPED-----LARFYIAELTCAVESVHKMGFIHRDIKPDNILI 134
Query: 958 DLERKKADGKPVVKLCDF-----------------------------------------D 976
D DG +KL DF D
Sbjct: 135 D-----RDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD 187
Query: 977 RAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033
R PL + H C+AH VGTP ++APEVL L D WS G
Sbjct: 188 RLKPLERRAARQHQRCLAHS-------LVGTPNYIAPEVLLRTGYTQL----CDWWSVGV 236
Query: 1034 LLLELLTLQVPYMGLSELE-----------IHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1082
+L E+L Q P++ + LE +H Q P +D + L E + +
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGK 296
Query: 1083 SGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113
+G+ K +T+ F D+ ++ P
Sbjct: 297 NGADEIKAHPFFKTIDFSSDLRQQSAPYIPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 68/255 (26%), Positives = 105/255 (41%), Gaps = 58/255 (22%)
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 952
+I ME++ GGS+ ++K E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA------VIKGLTYLREKHKIMHRDVKP 132
Query: 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1012
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 1013 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 1072
L+ H Y ++ DIWS G L+E+ + P + + +L M P D E+
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVEMAIGRYP---IPPPDAKELELMFGCPVEGDPAESE 226
Query: 1073 GSCHEHEVAQSGSGF----EKPEAELETLSFLV-----------------DVFRRCTEEN 1111
S + S + P A E L ++V D +C +N
Sbjct: 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKN 286
Query: 1112 PTERPTAGDLYEMFV 1126
P ER DL ++ V
Sbjct: 287 PAER---ADLKQLMV 298
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 65/247 (26%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G+ + +C+ ++ K ++E + + L E++ML L+ IVE+
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFK----DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEKLSETGEKHVSVKLALF 928
E + +++ EYV+ KN +E L E K+ +
Sbjct: 66 ----------------KEAFRRRGKLYLVFEYVE----KNMLELLEEMPNGVPPEKVRSY 105
Query: 929 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL--- 985
I Q + A+ H I+HRDIK EN+LI V+KLCDF A L
Sbjct: 106 IYQ-LIKAIHWCHKNDIVHRDIKPENLLIS-------HNDVLKLCDFGFARNLSEGSNAN 157
Query: 986 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
+T +A R +P++ +G P YG VD+WS GC+L EL Q +
Sbjct: 158 YTEYVATRWYRSPELLLGAP----------------YGKAVDMWSVGCILGELSDGQPLF 201
Query: 1046 MGLSELE 1052
G SE++
Sbjct: 202 PGESEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 37/188 (19%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E ++L L+H IV Y W DG I M + +GG + + +++
Sbjct: 49 EAQLLSQLKHPNIV-AY----RESW-EGEDG-------LLYIVMGFCEGGDLYHKLKE-- 93
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ G+ ++ + Q +A AL LH KHI+HRD+K++N+ L R ++K+ D
Sbjct: 94 QKGKLLPENQVVEWFVQ-IAMALQYLHEKHILHRDLKTQNVF--LTRTN-----IIKVGD 145
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
A R + C +A +GTP +M+PE+ +KP Y + D+W+ GC
Sbjct: 146 LGIA---RVLENQCDMA-------STLIGTPYYMSPELFS--NKP--YNYKSDVWALGCC 191
Query: 1035 LLELLTLQ 1042
+ E+ TL+
Sbjct: 192 VYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 26/160 (16%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 75 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 129
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D + + L DF L I H G + GTP ++APEVL H
Sbjct: 130 DSQGH-------IVLTDFG--------LCKENIEHNGTTS--TFCGTPEYLAPEVL---H 169
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
K Y VD W G +L E+L P+ + E++D I
Sbjct: 170 K-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 45/214 (21%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
L E +++ LRH +V++Y P + I EY+ GS+ ++++
Sbjct: 49 LQEAQVMKKLRHEKLVQLYA---------VVSEEPIY------IVTEYMSKGSLLDFLK- 92
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
E G+ +L AQ +A+ + + + +HRD+++ NIL+ V K+
Sbjct: 93 -GEMGKYLRLPQLVDMAAQ-IASGMAYVERMNYVHRDLRAANILVG-------ENLVCKV 143
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIW 1029
DF A + +T A +G P +W APE LYG ++ D+W
Sbjct: 144 ADFGLARLIEDNEYT---ARQGAKFP------IKWTAPEAA-------LYGRFTIKSDVW 187
Query: 1030 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1062
S+G LL EL T +VPY G+ E+ D ++ G R
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 31/153 (20%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ + + GG +K +I + E G + A+F A ++ L +LH + I++RD+K ENI
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEV 1012
L+D G +++ D AV +P VGT +MAPEV
Sbjct: 134 LLD-----DHGH--IRISDLGLAV--------------HVPEGQTIKGRVGTVGYMAPEV 172
Query: 1013 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
+ K Y D W+ GCLL E++ Q P+
Sbjct: 173 V----KNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 35/154 (22%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF-IAQDVAAALVELHSKHIMHRDIKSEN 954
+ +E++ GGS++ H++ + L +A+ + + + LH +HI+HRDIK N
Sbjct: 149 VLLEFMDGGSLEG----------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSN 198
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
+LI+ + VK+ DF + L + C + VGT +M+PE +
Sbjct: 199 LLINSAKN-------VKIADFGVSRILAQTMDPC----------NSSVGTIAYMSPERIN 241
Query: 1015 AMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMG 1047
Y G DIWS G +LE Y+G
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEF------YLG 269
|
Length = 353 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 50/195 (25%)
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
VA + L SK+ +HRD+ + NIL+ R + K+CDF A +R+ + +
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLARDIRNDSNYVVKGN 275
Query: 993 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-E 1050
+P +WMAPE + +Y E D+WSYG LL E+ +L PY G+ +
Sbjct: 276 ARLPV--------KWMAPESIFNC----VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 1051 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTE 1109
+ + +I+ G R PE A E + D+ + C +
Sbjct: 324 SKFYKMIKEGYR------------------------MLSPECAPSE----MYDIMKSCWD 355
Query: 1110 ENPTERPTAGDLYEM 1124
+P +RPT + ++
Sbjct: 356 ADPLKRPTFKQIVQL 370
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 58/240 (24%)
Query: 896 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 944
+ +EY G+++ Y+ G E+ ++ K + A VA + L S+
Sbjct: 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1004
+HRD+ + N+L+ + V+K+ DF A + + + + +P
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLARDVHNIDYYKKTTNGRLPV------- 200
Query: 1005 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1063
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 201 -KWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR- 254
Query: 1064 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
++ +C HE L + R C P++RPT L E
Sbjct: 255 -----MDKPANC-THE--------------------LYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 70/246 (28%)
Query: 896 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 944
+ +EY G+++ ++ +++ E+ +S K + A VA + L S+
Sbjct: 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR 154
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1004
+HRD+ + N+L+ + V+K+ DF A RG+ D T
Sbjct: 155 CIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RGVHDIDYYKKT 193
Query: 1005 P------RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI 1057
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L+
Sbjct: 194 SNGRLPVKWMAPEALF----DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249
Query: 1058 QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117
+ G R ++ +C HE L + R C PT+RPT
Sbjct: 250 REGHR------MDKPSNC-THE--------------------LYMLMRECWHAVPTQRPT 282
Query: 1118 AGDLYE 1123
L E
Sbjct: 283 FKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 58/240 (24%)
Query: 896 IFMEYVKGGSVKNYIEKLSETG-----------EKHVSVKLALFIAQDVAAALVELHSKH 944
+ +EY G+++ Y+ G E+ +S K + A VA + L SK
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1004
+HRD+ + N+L+ + V+K+ DF A + + + +P
Sbjct: 161 CIHRDLAARNVLVTEDN-------VMKIADFGLARDIHHIDYYKKTTNGRLPV------- 206
Query: 1005 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1063
+WMAPE L +Y + D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 207 -KWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR- 260
Query: 1064 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
+KP L ++ R C P++RPT L E
Sbjct: 261 -----------------------MDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 59/272 (21%), Positives = 104/272 (38%), Gaps = 65/272 (23%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 910
E+ M L H +V + G + P + +L EY G +K ++
Sbjct: 58 ELDMFRKLSHKNVVRLLGL--------CREAEPHYMIL------EYTDLGDLKQFLRATK 103
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
K + +S K + + +A + L + +HRD+ + N L+ +R+
Sbjct: 104 SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL-- 161
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1030
L + V + R P RW+APE ++ + + + D+WS
Sbjct: 162 SLS---KDVYNSEYYK-----LRNALIP------LRWLAPEAVQE----DDFSTKSDVWS 203
Query: 1031 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1089
+G L+ E+ T ++P+ GLS+ E+ + +Q GK E
Sbjct: 204 FGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-------------------------LEL 238
Query: 1090 PEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
P E S L + RC NP +RP+ +L
Sbjct: 239 PVPE-GCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 78/296 (26%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+T K C +S F L E ++ H IV++ G + ++ NP
Sbjct: 39 VKTCKNC-TSPSVREKF----LQEAYIMRQFDHPHIVKLIG--VITE-------NP---- 80
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I ME G +++Y++ + + L L+ Q ++ AL L SK +HRDI
Sbjct: 81 --VWIVMELAPLGELRSYLQVNKYSLD---LASLILYSYQ-LSTALAYLESKRFVHRDIA 134
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWM 1008
+ N+L+ VKL DF R + S+ A +G +P +WM
Sbjct: 135 ARNVLV-------SSPDCVKLGDFGLSRYLEDESYYK----ASKGKLPI--------KWM 175
Query: 1009 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTD 1067
APE + + D+W +G + E+L L V P+ G+ ++ I+ G+R
Sbjct: 176 APESINFRR----FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---- 227
Query: 1068 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
P TL L+ +C +P++RP +L
Sbjct: 228 --------------------PMPPNCPPTLYSLM---TKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 26/148 (17%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+ ++ GG + +++++ E + A F ++ AL LH ++++RD+K ENIL+
Sbjct: 72 LAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL 126
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D + A LCDF C + + + GTP ++APE+L
Sbjct: 127 DYQGHIA-------LCDFG----------LCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
Y VD W+ G LL E+LT P+
Sbjct: 170 ----YTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 61/273 (22%), Positives = 102/273 (37%), Gaps = 72/273 (26%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E +++ L H +V++YG K L I E+++ G + NY+ +
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPL--------------YIVTEFMENGCLLNYLRQ-- 92
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ +S + L + QDV + L +HRD+ + N L+ VVK+ D
Sbjct: 93 --RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-------VVKVSD 143
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F R L + G P +W PEV + Y + D+WS+G L
Sbjct: 144 FGMT---RYVLDDEYTSSSGAKFP------VKWSPPEVFNF----SKYSSKSDVWSFGVL 190
Query: 1035 LLELLTL-QVPYMGLSELEIHDLIQMGKR---PRLTDELEALGSCHEHEVAQSGSGFEKP 1090
+ E+ T ++P+ S E+ ++I G R P+L +
Sbjct: 191 MWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL--------ASM-------------- 228
Query: 1091 EAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
+ +V C E P RPT +L
Sbjct: 229 --------TVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 28/175 (16%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ M + GG +K +I + GE+ + ++ + + + ++ LHS I++RD+K EN+
Sbjct: 70 LVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV 126
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+D + +L D AV L+ A GT +MAPE+L
Sbjct: 127 LLDDQGN-------CRLSDLGLAVELKDGKTITQRA-----------GTNGYMAPEIL-- 166
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
K Y VD ++ GC + E++ + P+ E + + KR L DE++
Sbjct: 167 --KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 26/180 (14%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ ++Y+ GG + ++ + E+ V + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSG-----EIVLALEHLHKLGIIYRDIKLENI 136
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+D ++G V L DF + + F A C GT +MAP+++R
Sbjct: 137 LLD-----SNGHVV--LTDFGLS---KEFH-----EDEVERAYSFC-GTIEYMAPDIVRG 180
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ---MGKRPRLTDELEAL 1072
+ VD WS G L+ ELLT P+ E I + P E+ AL
Sbjct: 181 GDGG--HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 28/137 (20%)
Query: 927 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 986
L IA +AA + L S H +HRD+ + N L+ +G VK+ DF + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLV------GEGL-TVKISDFGLSRDIYSADY 179
Query: 987 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 1041
+ +P RWM PE + LYG E DIWS+G +L E+ + L
Sbjct: 180 YRVQSKSLLPV--------RWMPPEAI-------LYGKFTTESDIWSFGVVLWEIFSYGL 224
Query: 1042 QVPYMGLSELEIHDLIQ 1058
Q PY G S E+ ++I+
Sbjct: 225 Q-PYYGFSNQEVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 31/152 (20%)
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQDVAAALVELHSKH-IMHRDIKS 952
+I ME++ GGS+ +++ E+ + V +A V L L KH IMHRD+K
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA------VLRGLAYLREKHQIMHRDVKP 132
Query: 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1012
NIL+ + + +KLCDF + L + + VGT +M+PE
Sbjct: 133 SNILV-------NSRGEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPER 173
Query: 1013 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044
L+ H Y ++ DIWS G L+EL + P
Sbjct: 174 LQGTH----YSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 38/157 (24%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ ++YV GG + ++ + E V F + ++ AL LH I++RDIK ENI
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVR-----FYSGEIILALEHLHKLGIVYRDIKLENI 136
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFL-------HTCCIAHRGIPAPDVCVGTPRWM 1008
L+D ++G V L DF + + FL ++ C GT +M
Sbjct: 137 LLD-----SEGHVV--LTDFGLS---KEFLSEEKERTYSFC-------------GTIEYM 173
Query: 1009 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
APE++R +G VD WS G L+ ELLT P+
Sbjct: 174 APEIIRGKGG---HGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 60/230 (26%)
Query: 902 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961
K S E+ E ++ ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS--- 207
Query: 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI-PAPD-VCVGTPR----WMAPEVLRA 1015
VVK+CDF A R I PD V G R WMAPE +
Sbjct: 208 ----ENNVVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPESIF- 248
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALGS 1074
+Y + D+WS+G LL E+ +L PY G+ E + + K
Sbjct: 249 ---DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLKE------------ 291
Query: 1075 CHEHEVAQSGSGFEKPE-AELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
G+ PE A E S ++D C NP +RPT +L E
Sbjct: 292 ---------GTRMRAPEYATPEIYSIMLD----CWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 61/232 (26%)
Query: 898 MEYVKGGSVKNYIEK-----------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 946
+EY G++ +++ K ++ + +S + L A DVA + L K +
Sbjct: 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 146
Query: 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1006
HRD+ + NIL+ V K+ DF + ++ +P R
Sbjct: 147 HRDLAARNILVGENY-------VAKIADFGLSRGQEVYVKK---TMGRLPV--------R 188
Query: 1007 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1065
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++ + G R
Sbjct: 189 WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--- 241
Query: 1066 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117
EKP L + D+ R+C E P ERP+
Sbjct: 242 ---------------------LEKP---LNCDDEVYDLMRQCWREKPYERPS 269
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 23/100 (23%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
+HS ++HRD+K NILI+ + D +K+CDF A P
Sbjct: 124 VHSAGVVHRDLKPSNILIN---ENCD----LKICDFGLARIQD-------------PQMT 163
Query: 1000 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039
V T + APE++ K Y +EVDIWS GC+ E+L
Sbjct: 164 GYVSTRYYRAPEIMLTWQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 42/173 (24%), Positives = 63/173 (36%), Gaps = 50/173 (28%)
Query: 898 MEYVKGGSVKNYIEK---LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
MEY+ GG + + K +E + F + A+ +H +HRDIK +N
Sbjct: 80 MEYLPGGDMMTLLMKKDTFTE--------EETRFYIAETILAIDSIHKLGYIHRDIKPDN 131
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDV----------- 1000
+L+D A G +KL DF L+ ++H
Sbjct: 132 LLLD-----AKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 1001 --------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039
VGTP ++APEV Y E D WS G ++ E+L
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVF----LQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 36/158 (22%)
Query: 897 FMEYVKGGSVKN-----YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
M Y GS ++ + E L E FI +DV AL +HSK +HR +K
Sbjct: 80 LMAY---GSCEDLLKTHFPEGLPEL--------AIAFILKDVLNALDYIHSKGFIHRSVK 128
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMA 1009
+ +IL+ DGK V L +V + P V W++
Sbjct: 129 ASHILLS-----GDGK--VVLSGLRYSVSMIKHGKRQRVVHDF-----PKSSVKNLPWLS 176
Query: 1010 PEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPY 1045
PEVL+ NL Y + DI+S G EL VP+
Sbjct: 177 PEVLQQ----NLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (137), Expect = 5e-08
Identities = 44/172 (25%), Positives = 79/172 (45%), Gaps = 41/172 (23%)
Query: 896 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHS-------KHI 945
I ME+ G + I+K + E+H V I + + AL H+ + +
Sbjct: 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD----ITRQLLHALAYCHNLKDGPNGERV 146
Query: 946 MHRDIKSENIL----------IDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHR 993
+HRD+K +NI I + +G+P+ K+ DF + + + S H+C
Sbjct: 147 LHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC----- 201
Query: 994 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
VGTP + +PE+L +H+ Y + D+W+ GC++ EL + + P+
Sbjct: 202 --------VGTPYYWSPELL--LHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-08
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 38/158 (24%)
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
VA + L SK+ +HRD+ + N+LI +GK +VK+CDF A R +
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLI------CEGK-LVKICDFGLA---RDIMRDSNYIS 297
Query: 993 RG---IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 1048
+G +P +WMAPE + NLY D+WS+G LL E+ TL PY
Sbjct: 298 KGSTFLPL--------KWMAPESIFN----NLYTTLSDVWSFGILLWEIFTLGGTPY--- 342
Query: 1049 SELEIHDLI--------QMGKRPRLTDEL-EALGSCHE 1077
EL +++ +M K +DE+ E + C E
Sbjct: 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWE 380
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 22/148 (14%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
M + GG ++ +I + E A F + + L LH + I++RD+K EN+L+
Sbjct: 72 MTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL 130
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D DG V++ D AV L+ G GTP +MAPE+L+
Sbjct: 131 D-----NDGN--VRISDLGLAVELKD----------GQSKTKGYAGTPGFMAPELLQGEE 173
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
Y VD ++ G L E++ + P+
Sbjct: 174 ----YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 72/274 (26%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYI 910
L E ++ LRHS +V++ G + K +++ EY+ GS+ +Y
Sbjct: 47 LAEASVMTQLRHSNLVQLLGVIVEEK---------------GGLYIVTEYMAKGSLVDY- 90
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
L G + L + DV A+ L + + +HRD+ + N+L+ + V
Sbjct: 91 --LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-------VA 141
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1030
K+ DF S T +P +W APE LR + + D+WS
Sbjct: 142 KVSDFGLTKEASSTQDTG-----KLPV--------KWTAPEALRE----KKFSTKSDVWS 184
Query: 1031 YGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1089
+G LL E+ + +VPY + ++ ++ G + ++A C
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------MDAPDGC-------------- 224
Query: 1090 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
P + DV ++C + RP+ L E
Sbjct: 225 PPV-------VYDVMKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 52/236 (22%), Positives = 90/236 (38%), Gaps = 52/236 (22%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+E+ G +KNY+ + + +A +VA+ L+ LH +H D+ N +
Sbjct: 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL 133
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP----APDVCVGTP-RWMAPEV 1012
AD VK+ D+ +A P C P RW+APE+
Sbjct: 134 -----TADLS--VKIGDYG-------------LALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 1013 LRAMH---KPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDE 1068
+ P + +IWS G + EL T PY LS+ ++ + + +L
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--- 230
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
KP+ +L+ +V + C + P RPTA +++E+
Sbjct: 231 -------------------PKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHEL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
++ + GG + ++ + EK + F A ++ L +H++ +++RD+K NIL+
Sbjct: 76 LDLMNGGDLHYHLSQHGVFSEKEMR-----FYATEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D E + CDF + P S VGT +MAPEVL+
Sbjct: 131 D-EHGHVRISDLGLACDFSKKKPHAS------------------VGTHGYMAPEVLQ--- 168
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
K Y D +S GC+L +LL P+ + H++ +M
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 77/207 (37%)
Query: 851 SCLGEVRMLGALRHSCIVEMYG-----HKIS----------SKWLPSADGNPEHHLLQSA 895
S L E+ +L L+H IV +Y K++ K+ S +G+ + +++S
Sbjct: 45 SALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF 104
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+F + +KG L HS +++HRD+K +N+
Sbjct: 105 MF-QLLKG---------------------------------LAFCHSHNVLHRDLKPQNL 130
Query: 956 LIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
LI+ +G+ +KL DF A +P+R + V T + P+
Sbjct: 131 LIN-----KNGE--LKLADFGLARAFGIPVRCYSAE--------------VVTLWYRPPD 169
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLEL 1038
VL LY +D+WS GC+ EL
Sbjct: 170 VLFG---AKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 22/132 (16%)
Query: 928 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 987
F A ++ L +H++ +++RD+K NIL+D E + CDF + P S
Sbjct: 101 FYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 988 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
VGT +MAPEVL+ K Y D +S GC+L +LL P+
Sbjct: 156 --------------VGTHGYMAPEVLQ---KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
Query: 1048 LSELEIHDLIQM 1059
+ H++ +M
Sbjct: 199 HKTKDKHEIDRM 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 64/314 (20%), Positives = 127/314 (40%), Gaps = 67/314 (21%)
Query: 813 SVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872
SV + + + GS A V+ LK S+ +I F L E + H ++++ G
Sbjct: 14 SVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEF----LREAACMKEFDHPNVIKLIG 68
Query: 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFI--A 930
+ S+ + L + + ++K G + ++ +S GE+ ++ L +
Sbjct: 69 VSLRSR--------AKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFTLPLQTLVRFM 119
Query: 931 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTC 988
D+A+ + L SK+ +HRD+ + N +++ V + DF + + S +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMT-------VCVADFGLSKKIYSGDYYRQG 172
Query: 989 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG 1047
C + +P +W+A E L N+Y D+W++G + E++T Q PY G
Sbjct: 173 CASK--LPV--------KWLALESL----ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
Query: 1048 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1107
+ EI++ + G R ++P + L + ++ +C
Sbjct: 219 VENSEIYNYLIKGNR------------------------LKQP---PDCLEDVYELMCQC 251
Query: 1108 TEENPTERPTAGDL 1121
P RP+ L
Sbjct: 252 WSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 30/154 (19%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKL-ALFIAQDVAAALVELH-SKHIMHRDIKSE 953
I M+ ++G + + L E ++ ++ +F+ + AL LH K I+HRD+
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV--QMVLALRYLHKEKRIVHRDLTPN 143
Query: 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPE 1011
NI++ E K V + DF +A + P + VGT + PE
Sbjct: 144 NIMLG-EDDK------VTITDFG-------------LAKQKQPESKLTSVVGTILYSCPE 183
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
+++ P YG + D+W++GC+L ++ TLQ P+
Sbjct: 184 IVKNE--P--YGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 31/148 (20%)
Query: 901 VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960
+ GG +K +I + G + A+F A ++ L +L + I++RD+K ENIL+
Sbjct: 82 MNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL--- 135
Query: 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMH 1017
D + +++ D AV IP + VGT +MAPEV+
Sbjct: 136 ----DDRGHIRISDLGLAVQ--------------IPEGETVRGRVGTVGYMAPEVI---- 173
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
Y D W GCL+ E++ Q P+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 33/128 (25%)
Query: 928 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 987
FI Q + L +HS +++HRD+K N+L++ AD + +K+CDF A
Sbjct: 110 FIYQ-ILCGLKYIHSANVLHRDLKPGNLLVN-----ADCE--LKICDFGLA--------- 152
Query: 988 CCIAHRGI-PAPDVCVG------TPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039
RG P G RW APE++ + Y +D+WS GC+L ELL
Sbjct: 153 -----RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS---YTKAIDVWSVGCILAELL 204
Query: 1040 TLQVPYMG 1047
+ + G
Sbjct: 205 GRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 78/275 (28%)
Query: 849 EYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 908
E++C VR+LG + + G P + + ME + G +K+
Sbjct: 65 EFNCHHVVRLLGVV--------------------SQGQP------TLVIMELMTRGDLKS 98
Query: 909 YIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963
Y+ L + + S+K + +A ++A + L++ +HRD+ + N ++ +
Sbjct: 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-- 156
Query: 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1023
VK+ DF R T G V RWM+PE L K ++
Sbjct: 157 -----TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMSPESL----KDGVFT 199
Query: 1024 LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1082
D+WS+G +L E+ TL + PY G+S ++ +
Sbjct: 200 TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------------------------M 235
Query: 1083 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117
G +KP+ L ++ R C + NP RP+
Sbjct: 236 EGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 43/208 (20%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
E ++L + H V +YG +L + +E+V GG ++ +
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYL--------------YLVLEFVIGGEFFTFLRR 124
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
K + F A + L S +I++RD+K EN+L+D DG +K+
Sbjct: 125 -----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD-----KDG--FIKM 172
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF A + + +T C GTP ++APE+L + +G D W+ G
Sbjct: 173 TDFGFAKVVDTRTYTLC-------------GTPEYIAPEILLNVG----HGKAADWWTLG 215
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMG 1060
+ E+L P+ L I+ I G
Sbjct: 216 IFIYEILVGCPPFYANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 52/236 (22%)
Query: 896 IFMEYVKGGSVKNYIEKL-----SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 950
+ ME + G +K+Y+ L + G +++ + +A ++A + L++K +HRD+
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145
Query: 951 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1010
+ N ++ + VK+ DF R T G V RWMAP
Sbjct: 146 AARNCMVAHDF-------TVKIGDFGMT---RDIYETDYYRKGGKGLLPV-----RWMAP 190
Query: 1011 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1069
E L K ++ D+WS+G +L E+ +L + PY GLS ++ +
Sbjct: 191 ESL----KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 234
Query: 1070 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
G ++P+ E ++ D+ R C + NP RPT ++ +
Sbjct: 235 ------------MDGGYLDQPDNCPERVT---DLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 41/206 (19%)
Query: 834 TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 893
LKV GS + F + ++ L H +V++YG + D N
Sbjct: 34 VLKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYG-------VCVRDEN------- 75
Query: 894 SAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953
+ EYVK G + ++ + +VS+ L +A+ +A+AL L K ++H ++ +
Sbjct: 76 -IMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGK 130
Query: 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013
NIL+ P +KL D + + S R P W+APE +
Sbjct: 131 NILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIP--------WIAPECI 176
Query: 1014 RAMH-KPNLYGLEVDIWSYGCLLLEL 1038
R + D WS+G LLE+
Sbjct: 177 RNGQASLTIAA---DKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 44/241 (18%)
Query: 824 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883
G + A ++TLK G + + ++F L E ++G H I+ + G + +K+ P+
Sbjct: 30 GRKEVAVAIKTLKP-GYTEKQRQDF----LSEASIMGQFSHHNIIRLEG--VVTKFKPAM 82
Query: 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 943
I EY++ G++ Y L + + S +L + + +AA + L
Sbjct: 83 ------------IITEYMENGALDKY---LRDHDGEFSSYQLVGML-RGIAAGMKYLSDM 126
Query: 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 1002
+ +HRD+ + NIL+ + K+ DF + L G IP
Sbjct: 127 NYVHRDLAARNILV-------NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI----- 174
Query: 1003 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 1061
RW APE + A K + D+WS+G ++ E+++ + PY +S E+ I G
Sbjct: 175 ---RWTAPEAI-AYRK---FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227
Query: 1062 R 1062
R
Sbjct: 228 R 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 31/179 (17%)
Query: 896 IFMEYVKGGSVKNYIE-----------KLSETGEKHVSVKLALFIAQDVAAALVELHSKH 944
+ +EY G+++ Y+ ++ ++ ++ K + VA + L S+
Sbjct: 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK 157
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1004
+HRD+ + N+L+ V+K+ DF A + + + + +P
Sbjct: 158 CIHRDLAARNVLVTENN-------VMKIADFGLARDVNNIDYYKKTTNGRLPV------- 203
Query: 1005 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1062
+WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E+ L++ G R
Sbjct: 204 -KWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 38/133 (28%), Positives = 54/133 (40%), Gaps = 27/133 (20%)
Query: 937 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--------DRAVPLRSFLHTC 988
L LH + MHRD+ NI I+ K + K+ DF S T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFIN-------SKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 989 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1048
V T + APE+L K Y VD+WS GC+ ELLT + + G
Sbjct: 185 QRREEMTSK----VVTLWYRAPELLMGAEK---YHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 1049 SELEIHDLIQMGK 1061
+E++ Q+G+
Sbjct: 238 NEID-----QLGR 245
|
Length = 335 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-07
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 20/117 (17%)
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
VA + L SK+ +HRD+ + N+L+ DG+ V K+CDF A R ++
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLL------TDGR-VAKICDFGLA---RDIMNDSNYVV 270
Query: 993 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGL 1048
+G V +WMAPE + +Y ++ D+WSYG LL E+ +L + PY G+
Sbjct: 271 KGNARLPV-----KWMAPESIFDC----VYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-07
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 30/148 (20%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ ME++ +V Y++ + + L+ Q + AL +HSK I HRD+K +N+
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ-LCRALAYIHSKFICHRDLKPQNL 201
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPL----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
LID +KLCDF A L RS + C +R AP++ +G
Sbjct: 202 LIDPNTH------TLKLCDFGSAKNLLAGQRSVSYICSRFYR---APELMLGATN----- 247
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELL 1039
Y +D+WS GC++ E++
Sbjct: 248 ----------YTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 906 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965
++ Y++K+ G ++K + + L LH+ I+HRD+K ENIL+ +
Sbjct: 93 LRTYLDKVPPPGLPAETIK---DLMRQFLRGLDFLHANCIVHRDLKPENILV-----TSG 144
Query: 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1025
G+ VKL DF A +++C +A V T + APEVL + Y
Sbjct: 145 GQ--VKLADFGLAR-----IYSCQMAL------TPVVVTLWYRAPEVLLQ----STYATP 187
Query: 1026 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
VD+WS GC+ E+ + + G SE + Q+GK
Sbjct: 188 VDMWSVGCIFAEMFRRKPLFCGNSEAD-----QLGK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 57/241 (23%), Positives = 101/241 (41%), Gaps = 44/241 (18%)
Query: 824 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883
G + ++TLK G + + R+F L E ++G H I+ + G SK +
Sbjct: 29 GKREIPVAIKTLKA-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEGVVTKSKPV--- 80
Query: 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 943
I EY++ GS+ ++ K + +V + + + +A+ + L
Sbjct: 81 -----------MIVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCV 1002
+HRD+ + NIL++ V K+ DF + L G IP
Sbjct: 126 GYVHRDLAARNILVN-------SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI----- 173
Query: 1003 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGK 1061
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ I+ G
Sbjct: 174 ---RWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226
Query: 1062 R 1062
R
Sbjct: 227 R 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 40/126 (31%), Positives = 54/126 (42%), Gaps = 36/126 (28%)
Query: 921 VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 980
+ + AL I + + L LH++ I+HRD+K+ENI I+ D D
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---------------DVD---- 194
Query: 981 LRSFLHTCCIAHRG-----IPAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033
CI G + AP GT APEVL A K Y + DIWS G
Sbjct: 195 ------QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL-ARDK---YNSKADIWSAGI 244
Query: 1034 LLLELL 1039
+L E+L
Sbjct: 245 VLFEML 250
|
Length = 357 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 45/191 (23%), Positives = 67/191 (35%), Gaps = 61/191 (31%)
Query: 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP------- 996
I+HRD+K NIL+ D +KLCDF GI
Sbjct: 128 KIIHRDVKPSNILL-------DRNGNIKLCDF------------------GISGQLVDSI 162
Query: 997 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1056
A G +MAPE + + Y + D+WS G L E+ T + PY + + D
Sbjct: 163 AKTRDAGCRPYMAPERI-DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQ 219
Query: 1057 IQM---GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113
+ G P L + E E + S V+ C ++ +
Sbjct: 220 LTQVVKGDPPI-------LSNSEEREFSPS----------------FVNFINLCLIKDES 256
Query: 1114 ERPTAGDLYEM 1124
+RP +L E
Sbjct: 257 KRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 22/132 (16%)
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
+A + L K ++HRD+ + N+L+ + VK+ DF A L A
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQH-------VKITDFGLA-KLLDVDEKEYHAE 169
Query: 993 RGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 1050
G P +WMA E + +Y + D+WSYG + EL+T PY G+
Sbjct: 170 GGK--------VPIKWMALESILH----RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217
Query: 1051 LEIHDLIQMGKR 1062
+EI DL++ G+R
Sbjct: 218 VEIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 51/204 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM-EYVKGGSVKNYIEKL 913
E +L L+H+ IV + H I H ++ + EY+ +K Y++
Sbjct: 53 EASLLKDLKHANIVTL--HDII-------------HTKKTLTLVFEYLDT-DLKQYMDDC 96
Query: 914 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 973
G +V+L LF + L H + ++HRD+K +N+LI ER + +KL
Sbjct: 97 G-GGLSMHNVRLFLF---QLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGE------LKLA 145
Query: 974 DFDRA----VPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028
DF A VP +++ + + +R PDV +G+ Y +D+
Sbjct: 146 DFGLARAKSVPSKTYSNEVVTLWYR---PPDVLLGSTE---------------YSTSLDM 187
Query: 1029 WSYGCLLLELLTLQVPYMGLSELE 1052
W GC+ E+ T + + G +++E
Sbjct: 188 WGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-06
Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 212 LISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L SL ++NN+L +P G L L+ LDLS N LTS+ + +L++L+L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-06
Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 2/60 (3%)
Query: 188 NLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRL 245
NL+ LDLS N++ +P L L L ++ N L + L L +LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 47/169 (27%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
+ + Y+K G ++N+I E H +VK + VA + L SK +HRD+ + N
Sbjct: 74 VVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN 128
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
++D VK+ DF A + + H G P +WMA E L+
Sbjct: 129 CMLD-------ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP------VKWMALESLQ 175
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKR 1062
K + + D+WS+G LL EL+T PY + +I + G+R
Sbjct: 176 T-QK---FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR 220
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-06
Identities = 69/254 (27%), Positives = 111/254 (43%), Gaps = 49/254 (19%)
Query: 64 RGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNE-INLFPSEVGNLLGLECLQI 121
RG ++E L L N+L+ IP +G + L+ L GN + P+ + NL LE L +
Sbjct: 136 RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195
Query: 122 KISSPGVNGFA--LNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCH 173
S+ V L ++K LK + L ++P EI GL L L + +
Sbjct: 196 A-SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP---------YEIGGLTSLNHLDLVY 245
Query: 174 FSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-------- 223
++ +P +G L NL+ L L NK+ +P I L+ LISL +++N L
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305
Query: 224 -----------------ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
++P L L RL+ L L +N+ + +L +NL L+L
Sbjct: 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST 365
Query: 267 NKLLSYCQVPSWIC 280
N L ++P +C
Sbjct: 366 NNLTG--EIPEGLC 377
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-06
Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 6 SVEITQKSPEG----PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESY 61
S T K P P + L +NK + E ++ ++ +V+D+S + + E
Sbjct: 317 SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376
Query: 62 GNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL 119
+ G ++ L L+ N L IPKS+G LR ++ N + PSE L + L
Sbjct: 377 CSSG---NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433
Query: 120 QIKISSPGVNGFALNKLK----GLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
I S+ + G +N K L+ L L+ R L + G K L L +
Sbjct: 434 DI--SNNNLQG-RINSRKWDMPSLQMLSLA----RNKFFGGLPDSFGSKRLENLDLSRNQ 486
Query: 176 IR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLL 232
+P ++G LS L QL LS NK+ +P E+ K L+SL +++N+L ++P+ +
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L LDLS N+L+ +L + +L +N+ +N L
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583
|
Length = 968 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 60/300 (20%), Positives = 118/300 (39%), Gaps = 72/300 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG---HKISSKWLPSADGNPE 888
V+T+K+ + E+ +F L E + H ++ + G + S+ PS
Sbjct: 31 VKTMKIAICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP----- 81
Query: 889 HHLLQSAIFMEYVKGGSVKNYI--EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 946
+ + ++K G + +++ +L + + + L F+ D+A+ + L SK +
Sbjct: 82 ------VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT-DIASGMEYLSSKSFI 134
Query: 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGT 1004
HRD+ + N +++ V + DF + + + + IA +
Sbjct: 135 HRDLAARNCMLNENMN-------VCVADFGLSKKIYNGDYYRQGRIAKMPV--------- 178
Query: 1005 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1063
+W+A E L +Y + D+WS+G + E+ T Q PY G+ EI+D ++ G R
Sbjct: 179 -KWIAIESL----ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR- 232
Query: 1064 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
++P + L L + C NP +RP+ L
Sbjct: 233 -----------------------LKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 37/208 (17%)
Query: 848 FEYSCLGEVRMLGALRHSCIVEMYGHKI-SSKWLPSADGNPEHHLLQSAIFMEYVKGGSV 906
F + L E+++L L+H +V + +I +K P +L+ F E+ G +
Sbjct: 54 FPITALREIKILQLLKHENVVNLI--EICRTKATPYNRYKGSFYLVFE--FCEHDLAGLL 109
Query: 907 KNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 966
N K + E +K+ L L +H I+HRD+K+ NILI DG
Sbjct: 110 SNKNVKFTL-SEIKKVMKMLL-------NGLYYIHRNKILHRDMKAANILIT-----KDG 156
Query: 967 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC---VGTPRWMAPEVLRAMHKPNLYG 1023
++KL DF A R+F + P+ V T + PE+L YG
Sbjct: 157 --ILKLADFGLA---RAF------SLSKNSKPNRYTNRVVTLWYRPPELLLGERD---YG 202
Query: 1024 LEVDIWSYGCLLLELLTLQVPYM-GLSE 1050
+D+W GC++ E+ T P M G +E
Sbjct: 203 PPIDMWGAGCIMAEMWTRS-PIMQGNTE 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 39/117 (33%), Positives = 51/117 (43%), Gaps = 31/117 (26%)
Query: 928 FIAQDVAAALVELHSKHIMHRDIKSENILI--DLERKKADGKPVVKLCDFDRAVPLRSFL 985
F+ + L +HS I+HRD+K NI + D E +K+ DF A +
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---------LKILDFGLARHTDDEM 172
Query: 986 HTCCIAHRGIPAPDVCVGTPRW-MAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
V T RW APE+ L MH Y VDIWS GC++ ELLT
Sbjct: 173 TG-------------YVAT-RWYRAPEIMLNWMH----YNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 43/207 (20%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
LKV S RN+ S M+ L H +V YG + E ++Q
Sbjct: 32 LKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD---------ESIMVQ- 78
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
EYVK GS+ Y++K +++ L +A+ +A AL L K + H ++ ++N
Sbjct: 79 ----EYVKFGSLDTYLKKNKNL----INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKN 130
Query: 955 ILIDLERKKADGK-PVVKLCD--FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+L+ E + G P +KL D V + L IP W+ PE
Sbjct: 131 VLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL------LERIP----------WVPPE 174
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLEL 1038
+ P L D WS+G L E+
Sbjct: 175 CIE---NPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 36/110 (32%), Positives = 49/110 (44%), Gaps = 27/110 (24%)
Query: 936 ALVELHSKHIMHRDIKSENILI----DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA 991
L +HS +++HRD+K N+L+ DL K+CDF A R
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDL-----------KICDFGLA---RI--ADPEHD 161
Query: 992 HRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
H G V RW APE+ M Y +DIWS GC+L E+L+
Sbjct: 162 HTGFLTEYVAT---RWYRAPEI---MLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 52/223 (23%)
Query: 909 YIEKLSETGEKHVSVK---LALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965
Y++K+ E G ++K L D LHS ++HRD+K +NIL+ +
Sbjct: 98 YLDKVPEPGVPTETIKDMMFQLLRGLDF------LHSHRVVHRDLKPQNILV-----TSS 146
Query: 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1025
G+ +KL DF A + SF A V T + APEVL + Y
Sbjct: 147 GQ--IKLADFGLA-RIYSFQ----------MALTSVVVTLWYRAPEVLLQ----SSYATP 189
Query: 1026 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE----HEVA 1081
VD+WS GC+ E+ + + G S+++ Q+GK L+ +G E +VA
Sbjct: 190 VDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGKI------LDVIGLPGEEDWPRDVA 238
Query: 1082 QSGSGFE-KPEAELETLSFLVD-----VFRRCTEENPTERPTA 1118
F K +E +D + +C NP +R +A
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 24/102 (23%)
Query: 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1000
H ++HRD+K +N+LI+ + +KL DF A R+F GIP
Sbjct: 117 HENRVLHRDLKPQNLLIN-------KRGELKLADFGLA---RAF---------GIPVNTF 157
Query: 1001 C--VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
V T + AP+VL Y +DIWS GC++ E++T
Sbjct: 158 SNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-06
Identities = 57/200 (28%), Positives = 80/200 (40%), Gaps = 58/200 (29%)
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
VA + L S+ +HRD+ + NIL+ VVK+CDF A
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENN-------VVKICDFGLA-------------- 221
Query: 993 RGI-PAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 1045
R I PD V G+ R WMAPE + +Y + D+WS+G LL E+ +L PY
Sbjct: 222 RDIYKDPDYVRKGSARLPLKWMAPESIF----DKVYTTQSDVWSFGVLLWEIFSLGASPY 277
Query: 1046 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1105
G+ E + Q RL D G+ PE + +
Sbjct: 278 PGVQINE--EFCQ-----RLKD----------------GTRMRAPE---NATPEIYRIML 311
Query: 1106 RCTEENPTERPTAGDLYEMF 1125
C + +P ERPT L E+
Sbjct: 312 ACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-06
Identities = 39/122 (31%), Positives = 56/122 (45%), Gaps = 30/122 (24%)
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
VA + L S+ +HRD+ + NIL+ VVK+CDF +A
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLS-------ENNVVKICDFG-------------LAR 227
Query: 993 RGIPAPD-VCVGTPR----WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYM 1046
PD V G R WMAPE + +Y ++ D+WS+G LL E+ +L PY
Sbjct: 228 DIYKDPDYVRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSLGASPYP 283
Query: 1047 GL 1048
G+
Sbjct: 284 GV 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 61/233 (26%)
Query: 896 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 944
I +EY G++ +++ K + ET ++H ++ + L A DVA + L K
Sbjct: 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1004
+HRD+ + N+L+ K+ DF + ++ +P
Sbjct: 140 FIHRDLAARNVLVG-------ENLASKIADFGLSRGEEVYVKK---TMGRLPV------- 182
Query: 1005 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1063
RWMA E L ++Y + D+WS+G LL E+++L PY G++ E+++ + G R
Sbjct: 183 -RWMAIESLNY----SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 236
Query: 1064 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116
+E +C + + ++ R+C + P ERP
Sbjct: 237 -----MEKPRNCDDE---------------------VYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 20/101 (19%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
+HS +++HRD+K N+L++ D +K+CDF A T +
Sbjct: 124 IHSANVLHRDLKPSNLLLN---ANCD----LKICDFGLA-------RTTSEKGDFMTE-- 167
Query: 1000 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
V T + APE+L + Y +D+WS GC+ ELL
Sbjct: 168 -YVVTRWYRAPELLLNCSE---YTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 26/140 (18%)
Query: 909 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968
Y+++ + ++ A+ I + + AL LH + I+HRD+K+ENI +D +P
Sbjct: 175 YVDRSGP-----LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD--------EP 221
Query: 969 V-VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1027
L DF A L AH P GT +PE+L A+ + Y + D
Sbjct: 222 ENAVLGDFGAACKLD--------AHPDTPQCYGWSGTLETNSPELL-AL---DPYCAKTD 269
Query: 1028 IWSYGCLLLELLTLQVPYMG 1047
IWS G +L E+ V G
Sbjct: 270 IWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 61/254 (24%), Positives = 92/254 (36%), Gaps = 57/254 (22%)
Query: 897 FMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956
FM Y GS + ++ G + LF A L LH +HR+IK+ +IL
Sbjct: 80 FMAY---GSANSLLKTYFPEGMSEALIGNILFGA---LRGLNYLHQNGYIHRNIKASHIL 133
Query: 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA------PDVCVGTPRWMAP 1010
I DG V L H + G A P W++P
Sbjct: 134 I-----SGDG-----------LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177
Query: 1011 EVLRAMHKPNLYGLEV--DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1068
E+LR +LYG V DI+S G EL T +VP+ + ++ L+Q K P +
Sbjct: 178 ELLRQ----DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPL 231
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSF---------------------LVDVFRRC 1107
C E + S SG + E + ++ C
Sbjct: 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELC 291
Query: 1108 TEENPTERPTAGDL 1121
+++P +RP+A L
Sbjct: 292 LQQDPEKRPSASSL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 19/117 (16%)
Query: 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1000
H K+ +HRDIK NIL+ + K +KL DF A R + + P +
Sbjct: 133 HKKNFLHRDIKCSNILL-------NNKGQIKLADFGLA---RLY-----NSEESRPYTNK 177
Query: 1001 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
V T + PE+L + YG +D+WS GC+L EL T + + EL +LI
Sbjct: 178 -VITLWYRPPELLLGEER---YGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-05
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 19/109 (17%)
Query: 929 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 988
+A+ + +A+ +H + I+HRDIK+EN+L+ +G + L DF A R
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLV-------NGPEDICLGDFGAACFAR------ 311
Query: 989 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037
P GT APEVL + Y VDIWS G ++ E
Sbjct: 312 --GSWSTPFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 75/240 (31%)
Query: 896 IFMEYVKGGSVKNYIEK--LSET----GEKH-----VSVKLALFIAQDVAAALVELHSKH 944
+ +EY G++ +++ K + ET + +S + L A DVA + L K
Sbjct: 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 132
Query: 945 IMHRDIKSENILI--DLERKKAD-----GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 997
+HRD+ + NIL+ + K AD G+ V R +P+R
Sbjct: 133 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPVR--------------- 176
Query: 998 PDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDL 1056
WMA E L ++Y D+WSYG LL E+++L PY G++ E+++
Sbjct: 177 ---------WMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223
Query: 1057 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116
+ G R LE +C + + D+ R+C E P ERP
Sbjct: 224 LPQGYR------LEKPLNCDDE---------------------VYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 38/109 (34%), Positives = 53/109 (48%), Gaps = 24/109 (22%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 998
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 134 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 176
Query: 999 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
V T + APEV+ M Y VDIWS GC++ E++ V + G
Sbjct: 177 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 52/241 (21%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ ME++ GS+K Y+ + + +++K L A + + L S+ +HRD+ + N+
Sbjct: 85 LIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 140
Query: 956 LIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013
L++ E + VK+ DF +A+ +T D W APE L
Sbjct: 141 LVESEHQ-------VKIGDFGLTKAIETDKEYYT---------VKDDLDSPVFWYAPECL 184
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1073
+ + + D+WS+G L ELLT Y + ++M +G
Sbjct: 185 --IQSK--FYIASDVWSFGVTLYELLT----YCDSESSPMTLFLKM------------IG 224
Query: 1074 SCHEH-------EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1126
H V + G +P E + L+ R+C E P++R T +L E F
Sbjct: 225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLM---RKCWEFQPSKRTTFQNLIEGFE 281
Query: 1127 A 1127
A
Sbjct: 282 A 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 38/113 (33%), Positives = 53/113 (46%), Gaps = 22/113 (19%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
LHS I+HRD+K NI++ K+D +K+ DF A T C P
Sbjct: 139 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLA-------RTACTNFMMTPY-- 182
Query: 1000 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1052
V T + APEV+ M Y VDIWS GC++ EL+ V + G ++
Sbjct: 183 --VVTRYYRAPEVILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 47/220 (21%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
LKV +E ++ + E +L L+H+ IV + H I H ++
Sbjct: 35 LKVISMKTEE--GVPFTAIREASLLKGLKHANIVLL--HDII-------------HTKET 77
Query: 895 AIF-MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953
F EY+ + I+ G H + LF+ Q + L +H +HI+HRD+K +
Sbjct: 78 LTFVFEYMHTDLAQYMIQ---HPGGLH-PYNVRLFMFQ-LLRGLAYIHGQHILHRDLKPQ 132
Query: 954 NILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
N+LI + +KL DF RA + S ++ + PDV +G
Sbjct: 133 NLLISYLGE-------LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD----- 180
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1051
Y +DIW GC+ +E+L Q + G+S++
Sbjct: 181 ----------YSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-05
Identities = 37/122 (30%), Positives = 55/122 (45%), Gaps = 13/122 (10%)
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
V AL H++ I+HRD+K +NI++ + +P K+ DF L
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMV----SQTGVRPHAKVLDFGIGTLLPGVRD---ADV 140
Query: 993 RGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1051
+ +GTP + APE LR PN D++++G + LE LT Q G S
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPN-----SDLYAWGLIFLECLTGQRVVQGASVA 195
Query: 1052 EI 1053
EI
Sbjct: 196 EI 197
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 36/158 (22%)
Query: 904 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963
G+ N I K + + HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 105 GADLNNIVKCQKLTDDHVQ-----FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE- 158
Query: 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWM-APEV-LRAMHKP 1019
+K+ DF A HT D G RW APE+ L MH
Sbjct: 159 ------LKILDFGLA------RHT----------DDEMTGYVATRWYRAPEIMLNWMH-- 194
Query: 1020 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 195 --YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 41/212 (19%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
L E ++ L + IV M G + W+ + ME + G + +++K
Sbjct: 44 LREANVMQQLDNPYIVRMIGICEAESWM---------------LVMELAELGPLNKFLQK 88
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
KHV+ K + V+ + L + +HRD+ + N+L+ + K+
Sbjct: 89 -----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-------YAKI 136
Query: 973 CDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
DF + L + + H P +W APE + +K + + D+WS+
Sbjct: 137 SDFGLSKALGADENYYKAKTHGKWPV--------KWYAPECMN-YYK---FSSKSDVWSF 184
Query: 1032 GCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1062
G L+ E + Q PY G+ E+ +I+ G+R
Sbjct: 185 GVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLL-QRLENLDLSNN 243
L L LDL+ N+++ +E+ L L SL + NN + ++P + LL L+ LDLS+N
Sbjct: 91 NLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDN 150
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++ SL L + NL+NL+L +N L
Sbjct: 151 KIESL-PSPLRNLPNLKNLDLSFNDLSD 177
|
Length = 394 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 75/309 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ L+ +S + +F EV++L L I + G L
Sbjct: 51 VKVLR-PDASDNAREDFL----KEVKILSRLSDPNIARLLGVCTVDPPL----------- 94
Query: 892 LQSAIFMEYVKGGSVKNYIEK------LSETGEKHVSVKLALFIAQDVAAALVELHSKHI 945
+ MEY++ G + +++K K +S L++A +A+ + L S +
Sbjct: 95 ---CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF 151
Query: 946 MHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVG 1003
+HRD+ + N L+ +K+ DF R + + + R P P
Sbjct: 152 VHRDLATRNCLVGKNYT-------IKIADFGMSRNLYSSDY---YRVQGRA-PLP----- 195
Query: 1004 TPRWMAPE-VLRAMHKPNLYGLEVDIWSYGCLLLELLTL--QVPYMGLSELEIHDLIQ-M 1059
RWMA E VL + K + + D+W++G L E+LTL + PY L +I+
Sbjct: 196 -IRWMAWESVL--LGK---FTTKSDVWAFGVTLWEILTLCREQPY---EHLTDQQVIENA 246
Query: 1060 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119
G R L +P + + ++ C + +RPT
Sbjct: 247 GHFFRDDGRQIYLP---------------RPPNCPKD---IYELMLECWRRDEEDRPTFR 288
Query: 1120 DLYEMFVAR 1128
+++ +F+ R
Sbjct: 289 EIH-LFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 28/137 (20%)
Query: 927 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 986
+ I +AA + L S H++H+D+ + N+L+ K VK+ D + + +
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-------DKLNVKISDLGLFREVYAADY 179
Query: 987 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLT--L 1041
+ + +P RWM+PE + +YG ++ DIWSYG +L E+ + L
Sbjct: 180 YKLMGNSLLPI--------RWMSPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 1042 QVPYMGLSELEIHDLIQ 1058
Q PY G S ++ ++I+
Sbjct: 225 Q-PYCGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 46/217 (21%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 912
E +++ L H +V++YG +S I + E+++ G + +Y+
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTE----------------RSPICLVFEFMEHGCLSDYLR- 91
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
++ G+ S + L + DV + L S +++HRD+ + N L+ + VVK+
Sbjct: 92 -AQRGK--FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-------VVKV 141
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF R L + G P +W +PEV + Y + D+WS+G
Sbjct: 142 SDFGMT---RFVLDDQYTSSTGTKFP------VKWSSPEVF----SFSKYSSKSDVWSFG 188
Query: 1033 CLLLELLTL-QVPYMGLSELEIHDLIQMGKR---PRL 1065
L+ E+ + + PY S E+ + I G R PRL
Sbjct: 189 VLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL 225
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-05
Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 26/110 (23%)
Query: 936 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI 995
AL +H+ ++ HRD+K +NIL + AD K +K+CDF A +F T
Sbjct: 115 ALKYIHTANVFHRDLKPKNILAN-----ADCK--LKICDFGLARV--AFNDT-------- 157
Query: 996 PAPDVCVGT----PRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
P T RW APE+ + Y +DIWS GC+ E+LT
Sbjct: 158 --PTAIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 7e-05
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
+HS +++HRD+K N+L++ +++ DF A L S H+
Sbjct: 123 IHSANVIHRDLKPSNLLVN-------EDCELRIGDFGMARGLSSS----PTEHKYFMTEY 171
Query: 1000 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039
V RW APE+L ++ + Y +D+WS GC+ E+L
Sbjct: 172 V---ATRWYRAPELLLSLPE---YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 49/191 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 53 EVSLLKNLKHANIVTL--HDII------------HTERCLTLVFEYLDS-DLKQYLDNCG 97
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
H +VK+ +F + L H + I+HRD+K +N+LI + K +KL D
Sbjct: 98 NLMSMH-NVKIFMF---QLLRGLSYCHKRKILHRDLKPQNLLI-------NEKGELKLAD 146
Query: 975 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029
F ++VP +++ + + +R PDV +G+ + P +D+W
Sbjct: 147 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSTEYSTP---------------IDMW 188
Query: 1030 SYGCLLLELLT 1040
GC+L E+ T
Sbjct: 189 GVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 20/131 (15%)
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
+A + L + ++HRD+ + N+L+ VK+ DF A L +
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVK-------TPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 993 RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSEL 1051
+P +WMA E + +H+ +Y + D+WSYG + EL+T PY G+
Sbjct: 171 GKVPI--------KWMALESI--LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218
Query: 1052 EIHDLIQMGKR 1062
EI +++ G+R
Sbjct: 219 EISSILEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 50/215 (23%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSL--------------TLVFEYLDK-DLKQYMDDCG 98
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
H +VK+ L+ + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NIMSMH-NVKIFLY---QILRGLAYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 975 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029
F ++VP +++ + + +R PDV +G+ Y ++D+W
Sbjct: 148 FGLARAKSVPTKTYSNEVVTLWYR---PPDVLLGSSE---------------YSTQIDMW 189
Query: 1030 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 1063
GC+ E+ + + + G + E E+H + ++ P
Sbjct: 190 GVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 20/146 (13%)
Query: 918 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 977
+ ++ +L L +A ++ L + ++HRD+ + N+L+ VK+ DF
Sbjct: 103 KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH-------VKITDFGL 155
Query: 978 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037
A L +P +WMA E + + + D+WSYG + E
Sbjct: 156 ARLLEGDEKEYNADGGKMPI--------KWMALECIHYRK----FTHQSDVWSYGVTIWE 203
Query: 1038 LLTL-QVPYMGLSELEIHDLIQMGKR 1062
L+T PY G+ EI DL++ G+R
Sbjct: 204 LMTFGGKPYDGIPTREIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 40/133 (30%), Positives = 58/133 (43%), Gaps = 32/133 (24%)
Query: 925 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPV-----------VKL 972
LA I Q AL H++ H+MH D+K ENIL++ D PV V++
Sbjct: 233 LAQIIFQ-TGVALDYFHTELHLMHTDLKPENILMETSDTVVD--PVTNRALPPDPCRVRI 289
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
CD L CC A V T + +PEV+ + + D+WS G
Sbjct: 290 CD----------LGGCCDERHSRTA---IVSTRHYRSPEVVLGLG----WMYSTDMWSMG 332
Query: 1033 CLLLELLTLQVPY 1045
C++ EL T ++ Y
Sbjct: 333 CIIYELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 20/133 (15%)
Query: 927 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 986
L IA +AA + L S +H+D+ + NILI + VK+ D + + S +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-------VKISDLGLSREIYSADY 179
Query: 987 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PY 1045
+P RWM PE + + + DIWS+G +L E+ + + PY
Sbjct: 180 YRVQPKSLLPI--------RWMPPEAIMY----GKFSSDSDIWSFGVVLWEIFSFGLQPY 227
Query: 1046 MGLSELEIHDLIQ 1058
G S E+ ++++
Sbjct: 228 YGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 46/243 (18%)
Query: 824 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883
G + ++TLK G + + R+F L E ++G H I+ + G + +K P
Sbjct: 29 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNIIHLEG--VVTKSRPVM 81
Query: 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 943
I E+++ G++ +++ + + +V + + + +AA + L
Sbjct: 82 ------------IITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1003
+ +HRD+ + NIL+ + V K+ DF L FL P +G
Sbjct: 126 NYVHRDLAARNILV-------NSNLVCKVSDFG----LSRFLED----DTSDPTYTSSLG 170
Query: 1004 TP---RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 1059
RW APE + A K + D+WSYG ++ E+++ + PY +S ++ + I+
Sbjct: 171 GKIPIRWTAPEAI-AYRK---FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ 226
Query: 1060 GKR 1062
R
Sbjct: 227 DYR 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 36/112 (32%), Positives = 52/112 (46%), Gaps = 20/112 (17%)
Query: 929 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 988
I + + A+ +H K ++HRDIK ENI ++ DGK V L DF A+P
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLN-----CDGKIV--LGDFGTAMPFEK----- 319
Query: 989 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
VGT +PE+L + Y DIWS G +LL++L+
Sbjct: 320 ----EREAFDYGWVGTVATNSPEILAG----DGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 16/88 (18%)
Query: 892 LQSA----IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947
LQSA + MEY+ GG VK+ + E+ +A+ +VA AL LH I+H
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEVALALDYLHRHGIIH 127
Query: 948 RDIKSENILIDLERKKADGKPVVKLCDF 975
RD+K +N+LI E +KL DF
Sbjct: 128 RDLKPDNMLISNEGH-------IKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 39/202 (19%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 998
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T P
Sbjct: 142 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMT----------P 184
Query: 999 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 1057
V T + APEV+ M Y VDIWS GC++ E++ V + G ++ + +
Sbjct: 185 YVV--TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 1058 -QMGKR-PRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDV-FRRCTEENPT 1113
Q+G P +L+ + E+ +G FEK DV F +E N
Sbjct: 239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK---------LFPDVLFPADSEHNKL 289
Query: 1114 ERPTAGDLY-EMFVARTSSSIS 1134
+ A DL +M V S IS
Sbjct: 290 KASQARDLLSKMLVIDASKRIS 311
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 50/215 (23%), Positives = 98/215 (45%), Gaps = 50/215 (23%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV +L L+H+ IV ++ + K L + EY+ +K Y++
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSL--------------TLVFEYLDK-DLKQYLDDCG 98
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ H +VKL LF + L H + ++HRD+K +N+LI+ ER + +KL D
Sbjct: 99 NSINMH-NVKLFLF---QLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGE------LKLAD 147
Query: 975 FD----RAVPLRSFLH-TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029
F +++P +++ + + +R PD+ +G+ Y ++D+W
Sbjct: 148 FGLARAKSIPTKTYSNEVVTLWYR---PPDILLGSTD---------------YSTQIDMW 189
Query: 1030 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP 1063
GC+ E+ T + + G + E ++H + ++ P
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 38/204 (18%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
LKV S R+ + M+ + H IV +YG + +++
Sbjct: 37 LKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRD--------------VEN 79
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
+ E+V+ G + ++ + S+ ++ +A+ +A+AL L K ++H ++ ++N
Sbjct: 80 IMVEEFVEFGPLDLFMHRKSDV----LTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKN 135
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
IL+ E + P +KL D +P+ C+ IP W+APE +
Sbjct: 136 ILLAREGIDGECGPFIKLS--DPGIPITVLSRQECVER--IP----------WIAPECVE 181
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLEL 1038
NL + D WS+G L E+
Sbjct: 182 --DSKNL-SIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 24/109 (22%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA-VPLRSFLHTCCIAHRGIPAP 998
LHS I+HRD+K NI++ K+D +K+ DF A SF+ T + R AP
Sbjct: 135 LHSAGIIHRDLKPSNIVV-----KSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 999 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
+V +G Y VDIWS GC++ E++ ++ + G
Sbjct: 188 EVILGMG----------------YKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 899 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958
E+V+ G + + K E G V V + +AQ +A+AL L K+++H ++ ++NIL
Sbjct: 96 EFVEHGPLDVCLRK--EKG--RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL-- 149
Query: 959 LERKK-ADG-KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1016
L R A+G P +KL D P SF + + V W+APE +
Sbjct: 150 LARLGLAEGTSPFIKLSD-----PGVSF---------TALSREERVERIPWIAPECV--- 192
Query: 1017 HKPNLYGLE--VDIWSYGCLLLEL-LTLQVPYMGLSELEIHDLIQMGKRPRLTD----EL 1069
P L D WS+G LLE+ +VP + E + K+ RL + EL
Sbjct: 193 --PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE--KKHRLPEPSCKEL 248
Query: 1070 EAL-GSCHEHEVAQSGS 1085
L C +E Q S
Sbjct: 249 ATLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 57/256 (22%), Positives = 107/256 (41%), Gaps = 48/256 (18%)
Query: 799 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM 858
G S ++ G+ +++++ G + K+ LKV +E ++ + E +
Sbjct: 2 GKADSYEKLEKLGEGSYATVYK---GKSKVNGKLVALKVIRLQEEE--GTPFTAIREASL 56
Query: 859 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 918
L L+H+ IV + H I H + EYV + Y++K G
Sbjct: 57 LKGLKHANIVLL--HDII------------HTKETLTLVFEYVHT-DLCQYMDK-HPGGL 100
Query: 919 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD-- 976
+VKL LF + L +H ++I+HRD+K +N+LI + +KL DF
Sbjct: 101 HPENVKLFLF---QLLRGLSYIHQRYILHRDLKPQNLLISDTGE-------LKLADFGLA 150
Query: 977 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036
RA + S ++ + PDV +G+ Y +D+W GC+ +
Sbjct: 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTE---------------YSTCLDMWGVGCIFV 195
Query: 1037 ELLTLQVPYMGLSELE 1052
E++ + G+ +++
Sbjct: 196 EMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 6e-04
Identities = 34/113 (30%), Positives = 45/113 (39%), Gaps = 15/113 (13%)
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNKL----- 222
IR L + NLE LDL+ N L + LK+L L + +N L
Sbjct: 179 DAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238
Query: 223 VELPSGL-YLLQRLENLDLSNNRLTSLGSLDLCL----MHNLQNLNLQYNKLL 270
L S L L L LS N +T G+ DL +L L+L+ NK
Sbjct: 239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 65/265 (24%), Positives = 95/265 (35%), Gaps = 74/265 (27%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ ME++ GG + + K E+ +IA+ V A + +H +HRDIK +N+
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQ----FYIAETVLA-IDSIHQLGFIHRDIKPDNL 132
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR---------GIPAPDV------ 1000
L+ D K VKL DF L+ AHR +P+
Sbjct: 133 LL-------DSKGHVKLSDFGLCTGLKK-------AHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 1001 -----------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1043
VGTP ++APEV Y D WS G ++ E+L
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ----TGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 1044 PYMGLSELEIHDLIQMGKRPRLTDELEA----------LGSCHEHEVAQSGSGFEKPEAE 1093
P+ + E + + M + L E L C E E G E E
Sbjct: 235 PFCSETPQETYKKV-MNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVE----E 289
Query: 1094 LETLSFLVDVFRRCTEENPTERPTA 1118
++T F F E+ ERP A
Sbjct: 290 IKTNPF----FEGVDWEHIRERPAA 310
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 41/116 (35%), Positives = 49/116 (42%), Gaps = 20/116 (17%)
Query: 927 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 986
L I + V A+ LH I+HRDIK+ENI I+ D V L DF A
Sbjct: 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGD----VCLGDFGAA-------- 229
Query: 987 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042
C GT APE+L P YG VDIWS G +L E+ T
Sbjct: 230 -CFPVDINANKYYGWAGTIATNAPELL--ARDP--YGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 22/132 (16%)
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
+A + L ++HRD+ + N+L+ VK+ DF A L T A
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNH-------VKITDFGLA-RLLDIDETEYHAD 169
Query: 993 RG-IPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSE 1050
G +P +WMA E + +H+ + + D+WSYG + EL+T PY G+
Sbjct: 170 GGKVPI--------KWMALESI--LHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
Query: 1051 LEIHDLIQMGKR 1062
EI DL++ G+R
Sbjct: 218 REIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 27/127 (21%)
Query: 928 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 987
F+ + L +H+ I+HRD+K N+ ++ + + +K+ DF A S +
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-------LKILDFGLARQTDSEMTG 174
Query: 988 CCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
+ RW APEV L MH Y VDIWS GC++ E+LT + +
Sbjct: 175 YVVT--------------RWYRAPEVILNWMH----YTQTVDIWSVGCIMAEMLTGKPLF 216
Query: 1046 MGLSELE 1052
G L+
Sbjct: 217 KGHDHLD 223
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-04
Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 175 SIRYL---------PPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV- 223
S+RYL G + NLE LDLS N + +P +I +L L + N LV
Sbjct: 119 SLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG 178
Query: 224 ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
++P+ L L LE L L++N+L +L M +L+ + L YN L
Sbjct: 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
|
Length = 968 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 8e-04
Identities = 17/37 (45%), Positives = 23/37 (62%), Gaps = 2/37 (5%)
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LE LDLSNN++T L L + NL+ L+L NK+
Sbjct: 1 TNLETLDLSNNQITDLPPL--SNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 0.001
Identities = 64/255 (25%), Positives = 95/255 (37%), Gaps = 66/255 (25%)
Query: 834 TLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVE--MYGH-KISSKWLPSADGNPEH 889
+LKV G A E+R + G + + LR + ++E H + L ADG
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 890 HLLQS-------AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 942
+ S + ME++ GG + + K E+ +IA+ V A + +H
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQ----FYIAETVLA-IDAIHQ 119
Query: 943 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGI------- 995
+HRDIK +N+L+ D K VKL DF L+ AHR
Sbjct: 120 LGFIHRDIKPDNLLL-------DAKGHVKLSDFGLCTGLKK-------AHRTEFYRNLTH 165
Query: 996 -PAPDV------------------------CVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1030
P D VGTP ++APEV Y D WS
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG----YNKLCDWWS 221
Query: 1031 YGCLLLELLTLQVPY 1045
G ++ E+L P+
Sbjct: 222 LGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 27/110 (24%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
+HS I+HRD+K N+ ++ + + +K+ DF A R A
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCE-------LKILDFGLA--------------RHADAEM 171
Query: 1000 VCVGTPRWM-APEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
RW APEV L MH Y VDIWS GC++ E+LT + + G
Sbjct: 172 TGYVVTRWYRAPEVILNWMH----YNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 28/144 (19%)
Query: 904 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963
G+ N I K + ++HV F+ + L +HS I+HRD+K N+ ++ + +
Sbjct: 103 GADLNNIVKCQKLSDEHVQ-----FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE- 156
Query: 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1023
+++ DF A + T +A R AP++ +L MH Y
Sbjct: 157 ------LRILDFGLARQADDEM-TGYVATRWYRAPEI-----------MLNWMH----YN 194
Query: 1024 LEVDIWSYGCLLLELLTLQVPYMG 1047
VDIWS GC++ ELL + + G
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 65/263 (24%), Positives = 96/263 (36%), Gaps = 80/263 (30%)
Query: 833 RTLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHSCIVEMY-----GH---------KISS 877
T+KV G A E+R + G++ + L S EM+ H + S
Sbjct: 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS---EMFKKDQLAHVKAERDVLAESDS 60
Query: 878 KWLPSADGNPEHHLLQSAIF----MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDV 933
W+ S ++ Q A + ME++ GG + + K E + F +
Sbjct: 61 PWVVSL-----YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAEC 110
Query: 934 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF----------DRAV---P 980
A+ +H +HRDIK +NILID G +KL DF D A
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILID-----RGGH--IKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 981 LRSFLHTCCIAHRGIPAPDV------------------------CVGTPRWMAPEVLRAM 1016
L+ + I +R A D VGTP ++APE+
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 1017 HKPNLYGLEVDIWSYGCLLLELL 1039
YG E D WS G ++ E L
Sbjct: 224 G----YGQECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 1000 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
LH+ ++HRD+K NIL+ E + + VK+ D A S L + + D
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPE---RGRVKIADMGFARLFNSPL-------KPLADLD 173
Query: 1000 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
V T + APE+L Y +DIW+ GC+ ELLT
Sbjct: 174 PVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 49/210 (23%)
Query: 859 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE 918
+G+L H+ IV + G P A LQ + + GS+ +++ + ++
Sbjct: 63 MGSLDHAYIVRLLG------ICPGAS-------LQ--LVTQLSPLGSLLDHVRQHRDS-- 105
Query: 919 KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 978
+ + L +A + L ++HR++ + NIL+ K+D +V++ DF A
Sbjct: 106 --LDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL-----KSDS--IVQIADFGVA 156
Query: 979 VPL----RSFLHTCCIAHRGIPAPDVCVGTP-RWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033
L + + ++ TP +WMA L ++ Y + D+WSYG
Sbjct: 157 DLLYPDDKKYFYSE-------------HKTPIKWMA---LESILFGR-YTHQSDVWSYGV 199
Query: 1034 LLLELLTLQV-PYMGLSELEIHDLIQMGKR 1062
+ E+++ PY G+ E+ DL++ G+R
Sbjct: 200 TVWEMMSYGAEPYAGMRPHEVPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1137 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.93 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.9 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.68 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.64 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.6 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.59 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.58 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.47 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.46 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.11 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.06 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.02 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.01 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.94 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.94 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.9 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.89 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.76 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.75 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.57 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.53 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.52 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.47 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.46 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.44 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.35 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.31 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 98.29 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-59 Score=603.14 Aligned_cols=303 Identities=19% Similarity=0.197 Sum_probs=191.1
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCCCCcEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNL 96 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~-~IP~~~~~L~~L~~L 96 (1137)
.++.|.+..|++....+..|.++++|++|+|++|.+++.+|..+..+ ++|+.|+|++|.++ .+|..++.+++|+.|
T Consensus 285 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l---~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L 361 (968)
T PLN00113 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL---PRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361 (968)
T ss_pred CcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcC---CCCCEEECcCCCCcCcCChHHhCCCCCcEE
Confidence 57777777888877777777888888888888888887777766544 77788888888776 667777777788888
Q ss_pred EccCCCCC-cccccccCCCCCCEEEccCCCC-CCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCC
Q 001152 97 KFFGNEIN-LFPSEVGNLLGLECLQIKISSP-GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1137)
Q Consensus 97 ~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~~-~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1137)
+|++|+++ .+|..+..+.+|+.|+++.|.+ +..|..+..+++|+.|++++|.+ .+.+|..+..++.|+.|++++|
T Consensus 362 ~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l---~~~~p~~~~~l~~L~~L~Ls~N 438 (968)
T PLN00113 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF---SGELPSEFTKLPLVYFLDISNN 438 (968)
T ss_pred ECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEe---eeECChhHhcCCCCCEEECcCC
Confidence 88888776 5677777777777777777763 34556666677777777776433 3345556666666666666666
Q ss_pred CCc-ccCccccCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccCCcCCCCCcc
Q 001152 175 SIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSL 251 (1137)
Q Consensus 175 ~L~-~IP~~l~~L~~L~~L~Ls~N~L~-~LP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~N~Lsg~~p~ 251 (1137)
.++ .+|..+..+++|++|+|++|++. .+|..+ .+++|+.|+|++|+++ .+|..+.++++|+.|+|++|++++.+|.
T Consensus 439 ~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 517 (968)
T PLN00113 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPD 517 (968)
T ss_pred cccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCCh
Confidence 665 34444555555555555555554 333322 2345555555555554 4444455555555555555555555554
Q ss_pred cccCCCCCCEEEccCCcCCCC-----CCCCcchhhccCCCCCCCC-------CCCcccccccccccCCCc-----ccCCC
Q 001152 252 DLCLMHNLQNLNLQYNKLLSY-----CQVPSWICCNLEGNGKDSS-------NDDFISSSAEMDVYEGPM-----LENDG 314 (1137)
Q Consensus 252 ~l~~L~~L~~L~Ls~N~L~~~-----~~iP~~~~~~l~~n~l~~~-------~~~l~~~~~s~n~l~g~i-----l~~~~ 314 (1137)
.+..+++|++|+|++|.+++. ..++..-.+++++|.+... ...+..+++++|.+.|++ +.++.
T Consensus 518 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~ 597 (968)
T PLN00113 518 ELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAIN 597 (968)
T ss_pred HHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccC
Confidence 555555555555555555441 1122222334444444322 235677788888888866 46778
Q ss_pred CCcccCCCCCCcc
Q 001152 315 NVSFSGSRHTSSS 327 (1137)
Q Consensus 315 ~~sf~GN~~lC~~ 327 (1137)
..+|.||+++|..
T Consensus 598 ~~~~~~n~~lc~~ 610 (968)
T PLN00113 598 ASAVAGNIDLCGG 610 (968)
T ss_pred hhhhcCCccccCC
Confidence 8899999999943
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=412.20 Aligned_cols=276 Identities=24% Similarity=0.314 Sum_probs=222.5
Q ss_pred CCCCCCCC-ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 796 LDPGSFPS-LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 796 ~~~~~~~~-y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
..+.++.+ |.+.+.||+|+||.|-+|... +..||||++...+.......... ...+.+|++||++|+|||||++++
T Consensus 165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~-~~~v~~EieILkkL~HP~IV~~~d 243 (475)
T KOG0615|consen 165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAK-TRDVQNEIEILKKLSHPNIVRIKD 243 (475)
T ss_pred CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccc-hhhhHHHHHHHHhcCCCCEEEEee
Confidence 34455555 688899999999999999874 57899999655443332211111 122478999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
+|...+ ..||||||+.||+|.+.+-. .+.+.+..-+.+++|++.|+.|||++||+||||||
T Consensus 244 ~f~~~d--------------s~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKP 304 (475)
T KOG0615|consen 244 FFEVPD--------------SSYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKP 304 (475)
T ss_pred eeecCC--------------ceEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHcCcccccCCc
Confidence 999877 55999999999999999876 45788889999999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
+|||+..+. ....+||+|||+|+....... ..+.+|||.|.|||++... ....+..++|+||+|
T Consensus 305 eNILl~~~~----e~~llKItDFGlAK~~g~~sf-----------m~TlCGTpsYvAPEVl~~k-g~~~~~~kVDiWSlG 368 (475)
T KOG0615|consen 305 ENILLSNDA----EDCLLKITDFGLAKVSGEGSF-----------MKTLCGTPSYVAPEVLASK-GVEYYPSKVDIWSLG 368 (475)
T ss_pred ceEEeccCC----cceEEEecccchhhcccccee-----------hhhhcCCccccChhheecC-Ceecccchheeeecc
Confidence 999998762 337899999999987654321 2256799999999999863 223445699999999
Q ss_pred HHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001152 1033 CLLLELLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~e-l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
|++|-+++|.+||.+..... +.++|.+|.....+..+. ..+++..+||.+||..|
T Consensus 369 cvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~------------------------~Iseea~dlI~~mL~Vd 424 (475)
T KOG0615|consen 369 CVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD------------------------RISEEALDLINWMLVVD 424 (475)
T ss_pred ceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh------------------------hhhHHHHHHHHHhhEeC
Confidence 99999999999998754444 888888888655443322 56777999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 001152 1112 PTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~~~~~s 1131 (1137)
|++|||++|+++|+|++..+
T Consensus 425 P~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 425 PENRPSADEALNHPWFKDAP 444 (475)
T ss_pred cccCcCHHHHhcChhhhccc
Confidence 99999999999999998554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=401.38 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=218.5
Q ss_pred CCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
+..+.+....||+|..|+||+|+++. .-+|+|+..... . . .+++++.+|+++++.++|||||.+||.|+..
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~-~----~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--D-P----ALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--C-H----HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 45577888999999999999999975 556666542221 1 2 2344569999999999999999999999976
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeE
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 956 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NIL 956 (1137)
.. +.+|+||||++|||++++... +++++...-+|+.+|++||.|||+ ++||||||||+|||
T Consensus 150 ~~-------------~isI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlL 211 (364)
T KOG0581|consen 150 GE-------------EISICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLL 211 (364)
T ss_pred Cc-------------eEEeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHee
Confidence 51 479999999999999999862 579999999999999999999995 89999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.. |.|||||||.++.+.... ..+++||..|||||.+++ ..|+.++||||||+.++
T Consensus 212 vNsk-------GeVKicDFGVS~~lvnS~------------a~tfvGT~~YMsPERi~g----~~Ys~~sDIWSLGLsll 268 (364)
T KOG0581|consen 212 VNSK-------GEVKICDFGVSGILVNSI------------ANTFVGTSAYMSPERISG----ESYSVKSDIWSLGLSLL 268 (364)
T ss_pred eccC-------CCEEeccccccHHhhhhh------------cccccccccccChhhhcC----CcCCcccceecccHHHH
Confidence 9988 889999999998766532 236789999999999987 67999999999999999
Q ss_pred HHHhCCCCCCCC-----CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001152 1037 ELLTLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1037 ELLTG~~Pf~~~-----~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
|+++|++||... ...++..+|..+..|.++.. .+++++++|+..||++|
T Consensus 269 E~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--------------------------~fS~ef~~FV~~CL~Kd 322 (364)
T KOG0581|consen 269 ELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--------------------------EFSPEFRSFVSCCLRKD 322 (364)
T ss_pred HHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--------------------------cCCHHHHHHHHHHhcCC
Confidence 999999999763 67788888888777766642 25567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcC
Q 001152 1112 PTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~~~~~ 1130 (1137)
|.+||++.|+++|+|.+..
T Consensus 323 p~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 323 PSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred cccCCCHHHHhcCHHHhhc
Confidence 9999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=407.62 Aligned_cols=259 Identities=26% Similarity=0.383 Sum_probs=220.4
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
++.. .+|...+.||+|||+.+|.+++ .+..+|+||...+.... ....+ ++.+||+|.+.|+|||||+++++|
T Consensus 14 D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k-~~~re----Kv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 14 DPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK-PKQRE----KVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred cCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC-cchHH----HHHHHHHHHHhcCCCcEEeeeeEe
Confidence 4445 7799999999999999999998 46889999865432222 22233 348899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
++.+ ++|||.|+|+.++|..++++ ++.+++.+++.+++||+.||.|||+++|||||||..|
T Consensus 88 EDs~--------------nVYivLELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGN 148 (592)
T KOG0575|consen 88 EDSN--------------NVYIVLELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGN 148 (592)
T ss_pred ecCC--------------ceEEEEEecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhh
Confidence 9987 56999999999999999985 4679999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
+|++++ .+|||+|||+|..+..+.. ...+.+|||.|.|||++.. ..++..+||||+||+
T Consensus 149 lfL~~~-------~~VKIgDFGLAt~le~~~E----------rk~TlCGTPNYIAPEVl~k----~gHsfEvDiWSlGcv 207 (592)
T KOG0575|consen 149 LFLNEN-------MNVKIGDFGLATQLEYDGE----------RKKTLCGTPNYIAPEVLNK----SGHSFEVDIWSLGCV 207 (592)
T ss_pred eeecCc-------CcEEecccceeeeecCccc----------ccceecCCCcccChhHhcc----CCCCCchhhhhhhhH
Confidence 999988 7899999999988765422 1235689999999999975 678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
||.||+|++||+.....+.+..|...... +|. ..+.++++||.++|+.||.+
T Consensus 208 mYtLL~G~PPFetk~vkety~~Ik~~~Y~-~P~---------------------------~ls~~A~dLI~~lL~~~P~~ 259 (592)
T KOG0575|consen 208 MYTLLVGRPPFETKTVKETYNKIKLNEYS-MPS---------------------------HLSAEAKDLIRKLLRPNPSE 259 (592)
T ss_pred HHhhhhCCCCcccchHHHHHHHHHhcCcc-ccc---------------------------ccCHHHHHHHHHHhcCCccc
Confidence 99999999999998888888888654421 111 34456899999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001152 1115 RPTAGDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~ 1129 (1137)
|||+++|+.|.||..
T Consensus 260 Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 260 RPSLDEVLDHPFFKS 274 (592)
T ss_pred CCCHHHHhcCHhhhC
Confidence 999999999999954
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=386.68 Aligned_cols=263 Identities=26% Similarity=0.415 Sum_probs=209.9
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...+.+|.+.++||.|+||+||+|+++. ..||||. +.+..-.....+.. ..|+.+|+.++|||||++++++.
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~--i~~~~l~~k~~e~L----~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKC--IAKKKLNKKLVELL----LSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeee--ehhhccCHHHHHHH----HHHHHHHHhcCCcceeeEEEEEe
Confidence 4467899999999999999999999864 5566665 33332234444444 88999999999999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
.++ ..|||||||+||+|.+||+. ...+++.+++.++.|||.||++||+++||||||||+||
T Consensus 80 ~~~--------------~i~lVMEyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNi 140 (429)
T KOG0595|consen 80 DDD--------------FIYLVMEYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNI 140 (429)
T ss_pred cCC--------------eEEEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceE
Confidence 877 56999999999999999987 34799999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.... ......+||+|||+|+.+..... ..+.+|+|.|||||+++. ..|+.|+|+||+|+|+
T Consensus 141 LLs~~~~-~~~~~~LKIADFGfAR~L~~~~~-----------a~tlcGSplYMAPEV~~~----~~YdAKADLWSiG~Il 204 (429)
T KOG0595|consen 141 LLSTTAR-NDTSPVLKIADFGFARFLQPGSM-----------AETLCGSPLYMAPEVIMS----QQYDAKADLWSIGTIL 204 (429)
T ss_pred EeccCCC-CCCCceEEecccchhhhCCchhH-----------HHHhhCCccccCHHHHHh----ccccchhhHHHHHHHH
Confidence 9987621 11126899999999998764321 125579999999999975 6899999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCC--CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKR--PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~--p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
|+|++|+.||...+..++...+.++.. +.++.. ....+.+++...++.+|.
T Consensus 205 yq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~---------------------------~s~~~~~Ll~~ll~~~~~ 257 (429)
T KOG0595|consen 205 YQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAE---------------------------LSNPLRELLISLLQRNPK 257 (429)
T ss_pred HHHHhCCCCccccCHHHHHHHHhccccccCchhhh---------------------------ccCchhhhhhHHHhcCcc
Confidence 999999999999999999988876653 222221 112255666667777777
Q ss_pred CCCCHHHHHHHHHhh
Q 001152 1114 ERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~ 1128 (1137)
+|.++.+-..|.+..
T Consensus 258 ~~~~~~~~~~~~~l~ 272 (429)
T KOG0595|consen 258 DRISFEDFFDHPFLA 272 (429)
T ss_pred ccCchHHhhhhhhcc
Confidence 777777766665554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=380.34 Aligned_cols=265 Identities=27% Similarity=0.432 Sum_probs=215.9
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee-Ee
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH-KI 875 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~-~~ 875 (1137)
+..++.+|++.++||+|+||+||+|....+...++.+++.-...+....+ .+..|+.+|++|+|||||+++++ |.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq----~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQ----DCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHH----HHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 45577889999999999999999999754443333333332222222222 35899999999999999999995 43
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--eeeccCC
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--KH--IMHRDIK 951 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs--~g--IIHrDLK 951 (1137)
++.. -++||||||.+|+|..+|+...+ ....++++.+++++.|++.||.++|. .. |+|||||
T Consensus 90 ~~~e-------------vlnivmE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIK 155 (375)
T KOG0591|consen 90 EDNE-------------VLNIVMELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIK 155 (375)
T ss_pred ccch-------------hhHHHHHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCc
Confidence 3321 37999999999999999997554 45789999999999999999999998 34 8899999
Q ss_pred CCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001152 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031 (1137)
Q Consensus 952 P~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1031 (1137)
|.|||++.+ |.|||+|||+++.+...... ....+|||+||+||.+.+ .+|+.|+||||+
T Consensus 156 PaNIFl~~~-------gvvKLGDfGL~r~l~s~~tf----------A~S~VGTPyYMSPE~i~~----~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 156 PANIFLTAN-------GVVKLGDFGLGRFLSSKTTF----------AHSLVGTPYYMSPERIHE----SGYNFKSDIWSL 214 (375)
T ss_pred chheEEcCC-------CceeeccchhHhHhcchhHH----------HHhhcCCCcccCHHHHhc----CCCCcchhHHHH
Confidence 999999988 89999999999987654321 235689999999999986 789999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001152 1032 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1032 GviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
||++|||..-++||.+.+-.++...|.++..|+++.. .++.++..|+..|+..|
T Consensus 215 GCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~--------------------------~YS~~l~~li~~ci~vd 268 (375)
T KOG0591|consen 215 GCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDE--------------------------HYSTDLRELINMCIAVD 268 (375)
T ss_pred HHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHH--------------------------HhhhHHHHHHHHHccCC
Confidence 9999999999999999999999999999988776643 45566999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 001152 1112 PTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~ 1126 (1137)
|+.||+.-.++....
T Consensus 269 ~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 269 PEQRPDTVPYVQDIQ 283 (375)
T ss_pred cccCCCcchHHHHHH
Confidence 999998655544443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=396.75 Aligned_cols=264 Identities=30% Similarity=0.453 Sum_probs=217.7
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCcc-EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGSAD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~-vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
...+....+.+.||.|+||+||+|.|.++. ||||++.... .+... ...|.+|+.+|.+++|||||+++|++.+
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~--~~~~~----~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPD--FDDES----RKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchh--cChHH----HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 344556677788999999999999999988 9999854332 22222 3345999999999999999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCCCCe
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENI 955 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g-IIHrDLKP~NI 955 (1137)
... .++|||||+++|+|.++++.. ....+++..+++|+.|||+||+|||+++ ||||||||+||
T Consensus 111 ~~~-------------~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~Ni 174 (362)
T KOG0192|consen 111 PPG-------------SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNI 174 (362)
T ss_pred CCC-------------ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhE
Confidence 531 469999999999999999863 3457999999999999999999999999 99999999999
Q ss_pred EeccccccCCCCC-eEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 956 LIDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 956 Lld~~~~~~~~~~-~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
|++.+ . ++||+|||+++....... ......||+.|||||++.+. ...|+.|+||||||++
T Consensus 175 Lv~~~-------~~~~KI~DFGlsr~~~~~~~----------~~~~~~GT~~wMAPEv~~~~--~~~~~~K~DvySFgIv 235 (362)
T KOG0192|consen 175 LVDLK-------GKTLKIADFGLSREKVISKT----------SMTSVAGTYRWMAPEVLRGE--KSPYTEKSDVYSFGIV 235 (362)
T ss_pred EEcCC-------CCEEEECCCccceeeccccc----------cccCCCCCccccChhhhcCC--CCcCCccchhhhHHHH
Confidence 99988 5 899999999976553210 11125799999999999853 3679999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHH-HcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I-~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|||+||+.||.+....++...+ ..+.+|.++. .+++.+..++.+||..||.
T Consensus 236 lWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~---------------------------~~~~~l~~l~~~CW~~dp~ 288 (362)
T KOG0192|consen 236 LWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK---------------------------ECPPHLSSLMERCWLVDPS 288 (362)
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc---------------------------cCCHHHHHHHHHhCCCCCC
Confidence 99999999999998887777776 4555665553 2445699999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001152 1114 ERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~ 1129 (1137)
+||++.+|+..+....
T Consensus 289 ~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 289 RRPSFLEIVSRLESIM 304 (362)
T ss_pred cCCCHHHHHHHHHHHH
Confidence 9999999999988653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=383.59 Aligned_cols=261 Identities=27% Similarity=0.331 Sum_probs=221.6
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
.....+|++.++||+|+||.||.++.. ++-+|+|+.+.+.... ..+.+. +..|..||.+++||+||+++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~----~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRH----TKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHH----HHHHHHHHHhCCCCcEeeeEEecc
Confidence 456788999999999999999999874 5678888865444333 223333 388999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+.. ++|+|+||+.||.|..+|++ ...|++..++.++..|+.||.|||++|||||||||+||
T Consensus 96 t~~--------------kLylVld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENI 156 (357)
T KOG0598|consen 96 TEE--------------KLYLVLDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENI 156 (357)
T ss_pred cCC--------------eEEEEEeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHe
Confidence 876 77999999999999999987 45799999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|+|.+ |+++|+|||+|+....... ....++||+.|||||++.+ ..|+..+|+||||+++
T Consensus 157 LLd~~-------GHi~LtDFgL~k~~~~~~~----------~t~tfcGT~eYmAPEil~~----~gy~~~vDWWsLGill 215 (357)
T KOG0598|consen 157 LLDEQ-------GHIKLTDFGLCKEDLKDGD----------ATRTFCGTPEYMAPEILLG----KGYDKAVDWWSLGILL 215 (357)
T ss_pred eecCC-------CcEEEeccccchhcccCCC----------ccccccCCccccChHHHhc----CCCCcccchHhHHHHH
Confidence 99998 9999999999985433211 1235689999999999986 5899999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|||++|.+||.+.+...+.+.|..+..+..+.. .+.+.++++.++|+.||++|
T Consensus 216 YeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~---------------------------ls~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 216 YEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGY---------------------------LSEEARDLLKKLLKRDPRQR 268 (357)
T ss_pred HHHhhCCCCCcCccHHHHHHHHhcCcCCCCCcc---------------------------CCHHHHHHHHHHhccCHHHh
Confidence 999999999999999999999988774443322 23458999999999999999
Q ss_pred C----CHHHHHHHHHhhcC
Q 001152 1116 P----TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 P----Sa~EVL~~L~~~~~ 1130 (1137)
. .+.+|-+|+++..-
T Consensus 269 Lg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 269 LGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred cCCCCChHHhhcCcccccC
Confidence 5 79999999999754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=369.23 Aligned_cols=282 Identities=24% Similarity=0.330 Sum_probs=217.3
Q ss_pred CCceEeeeecccCceEEEEEEECCcc--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~~~--vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|+...++|+|+||+||+++++.+. ||||.| ....+ .+..+. -++|||++|++++|||+|.++++|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF--~Esed-d~~VkK---IAlREIrmLKqLkH~NLVnLiEVFrrkr- 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKF--VESED-DPVVKK---IALREIRMLKQLKHENLVNLIEVFRRKR- 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEee--ccCCc-cHHHHH---HHHHHHHHHHhcccchHHHHHHHHHhcc-
Confidence 35778889999999999999986554 555543 33222 223333 2599999999999999999999998776
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
.+++|+|||+ .++.+-++. . ...++...++++++|++.|+.|+|++++|||||||+||||+.
T Consensus 75 -------------klhLVFE~~d-hTvL~eLe~---~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~ 136 (396)
T KOG0593|consen 75 -------------KLHLVFEYCD-HTVLHELER---Y-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ 136 (396)
T ss_pred -------------eeEEEeeecc-hHHHHHHHh---c-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec
Confidence 6799999998 566555654 2 245899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||||||+|+.+..+.. ..+..++|.+|+|||.+.+ ...|++.+||||+||++.||+
T Consensus 137 ~-------gvvKLCDFGFAR~L~~pgd----------~YTDYVATRWYRaPELLvG---DtqYG~pVDiWAiGCv~aEl~ 196 (396)
T KOG0593|consen 137 N-------GVVKLCDFGFARTLSAPGD----------NYTDYVATRWYRAPELLVG---DTQYGKPVDIWAIGCVFAELL 196 (396)
T ss_pred C-------CcEEeccchhhHhhcCCcc----------hhhhhhhhhhccChhhhcc---cCcCCCcccchhhhHHHHHHh
Confidence 8 8999999999997764321 2235689999999999986 468999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHh---hhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELE---ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|++.|.+.++.+....|.....+-++.... ..+....-.+.+....-..+...+..+..+.+|+..||+.||++|+
T Consensus 197 ~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~ 276 (396)
T KOG0593|consen 197 TGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL 276 (396)
T ss_pred cCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc
Confidence 9999999999888888876655444443322 2111222222222111111222345666799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001152 1117 TAGDLYEMFVAR 1128 (1137)
Q Consensus 1117 Sa~EVL~~L~~~ 1128 (1137)
+.+|++.|.+|.
T Consensus 277 sc~qll~H~yFd 288 (396)
T KOG0593|consen 277 SCEQLLHHPYFD 288 (396)
T ss_pred cHHHHhcChHHH
Confidence 999999999883
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=388.14 Aligned_cols=286 Identities=23% Similarity=0.259 Sum_probs=221.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~ 877 (1137)
..+|.+.++||.|+||.||+|+... ..||+|. .+......++.-. +||+..|++++ |||||++.+++.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~--MK~Kf~s~ee~~n-----LREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKK--MKKKFYSWEECMN-----LREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHH--HHhhhccHHHHHH-----HHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 3679999999999999999999754 4556554 4444444444333 78999999999 99999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+. ++++|||||+ ..|++++++. +..|++..++.|++||++||+|+|.+|+.|||+||+|||+
T Consensus 82 ~~-------------~L~fVfE~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi 143 (538)
T KOG0661|consen 82 DR-------------ILYFVFEFMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI 143 (538)
T ss_pred Cc-------------eEeeeHHhhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe
Confidence 51 6899999997 8999999872 4689999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
... ..+||+|||+|+.+.... ..+..+.|.+|+|||++.. ...|+.++||||+|||++|
T Consensus 144 ~~~-------~~iKiaDFGLARev~Skp-----------PYTeYVSTRWYRAPEvLLr---s~~Ys~pvD~wA~GcI~aE 202 (538)
T KOG0661|consen 144 SGN-------DVIKIADFGLAREVRSKP-----------PYTEYVSTRWYRAPEVLLR---SGYYSSPVDMWAVGCIMAE 202 (538)
T ss_pred ccc-------ceeEecccccccccccCC-----------CcchhhhcccccchHHhhh---ccccCCchHHHHHHHHHHH
Confidence 865 689999999999776533 2335678999999999985 5789999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhh---hcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA---LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+.+-++.|.|.++.+....|...........+.. ....-.-... ...+..........+.++.++|.+||.+||++
T Consensus 203 l~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P-~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~k 281 (538)
T KOG0661|consen 203 LYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFP-QVKPSPLKDLLPNASSEAASLIERLLAWDPDK 281 (538)
T ss_pred HHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCC-cCCCCChHHhCcccCHHHHHHHHHHhcCCCcc
Confidence 9999999999998888777754332211111111 0000000000 01111112222357788999999999999999
Q ss_pred CCCHHHHHHHHHhhcCCCC
Q 001152 1115 RPTAGDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ss~ 1133 (1137)
||||.|+++|++|.....+
T Consensus 282 RpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 282 RPTASQALQHPFFQVGRAS 300 (538)
T ss_pred CccHHHHhcCccccccccc
Confidence 9999999999999876544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=374.52 Aligned_cols=275 Identities=25% Similarity=0.381 Sum_probs=225.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
.....|++.++||.|..++||+|+. .+..||+|+..++.... +.+.+ .+|+..|+.++||||++++..|..
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~---~ld~l----~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN---DLDAL----RKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh---hHHHH----HHHHHHhhhcCCCCcceEEEEEEe
Confidence 3456899999999999999999998 45778888877776533 23444 889999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
+. .+|+||.||.+||+.++++..+..+ +++..+..|++++++||.|||.+|.||||||+.|||
T Consensus 96 ~~--------------~LWvVmpfMa~GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 96 DS--------------ELWVVMPFMAGGSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL 158 (516)
T ss_pred cc--------------eeEEeehhhcCCcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence 77 6799999999999999999876554 999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
|+.+ |.|||+|||.+..+...... ....-..++||++|||||+++. ....|+.|+||||||++..
T Consensus 159 i~~d-------G~VkLadFgvsa~l~~~G~R------~~~rf~tfvgtp~wmAPEvl~q--~~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 159 IDSD-------GTVKLADFGVSASLFDSGDR------QVTRFNTFVGTPCWMAPEVLMQ--QLHGYDFKADIWSFGITAC 223 (516)
T ss_pred EcCC-------CcEEEcCceeeeeecccCce------eeEeeccccCcccccChHHhhh--cccCccchhhhhhhhHHHH
Confidence 9998 89999999988765542211 0011146789999999999665 3467999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
||++|..||....++++...-.++..|.+... . ...+.....+..+++++..||+.||.+||
T Consensus 224 ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~--~----------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRp 285 (516)
T KOG0582|consen 224 ELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS--G----------------LDKDEDKKFSKSFREMIALCLVKDPSKRP 285 (516)
T ss_pred HHhcCCCCcccCChHHHHHHHhcCCCCCcccc--c----------------CChHHhhhhcHHHHHHHHHHhhcCcccCC
Confidence 99999999999999887776666665532210 0 00011113344699999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
||+++++|.||+..
T Consensus 286 tAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 286 TASKLLKHAFFKKA 299 (516)
T ss_pred CHHHHhccHHHhhc
Confidence 99999999999854
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=394.25 Aligned_cols=259 Identities=28% Similarity=0.459 Sum_probs=217.7
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|...++||+|+.|.||.|+... ..||+|.+.+.. ....+ . +..|+.+|+..+|+|||.+++.|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~ke--L----ilnEi~Vm~~~~H~NiVnfl~Sylv~d- 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKE--L----LLNEILVMRDLHHPNIVNFLDSYLVGD- 343 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchh--h----hHHHHHHHHhccchHHHHHHHHhcccc-
Confidence 457788999999999999999855 455666544443 22222 2 378999999999999999999987665
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
++|+|||||+||+|.+.+.. ..+++.++..|+++++.||+|||.+||+|||||.+|||++.
T Consensus 344 -------------eLWVVMEym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~ 404 (550)
T KOG0578|consen 344 -------------ELWVVMEYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM 404 (550)
T ss_pred -------------eeEEEEeecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc
Confidence 77999999999999999976 35999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+|..+.... ..+..++|||+|||||++.. ..|++|+||||||++++||+
T Consensus 405 ~-------g~vKltDFGFcaqi~~~~----------~KR~TmVGTPYWMAPEVvtr----k~YG~KVDIWSLGIMaIEMv 463 (550)
T KOG0578|consen 405 D-------GSVKLTDFGFCAQISEEQ----------SKRSTMVGTPYWMAPEVVTR----KPYGPKVDIWSLGIMAIEMV 463 (550)
T ss_pred C-------CcEEEeeeeeeecccccc----------CccccccCCCCccchhhhhh----cccCccccchhhhhHHHHHh
Confidence 8 789999999998765432 23457899999999999976 68999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
.|++||-..++......|.....|.+... ...++++++|+.+||+.||.+|++|.
T Consensus 464 eGEPPYlnE~PlrAlyLIa~ng~P~lk~~-------------------------~klS~~~kdFL~~cL~~dv~~RasA~ 518 (550)
T KOG0578|consen 464 EGEPPYLNENPLRALYLIATNGTPKLKNP-------------------------EKLSPELKDFLDRCLVVDVEQRASAK 518 (550)
T ss_pred cCCCCccCCChHHHHHHHhhcCCCCcCCc-------------------------cccCHHHHHHHHHHhhcchhcCCCHH
Confidence 99999998888888888866555544321 14566799999999999999999999
Q ss_pred HHHHHHHhhcCCCCC
Q 001152 1120 DLYEMFVARTSSSIS 1134 (1137)
Q Consensus 1120 EVL~~L~~~~~ss~s 1134 (1137)
|+|+|+|+....+.+
T Consensus 519 eLL~HpFl~~a~p~s 533 (550)
T KOG0578|consen 519 ELLEHPFLKMAKPES 533 (550)
T ss_pred HHhcChhhhhcCCHH
Confidence 999999997655443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=353.57 Aligned_cols=289 Identities=21% Similarity=0.223 Sum_probs=223.4
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|...++||+|+||+||+|++.. +.||+|..++... .+.+...++|||++|+.++|+||+.++++|...+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~------kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~- 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA------KDGINRTALREIKLLQELKHPNIIELIDVFPHKS- 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc------ccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-
Confidence 468888999999999999999854 5566665433322 2233345689999999999999999999998766
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
.+.||+||++ .+|+..|++ ....++..+++.|+.++++||+|||.+.|+||||||.|+||+.
T Consensus 75 -------------~l~lVfEfm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~ 136 (318)
T KOG0659|consen 75 -------------NLSLVFEFMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS 136 (318)
T ss_pred -------------ceEEEEEecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC
Confidence 5699999997 899999986 3468999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+|+.+...... ....+-|.+|+|||.+.| .+.|+..+||||.|||+.||+
T Consensus 137 ~-------g~lKiADFGLAr~f~~p~~~----------~~~~V~TRWYRAPELLfG---sr~Yg~~VDmWavGCI~AELl 196 (318)
T KOG0659|consen 137 D-------GQLKIADFGLARFFGSPNRI----------QTHQVVTRWYRAPELLFG---SRQYGTGVDMWAVGCIFAELL 196 (318)
T ss_pred C-------CcEEeecccchhccCCCCcc----------cccceeeeeccChHHhcc---chhcCCcchhhhHHHHHHHHH
Confidence 8 89999999999987754322 112368899999999997 468999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
-|.+-|.+.++.+....|.......-++.++......+....+..+..........+++++.+|+.+||..||.+|+|+.
T Consensus 197 lr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~ 276 (318)
T KOG0659|consen 197 LRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS 276 (318)
T ss_pred ccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence 99999999888887777744333222222332221111111111111111112335566789999999999999999999
Q ss_pred HHHHHHHhhcCCCCCC
Q 001152 1120 DLYEMFVARTSSSISS 1135 (1137)
Q Consensus 1120 EVL~~L~~~~~ss~s~ 1135 (1137)
|+++|.||...+..+.
T Consensus 277 qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 277 QALKHPYFKSLPLPTP 292 (318)
T ss_pred HHhcchhhhcCCCCCC
Confidence 9999999997655443
|
|
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.25 Aligned_cols=180 Identities=37% Similarity=0.522 Sum_probs=144.8
Q ss_pred ccccccccccccccccCCCCCccccCCCC-------------CCcccccccccCCCCCcceEEEEcccCCHHHHHHHHHH
Q 001152 516 SNASQKYSSVSFCSIEDRLPDGFYDAGRD-------------RPFMQLTGYEQTPHLDSREVILVDRKSDEELDAIALSA 582 (1137)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (1137)
..+|||||++|+|+|+|+|||||||++++ |+++.|+++. +.+.++|||||||.+|+.|++|+++|
T Consensus 4 e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~--~~~~~~EvIlVDr~~D~~L~~L~~~a 81 (204)
T PF14381_consen 4 ESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVP--PDDSSREVILVDRRRDPSLKELEQRA 81 (204)
T ss_pred HHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCC--CCCCCeeEEEEccccCHHHHHHHHHH
Confidence 46899999999999999999999987654 3344444444 67999999999999999999999999
Q ss_pred HHHHHHhhccCCccccCcccccchHHHHHHHHHHHHhhcCCCcCCcccccccccccCCCCCCCcccccCCCCCCCcchhh
Q 001152 583 QALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQ 662 (1137)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~gg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (1137)
+.+...+. .+..+++.+||++||++|||++..++
T Consensus 82 ~~~~~~~~-------------~~~~~~v~~LA~lVa~~MGG~~~~~~--------------------------------- 115 (204)
T PF14381_consen 82 HELSKGLS-------------TNTKELVQKLAKLVADRMGGPVSDAE--------------------------------- 115 (204)
T ss_pred HHHHhccc-------------cCHHHHHHHHHHHHHHHhCCCCCcch---------------------------------
Confidence 99997641 13577889999999999999984331
Q ss_pred HHHHHHHHHhHhhhHHHHHHHHHhhhcCceeEeccccccchhhhHHHHHHHhhhccCCCCcccccccccccCC-Ccccee
Q 001152 663 KQILDAVEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDFQP-HAWNTI 741 (1137)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~g~~~hr~~l~k~~~d~~~~~~~~~~~~g~~~~~~-~~~~~~ 741 (1137)
....+ |+..++.+|. ++.+||||+|++|+|||||||||+|||+|+ ||||||||++||+. ..-+.+
T Consensus 116 -~~~~~---------w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~ig--lpCrLvrG~~y~g~~~~~a~~ 181 (204)
T PF14381_consen 116 -DMLFR---------WELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADRIG--LPCRLVRGCYYCGWDDDDASN 181 (204)
T ss_pred -hhhHH---------HHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHhcC--CCceEEeeccCCccCCCCceE
Confidence 11223 4565666666 999999999999999999999999999999 99999999999987 333345
Q ss_pred EEeeCCchhhhhhhhcC
Q 001152 742 LVKKGDSWIRMIVDACR 758 (1137)
Q Consensus 742 ~~~~~~~~~~~~~~~~~ 758 (1137)
+|..++ .++++||.+.
T Consensus 182 ~V~~~~-~~eyiVDLm~ 197 (204)
T PF14381_consen 182 LVKFDD-GREYIVDLMG 197 (204)
T ss_pred EEEcCC-CcEEEEEcCC
Confidence 555553 5678888873
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=382.66 Aligned_cols=269 Identities=23% Similarity=0.296 Sum_probs=219.5
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeE
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 874 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~ 874 (1137)
..+..+|.+++.||.|+|++|++|+.. +..+|+||...+.. -.+.. ...+.+|-.+|.+| .||.||++|..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I--ike~K---vkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI--IKEKK---VKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH--Hhhcc---cchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 567889999999999999999999974 57789998432211 11111 11246788999999 699999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.++. .+|+|+||+++|+|.++|++. +.|++..++.++.||+.||+|||++|||||||||+|
T Consensus 144 QD~~--------------sLYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPEN 204 (604)
T KOG0592|consen 144 QDEE--------------SLYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPEN 204 (604)
T ss_pred eccc--------------ceEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence 9876 679999999999999999983 579999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCcccccccccccccc---ccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI---AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~---~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1031 (1137)
||+|.+ +++||.|||.|+.+......... ..........++||..|.+||++.. ...++.+|+|||
T Consensus 205 ILLd~d-------mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~----~~~~~~sDiWAl 273 (604)
T KOG0592|consen 205 ILLDKD-------GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND----SPAGPSSDLWAL 273 (604)
T ss_pred eeEcCC-------CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC----CCCCcccchHHH
Confidence 999999 89999999999877654322110 0001111246899999999999976 678899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001152 1032 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1032 GviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
|||+|+|+.|++||.+.++--+++.|....... +. ..++.+++|+.+.|..|
T Consensus 274 GCilyQmlaG~PPFra~NeyliFqkI~~l~y~f-p~---------------------------~fp~~a~dLv~KLLv~d 325 (604)
T KOG0592|consen 274 GCILYQMLAGQPPFRAANEYLIFQKIQALDYEF-PE---------------------------GFPEDARDLIKKLLVRD 325 (604)
T ss_pred HHHHHHHhcCCCCCccccHHHHHHHHHHhcccC-CC---------------------------CCCHHHHHHHHHHHccC
Confidence 999999999999999999888888886544321 11 33455999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 001152 1112 PTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~~~~ 1129 (1137)
|.+|+|+.||-+|+||..
T Consensus 326 p~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 326 PSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred ccccccHHHHhhCccccc
Confidence 999999999999999964
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=381.03 Aligned_cols=293 Identities=21% Similarity=0.246 Sum_probs=227.0
Q ss_pred CCCCCCCCCceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 795 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 795 ~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
.+.+...+.|+..++||+|+||.||+|++..+ .||+|...++.. .+++...+.|||.||++|.|||||++.+
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~------~~~~~~t~~REI~ILr~l~HpNIikL~e 183 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE------KEGFPITAIREIKILRRLDHPNIIKLEE 183 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC------CCcchHHHHHHHHHHHhcCCCcccceee
Confidence 56677778899999999999999999998654 477775444432 2233444689999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
...+... ..+|||+|||+ .+|..++.. +...|++.+++.+++||+.||+|+|.+||+|||||.
T Consensus 184 ivt~~~~------------~siYlVFeYMd-hDL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~ 246 (560)
T KOG0600|consen 184 IVTSKLS------------GSIYLVFEYMD-HDLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKG 246 (560)
T ss_pred EEEecCC------------ceEEEEEeccc-chhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccc
Confidence 9887621 16799999997 899998875 456899999999999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
+|||||.+ |.+||+|||+|+.+...... ..+..+.|.+|+|||++.|. ..|+.++|+||.|
T Consensus 247 SNiLidn~-------G~LKiaDFGLAr~y~~~~~~---------~~T~rVvTLWYRpPELLLG~---t~Yg~aVDlWS~G 307 (560)
T KOG0600|consen 247 SNILIDNN-------GVLKIADFGLARFYTPSGSA---------PYTSRVVTLWYRPPELLLGA---TSYGTAVDLWSVG 307 (560)
T ss_pred cceEEcCC-------CCEEeccccceeeccCCCCc---------ccccceEEeeccChHHhcCC---cccccceeehhhh
Confidence 99999988 89999999999876543221 13356789999999999973 6899999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHh--hhcccccccccccCCCCC--CchhhhhhHHHHHHHHHHhc
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE--ALGSCHEHEVAQSGSGFE--KPEAELETLSFLVDVFRRCT 1108 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~--~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~L~dLl~~CL 1108 (1137)
|||.||++|++.|++....+....|.+.....-...+. ..+... ..+....+. ..+.....++...+|+..||
T Consensus 308 CIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~---~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL 384 (560)
T KOG0600|consen 308 CILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT---IFKPQQPYKRRLRETFKDFPASALDLLEKLL 384 (560)
T ss_pred HHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc---ccCCCCcccchHHHHhccCCHHHHHHHHHHh
Confidence 99999999999999998888877774433221111122 111111 111111111 11223456777899999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCCC
Q 001152 1109 EENPTERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1109 ~~DP~~RPSa~EVL~~L~~~~~ss 1132 (1137)
..||++|.||.+++++.||...+.
T Consensus 385 ~ldP~kR~tA~~aL~seyF~t~p~ 408 (560)
T KOG0600|consen 385 SLDPDKRGTASSALQSEYFTTEPL 408 (560)
T ss_pred ccCccccccHHHHhcCcccccCCC
Confidence 999999999999999999954443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=353.73 Aligned_cols=258 Identities=26% Similarity=0.350 Sum_probs=220.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
-.+.+|++.+.||.|+||.|.+++.+ +..+|+|+....... ...+.+. ...|..+|+.+.||+++++++.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-klKQveH----~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-KLKQVEH----THNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-HHHHHHH----HhhHHHHHhhccCceeEEEEEeecc
Confidence 56889999999999999999999974 577899885433221 1233333 3789999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ .+||||||++||.|..++++ ..+|++..++.++.||+.||+|||+++|++|||||+|||
T Consensus 116 ~~--------------~lymvmeyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiL 176 (355)
T KOG0616|consen 116 NS--------------NLYMVMEYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLL 176 (355)
T ss_pred CC--------------eEEEEEeccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHee
Confidence 76 67999999999999999987 357999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
+|.+ |.+||.|||+|+......- +.+|||.|+|||+++. ..|+.++|+|||||++|
T Consensus 177 lD~~-------G~iKitDFGFAK~v~~rT~-------------TlCGTPeYLAPEii~s----k~ynkavDWWalGVLIY 232 (355)
T KOG0616|consen 177 LDQN-------GHIKITDFGFAKRVSGRTW-------------TLCGTPEYLAPEIIQS----KGYNKAVDWWALGVLIY 232 (355)
T ss_pred eccC-------CcEEEEeccceEEecCcEE-------------EecCCccccChHHhhc----CCCCcchhHHHHHHHHH
Confidence 9988 8999999999987765321 4579999999999986 68999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC-
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER- 1115 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R- 1115 (1137)
||+.|.+||...++.+++..|..+... +|. ..+.++++|+.+.|+.|-.+|
T Consensus 233 EMlaG~pPF~~~~~~~iY~KI~~~~v~-fP~---------------------------~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 233 EMLAGYPPFYDDNPIQIYEKILEGKVK-FPS---------------------------YFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred HHHcCCCCCcCCChHHHHHHHHhCccc-CCc---------------------------ccCHHHHHHHHHHHhhhhHhhh
Confidence 999999999999999999999877632 221 223459999999999999999
Q ss_pred ----CCHHHHHHHHHhhcCCC
Q 001152 1116 ----PTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1116 ----PSa~EVL~~L~~~~~ss 1132 (1137)
....+|.+|+||+...+
T Consensus 285 gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 285 GNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred cCcCCCccccccCcccccccH
Confidence 36789999999986543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=358.92 Aligned_cols=292 Identities=26% Similarity=0.323 Sum_probs=225.4
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
-.++..|+...+|++|+||.||+|+++.+..+|+.++++.. .+.+.|....+|||.+|.+++|||||.+-.+....
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kme----kek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKME----KEKEGFPITSLREINILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccc----cccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence 35678899999999999999999999765555544444442 23345555668999999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
.. ...|||||||+ .+|..++... .++|...+++.++.|+++|++|||.+.|+|||||++|+|+
T Consensus 148 ~~------------d~iy~VMe~~E-hDLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm 210 (419)
T KOG0663|consen 148 NM------------DKIYIVMEYVE-HDLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL 210 (419)
T ss_pred cc------------ceeeeeHHHHH-hhHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee
Confidence 42 26799999997 8999999873 3579999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.. |.+||+|||+|+.+..+.. ..+..+-|.+|+|||.+.+ ...|++.+|+||+|||+.|
T Consensus 211 ~~~-------G~lKiaDFGLAR~ygsp~k----------~~T~lVVTLWYRaPELLLG---~~tyst~iDMWSvGCI~aE 270 (419)
T KOG0663|consen 211 SHK-------GILKIADFGLAREYGSPLK----------PYTPLVVTLWYRAPELLLG---AKTYSTAVDMWSVGCIFAE 270 (419)
T ss_pred ccC-------CcEEecccchhhhhcCCcc----------cCcceEEEeeecCHHHhcC---CcccCcchhhhhHHHHHHH
Confidence 988 8999999999998877532 2345678999999999997 3689999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCC-CCC--chhHHhhhcccc-----cccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGK-RPR--LTDELEALGSCH-----EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~-~p~--l~~~l~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
|+++++.|.+.+..+....|.+.. .|. ++..+...+... ..........+. ....++.-.+|+..+|.
T Consensus 271 ~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~----~~~lse~g~~Lln~llt 346 (419)
T KOG0663|consen 271 LLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFG----ALSLSEQGFDLLNKLLT 346 (419)
T ss_pred HHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhcc----ccccchhHHHHHHHHhc
Confidence 999999999998888777774422 221 111111111100 000000111110 01245778899999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcCCCCC
Q 001152 1110 ENPTERPTAGDLYEMFVARTSSSIS 1134 (1137)
Q Consensus 1110 ~DP~~RPSa~EVL~~L~~~~~ss~s 1134 (1137)
.||.+|.||+|.++|-||...+-..
T Consensus 347 ~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 347 YDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred cCccccccHHHhhcccccccCCCCC
Confidence 9999999999999999998755443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=369.63 Aligned_cols=263 Identities=33% Similarity=0.446 Sum_probs=206.0
Q ss_pred CCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|...+.||+|+||+||++.... ...|||...... ....+. +.+|+.+|++++|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~~~~~~----l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----SPTSES----LEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----chhHHH----HHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 4568899999999999999999864 788999754441 111333 378999999999999999999754432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. ..++++|||+++|||.+++.+ .+. .+++..++++++||++||+|||++|||||||||+|||++
T Consensus 88 ~------------~~~~i~mEy~~~GsL~~~~~~---~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~ 151 (313)
T KOG0198|consen 88 N------------DEYNIFMEYAPGGSLSDLIKR---YGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD 151 (313)
T ss_pred C------------eeeEeeeeccCCCcHHHHHHH---cCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe
Confidence 0 257999999999999999987 233 699999999999999999999999999999999999999
Q ss_pred c-ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 959 L-ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 959 ~-~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
. + +.+||+|||+++........ ........||+.|||||++... ....+++|||||||++.|
T Consensus 152 ~~~-------~~~KlaDFG~a~~~~~~~~~-------~~~~~~~~Gtp~~maPEvi~~g---~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 152 PSN-------GDVKLADFGLAKKLESKGTK-------SDSELSVQGTPNYMAPEVIRNG---EVARRESDIWSLGCTVVE 214 (313)
T ss_pred CCC-------CeEEeccCcccccccccccc-------ccccccccCCccccCchhhcCC---CcCCccchhhhcCCEEEe
Confidence 8 4 68999999998866531100 0112346799999999999841 223369999999999999
Q ss_pred HHhCCCCCCC-CCHHHHHHHHH-cCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1038 LLTLQVPYMG-LSELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1038 LLTG~~Pf~~-~~~~el~~~I~-~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|+||+.||.. ....+....+. ....|.++. ..++++++++.+|++.||.+|
T Consensus 215 M~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~---------------------------~ls~~a~~Fl~~C~~~~p~~R 267 (313)
T KOG0198|consen 215 MLTGKPPWSEFFEEAEALLLIGREDSLPEIPD---------------------------SLSDEAKDFLRKCFKRDPEKR 267 (313)
T ss_pred ccCCCCcchhhcchHHHHHHHhccCCCCCCCc---------------------------ccCHHHHHHHHHHhhcCcccC
Confidence 9999999986 33333333332 222333332 345569999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 001152 1116 PTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~s 1131 (1137)
|||+++++|+|.....
T Consensus 268 pta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 268 PTAEELLEHPFLKQNS 283 (313)
T ss_pred cCHHHHhhChhhhccc
Confidence 9999999999997644
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=374.71 Aligned_cols=263 Identities=23% Similarity=0.277 Sum_probs=215.4
Q ss_pred CCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEe
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 875 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~ 875 (1137)
.....|.+.+.||+|+||+|++|.+ .+..||+|+...+...... ......+.+|+.+++.++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 3567899999999999999999987 4588999975443222111 112223468999999999 999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
... +.++||||+.||+|.+++.+ ..++.+..+.++++||+.|++|+|++||+||||||+||
T Consensus 91 t~~--------------~~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENi 151 (370)
T KOG0583|consen 91 TPT--------------KIYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENI 151 (370)
T ss_pred cCC--------------eEEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence 876 57999999999999999986 35789999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+. +++||+|||++....... .......||+.|+|||++.+. ..+.+.++||||+||+|
T Consensus 152 lld~~~------~~~Kl~DFG~s~~~~~~~----------~~l~t~cGsp~Y~aPEvl~~~--~~Y~g~~aDvWS~GViL 213 (370)
T KOG0583|consen 152 LLDGNE------GNLKLSDFGLSAISPGED----------GLLKTFCGSPAYAAPEVLSGK--GTYSGKAADVWSLGVIL 213 (370)
T ss_pred EecCCC------CCEEEeccccccccCCCC----------CcccCCCCCcccCCHHHhCCC--CCcCCchhhhhhhHHHH
Confidence 999762 579999999997653110 122356799999999999872 12447999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh-HHHHHHHHHHhcccCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET-LSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~dLl~~CL~~DP~~ 1114 (1137)
|.|++|..||...+...+...|..+...- +. .. ++++++|+.+||..||.+
T Consensus 214 y~ml~G~~PF~d~~~~~l~~ki~~~~~~~-p~---------------------------~~~S~~~~~Li~~mL~~~P~~ 265 (370)
T KOG0583|consen 214 YVLLCGRLPFDDSNVPNLYRKIRKGEFKI-PS---------------------------YLLSPEARSLIEKMLVPDPST 265 (370)
T ss_pred HHHHhCCCCCCCccHHHHHHHHhcCCccC-CC---------------------------CcCCHHHHHHHHHHcCCCccc
Confidence 99999999999988888888877665321 11 11 455899999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001152 1115 RPTAGDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~ 1129 (1137)
|+|+.+|++|+|++.
T Consensus 266 R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 266 RITLLEILEHPWFQK 280 (370)
T ss_pred CCCHHHHhhChhhcc
Confidence 999999999999997
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=379.20 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=221.5
Q ss_pred CCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
.++..|++++.||.|+.|.|-+|++ +|+.+|||+........ . ...+.+.+||.||+.+.||||+++|++++.
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s-~----s~~~~IerEIviMkLi~HpnVl~LydVwe~ 83 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS-S----SQPAGIEREIVIMKLIEHPNVLRLYDVWEN 83 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccc-c----ccccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence 4577899999999999999999998 57889999865543221 1 112344789999999999999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. ++|+|.||++||-|.+++-. .+++++.++.++++||+.|+.|+|..+|+||||||+|+|
T Consensus 84 ~~--------------~lylvlEyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlL 144 (786)
T KOG0588|consen 84 KQ--------------HLYLVLEYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLL 144 (786)
T ss_pred Cc--------------eEEEEEEecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhh
Confidence 76 78999999999999999976 357999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
+|.. +++||+|||+|....... .-.+.+|+|.|.|||++.|. .+.+.++||||.|||||
T Consensus 145 Ld~~-------~nIKIADFGMAsLe~~gk-----------lLeTSCGSPHYA~PEIV~G~---pYdG~~sDVWSCGVILf 203 (786)
T KOG0588|consen 145 LDVK-------NNIKIADFGMASLEVPGK-----------LLETSCGSPHYAAPEIVSGR---PYDGRPSDVWSCGVILF 203 (786)
T ss_pred hhcc-------cCEeeeccceeecccCCc-----------cccccCCCcccCCchhhcCC---CCCCCccccchhHHHHH
Confidence 9988 669999999996533221 12245799999999999973 46689999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
.||||+.||++.+...+...+++|... ++. .++.++.+|+.+|+..||++|.
T Consensus 204 ALLtG~LPFdDdNir~LLlKV~~G~f~-MPs---------------------------~Is~eaQdLLr~ml~VDp~~Ri 255 (786)
T KOG0588|consen 204 ALLTGKLPFDDDNIRVLLLKVQRGVFE-MPS---------------------------NISSEAQDLLRRMLDVDPSTRI 255 (786)
T ss_pred HHHhCCCCCCCccHHHHHHHHHcCccc-CCC---------------------------cCCHHHHHHHHHHhccCccccc
Confidence 999999999999999999999988742 111 4566799999999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 001152 1117 TAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ss 1132 (1137)
|++||++|+|...-..
T Consensus 256 T~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 256 TTEEILKHPFLSGYTS 271 (786)
T ss_pred cHHHHhhCchhhcCCC
Confidence 9999999999986533
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=375.47 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=213.7
Q ss_pred ceEeeeecccCceEEEEEEECCc-cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGSA-DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~~-~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
+++++.||+|-||.||.|.|.+. +||+|..+.. .... +.| .+|+++|++|+|+|||+++|++..++
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~---~~f----~~Ea~iMk~L~H~~lV~l~gV~~~~~---- 274 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSP---EAF----LREAQIMKKLRHEKLVKLYGVCTKQE---- 274 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccCh---hHH----HHHHHHHHhCcccCeEEEEEEEecCC----
Confidence 57889999999999999999874 9999985432 1111 223 78999999999999999999998765
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
.++||||||+.|+|.++++. ..+..+...+.+.|+.|||+|++||+++++|||||.+.||||+++
T Consensus 275 ----------piyIVtE~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-- 339 (468)
T KOG0197|consen 275 ----------PIYIVTEYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-- 339 (468)
T ss_pred ----------ceEEEEEecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC--
Confidence 35999999999999999986 345679999999999999999999999999999999999999988
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1041 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G 1041 (1137)
..+||+|||+|+...+.... ... ...-...|.|||.+.. ..++.|||||||||+||||+| |
T Consensus 340 -----~~vKIsDFGLAr~~~d~~Y~---~~~------~~kfPIkWtAPEa~~~----~~FS~kSDVWSFGVlL~E~fT~G 401 (468)
T KOG0197|consen 340 -----LVVKISDFGLARLIGDDEYT---ASE------GGKFPIKWTAPEALNY----GKFSSKSDVWSFGVLLWELFTYG 401 (468)
T ss_pred -----ceEEEcccccccccCCCcee---ecC------CCCCCceecCHHHHhh----CCcccccceeehhhhHHHHhccC
Confidence 79999999999954433221 111 1112347999999975 679999999999999999999 8
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
+.||.+.+..++...+.+|.+..-|. .|++++.++|..||+.+|++||||+.+
T Consensus 402 ~~py~~msn~ev~~~le~GyRlp~P~---------------------------~CP~~vY~lM~~CW~~~P~~RPtF~~L 454 (468)
T KOG0197|consen 402 RVPYPGMSNEEVLELLERGYRLPRPE---------------------------GCPDEVYELMKSCWHEDPEDRPTFETL 454 (468)
T ss_pred CCCCCCCCHHHHHHHHhccCcCCCCC---------------------------CCCHHHHHHHHHHhhCCcccCCCHHHH
Confidence 99999999999999999988643332 677789999999999999999999988
Q ss_pred HHHHHhhcCC
Q 001152 1122 YEMFVARTSS 1131 (1137)
Q Consensus 1122 L~~L~~~~~s 1131 (1137)
...+......
T Consensus 455 ~~~l~~~~~~ 464 (468)
T KOG0197|consen 455 REVLEDFFTS 464 (468)
T ss_pred HHHHHHhhhc
Confidence 8877665443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=368.42 Aligned_cols=278 Identities=24% Similarity=0.254 Sum_probs=216.3
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCC-----hHHHH-HhHHhHHHHHHHHHhCCCCCcc
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSS-----ADEIR-NFEYSCLGEVRMLGALRHSCIV 868 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~-----~~~~e-~~~~~~lrEi~iL~~L~HpNIV 868 (1137)
+.+.++.|++.+.||+|.||.|-+|+.. +..||+||+..+..... ..... .-..++++||.||++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3456899999999999999999999984 57899998543221110 00000 0012458999999999999999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCeee
Q 001152 869 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMH 947 (1137)
Q Consensus 869 kllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~-ls~~~i~~I~~QIa~gL~yLHs~gIIH 947 (1137)
+++++..+... ..+|||+|||..|.+...= .... +++.++++|+++++.||+|||.+||||
T Consensus 172 ~LiEvLDDP~s------------~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiH 233 (576)
T KOG0585|consen 172 KLIEVLDDPES------------DKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIH 233 (576)
T ss_pred EEEEeecCccc------------CceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHhcCeec
Confidence 99999876542 2789999999988876542 2234 999999999999999999999999999
Q ss_pred ccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhh
Q 001152 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1027 (1137)
Q Consensus 948 rDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1027 (1137)
|||||+|+|++.+ ++|||+|||.+............ ..-...+|||.|+|||.+.+.......+.+.|
T Consensus 234 RDIKPsNLLl~~~-------g~VKIsDFGVs~~~~~~~~~~~d-----~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~D 301 (576)
T KOG0585|consen 234 RDIKPSNLLLSSD-------GTVKISDFGVSNEFPQGSDEGSD-----DQLSRTVGTPAFFAPELCSGGNSFSYSGFALD 301 (576)
T ss_pred cccchhheEEcCC-------CcEEeeccceeeecccCCccccH-----HHHhhcCCCccccchHhhcCCCCccccchhhh
Confidence 9999999999988 89999999998755221110000 00113589999999999987544456689999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001152 1028 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1107 (1137)
Q Consensus 1028 VWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~C 1107 (1137)
|||+||+||.|+.|+.||.+....+++..|...... ++. . .+..+.+++||.+|
T Consensus 302 iWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~-fP~------------------------~-pe~~e~~kDli~~l 355 (576)
T KOG0585|consen 302 IWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLE-FPE------------------------N-PEINEDLKDLIKRL 355 (576)
T ss_pred hhhhhhhHHHhhhccCCcccchHHHHHHHHhcCccc-CCC------------------------c-ccccHHHHHHHHHH
Confidence 999999999999999999999999999988654321 110 0 03455699999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 001152 1108 TEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1108 L~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
|++||++|.+..+|..|+|....
T Consensus 356 L~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 356 LEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hhcChhheeehhhheecceeccC
Confidence 99999999999999999998754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=371.18 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=219.2
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
.+|.+.+.||+|+||.||+|+.+.+...|+++.+.+......+.+.. .+|++|++.++|||||.++++|+...
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l----~~ev~i~r~lkHpniv~m~esfEt~~--- 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNL----RQEVRILRSLKHPNIVEMLESFETSA--- 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHH----HHHHHHHHhcCCcchhhHHHhhcccc---
Confidence 46888899999999999999987655444444466766667777776 89999999999999999999999876
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
++|+|+||+. |+|..++.+ +..++++.+..|+.|++.||.|||+++|+|||+||.|||++..
T Consensus 75 -----------~~~vVte~a~-g~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~- 136 (808)
T KOG0597|consen 75 -----------HLWVVTEYAV-GDLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG- 136 (808)
T ss_pred -----------eEEEEehhhh-hhHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-
Confidence 7899999997 599999987 4579999999999999999999999999999999999999988
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+++|+||||+|+...... .....+.|||.|||||++.+ ..|+..+|.||+|||+|||++|
T Consensus 137 ------~~~KlcdFg~Ar~m~~~t----------~vltsikGtPlYmAPElv~e----~pyd~~sDlWslGcilYE~~~G 196 (808)
T KOG0597|consen 137 ------GTLKLCDFGLARAMSTNT----------SVLTSIKGTPLYMAPELVEE----QPYDHTSDLWSLGCILYELYVG 196 (808)
T ss_pred ------CceeechhhhhhhcccCc----------eeeeeccCcccccCHHHHcC----CCccchhhHHHHHHHHHHHhcC
Confidence 899999999998765422 11235679999999999986 7899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
++||...+..++...|.....++.. ..+..+..++...|++||.+|.+-.++
T Consensus 197 ~PPF~a~si~~Lv~~I~~d~v~~p~----------------------------~~S~~f~nfl~gLL~kdP~~RltW~~L 248 (808)
T KOG0597|consen 197 QPPFYARSITQLVKSILKDPVKPPS----------------------------TASSSFVNFLQGLLIKDPAQRLTWTDL 248 (808)
T ss_pred CCCchHHHHHHHHHHHhcCCCCCcc----------------------------cccHHHHHHHHHHhhcChhhcccHHHH
Confidence 9999988888888888765543322 334558999999999999999999999
Q ss_pred HHHHHhhcC
Q 001152 1122 YEMFVARTS 1130 (1137)
Q Consensus 1122 L~~L~~~~~ 1130 (1137)
+.|+|.+..
T Consensus 249 l~HpF~k~~ 257 (808)
T KOG0597|consen 249 LGHPFWKGK 257 (808)
T ss_pred hcChHHhhh
Confidence 999987643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=368.44 Aligned_cols=272 Identities=22% Similarity=0.318 Sum_probs=216.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
++++|++.++||+|+||.||+|+-. +..+|+|+.+.... ....+.+.. +.|-.+|....+|+||++|..|.+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M-~~~~Qv~hV----~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM-LKKNQVEHV----RAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH-HhhhhHHHH----HHHHHHhhhcCCCcEEEEEEEecCC
Confidence 6789999999999999999999864 56678887432211 123344443 7788999999999999999999987
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ .+||||||+|||++..+|.. ...|++..++.++.+++.|++.||+.|||||||||+|+||
T Consensus 214 ~--------------~LYLiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi 274 (550)
T KOG0605|consen 214 E--------------YLYLIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI 274 (550)
T ss_pred C--------------eeEEEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee
Confidence 7 67999999999999999986 3579999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccc------------c-ccCCCC------------------------CCCc
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCC------------I-AHRGIP------------------------APDV 1000 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~------------~-~~~~~~------------------------~~~~ 1000 (1137)
|.. |++||+|||++..+........ . ...... ..-.
T Consensus 275 D~~-------GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~S 347 (550)
T KOG0605|consen 275 DAK-------GHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYS 347 (550)
T ss_pred cCC-------CCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhc
Confidence 988 9999999999965432111000 0 000000 0113
Q ss_pred ccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-chhHHhhhccccccc
Q 001152 1001 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR-LTDELEALGSCHEHE 1079 (1137)
Q Consensus 1001 ~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~-l~~~l~~~~~~~~~~ 1079 (1137)
.+|||.|||||++.+ ..|+..+|+||||||+||||.|.+||.+.++.+.+..|....... ++.
T Consensus 348 tVGTPDYiAPEVll~----kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~------------ 411 (550)
T KOG0605|consen 348 TVGTPDYIAPEVLLG----KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE------------ 411 (550)
T ss_pred ccCCccccchHHHhc----CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC------------
Confidence 589999999999987 569999999999999999999999999999999998886533111 111
Q ss_pred ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhcCCC
Q 001152 1080 VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1080 ~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP---Sa~EVL~~L~~~~~ss 1132 (1137)
....++++++||.+||. ||++|. .++||-+|+||+..-+
T Consensus 412 -------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 412 -------------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred -------------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 01344679999999999 999997 6999999999986533
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=378.76 Aligned_cols=259 Identities=27% Similarity=0.349 Sum_probs=217.8
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeE
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 874 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~ 874 (1137)
...+.+|++.++||+|+||+|++|..++ ..+|+|+.+...... .++.+.. +.|.+|+.... ||.++.++..|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~----~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESL----MCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHH----HHHHHHHHHhccCCeEeeccccc
Confidence 4457899999999999999999999854 678899865444333 4455554 78989888876 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+.+ ++|+||||+.||++..+++. ..|++..+..++..|+.||+|||++||||||||.+|
T Consensus 439 QT~~--------------~l~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdN 498 (694)
T KOG0694|consen 439 QTKE--------------HLFFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDN 498 (694)
T ss_pred ccCC--------------eEEEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhh
Confidence 9887 78999999999995554432 579999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||+|.+ |++||+|||+++...... ....++.|||.|||||++.+ ..|+.++|+|||||+
T Consensus 499 iLLD~e-------Gh~kiADFGlcKe~m~~g----------~~TsTfCGTpey~aPEil~e----~~Yt~aVDWW~lGVL 557 (694)
T KOG0694|consen 499 LLLDTE-------GHVKIADFGLCKEGMGQG----------DRTSTFCGTPEFLAPEVLTE----QSYTRAVDWWGLGVL 557 (694)
T ss_pred eEEccc-------CcEEecccccccccCCCC----------CccccccCChhhcChhhhcc----CcccchhhHHHHHHH
Confidence 999998 999999999998654221 12246789999999999987 689999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|||||.|+.||.+++.++++..|...... +|. ..+.+..++++++|..+|++
T Consensus 558 lyeML~Gq~PF~gddEee~FdsI~~d~~~-yP~---------------------------~ls~ea~~il~~ll~k~p~k 609 (694)
T KOG0694|consen 558 LYEMLVGESPFPGDDEEEVFDSIVNDEVR-YPR---------------------------FLSKEAIAIMRRLLRKNPEK 609 (694)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCC---------------------------cccHHHHHHHHHHhccCccc
Confidence 99999999999999999999999765432 121 34456899999999999999
Q ss_pred CCC-----HHHHHHHHHhhcC
Q 001152 1115 RPT-----AGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPS-----a~EVL~~L~~~~~ 1130 (1137)
|.. +++|.+|++|+.-
T Consensus 610 RLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 610 RLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ccCCCCCCchhhhhCCccccC
Confidence 973 6899999999753
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=353.32 Aligned_cols=289 Identities=19% Similarity=0.270 Sum_probs=217.8
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
|...+.||+|+||.|+.|.+..+...|+++++..........+ +..||+++|+.++|+||+.+++.+..+.
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~ak----RtlRElklLr~~~HeNIi~l~di~~p~~----- 94 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAK----RTLRELKLLRHLRHENIIGLLDIFRPPS----- 94 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHH----HHHHHHHHHHHhcCCCcceEEeeccccc-----
Confidence 4557899999999999999865444444433443333333333 3489999999999999999999987521
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
.......|+|+|+|+ .+|...++. +..++...+..+++||++||.|+|+.+|+||||||+|+|++.+
T Consensus 95 ----~~~f~DvYiV~elMe-tDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~--- 161 (359)
T KOG0660|consen 95 ----RDKFNDVYLVFELME-TDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD--- 161 (359)
T ss_pred ----ccccceeEEehhHHh-hHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC---
Confidence 113447899999995 899999986 3459999999999999999999999999999999999999988
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1043 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~ 1043 (1137)
..+||+|||+|+........ .-.+..+.|.+|+|||++.. ...|++++||||.|||+.||++|++
T Consensus 162 ----c~lKI~DFGLAR~~~~~~~~--------~~mTeYVaTRWYRAPElll~---~~~Yt~aiDiWSvGCI~AEmL~gkp 226 (359)
T KOG0660|consen 162 ----CDLKICDFGLARYLDKFFED--------GFMTEYVATRWYRAPELLLN---SSEYTKAIDIWSVGCILAEMLTGKP 226 (359)
T ss_pred ----CCEEeccccceeeccccCcc--------cchhcceeeeeecCHHHHhc---cccccchhhhhhhhHHHHHHHcCCC
Confidence 78999999999877542111 11124578999999999874 5789999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCC---CCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1044 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS---GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1044 Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
.|.|.+..+....|.......-+..+....+.......+... +...........+.+.+|+.+||..||.+|+|++|
T Consensus 227 lFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 227 LFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred CCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 999988877777775444333233333332111111111111 11222233477888999999999999999999999
Q ss_pred HHHHHHhhc
Q 001152 1121 LYEMFVART 1129 (1137)
Q Consensus 1121 VL~~L~~~~ 1129 (1137)
+++||++..
T Consensus 307 AL~hPYl~~ 315 (359)
T KOG0660|consen 307 ALAHPYLAP 315 (359)
T ss_pred HhcChhhhh
Confidence 999999874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=369.53 Aligned_cols=256 Identities=29% Similarity=0.428 Sum_probs=215.8
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|+..+.||+|+||.||+|.+. +..||+|+..++.. .++++.+ .+|+.+|..++++||.++|+.|....
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~---~deIedi----qqei~~Ls~~~~~~it~yygsyl~g~-- 84 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA---EDEIEDI----QQEISVLSQCDSPNITEYYGSYLKGT-- 84 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhc---chhhHHH----HHHHHHHHhcCcchHHhhhhheeecc--
Confidence 4667799999999999999985 46678887655543 4455555 77999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
.+|++||||.||++.+.++. ...+++..+..|+++++.||.|||.++.+|||||+.|||+..+
T Consensus 85 ------------~LwiiMey~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~ 147 (467)
T KOG0201|consen 85 ------------KLWIIMEYCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES 147 (467)
T ss_pred ------------cHHHHHHHhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc
Confidence 56999999999999999975 3455889999999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||.+..+..... ....++|||+|||||++.+ ..|+.|+||||||++.+||++
T Consensus 148 -------g~vkl~DfgVa~ql~~~~~----------rr~tfvGTPfwMAPEVI~~----~~Y~~KADIWSLGITaiEla~ 206 (467)
T KOG0201|consen 148 -------GDVKLADFGVAGQLTNTVK----------RRKTFVGTPFWMAPEVIKQ----SGYDTKADIWSLGITAIELAK 206 (467)
T ss_pred -------CcEEEEecceeeeeechhh----------ccccccccccccchhhhcc----ccccchhhhhhhhHHHHHHhc
Confidence 8899999999977655321 2247799999999999985 679999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|.+||....++.+...|-+..+|.+.. ..++.+++|+..||++||+.||+|.+
T Consensus 207 GePP~s~~hPmrvlflIpk~~PP~L~~---------------------------~~S~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 207 GEPPHSKLHPMRVLFLIPKSAPPRLDG---------------------------DFSPPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred CCCCCcccCcceEEEeccCCCCCcccc---------------------------ccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 999999888876666665555554443 33445999999999999999999999
Q ss_pred HHHHHHhhcCCC
Q 001152 1121 LYEMFVARTSSS 1132 (1137)
Q Consensus 1121 VL~~L~~~~~ss 1132 (1137)
+++|.|.+...+
T Consensus 260 LLKh~FIk~a~k 271 (467)
T KOG0201|consen 260 LLKHKFIKRAKK 271 (467)
T ss_pred HhhhHHHHhcCC
Confidence 999999987443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=356.71 Aligned_cols=252 Identities=27% Similarity=0.360 Sum_probs=206.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||+|.+. +..+|+|+........ .... ..+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR-LKQE----QHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-hHHH----HHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 36899999999999999999985 5778898754331110 1112 23478999999999999999998887655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~ 136 (291)
T cd05612 75 -------------FLYMLMEYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK 136 (291)
T ss_pred -------------eEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC
Confidence 67999999999999999976 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~~l~ 192 (291)
T cd05612 137 E-------GHIKLTDFGFAKKLRDRT-------------WTLCGTPEYLAPEVIQS----KGHNKAVDWWALGILIYEML 192 (291)
T ss_pred C-------CCEEEEecCcchhccCCc-------------ccccCChhhcCHHHHcC----CCCCchhhHHHHHHHHHHHH
Confidence 7 789999999987543211 12368999999999875 45789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 1117 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS-- 1117 (1137)
+|..||.+....+....+..+... ++. ..++.+.+++.+||+.||.+||+
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~~-~~~---------------------------~~~~~~~~li~~~l~~dp~~R~~~~ 244 (291)
T cd05612 193 VGYPPFFDDNPFGIYEKILAGKLE-FPR---------------------------HLDLYAKDLIKKLLVVDRTRRLGNM 244 (291)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCcC-CCc---------------------------cCCHHHHHHHHHHcCCCHHHccCCc
Confidence 999999988877777776554321 111 22345899999999999999995
Q ss_pred ---HHHHHHHHHhhc
Q 001152 1118 ---AGDLYEMFVART 1129 (1137)
Q Consensus 1118 ---a~EVL~~L~~~~ 1129 (1137)
++++++|+|+..
T Consensus 245 ~~~~~~~l~h~~~~~ 259 (291)
T cd05612 245 KNGADDVKNHRWFKS 259 (291)
T ss_pred cCCHHHHhcCccccC
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=354.74 Aligned_cols=284 Identities=21% Similarity=0.247 Sum_probs=214.2
Q ss_pred CceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|+-.+++|.|+||.||+|.... ..+|+|.. ..... .+ .+|+++|+.+.|||||++.-+|.....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv-~~d~r-----~k------nrEl~im~~l~HpNIV~L~~~f~~~~~- 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKV-LQDKR-----YK------NRELQIMRKLDHPNIVRLLYFFSSSTE- 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEe-cCCCC-----cC------cHHHHHHHhcCCcCeeeEEEEEEecCC-
Confidence 47788999999999999999854 66777743 22111 12 459999999999999999988876431
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
+ +...+.+|||||| .+|.+.++.... .+..++.-.++-+++||.+||.|||+.||+||||||.|||+|.+
T Consensus 92 ----~----d~~~lnlVleymP-~tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~ 161 (364)
T KOG0658|consen 92 ----S----DEVYLNLVLEYMP-ETLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD 161 (364)
T ss_pred ----C----chhHHHHHHHhch-HHHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC
Confidence 1 1236789999998 899999986433 34678899999999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+ +.+||||||.|+.+...... .....|.+|+|||.+.|. ..|+.++||||.||++.||+-
T Consensus 162 t------g~LKicDFGSAK~L~~~epn-----------iSYicSRyYRaPELifga---~~Yt~~IDiWSaGCV~aELl~ 221 (364)
T KOG0658|consen 162 T------GVLKICDFGSAKVLVKGEPN-----------ISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVMAELLK 221 (364)
T ss_pred C------CeEEeccCCcceeeccCCCc-----------eeEEEeccccCHHHHcCc---cccCceeEEhhhhHHHHHHhc
Confidence 5 89999999999877653322 244688899999999974 689999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccc-cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|++-|.|.+..+....|.+....+-.+++....... +....+.....-..-.....++++.+|+.++|+++|.+|.++.
T Consensus 222 g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~ 301 (364)
T KOG0658|consen 222 GQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL 301 (364)
T ss_pred CCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH
Confidence 999999988877777764443322222222221110 1111111110000012235677899999999999999999999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
|++.|++|..
T Consensus 302 ~~l~h~fFde 311 (364)
T KOG0658|consen 302 EALAHPFFDE 311 (364)
T ss_pred HHhcchhhHH
Confidence 9999999863
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=361.81 Aligned_cols=256 Identities=23% Similarity=0.287 Sum_probs=209.3
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...+.+|++.+.||+|+||.||+|++. +..+|+|+....... ..... ..+.+|+.++++++||||+++++++.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQV----QHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhH----HHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 335688999999999999999999985 467899986432111 11112 23488999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 89 ~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NI 149 (329)
T PTZ00263 89 DEN--------------RVYFLLEFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149 (329)
T ss_pred cCC--------------EEEEEEcCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHE
Confidence 765 67999999999999999876 24689999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++
T Consensus 150 ll~~~-------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 205 (329)
T PTZ00263 150 LLDNK-------GHVKVTDFGFAKKVPDRT-------------FTLCGTPEYLAPEVIQS----KGHGKAVDWWTMGVLL 205 (329)
T ss_pred EECCC-------CCEEEeeccCceEcCCCc-------------ceecCChhhcCHHHHcC----CCCCCcceeechHHHH
Confidence 99987 789999999987543211 12368999999999875 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|+|++|..||.+....+....+..+..+ ++. ..+..+.+|+.+||+.||.+|
T Consensus 206 ~elltg~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~L~~dP~~R 257 (329)
T PTZ00263 206 YEFIAGYPPFFDDTPFRIYEKILAGRLK-FPN---------------------------WFDGRARDLVKGLLQTDHTKR 257 (329)
T ss_pred HHHHcCCCCCCCCCHHHHHHHHhcCCcC-CCC---------------------------CCCHHHHHHHHHHhhcCHHHc
Confidence 9999999999988877777766554321 111 123458999999999999999
Q ss_pred CC-----HHHHHHHHHhhc
Q 001152 1116 PT-----AGDLYEMFVART 1129 (1137)
Q Consensus 1116 PS-----a~EVL~~L~~~~ 1129 (1137)
|+ ++++++|+|+..
T Consensus 258 ~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 258 LGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred CCCCCCCHHHHhcCCccCC
Confidence 96 799999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=351.09 Aligned_cols=281 Identities=20% Similarity=0.236 Sum_probs=207.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
..+.+|++.++||+|+||+||+|... +..+|+|+........ ... .+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~----~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APC----TAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC---cch----hHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 35778999999999999999999875 4678888754332111 111 23679999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. ..++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 75 ~~--------------~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil 135 (288)
T cd07871 75 ER--------------CLTLVFEYLD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLL 135 (288)
T ss_pred CC--------------eEEEEEeCCC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 55 5699999997 5999988652 235789999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+++....... ......+|+.|+|||++.+ ...++.++||||+||++|
T Consensus 136 ~~~~-------~~~kl~DfG~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~ 195 (288)
T cd07871 136 INEK-------GELKLADFGLARAKSVPTK----------TYSNEVVTLWYRPPDVLLG---STEYSTPIDMWGVGCILY 195 (288)
T ss_pred ECCC-------CCEEECcCcceeeccCCCc----------cccCceecccccChHHhcC---CcccCcHHHHHHHHHHHH
Confidence 9877 7899999999865432211 1112358899999999864 246789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccccccc-CCCC---CCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS-GSGF---EKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
+|++|+.||.+.+..+....+...........++..... ...... .... .........++++++|+.+||+.||
T Consensus 196 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp 273 (288)
T cd07871 196 EMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN--EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYET 273 (288)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc--hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCc
Confidence 999999999987776666555433222222111111000 000000 0000 0000112345678999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 001152 1113 TERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~ 1127 (1137)
.+|||++|+++|+|+
T Consensus 274 ~~R~t~~~~l~hp~f 288 (288)
T cd07871 274 KSRISAEAALRHSYF 288 (288)
T ss_pred ccCCCHHHHhcCCCC
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=340.40 Aligned_cols=261 Identities=26% Similarity=0.332 Sum_probs=217.5
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+.|++.++||+|.|+.||++.. .++.+|+|+...++... ..++.+ .+|++|-+.|+|||||++.+.+.+..
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l----~rEarIC~~LqHP~IvrL~~ti~~~~- 83 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKL----EREARICRKLQHPNIVRLHDSIQEES- 83 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHH----HHHHHHHHhcCCCcEeehhhhhcccc-
Confidence 4588999999999999999876 45788998865554433 244554 78999999999999999999988766
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..|||+|++.|++|..-|-.. ..+++..+-.+++||+.+|.|+|.+||||||+||+|+++..
T Consensus 84 -------------~~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLAS 145 (355)
T KOG0033|consen 84 -------------FHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLAS 145 (355)
T ss_pred -------------eeEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeee
Confidence 459999999999997755441 46899999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
.. ...-+||+|||+|..+.....+ ..++|||.|||||++.. .+|+..+|||+.||+||-|+
T Consensus 146 K~----~~A~vKL~~FGvAi~l~~g~~~-----------~G~~GtP~fmaPEvvrk----dpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 146 KA----KGAAVKLADFGLAIEVNDGEAW-----------HGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYILL 206 (355)
T ss_pred cc----CCCceeecccceEEEeCCcccc-----------ccccCCCcccCHHHhhc----CCCCCcchhhhhhHHHHHHH
Confidence 52 2357999999999877633222 24589999999999975 67999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
.|.+||.+.+...+++.|..+.......+++ ..+++.++|+++||..||.+|.|+.
T Consensus 207 ~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~------------------------~is~~Ak~LvrrML~~dP~kRIta~ 262 (355)
T KOG0033|consen 207 VGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD------------------------TVTPEAKSLIRRMLTVNPKKRITAD 262 (355)
T ss_pred hCCCCCCCccHHHHHHHHhccccCCCCcccC------------------------cCCHHHHHHHHHHhccChhhhccHH
Confidence 9999999999999999998876432222221 4566799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001152 1120 DLYEMFVARTS 1130 (1137)
Q Consensus 1120 EVL~~L~~~~~ 1130 (1137)
|+++|+|....
T Consensus 263 EAL~HpWi~~r 273 (355)
T KOG0033|consen 263 EALKHPWICNR 273 (355)
T ss_pred HHhCCchhcch
Confidence 99999999764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=360.67 Aligned_cols=258 Identities=20% Similarity=0.278 Sum_probs=209.3
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~---~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
....+.+|++.+.||+|+||.||+|.+.. ..+|+|+....... .....+ .+.+|+.+++.++|||||+++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~----~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVD----HVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHH----HHHHHHHHHHhCCCCCCcceEEE
Confidence 34567889999999999999999998743 45888875432211 112222 34789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+.+.. ..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 100 ~~~~~--------------~~~lv~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~ 160 (340)
T PTZ00426 100 FKDES--------------YLYLVLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPE 160 (340)
T ss_pred EEeCC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHH
Confidence 98765 67999999999999999976 346899999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.+ +.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||
T Consensus 161 NILl~~~-------~~ikL~DFG~a~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGv 216 (340)
T PTZ00426 161 NLLLDKD-------GFIKMTDFGFAKVVDTRT-------------YTLCGTPEYIAPEILLN----VGHGKAADWWTLGI 216 (340)
T ss_pred HEEECCC-------CCEEEecCCCCeecCCCc-------------ceecCChhhcCHHHHhC----CCCCccccccchhh
Confidence 9999877 789999999987543211 13469999999999875 45789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1034 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1034 iL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
++|||++|..||.+.+.......+..+... ++. ..++.+.+++.+||+.||.
T Consensus 217 il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~l~~dp~ 268 (340)
T PTZ00426 217 FIYEILVGCPPFYANEPLLIYQKILEGIIY-FPK---------------------------FLDNNCKHLMKKLLSHDLT 268 (340)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCC---------------------------CCCHHHHHHHHHHcccCHH
Confidence 999999999999988777666666544321 110 2234588999999999999
Q ss_pred CCC-----CHHHHHHHHHhhcC
Q 001152 1114 ERP-----TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1114 ~RP-----Sa~EVL~~L~~~~~ 1130 (1137)
+|+ +++++++|+|+...
T Consensus 269 ~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 269 KRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HcCCCCCCCHHHHHcCCCcCCC
Confidence 995 99999999999753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=366.87 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=215.7
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+....+...||+|+||+||+|+|.+ +||||+.. +.....+..+.| +.|+..+++-+|.||+-++||+..+.
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Ln--v~~pt~~qlqaF----KnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLN--VDDPTPEQLQAF----KNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc-ceEEEEEe--cCCCCHHHHHHH----HHHHHHHhhcchhhheeeehhhcCCc
Confidence 445567888999999999999999976 59999854 444445566666 99999999999999999999998654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..||+.+|+|.||+.+++.. +..|+..+.+.|++||++|+.|||.++|||||||..|||+.
T Consensus 462 ---------------~AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~ 522 (678)
T KOG0193|consen 462 ---------------LAIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH 522 (678)
T ss_pred ---------------eeeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc
Confidence 38999999999999999862 35799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
++ +.|||+|||++......... .......|...|||||++.. ....+|++.+||||||+++|||
T Consensus 523 ~~-------~kVkIgDFGLatvk~~w~g~--------~q~~qp~gsilwmAPEvIRm-qd~nPfS~qSDVYaFGiV~YEL 586 (678)
T KOG0193|consen 523 ED-------LKVKIGDFGLATVKTRWSGE--------QQLEQPHGSLLWMAPEVIRM-QDDNPFSFQSDVYAFGIVWYEL 586 (678)
T ss_pred cC-------CcEEEecccceeeeeeeccc--------cccCCCccchhhhcHHHHhh-cccCCCCcccchhhhhHHHHHH
Confidence 88 78999999998654332111 11123347789999999984 3567899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
+||..||.....++++.++.+|.. +.... ....+++++++|+..||..++++||.
T Consensus 587 ltg~lPysi~~~dqIifmVGrG~l~pd~s~------------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~ 642 (678)
T KOG0193|consen 587 LTGELPYSIQNRDQIIFMVGRGYLMPDLSK------------------------IRSNCPKAMKRLLSDCWKFDREERPL 642 (678)
T ss_pred HhCcCCcCCCChhheEEEecccccCccchh------------------------hhccCHHHHHHHHHHHHhcCcccCcc
Confidence 999999997666666666655531 11111 11267888999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001152 1118 AGDLYEMFVARTS 1130 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ 1130 (1137)
+.+|+..+.....
T Consensus 643 F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 643 FPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHHHHHhhh
Confidence 9999997666543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=354.07 Aligned_cols=291 Identities=20% Similarity=0.238 Sum_probs=205.9
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.++||+|+||.||+|.+. +..+|+|+..... ....... ++.+|+.++++++||||+++++++......
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDAT----RILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHH----HHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 5899999999999999999974 4678888643221 1112222 347899999999999999999988653310
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
.....|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~ 139 (338)
T cd07859 75 ---------EFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD 139 (338)
T ss_pred ---------CCceEEEEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 1225799999995 799998875 2468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||+++......... .......||+.|+|||++.+. ...++.++|||||||++|+|++
T Consensus 140 -------~~~kL~Dfg~~~~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 140 -------CKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred -------CcEEEccCccccccccccCcc-------ccccCCCCCCCcCCHHHHhcc--ccccCchhHHHHHHHHHHHHHc
Confidence 789999999987543221110 111234689999999998642 2467899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc-cccc--ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVA--QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|+.||.+.+.......+.................... .... ...............++.+.+++.+||+.||++|||
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 283 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC
Confidence 9999988766554444322211111111111100000 0000 000000001111234567899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001152 1118 AGDLYEMFVARTS 1130 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ 1130 (1137)
++|+++|+|+...
T Consensus 284 ~~e~l~hp~f~~~ 296 (338)
T cd07859 284 AEEALADPYFKGL 296 (338)
T ss_pred HHHHhcCchhhhc
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=346.21 Aligned_cols=281 Identities=24% Similarity=0.265 Sum_probs=202.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||+||+|++. +..+|+|+...... ..... ..+.+|+.+++.++||||+++++++..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVK----ETTLRELKMLRTLKQENIVELKEAFRRRG- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccch----hhHHHHHHHHHhCCCccccchhhhEecCC-
Confidence 36899999999999999999985 46688887543321 11112 23478999999999999999999987665
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||++++.+..+... ...+++..+..++.||+.||+|||+.||+||||||+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~ 135 (287)
T cd07848 74 -------------KLYLVFEYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135 (287)
T ss_pred -------------EEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 67999999997766554332 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslGvil~el~ 195 (287)
T cd07848 136 N-------DVLKLCDFGFARNLSEGSNA---------NYTEYVATRWYRSPELLLG----APYGKAVDMWSVGCILGELS 195 (287)
T ss_pred C-------CcEEEeeccCcccccccccc---------cccccccccccCCcHHHcC----CCCCCchhHHhHHHHHHHHH
Confidence 7 78999999998765332111 1123468999999999875 45789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccc---ccccccccCCCCC-CchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC---HEHEVAQSGSGFE-KPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
+|+.||.+.+..+....+.....+.....+...... ............. ........+.++.+|+.+||+.||++|
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R 275 (287)
T cd07848 196 DGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDR 275 (287)
T ss_pred hCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccC
Confidence 999999887665554444332222111111110000 0000000000000 000011356779999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001152 1116 PTAGDLYEMFVA 1127 (1137)
Q Consensus 1116 PSa~EVL~~L~~ 1127 (1137)
||++|+++|+|+
T Consensus 276 ~s~~~~l~hp~f 287 (287)
T cd07848 276 YLTEQCLNHPAF 287 (287)
T ss_pred CCHHHHhcCCCC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=357.71 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=200.5
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 885 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g 885 (1137)
+.||+|+||.||+|++. +..+|+|+....... ...... ++.+|+.++++++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~l~~l~hp~i~~~~~~~~~~~------- 68 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEVA----HTLTESRVLQNTRHPFLTALKYSFQTHD------- 68 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHH----HHHHHHHHHHhCCCCCCCCEEEEEEcCC-------
Confidence 46999999999999874 567899986533211 112222 3478999999999999999999988765
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCC
Q 001152 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965 (1137)
Q Consensus 886 ~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~ 965 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~----- 131 (323)
T cd05571 69 -------RLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD----- 131 (323)
T ss_pred -------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-----
Confidence 67999999999999999875 3468999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001152 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045 (1137)
Q Consensus 966 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf 1045 (1137)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 132 --~~~kl~DfG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~Pf 195 (323)
T cd05571 132 --GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEEeeCCCCcccccCCC----------cccceecCccccChhhhcC----CCCCccccCcccchhhhhhhcCCCCC
Confidence 7899999999864322111 1123469999999999875 56889999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 001152 1046 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 1120 (1137)
Q Consensus 1046 ~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-----Sa~E 1120 (1137)
...+.......+..... .++. ..++++.+++.+||+.||++|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p~---------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05571 196 YNQDHEKLFELILMEEI-RFPR---------------------------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE 247 (323)
T ss_pred CCCCHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence 88777666665543321 1110 2345689999999999999999 8999
Q ss_pred HHHHHHhhc
Q 001152 1121 LYEMFVART 1129 (1137)
Q Consensus 1121 VL~~L~~~~ 1129 (1137)
+++|+|+..
T Consensus 248 ll~h~~f~~ 256 (323)
T cd05571 248 IMEHRFFAS 256 (323)
T ss_pred HHcCCCcCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=347.53 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=199.6
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|++.+.||+|+||.||+|.+. +..+|+|+...+.... ... ...+.+|+.++++++|+||+++++++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~----~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-- 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKG----EAMALNEKRILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhh----HHHHHHHHHHHHhcCCCcEEEEEEEEccCC--
Confidence 3788999999999999999874 5778888753322111 111 123478999999999999999999988665
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++|+|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 74 ------------~~~lv~e~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~ 138 (285)
T cd05631 74 ------------ALCLVLTIMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR 138 (285)
T ss_pred ------------eEEEEEEecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 569999999999999888652 23468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~kl~Dfg~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslGvil~el~~ 196 (285)
T cd05631 139 -------GHIRISDLGLAVQIPEGET-----------VRGRVGTVGYMAPEVINN----EKYTFSPDWWGLGCLIYEMIQ 196 (285)
T ss_pred -------CCEEEeeCCCcEEcCCCCe-----------ecCCCCCCCccCHhhhcC----CCCCcccCchhHHHHHHHHHh
Confidence 7799999999875432111 113368999999999975 568899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 1117 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS--- 1117 (1137)
|+.||...........+......... . .....++++.+|+.+||+.||.+||+
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------~-----~~~~~s~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05631 197 GQSPFRKRKERVKREEVDRRVKEDQE-------------------E-----YSEKFSEDAKSICRMLLTKNPKERLGCRG 252 (285)
T ss_pred CCCCCCCCCcchhHHHHHHHhhcccc-------------------c-----CCccCCHHHHHHHHHHhhcCHHHhcCCCC
Confidence 99999875432222222110000000 0 00134456899999999999999997
Q ss_pred --HHHHHHHHHhhcC
Q 001152 1118 --AGDLYEMFVARTS 1130 (1137)
Q Consensus 1118 --a~EVL~~L~~~~~ 1130 (1137)
++++++|+|+...
T Consensus 253 ~~~~~~~~h~~~~~~ 267 (285)
T cd05631 253 NGAAGVKQHPIFKNI 267 (285)
T ss_pred CCHHHHhcCHhhcCC
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=344.60 Aligned_cols=284 Identities=21% Similarity=0.241 Sum_probs=202.8
Q ss_pred CCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeeEe
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 875 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L---~HpNIVkllg~~~ 875 (1137)
.+|++.+.||+|+||+||+|++. +..+|+|+......... .... +.+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~----~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLS----TIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--chHH----HHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 36899999999999999999873 45688887544332211 1111 25577766665 6999999999986
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
.... ......++||||++ ++|.+++... ....+++..+..|+.||+.||+|||++||+||||||+||
T Consensus 75 ~~~~---------~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Ni 141 (290)
T cd07862 75 VSRT---------DRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 141 (290)
T ss_pred cccC---------CCCCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 4321 01125799999996 7999998752 234589999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 142 l~~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il 199 (290)
T cd07862 142 LVTSS-------GQIKLADFGLARIYSFQM-----------ALTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCIF 199 (290)
T ss_pred EEcCC-------CCEEEccccceEeccCCc-----------ccccccccccccChHHHhC----CCCCCccchHHHHHHH
Confidence 99877 789999999987543221 1123468999999999865 4678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|||++|+.||.+....+....+........+..++.......... ...............++.+.+++.+||+.||++|
T Consensus 200 ~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 278 (290)
T cd07862 200 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 278 (290)
T ss_pred HHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhc-cCCCCCCHHHHccCCCHHHHHHHHHHhccCchhc
Confidence 999999999998877776666644322111111111000000000 0000000011112456678999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001152 1116 PTAGDLYEMFVA 1127 (1137)
Q Consensus 1116 PSa~EVL~~L~~ 1127 (1137)
||+.|+++|+|+
T Consensus 279 ~s~~~~l~hp~f 290 (290)
T cd07862 279 ISAYSALSHPYF 290 (290)
T ss_pred CCHHHHhcCCCC
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.29 Aligned_cols=267 Identities=23% Similarity=0.340 Sum_probs=220.3
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~ 877 (1137)
+..|.-.+.||.|..++|-++.. ++...|+|+..........+..++......+|+.||+++. ||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 45677788999999999998876 3567888875444333333335555556689999999996 99999999999987
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
.+ +++|+|.|+.|.|.+++.. ...++++...+|++|+..|++|||.++||||||||+|||+
T Consensus 96 sF--------------~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl 156 (411)
T KOG0599|consen 96 AF--------------VFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL 156 (411)
T ss_pred ch--------------hhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee
Confidence 74 4999999999999999976 4679999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc--CCCCCCchhhHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVWSLGviL 1035 (1137)
+++ .++||+|||+++.+...... ...+|||+|.|||.+.... +...|+..+|+||+|||+
T Consensus 157 ddn-------~~i~isDFGFa~~l~~GekL-----------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVIm 218 (411)
T KOG0599|consen 157 DDN-------MNIKISDFGFACQLEPGEKL-----------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIM 218 (411)
T ss_pred ccc-------cceEEeccceeeccCCchhH-----------HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHH
Confidence 988 78999999999877653321 2347999999999987533 345689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|.|+.|++||......-+...|..|....-..++. +.+.+.++||.+||+.||.+|
T Consensus 219 yTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa------------------------dis~~~KdLIsrlLqVdp~~R 274 (411)
T KOG0599|consen 219 YTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA------------------------DISATVKDLISRLLQVDPTKR 274 (411)
T ss_pred HHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh------------------------hccccHHHHHHHHHeeCchhc
Confidence 99999999998777777778888777533222221 455669999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001152 1116 PTAGDLYEMFVAR 1128 (1137)
Q Consensus 1116 PSa~EVL~~L~~~ 1128 (1137)
.|++|++.|+|++
T Consensus 275 itake~LaHpff~ 287 (411)
T KOG0599|consen 275 ITAKEALAHPFFI 287 (411)
T ss_pred ccHHHHhcChHHH
Confidence 9999999999995
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.62 Aligned_cols=261 Identities=23% Similarity=0.268 Sum_probs=219.2
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
..-++++|++++.||+|-||.||+|+.+.+ -||+||.... .-...+.+.++.+|++|.+.|+||||+++|++|
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs-----qi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS-----QILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHH-----HHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 345688999999999999999999998654 4666664322 222334556779999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.++. ..|+++||.++|+|...++. .....+++..+..+++|+|.||.|+|..+||||||||+|
T Consensus 92 hd~~--------------riyLilEya~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpen 154 (281)
T KOG0580|consen 92 HDSK--------------RIYLILEYAPRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPEN 154 (281)
T ss_pred eccc--------------eeEEEEEecCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHH
Confidence 9877 56999999999999999985 335679999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
+|++.+ +.+||+|||.+..... ....+.+||..|.+||+..+ ..++..+|+|++|++
T Consensus 155 lLlg~~-------~~lkiAdfGwsV~~p~------------~kR~tlcgt~dyl~pEmv~~----~~hd~~Vd~w~lgvl 211 (281)
T KOG0580|consen 155 LLLGSA-------GELKIADFGWSVHAPS------------NKRKTLCGTLDYLPPEMVEG----RGHDKFVDLWSLGVL 211 (281)
T ss_pred hccCCC-------CCeeccCCCceeecCC------------CCceeeecccccCCHhhcCC----CCccchhhHHHHHHH
Confidence 999988 7899999998764321 22346789999999999876 678899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
.||++.|.+||......+.++.|.+.... ++ ...+..+.++|.+|+..+|.+
T Consensus 212 ~yeflvg~ppFes~~~~etYkrI~k~~~~-~p---------------------------~~is~~a~dlI~~ll~~~p~~ 263 (281)
T KOG0580|consen 212 CYEFLVGLPPFESQSHSETYKRIRKVDLK-FP---------------------------STISGGAADLISRLLVKNPIE 263 (281)
T ss_pred HHHHHhcCCchhhhhhHHHHHHHHHcccc-CC---------------------------cccChhHHHHHHHHhccCccc
Confidence 99999999999988888888888654421 11 144556999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
|.+..|++.|+|...-
T Consensus 264 r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 264 RLALTEVMDHPWIVAN 279 (281)
T ss_pred cccHHHHhhhHHHHhc
Confidence 9999999999998753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=353.31 Aligned_cols=262 Identities=23% Similarity=0.353 Sum_probs=198.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
-++|++.++||+|+||.||+|.+. +..||+|+.+.. ......+. +.+|+.+++++ +|||||++++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~niv~~~~ 78 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKA----LMSELKILIHIGNHLNVVNLLG 78 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHH----HHHHHHHHHHhccCcceeeEEe
Confidence 357999999999999999999752 246888874321 11222333 48899999999 7999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------------------------------------
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------ 916 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~------------------------------------ 916 (1137)
++...+. ..++||||+++|+|.+++......
T Consensus 79 ~~~~~~~-------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (338)
T cd05102 79 ACTKPNG-------------PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVL 145 (338)
T ss_pred EecCCCC-------------ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcc
Confidence 8865431 469999999999999999753210
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeec
Q 001152 917 ---------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF 975 (1137)
Q Consensus 917 ---------------------~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DF 975 (1137)
....+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-------~~~kl~Df 218 (338)
T cd05102 146 FSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKICDF 218 (338)
T ss_pred ccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-------CcEEEeec
Confidence 01358889999999999999999999999999999999999877 78999999
Q ss_pred CccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH-HH
Q 001152 976 DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSEL-EI 1053 (1137)
Q Consensus 976 Gla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~-el 1053 (1137)
|+++........ .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.... ..
T Consensus 219 G~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~ 286 (338)
T cd05102 219 GLARDIYKDPDY--------VRKGSARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286 (338)
T ss_pred ccccccccCcch--------hcccCCCCCccccCcHHhhc----CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH
Confidence 998754322110 01112346678999999875 567899999999999999997 99999875432 23
Q ss_pred HHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1054 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1054 ~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
...+..+..+..+ ..+++++.+++.+||+.||.+|||+.||++.+...
T Consensus 287 ~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 287 CQRLKDGTRMRAP---------------------------ENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3333332221111 03345699999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=353.60 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=208.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|++. +..+|+|+....... ..... ..+.+|+.++..++||||+++++++.+.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEV----RHVLTERDILTTTKSEWLVKLLYAFQDDE- 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHH----HHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence 36899999999999999999985 467889986533211 11122 23478999999999999999999988765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 136 (333)
T cd05600 75 -------------YLYLAMEYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA 136 (333)
T ss_pred -------------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 67999999999999999975 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~Dfg~a~~~~~~-------------~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell 192 (333)
T cd05600 137 S-------GHIKLTDFGLSKGIVTY-------------ANSVVGSPDYMAPEVLRG----KGYDFTVDYWSLGCMLYEFL 192 (333)
T ss_pred C-------CCEEEEeCcCCcccccc-------------cCCcccCccccChhHhcC----CCCCCccceecchHHHhhhh
Confidence 7 78999999998754331 113469999999999875 46889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||...+..+....+....... . .+ .........++++.+++.+||..+|.+||+++
T Consensus 193 ~g~~pf~~~~~~~~~~~i~~~~~~~-~----~~---------------~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~ 252 (333)
T cd05600 193 CGFPPFSGSTPNETWENLKYWKETL-Q----RP---------------VYDDPRFNLSDEAWDLITKLINDPSRRFGSLE 252 (333)
T ss_pred hCCCCCCCCCHHHHHHHHHhccccc-c----CC---------------CCCccccccCHHHHHHHHHHhhChhhhcCCHH
Confidence 9999999887777666654322100 0 00 00000013456799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001152 1120 DLYEMFVARTS 1130 (1137)
Q Consensus 1120 EVL~~L~~~~~ 1130 (1137)
++++|+|+...
T Consensus 253 ~ll~h~~~~~~ 263 (333)
T cd05600 253 DIKNHPFFKEV 263 (333)
T ss_pred HHHhCcccCCC
Confidence 99999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=346.36 Aligned_cols=284 Identities=20% Similarity=0.264 Sum_probs=202.5
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
..++|++.+.||+|+||.||+|++. +..+|+|+........ .. ..+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG---TP----FTAIREASLLKGLKHANIVLLHDIIHTK 75 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc---cc----hhHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence 4578999999999999999999984 5678888754322111 11 1236799999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~--------------~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill 136 (303)
T cd07869 76 E--------------TLTLVFEYVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI 136 (303)
T ss_pred C--------------eEEEEEECCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 5 6799999996 7888887651 2458899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++........ ......+|+.|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ 196 (303)
T cd07869 137 SDT-------GELKLADFGLARAKSVPSH----------TYSNEVVTLWYRPPDVLLG---STEYSTCLDMWGVGCIFVE 196 (303)
T ss_pred CCC-------CCEEECCCCcceeccCCCc----------cCCCCcccCCCCChHHHcC---CCCCCcHHHHHHHHHHHHH
Confidence 877 7899999999864432111 1113358899999999864 2457899999999999999
Q ss_pred HHhCCCCCCCCCH-HHHHHHHHc-CCCCCchhHHhhhcccccccccccCCCCCCch-----hhhhhHHHHHHHHHHhccc
Q 001152 1038 LLTLQVPYMGLSE-LEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPE-----AELETLSFLVDVFRRCTEE 1110 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~-~el~~~I~~-g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~L~dLl~~CL~~ 1110 (1137)
|++|..||.+... .+....+.. ...+.. ..+...... ............... .....++.+.+|+.+||+.
T Consensus 197 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 274 (303)
T cd07869 197 MIQGVAAFPGMKDIQDQLERIFLVLGTPNE-DTWPGVHSL-PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQC 274 (303)
T ss_pred HHhCCCCCCCCccHHHHHHHHHHHhCCCCh-hhccchhhc-cccccccccccCCccHHHHhhccCCChHHHHHHHHHhcc
Confidence 9999999987433 222332211 111110 000000000 000000000000000 0112345688999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcCC
Q 001152 1111 NPTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1111 DP~~RPSa~EVL~~L~~~~~s 1131 (1137)
||++|||+.|+++|+|+....
T Consensus 275 dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 275 FPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred CchhccCHHHHhcCcccccCC
Confidence 999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=348.04 Aligned_cols=281 Identities=23% Similarity=0.300 Sum_probs=205.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.++|++.+.||+|+||.||+|++. +..+|+|+...+. .... ..++.+|+++|++++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAI----RNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHH----HHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 467999999999999999999986 4567777654321 1222 234588999999999999999999988765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeEe
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 957 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrDLKP~NILl 957 (1137)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+
T Consensus 77 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~ 137 (331)
T cd06649 77 --------------EISICMEHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV 137 (331)
T ss_pred --------------EEEEEeecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE
Confidence 67999999999999999976 24589999999999999999999986 69999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++||
T Consensus 138 ~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~e 194 (331)
T cd06649 138 NSR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 194 (331)
T ss_pred cCC-------CcEEEccCcccccccccc------------cccCCCCcCcCCHhHhcC----CCCCchHhHHHHHHHHHH
Confidence 887 789999999886543211 113468999999999875 468899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCC---chhHHhhhccccccccc----------------c-cCCCCCCchhhhhhH
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPR---LTDELEALGSCHEHEVA----------------Q-SGSGFEKPEAELETL 1097 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~---l~~~l~~~~~~~~~~~~----------------~-~~~~~~~~~~~~~~~ 1097 (1137)
|++|+.||......++...+....... ................. . ..............+
T Consensus 195 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
T cd06649 195 LAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFT 274 (331)
T ss_pred HHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCcccc
Confidence 999999998776665544332111000 00000000000000000 0 000000000011356
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1098 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1098 ~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+++.+|+.+||+.||++|||+.|+++|+|+...
T Consensus 275 ~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 275 PDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 779999999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=361.06 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=204.6
Q ss_pred CCCCCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 795 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 795 ~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
+.-...|....-.+.||.|+.|.||+|+..+..||||.. .+.++ .+|+-|++|+||||+.|.|+|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV---------~elkE------TdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKV---------RELKE------TDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHH---------hhhhh------hhHHHHHhccCcceeeEeeee
Confidence 334455566666789999999999999999999999852 22233 378999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
...- .+|||||||+.|-|...++. +..+.......|..+||.|+.|||.+.|||||||+-|
T Consensus 182 tqsP--------------cyCIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPN 242 (904)
T KOG4721|consen 182 TQSP--------------CYCIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPN 242 (904)
T ss_pred cCCc--------------eeEEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCc
Confidence 8765 56999999999999999986 4578889999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
|||..+ ..|||+|||-++...... ....++||..|||||++.. .+.+.|+|||||||+
T Consensus 243 iLIs~~-------d~VKIsDFGTS~e~~~~S-----------TkMSFaGTVaWMAPEvIrn----ePcsEKVDIwSfGVV 300 (904)
T KOG4721|consen 243 ILISYD-------DVVKISDFGTSKELSDKS-----------TKMSFAGTVAWMAPEVIRN----EPCSEKVDIWSFGVV 300 (904)
T ss_pred eEeecc-------ceEEeccccchHhhhhhh-----------hhhhhhhhHhhhCHHHhhc----CCcccccceehhHHH
Confidence 999988 689999999887655431 1236789999999999985 678999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|||||||..||...+...++. |.....- ..+ ....+++-++=|+++||+..|..
T Consensus 301 LWEmLT~EiPYkdVdssAIIw----GVGsNsL---------------------~Lp-vPstcP~GfklL~Kqcw~sKpRN 354 (904)
T KOG4721|consen 301 LWEMLTGEIPYKDVDSSAIIW----GVGSNSL---------------------HLP-VPSTCPDGFKLLLKQCWNSKPRN 354 (904)
T ss_pred HHHHHhcCCCccccchheeEE----eccCCcc---------------------ccc-CcccCchHHHHHHHHHHhcCCCC
Confidence 999999999997644432221 2111100 000 01166777999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001152 1115 RPTAGDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~ 1129 (1137)
||+|.+|+.|+....
T Consensus 355 RPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 355 RPSFRQILLHLDIAS 369 (904)
T ss_pred CccHHHHHHHHhhcC
Confidence 999999999987643
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=363.57 Aligned_cols=290 Identities=19% Similarity=0.229 Sum_probs=204.4
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.-.+|++.+.||+|+||.||+|.+. +..||+|...... . . ..+|+.+|+.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~--~----~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------Q--Y----KNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------c--h----HHHHHHHHHhcCCCCCcceeeeEeec
Confidence 3457999999999999999999984 4678888642111 0 1 14699999999999999999987653
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
... .......+++||||++ ++|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 132 ~~~------~~~~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl 203 (440)
T PTZ00036 132 CFK------KNEKNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI 203 (440)
T ss_pred ccc------cCCCceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEE
Confidence 211 0011225789999997 688887765322 23579999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.++ +.+||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++||
T Consensus 204 ~~~~------~~vkL~DFGla~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~e 263 (440)
T PTZ00036 204 DPNT------HTLKLCDFGSAKNLLAGQR-----------SVSYICSRFYRAPELMLG---ATNYTTHIDLWSLGCIIAE 263 (440)
T ss_pred cCCC------CceeeeccccchhccCCCC-----------cccCCCCcCccCHHHhcC---CCCCCcHHHHHHHHHHHHH
Confidence 8652 4699999999975543211 113468999999999865 2468899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcc-cccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS-CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++|.+||.+....+....+...........+..... ......................++++.+|+.+||++||.+||
T Consensus 264 lltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ 343 (440)
T PTZ00036 264 MILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL 343 (440)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc
Confidence 9999999998776655555432221111111111000 000000000000000000113456799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|+.|+++|+|+..
T Consensus 344 ta~e~l~hp~f~~ 356 (440)
T PTZ00036 344 NPIEALADPFFDD 356 (440)
T ss_pred CHHHHhCChhHHh
Confidence 9999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=354.42 Aligned_cols=268 Identities=20% Similarity=0.216 Sum_probs=202.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|... +..+|+|+....... .......+.+|+.++..++||||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~- 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-----EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL- 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 36899999999999999999884 467889885432110 1111233478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~ 136 (363)
T cd05628 75 -------------NLYLIMEFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS 136 (363)
T ss_pred -------------eEEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC
Confidence 67999999999999999976 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccc-------------------------cCCCCCCCcccCCCcccchhhhc
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------HRGIPAPDVCVGTPRWMAPEVLR 1014 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~-------------------------~~~~~~~~~~~GT~~Y~APE~l~ 1014 (1137)
+ +.+||+|||+++............ ..........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 209 (363)
T cd05628 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209 (363)
T ss_pred C-------CCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc
Confidence 7 789999999987543211100000 00000012347999999999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhh
Q 001152 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1093 (1137)
Q Consensus 1015 ~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1137)
+ ..++.++|||||||++|||++|..||.+....+....+..... ..++..
T Consensus 210 ~----~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~------------------------- 260 (363)
T cd05628 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPE------------------------- 260 (363)
T ss_pred C----CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCc-------------------------
Confidence 5 5688999999999999999999999998887777776654321 111110
Q ss_pred hhhHHHHHHHHHHhcc--cCCCCCCCHHHHHHHHHhhc
Q 001152 1094 LETLSFLVDVFRRCTE--ENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1094 ~~~~~~L~dLl~~CL~--~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
...++++.+++.+|+. .++..||+++||++|+|+..
T Consensus 261 ~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 261 VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCC
Confidence 0234458888888664 22334689999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=356.07 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=205.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||+||+|++. +..+|+|+....... ..... ..+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQV----AHVRAERDILAEADNPWVVKLYYSFQDEN- 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhCCCCCCcceEEEEEcCC-
Confidence 36899999999999999999984 567899986432111 11122 23478999999999999999999998766
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~ 136 (364)
T cd05599 75 -------------YLYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136 (364)
T ss_pred -------------eEEEEECCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 67999999999999999875 246999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccc---c-------------------------CCCCCCCcccCCCcccchh
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA---H-------------------------RGIPAPDVCVGTPRWMAPE 1011 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~---~-------------------------~~~~~~~~~~GT~~Y~APE 1011 (1137)
+ +.+||+|||++..+.......... . .........+||+.|+|||
T Consensus 137 ~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 137 K-------GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred C-------CCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 7 789999999987543211100000 0 0000011246999999999
Q ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CchhHHhhhcccccccccccCCCCCCc
Q 001152 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKP 1090 (1137)
Q Consensus 1012 ~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~ 1090 (1137)
++.. ..++.++|||||||++|||++|..||...+..+....+...... .++.
T Consensus 210 ~~~~----~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------------------- 262 (364)
T cd05599 210 VFLQ----TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPD----------------------- 262 (364)
T ss_pred HHcC----CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCC-----------------------
Confidence 9865 56889999999999999999999999988777766665432211 0000
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHhhc
Q 001152 1091 EAELETLSFLVDVFRRCTEENPTERPT---AGDLYEMFVART 1129 (1137)
Q Consensus 1091 ~~~~~~~~~L~dLl~~CL~~DP~~RPS---a~EVL~~L~~~~ 1129 (1137)
....++++.+++.+|+. +|.+|++ ++|+++|+|+..
T Consensus 263 --~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 263 --EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred --CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 00234568999999996 9999997 999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=349.10 Aligned_cols=247 Identities=24% Similarity=0.311 Sum_probs=197.9
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCC
Q 001152 810 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 810 LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 887 (1137)
||+|+||.||+|++. +..+|+|+....... ...... .+.+|+.++++++||||+++++++...+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------- 66 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVT----HTLAERTVLAQVNCPFIVPLKFSFQSPE--------- 66 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhCCCCcEeceeeEEecCC---------
Confidence 799999999999985 456888875422111 112222 3478999999999999999999988655
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCC
Q 001152 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 967 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~ 967 (1137)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 67 -----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~------- 129 (312)
T cd05585 67 -----KLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ------- 129 (312)
T ss_pred -----eEEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-------
Confidence 67999999999999999875 2468999999999999999999999999999999999999877
Q ss_pred CeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001152 968 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047 (1137)
Q Consensus 968 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~ 1047 (1137)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 130 ~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 130 GHIALCDFGLCKLNMKDDD----------KTNTFCGTPEYLAPELLLG----HGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred CcEEEEECcccccCccCCC----------ccccccCCcccCCHHHHcC----CCCCCccceechhHHHHHHHhCCCCcCC
Confidence 7899999999864322111 1123468999999999875 5678999999999999999999999988
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 001152 1048 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEM 1124 (1137)
Q Consensus 1048 ~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP---Sa~EVL~~ 1124 (1137)
....+....+..... .++. ..++++.+++.+||+.||.+|| ++.|++.|
T Consensus 196 ~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 196 ENVNEMYRKILQEPL-RFPD---------------------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHcCCC-CCCC---------------------------cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 777766666544321 1110 2345689999999999999997 58999999
Q ss_pred HHhhc
Q 001152 1125 FVART 1129 (1137)
Q Consensus 1125 L~~~~ 1129 (1137)
+|+..
T Consensus 248 p~~~~ 252 (312)
T cd05585 248 PFFSQ 252 (312)
T ss_pred CCcCC
Confidence 99875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=357.21 Aligned_cols=258 Identities=26% Similarity=0.321 Sum_probs=218.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
...|..++++|+|+||.+++++++ +..+++|.+.+..... .+.+. +.+|+.++++++|||||.+++.|..++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~--~~r~~----A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE--PERRS----AIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc--hhhHH----HHHHHHHHHhccCCCeeeeccchhcCC
Confidence 467899999999999999998875 4667777755554433 23223 378999999999999999999999876
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. .++|||+||+||++.+.|.+.. +..|+++.+.+|+.||+.|++|||+++|+|||||+.|||++
T Consensus 77 ~-------------~l~Ivm~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt 140 (426)
T KOG0589|consen 77 Q-------------LLCIVMEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT 140 (426)
T ss_pred c-------------eEEEEEeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc
Confidence 2 3799999999999999998732 46799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ ..|||+|||+|+.+..... .....+||+.||.||++.+ .+|+.|+|||||||++|||
T Consensus 141 k~-------~~VkLgDfGlaK~l~~~~~----------~a~tvvGTp~YmcPEil~d----~pYn~KSDiWsLGC~~yEm 199 (426)
T KOG0589|consen 141 KD-------KKVKLGDFGLAKILNPEDS----------LASTVVGTPYYMCPEILSD----IPYNEKSDIWSLGCCLYEM 199 (426)
T ss_pred cc-------CceeecchhhhhhcCCchh----------hhheecCCCcccCHHHhCC----CCCCccCcchhhcchHHHH
Confidence 88 6789999999998765431 1235689999999999987 6899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++-+++|.+.+...+...|..+....++. .++.+++.++..||..+|..||++
T Consensus 200 ~~lk~aF~a~~m~~Li~ki~~~~~~Plp~---------------------------~ys~el~~lv~~~l~~~P~~RPsa 252 (426)
T KOG0589|consen 200 CTLKPAFKASNMSELILKINRGLYSPLPS---------------------------MYSSELRSLVKSMLRKNPEHRPSA 252 (426)
T ss_pred HhcccccCccchHHHHHHHhhccCCCCCc---------------------------cccHHHHHHHHHHhhcCCccCCCH
Confidence 99999999999999998887766433332 445569999999999999999999
Q ss_pred HHHHHHHHhh
Q 001152 1119 GDLYEMFVAR 1128 (1137)
Q Consensus 1119 ~EVL~~L~~~ 1128 (1137)
.+++.++...
T Consensus 253 ~~LL~~P~l~ 262 (426)
T KOG0589|consen 253 LELLRRPHLL 262 (426)
T ss_pred HHHhhChhhh
Confidence 9999987654
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=351.10 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=198.9
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 885 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g 885 (1137)
+.||+|+||.||+|... +..+|+|+....... ...... .+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~~------- 68 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-AKDEVA----HTLTESRVLKNTRHPFLTSLKYSFQTKD------- 68 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhCCCCCCcceEEEEEcCC-------
Confidence 46999999999999974 577899986433211 122222 3478999999999999999999988765
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCC
Q 001152 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965 (1137)
Q Consensus 886 ~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~ 965 (1137)
..++||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~Ey~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~----- 131 (328)
T cd05593 69 -------RLCFVMEYVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD----- 131 (328)
T ss_pred -------EEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-----
Confidence 67999999999999988865 2468999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001152 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045 (1137)
Q Consensus 966 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf 1045 (1137)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 132 --~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~elltG~~Pf 195 (328)
T cd05593 132 --GHIKITDFGLCKEGITDAA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (328)
T ss_pred --CcEEEecCcCCccCCCccc----------ccccccCCcCccChhhhcC----CCCCccCCccccchHHHHHhhCCCCC
Confidence 7899999999864322111 1123468999999999875 46789999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 001152 1046 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 1120 (1137)
Q Consensus 1046 ~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-----Sa~E 1120 (1137)
...+..+....+..... .++. ..++++.+++.+||+.||.+|| ++.|
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p~---------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (328)
T cd05593 196 YNQDHEKLFELILMEDI-KFPR---------------------------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKE 247 (328)
T ss_pred CCCCHHHHHHHhccCCc-cCCC---------------------------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 88776666555533221 1110 2345689999999999999997 8999
Q ss_pred HHHHHHhhc
Q 001152 1121 LYEMFVART 1129 (1137)
Q Consensus 1121 VL~~L~~~~ 1129 (1137)
+++|+|+..
T Consensus 248 il~h~~~~~ 256 (328)
T cd05593 248 IMRHSFFTG 256 (328)
T ss_pred HhcCCCcCC
Confidence 999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=341.27 Aligned_cols=274 Identities=25% Similarity=0.322 Sum_probs=218.4
Q ss_pred CCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+..|++.+.||+|.-|+||+|+..+ ...|+||...+.. ..+.-..|+..|-+||+.+.||.++.+|+.|+.+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-----~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-----ASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH-----hhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 46778999999999999999999976 5688887432211 1111123557899999999999999999999988
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
++ .|+|||||+||+|..+.++ ++...|++..++.++..|+.||+|||-.|||+|||||+||||
T Consensus 150 ~~--------------~cl~meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv 212 (459)
T KOG0610|consen 150 KY--------------SCLVMEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV 212 (459)
T ss_pred ce--------------eEEEEecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE
Confidence 74 5999999999999999876 566789999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCcccccccccc---------------------ccc------c-c------------------
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLH---------------------TCC------I-A------------------ 991 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~---------------------~~~------~-~------------------ 991 (1137)
.++ |+|.|+||.++........ .+. . .
T Consensus 213 red-------GHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~a 285 (459)
T KOG0610|consen 213 RED-------GHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVA 285 (459)
T ss_pred ecC-------CcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhc
Confidence 988 8999999998864321000 000 0 0
Q ss_pred cCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhh
Q 001152 992 HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 1071 (1137)
Q Consensus 992 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~ 1071 (1137)
.........++||-.|.|||++.| ...+.++|+|+|||++|||+.|..||-+.+..+....|.... +.++..
T Consensus 286 ep~~~RSnSFVGThEYlAPEvI~G----~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~-l~Fp~~--- 357 (459)
T KOG0610|consen 286 EPTGARSNSFVGTHEYLAPEVIRG----EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP-LKFPEE--- 357 (459)
T ss_pred CCCCccccccccccccccceeeec----CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC-CcCCCC---
Confidence 000112346799999999999987 568899999999999999999999999988888887775432 122211
Q ss_pred hcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC----HHHHHHHHHhhcCCC
Q 001152 1072 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----AGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS----a~EVL~~L~~~~~ss 1132 (1137)
...+.++++||++.|.+||.+|.. |+||-+|+||+..-|
T Consensus 358 ----------------------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 358 ----------------------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred ----------------------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 034456999999999999999997 999999999986543
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=350.11 Aligned_cols=250 Identities=26% Similarity=0.326 Sum_probs=199.2
Q ss_pred eeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~-----~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
+.||+|+||.||+|+. .+..+|+|+............ ...+.+|+.+|+.++||||+++++++..++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~----~~~~~~E~~il~~l~hp~iv~~~~~~~~~~---- 73 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKD----TAHTKAERNILEAVKHPFIVDLIYAFQTGG---- 73 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhh----HHHHHHHHHHHHhCCCCchhceeeEEecCC----
Confidence 6799999999999986 346789998643221111111 123478999999999999999999988765
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
..|+||||+++++|.+++.. ...+.+..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 74 ----------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-- 136 (323)
T cd05584 74 ----------KLYLILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-- 136 (323)
T ss_pred ----------eEEEEEeCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC--
Confidence 56999999999999999875 2468899999999999999999999999999999999999877
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~ 1042 (1137)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 137 -----~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~G~ 197 (323)
T cd05584 137 -----GHVKLTDFGLCKESIHEGT----------VTHTFCGTIEYMAPEILMR----SGHGKAVDWWSLGALMYDMLTGA 197 (323)
T ss_pred -----CCEEEeeCcCCeecccCCC----------cccccCCCccccChhhccC----CCCCCcceecccHHHHHHHhcCC
Confidence 7899999998864322111 1123468999999999875 45789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----C
Q 001152 1043 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----T 1117 (1137)
Q Consensus 1043 ~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-----S 1117 (1137)
.||...+.......+..+... ++. ..++.+.+++.+||+.||++|| +
T Consensus 198 ~pf~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~li~~~l~~~p~~R~~~~~~~ 249 (323)
T cd05584 198 PPFTAENRKKTIDKILKGKLN-LPP---------------------------YLTPEARDLLKKLLKRNPSSRLGAGPGD 249 (323)
T ss_pred CCCCCCCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHcccCHhHcCCCCCCC
Confidence 999987776666666543321 110 2344589999999999999999 8
Q ss_pred HHHHHHHHHhhc
Q 001152 1118 AGDLYEMFVART 1129 (1137)
Q Consensus 1118 a~EVL~~L~~~~ 1129 (1137)
++++++|+|+..
T Consensus 250 ~~~l~~h~~~~~ 261 (323)
T cd05584 250 AAEVQSHPFFRH 261 (323)
T ss_pred HHHHhcCCCcCC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=349.73 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=199.4
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 885 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g 885 (1137)
+.||+|+||.||+|+.. +..+|+|+...+... ...... .+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~----~~~~E~~~l~~l~hp~i~~~~~~~~~~~------- 68 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVA----HTVTESRVLQNTRHPFLTALKYAFQTHD------- 68 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHH----HHHHHHHHHHhCCCCCCcceeeEEecCC-------
Confidence 46999999999999974 567889986533211 112222 3378999999999999999999988765
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCC
Q 001152 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965 (1137)
Q Consensus 886 ~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~ 965 (1137)
..|+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 -------~~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----- 131 (323)
T cd05595 69 -------RLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD----- 131 (323)
T ss_pred -------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-----
Confidence 67999999999999988865 2468999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001152 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045 (1137)
Q Consensus 966 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf 1045 (1137)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 132 --~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell~g~~Pf 195 (323)
T cd05595 132 --GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred --CCEEecccHHhccccCCCC----------ccccccCCcCcCCcccccC----CCCCchhchhhhHHHHHHHHhCCCCC
Confidence 7899999998864322111 1123468999999999875 46789999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHH
Q 001152 1046 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGD 1120 (1137)
Q Consensus 1046 ~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-----Sa~E 1120 (1137)
...+.......+..... .++. ..++++.+++.+||+.||.+|| ++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~-~~p~---------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (323)
T cd05595 196 YNQDHERLFELILMEEI-RFPR---------------------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 247 (323)
T ss_pred CCCCHHHHHHHHhcCCC-CCCC---------------------------CCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence 88777666655543221 1110 3345689999999999999998 9999
Q ss_pred HHHHHHhhc
Q 001152 1121 LYEMFVART 1129 (1137)
Q Consensus 1121 VL~~L~~~~ 1129 (1137)
+++|+|+..
T Consensus 248 ~l~h~~~~~ 256 (323)
T cd05595 248 VMEHRFFLS 256 (323)
T ss_pred HHcCCCcCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.61 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=213.6
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.|-+|.. .++.||+|..+.+...+ ..+.- .+.+||+||+.|+||||+.+|.+|+..+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd-eqDlv----hIRREIeIMSsLNHPhII~IyEVFENkd- 126 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD-EQDLV----HIRREIEIMSSLNHPHIIQIYEVFENKD- 126 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc-HHHHH----HHHHHHHHHhhcCCCceeehhhhhcCCc-
Confidence 5799999999999999999986 45788888754443322 22222 3589999999999999999999999876
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
...|||||..+|.|++|+.. ...+++.+++.+++||..|+.|+|.++++|||||.+|||+|.
T Consensus 127 -------------KIvivMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~ 188 (668)
T KOG0611|consen 127 -------------KIVIVMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQ 188 (668)
T ss_pred -------------eEEEEEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecC
Confidence 56999999999999999987 357999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +++||+|||++..+..... ..+++|+|.|.+||++.|. .+-++.+|.|||||+||.|+
T Consensus 189 N-------~NiKIADFGLSNly~~~kf-----------LqTFCGSPLYASPEIvNG~---PY~GPEVDsWsLGvLLYtLV 247 (668)
T KOG0611|consen 189 N-------NNIKIADFGLSNLYADKKF-----------LQTFCGSPLYASPEIVNGT---PYKGPEVDSWSLGVLLYTLV 247 (668)
T ss_pred C-------CCeeeeccchhhhhccccH-----------HHHhcCCcccCCccccCCC---CCCCCccchhhHHHHHHHHh
Confidence 8 7899999999876544321 1356899999999999873 34479999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
.|..||++.+...+..+|..|..... ..+....-||+.||..+|++|.|++
T Consensus 248 yGtMPFDG~Dhk~lvrQIs~GaYrEP-----------------------------~~PSdA~gLIRwmLmVNP~RRATie 298 (668)
T KOG0611|consen 248 YGTMPFDGRDHKRLVRQISRGAYREP-----------------------------ETPSDASGLIRWMLMVNPERRATIE 298 (668)
T ss_pred hcccccCCchHHHHHHHhhcccccCC-----------------------------CCCchHHHHHHHHHhcCcccchhHH
Confidence 99999999998889999988764221 1222367789999999999999999
Q ss_pred HHHHHHHhh
Q 001152 1120 DLYEMFVAR 1128 (1137)
Q Consensus 1120 EVL~~L~~~ 1128 (1137)
+|..|.|.-
T Consensus 299 DiAsHWWvN 307 (668)
T KOG0611|consen 299 DIASHWWVN 307 (668)
T ss_pred HHhhhheee
Confidence 999999974
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=340.71 Aligned_cols=286 Identities=19% Similarity=0.252 Sum_probs=209.2
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...+.+|++.++||+|+||.||+|++. +..+|+|+........ ... .+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~----~~~~E~~~l~~l~h~~iv~~~~~~~ 74 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APC----TAIREVSLLKDLKHANIVTLHDIVH 74 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC---cch----hHHHHHHHHHhCCCCCcceEEEEEe
Confidence 345788999999999999999999875 4668888754332211 111 2367999999999999999999988
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
.++ ..++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 75 ~~~--------------~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Ni 135 (309)
T cd07872 75 TDK--------------SLTLVFEYLD-KDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL 135 (309)
T ss_pred eCC--------------eEEEEEeCCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 765 5699999997 6898887652 24589999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++......... .....+|+.|+|||++.+ ...++.++|||||||++
T Consensus 136 ll~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il 195 (309)
T cd07872 136 LINER-------GELKLADFGLARAKSVPTKT----------YSNEVVTLWYRPPDVLLG---SSEYSTQIDMWGVGCIF 195 (309)
T ss_pred EECCC-------CCEEECccccceecCCCccc----------cccccccccccCCHHHhC---CCCCCcHHHHHHHHHHH
Confidence 99877 78999999998654322111 112357889999999864 24578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCC---chhhhhhHHHHHHHHHHhcccCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
|+|+||+.||.+.+..+....+...........++............ ...... .......++++.+++.+||+.||
T Consensus 196 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 274 (309)
T cd07872 196 FEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN-FPKYKPQPLINHAPRLDTEGIELLTKFLQYES 274 (309)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh-cCccCCCchhhhccCCCHHHHHHHHHhccCCh
Confidence 99999999998877666555553332222221111110000000000 000000 00112356678999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001152 1113 TERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~ 1130 (1137)
.+|||++|+++|+|+...
T Consensus 275 ~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 275 KKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhCCCHHHHhcChhhhhc
Confidence 999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=338.51 Aligned_cols=252 Identities=20% Similarity=0.254 Sum_probs=200.5
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 887 (1137)
..||+|++|.||+|.+.+..||+|+...... ......+ .+.+|+.+|++++|||||++++++.+..
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~-~~~~~~~----~~~~E~~~l~~l~h~nIv~~~g~~~~~~--------- 91 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHK-GHKVLID----ITENEIKNLRRIDSNNILKIYGFIIDIV--------- 91 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEecccccc-ccHHHHH----HHHHHHHHHHhcCCCCEEEEeeeEEecc---------
Confidence 5799999999999999999999998543211 1111122 3478999999999999999999987611
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeEeccccccCCC
Q 001152 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADG 966 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrDLKP~NILld~~~~~~~~ 966 (1137)
......++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||++.+
T Consensus 92 -~~~~~~~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~------ 159 (283)
T PHA02988 92 -DDLPRLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN------ 159 (283)
T ss_pred -cCCCceEEEEEeCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC------
Confidence 011257999999999999999976 24689999999999999999999984 99999999999999987
Q ss_pred CCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001152 967 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1046 (1137)
Q Consensus 967 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~ 1046 (1137)
+.+||+|||+++...... ....+|..|+|||++.+. ...++.++|||||||++|||++|+.||.
T Consensus 160 -~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~~--~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 160 -YKLKIICHGLEKILSSPP-------------FKNVNFMVYFSYKMLNDI--FSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred -CcEEEcccchHhhhcccc-------------ccccCcccccCHHHhhhc--cccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 789999999987543211 123588899999998652 2468899999999999999999999999
Q ss_pred CCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001152 1047 GLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125 (1137)
Q Consensus 1047 ~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L 1125 (1137)
+....++...+.... .+.++ ..+++++.+++.+||+.||++|||++|+++.+
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 224 NLTTKEIYDLIINKNNSLKLP---------------------------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred CCCHHHHHHHHHhcCCCCCCC---------------------------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 887777766664322 22111 13456699999999999999999999999988
Q ss_pred Hhh
Q 001152 1126 VAR 1128 (1137)
Q Consensus 1126 ~~~ 1128 (1137)
...
T Consensus 277 ~~~ 279 (283)
T PHA02988 277 SLY 279 (283)
T ss_pred HHH
Confidence 654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=352.36 Aligned_cols=267 Identities=24% Similarity=0.315 Sum_probs=207.4
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|++. +..+|+|+........ .... ..+.+|+.++..++||||+++++++.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQI----AHVRAERDILADADSPWIVKLYYSFQDEE- 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHH----HHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence 36899999999999999999986 6789999864332111 1122 23478999999999999999999988665
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
+.++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~ 136 (350)
T cd05573 75 -------------HLYLVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA 136 (350)
T ss_pred -------------eEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 67999999999999999976 246899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccc-------------------cCCCCCCCcccCCCcccchhhhccccCCC
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1020 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~-------------------~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 1020 (1137)
+ +.+||+|||++............. ...........||+.|+|||++.+ .
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~ 205 (350)
T cd05573 137 D-------GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG----T 205 (350)
T ss_pred C-------CCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC----C
Confidence 7 789999999987654322000000 000011224569999999999976 4
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001152 1021 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1099 (1137)
Q Consensus 1021 ~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1137)
.++.++|||||||++|+|++|+.||......+....+..... ..++. ....+++
T Consensus 206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~~~~ 260 (350)
T cd05573 206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPP-------------------------DPPVSPE 260 (350)
T ss_pred CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCC-------------------------CCCCCHH
Confidence 688999999999999999999999988776666655543111 00000 0024566
Q ss_pred HHHHHHHhcccCCCCCCC-HHHHHHHHHhhc
Q 001152 1100 LVDVFRRCTEENPTERPT-AGDLYEMFVART 1129 (1137)
Q Consensus 1100 L~dLl~~CL~~DP~~RPS-a~EVL~~L~~~~ 1129 (1137)
+.+++.+||. ||.+||+ ++++++|+|+..
T Consensus 261 ~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 261 AIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 9999999997 9999999 999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=362.27 Aligned_cols=259 Identities=26% Similarity=0.363 Sum_probs=206.5
Q ss_pred CCCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~---~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...|.+.+.||+|++|.||+|.... ..+|+|..... ...... .+.+|+.+|+.++|||||++++++...
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~----~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAA----YARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHH----HHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 3459999999999999999998743 45666643211 122222 247899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ +.||||||+++|+|.++++.... ....+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 138 ~--------------~~~lv~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll 202 (478)
T PTZ00267 138 D--------------KLLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL 202 (478)
T ss_pred C--------------EEEEEEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE
Confidence 5 67999999999999998875322 23468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 203 ~~~-------~~~kL~DFgla~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~e 263 (478)
T PTZ00267 203 MPT-------GIIKLGDFGFSKQYSDSVSL--------DVASSFCGTPYYLAPELWER----KRYSKKADMWSLGVILYE 263 (478)
T ss_pred CCC-------CcEEEEeCcCceecCCcccc--------ccccccCCCccccCHhHhCC----CCCCcHHhHHHHHHHHHH
Confidence 977 78999999999765432111 11123469999999999875 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|+.||.+....++...+..+..+.++. ..++++.+++.+||+.||++||+
T Consensus 264 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~Rps 316 (478)
T PTZ00267 264 LLTLHRPFKGPSQREIMQQVLYGKYDPFPC---------------------------PVSSGMKALLDPLLSKNPALRPT 316 (478)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCCc---------------------------cCCHHHHHHHHHHhccChhhCcC
Confidence 999999999887777777665544322211 23455899999999999999999
Q ss_pred HHHHHHHHHhh
Q 001152 1118 AGDLYEMFVAR 1128 (1137)
Q Consensus 1118 a~EVL~~L~~~ 1128 (1137)
+++++.+.|..
T Consensus 317 ~~~~l~~~~~~ 327 (478)
T PTZ00267 317 TQQLLHTEFLK 327 (478)
T ss_pred HHHHHhCHHHH
Confidence 99999987764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=348.51 Aligned_cols=257 Identities=25% Similarity=0.279 Sum_probs=198.5
Q ss_pred CceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEec
Q 001152 803 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 876 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~ 876 (1137)
+|++.+.||+|+||+||+|+. .+..+|+|+............. ..+.+|+.++..++ ||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTV----EHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHH----HHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 488999999999999999986 3567899986432211111112 23478999999995 9999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ ..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 77 ~~--------------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 77 EA--------------KLHLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred CC--------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 65 56999999999999999875 246899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+++........ ......||+.|+|||++.+ ...++.++|||||||++|
T Consensus 138 i~~~-------~~~kl~DfG~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 198 (332)
T cd05614 138 LDSE-------GHVVLTDFGLSKEFLSEEKE---------RTYSFCGTIEYMAPEIIRG---KGGHGKAVDWWSLGILIF 198 (332)
T ss_pred ECCC-------CCEEEeeCcCCccccccCCC---------ccccccCCccccCHHHhcC---CCCCCCccccccchhhhh
Confidence 9887 78999999998754322111 1113469999999999875 234678999999999999
Q ss_pred HHHhCCCCCCCCC----HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1037 ELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~----~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
||++|..||.... ...+...+.... +.++ ...++.+.+++.+||+.||
T Consensus 199 elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~li~~~l~~dp 250 (332)
T cd05614 199 ELLTGASPFTLEGERNTQSEVSRRILKCD-PPFP---------------------------SFIGPEAQDLLHKLLRKDP 250 (332)
T ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHhcCC-CCCC---------------------------CCCCHHHHHHHHHHcCCCH
Confidence 9999999996432 222222222211 1111 0234568999999999999
Q ss_pred CCCC-----CHHHHHHHHHhhc
Q 001152 1113 TERP-----TAGDLYEMFVART 1129 (1137)
Q Consensus 1113 ~~RP-----Sa~EVL~~L~~~~ 1129 (1137)
++|| +++++++|+|+..
T Consensus 251 ~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 251 KKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHcCCCCCCCHHHHHcCCCcCC
Confidence 9999 8899999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=354.65 Aligned_cols=267 Identities=22% Similarity=0.274 Sum_probs=200.4
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|++.+.||+|+||+||+|++. +..+|+|+....... ..... ..+.+|+.+++.++|||||++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~----~~~~~E~~il~~l~h~~iv~l~~~~~~~~-- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQV----AHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHH----HHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence 5889999999999999999985 467888875432111 11222 23488999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
+.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+|||++.+
T Consensus 75 ------------~~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~ 137 (381)
T cd05626 75 ------------NLYFVMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD 137 (381)
T ss_pred ------------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC
Confidence 67999999999999999876 2468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccc-------------------------------------cCCCCCCCcccC
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------------------HRGIPAPDVCVG 1003 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~G 1003 (1137)
+.+||+|||++............. ..........+|
T Consensus 138 -------~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (381)
T cd05626 138 -------GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG 210 (381)
T ss_pred -------CCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccC
Confidence 789999999875432110000000 000000123579
Q ss_pred CCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccc
Q 001152 1004 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQ 1082 (1137)
Q Consensus 1004 T~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~ 1082 (1137)
|+.|+|||++.+ ..++.++|||||||++|||++|..||......+....+.... ...++.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------------- 271 (381)
T cd05626 211 TPNYIAPEVLLR----KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP--------------- 271 (381)
T ss_pred CccccCHHHHcC----CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCC---------------
Confidence 999999999875 467899999999999999999999998876655554443211 111110
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhc--ccCCCCCCCHHHHHHHHHhhc
Q 001152 1083 SGSGFEKPEAELETLSFLVDVFRRCT--EENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1083 ~~~~~~~~~~~~~~~~~L~dLl~~CL--~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
....++++.+|+.+|+ ..+|..||+++++++|+|+..
T Consensus 272 ----------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 272 ----------QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred ----------CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 0023456889998854 556666999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.65 Aligned_cols=294 Identities=20% Similarity=0.250 Sum_probs=218.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC-cceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpN-IVkllg~~~~~ 877 (1137)
...|...++||+|+||+||+|+.. +..||+|...++... +.......+|+.+|+.++|+| ||.+++++...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 455778888999999999999984 567888876555332 223334588999999999999 99999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
..+ .....+++||||++ .+|..++....+.. ..++...++.+++||+.||+|||+++|+||||||+||||
T Consensus 84 ~~~--------~~~~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi 153 (323)
T KOG0594|consen 84 NNH--------RGIGKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI 153 (323)
T ss_pred ccc--------cccceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE
Confidence 521 12236799999997 89999998743221 357779999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+|+....+.. .....++|..|+|||++.+. ..|+..+||||+|||++|
T Consensus 154 ~~~-------G~lKlaDFGlAra~~ip~~----------~yt~evvTlWYRaPEvLlGs---~~Ys~~vDiWs~GcIfaE 213 (323)
T KOG0594|consen 154 SSS-------GVLKLADFGLARAFSIPMR----------TYTPEVVTLWYRAPEVLLGS---TSYSTSVDIWSLGCIFAE 213 (323)
T ss_pred CCC-------CcEeeeccchHHHhcCCcc----------cccccEEEeeccCHHHhcCC---CcCCCCcchHhHHHHHHH
Confidence 987 8899999999986553322 12345799999999999973 469999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCC-Cchh---hhhhHHHHHHHHHHhcccCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE-KPEA---ELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
|++++..|.+.+..+....|......+-...++.......... ....+. .... .....+...+++.+||+.+|.
T Consensus 214 m~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~ 291 (323)
T KOG0594|consen 214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPA 291 (323)
T ss_pred HHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcc
Confidence 9999999999988887777744332111111111111111100 011111 0000 112225789999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCC
Q 001152 1114 ERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~ss 1132 (1137)
+|.|++.++.|++|..-..
T Consensus 292 ~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 292 KRISAKGALTHPYFSELPE 310 (323)
T ss_pred cCcCHHHHhcChhhccccc
Confidence 9999999999999986543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=355.15 Aligned_cols=267 Identities=22% Similarity=0.273 Sum_probs=201.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.++||+|+||+||+|.+. +..+|+|+...... ...... ..+.+|+.+++.++|||||++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~E~~il~~l~hp~iv~~~~~~~~~~- 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQL----AHVKAERDVLAESDSPWVVSLYYSFQDAQ- 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHHH----HHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 36899999999999999999884 46788887532211 111122 33478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..|+||||+++|+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~ 136 (377)
T cd05629 75 -------------YLYLIMEFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR 136 (377)
T ss_pred -------------eeEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 56999999999999999875 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCcccccccccccccc--------ccCC-----------------------------CCCCCccc
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI--------AHRG-----------------------------IPAPDVCV 1002 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~--------~~~~-----------------------------~~~~~~~~ 1002 (1137)
+ +.+||+|||+++........... .... .......+
T Consensus 137 ~-------~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (377)
T cd05629 137 G-------GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209 (377)
T ss_pred C-------CCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence 7 78999999998633211000000 0000 00001246
Q ss_pred CCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhccccccccc
Q 001152 1003 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVA 1081 (1137)
Q Consensus 1003 GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~ 1081 (1137)
||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+....+..... ..++..
T Consensus 210 gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~------------- 272 (377)
T cd05629 210 GTPDYIAPEIFLQ----QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDD------------- 272 (377)
T ss_pred CCccccCHHHHcc----CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCC-------------
Confidence 9999999999875 5688999999999999999999999988777666665543211 111100
Q ss_pred ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHhhc
Q 001152 1082 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTER---PTAGDLYEMFVART 1129 (1137)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R---PSa~EVL~~L~~~~ 1129 (1137)
...+.++.+++.+||. +|.+| +++.|++.|+|+..
T Consensus 273 ------------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 273 ------------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred ------------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 0234568999999997 66664 69999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=350.99 Aligned_cols=262 Identities=28% Similarity=0.378 Sum_probs=217.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~ 878 (1137)
..|++.+.||+|.||.||+++.. +..+|+|+...+.... ....+. +.+|+++|+++. |||||.+++.|++..
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~----v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDRED----VRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHH----HHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 45899999999999999999984 5679999865443322 222233 378999999999 999999999999876
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.+++|||++.||.|.+.|... .+++..+..++.||+.|++|||+.||+||||||+|+|+.
T Consensus 110 --------------~~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~ 169 (382)
T KOG0032|consen 110 --------------SVYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLA 169 (382)
T ss_pred --------------eEEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeec
Confidence 679999999999999999872 399999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.. ..+.+.+|++|||++........ ....+||+.|+|||++.+ ..|+..+||||+||++|.|
T Consensus 170 ~~---~~~~~~ik~~DFGla~~~~~~~~-----------~~~~~Gtp~y~APEvl~~----~~y~~~~DiWS~Gvi~yiL 231 (382)
T KOG0032|consen 170 SK---DEGSGRIKLIDFGLAKFIKPGER-----------LHTIVGTPEYVAPEVLGG----RPYGDEVDVWSIGVILYIL 231 (382)
T ss_pred cc---cCCCCcEEEeeCCCceEccCCce-----------EeeecCCccccCchhhcC----CCCCcccchhHHHHHHHHH
Confidence 66 22336799999999987654211 124589999999999975 5799999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||.+.........|..+........++ ..+..+.+++.+|+..||.+|+|+
T Consensus 232 L~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~------------------------~is~~akd~i~~ll~~dp~~R~ta 287 (382)
T KOG0032|consen 232 LSGVPPFWGETEFEIFLAILRGDFDFTSEPWD------------------------DISESAKDFIRKLLEFDPRKRLTA 287 (382)
T ss_pred hhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc------------------------ccCHHHHHHHHHhcccCcccCCCH
Confidence 99999999998888888887766421111111 445669999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
.++++|||....
T Consensus 288 ~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 288 AQALQHPWIKSI 299 (382)
T ss_pred HHHhcCccccCC
Confidence 999999998764
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=355.34 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=208.9
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|++. +..+|+|+....... ..... ..+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDS----AFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhH----HHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4678999999999999999999985 467888875322111 01111 2246799999999999999999998876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 116 ~--------------~~~lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl 175 (370)
T cd05596 116 K--------------YLYMVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (370)
T ss_pred C--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 5 67999999999999999865 358889999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++........ .......||+.|+|||++.+......++.++|||||||++||
T Consensus 176 ~~~-------~~~kL~DfG~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilye 239 (370)
T cd05596 176 DKS-------GHLKLADFGTCMKMDANGM---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239 (370)
T ss_pred cCC-------CCEEEEeccceeeccCCCc---------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHH
Confidence 987 7899999999875432211 011234699999999998753333457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCC-CchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE-- 1114 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~-- 1114 (1137)
|++|..||.+.+.......+...... .++. ....+.++.+++.+||+.+|.+
T Consensus 240 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~p~r~~ 294 (370)
T cd05596 240 MLVGDTPFYADSLVGTYSKIMDHKNSLTFPD-------------------------DIEISKQAKDLICAFLTDREVRLG 294 (370)
T ss_pred HHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC-------------------------cCCCCHHHHHHHHHHccChhhccC
Confidence 99999999987776666666443211 1110 0134566999999999999988
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
||+++|+++|+|++..
T Consensus 295 R~s~~ell~h~~~~~~ 310 (370)
T cd05596 295 RNGVDEIKSHPFFKND 310 (370)
T ss_pred CCCHHHHhcCcccCCC
Confidence 9999999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=356.57 Aligned_cols=262 Identities=28% Similarity=0.463 Sum_probs=219.1
Q ss_pred CceEeeeecccCceEEEEEEECCcc--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~~~--vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
-|.|+..||.|+||.||+|....+. .|.|+ ++. ...++.+.| +-||.||..+.||+||++++.|+.++
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKv--Iet--kseEELEDy----lVEIeILa~CdHP~ivkLl~ayy~en-- 102 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKV--IET--KSEEELEDY----LVEIEILAECDHPVIVKLLSAYYFEN-- 102 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhh--hcc--cchhHHhhh----hhhhhhhhcCCChHHHHHHHHHhccC--
Confidence 4789999999999999999986544 34454 332 235666666 88999999999999999999887665
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
.+||..|||.||-++.++-.. +..+++.++..+++|++.||.|||+++|||||||+.|||++-+
T Consensus 103 ------------kLwiliEFC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld 166 (1187)
T KOG0579|consen 103 ------------KLWILIEFCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD 166 (1187)
T ss_pred ------------ceEEEEeecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec
Confidence 679999999999999987653 3579999999999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccc-cCCCCCCchhhHHHHHHHHHHHH
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
|.++|+|||.+....... ...+.+.|||+|||||+.... .+..+|+.++||||||++|.||.
T Consensus 167 -------GdirLADFGVSAKn~~t~----------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMA 229 (1187)
T KOG0579|consen 167 -------GDIRLADFGVSAKNKSTR----------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMA 229 (1187)
T ss_pred -------CcEeeecccccccchhHH----------hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHh
Confidence 889999999876543321 234578899999999998753 25678999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
.+.+|....+++.+.-.|....+|.+...- ..+..+.+++.+||..||..||+++
T Consensus 230 qiEPPHhelnpMRVllKiaKSePPTLlqPS-------------------------~Ws~~F~DfLk~cL~Knp~~Rp~aa 284 (1187)
T KOG0579|consen 230 QIEPPHHELNPMRVLLKIAKSEPPTLLQPS-------------------------HWSRSFSDFLKRCLVKNPRNRPPAA 284 (1187)
T ss_pred ccCCCccccchHHHHHHHhhcCCCcccCcc-------------------------hhhhHHHHHHHHHHhcCCccCCCHH
Confidence 999999999999999888877766543210 3344599999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001152 1120 DLYEMFVARTSSS 1132 (1137)
Q Consensus 1120 EVL~~L~~~~~ss 1132 (1137)
++++|+|+....+
T Consensus 285 qll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 285 QLLKHPFVQNAPS 297 (1187)
T ss_pred HHhhCcccccCCc
Confidence 9999999985543
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=345.74 Aligned_cols=254 Identities=25% Similarity=0.324 Sum_probs=202.0
Q ss_pred CceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCC-CcceeeeeEecCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKW 879 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~Hp-NIVkllg~~~~~~~ 879 (1137)
+|++.+.||+|+||.||+|.+.+ ..+|+|+........ ....+. +..|+.++..+.|+ +|+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~----~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDVEC----TMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHH----HHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 58899999999999999999854 578999865432211 122222 37799999999765 5778888887655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 136 (324)
T cd05587 75 -------------RLYFVMEYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136 (324)
T ss_pred -------------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC
Confidence 67999999999999999875 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (324)
T cd05587 137 E-------GHIKIADFGMCKENIFGGK----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (324)
T ss_pred C-------CCEEEeecCcceecCCCCC----------ceeeecCCccccChhhhcC----CCCCcccchhhhHHHHHHHH
Confidence 7 7899999998864321111 1113468999999999875 46789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA- 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa- 1118 (1137)
+|+.||.+....+....+..... .++. ..++++.+++.+||+.||.+|+++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 196 AGQPPFDGEDEDELFQSIMEHNV-SYPK---------------------------SLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred hCCCCCCCCCHHHHHHHHHcCCC-CCCC---------------------------CCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 99999998887777776654331 1111 234458999999999999999976
Q ss_pred ----HHHHHHHHhhc
Q 001152 1119 ----GDLYEMFVART 1129 (1137)
Q Consensus 1119 ----~EVL~~L~~~~ 1129 (1137)
+++++|+|+..
T Consensus 248 ~~~~~~~~~hp~~~~ 262 (324)
T cd05587 248 PTGERDIREHAFFRR 262 (324)
T ss_pred CCCHHHHhcCCCcCC
Confidence 89999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=346.36 Aligned_cols=252 Identities=27% Similarity=0.366 Sum_probs=200.0
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHH---HhCCCCCcceeeeeEecCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML---GALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL---~~L~HpNIVkllg~~~~~~ 878 (1137)
|++.+.||+|+||.||+|.+. +..+|+|+....... .....+ .+.+|+.++ +.++||||+++++++...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVE----SLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 678999999999999999985 467888886433211 111222 235665554 5667999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
+.|+||||+++++|..+++. ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 76 --------------~~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~ 135 (324)
T cd05589 76 --------------HVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135 (324)
T ss_pred --------------EEEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence 67999999999999988754 3699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 136 ~~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el 194 (324)
T cd05589 136 TE-------GFVKIADFGLCKEGMGFGD----------RTSTFCGTPEFLAPEVLTE----TSYTRAVDWWGLGVLIYEM 194 (324)
T ss_pred CC-------CcEEeCcccCCccCCCCCC----------cccccccCccccCHhHhcC----CCCCcccchhhHHHHHHHH
Confidence 87 7899999998864322111 1123468999999999875 4678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC--
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-- 1116 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-- 1116 (1137)
++|+.||.+.+..++...+..+... .+. ..++.+.+++.+||+.||.+||
T Consensus 195 ~~G~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 195 LVGESPFPGDDEEEVFDSIVNDEVR-YPR---------------------------FLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCC-CCC---------------------------CCCHHHHHHHHHHhhcCHhHcCCC
Confidence 9999999988777777666543321 111 2345589999999999999999
Q ss_pred ---CHHHHHHHHHhhc
Q 001152 1117 ---TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 ---Sa~EVL~~L~~~~ 1129 (1137)
++.++++|+|+..
T Consensus 247 ~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 247 GEKDAEDVKKQPFFRD 262 (324)
T ss_pred CCCCHHHHhhCCCcCC
Confidence 7999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=334.49 Aligned_cols=261 Identities=22% Similarity=0.368 Sum_probs=205.0
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
.+.+|++.+.||+|+||.||+|.+.. ..+++|... ... ..... ..+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~--~~~-~~~~~----~~~~~ei~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK--ENA-EPKVQ----QEFRQEAELMSDLQHPNIVCLLG 75 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecc--cCC-CHHHH----HHHHHHHHHHHhcCCcccceEEE
Confidence 35678999999999999999998743 246666532 211 12222 23488999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHH
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE-----------KHVSVKLALFIAQDVAAALVELH 941 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~-----------~~ls~~~i~~I~~QIa~gL~yLH 941 (1137)
++.... ..+++|||+++++|.+++........ ..+++..+..++.||+.||+|||
T Consensus 76 ~~~~~~--------------~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 76 VCTKEQ--------------PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred EEcCCC--------------ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 987655 45999999999999999976322111 46889999999999999999999
Q ss_pred hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001152 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 942 s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1021 (1137)
++||+||||||+||+++.+ +.+||+|||++......... .......+++.|+|||.+.+ ..
T Consensus 142 ~~~i~H~dlkp~Nil~~~~-------~~~~L~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 202 (283)
T cd05048 142 SHHFVHRDLAARNCLVGEG-------LTVKISDFGLSRDIYSADYY--------RVQSKSLLPVRWMPPEAILY----GK 202 (283)
T ss_pred hCCeeccccccceEEEcCC-------CcEEECCCcceeeccccccc--------cccCCCcccccccCHHHhcc----Cc
Confidence 9999999999999999877 78999999998754322111 01112346789999999865 46
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1100 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1100 (1137)
++.++|||||||++|||++ |..||.+....++...+..+..+..+. .+++++
T Consensus 203 ~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~ 255 (283)
T cd05048 203 FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPE---------------------------DCPARV 255 (283)
T ss_pred CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcc---------------------------cCCHHH
Confidence 7899999999999999998 999999888877777776544332211 445679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001152 1101 VDVFRRCTEENPTERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1101 ~dLl~~CL~~DP~~RPSa~EVL~~L~~ 1127 (1137)
.+|+.+||+.||.+||++.||++++..
T Consensus 256 ~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 256 YALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=346.77 Aligned_cols=249 Identities=27% Similarity=0.370 Sum_probs=199.0
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||+||+|++. +..+|+|+........ ....+ .+.+|+.++..+ +||||+++++++...+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~h~~iv~~~~~~~~~~------ 69 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDVE----CTMTEKRILSLARNHPFLTQLYCCFQTPD------ 69 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-ccHHH----HHHHHHHHHHhccCCCchhceeeEEEcCC------
Confidence 46999999999999985 4678898754332111 11222 236788888877 5999999999988765
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~iv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---- 132 (320)
T cd05590 70 --------RLFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---- 132 (320)
T ss_pred --------EEEEEEcCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 67999999999999998876 2468999999999999999999999999999999999999987
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (320)
T cd05590 133 ---GHCKLADFGMCKEGIFNGK----------TTSTFCGTPDYIAPEILQE----MLYGPSVDWWAMGVLLYEMLCGHAP 195 (320)
T ss_pred ---CcEEEeeCCCCeecCcCCC----------cccccccCccccCHHHHcC----CCCCCccchhhhHHHHHHHhhCCCC
Confidence 7899999998864322111 1123468999999999875 4678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH------
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA------ 1118 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa------ 1118 (1137)
|.+.+..++...+..+... ++. ..++++.+++.+||+.||.+||++
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~~~---------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (320)
T cd05590 196 FEAENEDDLFEAILNDEVV-YPT---------------------------WLSQDAVDILKAFMTKNPTMRLGSLTLGGE 247 (320)
T ss_pred CCCCCHHHHHHHHhcCCCC-CCC---------------------------CCCHHHHHHHHHHcccCHHHCCCCCCCCCH
Confidence 9988887777776543321 110 234458999999999999999998
Q ss_pred HHHHHHHHhhc
Q 001152 1119 GDLYEMFVART 1129 (1137)
Q Consensus 1119 ~EVL~~L~~~~ 1129 (1137)
+++++|+|+..
T Consensus 248 ~~~~~h~~f~~ 258 (320)
T cd05590 248 EAILRHPFFKE 258 (320)
T ss_pred HHHHcCCCcCC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=355.23 Aligned_cols=267 Identities=22% Similarity=0.259 Sum_probs=201.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|+.. +..+|+|+...... ........+.+|+.+|+.++||||+++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-----LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-----HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 36899999999999999999975 46788887532211 01111223478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.+++.+ ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~ 136 (376)
T cd05598 75 -------------NLYFVMDYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136 (376)
T ss_pred -------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC
Confidence 67999999999999999976 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccc---------------------------------cCCCCCCCcccCCCc
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA---------------------------------HRGIPAPDVCVGTPR 1006 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~GT~~ 1006 (1137)
+ +.+||+|||+|..+.......... ...........||+.
T Consensus 137 ~-------~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 209 (376)
T cd05598 137 D-------GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209 (376)
T ss_pred C-------CCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence 7 789999999975332100000000 000000113479999
Q ss_pred ccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CchhHHhhhcccccccccccCC
Q 001152 1007 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGS 1085 (1137)
Q Consensus 1007 Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p-~l~~~l~~~~~~~~~~~~~~~~ 1085 (1137)
|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+...... .++.
T Consensus 210 y~aPE~~~~----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------ 267 (376)
T cd05598 210 YIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS------------------ 267 (376)
T ss_pred ccCHHHHcC----CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCC------------------
Confidence 999999875 56789999999999999999999999987776655554332110 0000
Q ss_pred CCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhc
Q 001152 1086 GFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVART 1129 (1137)
Q Consensus 1086 ~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP---Sa~EVL~~L~~~~ 1129 (1137)
....++++.+++.+|+ .+|.+|+ ++.|+++|+|+..
T Consensus 268 -------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 268 -------QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred -------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 0134456888998876 5999999 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=353.86 Aligned_cols=266 Identities=23% Similarity=0.283 Sum_probs=201.3
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.++||+|+||+||+|+.. +..+|+|+...... ........+.+|+.+++.++|||||++++.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence 5889999999999999999985 45678887532211 11112234588999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 ------------~~~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~ 137 (382)
T cd05625 75 ------------NLYFVMDYIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD 137 (382)
T ss_pred ------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 67999999999999999875 2468999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccc-------------------------------------cCCCCCCCcccC
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------------------HRGIPAPDVCVG 1003 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~G 1003 (1137)
+.+||+|||++............. ..........+|
T Consensus 138 -------g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (382)
T cd05625 138 -------GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVG 210 (382)
T ss_pred -------CCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc
Confidence 789999999975332110000000 000001123469
Q ss_pred CCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccc
Q 001152 1004 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQ 1082 (1137)
Q Consensus 1004 T~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~ 1082 (1137)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+..... ...+.
T Consensus 211 t~~Y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--------------- 271 (382)
T cd05625 211 TPNYIAPEVLLR----TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP--------------- 271 (382)
T ss_pred CcccCCHHHhcC----CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC---------------
Confidence 999999999875 4688999999999999999999999998777665555543221 11110
Q ss_pred cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHhhc
Q 001152 1083 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT---AGDLYEMFVART 1129 (1137)
Q Consensus 1083 ~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS---a~EVL~~L~~~~ 1129 (1137)
....++++.+++.+|+ .+|.+|++ ++|+++|+|+..
T Consensus 272 ----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 272 ----------QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred ----------cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 0133456888898876 59999987 999999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=355.71 Aligned_cols=278 Identities=23% Similarity=0.273 Sum_probs=212.4
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-C-----CCcceeeeeE
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H-----SCIVEMYGHK 874 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-H-----pNIVkllg~~ 874 (1137)
+|++.+.||+|+||.|.+|.+. +..||+||.+-+. .|..+...|+.+|..++ | -|+|+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 7899999999999999999985 5778888854332 12223367999999997 4 3899999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
...+ |+|||+|++. .+|+++++.. ....++...++.|+.||+.||.+||+.||||+||||+|
T Consensus 258 ~fr~--------------HlciVfELL~-~NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPEN 319 (586)
T KOG0667|consen 258 YFRN--------------HLCIVFELLS-TNLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPEN 319 (586)
T ss_pred cccc--------------ceeeeehhhh-hhHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhh
Confidence 8776 7899999995 8999999873 34569999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||+....+ ..|||+|||.++....... ..+.+..|+|||++.| .+|+.++||||||||
T Consensus 320 ILL~~~~r-----~~vKVIDFGSSc~~~q~vy-------------tYiQSRfYRAPEVILG----lpY~~~IDmWSLGCI 377 (586)
T KOG0667|consen 320 ILLKDPKR-----SRIKVIDFGSSCFESQRVY-------------TYIQSRFYRAPEVILG----LPYDTAIDMWSLGCI 377 (586)
T ss_pred eeeccCCc-----CceeEEecccccccCCcce-------------eeeeccccccchhhcc----CCCCCccceeehhhh
Confidence 99986633 5899999999876554221 3467889999999998 679999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccc--------------cccc------------------ccc
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC--------------HEHE------------------VAQ 1082 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~--------------~~~~------------------~~~ 1082 (1137)
++||.+|.+.|.+.+..+....|........+.-+...... ..+. ...
T Consensus 378 lAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~ 457 (586)
T KOG0667|consen 378 LAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLER 457 (586)
T ss_pred HHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccc
Confidence 99999999999999998888777443322211111111000 0000 000
Q ss_pred cCCCCCC---chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1083 SGSGFEK---PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1083 ~~~~~~~---~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
..+.... ..........+.+++.+||++||.+|+|+.|+++|+|+..
T Consensus 458 ~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 458 RGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred cCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 0000000 0011144567899999999999999999999999999983
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=345.64 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=199.5
Q ss_pred eeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||.||+|++.+ ..+|+|+........ ....+ .+..|++++..+ +||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~----~~~~e~~il~~~~~hp~i~~~~~~~~~~~------ 69 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-DDDVD----CTMTEKRILALAAKHPFLTALHCCFQTKD------ 69 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHH----HHHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 469999999999999854 578899865332111 12222 236788888876 6999999999998765
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..|+||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~---- 132 (321)
T cd05591 70 --------RLFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE---- 132 (321)
T ss_pred --------eEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC----
Confidence 57999999999999998875 2468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~P 195 (321)
T cd05591 133 ---GHCKLADFGMCKEGILNGV----------TTTTFCGTPDYIAPEILQE----LEYGPSVDWWALGVLMYEMMAGQPP 195 (321)
T ss_pred ---CCEEEeecccceecccCCc----------cccccccCccccCHHHHcC----CCCCCccceechhHHHHHHhcCCCC
Confidence 7899999998864322111 1123468999999999875 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-------C
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-------T 1117 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-------S 1117 (1137)
|...+..+....+..+.... +. ..++++.+++.+||+.||++|| +
T Consensus 196 f~~~~~~~~~~~i~~~~~~~-p~---------------------------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~ 247 (321)
T cd05591 196 FEADNEDDLFESILHDDVLY-PV---------------------------WLSKEAVSILKAFMTKNPNKRLGCVASQGG 247 (321)
T ss_pred CCCCCHHHHHHHHHcCCCCC-CC---------------------------CCCHHHHHHHHHHhccCHHHcCCCCCCCCC
Confidence 99888887777765543211 10 2234589999999999999999 9
Q ss_pred HHHHHHHHHhhc
Q 001152 1118 AGDLYEMFVART 1129 (1137)
Q Consensus 1118 a~EVL~~L~~~~ 1129 (1137)
++++++|+|+..
T Consensus 248 ~~~~~~hp~~~~ 259 (321)
T cd05591 248 EDAIKQHPFFKE 259 (321)
T ss_pred HHHHhcCCccCC
Confidence 999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=347.89 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=198.6
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 885 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g 885 (1137)
+.||+|+||.||+|.+. +..+|+|+....... ...... ++.+|+++++.++||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~----~~~~e~~~l~~~~hp~i~~~~~~~~~~~------- 68 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVA----HTLTENRVLQNSRHPFLTALKYSFQTHD------- 68 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhCCCCCCCceEEEEEcCC-------
Confidence 46999999999999874 567888886533211 112222 3377999999999999999999988765
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeEeccccccC
Q 001152 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 886 ~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++|+|..++.. ...+++..+..|+.||+.||+|||+ +||+||||||+|||++.+
T Consensus 69 -------~~~lv~E~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~---- 132 (325)
T cd05594 69 -------RLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---- 132 (325)
T ss_pred -------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC----
Confidence 67999999999999998865 2468999999999999999999997 799999999999999987
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tG~~P 195 (325)
T cd05594 133 ---GHIKITDFGLCKEGIKDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLP 195 (325)
T ss_pred ---CCEEEecCCCCeecCCCCc----------ccccccCCcccCCHHHHcc----CCCCCccccccccceeeeeccCCCC
Confidence 7899999998864322111 1113469999999999875 4678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHH
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAG 1119 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-----Sa~ 1119 (1137)
|.+....+....+..... .++. ..++++.+++.+||+.||++|+ ++.
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~p~---------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (325)
T cd05594 196 FYNQDHEKLFELILMEEI-RFPR---------------------------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAK 247 (325)
T ss_pred CCCCCHHHHHHHHhcCCC-CCCC---------------------------CCCHHHHHHHHHHhhcCHHHhCCCCCCCHH
Confidence 988776666665543221 1110 2345689999999999999996 999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
++++|+|+..
T Consensus 248 ~il~h~~~~~ 257 (325)
T cd05594 248 EIMQHKFFAG 257 (325)
T ss_pred HHhcCCCcCC
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=338.10 Aligned_cols=266 Identities=20% Similarity=0.274 Sum_probs=197.4
Q ss_pred CCCceEeeeecccCceEEEEEEECC------------------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 862 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~------------------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L 862 (1137)
..+|++.++||+|+||.||+|.+.. ..+|+|+..... ...... .+.+|+.++.++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~----~~~~E~~~l~~l 76 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARN----DFLKEVKILSRL 76 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHH----HHHHHHHHHhhc
Confidence 3578999999999999999998632 247887653221 122222 348899999999
Q ss_pred CCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--------------CCCCCCHHHHHH
Q 001152 863 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--------------GEKHVSVKLALF 928 (1137)
Q Consensus 863 ~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~--------------~~~~ls~~~i~~ 928 (1137)
+||||+++++++.+.+ ..++||||+++++|.+++...... ....+++..+.+
T Consensus 77 ~h~niv~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (304)
T cd05096 77 KDPNIIRLLGVCVDED--------------PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLH 142 (304)
T ss_pred CCCCeeEEEEEEecCC--------------ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHH
Confidence 9999999999998765 469999999999999998653211 113478889999
Q ss_pred HHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCccc
Q 001152 929 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1008 (1137)
Q Consensus 929 I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 1008 (1137)
++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++........ .......++..|+
T Consensus 143 i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~-------~~~kl~DfG~~~~~~~~~~~--------~~~~~~~~~~~y~ 207 (304)
T cd05096 143 VALQIASGMKYLSSLNFVHRDLATRNCLVGEN-------LTIKIADFGMSRNLYAGDYY--------RIQGRAVLPIRWM 207 (304)
T ss_pred HHHHHHHHHHHHHHCCccccCcchhheEEcCC-------ccEEECCCccceecccCcee--------EecCcCCCCcccc
Confidence 99999999999999999999999999999977 78999999998754332111 0111234678899
Q ss_pred chhhhccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCC
Q 001152 1009 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1086 (1137)
Q Consensus 1009 APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT--G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~ 1086 (1137)
|||++.+ ..++.++|||||||++|||++ +..||......++...+...........
T Consensus 208 aPE~~~~----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------ 265 (304)
T cd05096 208 AWECILM----GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV------------------ 265 (304)
T ss_pred CHHHHhc----CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc------------------
Confidence 9999865 468899999999999999987 5678887666555544322110000000
Q ss_pred CCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001152 1087 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1087 ~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~ 1126 (1137)
.......++..+.+|+.+||+.||.+|||+.||.+.+.
T Consensus 266 --~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 266 --YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred --cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 00000134567999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=341.87 Aligned_cols=280 Identities=23% Similarity=0.310 Sum_probs=202.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.++||+|+||.||+|.+. +..+|+|+..... .....+ .+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 76 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRN----QIIRELQVLHECNSPYIVGFYGAFYSDG- 76 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHH----HHHHHHHHHHHCCCCcccceeEEEEECC-
Confidence 57999999999999999999985 4567777643321 122222 3488999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeEec
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILID 958 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrDLKP~NILld 958 (1137)
+.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++
T Consensus 77 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~ 138 (333)
T cd06650 77 -------------EISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN 138 (333)
T ss_pred -------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc
Confidence 67999999999999999975 24588999999999999999999975 799999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++....... .....||..|+|||++.+ ..++.++|||||||++|+|
T Consensus 139 ~~-------~~~kL~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~~l 195 (333)
T cd06650 139 SR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVEM 195 (333)
T ss_pred CC-------CCEEEeeCCcchhhhhhc------------cccCCCCccccCHHHhcC----CCCCcHHHHHHHHHHHHHH
Confidence 77 779999999886543211 113368899999999875 4678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHH--hhhccc--------ccc-------cccc-cCCCCCCchhhhhhHHHH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDEL--EALGSC--------HEH-------EVAQ-SGSGFEKPEAELETLSFL 1100 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l--~~~~~~--------~~~-------~~~~-~~~~~~~~~~~~~~~~~L 1100 (1137)
++|+.||......++...+............ ...... ... ...+ ..............++++
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (333)
T cd06650 196 AIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEF 275 (333)
T ss_pred HHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHH
Confidence 9999999876554443322111100000000 000000 000 0000 000000000001245679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1101 VDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1101 ~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
.+|+.+||+.||++|||+.|+++|+|++..
T Consensus 276 ~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 276 QDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred HHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=347.62 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=198.0
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
..+.+|+..++||+|+||.||+|++. +..||+|+..... ... ....+.+|+++++.++|+||+++++++..
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 143 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDT----VRRQICREIEILRDVNHPNVVKCHDMFDH 143 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHH----HHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence 34678999999999999999999985 5778888753221 111 22345889999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ ..++||||+++++|... ...++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 144 ~~--------------~~~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 200 (353)
T PLN00034 144 NG--------------EIQVLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLL 200 (353)
T ss_pred CC--------------eEEEEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 55 66999999999998643 23567788899999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL 1035 (1137)
++.+ +.+||+|||+++....... ......||..|+|||++.... ....++.++|||||||++
T Consensus 201 l~~~-------~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil 263 (353)
T PLN00034 201 INSA-------KNVKIADFGVSRILAQTMD----------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSI 263 (353)
T ss_pred EcCC-------CCEEEcccccceecccccc----------cccccccCccccCccccccccccCcCCCcchhHHHHHHHH
Confidence 9987 7899999999876543211 011346899999999875321 123456799999999999
Q ss_pred HHHHhCCCCCCCCCHHHH---HHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1036 LELLTLQVPYMGLSELEI---HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el---~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
|||++|+.||......+. ...+.....+..+ ...+.++.+||.+||+.||
T Consensus 264 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~P 316 (353)
T PLN00034 264 LEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP---------------------------ATASREFRHFISCCLQREP 316 (353)
T ss_pred HHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCC---------------------------CccCHHHHHHHHHHccCCh
Confidence 999999999974322221 2222111111110 1345569999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001152 1113 TERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~s 1131 (1137)
++|||+.|+++|+|+....
T Consensus 317 ~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 317 AKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred hhCcCHHHHhcCcccccCC
Confidence 9999999999999998763
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=360.35 Aligned_cols=269 Identities=24% Similarity=0.321 Sum_probs=211.1
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
-.+|++.+.||+|+||+||+|++ .+..+|+|+...+. ........ +.+|+.++..++|+||+++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~----~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG--MSEADKNR----AQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc--CCHHHHHH----HHHHHHHHhcCCCCcEEEeecceeccc
Confidence 35899999999999999999987 45788999854432 22333333 378999999999999999988776432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.. .......+++||||+++|+|.++++.... ....+++..+..|+.||+.||+|||+++|+||||||+|||++
T Consensus 105 ~~------~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~ 177 (496)
T PTZ00283 105 PR------NPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC 177 (496)
T ss_pred cc------CcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe
Confidence 10 01112247899999999999999976332 235699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 178 ~~-------~~vkL~DFGls~~~~~~~~~--------~~~~~~~Gt~~Y~aPE~~~~----~~~s~k~DVwSlGvilyeL 238 (496)
T PTZ00283 178 SN-------GLVKLGDFGFSKMYAATVSD--------DVGRTFCGTPYYVAPEIWRR----KPYSKKADMFSLGVLLYEL 238 (496)
T ss_pred CC-------CCEEEEecccCeeccccccc--------cccccccCCcceeCHHHhCC----CCCCcHHHHHHHHHHHHHH
Confidence 77 78999999998765432111 11123469999999999875 4688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|+.||.+....++...+..+....++. ..++++.+++.+||+.||.+||++
T Consensus 239 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~L~~dP~~RPs~ 291 (496)
T PTZ00283 239 LTLKRPFDGENMEEVMHKTLAGRYDPLPP---------------------------SISPEMQEIVTALLSSDPKRRPSS 291 (496)
T ss_pred HHCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcccChhhCcCH
Confidence 99999999887777766665544322211 344569999999999999999999
Q ss_pred HHHHHHHHhh
Q 001152 1119 GDLYEMFVAR 1128 (1137)
Q Consensus 1119 ~EVL~~L~~~ 1128 (1137)
.++++|+|.+
T Consensus 292 ~ell~~p~~~ 301 (496)
T PTZ00283 292 SKLLNMPICK 301 (496)
T ss_pred HHHHhCHHHH
Confidence 9999998865
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=346.46 Aligned_cols=285 Identities=16% Similarity=0.213 Sum_probs=202.9
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+.+|++.+.||+|+||.||+|.+. +..+|+|+.... .......+. +.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKR----AYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc--ccChHHHHH----HHHHHHHHHHhCCCchhceeeeeecc
Confidence 3578999999999999999999874 466788764322 222222223 37899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
... ......++||||++ ++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill 152 (355)
T cd07874 89 KSL--------EEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152 (355)
T ss_pred ccc--------cccceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE
Confidence 321 11225799999997 677777653 48889999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 153 ~~~-------~~~kl~Dfg~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il~e 210 (355)
T cd07874 153 KSD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 210 (355)
T ss_pred CCC-------CCEEEeeCcccccCCCcc-----------ccCCccccCCccCHHHHcC----CCCCchhhHHHHHHHHHH
Confidence 877 789999999987543221 1123468999999999875 467899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhc-----------ccccccccccCCCCC---CchhhhhhHHHHHHH
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG-----------SCHEHEVAQSGSGFE---KPEAELETLSFLVDV 1103 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~-----------~~~~~~~~~~~~~~~---~~~~~~~~~~~L~dL 1103 (1137)
|++|+.||.+.+..+....+........+....... ............... ........+.++++|
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (355)
T cd07874 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHH
Confidence 999999998876655444432211111111110000 000000000000000 000111235678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1104 FRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1104 l~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+.+||+.||++|||+.|+++|+|+.
T Consensus 291 i~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 291 LSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHHHhcCCchhcCCHHHHhcCcchh
Confidence 9999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=346.38 Aligned_cols=284 Identities=17% Similarity=0.213 Sum_probs=205.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||.||+|.+. +..+|+|+..... ......+. +.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKR----AYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHH----HHHHHHHHHhcCCCCccccceeecccc
Confidence 578999999999999999999974 4668888753221 11222223 378999999999999999999886543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.. ......|+||||++ ++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 97 ~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 160 (364)
T cd07875 97 SL--------EEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 160 (364)
T ss_pred cc--------cccCeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC
Confidence 21 11225799999997 688887753 478899999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 161 ~~-------~~~kL~DfG~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~el 218 (364)
T cd07875 161 SD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 218 (364)
T ss_pred CC-------CcEEEEeCCCccccCCCC-----------cccCCcccCCcCCHHHHhC----CCCCchhhHHhHHHHHHHH
Confidence 87 789999999987543211 1113468999999999875 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccc-----------ccccccccCCCCCC---chhhhhhHHHHHHHH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-----------HEHEVAQSGSGFEK---PEAELETLSFLVDVF 1104 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~-----------~~~~~~~~~~~~~~---~~~~~~~~~~L~dLl 1104 (1137)
++|+.||.+.+..+....+........+......... ......+....... ..........+++|+
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298 (364)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHH
Confidence 9999999988777666655433222211111110000 00000000000000 001112345689999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1105 RRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1105 ~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
.+||+.||.+|||+.|+++|+|+.
T Consensus 299 ~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 299 SKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHhcCcCcccCCCHHHHhcCcccc
Confidence 999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=345.55 Aligned_cols=249 Identities=26% Similarity=0.315 Sum_probs=195.8
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHHhCCCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~-iL~~L~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||+||+|.+. +..+|+|+........ ..... .+..|.. +++.++||||+++++++...+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~----~~~~e~~~~~~~l~hp~iv~~~~~~~~~~------ 69 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQK----HIMAERNVLLKNVKHPFLVGLHYSFQTAD------ 69 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHH----HHHHHHHHHHhhCCCCCCCCeeEEEEeCC------
Confidence 46999999999999984 5778999864332111 11111 2244544 567899999999999988665
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~---- 132 (323)
T cd05575 70 --------KLYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---- 132 (323)
T ss_pred --------EEEEEEcCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC----
Confidence 67999999999999998875 3468999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~p 195 (323)
T cd05575 133 ---GHVVLTDFGLCKEGIEHS----------KTTSTFCGTPEYLAPEVLRK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (323)
T ss_pred ---CcEEEeccCCCcccccCC----------CccccccCChhhcChhhhcC----CCCCccccccccchhhhhhhcCCCC
Confidence 789999999886432211 11123468999999999875 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 1120 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa----~E 1120 (1137)
|...+..++...+...... +. ...++.+.+++.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (323)
T cd05575 196 FYSRDTAEMYDNILNKPLR-LK---------------------------PNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247 (323)
T ss_pred CCCCCHHHHHHHHHcCCCC-CC---------------------------CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHH
Confidence 9987777776666543211 10 0234558999999999999999987 69
Q ss_pred HHHHHHhhc
Q 001152 1121 LYEMFVART 1129 (1137)
Q Consensus 1121 VL~~L~~~~ 1129 (1137)
+++|+|+..
T Consensus 248 il~~~~~~~ 256 (323)
T cd05575 248 IKNHVFFSS 256 (323)
T ss_pred HHcCCCcCC
Confidence 999999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.95 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=204.8
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|++|.||+|.+. +..+++|...... ......+. +.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK--MNRREREE----AIDEARVLAKLDSSYIIRYYESFLDKG-- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh--CCHHHHHH----HHHHHHHHHhcCCCCeehheeeeccCC--
Confidence 4788999999999999999984 4677888654332 22233333 488999999999999999999988665
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.++++.. ....+++..+..++.||+.||.|||+.||+||||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~ 137 (256)
T cd08529 73 ------------KLNIVMEYAENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137 (256)
T ss_pred ------------EEEEEEEeCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC
Confidence 569999999999999999762 23468999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||++......... .....+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 138 -------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~~ 196 (256)
T cd08529 138 -------DNVKIGDLGVAKLLSDNTNF----------ANTIVGTPYYLSPELCED----KPYNEKSDVWALGVVLYECCT 196 (256)
T ss_pred -------CCEEEcccccceeccCccch----------hhccccCccccCHHHhcC----CCCCCccchHHHHHHHHHHHh
Confidence 78999999988765432111 113357889999999875 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|+.||......+....+..+..+.++. ..+..+.+++.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 197 GKHPFDANNQGALILKIIRGVFPPVSQ---------------------------MYSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------ccCHHHHHHHHHHccCCcccCcCHHH
Confidence 999998877766666665544433221 23345899999999999999999999
Q ss_pred HHHHHH
Q 001152 1121 LYEMFV 1126 (1137)
Q Consensus 1121 VL~~L~ 1126 (1137)
+++++|
T Consensus 250 ll~~~~ 255 (256)
T cd08529 250 LLRNPS 255 (256)
T ss_pred HhhCCC
Confidence 999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=346.08 Aligned_cols=285 Identities=18% Similarity=0.218 Sum_probs=202.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
-..+|++.+.||+|+||.||+|.+. +..+|+|+..... ........ +.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKR----AYRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHH----HHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 3578999999999999999999874 4678888753322 11222223 37899999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
... ......|+||||++ ++|...+.. .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 93 ~~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~ 156 (359)
T cd07876 93 KSL--------EEFQDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 156 (359)
T ss_pred CCc--------cccceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 321 11225799999997 577776643 47889999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 157 ~~~-------~~~kl~Dfg~a~~~~~~~-----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~e 214 (359)
T cd07876 157 KSD-------CTLKILDFGLARTACTNF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGE 214 (359)
T ss_pred CCC-------CCEEEecCCCccccccCc-----------cCCCCcccCCCCCchhccC----CCCCcchhhHHHHHHHHH
Confidence 987 789999999986433211 1113468999999999875 467899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhh-----------cccccccccccCCCCCC---chhhhhhHHHHHHH
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL-----------GSCHEHEVAQSGSGFEK---PEAELETLSFLVDV 1103 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~-----------~~~~~~~~~~~~~~~~~---~~~~~~~~~~L~dL 1103 (1137)
|++|+.||.+.+..+....+............... +........+....+.. .......++++++|
T Consensus 215 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 294 (359)
T cd07876 215 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL 294 (359)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHH
Confidence 99999999887655444333221111111000000 00000000000000000 00111335678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1104 FRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1104 l~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+.+||+.||++|||+.|+++|+|+.
T Consensus 295 i~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 295 LSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHhccCcccCCCHHHHhcCchhh
Confidence 9999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=343.37 Aligned_cols=254 Identities=25% Similarity=0.324 Sum_probs=202.1
Q ss_pred CceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 879 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~ 879 (1137)
+|++.+.||+|+||.||+|.+.. ..+|+|+........ ....+ .+..|..++..+. |++|+++++++...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVE----CTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHH----HHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 58899999999999999999854 578888764332111 11222 2366888888775 899999999988665
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 136 (323)
T cd05616 75 -------------RLYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136 (323)
T ss_pred -------------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence 67999999999999998875 246899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~ell 195 (323)
T cd05616 137 E-------GHIKIADFGMCKENMWDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVLLYEML 195 (323)
T ss_pred C-------CcEEEccCCCceecCCCCC----------ccccCCCChhhcCHHHhcC----CCCCCccchhchhHHHHHHH
Confidence 7 7899999999864322111 1123468999999999875 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 1117 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS-- 1117 (1137)
+|+.||.+.+..++...+...... ++. ..++++.+++.+||+.||.+|++
T Consensus 196 tg~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 196 AGQAPFEGEDEDELFQSIMEHNVA-YPK---------------------------SMSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCC-CCC---------------------------cCCHHHHHHHHHHcccCHHhcCCCC
Confidence 999999988887777776543321 111 23455899999999999999997
Q ss_pred ---HHHHHHHHHhhc
Q 001152 1118 ---AGDLYEMFVART 1129 (1137)
Q Consensus 1118 ---a~EVL~~L~~~~ 1129 (1137)
..++.+|+|++.
T Consensus 248 ~~~~~~i~~h~~~~~ 262 (323)
T cd05616 248 PEGERDIKEHAFFRY 262 (323)
T ss_pred CCCHHHHhcCCCcCC
Confidence 489999988753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=352.12 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=206.7
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|++. +..+|+|+....... .....+ .+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSA----FFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHH----HHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 3467999999999999999999985 467888875322111 111122 247899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 116 ~--------------~~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl 175 (370)
T cd05621 116 K--------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL 175 (370)
T ss_pred C--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence 5 67999999999999999865 258899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++......... ......||+.|+|||++.+......++.++|||||||++|+
T Consensus 176 ~~~-------~~~kL~DFG~a~~~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilye 239 (370)
T cd05621 176 DKH-------GHLKLADFGTCMKMDETGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFE 239 (370)
T ss_pred CCC-------CCEEEEecccceecccCCce---------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHH
Confidence 877 78999999998765432110 11234699999999999753323457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE-- 1114 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~-- 1114 (1137)
|++|..||.+.+.......+..... ..++.. ...++.+++++.+||..++.+
T Consensus 240 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-------------------------~~~s~~~~~li~~~L~~~~~r~~ 294 (370)
T cd05621 240 MLVGDTPFYADSLVGTYSKIMDHKNSLNFPED-------------------------VEISKHAKNLICAFLTDREVRLG 294 (370)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc-------------------------ccCCHHHHHHHHHHccCchhccC
Confidence 9999999998777666666643221 111110 134556899999999866554
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
|+++.|+++|+|+...
T Consensus 295 R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 295 RNGVEEIKQHPFFKND 310 (370)
T ss_pred CCCHHHHhcCcccCCC
Confidence 8999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=348.01 Aligned_cols=268 Identities=27% Similarity=0.360 Sum_probs=197.8
Q ss_pred CCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
++|.-...||+|+||.||+|...+ ..||||. +....... ..+| .+|+.++.+++|||||+++|||.+.+.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~--~~~~~~~~--~~eF----~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKR--LSSNSGQG--EREF----LNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEE--ecCCCCcc--hhHH----HHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 456666899999999999999876 7888884 33322211 2334 899999999999999999999997651
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCCCCeEe
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILI 957 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~---gIIHrDLKP~NILl 957 (1137)
+.+||+|||++|||.++++.. ... .++|.++.+|+.++|+||+|||.. .||||||||+|||+
T Consensus 146 ------------~~~LVYEym~nGsL~d~L~~~--~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 146 ------------HRLLVYEYMPNGSLEDHLHGK--KGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred ------------eEEEEEEccCCCCHHHHhCCC--CCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 369999999999999999762 111 789999999999999999999975 49999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccc-cccccccccCCCCCCCcc-cCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVC-VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~-~~~~~~~~~~~~~~~~~~-~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|.+ .++||+|||+|+.... .... ... .||.+|+|||++.. +..+.|+|||||||++
T Consensus 211 D~~-------~~aKlsDFGLa~~~~~~~~~~-----------~~~~~gt~gY~~PEy~~~----g~lt~KsDVySFGVvl 268 (361)
T KOG1187|consen 211 DED-------FNAKLSDFGLAKLGPEGDTSV-----------STTVMGTFGYLAPEYAST----GKLTEKSDVYSFGVVL 268 (361)
T ss_pred CCC-------CCEEccCccCcccCCccccce-----------eeecCCCCccCChhhhcc----CCcCcccccccchHHH
Confidence 988 7899999999964432 1110 011 69999999999875 5678999999999999
Q ss_pred HHHHhCCCCCCCCC---HHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCC-CCCchhhhhhHHHHHHHHHHhccc
Q 001152 1036 LELLTLQVPYMGLS---ELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSG-FEKPEAELETLSFLVDVFRRCTEE 1110 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~---~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~dLl~~CL~~ 1110 (1137)
.||+||+.|.+... ...+..|...... ..+. .+.+.... ...+ .......+..+..+|++.
T Consensus 269 lElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~------------eiiD~~l~~~~~~--~~~~~~~~~~~a~~C~~~ 334 (361)
T KOG1187|consen 269 LELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLR------------EIVDPRLKEGEYP--DEKEVKKLAELALRCLRP 334 (361)
T ss_pred HHHHhCCcccCCCCCcccccHHHHHHHHHHCcchh------------heeCCCccCCCCC--hHHHHHHHHHHHHHHcCc
Confidence 99999998886432 2223333211000 0000 01111100 0010 003445588889999999
Q ss_pred CCCCCCCHHHHHHHHHhhc
Q 001152 1111 NPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1111 DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+|.+||+|.||++.+....
T Consensus 335 ~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 335 DPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CCCcCcCHHHHHHHHHhhc
Confidence 9999999999999985543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.96 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=198.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..+|++.+.||+|+||.||+|.+. +..+|+|+.+ .... ....+. +.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~--~~~~-~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLR--AGCS-DKQRRG----FLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecC--CCCC-HHHHHH----HHHHHHHHhcCCCCCcCeEEEEEe
Confidence 456899999999999999999863 2456666543 2211 222223 478999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
..+ +.++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 77 ~~~--------------~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ni 138 (266)
T cd05064 77 RGN--------------TMMIVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKV 138 (266)
T ss_pred cCC--------------CcEEEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhE
Confidence 655 569999999999999998751 24689999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+|++|||.+......... ......++..|+|||.+.+ ..++.++|||||||++
T Consensus 139 li~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 198 (266)
T cd05064 139 LVNSD-------LVCKISGFRRLQEDKSEAIY---------TTMSGKSPVLWAAPEAIQY----HHFSSASDVWSFGIVM 198 (266)
T ss_pred EEcCC-------CcEEECCCcccccccccchh---------cccCCCCceeecCHHHHhh----CCccchhHHHHHHHHH
Confidence 99877 78999999976543211100 0012235678999999875 5688999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
||+++ |..||......++...+..+..+..+. .++..+.+++.+||+.+|.+
T Consensus 199 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p~~ 251 (266)
T cd05064 199 WEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR---------------------------NCPNLLHQLMLDCWQKERGE 251 (266)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCchh
Confidence 99775 999999887777777665543322111 34456999999999999999
Q ss_pred CCCHHHHHHHHH
Q 001152 1115 RPTAGDLYEMFV 1126 (1137)
Q Consensus 1115 RPSa~EVL~~L~ 1126 (1137)
||++++|++.+.
T Consensus 252 RP~~~~i~~~l~ 263 (266)
T cd05064 252 RPRFSQIHSILS 263 (266)
T ss_pred CCCHHHHHHHHH
Confidence 999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=342.83 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=196.5
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||.||+|++. +..+|+|+.+...... ....+ .+..|+.++... +||||+++++++.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~~~~i~~~~~~~~~~~------ 69 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-DDDVE----CTMVEKRVLALAWENPFLTHLYCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-cchHH----HHHHHHHHHHhccCCCCccCeeEEEEeCC------
Confidence 47999999999999985 4678888765332111 11112 235677888754 7999999999998765
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
+.|+||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---- 132 (316)
T cd05620 70 --------HLFFVMEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---- 132 (316)
T ss_pred --------EEEEEECCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 67999999999999998875 2468999999999999999999999999999999999999977
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~el~~g~~P 195 (316)
T cd05620 133 ---GHIKIADFGMCKENVFGD----------NRASTFCGTPDYIAPEILQG----LKYTFSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEeCccCCCeecccCC----------CceeccCCCcCccCHHHHcC----CCCCcccchhhhHHHHHHHHhCCCC
Confidence 789999999886432111 11123468999999999875 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-HHHHH
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-GDLYE 1123 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa-~EVL~ 1123 (1137)
|.+.+..++...+.... +.++. ..+.++.+++.+||+.||.+||++ +++++
T Consensus 196 f~~~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 196 FHGDDEDELFESIRVDT-PHYPR---------------------------WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCCHHHHHHHHHhCC-CCCCC---------------------------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 99887776666654332 11111 233458999999999999999997 58889
Q ss_pred HHHhhcC
Q 001152 1124 MFVARTS 1130 (1137)
Q Consensus 1124 ~L~~~~~ 1130 (1137)
|+|+...
T Consensus 248 h~~f~~~ 254 (316)
T cd05620 248 HPFFKTI 254 (316)
T ss_pred CCCcCCC
Confidence 9998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=342.10 Aligned_cols=249 Identities=27% Similarity=0.380 Sum_probs=195.3
Q ss_pred eeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||.||+|++.+ ..||+|+.+...... ....+. +..|..++... +||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~----~~~e~~~l~~~~~hp~i~~~~~~~~~~~------ 69 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVEC----TMVERRVLALAWEHPFLTHLFCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHH----HHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 469999999999999854 568888865432111 111222 25566777654 7999999999988655
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++|+|..++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~gg~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~---- 132 (316)
T cd05592 70 --------HLFFVMEYLNGGDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD---- 132 (316)
T ss_pred --------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC----
Confidence 67999999999999999875 2468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kL~Dfg~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~G~~P 195 (316)
T cd05592 133 ---GHIKIADFGMCKENMNGE----------GKASTFCGTPDYIAPEILKG----QKYNESVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCcCCeECCCCC----------CccccccCCccccCHHHHcC----CCCCCcccchhHHHHHHHHHhCCCC
Confidence 789999999987543211 11123468999999999875 4678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-HHHHH
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-GDLYE 1123 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa-~EVL~ 1123 (1137)
|.+.+..++...+.... +.++. ..+.++.+++.+||+.||.+||++ .++++
T Consensus 196 f~~~~~~~~~~~i~~~~-~~~~~---------------------------~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 196 FHGEDEDELFDSILNDR-PHFPR---------------------------WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHcCC-CCCCC---------------------------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 99888777766664322 11111 234458899999999999999986 58889
Q ss_pred HHHhhc
Q 001152 1124 MFVART 1129 (1137)
Q Consensus 1124 ~L~~~~ 1129 (1137)
|+|+..
T Consensus 248 h~~~~~ 253 (316)
T cd05592 248 HPFFRG 253 (316)
T ss_pred CcccCC
Confidence 988764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=346.10 Aligned_cols=263 Identities=23% Similarity=0.281 Sum_probs=205.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|.+. +..+|+|+....... .... ...+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~----~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~- 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQET----VSFFEEERDILSISNSPWIPQLQYAFQDKD- 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhH----HHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence 36899999999999999999984 567888876433211 1112 223478999999999999999999987655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~ 137 (330)
T cd05601 75 -------------NLYLVMEYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137 (330)
T ss_pred -------------eEEEEECCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC
Confidence 579999999999999999762 246999999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC--CCCCCchhhHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--~~~~s~ksDVWSLGviL~E 1037 (1137)
+ +.+||+|||++......... ......||+.|+|||++..... ...++.++|||||||++|+
T Consensus 138 ~-------~~~kL~Dfg~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 201 (330)
T cd05601 138 T-------GHIKLADFGSAARLTANKMV---------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE 201 (330)
T ss_pred C-------CCEEeccCCCCeECCCCCce---------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeee
Confidence 7 78999999998765432111 1112368999999999864211 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++|..||...........+..... ..++. ....++++.+|+.+||+ +|.+||
T Consensus 202 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~~~~~~~li~~ll~-~p~~R~ 255 (330)
T cd05601 202 MIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE-------------------------DPKVSSDFLDLIQSLLC-GQKERL 255 (330)
T ss_pred eccCCCCCCCCCHHHHHHHHHcCCCccCCCC-------------------------CCCCCHHHHHHHHHHcc-ChhhCC
Confidence 9999999988777666665543321 11110 01345568999999998 999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
+++++++|+|+..
T Consensus 256 t~~~l~~h~~~~~ 268 (330)
T cd05601 256 GYEGLCCHPFFSK 268 (330)
T ss_pred CHHHHhCCCCcCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=334.60 Aligned_cols=284 Identities=18% Similarity=0.238 Sum_probs=208.6
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...+.+|++.+.||+|+||.||+|++. +..+|+|......... ... .+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~---~~~----~~~~E~~~l~~l~h~nI~~~~~~~~ 74 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG---APC----TAIREVSLLKDLKHANIVTLHDIIH 74 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC---chh----HHHHHHHHHHhcCCCCcceEEEEEe
Confidence 456889999999999999999999885 4667888754332211 111 2367999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
... ..++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 75 ~~~--------------~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Ni 135 (301)
T cd07873 75 TEK--------------SLTLVFEYLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL 135 (301)
T ss_pred cCC--------------eEEEEEeccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHE
Confidence 665 5799999997 6999988652 24588999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++
T Consensus 136 l~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l 195 (301)
T cd07873 136 LINER-------GELKLADFGLARAKSIPTKT----------YSNEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIF 195 (301)
T ss_pred EECCC-------CcEEECcCcchhccCCCCCc----------ccccceeecccCcHHHhC---CCCCccHHHHHHHHHHH
Confidence 99977 78999999988654322111 112347889999999864 24578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccC-CCCCC---chhhhhhHHHHHHHHHHhcccC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG-SGFEK---PEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
|+|++|+.||...+..+....+...........+..... ........ ..... .......++.+.+|+.+||+.|
T Consensus 196 ~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~d 273 (301)
T cd07873 196 YEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS--NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFE 273 (301)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc--cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCC
Confidence 999999999988776665555433222111111111000 00000000 00000 0111245667899999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 001152 1112 PTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~~~~ 1129 (1137)
|.+|||++|+++|+|++.
T Consensus 274 p~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 274 GRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccCcCHHHHhcCccccc
Confidence 999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=332.75 Aligned_cols=283 Identities=21% Similarity=0.213 Sum_probs=199.1
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeeEecC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISS 877 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L---~HpNIVkllg~~~~~ 877 (1137)
+|++.+.||+|+||+||+|.+. +..+|+|+........... . .+.+|+.+++.+ .||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~--~----~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP--L----STVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc--h----HHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 5889999999999999999985 4668888754432211111 1 124566666655 699999999988653
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
.. ......++||||++ ++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~~---------~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili 141 (288)
T cd07863 75 RT---------DRETKVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 141 (288)
T ss_pred cC---------CCCceEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 21 01226799999997 6999988752 23458999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++........ .....+|+.|+|||++.+ ..++.++|||||||++|+
T Consensus 142 ~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~ 199 (288)
T cd07863 142 TSG-------GQVKLADFGLARIYSCQMA-----------LTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGCIFAE 199 (288)
T ss_pred CCC-------CCEEECccCccccccCccc-----------CCCccccccccCchHhhC----CCCCCcchhhhHHHHHHH
Confidence 877 7899999999875432111 113458899999999875 468899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|.+||.+....+....+...........+............ ..............++.+.+++.+||+.||++|||
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (288)
T cd07863 200 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFS-PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278 (288)
T ss_pred HHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccC-CCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC
Confidence 99999999877666555444321111101111000000000000 00000001111245667899999999999999999
Q ss_pred HHHHHHHHHh
Q 001152 1118 AGDLYEMFVA 1127 (1137)
Q Consensus 1118 a~EVL~~L~~ 1127 (1137)
+.|++.|+||
T Consensus 279 ~~~~l~hp~f 288 (288)
T cd07863 279 AFRALQHPFF 288 (288)
T ss_pred HHHHhcCCCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=335.19 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=200.3
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|++.+.||+|+||+||++.+. +..+|+|+....... .. .....+.+|+.+++.++||||+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KR---KGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh--hh---hhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 4789999999999999999984 567888875322111 11 11223478999999999999999999987655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++.. .....+++..+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 74 ------------ALCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY 138 (285)
T ss_pred ------------eEEEEEeccCCCcHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC
Confidence 57999999999999998865 223468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||++........ .....|++.|+|||++.+ ..++.++||||+||++|+|++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Diws~G~~l~el~~ 196 (285)
T cd05605 139 -------GHIRISDLGLAVEIPEGET-----------IRGRVGTVGYMAPEVVKN----ERYTFSPDWWGLGCLIYEMIE 196 (285)
T ss_pred -------CCEEEeeCCCceecCCCCc-----------cccccCCCCccCcHHhcC----CCCCccccchhHHHHHHHHHH
Confidence 7899999998865432111 112358999999999865 467899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---- 1116 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP---- 1116 (1137)
|..||.+.........+......... . .....++.+.+|+.+||+.||.+||
T Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~~-~-----------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05605 197 GKSPFRQRKEKVKREEVERRVKEDQE-E-----------------------YSEKFSEAARSICRQLLTKDPGFRLGCRG 252 (285)
T ss_pred CCCCCCCCchhhHHHHHHHHhhhccc-c-----------------------cCcccCHHHHHHHHHHccCCHHHhcCCCC
Confidence 99999875543333222111100000 0 0013445689999999999999999
Q ss_pred -CHHHHHHHHHhhcC
Q 001152 1117 -TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 -Sa~EVL~~L~~~~~ 1130 (1137)
+++++++|+|+...
T Consensus 253 ~~~~~l~~~~~~~~~ 267 (285)
T cd05605 253 EGAEEVKAHPFFRTA 267 (285)
T ss_pred CCHHHHhcCcCccCC
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=364.31 Aligned_cols=268 Identities=25% Similarity=0.381 Sum_probs=215.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
+..+.++.+.||+|+||.||+|+.. +...+|.||.++.... ....+ .|+||+++|..++|||||+++|.+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~----dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQ----DFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHH----HHHHHHHHHHhccCCCeEEEEEEE
Confidence 3455678899999999999999862 2334444433443221 22333 459999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCe
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE---------KHVSVKLALFIAQDVAAALVELHSKHI 945 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~---------~~ls~~~i~~I~~QIa~gL~yLHs~gI 945 (1137)
.+++ -+++|+|||..|||.++|+....... .+++..+.+.|+.|||.||+||-++.+
T Consensus 559 ~~~~--------------P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~F 624 (774)
T KOG1026|consen 559 REGD--------------PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHF 624 (774)
T ss_pred ccCC--------------eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcc
Confidence 9877 45999999999999999987543322 238999999999999999999999999
Q ss_pred eeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCch
Q 001152 946 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1025 (1137)
Q Consensus 946 IHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~k 1025 (1137)
|||||-..|+||.++ ..|||+|||+++..-..+... . . ....-...|||||.++. +.++.+
T Consensus 625 VHRDLATRNCLVge~-------l~VKIsDfGLsRdiYssDYYk--~-~-----~~t~lPIRWMppEsIly----~kFTte 685 (774)
T KOG1026|consen 625 VHRDLATRNCLVGEN-------LVVKISDFGLSRDIYSSDYYK--V-R-----GNTLLPIRWMPPESILY----GKFTTE 685 (774)
T ss_pred cccchhhhhceeccc-------eEEEecccccchhhhhhhhhc--c-c-----CCceeeeecCCHHHhhc----Ccccch
Confidence 999999999999988 789999999998654332211 1 1 01124558999999986 689999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHH
Q 001152 1026 VDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1104 (1137)
Q Consensus 1026 sDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl 1104 (1137)
||||||||+|||+++ |+.||.+.+..++++.|+.+....-+ ..++.++.+||
T Consensus 686 SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~P---------------------------e~CP~~vY~LM 738 (774)
T KOG1026|consen 686 SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCP---------------------------ENCPTEVYSLM 738 (774)
T ss_pred hhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCC---------------------------CCCCHHHHHHH
Confidence 999999999999998 89999999999999999887742222 16788899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 001152 1105 RRCTEENPTERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1105 ~~CL~~DP~~RPSa~EVL~~L~~~~~ss 1132 (1137)
..||+.+|.+||+|.||-..|......+
T Consensus 739 ~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 739 LECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 9999999999999999998887765433
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=340.33 Aligned_cols=249 Identities=27% Similarity=0.353 Sum_probs=196.4
Q ss_pred eeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||.||+|++.. ..+|+|+........ ....+ ....|..++... +||||+++++++.+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~hp~iv~~~~~~~~~~------ 69 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVE----CTMVEKRVLSLAWEHPFLTHLYCTFQTKE------ 69 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHH----HHHHHHHHHHhccCCCcCcceEEEEEeCC------
Confidence 469999999999999854 568888765432111 11112 225677888764 8999999999998765
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~ey~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---- 132 (316)
T cd05619 70 --------NLFFVMEYLNGGDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---- 132 (316)
T ss_pred --------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC----
Confidence 67999999999999999875 2468999999999999999999999999999999999999987
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (316)
T cd05619 133 ---GHIKIADFGMCKENMLGDA----------KTCTFCGTPDYIAPEILLG----QKYNTSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ---CCEEEccCCcceECCCCCC----------ceeeecCCccccCHHHHcC----CCCCchhhhhhHHHHHHHHHhCCCC
Confidence 7899999998864322111 1123468999999999875 4678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG-DLYE 1123 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~-EVL~ 1123 (1137)
|.+.+..++...+..... .++. ..+.++.+++.+||+.||.+||++. ++.+
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 196 FHGHDEEELFQSIRMDNP-CYPR---------------------------WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHhCCC-CCCc---------------------------cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 998877777666644321 1111 2234589999999999999999996 8999
Q ss_pred HHHhhc
Q 001152 1124 MFVART 1129 (1137)
Q Consensus 1124 ~L~~~~ 1129 (1137)
|+|+..
T Consensus 248 h~~~~~ 253 (316)
T cd05619 248 HPFFRE 253 (316)
T ss_pred CcccCC
Confidence 999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=343.18 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=191.9
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||.||+|++. +..+|+|+.+...... ....+ .+.+|+.++..+ +||||+++++++.+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~-~~~~~----~~~~e~~il~~~~~hp~Iv~~~~~~~~~~------ 69 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND-DEDID----WVQTEKHVFETASNHPFLVGLHSCFQTES------ 69 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHH----HHHHHHHHHHhccCCCCCCceEEEEEcCC------
Confidence 46999999999999985 4678888864332111 11222 347899999998 6999999999998765
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~---- 132 (329)
T cd05588 70 --------RLFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---- 132 (329)
T ss_pred --------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 67999999999999998865 2469999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~P 195 (329)
T cd05588 133 ---GHIKLTDYGMCKEGIRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEECcCccccccccCCC----------ccccccCCccccCHHHHcC----CCCCCccceechHHHHHHHHHCCCC
Confidence 7899999998864221111 1123468999999999875 5678999999999999999999999
Q ss_pred CCCCCH--------H-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1045 YMGLSE--------L-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1045 f~~~~~--------~-el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|..... . .+...+.... ..++ ...+..+.+++.+||+.||.+|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p---------------------------~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 196 FDIVGMSDNPDQNTEDYLFQVILEKQ-IRIP---------------------------RSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred cccccccccccccchHHHHHHHHcCC-CCCC---------------------------CCCCHHHHHHHHHHhccCHHHc
Confidence 963211 1 1111121111 1111 0234568999999999999999
Q ss_pred CC------HHHHHHHHHhhc
Q 001152 1116 PT------AGDLYEMFVART 1129 (1137)
Q Consensus 1116 PS------a~EVL~~L~~~~ 1129 (1137)
|+ ++++++|+|+..
T Consensus 248 ~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 248 LGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCC
Confidence 87 799999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=340.55 Aligned_cols=249 Identities=26% Similarity=0.342 Sum_probs=198.6
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||+||+|.+. +..+|+|+........ ..... .+.+|+.+++.+ +||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~----~~~~e~~il~~~~~h~~i~~~~~~~~~~~------ 69 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDVE----CTMTEKRVLALAGKHPFLTQLHSCFQTKD------ 69 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHH----HHHHHHHHHHhccCCCCccceeeEEEcCC------
Confidence 46999999999999985 4678888865332111 11222 236788899888 5999999999988665
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
+.++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---- 132 (318)
T cd05570 70 --------RLFFVMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---- 132 (318)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC----
Confidence 67999999999999998876 2469999999999999999999999999999999999999987
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslGvil~~l~~G~~p 195 (318)
T cd05570 133 ---GHIKIADFGMCKEGILGGV----------TTSTFCGTPDYIAPEILSY----QPYGPAVDWWALGVLLYEMLAGQSP 195 (318)
T ss_pred ---CcEEecccCCCeecCcCCC----------cccceecCccccCHHHhcC----CCCCcchhhhhHHHHHHHHhhCCCC
Confidence 7899999998864221111 1113458999999999875 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----H
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----G 1119 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa-----~ 1119 (1137)
|.+.+..++...+..... .++. ..++.+.+|+.+||+.||.+||++ .
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~ 247 (318)
T cd05570 196 FEGDDEDELFQSILEDEV-RYPR---------------------------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQ 247 (318)
T ss_pred CCCCCHHHHHHHHHcCCC-CCCC---------------------------cCCHHHHHHHHHHccCCHHHcCCCCCCCHH
Confidence 998777776666544321 1110 234568999999999999999999 9
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
++++|+|+..
T Consensus 248 ~ll~~~~~~~ 257 (318)
T cd05570 248 DIKGHPFFRE 257 (318)
T ss_pred HHhcCCCcCC
Confidence 9999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=347.69 Aligned_cols=267 Identities=20% Similarity=0.231 Sum_probs=203.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||+|... +..+|+|+....... .......+.+|+.++..++||||+++++.+.+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR- 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 36899999999999999999985 467888875422111 1111234478999999999999999999988765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~ 136 (360)
T cd05627 75 -------------NLYLIMEFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA 136 (360)
T ss_pred -------------EEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC
Confidence 67999999999999999875 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccc-------------------------cCCCCCCCcccCCCcccchhhhc
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-------------------------HRGIPAPDVCVGTPRWMAPEVLR 1014 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~-------------------------~~~~~~~~~~~GT~~Y~APE~l~ 1014 (1137)
+ +.+||+|||++............. ..........+||+.|+|||++.
T Consensus 137 ~-------~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 209 (360)
T cd05627 137 K-------GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209 (360)
T ss_pred C-------CCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc
Confidence 7 789999999987543211000000 00000011346999999999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhh
Q 001152 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1093 (1137)
Q Consensus 1015 ~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1137)
+ ..++.++|||||||++|||++|..||.+.........+..... ..++..
T Consensus 210 ~----~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~------------------------- 260 (360)
T cd05627 210 Q----TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPE------------------------- 260 (360)
T ss_pred C----CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCC-------------------------
Confidence 5 5688999999999999999999999998877776666643221 111100
Q ss_pred hhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhc
Q 001152 1094 LETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVART 1129 (1137)
Q Consensus 1094 ~~~~~~L~dLl~~CL~~DP~~RP---Sa~EVL~~L~~~~ 1129 (1137)
...++++.+++.+|+. ||.+|+ +++|+++|+|+..
T Consensus 261 ~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 261 VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 0234568899999874 999998 5899999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=345.26 Aligned_cols=248 Identities=24% Similarity=0.296 Sum_probs=198.5
Q ss_pred eeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~-----~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
+.||+|+||.||+++. .+..+|+|+...... ..... .++.+|++++++++||||+++++++.+..
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 71 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDR----VRTKMERDILAEVNHPFIVKLHYAFQTEG---- 71 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhH----HHHHHHHHHHHhCCCCCcccEEEEEEcCC----
Confidence 5799999999999875 357789998643221 11111 23477999999999999999999988765
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
..|+||||+++++|.+++.+ ...+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 72 ----------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-- 134 (318)
T cd05582 72 ----------KLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-- 134 (318)
T ss_pred ----------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC--
Confidence 67999999999999999865 2468999999999999999999999999999999999999877
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~ 1042 (1137)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 135 -----~~~kL~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 135 -----GHIKLTDFGLSKESIDHEK----------KAYSFCGTVEYMAPEVVNR----RGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred -----CcEEEeeccCCcccCCCCC----------ceecccCChhhcCHHHHcC----CCCCCccceeccceEeeeeccCC
Confidence 7899999999875432211 1113468999999999875 45789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----
Q 001152 1043 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT----- 1117 (1137)
Q Consensus 1043 ~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS----- 1117 (1137)
.||......+....+...... ++. ..++.+.+++.+||+.||.+||+
T Consensus 196 ~p~~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~l~~~P~~R~~a~~~~ 247 (318)
T cd05582 196 LPFQGKDRKETMTMILKAKLG-MPQ---------------------------FLSPEAQSLLRALFKRNPANRLGAGPDG 247 (318)
T ss_pred CCCCCCCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence 999987777766666443211 110 23455899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001152 1118 AGDLYEMFVART 1129 (1137)
Q Consensus 1118 a~EVL~~L~~~~ 1129 (1137)
+.+++.|+|+..
T Consensus 248 ~~~~~~~~~~~~ 259 (318)
T cd05582 248 VEEIKRHPFFST 259 (318)
T ss_pred HHHHhCCCCcCC
Confidence 788999988753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=343.39 Aligned_cols=285 Identities=18% Similarity=0.230 Sum_probs=204.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|.+. +..||+|+.... .......+ ++.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP--FQSLIHAR----RTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch--hhhhHHHH----HHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 57999999999999999999874 456788864322 11111222 34789999999999999999998864321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ......+++||++ +++|.+++.. ..+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 89 ~--------~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~ 153 (343)
T cd07878 89 I--------ENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE 153 (343)
T ss_pred c--------cccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC
Confidence 1 1123679999988 6899888753 35999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++...... ....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 154 ~-------~~~kl~Dfg~~~~~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~ 210 (343)
T cd07878 154 D-------CELRILDFGLARQADDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 210 (343)
T ss_pred C-------CCEEEcCCccceecCCCc-------------CCccccccccCchHhcC---CccCCchhhhHhHHHHHHHHH
Confidence 7 789999999987543211 13368999999999874 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCC---chhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||.+.+..+....+...........+.................... .......++.+.+|+.+||+.||.+||
T Consensus 211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~ 290 (343)
T cd07878 211 KGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI 290 (343)
T ss_pred HCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCC
Confidence 99999987766655555433221111111111100000000000000000 001113345688999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|+.|+++|+|+...
T Consensus 291 s~~ell~hp~~~~~ 304 (343)
T cd07878 291 SASEALAHPYFSQY 304 (343)
T ss_pred CHHHHhcCcchhcc
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.30 Aligned_cols=255 Identities=22% Similarity=0.283 Sum_probs=193.4
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCC
Q 001152 810 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 810 LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 887 (1137)
||+|+||+||++.+. +..+|+|+....... .....+ .+..|+.+++.++||||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~----~~~~E~~il~~l~~~~i~~~~~~~~~~~--------- 66 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYE----GAMVEKRILAKVHSRFIVSLAYAFQTKT--------- 66 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHH----HHHHHHHHHHhCCCCcEeeeeEEEcCCC---------
Confidence 799999999999875 467888875322111 111122 3477999999999999999999887655
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCC
Q 001152 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 967 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~ 967 (1137)
..++||||+++|+|..++..... ....+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 67 -----~~~lv~e~~~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~------- 133 (280)
T cd05608 67 -----DLCLVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND------- 133 (280)
T ss_pred -----eEEEEEeCCCCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-------
Confidence 67999999999999988864322 23469999999999999999999999999999999999999877
Q ss_pred CeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001152 968 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047 (1137)
Q Consensus 968 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~ 1047 (1137)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 134 ~~~~l~dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 134 GNVRISDLGLAVELKDGQS----------KTKGYAGTPGFMAPELLQG----EEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred CCEEEeeCccceecCCCCc----------cccccCCCcCccCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 7899999999865433211 1123468999999999975 4678999999999999999999999976
Q ss_pred CCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHH
Q 001152 1048 LSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDL 1121 (1137)
Q Consensus 1048 ~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-----Sa~EV 1121 (1137)
.........+.... ..... .....++.+.+++.+||+.||++|| +++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 254 (280)
T cd05608 200 RGEKVENKELKQRILNDSVT-------------------------YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL 254 (280)
T ss_pred CCcchhHHHHHHhhcccCCC-------------------------CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence 43221111111100 00000 0013455689999999999999999 88999
Q ss_pred HHHHHhhcC
Q 001152 1122 YEMFVARTS 1130 (1137)
Q Consensus 1122 L~~L~~~~~ 1130 (1137)
++|+|+...
T Consensus 255 l~h~~~~~~ 263 (280)
T cd05608 255 RTHPLFRDL 263 (280)
T ss_pred hcChhhhcC
Confidence 999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=346.07 Aligned_cols=287 Identities=20% Similarity=0.215 Sum_probs=205.6
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||+|.+. +..+|+|+.. .........+ ++.+|+.+++.++||||+++++++......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMP--NVFQNLVSCK----RVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecc--ccccchHHHH----HHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 4678899999999999999974 5678888642 2222222223 348899999999999999999998764310
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
.....|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 ---------~~~~~~lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~ 139 (372)
T cd07853 75 ---------PFEEIYVVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN 139 (372)
T ss_pred ---------ccceEEEEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC
Confidence 1125799999996 788888754 3469999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||++......... ......+|+.|+|||++.+ ...++.++|||||||++|||++
T Consensus 140 -------~~~kL~Dfg~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~ 200 (372)
T cd07853 140 -------CVLKICDFGLARVEEPDESK---------HMTQEVVTQYYRAPEILMG---SRHYTSAVDIWSVGCIFAELLG 200 (372)
T ss_pred -------CCEEeccccceeecccCccc---------cCCCCCcCCCcCCHHHHcC---CCCCCcHHHHHhHHHHHHHHHc
Confidence 78999999998754322110 1112357889999999875 2357899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccc-cCCCCCCc---hhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ-SGSGFEKP---EAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|+.||.+.+..+....+...........+..........+.. ........ ......++++.+|+.+||+.||.+||
T Consensus 201 g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 280 (372)
T cd07853 201 RRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI 280 (372)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc
Confidence 999999887777666664322111111111100000000000 00000000 00113466799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|+.|+++|+|+..
T Consensus 281 t~~e~l~hp~~~~ 293 (372)
T cd07853 281 SAADALAHPYLDE 293 (372)
T ss_pred CHHHHhcCHhhCC
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=342.76 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=193.4
Q ss_pred eeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHH-HHHHhCCCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEV-RMLGALRHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi-~iL~~L~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||+||+|++.. ..+|+|+........ .... ..+..|. .+++.++||||+++++++...+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~----~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~------ 69 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-KKEE----KHIMSERNVLLKNVKHPFLVGLHFSFQTAD------ 69 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-hhHH----HHHHHHHHHHHHhCCCCCCCceeEEEEcCC------
Confidence 469999999999999853 568888864332111 1111 1224444 4567889999999999988765
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~---- 132 (325)
T cd05602 70 --------KLYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred --------eEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----
Confidence 67999999999999999875 2468889999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kl~DfG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (325)
T cd05602 133 ---GHIVLTDFGLCKENIEHNG----------TTSTFCGTPEYLAPEVLHK----QPYDRTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEccCCCCcccccCCC----------CcccccCCccccCHHHHcC----CCCCCccccccccHHHHHHhcCCCC
Confidence 7899999999864322111 1123469999999999875 5688999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH----H
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG----D 1120 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~----E 1120 (1137)
|.+.+..+....+...... +. ...++.+.+++.+||+.||.+||++. +
T Consensus 196 f~~~~~~~~~~~i~~~~~~-~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 196 FYSRNTAEMYDNILNKPLQ-LK---------------------------PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCHHHHHHHHHhCCcC-CC---------------------------CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 9988777766665432211 00 03345689999999999999999765 8
Q ss_pred HHHHHHhh
Q 001152 1121 LYEMFVAR 1128 (1137)
Q Consensus 1121 VL~~L~~~ 1128 (1137)
+++|+|+.
T Consensus 248 i~~~~~~~ 255 (325)
T cd05602 248 IKNHIFFS 255 (325)
T ss_pred HhcCcccC
Confidence 88888874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=347.56 Aligned_cols=259 Identities=28% Similarity=0.440 Sum_probs=215.0
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
|.-.+.||.|+||.||-|++..+..+|+|++..... ....+.. ..+++|+..|.+++|||+|.+-|+|..+.
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySG--KQs~EKW-qDIlKEVrFL~~l~HPntieYkgCyLre~----- 99 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKW-QDILKEVRFLRQLRHPNTIEYKGCYLREH----- 99 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccc--cccHHHH-HHHHHHHHHHHhccCCCcccccceeeccc-----
Confidence 566788999999999999986655555554433332 2222222 23489999999999999999999998665
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
..|||||||- ||-.+++.-. .+++.+..+..|+.+.+.||+|||+.+.||||||+.|||+++.
T Consensus 100 ---------TaWLVMEYCl-GSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~--- 162 (948)
T KOG0577|consen 100 ---------TAWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP--- 162 (948)
T ss_pred ---------hHHHHHHHHh-ccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC---
Confidence 5699999996 8888887642 3579999999999999999999999999999999999999988
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1043 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~ 1043 (1137)
+.|||+|||.|..... .+.++|||+|||||++..+ ..+.|+-|+||||||++..||...++
T Consensus 163 ----g~VKLaDFGSAsi~~P--------------AnsFvGTPywMAPEVILAM-DEGqYdgkvDvWSLGITCIELAERkP 223 (948)
T KOG0577|consen 163 ----GLVKLADFGSASIMAP--------------ANSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKP 223 (948)
T ss_pred ----CeeeeccccchhhcCc--------------hhcccCCccccchhHheec-cccccCCccceeeccchhhhhhhcCC
Confidence 8999999998854332 2367899999999999876 46789999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001152 1044 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123 (1137)
Q Consensus 1044 Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~ 1123 (1137)
|+..++.+.....|.....|.+... +.++.+++|+..||++-|.+|||.++++.
T Consensus 224 PlFnMNAMSALYHIAQNesPtLqs~--------------------------eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 224 PLFNMNAMSALYHIAQNESPTLQSN--------------------------EWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CccCchHHHHHHHHHhcCCCCCCCc--------------------------hhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 9999999998888887776665421 44566999999999999999999999999
Q ss_pred HHHhhcCCC
Q 001152 1124 MFVARTSSS 1132 (1137)
Q Consensus 1124 ~L~~~~~ss 1132 (1137)
|.|.....+
T Consensus 278 H~fv~R~Rp 286 (948)
T KOG0577|consen 278 HRFVLRERP 286 (948)
T ss_pred cchhccCCC
Confidence 999886644
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=347.20 Aligned_cols=265 Identities=21% Similarity=0.288 Sum_probs=205.8
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|++. +..+|+|+....... ..... ..+.+|+.+++.++||||+++++.+.+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~----~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDS----AFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHH----HHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 3578999999999999999999985 456788875322111 11111 2347899999999999999999998866
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 116 ~--------------~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll 175 (371)
T cd05622 116 R--------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (371)
T ss_pred C--------------EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence 5 67999999999999999865 348899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++........ .......||+.|+|||++.+......++.++|||||||++||
T Consensus 176 ~~~-------~~ikL~DfG~a~~~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilye 239 (371)
T cd05622 176 DKS-------GHLKLADFGTCMKMNKEGM---------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239 (371)
T ss_pred CCC-------CCEEEEeCCceeEcCcCCc---------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHH
Confidence 877 7899999999876532211 011234699999999998753223347899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE-- 1114 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~-- 1114 (1137)
|++|..||.+.+.......+..... ..++. ....+..+.+++.+||..++.+
T Consensus 240 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~~~~r~~ 294 (371)
T cd05622 240 MLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-------------------------DNDISKEAKNLICAFLTDREVRLG 294 (371)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCcccCCC-------------------------cCCCCHHHHHHHHHHcCChhhhcC
Confidence 9999999998877766666654321 11110 0134556899999999854443
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
|++++|+++|+|+...
T Consensus 295 r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 295 RNGVEEIKRHLFFKND 310 (371)
T ss_pred CCCHHHHhcCcccCCC
Confidence 7899999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.45 Aligned_cols=251 Identities=29% Similarity=0.495 Sum_probs=195.0
Q ss_pred eEeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 805 SSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 805 ~l~~~LG~GsfG~Vy~a~~~------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
++.+.||.|+||.||+|.+. +..|+||+.+ . .......+.+ .+|++++++++||||++++|++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~--~-~~~~~~~~~~----~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILK--P-SSSEEEEEEF----LNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEES--T-TSSHHHHHHH----HHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEec--c-ccccccceee----eecccccccccccccccccccccccc
Confidence 46789999999999999997 4667777752 2 2223334444 88999999999999999999998544
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++|+|.+++... ....+++..+..|+.||+.||+|||+++|+||||+++||+++
T Consensus 75 --------------~~~lv~e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 75 --------------PLFLVMEYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp --------------SEEEEEE--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred --------------ccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccc
Confidence 469999999999999999872 235699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++.......... ..........|+|||.+.. ..++.++||||||+++|||
T Consensus 138 ~~-------~~~Kl~~f~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~----~~~~~ksDVysfG~~l~ei 198 (259)
T PF07714_consen 138 SN-------GQVKLSDFGLSRPISEKSKYK--------NDSSQQLPLRYLAPEVLKD----GEYTKKSDVYSFGMLLYEI 198 (259)
T ss_dssp TT-------TEEEEESTTTGEETTTSSSEE--------ESTTSESGGGGS-HHHHHH----SEESHHHHHHHHHHHHHHH
T ss_pred cc-------ccccccccccccccccccccc--------ccccccccccccccccccc----ccccccccccccccccccc
Confidence 87 789999999987652211110 0112246678999999876 3478999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++ |+.||......++...+..+..+..+. .++..+.+++.+||..||.+|||
T Consensus 199 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~C~~~~p~~RPs 251 (259)
T PF07714_consen 199 LTLGKFPFSDYDNEEIIEKLKQGQRLPIPD---------------------------NCPKDIYSLIQQCWSHDPEKRPS 251 (259)
T ss_dssp HTTSSGTTTTSCHHHHHHHHHTTEETTSBT---------------------------TSBHHHHHHHHHHT-SSGGGS--
T ss_pred cccccccccccccccccccccccccceecc---------------------------chhHHHHHHHHHHcCCChhhCcC
Confidence 99 789999888888777776655433221 33455899999999999999999
Q ss_pred HHHHHHHH
Q 001152 1118 AGDLYEMF 1125 (1137)
Q Consensus 1118 a~EVL~~L 1125 (1137)
+.+|++.|
T Consensus 252 ~~~i~~~L 259 (259)
T PF07714_consen 252 FQEILQEL 259 (259)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcC
Confidence 99999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=323.02 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=199.5
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|+||.||+|.+.. ..+|+|... ..... .+. +.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~--~~~~~---~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN--EGAMS---EED----FIEEAKVMMKLSHPKLVQLYGVCTQQK- 72 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecc--cCCcc---HHH----HHHHHHHHHHCCCCCceeEEEEEccCC-
Confidence 3568899999999999999999865 467887643 21111 122 377999999999999999999987655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.++++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 73 -------------~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 73 -------------PLYIVTEFMENGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred -------------CEEEEEEcCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 569999999999999998751 235899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.+......... ......++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~s~G~~l~el~ 195 (256)
T cd05114 136 T-------GVVKVSDFGMTRYVLDDEYT---------SSSGAKFPVKWSPPEVFNF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCCCccccCCCcee---------ccCCCCCchhhCChhhccc----CccchhhhhHHHHHHHHHHH
Confidence 7 78999999988754322111 0112235568999999865 46789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |+.||...+..+....+..+..+..+. ..+..+.+++.+||+.+|++||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p~~Rps~ 248 (256)
T cd05114 196 TEGKMPFEKKSNYEVVEMISRGFRLYRPK---------------------------LASMTVYEVMYSCWHEKPEGRPTF 248 (256)
T ss_pred cCCCCCCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHccCCcccCcCH
Confidence 9 899998887777777776554322111 123458999999999999999999
Q ss_pred HHHHHHH
Q 001152 1119 GDLYEMF 1125 (1137)
Q Consensus 1119 ~EVL~~L 1125 (1137)
+++++.+
T Consensus 249 ~~l~~~l 255 (256)
T cd05114 249 AELLRAI 255 (256)
T ss_pred HHHHHhh
Confidence 9999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=323.82 Aligned_cols=264 Identities=20% Similarity=0.336 Sum_probs=199.4
Q ss_pred ceEeeeecccCceEEEEEEECCc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~~----~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
|.+.++||+|+||.||+|.+... .+|+|..+.. .......+.+ .+|+.+++.++||||+++++++.....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA--ICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQTVE 74 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC--cCCHHHHHHH----HHHHHHHHhCCCCCcceEEEEEccCCc
Confidence 34678999999999999998543 4677764332 2223333444 789999999999999999998754321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~-~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. ......++||||+++|+|.+++.... ......+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 75 ~--------~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 146 (272)
T cd05075 75 S--------EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN 146 (272)
T ss_pred c--------cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc
Confidence 0 01124699999999999999875321 11234589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++........ .......+++.|+|||...+ ..++.++|||||||++|||
T Consensus 147 ~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~~Di~slG~il~el 207 (272)
T cd05075 147 EN-------MNVCVADFGLSKKIYNGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTTKSDVWSFGVTMWEI 207 (272)
T ss_pred CC-------CCEEECCCCcccccCcccce--------ecCCcccCCcccCCHHHccC----CCcChHHHHHHHHHHHHHH
Confidence 77 78999999998765432110 00112246678999999865 5678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++ |+.||.+....+....+..+..+..+. ..++.+.+++.+||+.||++|||
T Consensus 208 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rps 260 (272)
T cd05075 208 ATRGQTPYPGVENSEIYDYLRQGNRLKQPP---------------------------DCLDGLYSLMSSCWLLNPKDRPS 260 (272)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCcccCcC
Confidence 99 899998877776666665543322111 23445899999999999999999
Q ss_pred HHHHHHHHHh
Q 001152 1118 AGDLYEMFVA 1127 (1137)
Q Consensus 1118 a~EVL~~L~~ 1127 (1137)
+.++++++..
T Consensus 261 ~~~l~~~l~~ 270 (272)
T cd05075 261 FETLRCELEK 270 (272)
T ss_pred HHHHHHHHHh
Confidence 9999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=337.84 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=214.4
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.-|.+.+.||+|.|.+|-+|++ .+..|||||. +++..+.-.... +.+|+++|+.++|||||++|++.....
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKvi--DKTKlD~~st~h----lfqEVRCMKLVQHpNiVRLYEViDTQT- 90 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVI--DKTKLDTLSTGH----LFQEVRCMKLVQHPNIVRLYEVIDTQT- 90 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEe--cccccchhhhhH----HHHHHHHHHHhcCcCeeeeeehhcccc-
Confidence 3488999999999999999986 7899999984 444333322223 378999999999999999999987655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
.+|||+|+-++|+|++||-++ ...+.+..+.+++.||+.|+.|+|+..+|||||||+||.+.+
T Consensus 91 -------------KlyLiLELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE 153 (864)
T KOG4717|consen 91 -------------KLYLILELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE 153 (864)
T ss_pred -------------eEEEEEEecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee
Confidence 679999999999999999873 346999999999999999999999999999999999998876
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
.- |.|||.|||++..+.... .....+|+..|-|||++.| ..+..+++||||||||||.|+
T Consensus 154 Kl------GlVKLTDFGFSNkf~PG~-----------kL~TsCGSLAYSAPEILLG---DsYDAPAVDiWSLGVILyMLV 213 (864)
T KOG4717|consen 154 KL------GLVKLTDFGFSNKFQPGK-----------KLTTSCGSLAYSAPEILLG---DSYDAPAVDIWSLGVILYMLV 213 (864)
T ss_pred ec------CceEeeeccccccCCCcc-----------hhhcccchhhccCchhhhc---CccCCcchhhhHHHHHHHHHH
Confidence 52 889999999986554322 1235679999999999997 345679999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
.|++||+..+..+....|....... + ...+.++++||.+||..||.+|.+.+
T Consensus 214 CGq~PFqeANDSETLTmImDCKYtv-P---------------------------shvS~eCrdLI~sMLvRdPkkRAslE 265 (864)
T KOG4717|consen 214 CGQPPFQEANDSETLTMIMDCKYTV-P---------------------------SHVSKECRDLIQSMLVRDPKKRASLE 265 (864)
T ss_pred hCCCccccccchhhhhhhhcccccC-c---------------------------hhhhHHHHHHHHHHHhcCchhhccHH
Confidence 9999999888888888876554321 1 15677799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
||..+.|.+.
T Consensus 266 eI~s~~Wlq~ 275 (864)
T KOG4717|consen 266 EIVSTSWLQA 275 (864)
T ss_pred HHhccccccC
Confidence 9999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=346.00 Aligned_cols=260 Identities=25% Similarity=0.377 Sum_probs=197.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
..+|++.+.||+|+||.||+|++. +..||||+.+.. .. ....+ .+.+|+.+++.+ +|||||++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~--~~-~~~~~----~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS--AH-LTERE----ALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC--cC-cHHHH----HHHHHHHHHHHhcCCcceeeeee
Confidence 347999999999999999999752 246788874322 11 22222 347899999999 7999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------------------------------------
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------- 915 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~------------------------------------- 915 (1137)
++.+.. ..++||||+++|+|.++++....
T Consensus 107 ~~~~~~--------------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (375)
T cd05104 107 ACTVGG--------------PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMK 172 (375)
T ss_pred eeccCC--------------cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcC
Confidence 988765 45999999999999999975211
Q ss_pred ---------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 916 ---------------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 916 ---------------------------------~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
.....+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-- 250 (375)
T cd05104 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-- 250 (375)
T ss_pred CCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC--
Confidence 012357889999999999999999999999999999999999876
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1041 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G 1041 (1137)
..+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |
T Consensus 251 -----~~~kl~DfG~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~sDi~slG~~l~ellt~g 313 (375)
T cd05104 251 -----RITKICDFGLARDIRNDSNY--------VVKGNARLPVKWMAPESIFN----CVYTFESDVWSYGILLWEIFSLG 313 (375)
T ss_pred -----CcEEEecCccceeccCcccc--------cccCCCCCCcceeChhHhcC----CCCCCCCCHHHHHHHHHHHHhcC
Confidence 67999999998755432111 00112235668999999875 568899999999999999998 8
Q ss_pred CCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1042 QVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1042 ~~Pf~~~~~~-el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
..||...... .....+..+..+..+ ...+.++.+|+.+||+.||++||++.|
T Consensus 314 ~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dP~~RPs~~e 366 (375)
T cd05104 314 SSPYPGMPVDSKFYKMIKEGYRMLSP---------------------------ECAPSEMYDIMKSCWDADPLKRPTFKQ 366 (375)
T ss_pred CCCCCCCCchHHHHHHHHhCccCCCC---------------------------CCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999765433 333333333221111 022446999999999999999999999
Q ss_pred HHHHHHh
Q 001152 1121 LYEMFVA 1127 (1137)
Q Consensus 1121 VL~~L~~ 1127 (1137)
|++.++.
T Consensus 367 il~~l~~ 373 (375)
T cd05104 367 IVQLIEQ 373 (375)
T ss_pred HHHHHHh
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=342.50 Aligned_cols=249 Identities=25% Similarity=0.297 Sum_probs=195.1
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHHhCCCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~-iL~~L~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||.||+|++. +..+|+|+...+.... ..... .+.+|.. +++.++||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~----~~~~e~~~~l~~~~hp~iv~~~~~~~~~~------ 69 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQK----HIMAERNVLLKNVKHPFLVGLHYSFQTTE------ 69 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHH----HHHHHHHHHHHhCCCCCCccEEEEEecCC------
Confidence 46999999999999984 5678999864332211 11112 2245554 567799999999999988765
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~---- 132 (325)
T cd05604 70 --------KLYFVLDFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---- 132 (325)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC----
Confidence 67999999999999988865 3468999999999999999999999999999999999999987
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~G~~p 195 (325)
T cd05604 133 ---GHVVLTDFGLCKEGIAQSD----------TTTTFCGTPEYLAPEVIRK----QPYDNTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ---CCEEEeecCCcccCCCCCC----------CcccccCChhhCCHHHHcC----CCCCCcCccccccceehhhhcCCCC
Confidence 7899999999864322111 1123468999999999875 5678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 1120 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa----~E 1120 (1137)
|...+..++...+....... . ...+..+.+++.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 196 FYCRDVAEMYDNILHKPLVL-R---------------------------PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCCHHHHHHHHHcCCccC-C---------------------------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 99877777666654432110 0 0233458899999999999999976 69
Q ss_pred HHHHHHhhc
Q 001152 1121 LYEMFVART 1129 (1137)
Q Consensus 1121 VL~~L~~~~ 1129 (1137)
+++|+|+..
T Consensus 248 i~~h~~f~~ 256 (325)
T cd05604 248 IQEHPFFES 256 (325)
T ss_pred HhcCCCcCC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=346.24 Aligned_cols=277 Identities=23% Similarity=0.270 Sum_probs=197.9
Q ss_pred CCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|.+.. ..+|+|.. .. .. +.+|+.++++++|||||++++++...
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~--~~--------~~----~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAG--QR--------GG----TATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEech--hh--------hh----hHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 34679999999999999999999854 56777642 11 11 26799999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++|||++. ++|..++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 156 ~--------------~~~lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll 215 (391)
T PHA03212 156 K--------------FTCLILPRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI 215 (391)
T ss_pred C--------------eeEEEEecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE
Confidence 5 5699999995 799988865 2458999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 216 ~~~-------~~vkL~DFG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~e 275 (391)
T PHA03212 216 NHP-------GDVCLGDFGAACFPVDINAN---------KYYGWAGTIATNAPELLAR----DPYGPAVDIWSAGIVLFE 275 (391)
T ss_pred cCC-------CCEEEEeCCccccccccccc---------ccccccCccCCCChhhhcC----CCCCcHHHHHHHHHHHHH
Confidence 877 78999999998643221110 1123469999999999875 468899999999999999
Q ss_pred HHhCCCCCCCCC--------HHHHHHHHHc-CCCCC-chhHH-hhhcccccccccc-cCCCCCCch--hhhhhHHHHHHH
Q 001152 1038 LLTLQVPYMGLS--------ELEIHDLIQM-GKRPR-LTDEL-EALGSCHEHEVAQ-SGSGFEKPE--AELETLSFLVDV 1103 (1137)
Q Consensus 1038 LLTG~~Pf~~~~--------~~el~~~I~~-g~~p~-l~~~l-~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~L~dL 1103 (1137)
|++|..||.... ...+...+.. +..+. ++... ............. .......+. .....+.++.+|
T Consensus 276 lltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L 355 (391)
T PHA03212 276 MATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYL 355 (391)
T ss_pred HHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHH
Confidence 999998875421 1122222221 21111 11000 0000000000000 000000110 112456679999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1104 FRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1104 l~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+.+||+.||.+|||++|+++|+|+..-
T Consensus 356 i~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 356 ICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHhcCChhhCCCHHHHhcChhhccC
Confidence 999999999999999999999999763
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=323.73 Aligned_cols=264 Identities=28% Similarity=0.387 Sum_probs=204.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~-~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+|.+...||+|++|.||+|.+. +..+|+|.......... ....+.+...+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 4778899999999999999874 47788887544333222 1222233345688999999999999999999988765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.
T Consensus 80 -------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~ 141 (267)
T cd06628 80 -------------HLNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN 141 (267)
T ss_pred -------------ccEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC
Confidence 45999999999999999976 246889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||.++.......... .........|+..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 142 K-------GGIKISDFGISKKLEANSLSTK----TNGARPSLQGSVFWMAPEVVKQ----TSYTRKADIWSLGCLVVEML 206 (267)
T ss_pred C-------CCEEecccCCCcccccccccCC----ccccccccCCCcCccChhHhcc----CCCCchhhhHHHHHHHHHHh
Confidence 7 7899999999876543211100 0011113357889999999875 45778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|+.||...........+.....+.++. ..+..+.+++.+||+.||.+||++.
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06628 207 TGKHPFPDCTQLQAIFKIGENASPEIPS---------------------------NISSEAIDFLEKTFEIDHNKRPTAA 259 (267)
T ss_pred hCCCCCCCccHHHHHHHHhccCCCcCCc---------------------------ccCHHHHHHHHHHccCCchhCcCHH
Confidence 9999998765544444433322222211 2345689999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
||++|+|+
T Consensus 260 ~il~~~~~ 267 (267)
T cd06628 260 ELLKHPFL 267 (267)
T ss_pred HHhhCCCC
Confidence 99999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=340.53 Aligned_cols=248 Identities=26% Similarity=0.299 Sum_probs=193.3
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHH-HHHHhCCCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEV-RMLGALRHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi-~iL~~L~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
++||+|+||.||+|++. +..+|+|+........ .... ..+.+|+ .+++.++||||+++++++.+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~----~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~------ 69 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQ----NHIMAERNVLLKNLKHPFLVGLHYSFQTAE------ 69 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHH----HHHHHHHHHHHHhCCCCCccceeeEEEcCC------
Confidence 46999999999999984 4678888864322111 1111 2234554 4678899999999999987665
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++++|..++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---- 132 (321)
T cd05603 70 --------KLYFVLDYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---- 132 (321)
T ss_pred --------EEEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 67999999999999988865 3468899999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~p 195 (321)
T cd05603 133 ---GHVVLTDFGLCKEGVEPEE----------TTSTFCGTPEYLAPEVLRK----EPYDRTVDWWCLGAVLYEMLYGLPP 195 (321)
T ss_pred ---CCEEEccCCCCccCCCCCC----------ccccccCCcccCCHHHhcC----CCCCCcCcccccchhhhhhhcCCCC
Confidence 7899999998864322111 1123468999999999875 4678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----HH
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----GD 1120 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa----~E 1120 (1137)
|...+..++...+..... .++. ..+.++.+++.+||+.||.+||++ .+
T Consensus 196 f~~~~~~~~~~~i~~~~~-~~~~---------------------------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (321)
T cd05603 196 FYSRDVSQMYDNILHKPL-QLPG---------------------------GKTVAACDLLVGLLHKDQRRRLGAKADFLE 247 (321)
T ss_pred CCCCCHHHHHHHHhcCCC-CCCC---------------------------CCCHHHHHHHHHHccCCHhhcCCCCCCHHH
Confidence 998777666666544321 1110 233458999999999999999865 59
Q ss_pred HHHHHHhh
Q 001152 1121 LYEMFVAR 1128 (1137)
Q Consensus 1121 VL~~L~~~ 1128 (1137)
+++|+|+.
T Consensus 248 ~~~~~~~~ 255 (321)
T cd05603 248 IKNHVFFS 255 (321)
T ss_pred HhCCCCcC
Confidence 99998875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=327.10 Aligned_cols=261 Identities=21% Similarity=0.359 Sum_probs=201.1
Q ss_pred CCCCceEeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
++.+|++.+.||+|+||+||+|.+. +..+++|.. .... ....... +.+|+.++++++||||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~--~~~~-~~~~~~~----~~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDIN-NPQQWGE----FQQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEec--cCCC-CHHHHHH----HHHHHHHHhhCCCCCeeeEEEE
Confidence 4678999999999999999999852 245666653 3221 1222233 4789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh------------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------TGEKHVSVKLALFIAQDVAAALVELH 941 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~------------~~~~~ls~~~i~~I~~QIa~gL~yLH 941 (1137)
+.... ..|+||||+++++|.+++..... .....+++..+..++.||+.||+|||
T Consensus 76 ~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 141 (283)
T cd05090 76 VTQEQ--------------PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred EecCC--------------ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 87655 45999999999999999864211 01235889999999999999999999
Q ss_pred hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001152 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 942 s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1021 (1137)
++||+||||||+|||++.+ +.+||+|||+++........ .......++..|+|||++.+ ..
T Consensus 142 ~~~i~H~dlkp~nili~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 202 (283)
T cd05090 142 SHFFVHKDLAARNILIGEQ-------LHVKISDLGLSREIYSADYY--------RVQPKSLLPIRWMPPEAIMY----GK 202 (283)
T ss_pred hcCeehhccccceEEEcCC-------CcEEeccccccccccCCcce--------ecccCCCccceecChHHhcc----CC
Confidence 9999999999999999977 67999999998765332111 01112345678999999865 45
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1100 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1100 (1137)
++.++|||||||++|||++ |..||.+.....+...+.....+..+. .+++.+
T Consensus 203 ~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 255 (283)
T cd05090 203 FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSE---------------------------DCPPRM 255 (283)
T ss_pred CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHH
Confidence 7899999999999999998 999998877766666665433222111 234568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001152 1101 VDVFRRCTEENPTERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1101 ~dLl~~CL~~DP~~RPSa~EVL~~L~~ 1127 (1137)
.+++.+||+.||.+||++.+|++++..
T Consensus 256 ~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 256 YSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=327.03 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=203.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
..+|.+.+.||+|+||.||+|.+. ...+|+|+.... .. .+..+ .+.+|+++++.++||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~~-~~~~~----~~~~e~~~l~~l~~~~i~~~~~~ 76 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--AS-NDARK----DFEREAELLTNFQHENIVKFYGV 76 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--CC-HHHHH----HHHHHHHHHHhcCCCCchheeeE
Confidence 456889999999999999999863 246788875322 11 21223 34889999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh---------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE---------TGEKHVSVKLALFIAQDVAAALVELHSKH 944 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~---------~~~~~ls~~~i~~I~~QIa~gL~yLHs~g 944 (1137)
+.... ..++||||+++++|.++++.... .....+++..+..++.||+.||+|||++|
T Consensus 77 ~~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 142 (280)
T cd05049 77 CTEGD--------------PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH 142 (280)
T ss_pred EecCC--------------CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence 88654 56999999999999999976321 12345889999999999999999999999
Q ss_pred eeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCc
Q 001152 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1024 (1137)
Q Consensus 945 IIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1024 (1137)
|+||||||+||+++.+ +.+||+|||.+......... .......+++.|+|||++.+ ..++.
T Consensus 143 i~h~dlkp~nili~~~-------~~~kl~d~g~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~ 203 (280)
T cd05049 143 FVHRDLATRNCLVGYD-------LVVKIGDFGMSRDVYTTDYY--------RVGGHTMLPIRWMPPESIMY----RKFTT 203 (280)
T ss_pred eeccccccceEEEcCC-------CeEEECCcccceecccCcce--------ecCCCCcccceecChhhhcc----CCcch
Confidence 9999999999999987 78999999988654321110 01112346788999999875 56889
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 001152 1025 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1103 (1137)
Q Consensus 1025 ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1103 (1137)
++|||||||++|||++ |..||......+....+..+..+..+. ..+..+.++
T Consensus 204 ~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l 256 (280)
T cd05049 204 ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR---------------------------TCPSEVYDI 256 (280)
T ss_pred hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHH
Confidence 9999999999999998 999998877777777666544322111 234559999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 001152 1104 FRRCTEENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1104 l~~CL~~DP~~RPSa~EVL~~L~ 1126 (1137)
+.+||+.||++||++.||++.+.
T Consensus 257 i~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 257 MLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHcCCCcccCCCHHHHHHHhh
Confidence 99999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=337.28 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=201.0
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 879 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~ 879 (1137)
+|++.+.||+|+||.||+|.+. +..||+|+........ ....+. +..|+.+++.+. |++|+++++++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~----~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVEC----TMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHH----HHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 4778899999999999999985 4678999864332111 112222 367888888886 577888988887665
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..|+||||+++|+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 75 -------------RLYFVMEYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred -------------EEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 57999999999999999875 246999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 137 ~-------~~ikL~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell 195 (323)
T cd05615 137 E-------GHIKIADFGMCKEHMVDGV----------TTRTFCGTPDYIAPEIIAY----QPYGKSVDWWAYGVLLYEML 195 (323)
T ss_pred C-------CCEEEeccccccccCCCCc----------cccCccCCccccCHHHHcC----CCCCCccchhhhHHHHHHHH
Confidence 7 7899999998864322111 1123458999999999875 46789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC--
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-- 1117 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS-- 1117 (1137)
+|..||.+.....+...+...... ++. ..+.++.+++.+||+.||.+|++
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 196 AGQPPFDGEDEDELFQSIMEHNVS-YPK---------------------------SLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCC-CCc---------------------------cCCHHHHHHHHHHcccCHhhCCCCC
Confidence 999999988877777666543321 110 23345899999999999999997
Q ss_pred ---HHHHHHHHHhhc
Q 001152 1118 ---AGDLYEMFVART 1129 (1137)
Q Consensus 1118 ---a~EVL~~L~~~~ 1129 (1137)
.+++.+|+|+..
T Consensus 248 ~~~~~~i~~h~~f~~ 262 (323)
T cd05615 248 PEGERDIREHAFFRR 262 (323)
T ss_pred CCCHHHHhcCcccCC
Confidence 578999998875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=319.62 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=201.3
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|++|.||++.+. +..+++|....+. ......+. +.+|+.++++++||||+++++.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN--ASRRERKA----AEQEAQLLSQLKHPNIVAYRESWEGED-- 72 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh--cCHHHHHH----HHHHHHHHHhCCCCCeeeeeeeecCCC--
Confidence 4899999999999999999974 4567887643322 11222223 377999999999999999998875432
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
...++||||+++++|.+++... ....+++.+++.++.|++.||+|||++||+||||||+||+++.+
T Consensus 73 -----------~~~~lv~e~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~ 138 (257)
T cd08223 73 -----------GLLYIVMGFCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138 (257)
T ss_pred -----------CEEEEEecccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC
Confidence 1469999999999999998752 23468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 139 -------~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08223 139 -------NIIKVGDLGIARVLENQCD----------MASTLIGTPYYMSPELFSN----KPYNYKSDVWALGCCVYEMAT 197 (257)
T ss_pred -------CcEEEecccceEEecccCC----------ccccccCCcCccChhHhcC----CCCCchhhhHHHHHHHHHHHc
Confidence 7899999999875533211 1113458889999999875 467889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||...+.......+..+..+..+. ..++++.+++.+||+.||.+||++.+
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 198 LKHAFNAKDMNSLVYRIIEGKLPPMPK---------------------------DYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCcc---------------------------ccCHHHHHHHHHHhccCcccCCCHHH
Confidence 999998766655555554443322211 33456999999999999999999999
Q ss_pred HHHHHHh
Q 001152 1121 LYEMFVA 1127 (1137)
Q Consensus 1121 VL~~L~~ 1127 (1137)
+++|+|+
T Consensus 251 ~l~~~~~ 257 (257)
T cd08223 251 ILRQPYI 257 (257)
T ss_pred HhcCCCC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=340.38 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=190.9
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||.||+|++. +..+|+|+........ ....+ .+.+|+.++.++ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~------ 69 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-DEDID----WVQTEKHVFEQASNHPFLVGLHSCFQTES------ 69 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-hhHHH----HHHHHHHHHHhcCCCCcCCceeeEEEeCC------
Confidence 46999999999999985 4668888764332111 22222 237788888777 6999999999988765
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++++|..++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~E~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~---- 132 (329)
T cd05618 70 --------RLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---- 132 (329)
T ss_pred --------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC----
Confidence 67999999999999988865 2468999999999999999999999999999999999999987
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kL~DfG~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~P 195 (329)
T cd05618 133 ---GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ---CCEEEeeCCccccccCCCC----------ccccccCCccccCHHHHcC----CCCCCccceecccHHHHHHhhCCCC
Confidence 7899999999864322111 1123468999999999875 5678999999999999999999999
Q ss_pred CCCCCH---------HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1045 YMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1045 f~~~~~---------~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|..... ..+...+.... ..++ ...+..+.+++.+||+.||++|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~i~~~~-~~~p---------------------------~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 196 FDIVGSSDNPDQNTEDYLFQVILEKQ-IRIP---------------------------RSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred CccCCCcCCcccccHHHHHHHHhcCC-CCCC---------------------------CCCCHHHHHHHHHHhcCCHHHc
Confidence 953110 11111121111 1111 1334558899999999999999
Q ss_pred CC------HHHHHHHHHhhc
Q 001152 1116 PT------AGDLYEMFVART 1129 (1137)
Q Consensus 1116 PS------a~EVL~~L~~~~ 1129 (1137)
|+ ++++++|+|+..
T Consensus 248 ~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 248 LGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CCCCCCCCHHHHhcCCCCCC
Confidence 98 589999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=322.00 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=201.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|++.+.||+|++|.||+|... +..+++|+....... .....+ ...+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~--~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS--PETKKE-VNALECEIQLLKNLQHERIVQYYGCLRDDE- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc--hhhHHH-HHHHHHHHHHHHhCCCCCeeeeEEEEccCC-
Confidence 35889999999999999999874 577888875433211 111111 123588999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+||||+|+||+++.
T Consensus 78 -------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~ 139 (263)
T cd06625 78 -------------TLSIFMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS 139 (263)
T ss_pred -------------eEEEEEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 67999999999999999876 235889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||.+.......... .......++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 140 ~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~el~ 201 (263)
T cd06625 140 A-------GNVKLGDFGASKRLQTICSSG-------TGMKSVTGTPYWMSPEVISG----EGYGRKADVWSVGCTVVEML 201 (263)
T ss_pred C-------CCEEEeecccceecccccccc-------ccccCCCcCccccCcceecc----CCCCchhhhHHHHHHHHHHH
Confidence 7 789999999987543221110 00112357889999999875 45789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+|+.||...........+.... .+.++ ...+..+.+++.+||..+|.+|||+
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (263)
T cd06625 202 TEKPPWAEFEAMAAIFKIATQPTNPQLP---------------------------SHVSPDARNFLRRTFVENAKKRPSA 254 (263)
T ss_pred hCCCCccccchHHHHHHHhccCCCCCCC---------------------------ccCCHHHHHHHHHHhhcCcccCCCH
Confidence 9999998765554443332221 11111 1344568999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
.++++|+|+
T Consensus 255 ~~ll~~~~~ 263 (263)
T cd06625 255 EELLRHFFV 263 (263)
T ss_pred HHHhhCCCC
Confidence 999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.27 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=213.1
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
|.++.+||+|+||.||+|.++....+|+|+++.+. .+.+++ .+||.||+++..|+||++||.|....
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEI----IKEISIMQQC~S~yVVKYYGSYFK~s----- 101 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEI----IKEISIMQQCKSKYVVKYYGSYFKHS----- 101 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHH----HHHHHHHHHcCCchhhhhhhhhccCC-----
Confidence 77889999999999999998776666666555542 334454 88999999999999999999987654
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
.+|||||||-.||+.+.++. .++++++.++..+++..++||+|||...-||||||+.|||++-+
T Consensus 102 ---------DLWIVMEYCGAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~--- 165 (502)
T KOG0574|consen 102 ---------DLWIVMEYCGAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD--- 165 (502)
T ss_pred ---------ceEeehhhcCCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc---
Confidence 67999999999999999976 24689999999999999999999999999999999999999988
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1043 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~ 1043 (1137)
|..||+|||.|..+.... ...+...|||.|||||++.. -.|+.++||||||++..||..|++
T Consensus 166 ----G~AKLADFGVAGQLTDTM----------AKRNTVIGTPFWMAPEVI~E----IGY~~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 166 ----GIAKLADFGVAGQLTDTM----------AKRNTVIGTPFWMAPEVIEE----IGYDTKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred ----chhhhhhccccchhhhhH----------HhhCccccCcccccHHHHHH----hccchhhhHhhhcchhhhhhcCCC
Confidence 899999999997665432 23346789999999999986 568899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001152 1044 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123 (1137)
Q Consensus 1044 Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~ 1123 (1137)
||....++.....|-...+|.+. .| ...+.++.+++++||.+.|++|-||.++++
T Consensus 228 PYsDIHPMRAIFMIPT~PPPTF~----------------------KP---E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 228 PYSDIHPMRAIFMIPTKPPPTFK----------------------KP---EEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CcccccccceeEeccCCCCCCCC----------------------Ch---HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 99987776554444333222221 11 145667999999999999999999999999
Q ss_pred HHHhhcCCC
Q 001152 1124 MFVARTSSS 1132 (1137)
Q Consensus 1124 ~L~~~~~ss 1132 (1137)
|+|.+....
T Consensus 283 H~FiknA~g 291 (502)
T KOG0574|consen 283 HTFIKNAPG 291 (502)
T ss_pred hhhhcCCCc
Confidence 999987654
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=365.82 Aligned_cols=273 Identities=21% Similarity=0.332 Sum_probs=206.4
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...+.+|++.+.||+|+||+||+|++.. ..+|+|+.... ......... +.+|+.++++++|||||+++++|.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~--~l~e~~~~~----~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR--GLKEREKSQ----LVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecc--ccCHHHHHH----HHHHHHHHHHcCCCCcCeEEEEEE
Confidence 4456889999999999999999999854 55777764432 222233333 488999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-------Ceeec
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-------HIMHR 948 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-------gIIHr 948 (1137)
.... ..+||||||+++++|.++|...... ...+++..++.|+.||+.||+|||+. +||||
T Consensus 83 de~~------------~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHR 149 (1021)
T PTZ00266 83 NKAN------------QKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHR 149 (1021)
T ss_pred ecCC------------CEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceec
Confidence 5431 1579999999999999999764332 24699999999999999999999984 49999
Q ss_pred cCCCCCeEeccccc----------cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001152 949 DIKSENILIDLERK----------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1018 (1137)
Q Consensus 949 DLKP~NILld~~~~----------~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1018 (1137)
||||+||||+.+.. .....+.+||+|||++........ .....||+.|+|||++.+ .
T Consensus 150 DLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-----------~~s~vGTp~YmAPEvL~g--e 216 (1021)
T PTZ00266 150 DLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-----------AHSCVGTPYYWSPELLLH--E 216 (1021)
T ss_pred cCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc-----------ccccCCCccccCHHHHhc--c
Confidence 99999999975311 012235699999999875432211 123469999999999865 2
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001152 1019 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1097 (1137)
Q Consensus 1019 ~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~-el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1137)
...++.++|||||||+||+|++|..||...... ++...+..... ++. ...+
T Consensus 217 ~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~--lpi--------------------------~~~S 268 (1021)
T PTZ00266 217 TKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPD--LPI--------------------------KGKS 268 (1021)
T ss_pred CCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCC--CCc--------------------------CCCC
Confidence 245789999999999999999999999765433 33333332211 100 0234
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1098 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1098 ~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
.++.+||..||+.+|.+||++.|++.|+|+...
T Consensus 269 ~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 269 KELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 568999999999999999999999999999743
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=335.05 Aligned_cols=289 Identities=20% Similarity=0.257 Sum_probs=200.2
Q ss_pred Eeeeeccc--CceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 806 SCDEAGKS--VSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 806 l~~~LG~G--sfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
+.++||+| +||+||++.+. +..||+|+...+. ......+ .+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~----~~~~e~~~l~~l~hpniv~~~~~~~~~~--- 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA--CTNEMVT----FLQGELHVSKLFNHPNIVPYRATFIADN--- 72 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh--ccHHHHH----HHHHHHHHHHhcCCCCeeeEEEEEEECC---
Confidence 56789999 77899999985 4667777643322 2222222 3477999999999999999999998765
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
..++||||+++++|.+++.... ...+++..++.|+.||+.||+|||+++|+||||||+|||++.+
T Consensus 73 -----------~~~lv~e~~~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~- 137 (327)
T cd08227 73 -----------ELWVVTSFMAYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD- 137 (327)
T ss_pred -----------EEEEEEeccCCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-
Confidence 6799999999999999986521 2358999999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.++++||+.+.............. .......++..|+|||++.+ ....++.++|||||||++|||++|
T Consensus 138 ------~~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 138 ------GKVYLSGLRSNLSMINHGQRLRVVH---DFPKYSVKVLPWLSPEVLQQ--NLQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred ------CcEEEcccchhhccccccccccccc---cccccccceecccChHHhhc--ccCCCCchhhHHHHHHHHHHHHHC
Confidence 6799999986543322111000000 01122357778999999875 224578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhH-------Hhhhc--ccccccccc------cCCC---CCCchhhhhhHHHHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDE-------LEALG--SCHEHEVAQ------SGSG---FEKPEAELETLSFLVDV 1103 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~-------l~~~~--~~~~~~~~~------~~~~---~~~~~~~~~~~~~L~dL 1103 (1137)
+.||......+.......+..+..... +.... ......... .... ..........++++.++
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (327)
T cd08227 207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286 (327)
T ss_pred CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHH
Confidence 999987655544433333332211100 00000 000000000 0000 00000112446779999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1104 FRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1104 l~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+.+||+.||++|||++|+++|+|++.
T Consensus 287 i~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 287 VEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred HHHHHhhCchhcCCHHHHhcChhhhh
Confidence 99999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=324.22 Aligned_cols=264 Identities=22% Similarity=0.383 Sum_probs=199.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...|++.+.||+|+||.||+|.+.. ..+.++++....... ...... +.+|+.+++.++|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~ 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESD----FLMEALIMSKFNHQNIVRLIGVSF 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHH----HHHHHHHHHhCCCCCEeeEEEEEc
Confidence 4568999999999999999999855 444444443333222 222223 478999999999999999999887
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~--~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+.. ..++||||+++++|.+++...... ....+++..+..++.||+.||+|||+++++||||||+
T Consensus 80 ~~~--------------~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~ 145 (277)
T cd05036 80 ERL--------------PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAAR 145 (277)
T ss_pred cCC--------------CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchh
Confidence 655 459999999999999999764211 1235899999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
||+++.+. ....+||+|||+++........ ........+..|+|||++.+ ..++.++|||||||
T Consensus 146 nil~~~~~----~~~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~ 209 (277)
T cd05036 146 NCLLTCKG----PGRVAKIADFGMARDIYRASYY--------RKGGRAMLPIKWMPPEAFLD----GIFTSKTDVWSFGV 209 (277)
T ss_pred eEEEeccC----CCcceEeccCccccccCCccce--------ecCCCCCccHhhCCHHHHhc----CCcCchhHHHHHHH
Confidence 99998652 1146999999998765321110 00011224568999999875 46889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1034 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1034 iL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
++|||++ |..||.+....++...+.....+..+ ...+..+.+++.+||+.+|
T Consensus 210 il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~cl~~~p 262 (277)
T cd05036 210 LLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP---------------------------KGCPGPVYRIMTDCWQHTP 262 (277)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCCc
Confidence 9999997 99999887766666555443222111 1334568999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 001152 1113 TERPTAGDLYEMFV 1126 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~ 1126 (1137)
++||++.+|++++.
T Consensus 263 ~~Rps~~~vl~~l~ 276 (277)
T cd05036 263 EDRPNFATILERIQ 276 (277)
T ss_pred ccCcCHHHHHHHhh
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=332.86 Aligned_cols=284 Identities=21% Similarity=0.262 Sum_probs=190.5
Q ss_pred eeeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 807 CDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
.++||+|+||+||+|++. +..+|+|+.. ..... . .+.+|+.++++++||||+++++++.....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~--~~~~~----~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE--GTGIS----M----SACREIALLRELKHPNVISLQKVFLSHAD--- 72 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEEC--CCCCc----H----HHHHHHHHHHhcCCCCCcceeeeEecCCC---
Confidence 368999999999999864 2457777643 22111 1 13679999999999999999998865331
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~----~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
...++||||+. ++|.+++...... ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 73 ---------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~ 142 (317)
T cd07868 73 ---------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred ---------cEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEe
Confidence 16799999996 7898887642211 123589999999999999999999999999999999999996
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ ....+.+||+|||+++........ ........||+.|+|||++.+ ...++.++||||+||++|+|
T Consensus 143 ~~---~~~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 209 (317)
T cd07868 143 GE---GPERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cC---CCCcCcEEEeecCceeccCCCCcc-------ccccCCccccccccCCHHHcC---CCCcCchhhHHHHHHHHHHH
Confidence 43 122368999999999765432111 011123568999999999875 24578999999999999999
Q ss_pred HhCCCCCCCCCH---------HHHHHHHHc-CCCCCchhHHhhhccccccc--cccc-CCCCC-------CchhhhhhHH
Q 001152 1039 LTLQVPYMGLSE---------LEIHDLIQM-GKRPRLTDELEALGSCHEHE--VAQS-GSGFE-------KPEAELETLS 1098 (1137)
Q Consensus 1039 LTG~~Pf~~~~~---------~el~~~I~~-g~~p~l~~~l~~~~~~~~~~--~~~~-~~~~~-------~~~~~~~~~~ 1098 (1137)
++|+.||..... .+....+.. ...+. ...+.......... .... ..... ..........
T Consensus 210 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (317)
T cd07868 210 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA-DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 288 (317)
T ss_pred HhCCCCccCCcccccccccccHHHHHHHHHhcCCCC-hHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCCh
Confidence 999999965322 112222211 11111 11111100000000 0000 00000 0000112234
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001152 1099 FLVDVFRRCTEENPTERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1099 ~L~dLl~~CL~~DP~~RPSa~EVL~~L~~ 1127 (1137)
.+.+|+.+||+.||.+|||++|+++|+|+
T Consensus 289 ~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 289 KAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 58899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=331.19 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=200.2
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeE
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 874 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~ 874 (1137)
...+++|++.+.||+|+||.||+|.+.. ..++++++..+... .....+. +.+|+.++.++ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~----~~~Ei~~l~~l~~h~~iv~~~~~~ 77 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRD----FAGELEVLCKLGHHPNIINLLGAC 77 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHH----HHHHHHHHHHhcCCCCcceEEEEE
Confidence 3467889999999999999999999743 34544544333221 1222233 47899999999 799999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSK 943 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-----------~~~~~ls~~~i~~I~~QIa~gL~yLHs~ 943 (1137)
...+ ..++||||+++++|.++++.... .....+++..++.++.||+.||+|||++
T Consensus 78 ~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 143 (303)
T cd05088 78 EHRG--------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 143 (303)
T ss_pred CCCC--------------CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 7665 45999999999999999975321 1123589999999999999999999999
Q ss_pred CeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCC
Q 001152 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1023 (1137)
Q Consensus 944 gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s 1023 (1137)
||+||||||+|||++.+ +.+||+|||++........ .....++..|+|||++.+ ..++
T Consensus 144 gi~H~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~ 201 (303)
T cd05088 144 QFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYT 201 (303)
T ss_pred CccccccchheEEecCC-------CcEEeCccccCcccchhhh-----------cccCCCcccccCHHHHhc----cCCc
Confidence 99999999999999877 7899999998853221100 011234567999998865 4578
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHH
Q 001152 1024 LEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 1102 (1137)
Q Consensus 1024 ~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~d 1102 (1137)
.++|||||||++|||+| |..||......+....+..+..+..+ ...++++.+
T Consensus 202 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~ 254 (303)
T cd05088 202 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYD 254 (303)
T ss_pred ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCC---------------------------CCCCHHHHH
Confidence 99999999999999998 99999877666655554332211110 023445899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1103 VFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1103 Ll~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
++.+||+.+|++||++++++.++...
T Consensus 255 li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 255 LMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=321.56 Aligned_cols=255 Identities=22% Similarity=0.378 Sum_probs=201.8
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
...+|++.++||+|+||.||+|.+.+ ..+|+|..... ....+. +.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-----~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-----TMSVQA----FLEEANLMKTLQHDKLVRLYAVVTKEE 74 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-----chhHHH----HHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45679999999999999999998754 56788764321 112233 378999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.++++.. ....+++..+..++.||+.||+|||+.+++||||||+||+++
T Consensus 75 --------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~ 137 (261)
T cd05072 75 --------------PIYIITEYMAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS 137 (261)
T ss_pred --------------CcEEEEecCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec
Confidence 459999999999999998752 234688999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.++|+|||.+......... ......++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 197 (261)
T cd05072 138 ES-------LMCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLYEI 197 (261)
T ss_pred CC-------CcEEECCCccceecCCCcee---------ccCCCccceecCCHHHhcc----CCCChhhhhhhhHHHHHHH
Confidence 77 78999999998765432111 0112235678999999865 4578899999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++ |..||......+....+..+...... ...+.++.+++.+||+.+|++||+
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~ 250 (261)
T cd05072 198 VTYGKIPYPGMSNSDVMSALQRGYRMPRM---------------------------ENCPDELYDIMKTCWKEKAEERPT 250 (261)
T ss_pred HccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccCcC
Confidence 98 99999887776666666543321110 023456899999999999999999
Q ss_pred HHHHHHHHHh
Q 001152 1118 AGDLYEMFVA 1127 (1137)
Q Consensus 1118 a~EVL~~L~~ 1127 (1137)
++++++.+..
T Consensus 251 ~~~i~~~l~~ 260 (261)
T cd05072 251 FDYLQSVLDD 260 (261)
T ss_pred HHHHHHHHhc
Confidence 9999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=325.26 Aligned_cols=258 Identities=21% Similarity=0.360 Sum_probs=199.0
Q ss_pred CCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
.+|++.+.||+|+||.||+|.+.+ ..+|+|+.. ... ......+ +.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~--~~~-~~~~~~~----~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAA-SMRERIE----FLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecc--ccC-CHHHHHH----HHHHHHHHHhCCCCCeeeEEEEE
Confidence 468999999999999999998642 357777632 211 1222223 47899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG-----EKHVSVKLALFIAQDVAAALVELHSKHIMHRD 949 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~-----~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrD 949 (1137)
.+.. ..++||||+++++|.++++...... ...+++..+..++.|++.||+|||+.|++|||
T Consensus 79 ~~~~--------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~d 144 (277)
T cd05062 79 SQGQ--------------PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRD 144 (277)
T ss_pred cCCC--------------CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 7654 5699999999999999997632210 23467889999999999999999999999999
Q ss_pred CCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHH
Q 001152 950 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029 (1137)
Q Consensus 950 LKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVW 1029 (1137)
|||+||+++.+ +.++|+|||++.......... ......+++.|+|||++.+ ..++.++|||
T Consensus 145 lkp~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~ 205 (277)
T cd05062 145 LAARNCMVAED-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSDVW 205 (277)
T ss_pred cchheEEEcCC-------CCEEECCCCCccccCCcceee--------cCCCCccCHhhcChhHhhc----CCcCchhHHH
Confidence 99999999977 789999999886543221110 0012245778999999875 4678999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001152 1030 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1108 (1137)
Q Consensus 1030 SLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL 1108 (1137)
||||++|||++ |..||.+....+....+.....+..+. .+++.+.+++.+||
T Consensus 206 slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l 258 (277)
T cd05062 206 SFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD---------------------------NCPDMLFELMRMCW 258 (277)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHHHHc
Confidence 99999999999 789998877776666554433222111 23456899999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 001152 1109 EENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1109 ~~DP~~RPSa~EVL~~L~ 1126 (1137)
+.||++|||+.|+++++.
T Consensus 259 ~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 259 QYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCChhhCcCHHHHHHHhh
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=352.07 Aligned_cols=284 Identities=20% Similarity=0.214 Sum_probs=197.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC------CCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~------HpNIVkllg 872 (1137)
-.+|++.++||+|+||+||+|.+. +..||||+.+... ...+. +..|+.+++.++ |++|+++++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~----~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRD----AKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHH----HHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 367999999999999999999874 4678888753211 11111 244666666664 456888888
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIK 951 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLK 951 (1137)
++.... .+.++|||++ +++|.+++.+ ...+++..+..|+.||+.||+|||+ .||||||||
T Consensus 199 ~~~~~~-------------~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlK 259 (467)
T PTZ00284 199 YFQNET-------------GHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259 (467)
T ss_pred EEEcCC-------------ceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence 887543 1679999998 6899998875 2469999999999999999999998 599999999
Q ss_pred CCCeEecccccc---------CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCC
Q 001152 952 SENILIDLERKK---------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022 (1137)
Q Consensus 952 P~NILld~~~~~---------~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1022 (1137)
|+|||++.++.. ....+.+||+|||.+..... .....+||+.|+|||++.+ ..+
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-------------~~~~~~gt~~Y~APE~~~~----~~~ 322 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-------------SRTAIVSTRHYRSPEVVLG----LGW 322 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-------------ccccccCCccccCcHHhhc----CCC
Confidence 999999865210 00123599999998753221 1124579999999999976 568
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc-c-ccc---ccCCCC----------
Q 001152 1023 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-H-EVA---QSGSGF---------- 1087 (1137)
Q Consensus 1023 s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~-~-~~~---~~~~~~---------- 1087 (1137)
+.++|||||||++|||++|+.||.+.+..+....+...... ++..+.......+ . .+. ......
T Consensus 323 ~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (467)
T PTZ00284 323 MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR-LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR 401 (467)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC-CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhc
Confidence 89999999999999999999999987776665555332211 1111110000000 0 000 000000
Q ss_pred CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1088 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1088 ~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
..........+.+.+||.+||++||.+|||++|+++|+|+..-
T Consensus 402 ~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 402 ARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred ccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 0001111234568899999999999999999999999999863
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=331.51 Aligned_cols=258 Identities=19% Similarity=0.313 Sum_probs=199.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC--Cc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~----~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
..+|++.+.||+|+||.||+|.+. +. .+|+|+.. .. ......++ +.+|+.+++.++||||+++++++
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~--~~-~~~~~~~~----~~~e~~~l~~l~h~niv~~~g~~ 78 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EA-TSPKANKE----ILDEAYVMASVDNPHVCRLLGIC 78 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecc--cc-CCHHHHHH----HHHHHHHHHhCCCCCCCeEEEEE
Confidence 457899999999999999999873 22 26777643 21 11222233 47899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
... ..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 79 ~~~---------------~~~~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~N 139 (316)
T cd05108 79 LTS---------------TVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARN 139 (316)
T ss_pred cCC---------------CceeeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence 753 237999999999999998762 2458899999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||+
T Consensus 140 ill~~~-------~~~kl~DfG~a~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slGv~ 200 (316)
T cd05108 140 VLVKTP-------QHVKITDFGLAKLLGADEKEY--------HAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVT 200 (316)
T ss_pred eEecCC-------CcEEEccccccccccCCCcce--------eccCCccceeecChHHhcc----CCCCchhhhHHHHHH
Confidence 999877 779999999997654322110 0011234668999999875 567899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|||++ |..||.+....++...+..+.....+. .++.++.+++.+||+.||.
T Consensus 201 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~ 253 (316)
T cd05108 201 VWELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMVKCWMIDAD 253 (316)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHccCChh
Confidence 999998 999998877666555444433221110 2334588999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001152 1114 ERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~ 1130 (1137)
+||++.+++.++.....
T Consensus 254 ~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 254 SRPKFRELIIEFSKMAR 270 (316)
T ss_pred hCcCHHHHHHHHHHHHc
Confidence 99999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=320.19 Aligned_cols=247 Identities=22% Similarity=0.337 Sum_probs=194.5
Q ss_pred eecccCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCC
Q 001152 809 EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 809 ~LG~GsfG~Vy~a~~----~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+||+|+||.||+|.+ .+..+|+|+.+.. .......+. +.+|+.+++.+.||||+++++++..+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~------- 68 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDE----LLREANVMQQLDNPYIVRMIGICEAE------- 68 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC--CCcHHHHHH----HHHHHHHHHhCCCCCcceEEEEEcCC-------
Confidence 689999999999976 2466888874322 222222333 48899999999999999999987533
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 69 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~---- 131 (257)
T cd05116 69 --------SWMLVMELAELGPLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ---- 131 (257)
T ss_pred --------CcEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC----
Confidence 34899999999999999865 2468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 1043 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~ 1043 (1137)
+.+||+|||++.......... .......++..|+|||.+.. ..++.++|||||||++|||++ |..
T Consensus 132 ---~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~t~g~~ 197 (257)
T cd05116 132 ---HYAKISDFGLSKALGADENYY-------KAKTHGKWPVKWYAPECMNY----YKFSSKSDVWSFGVLMWEAFSYGQK 197 (257)
T ss_pred ---CeEEECCCccccccCCCCCee-------eecCCCCCCccccCHhHhcc----CCcCchhHHHHHHHHHHHHHhCCCC
Confidence 789999999987654322110 00112234578999998864 457789999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001152 1044 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123 (1137)
Q Consensus 1044 Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~ 1123 (1137)
||......++...+..+..+..+. .+++++.+++.+||+.||++||++++|.+
T Consensus 198 p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 198 PYKGMKGNEVTQMIESGERMECPQ---------------------------RCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 998877777777776554332221 34456999999999999999999999998
Q ss_pred HHH
Q 001152 1124 MFV 1126 (1137)
Q Consensus 1124 ~L~ 1126 (1137)
.|.
T Consensus 251 ~l~ 253 (257)
T cd05116 251 RLR 253 (257)
T ss_pred HHh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.79 Aligned_cols=258 Identities=32% Similarity=0.445 Sum_probs=198.9
Q ss_pred ceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|++.+.||+|+||+||+|+..+. .+|+|+..... ....... ...+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~----~~~~e~~~~~~l~~~~i~~~~~~~~~~~--- 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE--IEEEERE----ENIREIKILRRLRHPNIVQILDVFQDDN--- 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT--HHHHHHH----HHHHHHHHHHHHTBTTBCHEEEEEEESS---
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc--ccccccc----hhhhhhhccccccccccccccccccccc---
Confidence 78999999999999999999654 58888854332 1111111 2255999999999999999999998765
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+|+||||+||+++.+
T Consensus 72 -----------~~~~v~~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~- 134 (260)
T PF00069_consen 72 -----------YLYIVMEYCPGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN- 134 (260)
T ss_dssp -----------EEEEEEEEETTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-
T ss_pred -----------cccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccc-
Confidence 67999999998899999983 2468999999999999999999999999999999999999977
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.++|+|||.+........ ......++..|+|||++.. ...++.++||||+|+++|+|++|
T Consensus 135 ------~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~~ 195 (260)
T PF00069_consen 135 ------GEVKLIDFGSSVKLSENNE----------NFNPFVGTPEYMAPEVLQQ---GKKYTRKSDIWSLGIILYELLTG 195 (260)
T ss_dssp ------SEEEESSGTTTEESTSTTS----------EBSSSSSSGGGSCHHHHTT---TSSBSTHHHHHHHHHHHHHHHHS
T ss_pred ------ccccccccccccccccccc----------ccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 7899999999875311111 1123468899999999871 25678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
..||......+....+.............. .....+.+.+++.+||+.||++||++.++
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 196 KLPFEESNSDDQLEIIEKILKRPLPSSSQQ---------------------SREKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp SSSSTTSSHHHHHHHHHHHHHTHHHHHTTS---------------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred ccccccccchhhhhhhhhcccccccccccc---------------------cchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 999987643333333322111111100000 00123679999999999999999999999
Q ss_pred HHHHHh
Q 001152 1122 YEMFVA 1127 (1137)
Q Consensus 1122 L~~L~~ 1127 (1137)
++|+|+
T Consensus 255 ~~~~~~ 260 (260)
T PF00069_consen 255 LKHPWF 260 (260)
T ss_dssp HTSGGG
T ss_pred hcCCCC
Confidence 999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=326.92 Aligned_cols=265 Identities=23% Similarity=0.374 Sum_probs=204.8
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
+..+|.+.+.||+|+||.||+|.+.. ..+++|. .... .....+. +.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~--~~~~--~~~~~~~----~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA--LKDP--TLAARKD----FQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEe--cCCc--cHHHHHH----HHHHHHHHhcCCCCCcceEEE
Confidence 35678999999999999999998532 2355554 3221 1222223 478999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELH 941 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-----------~~~~~ls~~~i~~I~~QIa~gL~yLH 941 (1137)
++.... ..++||||+++++|.+++..... .....+++..++.++.||+.||+|||
T Consensus 75 ~~~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 75 VCGDGD--------------PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred EEccCC--------------ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 987655 56999999999999999975321 11235899999999999999999999
Q ss_pred hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001152 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 942 s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1021 (1137)
++||+||||||+|||++.+ +.++|+|||++......... .......++..|+|||++.+ ..
T Consensus 141 ~~~i~H~dlkp~Nil~~~~-------~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 201 (291)
T cd05094 141 SQHFVHRDLATRNCLVGAN-------LLVKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMY----RK 201 (291)
T ss_pred hCCeeecccCcceEEEccC-------CcEEECCCCcccccCCCcee--------ecCCCCCcceeecChHHhcc----CC
Confidence 9999999999999999987 78999999998754332111 01113346789999999875 46
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1100 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1100 (1137)
++.++|||||||++|||++ |..||......+....+..+..+..+. ..+..+
T Consensus 202 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 254 (291)
T cd05094 202 FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPR---------------------------VCPKEV 254 (291)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCc---------------------------cCCHHH
Confidence 7889999999999999999 999998877766666655443322111 234558
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 001152 1101 VDVFRRCTEENPTERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1101 ~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ss 1132 (1137)
.+++.+||+.||.+||++.+|++.+.....+.
T Consensus 255 ~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 255 YDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred HHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 99999999999999999999999998875543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=343.87 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=196.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
..+|++.+.||+|+||.||+|.+.. ..||+|+..... ..+..+ .+.+|+.+++.+ +|||||++++
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~----~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDERE----ALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHH----HHHHHHHHHHhhccCCceeeEee
Confidence 4579999999999999999998621 357887743221 122223 347899999999 7999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------------------------------------
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------- 915 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~------------------------------------- 915 (1137)
++.... ..++||||+++|+|.++++....
T Consensus 110 ~~~~~~--------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (374)
T cd05106 110 ACTHGG--------------PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSS 175 (374)
T ss_pred EecCCC--------------CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccc
Confidence 988665 56999999999999999865321
Q ss_pred ----------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCC
Q 001152 916 ----------------------------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 967 (1137)
Q Consensus 916 ----------------------------~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~ 967 (1137)
.....+++..+++|+.||+.||+|||++||+||||||+|||++.+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~------- 248 (374)
T cd05106 176 QGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG------- 248 (374)
T ss_pred cccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-------
Confidence 011357889999999999999999999999999999999999877
Q ss_pred CeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 001152 968 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYM 1046 (1137)
Q Consensus 968 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf~ 1046 (1137)
+.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.
T Consensus 249 ~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlGvil~ellt~G~~Pf~ 316 (374)
T cd05106 249 RVAKICDFGLARDIMNDSNY--------VVKGNARLPVKWMAPESIFD----CVYTVQSDVWSYGILLWEIFSLGKSPYP 316 (374)
T ss_pred CeEEEeeceeeeeccCCcce--------eeccCCCCccceeCHHHhcC----CCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 78999999998754332110 00112235668999999865 568899999999999999997 999997
Q ss_pred CCCHHHHHHH-HHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001152 1047 GLSELEIHDL-IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125 (1137)
Q Consensus 1047 ~~~~~el~~~-I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L 1125 (1137)
.......... +..+..+..+ ...++++.+++.+||+.||.+|||+.+|++.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 317 GILVNSKFYKMVKRGYQMSRP---------------------------DFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred cccccHHHHHHHHcccCccCC---------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 6543332222 2221111110 02345699999999999999999999999998
Q ss_pred Hhh
Q 001152 1126 VAR 1128 (1137)
Q Consensus 1126 ~~~ 1128 (1137)
...
T Consensus 370 ~~~ 372 (374)
T cd05106 370 QRQ 372 (374)
T ss_pred HHH
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=321.21 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=201.5
Q ss_pred CCCceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..+|++.+.||+|+||+||+|.+.. ..+|+|+.. ... ....... +.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~--~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK--AGS-SDKQRLD----FLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcC--CCC-ChHHHHH----HHHHHHHHHhCCCCCcceEeEEEe
Confidence 3568999999999999999999842 356777542 221 1222223 478999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
... ..++||||+++++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 76 ~~~--------------~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 76 KSR--------------PVMIITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred cCC--------------ceEEEEEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 655 469999999999999998752 23689999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.++|+|||++.......... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 138 li~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Dv~slG~~l 198 (266)
T cd05033 138 LVNSN-------LVCKVSDFGLSRRLEDSEATY--------TTKGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVM 198 (266)
T ss_pred EEcCC-------CCEEECccchhhcccccccce--------eccCCCCCccccChhhhcc----CCCccccchHHHHHHH
Confidence 99987 789999999998664211110 0011235678999999875 4678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+|++ |..||......++...+..+.....+ ..+++.+.+++.+||+.+|++
T Consensus 199 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~cl~~~p~~ 251 (266)
T cd05033 199 WEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP---------------------------MDCPSALYQLMLDCWQKDRNE 251 (266)
T ss_pred HHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCccc
Confidence 99998 99999877777776666544322111 033456899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001152 1115 RPTAGDLYEMFVA 1127 (1137)
Q Consensus 1115 RPSa~EVL~~L~~ 1127 (1137)
||++.||++++..
T Consensus 252 Rp~~~ei~~~l~~ 264 (266)
T cd05033 252 RPTFSQIVSTLDK 264 (266)
T ss_pred CcCHHHHHHHHHh
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.40 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=200.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||++.+. +..+++|.+..... ....+. +.+|+.+++.++||||+++++.+.+.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS---SSAVED----SRKEAVLLAKMKHPNIVAFKESFEADG-- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc---hHHHHH----HHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 5889999999999999999984 46678887543321 222233 377999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++.. .....+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 72 ------------~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~ 136 (255)
T cd08219 72 ------------HLYIVMEYCDGGDLMQKIKL---QRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136 (255)
T ss_pred ------------EEEEEEeeCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence 67999999999999998865 223468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+......... .....+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~i~~~l~~ 195 (255)
T cd08219 137 -------GKVKLGDFGSARLLTSPGAY----------ACTYVGTPYYVPPEIWEN----MPYNNKSDIWSLGCILYELCT 195 (255)
T ss_pred -------CcEEEcccCcceeecccccc----------cccccCCccccCHHHHcc----CCcCchhhhhhhchhheehhh
Confidence 78999999988654332111 113468889999999875 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||...+.......+..+....++. ..+..+.+++.+||+.||++||++.+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 196 LKHPFQANSWKNLILKVCQGSYKPLPS---------------------------HYSYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred ccCCCCCCCHHHHHHHHhcCCCCCCCc---------------------------ccCHHHHHHHHHHHhCCcccCCCHHH
Confidence 999998877666665555444332221 23345899999999999999999999
Q ss_pred HHHH
Q 001152 1121 LYEM 1124 (1137)
Q Consensus 1121 VL~~ 1124 (1137)
++..
T Consensus 249 il~~ 252 (255)
T cd08219 249 ILSR 252 (255)
T ss_pred Hhhc
Confidence 9864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.86 Aligned_cols=254 Identities=22% Similarity=0.397 Sum_probs=201.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||.||+|.+. +..+++|+.. .. ....+. +.+|+++++.++||||+++++++..+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~--~~---~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--ED---TMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEec--CC---chHHHH----HHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 456889999999999999999985 4667787643 21 122233 378999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++.. .....+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 76 --------------~~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~ 138 (263)
T cd05052 76 --------------PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138 (263)
T ss_pred --------------CcEEEEEeCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 45999999999999999875 2234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||.+......... ......++..|+|||.+.+ ..++.++|||||||++|||
T Consensus 139 ~~-------~~~kl~df~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el 198 (263)
T cd05052 139 EN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWEI 198 (263)
T ss_pred CC-------CcEEeCCCccccccccceee---------ccCCCCCccccCCHHHhcc----CCCCchhHHHHHHHHHHHH
Confidence 77 78999999998765432111 0111234568999999865 4678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++ |..||.+....+....+..+..+..+ ...+.++.+++.+||+.||++||+
T Consensus 199 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rp~ 251 (263)
T cd05052 199 ATYGMSPYPGIDLSQVYELLEKGYRMERP---------------------------EGCPPKVYELMRACWQWNPSDRPS 251 (263)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCCCCCCCC---------------------------CCCCHHHHHHHHHHccCCcccCCC
Confidence 98 99999887776666665543322111 134556999999999999999999
Q ss_pred HHHHHHHHHh
Q 001152 1118 AGDLYEMFVA 1127 (1137)
Q Consensus 1118 a~EVL~~L~~ 1127 (1137)
+.++++.+..
T Consensus 252 ~~~l~~~l~~ 261 (263)
T cd05052 252 FAEIHQAFET 261 (263)
T ss_pred HHHHHHHHHh
Confidence 9999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.19 Aligned_cols=258 Identities=29% Similarity=0.418 Sum_probs=204.8
Q ss_pred CceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||.|+||.||+|.+.. ..+++|+.... .......+. +..|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG--NMTEKEKQQ----LVSEVNILRELKHPNIVRYYDRIIDRSN- 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecc--cCCHHHHHH----HHHHHHHHHhcCCCccceeeeeeecCCC-
Confidence 48899999999999999998744 56777764322 222333333 4789999999999999999998765331
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCeeeccCCCCCe
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-----SKHIMHRDIKSENI 955 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLH-----s~gIIHrDLKP~NI 955 (1137)
...++||||+++++|.+++..... ....+++..++.++.||+.||+||| +.+|+||||||+||
T Consensus 74 -----------~~~~~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ni 141 (265)
T cd08217 74 -----------QTLYIVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141 (265)
T ss_pred -----------CEEEEEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHE
Confidence 167999999999999999976432 2357999999999999999999999 88999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
+++.+ +.+||+|||++......... .....+++.|+|||++.+ ..++.++||||||+++
T Consensus 142 li~~~-------~~~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~pE~~~~----~~~~~~~Dv~slG~il 200 (265)
T cd08217 142 FLDAN-------NNVKLGDFGLAKILGHDSSF----------AKTYVGTPYYMSPEQLNH----MSYDEKSDIWSLGCLI 200 (265)
T ss_pred EEecC-------CCEEEecccccccccCCccc----------ccccccCCCccChhhhcC----CCCCchhHHHHHHHHH
Confidence 99977 78999999998765432210 112358889999999875 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|+|++|+.||......++...+..+..+.++. ..+..+.+++.+||+.+|++|
T Consensus 201 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~~l~~~p~~R 253 (265)
T cd08217 201 YELCALSPPFTARNQLQLASKIKEGKFRRIPY---------------------------RYSSELNEVIKSMLNVDPDKR 253 (265)
T ss_pred HHHHHCCCcccCcCHHHHHHHHhcCCCCCCcc---------------------------ccCHHHHHHHHHHccCCcccC
Confidence 99999999998877666666665544332221 234558999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001152 1116 PTAGDLYEMFVA 1127 (1137)
Q Consensus 1116 PSa~EVL~~L~~ 1127 (1137)
|++.+|++|+|.
T Consensus 254 p~~~~il~~~~~ 265 (265)
T cd08217 254 PSTEELLQLPLI 265 (265)
T ss_pred CCHHHHhhCCCC
Confidence 999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.85 Aligned_cols=261 Identities=25% Similarity=0.412 Sum_probs=202.2
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|++.+.||+|+||.||+|++ .+..+|+|....... ....... .+.+|+.+++.++||||+++++++.+.+
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQ----DCVKEIDLLKQLNHPNVIKYLDSFIEDN 75 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHH----HHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence 35799999999999999999997 457788886432211 1122222 3478999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++..... ....+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 76 --------------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~ 140 (267)
T cd08228 76 --------------ELNIVLELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred --------------eEEEEEEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc
Confidence 56999999999999999875332 234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.++|+|||.+......... .....+++.|+|||.+.+ ..++.++||||||+++|+|
T Consensus 141 ~~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~el 199 (267)
T cd08228 141 AT-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECccccceeccchhHH----------HhcCCCCccccChhhhcc----CCCCchhhHHHHHHHHHHH
Confidence 77 67999999988765432110 112358889999999875 4577899999999999999
Q ss_pred HhCCCCCCCCC--HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1039 LTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1039 LTG~~Pf~~~~--~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
++|..||.... ..+....+.....+..+. ...+..+.+++.+||+.+|++||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~cl~~~p~~Rp 253 (267)
T cd08228 200 AALQSPFYGDKMNLFSLCQKIEQCDYPPLPT--------------------------EHYSEKLRELVSMCIYPDPDQRP 253 (267)
T ss_pred hcCCCCCccccccHHHHHHHHhcCCCCCCCh--------------------------hhcCHHHHHHHHHHCCCCcccCc
Confidence 99999996543 234444443333222111 13345699999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001152 1117 TAGDLYEMFVAR 1128 (1137)
Q Consensus 1117 Sa~EVL~~L~~~ 1128 (1137)
++.+|++.+...
T Consensus 254 ~~~~vl~~~~~~ 265 (267)
T cd08228 254 DIGYVHQIAKQM 265 (267)
T ss_pred CHHHHHHHHHHh
Confidence 999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=325.08 Aligned_cols=282 Identities=21% Similarity=0.230 Sum_probs=200.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|++|.||+|+.. +..+|+|+....... ....+ .+.+|+.+++.++||||+++++++.++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE--EGVPS----TAIREISLLKELQHPNIVCLQDVLMQES-- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc--CCchH----HHHHHHHHHHhcCCCCEeeeEEEEeeCC--
Confidence 4889999999999999999984 567888875433211 11112 2367999999999999999999998655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||++ ++|.+++.... ....+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 73 ------------~~~~v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~ 137 (285)
T cd07861 73 ------------RLYLIFEFLS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK 137 (285)
T ss_pred ------------eEEEEEecCC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC
Confidence 6699999997 78998886532 22468999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||++........ ......+++.|+|||++.+ ...++.++|||||||++|+|+|
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 138 -------GVIKLADFGLARAFGIPVR----------VYTHEVVTLWYRAPEVLLG---SPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred -------CcEEECcccceeecCCCcc----------cccCCcccccccChHHhcC---CCCcCcHHHHHHHHHHHHHHHH
Confidence 7899999998865432211 1112357889999999864 2356889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccc-ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|+.||.+....+....+...........+.......... .................++++.+++.+||+.||++|||+.
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 277 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 999998766544333332111111111110000000000 0000000000011123567789999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
+|++|+|+
T Consensus 278 ~ll~~~~~ 285 (285)
T cd07861 278 KALNHPYF 285 (285)
T ss_pred HHhcCCCC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.09 Aligned_cols=264 Identities=22% Similarity=0.370 Sum_probs=202.8
Q ss_pred ceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~-----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
|++.+.||+|+||.||+|.+.. ..+|+|+.+.+ .......+.+ .+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD--IHTYSEIEEF----LSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC--cCCHHHHHHH----HHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5688999999999999998743 45888875432 2223333333 88999999999999999999876543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
.. ......++||||+++++|..++..... .....+++..+..++.|++.||+|||+++|+||||||+||++
T Consensus 75 ~~--------~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~ 146 (273)
T cd05035 75 SL--------QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML 146 (273)
T ss_pred cc--------ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE
Confidence 21 112246999999999999999865321 123468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+++ +.+||+|||.++........ .......++..|+|||++.+ ..++.++|||||||++||
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~SlG~il~e 207 (273)
T cd05035 147 RED-------MTVCVADFGLSKKIYSGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTSKSDVWAFGVTMWE 207 (273)
T ss_pred CCC-------CeEEECCccceeeccccccc--------cccccccCCccccCHhhccc----CCCCcccchHHHHHHHHH
Confidence 877 78999999998755432111 00112235678999999864 467899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++ |..||.+....++...+..+..+..+. .+++++.+++.+||+.||.+||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 260 (273)
T cd05035 208 IATRGQTPYPGVENHEIYDYLRHGNRLKQPE---------------------------DCLDELYDLMYSCWRADPKDRP 260 (273)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------CCCHHHHHHHHHHcCCChhhCc
Confidence 999 899998877777776665544322211 3345699999999999999999
Q ss_pred CHHHHHHHHHh
Q 001152 1117 TAGDLYEMFVA 1127 (1137)
Q Consensus 1117 Sa~EVL~~L~~ 1127 (1137)
|+.|+++++..
T Consensus 261 ~~~e~~~~l~~ 271 (273)
T cd05035 261 TFTKLREVLEN 271 (273)
T ss_pred CHHHHHHHHHh
Confidence 99999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=341.29 Aligned_cols=249 Identities=25% Similarity=0.301 Sum_probs=194.8
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeeEecCCCCCCCC
Q 001152 810 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 810 LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L---~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
||+|+||+||+|++. +..+|+|+........ ..... ....|..++... .||||+++++++....
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~----~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~------ 69 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVA----HTIGERNILVRTLLDESPFIVGLKFSFQTDS------ 69 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHH----HHHHHHHHHHHhccCCCCcCcceEEEEecCC------
Confidence 799999999999985 5778888754321111 11111 225566777655 6999999999988765
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..|+||||+++|+|..++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~---- 132 (330)
T cd05586 70 --------DLYLVTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT---- 132 (330)
T ss_pred --------eEEEEEcCCCCChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC----
Confidence 56999999999999998875 3468999999999999999999999999999999999999977
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.|
T Consensus 133 ---~~~kl~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGvil~elltG~~P 196 (330)
T cd05586 133 ---GHIALCDFGLSKANLTDNK----------TTNTFCGTTEYLAPEVLLD---EKGYTKHVDFWSLGVLVFEMCCGWSP 196 (330)
T ss_pred ---CCEEEecCCcCcCCCCCCC----------CccCccCCccccCHHHHcC---CCCCCCccceeccccEEEEeccCCCC
Confidence 7899999999864322111 1123469999999999864 23578999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC----CHHH
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----TAGD 1120 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP----Sa~E 1120 (1137)
|.+....+....+..+... ++. ...++++.+++.+||+.||.+|| ++.+
T Consensus 197 f~~~~~~~~~~~i~~~~~~-~~~--------------------------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 249 (330)
T cd05586 197 FYAEDTQQMYRNIAFGKVR-FPK--------------------------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVE 249 (330)
T ss_pred CCCCCHHHHHHHHHcCCCC-CCC--------------------------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHH
Confidence 9987777776666544321 110 02345589999999999999998 7999
Q ss_pred HHHHHHhhc
Q 001152 1121 LYEMFVART 1129 (1137)
Q Consensus 1121 VL~~L~~~~ 1129 (1137)
+++|+|+..
T Consensus 250 ll~h~~~~~ 258 (330)
T cd05586 250 LKEHPFFAD 258 (330)
T ss_pred HhcCccccC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=320.63 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=199.0
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|+||+||+|.+.+ ..+|+|... ..... .+. +.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~--~~~~~---~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMS---EDE----FIEEAKVMMKLSHEKLVQLYGVCTKQR- 72 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcC--CCccc---HHH----HHHHHHHHhcCCCCCeeeEEEEEccCC-
Confidence 4568999999999999999999865 458888643 21111 122 378999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ...+++..++.++.||+.||+|||+.||+|+||||+||+++.
T Consensus 73 -------------~~~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 73 -------------PIYIVTEYMSNGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred -------------CcEEEEEcCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 359999999999999998752 236899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.++........ ......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~~l~ 195 (256)
T cd05113 136 Q-------GCVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLLY----SKFSSKSDVWAFGVLMWEVY 195 (256)
T ss_pred C-------CCEEECCCccceecCCCcee---------ecCCCccChhhCCHHHHhc----CcccchhHHHHHHHHHHHHh
Confidence 7 78999999988654322110 0011235668999999875 45789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||......+....+..+..+..+. ..+..+.+++.+||+.||.+||++
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~~Rp~~ 248 (256)
T cd05113 196 SLGKMPYERFNNSETVEKVSQGLRLYRPH---------------------------LASEKVYAIMYSCWHEKAEERPTF 248 (256)
T ss_pred cCCCCCcCcCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCcccCCCH
Confidence 8 999998777766666665544322111 123458999999999999999999
Q ss_pred HHHHHHH
Q 001152 1119 GDLYEMF 1125 (1137)
Q Consensus 1119 ~EVL~~L 1125 (1137)
.+|++.+
T Consensus 249 ~~ll~~~ 255 (256)
T cd05113 249 QQLLSSI 255 (256)
T ss_pred HHHHHhh
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=335.25 Aligned_cols=265 Identities=23% Similarity=0.289 Sum_probs=202.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||+||+|+.. +..+|+|+...... ...... ..+.+|+.+++.++||||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAET----ACFREERDVLVNGDRRWITNLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhH----HHHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence 36899999999999999999985 46788887542111 011112 23477999999999999999999988765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
+.|+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 137 (331)
T cd05597 75 -------------NLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK 137 (331)
T ss_pred -------------eEEEEEecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC
Confidence 679999999999999999752 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC-CCCCCchhhHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~s~ksDVWSLGviL~EL 1038 (1137)
+ +.+||+|||++......... ......||+.|+|||++..... ...++.++|||||||++|+|
T Consensus 138 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el 201 (331)
T cd05597 138 N-------GHIRLADFGSCLRLLADGTV---------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEECCceeecCCCCCc---------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHH
Confidence 7 78999999988654322110 1112468999999999874211 23578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 1115 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~--R 1115 (1137)
++|+.||.+.+..+....+..... ..++.. ....++.+++++.+||..++.+ |
T Consensus 202 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~~li~~ll~~~~~r~~r 257 (331)
T cd05597 202 LYGETPFYAESLVETYGKIMNHKEHFQFPPD------------------------VTDVSEEAKDLIRRLICSPETRLGR 257 (331)
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCcccCCCc------------------------cCCCCHHHHHHHHHHccCcccccCC
Confidence 999999988776666655543221 111100 0124556899999988654444 8
Q ss_pred CCHHHHHHHHHhhc
Q 001152 1116 PTAGDLYEMFVART 1129 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~ 1129 (1137)
|+++++++|+|+..
T Consensus 258 ~~~~~~l~hp~~~~ 271 (331)
T cd05597 258 NGLQDFKDHPFFEG 271 (331)
T ss_pred CCHHHHhcCCCCCC
Confidence 89999999999854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=324.15 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=203.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC-----Cc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-----SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-----~~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
..+|.+.+.||+|+||.||++... .. .+|+|. .... .....+. +.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~--~~~~--~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~ 75 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKT--LKDA--SDNARKD----FHREAELLTNLQHEHIVKFYGV 75 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEe--cCCc--CHHHHHH----HHHHHHHHHhCCCCCcceEEEE
Confidence 456889999999999999999852 22 355554 3221 1222233 4889999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------TGEKHVSVKLALFIAQDVAAALVELHSKHI 945 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~--------~~~~~ls~~~i~~I~~QIa~gL~yLHs~gI 945 (1137)
+.... ..++||||+++++|.+++..... .....+++..+..++.||+.||+|||++||
T Consensus 76 ~~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i 141 (288)
T cd05093 76 CVEGD--------------PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF 141 (288)
T ss_pred EecCC--------------ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 88655 45999999999999999975321 112358999999999999999999999999
Q ss_pred eeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCch
Q 001152 946 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1025 (1137)
Q Consensus 946 IHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~k 1025 (1137)
+||||||+|||++.+ +.+||+|||++......... .......++..|+|||++.+ ..++.+
T Consensus 142 ~H~dlkp~Nili~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~ 202 (288)
T cd05093 142 VHRDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYY--------RVGGHTMLPIRWMPPESIMY----RKFTTE 202 (288)
T ss_pred eecccCcceEEEccC-------CcEEeccCCccccccCCcee--------ecCCCCCccccccCHHHhcc----CCCCch
Confidence 999999999999877 78999999998754322111 00112345778999999875 467899
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHH
Q 001152 1026 VDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1104 (1137)
Q Consensus 1026 sDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl 1104 (1137)
+|||||||++|+|++ |..||......+....+..+..+..+. ..+.++.+|+
T Consensus 203 sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li 255 (288)
T cd05093 203 SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR---------------------------TCPKEVYDLM 255 (288)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHH
Confidence 999999999999998 999998877777777666554322111 2334599999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001152 1105 RRCTEENPTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1105 ~~CL~~DP~~RPSa~EVL~~L~~~~~s 1131 (1137)
.+||+.||.+|||+.+|++.+......
T Consensus 256 ~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 256 LGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=318.00 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=202.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||+|... +..+++|..... .......+. +.+|+.+++.++||||+++++.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE--QMTKDERLA----AQNECQVLKLLSHPNIIEYYENFLEDK-- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecc--ccccHHHHH----HHHHHHHHhhCCCCchhheeeeEecCC--
Confidence 5889999999999999999874 466788875432 222233333 488999999999999999999887654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||++||+||||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 137 (256)
T cd08220 73 ------------ALMIVMEYAPGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137 (256)
T ss_pred ------------EEEEEEecCCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 679999999999999999762 23458999999999999999999999999999999999999755
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
. ..+||+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~~l~~ 196 (256)
T cd08220 138 K------MVVKIGDFGISKILSSKSK-----------AYTVVGTPCYISPELCEG----KPYNQKSDIWALGCVLYELAS 196 (256)
T ss_pred C------CEEEEccCCCceecCCCcc-----------ccccccCCcccCchhccC----CCCCcccchHHHHHHHHHHHh
Confidence 2 5689999999876543211 112458889999999875 457789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||...+.......+.......++. ..+..+.+++.+||+.+|++|||+.|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 197 LKRAFEAANLPALVLKIMSGTFAPISD---------------------------RYSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred CCCCcccCchHHHHHHHHhcCCCCCCC---------------------------CcCHHHHHHHHHHccCChhhCCCHHH
Confidence 999998776666555554433222211 23445899999999999999999999
Q ss_pred HHHHHHh
Q 001152 1121 LYEMFVA 1127 (1137)
Q Consensus 1121 VL~~L~~ 1127 (1137)
+++|+|+
T Consensus 250 ll~~p~~ 256 (256)
T cd08220 250 IMAQPIC 256 (256)
T ss_pred HhhCCCC
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=347.59 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=213.1
Q ss_pred CCc-eEeeeecccCceEEEEEEECCccEEEEEE--ecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 802 PSL-SSCDEAGKSVSSSLFRCKFGSADAAAKVR--TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y-~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~--~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.+| +...+||+|+|-+||+|.+..+.+.|+.- ++........+.+. +..|+.+|+.|+|||||++|.++.+..
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR----~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELER----LYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHH----HHHHHHHHccCCCCceeeeeeheecCC
Confidence 344 56678999999999999997776666542 22222233444444 489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCCCCeE
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENIL 956 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~--gIIHrDLKP~NIL 956 (1137)
. ...-+|+|++..|+|..|++++ ...+.+.++.|++||++||.|||++ .|||||||-+|||
T Consensus 115 n------------~~in~iTEL~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIF 177 (632)
T KOG0584|consen 115 N------------KTINFITELFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIF 177 (632)
T ss_pred C------------ceeeeeeecccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEE
Confidence 2 2578999999999999999884 4688999999999999999999988 6999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
|+.+. |.|||+|+|+|........ ..++|||.|||||++.. .|+..+||||||+.++
T Consensus 178 inG~~------G~VKIGDLGLAtl~r~s~a------------ksvIGTPEFMAPEmYEE-----~YnE~VDVYaFGMCmL 234 (632)
T KOG0584|consen 178 VNGNL------GEVKIGDLGLATLLRKSHA------------KSVIGTPEFMAPEMYEE-----NYNELVDVYAFGMCML 234 (632)
T ss_pred EcCCc------CceeecchhHHHHhhcccc------------ceeccCccccChHHHhh-----hcchhhhhhhhhHHHH
Confidence 99774 8899999999986654321 24689999999999874 7899999999999999
Q ss_pred HHHhCCCCCCC-CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLTG~~Pf~~-~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
||+|+.+||.. .++.++++.+..|..|.- +.. ...+++++||.+||.. ..+|
T Consensus 235 EMvT~eYPYsEC~n~AQIYKKV~SGiKP~s---l~k-----------------------V~dPevr~fIekCl~~-~~~R 287 (632)
T KOG0584|consen 235 EMVTSEYPYSECTNPAQIYKKVTSGIKPAA---LSK-----------------------VKDPEVREFIEKCLAT-KSER 287 (632)
T ss_pred HHHhccCChhhhCCHHHHHHHHHcCCCHHH---hhc-----------------------cCCHHHHHHHHHHhcC-chhc
Confidence 99999999965 788999999999886542 222 1234699999999999 8999
Q ss_pred CCHHHHHHHHHhhcC
Q 001152 1116 PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ 1130 (1137)
||+.|+|+|+|+...
T Consensus 288 ~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 288 LSAKELLKDPFFDED 302 (632)
T ss_pred cCHHHHhhChhhccc
Confidence 999999999999754
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=325.73 Aligned_cols=262 Identities=29% Similarity=0.487 Sum_probs=207.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.++|++.+.||+|+||.||+|.+. +..+|+|+.... .....+.+ .+|+.++++++||||+++++++....
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDF----MVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHH----HHHHHHHHhCCCCceeEEEEEEecCC
Confidence 356899999999999999999985 466788875432 12333333 78999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 76 --------------~~~lv~e~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~ 137 (280)
T cd06611 76 --------------KLWILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT 137 (280)
T ss_pred --------------eEEEEeeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC
Confidence 569999999999999998762 24689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~E 1037 (1137)
.+ +.++|+|||.+........ ......+++.|+|||++.... ....++.++||||||+++|+
T Consensus 138 ~~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~ 200 (280)
T cd06611 138 LD-------GDVKLADFGVSAKNKSTLQ----------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200 (280)
T ss_pred CC-------CCEEEccCccchhhccccc----------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHH
Confidence 77 7899999998765432111 112345888999999986321 23456789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|..||......+....+..+..+.+... ...+.++.+++.+||+.+|.+||+
T Consensus 201 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~Rps 255 (280)
T cd06611 201 LAQMEPPHHELNPMRVLLKILKSEPPTLDQP-------------------------SKWSSSFNDFLKSCLVKDPDDRPT 255 (280)
T ss_pred HHhCCCCcccCCHHHHHHHHhcCCCCCcCCc-------------------------ccCCHHHHHHHHHHhccChhhCcC
Confidence 9999999988776665555554433221100 023456899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001152 1118 AGDLYEMFVARTS 1130 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ 1130 (1137)
+.++++|+|+...
T Consensus 256 ~~~il~~~~~~~~ 268 (280)
T cd06611 256 AAELLKHPFVSDQ 268 (280)
T ss_pred HHHHhcChhhccc
Confidence 9999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=322.24 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=197.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--Ccc----EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SAD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~----vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
..+|++.+.||+|+||+||+|.+. +.. +++|.. ... .......+ +..|+.+++++.||||+++++++
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~--~~~-~~~~~~~~----~~~~~~~l~~l~h~~iv~~~~~~ 78 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDR-SGRQTFQE----ITDHMLAMGSLDHAYIVRLLGIC 78 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeec--ccc-cchHHHHH----HHHHHHHHhcCCCCCcceEEEEE
Confidence 357889999999999999999984 333 344432 211 11222223 36788899999999999999987
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
... ..++||||+++|+|.+++... ...+++..+..|+.||+.||+|||++|++||||||+|
T Consensus 79 ~~~---------------~~~~i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~n 139 (279)
T cd05111 79 PGA---------------SLQLVTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARN 139 (279)
T ss_pred CCC---------------ccEEEEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcce
Confidence 532 348999999999999999752 2468999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
|+++.+ +.+||+|||.++........ .......++..|+|||.+.+ ..++.++|||||||+
T Consensus 140 ili~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~i 200 (279)
T cd05111 140 ILLKSD-------SIVQIADFGVADLLYPDDKK--------YFYSEHKTPIKWMALESILF----GRYTHQSDVWSYGVT 200 (279)
T ss_pred EEEcCC-------CcEEEcCCccceeccCCCcc--------cccCCCCCcccccCHHHhcc----CCcCchhhHHHHHHH
Confidence 999877 78999999998754322111 01112346778999999875 467899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|||++ |..||.+.....+...+..+..+..+. .++.++.+++.+||..||+
T Consensus 201 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p~ 253 (279)
T cd05111 201 VWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ---------------------------ICTIDVYMVMVKCWMIDEN 253 (279)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC---------------------------CCCHHHHHHHHHHcCCCcc
Confidence 999998 999998877766666665544332111 1233478899999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001152 1114 ERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~ 1130 (1137)
+|||+.|+++.+.....
T Consensus 254 ~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 254 VRPTFKELANEFTRMAR 270 (279)
T ss_pred cCcCHHHHHHHHHHHHh
Confidence 99999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.43 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=201.3
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
..+|++.+.||+|+||.||++...+..+++|..... ...+. +.+|+.++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~------~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQA----FLAEASVMTQLRHSNLVQLLGVIVEEK-- 72 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC------chHHH----HHHHHHHHHhCCCCCeeeEEEEEEcCC--
Confidence 457899999999999999999999999999975321 11222 378999999999999999999865432
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
...++||||+++++|.++++. .....+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 73 -----------~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~ 138 (256)
T cd05082 73 -----------GGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED 138 (256)
T ss_pred -----------CceEEEEECCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC
Confidence 146999999999999999876 223458999999999999999999999999999999999999887
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||++....... ....++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~~l~~ 194 (256)
T cd05082 139 -------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred -------CcEEecCCccceeccccC-------------CCCccceeecCHHHHcc----CCCCchhhhHHHHHHHHHHHh
Confidence 789999999886543211 11234568999999865 467899999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|+.||......++...+..+..+..+. .+++.+.+++.+||+.+|++|||+.
T Consensus 195 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rpt~~ 247 (256)
T cd05082 195 FGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPVVYDVMKQCWHLDAATRPSFL 247 (256)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHhcCChhhCcCHH
Confidence 999998777766666665443222111 3455699999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
++++.+..
T Consensus 248 ~l~~~l~~ 255 (256)
T cd05082 248 QLREQLEH 255 (256)
T ss_pred HHHHHHhc
Confidence 99998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=344.53 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=204.4
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 887 (1137)
-+||+|+||+||.|++..+.|-++|+.+..... ...+- +..||..-++++|.|||+++|.+-+.+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QP----LhEEIaLH~~LrHkNIVrYLGs~senG--------- 645 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQP----LHEEIALHSTLRHKNIVRYLGSVSENG--------- 645 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc--hhhcc----HHHHHHHHHHHhhHhHHHHhhccCCCC---------
Confidence 369999999999999988888777765554322 22222 367899999999999999999987666
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCC
Q 001152 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 967 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~ 967 (1137)
..-|.||-+|||||.++++.. .+...-.+.++-.+.+||++||.|||++.|||||||-+||||+-- .
T Consensus 646 -----f~kIFMEqVPGGSLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy------S 712 (1226)
T KOG4279|consen 646 -----FFKIFMEQVPGGSLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY------S 712 (1226)
T ss_pred -----eEEEEeecCCCCcHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec------c
Confidence 458999999999999999873 343334889999999999999999999999999999999999754 3
Q ss_pred CeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001152 968 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047 (1137)
Q Consensus 968 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~ 1047 (1137)
|.+||+|||-++.+.... +-..++.||..|||||++.. ....|++++|||||||++.||.||++||..
T Consensus 713 GvlKISDFGTsKRLAgin----------P~TETFTGTLQYMAPEvIDq--G~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 713 GVLKISDFGTSKRLAGIN----------PCTETFTGTLQYMAPEVIDQ--GPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred ceEEecccccchhhccCC----------ccccccccchhhhChHhhcc--CCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 899999999988765422 12236789999999999987 457899999999999999999999999976
Q ss_pred CCHHH-HHHHH-HcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001152 1048 LSELE-IHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125 (1137)
Q Consensus 1048 ~~~~e-l~~~I-~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L 1125 (1137)
....+ ....+ .....|.++. +.+.+++.+|.+|+.+||.+||+|.+++..+
T Consensus 781 lgspqAAMFkVGmyKvHP~iPe---------------------------elsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 781 LGSPQAAMFKVGMYKVHPPIPE---------------------------ELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred cCChhHhhhhhcceecCCCCcH---------------------------HHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 44332 22222 1111233333 4556699999999999999999999999999
Q ss_pred HhhcC
Q 001152 1126 VARTS 1130 (1137)
Q Consensus 1126 ~~~~~ 1130 (1137)
|....
T Consensus 834 Flq~~ 838 (1226)
T KOG4279|consen 834 FLQHN 838 (1226)
T ss_pred ccccC
Confidence 98643
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.40 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=204.0
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||++... +..+++|....... .....+. +.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREE----SRKEVAVLSNMKHPNIVQYQESFEENG-- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHH----HHHHHHHHHhCCCCCeeeeEeeecCCC--
Confidence 5889999999999999999874 46788887543321 1223333 378999999999999999999987655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
+.++||||+++++|.+++.. .....+++..+..|+.||+.||+|||++|++|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~ 137 (256)
T cd08218 73 ------------NLYIVMDYCEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137 (256)
T ss_pred ------------eEEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 67999999999999999875 222358899999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+......... .....|++.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 138 -------GTIKLGDFGIARVLNSTVEL----------ARTCIGTPYYLSPEICEN----RPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred -------CCEEEeeccceeecCcchhh----------hhhccCCccccCHHHhCC----CCCCCccchhHHHHHHHHHHc
Confidence 67999999988755432111 112357889999999865 457789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||......+....+..+..+..+. ..+.++.+++.+||+.+|++||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08218 197 LKHAFEAGNMKNLVLKIIRGSYPPVSS---------------------------HYSYDLRNLVSQLFKRNPRDRPSVNS 249 (256)
T ss_pred CCCCccCCCHHHHHHHHhcCCCCCCcc---------------------------cCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 999998777766666665544332221 23445899999999999999999999
Q ss_pred HHHHHHh
Q 001152 1121 LYEMFVA 1127 (1137)
Q Consensus 1121 VL~~L~~ 1127 (1137)
|++|+|+
T Consensus 250 vl~~~~~ 256 (256)
T cd08218 250 ILEKNFI 256 (256)
T ss_pred HhhCcCC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=323.73 Aligned_cols=259 Identities=28% Similarity=0.392 Sum_probs=197.1
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|++. +..+|+|+..... ...... +.+|+.++++++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~----~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSL----IQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHH----HHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 3457999999999999999999974 4668888754321 112222 37799999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+++++|.++++. ...+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 79 ~--------------~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill 139 (267)
T cd06646 79 E--------------KLWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL 139 (267)
T ss_pred C--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 5 67999999999999999865 2468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++........ ......+++.|+|||.+... ....++.++|||||||++||
T Consensus 140 ~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~-~~~~~~~~~Dvws~G~il~e 201 (267)
T cd06646 140 TDN-------GDVKLADFGVAAKITATIA----------KRKSFIGTPYWMAPEVAAVE-KNGGYNQLCDIWAVGITAIE 201 (267)
T ss_pred CCC-------CCEEECcCccceeeccccc----------ccCccccCccccCHhHcccc-cCCCCcchhhHHHHHHHHHH
Confidence 877 7799999999875532111 11133588899999997532 12446789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|+.||......+....+....... + .. ......+..+.+++.+||+.+|++||+
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~~~~~~~-~-~~---------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~ 258 (267)
T cd06646 202 LAELQPPMFDLHPMRALFLMSKSNFQP-P-KL---------------------KDKTKWSSTFHNFVKISLTKNPKKRPT 258 (267)
T ss_pred HHhCCCCccccchhhhheeeecCCCCC-C-CC---------------------ccccccCHHHHHHHHHHhhCChhhCcC
Confidence 999999996544332221111111000 0 00 000133456999999999999999999
Q ss_pred HHHHHHHHH
Q 001152 1118 AGDLYEMFV 1126 (1137)
Q Consensus 1118 a~EVL~~L~ 1126 (1137)
+++|++|+|
T Consensus 259 ~~~il~~l~ 267 (267)
T cd06646 259 AERLLTHLF 267 (267)
T ss_pred HHHHhcCCC
Confidence 999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=320.62 Aligned_cols=260 Identities=20% Similarity=0.303 Sum_probs=201.1
Q ss_pred CCCCceEeeeecccCceEEEEEEECC--c----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS--A----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~--~----~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
...+|++.++||+|+||+||+|++.. . .||+|+..... .....+. +.+|+.+++.+.||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~ 77 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKE----ILDEAYVMAGVGSPYVCRLLGI 77 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHH----HHHHHHHHHhcCCCCCceEEEE
Confidence 34678999999999999999998732 2 36777643221 1222223 4789999999999999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+... ..+++|||+++|+|.++++. ....+++..+..++.||+.||+|||+++|+||||||+
T Consensus 78 ~~~~---------------~~~l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~ 138 (279)
T cd05109 78 CLTS---------------TVQLVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAAR 138 (279)
T ss_pred EcCC---------------CcEEEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 8643 34799999999999999875 1246899999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.+ +.+||+|||+++......... ......+++.|+|||.+.+ ..++.++|||||||
T Consensus 139 Nil~~~~-------~~~kL~dfG~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~ 199 (279)
T cd05109 139 NVLVKSP-------NHVKITDFGLARLLDIDETEY--------HADGGKVPIKWMALESILH----RRFTHQSDVWSYGV 199 (279)
T ss_pred eEEEcCC-------CcEEECCCCceeeccccccee--------ecCCCccchhhCCHHHhcc----CCCCchhHHHHHHH
Confidence 9999876 679999999987654321110 0011235678999999865 46789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1034 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1034 iL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
++|||++ |..||.......+...+..+..+..+. .++.++.+++.+||+.||
T Consensus 200 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~dp 252 (279)
T cd05109 200 TVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP---------------------------ICTIDVYMIMVKCWMIDS 252 (279)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCc---------------------------cCCHHHHHHHHHHcCCCh
Confidence 9999998 999998777666666665543322111 234568999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001152 1113 TERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~s 1131 (1137)
++||++.++++.+......
T Consensus 253 ~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 253 ECRPRFRELVDEFSRMARD 271 (279)
T ss_pred hhCcCHHHHHHHHHHhhcC
Confidence 9999999999887766543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=325.49 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=189.3
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCC
Q 001152 810 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 810 LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 887 (1137)
||+|+||.||+++.. +..+|+|....+.... .... ..+..|++++++++||||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~----~~~~~E~~il~~l~hp~i~~~~~~~~~~~--------- 66 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGE----KMALLEKEILEKVNSPFIVNLAYAFESKT--------- 66 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhh----HHHHHHHHHHHhcCCCcEEEEEEEEecCC---------
Confidence 799999999999875 5667777643221111 1111 12356999999999999999999987655
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCC
Q 001152 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 967 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~ 967 (1137)
+.++||||++|++|.+++.. .....+++..+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus 67 -----~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~------- 131 (277)
T cd05607 67 -----HLCLVMSLMNGGDLKYHIYN---VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ------- 131 (277)
T ss_pred -----eEEEEEecCCCCCHHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-------
Confidence 67999999999999998865 233458999999999999999999999999999999999999877
Q ss_pred CeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001152 968 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047 (1137)
Q Consensus 968 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~ 1047 (1137)
+.++|+|||++........ .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 132 ~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 132 GNCRLSDLGLAVELKDGKT-----------ITQRAGTNGYMAPEILKE----EPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CCEEEeeceeeeecCCCce-----------eeccCCCCCccCHHHHcc----CCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 7899999998875443211 112358899999999875 4588999999999999999999999975
Q ss_pred CCHH----HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH----H
Q 001152 1048 LSEL----EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA----G 1119 (1137)
Q Consensus 1048 ~~~~----el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa----~ 1119 (1137)
.... ++.........+. .....++++.+++.+||+.||.+||++ +
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 197 HKEKVAKEELKRRTLEDEVKF---------------------------EHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CcchhhHHHHHHHhhcccccc---------------------------ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 4321 1111111100000 001345568999999999999999999 6
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
+++.|+|+..
T Consensus 250 ~~~~h~~f~~ 259 (277)
T cd05607 250 DPRKHEFFKT 259 (277)
T ss_pred hhhcChhhcC
Confidence 7889999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=336.38 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=191.2
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||.||+|... +..+|+|+...+... .....+ .+.+|+.++.++ +||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~----~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------ 69 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDID----WVQTEKHVFEQASSNPFLVGLHSCFQTTS------ 69 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHH----HHHHHHHHHHhhcCCCCEeeEEEEEEeCC------
Confidence 46999999999999985 467888876433211 112222 347899999888 5999999999988665
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++++|..++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 70 --------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---- 132 (327)
T cd05617 70 --------RLFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---- 132 (327)
T ss_pred --------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC----
Confidence 67999999999999998865 2469999999999999999999999999999999999999887
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 133 ---~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~ell~g~~p 195 (327)
T cd05617 133 ---GHIKLTDYGMCKEGLGPGD----------TTSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLMFEMMAGRSP 195 (327)
T ss_pred ---CCEEEeccccceeccCCCC----------ceecccCCcccCCHHHHCC----CCCCchheeehhHHHHHHHHhCCCC
Confidence 7899999998864322111 1113468999999999875 5678999999999999999999999
Q ss_pred CCCCC------HH-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1045 YMGLS------EL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1045 f~~~~------~~-el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|.... .. .+...+... ...++. ..+..+.+++.+||+.||.+|++
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~-~~~~p~---------------------------~~~~~~~~li~~~L~~dP~~R~~ 247 (327)
T cd05617 196 FDIITDNPDMNTEDYLFQVILEK-PIRIPR---------------------------FLSVKASHVLKGFLNKDPKERLG 247 (327)
T ss_pred CCccCCCcccccHHHHHHHHHhC-CCCCCC---------------------------CCCHHHHHHHHHHhccCHHHcCC
Confidence 96321 11 122222211 111111 23445899999999999999997
Q ss_pred ------HHHHHHHHHhhc
Q 001152 1118 ------AGDLYEMFVART 1129 (1137)
Q Consensus 1118 ------a~EVL~~L~~~~ 1129 (1137)
++++++|+|+..
T Consensus 248 ~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 248 CQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred CCCCCCHHHHHcCCCCCC
Confidence 579999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=324.25 Aligned_cols=260 Identities=21% Similarity=0.359 Sum_probs=199.8
Q ss_pred CceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
+|++.+.||+|+||.||+|.... ..+++|+.. .... ....+. +.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~--~~~~-~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK--ENAS-SSELRD----LLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecC--CCCC-HHHHHH----HHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47788999999999999998732 345665532 2211 222333 478999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------------------cCCCCCCHHHHHHHHHHHHHH
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDVAAA 936 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-------------------~~~~~ls~~~i~~I~~QIa~g 936 (1137)
..+ ..++||||+++++|.+++..... .....+++..++.++.||+.|
T Consensus 74 ~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~ 139 (290)
T cd05045 74 QDG--------------PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRG 139 (290)
T ss_pred cCC--------------CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHH
Confidence 655 45999999999999999875321 112358899999999999999
Q ss_pred HHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccc
Q 001152 937 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1016 (1137)
Q Consensus 937 L~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 1016 (1137)
|+|||+++|+||||||+|||++.+ +.+||+|||++......... .......++..|+|||++.+
T Consensus 140 l~~LH~~~ivH~dikp~nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~apE~~~~- 203 (290)
T cd05045 140 MQYLAEMKLVHRDLAARNVLVAEG-------RKMKISDFGLSRDVYEEDSY--------VKRSKGRIPVKWMAIESLFD- 203 (290)
T ss_pred HHHHHHCCeehhhhhhheEEEcCC-------CcEEeccccccccccCccch--------hcccCCCCCccccCHHHHcc-
Confidence 999999999999999999999877 78999999998754322110 00112235678999999865
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 001152 1017 HKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1095 (1137)
Q Consensus 1017 ~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1137)
..++.++||||||+++|+|++ |..||.+..+.++...+........+ ..
T Consensus 204 ---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 253 (290)
T cd05045 204 ---HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP---------------------------EN 253 (290)
T ss_pred ---CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC---------------------------CC
Confidence 467899999999999999998 99999887777766655443322111 03
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1096 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1096 ~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
++.++.+++.+||+.+|.+||+++|+++.+....
T Consensus 254 ~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 254 CSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 3456999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=324.93 Aligned_cols=280 Identities=21% Similarity=0.264 Sum_probs=198.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||+|++. +..+++|+...+... .. ....+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~--~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EG----VPSSALREICLLKELKHKNIVRLYDVLHSDK-- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc--cc----CccchhHHHHHHHhcCCCCeeeHHHHhccCC--
Confidence 5889999999999999999984 567888875433211 11 1123367999999999999999999987655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~ 135 (284)
T cd07839 73 ------------KLTLVFEYCD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135 (284)
T ss_pred ------------ceEEEEecCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC
Confidence 5699999997 6888887641 2468999999999999999999999999999999999999977
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|+|
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~t 195 (284)
T cd07839 136 -------GELKLADFGLARAFGIPVRC----------YSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAELAN 195 (284)
T ss_pred -------CcEEECccchhhccCCCCCC----------cCCCccccCCcChHHHhC---CcccCcHHHHHHHHHHHHHHHh
Confidence 78999999998754332111 112357889999999865 2456899999999999999999
Q ss_pred CCCCCC-CCCHHHHHHHHHcCCCCCchhHHhhhccccccc-ccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1041 LQVPYM-GLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1041 G~~Pf~-~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
|..||. +.+..+....+...........+.......... .................++++.+++.+||+.||.+|||+
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 275 (284)
T cd07839 196 AGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA 275 (284)
T ss_pred cCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH
Confidence 988864 444444444442222111111111100000000 000000000001112456779999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
+++++|+|+
T Consensus 276 ~~il~h~~f 284 (284)
T cd07839 276 EEALQHPYF 284 (284)
T ss_pred HHHhcCCCC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=321.88 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=198.5
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~ 878 (1137)
..|++.+.||+|+||.||+|.+. +..+|+|+.... .. .... +.+|+.+++++ +||||+++++++....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~---~~~~----~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GD---EEEE----IKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--Cc---cHHH----HHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 35788899999999999999985 456777765432 11 1122 36799999998 6999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. . ......++||||+++++|.+++... ....+++..+..++.||+.||+|||+++|+||||||+||+++
T Consensus 77 ~----~----~~~~~~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~ 145 (272)
T cd06637 77 P----P----GMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145 (272)
T ss_pred C----C----CCCcEEEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC
Confidence 1 0 0112679999999999999998762 234689999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~E 1037 (1137)
.+ +.++|+|||++........ ......|++.|+|||++.+.. ....++.++|||||||++|+
T Consensus 146 ~~-------~~~~l~Dfg~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~e 208 (272)
T cd06637 146 EN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208 (272)
T ss_pred CC-------CCEEEccCCCceecccccc----------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHH
Confidence 77 7799999999875432111 112346889999999986421 12457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|+.||...........+.....+... ....+.++.+|+.+||..||.+|||
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rpt 262 (272)
T cd06637 209 MAEGAPPLCDMHPMRALFLIPRNPAPRLK--------------------------SKKWSKKFQSFIESCLVKNHSQRPT 262 (272)
T ss_pred HHhCCCCccccCHHHHHHHHhcCCCCCCC--------------------------CCCcCHHHHHHHHHHcCCChhhCCC
Confidence 99999999765544333322211110000 0023456899999999999999999
Q ss_pred HHHHHHHHHh
Q 001152 1118 AGDLYEMFVA 1127 (1137)
Q Consensus 1118 a~EVL~~L~~ 1127 (1137)
+.++++|+|+
T Consensus 263 ~~~il~~~~~ 272 (272)
T cd06637 263 TEQLMKHPFI 272 (272)
T ss_pred HHHHhhCCCC
Confidence 9999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.57 Aligned_cols=262 Identities=25% Similarity=0.408 Sum_probs=201.9
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
|++.+.||+|+||.||+|.+..+...++++..... .....+.+ .+|+.+++.++||||+++++++....
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~----~~e~~~l~~l~h~~ii~~~~~~~~~~----- 75 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDY----MVEIDILASCDHPNIVKLLDAFYYEN----- 75 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHH----HHHHHHHHHCCCCCeeeEEEEEeeCC-----
Confidence 67889999999999999998654443333333322 12333333 78999999999999999999987655
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
..++||||+++++|..++.+ ....+++..+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus 76 ---------~~~~v~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~--- 139 (282)
T cd06643 76 ---------NLWILIEFCAGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD--- 139 (282)
T ss_pred ---------EEEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC---
Confidence 56999999999999998764 12468999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHHHhCC
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLELLTLQ 1042 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~ELLTG~ 1042 (1137)
+.+||+|||++........ ......+++.|+|||++.... ....++.++|||||||++|+|++|+
T Consensus 140 ----~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 205 (282)
T cd06643 140 ----GDIKLADFGVSAKNTRTIQ----------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE 205 (282)
T ss_pred ----CCEEEcccccccccccccc----------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCC
Confidence 7799999998865432110 112346889999999985321 2345778999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001152 1043 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1122 (1137)
Q Consensus 1043 ~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL 1122 (1137)
.||...+..+....+.....+..... ...+.++.+++.+||+.||.+||++++++
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 206 PPHHELNPMRVLLKIAKSEPPTLAQP-------------------------SRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CCccccCHHHHHHHHhhcCCCCCCCc-------------------------cccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 99987766655555443332211100 02345699999999999999999999999
Q ss_pred HHHHhhcCC
Q 001152 1123 EMFVARTSS 1131 (1137)
Q Consensus 1123 ~~L~~~~~s 1131 (1137)
+|+|+....
T Consensus 261 ~~~~~~~~~ 269 (282)
T cd06643 261 QHPFVTVNS 269 (282)
T ss_pred cCCCEeccC
Confidence 999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.88 Aligned_cols=254 Identities=27% Similarity=0.403 Sum_probs=203.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||.++.. +..+++|...... ........ +.+|++++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR--LSEKERRD----ALNEIVILSLLQHPNIIAYYNHFMDDN-- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc--cchhHHHH----HHHHHHHHHhCCCCCeeEEEeEEecCC--
Confidence 5889999999999999988874 4667777643332 22233333 378999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||+.|++||||+|+||+++.+
T Consensus 73 ------------~~~~~~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 73 ------------TLLIEMEYANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137 (256)
T ss_pred ------------eEEEEEEecCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC
Confidence 679999999999999998762 13468999999999999999999999999999999999999977
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||.+........ ......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 138 -------~~~kl~d~~~~~~~~~~~~----------~~~~~~~~~~y~ape~~~~----~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08221 138 -------GLIKLGDFGISKILGSEYS----------MAETVVGTPYYMSPELCQG----VKYNFKSDIWALGCVLYELLT 196 (256)
T ss_pred -------CCEEECcCcceEEcccccc----------cccccCCCccccCHhhcCC----CCCCCcchhHHHHHHHHHHHH
Confidence 6799999998875533221 1123468899999999875 346789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||......+....+..+..+... ...+.++.+++.+||+.+|++||++.+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 197 LKRTFDATNPLNLVVKIVQGNYTPVV---------------------------SVYSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCc---------------------------cccCHHHHHHHHHHcccCcccCCCHHH
Confidence 99999887776666666544332211 133456899999999999999999999
Q ss_pred HHHHHHh
Q 001152 1121 LYEMFVA 1127 (1137)
Q Consensus 1121 VL~~L~~ 1127 (1137)
+++++|.
T Consensus 250 ll~~~~l 256 (256)
T cd08221 250 VLDQPLL 256 (256)
T ss_pred HhhCcCC
Confidence 9999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=323.79 Aligned_cols=287 Identities=21% Similarity=0.234 Sum_probs=207.8
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||+|.+. +..+++|............ .....+..|+.+++.++|+||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKD---GINFTALREIKLLQELKHPNIIGLLDVFGHKS-- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccc---hhhHHHHHHHHHHhhcCCCCChhhhheeecCC--
Confidence 4788999999999999999984 4678888764433221111 12233477999999999999999999998754
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+ +++|.+++... ...+++..+..++.||++||+|||++||+||||||+||+++.+
T Consensus 76 ------------~~~lv~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~ 138 (298)
T cd07841 76 ------------NINLVFEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD 138 (298)
T ss_pred ------------EEEEEEccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC
Confidence 569999999 89999999751 1369999999999999999999999999999999999999977
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||++......... .....+++.|+|||.+.+ ...++.++|||||||++|+|++
T Consensus 139 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 139 -------GVLKLADFGLARSFGSPNRK----------MTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred -------CCEEEccceeeeeccCCCcc----------ccccccceeeeCHHHHhC---CCCCCcHHHHHHHHHHHHHHHc
Confidence 78999999998765432111 112346789999999864 2457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|.+||.+....+....+...........+...........................+..+.+++.+||+.||++|||+.|
T Consensus 199 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred CCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 98888876665555444322211111111111000000000011111111111244677999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 001152 1121 LYEMFVARTSS 1131 (1137)
Q Consensus 1121 VL~~L~~~~~s 1131 (1137)
+++|.|+....
T Consensus 279 ~l~~~~~~~~~ 289 (298)
T cd07841 279 ALEHPYFSNDP 289 (298)
T ss_pred HhhCccccCCC
Confidence 99999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.74 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=202.8
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
..+|++.+.||+|+||.||++.+.+ ..+|+|+.... . ....... +.+|+.+++++ +||||+++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~--~-~~~~~~~----~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--A-TEKDLSD----LVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC--C-CHHHHHH----HHHHHHHHHhhcCCCCeeeEEE
Confidence 4568999999999999999998743 35677764322 1 1222233 47899999999 7999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELH 941 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-----------~~~~~ls~~~i~~I~~QIa~gL~yLH 941 (1137)
++.... ..++||||+++++|..+++.... .....+++..+..++.||+.||+|||
T Consensus 84 ~~~~~~--------------~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 149 (293)
T cd05053 84 VCTQEG--------------PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA 149 (293)
T ss_pred EEcCCC--------------CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 987655 46999999999999999975311 12346899999999999999999999
Q ss_pred hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001152 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 942 s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1021 (1137)
+++|+||||||+|||++.+ +.+||+|||.++......... ......++..|+|||++.+ ..
T Consensus 150 ~~~ivH~dlkp~Nil~~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~ 210 (293)
T cd05053 150 SKKCIHRDLAARNVLVTED-------HVMKIADFGLARDIHHIDYYR--------KTTNGRLPVKWMAPEALFD----RV 210 (293)
T ss_pred HCCccccccceeeEEEcCC-------CeEEeCcccccccccccccee--------ccCCCCCCccccCHHHhcc----CC
Confidence 9999999999999999877 789999999987654321110 0011234568999999865 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1100 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1100 (1137)
++.++|||||||++|||++ |..||......++...+..+..+..+. .++..+
T Consensus 211 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 263 (293)
T cd05053 211 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQ---------------------------NCTQEL 263 (293)
T ss_pred cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHH
Confidence 7899999999999999997 999998877777766665443222111 234568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1101 VDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1101 ~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
.+|+.+||..||.+|||+.|+++++...
T Consensus 264 ~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 264 YHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.50 Aligned_cols=262 Identities=26% Similarity=0.355 Sum_probs=201.6
Q ss_pred CceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~-~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
+|++.+.||+|+||.||+|.. .+..+|+|+...+... ....+....++.+|+.++++++|+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--- 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc--hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC---
Confidence 478889999999999999987 4567888875443221 1222222345689999999999999999999988765
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
..++||||+++++|.+++.+ ...+++..+..++.||+.||+|||+.+|+|+||+|+||+++.+
T Consensus 76 -----------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~- 138 (265)
T cd06631 76 -----------TISIFMEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN- 138 (265)
T ss_pred -----------eEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-
Confidence 56999999999999999975 2358899999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.++|+|||.+............ ........++..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 139 ------~~~~l~dfg~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 139 ------GIIKLIDFGCARRLAWVGLHGTH----SNMLKSMHGTPYWMAPEVINE----SGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred ------CeEEeccchhhHhhhhccccccc----cccccccCCCccccChhhhcC----CCCcchhhHHHHHHHHHHHHhC
Confidence 78999999988754321111000 001123458889999999875 4578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcC--CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1042 QVPYMGLSELEIHDLIQMG--KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g--~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
..||...+.......+... ..+.++ ...+.++.+++.+||+.+|.+||++.
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~ 257 (265)
T cd06631 205 KPPLASMDRLAAMFYIGAHRGLMPRLP---------------------------DSFSAAAIDFVTSCLTRDQHERPSAL 257 (265)
T ss_pred CCccccCChHHHHHHhhhccCCCCCCC---------------------------CCCCHHHHHHHHHHhcCCcccCCCHH
Confidence 9999875544433333221 111111 13455689999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
|+++|+|+
T Consensus 258 ~~l~~~~~ 265 (265)
T cd06631 258 QLLRHDFL 265 (265)
T ss_pred HHhcCCCC
Confidence 99999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.18 Aligned_cols=259 Identities=22% Similarity=0.363 Sum_probs=202.0
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
.++|++.+.||+|+||.||+|.+.. ..+|+|.. .... ....... +.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~--~~~~-~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~ 77 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV--NENA-SMRERIE----FLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEec--CCcc-CHHHHHH----HHHHHHHHHhCCCCceeEEEEE
Confidence 3578999999999999999998743 45777763 2211 1222223 4789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHr 948 (1137)
+.... ..++||||+++++|.+++...... ....+++..+..|+.||+.||.|||+.+|+||
T Consensus 78 ~~~~~--------------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 143 (277)
T cd05032 78 VSTGQ--------------PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR 143 (277)
T ss_pred EcCCC--------------CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 88655 459999999999999999763221 12347889999999999999999999999999
Q ss_pred cCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhH
Q 001152 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028 (1137)
Q Consensus 949 DLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1028 (1137)
||||+|||++.+ +.+||+|||+++........ .......++..|+|||.+.+ ..++.++||
T Consensus 144 di~p~nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di 204 (277)
T cd05032 144 DLAARNCMVAED-------LTVKIGDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKD----GVFTTKSDV 204 (277)
T ss_pred ccChheEEEcCC-------CCEEECCcccchhhccCccc--------ccCCCCCccccccCHHHHhc----CCCCcccch
Confidence 999999999987 78999999998754432110 01112346789999999864 457899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001152 1029 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1107 (1137)
Q Consensus 1029 WSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~C 1107 (1137)
|||||++|||++ |..||...+..+....+..+..+..+. ..+.++.+++.+|
T Consensus 205 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~ 257 (277)
T cd05032 205 WSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE---------------------------NCPDKLLELMRMC 257 (277)
T ss_pred HHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHH
Confidence 999999999998 999998877777766665433222211 2345689999999
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 001152 1108 TEENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1108 L~~DP~~RPSa~EVL~~L~ 1126 (1137)
|+.+|++|||+.++++.+.
T Consensus 258 l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 258 WQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCChhhCCCHHHHHHHhc
Confidence 9999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=325.06 Aligned_cols=259 Identities=20% Similarity=0.314 Sum_probs=201.4
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
+.+|++.+.||+|+||.||+|.+.+ ..+|+|+...+ . ..... ..+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~--~-~~~~~----~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK--A-EGPLR----EEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC--C-CHHHH----HHHHHHHHHHhcCCCCCcCeEEEE
Confidence 4568899999999999999998732 45777764322 1 12222 234789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHS 942 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-----------~~~~~ls~~~i~~I~~QIa~gL~yLHs 942 (1137)
+.... ..++++||+++++|.+++..... .....+++..+..++.|++.||+|||+
T Consensus 77 ~~~~~--------------~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~ 142 (283)
T cd05091 77 VTKEQ--------------PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS 142 (283)
T ss_pred EcCCC--------------ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 88665 46999999999999999853110 112358889999999999999999999
Q ss_pred CCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCC
Q 001152 943 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022 (1137)
Q Consensus 943 ~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1022 (1137)
+||+||||||+||+++.+ +.+||+|||+++........ .......+++.|+|||++.+ ..+
T Consensus 143 ~gi~H~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~ 203 (283)
T cd05091 143 HHVVHKDLATRNVLVFDK-------LNVKISDLGLFREVYAADYY--------KLMGNSLLPIRWMSPEAIMY----GKF 203 (283)
T ss_pred cCccccccchhheEecCC-------CceEecccccccccccchhe--------eeccCccCCccccCHHHHhc----CCC
Confidence 999999999999999877 67999999998754332111 00112346779999999865 457
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001152 1023 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1101 (1137)
Q Consensus 1023 s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1101 (1137)
+.++|||||||++|||++ |..||.+....+....+........+. .++..+.
T Consensus 204 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~ 256 (283)
T cd05091 204 SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD---------------------------DCPAWVY 256 (283)
T ss_pred CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHH
Confidence 899999999999999998 889998887777777776544322211 3455689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 001152 1102 DVFRRCTEENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1102 dLl~~CL~~DP~~RPSa~EVL~~L~ 1126 (1137)
+++.+||+.+|.+||++++|+..+.
T Consensus 257 ~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 257 TLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHHhCCCcccCCCHHHHHHHhh
Confidence 9999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=324.35 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=197.7
Q ss_pred CCCceEeeeecccCceEEEEEEECCc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~----~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~ 875 (1137)
+++|++.+.||+|+||.||+|.+... .+++|.. +... .....+. +.+|+.++.++ +||||+++++++.
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~--~~~~-~~~~~~~----~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKML--KEFA-SENDHRD----FAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEc--cccC-CHHHHHH----HHHHHHHHHhhcCCCchhheEEEEc
Confidence 46899999999999999999987542 2455543 2211 1222233 37899999999 6999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELHSKH 944 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------~~~~ls~~~i~~I~~QIa~gL~yLHs~g 944 (1137)
... ..++||||+++++|.+++...... ....+++..+..|+.||+.||+|||++|
T Consensus 74 ~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 139 (297)
T cd05089 74 NRG--------------YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ 139 (297)
T ss_pred cCC--------------cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 655 459999999999999999752210 1135889999999999999999999999
Q ss_pred eeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCc
Q 001152 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1024 (1137)
Q Consensus 945 IIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1024 (1137)
|+||||||+|||++.+ +.+||+|||++........ ......+..|+|||++.+ ..++.
T Consensus 140 ivH~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~ 197 (297)
T cd05089 140 FIHRDLAARNVLVGEN-------LASKIADFGLSRGEEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTT 197 (297)
T ss_pred cccCcCCcceEEECCC-------CeEEECCcCCCccccceec-----------cCCCCcCccccCchhhcc----CCCCc
Confidence 9999999999999877 7899999998753221100 011123457999999865 46789
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 001152 1025 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1103 (1137)
Q Consensus 1025 ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1103 (1137)
++|||||||++|||++ |..||......++...+..+..+..+. .++..+.+|
T Consensus 198 ~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l 250 (297)
T cd05089 198 KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPR---------------------------NCDDEVYEL 250 (297)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHH
Confidence 9999999999999997 999998877777666654433221111 234568999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1104 FRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1104 l~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+.+||+.+|.+||+++++++.+...
T Consensus 251 i~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 251 MRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.46 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=191.5
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 885 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g 885 (1137)
+.||+|+||.||+|++. ++.+|+|+.... ...+.. ..+.+|++++++++||||+++++++....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 66 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLK----AKFLQEARILKQYSHPNIVRLIGVCTQKQ------- 66 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHH----HHHHHHHHHHHhCCCCCcceEEEEEcCCC-------
Confidence 46999999999999984 566888864211 112222 23488999999999999999999987655
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCC
Q 001152 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965 (1137)
Q Consensus 886 ~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~ 965 (1137)
..++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 67 -------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~----- 130 (252)
T cd05084 67 -------PIYIVMELVQGGDFLTFLRT----EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK----- 130 (252)
T ss_pred -------CeEEEEeeccCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-----
Confidence 46999999999999999865 12458999999999999999999999999999999999999877
Q ss_pred CCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 001152 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVP 1044 (1137)
Q Consensus 966 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~P 1044 (1137)
+.+||+|||.+......... . ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..|
T Consensus 131 --~~~kl~dfg~~~~~~~~~~~---~-----~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e~~~~~~~p 196 (252)
T cd05084 131 --NVLKISDFGMSREEEDGVYA---S-----TGGMKQIPVKWTAPEALNY----GRYSSESDVWSFGILLWEAFSLGAVP 196 (252)
T ss_pred --CcEEECccccCccccccccc---c-----cCCCCCCceeecCchhhcC----CCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 67999999998654321110 0 0011123457999999865 457899999999999999998 8999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~ 1124 (1137)
|...........+........+. ..+..+.+++.+||+.+|++|||+.+|++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 249 (252)
T cd05084 197 YANLSNQQTREAIEQGVRLPCPE---------------------------LCPDAVYRLMERCWEYDPGQRPSFSTVHQE 249 (252)
T ss_pred ccccCHHHHHHHHHcCCCCCCcc---------------------------cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 98766655555554432221111 234568999999999999999999999988
Q ss_pred HH
Q 001152 1125 FV 1126 (1137)
Q Consensus 1125 L~ 1126 (1137)
+.
T Consensus 250 l~ 251 (252)
T cd05084 250 LQ 251 (252)
T ss_pred Hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=324.58 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=201.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||.||+|.+. +..+++|....... ...+. +.+|+.+++.+.||||+++++.+....
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~----~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKEL----IINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHH----HHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 357999999999999999999874 46677776543221 12222 378999999999999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
+.++||||+++++|.+++.. ..+++.++..++.|++.||+|||+.||+||||||+|||++
T Consensus 91 --------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~ 150 (296)
T cd06654 91 --------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (296)
T ss_pred --------------EEEEeecccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence 67999999999999999865 3588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||.+........ ......+++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 151 ~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~~l 209 (296)
T cd06654 151 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 209 (296)
T ss_pred CC-------CCEEECccccchhcccccc----------ccCcccCCccccCHHHHcC----CCCCccchHHHHHHHHHHH
Confidence 77 7899999998865432110 0113368889999999875 4567999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|+.||...........+.....+.... ....++.+.+++.+||..||++||++
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~ 264 (296)
T cd06654 210 IEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLDMDVEKRGSA 264 (296)
T ss_pred HhCCCCCCCCCHHHhHHHHhcCCCCCCCC-------------------------ccccCHHHHHHHHHHCcCCcccCcCH
Confidence 99999998765543332222211111100 00234558999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001152 1119 GDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ss~ 1133 (1137)
.++++|+|+...-+.
T Consensus 265 ~eil~~~~~~~~~~~ 279 (296)
T cd06654 265 KELLQHQFLKIAKPL 279 (296)
T ss_pred HHHhhChhhhccCCc
Confidence 999999999765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.51 Aligned_cols=259 Identities=23% Similarity=0.303 Sum_probs=196.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|++.+.||+|+||.||+|.+. +..+|+|........ .. .....+.+|+.+++.++|+||+++++.+.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~--~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KR---KGESMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc--ch---HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence 3778899999999999999985 456777764322111 11 11123478999999999999999999987665
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~ 138 (285)
T cd05630 74 ------------ALCLVLTLMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH 138 (285)
T ss_pred ------------EEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 579999999999999988652 23458999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||++........ .....||..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~~l~Dfg~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~l~~ 196 (285)
T cd05630 139 -------GHIRISDLGLAVHVPEGQT-----------IKGRVGTVGYMAPEVVKN----ERYTFSPDWWALGCLLYEMIA 196 (285)
T ss_pred -------CCEEEeeccceeecCCCcc-----------ccCCCCCccccChHHHcC----CCCCCccccHHHHHHHHHHHh
Confidence 6799999998865432111 112368999999999875 467899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 1117 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS--- 1117 (1137)
|..||................. ..... .....++++.+|+.+||+.||.+|||
T Consensus 197 g~~Pf~~~~~~~~~~~~~~~~~-~~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 252 (285)
T cd05630 197 GQSPFQQRKKKIKREEVERLVK-EVQEE-----------------------YSEKFSPDARSLCKMLLCKDPKERLGCQG 252 (285)
T ss_pred CCCCCCCCCccchHHHHHhhhh-hhhhh-----------------------cCccCCHHHHHHHHHHhhcCHHHccCCCC
Confidence 9999976432111111110000 00000 00133456899999999999999999
Q ss_pred --HHHHHHHHHhhc
Q 001152 1118 --AGDLYEMFVART 1129 (1137)
Q Consensus 1118 --a~EVL~~L~~~~ 1129 (1137)
++|+++|+|+..
T Consensus 253 ~~~~~~~~h~~~~~ 266 (285)
T cd05630 253 GGAREVKEHPLFKQ 266 (285)
T ss_pred CchHHHHcChhhhc
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=326.09 Aligned_cols=279 Identities=23% Similarity=0.297 Sum_probs=201.1
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||+|.+.. ..+++|+...+ . .... ..++.+|++++++++||||+++++++..++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~-~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--I-KPAI----RNQIIRELKVLHECNSPYIVGFYGAFYSDG- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--c-CHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence 368999999999999999999865 44555553222 1 1222 223488999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeEec
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 958 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NILld 958 (1137)
+.++||||+++++|.++++. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++
T Consensus 73 -------------~~~lv~ey~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~ 134 (308)
T cd06615 73 -------------EISICMEHMDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134 (308)
T ss_pred -------------EEEEEeeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe
Confidence 67999999999999999976 2468999999999999999999997 5999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++....... .....+++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 135 ~~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~l 191 (308)
T cd06615 135 SR-------GEIKLCDFGVSGQLIDSM------------ANSFVGTRSYMSPERLQG----THYTVQSDIWSLGLSLVEM 191 (308)
T ss_pred cC-------CcEEEccCCCcccccccc------------cccCCCCcCccChhHhcC----CCCCccchHHHHHHHHHHH
Confidence 77 779999999886443211 113468899999999865 4578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHh-hhcccccc---------c-ccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELE-ALGSCHEH---------E-VAQSGSGFEKPEAELETLSFLVDVFRRC 1107 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~-~~~~~~~~---------~-~~~~~~~~~~~~~~~~~~~~L~dLl~~C 1107 (1137)
++|..||...........+..... ....... ........ . .........+.......+.++++++.+|
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 270 (308)
T cd06615 192 AIGRYPIPPPDAKELEAMFGRPVS-EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKC 270 (308)
T ss_pred HhCCCCCCCcchhhHHHhhcCccc-cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHH
Confidence 999999976655444433322111 0000000 00000000 0 0000000000000112456799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 001152 1108 TEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1108 L~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
|..||++|||+.||++|+|+...
T Consensus 271 l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 271 LKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccCChhhCcCHHHHhcChhhhhc
Confidence 99999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=321.21 Aligned_cols=281 Identities=23% Similarity=0.294 Sum_probs=202.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|++|.||+|.+. +..+|+|+....... ....+ .+.+|+.++++++||||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD--PVIKK----IALREIRMLKQLKHPNLVNLIEVFRRKR- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC--ccccH----HHHHHHHHHHhCCCCCEeeeeeEEeeCC-
Confidence 36899999999999999999985 567888875432211 11111 2377999999999999999999988665
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|..++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 74 -------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~ 135 (286)
T cd07847 74 -------------KLHLVFEYCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135 (286)
T ss_pred -------------EEEEEEeccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC
Confidence 67999999998888777654 235899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||++........ ......++..|+|||++.+ ...++.++|||||||++|+|+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~i~~~l~ 195 (286)
T cd07847 136 Q-------GQIKLCDFGFARILTGPGD----------DYTDYVATRWYRAPELLVG---DTQYGPPVDVWAIGCVFAELL 195 (286)
T ss_pred C-------CcEEECccccceecCCCcc----------cccCcccccccCCHHHHhC---CCCcCchhhhHHHHHHHHHHH
Confidence 7 7899999999876543211 0112357789999999864 245778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhc--c-cccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG--S-CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|..||.+....+....+................ . ......................+..+.+|+.+||+.||++||
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 275 (286)
T cd07847 196 TGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL 275 (286)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC
Confidence 9999998776655444443222111111100000 0 000000000000000011123467799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001152 1117 TAGDLYEMFVA 1127 (1137)
Q Consensus 1117 Sa~EVL~~L~~ 1127 (1137)
++.|++.|+|+
T Consensus 276 ~~~eil~~~~f 286 (286)
T cd07847 276 SCEELLEHPYF 286 (286)
T ss_pred CHHHHhcCCCC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.34 Aligned_cols=265 Identities=24% Similarity=0.382 Sum_probs=205.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||.|+||+||+|.+. +..+++|+....... . .... +.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~-~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--T-SVDE----LRKEVQAMSQCNHPNVVKYYTSFVVGD- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--h-HHHH----HHHHHHHHHhcCCCCEEEEEEEEeeCC-
Confidence 36899999999999999999974 456777775332221 1 2333 378999999999999999999887655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.++++.... ...+++..+..++.||+.||+|||++||+||||+|+||++++
T Consensus 73 -------------~~~iv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~ 137 (267)
T cd06610 73 -------------ELWLVMPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137 (267)
T ss_pred -------------EEEEEEeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC
Confidence 67999999999999999976321 246899999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||++.......... ........|+..|+|||++... ..++.++|+|||||++|+|+
T Consensus 138 ~-------~~~~l~df~~~~~~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~---~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 138 D-------GSVKIADFGVSASLADGGDRT------RKVRKTFVGTPCWMAPEVMEQV---HGYDFKADIWSFGITAIELA 201 (267)
T ss_pred C-------CCEEEcccchHHHhccCcccc------ccccccccCChhhcChHHHccc---cCcCcccchHhHhHHHHHHH
Confidence 7 679999999987655432110 0112244688999999998752 35789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|+.||...+.......+.....+.+.... .....++.+.+++.+||+.||++||++.
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQNDPPSLETGA----------------------DYKKYSKSFRKMISLCLQKDPSKRPTAE 259 (267)
T ss_pred hCCCCccccChhhhHHHHhcCCCCCcCCcc----------------------ccccccHHHHHHHHHHcCCChhhCcCHH
Confidence 999999876665544444333222111100 0113456689999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
++++|+|+
T Consensus 260 ~ll~~p~~ 267 (267)
T cd06610 260 ELLKHKFF 267 (267)
T ss_pred HHhhCCCC
Confidence 99999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.21 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=202.3
Q ss_pred CCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.+|++.++||.|+||.||+|.+.+ ..+++|+..... ...... +.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~----~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 75 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD----LLKQQD----FQKEVQALKRLRHKHLISLFAVCSVGE-- 75 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc----hhhHHH----HHHHHHHHhcCCCcchhheeeeEecCC--
Confidence 468899999999999999999865 667787743221 112223 377999999999999999999988665
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.++++.. ....+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 76 ------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~ 140 (261)
T cd05148 76 ------------PVYIITELMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED 140 (261)
T ss_pred ------------CeEEEEeecccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC
Confidence 469999999999999999762 23468999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||.+......... .....++..|+|||.+.. ..++.++||||||+++|+|++
T Consensus 141 -------~~~kl~d~g~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~----~~~~~~~DiwslG~~l~~l~~ 199 (261)
T cd05148 141 -------LVCKVADFGLARLIKEDVYL----------SSDKKIPYKWTAPEAASH----GTFSTKSDVWSFGILLYEMFT 199 (261)
T ss_pred -------ceEEEccccchhhcCCcccc----------ccCCCCceEecCHHHHcc----CCCCchhhHHHHHHHHHHHHc
Confidence 78999999998755332111 012235678999999865 467889999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|..||......+....+..+..+..+ ..+++.+.+++.+||+.||.+|||+.
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~ 252 (261)
T cd05148 200 YGQVPYPGMNNHEVYDQITAGYRMPCP---------------------------AKCPQEIYKIMLECWAAEPEDRPSFK 252 (261)
T ss_pred CCCCCCCcCCHHHHHHHHHhCCcCCCC---------------------------CCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 89999887777776666543322111 13445689999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
++++.|..
T Consensus 253 ~l~~~L~~ 260 (261)
T cd05148 253 ALREELDN 260 (261)
T ss_pred HHHHHHhc
Confidence 99998863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=323.91 Aligned_cols=261 Identities=28% Similarity=0.448 Sum_probs=202.5
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+.|++.++||+|+||.||+|++.. ..+++|+.... .....+.+ .+|+.+++.++||||+++++++..+.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~- 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDY----MVEIEILATCNHPYIVKLLGAFYWDG- 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHH----HHHHHHHHhCCCCcEeeeEEEEEeCC-
Confidence 568999999999999999999854 56777764322 12333333 78999999999999999999987655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|..++.+. ...+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 83 -------------~~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~ 145 (292)
T cd06644 83 -------------KLWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL 145 (292)
T ss_pred -------------eEEEEEecCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC
Confidence 569999999999999887642 245899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~EL 1038 (1137)
+ +.+||+|||++........ ......+++.|+|||++.+.. ....++.++|||||||++|+|
T Consensus 146 ~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el 208 (292)
T cd06644 146 D-------GDIKLADFGVSAKNVKTLQ----------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208 (292)
T ss_pred C-------CCEEEccCccceecccccc----------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHH
Confidence 6 7899999998764322111 112345788999999985321 124568899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||...+.......+.....+.... ....+.++.+++.+||+.||++||++
T Consensus 209 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~ 263 (292)
T cd06644 209 AQIEPPHHELNPMRVLLKIAKSEPPTLSQ-------------------------PSKWSMEFRDFLKTALDKHPETRPSA 263 (292)
T ss_pred hcCCCCCccccHHHHHHHHhcCCCccCCC-------------------------CcccCHHHHHHHHHHhcCCcccCcCH
Confidence 99999998766555444443332221110 00334458999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
+++++|+|+..-
T Consensus 264 ~~il~~~~~~~~ 275 (292)
T cd06644 264 AQLLEHPFVSSV 275 (292)
T ss_pred HHHhcCcccccc
Confidence 999999998753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=360.74 Aligned_cols=267 Identities=26% Similarity=0.416 Sum_probs=213.9
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEECC---c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceee
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKFGS---A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMY 871 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~---~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkll 871 (1137)
+.......++.+.||+|+||.||.|...+ . ++.||++.++.... ..+..+| ++|..+|++++|||||+++
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~F----l~Ea~~m~~f~HpNiv~li 761 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDF----LKEALLMSKFDHPNIVSLI 761 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHH----HHHHHHHhcCCCcceeeEE
Confidence 33445567889999999999999999732 2 55566665665433 4455555 9999999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSKHIMHRD 949 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~--~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrD 949 (1137)
|++.+.. ..+|++|||+||+|..+|++.+... ...++..+.+.++.|||+|+.||+++++||||
T Consensus 762 Gv~l~~~--------------~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRD 827 (1025)
T KOG1095|consen 762 GVCLDSG--------------PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRD 827 (1025)
T ss_pred EeecCCC--------------CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcc
Confidence 9998754 4599999999999999999853221 35689999999999999999999999999999
Q ss_pred CCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHH
Q 001152 950 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029 (1137)
Q Consensus 950 LKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVW 1029 (1137)
|.+.|+|++.. ..|||+|||+|+.+-..... ..+ + ...-...|||||.+.. ..++.|+|||
T Consensus 828 LAaRNCLL~~~-------r~VKIaDFGlArDiy~~~yy--r~~-~-----~a~lPvkWm~PEsl~d----~iFtskSDvW 888 (1025)
T KOG1095|consen 828 LAARNCLLDER-------RVVKIADFGLARDIYDKDYY--RKH-G-----EAMLPVKWMPPESLKD----GIFTSKSDVW 888 (1025)
T ss_pred hhhhheeeccc-------CcEEEcccchhHhhhhchhe--ecc-C-----ccccceecCCHHHHhh----cccccccchh
Confidence 99999999988 78999999999843322211 111 0 1122348999999986 6789999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001152 1030 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1108 (1137)
Q Consensus 1030 SLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL 1108 (1137)
||||++||++| |..||.+.+..++...+..+.+...+. .|++.+.++|..||
T Consensus 889 sFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~---------------------------~CP~~ly~lM~~CW 941 (1025)
T KOG1095|consen 889 SFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS---------------------------YCPEKLYQLMLQCW 941 (1025)
T ss_pred hhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC---------------------------CCChHHHHHHHHHc
Confidence 99999999999 899999999999888776555433221 56667999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhh
Q 001152 1109 EENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1109 ~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+.+|++||++..|++.+...
T Consensus 942 ~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 942 KHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred cCChhhCccHHHHHhhhhhh
Confidence 99999999999999976654
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=333.66 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=198.6
Q ss_pred CCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeee
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGH 873 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~ 873 (1137)
++|++.+.||+|+||.||+|.+.+ +.||+|++.... .....+. +.+|+.++.++ +||||++++++
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~----~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKA----LMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHH----HHHHHHHHHhhccCcchhheeee
Confidence 479999999999999999997532 468888753221 1223333 37899999999 79999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-------------------------------------
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------- 916 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~------------------------------------- 916 (1137)
+...+. ..++||||+++++|.+++......
T Consensus 80 ~~~~~~-------------~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (337)
T cd05054 80 CTKPGG-------------PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSG 146 (337)
T ss_pred EecCCC-------------CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccc
Confidence 875431 568999999999999998642110
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCc
Q 001152 917 -------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 977 (1137)
Q Consensus 917 -------------------~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGl 977 (1137)
....+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-------~~vkL~DfG~ 219 (337)
T cd05054 147 FIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-------NVVKICDFGL 219 (337)
T ss_pred cccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-------CcEEEecccc
Confidence 01368999999999999999999999999999999999999977 7899999999
Q ss_pred cccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHH
Q 001152 978 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHD 1055 (1137)
Q Consensus 978 a~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~e-l~~ 1055 (1137)
+..+...... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+ ...
T Consensus 220 a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~ 287 (337)
T cd05054 220 ARDIYKDPDY--------VRKGDARLPLKWMAPESIFD----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287 (337)
T ss_pred chhcccCcch--------hhccCCCCCccccCcHHhcC----CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH
Confidence 9765332111 01112346678999999875 568899999999999999998 999997644322 223
Q ss_pred HHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1056 LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1056 ~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
.+..+..+..+ ...++++.+++.+||+.+|++||++.||++++...-
T Consensus 288 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 288 RLKEGTRMRAP---------------------------EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHhccCCCCCC---------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 33332221111 023456899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.76 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=197.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|+||.||+|.+.. ..+|+|+.. ..... ... +.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~--~~~~~---~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIR--EGAMS---EDD----FIEEAKVMMKLSHPNLVQLYGVCTKQR- 72 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEec--cCCCC---HHH----HHHHHHHHHhCCCCCEEEEEEEEcCCC-
Confidence 4568899999999999999999854 468888743 21111 122 367999999999999999999987655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ...+++..+..|+.||+.||+|||++||+||||||+||+++.
T Consensus 73 -------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05059 73 -------------PIFIVTEYMANGCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135 (256)
T ss_pred -------------ceEEEEecCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC
Confidence 459999999999999998752 236899999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.++........ ......++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~il~~l~ 195 (256)
T cd05059 136 D-------NVVKVSDFGLARYVLDDQYT---------SSQGTKFPVKWAPPEVFDY----SRFSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CcEEECCcccceeccccccc---------ccCCCCCCccccCHHHhcc----CCCCchhhHHHHHHHHHHHh
Confidence 7 78999999988754322110 0011123457999999875 46788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||......+....+..+..+..+. ..+.++.+++.+||..+|++|||+
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~~Rpt~ 248 (256)
T cd05059 196 SEGKMPYERFSNSEVVESVSAGYRLYRPK---------------------------LAPTEVYTIMYSCWHEKPEDRPAF 248 (256)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHHHHhcCChhhCcCH
Confidence 9 899998777666666655443221110 245569999999999999999999
Q ss_pred HHHHHHH
Q 001152 1119 GDLYEMF 1125 (1137)
Q Consensus 1119 ~EVL~~L 1125 (1137)
.|+++.+
T Consensus 249 ~~~l~~l 255 (256)
T cd05059 249 KKLLSQL 255 (256)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=326.47 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=201.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|... +..+|+|....... ...+. +.+|+.+++.++||||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~~- 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKEL----IINEILVMRENKNPNIVNYLDSYLVGD- 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHH----HHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 67999999999999999999873 57788887543221 12222 377999999999999999999998665
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.
T Consensus 90 -------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~ 150 (297)
T cd06656 90 -------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM 150 (297)
T ss_pred -------------EEEEeecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 67999999999999999865 35889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||.+........ ......+++.|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 151 ~-------~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slGvil~~l~ 209 (297)
T cd06656 151 D-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEMV 209 (297)
T ss_pred C-------CCEEECcCccceEccCCcc----------CcCcccCCccccCHHHHcC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 7899999998865432211 0113358889999999875 45789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||...+.......+.....+... .....++.+.+++.+||+.+|++||+++
T Consensus 210 tg~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ 264 (297)
T cd06656 210 EGEPPYLNENPLRALYLIATNGTPELQ-------------------------NPERLSAVFRDFLNRCLEMDVDRRGSAK 264 (297)
T ss_pred hCCCCCCCCCcchheeeeccCCCCCCC-------------------------CccccCHHHHHHHHHHccCChhhCcCHH
Confidence 999999765443222222111111100 0013345589999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 001152 1120 DLYEMFVARTSSSI 1133 (1137)
Q Consensus 1120 EVL~~L~~~~~ss~ 1133 (1137)
++++|+|+......
T Consensus 265 ~il~~~~~~~~~~~ 278 (297)
T cd06656 265 ELLQHPFLKLAKPL 278 (297)
T ss_pred HHhcCchhcccccc
Confidence 99999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=324.12 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=205.1
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||.|++|.||+|.+ .+..+++|....... ...+. +.+|+.+++.++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKEL----IINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHH----HHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 45799999999999999999987 456788887543221 11222 377999999999999999999988655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|..++.. ..+++.++..++.|++.||+|||++||+||||||+||+++
T Consensus 90 --------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~ 149 (296)
T cd06655 90 --------------ELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149 (296)
T ss_pred --------------eEEEEEEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 67999999999999998865 3589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 150 ~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~~l 208 (296)
T cd06655 150 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 208 (296)
T ss_pred CC-------CCEEEccCccchhcccccc----------cCCCcCCCccccCcchhcC----CCCCchhhHHHHHHHHHHH
Confidence 77 7899999998875432211 0112358889999999865 4578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||...+.......+.....+.+.. ....++.+.+++.+||..||.+||++
T Consensus 209 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~Rpt~ 263 (296)
T cd06655 209 VEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSPIFRDFLNRCLEMDVEKRGSA 263 (296)
T ss_pred HhCCCCCCCCCHHHHHHHHHhcCCcccCC-------------------------cccCCHHHHHHHHHHhhcChhhCCCH
Confidence 99999998876655444443222111110 00344568999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001152 1119 GDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ss~ 1133 (1137)
.+++.|+|+......
T Consensus 264 ~~il~~~~~~~~~~~ 278 (296)
T cd06655 264 KELLQHPFLKLAKPL 278 (296)
T ss_pred HHHhhChHhhhcccc
Confidence 999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.52 Aligned_cols=255 Identities=30% Similarity=0.453 Sum_probs=205.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||.|++|.||+|.+. +..+++|+...+.. ......+ .+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA---EDEIEDI----QQEIQFLSQCRSPYITKYYGSFLKGS- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc---chHHHHH----HHHHHHHHHcCCCCeeeeeEEEEECC-
Confidence 36888999999999999999984 46788887643321 2222333 77999999999999999999988654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++|+||||+|+||+++.
T Consensus 73 -------------~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (274)
T cd06609 73 -------------KLWIIMEYCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133 (274)
T ss_pred -------------eEEEEEEeeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 67999999999999999875 26899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||.+........ ......+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 134 ~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~sDv~slG~il~~l~ 192 (274)
T cd06609 134 E-------GDVKLADFGVSGQLTSTMS----------KRNTFVGTPFWMAPEVIKQ----SGYDEKADIWSLGITAIELA 192 (274)
T ss_pred C-------CCEEEcccccceeeccccc----------ccccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 7899999999876553211 1113458889999999875 34889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|+.||...+.......+.....+.+... ..+..+.+++.+||..||++|||++
T Consensus 193 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~~l~~~p~~Rpt~~ 246 (274)
T cd06609 193 KGEPPLSDLHPMRVLFLIPKNNPPSLEGN--------------------------KFSKPFKDFVSLCLNKDPKERPSAK 246 (274)
T ss_pred hCCCCcccCchHHHHHHhhhcCCCCCccc--------------------------ccCHHHHHHHHHHhhCChhhCcCHH
Confidence 99999987666555544444332222110 1344589999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001152 1120 DLYEMFVARTS 1130 (1137)
Q Consensus 1120 EVL~~L~~~~~ 1130 (1137)
++++|+|+...
T Consensus 247 ~il~~~~~~~~ 257 (274)
T cd06609 247 ELLKHKFIKKA 257 (274)
T ss_pred HHhhChhhcCC
Confidence 99999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=338.71 Aligned_cols=262 Identities=25% Similarity=0.349 Sum_probs=198.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg 872 (1137)
-.+|++.++||+|+||.||+|++.+ ..||+|+.... . .....+ .+.+|+.+++++. |||||++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~-~~~~~~----~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--A-RSSEKQ----ALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--C-ChHHHH----HHHHHHHHHHhcCCCCCeeeEEE
Confidence 3568899999999999999998632 24788874322 1 122223 3488999999996 999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------------------------------------
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------ 916 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~------------------------------------ 916 (1137)
++.+.. ..++|||||++|+|.+++......
T Consensus 109 ~~~~~~--------------~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (400)
T cd05105 109 ACTKSG--------------PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK 174 (400)
T ss_pred EEccCC--------------ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence 997655 569999999999999998753210
Q ss_pred -------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 001152 917 -------------------------------------------------------GEKHVSVKLALFIAQDVAAALVELH 941 (1137)
Q Consensus 917 -------------------------------------------------------~~~~ls~~~i~~I~~QIa~gL~yLH 941 (1137)
....+++..+..++.||+.||+|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 254 (400)
T cd05105 175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA 254 (400)
T ss_pred ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 1134788899999999999999999
Q ss_pred hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001152 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 942 s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1021 (1137)
+++|+||||||+|||++.+ +.+||+|||+++........ .......+++.|+|||.+.+ ..
T Consensus 255 ~~~ivH~dikp~Nill~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~ 315 (400)
T cd05105 255 SKNCVHRDLAARNVLLAQG-------KIVKICDFGLARDIMHDSNY--------VSKGSTFLPVKWMAPESIFD----NL 315 (400)
T ss_pred hCCeeCCCCChHhEEEeCC-------CEEEEEeCCcceeccccccc--------cccCCcCCCcceEChhhhcC----CC
Confidence 9999999999999999877 78999999998754332111 11112346788999999875 46
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1099 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~e-l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1137)
++.++|||||||++|||++ |..||......+ ....+..+..+..+ ...+.+
T Consensus 316 ~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~ 368 (400)
T cd05105 316 YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP---------------------------DHATQE 368 (400)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCC---------------------------ccCCHH
Confidence 7899999999999999997 999997654332 23333332221111 134556
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1100 LVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1100 L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+.+++.+||+.||++||++.+|.+.+....
T Consensus 369 l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 369 VYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=314.43 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=202.7
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
..+|++.+.||+|+||.||+|...+..+|+|....... ..+ ++.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-----~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 73 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-----AAQ----AFLAEASVMTTLRHPNLVQLLGVVLQGN-- 73 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-----HHH----HHHHHHHHHHhcCCcceeeeEEEEcCCC--
Confidence 45788999999999999999999999999998643321 222 3488999999999999999999987644
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.++++.. ....+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 74 ------------~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~ 138 (256)
T cd05039 74 ------------PLYIVTEYMAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED 138 (256)
T ss_pred ------------CeEEEEEecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC
Confidence 569999999999999998762 22368999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||.+........ ....+..|+|||++.. ..++.++||||||+++|+|++
T Consensus 139 -------~~~~l~d~g~~~~~~~~~~-------------~~~~~~~~~ape~~~~----~~~~~~~Di~slG~il~~l~~ 194 (256)
T cd05039 139 -------LVAKVSDFGLAKEASQGQD-------------SGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred -------CCEEEcccccccccccccc-------------cCCCcccccCchhhcC----CcCCcHHHHHHHHHHHHHHHh
Confidence 7899999999876532110 1124557999999864 457789999999999999997
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|..||......++...+..+..+..+ ...++.+.+++.+||..+|++||++.
T Consensus 195 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 247 (256)
T cd05039 195 FGRVPYPRIPLKDVVPHVEKGYRMEAP---------------------------EGCPPEVYKVMKDCWELDPAKRPTFK 247 (256)
T ss_pred cCCCCCCCCCHHHHHHHHhcCCCCCCc---------------------------cCCCHHHHHHHHHHhccChhhCcCHH
Confidence 99999887776666655543222111 03345699999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
++++.+..
T Consensus 248 ~l~~~l~~ 255 (256)
T cd05039 248 QLREQLAL 255 (256)
T ss_pred HHHHHHhc
Confidence 99998853
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=323.01 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=199.5
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|+..+.||+|+||+||+|.+. +..+|+|+........ ... ...+.+|+++++.++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~----~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKG----ESMALNEKQILEKVNSQFVVNLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-hhH----HHHHHHHHHHHHHcCCcCceeEEEEEecCC--
Confidence 3678899999999999999985 4678888753322111 111 122477999999999999999999887665
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++... +...+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~ 138 (285)
T cd05632 74 ------------ALCLVLTIMNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY 138 (285)
T ss_pred ------------EEEEEEEeccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC
Confidence 569999999999999988652 23469999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||++........ .....|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 139 -------~~~kl~Dfg~~~~~~~~~~-----------~~~~~g~~~~~aPE~~~~----~~~~~~~Di~slG~~l~~l~~ 196 (285)
T cd05632 139 -------GHIRISDLGLAVKIPEGES-----------IRGRVGTVGYMAPEVLNN----QRYTLSPDYWGLGCLIYEMIE 196 (285)
T ss_pred -------CCEEEecCCcceecCCCCc-----------ccCCCCCcCccChHHhcC----CCCCcccchHHHHHHHHHHHh
Confidence 6799999998865432110 113368999999999875 467899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC---
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT--- 1117 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS--- 1117 (1137)
|..||...........+....... ...+ ....++++.+|+.+||+.||++||+
T Consensus 197 g~~P~~~~~~~~~~~~~~~~~~~~-~~~~-----------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 197 GQSPFRGRKEKVKREEVDRRVLET-EEVY-----------------------SAKFSEEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHhhhcc-cccc-----------------------CccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence 999998765543333332111000 0000 0133456899999999999999999
Q ss_pred --HHHHHHHHHhhcC
Q 001152 1118 --AGDLYEMFVARTS 1130 (1137)
Q Consensus 1118 --a~EVL~~L~~~~~ 1130 (1137)
++++++|.|+...
T Consensus 253 ~~~~~l~~~~~~~~~ 267 (285)
T cd05632 253 EGAGEVKRHPFFRNM 267 (285)
T ss_pred cChHHHHcChhhhcC
Confidence 8999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=333.63 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=202.8
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||++++.. ..+|+|+...... ...... ..+.+|+.++..++|+||+++++++.+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~l~~~~~~~~- 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAET----ACFREERNVLVNGDCQWITTLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHH----HHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 468999999999999999999854 5688887532111 011111 23477899999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..|+||||++||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~ 137 (331)
T cd05624 75 -------------YLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM 137 (331)
T ss_pred -------------EEEEEEeCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC
Confidence 679999999999999999752 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC-CCCCCchhhHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~s~ksDVWSLGviL~EL 1038 (1137)
+ +.+||+|||++......... ......||+.|+|||++.+... ...++.++|||||||++|+|
T Consensus 138 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el 201 (331)
T cd05624 138 N-------GHIRLADFGSCLKMNQDGTV---------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 201 (331)
T ss_pred C-------CCEEEEeccceeeccCCCce---------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence 7 78999999998754332110 1113469999999999875211 13567899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 1115 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~--R 1115 (1137)
++|+.||...+..+....+.... ...++.. ....++++.+++.+||..++.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~------------------------~~~~~~~~~~li~~ll~~~~~~~~~ 257 (331)
T cd05624 202 LYGETPFYAESLVETYGKIMNHEERFQFPSH------------------------ITDVSEEAKDLIQRLICSRERRLGQ 257 (331)
T ss_pred hhCCCCccCCCHHHHHHHHHcCCCcccCCCc------------------------cccCCHHHHHHHHHHccCchhhcCC
Confidence 99999998877766666554322 1111110 0134556999999999876655 5
Q ss_pred CCHHHHHHHHHhhc
Q 001152 1116 PTAGDLYEMFVART 1129 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~ 1129 (1137)
++++++++|+|+..
T Consensus 258 ~~~~~~~~h~~f~~ 271 (331)
T cd05624 258 NGIEDFKKHAFFEG 271 (331)
T ss_pred CCHHHHhcCCCcCC
Confidence 79999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=325.12 Aligned_cols=263 Identities=24% Similarity=0.373 Sum_probs=202.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 870 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~---------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkl 870 (1137)
.++|.+.+.||+|+||.||+|.+.+ ..+|+|+..... ....... +.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~----~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSD----LISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHH----HHHHHHHHHHhcCCCCEeeE
Confidence 4679999999999999999998632 347777643221 1222333 37799999999 69999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001152 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 939 (1137)
Q Consensus 871 lg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------~~~~ls~~~i~~I~~QIa~gL~y 939 (1137)
++++...+ ..++||||+++++|.+++...... ....+++.+++.++.||+.||+|
T Consensus 90 ~~~~~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 155 (307)
T cd05098 90 LGACTQDG--------------PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEY 155 (307)
T ss_pred EEEEecCC--------------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 99987665 569999999999999999763211 12358999999999999999999
Q ss_pred HHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 940 LHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
||++||+||||||+||+++.+ +.+||+|||.+.......... ......+++.|+|||++.+
T Consensus 156 lH~~gi~H~dlkp~Nill~~~-------~~~kL~dfg~a~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 216 (307)
T cd05098 156 LASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYYK--------KTTNGRLPVKWMAPEALFD---- 216 (307)
T ss_pred HHHCCcccccccHHheEEcCC-------CcEEECCCcccccccccchhh--------ccccCCCccceeChHHhcc----
Confidence 999999999999999999877 789999999886543211100 0001124568999999875
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001152 1020 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1098 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1137)
..++.++|||||||++|+|++ |..||.+....++...+..+.....+. ..+.
T Consensus 217 ~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 269 (307)
T cd05098 217 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS---------------------------NCTN 269 (307)
T ss_pred CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCC---------------------------cCCH
Confidence 457899999999999999998 889998877666666655433221111 3345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1099 FLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1099 ~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
++.+++.+||+.+|.+||++.+|++++.....
T Consensus 270 ~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 270 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 68999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=316.06 Aligned_cols=254 Identities=23% Similarity=0.379 Sum_probs=199.8
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|++|.||+|.+.. ..+|+|..... .. ..++ +.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~---~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG--TM---DPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEE- 74 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC--cc---cHHH----HHHHHHHHHHCCCCCccceeEEEecCC-
Confidence 3568999999999999999998754 56777764322 11 1223 378999999999999999999987655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 75 -------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 138 (261)
T cd05068 75 -------------PIYIVTELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE 138 (261)
T ss_pred -------------CeeeeeecccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC
Confidence 469999999999999999762 2346899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++......... .......+..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 139 ~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~ 198 (261)
T cd05068 139 N-------NICKVADFGLARVIKEDIYE---------AREGAKFPIKWTAPEAALY----NRFSIKSDVWSFGILLTEIV 198 (261)
T ss_pred C-------CCEEECCcceEEEccCCccc---------ccCCCcCceeccCcccccc----CCCCchhhHHHHHHHHHHHH
Confidence 7 78999999998765422111 0001123457999998865 46789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |+.||.+....++...+........+. ..+..+.+++.+||+.+|.+||++
T Consensus 199 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~P~~Rp~~ 251 (261)
T cd05068 199 TYGRMPYPGMTNAEVLQQVDQGYRMPCPP---------------------------GCPKELYDIMLDCWKEDPDDRPTF 251 (261)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHhhcCcccCCCH
Confidence 9 999998877766666664432211110 234569999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
.++++.++.
T Consensus 252 ~~l~~~l~~ 260 (261)
T cd05068 252 ETLQWKLED 260 (261)
T ss_pred HHHHHHHhc
Confidence 999998763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=321.59 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=193.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.++||+|+||.||+|.+. +..+|+|+..... .....+ .+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 72 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQK----QIMSELEILYKCDSPYIIGFYGAFFVEN-- 72 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHH----HHHHHHHHHHhCCCCCeeeEEEEEEECC--
Confidence 5788899999999999999874 4668888754321 122222 3478999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|..+. .+++..+..++.|++.||+|||+.||+|+||||+|||++.+
T Consensus 73 ------------~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~ 131 (279)
T cd06619 73 ------------RISICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR 131 (279)
T ss_pred ------------EEEEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC
Confidence 569999999999996542 36788999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||++....... .....+|..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 132 -------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~l~~ 188 (279)
T cd06619 132 -------GQVKLCDFGVSTQLVNSI------------AKTYVGTNAYMAPERISG----EQYGIHSDVWSLGISFMELAL 188 (279)
T ss_pred -------CCEEEeeCCcceeccccc------------ccCCCCChhhcCceeecC----CCCCCcchHHHHHHHHHHHHh
Confidence 789999999987543221 113468999999999875 457899999999999999999
Q ss_pred CCCCCCCCCHH-------HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1041 LQVPYMGLSEL-------EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1041 G~~Pf~~~~~~-------el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
|+.||...... .....+.....+.. .....++++.+++.+||+.||+
T Consensus 189 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~P~ 242 (279)
T cd06619 189 GRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL--------------------------PVGQFSEKFVHFITQCMRKQPK 242 (279)
T ss_pred CCCCchhhcccccccchHHHHHHHhccCCCCC--------------------------CCCcCCHHHHHHHHHHhhCChh
Confidence 99999642211 11111111110000 0012345689999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001152 1114 ERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~ 1130 (1137)
+||+++|+++|+|+...
T Consensus 243 ~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 243 ERPAPENLMDHPFIVQY 259 (279)
T ss_pred hCCCHHHHhcCcccccc
Confidence 99999999999998744
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=334.13 Aligned_cols=265 Identities=23% Similarity=0.289 Sum_probs=203.1
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.++||+|+||.||++++.. ..+|+|+...... ...... ..+..|+.++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAET----ACFREERDVLVNGDNQWITTLHYAFQDEN- 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HHhhHH----HHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 368999999999999999999854 5678887532111 001111 22477899999999999999999988665
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.+++.+. ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 75 -------------~~~lv~ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~ 137 (332)
T cd05623 75 -------------NLYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 137 (332)
T ss_pred -------------EEEEEEeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC
Confidence 679999999999999999752 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~EL 1038 (1137)
+ +.+||+|||++........ .......||+.|+|||++.+.. ....++.++|||||||++|||
T Consensus 138 ~-------~~~kL~DfG~a~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el 201 (332)
T cd05623 138 N-------GHIRLADFGSCLKLMEDGT---------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201 (332)
T ss_pred C-------CCEEEeecchheecccCCc---------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence 7 7899999999865432111 0112346999999999986421 124578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--C
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE--R 1115 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~--R 1115 (1137)
++|+.||...+..+....+..... ..++. .....++++.+++.+|+..++.+ |
T Consensus 202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------~~~~~s~~~~~li~~ll~~~~~r~~r 257 (332)
T cd05623 202 LYGETPFYAESLVETYGKIMNHKERFQFPA------------------------QVTDVSEDAKDLIRRLICSREHRLGQ 257 (332)
T ss_pred hcCCCCCCCCCHHHHHHHHhCCCccccCCC------------------------ccccCCHHHHHHHHHHccChhhhcCC
Confidence 999999998877777666644321 11110 00134566899999999665555 7
Q ss_pred CCHHHHHHHHHhhc
Q 001152 1116 PTAGDLYEMFVART 1129 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~ 1129 (1137)
++++|+++|+|+..
T Consensus 258 ~~~~~~~~h~~f~~ 271 (332)
T cd05623 258 NGIEDFKQHPFFTG 271 (332)
T ss_pred CCHHHHhCCCCcCC
Confidence 89999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=316.89 Aligned_cols=261 Identities=27% Similarity=0.401 Sum_probs=196.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|+..+.||+|+||.||+|... +..+++|+........ ... .....+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~--~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESP--ETS-KEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCc--hhH-HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 36888999999999999999874 4678888654332211 111 111234889999999999999999998875321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
...++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+||+++.
T Consensus 79 ------------~~~~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~ 141 (266)
T cd06651 79 ------------KTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS 141 (266)
T ss_pred ------------CEEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence 157999999999999999975 235889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++.......... .......++..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 142 A-------GNVKLGDFGASKRLQTICMSG-------TGIRSVTGTPYWMSPEVISG----EGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred C-------CCEEEccCCCccccccccccC-------CccccCCccccccCHHHhCC----CCCCchhhhHHHHHHHHHHH
Confidence 7 679999999987543211110 01112357889999999875 45789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHc-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~-g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+|+.||...........+.. ...+.++. ..++.+.+++ +||..+|++||++
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li-~~~~~~p~~Rp~~ 255 (266)
T cd06651 204 TEKPPWAEYEAMAAIFKIATQPTNPQLPS---------------------------HISEHARDFL-GCIFVEARHRPSA 255 (266)
T ss_pred HCCCCccccchHHHHHHHhcCCCCCCCch---------------------------hcCHHHHHHH-HHhcCChhhCcCH
Confidence 99999986554433333221 11111111 2334577787 6888999999999
Q ss_pred HHHHHHHHhh
Q 001152 1119 GDLYEMFVAR 1128 (1137)
Q Consensus 1119 ~EVL~~L~~~ 1128 (1137)
+||++|+|+.
T Consensus 256 ~eil~hp~~~ 265 (266)
T cd06651 256 EELLRHPFAQ 265 (266)
T ss_pred HHHhcCcccc
Confidence 9999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=319.67 Aligned_cols=265 Identities=22% Similarity=0.364 Sum_probs=201.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
..+|++.++||+|+||.||+|... ...+|+|.. .... ...... .+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~--~~~~-~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~ 77 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESA-SLRERI----EFLNEASVMKGFTCHHVVRLLGV 77 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEEC--CCcC-CHHHHH----HHHHHHHHHHhCCCCCeeeEEEE
Confidence 457999999999999999999753 235677653 2221 122222 24789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHr 948 (1137)
+.+.. ..++||||+++|+|.++++..... ....+++..+..++.||+.||.|||+++|+||
T Consensus 78 ~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~ 143 (288)
T cd05061 78 VSKGQ--------------PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHR 143 (288)
T ss_pred EcCCC--------------CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 87655 459999999999999999763221 12346778899999999999999999999999
Q ss_pred cCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhH
Q 001152 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028 (1137)
Q Consensus 949 DLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1028 (1137)
||||+||+++.+ +.++|+|||+++........ .......++..|+|||.+.+ ..++.++||
T Consensus 144 dikp~nili~~~-------~~~~L~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv 204 (288)
T cd05061 144 DLAARNCMVAHD-------FTVKIGDFGMTRDIYETDYY--------RKGGKGLLPVRWMAPESLKD----GVFTTSSDM 204 (288)
T ss_pred CCChheEEEcCC-------CcEEECcCCccccccccccc--------cccCCCcccccccCHHHhcc----CCCChHhHH
Confidence 999999999977 78999999998754322110 00112235678999999875 457899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001152 1029 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1107 (1137)
Q Consensus 1029 WSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~C 1107 (1137)
|||||++|||++ |..||.+....++...+..+..+..+. ..++.+.+++.+|
T Consensus 205 wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~ 257 (288)
T cd05061 205 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD---------------------------NCPERVTDLMRMC 257 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHH
Confidence 999999999998 789998877776666554433222111 2345699999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcCCC
Q 001152 1108 TEENPTERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1108 L~~DP~~RPSa~EVL~~L~~~~~ss 1132 (1137)
|+.||++|||+.++++.+.....++
T Consensus 258 l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 258 WQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred cCCChhHCcCHHHHHHHHHhhcCCC
Confidence 9999999999999999877654443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=313.92 Aligned_cols=258 Identities=28% Similarity=0.416 Sum_probs=201.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|.+. +..+++|+...... ...+. +.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~~~- 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFEI----IQQEISMLKECRHPNIVAYFGSYLRRD- 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhHHH----HHHHHHHHHhCCCCChhceEEEEEeCC-
Confidence 57899999999999999999984 46788888653321 12233 378999999999999999999987655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus 74 -------------~~~l~~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 136 (262)
T cd06613 74 -------------KLWIVMEYCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE 136 (262)
T ss_pred -------------EEEEEEeCCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC
Confidence 679999999999999998762 246899999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.+........ ......++..|+|||.+.+.. ...++.++|||||||++|+|+
T Consensus 137 ~-------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~Pe~~~~~~-~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 137 D-------GDVKLADFGVSAQLTATIA----------KRKSFIGTPYWMAPEVAAVER-KGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred C-------CCEEECccccchhhhhhhh----------ccccccCCccccCchhhcccc-cCCcCchhhhHHHHHHHHHHH
Confidence 7 7799999998875443211 011335788999999986521 136778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|+.||...........+......... . ......+.++.+++.+||..+|.+|||+.
T Consensus 199 tg~~p~~~~~~~~~~~~~~~~~~~~~~--~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 255 (262)
T cd06613 199 ELQPPMFDLHPMRALFLISKSNFPPPK--L---------------------KDKEKWSPVFHDFIKKCLTKDPKKRPTAT 255 (262)
T ss_pred hCCCCCCCCCHHHHHHHHHhccCCCcc--c---------------------cchhhhhHHHHHHHHHHcCCChhhCCCHH
Confidence 999999877665544444332111000 0 00113456699999999999999999999
Q ss_pred HHHHHHH
Q 001152 1120 DLYEMFV 1126 (1137)
Q Consensus 1120 EVL~~L~ 1126 (1137)
+|+.|.|
T Consensus 256 ~il~~~~ 262 (262)
T cd06613 256 KLLQHPF 262 (262)
T ss_pred HHhcCCC
Confidence 9999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=318.69 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=202.5
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|+..+.||+|+||.||+|.+. +..+|+|+...... ...... +.+|+.+++++.||||+++++++.+..
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA---EDEIED----IQQEITVLSQCDSPYVTKYYGSYLKGT-- 75 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc---HHHHHH----HHHHHHHHHhCCCCCEeeEEEEEEECC--
Confidence 4778899999999999999974 46788887543321 222333 478999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.+
T Consensus 76 ------------~~~lv~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~ 137 (277)
T cd06640 76 ------------KLWIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ 137 (277)
T ss_pred ------------EEEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC
Confidence 67999999999999998864 358899999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||++......... .....++..|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~apE~~~~----~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06640 138 -------GDVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIQQ----SAYDSKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEcccccceeccCCccc----------cccccCcccccCHhHhcc----CCCccHHHHHHHHHHHHHHHH
Confidence 67999999998654332110 112357889999999865 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|+.||...........+.....+.+. ...+..+.+++.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06640 197 GEPPNSDMHPMRVLFLIPKNNPPTLT---------------------------GEFSKPFKEFIDACLNKDPSFRPTAKE 249 (277)
T ss_pred CCCCCCCcChHhHhhhhhcCCCCCCc---------------------------hhhhHHHHHHHHHHcccCcccCcCHHH
Confidence 99999876665554444332222211 134556899999999999999999999
Q ss_pred HHHHHHhhcC
Q 001152 1121 LYEMFVARTS 1130 (1137)
Q Consensus 1121 VL~~L~~~~~ 1130 (1137)
++.|+|+...
T Consensus 250 il~~~~~~~~ 259 (277)
T cd06640 250 LLKHKFIVKN 259 (277)
T ss_pred HHhChHhhhc
Confidence 9999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=321.26 Aligned_cols=261 Identities=25% Similarity=0.359 Sum_probs=201.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||+|.+. +..+|+|....+. ....... +.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~- 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQ----IIMELDILHKAVSPYIVDFYGAFFIEG- 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHH----HHHHHHHHHhcCCCcHHhhhhheecCC-
Confidence 36889999999999999999985 5677887654321 1222233 478999999999999999999988655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeEec
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILID 958 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|..+++.. .....+++..+..++.||+.||.|||+ .+|+||||||+||+++
T Consensus 73 -------------~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~ 137 (286)
T cd06622 73 -------------AVYMCMEYMDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137 (286)
T ss_pred -------------eEEEEEeecCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC
Confidence 569999999999999988752 112368999999999999999999996 5999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc--CCCCCCchhhHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVWSLGviL~ 1036 (1137)
.+ +.+||+|||.+....... .....+++.|+|||.+.+.. ....++.++|||||||++|
T Consensus 138 ~~-------~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 138 GN-------GQVKLCDFGVSGNLVASL------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred CC-------CCEEEeecCCcccccCCc------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 76 789999999886543211 11235788999999986421 1124578999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHH---HcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLI---QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I---~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|++|+.||...........+ ..+..+.++. ..++++.+++.+||+.+|+
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~ 251 (286)
T cd06622 199 EMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS---------------------------GYSDDAQDFVAKCLNKIPN 251 (286)
T ss_pred HHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc---------------------------ccCHHHHHHHHHHcccCcc
Confidence 999999999765444333322 2222222111 3455689999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 001152 1114 ERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~s 1131 (1137)
+||+++++++|+|+....
T Consensus 252 ~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 252 RRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cCCCHHHHhcChhhhhcc
Confidence 999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=316.60 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=187.4
Q ss_pred eeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
+.||+|+||.||+|.... ..+++|. ..... ...... .+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~--~~~~~-~~~~~~----~~~~e~~~~~~l~h~nii~~~~~~~~~~----- 68 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKE--LRASA-TPDEQL----LFLQEVQPYRELNHPNVLQCLGQCIESI----- 68 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEee--cCccC-ChHHHH----HHHHHHHHHHhCCCCCcceEEEEECCCC-----
Confidence 369999999999997532 2345553 22221 122222 3478999999999999999999987655
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
..++||||+++|+|.+++...........++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 ---------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~--- 136 (269)
T cd05042 69 ---------PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD--- 136 (269)
T ss_pred ---------ceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC---
Confidence 56999999999999999976432222345788889999999999999999999999999999999987
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc---CCCCCCchhhHHHHHHHHHHHHh
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||++......... .......+++.|+|||++.... ....++.++|||||||++|||++
T Consensus 137 ----~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05042 137 ----LSVKIGDYGLALEQYPEDYY--------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204 (269)
T ss_pred ----CcEEEeccccccccccchhe--------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence 78999999988643221100 0011234667899999975311 12356889999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|..||......+....+.......++.. ......++.+.+++..|| .||++|||++
T Consensus 205 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~ 261 (269)
T cd05042 205 AADQPYPDLSDEQVLKQVVREQDIKLPKP----------------------QLDLKYSDRWYEVMQFCW-LDPETRPTAE 261 (269)
T ss_pred CCCCCCCcCCHHHHHHHHhhccCccCCCC----------------------cccccCCHHHHHHHHHHh-cCcccccCHH
Confidence 7889987766555544433222111110 001134456788899998 5999999999
Q ss_pred HHHHHH
Q 001152 1120 DLYEMF 1125 (1137)
Q Consensus 1120 EVL~~L 1125 (1137)
+|++.+
T Consensus 262 ~v~~~l 267 (269)
T cd05042 262 EVHELL 267 (269)
T ss_pred HHHHHh
Confidence 999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=317.02 Aligned_cols=269 Identities=25% Similarity=0.360 Sum_probs=205.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEe
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 875 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~ 875 (1137)
...++|++.+.||+|++|.||+|.+. +..+++|+..... ...+. +.+|+.+++++ .||||+++++++.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~----~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEE----IKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHH----HHHHHHHHHHhcCCCChheEEEEEE
Confidence 34578999999999999999999985 3568888754321 12223 37899999999 6999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
..... ......++||||+++++|.++++..... ...+++..+..++.|++.||+|||++||+||||+|+||
T Consensus 74 ~~~~~--------~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni 144 (275)
T cd06608 74 KKNPP--------GNDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI 144 (275)
T ss_pred ecCCC--------CcceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 64410 1123679999999999999998764322 35689999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGvi 1034 (1137)
+++.+ +.++|+|||.+........ ......+++.|+|||++.... ....++.++|||||||+
T Consensus 145 ~~~~~-------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i 207 (275)
T cd06608 145 LLTKN-------AEVKLVDFGVSAQLDSTLG----------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGIT 207 (275)
T ss_pred EEccC-------CeEEECCCccceecccchh----------hhcCccccccccCHhHhcccccccCCccccccHHHhHHH
Confidence 99977 7899999998865432111 112345888999999986421 12456789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+|++|+.||...........+.....+.+.. ....++++.+++.+||..||.+
T Consensus 208 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~ 262 (275)
T cd06608 208 AIELADGKPPLCDMHPMRALFKIPRNPPPTLKS-------------------------PENWSKKFNDFISECLIKNYEQ 262 (275)
T ss_pred HHHHHhCCCCccccchHHHHHHhhccCCCCCCc-------------------------hhhcCHHHHHHHHHHhhcChhh
Confidence 999999999998655544444443322211110 0124556999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001152 1115 RPTAGDLYEMFVA 1127 (1137)
Q Consensus 1115 RPSa~EVL~~L~~ 1127 (1137)
|||+.++++|+|.
T Consensus 263 Rpt~~~ll~~~~~ 275 (275)
T cd06608 263 RPFMEELLEHPFI 275 (275)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999984
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=339.25 Aligned_cols=279 Identities=20% Similarity=0.232 Sum_probs=198.0
Q ss_pred CCceEeeeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+|++.+.||+|+||.||+|...+ ..+++|+.... .. ..+|+.+|++++|||||++++++...
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~----~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KT----PGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------cc----HHHHHHHHHhcCCCCccceeeeEeeC
Confidence 469999999999999999998643 44666653211 11 25699999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+. ++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 159 ~--------------~~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill 218 (392)
T PHA03207 159 S--------------TVCMVMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL 218 (392)
T ss_pred C--------------EEEEEehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 5 6799999996 789988854 3469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 219 ~~~-------~~~~l~DfG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~e 279 (392)
T PHA03207 219 DEP-------ENAVLGDFGAACKLDAHPDT--------PQCYGWSGTLETNSPELLAL----DPYCAKTDIWSAGLVLFE 279 (392)
T ss_pred cCC-------CCEEEccCccccccCccccc--------ccccccccccCccCHhHhcC----CCCCchhhHHHHHHHHHH
Confidence 877 78999999998755432111 11123469999999999875 468899999999999999
Q ss_pred HHhCCCCCCCCCH---HHHHHHHHc-CCCC--CchhHH-hhhcccccccccccCCCCCCch--hhhhhHHHHHHHHHHhc
Q 001152 1038 LLTLQVPYMGLSE---LEIHDLIQM-GKRP--RLTDEL-EALGSCHEHEVAQSGSGFEKPE--AELETLSFLVDVFRRCT 1108 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~---~el~~~I~~-g~~p--~l~~~l-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~L~dLl~~CL 1108 (1137)
|++|+.||.+... ......+.. .... .++... .................+..+. .....+.++.++|.+||
T Consensus 280 l~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml 359 (392)
T PHA03207 280 MSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKML 359 (392)
T ss_pred HHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHh
Confidence 9999999976432 122222211 1110 111000 0000000000000011111111 01134566889999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCCC
Q 001152 1109 EENPTERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1109 ~~DP~~RPSa~EVL~~L~~~~~ss 1132 (1137)
+.||++|||+.|++.|+|+....+
T Consensus 360 ~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 360 TFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred ccChhhCCCHHHHhhCchhhccch
Confidence 999999999999999999986543
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=335.40 Aligned_cols=272 Identities=19% Similarity=0.198 Sum_probs=191.1
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|++.+.||+|+||.||+|++.+ ..+|+|+. ... . ...|+.++++++||||+++++++....
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~--~~~--------~----~~~E~~~l~~l~h~~iv~~~~~~~~~~- 130 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIG--QKG--------T----TLIEAMLLQNVNHPSVIRMKDTLVSGA- 130 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeC--Ccc--------c----cHHHHHHHHhCCCCCCcChhheEEeCC-
Confidence 469999999999999999999865 46777752 111 1 145889999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+. ++|.+++.. ....+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 131 -------------~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 192 (357)
T PHA03209 131 -------------ITCMVLPHYS-SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND 192 (357)
T ss_pred -------------eeEEEEEccC-CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 5699999995 789888865 2346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.+........ .....||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 193 ~-------~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvvl~ell 250 (357)
T PHA03209 193 V-------DQVCIGDLGAAQFPVVAPA-----------FLGLAGTVETNAPEVLAR----DKYNSKADIWSAGIVLFEML 250 (357)
T ss_pred C-------CCEEEecCccccccccCcc-----------cccccccccccCCeecCC----CCCCchhhHHHHHHHHHHHH
Confidence 7 7799999998864322111 113468999999999875 46889999999999999999
Q ss_pred hCCCCC-CCCCH----------HHHHHHHHc-CCCC-Cchh----HHhhhcccccccccccCCCCCCchhhhhhHHHHHH
Q 001152 1040 TLQVPY-MGLSE----------LEIHDLIQM-GKRP-RLTD----ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 1102 (1137)
Q Consensus 1040 TG~~Pf-~~~~~----------~el~~~I~~-g~~p-~l~~----~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~d 1102 (1137)
++..|+ ..... ..+...+.. +..+ .++. ...................+ ........+.++.+
T Consensus 251 ~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 329 (357)
T PHA03209 251 AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRY-PCFQRVNLPIDGEF 329 (357)
T ss_pred HcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCccccc-HHHhccCCCchHHH
Confidence 865554 32111 111222211 1111 1110 00000000000000000000 00001234556788
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1103 VFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1103 Ll~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+|.+||+.||.+||||.||++|+|++.
T Consensus 330 li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 330 LVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 999999999999999999999999974
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=314.30 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=192.7
Q ss_pred eecccCceEEEEEEEC--C--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCC
Q 001152 809 EAGKSVSSSLFRCKFG--S--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 809 ~LG~GsfG~Vy~a~~~--~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
.||+|+||.||+|.+. + ..+|+|+.... . .....+ .+.+|+.++++++||||+++++++...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~-~~~~~~----~~~~E~~~l~~l~h~~ii~~~~~~~~~------- 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--N-EKSVRD----EMMREAEIMHQLDNPYIVRMIGVCEAE------- 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc--c-ChHHHH----HHHHHHHHHHhcCCCCeEEEEEEEcCC-------
Confidence 4899999999999874 2 34677764322 1 122222 348899999999999999999987532
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++++|.+++.. ....+++..+.+++.||+.||+|||++|++||||||+|||++.+
T Consensus 68 --------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---- 131 (257)
T cd05115 68 --------ALMLVMEMASGGPLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ---- 131 (257)
T ss_pred --------CeEEEEEeCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC----
Confidence 45999999999999999864 13468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQV 1043 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~ 1043 (1137)
+.+||+|||++.......... .......+++.|+|||++.. ..++.++|||||||++|+|++ |..
T Consensus 132 ---~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~ 197 (257)
T cd05115 132 ---HYAKISDFGLSKALGADDSYY-------KARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGITMWEAFSYGQK 197 (257)
T ss_pred ---CcEEeccCCccccccCCccce-------eccCCCCCCcccCCHHHHcc----CCCCchhhHHHHHHHHHHHhcCCCC
Confidence 789999999987543321110 00111224568999999864 457889999999999999996 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001152 1044 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123 (1137)
Q Consensus 1044 Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~ 1123 (1137)
||......++...+..+..+..+. .+++++.+++.+||..||++||++.+|.+
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 198 PYKKMKGPEVMSFIEQGKRLDCPA---------------------------ECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CcCcCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 998887777776666654332221 34556999999999999999999999998
Q ss_pred HHHh
Q 001152 1124 MFVA 1127 (1137)
Q Consensus 1124 ~L~~ 1127 (1137)
.+..
T Consensus 251 ~l~~ 254 (257)
T cd05115 251 RMRT 254 (257)
T ss_pred HHhh
Confidence 8754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=317.08 Aligned_cols=281 Identities=20% Similarity=0.244 Sum_probs=204.9
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||+|.+. +..+++|+....... ....+ .+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIPN----QALREIKALQACQHPYVVKLLDVFPHGS-- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhhH----HHHHHHHHHHhCCCCCCcceeeEEecCC--
Confidence 5889999999999999999984 577888875443221 11122 3478999999999999999999988655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+|+||||+||+++.+
T Consensus 73 ------------~~~~v~e~~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~ 135 (286)
T cd07832 73 ------------GFVLVMEYM-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135 (286)
T ss_pred ------------eeEEEeccc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC
Confidence 569999999 99999998752 2469999999999999999999999999999999999999976
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+........ .......++..|+|||++.+ ...++.++||||+||++|+|++
T Consensus 136 -------~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~t 196 (286)
T cd07832 136 -------GVLKIADFGLARLFSEEEP---------RLYSHQVATRWYRAPELLYG---ARKYDPGVDLWAVGCIFAELLN 196 (286)
T ss_pred -------CcEEEeeeeecccccCCCC---------CccccccCcccccCceeeec---cccCCchhHHHHHHHHHHHHHc
Confidence 7899999998876543221 01112358889999999864 2456899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccc--cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH--EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
|.+||.+.........+...........++...... ....................+..+.+++.+||+.||.+||++
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 197 GSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred CCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence 998888776655555543322111111111100000 000000000000011112445789999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
+++++|+|+
T Consensus 277 ~~~l~h~~~ 285 (286)
T cd07832 277 AEALRHPYF 285 (286)
T ss_pred HHHhhCcCc
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=315.40 Aligned_cols=252 Identities=26% Similarity=0.363 Sum_probs=197.2
Q ss_pred CCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.+|++.++||+|+||.||+|.+.+ ..+|+|+.... ... .+. +.+|++++++++||||+++++++.+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~--~~~---~~~----~~~E~~~l~~l~~~~i~~~~~~~~~~--- 73 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSEE--- 73 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC--ccC---HHH----HHHHHHHHHhCCCCCcceEEEEECCC---
Confidence 569999999999999999998855 46777764321 111 122 37899999999999999999886432
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.++++.. ....+++..+..++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~ 138 (262)
T cd05071 74 ------------PIYIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 138 (262)
T ss_pred ------------CcEEEEEcCCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC
Confidence 348999999999999999752 23458999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||.+......... ......++..|+|||+..+ ..++.++|||||||++|+|+|
T Consensus 139 -------~~~~L~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~l~ellt 198 (262)
T cd05071 139 -------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELTT 198 (262)
T ss_pred -------CcEEeccCCceeeccccccc---------cccCCcccceecCHhHhcc----CCCCchhhHHHHHHHHHHHHc
Confidence 78999999998755432111 0112246678999998864 467899999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|..||.+....++...+..+...... ...+..+.+++.+||+.||++||++.
T Consensus 199 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rp~~~ 251 (262)
T cd05071 199 KGRVPYPGMVNREVLDQVERGYRMPCP---------------------------PECPESLHDLMCQCWRKEPEERPTFE 251 (262)
T ss_pred CCCCCCCCCChHHHHHHHhcCCCCCCc---------------------------cccCHHHHHHHHHHccCCcccCCCHH
Confidence 88899877666665555433221111 13445689999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
++++.+..
T Consensus 252 ~~~~~l~~ 259 (262)
T cd05071 252 YLQAFLED 259 (262)
T ss_pred HHHHHHHH
Confidence 99988754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=321.06 Aligned_cols=291 Identities=18% Similarity=0.222 Sum_probs=202.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~ 878 (1137)
++|++.+.||+|+||.||+|.+. +..+|+|+....... ..... .+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--~~~~~----~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EGIPP----TALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--cCCch----HHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 36889999999999999999984 467888875443221 11112 2377999999996 699999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.. .....|+||||++ ++|.+++..........+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 75 ~~---------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~ 144 (295)
T cd07837 75 KN---------GKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD 144 (295)
T ss_pred CC---------CCceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe
Confidence 10 1124799999998 5899988764333235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+. +.+||+|||++......... .....+++.|+|||++.+ ...++.++||||||+++|+|
T Consensus 145 ~~~------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l 205 (295)
T cd07837 145 KQK------GLLKIADLGLGRAFSIPVKS----------YTHEIVTLWYRAPEVLLG---STHYSTPVDIWSVGCIFAEM 205 (295)
T ss_pred cCC------CeEEEeecccceecCCCccc----------cCCcccccCCCChHHhhC---CCCCCchHHHHHHHHHHHHH
Confidence 721 68999999998754322111 112246789999999864 24578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++|..||.+.+..+....+.... .+. ...+...........................++++.++|.+||+.||.+||+
T Consensus 206 ~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~ 284 (295)
T cd07837 206 SRKQPLFPGDSELQQLLHIFKLLGTPT-EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284 (295)
T ss_pred HcCCCCCCCCCHHHHHHHHHHHhCCCC-hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC
Confidence 99999998876655444432211 111 0000000000000000000000001111245677999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001152 1118 AGDLYEMFVAR 1128 (1137)
Q Consensus 1118 a~EVL~~L~~~ 1128 (1137)
+.|++.|+|+.
T Consensus 285 ~~eil~~~~~~ 295 (295)
T cd07837 285 AKAALTHPYFD 295 (295)
T ss_pred HHHHhcCCCcC
Confidence 99999999974
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=313.10 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~-----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
++||+|+||.||+|.+.. ..+|+|+.... ... ... ..+.+|+.+++.+.|||||++++++...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~--~~~-~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 68 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE--HIA-AGK----KEFLREASVMAQLDHPCIVRLIGVCKGE----- 68 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccc--cch-HHH----HHHHHHHHHHHhcCCCCeeeEEEEEcCC-----
Confidence 479999999999998743 34677764322 111 122 2348899999999999999999987532
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-- 131 (257)
T cd05060 69 ----------PLMLVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-- 131 (257)
T ss_pred ----------ceEEEEEeCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC--
Confidence 45999999999999999976 2368999999999999999999999999999999999999877
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1041 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G 1041 (1137)
+.+||+|||.++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |
T Consensus 132 -----~~~kl~df~~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~~~~~g 195 (257)
T cd05060 132 -----HQAKISDFGMSRALGAGSDYY-------RATTAGRWPLKWYAPECINY----GKFSSKSDVWSYGVTLWEAFSYG 195 (257)
T ss_pred -----CcEEeccccccceeecCCccc-------ccccCccccccccCHHHhcC----CCCCccchHHHHHHHHHHHHcCC
Confidence 789999999987654322110 00011124567999999865 467899999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
..||......++...+........+. .++..+.+++.+||..+|.+||++.++
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~~p~~Rp~~~~l 248 (257)
T cd05060 196 AKPYGEMKGAEVIAMLESGERLPRPE---------------------------ECPQEIYSIMLSCWKYRPEDRPTFSEL 248 (257)
T ss_pred CCCcccCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 99998877777776665543221110 334568999999999999999999999
Q ss_pred HHHHHhh
Q 001152 1122 YEMFVAR 1128 (1137)
Q Consensus 1122 L~~L~~~ 1128 (1137)
++.+...
T Consensus 249 ~~~l~~~ 255 (257)
T cd05060 249 ESTFRRD 255 (257)
T ss_pred HHHHHhc
Confidence 9988754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.78 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=197.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|++. +..+|+|+.+... ...... +.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~----~~~e~~~~~~l~h~~ii~~~~~~~~~~- 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAV----VQQEIIMMKDCKHSNIVAYFGSYLRRD- 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHH----HHHHHHHHHhCCCCCeeeEEEEEEeCC-
Confidence 47889999999999999999984 4678888754332 122222 377999999999999999999987665
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+|+||||+||+++.
T Consensus 80 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~ 141 (267)
T cd06645 80 -------------KLWICMEFCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD 141 (267)
T ss_pred -------------EEEEEEeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 66999999999999999875 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||++........ ......|++.|+|||++... ....++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~-~~~~~~~~~DvwSlG~il~~l~ 203 (267)
T cd06645 142 N-------GHVKLADFGVSAQITATIA----------KRKSFIGTPYWMAPEVAAVE-RKGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred C-------CCEEECcceeeeEccCccc----------ccccccCcccccChhhhccc-cCCCCCchhhhHHHHHHHHHHh
Confidence 7 7799999999865432111 11234689999999997421 1245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||....+......+....... + ... .....+..+.+++.+||+.+|++||+++
T Consensus 204 ~~~~p~~~~~~~~~~~~~~~~~~~~-~-~~~---------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~ 260 (267)
T cd06645 204 ELQPPMFDLHPMRALFLMTKSNFQP-P-KLK---------------------DKMKWSNSFHHFVKMALTKNPKKRPTAE 260 (267)
T ss_pred cCCCCcccccchhhHHhhhccCCCC-C-ccc---------------------ccCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 9999997654433222221111100 0 000 0002344589999999999999999999
Q ss_pred HHHHHHH
Q 001152 1120 DLYEMFV 1126 (1137)
Q Consensus 1120 EVL~~L~ 1126 (1137)
+|++|+|
T Consensus 261 ~ll~~~~ 267 (267)
T cd06645 261 KLLQHPF 267 (267)
T ss_pred HHhcCCC
Confidence 9999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=351.98 Aligned_cols=267 Identities=24% Similarity=0.355 Sum_probs=203.5
Q ss_pred CceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeee-EecCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGH-KISSK 878 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~-~~~~~ 878 (1137)
++++.++|.+|||+.||+|.+.+ ..+|+|..... +....+.. .+||.+|++|+ |+|||.+++. .....
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v----~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAV----KREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHH----HHHHHHHHHhcCCCceeeEecccccccc
Confidence 46899999999999999999843 68888875433 24444444 89999999998 9999999994 33221
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeE
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 956 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g--IIHrDLKP~NIL 956 (1137)
+.. ...+++|.||||.||+|-+++.... ...|++.++++|++|+++|+++||..+ |||||||-+|||
T Consensus 110 ---~~~-----~~~EvllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvL 178 (738)
T KOG1989|consen 110 ---SNN-----GVWEVLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVL 178 (738)
T ss_pred ---CCC-----ceeEEEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheE
Confidence 011 1237899999999999999998632 235999999999999999999999886 999999999999
Q ss_pred eccccccCCCCCeEEEeecCcccccccccccc---ccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTC---CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~---~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|+.+ +.+||||||.|.......... ...+..+ ....|+.|+|||++.-. .+..+++|+|||||||
T Consensus 179 ls~~-------g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI----~k~TTp~YRsPEMIDly-sg~pI~eKsDIWALGc 246 (738)
T KOG1989|consen 179 LSAD-------GNYKLCDFGSATTKILSPTSAQEVNYVEEEI----EKYTTPQYRSPEMIDLY-SGLPIGEKSDIWALGC 246 (738)
T ss_pred EcCC-------CCEEeCcccccccccCCCccHHHHHHHHHHH----HhhCCccccChHHHhhh-cCCCCcchhHHHHHHH
Confidence 9988 789999999886433221000 0001111 12478999999998643 4567899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1034 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1034 iL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+||-|+..+.||...... +|..+... .|.. ..++..+.+||..||+.||+
T Consensus 247 lLYkLCy~t~PFe~sg~l----aIlng~Y~-------------------------~P~~-p~ys~~l~~LI~~mL~~nP~ 296 (738)
T KOG1989|consen 247 LLYKLCYFTTPFEESGKL----AILNGNYS-------------------------FPPF-PNYSDRLKDLIRTMLQPNPD 296 (738)
T ss_pred HHHHHHHhCCCcCcCcce----eEEecccc-------------------------CCCC-ccHHHHHHHHHHHHhccCcc
Confidence 999999999999864322 23333211 0110 15566799999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001152 1114 ERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~ 1130 (1137)
+||++-||+.+++....
T Consensus 297 ~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 297 ERPNIYQVLEEIFELAN 313 (738)
T ss_pred cCCCHHHHHHHHHHHhc
Confidence 99999999999988754
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.31 Aligned_cols=252 Identities=28% Similarity=0.419 Sum_probs=198.6
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|+..+.||+|+||.||+|.+. +..+|+|+..... . ....+ .+.+|+.++++++||||+++++++....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~-~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--A-EDEIE----DIQQEITVLSQCDSPYITRYYGSYLKGT-- 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--c-hHHHH----HHHHHHHHHHcCCCCccHhhhcccccCC--
Confidence 3677789999999999999874 4567888643221 1 22222 3478999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|+||+++.+
T Consensus 76 ------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~ 137 (277)
T cd06642 76 ------------KLWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ 137 (277)
T ss_pred ------------ceEEEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC
Confidence 56999999999999998854 358999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||++......... .....++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 138 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06642 138 -------GDVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDFKADIWSLGITAIELAK 196 (277)
T ss_pred -------CCEEEccccccccccCcchh----------hhcccCcccccCHHHhCc----CCCchhhhHHHHHHHHHHHHh
Confidence 77999999998755432110 112357889999999875 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||...........+.....+.+. ...+..+.+++.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06642 197 GEPPNSDLHPMRVLFLIPKNSPPTLE---------------------------GQYSKPFKEFVEACLNKDPRFRPTAKE 249 (277)
T ss_pred CCCCCcccchhhHHhhhhcCCCCCCC---------------------------cccCHHHHHHHHHHccCCcccCcCHHH
Confidence 99999765554444333222211111 123456899999999999999999999
Q ss_pred HHHHHHhhc
Q 001152 1121 LYEMFVART 1129 (1137)
Q Consensus 1121 VL~~L~~~~ 1129 (1137)
+++|+|+..
T Consensus 250 il~~~~~~~ 258 (277)
T cd06642 250 LLKHKFITR 258 (277)
T ss_pred HHHhHHHHH
Confidence 999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=315.07 Aligned_cols=260 Identities=26% Similarity=0.433 Sum_probs=199.7
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|++.+.||+|+||.||+|.+ .+..+++|....... ....... .+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARA----DCIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHH----HHHHHHHHHHHccCCchhhhhheeEeCC
Confidence 45788999999999999999997 456788886432211 1122222 3478999999999999999999988765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++..... ....+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 76 --------------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~ 140 (267)
T cd08229 76 --------------ELNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred --------------eEEEEEEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 56999999999999999875322 235689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.++|+|||++........ ......++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 141 AT-------GVVKLGDLGLGRFFSSKTT----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred CC-------CCEEECcchhhhccccCCc----------ccccccCCcCccCHHHhcC----CCccchhhHHHHHHHHHHH
Confidence 77 7899999998865432211 0112358889999999865 4578899999999999999
Q ss_pred HhCCCCCCCCCH--HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1039 LTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1039 LTG~~Pf~~~~~--~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
++|..||.+... .+....+.....+..+. ...++.+.+++.+||+.||.+||
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~Rp 253 (267)
T cd08229 200 AALQSPFYGDKMNLYSLCKKIEQCDYPPLPS--------------------------DHYSEELRQLVNMCINPDPEKRP 253 (267)
T ss_pred HhCCCCcccccchHHHHhhhhhcCCCCCCCc--------------------------ccccHHHHHHHHHhcCCCcccCC
Confidence 999999975432 22333333222211110 13455699999999999999999
Q ss_pred CHHHHHHHHHh
Q 001152 1117 TAGDLYEMFVA 1127 (1137)
Q Consensus 1117 Sa~EVL~~L~~ 1127 (1137)
|+.+|++.+..
T Consensus 254 t~~~i~~~~~~ 264 (267)
T cd08229 254 DITYVYDVAKR 264 (267)
T ss_pred CHHHHHHHHhh
Confidence 99999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=322.31 Aligned_cols=264 Identities=22% Similarity=0.361 Sum_probs=203.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcce
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 869 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~---------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVk 869 (1137)
...+|++.+.||+|+||.||+|++. ...+|+|+.... ......+. +.+|+.+++.+ +||||++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD----LVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHH----HHHHHHHHHhhccCCCchh
Confidence 3567899999999999999999752 124667764311 11222333 37899999999 7999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHH
Q 001152 870 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALV 938 (1137)
Q Consensus 870 llg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------~~~~ls~~~i~~I~~QIa~gL~ 938 (1137)
+++++.... ..++||||+++++|.+++...... ....+++..+..++.||+.||+
T Consensus 86 ~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 151 (304)
T cd05101 86 LLGACTQDG--------------PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGME 151 (304)
T ss_pred eeEEEecCC--------------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHH
Confidence 999988655 569999999999999999763211 1235888999999999999999
Q ss_pred HHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001152 939 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1018 (1137)
Q Consensus 939 yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1018 (1137)
|||++||+||||||+||+++.+ +.+||+|||.++......... ......+++.|+|||++.+
T Consensus 152 ~LH~~givH~dlkp~Nili~~~-------~~~kl~D~g~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~--- 213 (304)
T cd05101 152 YLASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDVNNIDYYK--------KTTNGRLPVKWMAPEALFD--- 213 (304)
T ss_pred HHHHCCeeecccccceEEEcCC-------CcEEECCCccceecccccccc--------cccCCCCCceeeCchhhcc---
Confidence 9999999999999999999877 789999999987654321110 0011235678999999865
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001152 1019 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1097 (1137)
Q Consensus 1019 ~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1137)
..++.++||||||+++|+|++ |..||.+....++...+..+.....+ ..++
T Consensus 214 -~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 265 (304)
T cd05101 214 -RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP---------------------------ANCT 265 (304)
T ss_pred -CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC---------------------------CCCC
Confidence 467899999999999999998 78899887777777666544322111 0344
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1098 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1098 ~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
.++.+++.+||+.+|.+|||+.|+++.+.....
T Consensus 266 ~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 266 NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 569999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.82 Aligned_cols=260 Identities=27% Similarity=0.403 Sum_probs=202.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|.+. +..+++|......... ....+ ++.+|++++++++|+||+++++++...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~----~~~~ei~~l~~~~~~~i~~~~~~~~~~~- 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQ----DCLKEIDLLKQLDHPNVIKYLASFIENN- 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-hhhHH----HHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 57999999999999999999985 5778888754322211 22222 3488999999999999999999988655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++..... ....+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~ 141 (267)
T cd08224 76 -------------ELNIVLELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA 141 (267)
T ss_pred -------------eEEEEEecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC
Confidence 56999999999999999876432 2346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||++......... .....+++.|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 142 ~-------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 142 T-------GVVKLGDLGLGRFFSSKTTA----------AHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred C-------CcEEEeccceeeeccCCCcc----------cceecCCccccCHHHhcc----CCCCchhcHHHHHHHHHHHH
Confidence 7 78999999988654332110 112357889999999865 45788999999999999999
Q ss_pred hCCCCCCCCC--HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1040 TLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1040 TG~~Pf~~~~--~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
+|+.||.... ..++...+..+..+..+. ...+..+.+++.+||..+|++|||
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~cl~~~p~~Rp~ 254 (267)
T cd08224 201 ALQSPFYGDKMNLYSLCKKIEKCDYPPLPA--------------------------DHYSEELRDLVSRCINPDPEKRPD 254 (267)
T ss_pred HCCCCcccCCccHHHHHhhhhcCCCCCCCh--------------------------hhcCHHHHHHHHHHcCCCcccCCC
Confidence 9999996532 223333333332222111 133456899999999999999999
Q ss_pred HHHHHHHHHhh
Q 001152 1118 AGDLYEMFVAR 1128 (1137)
Q Consensus 1118 a~EVL~~L~~~ 1128 (1137)
+.+|++.+...
T Consensus 255 ~~~il~~~~~~ 265 (267)
T cd08224 255 ISYVLQVAKEM 265 (267)
T ss_pred HHHHHHHHHHh
Confidence 99999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=318.53 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=198.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHH-HHhCCCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~i-L~~L~HpNIVkllg~~~~~~ 878 (1137)
++|++.+.||+|+||.||+|.+. +..||+|...... ....+. ++..|+.+ ++.++||||+++++++..+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~-----~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQK-----RLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC--CcHHHH-----HHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 46899999999999999999985 5678888654322 212221 22456554 56678999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeEe
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 957 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrDLKP~NILl 957 (1137)
..++||||++ ++|.++++..... ...+++..++.++.||+.||+|||++ +++||||||+||++
T Consensus 74 --------------~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~ 137 (283)
T cd06617 74 --------------DVWICMEVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137 (283)
T ss_pred --------------cEEEEhhhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 5699999997 8999988764332 35799999999999999999999997 99999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||.+....... ......++..|+|||.+.+......++.++|+|||||++|+
T Consensus 138 ~~~-------~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 138 NRN-------GQVKLCDFGISGYLVDSV-----------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred CCC-------CCEEEeeccccccccccc-----------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 887 789999999987543211 01123578899999998653333457889999999999999
Q ss_pred HHhCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~-~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++|+.||... ...+....+.....+.++. ...+.++.+++.+||..+|++||
T Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rp 253 (283)
T cd06617 200 LATGRFPYDSWKTPFQQLKQVVEEPSPQLPA--------------------------EKFSPEFQDFVNKCLKKNYKERP 253 (283)
T ss_pred HHhCCCCCCccccCHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCc
Confidence 99999999642 2222222222222221110 02345699999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001152 1117 TAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~s 1131 (1137)
+++++++|+|+....
T Consensus 254 ~~~~il~~~~~~~~~ 268 (283)
T cd06617 254 NYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHhcCchhhhcc
Confidence 999999999998653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=314.02 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=200.1
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||+|.+.. ..+++|...... ..+. +.+|+.++++++||||+++++++....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~----~~~e~~~~~~l~~~~i~~~~~~~~~~~- 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQE----IIKEISILKQCDSPYIVKYYGSYFKNT- 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHH----HHHHHHHHHhCCCCcEeeeeeeeecCC-
Confidence 578899999999999999999864 667887753221 1233 478999999999999999999988765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..|+||||+++++|.+++... ...+++..+..++.||+.||.|||+.+|+||||+|+||+++.
T Consensus 72 -------------~~~l~~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~ 134 (256)
T cd06612 72 -------------DLWIVMEYCGAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE 134 (256)
T ss_pred -------------cEEEEEecCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC
Confidence 569999999999999998652 246899999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||++........ ......++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 135 ~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~s~G~il~~l~ 193 (256)
T cd06612 135 E-------GQAKLADFGVSGQLTDTMA----------KRNTVIGTPFWMAPEVIQE----IGYNNKADIWSLGITAIEMA 193 (256)
T ss_pred C-------CcEEEcccccchhcccCcc----------ccccccCCccccCHHHHhc----CCCCchhhHHHHHHHHHHHH
Confidence 7 7899999999876543211 1123457889999999875 46789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|+.||......+....+.....+.+. .....+..+.+++.+||+.||.+|||+.
T Consensus 194 ~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~i~~~l~~~P~~Rps~~ 248 (256)
T cd06612 194 EGKPPYSDIHPMRAIFMIPNKPPPTLS-------------------------DPEKWSPEFNDFVKKCLVKDPEERPSAI 248 (256)
T ss_pred hCCCCCCCcchhhhhhhhccCCCCCCC-------------------------chhhcCHHHHHHHHHHHhcChhhCcCHH
Confidence 999999875554333322211111100 0013345689999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
||++|+|+
T Consensus 249 ~il~~~~~ 256 (256)
T cd06612 249 QLLQHPFI 256 (256)
T ss_pred HHhcCCCC
Confidence 99999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=319.70 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=204.5
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||+|.+. +..+|+|+....... ..... ..+.+|+++++++.||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQV----EHVLNEKRILQSIRHPFLVNLYGSFQDDS- 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHH----HHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence 36899999999999999999984 467888875422111 11112 23488999999999999999999988765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+|||++.
T Consensus 75 -------------~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~ 136 (290)
T cd05580 75 -------------NLYLVMEYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS 136 (290)
T ss_pred -------------eEEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence 56999999999999999876 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 137 ~-------~~~kl~dfg~~~~~~~~-------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 192 (290)
T cd05580 137 D-------GYIKITDFGFAKRVKGR-------------TYTLCGTPEYLAPEIILS----KGYGKAVDWWALGILIYEML 192 (290)
T ss_pred C-------CCEEEeeCCCccccCCC-------------CCCCCCCccccChhhhcC----CCCCccccHHHHHHHHHHHH
Confidence 7 78999999988754332 112358889999999865 35678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP--- 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP--- 1116 (1137)
+|..||......+....+..+.. .++. ..+..+.+++.+||+.||.+||
T Consensus 193 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~l~~li~~~l~~~p~~R~~~~ 244 (290)
T cd05580 193 AGYPPFFDDNPIQIYEKILEGKV-RFPS---------------------------FFSPDAKDLIRNLLQVDLTKRLGNL 244 (290)
T ss_pred hCCCCCCCCCHHHHHHHHhcCCc-cCCc---------------------------cCCHHHHHHHHHHccCCHHHccCcc
Confidence 99999987776655555543321 1111 1234589999999999999999
Q ss_pred --CHHHHHHHHHhhcCC
Q 001152 1117 --TAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1117 --Sa~EVL~~L~~~~~s 1131 (1137)
+++|+++|+|+....
T Consensus 245 ~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 245 KNGVNDIKNHPWFAGID 261 (290)
T ss_pred cCCHHHHHcCcccccCC
Confidence 999999999986543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=310.83 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=199.1
Q ss_pred eeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~-----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
+.||+|+||.||+|.+. +..+++|+..... . ....+. +.+|+.+++.++|+||+++++++....
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~-~~~~~~----~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 69 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--S-EEERKD----FLKEARVMKKLGHPNVVRLLGVCTEEE---- 69 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc--c-hhHHHH----HHHHHHHHhhcCCCChheeeeeecCCC----
Confidence 46999999999999985 5667887753222 1 112333 488999999999999999999988754
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~----~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++...... ....+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 70 ----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~ 139 (262)
T cd00192 70 ----------PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG 139 (262)
T ss_pred ----------ceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC
Confidence 569999999999999999863111 025799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||.+......... .......+++.|+|||.+.. ..++.++|||||||++|+|
T Consensus 140 ~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 200 (262)
T cd00192 140 ED-------LVVKISDFGLSRDVYDDDYY--------RKKTGGKLPIRWMAPESLKD----GIFTSKSDVWSFGVLLWEI 200 (262)
T ss_pred CC-------CcEEEccccccccccccccc--------ccccCCCcCccccCHHHhcc----CCcchhhccHHHHHHHHHH
Confidence 87 78999999998765432210 01123357889999999875 3678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++ |..||......++...+..+.....+. .++.++.+++.+||+.+|.+|||
T Consensus 201 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rps 253 (262)
T cd00192 201 FTLGATPYPGLSNEEVLEYLRKGYRLPKPE---------------------------YCPDELYELMLSCWQLDPEDRPT 253 (262)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCChHHHHHHHHHccCCcccCcC
Confidence 99 699999887777777665533222111 33456999999999999999999
Q ss_pred HHHHHHHH
Q 001152 1118 AGDLYEMF 1125 (1137)
Q Consensus 1118 a~EVL~~L 1125 (1137)
+.|+++++
T Consensus 254 ~~~l~~~l 261 (262)
T cd00192 254 FSELVERL 261 (262)
T ss_pred HHHHHHhh
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=318.51 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=200.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
.++|++.+.||+|+||.||+|.+. +..+|+|+.... . ....... +.+|+.+++++.||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~--~-~~~~~~~----~~~ei~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--A-SADMQAD----FQREAALMAEFDHPNIVKLLGV 76 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC--c-CHHHHHH----HHHHHHHHHhcCCCchheEEEE
Confidence 467899999999999999999863 356777764322 1 1222233 4789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------------cCCCCCCHHHHHHHHHHHHHH
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------------TGEKHVSVKLALFIAQDVAAA 936 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-----------------~~~~~ls~~~i~~I~~QIa~g 936 (1137)
+.+.. ..++||||+++++|.+++..... .....+++..++.++.||+.|
T Consensus 77 ~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~a 142 (288)
T cd05050 77 CAVGK--------------PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAG 142 (288)
T ss_pred EcCCC--------------ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHH
Confidence 87655 45999999999999999975321 112357889999999999999
Q ss_pred HHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccc
Q 001152 937 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1016 (1137)
Q Consensus 937 L~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 1016 (1137)
|+|||+++++||||||+|||++.+ +.++|+|||.+......... ........+..|+|||.+.+
T Consensus 143 L~~lH~~~i~H~dl~p~nil~~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~- 206 (288)
T cd05050 143 MAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYY--------KASENDAIPIRWMPPESIFY- 206 (288)
T ss_pred HHHHHhCCeecccccHhheEecCC-------CceEECccccceecccCccc--------cccCCCccChhhcCHHHHhc-
Confidence 999999999999999999999877 78999999988654322110 00112234667999999865
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 001152 1017 HKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1095 (1137)
Q Consensus 1017 ~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1137)
..++.++|||||||++|+|++ |..||.+....+....+..+.....+. .
T Consensus 207 ---~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~ 256 (288)
T cd05050 207 ---NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPD---------------------------N 256 (288)
T ss_pred ---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------C
Confidence 467899999999999999997 888998877777666665443221110 2
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001152 1096 TLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1096 ~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~ 1126 (1137)
.+.++.+++.+||+.||.+|||+.|+++.|+
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 257 CPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 3456999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=320.06 Aligned_cols=266 Identities=21% Similarity=0.312 Sum_probs=199.3
Q ss_pred CCCceEeeeecccCceEEEEEEECC------------------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 862 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~------------------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L 862 (1137)
..+|++.++||+|+||.||+|.+.. ..+|+|+..... .....+. +.+|+++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~----~~~e~~~l~~l 76 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNARED----FLKEVKILSRL 76 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHH----HHHHHHHHHhc
Confidence 4578999999999999999998743 236677643221 1222333 48899999999
Q ss_pred CCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC------CCCCCHHHHHHHHHHHHHH
Q 001152 863 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG------EKHVSVKLALFIAQDVAAA 936 (1137)
Q Consensus 863 ~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~------~~~ls~~~i~~I~~QIa~g 936 (1137)
+||||+++++++..+. ..++||||+++++|.+++....... ...+++..++.++.||+.|
T Consensus 77 ~~~~i~~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a 142 (296)
T cd05051 77 SDPNIARLLGVCTVDP--------------PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASG 142 (296)
T ss_pred CCCCEeEEEEEEecCC--------------CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHH
Confidence 9999999999988655 4599999999999999997643111 2268999999999999999
Q ss_pred HHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccc
Q 001152 937 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1016 (1137)
Q Consensus 937 L~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 1016 (1137)
|+|||++||+||||||+||+++.+ +.++|+|||++......... .......+++.|+|||++.+
T Consensus 143 l~~LH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~- 206 (296)
T cd05051 143 MRYLESLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSSDYY--------RVQGRAPLPIRWMAWESVLL- 206 (296)
T ss_pred HHHHHHcCccccccchhceeecCC-------CceEEccccceeecccCcce--------eecCcCCCCceecCHHHhhc-
Confidence 999999999999999999999987 78999999988654322110 01113346778999999875
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhh
Q 001152 1017 HKPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094 (1137)
Q Consensus 1017 ~~~~~~s~ksDVWSLGviL~ELLT--G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1137)
..++.++|||||||++|||++ +..||......++...+.......-.. ... ....
T Consensus 207 ---~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~-~~~~ 263 (296)
T cd05051 207 ---GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ-------------------IYL-PRPP 263 (296)
T ss_pred ---CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccccc-------------------ccC-CCcc
Confidence 457899999999999999998 778887766655555443221000000 000 0001
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001152 1095 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1095 ~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~ 1126 (1137)
.++.++.+++.+||+.||.+|||+.||++.|.
T Consensus 264 ~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 264 NCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 34467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=322.30 Aligned_cols=269 Identities=25% Similarity=0.305 Sum_probs=205.8
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|++|+||+|... +..+|+|........ ..... ..+..|+++++.++||||+++++.+.+..
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 74 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKV----KRVLTEQEILATLDHPFLPTLYASFQTET-- 74 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHH----HHHHHHHHHHHhCCCCCchhheeeeecCC--
Confidence 6889999999999999999985 477888875433211 11122 23488999999999999999999987655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+.+++|.+++.. .....+++..+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus 75 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~ 139 (316)
T cd05574 75 ------------YLCLVMDYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES 139 (316)
T ss_pred ------------EEEEEEEecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC
Confidence 56999999999999999875 223568999999999999999999999999999999999999977
Q ss_pred cccCCCCCeEEEeecCcccccccccccccc-------------------ccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCI-------------------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~-------------------~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1021 (1137)
+.++|+|||++............ ............||..|+|||++.+ ..
T Consensus 140 -------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~ 208 (316)
T cd05574 140 -------GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG----DG 208 (316)
T ss_pred -------CCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC----CC
Confidence 78999999988754322110000 0000011123468899999999875 45
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1101 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1101 (1137)
++.++||||||+++|+|++|..||.+.+.......+...... ++.. ...++.+.
T Consensus 209 ~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~ 262 (316)
T cd05574 209 HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVT-FPGS-------------------------PPVSSSAR 262 (316)
T ss_pred CCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCcc-CCCc-------------------------cccCHHHH
Confidence 789999999999999999999999877665554444321111 0000 02455699
Q ss_pred HHHHHhcccCCCCCCC----HHHHHHHHHhhcC
Q 001152 1102 DVFRRCTEENPTERPT----AGDLYEMFVARTS 1130 (1137)
Q Consensus 1102 dLl~~CL~~DP~~RPS----a~EVL~~L~~~~~ 1130 (1137)
+++.+||+.||++||+ ++|+++|+|+...
T Consensus 263 ~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 263 DLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 9999999999999999 9999999999764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=314.46 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=198.4
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.++||+|+||.||+|.+.+ ..+|+|...... ... +. +.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~---~~----~~~E~~~l~~l~~~~i~~~~~~~~~~-- 73 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSP---ES----FLEEAQIMKKLRHDKLVQLYAVVSEE-- 73 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCH---HH----HHHHHHHHHhcCCCceEEEEeEECCC--
Confidence 4578999999999999999998754 567777653221 111 22 37899999999999999999887432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.++++. .....+++..+..++.|++.||+|||+++|+||||||+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~ 137 (260)
T cd05070 74 -------------PIYIVTEYMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD 137 (260)
T ss_pred -------------CcEEEEEecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC
Confidence 34899999999999999875 22345899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||.+......... ......++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 138 ~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~ 197 (260)
T cd05070 138 G-------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELV 197 (260)
T ss_pred C-------ceEEeCCceeeeeccCcccc---------cccCCCCCccccChHHHhc----CCCcchhhhHHHHHHHHHHH
Confidence 7 78999999998754332111 0011235568999999864 45789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||.+....+....+..+..+..+. ..+..+.+++.+||..+|++|||+
T Consensus 198 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rpt~ 250 (260)
T cd05070 198 TKGRVPYPGMNNREVLEQVERGYRMPCPQ---------------------------DCPISLHELMLQCWKKDPEERPTF 250 (260)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcccCcccCcCH
Confidence 9 899998877766666665433221111 334569999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
+++.+.+..
T Consensus 251 ~~l~~~l~~ 259 (260)
T cd05070 251 EYLQSFLED 259 (260)
T ss_pred HHHHHHHhc
Confidence 999987753
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=340.69 Aligned_cols=273 Identities=19% Similarity=0.270 Sum_probs=196.4
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|.+.+.||+|+||.||+|.+.. ..||+|... . . .+.+|+++|++++|||||++++++...+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~--------~----~~~~E~~iL~~L~HpnIv~l~~~~~~~~- 233 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--Y--------A----SSVHEARLLRRLSHPAVLALLDVRVVGG- 233 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--c--------c----CHHHHHHHHHHCCCCCCCcEEEEEEECC-
Confidence 469999999999999999999865 556666421 0 1 1257999999999999999999987665
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++|||++. ++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 234 -------------~~~lv~e~~~-~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~ 295 (461)
T PHA03211 234 -------------LTCLVLPKYR-SDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG 295 (461)
T ss_pred -------------EEEEEEEccC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC
Confidence 5699999995 7999888651 236999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 296 ~-------~~vkL~DFGla~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~sDvwSlGviL~El~ 356 (461)
T PHA03211 296 P-------EDICLGDFGAACFARGSWST--------PFHYGIAGTVDTNAPEVLAG----DPYTPSVDIWSAGLVIFEAA 356 (461)
T ss_pred C-------CCEEEcccCCceeccccccc--------ccccccCCCcCCcCHHHHcC----CCCCchHHHHHHHHHHHHHH
Confidence 7 67999999998754332111 11123469999999999975 46889999999999999999
Q ss_pred hCCCCCCCC--------CHHHHHHHHHcCCCC--Cchh----HH-hhhcccccccccccCCCCCCchh--hhhhHHHHHH
Q 001152 1040 TLQVPYMGL--------SELEIHDLIQMGKRP--RLTD----EL-EALGSCHEHEVAQSGSGFEKPEA--ELETLSFLVD 1102 (1137)
Q Consensus 1040 TG~~Pf~~~--------~~~el~~~I~~g~~p--~l~~----~l-~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~L~d 1102 (1137)
+|..|+... ...++...+...... .++. .+ ....... ..........+.. .......+.+
T Consensus 357 ~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~d 433 (461)
T PHA03211 357 VHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRA---ARNRRPAYTRPAWTRYYKLDLDVEY 433 (461)
T ss_pred HcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhh---hcccCCccCCcchhhhccccchHHH
Confidence 987655321 223444444332211 1110 00 0000000 0000000000000 0123456899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1103 VFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1103 Ll~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
|+.+||+.||.+|||+.|+++|+||..
T Consensus 434 li~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 434 LVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHcccChhhCcCHHHHhhCcccCC
Confidence 999999999999999999999999964
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=323.41 Aligned_cols=262 Identities=23% Similarity=0.373 Sum_probs=202.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 870 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~---------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkl 870 (1137)
..+|.+.++||+|+||.||+|+.. ...+|+|+.... . ....... +.+|+.+++++ +||||+++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~--~-~~~~~~~----~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--A-TDKDLAD----LISEMELMKLIGKHKNIINL 83 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC--C-ChHHHHH----HHHHHHHHHhccCCCCeeeE
Confidence 467899999999999999999752 234777764322 1 1223333 37899999999 59999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001152 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 939 (1137)
Q Consensus 871 lg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------~~~~ls~~~i~~I~~QIa~gL~y 939 (1137)
++++.... ..++||||+++|+|.+++...... ....+++..+..++.||+.||+|
T Consensus 84 ~~~~~~~~--------------~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 149 (314)
T cd05099 84 LGVCTQEG--------------PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEY 149 (314)
T ss_pred EEEEccCC--------------ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHH
Confidence 99987654 469999999999999999763211 12458999999999999999999
Q ss_pred HHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 940 LHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
||++||+||||||+|||++.+ +.+||+|||.++......... ......++..|+|||++.+
T Consensus 150 lH~~gi~H~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 210 (314)
T cd05099 150 LESRRCIHRDLAARNVLVTED-------NVMKIADFGLARGVHDIDYYK--------KTSNGRLPVKWMAPEALFD---- 210 (314)
T ss_pred HHHCCeeeccccceeEEEcCC-------CcEEEcccccccccccccccc--------ccccCCCCccccCHHHHcc----
Confidence 999999999999999999877 789999999987554321110 0011124467999999865
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001152 1020 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1098 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1137)
..++.++|||||||++|+|++ |..||.+....++...+..+.....+. .++.
T Consensus 211 ~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 263 (314)
T cd05099 211 RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPS---------------------------NCTH 263 (314)
T ss_pred CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCH
Confidence 467899999999999999999 899998877777776665443221110 3345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1099 FLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1099 ~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
++.+++.+||+.||++|||+.++++.++...
T Consensus 264 ~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 264 ELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 6899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=313.98 Aligned_cols=259 Identities=20% Similarity=0.330 Sum_probs=199.3
Q ss_pred CCCceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..+|++.+.||+|+||.||+|.+.. ..+|+|+.... ......+. +..|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~----~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRD----FLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHH----HHHHHHHHHhCCCcCcceEEEEEC
Confidence 4568999999999999999999743 24777764322 12223333 488999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+.. ..++||||+++++|.++++.. ...+++..+..++.|++.||+|||++|++||||||+||
T Consensus 76 ~~~--------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 76 KSR--------------PVMIITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred CCC--------------ceEEEEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 655 569999999999999998752 24689999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
+++.+ +.+||+|||.+........... .........+..|+|||++.+ ..++.++|||||||++
T Consensus 138 li~~~-------~~~kl~dfg~~~~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~----~~~~~~~DvwslG~~l 201 (269)
T cd05065 138 LVNSN-------LVCKVSDFGLSRFLEDDTSDPT-----YTSSLGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIVM 201 (269)
T ss_pred EEcCC-------CcEEECCCccccccccCccccc-----cccccCCCcceeecCHhHhcc----CcccchhhhhhhHHHH
Confidence 99877 7899999998865433211100 000001112457999999875 4678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|||++ |..||...+..+....+........+ ..++..+.+++.+||+.+|++
T Consensus 202 ~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 254 (269)
T cd05065 202 WEVMSYGERPYWDMSNQDVINAIEQDYRLPPP---------------------------MDCPTALHQLMLDCWQKDRNA 254 (269)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc---------------------------ccCCHHHHHHHHHHcCCChhh
Confidence 99886 99999887777766666443211111 133456899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001152 1115 RPTAGDLYEMFVA 1127 (1137)
Q Consensus 1115 RPSa~EVL~~L~~ 1127 (1137)
||++++|+..+..
T Consensus 255 Rp~~~~i~~~l~~ 267 (269)
T cd05065 255 RPKFGQIVSTLDK 267 (269)
T ss_pred CcCHHHHHHHHHh
Confidence 9999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=339.76 Aligned_cols=257 Identities=27% Similarity=0.480 Sum_probs=206.3
Q ss_pred CceEeeeecccCceEEEEEEECC-----cc-EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS-----AD-AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~-----~~-vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
+..+.++||+|+||.||+|++.. .. ||||..+.+ .....++..++ ++|+++|++++|||||++||+...
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~-~~~~~~~~~e~----m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS-SELTKEQIKEF----MKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc-ccccHHHHHHH----HHHHHHHHhCCCCCEEEEEEEEcC
Confidence 44566999999999999998732 12 566654432 12335555565 999999999999999999999887
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. -+++|||+|+||+|.+++++. ...++..+...++.+.|.||+|||++++|||||-+.|+|
T Consensus 233 ~~--------------Pl~ivmEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL 294 (474)
T KOG0194|consen 233 EE--------------PLMLVMELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCL 294 (474)
T ss_pred CC--------------ccEEEEEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhe
Confidence 66 359999999999999999872 236999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ ..+||+|||+++.-...... . ....-...|+|||.+.. ..|+.++|||||||++|
T Consensus 295 ~~~~-------~~vKISDFGLs~~~~~~~~~-----~-----~~~klPirWLAPEtl~~----~~~s~kTDV~sfGV~~~ 353 (474)
T KOG0194|consen 295 YSKK-------GVVKISDFGLSRAGSQYVMK-----K-----FLKKLPIRWLAPETLNT----GIFSFKTDVWSFGVLLW 353 (474)
T ss_pred ecCC-------CeEEeCccccccCCcceeec-----c-----ccccCcceecChhhhcc----CccccccchhheeeeEE
Confidence 9987 67899999998654311110 0 01123458999999975 47999999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHH-HcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1037 ELLT-LQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1037 ELLT-G~~Pf~~~~~~el~~~I-~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+++ |..||.+....++..+| ..+.+...+. ..+.++..++.+||..||++
T Consensus 354 Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~---------------------------~~p~~~~~~~~~c~~~~p~~ 406 (474)
T KOG0194|consen 354 EIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS---------------------------KTPKELAKVMKQCWKKDPED 406 (474)
T ss_pred eeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC---------------------------CCHHHHHHHHHHhccCChhh
Confidence 9999 88899999999999998 5454433332 34556889999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
||+|.++.+.+.....
T Consensus 407 R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 407 RPTMSTIKKKLEALEK 422 (474)
T ss_pred ccCHHHHHHHHHHHHh
Confidence 9999999998877643
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=313.51 Aligned_cols=257 Identities=22% Similarity=0.355 Sum_probs=199.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC---Cc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~---~~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..+|++.+.||+|+||.||+|.+. +. .+|+|. ++.... ....+. +.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~--~~~~~~-~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKT--LKAGYT-EKQRRD----FLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEE--CCCCCC-HHHHHH----HHHHHHHHHhCCCCCcceEEEEEe
Confidence 357889999999999999999873 22 355554 333221 222333 488999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
..+ ..++||||+++++|.+++... ...+++.++..|+.||+.||+|||+++|+||||||+||
T Consensus 76 ~~~--------------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 76 KSK--------------PVMIVTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred cCC--------------ccEEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 655 459999999999999999751 24689999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.++|+|||++.......... .......++..|+|||++.+ ..++.++|||||||++
T Consensus 138 li~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l 199 (267)
T cd05066 138 LVNSN-------LVCKVSDFGLSRVLEDDPEAA-------YTTRGGKIPIRWTAPEAIAY----RKFTSASDVWSYGIVM 199 (267)
T ss_pred EECCC-------CeEEeCCCCccccccccccee-------eecCCCccceeecCHhHhcc----CccCchhhhHHHHHHH
Confidence 99877 789999999987654321110 00011223568999999875 4678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|++++ |..||......+....+..+..+..+ ..+++.+.+++.+||+.+|.+
T Consensus 200 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 252 (267)
T cd05066 200 WEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP---------------------------MDCPAALHQLMLDCWQKDRNE 252 (267)
T ss_pred HHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC---------------------------CCCCHHHHHHHHHHcccCchh
Confidence 99886 99999887766666666544321111 033456899999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001152 1115 RPTAGDLYEMFVA 1127 (1137)
Q Consensus 1115 RPSa~EVL~~L~~ 1127 (1137)
||++.++++.+..
T Consensus 253 Rp~~~~i~~~l~~ 265 (267)
T cd05066 253 RPKFEQIVSILDK 265 (267)
T ss_pred CCCHHHHHHHHHh
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=319.66 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=199.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~ 877 (1137)
...|++.+.||+|+||.||+|.+. +..+|+|+.... ...... +..|+.+++++ +||||+++++++...
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~----~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEE----IKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHH----HHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 367889999999999999999984 467788875332 112222 36789999998 599999999998643
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
.. .......++||||+++++|.+++... ....+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 86 ~~--------~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili 154 (282)
T cd06636 86 SP--------PGHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL 154 (282)
T ss_pred cc--------cCCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 20 01123679999999999999998752 23458899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~ 1036 (1137)
+.+ +.++|+|||++........ ......|++.|+|||++.... ....++.++|||||||++|
T Consensus 155 ~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~ 217 (282)
T cd06636 155 TEN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAI 217 (282)
T ss_pred CCC-------CCEEEeeCcchhhhhcccc----------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHH
Confidence 977 6799999998865432111 112346889999999975311 1245788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|++|..||...........+.....+... ...++.++.+++.+||+.||.+||
T Consensus 218 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~cl~~~p~~Rp 271 (282)
T cd06636 218 EMAEGAPPLCDMHPMRALFLIPRNPPPKLK--------------------------SKKWSKKFIDFIEGCLVKNYLSRP 271 (282)
T ss_pred HHHhCCCCccccCHHhhhhhHhhCCCCCCc--------------------------ccccCHHHHHHHHHHhCCChhhCc
Confidence 999999999765544333322221111100 013455699999999999999999
Q ss_pred CHHHHHHHHHh
Q 001152 1117 TAGDLYEMFVA 1127 (1137)
Q Consensus 1117 Sa~EVL~~L~~ 1127 (1137)
++.|+++|+|+
T Consensus 272 ~~~ell~~~~~ 282 (282)
T cd06636 272 STEQLLKHPFI 282 (282)
T ss_pred CHHHHhcCCCC
Confidence 99999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=323.37 Aligned_cols=284 Identities=19% Similarity=0.263 Sum_probs=189.3
Q ss_pred eeeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 807 CDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~~----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
..+||+|+||+||+|+... ..+|+|.. ..... .. .+.+|+.+++.++||||+++++++.....
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~--~~~~~----~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGI----SM----SACREIALLRELKHPNVIALQKVFLSHSD--- 72 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEe--cCCCC----cH----HHHHHHHHHHhCCCCCeeeEEEEEeccCC---
Confidence 3689999999999999642 45777753 22111 11 23679999999999999999999865321
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhh----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE----TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~----~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
...++||||+. ++|.+++..... .....+++..+..++.||+.||+|||++||+||||||+|||+.
T Consensus 73 ---------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~ 142 (317)
T cd07867 73 ---------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 142 (317)
T ss_pred ---------CeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEc
Confidence 16799999996 688888754211 1123588999999999999999999999999999999999995
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ ....+.+||+|||+++........ ........+|+.|+|||++.+ ...++.++|||||||++|||
T Consensus 143 ~~---~~~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~el 209 (317)
T cd07867 143 GE---GPERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred cC---CCCCCcEEEeeccceeccCCCccc-------ccccCcceecccccCcHHhcC---CCccCcHHHHHhHHHHHHHH
Confidence 43 122368999999999765432211 011123468999999999874 24578999999999999999
Q ss_pred HhCCCCCCCCCH----------HHHHHHHHcCCCCCchhHHhhhccccccc-cccc--CCCCC-------CchhhhhhHH
Q 001152 1039 LTLQVPYMGLSE----------LEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQS--GSGFE-------KPEAELETLS 1098 (1137)
Q Consensus 1039 LTG~~Pf~~~~~----------~el~~~I~~g~~p~l~~~l~~~~~~~~~~-~~~~--~~~~~-------~~~~~~~~~~ 1098 (1137)
+||+.||..... .++...+.....+. ...+.......... .... ..... ..........
T Consensus 210 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (317)
T cd07867 210 LTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPA-DKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDS 288 (317)
T ss_pred HhCCCCcccccccccccccccHHHHHHHHHhcCCCC-hhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCCh
Confidence 999999965321 11111111111111 00011000000000 0000 00000 0000112345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001152 1099 FLVDVFRRCTEENPTERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1099 ~L~dLl~~CL~~DP~~RPSa~EVL~~L~~ 1127 (1137)
.+.+|+.+||+.||.+|||++|+++|+|+
T Consensus 289 ~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 289 KVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 58899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=315.80 Aligned_cols=266 Identities=25% Similarity=0.418 Sum_probs=200.5
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCC--hHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSS--ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~--~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+|.+.+.||+|+||.||+|... +..+|+|.......... ..........+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788899999999999999864 56788887543322111 1112222334578999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.++++.. ..+++..+..++.||+.||.|||+++++||||+|+||+++
T Consensus 82 --------------~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~ 142 (272)
T cd06629 82 --------------YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD 142 (272)
T ss_pred --------------ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc
Confidence 569999999999999999762 4689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.++|+|||++......... .......++..|+|||.+... ...++.++||||||+++|+|
T Consensus 143 ~~-------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~--~~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 143 AD-------GICKISDFGISKKSDDIYDN--------DQNMSMQGSVFWMAPEVIHSY--SQGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred CC-------CeEEEeeccccccccccccc--------cccccccCCccccCHHHhccc--cCCCCccchhHHHHHHHHHH
Confidence 77 78999999988654321110 011123578899999998752 23478999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g-~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++|..||......+....+... ..+.++. ......+..+.+++.+||+.+|++||+
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (272)
T cd06629 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPP-----------------------DVSMNLSPVALDFLNACFTINPDNRPT 262 (272)
T ss_pred HhCCCCCcCcchHHHHHHhhccccCCcCCc-----------------------cccccCCHHHHHHHHHHhcCChhhCCC
Confidence 9999999765443333222111 1111111 011134567999999999999999999
Q ss_pred HHHHHHHHHh
Q 001152 1118 AGDLYEMFVA 1127 (1137)
Q Consensus 1118 a~EVL~~L~~ 1127 (1137)
+++|++|+|+
T Consensus 263 ~~~il~~~~~ 272 (272)
T cd06629 263 ARELLQHPFI 272 (272)
T ss_pred HHHHhhCCCC
Confidence 9999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=313.12 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=199.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||+|.+. +..+|+|...... ....+.+. +.+|+.+++.++||||+++++.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~----~~~E~~~l~~~~h~~i~~~~~~~~~~~-- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK--MPVKEKEA----SKKEVILLAKMKHPNIVTFFASFQENG-- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh--ccchhhHH----HHHHHHHHHhCCCCChhhhhheeccCC--
Confidence 5889999999999999999985 4667777654321 11122222 378999999999999999999987655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++.. .....+++..+..|+.||+.||+|||+.+|+|+||||+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~ 137 (257)
T cd08225 73 ------------RLFIVMEYCDGGDLMKRINR---QRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137 (257)
T ss_pred ------------eEEEEEecCCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC
Confidence 56999999999999999875 223458999999999999999999999999999999999999866
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
. ..+||+|||.+........ ......|++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 138 ~------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~ape~~~~----~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08225 138 G------MVAKLGDFGIARQLNDSME----------LAYTCVGTPYYLSPEICQN----RPYNNKTDIWSLGCVLYELCT 197 (257)
T ss_pred C------CeEEecccccchhccCCcc----------cccccCCCccccCHHHHcC----CCCCchhhHHHHHHHHHHHHh
Confidence 2 3579999998875543211 1113458889999999865 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||......+....+.....+... ...+.++.+++.+||+.+|++|||+.+
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 198 LKHPFEGNNLHQLVLKICQGYFAPIS---------------------------PNFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred CCCCCCCccHHHHHHHHhcccCCCCC---------------------------CCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 99999876655554444332221111 023445999999999999999999999
Q ss_pred HHHHHHh
Q 001152 1121 LYEMFVA 1127 (1137)
Q Consensus 1121 VL~~L~~ 1127 (1137)
+++|+|+
T Consensus 251 ll~~~~~ 257 (257)
T cd08225 251 ILKRPFL 257 (257)
T ss_pred HhhCCCC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=313.04 Aligned_cols=259 Identities=27% Similarity=0.394 Sum_probs=197.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCC-hHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSS-ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~-~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.+|++.+.||+|+||.||+|.+. +..+++|....+..... ....+ .+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVN----ALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHH----HHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 46889999999999999999974 46688886543322211 22223 3478999999999999999999876542
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. ...++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++|+|+||||+||+++
T Consensus 78 ~------------~~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~ 140 (265)
T cd06652 78 E------------RTLSIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140 (265)
T ss_pred C------------ceEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence 1 156899999999999999875 23578999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.++|+|||.+.......... .......++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 141 SV-------GNVKLGDFGASKRLQTICLSG-------TGMKSVTGTPYWMSPEVISG----EGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred CC-------CCEEECcCccccccccccccc-------cccccCCCCccccChhhhcC----CCCCcchhHHHHHHHHHHH
Confidence 77 789999999887543211110 01112358889999999875 4578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++|+.||...........+.... .+..+ ...+..+.+++.+||. +|.+||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~-~p~~Rp~ 254 (265)
T cd06652 203 LTEKPPWAEFEAMAAIFKIATQPTNPVLP---------------------------PHVSDHCRDFLKRIFV-EAKLRPS 254 (265)
T ss_pred hhCCCCCCccchHHHHHHHhcCCCCCCCc---------------------------hhhCHHHHHHHHHHhc-ChhhCCC
Confidence 99999998654443333332211 11111 1234458899999995 9999999
Q ss_pred HHHHHHHHHh
Q 001152 1118 AGDLYEMFVA 1127 (1137)
Q Consensus 1118 a~EVL~~L~~ 1127 (1137)
++||++|+|.
T Consensus 255 ~~~il~~~~~ 264 (265)
T cd06652 255 ADELLRHTFV 264 (265)
T ss_pred HHHHhcCccc
Confidence 9999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=316.63 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=198.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
+.+|++.++||+|+||.||+|... +..+++|.. ... .....+. +.+|+++++.++||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~--~~~--~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~ 75 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEA--SESARQD----FQREAELLTVLQHQHIVRFYGV 75 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEec--CcC--CHHHHHH----HHHHHHHHhcCCCCCCceEEEE
Confidence 456889999999999999999742 234555543 221 1222233 4889999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------GEKHVSVKLALFIAQDVAAALVELHSK 943 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~----------~~~~ls~~~i~~I~~QIa~gL~yLHs~ 943 (1137)
+.... ..++||||+++++|.+++...... ....+++..+..++.||+.||+|||++
T Consensus 76 ~~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 141 (280)
T cd05092 76 CTEGR--------------PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL 141 (280)
T ss_pred EecCC--------------ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 87655 459999999999999999763211 113588999999999999999999999
Q ss_pred CeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCC
Q 001152 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1023 (1137)
Q Consensus 944 gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s 1023 (1137)
||+||||||+|||++.+ +.+||+|||++......... .......+++.|+|||.+.+ ..++
T Consensus 142 ~i~H~dlkp~nil~~~~-------~~~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~ 202 (280)
T cd05092 142 HFVHRDLATRNCLVGQG-------LVVKIGDFGMSRDIYSTDYY--------RVGGRTMLPIRWMPPESILY----RKFT 202 (280)
T ss_pred CeecccccHhhEEEcCC-------CCEEECCCCceeEcCCCcee--------ecCCCccccccccCHHHhcc----CCcC
Confidence 99999999999999877 78999999988654321110 00112345678999999875 4578
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHH
Q 001152 1024 LEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 1102 (1137)
Q Consensus 1024 ~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~d 1102 (1137)
.++|||||||++|||++ |..||......+....+..+..+..+. .+++.+.+
T Consensus 203 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~ 255 (280)
T cd05092 203 TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPR---------------------------TCPPEVYA 255 (280)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCC---------------------------CCCHHHHH
Confidence 99999999999999998 999998777666666555443221111 33456899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 001152 1103 VFRRCTEENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1103 Ll~~CL~~DP~~RPSa~EVL~~L~ 1126 (1137)
++.+||+.||.+||++++|++.+.
T Consensus 256 li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 256 IMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHccCChhhCCCHHHHHHHHh
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.80 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=197.2
Q ss_pred CCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.+|++.++||+|++|.||+|.+.+ ..+++|+.. .... .. ..+.+|+.++++++||||+++++++.. +
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~--~~~~---~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-- 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLK--PGTM---MP----EAFLQEAQIMKKLRHDKLVPLYAVVSE-E-- 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcc--cCCc---cH----HHHHHHHHHHHhCCCCCeeeEEEEEcC-C--
Confidence 568999999999999999999865 467777632 2111 11 224779999999999999999988743 2
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.++++.. ....+++..+..++.||+.||+|||+.||+|+||||+||+++.+
T Consensus 74 ------------~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~ 138 (260)
T cd05069 74 ------------PIYIVTEFMGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN 138 (260)
T ss_pred ------------CcEEEEEcCCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC
Confidence 348999999999999999752 23458999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+......... ......++..|+|||...+ ..++.++||||||+++|+|++
T Consensus 139 -------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~~l~el~t 198 (260)
T cd05069 139 -------LVCKIADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred -------CeEEECCCccceEccCCccc---------ccCCCccchhhCCHHHhcc----CCcChHHHHHHHHHHHHHHHh
Confidence 78999999998754322111 0112235678999998864 457899999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|..||.+....+....+..+..+..+. ..+..+.+++.+||+.||.+||+++
T Consensus 199 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05069 199 KGRVPYPGMVNREVLEQVERGYRMPCPQ---------------------------GCPESLHELMKLCWKKDPDERPTFE 251 (260)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHHccCCcccCcCHH
Confidence 899998877766666655433221111 2345699999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
+|++.+..
T Consensus 252 ~i~~~l~~ 259 (260)
T cd05069 252 YIQSFLED 259 (260)
T ss_pred HHHHHHhc
Confidence 99998753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=314.15 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=187.9
Q ss_pred eeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
+.||+|+||.||+|.+.+ ..+++|. ++.... ..... .+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~--~~~~~~-~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 68 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKE--LRVSAS-VQEQM----KFLEEAQPYRSLQHSNLLQCLGQCTEVT----- 68 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEe--cCCCCC-hHHHH----HHHHHHHHHHhCCCCCEeeEEEEEcCCC-----
Confidence 368999999999998643 2355554 332222 12222 3478999999999999999999987654
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
..++||||+++|+|.++++.........+++..+..++.|++.||+|||+++|+||||||+||+++.+
T Consensus 69 ---------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~--- 136 (269)
T cd05087 69 ---------PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD--- 136 (269)
T ss_pred ---------CcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---
Confidence 45999999999999999976433333456788889999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC---CCCCCchhhHHHHHHHHHHHHh
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK---PNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||.+......... .......++..|+|||++.+... ...++.++||||||+++|||++
T Consensus 137 ----~~~kL~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05087 137 ----LTVKIGDYGLSHNKYKEDYY--------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE 204 (269)
T ss_pred ----CcEEECCccccccccCccee--------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence 78999999988643321110 01112357788999999864211 1235789999999999999996
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|..||......+............++. +......++.+.+++.+|| .+|++|||++
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~ 261 (269)
T cd05087 205 LGSQPYRHLSDEQVLTYTVREQQLKLPK----------------------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAE 261 (269)
T ss_pred CCCCCCCCCChHHHHHHHhhcccCCCCC----------------------CccCCCCChHHHHHHHHHh-cCcccCCCHH
Confidence 999998766555443322211111110 0001123445889999999 6899999999
Q ss_pred HHHHHHH
Q 001152 1120 DLYEMFV 1126 (1137)
Q Consensus 1120 EVL~~L~ 1126 (1137)
||+..|.
T Consensus 262 ~l~~~l~ 268 (269)
T cd05087 262 EVHLLLS 268 (269)
T ss_pred HHHHHhc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=316.60 Aligned_cols=270 Identities=23% Similarity=0.311 Sum_probs=193.6
Q ss_pred Cc-eEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 803 SL-SSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 803 ~y-~l~~~LG~GsfG~Vy~a~~------~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
+| ++.+.||+|+||+||++.+ .+..+|+|+...... ....+. +.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~ 76 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG---QQNTSG----WKKEINILKTLYHENIVKYKGCCS 76 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC---hHHHHH----HHHHHHHHHhCCCCCEeeEEEEEe
Confidence 44 8899999999999988764 235688887543221 112223 478999999999999999999876
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
.... ...++||||+++++|.+++.. ..+++..+..|+.|++.||+|||++||+||||||+||
T Consensus 77 ~~~~------------~~~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Ni 138 (283)
T cd05080 77 EQGG------------KGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV 138 (283)
T ss_pred cCCC------------ceEEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheE
Confidence 5321 156999999999999999875 3589999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++.......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 139 li~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~~l 200 (283)
T cd05080 139 LLDND-------RLVKIGDFGLAKAVPEGHEYY-------RVREDGDSPVFWYAVECLKE----NKFSYASDVWSFGVTL 200 (283)
T ss_pred EEcCC-------CcEEEeecccccccCCcchhh-------ccCCCCCCCceeeCHhHhcc----cCCCcccccHHHHHHH
Confidence 99877 789999999987654322110 00112235667999999865 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCch-hHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLT-DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+|++|..||...... ....+. ....... ..+... . ..... .......+.++.+++.+||+.||++
T Consensus 201 ~el~tg~~p~~~~~~~-~~~~~~-~~~~~~~~~~~~~~-------~-~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~ 267 (283)
T cd05080 201 YELLTHCDSKQSPPKK-FEEMIG-PKQGQMTVVRLIEL-------L-ERGMR---LPCPKNCPQEVYILMKNCWETEAKF 267 (283)
T ss_pred HHHHhCCCCCCCCcch-hhhhhc-ccccccchhhhhhh-------h-hcCCC---CCCCCCCCHHHHHHHHHHhccChhh
Confidence 9999999998653321 111110 0000000 000000 0 00000 0011245667999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001152 1115 RPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~ 1128 (1137)
|||+++|++.+...
T Consensus 268 Rps~~~i~~~l~~~ 281 (283)
T cd05080 268 RPTFRSLIPILKEM 281 (283)
T ss_pred CCCHHHHHHHHHHh
Confidence 99999999988764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=326.92 Aligned_cols=285 Identities=17% Similarity=0.208 Sum_probs=204.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||.||+|.+. +..+|+|+.. .........+. +.+|+.++++++||||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS--RPFQNVTHAKR----AYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecC--ccccChhHHHH----HHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 467999999999999999999974 4678888643 22112222223 367999999999999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.+ ......|+||||+. ++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 89 ~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~ 152 (353)
T cd07850 89 SL--------EEFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 152 (353)
T ss_pred Cc--------cccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence 21 11225799999996 689888764 288999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++........ .....+++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 153 ~~-------~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~l 210 (353)
T cd07850 153 SD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 210 (353)
T ss_pred CC-------CCEEEccCccceeCCCCCC-----------CCCCcccccccCHHHHhC----CCCCCchhhHhHHHHHHHH
Confidence 87 7899999999875433211 112357889999999875 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccc-----------ccccccccCCC----CCCchhhhhhHHHHHHH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-----------HEHEVAQSGSG----FEKPEAELETLSFLVDV 1103 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~-----------~~~~~~~~~~~----~~~~~~~~~~~~~L~dL 1103 (1137)
++|+.||...+.......+.................. ......+.... ..........++.+.++
T Consensus 211 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (353)
T cd07850 211 IRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290 (353)
T ss_pred HHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHH
Confidence 9999999887765555554322211111111100000 00000000000 00000112346678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1104 FRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1104 l~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+.+||+.||++|||+.|+++|+|+..
T Consensus 291 i~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 291 LSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHHHcCCChhhCcCHHHHhcChhHhh
Confidence 99999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=319.52 Aligned_cols=255 Identities=28% Similarity=0.404 Sum_probs=198.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||+||+|.+. +..+|+|+..... .... ..++.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSV----RKQILRELQIMHECRSPYIVSFYGAFLNEN 76 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchH----HHHHHHHHHHHHHcCCCCcceEeeeEecCC
Confidence 457899999999999999999985 5678888754321 1112 223488999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeEe
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILI 957 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NILl 957 (1137)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||++
T Consensus 77 --------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~ 137 (284)
T cd06620 77 --------------NICMCMEFMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV 137 (284)
T ss_pred --------------EEEEEEecCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE
Confidence 67999999999999999875 2468999999999999999999997 599999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.++|+|||++....... .....|+..|+|||++.+ ..++.++|||||||++|+
T Consensus 138 ~~~-------~~~~l~d~gl~~~~~~~~------------~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~l~~ 194 (284)
T cd06620 138 NSR-------GQIKLCDFGVSGELINSI------------ADTFVGTSTYMSPERIQG----GKYTVKSDVWSLGISIIE 194 (284)
T ss_pred CCC-------CcEEEccCCcccchhhhc------------cCccccCcccCCHHHHcc----CCCCccchHHHHHHHHHH
Confidence 877 789999999876432211 113368899999999865 467889999999999999
Q ss_pred HHhCCCCCCCCCHH-----------HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001152 1038 LLTLQVPYMGLSEL-----------EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1106 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~-----------el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~ 1106 (1137)
|++|..||...... +....+.....+.++ ....+..+.+++.+
T Consensus 195 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~ 248 (284)
T cd06620 195 LALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP--------------------------SSDFPEDLRDFVDA 248 (284)
T ss_pred HHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--------------------------chhcCHHHHHHHHH
Confidence 99999999764432 111111111111100 01244568999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1107 CTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1107 CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
||+.||++|||+.|+++++|+...
T Consensus 249 ~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 249 CLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HhcCCcccCcCHHHHhcCcccccc
Confidence 999999999999999999988754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=320.81 Aligned_cols=289 Identities=21% Similarity=0.228 Sum_probs=209.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
++.+|++.+.||+|+||.||+|.+. +..||+|+...+...... . ..+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~--~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI--P----ISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC--c----chhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 5678999999999999999999984 577888876544322111 1 1225799999999999999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
.. ...++||||+. ++|.+++... ...+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus 79 ~~------------~~~~lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 141 (309)
T cd07845 79 HL------------DSIFLVMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL 141 (309)
T ss_pred CC------------CeEEEEEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 31 15699999996 6898888752 2468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||.+......... .....+++.|+|||.+.+ ...++.++|||||||++|+
T Consensus 142 ~~~-------~~~kL~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 142 TDK-------GCLKIADFGLARTYGLPAKP----------MTPKVVTLWYRAPELLLG---CTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred CCC-------CCEEECccceeeecCCccCC----------CCcccccccccChhhhcC---CCCcCchHHHHHHHHHHHH
Confidence 877 78999999998765432111 112245778999999864 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc-ccccccCCCCCC-chhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGSGFEK-PEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|++|+.||...+..+....+...........++....... ............ .......++++.++|.+||+.||.+|
T Consensus 202 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 281 (309)
T cd07845 202 LLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR 281 (309)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhC
Confidence 9999999998887777666644322111111110000000 000000000000 00011246678999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 001152 1116 PTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~s 1131 (1137)
||+.|++.|+|+....
T Consensus 282 ~t~~~il~h~~f~~~~ 297 (309)
T cd07845 282 ATAEEALESSYFKEKP 297 (309)
T ss_pred cCHHHHhcChhhccCC
Confidence 9999999999998543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=312.08 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=200.0
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+.+|++.+.||+|+||.||++...+..+|+|+..... ..+ .+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~------~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 71 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV------TAQ----AFLEETAVMTKLHHKNLVRLLGVILHN-- 71 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc------hHH----HHHHHHHHHHhCCCCCcCeEEEEEcCC--
Confidence 35678999999999999999999888889999753221 112 237899999999999999999987643
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 72 -------------~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~ 135 (254)
T cd05083 72 -------------GLYIVMELMSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE 135 (254)
T ss_pred -------------CcEEEEECCCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 248999999999999999762 2345899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.+....... .....+..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~l~el~ 191 (254)
T cd05083 136 D-------GVAKVSDFGLARVGSMGV-------------DNSKLPVKWTAPEALKH----KKFSSKSDVWSYGVLLWEVF 191 (254)
T ss_pred C-------CcEEECCCccceeccccC-------------CCCCCCceecCHHHhcc----CCcCchhhHHHHHHHHHHHH
Confidence 7 789999999886533211 01124568999999864 46789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||......+....+..+..+..+ ...+..+.+++.+||+.+|++||++
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 244 (254)
T cd05083 192 SYGRAPYPKMSLKEVKECVEKGYRMEPP---------------------------EGCPADVYVLMTSCWETEPKKRPSF 244 (254)
T ss_pred hCCCCCCccCCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHcCCChhhCcCH
Confidence 8 99999887776666655543322111 0334568999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
+++++.+..
T Consensus 245 ~~l~~~l~~ 253 (254)
T cd05083 245 HKLREKLEK 253 (254)
T ss_pred HHHHHHHcc
Confidence 999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=322.28 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=201.8
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|.....||+|+||.||++... +..+|+|...... ....+. +.+|+.+++.++||||+++++.+...+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~----~~~e~~~l~~l~h~~ii~~~~~~~~~~--- 92 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRREL----LFNEVVIMRDYHHENVVDMYNSYLVGD--- 92 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHH----HHHHHHHHHhCCCCcHHHHHHheecCC---
Confidence 455678999999999999874 4678887643221 222222 478999999999999999999987655
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
..++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 93 -----------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~- 154 (292)
T cd06658 93 -----------ELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD- 154 (292)
T ss_pred -----------eEEEEEeCCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-
Confidence 56999999999999998854 358899999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.++|+|||++........ ......++..|+|||++.+ ..++.++||||||+++|||++|
T Consensus 155 ------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvil~el~~g 214 (292)
T cd06658 155 ------GRIKLSDFGFCAQVSKEVP----------KRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMIDG 214 (292)
T ss_pred ------CCEEEccCcchhhcccccc----------cCceeecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHHhC
Confidence 7899999998864432111 1123458889999999865 4578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
+.||......+....+.....+.... ....+..+.+++.+||..||.+|||++|+
T Consensus 215 ~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~i 269 (292)
T cd06658 215 EPPYFNEPPLQAMRRIRDNLPPRVKD-------------------------SHKVSSVLRGFLDLMLVREPSQRATAQEL 269 (292)
T ss_pred CCCCCCCCHHHHHHHHHhcCCCcccc-------------------------ccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99998776655554443322111110 00234458899999999999999999999
Q ss_pred HHHHHhhcCCCCCC
Q 001152 1122 YEMFVARTSSSISS 1135 (1137)
Q Consensus 1122 L~~L~~~~~ss~s~ 1135 (1137)
++|+|+......++
T Consensus 270 l~~~~~~~~~~~~~ 283 (292)
T cd06658 270 LQHPFLKLAGPPSC 283 (292)
T ss_pred hhChhhhccCCccc
Confidence 99999997655544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=325.07 Aligned_cols=262 Identities=23% Similarity=0.377 Sum_probs=202.3
Q ss_pred CCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceee
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 871 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~---------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkll 871 (1137)
.+|++.+.||+|+||.||+|.+.+ ..+|+|+.... ......+. +.+|+.+++++ +||||++++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSD----LVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHH----HHHHHHHHHhhcCCCCeeeee
Confidence 468999999999999999998621 24677764322 11222333 37899999999 799999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHH
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVEL 940 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-----------~~~~~ls~~~i~~I~~QIa~gL~yL 940 (1137)
+++.... ..++||||+++|+|.+++..... .....+++..+..++.||+.||+||
T Consensus 85 ~~~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 85 GACTQDG--------------PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred EEEccCC--------------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 9987655 46999999999999999976321 1123588899999999999999999
Q ss_pred HhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCC
Q 001152 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1020 (1137)
Q Consensus 941 Hs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 1020 (1137)
|++||+||||||+|||++.+ +.+||+|||.++......... ......++..|+|||++.+ .
T Consensus 151 H~~givH~dlkp~Nill~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~ 211 (334)
T cd05100 151 ASQKCIHRDLAARNVLVTED-------NVMKIADFGLARDVHNIDYYK--------KTTNGRLPVKWMAPEALFD----R 211 (334)
T ss_pred HHCCeeccccccceEEEcCC-------CcEEECCcccceecccccccc--------cccCCCcCceEcCHHHhcc----C
Confidence 99999999999999999877 789999999987554321110 0111234567999999875 4
Q ss_pred CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001152 1021 LYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1099 (1137)
Q Consensus 1021 ~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1137)
.++.++|||||||++|||++ |..||.+....+....+.....+..+. ..+.+
T Consensus 212 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 264 (334)
T cd05100 212 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NCTHE 264 (334)
T ss_pred CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHH
Confidence 67899999999999999998 889998877777766665433222111 23445
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1100 LVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1100 L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+.+++.+||+.+|.+||++.|+++++.....
T Consensus 265 l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 265 LYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 8999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=367.03 Aligned_cols=264 Identities=28% Similarity=0.444 Sum_probs=214.9
Q ss_pred CceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|.-..+||.|.||.||-|....+ ..|||- ++........+... .+|..++..++|||+|++||+-.+.+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKE--I~iq~~~~k~~~~i----~eEm~vlE~lnHpNlV~YyGVEvHRe-- 1307 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKE--IKIQDSDHKTFKLI----AEEMKVLEGLNHPNLVRYYGVEVHRE-- 1307 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhh--hhcCccccccCcch----HHHHHHHHhccCccccccCceeecHH--
Confidence 456667899999999999997554 455554 33332223333333 77999999999999999999987765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
.++|.||||.+|+|.+.++. +...++.....+..|++.|++|||++|||||||||.||+++.+
T Consensus 1308 ------------kv~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~ 1370 (1509)
T KOG4645|consen 1308 ------------KVYIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN 1370 (1509)
T ss_pred ------------HHHHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC
Confidence 56999999999999999976 3457788888899999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
|.+|++|||.|..+.....+.. ......+||+.|||||++.+.. .....-+.||||+||++.||+|
T Consensus 1371 -------g~iK~~DFGsa~ki~~~~~~~~------~el~~~~GT~~YMAPEvit~t~-~kG~~~A~DiWslGCVVlEM~t 1436 (1509)
T KOG4645|consen 1371 -------GLIKYGDFGSAVKIKNNAQTMP------GELQSMMGTPMYMAPEVITGTK-GKGHGGAADIWSLGCVVLEMAT 1436 (1509)
T ss_pred -------CcEEeecccceeEecCchhcCC------HHHHhhcCCchhcCchhhcccc-cCCCCcchhhhcccceEEEeec
Confidence 8999999999987765432211 1223568999999999998743 3456789999999999999999
Q ss_pred CCCCCCC-CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 LQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 G~~Pf~~-~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|+.||.. ++..++...+..|..|.+|..+ +.+-++++.+||+.||.+|+++.
T Consensus 1437 GkrPW~~~dne~aIMy~V~~gh~Pq~P~~l---------------------------s~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1437 GKRPWAELDNEWAIMYHVAAGHKPQIPERL---------------------------SSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred CCCchhhccchhHHHhHHhccCCCCCchhh---------------------------hHhHHHHHHHHHhcCchhhhHHH
Confidence 9999976 4567788888999888877543 34589999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001152 1120 DLYEMFVARTSSS 1132 (1137)
Q Consensus 1120 EVL~~L~~~~~ss 1132 (1137)
|+++|=+.+....
T Consensus 1490 qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1490 QLLEHAFGKSCTD 1502 (1509)
T ss_pred HHHHhhccccccc
Confidence 9999988875543
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=315.18 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=199.8
Q ss_pred CceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|+..+.||+|++|.||+|.. .+..+|+|+........ ...+.....+.+|+.++++++||||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS--SEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc--hhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--
Confidence 477889999999999999987 45778888754332211 122222345588999999999999999999987655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
+.++||||+++++|.+++.+ ...+++..+..|+.||+.||+|||++||+|+||||+||+++.+
T Consensus 77 ------------~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~ 139 (268)
T cd06630 77 ------------HFNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139 (268)
T ss_pred ------------eEEEEEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 66999999999999999875 2368999999999999999999999999999999999999765
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+ ..+||+|||.+.......... ........++..|+|||.+.+ ..++.++||||+|+++|+|++
T Consensus 140 ~------~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 140 G------QRLRIADFGAAARLAAKGTGA------GEFQGQLLGTIAFMAPEVLRG----EQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred C------CEEEEcccccccccccccccC------CccccccccccceeCHhHhcc----CCCCcccchHHHHHHHHHHHh
Confidence 2 369999999987654321110 011123468889999999865 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHH---c-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1041 LQVPYMGLSELEIHDLIQ---M-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~---~-g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|..||...........+. . ...+..+ ...++++.+++.+||+.+|++||
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~ 256 (268)
T cd06630 204 AKPPWNAEKHSNHLALIFKIASATTAPSIP---------------------------EHLSPGLRDVTLRCLELQPEDRP 256 (268)
T ss_pred CCCCCCCCCCcchHHHHHHHhccCCCCCCc---------------------------hhhCHHHHHHHHHHcCCCcccCc
Confidence 999997543222121111 1 1111111 13455689999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001152 1117 TAGDLYEMFVAR 1128 (1137)
Q Consensus 1117 Sa~EVL~~L~~~ 1128 (1137)
++.++++|+|++
T Consensus 257 ~~~~ll~~~~~~ 268 (268)
T cd06630 257 PSRELLKHPVFR 268 (268)
T ss_pred CHHHHhcCcccC
Confidence 999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=317.14 Aligned_cols=267 Identities=27% Similarity=0.382 Sum_probs=199.4
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEec
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 876 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~ 876 (1137)
...+|++.+.||+|+||.||+|.+. +..+|+|+.. ... ..... +.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~--~~~---~~~~~----~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD--PIH---DIDEE----IEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeec--ccc---chHHH----HHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4568999999999999999999884 4678888643 211 11122 36789999999 69999999998864
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
... ......++||||+++++|.+++...... ...+++..+..++.|++.||.|||+++|+||||||+||+
T Consensus 87 ~~~---------~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil 156 (286)
T cd06638 87 KDV---------KNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNIL 156 (286)
T ss_pred ccc---------CCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEE
Confidence 321 0112679999999999999988753222 346899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL 1035 (1137)
++.+ +.+||+|||++........ ......|++.|+|||++.... ....++.++|||||||++
T Consensus 157 i~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~ 219 (286)
T cd06638 157 LTTE-------GGVKLVDFGVSAQLTSTRL----------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA 219 (286)
T ss_pred ECCC-------CCEEEccCCceeecccCCC----------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHH
Confidence 9987 6799999999875532111 112346889999999975311 124578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|+|++|+.||...........+.....+... .+ ...+..+.+++.+||+.||++|
T Consensus 220 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~---~~~~~~~~~li~~~l~~~p~~R 274 (286)
T cd06638 220 IELGDGDPPLADLHPMRALFKIPRNPPPTLH----------------------QP---ELWSNEFNDFIRKCLTKDYEKR 274 (286)
T ss_pred HHHhcCCCCCCCCchhHHHhhccccCCCccc----------------------CC---CCcCHHHHHHHHHHccCCcccC
Confidence 9999999999876543333222221111100 00 0223458999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001152 1116 PTAGDLYEMFVA 1127 (1137)
Q Consensus 1116 PSa~EVL~~L~~ 1127 (1137)
||+.||++|+|+
T Consensus 275 ps~~ell~~~~~ 286 (286)
T cd06638 275 PTVSDLLQHVFI 286 (286)
T ss_pred CCHHHHhhcccC
Confidence 999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=312.33 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=198.5
Q ss_pred CCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.+|++.++||+|+||.||+|... +..+|+|..... ... .+. +.+|+.++++++||||+++++++.. +
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~--~~~---~~~----~~~E~~~l~~l~h~~i~~~~~~~~~-~-- 73 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG--SMS---PEA----FLAEANLMKQLQHPRLVRLYAVVTQ-E-- 73 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCC--CCc---HHH----HHHHHHHHHhcCCcCeeeEEEEEcc-C--
Confidence 56899999999999999999974 477888875322 111 122 3779999999999999999988643 2
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++.. .....+++..+..++.|++.||+|||+.||+||||||+||+++.+
T Consensus 74 ------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~ 138 (260)
T cd05067 74 ------------PIYIITEYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET 138 (260)
T ss_pred ------------CcEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC
Confidence 35999999999999999865 233568999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+......... ......++..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 139 -------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slG~~l~el~~ 198 (260)
T cd05067 139 -------LCCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIVT 198 (260)
T ss_pred -------CCEEEccCcceeecCCCCcc---------cccCCcccccccCHHHhcc----CCcCcccchHHHHHHHHHHHh
Confidence 78999999988655421111 0112235678999999865 457889999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|..||.+.+..+....+..+.....+. ..+.++.+++.+||+.+|++||+++
T Consensus 199 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05067 199 YGRIPYPGMTNPEVIQNLERGYRMPRPD---------------------------NCPEELYELMRLCWKEKPEERPTFE 251 (260)
T ss_pred CCCCCCCCCChHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCCCHH
Confidence 999998877766666654433221110 2345699999999999999999999
Q ss_pred HHHHHHH
Q 001152 1120 DLYEMFV 1126 (1137)
Q Consensus 1120 EVL~~L~ 1126 (1137)
++++.+.
T Consensus 252 ~l~~~l~ 258 (260)
T cd05067 252 YLRSVLE 258 (260)
T ss_pred HHHHHhh
Confidence 9998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=314.91 Aligned_cols=282 Identities=19% Similarity=0.249 Sum_probs=199.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
+.+.+|++.+.||+|++|.||+|... +..+|+|......... ... .+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APF----TAIREASLLKDLKHANIVTLHDIIHT 74 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---Cch----hHHHHHHHHhhCCCcceeeEEEEEec
Confidence 45788999999999999999999974 5678888754332111 111 12679999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ ..++||||++ ++|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 75 ~~--------------~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil 135 (291)
T cd07844 75 KK--------------TLTLVFEYLD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLL 135 (291)
T ss_pred CC--------------eEEEEEecCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEE
Confidence 65 6699999997 5999988752 236899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||.+......... .....++..|+|||++.+ ...++.++||||+||++|
T Consensus 136 ~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~il~ 195 (291)
T cd07844 136 ISER-------GELKLADFGLARAKSVPSKT----------YSNEVVTLWYRPPDVLLG---STEYSTSLDMWGVGCIFY 195 (291)
T ss_pred EcCC-------CCEEECccccccccCCCCcc----------ccccccccccCCcHHhhc---CcccCcHHHHHHHHHHHH
Confidence 9887 78999999988643321111 112246789999999864 235788999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchh-----hhhhHHHHHHHHHHhccc
Q 001152 1037 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA-----ELETLSFLVDVFRRCTEE 1110 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~-~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~L~dLl~~CL~~ 1110 (1137)
+|++|+.||.... ..+....+...........+.......... ............ .......+.+++.+||+.
T Consensus 196 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 274 (291)
T cd07844 196 EMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK-PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQY 274 (291)
T ss_pred HHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc-cccccccCChhHHHhCcCCCCchhHHHHHHHHhcc
Confidence 9999999997654 333333222111111111111110000000 000000000000 011125688999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 001152 1111 NPTERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1111 DP~~RPSa~EVL~~L~~ 1127 (1137)
+|.+|||+.|+++|+||
T Consensus 275 ~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 275 EPKKRISAAEAMKHPYF 291 (291)
T ss_pred CcccccCHHHHhcCCCC
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=313.62 Aligned_cols=263 Identities=24% Similarity=0.325 Sum_probs=203.2
Q ss_pred CCCceEeeeecccCceEEEEEEECC------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
-.+|++.+.||+|+||.||+|.+.. ..+++|+. ... ......+. +.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~--~~~-~~~~~~~~----~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV--KDH-ASEIQVTL----LLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEc--cCC-CCHHHHHH----HHHHHHHHHhCCCCCCCeEEEEE
Confidence 4578999999999999999999854 45666653 221 22333333 37899999999999999999987
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~---~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLK 951 (1137)
..... ..++++||+++++|.+++...... ....+++..+..++.||+.||+|||+++|+|||||
T Consensus 78 ~~~~~-------------~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~ 144 (280)
T cd05043 78 IEDGE-------------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIA 144 (280)
T ss_pred ecCCC-------------CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence 65321 459999999999999999763221 11468999999999999999999999999999999
Q ss_pred CCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001152 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031 (1137)
Q Consensus 952 P~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1031 (1137)
|+||+++.+ +.+||+|||+++.+....... ......++..|+|||++.+ ..++.++|||||
T Consensus 145 p~nil~~~~-------~~~kl~d~g~~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~----~~~~~~~Di~sl 205 (280)
T cd05043 145 ARNCVIDEE-------LQVKITDNALSRDLFPMDYHC--------LGDNENRPVKWMALESLVN----KEYSSASDVWSF 205 (280)
T ss_pred HhhEEEcCC-------CcEEECCCCCcccccCCceEE--------eCCCCCcchhccCHHHHhc----CCCCchhhHHHh
Confidence 999999877 789999999987543321110 0012235678999999865 457899999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 001152 1032 GCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1110 (1137)
Q Consensus 1032 GviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~ 1110 (1137)
||++||+++ |..||......++...+..+.....+ ..+++++.+++.+||..
T Consensus 206 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~ 258 (280)
T cd05043 206 GVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP---------------------------INCPDELFAVMACCWAL 258 (280)
T ss_pred HHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC---------------------------CcCCHHHHHHHHHHcCC
Confidence 999999999 99999887777766665543321110 02345689999999999
Q ss_pred CCCCCCCHHHHHHHHHhhc
Q 001152 1111 NPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1111 DP~~RPSa~EVL~~L~~~~ 1129 (1137)
||++|||+.++++.+....
T Consensus 259 ~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 259 DPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ChhhCCCHHHHHHHHHHHH
Confidence 9999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=320.21 Aligned_cols=285 Identities=21% Similarity=0.282 Sum_probs=204.7
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+.+|++.+.||+|+||.||+|.+. +..+++|..+..... +.+...+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 3567899999999999999999986 456777765433211 11222346799999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+. ...++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 77 ~~------------~~~~lv~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 77 NL------------DKIYMVMEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred CC------------CcEEEEehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 21 16799999997 6999988752 2368999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||.+......... .....+++.|+|||.+.+. ..++.++||||||+++|+
T Consensus 140 ~~~-------~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~l~~ 199 (293)
T cd07843 140 NNR-------GILKICDFGLAREYGSPLKP----------YTQLVVTLWYRAPELLLGA---KEYSTAIDMWSVGCIFAE 199 (293)
T ss_pred CCC-------CcEEEeecCceeeccCCccc----------cccccccccccCchhhcCC---ccccchhhHHHHHHHHHH
Confidence 977 78999999988765442111 1123578899999998752 346789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhh---cccccccccccCCCCCCchhhh-hhHHHHHHHHHHhcccCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL---GSCHEHEVAQSGSGFEKPEAEL-ETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~~L~dLl~~CL~~DP~ 1113 (1137)
|++|..||......+....+...........+... ...................... ..++.+.+++.+||+.||+
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 200 LLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcc
Confidence 99999999987776666555332221111111111 0000000000000000000000 1366789999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001152 1114 ERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~ 1127 (1137)
+|||+.|+++|+|+
T Consensus 280 ~R~t~~ell~~~~f 293 (293)
T cd07843 280 KRISAEDALKHPYF 293 (293)
T ss_pred ccCCHHHHhcCCCC
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.57 Aligned_cols=254 Identities=29% Similarity=0.432 Sum_probs=199.0
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~-~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+|+..+.||+|++|.||+|... +..+++|+........ ..+..+ .+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~----~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK----QLEQEIALLSKLQHPNIVQYLGTEREED- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHH----HHHHHHHHHHhcCCCCchheeeeEecCC-
Confidence 4778899999999999999984 5778888754332211 122223 3488999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.+ ...+++..+..++.||+.||+|||+.||+|+||+|+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~ 137 (258)
T cd06632 76 -------------NLYIFLELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT 137 (258)
T ss_pred -------------eEEEEEEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 56999999999999999976 235889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.+........ .....++..|+|||.+... ..++.++|+|||||++|+|+
T Consensus 138 ~-------~~~kl~d~~~~~~~~~~~~-----------~~~~~~~~~y~~pe~~~~~---~~~~~~~D~~slG~~l~~l~ 196 (258)
T cd06632 138 N-------GVVKLADFGMAKQVVEFSF-----------AKSFKGSPYWMAPEVIAQQ---GGYGLAADIWSLGCTVLEMA 196 (258)
T ss_pred C-------CCEEEccCccceecccccc-----------ccccCCCcceeCHHHhcCC---CCCCchhhhHHHHHHHHHHH
Confidence 7 7899999998875443210 1134588899999998641 23789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHc-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~-g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+|..||......+....+.. ...+.++ ...++.+.+++.+||+.+|.+||++
T Consensus 197 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 249 (258)
T cd06632 197 TGKPPWSQLEGVAAVFKIGRSKELPPIP---------------------------DHLSDEAKDFILKCLQRDPSLRPTA 249 (258)
T ss_pred hCCCCcccCcHHHHHHHHHhcccCCCcC---------------------------CCcCHHHHHHHHHHhhcCcccCcCH
Confidence 99999976554433333322 1111111 1334568999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
.+++.|+|+
T Consensus 250 ~~~l~~~~~ 258 (258)
T cd06632 250 AELLEHPFV 258 (258)
T ss_pred HHHhcCCCC
Confidence 999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=317.27 Aligned_cols=278 Identities=20% Similarity=0.267 Sum_probs=199.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||.|++|.||+|++. +..+++|....+... ..... .+.+|++++++++||||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPS----TAIREISLLKELNHPNIVKLLDVIHTEN-- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc--cccch----HHHHHHHHHHhcCCCCCcchhhhcccCC--
Confidence 4789999999999999999984 466788765433211 11112 3478999999999999999999987655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+. ++|..++.. .....+++..+..++.||+.||+|||+.+++||||+|+||+++.+
T Consensus 73 ------------~~~~v~e~~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~ 136 (284)
T cd07860 73 ------------KLYLVFEFLH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 136 (284)
T ss_pred ------------cEEEEeeccc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 5699999996 789998865 223468999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||.+......... .....+++.|+|||++.+ ...++.++|||||||++|+|+|
T Consensus 137 -------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~t 196 (284)
T cd07860 137 -------GAIKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEMVT 196 (284)
T ss_pred -------CCEEEeeccchhhcccCccc----------cccccccccccCCeEEec---CCCCCcHHHHHHHHHHHHHHHH
Confidence 78999999988654322111 112246789999998764 2346789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHH-HcCCCCCchhHHh---hhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1041 LQVPYMGLSELEIHDLI-QMGKRPRLTDELE---ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I-~~g~~p~l~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|+.||.+.+..+....+ .....+. ...++ ..+... ....+ .............++++++++.+||+.||.+||
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 273 (284)
T cd07860 197 RRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSLPDYK-PSFPK-WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI 273 (284)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCC-hhhhhhhhHHHHHH-hhccc-ccccCHHHHcccCCHHHHHHHHHhcCCCcccCC
Confidence 99999876655444333 2222111 11000 000000 00000 000000001113456689999999999999999
Q ss_pred CHHHHHHHHHh
Q 001152 1117 TAGDLYEMFVA 1127 (1137)
Q Consensus 1117 Sa~EVL~~L~~ 1127 (1137)
|++++++|+||
T Consensus 274 t~~~~l~~~~f 284 (284)
T cd07860 274 SAKAALAHPFF 284 (284)
T ss_pred CHHHHhcCCCC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.88 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=199.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
-++|++.++||+|+||+||+|.+.+ ..+++|... ..... .+. +.+|+.++++++||||+++++++....
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~--~~~~~---~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK--PGTMS---PEA----FLQEAQIMKKLRHDKLVQLYAVCSEEE- 74 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEec--CCccC---HHH----HHHHHHHHhhCCCCCEeeeeeeeecCC-
Confidence 4679999999999999999998754 567777643 22111 122 377999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. .....+++..+..|+.||+.||+|||++||+||||||+||+++.
T Consensus 75 -------------~~~~v~e~~~~~~L~~~i~~---~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~ 138 (261)
T cd05034 75 -------------PIYIVTEYMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE 138 (261)
T ss_pred -------------ceEEEEeccCCCCHHHHHhc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcC
Confidence 46999999999999999976 22346899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.+......... ......++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 139 ~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~l~ 198 (261)
T cd05034 139 N-------LVCKIADFGLARLIEDDEYT---------AREGAKFPIKWTAPEAANY----GRFTIKSDVWSFGILLTEIV 198 (261)
T ss_pred C-------CCEEECccccceeccchhhh---------hhhccCCCccccCHHHhcc----CCcCchhHHHHHHHHHHHHH
Confidence 7 78999999988765431111 0011234568999999875 45789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |+.||.+.........+..+.....+. ..+.++.+++.+||+.+|++||++
T Consensus 199 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~ 251 (261)
T cd05034 199 TYGRVPYPGMTNREVLEQVERGYRMPRPP---------------------------NCPEELYDLMLQCWDKDPEERPTF 251 (261)
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcccCcccCCCH
Confidence 8 999998877766666665433211110 224568999999999999999999
Q ss_pred HHHHHHHH
Q 001152 1119 GDLYEMFV 1126 (1137)
Q Consensus 1119 ~EVL~~L~ 1126 (1137)
+++++.+.
T Consensus 252 ~~l~~~l~ 259 (261)
T cd05034 252 EYLQSFLE 259 (261)
T ss_pred HHHHHHHh
Confidence 99998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=315.59 Aligned_cols=256 Identities=32% Similarity=0.489 Sum_probs=200.4
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC---CCCcceeeeeEecC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISS 877 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~---HpNIVkllg~~~~~ 877 (1137)
.|++.+.||+|+||.||+|.+. +..+++|+...... ....+.+ .+|+.+++.++ ||||+++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~----~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP---DDDVSDI----QREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC---chhHHHH----HHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 4778899999999999999984 46788887543221 2223333 67999999986 99999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+++++|.++++. ..+++..+..++.||+.||.|||+.||+||||+|+||++
T Consensus 75 ~--------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i 134 (277)
T cd06917 75 P--------------RLWIIMEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134 (277)
T ss_pred C--------------EEEEEEecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence 4 56999999999999998864 268999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.++|+|||.+........ ......|+..|+|||++.+ ...++.++|||||||++|+
T Consensus 135 ~~~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 194 (277)
T cd06917 135 TNT-------GNVKLCDFGVAALLNQNSS----------KRSTFVGTPYWMAPEVITE---GKYYDTKADIWSLGITIYE 194 (277)
T ss_pred cCC-------CCEEEccCCceeecCCCcc----------ccccccCCcceeCHHHhcc---CCccccchhHHHHHHHHHH
Confidence 977 7899999998876543221 1113358889999999864 2456889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|..||...........+.....+.+.. ...+.++.+++.+||+.||++||+
T Consensus 195 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~i~~~l~~~p~~R~~ 248 (277)
T cd06917 195 MATGNPPYSDVDAFRAMMLIPKSKPPRLED--------------------------NGYSKLLREFVAACLDEEPKERLS 248 (277)
T ss_pred HHhCCCCCCCCChhhhhhccccCCCCCCCc--------------------------ccCCHHHHHHHHHHcCCCcccCcC
Confidence 999999998765544333222221111110 013456899999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001152 1118 AGDLYEMFVARTSS 1131 (1137)
Q Consensus 1118 a~EVL~~L~~~~~s 1131 (1137)
+.+++.|.|++...
T Consensus 249 ~~~il~~~~~~~~~ 262 (277)
T cd06917 249 AEELLKSKWIKAHS 262 (277)
T ss_pred HHHHhhChHhhccc
Confidence 99999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=317.90 Aligned_cols=281 Identities=23% Similarity=0.282 Sum_probs=200.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.++||+|+||.||+|.+. +..+|+|+...... .....+ .+.+|+++++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKK----IAMREIRMLKQLRHENLVNLIEVFRRKK- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhH----HHHHHHHHHHhcCCcchhhHHHhcccCC-
Confidence 36889999999999999999985 46788887432221 111122 2478999999999999999999987655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|..+... ...+++..+..++.||+.||+|||+.||+||||+|+||+++.
T Consensus 74 -------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~ 135 (286)
T cd07846 74 -------------RLYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135 (286)
T ss_pred -------------eEEEEEecCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 67999999998888887654 235899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||++........ ......++..|+|||++.+ ...++.++||||||+++|+|+
T Consensus 136 ~-------~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~el~ 195 (286)
T cd07846 136 S-------GVVKLCDFGFARTLAAPGE----------VYTDYVATRWYRAPELLVG---DTKYGRAVDIWAVGCLVTEML 195 (286)
T ss_pred C-------CcEEEEeeeeeeeccCCcc----------ccCcccceeeccCcHHhcc---ccccCchHhHHHHHHHHHHHH
Confidence 7 7899999998875433211 1112357889999999864 235678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhc---ccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG---SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|..||......+....+................ .......................+..+.+++.+||+.+|++||
T Consensus 196 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 275 (286)
T cd07846 196 TGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275 (286)
T ss_pred cCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch
Confidence 9999998766554443332211111000000000 0000000000000000000124567799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001152 1117 TAGDLYEMFVA 1127 (1137)
Q Consensus 1117 Sa~EVL~~L~~ 1127 (1137)
++.++++|+|+
T Consensus 276 ~~~~il~~~~~ 286 (286)
T cd07846 276 SSSQLLHHEFF 286 (286)
T ss_pred hHHHHhcCCCC
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=319.14 Aligned_cols=294 Identities=21% Similarity=0.247 Sum_probs=201.2
Q ss_pred CceEeeeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+|++.++||+|+||.||+|.+. +..+|+|+........ .. +...+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~-~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY-TG----ISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc-cC----ccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 4889999999999999999984 4779999865432110 11 1122367999999999999999999998652
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. ...++||||++ ++|.+++..........+++..++.|+.||+.||+|||+++|+||||||+||+++
T Consensus 76 ~------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~ 142 (316)
T cd07842 76 D------------KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVM 142 (316)
T ss_pred C------------ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEc
Confidence 1 16799999997 6888877654433334789999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.++ ...+.+||+|||++......... ........+++.|+|||++.+ ...++.++|||||||++|+|
T Consensus 143 ~~~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~l 209 (316)
T cd07842 143 GEG---PERGVVKIGDLGLARLFNAPLKP-------LADLDPVVVTIWYRAPELLLG---ARHYTKAIDIWAIGCIFAEL 209 (316)
T ss_pred CCC---CccceEEECCCccccccCCCccc-------ccccCCccccccccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 831 12378999999998765432211 011223468889999998864 24578999999999999999
Q ss_pred HhCCCCCCCCCHHH---------HHHHH-HcCCCCCch--hHHhhhcccccccccccCCCCCCch----hhh--hhHHHH
Q 001152 1039 LTLQVPYMGLSELE---------IHDLI-QMGKRPRLT--DELEALGSCHEHEVAQSGSGFEKPE----AEL--ETLSFL 1100 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~e---------l~~~I-~~g~~p~l~--~~l~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~~L 1100 (1137)
++|..||.+..... ....+ .....+... ..+.................+.... ... ..+.++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (316)
T cd07842 210 LTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289 (316)
T ss_pred HhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHH
Confidence 99999997643321 11111 111111000 0000000000000000000000000 011 345679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001152 1101 VDVFRRCTEENPTERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1101 ~dLl~~CL~~DP~~RPSa~EVL~~L~~ 1127 (1137)
.+++.+||+.||++|||+.|+++|+||
T Consensus 290 ~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 290 FDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=311.27 Aligned_cols=254 Identities=21% Similarity=0.324 Sum_probs=198.1
Q ss_pred CCceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~-----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
.+|++.+.||+|+||.||+|.+.. ..+++|..... . .....+. +.+|+.+++++.||||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~-~~~~~~~----~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--T-SPSVREK----FLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--C-CHHHHHH----HHHHHHHHHhCCCCchhceeEEEcC
Confidence 458899999999999999998743 24666654222 1 1222233 4789999999999999999998764
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
. ..++||||+++++|.+++... ...+++..+..++.||+.||+|||+.|++||||||+||+
T Consensus 79 ~---------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nil 139 (270)
T cd05056 79 N---------------PVWIVMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL 139 (270)
T ss_pred C---------------CcEEEEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEE
Confidence 3 348999999999999999752 235899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++......... ......++..|+|||.+.. ..++.++||||||+++|
T Consensus 140 i~~~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 199 (270)
T cd05056 140 VSSP-------DCVKLGDFGLSRYLEDESYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCMW 199 (270)
T ss_pred EecC-------CCeEEccCceeeecccccce---------ecCCCCccccccChhhhcc----CCCCchhhhHHHHHHHH
Confidence 9877 78999999988755432111 0011234568999998864 46789999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
+|++ |..||......+....+..+.....+. .++..+.+++.+||..+|++|
T Consensus 200 el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~P~~R 252 (270)
T cd05056 200 EILMLGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPSKR 252 (270)
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHHHHcCCChhhC
Confidence 9986 999998877766666665444322111 334569999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001152 1116 PTAGDLYEMFVAR 1128 (1137)
Q Consensus 1116 PSa~EVL~~L~~~ 1128 (1137)
||+.+++..+...
T Consensus 253 pt~~~~~~~l~~~ 265 (270)
T cd05056 253 PRFTELKAQLSDI 265 (270)
T ss_pred cCHHHHHHHHHHH
Confidence 9999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=313.72 Aligned_cols=266 Identities=29% Similarity=0.433 Sum_probs=202.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|+..+.||.|++|.||+|.+. +..+|+|+...... .... .++.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN---PDLQ----KQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc---hHHH----HHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 36889999999999999999984 46788887543211 1222 234889999999999999999999875431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
...++||||+++++|.+++..... ....+++..+..|+.||+.||.|||+.|++|+||+|+||+++.
T Consensus 74 ------------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~ 140 (287)
T cd06621 74 ------------SSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140 (287)
T ss_pred ------------CeEEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence 157999999999999998875433 2356899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||++........ ....++..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 141 ~-------~~~~l~dfg~~~~~~~~~~------------~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~ 197 (287)
T cd06621 141 K-------GQVKLCDFGVSGELVNSLA------------GTFTGTSFYMAPERIQG----KPYSITSDVWSLGLTLLEVA 197 (287)
T ss_pred C-------CeEEEeecccccccccccc------------ccccCCccccCHHHhcC----CCCCchhhHHHHHHHHHHHH
Confidence 7 6799999998865432111 12347789999999865 46788999999999999999
Q ss_pred hCCCCCCCC-----CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1040 TLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1040 TG~~Pf~~~-----~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+.||... ...+....+.....+.+... +......++++.+++.+||+.+|.+
T Consensus 198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~ 256 (287)
T cd06621 198 QNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE---------------------PGNGIKWSEEFKDFIKQCLEKDPTR 256 (287)
T ss_pred hCCCCCCcccCCCCChHHHHHHHhcCCchhhccC---------------------CCCCCchHHHHHHHHHHHcCCCccc
Confidence 999999754 22333333332221111100 0000123567999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 001152 1115 RPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~s 1131 (1137)
|||+.||++|+|++...
T Consensus 257 Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 257 RPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCHHHHHhCccccccc
Confidence 99999999999997543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=317.63 Aligned_cols=269 Identities=22% Similarity=0.268 Sum_probs=203.3
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||++.+.. ..+++|....... ...... ..+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQI----QQVFVERDILTFAENPFVVSMFCSFETKR- 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHH----HHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence 368899999999999999999854 5688886432211 011112 23478999999999999999999988655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
+.++||||++|++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus 75 -------------~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~ 136 (305)
T cd05609 75 -------------HLCMVMEYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136 (305)
T ss_pred -------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC
Confidence 67999999999999999976 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCcccccccccccccc-----ccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~-----~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
+ +.+||+|||+++........... ............++..|+|||.+.+ ..++.++|||||||+
T Consensus 137 ~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~v 205 (305)
T cd05609 137 M-------GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR----QGYGKPVDWWAMGII 205 (305)
T ss_pred C-------CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC----CCCCchhhHHHHHHH
Confidence 7 78999999988632111100000 0000001112357889999999865 467899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|||++|..||.+....++...+..+..+.... ....++++.+++.+||+.||++
T Consensus 206 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~P~~ 260 (305)
T cd05609 206 LYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG-------------------------DEALPADAQDLISRLLRQNPLE 260 (305)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCc-------------------------cccCCHHHHHHHHHHhccChhh
Confidence 999999999998877766666554432211100 0024456899999999999999
Q ss_pred CCC---HHHHHHHHHhhcC
Q 001152 1115 RPT---AGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPS---a~EVL~~L~~~~~ 1130 (1137)
||+ +.++++|+|+...
T Consensus 261 R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 261 RLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccCccCHHHHHhCccccCC
Confidence 997 7999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=307.40 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=198.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|+||.||+|.+. +..+++|+.. ...... .. +.+|+++++++.||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~--~~~~~~---~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR--EGAMSE---ED----FIEEAQVMMKLSHPKLVQLYGVCTERS- 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECC--CCCCCH---HH----HHHHHHHHHhCCCCCeeeEEEEEccCC-
Confidence 457889999999999999999885 5678888643 222211 22 377999999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||+++++||||||+||+++.
T Consensus 73 -------------~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 73 -------------PICLVFEFMEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred -------------ceEEEEEcCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 569999999999999998751 235889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.+......... ......++..|+|||++.+ ..++.++||||||+++|||+
T Consensus 136 ~-------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~aPe~~~~----~~~~~~~Dv~slG~~l~el~ 195 (256)
T cd05112 136 N-------QVVKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWSSPEVFSF----SKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred C-------CeEEECCCcceeecccCccc---------ccCCCccchhhcCHhHhcc----CCcChHHHHHHHHHHHHHHH
Confidence 6 78999999988654322110 0112235668999999875 45788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||.......+...+..+..+..+. ..++++.+|+.+||+.+|++|||+
T Consensus 196 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~~l~~~p~~Rp~~ 248 (256)
T cd05112 196 SEGKTPYENRSNSEVVETINAGFRLYKPR---------------------------LASQSVYELMQHCWKERPEDRPSF 248 (256)
T ss_pred cCCCCCCCcCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHcccChhhCCCH
Confidence 8 999998777666666655433221110 123559999999999999999999
Q ss_pred HHHHHHH
Q 001152 1119 GDLYEMF 1125 (1137)
Q Consensus 1119 ~EVL~~L 1125 (1137)
.++++++
T Consensus 249 ~~~l~~l 255 (256)
T cd05112 249 SLLLHQL 255 (256)
T ss_pred HHHHHhh
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=326.22 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=196.3
Q ss_pred CCCceEeeeecccCceEEEEEEE-------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~-------~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
.++|++.+.||+|+||.||+|.+ .+..+|||+.+... ....... +.+|+.++.++ +||||+++++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~----~~~E~~~l~~l~~h~niv~~~~ 78 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRA----LMSELKILIHIGHHLNVVNLLG 78 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHH----HHHHHHHHHhccCCccHhhhcc
Confidence 35799999999999999999985 23568888753221 1222333 37899999999 5899999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------------------------------------
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------------------------ 916 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~------------------------------------ 916 (1137)
++...+. ..++||||+++|+|.++++.....
T Consensus 79 ~~~~~~~-------------~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (343)
T cd05103 79 ACTKPGG-------------PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQ 145 (343)
T ss_pred eeecCCC-------------ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccc
Confidence 8865431 468999999999999998752100
Q ss_pred --------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeE
Q 001152 917 --------------------------GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970 (1137)
Q Consensus 917 --------------------------~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~v 970 (1137)
....+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-------~~~ 218 (343)
T cd05103 146 SSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-------NVV 218 (343)
T ss_pred ccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-------CcE
Confidence 01247888999999999999999999999999999999999877 789
Q ss_pred EEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 001152 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLS 1049 (1137)
Q Consensus 971 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~ 1049 (1137)
||+|||++......... .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||....
T Consensus 219 kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 219 KICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred EEEecccccccccCcch--------hhcCCCCCCcceECcHHhcC----CCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 99999998754322111 00112235678999999865 467899999999999999997 999997643
Q ss_pred HH-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1050 EL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1050 ~~-el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
.. .....+..+..+..+. ..++++.+++.+||+.||.+|||+.||++++...
T Consensus 287 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 287 IDEEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred ccHHHHHHHhccCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 32 2333333322211110 1234589999999999999999999999998765
Q ss_pred c
Q 001152 1129 T 1129 (1137)
Q Consensus 1129 ~ 1129 (1137)
.
T Consensus 340 ~ 340 (343)
T cd05103 340 L 340 (343)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=315.16 Aligned_cols=245 Identities=21% Similarity=0.350 Sum_probs=182.5
Q ss_pred eecccCceEEEEEEECC--------------------------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC
Q 001152 809 EAGKSVSSSLFRCKFGS--------------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL 862 (1137)
Q Consensus 809 ~LG~GsfG~Vy~a~~~~--------------------------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L 862 (1137)
.||+|+||.||+|.+.. ..+++|+. +.. ... ....+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~--~~~--~~~----~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVL--DPS--HRD----IALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEec--ChH--HHH----HHHHHHHHHHHHhcC
Confidence 69999999999987521 12455543 211 111 122347789999999
Q ss_pred CCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001152 863 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 942 (1137)
Q Consensus 863 ~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs 942 (1137)
+||||+++++++.... ..++||||+++++|..++.. ....+++..+..++.||++||+|||+
T Consensus 74 ~h~niv~~~~~~~~~~--------------~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~ 135 (274)
T cd05076 74 SHIHLAFVHGVCVRGS--------------ENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED 135 (274)
T ss_pred CCCCeeeEEEEEEeCC--------------ceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc
Confidence 9999999999998765 45999999999999998865 23468999999999999999999999
Q ss_pred CCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCC
Q 001152 943 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022 (1137)
Q Consensus 943 ~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1022 (1137)
+||+||||||+|||++...........+|++|||.+...... ....++..|+|||.+.+ ...+
T Consensus 136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--------------~~~~~~~~~~aPe~~~~---~~~~ 198 (274)
T cd05076 136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--------------EERVERIPWIAPECVPG---GNSL 198 (274)
T ss_pred CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--------------cccccCCcccCchhhcC---CCCC
Confidence 999999999999999865321222346899999987533211 12247788999998864 2457
Q ss_pred CchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001152 1023 GLEVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1101 (1137)
Q Consensus 1023 s~ksDVWSLGviL~ELL-TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1101 (1137)
+.++|||||||++|||+ +|+.||......+....+.... ..+. ...+.+.
T Consensus 199 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~---------------------------~~~~~~~ 249 (274)
T cd05076 199 STAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKH--RLPE---------------------------PSCKELA 249 (274)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhcc--CCCC---------------------------CCChHHH
Confidence 89999999999999984 7999998765544333222111 0000 1123488
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 001152 1102 DVFRRCTEENPTERPTAGDLYEMF 1125 (1137)
Q Consensus 1102 dLl~~CL~~DP~~RPSa~EVL~~L 1125 (1137)
+++.+||+.+|++|||+.+|+++|
T Consensus 250 ~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 250 TLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHcccChhhCcCHHHHHHhh
Confidence 999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=314.98 Aligned_cols=267 Identities=25% Similarity=0.348 Sum_probs=201.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~ 877 (1137)
..+|++.+.||+|+||.||+|... +..+|+|+.... . ...+. +.+|+.+++++ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~---~~~~~----~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--S---DVDEE----IEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--c---cHHHH----HHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 567999999999999999999984 467888874321 1 11122 36788999998 799999999998754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+.. .....++||||+++++|.++++..... ...+++..+..++.|++.||+|||+.||+||||||+||++
T Consensus 92 ~~~---------~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili 161 (291)
T cd06639 92 DKL---------VGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL 161 (291)
T ss_pred ccc---------CCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence 311 112579999999999999998753222 3468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~ 1036 (1137)
+.+ +.+||+|||.+......... .....|+..|+|||++.... ....++.++|||||||++|
T Consensus 162 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~ 224 (291)
T cd06639 162 TTE-------GGVKLVDFGVSAQLTSTRLR----------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAI 224 (291)
T ss_pred cCC-------CCEEEeecccchhccccccc----------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHH
Confidence 877 67999999988754432110 11235888999999976421 1123679999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|++|+.||...........+.....+.+.. + ......+.+++.+||+.+|++||
T Consensus 225 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~---~~~~~~l~~li~~~l~~~p~~Rp 279 (291)
T cd06639 225 ELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH----------------------P---EKWCRSFNHFISQCLIKDFEARP 279 (291)
T ss_pred HHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc----------------------c---cccCHHHHHHHHHHhhcChhhCc
Confidence 9999999998766544444443332221110 0 02334589999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001152 1117 TAGDLYEMFVAR 1128 (1137)
Q Consensus 1117 Sa~EVL~~L~~~ 1128 (1137)
++.|+++|+|++
T Consensus 280 s~~~il~~~~~~ 291 (291)
T cd06639 280 SVTHLLEHPFIK 291 (291)
T ss_pred CHHHHhcCcccC
Confidence 999999999974
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=318.22 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=196.0
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 871 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkll 871 (1137)
..++|.+.+.||+|+||.||+|.+. ...+|+|+.. .... ....+. +.+|+.+++++ +||||++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~--~~~~-~~~~~~----~~~E~~~l~~l~~h~~iv~~~ 105 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK--PTAH-SSEREA----LMSELKIMSHLGNHENIVNLL 105 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecC--ccCC-hHHHHH----HHHHHHHHHhccCCCCcceEE
Confidence 3467999999999999999999852 1346666533 2211 222233 47899999999 799999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLK 951 (1137)
+++...+ ..++||||+++++|.++++.. ....+++.++..|+.||+.||+|||+++|+|+|||
T Consensus 106 ~~~~~~~--------------~~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk 168 (302)
T cd05055 106 GACTIGG--------------PILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLA 168 (302)
T ss_pred EEEecCC--------------ceEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhc
Confidence 9987655 469999999999999999752 22348999999999999999999999999999999
Q ss_pred CCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001152 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031 (1137)
Q Consensus 952 P~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1031 (1137)
|+|||++.+ +.++|+|||+++......... ......++..|+|||++.+ ..++.++|||||
T Consensus 169 p~Nil~~~~-------~~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Diwsl 229 (302)
T cd05055 169 ARNVLLTHG-------KIVKICDFGLARDIMNDSNYV--------VKGNARLPVKWMAPESIFN----CVYTFESDVWSY 229 (302)
T ss_pred cceEEEcCC-------CeEEECCCcccccccCCCcee--------ecCCCCcccccCCHhhhcc----CCCCcHhHHHHH
Confidence 999999876 689999999987554321110 0112246778999999875 457899999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHH-HHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001152 1032 GCLLLELLT-LQVPYMGLSELEIHDL-IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1032 GviL~ELLT-G~~Pf~~~~~~el~~~-I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
||++|+|++ |..||......+.... +..+..+..+ ...++++.+++.+||+
T Consensus 230 Gvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~cl~ 282 (302)
T cd05055 230 GILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP---------------------------EHAPAEIYDIMKTCWD 282 (302)
T ss_pred HHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcC
Confidence 999999998 9999987554433322 2222111100 0234569999999999
Q ss_pred cCCCCCCCHHHHHHHHHh
Q 001152 1110 ENPTERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1110 ~DP~~RPSa~EVL~~L~~ 1127 (1137)
.+|++|||+.|+++.+..
T Consensus 283 ~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 283 ADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCchhCcCHHHHHHHHHh
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=308.49 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=198.0
Q ss_pred CCceEeeeecccCceEEEEEEECC--c---cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--A---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~---~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
.+|+..+.||+|+||.||+|+... . .+++|.. +... .....+. +.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~--~~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGY-TEKQRQD----FLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEec--cccC-CHHHHHH----HHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 468889999999999999999742 2 3566553 3221 1222233 4789999999999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ ..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.||+||||||+||+
T Consensus 78 ~~--------------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil 139 (268)
T cd05063 78 FK--------------PAMIITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNIL 139 (268)
T ss_pred CC--------------CcEEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEE
Confidence 55 45999999999999999875 1246899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++.......... ........+..|+|||++.+ ..++.++|||||||++|
T Consensus 140 i~~~-------~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~il~ 201 (268)
T cd05063 140 VNSN-------LECKVSDFGLSRVLEDDPEGT-------YTTSGGKIPIRWTAPEAIAY----RKFTSASDVWSFGIVMW 201 (268)
T ss_pred EcCC-------CcEEECCCccceecccccccc-------eeccCCCcCceecCHHHhhc----CCcChHhHHHHHHHHHH
Confidence 9877 789999999987554321110 00011123457999999875 45789999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
||++ |..||......++...+..+...... ..++.++.+++.+||+.+|++|
T Consensus 202 ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~li~~c~~~~p~~R 254 (268)
T cd05063 202 EVMSFGERPYWDMSNHEVMKAINDGFRLPAP---------------------------MDCPSAVYQLMLQCWQQDRARR 254 (268)
T ss_pred HHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC---------------------------CCCCHHHHHHHHHHcCCCcccC
Confidence 9997 99999877776666666543221110 0334568999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001152 1116 PTAGDLYEMFVA 1127 (1137)
Q Consensus 1116 PSa~EVL~~L~~ 1127 (1137)
|++.+|++.+..
T Consensus 255 p~~~~i~~~l~~ 266 (268)
T cd05063 255 PRFVDIVNLLDK 266 (268)
T ss_pred cCHHHHHHHHHh
Confidence 999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=311.05 Aligned_cols=252 Identities=26% Similarity=0.438 Sum_probs=189.3
Q ss_pred eeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||.||+|.+.+. .+.++++...... .....+. +.+|+.+++++ +||||+++++++....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~----~~~E~~~l~~l~~h~~iv~~~~~~~~~~------ 69 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRD----FAGELEVLCKLGHHPNIINLLGACEHRG------ 69 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHH----HHHHHHHHHhhccCCCeeeEEEEEecCC------
Confidence 3689999999999998542 2333333233211 1222233 37899999999 6999999999988665
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-----------~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
..++||||+++++|.+++..... .....+++..+..++.||+.||+|||++||+||||||+
T Consensus 70 --------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~ 141 (270)
T cd05047 70 --------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 141 (270)
T ss_pred --------CceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccc
Confidence 45999999999999999976321 11235889999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.+ +.+||+|||++........ ......+..|+|||++.. ..++.++|||||||
T Consensus 142 nili~~~-------~~~kl~dfgl~~~~~~~~~-----------~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~ 199 (270)
T cd05047 142 NILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY----SVYTTNSDVWSYGV 199 (270)
T ss_pred eEEEcCC-------CeEEECCCCCccccchhhh-----------ccCCCCccccCChHHHcc----CCCCchhhHHHHHH
Confidence 9999987 7899999998753221100 011124567999999864 56789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1034 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1034 iL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
++|||++ |..||.+.+..+....+..+.....+ ...+.++.+++.+||..||
T Consensus 200 il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p 252 (270)
T cd05047 200 LLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---------------------------LNCDDEVYDLMRQCWREKP 252 (270)
T ss_pred HHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC---------------------------CcCCHHHHHHHHHHcccCh
Confidence 9999997 99999877666665555433221111 0234458999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 001152 1113 TERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~ 1127 (1137)
.+|||+.++++.+..
T Consensus 253 ~~Rps~~~il~~l~~ 267 (270)
T cd05047 253 YERPSFAQILVSLNR 267 (270)
T ss_pred hhCCCHHHHHHHHHH
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=342.03 Aligned_cols=265 Identities=21% Similarity=0.370 Sum_probs=219.4
Q ss_pred CCCCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
+.....+.++||.|.||.|++|+.+ ++.+.|+|+.++.... ..+..+| +.|+.||.++.||||+++.|+...
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdF----L~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDF----LSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhh----hhhhhhcccCCCCcEEEEEEEEec
Confidence 3455689999999999999999984 3556666665665433 4444444 999999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ -+.||+|||++|+|+.+|+.. +..|++-+...|+++||.|++||-+.++|||||.+.|||
T Consensus 702 s~--------------PvMIiTEyMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 702 SK--------------PVMIITEYMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNIL 763 (996)
T ss_pred Cc--------------eeEEEhhhhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhee
Confidence 65 459999999999999999872 346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ ..+|++|||+++.+.+.....+.+..+ .-...|.|||.+.. .+++.++|||||||+||
T Consensus 764 VNsn-------LvCKVsDFGLSRvledd~~~~ytt~GG-------KIPiRWTAPEAIa~----RKFTsASDVWSyGIVmW 825 (996)
T KOG0196|consen 764 VNSN-------LVCKVSDFGLSRVLEDDPEAAYTTLGG-------KIPIRWTAPEAIAY----RKFTSASDVWSYGIVMW 825 (996)
T ss_pred eccc-------eEEEeccccceeecccCCCccccccCC-------ccceeecChhHhhh----cccCchhhccccceEEE
Confidence 9988 889999999999776544322211111 12358999999975 67899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|.++ |..||..++..+++..|..+.+.+.+ ++|+..|.+|+..||++|-.+|
T Consensus 826 EVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---------------------------mDCP~aL~qLMldCWqkdR~~R 878 (996)
T KOG0196|consen 826 EVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---------------------------MDCPAALYQLMLDCWQKDRNRR 878 (996)
T ss_pred EecccCCCcccccchHHHHHHHHhccCCCCC---------------------------CCCcHHHHHHHHHHHHHHhhcC
Confidence 9776 99999999999999999888754322 2677889999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001152 1116 PTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ss 1132 (1137)
|++.||+.+|....+.+
T Consensus 879 P~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 879 PKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCHHHHHHHHHHHhcCc
Confidence 99999999998765443
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=317.78 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=202.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|++.+.||+|+||+||+|.+. +..+|+|+...... ......+. +.+|+.+++.++||||+++++++.+.+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~----~~~Ei~~l~~l~h~niv~~~~~~~~~~- 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQD----IIKEVRFLQQLRHPNTIEYKGCYLREH- 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHH----HHHHHHHHHhCCCCCEEEEEEEEEeCC-
Confidence 45888999999999999999974 57788887532211 11222233 478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||++ |+|.+++... ...+++..+..++.||+.||.|||+.||+||||+|+||+++.
T Consensus 89 -------------~~~lv~e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~ 150 (307)
T cd06607 89 -------------TAWLVMEYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE 150 (307)
T ss_pred -------------eEEEEHHhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC
Confidence 5699999997 7888877541 235899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||++...... ....+++.|+|||++.+. ....++.++||||||+++|||+
T Consensus 151 ~-------~~~kL~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~-~~~~~~~~sDv~s~G~il~el~ 208 (307)
T cd06607 151 P-------GTVKLADFGSASLVSPA--------------NSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELA 208 (307)
T ss_pred C-------CCEEEeecCcceecCCC--------------CCccCCccccCceeeecc-CCCCCCcccchHHHHHHHHHHH
Confidence 7 78999999987643221 123578899999987532 2345788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|+.||...+.......+.....+.+.. ...+..+.+++.+||..||++||++.
T Consensus 209 tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 262 (307)
T cd06607 209 ERKPPLFNMNAMSALYHIAQNDSPTLSS--------------------------NDWSDYFRNFVDSCLQKIPQDRPSSE 262 (307)
T ss_pred cCCCCCCCccHHHHHHHHhcCCCCCCCc--------------------------hhhCHHHHHHHHHHhcCChhhCcCHH
Confidence 9999998776655544444332222110 02345699999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001152 1120 DLYEMFVARTSS 1131 (1137)
Q Consensus 1120 EVL~~L~~~~~s 1131 (1137)
+|+.|+|+....
T Consensus 263 ~il~~~~~~~~~ 274 (307)
T cd06607 263 ELLKHRFVLRER 274 (307)
T ss_pred HHhcChhhcccC
Confidence 999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=305.06 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=192.1
Q ss_pred eeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 886 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~ 886 (1137)
+.||+|+||.||+|... +..+|+|+.... . ...... .+.+|+.++++++||||+++++++....
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~--~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 65 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED--L-PQELKI----KFLSEARILKQYDHPNIVKLIGVCTQRQ-------- 65 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCc--C-CHHHHH----HHHHHHHHHHhCCCCCcCeEEEEEecCC--------
Confidence 36899999999999874 366888864321 1 122222 3478999999999999999999987655
Q ss_pred CccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCC
Q 001152 887 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 966 (1137)
Q Consensus 887 ~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~ 966 (1137)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 66 ------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~------ 129 (250)
T cd05085 66 ------PIYIVMELVPGGDFLSFLRKK----KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN------ 129 (250)
T ss_pred ------ccEEEEECCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC------
Confidence 459999999999999988651 2358899999999999999999999999999999999999877
Q ss_pred CCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 001152 967 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 1045 (1137)
Q Consensus 967 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf 1045 (1137)
+.+||+|||++......... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ll~~~~~~g~~p~ 195 (250)
T cd05085 130 -NVLKISDFGMSRQEDDGIYS---------SSGLKQIPIKWTAPEALNY----GRYSSESDVWSYGILLWETFSLGVCPY 195 (250)
T ss_pred -CeEEECCCccceeccccccc---------cCCCCCCcccccCHHHhcc----CCCCchhHHHHHHHHHHHHhcCCCCCC
Confidence 78999999988643321110 0111234567999999865 457889999999999999998 99999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001152 1046 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125 (1137)
Q Consensus 1046 ~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L 1125 (1137)
...........+..+.....+. ..+..+.+++.+||..+|++||++.|+++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 196 PGMTNQQAREQVEKGYRMSCPQ---------------------------KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred CCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 8877666665554433221111 2345699999999999999999999999876
Q ss_pred H
Q 001152 1126 V 1126 (1137)
Q Consensus 1126 ~ 1126 (1137)
.
T Consensus 249 ~ 249 (250)
T cd05085 249 A 249 (250)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=332.14 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=199.3
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMY 871 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkll 871 (1137)
+..+|.+.++||+|+||.||+|++.+ ..||+|+..... .....+. +.+|+.+|.++. |||||+++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~----~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQA----LMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHH----HHHHHHHHHhcCCCCCeEEEE
Confidence 34568889999999999999999742 468888753221 1222223 478999999997 99999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh------------------------------------
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE------------------------------------ 915 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~------------------------------------ 915 (1137)
+++.... ..++||||+++|+|.++++....
T Consensus 108 ~~~~~~~--------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (401)
T cd05107 108 GACTKGG--------------PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173 (401)
T ss_pred EEEccCC--------------CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhc
Confidence 9988655 46999999999999999975321
Q ss_pred ---------------------------------------------------------cCCCCCCHHHHHHHHHHHHHHHH
Q 001152 916 ---------------------------------------------------------TGEKHVSVKLALFIAQDVAAALV 938 (1137)
Q Consensus 916 ---------------------------------------------------------~~~~~ls~~~i~~I~~QIa~gL~ 938 (1137)
.....+++..++.|+.||+.||+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 253 (401)
T cd05107 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGME 253 (401)
T ss_pred cCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 01134778889999999999999
Q ss_pred HHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001152 939 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1018 (1137)
Q Consensus 939 yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1018 (1137)
|||+.+|+||||||+|||++.+ +.+||+|||+++........ .......+++.|+|||.+.+
T Consensus 254 ~LH~~~ivHrdlkp~NiLl~~~-------~~~kL~DfGla~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~--- 315 (401)
T cd05107 254 FLASKNCVHRDLAARNVLICEG-------KLVKICDFGLARDIMRDSNY--------ISKGSTFLPLKWMAPESIFN--- 315 (401)
T ss_pred HHhcCCcCcccCCcceEEEeCC-------CEEEEEecCcceeccccccc--------ccCCCcCCCCceeChHHhcC---
Confidence 9999999999999999999876 78999999998754322110 01112346788999999875
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh
Q 001152 1019 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 1096 (1137)
Q Consensus 1019 ~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~-~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1137)
..++.++|||||||++|||++ |..||......+.. ..+..+..+..+ ..+
T Consensus 316 -~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p---------------------------~~~ 367 (401)
T cd05107 316 -NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP---------------------------AHA 367 (401)
T ss_pred -CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC---------------------------CCC
Confidence 457899999999999999998 88999765444432 333333222111 033
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1097 LSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1097 ~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+.++.+|+.+||+.+|.+||+++||++.|...
T Consensus 368 ~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 368 SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 45699999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=307.88 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=189.2
Q ss_pred eeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~-----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
+.||+|+||.||+|.+.. ..+|+|.. ... ......+. +.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~--~~~-~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRI-TDLEEVEQ----FLKEGIIMKDFSHPNVLSLLGICLPSEG--- 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEec--Ccc-CCHHHHHH----HHHHHHHHccCCCCCcceEEEEeecCCC---
Confidence 368999999999998632 34666653 221 11222333 3789999999999999999997754321
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
..++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+|+||||||+|||++.+
T Consensus 71 ----------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-- 134 (262)
T cd05058 71 ----------SPLVVLPYMKHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-- 134 (262)
T ss_pred ----------CcEEEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC--
Confidence 358999999999999999752 2346788889999999999999999999999999999999877
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1041 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G 1041 (1137)
+.+||+|||+++......... ........++..|+|||.+.+ ..++.++|||||||++|||++ |
T Consensus 135 -----~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 135 -----FTVKVADFGLARDIYDKEYYS------VHNHTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred -----CcEEECCccccccccCCccee------ecccccCcCCccccChhHhcc----CccchHHHHHHHHHHHHHHHcCC
Confidence 789999999987543221100 001112345678999999865 467899999999999999999 4
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
.+||......+....+..+..+..+. ..++.+.+++.+||+.+|++||++.+|
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~i 252 (262)
T cd05058 200 APPYPDVDSFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLSCWHPKPEMRPTFSEL 252 (262)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 66777666666665554433222111 233458999999999999999999999
Q ss_pred HHHHHhh
Q 001152 1122 YEMFVAR 1128 (1137)
Q Consensus 1122 L~~L~~~ 1128 (1137)
++.+...
T Consensus 253 l~~l~~~ 259 (262)
T cd05058 253 VSRIEQI 259 (262)
T ss_pred HHHHHHH
Confidence 9988754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.63 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=194.4
Q ss_pred eeecccCceEEEEEEECC--------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS--------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~--------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+.||+|+||.||+|++.. ..+++|..... . ....... +.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~--~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG--A-TDQEKKE----FLKEAHLMSNFNHPNIVKLLGVCLLNE- 72 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc--c-chhhHHH----HHHHHHHHHhcCCCCeeeEeeeecCCC-
Confidence 368999999999998743 34677753211 1 1122233 478999999999999999999987655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~--~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
..++||||+++++|.+++++.... ....+++..+..++.||+.||+|||+.+++|+||||+||++
T Consensus 73 -------------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~ 139 (269)
T cd05044 73 -------------PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLV 139 (269)
T ss_pred -------------CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEE
Confidence 469999999999999999763221 22458899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+.. .....++|+|||++......... .......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 140 ~~~~~--~~~~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~e 205 (269)
T cd05044 140 SEKGY--DADRVVKIGDFGLARDIYKSDYY--------RKEGEGLLPVRWMAPESLLD----GKFTTQSDVWSFGVLMWE 205 (269)
T ss_pred ecCCC--CCCcceEECCccccccccccccc--------ccCcccCCCccccCHHHHcc----CCcccchhHHHHHHHHHH
Confidence 87620 11237999999998754322111 01112245678999999875 457899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++ |..||......+....+..+.....+. ..+..+.+++.+||+.+|.+||
T Consensus 206 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 206 ILTLGQQPYPALNNQEVLQHVTAGGRLQKPE---------------------------NCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred HHHcCCCCCcccCHHHHHHHHhcCCccCCcc---------------------------cchHHHHHHHHHHcCCCcccCC
Confidence 998 999998777666665554332221111 3455689999999999999999
Q ss_pred CHHHHHHHHH
Q 001152 1117 TAGDLYEMFV 1126 (1137)
Q Consensus 1117 Sa~EVL~~L~ 1126 (1137)
++++|++.+.
T Consensus 259 ~~~~i~~~l~ 268 (269)
T cd05044 259 TFDRIQEILQ 268 (269)
T ss_pred CHHHHHHHHh
Confidence 9999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=329.77 Aligned_cols=341 Identities=23% Similarity=0.269 Sum_probs=249.3
Q ss_pred hhhhHHHHHHHhhhccCCCCccccccccc-ccCCCccceeEEeeCCchhhhhhhhcCCCCCccCCCccceeecccccccc
Q 001152 703 VCRHRAVLLKYLCDRVEPPVPCELVRGYL-DFQPHAWNTILVKKGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTI 781 (1137)
Q Consensus 703 ~~~hr~~l~k~~~d~~~~~~~~~~~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 781 (1137)
.++-|.++-.+|.+..-..+||=-..+.. .|+.|....+.-.--....+.+...++..++....+..||-+...|...
T Consensus 99 ~~~~~~i~~~~l~~~~~~~~~~~s~~~~v~~~~~~l~~~~~~~lf~~~~~~~~~~L~~~pF~~f~~S~yf~rFlQWK~l- 177 (591)
T KOG0986|consen 99 KDKARQILDAYLMKELLACLPQFSSKDLVTHVQEHLLEKPPKDLFQPLARAICAYLRGDPFQEFLESDYFTRFLQWKWL- 177 (591)
T ss_pred hhhHHHHHHHHhhccccccCCCcchhhhhHHHhhhccccCchhhhHHHHHHHHHHhccchHhHhHHHHHHHHHHHHHHH-
Confidence 35667777777776654444433211111 1222221110000011335666777789999999999999999888875
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHH
Q 001152 782 APFSTESDHSPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML 859 (1137)
Q Consensus 782 ~~~~~~~~~~~~~~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL 859 (1137)
++.+.+-+.|+..++||+|+||.||-+.. ++..+|.|. +++..... +.-+...+.|-.||
T Consensus 178 -------------E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKk--L~KKRiKk---r~ge~maLnEk~iL 239 (591)
T KOG0986|consen 178 -------------ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKK--LDKKRIKK---RKGETMALNEKQIL 239 (591)
T ss_pred -------------HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHH--HHHHHHHH---hhhhHHhhHHHHHH
Confidence 33566677888999999999999997765 455666664 22211111 11122347899999
Q ss_pred HhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 001152 860 GALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE 939 (1137)
Q Consensus 860 ~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~y 939 (1137)
.+++.+.||.+--.|++++ .+|+||..|+||+|.-+|.+ .+...|++..++.++.+|+.||+|
T Consensus 240 ~kV~s~FiVslaYAfeTkd--------------~LClVLtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLeh 302 (591)
T KOG0986|consen 240 EKVSSPFIVSLAYAFETKD--------------ALCLVLTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEH 302 (591)
T ss_pred HHhccCcEEEEeeeecCCC--------------ceEEEEEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHH
Confidence 9999999998877777766 67999999999999999876 445679999999999999999999
Q ss_pred HHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 940 LHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
||+++||+|||||+|||+|+. |+++|+|+|+|..+..... ....+||.+|||||++..
T Consensus 303 lH~~~iVYRDLKPeNILLDd~-------GhvRISDLGLAvei~~g~~-----------~~~rvGT~GYMAPEvl~n---- 360 (591)
T KOG0986|consen 303 LHRRRIVYRDLKPENILLDDH-------GHVRISDLGLAVEIPEGKP-----------IRGRVGTVGYMAPEVLQN---- 360 (591)
T ss_pred HHhcceeeccCChhheeeccC-------CCeEeeccceEEecCCCCc-----------cccccCcccccCHHHHcC----
Confidence 999999999999999999988 8999999999987654321 123489999999999986
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 001152 1020 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL----EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1095 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~----el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1137)
..|+...|+|||||+||||+.|+.||...... ++-+.+.... ..+ ...
T Consensus 361 e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~-~ey---------------------------~~k 412 (591)
T KOG0986|consen 361 EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP-EEY---------------------------SDK 412 (591)
T ss_pred CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch-hhc---------------------------ccc
Confidence 45999999999999999999999999753332 2222222111 001 114
Q ss_pred hHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHhhc
Q 001152 1096 TLSFLVDVFRRCTEENPTERP-----TAGDLYEMFVART 1129 (1137)
Q Consensus 1096 ~~~~L~dLl~~CL~~DP~~RP-----Sa~EVL~~L~~~~ 1129 (1137)
.++++++|.+..|+.||.+|. .+++|-+|++|+.
T Consensus 413 FS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 413 FSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred cCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 456799999999999999997 7889999999975
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=317.38 Aligned_cols=266 Identities=20% Similarity=0.286 Sum_probs=195.2
Q ss_pred CCCceEeeeecccCceEEEEEEECC--------------c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS--------------A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH 864 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~--------------~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H 864 (1137)
..+|++.++||+|+||.||+|.+.+ + .+|+|+.. ... .....+. +.+|++++++++|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~----~~~ei~~l~~l~h 76 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR--ADV-TKTARND----FLKEIKIMSRLKN 76 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecC--CCC-CHHHHHH----HHHHHHHHHhCCC
Confidence 4579999999999999999987643 1 35666533 211 1222223 4889999999999
Q ss_pred CCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-------CCCCCCHHHHHHHHHHHHHHH
Q 001152 865 SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------GEKHVSVKLALFIAQDVAAAL 937 (1137)
Q Consensus 865 pNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-------~~~~ls~~~i~~I~~QIa~gL 937 (1137)
|||+++++++.... ..++||||+++++|.+++...... ....+++..+..++.||+.||
T Consensus 77 ~~i~~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 142 (295)
T cd05097 77 PNIIRLLGVCVSDD--------------PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGM 142 (295)
T ss_pred CCcCeEEEEEcCCC--------------ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHH
Confidence 99999999987655 469999999999999998652110 112478899999999999999
Q ss_pred HHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc
Q 001152 938 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017 (1137)
Q Consensus 938 ~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1017 (1137)
+|||++|++||||||+||+++.+ +.+||+|||++......... .......++..|+|||++.+
T Consensus 143 ~~lH~~~i~H~dlkp~Nill~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-- 205 (295)
T cd05097 143 KYLASLNFVHRDLATRNCLVGNH-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMAWESILL-- 205 (295)
T ss_pred HHHHhcCeeccccChhhEEEcCC-------CcEEecccccccccccCcce--------eccCcCcCceeecChhhhcc--
Confidence 99999999999999999999877 67999999998654322111 01112345678999999865
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 001152 1018 KPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1095 (1137)
Q Consensus 1018 ~~~~~s~ksDVWSLGviL~ELLT--G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1137)
..++.++|||||||++|+|++ +..||......+....+........... .. .....
T Consensus 206 --~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~-----~~~~~ 263 (295)
T cd05097 206 --GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQI---------------YL-----SQTPL 263 (295)
T ss_pred --CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccc---------------cC-----CCCCC
Confidence 457899999999999999998 6788887666555444322100000000 00 00012
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001152 1096 TLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1096 ~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~ 1126 (1137)
.++.+.+|+.+||+.||++|||+++|++.|.
T Consensus 264 ~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 264 CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 3456999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=307.55 Aligned_cols=252 Identities=22% Similarity=0.378 Sum_probs=198.3
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
-.+|++.+.||+|+||.||+|.+.. ..+++|..... ....+. +.+|+.++++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~-~- 73 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEA----FLAEANVMKTLQHDKLVKLHAVVTK-E- 73 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHHH----HHHHHHHHHhcCCCCcceEEEEEcC-C-
Confidence 3578999999999999999998754 56777764311 222223 4789999999999999999998865 3
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. .....+++..+..++.||+.||+|||+.|++||||||+||+++.
T Consensus 74 -------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~ 137 (260)
T cd05073 74 -------------PIYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA 137 (260)
T ss_pred -------------CeEEEEEeCCCCcHHHHHHh---CCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC
Confidence 45999999999999999976 22346889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.+......... ......++..|+|||++.. ..++.++|||||||++|+|+
T Consensus 138 ~-------~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~l~ 197 (260)
T cd05073 138 S-------LVCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLMEIV 197 (260)
T ss_pred C-------CcEEECCCcceeeccCCCcc---------cccCCcccccccCHhHhcc----CCcCccccchHHHHHHHHHH
Confidence 7 78999999988654322111 0112235667999999865 45788999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||.+.+..++...+..+...... ...+.++.+++.+||+.+|++||++
T Consensus 198 t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~ 250 (260)
T cd05073 198 TYGRIPYPGMSNPEVIRALERGYRMPRP---------------------------ENCPEELYNIMMRCWKNRPEERPTF 250 (260)
T ss_pred hcCCCCCCCCCHHHHHHHHhCCCCCCCc---------------------------ccCCHHHHHHHHHHcccCcccCcCH
Confidence 9 99999887776666665543321111 0334569999999999999999999
Q ss_pred HHHHHHHH
Q 001152 1119 GDLYEMFV 1126 (1137)
Q Consensus 1119 ~EVL~~L~ 1126 (1137)
.++++.|.
T Consensus 251 ~~l~~~L~ 258 (260)
T cd05073 251 EYIQSVLD 258 (260)
T ss_pred HHHHHHHh
Confidence 99998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=310.63 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=200.0
Q ss_pred CCCCceEeeeecccCceEEEEEEECC--c----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS--A----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~--~----~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
...+|++.+.||+|+||.||+|.+.. . .+|+|+. ..... ....+. +.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~--~~~~~-~~~~~~----~~~e~~~l~~l~h~~i~~~~~~ 77 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETS-PKANKE----ILDEAYVMASVDHPHVVRLLGI 77 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEec--cCCCC-HHHHHH----HHHHHHHHHhCCCCCcceEEEE
Confidence 34678999999999999999998742 2 3566653 22211 222233 3789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+.. . ..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+
T Consensus 78 ~~~-~--------------~~~~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~ 138 (279)
T cd05057 78 CLS-S--------------QVQLITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAAR 138 (279)
T ss_pred Eec-C--------------ceEEEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcc
Confidence 875 2 46999999999999999875 1235899999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
||+++.+ +.+||+|||.++......... ......++..|+|||.+.. ..++.++|||||||
T Consensus 139 nil~~~~-------~~~kL~dfg~~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~ 199 (279)
T cd05057 139 NVLVKTP-------QHVKITDFGLAKLLDVDEKEY--------HAEGGKVPIKWMALESILH----RIYTHKSDVWSYGV 199 (279)
T ss_pred eEEEcCC-------CeEEECCCcccccccCcccce--------ecCCCcccccccCHHHhhc----CCcCchhhHHHHHH
Confidence 9999877 679999999987654322110 0011224568999998864 46789999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1034 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1034 iL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
++||+++ |..||.+....++...+..+.....+. .++..+.+++.+||..||
T Consensus 200 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~l~~~p 252 (279)
T cd05057 200 TVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP---------------------------ICTIDVYMVLVKCWMIDA 252 (279)
T ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCh
Confidence 9999998 999999888777777666543222111 223348899999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001152 1113 TERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~ 1128 (1137)
.+||++.++++.+...
T Consensus 253 ~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 253 ESRPTFKELINEFSKM 268 (279)
T ss_pred hhCCCHHHHHHHHHHH
Confidence 9999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=310.04 Aligned_cols=246 Identities=20% Similarity=0.374 Sum_probs=182.4
Q ss_pred eeecccCceEEEEEEECC--------------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 808 DEAGKSVSSSLFRCKFGS--------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~--------------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
+.||+|+||.||+|++.. ..+++|+. ... ... ....+.+|+.+++.++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~--~~~--~~~----~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVL--DPS--HRD----ISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeec--Chh--hhh----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 468999999999998532 12555542 211 111 12234778999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+..+. ..++||||+++++|..++.. ....+++..++.|+.||+.||+|||+++|+||||||+
T Consensus 73 ~~~~~--------------~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 134 (262)
T cd05077 73 CVRDV--------------ENIMVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTK 134 (262)
T ss_pred EecCC--------------CCEEEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcc
Confidence 88655 45999999999999988764 1245899999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.+.........++++|||.+...... ....++..|+|||.+.. ...++.++|||||||
T Consensus 135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~ 197 (262)
T cd05077 135 NILLAREGIDGECGPFIKLSDPGIPITVLSR--------------QECVERIPWIAPECVED---SKNLSIAADKWSFGT 197 (262)
T ss_pred cEEEecCCccCCCCceeEeCCCCCCccccCc--------------ccccccccccChhhhcC---CCCCCchhHHHHHHH
Confidence 9999866322222345999999987643221 12357889999998763 246789999999999
Q ss_pred HHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1034 LLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1034 iL~ELL-TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
++|||+ +|..||......+...... ..... .. ...+++.+|+.+||+.||
T Consensus 198 ~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~-----------------------~~-----~~~~~~~~li~~cl~~dp 248 (262)
T cd05077 198 TLWEICYNGEIPLKDKTLAEKERFYE-GQCML-----------------------VT-----PSCKELADLMTHCMNYDP 248 (262)
T ss_pred HHHHHHhCCCCCCCCcchhHHHHHHh-cCccC-----------------------CC-----CChHHHHHHHHHHcCCCh
Confidence 999998 5888887654333222111 11000 00 123458999999999999
Q ss_pred CCCCCHHHHHHHH
Q 001152 1113 TERPTAGDLYEMF 1125 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L 1125 (1137)
.+||++.+|++++
T Consensus 249 ~~Rp~~~~il~~~ 261 (262)
T cd05077 249 NQRPFFRAIMRDI 261 (262)
T ss_pred hhCcCHHHHHHhc
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=311.02 Aligned_cols=272 Identities=24% Similarity=0.364 Sum_probs=193.7
Q ss_pred CceEeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
+|++.+.||+|+||+||+|.+. +..+++|..... .....+. +.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRD----FEREIEILKSLQHDNIVKYKGVCYS 76 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHH----HHHHHHHHHhCCCCCeeEEEEEEcc
Confidence 6889999999999999999852 456788764322 1223333 4789999999999999999998764
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+. ...++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||+
T Consensus 77 ~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nil 140 (284)
T cd05081 77 AGR------------RNLRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNIL 140 (284)
T ss_pred CCC------------CceEEEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEE
Confidence 321 1569999999999999998752 235899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++........... ......++..|+|||++.+ ..++.++|||||||++|
T Consensus 141 i~~~-------~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~ 202 (284)
T cd05081 141 VESE-------NRVKIGDFGLTKVLPQDKEYYK-------VREPGESPIFWYAPESLTE----SKFSVASDVWSFGVVLY 202 (284)
T ss_pred ECCC-------CeEEECCCcccccccCCCccee-------ecCCCCCceEeeCHHHhcc----CCcChHHHHHHHHHHHH
Confidence 9877 7899999999876543211100 0011124456999999865 45789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
||++|..|+..... .....+..... +.....+... ... .... ......+.++.+++.+||..+|++|
T Consensus 203 el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-------~~~-~~~~---~~~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05081 203 ELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIEL-------LKN-NGRL---PAPPGCPAEIYAIMKECWNNDPSQR 270 (284)
T ss_pred HHhhcCCcCCCcch-hhhhhcccccccccchHHHHHH-------Hhc-CCcC---CCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999877654321 12222111111 1111111000 000 0000 0011445679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001152 1116 PTAGDLYEMFVAR 1128 (1137)
Q Consensus 1116 PSa~EVL~~L~~~ 1128 (1137)
||+.||++.+...
T Consensus 271 pt~~ei~~~l~~~ 283 (284)
T cd05081 271 PSFSELALQVEAI 283 (284)
T ss_pred CCHHHHHHHHHhc
Confidence 9999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=315.18 Aligned_cols=295 Identities=17% Similarity=0.212 Sum_probs=202.8
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+.+|++.++||+|+||.||+|... +..+|+|+........ . +...+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE--G----FPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC--C----chhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 4678999999999999999999984 5678888754332111 1 111236799999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
... ........++||||+. ++|.+++.. ....+++..++.++.||+.||+|||++||+|+||||+||++
T Consensus 84 ~~~------~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~ 152 (310)
T cd07865 84 ATP------YNRYKGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI 152 (310)
T ss_pred ccc------ccCCCceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 311 0011236799999996 688888765 12368999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||.+.......... ........++..|+|||.+.+ ...++.++||||||+++|+
T Consensus 153 ~~~-------~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~e 216 (310)
T cd07865 153 TKD-------GILKLADFGLARAFSLSKNSK------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDMWGAGCIMAE 216 (310)
T ss_pred CCC-------CcEEECcCCCcccccCCcccC------CCCccCcccCccccCcHHhcC---CcccCchhhhHHHHHHHHH
Confidence 877 789999999987654322110 011122357889999999864 2346789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcc---cccccccccCC-CCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS---CHEHEVAQSGS-GFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
|++|..||.+.........+........+..++.... .......+... ..............+.+++.+||..||.
T Consensus 217 l~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~ 296 (310)
T cd07865 217 MWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA 296 (310)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChh
Confidence 9999999988776555444432211100000000000 00000000000 0000000001235578999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001152 1114 ERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~ 1127 (1137)
+|||++|+++|+|+
T Consensus 297 ~R~t~~e~l~h~~f 310 (310)
T cd07865 297 KRIDADTALNHDFF 310 (310)
T ss_pred hccCHHHHhcCCCC
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.27 Aligned_cols=253 Identities=30% Similarity=0.434 Sum_probs=199.9
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||+|.+. +..+++|+..... . .... .++.+|+.+++.++||||+++++.+....
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~-~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--N-EAIQ----KQILRELDILHKCNSPYIVGFYGAFYNNG-- 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--C-hHHH----HHHHHHHHHHHHCCCCchhhhheeeecCC--
Confidence 5778899999999999999986 4667887653321 1 1222 23488999999999999999999988665
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeEecc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDL 959 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .|++||||||+||+++.
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~ 136 (265)
T cd06605 73 ------------DISICMEYMDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS 136 (265)
T ss_pred ------------EEEEEEEecCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC
Confidence 679999999999999998762 1568999999999999999999999 99999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||.+......... ...++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 137 ~-------~~~~l~d~g~~~~~~~~~~~------------~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l~ 193 (265)
T cd06605 137 R-------GQIKLCDFGVSGQLVNSLAK------------TFVGTSSYMAPERIQG----NDYSVKSDIWSLGLSLIELA 193 (265)
T ss_pred C-------CCEEEeecccchhhHHHHhh------------cccCChhccCHHHHcC----CCCCchhhHHHHHHHHHHHH
Confidence 7 78999999988655322110 1357889999999875 46789999999999999999
Q ss_pred hCCCCCCCCC-----HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1040 TLQVPYMGLS-----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1040 TG~~Pf~~~~-----~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|..||.... ..+....+.....+..+.. ..+.++.+++.+||..||++
T Consensus 194 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~li~~~l~~~p~~ 247 (265)
T cd06605 194 TGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG--------------------------KFSPDFQDFVNLCLIKDPRE 247 (265)
T ss_pred hCCCCCCccccccccHHHHHHHHhcCCCCCCChh--------------------------hcCHHHHHHHHHHcCCCchh
Confidence 9999997542 2223333332222221110 14556999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001152 1115 RPTAGDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~ 1129 (1137)
|||+.+++.|+|++.
T Consensus 248 Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 248 RPSYKELLEHPFIKK 262 (265)
T ss_pred CcCHHHHhhCchhhc
Confidence 999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=316.61 Aligned_cols=301 Identities=20% Similarity=0.214 Sum_probs=206.7
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
..+.+|++.++||+|+||.||+|.+. +..+++|+.......... .. .+.+|+++++.++||||+++++++.+
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~--~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PI----TALREIKILKKLKHPNVVPLIDMAVE 78 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc--ch----hHHHHHHHHHhcCCCCccchhhheec
Confidence 34789999999999999999999985 466888875433222111 11 23679999999999999999998765
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
..... .......++||||+. ++|...+.. ....+++..+..++.||++||+|||++||+||||||+||+
T Consensus 79 ~~~~~------~~~~~~~~lv~~~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil 147 (311)
T cd07866 79 RPDKS------KRKRGSVYMVTPYMD-HDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANIL 147 (311)
T ss_pred ccccc------cccCceEEEEEecCC-cCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 43110 011226799999996 678777654 2346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCcccccccccccccccc-CCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH-RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
++.+ +.++|+|||++.............. ..........+++.|+|||++.+ ...++.++|||||||++
T Consensus 148 ~~~~-------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il 217 (311)
T cd07866 148 IDNQ-------GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG---ERRYTTAVDIWGIGCVF 217 (311)
T ss_pred ECCC-------CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC---CCccCchhHhHHHHHHH
Confidence 9987 7899999999875543221110000 00011123457889999999864 24578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhh---hcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA---LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
|+|++|+.||.+.+.......+........+..+.. ........... ..............+.+.+++.+||+.||
T Consensus 218 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 296 (311)
T cd07866 218 AEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFT-NYPRTLEERFGKLGPEGLDLLSKLLSLDP 296 (311)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCC-CCCccHHHHcccCChhHHHHHHHHcccCc
Confidence 999999999988777665555432221111111111 10000000000 00000001111334668999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 001152 1113 TERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~ 1127 (1137)
.+|||+.|++.|+|+
T Consensus 297 ~~R~t~~ell~~~~f 311 (311)
T cd07866 297 YKRLTASDALEHPYF 311 (311)
T ss_pred ccCcCHHHHhcCCCC
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=307.74 Aligned_cols=261 Identities=30% Similarity=0.466 Sum_probs=201.1
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||+|.+. +..+++|+...... ..... ..+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~----~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTI----KEIADEMKVLELLKHPNLVKYYGVEVHRE-- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHH----HHHHHHHHHHHhCCCCChhheeeeEecCC--
Confidence 5889999999999999999874 46788887544322 12233 34488999999999999999999877654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++.. ...+++..+..|+.|++.||+|||+.||+|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~ 135 (264)
T cd06626 73 ------------KVYIFMEYCSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135 (264)
T ss_pred ------------EEEEEEecCCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 67999999999999999875 2358899999999999999999999999999999999999977
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||.+........... .......+++.|+|||++.+.. ...++.++||||||+++|+|++
T Consensus 136 -------~~~kl~d~g~~~~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~-~~~~~~~~Dv~s~G~il~~l~~ 201 (264)
T cd06626 136 -------GVIKLGDFGCAVKLKNNTTTMG------EEVQSLAGTPAYMAPEVITGGK-GKGHGRAADIWSLGCVVLEMAT 201 (264)
T ss_pred -------CCEEEcccccccccCCCCCccc------ccccCCcCCcCccChhhccCCC-CCCCCcccchHHHHHHHHHHHh
Confidence 7899999999876543221110 0011235788999999987521 1347899999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 G~~Pf~~~~-~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|+.||.... .......+..+..+.++.. ...++.+.+++.+||+.+|.+||++.
T Consensus 202 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~R~~~~ 256 (264)
T cd06626 202 GKRPWSELDNEFQIMFHVGAGHKPPIPDS-------------------------LQLSPEGKDFLDRCLESDPKKRPTAS 256 (264)
T ss_pred CCCCccCCcchHHHHHHHhcCCCCCCCcc-------------------------cccCHHHHHHHHHHccCCcccCCCHH
Confidence 999997643 3333333333322222211 02345588999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
+++.|+|.
T Consensus 257 ~i~~~~~~ 264 (264)
T cd06626 257 ELLQHPFV 264 (264)
T ss_pred HHhcCCCC
Confidence 99999884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=314.55 Aligned_cols=265 Identities=21% Similarity=0.318 Sum_probs=193.9
Q ss_pred CCceEeeeecccCceEEEEEEECC------------------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS------------------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR 863 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~------------------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~ 863 (1137)
.+|++.++||+|+||.||+|.+.+ ..+|+|+.... . ...... .+.+|+.+++.++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~-~~~~~~----~~~~E~~~l~~l~ 77 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--A-NKNARN----DFLKEIKIMSRLK 77 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--C-CHHHHH----HHHHHHHHHHhCC
Confidence 468999999999999999986532 24666654322 1 122222 3478999999999
Q ss_pred CCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------CCCCCCHHHHHHHHHHHHHHH
Q 001152 864 HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------GEKHVSVKLALFIAQDVAAAL 937 (1137)
Q Consensus 864 HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~------~~~~ls~~~i~~I~~QIa~gL 937 (1137)
||||+++++++...+ ..++||||+++++|.+++...... ....+++..+..++.||+.||
T Consensus 78 ~~~i~~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al 143 (296)
T cd05095 78 DPNIIRLLAVCITSD--------------PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGM 143 (296)
T ss_pred CCCcceEEEEEecCC--------------ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHH
Confidence 999999999988765 459999999999999999763211 113478889999999999999
Q ss_pred HHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc
Q 001152 938 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017 (1137)
Q Consensus 938 ~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1017 (1137)
+|||++||+||||||+|||++.+ +.++|+|||++......... .......+++.|+|||...+
T Consensus 144 ~~lH~~~i~H~dlkp~Nili~~~-------~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~-- 206 (296)
T cd05095 144 KYLSSLNFVHRDLATRNCLVGKN-------YTIKIADFGMSRNLYSGDYY--------RIQGRAVLPIRWMSWESILL-- 206 (296)
T ss_pred HHHHHCCeecccCChheEEEcCC-------CCEEeccCcccccccCCcce--------eccCcCcCccccCCHHHHhc--
Confidence 99999999999999999999876 78999999998754322110 00112234678999998765
Q ss_pred CCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 001152 1018 KPNLYGLEVDIWSYGCLLLELLT--LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1095 (1137)
Q Consensus 1018 ~~~~~s~ksDVWSLGviL~ELLT--G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1137)
..++.++|||||||++|||++ |..||......+.............. .. .... ...
T Consensus 207 --~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~--~~~~---~~~ 264 (296)
T cd05095 207 --GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGR---------------QV--YLPK---PAL 264 (296)
T ss_pred --CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccc---------------cc--cCCC---CCC
Confidence 468899999999999999998 77899776655544332110000000 00 0000 013
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001152 1096 TLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1096 ~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~ 1126 (1137)
+++.+.+++.+||+.||.+||++.+|++.+.
T Consensus 265 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 265 CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 4467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=312.05 Aligned_cols=285 Identities=20% Similarity=0.247 Sum_probs=201.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|++.+.||+|++|+||+|.+. +..+++|....... .....+ .+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPS----TAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchH----HHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 357999999999999999999985 46688886433221 111112 2377999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||++ ++|.+++.. .....+++..+..++.||+.||+|||+++|+||||+|+||+++
T Consensus 75 --------------~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 75 --------------RLYLVFEYLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (294)
T ss_pred --------------eEEEEEeccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE
Confidence 6799999996 688888754 2233468899999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.++ +.+||+|||++......... .....+++.|+|||++.+ ...++.++|||||||++|+|
T Consensus 137 ~~~------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~i~~~l 197 (294)
T PLN00009 137 RRT------NALKLADFGLARAFGIPVRT----------FTHEVVTLWYRAPEILLG---SRHYSTPVDIWSVGCIFAEM 197 (294)
T ss_pred CCC------CEEEEcccccccccCCCccc----------cccCceeecccCHHHHhC---CCCCCcHHHHHHHHHHHHHH
Confidence 542 56999999998654321110 112357889999999864 24578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCc---hhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP---EAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
+||..||......+....+...........+......... ......+... ......++++.+++.+||+.+|++|
T Consensus 198 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 275 (294)
T PLN00009 198 VNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY--KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKR 275 (294)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh--hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhC
Confidence 9999999876665544443221111111100000000000 0000000000 0112345678999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001152 1116 PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ 1130 (1137)
|++.++++|+|+...
T Consensus 276 ps~~~~l~~~~~~~~ 290 (294)
T PLN00009 276 ITARAALEHEYFKDL 290 (294)
T ss_pred cCHHHHhcCchHhHH
Confidence 999999999999753
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=317.27 Aligned_cols=260 Identities=26% Similarity=0.433 Sum_probs=202.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||++... +..+++|...... ....+. +.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~----~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKEL----IINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHH----HHHHHHHHhhcCCCCeeehhheeeeC
Confidence 3578999999999999999999863 4668888753221 112222 47899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 89 ~--------------~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili 148 (293)
T cd06647 89 D--------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 148 (293)
T ss_pred C--------------cEEEEEecCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE
Confidence 5 56999999999999999875 357899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.++|+|||++........ ......+++.|+|||.+.+ ..++.++|||||||++|+
T Consensus 149 ~~~-------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~ll~~ 207 (293)
T cd06647 149 GMD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIE 207 (293)
T ss_pred cCC-------CCEEEccCcceeccccccc----------ccccccCChhhcCchhhcc----CCCCchhhHHHHHHHHHH
Confidence 877 7899999998765432211 1113358889999999865 457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|..||......+....+.....+.+.. ....+..+.+++.+||+.+|.+||+
T Consensus 208 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rp~ 262 (293)
T cd06647 208 MVEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLEMDVEKRGS 262 (293)
T ss_pred HHhCCCCCCCCChhhheeehhcCCCCCCCC-------------------------ccccCHHHHHHHHHHccCChhhCcC
Confidence 999999998755443322222211111100 0023456899999999999999999
Q ss_pred HHHHHHHHHhhcCCCC
Q 001152 1118 AGDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ss~ 1133 (1137)
+.+++.|.|+...-..
T Consensus 263 ~~~il~h~~~~~~~~~ 278 (293)
T cd06647 263 AKELLQHPFLKIAKPL 278 (293)
T ss_pred HHHHhcCHHHhcCccc
Confidence 9999999999866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=309.97 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=185.7
Q ss_pred eeecccCceEEEEEEEC-CccEEEEEEe-cccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG-SADAAAKVRT-LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 885 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~-~~~vAVKi~~-l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g 885 (1137)
+.||+|+||.||+|.+. ...++.++.+ .... ......+. +.+|+.+++.++||||+++++.+....
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~----~~~e~~~~~~l~h~~iv~~~~~~~~~~------- 68 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNE----FLQQGDPYRILQHPNILQCLGQCVEAI------- 68 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHH----HHHHHHHHhccCCcchhheEEEecCCC-------
Confidence 36999999999999753 2333322221 2221 11222333 488999999999999999999988654
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCC
Q 001152 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965 (1137)
Q Consensus 886 ~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~ 965 (1137)
..++||||+++|+|.+++++.... ...+++..+..++.||+.||+|||+.+|+||||||+|||++.+
T Consensus 69 -------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~----- 135 (268)
T cd05086 69 -------PYLLVFEYCELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD----- 135 (268)
T ss_pred -------ccEEEEecCCCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-----
Confidence 469999999999999999763211 2356778889999999999999999999999999999999877
Q ss_pred CCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc---CCCCCCchhhHHHHHHHHHHHHh-C
Q 001152 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGCLLLELLT-L 1041 (1137)
Q Consensus 966 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~s~ksDVWSLGviL~ELLT-G 1041 (1137)
+.+||+|||++......... .......++..|+|||++.... ....++.++|||||||++|||++ |
T Consensus 136 --~~~~l~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 136 --LTVKVGDYGIGPSRYKEDYI--------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred --ccEEecccccccccCcchhh--------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 78999999987532211100 0111335788999999975321 11245789999999999999997 5
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
..||......+....+.......+.. +......++.+.+++..|| .+|++||++++|
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i 262 (268)
T cd05086 206 AQPYSHLSDREVLNHVIKDQQVKLFK----------------------PQLELPYSERWYEVLQFCW-LSPEKRATAEEV 262 (268)
T ss_pred CCCCCCCCHHHHHHHHHhhcccccCC----------------------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHH
Confidence 77887766666555543322211110 0000123456888999999 679999999999
Q ss_pred HHHHH
Q 001152 1122 YEMFV 1126 (1137)
Q Consensus 1122 L~~L~ 1126 (1137)
++.+.
T Consensus 263 ~~~l~ 267 (268)
T cd05086 263 HRLLT 267 (268)
T ss_pred HHHhc
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=311.36 Aligned_cols=279 Identities=18% Similarity=0.252 Sum_probs=203.1
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.++||+|++|.||+|++. +..+|+|+....... ...+ .+.+|+.++++++||||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPS----TAIREISLMKELKHENIVRLHDVIHTEN-- 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchH----HHHHHHHHHHhhcCCCEeeeeeeEeeCC--
Confidence 4889999999999999999984 567888875443221 1112 2367999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||++ ++|.+++.... ....+++..+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus 72 ------------~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~ 136 (284)
T cd07836 72 ------------KLMLVFEYMD-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR 136 (284)
T ss_pred ------------cEEEEEecCC-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 5699999998 58999886522 12468999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+........ ......++..|++||++.+ ...++.++|||||||++|+|++
T Consensus 137 -------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 137 -------GELKLADFGLARAFGIPVN----------TFSNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred -------CcEEEeecchhhhhcCCcc----------ccccccccccccChHHhcC---CCCCCcHHHHHHHHHHHHHHHh
Confidence 7899999998865432211 0112357889999999865 2356889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCC---chhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|+.||.+.+..+....+...........+....... ........... .......++.+.+++.+||+.||.+||+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 274 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP--EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS 274 (284)
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc--hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC
Confidence 999998876665555543222111111111111000 00000000000 0011234677899999999999999999
Q ss_pred HHHHHHHHHh
Q 001152 1118 AGDLYEMFVA 1127 (1137)
Q Consensus 1118 a~EVL~~L~~ 1127 (1137)
+.|+++|+||
T Consensus 275 ~~~~l~~~~f 284 (284)
T cd07836 275 AHDALQHPWF 284 (284)
T ss_pred HHHHhcCCCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.29 Aligned_cols=276 Identities=22% Similarity=0.251 Sum_probs=203.6
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|||+.||+++. .+..+|+|...... .++.+.. ++|+..-++++||||++++++...+.
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~----~rEid~~rkf~s~~vl~l~dh~l~~~- 91 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEA----LREIDNHRKFNSPNVLRLVDHQLREE- 91 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHH----HHHHHHHHhhCCcchHHHHHHHHHhh-
Confidence 5799999999999999999985 45667777643322 3444444 89999999999999999999976543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeEe
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILI 957 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g--IIHrDLKP~NILl 957 (1137)
.|+ .-+.||+++|+..|||.+.++..... +..+++.+++.|+.+|.+||++||+.. ++||||||.|||+
T Consensus 92 ---~D~-----~~~~yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl 162 (302)
T KOG2345|consen 92 ---KDG-----KHEAYLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL 162 (302)
T ss_pred ---ccC-----ceeEEEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe
Confidence 112 22689999999999999999875444 457999999999999999999999998 9999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
.++ +.++|.|||.+..............+-... .....|..|+|||.+.-. .....+.++|||||||++|+
T Consensus 163 s~~-------~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~-a~e~Ct~pyRAPELf~vk-~~~ti~ertDIWSLGCtLYa 233 (302)
T KOG2345|consen 163 SDS-------GLPVLMDLGSATQAPIQIEGSRQALRLQEW-AEERCTIPYRAPELFNVK-SHCTITERTDIWSLGCTLYA 233 (302)
T ss_pred cCC-------CceEEEeccCccccceEeechHHHHHHHHH-HHHhCCCcccCchheecc-cCcccccccchhhhhHHHHH
Confidence 986 789999999887544322111110000000 012478899999998643 34567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|+.|..||+.. ..+|....+.-. ...+..|... .+++.+.++++.||+.||.+||+
T Consensus 234 ~mf~~sPfe~~--------~~~GgSlaLAv~---------------n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~ 289 (302)
T KOG2345|consen 234 MMFGESPFERI--------YQQGGSLALAVQ---------------NAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPT 289 (302)
T ss_pred HHHcCCcchHH--------hhcCCeEEEeee---------------ccccccCCCC-CccHHHHHHHHHHhcCCcccCCC
Confidence 99999999631 112221111000 0001111111 36677999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001152 1118 AGDLYEMFVAR 1128 (1137)
Q Consensus 1118 a~EVL~~L~~~ 1128 (1137)
+.+++.++...
T Consensus 290 i~~ll~~~d~L 300 (302)
T KOG2345|consen 290 IPELLSKLDDL 300 (302)
T ss_pred HHHHHHHHHhh
Confidence 99999987653
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.25 Aligned_cols=281 Identities=25% Similarity=0.312 Sum_probs=200.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|++|.||+|.+. +..+++|+...... .. .....+.+|++++++++|+||+++++++...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DE----DVKKTALREVKVLRQLRHENIVNLKEAFRRKG- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cc----cchhHHHHHHHHHHhcCCCCeeehhheEEECC-
Confidence 36899999999999999999985 45678886433221 11 12233478999999999999999999998655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||++++.+..+... ...+++..+..++.||+.||.|||+++|+||||+|+||+++.
T Consensus 74 -------------~~~iv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~ 135 (288)
T cd07833 74 -------------RLYLVFEYVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135 (288)
T ss_pred -------------EEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence 67999999997666655543 245899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.+......... ......++..|+|||++.+. ..++.++||||||+++|+|+
T Consensus 136 ~-------~~~kl~d~g~~~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~~---~~~~~~~Dv~slG~~l~~l~ 196 (288)
T cd07833 136 S-------GVLKLCDFGFARALRARPAS---------PLTDYVATRWYRAPELLVGD---TNYGKPVDVWAIGCIMAELL 196 (288)
T ss_pred C-------CCEEEEeeecccccCCCccc---------cccCcccccCCcCCchhcCC---CCcCchhhHHHHHHHHHHHH
Confidence 7 78999999998765432210 11234578899999998752 26789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCch-----hhhhhHHHHHHHHHHhcccCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE-----AELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|..||.+....+....+........+....... ...............+. .....+.++.+++.+||..+|++
T Consensus 197 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 275 (288)
T cd07833 197 DGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS-SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKE 275 (288)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc-cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchh
Confidence 9999998766555444332211111111000000 00000000000000000 01123677999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001152 1115 RPTAGDLYEMFVA 1127 (1137)
Q Consensus 1115 RPSa~EVL~~L~~ 1127 (1137)
||+++++++|+|+
T Consensus 276 Rps~~~il~~~~f 288 (288)
T cd07833 276 RLTCDELLQHPYF 288 (288)
T ss_pred cccHHHHhcCCCC
Confidence 9999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=304.26 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=205.4
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||.|+||.||+|.+. +..+++|+..... ......+. +.+|+++++.++|||++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~----~~~e~~~l~~l~~~~~~~~~~~~~~~~-- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKERED----ALNEVKILKKLNHPNIIKYYESFEEKG-- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc--CChHHHHH----HHHHHHHHHhcCCCChhheEEEEecCC--
Confidence 5889999999999999999986 5678888754322 22223333 478999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.++++.... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~ 139 (258)
T cd08215 73 ------------KLCIVMEYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN 139 (258)
T ss_pred ------------EEEEEEEecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC
Confidence 67999999999999999986322 23579999999999999999999999999999999999999977
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+........ ......|++.|+|||.+.+ ..++.++||||+|+++|+|++
T Consensus 140 -------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 140 -------GLVKLGDFGISKVLSSTVD----------LAKTVVGTPYYLSPELCQN----KPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred -------CcEEECCccceeecccCcc----------eecceeeeecccChhHhcc----CCCCccccHHHHHHHHHHHHc
Confidence 7899999998876543220 1112358889999999765 457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||......++...+.....+.++. ..+..+.+++.+||..+|++|||+.+
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 199 LKHPFEGENLLELALKILKGQYPPIPS---------------------------QYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999998877666666554433322221 23445899999999999999999999
Q ss_pred HHHHHHh
Q 001152 1121 LYEMFVA 1127 (1137)
Q Consensus 1121 VL~~L~~ 1127 (1137)
+++|+|+
T Consensus 252 ll~~~~~ 258 (258)
T cd08215 252 ILQSPFI 258 (258)
T ss_pred HhcCCCC
Confidence 9999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=305.83 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=202.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|++|.||+|.+. +..+++|+...... ....+ .+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRK----QLLRELKTLRSCESPYVVKCYGAFYKEG-- 72 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHH----HHHHHHHHHHhcCCCCeeeEEEEEccCC--
Confidence 5889999999999999999985 56788887543321 12223 3478999999999999999999988655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeEecc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDL 959 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+++||||+|+||+++.
T Consensus 73 ------------~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~ 135 (264)
T cd06623 73 ------------EISIVLEYMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS 135 (264)
T ss_pred ------------eEEEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC
Confidence 679999999999999999762 468999999999999999999999 99999999999999988
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||.+......... .....++..|+|||.+.. ..++.++||||||+++|+|+
T Consensus 136 ~-------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~ 194 (264)
T cd06623 136 K-------GEVKIADFGISKVLENTLDQ----------CNTFVGTVTYMSPERIQG----ESYSYAADIWSLGLTLLECA 194 (264)
T ss_pred C-------CCEEEccCccceecccCCCc----------ccceeecccccCHhhhCC----CCCCchhhHHHHHHHHHHHH
Confidence 7 78999999988765432211 112357889999999865 46789999999999999999
Q ss_pred hCCCCCCCC---CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~---~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|..||... ...+....+.....+..+.. ..+..+.+++.+||..+|++||
T Consensus 195 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~l~~li~~~l~~~p~~R~ 248 (264)
T cd06623 195 LGKFPFLPPGQPSFFELMQAICDGPPPSLPAE--------------------------EFSPEFRDFISACLQKDPKKRP 248 (264)
T ss_pred hCCCCCccccccCHHHHHHHHhcCCCCCCCcc--------------------------cCCHHHHHHHHHHccCChhhCC
Confidence 999999765 33444444443222211110 1445699999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
++.|+++|+|++.
T Consensus 249 ~~~~ll~~~~~~~ 261 (264)
T cd06623 249 SAAELLQHPFIKK 261 (264)
T ss_pred CHHHHHhCHHHHh
Confidence 9999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=310.98 Aligned_cols=252 Identities=29% Similarity=0.422 Sum_probs=200.3
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|++.+.||+|+||.||+|.+. +..+|+|+..... .....+ .+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 75 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIE----DIQQEITVLSQCDSPYVTKYYGSYLKDT--- 75 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHH----HHHHHHHHHHhcCCCCEeEEEEEEEeCC---
Confidence 677889999999999999874 4678888743221 112222 3478999999999999999999998765
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
..++||||+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||||+||+++.+
T Consensus 76 -----------~~~lv~e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~- 137 (277)
T cd06641 76 -----------KLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH- 137 (277)
T ss_pred -----------eEEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-
Confidence 56999999999999999864 358999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.++|+|||++......... .....++..|+|||.+.+ ..++.++|||||||++|+|++|
T Consensus 138 ------~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slG~~l~~l~~g 197 (277)
T cd06641 138 ------GEVKLADFGVAGQLTDTQIK----------RNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAIELAKG 197 (277)
T ss_pred ------CCEEEeecccceecccchhh----------hccccCCccccChhhhcc----CCCCchhhHHHHHHHHHHHHcC
Confidence 77999999988654332110 112357889999999865 4567899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
..||...........+.....+.+.. ..+.++.+++.+||+.+|.+||++.++
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 250 (277)
T cd06641 198 EPPHSELHPMKVLFLIPKNNPPTLEG---------------------------NYSKPLKEFVEACLNKEPSFRPTAKEL 250 (277)
T ss_pred CCCCCccchHHHHHHHhcCCCCCCCc---------------------------ccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99998766555554443332222111 334568999999999999999999999
Q ss_pred HHHHHhhcC
Q 001152 1122 YEMFVARTS 1130 (1137)
Q Consensus 1122 L~~L~~~~~ 1130 (1137)
++|+|+...
T Consensus 251 l~~~~~~~~ 259 (277)
T cd06641 251 LKHKFIVRF 259 (277)
T ss_pred HhCHHHhhh
Confidence 999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=320.82 Aligned_cols=289 Identities=19% Similarity=0.236 Sum_probs=203.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.++||+|+||.||+|.+. +..||+|+.. .... .... .++.+|+.++++++||||+++++++....+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~--~~~~-~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS--PFEH-QTFC----QRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEec--cccc-chhH----HHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 57999999999999999999874 4678888643 1111 1112 234789999999999999999998765432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. .....++||||+. ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 78 ~---------~~~~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~ 141 (336)
T cd07849 78 E---------SFNDVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 141 (336)
T ss_pred c---------ccceEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 1 1226799999996 688887754 46999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++.......... .......||+.|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 142 ~-------~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGvil~el~ 204 (336)
T cd07849 142 N-------CDLKICDFGLARIADPEHDHT-------GFLTEYVATRWYRAPEIMLN---SKGYTKAIDIWSVGCILAEML 204 (336)
T ss_pred C-------CCEEECcccceeecccccccc-------CCcCCcCcCCCccChHHhhC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 789999999987543321110 01123468899999998754 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc-cccccc--CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||.+.+.......+...........+........ ...... .............++++.+++.+||+.||.+||
T Consensus 205 ~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 284 (336)
T cd07849 205 SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284 (336)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc
Confidence 99999987665554444422221111111111000000 000000 000000011123466799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|+.|+++|+|+..-
T Consensus 285 t~~e~l~hp~~~~~ 298 (336)
T cd07849 285 TVEEALAHPYLEQY 298 (336)
T ss_pred CHHHHhcCcccccc
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=344.04 Aligned_cols=293 Identities=18% Similarity=0.204 Sum_probs=192.7
Q ss_pred CCCceEeeeecccCceEEEEEEECCc---cEEEEEEeccc---------CCCChHHHHHhHHhHHHHHHHHHhCCCCCcc
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKV---------CGSSADEIRNFEYSCLGEVRMLGALRHSCIV 868 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~---~vAVKi~~l~~---------~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIV 868 (1137)
..+|++.++||+|+||+||+|.+... .++.|...... .............++.+|+.+|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 56899999999999999999876421 11111000000 0000001111223458899999999999999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 001152 869 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948 (1137)
Q Consensus 869 kllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHr 948 (1137)
++++++...+ ..|+|||++. ++|..++...............+..|+.||+.||+|||++|||||
T Consensus 227 ~l~~~~~~~~--------------~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHr 291 (501)
T PHA03210 227 KIEEILRSEA--------------NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291 (501)
T ss_pred cEeEEEEECC--------------eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 9999998765 5699999995 788887754211112234567788999999999999999999999
Q ss_pred cCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhH
Q 001152 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028 (1137)
Q Consensus 949 DLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1028 (1137)
||||+|||++.+ +.+||+|||+++.+...... ......||+.|+|||++.+ ..++.++||
T Consensus 292 DLKP~NILl~~~-------~~vkL~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di 351 (501)
T PHA03210 292 DIKLENIFLNCD-------GKIVLGDFGTAMPFEKEREA---------FDYGWVGTVATNSPEILAG----DGYCEITDI 351 (501)
T ss_pred CCCHHHEEECCC-------CCEEEEeCCCceecCccccc---------ccccccCCcCCCCchhhcC----CCCCcHHHH
Confidence 999999999877 78999999999765432111 1113469999999999875 468899999
Q ss_pred HHHHHHHHHHHhCCCCC-CCC--CH-HHHHHHHHcCCC--CCchh---HHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001152 1029 WSYGCLLLELLTLQVPY-MGL--SE-LEIHDLIQMGKR--PRLTD---ELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1099 (1137)
Q Consensus 1029 WSLGviL~ELLTG~~Pf-~~~--~~-~el~~~I~~g~~--p~l~~---~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1137)
|||||++|||++|..++ ... .. .++...+..... ..++. .+... .....+..........-.....+..
T Consensus 352 wSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~--i~~~~~~~~~~~~~~~~~~~~~~~~ 429 (501)
T PHA03210 352 WSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDY--IDSAEIDHAGHSVPPLIRNLGLPAD 429 (501)
T ss_pred HHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHH--hhhhhcccCccchhhHHHhcCCChH
Confidence 99999999999987544 321 22 233333322111 01111 00000 0000000000000000011234556
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1100 LVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1100 L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+.+++.+||+.||.+|||+.|++.|+||...
T Consensus 430 ~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 430 FEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 8889999999999999999999999998653
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=326.88 Aligned_cols=263 Identities=21% Similarity=0.317 Sum_probs=196.6
Q ss_pred CCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~ 879 (1137)
..|++.++||+||.+.||++...+ +.+|+|..... ..+......| ..|+..|.+|+ |.+||++|+|-..++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~--~~D~qtl~gy----~nEI~lL~KLkg~~~IIqL~DYEv~d~- 433 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL--EADNQTLDGY----RNEIALLNKLKGHDKIIQLYDYEVTDG- 433 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh--hcCHHHHHHH----HHHHHHHHHhcCCceEEEEeeeeccCc-
Confidence 458999999999999999999864 55555532222 2223344444 89999999997 999999999988776
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
.+||||||-+ .+|..+|++. ....+...++.+.+||+.|+.++|.+||||.||||.|+|+-.
T Consensus 434 -------------~lYmvmE~Gd-~DL~kiL~k~----~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk 495 (677)
T KOG0596|consen 434 -------------YLYMVMECGD-IDLNKILKKK----KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK 495 (677)
T ss_pred -------------eEEEEeeccc-ccHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe
Confidence 5699999764 8999999872 123333478899999999999999999999999999998854
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC-------CCCCchhhHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-------NLYGLEVDIWSYG 1032 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-------~~~s~ksDVWSLG 1032 (1137)
|.+||+|||+|..+...... -.....+||+.||+||.+..+... -..+.++||||+|
T Consensus 496 --------G~LKLIDFGIA~aI~~DTTs--------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG 559 (677)
T KOG0596|consen 496 --------GRLKLIDFGIANAIQPDTTS--------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG 559 (677)
T ss_pred --------eeEEeeeechhcccCccccc--------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence 68999999999876543221 122355899999999999764322 1367899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
||||+|+.|+.||.... .....+.....|.-. +.+++. ....++.++++.||+.||
T Consensus 560 CILYqMvYgktPf~~~~--n~~aKl~aI~~P~~~--------------------Iefp~~--~~~~~li~~mK~CL~rdP 615 (677)
T KOG0596|consen 560 CILYQMVYGKTPFGQII--NQIAKLHAITDPNHE--------------------IEFPDI--PENDELIDVMKCCLARDP 615 (677)
T ss_pred hHHHHHHhcCCchHHHH--HHHHHHHhhcCCCcc--------------------ccccCC--CCchHHHHHHHHHHhcCc
Confidence 99999999999997432 122233222222110 111111 112238999999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 001152 1113 TERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~ 1129 (1137)
.+|||+.|+|+|+|...
T Consensus 616 kkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 616 KKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccCCCcHHHhcCccccc
Confidence 99999999999999865
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=304.28 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=193.4
Q ss_pred eeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 886 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~ 886 (1137)
++||+|+||.||+|.+. +..+++|+..... . ....+ .+.+|+.+++++.||||+++++++.+..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~--~-~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 65 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTL--P-PDLKR----KFLQEAEILKQYDHPNIVKLIGVCVQKQ-------- 65 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccC--C-HHHHH----HHHHHHHHHHhCCCCCeEEEEEEEecCC--------
Confidence 47999999999999986 5778888643322 1 12223 3488999999999999999999988665
Q ss_pred CccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCC
Q 001152 887 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 966 (1137)
Q Consensus 887 ~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~ 966 (1137)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 66 ------~~~~v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~------ 129 (251)
T cd05041 66 ------PIYIVMELVPGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN------ 129 (251)
T ss_pred ------CeEEEEEcCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC------
Confidence 569999999999999998752 2358899999999999999999999999999999999999877
Q ss_pred CCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 001152 967 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPY 1045 (1137)
Q Consensus 967 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf 1045 (1137)
+.+||+|||.+......... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 130 -~~~~l~d~g~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~i~~~l~t~~~~p~ 196 (251)
T cd05041 130 -NVLKISDFGMSREEEGGIYT--------VSDGLKQIPIKWTAPEALNY----GRYTSESDVWSYGILLWETFSLGDTPY 196 (251)
T ss_pred -CcEEEeeccccccccCCcce--------eccccCcceeccCChHhhcc----CCCCcchhHHHHHHHHHHHHhccCCCC
Confidence 78999999998754321111 00011223567999999865 467899999999999999999 88999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001152 1046 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125 (1137)
Q Consensus 1046 ~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L 1125 (1137)
...........+........+. ..+.++.+++.+||+.+|.+|||+.|+++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 197 PGMSNQQTRERIESGYRMPAPQ---------------------------LCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred ccCCHHHHHHHHhcCCCCCCCc---------------------------cCCHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 8776665555554332211110 2345699999999999999999999999987
Q ss_pred H
Q 001152 1126 V 1126 (1137)
Q Consensus 1126 ~ 1126 (1137)
.
T Consensus 250 ~ 250 (251)
T cd05041 250 Q 250 (251)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=304.85 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=203.4
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.++||+|+||.||++.+. +..+++|...... ....+... +.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS--MSQKERED----AVNEIRILASVNHPNIISYKEAFLDGN-- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh--ccHHHHHH----HHHHHHHHHhCCCCCchhhhhhhccCC--
Confidence 5889999999999999999875 4567777654322 12222333 378999999999999999999887654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++.+... ....+++..+..++.|++.||+|||+.|++||||+|+||+++.+
T Consensus 73 ------------~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~ 139 (256)
T cd08530 73 ------------KLCIVMEYAPFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN 139 (256)
T ss_pred ------------EEEEEehhcCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC
Confidence 67999999999999999876432 23568999999999999999999999999999999999999976
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||++........ ....+++.|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 140 -------~~~kl~d~g~~~~~~~~~~------------~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 140 -------DLVKIGDLGISKVLKKNMA------------KTQIGTPHYMAPEVWKG----RPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred -------CcEEEeeccchhhhccCCc------------ccccCCccccCHHHHCC----CCCCchhhHHHHHHHHHHHHh
Confidence 7799999999876543210 12347889999999875 457789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|+.||...+.......+..+..+.++. ..+.++.+++.+||+.+|++||++.+
T Consensus 197 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 197 FAPPFEARSMQDLRYKVQRGKYPPIPP---------------------------IYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCch---------------------------hhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999998877766666655444333221 33455999999999999999999999
Q ss_pred HHHHHH
Q 001152 1121 LYEMFV 1126 (1137)
Q Consensus 1121 VL~~L~ 1126 (1137)
+++||+
T Consensus 250 ~l~~p~ 255 (256)
T cd08530 250 ILASPA 255 (256)
T ss_pred HhcCCC
Confidence 999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=308.12 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=188.9
Q ss_pred EeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 806 SCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 806 l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
....||+|+||.||+|++.. ..+++|..... .....+. +.+|+.+++.++|+||+++++++...+
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 78 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQP----LHEEIALHSYLKHRNIVQYLGSDSENG----- 78 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHH----HHHHHHHHHhcCCCCeeeeeeeeccCC-----
Confidence 34689999999999999754 45666653222 1222333 378999999999999999999987655
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
..++||||+++++|.++++... .....++..+..++.||+.||+|||++||+||||||+||+++.+.
T Consensus 79 ---------~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-- 145 (268)
T cd06624 79 ---------FFKIFMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-- 145 (268)
T ss_pred ---------EEEEEEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--
Confidence 5699999999999999997521 111237888999999999999999999999999999999997631
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1043 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~ 1043 (1137)
+.++|+|||.+........ ......+++.|+|||++.. ....++.++||||||+++|+|++|..
T Consensus 146 ----~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~--~~~~~~~~~Dv~slGvvl~~l~~g~~ 209 (268)
T cd06624 146 ----GVVKISDFGTSKRLAGINP----------CTETFTGTLQYMAPEVIDK--GPRGYGAPADIWSLGCTIVEMATGKP 209 (268)
T ss_pred ----CeEEEecchhheecccCCC----------ccccCCCCccccChhhhcc--ccccCCchhhhHHHHHHHHHHHhCCC
Confidence 5799999998865432111 1112357889999999865 22457899999999999999999999
Q ss_pred CCCCCCHHHHHH-HH-HcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1044 PYMGLSELEIHD-LI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1044 Pf~~~~~~el~~-~I-~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
||.......... .+ .....+.++ ...++++.+++.+||+.+|.+|||+.|+
T Consensus 210 p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l 262 (268)
T cd06624 210 PFIELGEPQAAMFKVGMFKIHPEIP---------------------------ESLSAEAKNFILRCFEPDPDKRASAHDL 262 (268)
T ss_pred CCccccChhhhHhhhhhhccCCCCC---------------------------cccCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 997533221111 11 001111111 1344568999999999999999999999
Q ss_pred HHHHHh
Q 001152 1122 YEMFVA 1127 (1137)
Q Consensus 1122 L~~L~~ 1127 (1137)
+.|+|+
T Consensus 263 l~~~~~ 268 (268)
T cd06624 263 LQDPFL 268 (268)
T ss_pred HhCCCC
Confidence 999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=308.09 Aligned_cols=247 Identities=27% Similarity=0.323 Sum_probs=196.6
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCC
Q 001152 810 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 810 LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 887 (1137)
||.|++|.||+|++. +..+++|+........ ... ...+.+|+.+++.++||||+++++++.+..
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------- 66 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-TGQ----QEHIFSEKEILEECNHPFIVKLYRTFKDKK--------- 66 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-hhH----HHHHHHHHHHHHhCCCCCEeeeeeeEEcCC---------
Confidence 799999999999986 6778888754332111 112 233588999999999999999999987665
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCC
Q 001152 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 967 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~ 967 (1137)
..++||||+++++|.+++.+ ...+++..+..++.||+.||+|||+++++|+||+|+||+++.+
T Consensus 67 -----~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~------- 129 (262)
T cd05572 67 -----YIYMLMEYCLGGELWTILRD-----RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN------- 129 (262)
T ss_pred -----ccEEEEecCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-------
Confidence 56999999999999999976 2358999999999999999999999999999999999999877
Q ss_pred CeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001152 968 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047 (1137)
Q Consensus 968 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~ 1047 (1137)
+.++|+|||.+........ .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 130 ~~~~l~df~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 130 GYVKLVDFGFAKKLKSGQK-----------TWTFCGTPEYVAPEIILN----KGYDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred CCEEEeeCCcccccCcccc-----------cccccCCcCccChhHhcC----CCCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 7899999998876543210 112357889999999864 4578999999999999999999999987
Q ss_pred CC--HHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC-----HH
Q 001152 1048 LS--ELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT-----AG 1119 (1137)
Q Consensus 1048 ~~--~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS-----a~ 1119 (1137)
.. ..+....+..+. .+..+. ..++++.+++.+||+.+|++||+ ++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 247 (262)
T cd05572 195 DDEDPMEIYNDILKGNGKLEFPN---------------------------YIDKAAKDLIKQLLRRNPEERLGNLKGGIK 247 (262)
T ss_pred CCCCHHHHHHHHhccCCCCCCCc---------------------------ccCHHHHHHHHHHccCChhhCcCCcccCHH
Confidence 65 444554443211 111110 22456999999999999999999 99
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
|+++|+|+..
T Consensus 248 ~l~~~~~~~~ 257 (262)
T cd05572 248 DIKKHKWFNG 257 (262)
T ss_pred HHhcChhhhC
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=304.46 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=193.6
Q ss_pred eeecccCceEEEEEEECC---c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS---A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~---~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
+.||+|++|.||+|.+.. + .+|+|+..... .. ... ..+.+|+.++++++||||+++++++.+ .
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~--~~-~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~-~---- 68 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK--LS-DIM----DDFLKEAAIMHSLDHENLIRLYGVVLT-H---- 68 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcc--cH-HHH----HHHHHHHHHHhhcCCCCccceeEEEcC-C----
Confidence 468999999999998743 2 46777643222 11 222 344889999999999999999999876 3
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
..++||||+++++|.+++.+.. ...+++..+..++.|++.||+|||++|++||||||+||+++.+
T Consensus 69 ----------~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-- 133 (257)
T cd05040 69 ----------PLMMVTELAPLGSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-- 133 (257)
T ss_pred ----------eEEEEEEecCCCcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC--
Confidence 5699999999999999997621 1468999999999999999999999999999999999999987
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1041 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G 1041 (1137)
+.+||+|||++.......... .......++..|+|||++.+ ..++.++|||||||++|+|++ |
T Consensus 134 -----~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Di~slG~~l~el~t~g 197 (257)
T cd05040 134 -----DKVKIGDFGLMRALPQNEDHY-------VMEEHLKVPFAWCAPESLRT----RTFSHASDVWMFGVTLWEMFTYG 197 (257)
T ss_pred -----CEEEeccccccccccccccce-------ecccCCCCCceecCHHHhcc----cCcCchhhhHHHHHHHHHHHhCC
Confidence 789999999987654322110 00112346789999999865 467899999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
..||......+....+...... .. . + ...+..+.+++.+||+.+|++||++.++
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~-~~----~------------------~---~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 198 EEPWAGLSGSQILKKIDKEGER-LE----R------------------P---EACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred CCCCCCCCHHHHHHHHHhcCCc-CC----C------------------C---ccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 9999877777666655431110 00 0 0 0234569999999999999999999999
Q ss_pred HHHHH
Q 001152 1122 YEMFV 1126 (1137)
Q Consensus 1122 L~~L~ 1126 (1137)
++.+.
T Consensus 252 ~~~l~ 256 (257)
T cd05040 252 REFLP 256 (257)
T ss_pred HHHhc
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=316.96 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=199.4
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|.....||+|+||.||+|... +..+|+|+...... ...+. +.+|+.+++.+.||||+++++++...+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~----~~~e~~~l~~l~hp~i~~~~~~~~~~~--- 91 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRREL----LFNEVVIMRDYQHQNVVEMYKSYLVGE--- 91 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHH----HHHHHHHHHhCCCCchhhhhhheeeCC---
Confidence 445568999999999999874 57788987543221 11222 378999999999999999999987655
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
..++||||+++++|..++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 92 -----------~~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~- 153 (297)
T cd06659 92 -----------ELWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD- 153 (297)
T ss_pred -----------eEEEEEecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-
Confidence 56999999999999998754 358999999999999999999999999999999999999887
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.+||+|||++........ ......++..|+|||++.+ ..++.++|||||||++|||++|
T Consensus 154 ------~~~kL~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~~g 213 (297)
T cd06659 154 ------GRVKLSDFGFCAQISKDVP----------KRKSLVGTPYWMAPEVISR----TPYGTEVDIWSLGIMVIEMVDG 213 (297)
T ss_pred ------CcEEEeechhHhhcccccc----------cccceecCccccCHHHHcc----CCCCchhhHHHHHHHHHHHHhC
Confidence 7899999998864432211 1113458899999999875 4578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
+.||......+....+.....+.... ....++.+.+++.+||+.+|.+||+++++
T Consensus 214 ~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~~i~~~l~~~P~~Rps~~~l 268 (297)
T cd06659 214 EPPYFSDSPVQAMKRLRDSPPPKLKN-------------------------AHKISPVLRDFLERMLTREPQERATAQEL 268 (297)
T ss_pred CCCCCCCCHHHHHHHHhccCCCCccc-------------------------cCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 99998776655555443322111100 00234558999999999999999999999
Q ss_pred HHHHHhhcC
Q 001152 1122 YEMFVARTS 1130 (1137)
Q Consensus 1122 L~~L~~~~~ 1130 (1137)
++|+|+...
T Consensus 269 l~~~~~~~~ 277 (297)
T cd06659 269 LDHPFLLQT 277 (297)
T ss_pred hhChhhccC
Confidence 999998755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.48 Aligned_cols=251 Identities=26% Similarity=0.333 Sum_probs=198.4
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||.||+|.+. +..+++|+...+... .....+ .+.+|++++++++||||+++++.+.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVR----NVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-chhHHH----HHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 4889999999999999999985 577888876433211 112223 3488999999999999999999887655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++.. ...+++..+..|+.||+.||.|||+++|+|+||+|+||+++.+
T Consensus 74 ------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 136 (258)
T cd05578 74 ------------NMYLVVDLLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136 (258)
T ss_pred ------------eEEEEEeCCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC
Confidence 67999999999999999976 2468999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+........ .....|+..|+|||.+.. ..++.++|+||||+++|+|++
T Consensus 137 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~l~~ 194 (258)
T cd05578 137 -------GHVHITDFNIATKVTPDTL-----------TTSTSGTPGYMAPEVLCR----QGYSVAVDWWSLGVTAYECLR 194 (258)
T ss_pred -------CCEEEeecccccccCCCcc-----------ccccCCChhhcCHHHHcc----cCCCCcccchhhHHHHHHHHh
Confidence 7899999998865433211 112357889999999875 347899999999999999999
Q ss_pred CCCCCCCCCH---HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1041 LQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1041 G~~Pf~~~~~---~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|..||..... ..+...... ..+..+ ...+..+.+++.+||+.||.+||+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~-~~~~~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~ 246 (258)
T cd05578 195 GKRPYRGHSRTIRDQIRAKQET-ADVLYP---------------------------ATWSTEAIDAINKLLERDPQKRLG 246 (258)
T ss_pred CCCCCCCCCccHHHHHHHHhcc-ccccCc---------------------------ccCcHHHHHHHHHHccCChhHcCC
Confidence 9999987653 222222111 111111 123456999999999999999999
Q ss_pred H--HHHHHHHHh
Q 001152 1118 A--GDLYEMFVA 1127 (1137)
Q Consensus 1118 a--~EVL~~L~~ 1127 (1137)
+ .|+++|+|+
T Consensus 247 ~~~~~l~~~~~~ 258 (258)
T cd05578 247 DNLKDLKNHPYF 258 (258)
T ss_pred ccHHHHhcCCCC
Confidence 9 999999885
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=308.20 Aligned_cols=257 Identities=25% Similarity=0.360 Sum_probs=198.0
Q ss_pred CceEeeeecccCceEEEEEEECC--ccEEEEEEec-ccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTL-KVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l-~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+|.+.+.||+|+||.||++.+.. ..+++|+.+. ........... ++.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV----QANQEAQLLSKLDHPAIVKFHASFLERD- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHH----HHHHHHHHHHhCCCCcHHHHHHHHhcCC-
Confidence 58899999999999999999854 3455555322 11111111112 2367899999999999999999987654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++...... ...+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 76 -------------~~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~ 141 (260)
T cd08222 76 -------------AFCIITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141 (260)
T ss_pred -------------ceEEEEEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec
Confidence 569999999999999998764322 357999999999999999999999999999999999999974
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+.++|+|||.+........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|+
T Consensus 142 --------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~----~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 142 --------NLLKIGDFGVSRLLMGSCD----------LATTFTGTPYYMSPEALKH----QGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred --------CCEeecccCceeecCCCcc----------cccCCCCCcCccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 3599999998865433211 1113357889999999864 45678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||...........+..+..+..+. ..+.++.+++.+||+.+|++||++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (260)
T cd08222 200 CLAHAFEGQNFLSVVLRIVEGPTPSLPE---------------------------TYSRQLNSIMQSMLNKDPSLRPSAA 252 (260)
T ss_pred hCCCCCCCccHHHHHHHHHcCCCCCCcc---------------------------hhcHHHHHHHHHHhcCChhhCcCHH
Confidence 9999998766555555544433332221 3445689999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
|+++|+|+
T Consensus 253 ~il~~~~~ 260 (260)
T cd08222 253 EILRNPFI 260 (260)
T ss_pred HHhhCCCC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=346.65 Aligned_cols=271 Identities=24% Similarity=0.293 Sum_probs=196.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|++.++||+|+||.||+|.+. +..||+|+...+.. .. +....++.+|++++++++||||+++++++.+.+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--~~---e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--EN---PLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--cC---HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 368999999999999999999985 46788887532221 11 122334589999999999999999999988665
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG------EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~------~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
..++||||++|++|.+++....... ...+++..+..++.||+.||+|||++||+||||||
T Consensus 76 --------------~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKP 141 (932)
T PRK13184 76 --------------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKP 141 (932)
T ss_pred --------------EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence 5699999999999999987532211 23466778899999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccc--------cccCCCCCCCcccCCCcccchhhhccccCCCCCCc
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC--------IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1024 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~--------~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1024 (1137)
+|||++.+ +.+||+|||+++.......... ............+||+.|+|||++.+ ..++.
T Consensus 142 eNILLd~d-------g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g----~~~S~ 210 (932)
T PRK13184 142 DNILLGLF-------GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG----VPASE 210 (932)
T ss_pred heEEEcCC-------CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC----CCCCc
Confidence 99999887 7799999999976521110000 00001111234579999999999875 46789
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHH
Q 001152 1025 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1104 (1137)
Q Consensus 1025 ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl 1104 (1137)
++|||||||++|||+||..||.......+...... ..+ .... .....++.+.+++
T Consensus 211 kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i-~~P---~~~~---------------------p~~~iP~~L~~LI 265 (932)
T PRK13184 211 STDIYALGVILYQMLTLSFPYRRKKGRKISYRDVI-LSP---IEVA---------------------PYREIPPFLSQIA 265 (932)
T ss_pred HhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhc-cCh---hhcc---------------------ccccCCHHHHHHH
Confidence 99999999999999999999976443332221100 000 0000 0014456689999
Q ss_pred HHhcccCCCCCCC-HHHHHHHHH
Q 001152 1105 RRCTEENPTERPT-AGDLYEMFV 1126 (1137)
Q Consensus 1105 ~~CL~~DP~~RPS-a~EVL~~L~ 1126 (1137)
.+||+.||++||+ ++++++.+.
T Consensus 266 ~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 266 MKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred HHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999975 455555443
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=311.41 Aligned_cols=270 Identities=23% Similarity=0.326 Sum_probs=191.7
Q ss_pred ceEeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
|++.+.||+|+||.||+|++. +..+|+|... ... .....+ .+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~--~~~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PES-GGNHIA----DLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcC--ccc-cHHHHH----HHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 678899999999999999852 4567777642 221 122222 348899999999999999999988764
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+. ...++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 79 ~~------------~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~ 142 (284)
T cd05079 79 GG------------NGIKLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 142 (284)
T ss_pred CC------------CceEEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE
Confidence 21 1469999999999999998651 2358999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.++|+|||++.......... .......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 143 ~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~apE~~~~----~~~~~~~Di~slG~il~e 204 (284)
T cd05079 143 ESE-------HQVKIGDFGLTKAIETDKEYY-------TVKDDLDSPVFWYAPECLIQ----SKFYIASDVWSFGVTLYE 204 (284)
T ss_pred cCC-------CCEEECCCccccccccCccce-------eecCCCCCCccccCHHHhcc----CCCCccccchhhhhhhhh
Confidence 877 779999999987654321110 01113356778999999865 457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCC--chhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPR--LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~--l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|++++.|+..... ............ ........ .. ..... ....++..+.+|+.+||+.+|++|
T Consensus 205 llt~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~R 270 (284)
T cd05079 205 LLTYCDSESSPMT--LFLKMIGPTHGQMTVTRLVRVL--------EE-GKRLP---RPPNCPEEVYQLMRKCWEFQPSKR 270 (284)
T ss_pred hhcCCCCCccccc--hhhhhcccccccccHHHHHHHH--------Hc-CccCC---CCCCCCHHHHHHHHHHccCCcccC
Confidence 9998776543111 110000000000 00000000 00 00000 011355679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001152 1116 PTAGDLYEMFVAR 1128 (1137)
Q Consensus 1116 PSa~EVL~~L~~~ 1128 (1137)
||+.++++.+...
T Consensus 271 pt~~~il~~l~~~ 283 (284)
T cd05079 271 TTFQNLIEGFEAI 283 (284)
T ss_pred cCHHHHHHHHHhh
Confidence 9999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=311.56 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=201.0
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|...+.||+|++|.||+|.+. +..+++|+..... ....+. +.+|+.+++.+.||||+++++++...+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~----~~~e~~~l~~~~h~~vv~~~~~~~~~~--- 89 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRREL----LFNEVVIMRDYQHPNIVEMYSSYLVGD--- 89 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHH----HHHHHHHHHHcCCCChheEEEEEEcCC---
Confidence 445679999999999999874 4668887643221 122222 478999999999999999999987655
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
+.++||||+++++|.+++.. ..+++..+..|+.||+.||+|||++||+||||+|+||+++.+
T Consensus 90 -----------~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~- 151 (285)
T cd06648 90 -----------ELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD- 151 (285)
T ss_pred -----------eEEEEEeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-
Confidence 56999999999999999875 358999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.++|+|||.+........ ......|++.|+|||.+.+ ..++.++|||||||++|+|++|
T Consensus 152 ------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slGv~l~ell~g 211 (285)
T cd06648 152 ------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPEVISR----LPYGTEVDIWSLGIMVIEMVDG 211 (285)
T ss_pred ------CcEEEcccccchhhccCCc----------ccccccCCccccCHHHhcC----CCCCCcccHHHHHHHHHHHHhC
Confidence 7899999998764432111 1113358889999999865 4578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
+.||...+.......+.....+..... ...+..+.+++.+||+.+|++||++.++
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~i 266 (285)
T cd06648 212 EPPYFNEPPLQAMKRIRDNLPPKLKNL-------------------------HKVSPRLRSFLDRMLVRDPAQRATAAEL 266 (285)
T ss_pred CCCCcCCCHHHHHHHHHhcCCCCCccc-------------------------ccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 999987766666555544322211100 0234569999999999999999999999
Q ss_pred HHHHHhhcCCC
Q 001152 1122 YEMFVARTSSS 1132 (1137)
Q Consensus 1122 L~~L~~~~~ss 1132 (1137)
++|+|+.....
T Consensus 267 l~~~~~~~~~~ 277 (285)
T cd06648 267 LNHPFLAKAGP 277 (285)
T ss_pred ccCcccccCCC
Confidence 99999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=313.22 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=196.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--Cc----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SA----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~----~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
..+|+..+.||+|+||.||+|.+. +. .+|+|+.. ... ...... .+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~--~~~-~~~~~~----~~~~e~~~~~~l~h~niv~~~~~~ 78 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETT-GPKANV----EFMDEALIMASMDHPHLVRLLGVC 78 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecc--ccC-CHHHHH----HHHHHHHHHHhCCCCCcccEEEEE
Confidence 456788899999999999999873 23 24555532 211 122222 247899999999999999999988
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
... ..++||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 79 ~~~---------------~~~~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~N 139 (303)
T cd05110 79 LSP---------------TIQLVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARN 139 (303)
T ss_pred cCC---------------CceeeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccce
Confidence 643 237899999999999998751 2358999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
|+++.+ +.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||+
T Consensus 140 ill~~~-------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~----~~~~~~~DiwslG~~ 200 (303)
T cd05110 140 VLVKSP-------NHVKITDFGLARLLEGDEKE--------YNADGGKMPIKWMALECIHY----RKFTHQSDVWSYGVT 200 (303)
T ss_pred eeecCC-------CceEEccccccccccCcccc--------cccCCCccccccCCHHHhcc----CCCChHHHHHHHHHH
Confidence 999876 67999999998765432111 00112245678999999865 567899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|||++ |..||.+....+....+..+..+..+. .++..+.+++.+||..+|+
T Consensus 201 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~c~~~~p~ 253 (303)
T cd05110 201 IWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP---------------------------ICTIDVYMVMVKCWMIDAD 253 (303)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChh
Confidence 999997 899998776666665555433221110 2234588999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001152 1114 ERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~ 1129 (1137)
+||+++++++.+....
T Consensus 254 ~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 254 SRPKFKELAAEFSRMA 269 (303)
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999988753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=305.81 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=198.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~-~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.+|++.+.||+|+||.||+|.+. +..+++|+........ ..... ..+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~----~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV----NALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHH----HHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 36889999999999999999974 4678888754322111 11222 24588999999999999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. ...++||||+++++|.+++.. ...+++..+..|+.||+.||.|||++||+|+||||+||+++
T Consensus 78 ~------------~~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~ 140 (264)
T cd06653 78 E------------KKLSIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD 140 (264)
T ss_pred C------------CEEEEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 1 157899999999999999875 23588999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.++|+|||.+.......... .......++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 141 ~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 202 (264)
T cd06653 141 SA-------GNVKLGDFGASKRIQTICMSG-------TGIKSVTGTPYWMSPEVISG----EGYGRKADVWSVACTVVEM 202 (264)
T ss_pred CC-------CCEEECccccccccccccccC-------ccccccCCcccccCHhhhcC----CCCCccccHHHHHHHHHHH
Confidence 77 679999999987543211100 01113458889999999875 4577899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++|+.||...........+.... .+.++. ..++.+.+++.+||+ +|.+||+
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~---------------------------~~~~~~~~~i~~~l~-~~~~r~~ 254 (264)
T cd06653 203 LTEKPPWAEYEAMAAIFKIATQPTKPMLPD---------------------------GVSDACRDFLKQIFV-EEKRRPT 254 (264)
T ss_pred HhCCCCCCccCHHHHHHHHHcCCCCCCCCc---------------------------ccCHHHHHHHHHHhc-CcccCcc
Confidence 99999998765554443332211 111111 334569999999999 5799999
Q ss_pred HHHHHHHHH
Q 001152 1118 AGDLYEMFV 1126 (1137)
Q Consensus 1118 a~EVL~~L~ 1126 (1137)
+.+++.|+|
T Consensus 255 ~~~~~~~~~ 263 (264)
T cd06653 255 AEFLLRHPF 263 (264)
T ss_pred HHHHhcCCC
Confidence 999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=310.15 Aligned_cols=282 Identities=21% Similarity=0.241 Sum_probs=196.4
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|... +..+++|+...+.... .. ..+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~----~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 75 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG---VP----FTAIREASLLKGLKHANIVLLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC---Cc----HHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 3568999999999999999999874 5778888764332111 11 1236799999999999999999998865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+. ++|.+++.. ....+++..+..++.||+.||+|||++||+|+||||+|||+
T Consensus 76 ~--------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~ 136 (291)
T cd07870 76 E--------------TLTFVFEYMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI 136 (291)
T ss_pred C--------------eEEEEEeccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE
Confidence 5 5699999996 788777654 12357888899999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++........ .....+++.|+|||++.+ ...++.++|||||||++|+
T Consensus 137 ~~~-------~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ 196 (291)
T cd07870 137 SYL-------GELKLADFGLARAKSIPSQT----------YSSEVVTLWYRPPDVLLG---ATDYSSALDIWGAGCIFIE 196 (291)
T ss_pred cCC-------CcEEEeccccccccCCCCCC----------CCCccccccccCCceeec---CCCCCcHHHHHHHHHHHHH
Confidence 877 78999999988654322111 112357889999999864 2346789999999999999
Q ss_pred HHhCCCCCCCCCHH-HHHHHHHc-CCCCC--chhHHhhhccccccccccc-CCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1038 LLTLQVPYMGLSEL-EIHDLIQM-GKRPR--LTDELEALGSCHEHEVAQS-GSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~-el~~~I~~-g~~p~--l~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
|++|..||...... +....+.. ...|. ....+.............. .............+..+.+++.+|++.||
T Consensus 197 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp 276 (291)
T cd07870 197 MLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276 (291)
T ss_pred HHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCc
Confidence 99999999765432 22222211 11110 0000000000000000000 00000000011234568999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 001152 1113 TERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~ 1127 (1137)
.+|||+.|++.|+|+
T Consensus 277 ~~R~t~~~~l~h~~~ 291 (291)
T cd07870 277 KDRISAQDALLHPYF 291 (291)
T ss_pred ccCcCHHHHhcCCCC
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=314.25 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=195.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~ 878 (1137)
.+|+..+.||+|+||.||++.+. +..+|+|..... ... ... ..+.+|+.++.++. ||||+++++++..+.
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~--~~~-~~~----~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDE-KEQ----KRLLMDLDVVMRSSDCPYIVKFYGALFREG 76 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhc--cCh-HHH----HHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence 45677789999999999999985 466777764322 111 222 23478999999997 999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeEe
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILI 957 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrDLKP~NILl 957 (1137)
..++||||+. ++|.++...........+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 77 --------------~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~ 141 (288)
T cd06616 77 --------------DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL 141 (288)
T ss_pred --------------cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE
Confidence 5699999986 6777655432223335799999999999999999999975 99999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++........ .....|++.|+|||++.+.. ...++.++|||||||++|+
T Consensus 142 ~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~e 202 (288)
T cd06616 142 DRN-------GNIKLCDFGISGQLVDSIA-----------KTRDAGCRPYMAPERIDPSA-RDGYDVRSDVWSLGITLYE 202 (288)
T ss_pred ccC-------CcEEEeecchhHHhccCCc-----------cccccCccCccCHHHhcccc-ccCCcchhhhhHHHHHHHH
Confidence 877 7899999999865433211 11235888999999987521 1367899999999999999
Q ss_pred HHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~-~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++|+.||..... .+....+..+..+.+... .....+.++.+|+.+||+.||++||
T Consensus 203 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rp 259 (288)
T cd06616 203 VATGKFPYPKWNSVFDQLTQVVKGDPPILSNS-----------------------EEREFSPSFVNFINLCLIKDESKRP 259 (288)
T ss_pred HHhCCCCchhcchHHHHHhhhcCCCCCcCCCc-----------------------CCCccCHHHHHHHHHHccCChhhCc
Confidence 9999999975431 111122212221111100 0013556799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|+++|++|+|+..
T Consensus 260 t~~~i~~~~~~~~ 272 (288)
T cd06616 260 KYKELLEHPFIKD 272 (288)
T ss_pred CHHHHhcChhhhc
Confidence 9999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=305.59 Aligned_cols=265 Identities=20% Similarity=0.332 Sum_probs=199.2
Q ss_pred ceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~-----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
|++.+.||+|+||.||+|.+. +..+|+|+...+. ......+.+ .+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~----~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEF----LREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHH----HHHHHHHhcCCCCCcceEEEEEccCC
Confidence 567889999999999999863 3568888754332 223333333 78999999999999999999886532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
.. ......++++||+++|+|.+++..... .....+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 75 ~~--------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili 146 (273)
T cd05074 75 AK--------GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML 146 (273)
T ss_pred CC--------CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE
Confidence 10 011235789999999999988754221 122357899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||.++........ .......+++.|++||.+.. ..++.++|||||||++|+
T Consensus 147 ~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~----~~~~~~sDi~slG~il~e 207 (273)
T cd05074 147 NEN-------MTVCVADFGLSKKIYSGDYY--------RQGCASKLPVKWLALESLAD----NVYTTHSDVWAFGVTMWE 207 (273)
T ss_pred cCC-------CCEEECcccccccccCCcce--------ecCCCccCchhhcCHhHHhc----CccchhhhhHHHHHHHHH
Confidence 877 77999999988754322110 00112235678999999865 457889999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++ |..||.+....+....+..+.....+ ...++.+.+++.+||+.+|++||
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~~l~~~p~~Rp 260 (273)
T cd05074 208 IMTRGQTPYAGVENSEIYNYLIKGNRLKQP---------------------------PDCLEDVYELMCQCWSPEPKCRP 260 (273)
T ss_pred HhhCCCCCCCCCCHHHHHHHHHcCCcCCCC---------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 999 89999887776666665543321111 02345699999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001152 1117 TAGDLYEMFVAR 1128 (1137)
Q Consensus 1117 Sa~EVL~~L~~~ 1128 (1137)
++.+++..+...
T Consensus 261 s~~~~~~~l~~~ 272 (273)
T cd05074 261 SFQHLRDQLELI 272 (273)
T ss_pred CHHHHHHHHHhh
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=307.70 Aligned_cols=258 Identities=21% Similarity=0.344 Sum_probs=196.9
Q ss_pred CCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
.+|++.+.||+|+||.||+|++. ...+++|+.. .. ......+. +.+|++++++++||||+++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~--~~-~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ--KT-KDENLQSE----FRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccC--Cc-cchHHHHH----HHHHHHHHHhcCCcceeeeEEEE
Confidence 46889999999999999999963 2346666532 21 11112233 48899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 950 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~----~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDL 950 (1137)
.+.. ..++||||+++++|.+++....... ...+++..+..++.||+.||+|||+++|+||||
T Consensus 78 ~~~~--------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl 143 (275)
T cd05046 78 REAE--------------PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDL 143 (275)
T ss_pred CCCC--------------cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcC
Confidence 7655 4599999999999999997632111 125899999999999999999999999999999
Q ss_pred CCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHH
Q 001152 951 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1030 (1137)
Q Consensus 951 KP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWS 1030 (1137)
||+||+++.+ +.++++|||++........ .......++..|+|||.+.+ ..++.++||||
T Consensus 144 kp~Nili~~~-------~~~~l~~~~~~~~~~~~~~---------~~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~s 203 (275)
T cd05046 144 AARNCLVSSQ-------REVKVSLLSLSKDVYNSEY---------YKLRNALIPLRWLAPEAVQE----DDFSTKSDVWS 203 (275)
T ss_pred ccceEEEeCC-------CcEEEcccccccccCcccc---------cccCCceeEEeecChhhhcc----CCCCchhhHHH
Confidence 9999999887 7899999998864332111 01112346778999999875 35678999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001152 1031 YGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1031 LGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
||+++|+|++ |..||.......+...+..+...+.. ....+..+.+++.+||+
T Consensus 204 lG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~~i~~~l~ 257 (275)
T cd05046 204 FGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV--------------------------PEGCPSRLYKLMTRCWA 257 (275)
T ss_pred HHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC--------------------------CCCCCHHHHHHHHHHcC
Confidence 9999999998 88899776666555555433321100 00344569999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 001152 1110 ENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1110 ~DP~~RPSa~EVL~~L~ 1126 (1137)
.+|.+||++.|++..+.
T Consensus 258 ~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 258 VNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcccCCCHHHHHHHhc
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.69 Aligned_cols=278 Identities=22% Similarity=0.267 Sum_probs=198.1
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~~ 880 (1137)
|++.++||+|+||.||+|... +..+|+|+..... ....... ..+|+.++.++. ||||+++++++.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~--~~~~~~~-----~~~e~~~l~~l~~h~~i~~~~~~~~~~~~- 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF--KSLEQVN-----NLREIQALRRLSPHPNILRLIEVLFDRKT- 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc--CCchhhh-----HHHHHHHHhhcCCCCCccceEEEEecCCC-
Confidence 678899999999999999974 4678888653221 1122211 256889999986 9999999999886521
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
...++||||++ ++|.+.+... ...+++..+..++.||+.||+|||+.||+||||||+||+++.
T Consensus 73 -----------~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~- 135 (282)
T cd07831 73 -----------GRLALVFELMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD- 135 (282)
T ss_pred -----------CcEEEEEecCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-
Confidence 15699999997 6888887651 246899999999999999999999999999999999999975
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||.+........ .....++..|+|||++.. ...++.++|||||||++|||++
T Consensus 136 -------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 136 -------DILKLADFGSCRGIYSKPP-----------YTEYISTRWYRAPECLLT---DGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred -------CCeEEEecccccccccCCC-----------cCCCCCCcccCChhHhhc---CCCCCcchhHHHHHHHHHHHHc
Confidence 4699999999875532211 112357889999998753 2456789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccc-cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV-AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|..||.+.+..+....+....................... ................+.++.+++.+||+.+|++||+++
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 274 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK 274 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence 9999998777666655533221111111000000000000 000000000011124577899999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
++++|+|+
T Consensus 275 ~~l~~~~~ 282 (282)
T cd07831 275 QALRHPYF 282 (282)
T ss_pred HHhhCCCC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=320.44 Aligned_cols=291 Identities=17% Similarity=0.231 Sum_probs=205.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|... +..+++|+..... ....... ++.+|+.+|++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~--~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLAK----RTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc--ccccchH----HHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 56899999999999999999874 5678888653221 1111222 33679999999999999999998764321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
.....++||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 79 ----------~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~ 142 (334)
T cd07855 79 ----------DFKDVYVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE 142 (334)
T ss_pred ----------CCceEEEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 1236799999996 789888864 245899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++......... .........++..|+|||++.+ ...++.++|||||||++|+|+
T Consensus 143 ~-------~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~l~el~ 206 (334)
T cd07855 143 D-------CELRIGDFGMARGLSSSPTE------HKYFMTEYVATRWYRAPELLLS---LPEYTTAIDMWSVGCIFAEML 206 (334)
T ss_pred C-------CcEEecccccceeecccCcC------CCcccccccccccccChHHhcC---CcccccccchHHHHHHHHHHH
Confidence 7 78999999998755432211 0011123468889999999864 235789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhcccc-cccccc--cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSCH-EHEVAQ--SGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g-~~p~l~~~l~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
+|+.||.+.+.......+... ..+. ...+....... ...... ..............++++.+++.+||+.+|++|
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 285 (334)
T cd07855 207 GRRQLFPGKNYVHQLKLILSVLGSPS-EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER 285 (334)
T ss_pred cCCCccCCCChHHHHHHHHHHhCCCh-hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhC
Confidence 999999887665544444221 1111 00010000000 000000 000011111112456779999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 001152 1116 PTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~s 1131 (1137)
|++++++.|+|+....
T Consensus 286 pt~~~~l~~~~~~~~~ 301 (334)
T cd07855 286 ITVEQALQHPFLAQYH 301 (334)
T ss_pred cCHHHHHhChhhhhcc
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=309.71 Aligned_cols=280 Identities=20% Similarity=0.239 Sum_probs=199.4
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|++.+.||.|++|.||+|.+. +..+++|+...+... ....+. +.+|+.+++.++||||+++++++.+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~----~~~E~~~l~~l~~~~iv~~~~~~~~~~--- 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED--EGVPST----AIREISLLKELNHPNIVRLLDVVHSEN--- 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc--ccchhH----HHHHHHHHHhcCCCCccCHhheeccCC---
Confidence 567899999999999999874 577888875443211 111122 367999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
..++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++++||||+|+||+++.+
T Consensus 72 -----------~~~iv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~- 135 (283)
T cd07835 72 -----------KLYLVFEFLD-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE- 135 (283)
T ss_pred -----------eEEEEEeccC-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-
Confidence 5699999995 7999998752 22368999999999999999999999999999999999999876
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.++|+|||.+......... .....+++.|+|||++.+ ...++.++||||||+++|+|++|
T Consensus 136 ------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 136 ------GALKLADFGLARAFGVPVRT----------YTHEVVTLWYRAPEILLG---SRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred ------CcEEEeecccccccCCCccc----------cCccccccCCCCCceeec---CcccCcHHHHHHHHHHHHHHHhC
Confidence 78999999998654322110 112246789999998764 23567899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccccc-ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA-QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
+.||...+.......+...........+............ ...............+..+.+++.+||+.||.+|||++|
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 197 RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 9999877665444333222111111111000000000000 000000001111244567999999999999999999999
Q ss_pred HHHHHHh
Q 001152 1121 LYEMFVA 1127 (1137)
Q Consensus 1121 VL~~L~~ 1127 (1137)
+++|+|+
T Consensus 277 il~~~~~ 283 (283)
T cd07835 277 ALQHPYF 283 (283)
T ss_pred HhcCCCC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=305.45 Aligned_cols=250 Identities=23% Similarity=0.257 Sum_probs=191.7
Q ss_pred eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHH-HhCCCCCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML-GALRHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL-~~L~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
+.||+|+||.||+|.+. +..+|+|+....... ...... .+..|..++ ....||||+++++++...+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~~----~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------ 70 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVT----NVKAERAIMMIQGESPYVAKLYYSFQSKD------ 70 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHHH----HHHHHHHHHhhcCCCCCeeeeeeeEEcCC------
Confidence 57999999999999984 467888875322110 011111 124454444 4557999999999998655
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..++||||+++++|.++++. ...+++..+..++.||+.||.|||+.+|+||||+|+||+++.+
T Consensus 71 --------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~---- 133 (260)
T cd05611 71 --------YLYLVMEYLNGGDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT---- 133 (260)
T ss_pred --------eEEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC----
Confidence 56999999999999999975 2468999999999999999999999999999999999999877
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.++|+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 134 ---~~~~l~dfg~~~~~~~~--------------~~~~~~~~y~~pe~~~~----~~~~~~~Dv~slG~il~~l~~g~~p 192 (260)
T cd05611 134 ---GHLKLTDFGLSRNGLEN--------------KKFVGTPDYLAPETILG----VGDDKMSDWWSLGCVIFEFLFGYPP 192 (260)
T ss_pred ---CcEEEeecccceecccc--------------ccCCCCcCccChhhhcC----CCCcchhhhHHHHHHHHHHHHCCCC
Confidence 67999999987643221 12357889999999875 3478999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHH
Q 001152 1045 YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP---TAGDL 1121 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP---Sa~EV 1121 (1137)
|......++...+......... . ....+++.+.+++.+||+.+|++|| +++|+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~-~-----------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 193 FHAETPDAVFDNILSRRINWPE-E-----------------------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred CCCCCHHHHHHHHHhcccCCCC-c-----------------------ccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 9887776666555433211100 0 0013456699999999999999999 55899
Q ss_pred HHHHHhhcC
Q 001152 1122 YEMFVARTS 1130 (1137)
Q Consensus 1122 L~~L~~~~~ 1130 (1137)
+.|+|+...
T Consensus 249 l~~~~~~~~ 257 (260)
T cd05611 249 KSHPFFKSI 257 (260)
T ss_pred HcChHhhcC
Confidence 999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=329.31 Aligned_cols=258 Identities=25% Similarity=0.350 Sum_probs=213.2
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
....+..|.+.+.||+|.|+.|.+|++ .+..||+|+ ++++.......+. +.+|+++|+.++|||||+++.+.
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~--idkt~ln~~~~~k----~~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKI--IDKTQLNPSKRQK----LGREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEE--ehhcccChHHHHH----HHHHHHHHHhcCCcceeeeeeee
Confidence 345677899999999999999999997 567888887 4444433333222 37899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.... .+|+||||+.+|.+++++.+ ..+..+..+..++.|+.+|++|||+++|||||||++|
T Consensus 125 ~t~~--------------~lylV~eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 125 ETEA--------------TLYLVMEYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred eecc--------------eeEEEEEeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence 8776 67999999999999999987 2456779999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ .++||+|||++..+.... ......|++.|.|||++.+. .+.++.+|+||+|++
T Consensus 186 ilL~~~-------mnikIaDfgfS~~~~~~~-----------~lqt~cgsppyAaPEl~~g~---~y~gpe~D~Wslgvv 244 (596)
T KOG0586|consen 186 ILLDEN-------MNIKIADFGFSTFFDYGL-----------MLQTFCGSPPYAAPELFNGK---KYDGPEVDIWSLGVV 244 (596)
T ss_pred cccccc-------cceeeeccccceeecccc-----------cccccCCCCCccChHhhcCc---ccCCcceehhhhhhh
Confidence 999988 779999999997765322 12356799999999999873 467899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|.|+.|..||++..-.++...+..+.. .++. ..+.++.++|.++|..+|.+
T Consensus 245 ly~LV~GsLPFDG~~lk~Lr~rvl~gk~-rIp~---------------------------~ms~dce~lLrk~lvl~Psk 296 (596)
T KOG0586|consen 245 LYALVEGSLPFDGQNLKELRPRVLRGKY-RIPF---------------------------YMSCDCEDLLRKFLVLNPSK 296 (596)
T ss_pred heeeeecccccCCcccccccchheeeee-cccc---------------------------eeechhHHHHHHhhccCccc
Confidence 9999999999998776666666554442 1111 12334889999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001152 1115 RPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~ 1128 (1137)
|++.+++.+|.|.-
T Consensus 297 r~~~dqim~~~W~n 310 (596)
T KOG0586|consen 297 RGPCDQIMKDRWRN 310 (596)
T ss_pred cCCHHHhhhhcccc
Confidence 99999999999874
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.42 Aligned_cols=251 Identities=28% Similarity=0.454 Sum_probs=198.0
Q ss_pred ceEeeeecccCceEEEEEEECC------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
+++.+.||.|+||.||++.+.. ..+|+|+.... .. ....+. +..|+.+++.++|+||+++++++.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~~-~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED--AD-EQQIEE----FLREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC--CC-hHHHHH----HHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3577899999999999999865 55777764322 11 112333 47899999999999999999998876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..++||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+|+||||||+||++
T Consensus 74 ~--------------~~~~i~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~ 136 (258)
T smart00219 74 E--------------PLMIVMEYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136 (258)
T ss_pred C--------------eeEEEEeccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence 5 5699999999999999987621 1128999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.++|+|||++.......... .....+++.|+|||.+.+ ..++.++||||||+++|+
T Consensus 137 ~~~-------~~~~l~dfg~~~~~~~~~~~~---------~~~~~~~~~y~~Pe~~~~----~~~~~~~Di~slG~i~~~ 196 (258)
T smart00219 137 GEN-------LVVKISDFGLSRDLYDDDYYK---------KKGGKLPIRWMAPESLKD----GKFTSKSDVWSFGVLLWE 196 (258)
T ss_pred ccC-------CeEEEcccCCceecccccccc---------cccCCCcccccChHHhcc----CCCCcchhHHHHHHHHHH
Confidence 987 789999999987654331110 001236789999999854 567899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++ |..||......++...+..+..+..+. ..+.++.+++.+||..||.+||
T Consensus 197 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~Rp 249 (258)
T smart00219 197 IFTLGESPYPGMSNEEVLEYLKKGYRLPKPE---------------------------NCPPEIYKLMLQCWAEDPEDRP 249 (258)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------cCCHHHHHHHHHHCcCChhhCc
Confidence 998 889998877777777665544322111 2345699999999999999999
Q ss_pred CHHHHHHHH
Q 001152 1117 TAGDLYEMF 1125 (1137)
Q Consensus 1117 Sa~EVL~~L 1125 (1137)
|+.|+++.+
T Consensus 250 t~~~ll~~l 258 (258)
T smart00219 250 TFSELVEIL 258 (258)
T ss_pred CHHHHHhhC
Confidence 999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=313.33 Aligned_cols=291 Identities=19% Similarity=0.204 Sum_probs=201.3
Q ss_pred eEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCC
Q 001152 805 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 805 ~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
.+.+.+|.|+++.||++...+..+|+|+..... ......+. +.+|+.+++.++||||+++++++....
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~----~~~Ei~~l~~l~h~~i~~~~~~~~~~~------ 72 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKL----LQQEIITSRQLQHPNILPYVTSFIVDS------ 72 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc--cchhHHHH----HHHHHHHHHhcCCcchhhhhheeecCC------
Confidence 455666777777777777777889999865432 12223333 488999999999999999999988765
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
..+++|||+++++|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+||+++.+
T Consensus 73 --------~~~~~~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~---- 137 (314)
T cd08216 73 --------ELYVVSPLMAYGSCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD---- 137 (314)
T ss_pred --------eEEEEEeccCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC----
Confidence 5699999999999999997632 2358899999999999999999999999999999999999977
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
+.+||+|||.+............ .........++..|+|||++... ...++.++|||||||++|||++|..|
T Consensus 138 ---~~~kl~d~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Diws~G~il~el~~g~~p 209 (314)
T cd08216 138 ---GKVVLSGLRYSVSMIKHGKRQRV---VHDFPKSSVKNLPWLSPEVLQQN--LQGYNEKSDIYSVGITACELANGHVP 209 (314)
T ss_pred ---CceEEecCccceeeccccccccc---cccccccccccccccCHHHhcCC--CCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 78999999988755432211000 00111234577899999998752 23578999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCC-chhH-Hhhhccccccc---ccccC-CCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1045 YMGLSELEIHDLIQMGKRPR-LTDE-LEALGSCHEHE---VAQSG-SGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1045 f~~~~~~el~~~I~~g~~p~-l~~~-l~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
|..............+..+. +... .+......... ..... ..............++.+++.+||+.||++|||+
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 289 (314)
T cd08216 210 FKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA 289 (314)
T ss_pred CCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH
Confidence 98755443322222221111 1100 00000000000 00000 0000001122445678999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
+++++|+|+...
T Consensus 290 ~~ll~~p~~~~~ 301 (314)
T cd08216 290 SQLLNHSFFKQC 301 (314)
T ss_pred HHHhcCchHhhh
Confidence 999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=305.56 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=199.8
Q ss_pred CceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCCh--HHHHHhHHhHHHHHHHHHh-CCCCCcceeeeeEec
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSA--DEIRNFEYSCLGEVRMLGA-LRHSCIVEMYGHKIS 876 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~---~~vAVKi~~l~~~~~~~--~~~e~~~~~~lrEi~iL~~-L~HpNIVkllg~~~~ 876 (1137)
.|++.+.||+|+||.||+|.+.. ..+|+|........... ...+....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999854 66888875433221110 0111111234778888865 789999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCe
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 955 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NI 955 (1137)
.+ ..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+ .+|+||||+|+||
T Consensus 81 ~~--------------~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ni 145 (269)
T cd08528 81 ND--------------RLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNI 145 (269)
T ss_pred CC--------------eEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHE
Confidence 65 669999999999999998654333 3569999999999999999999996 6899999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
+++.+ +.+||+|||.+....... ......++..|+|||++.+ ..++.++||||||+++
T Consensus 146 l~~~~-------~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~ll 203 (269)
T cd08528 146 MLGED-------DKVTITDFGLAKQKQPES-----------KLTSVVGTILYSCPEIVKN----EPYGEKADVWAFGCIL 203 (269)
T ss_pred EECCC-------CcEEEecccceeeccccc-----------ccccccCcccCcChhhhcC----CCCchHHHHHHHHHHH
Confidence 99877 789999999987544321 1113458889999999875 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|+|++|+.||...........+.......... ...++.+.+++.+||+.||++|
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~cl~~~p~~R 257 (269)
T cd08528 204 YQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE--------------------------GMYSEDVTDVITSCLTPDAEAR 257 (269)
T ss_pred HHHHhCCCcccccCHHHHHHHHhhccCCcCCc--------------------------ccCCHHHHHHHHHHCCCCCccC
Confidence 99999999998766665555554332211110 0234569999999999999999
Q ss_pred CCHHHHHHHHH
Q 001152 1116 PTAGDLYEMFV 1126 (1137)
Q Consensus 1116 PSa~EVL~~L~ 1126 (1137)
|++.|+..++.
T Consensus 258 p~~~e~~~~~~ 268 (269)
T cd08528 258 PDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHhc
Confidence 99999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.37 Aligned_cols=299 Identities=19% Similarity=0.253 Sum_probs=215.9
Q ss_pred CCCCCceEeeeecccCceEEEEEEECC------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
..+..|++...||+|+||.||+|...+ ..+|+|.++.++... .+...+.||+..++.++|||||.+..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t------GiS~SAcREiaL~REl~h~nvi~Lv~ 94 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT------GISMSACREIALLRELKHPNVISLVK 94 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC------CcCHHHHHHHHHHHHhcCCcchhHHH
Confidence 346779999999999999999996522 256777654443322 22234478999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
+|...+ ..+++++||.+ .+|...|+-.+......++...++.|++||+.|+.|||++=|+||||||
T Consensus 95 Vfl~~d-------------~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP 160 (438)
T KOG0666|consen 95 VFLSHD-------------KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP 160 (438)
T ss_pred HHhccC-------------ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence 887632 16799999997 8999999876666567899999999999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
.|||+..++ ...|.|||+|||+++.+..+...- ...+..+-|.+|+|||.+.|. ..|++++||||.|
T Consensus 161 aNIlvmgdg---perG~VKIaDlGlaR~~~~plkpl-------~s~d~VVVTiWYRAPELLLGa---~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 161 ANILVMGDG---PERGRVKIADLGLARLFNNPLKPL-------ASLDPVVVTIWYRAPELLLGA---RHYTKAIDVWAIG 227 (438)
T ss_pred ceEEEeccC---CccCeeEeecccHHHHhhcccccc-------ccCCceEEEEEecChHHhccc---ccccchhhhHHHH
Confidence 999999873 346899999999999877654331 223456789999999999974 6799999999999
Q ss_pred HHHHHHHhCCCCCCCCCH---------HHHHHHHHcCCCCCchhHHhhhccccccc--ccccC-CCCCCc------hhhh
Q 001152 1033 CLLLELLTLQVPYMGLSE---------LEIHDLIQMGKRPRLTDELEALGSCHEHE--VAQSG-SGFEKP------EAEL 1094 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~---------~el~~~I~~g~~p~l~~~l~~~~~~~~~~--~~~~~-~~~~~~------~~~~ 1094 (1137)
||+.||+|-++.|.+... .+....|.......-...++......++. +.+.. ..+... ..-.
T Consensus 228 CIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k 307 (438)
T KOG0666|consen 228 CIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHK 307 (438)
T ss_pred HHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhc
Confidence 999999999888865221 22333342222111111122221111110 00000 000000 0001
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1095 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1095 ~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
..++...+|+.+||++||.+|.|++++++|++|...
T Consensus 308 ~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 308 VKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred CCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 123447899999999999999999999999999865
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=303.39 Aligned_cols=245 Identities=23% Similarity=0.369 Sum_probs=183.5
Q ss_pred eeecccCceEEEEEEECCcc------------EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 808 DEAGKSVSSSLFRCKFGSAD------------AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~~~------------vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
+.||+|+||.||+|.+.... +++|+.... ..... .+.+|+.++++++||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-----HRDSL----AFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc-----hhhHH----HHHHHHHHHHcCCCcchhheeeEEe
Confidence 46999999999999986433 445543211 11122 3478999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
. . ..++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 72 ~-~--------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni 132 (259)
T cd05037 72 R-D--------------ENIMVEEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI 132 (259)
T ss_pred c-C--------------CcEEEEEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence 6 3 348999999999999999762 12689999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+.........+||+|||++...... ....++..|+|||++.+. ...++.++|||||||++
T Consensus 133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~~~ 196 (259)
T cd05037 133 LVARYGLNEGYVPFIKLSDPGIPITVLSR--------------EERVERIPWIAPECIRNG--QASLTIAADKWSFGTTL 196 (259)
T ss_pred EEecCccccCCceeEEeCCCCcccccccc--------------cccccCCCccChhhhcCC--CCCcchhhHHHHHHHHH
Confidence 99877321122347999999988754331 122466789999998752 13678999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+|++ |..||................... . .....+.+++.+||..+|.+
T Consensus 197 ~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~------------------------~-----~~~~~~~~li~~~l~~~p~~ 247 (259)
T cd05037 197 LEICSNGEEPLSTLSSSEKERFYQDQHRLP------------------------M-----PDCAELANLINQCWTYDPTK 247 (259)
T ss_pred HHHHhCCCCCcccCCchhHHHHHhcCCCCC------------------------C-----CCchHHHHHHHHHhccChhh
Confidence 99999 578887654333222222111000 0 01145899999999999999
Q ss_pred CCCHHHHHHHH
Q 001152 1115 RPTAGDLYEMF 1125 (1137)
Q Consensus 1115 RPSa~EVL~~L 1125 (1137)
|||+.+|++.+
T Consensus 248 Rpt~~~il~~l 258 (259)
T cd05037 248 RPSFRAILRDL 258 (259)
T ss_pred CCCHHHHHHhc
Confidence 99999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.15 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=218.3
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 796 LDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 796 ~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
....+..+|...++||+|.||.|.+++-+ +..+|+||.+.++... .++.... +.|-++|+..+||.+..+--.
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAHT----lTE~RVL~~~~HPFLt~LKYs 236 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAHT----LTENRVLQNCRHPFLTSLKYS 236 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhhh----hhHHHHHHhccCcHHHHhhhh
Confidence 34567889999999999999999999874 5789999976665544 3444433 789999999999999988777
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
|...+ ++|+||||..||.|.-++.+ ...|++..++.+...|+.||.|||+++||+||||.+
T Consensus 237 FQt~d--------------rlCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLE 297 (516)
T KOG0690|consen 237 FQTQD--------------RLCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLE 297 (516)
T ss_pred hccCc--------------eEEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhh
Confidence 77665 77999999999999999876 357999999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|.|+|.+ |++||.|||+++.-..... ....++|||.|.|||++.. ..|+.++|+|.+||
T Consensus 298 NLlLDkD-------GHIKitDFGLCKE~I~~g~----------t~kTFCGTPEYLAPEVleD----nDYgraVDWWG~GV 356 (516)
T KOG0690|consen 298 NLLLDKD-------GHIKITDFGLCKEEIKYGD----------TTKTFCGTPEYLAPEVLED----NDYGRAVDWWGVGV 356 (516)
T ss_pred hheeccC-------CceEeeecccchhcccccc----------eeccccCChhhcCchhhcc----ccccceeehhhhhH
Confidence 9999999 8999999999975433221 1236789999999999975 67999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1034 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1034 iL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
++|||+.|+.||...+...++..|..... .++. ..+++.+.|+...|..||.
T Consensus 357 VMYEMmCGRLPFyn~dh~kLFeLIl~ed~-kFPr---------------------------~ls~eAktLLsGLL~kdP~ 408 (516)
T KOG0690|consen 357 VMYEMMCGRLPFYNKDHEKLFELILMEDL-KFPR---------------------------TLSPEAKTLLSGLLKKDPK 408 (516)
T ss_pred HHHHHHhccCcccccchhHHHHHHHhhhc-cCCc---------------------------cCCHHHHHHHHHHhhcChH
Confidence 99999999999998888778877754331 1111 3445689999999999999
Q ss_pred CCC-----CHHHHHHHHHhhcC
Q 001152 1114 ERP-----TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1114 ~RP-----Sa~EVL~~L~~~~~ 1130 (1137)
+|. .+.||.+|.+|...
T Consensus 409 kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 409 KRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred hhcCCCchhHHHHHhhhhhccC
Confidence 996 78999999998754
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.10 Aligned_cols=251 Identities=29% Similarity=0.488 Sum_probs=199.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|++|.||++.+. +..+++|+...... ...+ .+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKE----KIINEIQILKKCKHPNIVKYYGSYLKKD-- 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHH----HHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 4788999999999999999986 56688887543221 1222 3478999999999999999999988665
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||++|++||||+|+||+++.+
T Consensus 71 ------------~~~l~~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~ 134 (253)
T cd05122 71 ------------ELWIVMEFCSGGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD 134 (253)
T ss_pred ------------eEEEEEecCCCCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC
Confidence 569999999999999998762 1468999999999999999999999999999999999999977
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 135 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~il~~l~~ 192 (253)
T cd05122 135 -------GEVKLIDFGLSAQLSDTKA-----------RNTMVGTPYWMAPEVING----KPYDYKADIWSLGITAIELAE 192 (253)
T ss_pred -------CeEEEeecccccccccccc-----------ccceecCCcccCHHHHcC----CCCCccccHHHHHHHHHHHHh
Confidence 7899999998875543211 123458889999999875 347899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||...+.......+.....+..... ...+..+.+++.+||+.||.+|||+.+
T Consensus 193 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 193 GKPPYSELPPMKALFKIATNGPPGLRNP-------------------------EKWSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred CCCCCCCCchHHHHHHHHhcCCCCcCcc-------------------------cccCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999987655444444333222211110 012456999999999999999999999
Q ss_pred HHHHHH
Q 001152 1121 LYEMFV 1126 (1137)
Q Consensus 1121 VL~~L~ 1126 (1137)
+++|+|
T Consensus 248 ~l~~~~ 253 (253)
T cd05122 248 LLKHPF 253 (253)
T ss_pred HhcCCC
Confidence 999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.08 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=205.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
...|++.+.||+|++|.||+|.+. +..+++|+...... ..+. +.+|+++++.++|+||+++++++....
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~ 88 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKEL----IINEILIMKDCKHPNIVDYYDSYLVGD 88 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHH----HHHHHHHHHHCCCCCeeEEEEEEEECC
Confidence 455888899999999999999986 57788887543321 2223 377999999999999999999988765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++... ...+++..+..++.||+.||+|||+.||+|+||+|+||+++
T Consensus 89 --------------~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~ 150 (286)
T cd06614 89 --------------ELWVVMEYMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS 150 (286)
T ss_pred --------------EEEEEEeccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc
Confidence 679999999999999999862 13699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.++|+|||.+........ ......++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 151 ~~-------~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~----~~~~~~~Dv~slGvil~~l 209 (286)
T cd06614 151 KD-------GSVKLADFGFAAQLTKEKS----------KRNSVVGTPYWMAPEVIKR----KDYGPKVDIWSLGIMCIEM 209 (286)
T ss_pred CC-------CCEEECccchhhhhccchh----------hhccccCCcccCCHhHhcC----CCCCCccccHHHHHHHHHH
Confidence 77 7899999998764432211 1112347789999999865 4578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||...........+.....+..... ...+..+.+++.+||+.+|.+||++
T Consensus 210 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~~l~~~p~~Rpt~ 264 (286)
T cd06614 210 AEGEPPYLREPPLRALFLITTKGIPPLKNP-------------------------EKWSPEFKDFLNKCLVKDPEKRPSA 264 (286)
T ss_pred HhCCCCCCCCCHHHHHHHHHhcCCCCCcch-------------------------hhCCHHHHHHHHHHhccChhhCcCH
Confidence 999999987766555544433222211100 0244569999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
.++++|+|+...
T Consensus 265 ~~il~~~~~~~~ 276 (286)
T cd06614 265 EELLQHPFLKKA 276 (286)
T ss_pred HHHhhChHhhcc
Confidence 999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=303.10 Aligned_cols=258 Identities=26% Similarity=0.329 Sum_probs=199.0
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCC
Q 001152 810 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 810 LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 887 (1137)
||.|+||.||+|.+. +..+++|+...... ..+.....+.+|+.++++++||||+++++.+....
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--------- 66 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--------- 66 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-----hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc---------
Confidence 689999999999985 57788887532211 11122234588999999999999999998887654
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCC
Q 001152 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 967 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~ 967 (1137)
..++||||+++++|.+++.+. ..+++..+..|+.||+.||+|||++||+||||+|+||+++.+
T Consensus 67 -----~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~------- 129 (265)
T cd05579 67 -----NLYLVMEYLPGGDLASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN------- 129 (265)
T ss_pred -----EEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-------
Confidence 679999999999999999762 368999999999999999999999999999999999999987
Q ss_pred CeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001152 968 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047 (1137)
Q Consensus 968 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~ 1047 (1137)
+.++|+|||++........... ...........++..|+|||.... ..++.++||||||+++|+|++|..||..
T Consensus 130 ~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 130 GHLKLTDFGLSKVGLVRRQINL--NDDEKEDKRIVGTPDYIAPEVILG----QGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred CCEEEEecccchhcccCccccc--ccccccccCcccCccccCHHHhcC----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 7899999998865432211000 000011123457889999999875 3478899999999999999999999988
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 001152 1048 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 1124 (1137)
Q Consensus 1048 ~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa---~EVL~~ 1124 (1137)
....+....+..+..+. +... ..++.+.+++.+||+.+|++|||+ .++++|
T Consensus 204 ~~~~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 204 ETPEEIFQNILNGKIEW-PEDV-------------------------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCHHHHHHHHhcCCcCC-Cccc-------------------------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 77776666655433211 1000 124568999999999999999999 999999
Q ss_pred HHhhcC
Q 001152 1125 FVARTS 1130 (1137)
Q Consensus 1125 L~~~~~ 1130 (1137)
+|+...
T Consensus 258 ~~~~~~ 263 (265)
T cd05579 258 PFFKGI 263 (265)
T ss_pred ccccCC
Confidence 999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=308.87 Aligned_cols=249 Identities=21% Similarity=0.280 Sum_probs=185.6
Q ss_pred eecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH---HHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 809 EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR---MLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 809 ~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~---iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
.||+|+||.||+|.+. +..+|+|+........... ... +.+|.. ++....||||+.+++++...+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----- 70 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETL----ALNERIMLSLVSTGDCPFIVCMTYAFHTPD----- 70 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH-HHH----HHHHHHHHHHHhhCCCCcEeEEEEEEecCC-----
Confidence 4899999999999984 4678888754332211111 111 133433 344457999999999988655
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
..++||||+++++|.+++.. ...+++..+..|+.||+.||+|||+++|+||||||+|||++.+
T Consensus 71 ---------~~~lv~e~~~~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~--- 133 (279)
T cd05633 71 ---------KLCFILDLMNGGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH--- 133 (279)
T ss_pred ---------eEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC---
Confidence 56999999999999998875 2469999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1043 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~ 1043 (1137)
+.++|+|||++....... .....||+.|+|||.+.. ...++.++|||||||++|+|++|..
T Consensus 134 ----~~~~l~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~ 194 (279)
T cd05633 134 ----GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GTAYDSSADWFSLGCMLFKLLRGHS 194 (279)
T ss_pred ----CCEEEccCCcceeccccC------------ccCcCCCcCccCHHHhcC---CCCCCchhhhHHHHHHHHHHHhCCC
Confidence 789999999886443211 012358999999999763 2457899999999999999999999
Q ss_pred CCCCCCHHHH--HHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----
Q 001152 1044 PYMGLSELEI--HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP----- 1116 (1137)
Q Consensus 1044 Pf~~~~~~el--~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP----- 1116 (1137)
||........ ...........++ ...++++.+++.+||+.||.+||
T Consensus 195 pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~ 247 (279)
T cd05633 195 PFRQHKTKDKHEIDRMTLTVNVELP---------------------------DSFSPELKSLLEGLLQRDVSKRLGCLGR 247 (279)
T ss_pred CcCCCCCcCHHHHHHHhhcCCcCCc---------------------------cccCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence 9975322111 1111100000010 13455699999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
+++|+++|+|++..
T Consensus 248 ~~~~~~~h~~~~~~ 261 (279)
T cd05633 248 GAQEVKEHVFFKGI 261 (279)
T ss_pred CHHHHHhCccccCC
Confidence 69999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=311.52 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=200.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|+..+.||+|+||.||+|++. +..+|+|+...... ....... .+.+|++++++++|||++++++++.++.
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 98 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQ----DIIKEVKFLQRIKHPNSIEYKGCYLREH-- 98 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHH----HHHHHHHHHHhCCCCCEEEEEEEEeeCC--
Confidence 3778899999999999999974 46677776432211 1122222 3488999999999999999999988765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||+|+||+++.+
T Consensus 99 ------------~~~lv~e~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~ 161 (317)
T cd06635 99 ------------TAWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 161 (317)
T ss_pred ------------eEEEEEeCCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC
Confidence 5699999997 6888877541 2458999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||++...... ....+++.|+|||++... ....++.++|||||||++|+|++
T Consensus 162 -------~~~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~-~~~~~~~~~Dv~slGvil~el~~ 219 (317)
T cd06635 162 -------GQVKLADFGSASIASPA--------------NSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAE 219 (317)
T ss_pred -------CCEEEecCCCccccCCc--------------ccccCCccccChhhhhcC-CCCCCCccccHHHHHHHHHHHHh
Confidence 78999999987543221 123588899999997531 12457889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|+.||...........+.....+.... ...++.+.+++.+||+.+|.+||++.+
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~ 273 (317)
T cd06635 220 RKPPLFNMNAMSALYHIAQNESPTLQS--------------------------NEWSDYFRNFVDSCLQKIPQDRPTSEE 273 (317)
T ss_pred CCCCCCCccHHHHHHHHHhccCCCCCC--------------------------ccccHHHHHHHHHHccCCcccCcCHHH
Confidence 999998766655555554433221110 023455899999999999999999999
Q ss_pred HHHHHHhhcCCC
Q 001152 1121 LYEMFVARTSSS 1132 (1137)
Q Consensus 1121 VL~~L~~~~~ss 1132 (1137)
+++|+|+....+
T Consensus 274 il~~~~~~~~~~ 285 (317)
T cd06635 274 LLKHMFVLRERP 285 (317)
T ss_pred HHhChhhhccCc
Confidence 999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=307.07 Aligned_cols=246 Identities=22% Similarity=0.384 Sum_probs=182.2
Q ss_pred eeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 808 DEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~---------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.||+|+||.||+|.+.. ..+++|+.. .. ..... ..+..|+.+++.+.||||+++++++....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~--~~--~~~~~----~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 72 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD--KS--HRNYS----ESFFEAASMMSQLSHKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhc--ch--hHHHH----HHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence 469999999999998743 125555421 11 11112 23477999999999999999999998655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++|+|.++++.. ...+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 73 --------------~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~ 134 (258)
T cd05078 73 --------------ESIMVQEYVKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI 134 (258)
T ss_pred --------------CcEEEEecCCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe
Confidence 459999999999999999752 23689999999999999999999999999999999999998
Q ss_pred ccccc-CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 959 LERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 959 ~~~~~-~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
.++.. ....+.++++|||.+...... ....+++.|+|||++.+ ...++.++|||||||++|+
T Consensus 135 ~~~~~~~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~ 197 (258)
T cd05078 135 REEDRKTGNPPFIKLSDPGISITVLPK--------------EILLERIPWVPPECIEN---PQNLSLAADKWSFGTTLWE 197 (258)
T ss_pred cccccccCCCceEEecccccccccCCc--------------hhccccCCccCchhccC---CCCCCchhhHHHHHHHHHH
Confidence 76321 122245899999987543221 12357889999999874 2357889999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG-~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++| ..||.............. ...++. ....++.+++.+||+.||++||
T Consensus 198 l~~g~~~~~~~~~~~~~~~~~~~--~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 248 (258)
T cd05078 198 IFSGGDKPLSALDSQKKLQFYED--RHQLPA---------------------------PKWTELANLINQCMDYEPDFRP 248 (258)
T ss_pred HHcCCCCChhhccHHHHHHHHHc--cccCCC---------------------------CCcHHHHHHHHHHhccChhhCC
Confidence 9998 466655444332221111 111110 1224589999999999999999
Q ss_pred CHHHHHHHH
Q 001152 1117 TAGDLYEMF 1125 (1137)
Q Consensus 1117 Sa~EVL~~L 1125 (1137)
|++++++.+
T Consensus 249 s~~~il~~l 257 (258)
T cd05078 249 SFRAIIRDL 257 (258)
T ss_pred CHHHHHHhc
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=298.69 Aligned_cols=252 Identities=31% Similarity=0.449 Sum_probs=200.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|++|.||+|.+. +..+++|..... .......+ .+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLE--KIKEEALK----SIMQEIDLLKNLKHPNIVKYIGSIETSD-- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccc--ccCHHHHH----HHHHHHHHHHhCCCCCccEEEEEEEeCC--
Confidence 4789999999999999999874 467888875433 22222333 3488999999999999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus 73 ------------~~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~ 135 (254)
T cd06627 73 ------------SLYIILEYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD 135 (254)
T ss_pred ------------EEEEEEecCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC
Confidence 569999999999999998762 468999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+......... .....++..|+|||...+ ..++.++||||+|+++|+|++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~y~~pe~~~~----~~~~~~~Dv~~lG~~l~~l~~ 194 (254)
T cd06627 136 -------GVVKLADFGVATKLNDVSKD----------DASVVGTPYWMAPEVIEM----SGASTASDIWSLGCTVIELLT 194 (254)
T ss_pred -------CCEEEeccccceecCCCccc----------ccccccchhhcCHhhhcC----CCCCcchhHHHHHHHHHHHHh
Confidence 78999999998765432211 113357889999999865 347899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||...........+.....+.++. ..++.+.+++.+||..+|++||++.+
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 195 GNPPYYDLNPMAALFRIVQDDHPPLPE---------------------------GISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred CCCCCCCccHHHHHHHHhccCCCCCCC---------------------------CCCHHHHHHHHHHHhCChhhCcCHHH
Confidence 999998765444333333222211111 23456899999999999999999999
Q ss_pred HHHHHHh
Q 001152 1121 LYEMFVA 1127 (1137)
Q Consensus 1121 VL~~L~~ 1127 (1137)
++.++|+
T Consensus 248 ~l~~~~~ 254 (254)
T cd06627 248 LLKHPWI 254 (254)
T ss_pred HhcCCCC
Confidence 9999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=308.17 Aligned_cols=253 Identities=25% Similarity=0.324 Sum_probs=191.6
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCC
Q 001152 810 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 810 LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 887 (1137)
||+|+||+||+|.+. +..+++|+........ ... ...+.+|+.+++.++||||+++++++...+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------- 66 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-RKG----EQMALNEKKILEKVSSRFIVSLAYAFETKD--------- 66 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-hhh----hHHHHHHHHHHHhCCCCCEeeeeeEEecCC---------
Confidence 699999999999874 5678888754221111 111 223477999999999999999999987655
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCC
Q 001152 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 967 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~ 967 (1137)
..|+||||+++++|.+++... ....+++..+..++.|++.||.|||+.||+||||+|+||+++.+
T Consensus 67 -----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~------- 131 (277)
T cd05577 67 -----DLCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH------- 131 (277)
T ss_pred -----eEEEEEecCCCCcHHHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-------
Confidence 569999999999999998762 22468999999999999999999999999999999999999887
Q ss_pred CeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001152 968 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047 (1137)
Q Consensus 968 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~ 1047 (1137)
+.++|+|||.+........ .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 132 ~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 132 GNVRISDLGLAVELKGGKK-----------IKGRAGTPGYMAPEVLQG----EVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred CCEEEccCcchhhhccCCc-----------cccccCCCCcCCHHHhcC----CCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 7899999998865432110 112357889999999875 3478999999999999999999999976
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 001152 1048 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TAGDLY 1122 (1137)
Q Consensus 1048 ~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-----Sa~EVL 1122 (1137)
.........+....... ... .....++.+.+++.+||+.||.+|| ++.+++
T Consensus 197 ~~~~~~~~~~~~~~~~~-~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 197 RKEKVEKEELKRRTLEM-AVE-----------------------YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred CcccccHHHHHhccccc-ccc-----------------------CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 44311111121111000 000 0012355689999999999999999 899999
Q ss_pred HHHHhhcC
Q 001152 1123 EMFVARTS 1130 (1137)
Q Consensus 1123 ~~L~~~~~ 1130 (1137)
.|+|+...
T Consensus 253 ~h~~~~~~ 260 (277)
T cd05577 253 EHPLFKDL 260 (277)
T ss_pred hChhhhcC
Confidence 99999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=317.10 Aligned_cols=290 Identities=23% Similarity=0.255 Sum_probs=206.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~ 877 (1137)
..+|++.+.||+|+||.||+|.+. +..+|+|..... ......... +.+|+.+++++ +||||+++++++...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~~~----~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA--FRNATDAQR----TFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccc--cCcchhhhh----hhHHHHHHHHhcCCCCccceeeeeccC
Confidence 467999999999999999999984 466777764221 111222222 36799999999 899999999988654
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+. ...++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus 80 ~~------------~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill 140 (337)
T cd07852 80 ND------------KDIYLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL 140 (337)
T ss_pred CC------------ceEEEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 31 15799999997 699988865 268899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||.+.......... .........||+.|+|||++.+ ...++.++||||||+++|+
T Consensus 141 ~~~-------~~~kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~~l~e 205 (337)
T cd07852 141 NSD-------CRVKLADFGLARSLSELEENP-----ENPVLTDYVATRWYRAPEILLG---STRYTKGVDMWSVGCILGE 205 (337)
T ss_pred cCC-------CcEEEeeccchhccccccccc-----cCcchhcccccccccCceeeec---cccccccchHHHHHHHHHH
Confidence 987 789999999987654322110 0011123468899999998764 2456789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|++|+.||.+....+....+...........+............. ..............+.++.+++.+||+.||++
T Consensus 206 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~ 285 (337)
T cd07852 206 MLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNK 285 (337)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccc
Confidence 999999998876666555543322111111111110000000000 00000001111235678999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
|||+.++++|+|+...
T Consensus 286 Rps~~~il~~~~~~~~ 301 (337)
T cd07852 286 RLTAEEALEHPYVAQF 301 (337)
T ss_pred ccCHHHHhhChhhhhh
Confidence 9999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=310.40 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=200.5
Q ss_pred eEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 805 SSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 805 ~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
....+||+|+||.||++... +..+|+|...... .... ..+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 90 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRR----ELLFNEVVIMRDYQHENVVEMYNSYLVGD---- 90 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHH----HHHHHHHHHHHhcCCcchhheeeEEEeCC----
Confidence 44578999999999999884 4667777642211 1122 23488999999999999999999988765
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
..++||||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||+|+||+++.+
T Consensus 91 ----------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-- 152 (292)
T cd06657 91 ----------ELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-- 152 (292)
T ss_pred ----------EEEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC--
Confidence 67999999999999998754 358999999999999999999999999999999999999977
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~ 1042 (1137)
+.++|+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 153 -----~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slGvil~el~tg~ 213 (292)
T cd06657 153 -----GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMVDGE 213 (292)
T ss_pred -----CCEEEcccccceecccccc----------cccccccCccccCHHHhcC----CCCCchhhHHHHHHHHHHHHhCC
Confidence 6799999998765432111 1113458889999998864 45688999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001152 1043 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1122 (1137)
Q Consensus 1043 ~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL 1122 (1137)
.||.+....+....+.....+.+.. . ...+..+.+++.+||+.||.+||++.+++
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~~~~~~-~------------------------~~~~~~l~~li~~~l~~~P~~R~~~~~ll 268 (292)
T cd06657 214 PPYFNEPPLKAMKMIRDNLPPKLKN-L------------------------HKVSPSLKGFLDRLLVRDPAQRATAAELL 268 (292)
T ss_pred CCCCCCCHHHHHHHHHhhCCcccCC-c------------------------ccCCHHHHHHHHHHHhCCcccCcCHHHHh
Confidence 9998776665555444322211110 0 02344588999999999999999999999
Q ss_pred HHHHhhcCCCCCC
Q 001152 1123 EMFVARTSSSISS 1135 (1137)
Q Consensus 1123 ~~L~~~~~ss~s~ 1135 (1137)
+|+|+......++
T Consensus 269 ~~~~~~~~~~~~~ 281 (292)
T cd06657 269 KHPFLAKAGPPSC 281 (292)
T ss_pred cChHHhccCCCcc
Confidence 9999987655544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.38 Aligned_cols=282 Identities=22% Similarity=0.253 Sum_probs=201.7
Q ss_pred ceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|++.+.||+|+||.||+|.+.. ..+++|+..... ......+ .+.+|+.+++.++||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPI----TAIREIKLLQKLRHPNIVRLKEIVTSKG--- 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchH----HHHHHHHHHHhccCCCeeeheeeEecCC---
Confidence 6788999999999999999854 678888765432 1111122 2377999999999999999999987651
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
....++||||++ ++|.+++.. ....+++..+..++.||+.||+|||++|++|+||||+||+++.+
T Consensus 72 ---------~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~- 136 (287)
T cd07840 72 ---------KGSIYMVFEYMD-HDLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND- 136 (287)
T ss_pred ---------CCcEEEEecccc-ccHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-
Confidence 016799999997 699888865 12468999999999999999999999999999999999999987
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.+||+|||.+......... ......++..|+|||.+.+ ...++.++||||||+++|+|++|
T Consensus 137 ------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 137 ------GVLKLADFGLARPYTKRNSA---------DYTNRVITLWYRPPELLLG---ATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred ------CCEEEccccceeeccCCCcc---------cccccccccccCCceeeEc---cccCChHHHHHHHHHHHHHHHhC
Confidence 78999999998765442210 0112346788999998764 23578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCC--CCCCchhhhh-hHHHHHHHHHHhcccCCCCCCCH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS--GFEKPEAELE-TLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+.||...........+...........+................ .....+.... +++.+.+++.+||..+|.+||++
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 278 (287)
T cd07840 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278 (287)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 99998877666555553322111111111100000000000000 0000001112 36779999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
.++++++|+
T Consensus 279 ~~~l~~~~~ 287 (287)
T cd07840 279 DQALQHEYF 287 (287)
T ss_pred HHHhhCcCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=312.96 Aligned_cols=286 Identities=19% Similarity=0.258 Sum_probs=198.3
Q ss_pred eeeccc--CceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 808 DEAGKS--VSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 808 ~~LG~G--sfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
..||+| +||+||+|++ .++.||+|+...... .....+ .+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~----~~~~e~~~~~~l~h~niv~~~~~~~~~~----- 72 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLK----ALQNEVVLSHFFRHPNIMTSWTVFTTGS----- 72 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHH----HHHHHHHHHHhCCCCCcceEeeeEecCC-----
Confidence 456776 9999999998 468899998654322 222233 3478999999999999999999998765
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
..++||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 73 ---------~~~~v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~--- 137 (328)
T cd08226 73 ---------WLWVISPFMAYGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD--- 137 (328)
T ss_pred ---------ceEEEEecccCCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC---
Confidence 5699999999999999987632 2358999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1043 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~ 1043 (1137)
+.++++||+.+............ .........++..|+|||++.+. ...++.++|||||||++|+|++|..
T Consensus 138 ----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~~l~el~~g~~ 208 (328)
T cd08226 138 ----GLVSLSGLSHLYSLVRNGQKAKV---VYDFPQFSTSVLPWLSPELLRQD--LYGYNVKSDIYSVGITACELATGRV 208 (328)
T ss_pred ----CcEEEechHHHhhhhccCccccc---cccccccccCccCccChhhhcCC--CCCCCchhhHHHHHHHHHHHHhCCC
Confidence 78999999865432211100000 00011122356679999998752 2357899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHh-------hhccc--------cccccc-----ccCCCCCCchhhhhhHHHHHHH
Q 001152 1044 PYMGLSELEIHDLIQMGKRPRLTDELE-------ALGSC--------HEHEVA-----QSGSGFEKPEAELETLSFLVDV 1103 (1137)
Q Consensus 1044 Pf~~~~~~el~~~I~~g~~p~l~~~l~-------~~~~~--------~~~~~~-----~~~~~~~~~~~~~~~~~~L~dL 1103 (1137)
||......+........... .+.... ..... .+.... ...............++.+.+|
T Consensus 209 p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 287 (328)
T cd08226 209 PFQDMLRTQMLLQKLKGPPY-SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNL 287 (328)
T ss_pred CCCCcChHHHHHHHhcCCCC-CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHH
Confidence 99876554433333222111 000000 00000 000000 0000000111123567789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1104 FRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1104 l~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+.+||+.||++|||++|+++|+|+..
T Consensus 288 i~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 288 VELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred HHHHccCCcccCCCHHHHhhCHHHHH
Confidence 99999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=316.08 Aligned_cols=287 Identities=17% Similarity=0.223 Sum_probs=203.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|.+.+.||+|+||+||+|.+. +..+|+|..... ......... +.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA--FDNRIDAKR----TLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccc--ccccchhHH----HHHHHHHHHhcCCCCccchHHheecccc
Confidence 46899999999999999999974 467888864322 111122222 3679999999999999999998765321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
......++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++++||||||+||+++.
T Consensus 79 ---------~~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~ 143 (337)
T cd07858 79 ---------EAFNDVYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA 143 (337)
T ss_pred ---------cccCcEEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 01125799999996 789888865 246999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++........ ......++..|+|||.+.. ...++.++|||||||++|+|+
T Consensus 144 ~-------~~~kL~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~ 203 (337)
T cd07858 144 N-------CDLKICDFGLARTTSEKGD----------FMTEYVVTRWYRAPELLLN---CSEYTTAIDVWSVGCIFAELL 203 (337)
T ss_pred C-------CCEEECcCccccccCCCcc----------cccccccccCccChHHHhc---CCCCCCcccHHHHHHHHHHHH
Confidence 7 7899999999875533211 0112357889999999864 134789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccc-ccccC--CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||.+.+.......+........+..+.......... ..... ............++++.+++.+||+.||++||
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 283 (337)
T cd07858 204 GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283 (337)
T ss_pred cCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc
Confidence 9999998766554444442221111111111000000000 00000 00000111124567799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|++|+++|+|+..
T Consensus 284 s~~ell~h~~~~~ 296 (337)
T cd07858 284 TVEEALAHPYLAS 296 (337)
T ss_pred CHHHHHcCcchhh
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=297.08 Aligned_cols=256 Identities=32% Similarity=0.492 Sum_probs=199.4
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|++|.||+|.+. +..+++|+...... .....+. +.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~----~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEA----LEREIRILSSLQHPNIVRYYGSERDEE-- 72 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHH----HHHHHHHHHHcCCCCEeeEEEEEecCC--
Confidence 4788899999999999999986 56788887543322 1233333 488999999999999999999988651
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.|++||||+|+||+++.+
T Consensus 73 ----------~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~ 137 (260)
T cd06606 73 ----------KNTLNIFLEYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137 (260)
T ss_pred ----------CCeEEEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 01679999999999999999762 278999999999999999999999999999999999999986
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+......... .......++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 138 -------~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~y~~pE~~~~----~~~~~~~Dv~slG~il~~l~~ 198 (260)
T cd06606 138 -------GVVKLADFGCAKRLGDIETG--------EGTGSVRGTPYWMAPEVIRG----EEYGRAADIWSLGCTVIEMAT 198 (260)
T ss_pred -------CCEEEcccccEEeccccccc--------ccccCCCCCccccCHhhhcC----CCCCchhhHHHHHHHHHHHHh
Confidence 78999999988765543210 00113458889999999875 347899999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHHc-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1041 LQVPYMGLS-ELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1041 G~~Pf~~~~-~~el~~~I~~-g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
|..||.... .......+.. ...+.++ ...++.+.+++.+||+.||++||++
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~~i~~~l~~~p~~Rp~~ 251 (260)
T cd06606 199 GKPPWSELGNPMAALYKIGSSGEPPEIP---------------------------EHLSEEAKDFLRKCLRRDPKKRPTA 251 (260)
T ss_pred CCCCCCCCCchHHHHHhccccCCCcCCC---------------------------cccCHHHHHHHHHhCcCChhhCCCH
Confidence 999998754 2222222211 1111111 1234569999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
.+++.|+|+
T Consensus 252 ~~ll~~~~~ 260 (260)
T cd06606 252 DELLQHPFL 260 (260)
T ss_pred HHHhhCCCC
Confidence 999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=315.57 Aligned_cols=300 Identities=17% Similarity=0.188 Sum_probs=205.0
Q ss_pred CCCce-EeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHH------HHhHHhHHHHHHHHHhCCCCCcceee
Q 001152 801 FPSLS-SCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEI------RNFEYSCLGEVRMLGALRHSCIVEMY 871 (1137)
Q Consensus 801 ~~~y~-l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~------e~~~~~~lrEi~iL~~L~HpNIVkll 871 (1137)
..+|. +.+.||+|+||+||+|.+. +..+|+|+............. ..+...+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34564 4577999999999999874 577888875433221100000 01112357899999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLK 951 (1137)
+++...+ ..++||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.||+||||+
T Consensus 87 ~~~~~~~--------------~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~ 146 (335)
T PTZ00024 87 DVYVEGD--------------FINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLS 146 (335)
T ss_pred EEEecCC--------------cEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 9988665 5699999997 799998865 3468999999999999999999999999999999
Q ss_pred CCCeEeccccccCCCCCeEEEeecCcccccccccccccccc----CCCCCCCcccCCCcccchhhhccccCCCCCCchhh
Q 001152 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH----RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1027 (1137)
Q Consensus 952 P~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~----~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1027 (1137)
|+||+++.+ +.++|+|||++.............. ..........+++.|+|||++.+ ...++.++|
T Consensus 147 ~~nill~~~-------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~D 216 (335)
T PTZ00024 147 PANIFINSK-------GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG---AEKYHFAVD 216 (335)
T ss_pred HHHeEECCC-------CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc---CCCCCcHHH
Confidence 999999877 7899999999876542110000000 00011112346889999999865 235689999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001152 1028 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1107 (1137)
Q Consensus 1028 VWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~C 1107 (1137)
||||||++|+|++|+.||.+.+..+....+...........++..........................++.+.+++.+|
T Consensus 217 v~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 296 (335)
T PTZ00024 217 MWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSL 296 (335)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHH
Confidence 99999999999999999988777665555432111111100000000000000000000000011123456789999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhcC
Q 001152 1108 TEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1108 L~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
|+.+|++||+++|++.|+|+...
T Consensus 297 l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 297 LKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred cCCCchhccCHHHHhcCcccCCC
Confidence 99999999999999999999854
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=315.63 Aligned_cols=284 Identities=19% Similarity=0.235 Sum_probs=202.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||+|.+. +..+|+|+... ........+ .+.+|+.++++++||||+++++++.....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~----~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAK----RTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecC--cchhhHHHH----HHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 67999999999999999999874 46677776432 111111222 34789999999999999999998865432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ......++|++++ +++|.++++. ..+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 91 ~--------~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 91 L--------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 155 (345)
T ss_pred c--------cccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC
Confidence 1 0112468899987 7899888764 35899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++....... ....++..|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 156 ~-------~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~ 212 (345)
T cd07877 156 D-------CELKILDFGLARHTDDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 212 (345)
T ss_pred C-------CCEEEecccccccccccc-------------cccccCCCccCHHHHhC---ccCCCchhhHHHHHHHHHHHH
Confidence 7 789999999886533211 12357889999999864 235778999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||...........+........+................ ........+.....++.+.+++.+||+.||.+||
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 292 (345)
T cd07877 213 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 292 (345)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC
Confidence 9999998766655554443322211111111111000000000 0000001111113456789999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
++.+++.|+|+..
T Consensus 293 t~~e~l~h~~f~~ 305 (345)
T cd07877 293 TAAQALAHAYFAQ 305 (345)
T ss_pred CHHHHhcChhhhh
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=314.17 Aligned_cols=285 Identities=20% Similarity=0.235 Sum_probs=204.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|.+. +..||+|+..... .... ...++.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSEL----FAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchH----HHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 56999999999999999999874 4678888753221 1111 12234789999999999999999999875431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ......++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.
T Consensus 89 ~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~ 153 (343)
T cd07880 89 L--------DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE 153 (343)
T ss_pred c--------cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 1 1122569999999 6899988754 36899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||++....... ....+++.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 154 ~-------~~~kl~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~ll~~l~ 210 (343)
T cd07880 154 D-------CELKILDFGLARQTDSEM-------------TGYVVTRWYRAPEVILN---WMHYTQTVDIWSVGCIMAEML 210 (343)
T ss_pred C-------CCEEEeecccccccccCc-------------cccccCCcccCHHHHhC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 789999999886543211 12357889999999864 234789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCC---chhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK---PEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|..||...........+................................ .......++.+.+++.+||+.||.+||
T Consensus 211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 290 (343)
T cd07880 211 TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI 290 (343)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC
Confidence 99999987665554444433222111111111000000000000000000 011124566799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|+.++++|+|+...
T Consensus 291 t~~~~l~~~~~~~~ 304 (343)
T cd07880 291 TAAEALAHPYFEEF 304 (343)
T ss_pred CHHHHhcCccHhhh
Confidence 99999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.12 Aligned_cols=263 Identities=22% Similarity=0.388 Sum_probs=209.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecC
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 877 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~ 877 (1137)
.++++.++...||.|+.|.||++++..+...++|+....+.. .++.++ ++..+.++.+.+ +|+||+.+|||..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kR----ILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKR----ILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHH----HHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 456677788899999999999999987555555544444332 344444 488888887776 99999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeE
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENIL 956 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NIL 956 (1137)
. .+++.||.|. .-++.++++. ..++++..+=++...+++||.||-+ +||+|||+||+|||
T Consensus 164 ~--------------dV~IcMelMs-~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNIL 224 (391)
T KOG0983|consen 164 T--------------DVFICMELMS-TCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL 224 (391)
T ss_pred c--------------hHHHHHHHHH-HHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceE
Confidence 5 4589999984 5666666552 3569999999999999999999996 59999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
+|+. |++||||||++..+.+.. ++...+|-+.|||||.+.-. ....|+-++||||||+.++
T Consensus 225 lDe~-------GniKlCDFGIsGrlvdSk-----------AhtrsAGC~~YMaPERidp~-~~~kYDiRaDVWSlGITlv 285 (391)
T KOG0983|consen 225 LDER-------GNIKLCDFGISGRLVDSK-----------AHTRSAGCAAYMAPERIDPP-DKPKYDIRADVWSLGITLV 285 (391)
T ss_pred EccC-------CCEEeecccccceeeccc-----------ccccccCCccccCccccCCC-CCCccchhhhhhhhccchh
Confidence 9988 899999999997765532 22345789999999998743 2467899999999999999
Q ss_pred HHHhCCCCCCC-CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLTG~~Pf~~-~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
||.||+.||.+ ....++...|....+|.++... ..++.+.+++..||+.|+.+|
T Consensus 286 eLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~-------------------------gFSp~F~~fv~~CL~kd~r~R 340 (391)
T KOG0983|consen 286 ELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM-------------------------GFSPDFQSFVKDCLTKDHRKR 340 (391)
T ss_pred hhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc-------------------------CcCHHHHHHHHHHhhcCcccC
Confidence 99999999987 4567778888776655554321 234569999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001152 1116 PTAGDLYEMFVART 1129 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~ 1129 (1137)
|...++++|+|.+.
T Consensus 341 P~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 341 PKYNKLLEHPFIKR 354 (391)
T ss_pred cchHHHhcCcceee
Confidence 99999999998764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=315.84 Aligned_cols=297 Identities=22% Similarity=0.251 Sum_probs=203.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||.|+||.||+|... +..+|+|....... ...+. +.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~----~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKH----ALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHH----HHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 57999999999999999999985 45677776433321 22222 3779999999999999999988765321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
....+-.........++||||++ ++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~ 149 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT 149 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC
Confidence 00000000111235799999997 689887754 35899999999999999999999999999999999999975
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
++ ..+||+|||.+.......... .......++..|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 150 ~~------~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 150 ED------LVLKIGDFGLARIVDPHYSHK-------GYLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred CC------ceEEECCcccceecCCccccc-------cccccccccccccCHHHHhC---ccccCchhhHHHHHHHHHHHH
Confidence 42 578999999987543221110 01112357889999998754 245788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCC--CCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS--GFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
+|+.||......+....+............................ ...........+.++.+++.+||+.||.+|||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 214 TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence 9999998877666555543332211111111000000000000000 00001111245567999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001152 1118 AGDLYEMFVART 1129 (1137)
Q Consensus 1118 a~EVL~~L~~~~ 1129 (1137)
+.|++.|+|+..
T Consensus 294 ~~ell~h~~~~~ 305 (342)
T cd07854 294 AEEALMHPYMSC 305 (342)
T ss_pred HHHHhCCCcccc
Confidence 999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=304.64 Aligned_cols=274 Identities=23% Similarity=0.344 Sum_probs=195.1
Q ss_pred CCceEeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..|++.+.||+|+||.||+|.+. +..+|+|+..... .. ...+. +.+|+.+++.+.||||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~--~~-~~~~~----~~~ei~~l~~l~~~~i~~~~~~~~ 76 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--EE-QHRSD----FEREIEILRTLDHENIVKYKGVCE 76 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEecccc--ch-HHHHH----HHHHHHHHHhCCCCChheEEeeee
Confidence 45778899999999999999864 3568888754222 11 12233 488999999999999999999887
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
.... ...++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 77 ~~~~------------~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 140 (284)
T cd05038 77 KPGG------------RSLRLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNI 140 (284)
T ss_pred cCCC------------CceEEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhE
Confidence 5321 1569999999999999999762 23589999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
+++.+ +.++|+|||.+.......... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 141 l~~~~-------~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di~slG~~l 202 (284)
T cd05038 141 LVESE-------DLVKISDFGLAKVLPEDKDYY-------YVKEPGESPIFWYAPECLRT----SKFSSASDVWSFGVTL 202 (284)
T ss_pred EEcCC-------CCEEEcccccccccccCCcce-------eccCCCCCcccccCcHHHcc----CCCCcccchHHHhhhh
Confidence 99877 789999999987654221110 00011234567999999865 4678899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|||++|..|+...........-............... ........ ...++.++.+++.+||+.+|.+|
T Consensus 203 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05038 203 YELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL---------KEGERLPR---PPSCPDEVYDLMKLCWEAEPQDR 270 (284)
T ss_pred heeeccCCCcccccchhccccccccccccHHHHHHHH---------HcCCcCCC---CccCCHHHHHHHHHHhccChhhC
Confidence 9999999998653221110000000000000000000 00000000 11345679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001152 1116 PTAGDLYEMFVAR 1128 (1137)
Q Consensus 1116 PSa~EVL~~L~~~ 1128 (1137)
||+.||++.+...
T Consensus 271 pt~~ei~~~l~~i 283 (284)
T cd05038 271 PSFADLILIVDRL 283 (284)
T ss_pred CCHHHHHHHHhhc
Confidence 9999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=302.61 Aligned_cols=282 Identities=22% Similarity=0.211 Sum_probs=200.8
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeeEecCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKISSK 878 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L---~HpNIVkllg~~~~~~ 878 (1137)
|++.+.||+|+||.||+|++. +..+|+|+........ .... .+.+|+.+++++ .||||+++++++...+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~----~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE--GIPL----STLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc--hhhh----hHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678899999999999999985 5778888865433211 1111 225677777665 5999999999988654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.. .....+++|||++ ++|.+++... ....+++..+..++.||+.||+|||+.+|+|+||+|+||+++
T Consensus 75 ~~---------~~~~~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~ 141 (287)
T cd07838 75 TD---------RELKLTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141 (287)
T ss_pred CC---------CCceeEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc
Confidence 20 1224799999997 6899988752 223589999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||.+........ .....++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 142 ~~-------~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~----~~~~~~~Di~s~G~~l~~l 199 (287)
T cd07838 142 SD-------GQVKIADFGLARIYSFEMA-----------LTSVVVTLWYRAPEVLLQ----SSYATPVDMWSVGCIFAEL 199 (287)
T ss_pred cC-------CCEEEeccCcceeccCCcc-----------cccccccccccChHHhcc----CCCCCcchhhhHHHHHHHH
Confidence 87 7899999998876543211 112347889999999875 4578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||......+....+...........+.... ......................++.+.+++.+||+.||.+||++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~ 278 (287)
T cd07838 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV-SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278 (287)
T ss_pred HhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH
Confidence 99999998877766655553211111000000000 00000000000011111122456778999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
.+++.|+|+
T Consensus 279 ~~il~~~~~ 287 (287)
T cd07838 279 FEALQHPYF 287 (287)
T ss_pred HHHhcCcCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=315.80 Aligned_cols=284 Identities=20% Similarity=0.216 Sum_probs=202.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|.+.+.||+|+||.||+|.+. +..+|+|+...... ... +...+.+|+.+++.++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEI----FAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--ccc----chhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 57899999999999999999974 57788887532211 111 11234789999999999999999999875431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ......++||||+. .+|..++. ..+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 89 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~ 152 (342)
T cd07879 89 G--------DEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE 152 (342)
T ss_pred C--------CCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 1 11235799999996 57766542 25899999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++...... ....+++.|+|||++.+ ...++.++|||||||++|||+
T Consensus 153 ~-------~~~kL~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 153 D-------CELKILDFGLARHADAEM-------------TGYVVTRWYRAPEVILN---WMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred C-------CCEEEeeCCCCcCCCCCC-------------CCceeeecccChhhhcC---ccccCchHHHHHHHHHHHHHH
Confidence 7 789999999886532211 12357889999999864 235789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCc---hhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP---EAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||.+.+.......+........+........................ ......++.+.+++.+||+.||.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 999999987766555555432222211111111000000000000000000 00113456789999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
++++++.|+|+..-
T Consensus 290 ~~~e~l~h~~f~~~ 303 (342)
T cd07879 290 TATEALEHPYFDSF 303 (342)
T ss_pred CHHHHhcCcchhhc
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=304.78 Aligned_cols=263 Identities=24% Similarity=0.305 Sum_probs=203.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~ 878 (1137)
.+|.+.+.||+|+||.||+|... +..+++|+........ .... ..+.+|+.+++++. ||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKV----KYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc-hHHH----HHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 36899999999999999999984 5778888864322111 1112 23478999999999 999999999887655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++.+ ...+++..+..|+.||+.||.|||+.|++|+||+|+||+++
T Consensus 76 --------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~ 136 (280)
T cd05581 76 --------------NLYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136 (280)
T ss_pred --------------eEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 56999999999999999976 23699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccc----------cccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCC----------IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~----------~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1028 (1137)
.+ +.++|+|||++........... .............++..|+|||++.+ ..++.++||
T Consensus 137 ~~-------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Di 205 (280)
T cd05581 137 KD-------MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE----KPAGKSSDL 205 (280)
T ss_pred CC-------CCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC----CCCChhhhH
Confidence 77 7899999999876543221100 00000112234567889999999865 457899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001152 1029 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1108 (1137)
Q Consensus 1029 WSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL 1108 (1137)
||||++++++++|..||...........+..... .++. ..++.+.+++.+||
T Consensus 206 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~li~~~l 257 (280)
T cd05581 206 WALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY-SFPP---------------------------NFPPDAKDLIEKLL 257 (280)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC-CCCC---------------------------ccCHHHHHHHHHHh
Confidence 9999999999999999987765554444432111 0110 22455899999999
Q ss_pred ccCCCCCCCH----HHHHHHHHh
Q 001152 1109 EENPTERPTA----GDLYEMFVA 1127 (1137)
Q Consensus 1109 ~~DP~~RPSa----~EVL~~L~~ 1127 (1137)
+.+|.+||++ +++++|+|+
T Consensus 258 ~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 258 VLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cCCHhhCCCcccCHHHHhcCCCC
Confidence 9999999999 999999985
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=321.35 Aligned_cols=252 Identities=22% Similarity=0.386 Sum_probs=207.4
Q ss_pred eEeeeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 805 SSCDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 805 ~l~~~LG~GsfG~Vy~a~~~----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
++.+.||.|-||.||+|.+. +...||+|+.-+.... .+..+.| +.|..+|+.++|||||+++|.+.+.
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekf----lqEa~iMrnfdHphIikLIGv~~e~--- 463 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKF----LQEASIMRNFDHPHIIKLIGVCVEQ--- 463 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHH----HHHHHHHHhCCCcchhheeeeeecc---
Confidence 44577999999999999873 4556666654544333 3334555 9999999999999999999999864
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
-.|||||+++-|.|..|++. ....++......+++||..||+|||+.++|||||...|||+...
T Consensus 464 ------------P~WivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp 527 (974)
T KOG4257|consen 464 ------------PMWIVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP 527 (974)
T ss_pred ------------ceeEEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc
Confidence 35999999999999999986 24579999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
..|||+|||+++.+...... .+. ...-...|||||.+.. ..++.++|||.|||.+||++.
T Consensus 528 -------~CVKLaDFGLSR~~ed~~yY--kaS-------~~kLPIKWmaPESINf----RrFTtASDVWMFgVCmWEIl~ 587 (974)
T KOG4257|consen 528 -------QCVKLADFGLSRYLEDDAYY--KAS-------RGKLPIKWMAPESINF----RRFTTASDVWMFGVCMWEILS 587 (974)
T ss_pred -------ceeeecccchhhhccccchh--hcc-------ccccceeecCccccch----hcccchhhHHHHHHHHHHHHH
Confidence 68999999999987764422 111 1123457999999865 678999999999999999886
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|..||.+....++...+..|.+++.+. .|++.+..|+.+||.+||.+||.+.
T Consensus 588 lGvkPfqgvkNsDVI~~iEnGeRlP~P~---------------------------nCPp~LYslmskcWayeP~kRPrft 640 (974)
T KOG4257|consen 588 LGVKPFQGVKNSDVIGHIENGERLPCPP---------------------------NCPPALYSLMSKCWAYEPSKRPRFT 640 (974)
T ss_pred hcCCccccccccceEEEecCCCCCCCCC---------------------------CCChHHHHHHHHHhccCcccCCcHH
Confidence 899999988888888888887665443 6777899999999999999999999
Q ss_pred HHHHHHHh
Q 001152 1120 DLYEMFVA 1127 (1137)
Q Consensus 1120 EVL~~L~~ 1127 (1137)
|+...+..
T Consensus 641 ei~~~lsd 648 (974)
T KOG4257|consen 641 EIKAILSD 648 (974)
T ss_pred HHHHHHHH
Confidence 98776544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.19 Aligned_cols=261 Identities=25% Similarity=0.314 Sum_probs=213.9
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeee
Q 001152 796 LDPGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 872 (1137)
Q Consensus 796 ~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg 872 (1137)
.+.....+|.+..+||+|+||.|.+|..++ ..+||||.+.++... .++.+-- +.|-++|.... -|.++++..
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ-dDDvect----m~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ-DDDVECT----MVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeee-cCcccce----ehhhhheecCCCCchHHHHHH
Confidence 445667889999999999999999999866 568899866555433 2233322 55778887664 789999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
+|..-+ .+|+||||+.||+|..+|++. ..+.+..+..++..||-||-|||++|||+||||.
T Consensus 418 cFQTmD--------------RLyFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKL 478 (683)
T KOG0696|consen 418 CFQTMD--------------RLYFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKL 478 (683)
T ss_pred Hhhhhh--------------heeeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccc
Confidence 998766 679999999999999999873 4688999999999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
+|||++.+ |++||+|||+++.......+ ..++.|||.|+|||++.- ++|+..+|+||||
T Consensus 479 DNvmLd~e-------GHiKi~DFGmcKEni~~~~T----------TkTFCGTPdYiAPEIi~Y----qPYgksvDWWa~G 537 (683)
T KOG0696|consen 479 DNVMLDSE-------GHIKIADFGMCKENIFDGVT----------TKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFG 537 (683)
T ss_pred cceEeccC-------CceEeeecccccccccCCcc----------eeeecCCCcccccceEEe----cccccchhHHHHH
Confidence 99999988 89999999999754332222 236789999999999975 7899999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
|+||||+.|++||.+.+..++++.|..... .++. ..+.+..+++...|...|
T Consensus 538 VLLyEmlaGQpPFdGeDE~elF~aI~ehnv-syPK---------------------------slSkEAv~ickg~ltK~P 589 (683)
T KOG0696|consen 538 VLLYEMLAGQPPFDGEDEDELFQAIMEHNV-SYPK---------------------------SLSKEAVAICKGLLTKHP 589 (683)
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHccC-cCcc---------------------------cccHHHHHHHHHHhhcCC
Confidence 999999999999999999999999854332 1111 344568889999999999
Q ss_pred CCCCC-----HHHHHHHHHhhc
Q 001152 1113 TERPT-----AGDLYEMFVART 1129 (1137)
Q Consensus 1113 ~~RPS-----a~EVL~~L~~~~ 1129 (1137)
.+|.. -.+|-+|++|+.
T Consensus 590 ~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 590 GKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred ccccCCCCccccchhhCcchhh
Confidence 99963 367888888864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=299.36 Aligned_cols=269 Identities=24% Similarity=0.336 Sum_probs=208.4
Q ss_pred ceEe-eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCC
Q 001152 804 LSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 879 (1137)
Q Consensus 804 y~l~-~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~ 879 (1137)
|++. +.||+|+|+.|--+.. .+..+|||| +++.. .. .+.++.||++++.+++ |+||++++++|+++.
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKi--idKq~--gH----sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~- 149 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKI--IDKQP--GH----SRSRVFREVETFYQCQGHKNILQLIEFFEDDT- 149 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhh--hhcCC--ch----HHHHHHHHHHHHHHhcCCccHHHHHHHhcccc-
Confidence 4443 6799999999988765 678899998 44431 11 1234589999999997 999999999999887
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..|||||-|.||+|..+|++ ...|++.++.+++++|+.||.|||.+||.||||||+|||-..
T Consensus 150 -------------~FYLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 150 -------------RFYLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCES 211 (463)
T ss_pred -------------eEEEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecC
Confidence 55999999999999999987 357999999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ .-.-||||||.+..-+......... ..+...+-+|+..|||||+..-.. ....|+++.|.||||||+|-|
T Consensus 212 pn----~vsPvKiCDfDLgSg~k~~~~~spa---stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYIm 284 (463)
T KOG0607|consen 212 PN----KVSPVKICDFDLGSGIKLNNDCSPA---STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIM 284 (463)
T ss_pred CC----CcCceeeeccccccccccCCCCCCC---CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHH
Confidence 52 2245999999887543322111111 111122447899999999864321 235789999999999999999
Q ss_pred HhCCCCCCCCC---------------HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 001152 1039 LTLQVPYMGLS---------------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1103 (1137)
Q Consensus 1039 LTG~~Pf~~~~---------------~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1103 (1137)
|.|.+||.+.- ...++..|+.|.......++. .++.+.+++
T Consensus 285 LsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWa------------------------hIS~eakdl 340 (463)
T KOG0607|consen 285 LSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWA------------------------HISSEAKDL 340 (463)
T ss_pred HhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhH------------------------HhhHHHHHH
Confidence 99999997632 234667777776533332222 567789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1104 FRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1104 l~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+...|..|+.+|.++.++++|||+...
T Consensus 341 isnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 341 ISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHhccHHhhhhhhhccCCcccccc
Confidence 999999999999999999999999753
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=307.89 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=198.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEe
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 875 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~ 875 (1137)
..+.+|++.+.||+|+||.||+|.+. +..+|+|+..... . ...... +.+|+.++.+.. ||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~-~~~~~~----~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--N-KEENKR----ILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--C-hHHHHH----HHHHHHHHHhccCCCchHhhheeee
Confidence 45678999999999999999999996 6778888754321 1 112222 256777776775 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCC
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSEN 954 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~N 954 (1137)
+.. ..++||||++ ++|.+++... ...+++..+..++.||+.||+|||+ .||+||||+|+|
T Consensus 85 ~~~--------------~~~~v~e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~n 145 (296)
T cd06618 85 TDS--------------DVFICMELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSN 145 (296)
T ss_pred cCC--------------eEEEEeeccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHH
Confidence 765 5699999985 6888877552 2368999999999999999999997 599999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
|+++.+ +.+||+|||++........ .....++..|+|||++.+......++.++||||||++
T Consensus 146 ill~~~-------~~~kL~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 207 (296)
T cd06618 146 ILLDAS-------GNVKLCDFGISGRLVDSKA-----------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGIS 207 (296)
T ss_pred EEEcCC-------CCEEECccccchhccCCCc-----------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHH
Confidence 999877 7899999998865432211 1122477899999998753222457889999999999
Q ss_pred HHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~-~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|+|++|+.||..... .+....+.....+..+.. ...++++.+++.+||+.||.
T Consensus 208 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~~l~~~p~ 262 (296)
T cd06618 208 LVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN-------------------------EGFSPDFCSFVDLCLTKDHR 262 (296)
T ss_pred HHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC-------------------------CCCCHHHHHHHHHHccCChh
Confidence 9999999999975322 233333332221111100 02345699999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001152 1114 ERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~ 1130 (1137)
+||+++++++|+|+...
T Consensus 263 ~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 263 KRPKYRELLQHPFIRRY 279 (296)
T ss_pred hCCCHHHHhcChhhhcc
Confidence 99999999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=304.10 Aligned_cols=278 Identities=22% Similarity=0.274 Sum_probs=201.0
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|++.+.||+|++|.||+|... +..+++|........ ... ...+.+|+.++++++||||+++++++....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES--EGI----PKTALREIKLLKELNHPNIIKLLDVFRHKG--- 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc--chh----HHHHHHHHHHHHHhcCCCcchHHHhhccCC---
Confidence 567789999999999999984 466777764332211 111 223478999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
..++||||++ ++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||+++.+
T Consensus 72 -----------~~~~v~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~- 134 (283)
T cd05118 72 -----------DLYLVFEFMD-TDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE- 134 (283)
T ss_pred -----------CEEEEEeccC-CCHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-
Confidence 5699999997 5898888651 2468999999999999999999999999999999999999977
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.++|+|||.+......... .....++..|+|||.+.+ ...++.++||||||+++|+|++|
T Consensus 135 ------~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~slG~~l~~l~tg 195 (283)
T cd05118 135 ------GVLKLADFGLARSFGSPVRP----------YTHYVVTRWYRAPELLLG---DKGYSTPVDIWSVGCIFAELLSR 195 (283)
T ss_pred ------CcEEEeeeeeeEecCCCccc----------ccCccCcccccCcHHHhc---CCCCCchhHHHHHHHHHHHHHhC
Confidence 78999999988655432200 112357789999999875 23678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcc---cccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGS---CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+.||...+..+....+........+..+..... ....... ..............+.++.+++.+||+.||.+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 274 (283)
T cd05118 196 RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP-KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA 274 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc-cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH
Confidence 999988776655544422211111111111000 0000000 000001111122467789999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
.+++.|+|+
T Consensus 275 ~~ll~~~~~ 283 (283)
T cd05118 275 EQALAHPYF 283 (283)
T ss_pred HHHhhCCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=305.41 Aligned_cols=251 Identities=21% Similarity=0.258 Sum_probs=187.4
Q ss_pred eecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCC
Q 001152 809 EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGN 886 (1137)
Q Consensus 809 ~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~ 886 (1137)
.||+|+||.||+|.+. +..+|+|+...+.......+. .+ ......+.+++...||||+++++++...+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-------- 70 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-LA-LNERIMLSLVSTGDCPFIVCMSYAFHTPD-------- 70 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHH-HH-HHHHHHHHHHHhCCCCcEeeeeeeeecCC--------
Confidence 4899999999999874 467899875433221111111 11 00122344555668999999999988765
Q ss_pred CccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCC
Q 001152 887 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 966 (1137)
Q Consensus 887 ~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~ 966 (1137)
..++||||++|++|..++.. ...+++..+..|+.|++.||+|||+.+|+||||||+||+++.+
T Consensus 71 ------~~~~v~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~------ 133 (278)
T cd05606 71 ------KLSFILDLMNGGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH------ 133 (278)
T ss_pred ------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC------
Confidence 66999999999999998865 2469999999999999999999999999999999999999877
Q ss_pred CCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001152 967 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1046 (1137)
Q Consensus 967 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~ 1046 (1137)
+.+||+|||++....... .....|+..|+|||++.+ ...++.++||||+||++|+|++|..||.
T Consensus 134 -~~~kl~dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 134 -GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred -CCEEEccCcCccccCccC------------CcCcCCCcCCcCcHHhcC---CCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 679999999886543211 112368999999999864 2357899999999999999999999997
Q ss_pred CCCH---HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----CH
Q 001152 1047 GLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----TA 1118 (1137)
Q Consensus 1047 ~~~~---~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-----Sa 1118 (1137)
.... ......+.. ..+.++ ...++++.+++.+||..+|.+|| ++
T Consensus 198 ~~~~~~~~~~~~~~~~-~~~~~~---------------------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~ 249 (278)
T cd05606 198 QHKTKDKHEIDRMTLT-MAVELP---------------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGA 249 (278)
T ss_pred CCCccchHHHHHHhhc-cCCCCC---------------------------CcCCHHHHHHHHHHhhcCHHhccCCCCCCH
Confidence 6522 211111111 111111 02345699999999999999999 99
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
.++++|+|++..
T Consensus 250 ~~ll~~~~~~~~ 261 (278)
T cd05606 250 QEVKEHPFFRSL 261 (278)
T ss_pred HHHHhCccccCC
Confidence 999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=306.13 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=197.2
Q ss_pred CceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEec
Q 001152 803 SLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 876 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~ 876 (1137)
.|++.+.||+|+||.||+|.. .+..+|+|+............ ...+.+|+.+++++. |+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKT----TEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchH----HHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 478999999999999999986 356788887543221111111 123477999999995 9999999998876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
+. ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++||||+|+|||
T Consensus 77 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 77 DT--------------KLHLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred CC--------------eEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 54 56999999999999999876 245889999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++......... ......|+..|+|||.+.+ ....++.++||||||+++|
T Consensus 138 ~~~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~--~~~~~~~~~Dv~slG~~l~ 199 (290)
T cd05613 138 LDSN-------GHVVLTDFGLSKEFHEDEVE---------RAYSFCGTIEYMAPDIVRG--GDGGHDKAVDWWSMGVLMY 199 (290)
T ss_pred ECCC-------CCEEEeeCccceeccccccc---------ccccccCCcccCChhhccC--CCCCCCccccHHHHHHHHH
Confidence 9877 78999999988754321110 1113458889999999864 2235678999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1037 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~----~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
+|++|..||..... ..+...+..... .++ ...++.+.+++.+||+.||
T Consensus 200 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~ll~~~l~~~p 251 (290)
T cd05613 200 ELLTGASPFTVDGEKNSQAEISRRILKSEP-PYP---------------------------QEMSALAKDIIQRLLMKDP 251 (290)
T ss_pred HHhcCCCCCCcCCccccHHHHHHHhhccCC-CCC---------------------------ccCCHHHHHHHHHHhcCCH
Confidence 99999999964322 222222221111 111 0234558999999999999
Q ss_pred CCCC-----CHHHHHHHHHhhcCC
Q 001152 1113 TERP-----TAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1113 ~~RP-----Sa~EVL~~L~~~~~s 1131 (1137)
++|| ++++++.|+|+....
T Consensus 252 ~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 252 KKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHhcCCCCCCHHHHHcCcccccCC
Confidence 9997 899999999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=346.77 Aligned_cols=266 Identities=23% Similarity=0.280 Sum_probs=213.3
Q ss_pred CCCceEeeeecccCceEEEEEEECC--ccEEEEEEec-ccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTL-KVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l-~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
-.+|.+.++||+|+||.|.+++..+ .-+|+|+... ++.. ..+. +.|..|-.+|.....+-||.++-.|.++
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK--r~~t----A~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK--RAET----ACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh--chhH----HHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 3578999999999999999999865 5567776321 1110 1111 1246688899999999999999888887
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ++|+|||||+||+|..++.++ .++++..++.++..|+.||.-||+.|+|||||||+|||+
T Consensus 148 ~--------------~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 148 R--------------YLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL 208 (1317)
T ss_pred c--------------ceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe
Confidence 7 679999999999999999873 269999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC-CCCCchhhHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~s~ksDVWSLGviL~ 1036 (1137)
|.. |++||+|||.|..+..... ......+|||.|.+||+++....+ +.|++.+|+||+||++|
T Consensus 209 d~~-------GHikLADFGsClkm~~dG~---------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~Y 272 (1317)
T KOG0612|consen 209 DKS-------GHIKLADFGSCLKMDADGT---------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMY 272 (1317)
T ss_pred ccc-------CcEeeccchhHHhcCCCCc---------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHH
Confidence 988 9999999999877664322 222356899999999999876655 78999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
||+.|..||..++-.+.+..|..... .+.+| ....+++++++||.+.+ -+|+.|.
T Consensus 273 EMlyG~TPFYadslveTY~KIm~hk~-----------------------~l~FP-~~~~VSeeakdLI~~ll-~~~e~RL 327 (1317)
T KOG0612|consen 273 EMLYGETPFYADSLVETYGKIMNHKE-----------------------SLSFP-DETDVSEEAKDLIEALL-CDREVRL 327 (1317)
T ss_pred HHHcCCCcchHHHHHHHHHHHhchhh-----------------------hcCCC-cccccCHHHHHHHHHHh-cChhhhc
Confidence 99999999999888888888754321 11122 11246778999998877 4777877
Q ss_pred C---HHHHHHHHHhhcCCC
Q 001152 1117 T---AGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1117 S---a~EVL~~L~~~~~ss 1132 (1137)
. ++++-.|+||..-.|
T Consensus 328 grngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 328 GRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ccccHHHHHhCccccCCCh
Confidence 6 999999999975433
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=313.89 Aligned_cols=290 Identities=19% Similarity=0.207 Sum_probs=208.8
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|++|.||+|++. +..+++|+.. ......... ..+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~--~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS--NVFDDLIDA----KRILREIKLLRHLRHENIIGLLDILRPPSP- 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeec--cccccchhh----hhHHHHHHHHHhcCCcchhhhhhhhcccCc-
Confidence 5889999999999999999985 4667777643 221111222 234789999999999999999999876431
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
......|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 74 --------~~~~~~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~ 139 (330)
T cd07834 74 --------EDFNDVYIVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN 139 (330)
T ss_pred --------ccccceEEEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 11225799999997 689888865 2379999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||++.......... .......+++.|+|||++.+. ..++.++||||||+++|+|++
T Consensus 140 -------~~~~L~dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~il~~l~~ 202 (330)
T cd07834 140 -------CDLKICDFGLARGVDPDEDEK-------GFLTEYVVTRWYRAPELLLSS---SRYTKAIDIWSVGCIFAELLT 202 (330)
T ss_pred -------CCEEEcccCceEeeccccccc-------ccccccccccCcCCceeeecc---cCCCcchhHHHHHHHHHHHHc
Confidence 789999999987654432100 011233578899999998762 267899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccc-cccccccCC--CCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHEVAQSGS--GFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|..||.+....+....+...........+....... ...+..... ...........+..+.+++.+||+.+|.+||+
T Consensus 203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 282 (330)
T cd07834 203 RKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282 (330)
T ss_pred CCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC
Confidence 999999888777666654432222111111000000 000000000 00001111235677999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001152 1118 AGDLYEMFVARTS 1130 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ 1130 (1137)
+++++.|+|+...
T Consensus 283 ~~~ll~~~~~~~~ 295 (330)
T cd07834 283 ADEALAHPYLAQL 295 (330)
T ss_pred HHHHHhCccHHhh
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=303.23 Aligned_cols=277 Identities=24% Similarity=0.267 Sum_probs=199.5
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~~ 880 (1137)
|++.+.||+|++|+||+|.+. +..+++|....+.. ..... ...+|+..+++++ ||||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~-----~~~~e~~~l~~~~~h~~i~~~~~~~~~~~-- 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEEC-----MNLREVKSLRKLNEHPNIVKLKEVFREND-- 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHH-----HHHHHHHHHHhccCCCCchhHHHHhhcCC--
Confidence 678899999999999999985 45677776432221 11111 1256899999999 999999999987654
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+ +++|.+++... ....+++..+..++.|++.||.|||++||+|+||+|+||+++.+
T Consensus 72 ------------~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 72 ------------ELYFVFEYM-EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135 (283)
T ss_pred ------------cEEEEEecC-CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence 569999999 78999988762 12468999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+........ .....++..|+|||++.. ...++.++||||||+++|+|++
T Consensus 136 -------~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~s~G~~l~el~~ 194 (283)
T cd07830 136 -------EVVKIADFGLAREIRSRPP-----------YTDYVSTRWYRAPEILLR---STSYSSPVDIWALGCIMAELYT 194 (283)
T ss_pred -------CCEEEeecccceeccCCCC-----------cCCCCCcccccCceeeec---CcCcCCccchhhHHHHHHHHHh
Confidence 7899999998875433211 113457889999998864 2457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhc---ccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALG---SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|+.||......+....+.....+.....+.... ......... .............+..+.+++.+||+.||++|||
T Consensus 195 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 273 (283)
T cd07830 195 LRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ-FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT 273 (283)
T ss_pred CCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccc-cccccHHHHcccCCHHHHHHHHHhcccCcccCCC
Confidence 999998776655554443322111111111000 000000000 0000000111123567999999999999999999
Q ss_pred HHHHHHHHHh
Q 001152 1118 AGDLYEMFVA 1127 (1137)
Q Consensus 1118 a~EVL~~L~~ 1127 (1137)
+.|++.|+|+
T Consensus 274 ~~ei~~~~~~ 283 (283)
T cd07830 274 ASQALQHPYF 283 (283)
T ss_pred HHHHhhCCCC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=310.46 Aligned_cols=288 Identities=19% Similarity=0.231 Sum_probs=201.5
Q ss_pred CceEeeeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 877 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~ 877 (1137)
+|++.+.||+|+||.||+|.+.. ..+|+|+.... ....... .++.+|+.+++++. ||||++++++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~----~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV--FSKKILA----KRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccc--cccchhH----HHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 48899999999999999999854 46788864322 1111112 23478999999995 99999999875432
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ......+++|||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~----------~~~~~~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili 138 (332)
T cd07857 75 P----------GNFNELYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138 (332)
T ss_pred c----------ccCCcEEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence 1 01125689999986 799998864 3468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||.++......... ........||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 139 ~~~-------~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~~ 202 (332)
T cd07857 139 NAD-------CELKICDFGLARGFSENPGEN------AGFMTEYVATRWYRAPEIMLS---FQSYTKAIDVWSVGCILAE 202 (332)
T ss_pred cCC-------CCEEeCcCCCceecccccccc------cccccCcccCccccCcHHHhC---CCCCCcHHHHHHHHHHHHH
Confidence 877 789999999997654322110 011123468999999998764 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|++|..||...+.......+...........+............. ..............+..+.+++.+||+.||.+
T Consensus 203 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 282 (332)
T cd07857 203 LLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTK 282 (332)
T ss_pred HHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCccc
Confidence 999999998877665555543322111111111110000000000 00000001111134567999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001152 1115 RPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~ 1128 (1137)
|||+.+++.|+|+.
T Consensus 283 R~t~~~ll~~~~~~ 296 (332)
T cd07857 283 RISVEEALEHPYLA 296 (332)
T ss_pred CCCHHHHhcChhhh
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=307.76 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=198.4
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|...++||+|+||+||+|++. +..+++|+...... ......+. +.+|+.+++.++||||+++++++.+..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 94 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQD----IIKEVKFLQQLKHPNTIEYKGCYLKEH--- 94 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHH----HHHHHHHHHhCCCCCCccEEEEEEeCC---
Confidence 566788999999999999974 46677776432221 12222233 378999999999999999999998765
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
..|+||||+. ++|.+++.. ....+++..+..++.||+.||+|||++||+||||+|+||+++.+
T Consensus 95 -----------~~~lv~e~~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~- 157 (313)
T cd06633 95 -----------TAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP- 157 (313)
T ss_pred -----------EEEEEEecCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-
Confidence 5699999996 688887754 12468999999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.+||+|||++..... .....|+..|+|||++... ....++.++|||||||++|+|++|
T Consensus 158 ------~~~kL~dfg~~~~~~~--------------~~~~~~~~~y~aPE~~~~~-~~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 158 ------GQVKLADFGSASKSSP--------------ANSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred ------CCEEEeecCCCcccCC--------------CCCccccccccChhhcccc-CCCCCCchhhHHHHHHHHHHHHhC
Confidence 7799999998753211 1134588899999998532 124578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
..||...........+.....+.... ...+..+.+++.+||+.+|.+||++.++
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~P~~Rp~~~~~ 270 (313)
T cd06633 217 KPPLFNMNAMSALYHIAQNDSPTLQS--------------------------NEWTDSFRGFVDYCLQKIPQERPASAEL 270 (313)
T ss_pred CCCCCCCChHHHHHHHHhcCCCCCCc--------------------------cccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99998776655555544332221110 0223458999999999999999999999
Q ss_pred HHHHHhhcCC
Q 001152 1122 YEMFVARTSS 1131 (1137)
Q Consensus 1122 L~~L~~~~~s 1131 (1137)
+.|+|+....
T Consensus 271 l~~~~~~~~~ 280 (313)
T cd06633 271 LRHDFVRRDR 280 (313)
T ss_pred hcCcccCCCc
Confidence 9999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=322.46 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=208.7
Q ss_pred CCceEeeeecccCceEEEEEEEC---C--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG---S--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~---~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
....+.++||+|+||+|++|.|+ + -.||||+.+... ... ....| ++|+.+|.+|+|||+|++||...+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~--l~~-~mddf----lrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS--LNA-IMDDF----LREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc--cch-hHHHH----HHHHHHHHhccCcceeEEeeeecc
Confidence 34567789999999999999995 2 356777643332 221 33444 999999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
. ...+|||+++.|||.+++++ .....|-......++.|||.||.||..++.|||||-..|||
T Consensus 183 q---------------p~mMV~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNll 244 (1039)
T KOG0199|consen 183 Q---------------PAMMVFELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLL 244 (1039)
T ss_pred c---------------hhhHHhhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhe
Confidence 3 34799999999999999987 33457889999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
+... -.|||+|||+.+.+........+.. ...-.+.|+|||.+.. ..++.++|||+|||+||
T Consensus 245 lasp-------rtVKI~DFGLmRaLg~ned~Yvm~p-------~rkvPfAWCaPEsLrh----~kFShaSDvWmyGVTiW 306 (1039)
T KOG0199|consen 245 LASP-------RTVKICDFGLMRALGENEDMYVMAP-------QRKVPFAWCAPESLRH----RKFSHASDVWMYGVTIW 306 (1039)
T ss_pred eccc-------ceeeeecccceeccCCCCcceEecC-------CCcCcccccCHhHhcc----ccccccchhhhhhhhHH
Confidence 9866 6899999999998876543321111 1123458999999975 67899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
||+| |+.||-+....++.+.|..+.+..-+ ..|++++.+++.+||..+|++|
T Consensus 307 EMFtyGEePW~G~~g~qIL~~iD~~erLpRP---------------------------k~csedIY~imk~cWah~paDR 359 (1039)
T KOG0199|consen 307 EMFTYGEEPWVGCRGIQILKNIDAGERLPRP---------------------------KYCSEDIYQIMKNCWAHNPADR 359 (1039)
T ss_pred hhhccCCCCCCCCCHHHHHHhccccccCCCC---------------------------CCChHHHHHHHHHhccCCcccc
Confidence 9998 79999999999999888755432211 1577889999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001152 1116 PTAGDLYEMFVART 1129 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~ 1129 (1137)
|||..|.+.+....
T Consensus 360 ptFsair~~~~l~e 373 (1039)
T KOG0199|consen 360 PTFSAIREDLVLAE 373 (1039)
T ss_pred ccHHHHHHhHHHHh
Confidence 99999987665543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=316.05 Aligned_cols=257 Identities=24% Similarity=0.421 Sum_probs=211.2
Q ss_pred CceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
+.+..++||-|.||.||.+.|+.-...|+|+.++.. ..+.++| +.|+++|+.++|||+|+++|+|..+-
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEF----LkEAAvMKeikHpNLVqLLGVCT~Ep---- 336 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTHEP---- 336 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHH----HHHHHHHHhhcCccHHHHhhhhccCC----
Confidence 356779999999999999999875444444434432 4566676 99999999999999999999998765
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
-.|||+|||..|.|.+|++.+. +..++.-..+.|+.||+.|++||..+++|||||.+.|.|+.++
T Consensus 337 ----------PFYIiTEfM~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-- 401 (1157)
T KOG4278|consen 337 ----------PFYIITEFMCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-- 401 (1157)
T ss_pred ----------CeEEEEecccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc--
Confidence 3499999999999999999853 3457888889999999999999999999999999999999988
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-C
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-L 1041 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G 1041 (1137)
..||++|||+++.+.....+ ++-+ ..-...|.|||-+.. ..++.|+|||+|||+|||+.| |
T Consensus 402 -----hiVKvADFGLsRlMtgDTYT---AHAG------AKFPIKWTAPEsLAy----NtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 402 -----HIVKVADFGLSRLMTGDTYT---AHAG------AKFPIKWTAPESLAY----NTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred -----ceEEeeccchhhhhcCCcee---cccC------ccCcccccCcccccc----cccccchhhHHHHHHHHHHHhcC
Confidence 68999999999987664432 1211 112347999999864 578899999999999999998 8
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
..||.+.+..+++..+.++.+..-+ ..|++.+.+||+.||++.|.+||+++|+
T Consensus 464 MsPYPGidlSqVY~LLEkgyRM~~P---------------------------eGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 464 MSPYPGIDLSQVYGLLEKGYRMDGP---------------------------EGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCCCCccHHHHHHHHhccccccCC---------------------------CCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 8999999999999888776643221 1677889999999999999999999999
Q ss_pred HHHHHhhcC
Q 001152 1122 YEMFVARTS 1130 (1137)
Q Consensus 1122 L~~L~~~~~ 1130 (1137)
-+.++-.-+
T Consensus 517 HqafEtmf~ 525 (1157)
T KOG4278|consen 517 HQAFETMFS 525 (1157)
T ss_pred HHHHHHHhc
Confidence 888776533
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=306.87 Aligned_cols=293 Identities=20% Similarity=0.199 Sum_probs=202.9
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|.+. +..+|+|+......... . ...+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~--~----~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG--F----PITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC--c----hHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 4567999999999999999999984 46788887544322111 1 11236799999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
..... ........++||||++ +++...+.. ....+++..+..|+.||+.||+|||+.||+||||||+||++
T Consensus 79 ~~~~~----~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 149 (302)
T cd07864 79 QDALD----FKKDKGAFYLVFEYMD-HDLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL 149 (302)
T ss_pred chhhh----ccccCCcEEEEEcccC-ccHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 30000 0001126799999997 578777654 12468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||.+......... ......++..|+|||.+.+ ...++.++|||||||++|+
T Consensus 150 ~~~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~~~e 210 (302)
T cd07864 150 NNK-------GQIKLADFGLARLYNSEESR---------PYTNKVITLWYRPPELLLG---EERYGPAIDVWSCGCILGE 210 (302)
T ss_pred CCC-------CcEEeCcccccccccCCccc---------ccccceeccCccChHHhcC---CCCCCchhHHHHHHHHHHH
Confidence 877 78999999988755432210 0112246778999998864 2346789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhh---cccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL---GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|++|+.||...+..+....+........+..++.. ................. ......+..+.+++.+||+.||.+
T Consensus 211 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~ 289 (302)
T cd07864 211 LFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSK 289 (302)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhh
Confidence 99999999876666555554332211111111110 00000000000000000 001134667999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001152 1115 RPTAGDLYEMFVA 1127 (1137)
Q Consensus 1115 RPSa~EVL~~L~~ 1127 (1137)
||++.+++.|+|+
T Consensus 290 Rp~~~~il~~~~~ 302 (302)
T cd07864 290 RCTAEEALNSPWL 302 (302)
T ss_pred CCCHHHHhcCCCC
Confidence 9999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=315.03 Aligned_cols=286 Identities=20% Similarity=0.229 Sum_probs=206.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.++|++.+.||+|++|.||+|++. +..+|+|+.... .......+ .+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--FQSAIHAK----RTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc--cchhhHHH----HHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 457999999999999999999985 466888864322 11122222 2378999999999999999998876543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.. ......++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++
T Consensus 88 ~~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~ 152 (343)
T cd07851 88 SL--------EDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 152 (343)
T ss_pred cc--------cccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 10 1122579999998 5899998864 3699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.++|+|||++....... ....++..|+|||.+.+ ...++.++|||||||++|+|
T Consensus 153 ~~-------~~~kL~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGv~l~el 209 (343)
T cd07851 153 ED-------CELKILDFGLARHTDDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred CC-------CCEEEccccccccccccc-------------cCCcccccccCHHHHhC---CCCCCchHhHHHHHHHHHHH
Confidence 77 789999999987543211 12357889999999864 23578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCC---CCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF---EKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
++|+.||.+....+....+........+..................... .........++.+.+++.+||+.||.+|
T Consensus 210 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~R 289 (343)
T cd07851 210 LTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR 289 (343)
T ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhC
Confidence 9999999887766655555443322111111111000000000000000 0011112346779999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001152 1116 PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ 1130 (1137)
||+.||++|+|+...
T Consensus 290 pt~~ell~h~~~~~~ 304 (343)
T cd07851 290 ITAAEALAHPYLAEY 304 (343)
T ss_pred CCHHHHhcCCCcccc
Confidence 999999999999753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=298.93 Aligned_cols=261 Identities=24% Similarity=0.262 Sum_probs=204.1
Q ss_pred CCCceEe-eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEec
Q 001152 801 FPSLSSC-DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 876 (1137)
Q Consensus 801 ~~~y~l~-~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~ 876 (1137)
..+|++. ++||-|-.|.|..+..+ +...|+|+.. . ... +++|++.--... |||||.++++|..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--D-------s~K----ARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--D-------SPK----ARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--c-------CHH----HHhHhhhhhhhcCCCceEEeehhhhh
Confidence 3567665 78999999999988874 5678888731 1 111 267888765554 9999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.-. ....+.+|||.|+||.|...|++ .+...|+++++-.|++||..|++|||+.+|.||||||+|+|
T Consensus 127 s~~----------~rkcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLL 193 (400)
T KOG0604|consen 127 SYQ----------GRKCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLL 193 (400)
T ss_pred hcc----------CceeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhee
Confidence 321 12378999999999999999987 45677999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
.... ..+..+||+|||+|+....... ..+-.-||+|.|||++.. ..|+...|+||+||++|
T Consensus 194 yt~t----~~na~lKLtDfGFAK~t~~~~~-----------L~TPc~TPyYvaPevlg~----eKydkscdmwSlgVimY 254 (400)
T KOG0604|consen 194 YTTT----SPNAPLKLTDFGFAKETQEPGD-----------LMTPCFTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 254 (400)
T ss_pred eecC----CCCcceEecccccccccCCCcc-----------ccCCcccccccCHHHhCc----hhcCCCCCccchhHHHH
Confidence 9865 3347899999999986543211 113358999999999854 56999999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1037 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~----~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
-|+.|.+||..... ..+...|..+.......++. ..+++.+++|+.+|..+|
T Consensus 255 IlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs------------------------~VSe~aKdlIR~LLkt~P 310 (400)
T KOG0604|consen 255 ILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS------------------------CVSEAAKDLIRKLLKTEP 310 (400)
T ss_pred HhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh------------------------HHHHHHHHHHHHHhcCCc
Confidence 99999999976432 23455555554322222221 667889999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001152 1113 TERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~ 1130 (1137)
.+|.|+.|+++|+|....
T Consensus 311 teRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 311 TERLTIEEVMDHPWINQY 328 (400)
T ss_pred hhheeHHHhhcCchhccc
Confidence 999999999999998754
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=306.93 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=199.2
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|+..+.||+|+||.||+|++. +..+++|........ .....+. +.+|+.+++.++|+|++++++++....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 88 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQD----IIKEVRFLQKLRHPNTIQYRGCYLREH-- 88 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHH----HHHHHHHHHhCCCCCcccEEEEEEcCC--
Confidence 4777889999999999999984 456777764322111 1222223 478999999999999999999988655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+. |+|.+++.. ....+++..+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 89 ------------~~~lv~e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~ 151 (308)
T cd06634 89 ------------TAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151 (308)
T ss_pred ------------eeEEEEEccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC
Confidence 5699999996 688887754 12458999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+...... ....+++.|+|||.+.+. ....++.++|||||||++|+|++
T Consensus 152 -------~~~kl~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~el~~ 209 (308)
T cd06634 152 -------GLVKLGDFGSASIMAPA--------------NXFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAE 209 (308)
T ss_pred -------CcEEECCcccceeecCc--------------ccccCCccccCHHHHhhc-ccCCCCcccchHHHHHHHHHHHc
Confidence 78999999987643321 123578899999998532 12356789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||......+....+..+..+.... ...+..+.+++.+||+.+|.+||++++
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~cl~~~P~~Rp~~~~ 263 (308)
T cd06634 210 RKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (308)
T ss_pred CCCCCccccHHHHHHHHhhcCCCCcCc--------------------------ccccHHHHHHHHHHhhCCcccCCCHHH
Confidence 999998766555444443333222110 033455899999999999999999999
Q ss_pred HHHHHHhhcCCC
Q 001152 1121 LYEMFVARTSSS 1132 (1137)
Q Consensus 1121 VL~~L~~~~~ss 1132 (1137)
+++|+|+....+
T Consensus 264 ll~~~~~~~~~~ 275 (308)
T cd06634 264 LLKHRFVLRERP 275 (308)
T ss_pred HhhCccccccCC
Confidence 999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=300.54 Aligned_cols=279 Identities=23% Similarity=0.265 Sum_probs=202.2
Q ss_pred ceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|++.+.||+|++|.||+|+.. +..+++|+..... ......+ .+.+|+.+++.++||||+++++++.+..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~----~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPS----TALREISLLKELKHPNIVKLLDVIHTER--- 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccH----HHHHHHHHHHhcCCCCHHHHHhhhhcCC---
Confidence 567889999999999999985 5778888754332 1111122 2367999999999999999999988654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
..++||||++ ++|.+++... ...+++..+..++.|++.||+|||++||+||||+|+||+++.+
T Consensus 72 -----------~~~~v~e~~~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~- 134 (282)
T cd07829 72 -----------KLYLVFEYCD-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD- 134 (282)
T ss_pred -----------ceEEEecCcC-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-
Confidence 5699999997 6999999762 1469999999999999999999999999999999999999987
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.++|+|||.+........ ......++..|+|||++.+ ...++.++|||||||++|||++|
T Consensus 135 ------~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~~l~~l~~~ 195 (282)
T cd07829 135 ------GVLKLADFGLARAFGIPLR----------TYTHEVVTLWYRAPEILLG---SKHYSTAVDIWSVGCIFAEMITG 195 (282)
T ss_pred ------CCEEEecCCcccccCCCcc----------ccCccccCcCcCChHHhcC---CcCCCccccHHHHHHHHHHHHhC
Confidence 7899999998875433211 1112245778999999865 23678999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccc-cccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH-EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
..||......+....+...........+....... ....................+..+.+++.+||+.||++||++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 99998877665555553322211111111111000 00000000000000111133667999999999999999999999
Q ss_pred HHHHHHh
Q 001152 1121 LYEMFVA 1127 (1137)
Q Consensus 1121 VL~~L~~ 1127 (1137)
++.|+|+
T Consensus 276 ~l~~p~~ 282 (282)
T cd07829 276 ALKHPYF 282 (282)
T ss_pred HhhCcCC
Confidence 9999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=303.10 Aligned_cols=273 Identities=18% Similarity=0.203 Sum_probs=185.9
Q ss_pred CCceEeeeecccCceEEEEEEECCc-----cEEEEEEecccCCCChHHHH---HhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIR---NFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~~-----~vAVKi~~l~~~~~~~~~~e---~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
.+|++.+.||+|+||+||+|.+.+. .+++|+..........+... ........+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4799999999999999999998543 45666543332111011000 001112334455667789999999987
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+..... .....+++||++. .++.+.+... ...++..+..|+.||+.||+|||+++|+||||||+
T Consensus 92 ~~~~~~----------~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~ 155 (294)
T PHA02882 92 GSFKRC----------RMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPE 155 (294)
T ss_pred eeEecC----------CceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 654331 1124588899875 6777776541 23678889999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.+ +.++|+|||+++.......... ..........||+.|+|||+..+ ..++.++|||||||
T Consensus 156 Nill~~~-------~~~~l~DFGla~~~~~~~~~~~---~~~~~~~~~~gt~~y~ape~~~~----~~~~~~~DiwSlG~ 221 (294)
T PHA02882 156 NIMVDGN-------NRGYIIDYGIASHFIIHGKHIE---YSKEQKDLHRGTLYYAGLDAHNG----ACVTRRGDLESLGY 221 (294)
T ss_pred HEEEcCC-------CcEEEEEcCCceeeccCCcccc---cccccccccCCCccccCHHHhCC----CCCCcHHHHHHHHH
Confidence 9999876 6799999999976543211100 00011223469999999999875 56889999999999
Q ss_pred HHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1034 LLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1034 iL~ELLTG~~Pf~~~~~-~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
++|||++|+.||.+... ..............+... .. ....+++++.+++..|++.+|
T Consensus 222 ~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~------~~~~~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 222 CMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEG---------------KI------KIKNANKFIYDFIECVTKLSY 280 (294)
T ss_pred HHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhh---------------hh------ccCCCCHHHHHHHHHHHhCCC
Confidence 99999999999987532 222221111000000000 00 001345679999999999999
Q ss_pred CCCCCHHHHHHHH
Q 001152 1113 TERPTAGDLYEMF 1125 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L 1125 (1137)
++||+++++++.+
T Consensus 281 ~~rp~~~~l~~~~ 293 (294)
T PHA02882 281 EEKPDYDALIKIF 293 (294)
T ss_pred CCCCCHHHHHHhh
Confidence 9999999998764
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=301.62 Aligned_cols=245 Identities=20% Similarity=0.273 Sum_probs=184.2
Q ss_pred CCceEeeee--cccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEec
Q 001152 802 PSLSSCDEA--GKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 876 (1137)
Q Consensus 802 ~~y~l~~~L--G~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~ 876 (1137)
+.|++.+.+ |+|+||.||++... +..+|+|+...... . .. |+.....+ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~-----~~------e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF--N-----AI------EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc--c-----hh------hHHHHHHhhcCCCEEEEEEEEec
Confidence 345555555 99999999999974 46677777532211 1 11 22222222 69999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ ..++||||+++++|.+++.. ...+++..+..++.||++||+|||+.||+||||||+||+
T Consensus 81 ~~--------------~~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 141 (267)
T PHA03390 81 LK--------------GHVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL 141 (267)
T ss_pred CC--------------eeEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 65 56999999999999999976 237899999999999999999999999999999999999
Q ss_pred eccccccCCCCC-eEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 957 IDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 957 ld~~~~~~~~~~-~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
++.+ + .++|+|||.+...... ....++..|+|||++.+ ..++.++||||||+++
T Consensus 142 ~~~~-------~~~~~l~dfg~~~~~~~~--------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il 196 (267)
T PHA03390 142 YDRA-------KDRIYLCDYGLCKIIGTP--------------SCYDGTLDYFSPEKIKG----HNYDVSFDWWAVGVLT 196 (267)
T ss_pred EeCC-------CCeEEEecCccceecCCC--------------ccCCCCCcccChhhhcC----CCCCchhhHHHHHHHH
Confidence 9877 4 7999999988654321 12357889999999875 4578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~-~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+|++|..||......... ..+......... .....++.+.+++.+||+.+|.+
T Consensus 197 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~ 251 (267)
T PHA03390 197 YELLTGKHPFKEDEDEELDLESLLKRQQKKLP-------------------------FIKNVSKNANDFVQSMLKYNINY 251 (267)
T ss_pred HHHHHCCCCCCCCCcchhhHHHHHHhhcccCC-------------------------cccccCHHHHHHHHHHhccChhh
Confidence 9999999999754332211 111100000000 00134566999999999999999
Q ss_pred CCC-HHHHHHHHHhh
Q 001152 1115 RPT-AGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPS-a~EVL~~L~~~ 1128 (1137)
||+ ++|+++|+|++
T Consensus 252 R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 252 RLTNYNEIIKHPFLK 266 (267)
T ss_pred CCchHHHHhcCCccc
Confidence 996 69999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=334.51 Aligned_cols=149 Identities=26% Similarity=0.287 Sum_probs=126.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+.+|++.++||+|+||+||+|.+. +..||+|+....... ..... .++.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-~~~~~----~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMV----HQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-CHHHH----HHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 3678999999999999999999986 678999986433211 12222 2347899999999999999999888765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. +.|+||||+++++|.+++.. ...+++..++.|+.||+.||+|||.++|+||||||+|||+
T Consensus 77 ~--------------~~~lVmEy~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl 137 (669)
T cd05610 77 N--------------NVYLVMEYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137 (669)
T ss_pred C--------------EEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE
Confidence 5 67999999999999999975 2358899999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccc
Q 001152 958 DLERKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~ 979 (1137)
+.+ +.+||+|||+++
T Consensus 138 ~~~-------g~vkL~DFGls~ 152 (669)
T cd05610 138 SNE-------GHIKLTDFGLSK 152 (669)
T ss_pred cCC-------CCEEEEeCCCCc
Confidence 877 789999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=300.94 Aligned_cols=260 Identities=24% Similarity=0.250 Sum_probs=194.7
Q ss_pred CceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEec
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 876 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~ 876 (1137)
+|++.+.||+|++|.||+|++. +..+|+|+.+..... ........+.+|+.++.++. ||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 4789999999999999999852 466888875432111 11112223478999999995 9999999988876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. ..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+++||||||+||+
T Consensus 77 ~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 77 DT--------------KLHLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred CC--------------EEEEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 54 56999999999999999865 245899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.++|+|||++......... ......|+..|+|||.+.+. ....+.++||||||+++|
T Consensus 138 ~~~~-------~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Dv~slG~il~ 199 (288)
T cd05583 138 LDSE-------GHVVLTDFGLSKEFLAEEEE---------RAYSFCGTIEYMAPEVIRGG--SGGHDKAVDWWSLGVLTF 199 (288)
T ss_pred ECCC-------CCEEEEECcccccccccccc---------ccccccCCccccCHHHhcCC--CCCCcchhhhHHHHHHHH
Confidence 9877 67999999988654322110 11123578899999998652 224678999999999999
Q ss_pred HHHhCCCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1037 ELLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~----~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
+|++|..||..... .+....+..... ..+ ...+..+.+++.+||+.||
T Consensus 200 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~l~~li~~~l~~~p 251 (288)
T cd05583 200 ELLTGASPFTVDGEQNSQSEISRRILKSKP-PFP---------------------------KTMSAEARDFIQKLLEKDP 251 (288)
T ss_pred HHHhCCCCcccCcccchHHHHHHHHHccCC-CCC---------------------------cccCHHHHHHHHHHhcCCH
Confidence 99999999964321 122222211111 000 0234458999999999999
Q ss_pred CCCCC---HHHHHHHHHhhcCC
Q 001152 1113 TERPT---AGDLYEMFVARTSS 1131 (1137)
Q Consensus 1113 ~~RPS---a~EVL~~L~~~~~s 1131 (1137)
++||| +.++++|+|++...
T Consensus 252 ~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 252 KKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred hhccCcchHHHHhcCcccccCC
Confidence 99998 56779999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=306.63 Aligned_cols=279 Identities=20% Similarity=0.245 Sum_probs=198.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||+|.+. +..+|+|........ ....+. +.+|+.+++.++||||+++++++.....
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST--PVLAKR----TYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc--cchhHH----HHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 57999999999999999999875 466888864322211 112222 3679999999999999999998865321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+ +++|.++++. ..+++..+..++.||+.||+|||++||+||||+|+||+++.
T Consensus 84 -------------~~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~ 143 (328)
T cd07856 84 -------------DIYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE 143 (328)
T ss_pred -------------cEEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC
Confidence 468999998 5799888764 35788899999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++|+|||.+....... ....+++.|+|||.+.+ ...++.++|||||||++|+|+
T Consensus 144 ~-------~~~~l~dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el~ 200 (328)
T cd07856 144 N-------CDLKICDFGLARIQDPQM-------------TGYVSTRYYRAPEIMLT---WQKYDVEVDIWSAGCIFAEML 200 (328)
T ss_pred C-------CCEEeCccccccccCCCc-------------CCCcccccccCceeeec---cCCcCcHHHHHHHHHHHHHHH
Confidence 6 789999999886432210 12357889999998753 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc-ccccccC--CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||...........+.................... ....... ............++.+.+++.+||+.+|++||
T Consensus 201 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 280 (328)
T cd07856 201 EGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280 (328)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC
Confidence 99999987665443333322111111100000000000 0000000 00000111123567799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
++++++.|+|+..
T Consensus 281 t~~ell~~~~~~~ 293 (328)
T cd07856 281 SAAEALAHPYLAP 293 (328)
T ss_pred CHHHHhcCCcccc
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-33 Score=315.01 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=202.5
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 885 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g 885 (1137)
++||.|.||+||-|++ .+++||||+. ++......+... +..|++||+.+.||.||.+...|+..+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvI--dKlrFp~kqesq----lR~EVaILq~l~HPGiV~le~M~ET~e------- 636 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVI--DKLRFPTKQESQ----LRNEVAILQNLHHPGIVNLECMFETPE------- 636 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeee--ecccCCCchHHH----HHHHHHHHHhcCCCCeeEEEEeecCCc-------
Confidence 7899999999999987 4688999984 333333333233 378999999999999999999998876
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCC
Q 001152 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965 (1137)
Q Consensus 886 ~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~ 965 (1137)
..++|||-+.|.-|.-++.. ...+++++..+.++.||+.||.|||-++|+|+||||+|||+... +
T Consensus 637 -------rvFVVMEKl~GDMLEMILSs----EkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~----~ 701 (888)
T KOG4236|consen 637 -------RVFVVMEKLHGDMLEMILSS----EKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA----S 701 (888)
T ss_pred -------eEEEEehhhcchHHHHHHHh----hcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC----C
Confidence 66999999974444444443 34579999999999999999999999999999999999999865 3
Q ss_pred CCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001152 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045 (1137)
Q Consensus 966 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf 1045 (1137)
.-.++||||||+|+.+.+... ....+|||.|.|||+++. +.|+..-|+||.|||+|.-++|..||
T Consensus 702 ~FPQvKlCDFGfARiIgEksF-----------RrsVVGTPAYLaPEVLrn----kGyNrSLDMWSVGVIiYVsLSGTFPF 766 (888)
T KOG4236|consen 702 PFPQVKLCDFGFARIIGEKSF-----------RRSVVGTPAYLAPEVLRN----KGYNRSLDMWSVGVIIYVSLSGTFPF 766 (888)
T ss_pred CCCceeeccccceeecchhhh-----------hhhhcCCccccCHHHHhh----ccccccccceeeeEEEEEEecccccC
Confidence 347899999999998775432 235689999999999986 67899999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001152 1046 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125 (1137)
Q Consensus 1046 ~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L 1125 (1137)
... +++-++|+.......+..+ .+++++..+||...|+..-.+|.|++..+.|+
T Consensus 767 NEd--EdIndQIQNAaFMyPp~PW------------------------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 767 NED--EDINDQIQNAAFMYPPNPW------------------------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred CCc--cchhHHhhccccccCCCch------------------------hhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 753 3455666544321111111 15566799999999999999999999999999
Q ss_pred Hhhc
Q 001152 1126 VART 1129 (1137)
Q Consensus 1126 ~~~~ 1129 (1137)
|.+.
T Consensus 821 Wlq~ 824 (888)
T KOG4236|consen 821 WLQD 824 (888)
T ss_pred hhhc
Confidence 9863
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=323.71 Aligned_cols=265 Identities=23% Similarity=0.377 Sum_probs=216.1
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~ 878 (1137)
+.|++.++||+|.+|.||+++. .++.+|+||+... .+..++ + ..|..||+... |||++.+|++|.-.+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~--~d~deE---i----E~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT--EDEEEE---I----ELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC--ccccHH---H----HHHHHHHHhccCCCCcceEEEEEEEec
Confidence 4588999999999999999886 5688999985433 222222 2 33888998886 999999999998755
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. ....++|||||||.|||..++++.+. +.++.|..+..|++.++.||.|||++.++|||||-.|||++
T Consensus 90 ~---------~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT 157 (953)
T KOG0587|consen 90 P---------GNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT 157 (953)
T ss_pred C---------CCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe
Confidence 2 12338999999999999999999864 46799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC-CCCCCchhhHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~s~ksDVWSLGviL~E 1037 (1137)
.+ +.|||+|||++..++... ....+++|||.|||||++..... ...|+.++|+||||++..|
T Consensus 158 ~e-------~~VKLvDFGvSaQldsT~----------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIE 220 (953)
T KOG0587|consen 158 EN-------AEVKLVDFGVSAQLDSTV----------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIE 220 (953)
T ss_pred cc-------CcEEEeeeeeeeeeeccc----------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeeh
Confidence 88 789999999987766532 23457789999999999876432 3457889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|..|.+|+..+.++...-.|-...+|.+... ....+++.++|..||.+|-.+||+
T Consensus 221 ladG~PPl~DmHPmraLF~IpRNPPPkLkrp-------------------------~kWs~~FndFIs~cL~Kd~e~RP~ 275 (953)
T KOG0587|consen 221 MAEGAPPLCDMHPMRALFLIPRNPPPKLKRP-------------------------KKWSKKFNDFISTCLVKDYEQRPS 275 (953)
T ss_pred hcCCCCCccCcchhhhhccCCCCCCccccch-------------------------hhHHHHHHHHHHHHHhhccccCcc
Confidence 9999999998888766666555444443211 134566999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001152 1118 AGDLYEMFVART 1129 (1137)
Q Consensus 1118 a~EVL~~L~~~~ 1129 (1137)
+.++++|+|...
T Consensus 276 ~~~ll~hpFi~e 287 (953)
T KOG0587|consen 276 TEELLKHPFITE 287 (953)
T ss_pred hhhhccCCcccc
Confidence 999999999863
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=291.63 Aligned_cols=245 Identities=30% Similarity=0.367 Sum_probs=194.5
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCC
Q 001152 810 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 810 LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 887 (1137)
||+|+||.||++.+. +..+++|+....... .....+. +..|+.++++++||||+++++.+....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~--------- 66 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-KRKEVEH----TLTERNILSRINHPFIVKLHYAFQTEE--------- 66 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-chHHHHH----HHHHHHHHHHcCCCcHHHHHHHeecCC---------
Confidence 699999999999985 577888875433221 1222233 378999999999999999999987655
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCC
Q 001152 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 967 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~ 967 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||+++.+
T Consensus 67 -----~~~~v~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~------- 129 (250)
T cd05123 67 -----KLYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD------- 129 (250)
T ss_pred -----eeEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-------
Confidence 56999999999999999976 2368999999999999999999999999999999999999877
Q ss_pred CeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 001152 968 PVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047 (1137)
Q Consensus 968 ~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~ 1047 (1137)
+.++|+|||.+........ ......++..|+|||.+.+ ...+.++|+||||+++|+|++|..||..
T Consensus 130 ~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~Pe~~~~----~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 130 GHIKLTDFGLAKELSSEGS----------RTNTFCGTPEYLAPEVLLG----KGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred CcEEEeecCcceecccCCC----------cccCCcCCccccChHHhCC----CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 7899999998875543210 1123457889999999875 3467899999999999999999999987
Q ss_pred CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 001152 1048 LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA---GDLYEM 1124 (1137)
Q Consensus 1048 ~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa---~EVL~~ 1124 (1137)
.+.......+.... ..++. ..+..+.+++.+||..||++||++ +++++|
T Consensus 196 ~~~~~~~~~~~~~~-~~~~~---------------------------~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 196 EDRKEIYEKILKDP-LRFPE---------------------------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCHHHHHHHHhcCC-CCCCC---------------------------CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 76655555554321 11111 224458999999999999999999 999999
Q ss_pred HHh
Q 001152 1125 FVA 1127 (1137)
Q Consensus 1125 L~~ 1127 (1137)
+||
T Consensus 248 ~~f 250 (250)
T cd05123 248 PFF 250 (250)
T ss_pred CCC
Confidence 986
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=294.72 Aligned_cols=300 Identities=18% Similarity=0.240 Sum_probs=216.7
Q ss_pred CCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
...|+-..+||+|.||.||+|+.++ ..||+|++..+. +.+.|....++|+.+|..++|+|++.+++.+....
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen------eKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN------EKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc------cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 3457778899999999999998754 556776543322 22333344588999999999999999998887643
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.- ..+ .....|+||.+|+ .+|..++.. ...+++..++.++++++..||.|+|...|+|||+||.|+||+
T Consensus 90 Tp--~~r----~r~t~ylVf~~ce-hDLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt 158 (376)
T KOG0669|consen 90 TP--TNR----DRATFYLVFDFCE-HDLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT 158 (376)
T ss_pred CC--ccc----ccceeeeeHHHhh-hhHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc
Confidence 21 111 1236899999997 899999875 346799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++.+....... .+..+..+-|.+|++||.+.| ...|+++.|||+.|||+.||
T Consensus 159 ~d-------gilklADFGlar~fs~~~n~~------kprytnrvvTLwYrppEllLG---~r~yg~~iDiWgAgCimaeM 222 (376)
T KOG0669|consen 159 KD-------GILKLADFGLARAFSTSKNVV------KPRYTNRVVTLWYRPPELLLG---DREYGPPIDIWGAGCIMAEM 222 (376)
T ss_pred CC-------ceEEeeccccccceecccccC------CCCcccceeeeecCCHHHhhc---ccccCCcchhHhHHHHHHHH
Confidence 88 899999999998765433211 112334567999999999997 46899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCC---CCCchh---HHhhhcccccccccccCCCC-CCchhhhhhHHHHHHHHHHhcccC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGK---RPRLTD---ELEALGSCHEHEVAQSGSGF-EKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~---~p~l~~---~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
.|+.+-+++....+....|..-. .+..+. .++.+...+.+.+.+...+. ..........++..+|+.++|..|
T Consensus 223 wtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~D 302 (376)
T KOG0669|consen 223 WTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLD 302 (376)
T ss_pred HccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccC
Confidence 99999999988777666663211 121111 12222222111111111100 000001122456889999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCCC
Q 001152 1112 PTERPTAGDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~~~~~ss~ 1133 (1137)
|.+|++++++++|.||...+..
T Consensus 303 P~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 303 PTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccCcchHhhhchhhhhcCCcc
Confidence 9999999999999999876543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=311.79 Aligned_cols=262 Identities=21% Similarity=0.316 Sum_probs=204.2
Q ss_pred CceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
...+.++||+|-||.|.++...+ ..||||+.+-..+ ..... .|.+||++|.+|+|||||+++|+|..++
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~---~~~r~----~F~kEIkiLsqLkhPNIveLvGVC~~De--- 608 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT---KNARN----DFLKEIKILSRLKHPNIVELLGVCVQDD--- 608 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccc---hhHHH----HHHHHHHHHhccCCCCeeEEEeeeecCC---
Confidence 35788999999999999999876 8899997543222 22223 3499999999999999999999999877
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
-+++||||+++|+|.+++.+... ..+.......|+.||+.||+||.+.++|||||.+.|+|++.+
T Consensus 609 -----------PicmI~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e- 673 (807)
T KOG1094|consen 609 -----------PLCMITEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE- 673 (807)
T ss_pred -----------chHHHHHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-
Confidence 34999999999999999987321 124556667899999999999999999999999999999988
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT- 1040 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT- 1040 (1137)
+++||+|||+++.+-..... ......+-...|||||.+.- ++++.++|||+||+++||+++
T Consensus 674 ------~~iKiadfgmsR~lysg~yy--------~vqgr~vlpiRwmawEsill----gkFttaSDvWafgvTlwE~~~~ 735 (807)
T KOG1094|consen 674 ------FTIKIADFGMSRNLYSGDYY--------RVQGRAVLPIRWMAWESILL----GKFTTASDVWAFGVTLWEVFML 735 (807)
T ss_pred ------ccEEecCcccccccccCCce--------eeecceeeeeeehhHHHHHh----ccccchhhhhhhHHHHHHHHHH
Confidence 89999999999855433211 11123455679999999875 578999999999999999876
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCch-hHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLT-DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
.+.||......++.+.........-. ..+.. ..-++..+.+++.+||..|-.+||++
T Consensus 736 C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~---------------------P~~cp~~lyelml~Cw~~es~~RPsF 794 (807)
T KOG1094|consen 736 CREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR---------------------PPACPQGLYELMLRCWRRESEQRPSF 794 (807)
T ss_pred HhhCchhhhhHHHHHHhhhhhcCCCCcceeccC---------------------CCcCcHHHHHHHHHHhchhhhcCCCH
Confidence 67899888777776654332211100 00100 11567779999999999999999999
Q ss_pred HHHHHHHHhh
Q 001152 1119 GDLYEMFVAR 1128 (1137)
Q Consensus 1119 ~EVL~~L~~~ 1128 (1137)
+++..++...
T Consensus 795 e~lh~~lq~~ 804 (807)
T KOG1094|consen 795 EQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHh
Confidence 9999988754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=334.48 Aligned_cols=281 Identities=25% Similarity=0.353 Sum_probs=195.7
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|+..+.||+||||.||+++. .++.+|||...++. ..... .++.+|+.+|++|+|||||++|..+.+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~----skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLY----SKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHH----HHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 45568889999999999999997 57889998654432 12222 34589999999999999999997765211
Q ss_pred ------------------------------------------------------CCC----C------------------
Q 001152 879 ------------------------------------------------------WLP----S------------------ 882 (1137)
Q Consensus 879 ------------------------------------------------------~~~----~------------------ 882 (1137)
+.+ .
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 000 0
Q ss_pred -----CCC-------------------CCcc-----ccceEEEEEeeccCCCHHHHHHHhhhcCCCCC-CHHHHHHHHHH
Q 001152 883 -----ADG-------------------NPEH-----HLLQSAIFMEYVKGGSVKNYIEKLSETGEKHV-SVKLALFIAQD 932 (1137)
Q Consensus 883 -----~~g-------------------~~~~-----~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~l-s~~~i~~I~~Q 932 (1137)
.++ ..++ .+..+||-||||+...|.+++++. ... .....+++++|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N-----~~~~~~d~~wrLFre 705 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN-----HFNSQRDEAWRLFRE 705 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc-----ccchhhHHHHHHHHH
Confidence 000 0000 124689999999977777777761 122 46788999999
Q ss_pred HHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCcccccc----cc---cc-ccccccCCCCCCCcccCC
Q 001152 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR----SF---LH-TCCIAHRGIPAPDVCVGT 1004 (1137)
Q Consensus 933 Ia~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~----~~---~~-~~~~~~~~~~~~~~~~GT 1004 (1137)
|+.||+|+|++|||||||||.|||++.+ ..|||+|||+|+... .. .. ............+..+||
T Consensus 706 IlEGLaYIH~~giIHRDLKP~NIFLd~~-------~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGT 778 (1351)
T KOG1035|consen 706 ILEGLAYIHDQGIIHRDLKPRNIFLDSR-------NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGT 778 (1351)
T ss_pred HHHHHHHHHhCceeeccCCcceeEEcCC-------CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccce
Confidence 9999999999999999999999999977 789999999998622 00 00 111111111234567899
Q ss_pred CcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCchhHHhhhccccccccccc
Q 001152 1005 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 1083 (1137)
Q Consensus 1005 ~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~-~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~ 1083 (1137)
.-|+|||++.+... ..|+.|+|+||||||++||+. ||.. +....+...+..+..|... .+
T Consensus 779 alYvAPEll~~~~~-~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~-~f-------------- 839 (1351)
T KOG1035|consen 779 ALYVAPELLSDTSS-NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPA-DF-------------- 839 (1351)
T ss_pred eeeecHHHhccccc-ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCc-cc--------------
Confidence 99999999987432 479999999999999999984 6642 2222333333433332210 00
Q ss_pred CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1084 GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1084 ~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
....-+.-..+|+.|++.||.+||||.|+|++=++-
T Consensus 840 ---------~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 840 ---------FDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ---------ccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 011222356789999999999999999999875553
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=274.39 Aligned_cols=283 Identities=20% Similarity=0.266 Sum_probs=208.9
Q ss_pred CceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|...++||+|+||+||+|+... .-||+|..+++....+ .....++||.+|+.++|.|||++++....++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg------vpssalreicllkelkhknivrl~dvlhsdk-- 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG------VPSSALREICLLKELKHKNIVRLHDVLHSDK-- 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC------CcHHHHHHHHHHHHhhhcceeehhhhhccCc--
Confidence 46667899999999999999765 4566776555544333 2334589999999999999999999988766
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
.+.+|+|||. .+|..+.... +..++.+.++.++.|+++||.|+|++++.||||||.|.||+.+
T Consensus 75 ------------kltlvfe~cd-qdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n 137 (292)
T KOG0662|consen 75 ------------KLTLVFEFCD-QDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN 137 (292)
T ss_pred ------------eeEEeHHHhh-HHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC
Confidence 6799999997 7888887653 4579999999999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
|.+|++|||+++.+..+... + ...+-|.+|++|.++.+. ..|+...|+||.|||+.|+..
T Consensus 138 -------gelkladfglarafgipvrc-y---------saevvtlwyrppdvlfga---kly~tsidmwsagcifaelan 197 (292)
T KOG0662|consen 138 -------GELKLADFGLARAFGIPVRC-Y---------SAEVVTLWYRPPDVLFGA---KLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_pred -------CcEEecccchhhhcCCceEe-e---------eceeeeeeccCcceeeee---ehhccchHhhhcchHHHHHhh
Confidence 88999999999877654321 1 123578899999999873 578999999999999999986
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhh---cccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEAL---GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|.+.|.+.+..+....|.......-.+.++.. +......+......+ ...-+.....-++++++.|.-+|.+|.
T Consensus 198 agrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattsw--sqivp~lns~grdllqkll~cnp~qri 275 (292)
T KOG0662|consen 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSW--SQIVPKLNSTGRDLLQKLLKCNPAQRI 275 (292)
T ss_pred cCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchH--HHHhhhhcchhHHHHHHHhccCccccc
Confidence 67778887777777666432211111111110 000000000000000 000112233457899999999999999
Q ss_pred CHHHHHHHHHhhcCCC
Q 001152 1117 TAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ss 1132 (1137)
+++++++|++|...++
T Consensus 276 saeaalqhpyf~d~s~ 291 (292)
T KOG0662|consen 276 SAEAALQHPYFSDFSP 291 (292)
T ss_pred CHHHHhcCccccccCC
Confidence 9999999999986654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=313.10 Aligned_cols=263 Identities=25% Similarity=0.303 Sum_probs=222.7
Q ss_pred CCCCCCCCCceEeeeecccCceEEEEEEECCcc--EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 795 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSAD--AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 795 ~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~--vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
++....+.+++.+..||-|+||.|-++...++. .|+|+.+.....+ ..+.+.. ..|-.||..++.|.||++|.
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv----~sEr~Im~~~~s~fIvrLYr 487 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHV----FSERNIMMECRSDFIVRLYR 487 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHH----HhHHHHHHhcCchHHHHHHH
Confidence 345566788888999999999999999987655 6788754443332 3344443 77999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
.|.++. .+|+.||-|-||.|+..+++ +..|+..+++.++..++.|++|||++|||+|||||
T Consensus 488 Tfrd~k--------------yvYmLmEaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKP 548 (732)
T KOG0614|consen 488 TFRDSK--------------YVYMLMEACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKP 548 (732)
T ss_pred Hhccch--------------hhhhhHHhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcCceeccCCh
Confidence 999887 45999999999999999987 46799999999999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
+|.+++.+ |-+||.|||+|+.+.....+. +++|||.|.|||++.. ...+.++|.||||
T Consensus 549 ENllLd~~-------Gy~KLVDFGFAKki~~g~KTw-----------TFcGTpEYVAPEIILn----KGHD~avDyWaLG 606 (732)
T KOG0614|consen 549 ENLLLDNR-------GYLKLVDFGFAKKIGSGRKTW-----------TFCGTPEYVAPEIILN----KGHDRAVDYWALG 606 (732)
T ss_pred hheeeccC-------CceEEeehhhHHHhccCCcee-----------eecCCcccccchhhhc----cCcchhhHHHHHH
Confidence 99999988 889999999999888765543 5689999999999986 5678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-chhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPR-LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~-l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
+++|||++|.+||.+.+++..+..|.+|.... +|. .+.....+|+++.+..+
T Consensus 607 Ili~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr---------------------------~I~k~a~~Lik~LCr~~ 659 (732)
T KOG0614|consen 607 ILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR---------------------------RITKTATDLIKKLCRDN 659 (732)
T ss_pred HHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc---------------------------ccchhHHHHHHHHHhcC
Confidence 99999999999999999999999998876321 111 33445889999999999
Q ss_pred CCCCC-----CHHHHHHHHHhhcC
Q 001152 1112 PTERP-----TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1112 P~~RP-----Sa~EVL~~L~~~~~ 1130 (1137)
|.+|. .+.+|-+|-||..-
T Consensus 660 P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 660 PTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred cHhhhccccCChHHHHhhhhhhcC
Confidence 99997 48999999999643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=297.75 Aligned_cols=266 Identities=26% Similarity=0.367 Sum_probs=199.5
Q ss_pred CceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHH--hCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG--ALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~--~L~HpNIVkllg~~~~~~~~ 880 (1137)
..++.+.||+|.||.||+|+|.+..||||||.... . +.+.||.+|.+ .|+|+||+.+++.-..+.
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-------E----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-- 278 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-------E----RSWFRETEIYQTVMLRHENILGFIAADNKDN-- 278 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEecccc-------h----hhhhhHHHHHHHHHhccchhhhhhhccccCC--
Confidence 46899999999999999999999999999975321 1 12245655555 568999999998754332
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCCC
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKS 952 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~--------gIIHrDLKP 952 (1137)
..-.++|||++|-+.|||++|+.. ..++....++++..+|.||+|||.. .|.|||||+
T Consensus 279 --------gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 279 --------GSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred --------CceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 124589999999999999999986 4699999999999999999999953 499999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCC--CchhhHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY--GLEVDIWS 1030 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~--s~ksDVWS 1030 (1137)
.||||..+ +++-|+|+|+|.........- ....+..+||..|||||++....+...+ -..+||||
T Consensus 345 KNILVKkn-------~~C~IADLGLAv~h~~~t~~i------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa 411 (513)
T KOG2052|consen 345 KNILVKKN-------GTCCIADLGLAVRHDSDTDTI------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA 411 (513)
T ss_pred ccEEEccC-------CcEEEeeceeeEEecccCCcc------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence 99999988 889999999998765543221 1233456899999999999753322211 25799999
Q ss_pred HHHHHHHHHhC----------CCCCCC-----CCHHHHHHHH-HcCCCCCchhHHhhhcccccccccccCCCCCCchhhh
Q 001152 1031 YGCLLLELLTL----------QVPYMG-----LSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094 (1137)
Q Consensus 1031 LGviL~ELLTG----------~~Pf~~-----~~~~el~~~I-~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1137)
||.++||++.. +.||.+ ++.+++.+-+ .+..+|.++..+. ..
T Consensus 412 fgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~----------------------s~ 469 (513)
T KOG2052|consen 412 FGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK----------------------SD 469 (513)
T ss_pred HHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccc----------------------cC
Confidence 99999999863 677754 2233333333 2222344332221 12
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1095 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1095 ~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+....+.++|+.||..+|.-|-||--|-+.+-....
T Consensus 470 ~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 470 PALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 556678899999999999999999888777766543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-33 Score=294.88 Aligned_cols=264 Identities=24% Similarity=0.321 Sum_probs=203.8
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~ 882 (1137)
.+-...||.|+||+|++..++...+.++|+++..+.. ..+. .+++.|.....+- +.||||++||....++
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq----~rll~e~d~~mks~~cp~IVkfyGa~F~EG---- 136 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQ----KRLLMEHDTVMKSSNCPNIVKFYGALFSEG---- 136 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHH----HHHHHHHHHHHhhcCCcHHHHHhhhhhcCC----
Confidence 4455779999999999999876554444444544433 2222 3457887765554 5999999999987655
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeEecccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NILld~~~ 961 (1137)
..||.||+|+ .||+.+.+..+.-....+++...-.|+.-.+.||.||-. ..|||||+||+|||++..
T Consensus 137 ----------dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~- 204 (361)
T KOG1006|consen 137 ----------DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH- 204 (361)
T ss_pred ----------ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-
Confidence 5699999996 888887765554455679999999999999999999995 489999999999999988
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
|.+||||||++..+..... .+.-+|-..|||||.+.. ....|+-++||||||++|||+.||
T Consensus 205 ------G~vKLCDFGIcGqLv~SiA-----------kT~daGCrpYmAPERi~p--~~~gyDiRSDvWSLGITL~EvAtG 265 (361)
T KOG1006|consen 205 ------GDVKLCDFGICGQLVDSIA-----------KTVDAGCRPYMAPERIDP--SDKGYDIRSDVWSLGITLYEVATG 265 (361)
T ss_pred ------CCEeeecccchHhHHHHHH-----------hhhccCCccccChhccCC--ccCCcchhhhhhhhcceEeeeecC
Confidence 8899999999976654321 124478889999999975 334689999999999999999999
Q ss_pred CCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1042 QVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1042 ~~Pf~~~~-~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
.+||.+.+ ..+....+..+.+|.+...... .+.+..+..++..||.+|-..||+..+
T Consensus 266 ~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~----------------------~~~s~~~~~fintCl~Kd~~~Rpky~~ 323 (361)
T KOG1006|consen 266 NFPYRKWDSVFEQLCQVVIGDPPILLFDKEC----------------------VHYSFSMVRFINTCLIKDRSDRPKYDD 323 (361)
T ss_pred CCCcchHHHHHHHHHHHHcCCCCeecCcccc----------------------cccCHHHHHHHHHHhhcccccCcchhh
Confidence 99998743 3455555666666554432211 245666999999999999999999999
Q ss_pred HHHHHHhhc
Q 001152 1121 LYEMFVART 1129 (1137)
Q Consensus 1121 VL~~L~~~~ 1129 (1137)
+.++++.+.
T Consensus 324 Lk~~~fyr~ 332 (361)
T KOG1006|consen 324 LKKFPFYRM 332 (361)
T ss_pred hhcCchhhh
Confidence 999988763
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=299.05 Aligned_cols=268 Identities=22% Similarity=0.336 Sum_probs=201.6
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHH--hCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG--ALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~--~L~HpNIVkllg~~~~~~ 878 (1137)
+...++.+.||+|.||.||+|...++.||||++. ..+.+.+ +.|-.|.+ .++|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-------~~~kqs~----~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-------EQEKQSF----QNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecC-------HHHHHHH----HhHHHHHhccCccchhHHHhhchhccCC
Confidence 4556788999999999999999999999999975 2333333 55655555 557999999998755322
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------Ceeecc
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMHRD 949 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~---------gIIHrD 949 (1137)
....+++||+||.+.|||.+|+.. ..++|....+|+..|++||+|||+. .|+|||
T Consensus 278 ----------~~~~eywLVt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRD 341 (534)
T KOG3653|consen 278 ----------ADRMEYWLVTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRD 341 (534)
T ss_pred ----------ccccceeEEeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccc
Confidence 113378999999999999999987 4799999999999999999999963 599999
Q ss_pred CCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCC--CCCchhh
Q 001152 950 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEVD 1027 (1137)
Q Consensus 950 LKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~--~~s~ksD 1027 (1137)
||+.||||..| +++.|+|||+|..+...... . ... ..+||..|||||++.+..+-+ ..=.+.|
T Consensus 342 lkSkNVLvK~D-------lTccIaDFGLAl~~~p~~~~-~------d~~-~qVGT~RYMAPEvLEgainl~d~~Afkr~D 406 (534)
T KOG3653|consen 342 LKSKNVLVKND-------LTCCIADFGLALRLEPGKPQ-G------DTH-GQVGTRRYMAPEVLEGAINLQDRDAFKRID 406 (534)
T ss_pred ccccceEEccC-------CcEEeeccceeEEecCCCCC-c------chh-hhhhhhhhcCHHHHhhhcccccHHHHHHHH
Confidence 99999999988 88999999999877632211 0 112 258999999999998754322 1125799
Q ss_pred HHHHHHHHHHHHhCCCC------------CC-----CCCHHHHHHHH-HcCCCCCchhHHhhhcccccccccccCCCCCC
Q 001152 1028 IWSYGCLLLELLTLQVP------------YM-----GLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1089 (1137)
Q Consensus 1028 VWSLGviL~ELLTG~~P------------f~-----~~~~~el~~~I-~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~ 1089 (1137)
|||+|.++|||++...- |. .....++...+ .+..+|.++..+...
T Consensus 407 vYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----------------- 469 (534)
T KOG3653|consen 407 VYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH----------------- 469 (534)
T ss_pred HHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-----------------
Confidence 99999999999986433 32 12223344443 334455555443321
Q ss_pred chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 001152 1090 PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1090 ~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ss 1132 (1137)
....-+.+.+..||..||+.|.|+.=|.+.++.....+
T Consensus 470 -----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 470 -----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred -----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 33445899999999999999999988888877765544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=310.31 Aligned_cols=242 Identities=25% Similarity=0.276 Sum_probs=193.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~ 877 (1137)
...|.+...+|.|+|+.|-.+... +...+||+.... .. + ..+|+.++... .||||+++.+.+.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~---~-------~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--AD---D-------NQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc--cc---c-------cccccchhhhhcCCCcceeecceecCC
Confidence 567899999999999999998874 467888885332 11 1 13466666666 499999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. +.|+|||++.|+-|.+.+.. .+.....+..|+.+|+.|+.|||++|||||||||+|||+
T Consensus 389 ~--------------~~~~v~e~l~g~ell~ri~~------~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~ 448 (612)
T KOG0603|consen 389 K--------------EIYLVMELLDGGELLRRIRS------KPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILL 448 (612)
T ss_pred c--------------eeeeeehhccccHHHHHHHh------cchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheee
Confidence 5 77999999999988888765 122337788899999999999999999999999999999
Q ss_pred c-cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 958 D-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 958 d-~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
+ .. ++++|+|||.++....... .-+-|..|.|||++.. ..|++++||||||++||
T Consensus 449 ~~~~-------g~lrltyFG~a~~~~~~~~-------------tp~~t~~y~APEvl~~----~~yt~acD~WSLGvlLy 504 (612)
T KOG0603|consen 449 DGSA-------GHLRLTYFGFWSELERSCD-------------TPALTLQYVAPEVLAI----QEYTEACDWWSLGVLLY 504 (612)
T ss_pred cCCC-------CcEEEEEechhhhCchhhc-------------ccchhhcccChhhhcc----CCCCcchhhHHHHHHHH
Confidence 5 44 7899999999976554311 1246779999999874 68999999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~-~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
+||+|+.||.... ..++...+..+.. . ...++++++|+..||+.||.+|
T Consensus 505 ~ML~G~tp~~~~P~~~ei~~~i~~~~~---s---------------------------~~vS~~AKdLl~~LL~~dP~~R 554 (612)
T KOG0603|consen 505 EMLTGRTLFAAHPAGIEIHTRIQMPKF---S---------------------------ECVSDEAKDLLQQLLQVDPALR 554 (612)
T ss_pred HHHhCCCccccCCchHHHHHhhcCCcc---c---------------------------cccCHHHHHHHHHhccCChhhC
Confidence 9999999997643 3355555544321 1 1556679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001152 1116 PTAGDLYEMFVAR 1128 (1137)
Q Consensus 1116 PSa~EVL~~L~~~ 1128 (1137)
|++.++..|+|+.
T Consensus 555 l~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 555 LGADEIGAHPWFL 567 (612)
T ss_pred cChhhhccCcchh
Confidence 9999999999993
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=311.25 Aligned_cols=212 Identities=25% Similarity=0.365 Sum_probs=170.4
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|...+.||+||||.||+++.+ |..||||.+... ....+ .+ +..+|+++|++++|||||++++.-++...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~--~~~r~-~e----~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKE--SSLRP-RE----RWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhh--cccch-HH----HHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 44567789999999999999974 577888875432 22122 12 23789999999999999999988654331
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. . -.....+|||||+||||...+++ +.....+++.+.+.++.++..||.|||++|||||||||.||++..
T Consensus 86 ~--~------~~~~~vlvmEyC~gGsL~~~L~~--PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~ 155 (732)
T KOG4250|consen 86 G--L------VTRLPVLVMEYCSGGSLRKVLNS--PENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQI 155 (732)
T ss_pred C--c------ccccceEEEeecCCCcHHHHhcC--cccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee
Confidence 0 1 11256999999999999999986 344457999999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
. .++.-..||+|||.|+.+.+.... ...+||+.|.+||++.. ...|+..+|.|||||++|+.+
T Consensus 156 G---edgq~IyKLtDfG~Arel~d~s~~-----------~S~vGT~~YLhPel~E~---q~~y~~tVDLWS~GvtlY~ca 218 (732)
T KOG4250|consen 156 G---EDGQSIYKLTDFGAARELDDNSLF-----------TSLVGTEEYLHPELYER---QKKYTATVDLWSFGVTLYECA 218 (732)
T ss_pred c---CCCceEEeeecccccccCCCCCee-----------eeecCchhhcChHHHhh---ccCcCceeehhhhhhHHHHHh
Confidence 5 335567999999999987764322 35789999999999873 367899999999999999999
Q ss_pred hCCCCCCC
Q 001152 1040 TLQVPYMG 1047 (1137)
Q Consensus 1040 TG~~Pf~~ 1047 (1137)
||..||-.
T Consensus 219 TG~lPF~p 226 (732)
T KOG4250|consen 219 TGELPFIP 226 (732)
T ss_pred ccCCCCCc
Confidence 99999953
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=294.79 Aligned_cols=286 Identities=19% Similarity=0.241 Sum_probs=204.0
Q ss_pred CCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC--CC----cceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SC----IVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H--pN----IVkllg 872 (1137)
-.+|.+...+|+|+||.|-.+.+.. ..||+||.+ .+..+....+-|+.+|+++.+ |+ +|++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik---------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK---------NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHH---------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 3689999999999999999998754 678888732 122222334679999999952 32 567777
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
+|.-.+ +.|||+|.+ |-|+.+++.. ++..+++...++.|++|++.+++|||+.+++|-||||
T Consensus 159 wFdyrg--------------hiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKP 220 (415)
T KOG0671|consen 159 WFDYRG--------------HICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKP 220 (415)
T ss_pred hhhccC--------------ceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCCh
Confidence 777655 679999988 5799999976 4567899999999999999999999999999999999
Q ss_pred CCeEecccc-------------ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 953 ENILIDLER-------------KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 953 ~NILld~~~-------------~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
+|||+-... ........|+|+|||.|...... +...+.|..|+|||++.+
T Consensus 221 ENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-------------hs~iVsTRHYRAPEViLg---- 283 (415)
T KOG0671|consen 221 ENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-------------HSTIVSTRHYRAPEVILG---- 283 (415)
T ss_pred heEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-------------cceeeeccccCCchheec----
Confidence 999986542 01223567999999988654332 125689999999999997
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhH-Hhhh---c----cccc----------cccc
Q 001152 1020 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE-LEAL---G----SCHE----------HEVA 1081 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~-l~~~---~----~~~~----------~~~~ 1081 (1137)
-.++.++||||+||||+|+.||...|+.-+..+-...++....| +|.. +... + ...+ ..+.
T Consensus 284 LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp-~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~ 362 (415)
T KOG0671|consen 284 LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGP-IPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVF 362 (415)
T ss_pred cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCC-CcHHHhhhhhhHhhhhcccccCccccccccchhhh
Confidence 57899999999999999999999999875544433333222222 1211 1111 0 0000 0000
Q ss_pred ccCCCCCCch-hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001152 1082 QSGSGFEKPE-AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1082 ~~~~~~~~~~-~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~s 1131 (1137)
+...+..... ........|.+|+++||..||.+|+|+.|++.|+||....
T Consensus 363 ~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 363 EPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred cCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 0000000000 0113345589999999999999999999999999998654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=295.48 Aligned_cols=280 Identities=20% Similarity=0.213 Sum_probs=218.1
Q ss_pred CCCC-CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 798 PGSF-PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 798 ~~~~-~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
...+ .+|-+.+.||+|+|+.||+|.+ ..+.|||||-.+.+... .+..+.+..-+.+|..|-+.|.||.||++|+||
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr-dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR-DEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchh-hHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 3344 4688999999999999999987 46889999976665443 233445666778999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKS 952 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~--gIIHrDLKP 952 (1137)
.-+.. ..|-|+|||+|.+|+-|++. ...+++.+++.|+.||+.||.||... .|||-||||
T Consensus 537 slDtd-------------sFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKP 598 (775)
T KOG1151|consen 537 SLDTD-------------SFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKP 598 (775)
T ss_pred eeccc-------------cceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCC
Confidence 75431 46999999999999999987 35799999999999999999999976 699999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
.|||+-..+ .-|.+||.|||+++.+...... ...++......+||.+|.+||.+.-.......+.|+||||.|
T Consensus 599 gNILLv~Gt----acGeIKITDFGLSKIMdddSy~---~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvG 671 (775)
T KOG1151|consen 599 GNILLVNGT----ACGEIKITDFGLSKIMDDDSYN---SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVG 671 (775)
T ss_pred ccEEEecCc----ccceeEeeecchhhhccCCccC---cccceeeecccCceeeecCcceeecCCCCCccccceeeEeee
Confidence 999996552 2378999999999887654322 233445556778999999999987655567789999999999
Q ss_pred HHHHHHHhCCCCCCCCCH-HHHHHH--HHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001152 1033 CLLLELLTLQVPYMGLSE-LEIHDL--IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~-~el~~~--I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
||+|..+.|+.||..... .++... |.......++ . .+..+.+..++|++||+
T Consensus 672 VIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP------------------------~-KPvVsseAkaFIRRCLa 726 (775)
T KOG1151|consen 672 VIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFP------------------------P-KPVVSSEAKAFIRRCLA 726 (775)
T ss_pred hhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCC------------------------C-CCccCHHHHHHHHHHHH
Confidence 999999999999965322 222211 1111100111 0 01455678999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 001152 1110 ENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1110 ~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+.-++|....++..++++.
T Consensus 727 YRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 727 YRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hhhhhhhhHHHHccCcccc
Confidence 9999999999999998885
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=306.02 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=204.3
Q ss_pred ceEeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+..++||+|+||+||+|.|- +.+||+|++.-. ......+++ +.|+.+|.++.|||+++++|++..+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~----LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIEL----LDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHH----HHHHHHHhcCCCchHHHHhhhcccc
Confidence 345689999999999999982 246777765322 223333444 8899999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. +.||++|+|.|+|.++++.. +..+-.+..+.|..|||+||.|||.+++|||||-+.||||
T Consensus 771 ~---------------~qlvtq~mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV 831 (1177)
T KOG1025|consen 771 T---------------LQLVTQLMPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV 831 (1177)
T ss_pred h---------------HHHHHHhcccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee
Confidence 3 47999999999999999873 3468889999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
..- ..+||.|||+++.+...... +.+ ....-.+.|||-|.+.. ..|+.++|||||||++||
T Consensus 832 ksP-------~hvkitdfgla~ll~~d~~e-y~~-------~~gK~pikwmale~i~~----~~~thqSDVWsfGVtiWE 892 (1177)
T KOG1025|consen 832 KSP-------NHVKITDFGLAKLLAPDEKE-YSA-------PGGKVPIKWMALESIRI----RKYTHQSDVWSFGVTIWE 892 (1177)
T ss_pred cCC-------CeEEEEecchhhccCccccc-ccc-------cccccCcHHHHHHHhhc----cCCCchhhhhhhhhhHHH
Confidence 877 68999999999876654322 111 11223457888888864 689999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
++| |..||.+....++...+..+.+..-+. .++-++..++.+||..|+..||
T Consensus 893 lmTFGa~Py~gi~~~eI~dlle~geRLsqPp---------------------------iCtiDVy~~mvkCwmid~~~rp 945 (1177)
T KOG1025|consen 893 LMTFGAKPYDGIPAEEIPDLLEKGERLSQPP---------------------------ICTIDVYMVMVKCWMIDADSRP 945 (1177)
T ss_pred HHhcCCCccCCCCHHHhhHHHhccccCCCCC---------------------------CccHHHHHHHHHHhccCcccCc
Confidence 998 899999999999988888777532221 4555688999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
+|+++...+-...
T Consensus 946 ~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 946 TFKELAEEFSRMA 958 (1177)
T ss_pred cHHHHHHHHHHHh
Confidence 9999988765543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=278.88 Aligned_cols=227 Identities=21% Similarity=0.155 Sum_probs=172.9
Q ss_pred cCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCCccc
Q 001152 813 SVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 890 (1137)
Q Consensus 813 GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~ 890 (1137)
|.+|.||+|.+. +..+|+|+..... . . .+|...+....||||+++++++.+.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~---~----~~~~~~~~~~~~~~i~~~~~~~~~~~------------ 58 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------E---Y----SRERLTIIPHCVPNMVCLHKYIVSED------------ 58 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------h---h----hhHHHHHHhcCCCceeehhhheecCC------------
Confidence 899999999984 4668888643221 1 1 22444555667999999999988655
Q ss_pred cceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeE
Q 001152 891 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970 (1137)
Q Consensus 891 ~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~v 970 (1137)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+
T Consensus 59 --~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-------~~~ 124 (237)
T cd05576 59 --SVFLVLQHAEGGKLWSHISKF-----LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-------GHI 124 (237)
T ss_pred --eEEEEEecCCCCCHHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-------CCE
Confidence 669999999999999998762 358999999999999999999999999999999999999987 679
Q ss_pred EEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 001152 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1050 (1137)
Q Consensus 971 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~ 1050 (1137)
+++|||.+....... ....++..|+|||++.+ ..++.++||||+|+++|+|++|..|+.....
T Consensus 125 ~l~df~~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~~~~~~~~ 187 (237)
T cd05576 125 QLTYFSRWSEVEDSC-------------DGEAVENMYCAPEVGGI----SEETEACDWWSLGAILFELLTGKTLVECHPS 187 (237)
T ss_pred EEecccchhcccccc-------------ccCCcCccccCCcccCC----CCCCchhhHHHHHHHHHHHHHCcchhhcCch
Confidence 999999775443211 01235678999998754 4578899999999999999999988753211
Q ss_pred HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHHH
Q 001152 1051 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA-----GDLYEMF 1125 (1137)
Q Consensus 1051 ~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa-----~EVL~~L 1125 (1137)
. +.......++ ...++.+.+++.+||+.||++||++ +++++|+
T Consensus 188 ~-----~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~ 235 (237)
T cd05576 188 G-----INTHTTLNIP---------------------------EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHP 235 (237)
T ss_pred h-----cccccccCCc---------------------------ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCC
Confidence 0 0000000000 1234568999999999999999986 9999998
Q ss_pred Hh
Q 001152 1126 VA 1127 (1137)
Q Consensus 1126 ~~ 1127 (1137)
|+
T Consensus 236 ~~ 237 (237)
T cd05576 236 FF 237 (237)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=268.72 Aligned_cols=280 Identities=20% Similarity=0.258 Sum_probs=208.0
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeee
Q 001152 796 LDPGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYG 872 (1137)
Q Consensus 796 ~~~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg 872 (1137)
++-+..++|++.+++|+|-|+.||.|.. .+..+++|+.+.- ..+. +.||+.||..|. ||||+++++
T Consensus 32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-------kkkK----IkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-------KKKK----IKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred eeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-------HHHH----HHHHHHHHHhccCCCCeeehhh
Confidence 3445678999999999999999999985 5577888884311 1122 388999999998 999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
...+...- ...+|+||+++.+...+... ++...+..++.++++||.|+|++||+|||+||
T Consensus 101 iV~Dp~Sk------------tpaLiFE~v~n~Dfk~ly~t--------l~d~dIryY~~elLkALdyCHS~GImHRDVKP 160 (338)
T KOG0668|consen 101 IVKDPESK------------TPSLIFEYVNNTDFKQLYPT--------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKP 160 (338)
T ss_pred hhcCcccc------------CchhHhhhhccccHHHHhhh--------hchhhHHHHHHHHHHHHhHHHhcCcccccCCc
Confidence 98875421 45899999998888877643 78889999999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
+|++||... -.++|+|+|+|........ .+..+++.+|.-||.+.. -+.|+..-|+||||
T Consensus 161 hNvmIdh~~------rkLrlIDWGLAEFYHp~~e-----------YnVRVASRyfKGPELLVd---y~~YDYSLD~WS~G 220 (338)
T KOG0668|consen 161 HNVMIDHEL------RKLRLIDWGLAEFYHPGKE-----------YNVRVASRYFKGPELLVD---YQMYDYSLDMWSLG 220 (338)
T ss_pred ceeeechhh------ceeeeeecchHhhcCCCce-----------eeeeeehhhcCCchheee---chhccccHHHHHHH
Confidence 999999874 4699999999976554321 235578889999999875 35788999999999
Q ss_pred HHHHHHHhCCCCCCC-CCHHHHHHHHHcCC-CCC-----------chhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001152 1033 CLLLELLTLQVPYMG-LSELEIHDLIQMGK-RPR-----------LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1099 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~-~~~~el~~~I~~g~-~p~-----------l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1137)
|++..|+..+.||.. .+..+..-.|.+.. ... ++..+...- .......+..+...+...-.+++
T Consensus 221 cmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~---~~~~rk~w~~Fi~~~n~hl~~pe 297 (338)
T KOG0668|consen 221 CMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDIL---GRHSRKPWSRFINSENQHLVSPE 297 (338)
T ss_pred HHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHh---hccccccHHHhCCccccccCChH
Confidence 999999999999853 33322222222111 111 111111110 01111222333333333344678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1100 LVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1100 L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+.+|+.+.|..|-.+|+||.|++.|++|..
T Consensus 298 aiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 298 AIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 999999999999999999999999999974
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=308.94 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=201.8
Q ss_pred eEeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeE
Q 001152 805 SSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 874 (1137)
Q Consensus 805 ~l~~~LG~GsfG~Vy~a~~~---------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~ 874 (1137)
.+.+.||+|+||.|++|... ...||||. .+..... .+.+.+ ..|+++|+.+. |||||.++|++
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~--~k~~~~~-~~~~~~----~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKM--LKENASS-SEKKDL----MSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEe--cccccCc-HHHHHH----HHHHHHHHHhcCCcchhhheeee
Confidence 56679999999999999742 23466665 4433333 444444 88999999996 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhh---------hcCCC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS---------ETGEK--HVSVKLALFIAQDVAAALVELHSK 943 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~---------~~~~~--~ls~~~i~~I~~QIa~gL~yLHs~ 943 (1137)
..+. ..++|+||+..|+|..+++..+ ..... .++..+.+.+++|||.|++||++.
T Consensus 372 t~~~--------------~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~ 437 (609)
T KOG0200|consen 372 TQDG--------------PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV 437 (609)
T ss_pred ccCC--------------ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC
Confidence 8754 4699999999999999998855 11111 389999999999999999999999
Q ss_pred CeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccC--CCcccchhhhccccCCCC
Q 001152 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG--TPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 944 gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~G--T~~Y~APE~l~~~~~~~~ 1021 (1137)
++|||||-+.|||+..+ ..+||+|||+|+......... .. ...+ ...|||||.+.. ..
T Consensus 438 ~~vHRDLAaRNVLi~~~-------~~~kIaDFGlar~~~~~~~y~--~~-------~~~~~LP~kWmApEsl~~----~~ 497 (609)
T KOG0200|consen 438 PCVHRDLAARNVLITKN-------KVIKIADFGLARDHYNKDYYR--TK-------SSAGTLPVKWMAPESLFD----RV 497 (609)
T ss_pred CccchhhhhhhEEecCC-------CEEEEccccceeccCCCCceE--ec-------CCCCccceeecCHHHhcc----Cc
Confidence 99999999999999988 789999999998544322110 00 1112 235999999975 67
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLT-LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1099 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLT-G~~Pf~~~~-~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1137)
|+.|+|||||||++||++| |..||.+.. ..++...+..|.+...+. .+.++
T Consensus 498 ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~---------------------------~c~~e 550 (609)
T KOG0200|consen 498 FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPE---------------------------HCSDE 550 (609)
T ss_pred ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCC---------------------------CCCHH
Confidence 9999999999999999999 789998754 666777777777644332 45667
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001152 1100 LVDVFRRCTEENPTERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1100 L~dLl~~CL~~DP~~RPSa~EVL~~L~~ 1127 (1137)
+.++++.||+.+|++||++.++.+.+..
T Consensus 551 iY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 551 IYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 9999999999999999999999887765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=282.88 Aligned_cols=285 Identities=23% Similarity=0.293 Sum_probs=202.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-----C---CCcceee
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----H---SCIVEMY 871 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-----H---pNIVkll 871 (1137)
.+|.+.++||-|.|++||+|.+. .+.||+||.+.. +.+....+.||++|++++ | .+||+++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---------QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---------hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 57999999999999999999985 478999985422 122223478999999985 2 3799999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccC
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDI 950 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrDL 950 (1137)
++|...+ ++..|+|||+|++ |..|..+|.... ...++...++.|++||+.||.|||.. ||||-||
T Consensus 149 D~FkhsG----------pNG~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDl 214 (590)
T KOG1290|consen 149 DHFKHSG----------PNGQHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDL 214 (590)
T ss_pred ccceecC----------CCCcEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCC
Confidence 9998754 3455999999999 789999998743 34599999999999999999999965 9999999
Q ss_pred CCCCeEecccc---------------------------------------------------------------------
Q 001152 951 KSENILIDLER--------------------------------------------------------------------- 961 (1137)
Q Consensus 951 KP~NILld~~~--------------------------------------------------------------------- 961 (1137)
||+|||+....
T Consensus 215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~ 294 (590)
T KOG1290|consen 215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI 294 (590)
T ss_pred CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence 99999995431
Q ss_pred ------------------------------------------cc------------------------------------
Q 001152 962 ------------------------------------------KK------------------------------------ 963 (1137)
Q Consensus 962 ------------------------------------------~~------------------------------------ 963 (1137)
..
T Consensus 295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~ 374 (590)
T KOG1290|consen 295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI 374 (590)
T ss_pred cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence 00
Q ss_pred ------------CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001152 964 ------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031 (1137)
Q Consensus 964 ------------~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1031 (1137)
......|||+|||.|+...... +.-+.|..|+|||++.+ ..|++.+||||+
T Consensus 375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khF-------------T~DIQTRQYRapEVllG----sgY~~~ADiWS~ 437 (590)
T KOG1290|consen 375 ASNPLVNPDIPLPECDIRVKIADLGNACWVHKHF-------------TEDIQTRQYRAPEVLLG----SGYSTSADIWST 437 (590)
T ss_pred ccccccCCCCCCCccceeEEEeeccchhhhhhhh-------------chhhhhhhccCcceeec----CCCCCchhHHHH
Confidence 0001246777777776543211 12258889999999997 689999999999
Q ss_pred HHHHHHHHhCCCCCCC-------CCHHHHHHHH-HcCCCCCchhHHhhhccc---------ccccccccCCCCC------
Q 001152 1032 GCLLLELLTLQVPYMG-------LSELEIHDLI-QMGKRPRLTDELEALGSC---------HEHEVAQSGSGFE------ 1088 (1137)
Q Consensus 1032 GviL~ELLTG~~Pf~~-------~~~~el~~~I-~~g~~p~l~~~l~~~~~~---------~~~~~~~~~~~~~------ 1088 (1137)
+|++|||+||.+.|.. .+...+...+ .-|..|+ .+...+.. ....+.+. ..+.
T Consensus 438 AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr---~ia~~Gk~SRdFFnr~G~LrhI~~L-K~WpL~~VL~ 513 (590)
T KOG1290|consen 438 ACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPR---KIALGGKYSRDFFNRRGELRHIRRL-KPWPLYEVLI 513 (590)
T ss_pred HHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccH---HHHhcCcchHhhhccccceeccccc-CCCcHHHHHH
Confidence 9999999999988852 2222233333 2222222 11111000 00001110 0110
Q ss_pred -CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1089 -KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1089 -~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+.....+...++.+|+.-||+.+|++||||.++++|+|....
T Consensus 514 eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 514 EKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPV 556 (590)
T ss_pred HHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCC
Confidence 112233667889999999999999999999999999999844
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=305.33 Aligned_cols=290 Identities=14% Similarity=0.118 Sum_probs=175.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
...+|++.++||+|+||.||+|++. +..+|+|.. .... .. +.. .. ..+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~--~~~~--~~--e~~----~~--e~l~~~~~~~~~~~~~~ 197 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKA--TEYG--AV--EIW----MN--ERVRRACPNSCADFVYG 197 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEe--cccc--hh--HHH----HH--HHHHhhchhhHHHHHHh
Confidence 4678999999999999999999985 346777753 2211 11 111 11 11222233344433333
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc---------------CCCCCCHHHHHHHHHHHHHHHH
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------------GEKHVSVKLALFIAQDVAAALV 938 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~---------------~~~~ls~~~i~~I~~QIa~gL~ 938 (1137)
+..... .....+.++||||+++++|.++++..... .........+..|+.||+.||+
T Consensus 198 ~~~~~~--------~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~ 269 (566)
T PLN03225 198 FLEPVS--------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALD 269 (566)
T ss_pred hhcccc--------cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHH
Confidence 221110 00122679999999999999998652100 0011223456789999999999
Q ss_pred HHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001152 939 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1018 (1137)
Q Consensus 939 yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1018 (1137)
|||+++|+||||||+|||++.+. +.+||+|||+++.+..... .......+|+.|+|||.+.....
T Consensus 270 yLH~~gIiHRDLKP~NILl~~~~------~~~KL~DFGlA~~l~~~~~---------~~~~~~~~t~~Y~APE~~~~~~~ 334 (566)
T PLN03225 270 GLHSTGIVHRDVKPQNIIFSEGS------GSFKIIDLGAAADLRVGIN---------YIPKEFLLDPRYAAPEQYIMSTQ 334 (566)
T ss_pred HHHHCCEEeCcCCHHHEEEeCCC------CcEEEEeCCCccccccccc---------cCCcccccCCCccChHHhhccCC
Confidence 99999999999999999998542 6799999999975432211 11124568999999997643111
Q ss_pred C------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccc
Q 001152 1019 P------------------NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV 1080 (1137)
Q Consensus 1019 ~------------------~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~ 1080 (1137)
. ..++.++|||||||++|||+++..|+.. ........+...... +.. +.... .....
T Consensus 335 ~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~-~~~~~~~~l~~~~~~-~~~-~~~~~--~~~~~ 409 (566)
T PLN03225 335 TPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS-NLIQFNRQLKRNDYD-LVA-WRKLV--EPRAS 409 (566)
T ss_pred CCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch-HHHHHHHHHHhcCCc-HHH-HHHhh--ccccc
Confidence 0 1234577999999999999998666532 122222222221111 110 00000 00000
Q ss_pred cccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 001152 1081 AQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ss 1132 (1137)
.+....+.. .........+|+.+||+.||.+|||+.|+++|+|+.....
T Consensus 410 ~~~~~~~~~---~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 410 PDLRRGFEV---LDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hhhhhhhhh---ccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 000000000 0012234678999999999999999999999999986544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=265.20 Aligned_cols=241 Identities=33% Similarity=0.418 Sum_probs=188.9
Q ss_pred CceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCCcccc
Q 001152 814 VSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891 (1137)
Q Consensus 814 sfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~ 891 (1137)
+||.||+|.+.+ ..+++|+....... .. .+. +.+|++.+++++|+||+++++++....
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~~-~~~----~~~e~~~~~~l~~~~i~~~~~~~~~~~------------- 60 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK--KK-RER----ILREISILKKLKHPNIVRLYDVFEDED------------- 60 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc--cH-HHH----HHHHHHHHHhCCCCcHHHHHhheeeCC-------------
Confidence 589999999854 77888875433221 11 233 478999999999999999999987654
Q ss_pred ceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEE
Q 001152 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971 (1137)
Q Consensus 892 ~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vK 971 (1137)
..++||||+++++|.+++... ..+++..+..++.+++.++.|||+.+|+|+||+|+||+++.+ +.++
T Consensus 61 -~~~l~~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-------~~~~ 127 (244)
T smart00220 61 -KLYLVMEYCDGGDLFDLLKKR-----GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-------GHVK 127 (244)
T ss_pred -EEEEEEeCCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-------CcEE
Confidence 569999999988999998761 238999999999999999999999999999999999999977 7899
Q ss_pred EeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCH
Q 001152 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSE 1050 (1137)
Q Consensus 972 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~-~~~ 1050 (1137)
|+|||.+........ .....++..|++||.+.+ ..++.++||||||+++|+|++|..||.. ...
T Consensus 128 l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~pE~~~~----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~ 192 (244)
T smart00220 128 LADFGLARQLDPGGL-----------LTTFVGTPEYMAPEVLLG----KGYGKAVDVWSLGVILYELLTGKPPFPGDDQL 192 (244)
T ss_pred Eccccceeeeccccc-----------cccccCCcCCCCHHHHcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999876543211 113357889999999874 4567899999999999999999999977 444
Q ss_pred HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001152 1051 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1051 ~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~ 1127 (1137)
......+........... ...+.++.+++.+||..+|++||++.++++++|+
T Consensus 193 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 193 LELFKKIGKPKPPFPPPE-------------------------WKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHHhccCCCCcccc-------------------------ccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 444444443332111100 0134568999999999999999999999999875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=289.97 Aligned_cols=266 Identities=21% Similarity=0.256 Sum_probs=194.5
Q ss_pred ceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|..++.||-|+||.|.+++..++ .+|+|. +.+... ..++.-.-+..|-.||.....+-||++|-.|.+++
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKT--LrKaDV---l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--- 702 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKT--LRKADV---LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--- 702 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhh--hHHHHH---HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC---
Confidence 56778999999999999986554 455554 332111 11111122366889999999999999999999887
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
.+|+||+|++||++..+|-+ ...|.+..++.++..+..|+++.|..|+|||||||+|||||.+
T Consensus 703 -----------nLYFVMdYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd- 765 (1034)
T KOG0608|consen 703 -----------NLYFVMDYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD- 765 (1034)
T ss_pred -----------ceEEEEeccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-
Confidence 67999999999999998866 2579999999999999999999999999999999999999998
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCC--------------------------------CCCCCcccCCCcccc
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--------------------------------IPAPDVCVGTPRWMA 1009 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~GT~~Y~A 1009 (1137)
|++||.|||+|.-+.-.....+..... .......+||+.|+|
T Consensus 766 ------GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyia 839 (1034)
T KOG0608|consen 766 ------GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIA 839 (1034)
T ss_pred ------CceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccC
Confidence 999999999996432111111110000 001123589999999
Q ss_pred hhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCC
Q 001152 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFE 1088 (1137)
Q Consensus 1010 PE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~ 1088 (1137)
||++.. ..|++-+|+||.|||||||+.|+.||....+.+....|.... ...++
T Consensus 840 pevl~r----~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~---------------------- 893 (1034)
T KOG0608|consen 840 PEVLAR----TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIP---------------------- 893 (1034)
T ss_pred hHHhcc----cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccc----------------------
Confidence 999975 678999999999999999999999998766554433332110 00011
Q ss_pred CchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhcC
Q 001152 1089 KPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1089 ~~~~~~~~~~~L~dLl~~CL~~DP~~RP---Sa~EVL~~L~~~~~ 1130 (1137)
...+.++++.++|.+++ -+++.|. -++||-.|+||+.-
T Consensus 894 ---~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 894 ---YQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred ---cccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 11245566778776654 3556665 67889999999753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=305.18 Aligned_cols=258 Identities=26% Similarity=0.328 Sum_probs=192.2
Q ss_pred eEeeeecccCceE-EEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCCCCC
Q 001152 805 SSCDEAGKSVSSS-LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 805 ~l~~~LG~GsfG~-Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~~~~ 882 (1137)
.-.+.+|.|+.|+ ||+|.+.++.||||.+. .++...+.+||..|+.-. |||||++|+.-.+..
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll-----------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q---- 576 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLL-----------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQ---- 576 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeCCceehHHHHh-----------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCc----
Confidence 3446799999987 79999999999998642 122233588999999986 999999998876665
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
..||..|+|. .+|.+++.... ........-..+.++.|+++||+|||+.+||||||||.||||+...
T Consensus 577 ----------F~YIalELC~-~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~- 643 (903)
T KOG1027|consen 577 ----------FLYIALELCA-CSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS- 643 (903)
T ss_pred ----------eEEEEehHhh-hhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC-
Confidence 5699999996 99999998631 1111111134577899999999999999999999999999998742
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC-
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL- 1041 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG- 1041 (1137)
..+...++|+|||+++.+......- .......||-+|+|||++... .-+.++|||||||++|+.++|
T Consensus 644 -~~~~~ra~iSDfglsKkl~~~~sS~-------~r~s~~sGt~GW~APE~L~~~----~~~~avDiFslGCvfyYvltgG 711 (903)
T KOG1027|consen 644 -ADGTLRAKISDFGLSKKLAGGKSSF-------SRLSGGSGTSGWQAPEQLRED----RKTQAVDIFSLGCVFYYVLTGG 711 (903)
T ss_pred -CCcceeEEecccccccccCCCcchh-------hcccCCCCcccccCHHHHhcc----ccCcccchhhcCceEEEEecCC
Confidence 2344789999999999876543221 113356799999999999863 335699999999999999986
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 001152 1042 QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121 (1137)
Q Consensus 1042 ~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EV 1121 (1137)
.+||... .+....|..+...-. .. ....++ ++.+||.+|+++||..||+|.+|
T Consensus 712 ~HpFGd~--~~R~~NIl~~~~~L~-----~L------------------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~V 764 (903)
T KOG1027|consen 712 SHPFGDS--LERQANILTGNYTLV-----HL------------------EPLPDC--EAKDLISRMLNPDPQLRPSATDV 764 (903)
T ss_pred ccCCCch--HHhhhhhhcCcccee-----ee------------------ccCchH--HHHHHHHHhcCCCcccCCCHHHH
Confidence 9999642 222233443332110 00 000011 68999999999999999999999
Q ss_pred HHHHHhhc
Q 001152 1122 YEMFVART 1129 (1137)
Q Consensus 1122 L~~L~~~~ 1129 (1137)
+.||+|..
T Consensus 765 L~HPlFW~ 772 (903)
T KOG1027|consen 765 LNHPLFWD 772 (903)
T ss_pred hCCCccCC
Confidence 99998864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=256.86 Aligned_cols=227 Identities=24% Similarity=0.377 Sum_probs=180.7
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~ 880 (1137)
++......||+|++|.|-+.++......++++.+..+..... +.+.++|+.+..+. .+|.+|.+||.+....
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~-----q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-- 118 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE-----QKRLLMDLDIIMRTVDCPFTVHFYGALFREG-- 118 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH-----HHHHHHhhhhhccCCCCCeEEEeehhhhccc--
Confidence 344566789999999998888755444444433444433222 23447898877666 4999999999887655
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeEecc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDL 959 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrDLKP~NILld~ 959 (1137)
..||.||.|+ .||..+.++..+.+ ..+++..+=+|+..|+.||.|||++ .|||||+||+||||+.
T Consensus 119 ------------dvwIcME~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~ 184 (282)
T KOG0984|consen 119 ------------DVWICMELMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY 184 (282)
T ss_pred ------------cEEEeHHHhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc
Confidence 5699999996 89999888776665 5799999999999999999999986 8999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ |+||+||||.+..+.+.... +..+|-..|||||.+....+...|+-|+||||||+.+.||.
T Consensus 185 ~-------GqVKiCDFGIsG~L~dSiAk-----------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA 246 (282)
T KOG0984|consen 185 D-------GQVKICDFGISGYLVDSIAK-----------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA 246 (282)
T ss_pred C-------CcEEEcccccceeehhhhHH-----------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh
Confidence 8 89999999999776653321 23467789999999987766678999999999999999999
Q ss_pred hCCCCCCC-CCHHHHHHHHHcCCCCCchh
Q 001152 1040 TLQVPYMG-LSELEIHDLIQMGKRPRLTD 1067 (1137)
Q Consensus 1040 TG~~Pf~~-~~~~el~~~I~~g~~p~l~~ 1067 (1137)
++++||.. ..+.+...++.....|.++.
T Consensus 247 ~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 247 ILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 99999975 57788888887777666653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=270.39 Aligned_cols=258 Identities=21% Similarity=0.330 Sum_probs=199.7
Q ss_pred CCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEec
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 876 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~ 876 (1137)
.+.+|.+.++||+|+|..|.+++... +-+|+||.+.+....+. + ..+.+.|-.+..+. +||.+|-+..+|..
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndde-d----idwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDE-D----IDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcc-c----chhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 46889999999999999999999865 55778875544332211 1 12446677777766 59999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
+. .+++|.||++||+|.-++++ ...++++.++.+...|..||.|||++|||+||||.+|+|
T Consensus 323 es--------------rlffvieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvl 383 (593)
T KOG0695|consen 323 ES--------------RLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVL 383 (593)
T ss_pred cc--------------eEEEEEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceE
Confidence 76 67999999999999988876 346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
+|.+ +++||.|||+++.--.+. ....++.|||.|.|||++.+ ..|+..+|+|+|||+++
T Consensus 384 ldae-------ghikltdygmcke~l~~g----------d~tstfcgtpnyiapeilrg----eeygfsvdwwalgvlmf 442 (593)
T KOG0695|consen 384 LDAE-------GHIKLTDYGMCKEGLGPG----------DTTSTFCGTPNYIAPEILRG----EEYGFSVDWWALGVLMF 442 (593)
T ss_pred EccC-------CceeecccchhhcCCCCC----------cccccccCCCcccchhhhcc----cccCceehHHHHHHHHH
Confidence 9988 899999999997543322 22346789999999999987 67999999999999999
Q ss_pred HHHhCCCCCCC-------CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001152 1037 ELLTLQVPYMG-------LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1037 ELLTG~~Pf~~-------~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
||+.|+.||.- .+..+...++.-...-.++..+ +-....+++.-|+
T Consensus 443 emmagrspfdivgm~n~d~ntedylfqvilekqiriprsl---------------------------svkas~vlkgfln 495 (593)
T KOG0695|consen 443 EMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL---------------------------SVKASHVLKGFLN 495 (593)
T ss_pred HHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee---------------------------ehhhHHHHHHhhc
Confidence 99999999952 2222322222111111222211 1125667888899
Q ss_pred cCCCCCC------CHHHHHHHHHhhc
Q 001152 1110 ENPTERP------TAGDLYEMFVART 1129 (1137)
Q Consensus 1110 ~DP~~RP------Sa~EVL~~L~~~~ 1129 (1137)
+||.+|. .++++-.|.+|+.
T Consensus 496 kdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 496 KDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred CCcHHhcCCCcccchhhhhcchhhhh
Confidence 9999985 5789999988863
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=284.80 Aligned_cols=280 Identities=21% Similarity=0.281 Sum_probs=209.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC------CCCcceeeee
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR------HSCIVEMYGH 873 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~------HpNIVkllg~ 873 (1137)
.+|.+....|+|-|++|.+|.+. +..|||||..-... -.+.- ++|++||++|+ --|+++++..
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-----M~KtG----l~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-----MHKTG----LKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-----Hhhhh----hHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 46888899999999999999984 57899998542211 11111 67999999996 2489999988
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
|...+ |+|||+|-+. ..|.+.++++... ..|....+..+++|+..||.+|-..||+|.||||+
T Consensus 503 F~hkn--------------HLClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPD 565 (752)
T KOG0670|consen 503 FKHKN--------------HLCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPD 565 (752)
T ss_pred hhhcc--------------eeEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcCeeecccCcc
Confidence 88665 8899999885 8999999986433 46888999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||+++.. ..+||||||.|........+. ..-+..|.|||++.| .+|+...|+||.||
T Consensus 566 NiLVNE~k------~iLKLCDfGSA~~~~eneitP------------YLVSRFYRaPEIiLG----~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 566 NILVNESK------NILKLCDFGSASFASENEITP------------YLVSRFYRAPEIILG----LPYDYPIDTWSVGC 623 (752)
T ss_pred ceEeccCc------ceeeeccCccccccccccccH------------HHHHHhccCcceeec----CcccCCccceeece
Confidence 99998763 689999999997766544332 234558999999998 57899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHH--HcCCCCCc--------hhHHhhhccc---ccccccccC----------------
Q 001152 1034 LLLELLTLQVPYMGLSELEIHDLI--QMGKRPRL--------TDELEALGSC---HEHEVAQSG---------------- 1084 (1137)
Q Consensus 1034 iL~ELLTG~~Pf~~~~~~el~~~I--~~g~~p~l--------~~~l~~~~~~---~~~~~~~~~---------------- 1084 (1137)
+||||.||+..|.+....++.... ..|..|.- .+.+...-.. ....+....
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s 703 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGS 703 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHH
Confidence 999999999999997776666554 33443320 0001000000 000000000
Q ss_pred ---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1085 ---SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1085 ---~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
..-..++.......++++|+.+||..||++|.|..|+|+|+|+..
T Consensus 704 ~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 704 ELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 000123334466788999999999999999999999999999863
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=286.66 Aligned_cols=293 Identities=18% Similarity=0.191 Sum_probs=185.0
Q ss_pred CCCCceEeeeecccCceEEEEEEE------------------CCccEEEEEEecccCCCChHHH------HHhHHhHHHH
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKF------------------GSADAAAKVRTLKVCGSSADEI------RNFEYSCLGE 855 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~------------------~~~~vAVKi~~l~~~~~~~~~~------e~~~~~~lrE 855 (1137)
+.++|++.++||+|+||+||+|.+ .+..||||...........+-. .........|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 456899999999999999999964 1245788864332211100000 0011123457
Q ss_pred HHHHHhCCCCCc-----ceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--------------
Q 001152 856 VRMLGALRHSCI-----VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------- 916 (1137)
Q Consensus 856 i~iL~~L~HpNI-----Vkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-------------- 916 (1137)
+.++.+++|.++ +++++++.... .++. ......++||||+++++|.++++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~----~~g~--~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~ 296 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNT----ADGA--FTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKK 296 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhccccc----cccc--ccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCc
Confidence 788888876654 67777775421 0111 0112579999999999999998742100
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccc
Q 001152 917 -----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA 991 (1137)
Q Consensus 917 -----~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~ 991 (1137)
....+++..++.|+.||+.||.|||+++|+||||||+|||++.+ +.+||+|||++.........
T Consensus 297 l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-------~~~kL~DFGla~~~~~~~~~---- 365 (507)
T PLN03224 297 IPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-------GQVKIIDFGAAVDMCTGINF---- 365 (507)
T ss_pred hhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-------CcEEEEeCcCccccccCCcc----
Confidence 11235678899999999999999999999999999999999877 67999999998654321110
Q ss_pred cCCCCCCCcccCCCcccchhhhccccCCC----------------CC--CchhhHHHHHHHHHHHHhCCC-CCCCCCHHH
Q 001152 992 HRGIPAPDVCVGTPRWMAPEVLRAMHKPN----------------LY--GLEVDIWSYGCLLLELLTLQV-PYMGLSELE 1052 (1137)
Q Consensus 992 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~----------------~~--s~ksDVWSLGviL~ELLTG~~-Pf~~~~~~e 1052 (1137)
......+|+.|+|||.+....... .+ ..+.||||+||++|+|+++.. ||.......
T Consensus 366 -----~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~ 440 (507)
T PLN03224 366 -----NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN 440 (507)
T ss_pred -----CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh
Confidence 011223578999999975311000 01 235799999999999999875 665422111
Q ss_pred HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC---CCCCCHHHHHHHHHhhc
Q 001152 1053 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP---TERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1053 l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP---~~RPSa~EVL~~L~~~~ 1129 (1137)
. .+... ......+. ........+. .....++..++|+.+||..+| .+|+|++|+++|+|+..
T Consensus 441 ~--~~~~~-----~~~~~~~r-----~~~~~~~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 441 T--ELRQY-----DNDLNRWR-----MYKGQKYDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred h--HHhhc-----cchHHHHH-----hhcccCCCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 1 00000 00000000 0000000011 011345679999999999866 68999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=270.31 Aligned_cols=282 Identities=19% Similarity=0.235 Sum_probs=201.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|.-.+.+|.|+- .|..|.+. ++.||+|....+ .......+ ++.+|..++..+.|+||++++.+|.-...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~ak----ra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAK----RAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCc--cccCccch----hhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 46777888999998 67777664 456666643222 22222222 34889999999999999999999875442
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ....+.|+|||||. .+|...+.- .++-.++..|++|++.|++|||+.||+||||||+||++..
T Consensus 90 l--------~~~~e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~ 153 (369)
T KOG0665|consen 90 L--------EEFQEVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNS 153 (369)
T ss_pred H--------HHHHhHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecc
Confidence 2 23446899999996 899998873 4788999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||.|||+|+...... ..+..+.|..|+|||++.+. .|.+.+||||+||++.||+
T Consensus 154 ~-------~~lKi~dfg~ar~e~~~~-----------~mtpyVvtRyyrapevil~~----~~ke~vdiwSvGci~gEli 211 (369)
T KOG0665|consen 154 D-------CTLKILDFGLARTEDTDF-----------MMTPYVVTRYYRAPEVILGM----GYKENVDIWSVGCIMGELI 211 (369)
T ss_pred h-------hheeeccchhhcccCccc-----------ccCchhheeeccCchheecc----CCcccchhhhhhhHHHHHh
Confidence 8 889999999997544321 12245788999999999873 3889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHH-cCCCCC--chhHHhhhcccc-----ccc---ccccCCCCCCchh---hhhhHHHHHHHHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQ-MGKRPR--LTDELEALGSCH-----EHE---VAQSGSGFEKPEA---ELETLSFLVDVFR 1105 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~-~g~~p~--l~~~l~~~~~~~-----~~~---~~~~~~~~~~~~~---~~~~~~~L~dLl~ 1105 (1137)
+|+.-|.+.+..+...++. .-..|. +-..+....... .+. ..+..+...++.. +......+++++.
T Consensus 212 ~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~ 291 (369)
T KOG0665|consen 212 LGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLS 291 (369)
T ss_pred hceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHH
Confidence 9999999876665555542 222222 111111110000 000 0001111111110 1134556899999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhh
Q 001152 1106 RCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1106 ~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+||..||++|.+++++|.||+++
T Consensus 292 ~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 292 KMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhccChhhcccHHHHhcCCeee
Confidence 99999999999999999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=267.67 Aligned_cols=286 Identities=18% Similarity=0.235 Sum_probs=202.3
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+.+--+.||-|+||+||.+++. ++.++.|. .......... .+++.+|+++|..++|.|++..++...-...
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK--~pnvfq~L~s----~krvFre~kmLcfFkHdNVLSaLDILQPph~- 126 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKK--MPNVFQNLAS----CKRVFREIKMLSSFRHDNVLSLLDILQPANP- 126 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhh--cchHHHHHHH----HHHHHHHHHHHHhhccccHHHHHHhcCCCCc-
Confidence 4455578999999999999984 45566653 2222111222 2345899999999999999998887654220
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
.-..+.|+|+|+|. .+|..+|-. ...++...++-+++||++||+|||+.+|.||||||.|.|++.+
T Consensus 127 --------dfFqEiYV~TELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN 192 (449)
T KOG0664|consen 127 --------SFFQELYVLTELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN 192 (449)
T ss_pred --------hHHHHHHHHHHHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC
Confidence 01235789999995 899988865 4579999999999999999999999999999999999999988
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
..+||||||+++........ ..+..+-|.+|+|||+++|. ..|+.++||||.|||+.||+.
T Consensus 193 -------CvLKICDFGLARvee~d~~~---------hMTqEVVTQYYRAPEiLMGa---RhYs~AvDiWSVGCIFaELLg 253 (449)
T KOG0664|consen 193 -------CILKICDFGLARTWDQRDRL---------NMTHEVVTQYYRAPELLMGA---RRYTGAVDIWSVGCIFAELLQ 253 (449)
T ss_pred -------ceEEecccccccccchhhhh---------hhHHHHHHHHhccHHHhhcc---hhhcCccceehhhHHHHHHHh
Confidence 89999999999864432211 11123568899999999973 678999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchh-----hhhhHHHHHHHHHHhcccCCCC
Q 001152 1041 LQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEA-----ELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
.+..|+..++.+..+.|..-. .|....--..-.+...+.........+.+.. ......+...++..++..||++
T Consensus 254 RrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dk 333 (449)
T KOG0664|consen 254 RKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDK 333 (449)
T ss_pred hhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcc
Confidence 999999888877777764322 2222211000001111111111111111100 1133445677889999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001152 1115 RPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~ 1128 (1137)
|.+.++.+.|++..
T Consensus 334 ris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 334 RISVEEALQHRYLE 347 (449)
T ss_pred cccHhhhccccccc
Confidence 99999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=291.41 Aligned_cols=260 Identities=28% Similarity=0.430 Sum_probs=211.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
-++|++.+++|.|+||.||+|++. +..+|+|+.+++.. +++... ++|+-+++..+|||||.+++.|...+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~i----qqei~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGI----QQEIGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC----cccccc----ccceeeeecCCCcChHHHHhhhhhhc
Confidence 467999999999999999999984 57899999877753 233333 66899999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.+|++||||.||+|.+..+- ..++++.++..+.+..++||+|||++|-+|||||-.||+++
T Consensus 86 --------------klwicMEycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt 146 (829)
T KOG0576|consen 86 --------------KLWICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT 146 (829)
T ss_pred --------------CcEEEEEecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec
Confidence 56999999999999997654 35799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
+. +.+|++|||.+..+.... .....+.||++|||||+..- .....|.+++|||++|+...|+
T Consensus 147 d~-------gDvklaDfgvsaqitati----------~KrksfiGtpywmapEvaav-erkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 147 DE-------GDVKLADFGVSAQITATI----------AKRKSFIGTPYWMAPEVAAV-ERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred cc-------CceeecccCchhhhhhhh----------hhhhcccCCccccchhHHHH-Hhcccccccccccccccchhhh
Confidence 88 789999999886554321 22346789999999998642 2456799999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHc-CCCCC-chhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQM-GKRPR-LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~-g~~p~-l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
..-++|.....+++....+.+ +..|. +.+. ....+.+.+|++.++..+|++||
T Consensus 209 ~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk-------------------------~kws~~fh~fvK~altknpKkRp 263 (829)
T KOG0576|consen 209 GELQPPLFDLHPMRALFLMTKSGFQPPTLKDK-------------------------TKWSEFFHNFVKGALTKNPKKRP 263 (829)
T ss_pred hhcCCcccccchHHHHHHhhccCCCCCcccCC-------------------------ccchHHHHHHHHHHhcCCCccCC
Confidence 999999888888777666633 22221 1110 02344589999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
+++.++.|++...+
T Consensus 264 taeklL~h~fvs~~ 277 (829)
T KOG0576|consen 264 TAEKLLQHPFVSQT 277 (829)
T ss_pred Chhhheeceeeccc
Confidence 99999999876543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=273.64 Aligned_cols=210 Identities=26% Similarity=0.346 Sum_probs=167.9
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCCh-HHHHHhHHhHHHHHHHHHhCC---CCCcce
Q 001152 796 LDPGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSA-DEIRNFEYSCLGEVRMLGALR---HSCIVE 869 (1137)
Q Consensus 796 ~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~-~~~e~~~~~~lrEi~iL~~L~---HpNIVk 869 (1137)
..+..+.+|+..+.+|.|+||.|++|.++. ..|++|....+..-.+. -..+.. -.+-.||+||..++ |+||++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkL-GtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKL-GTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhccccc-CccchhHHHHHHhhhcCccchhh
Confidence 345678899999999999999999999965 45666653322211100 000000 01245999999997 999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeec-cCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 001152 870 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYV-KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948 (1137)
Q Consensus 870 llg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~-~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHr 948 (1137)
++++|+++++ +||+||-- +|-+|.++|.. .+.+++..+..|++||+.|++|||++|||||
T Consensus 634 lLdfFEddd~--------------yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~ivhr 694 (772)
T KOG1152|consen 634 LLDFFEDDDY--------------YYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHR 694 (772)
T ss_pred hhheeecCCe--------------eEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccCceec
Confidence 9999999884 49999974 45699999976 4679999999999999999999999999999
Q ss_pred cCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhH
Q 001152 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028 (1137)
Q Consensus 949 DLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1028 (1137)
|||-+|+.++.+ |.+||+|||.+....... -+.++||..|.|||++.| ..+.++.-||
T Consensus 695 dikdenvivd~~-------g~~klidfgsaa~~ksgp------------fd~f~gtv~~aapevl~g---~~y~gk~qdi 752 (772)
T KOG1152|consen 695 DIKDENVIVDSN-------GFVKLIDFGSAAYTKSGP------------FDVFVGTVDYAAPEVLGG---EKYLGKPQDI 752 (772)
T ss_pred ccccccEEEecC-------CeEEEeeccchhhhcCCC------------cceeeeeccccchhhhCC---CccCCCcchh
Confidence 999999999988 899999999886544322 236789999999999986 3456899999
Q ss_pred HHHHHHHHHHHhCCCCCCC
Q 001152 1029 WSYGCLLLELLTLQVPYMG 1047 (1137)
Q Consensus 1029 WSLGviL~ELLTG~~Pf~~ 1047 (1137)
||+|+++|.++....||..
T Consensus 753 walgillytivykenpyyn 771 (772)
T KOG1152|consen 753 WALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhheeeEEEeccCCCcC
Confidence 9999999999999989863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=302.29 Aligned_cols=282 Identities=23% Similarity=0.290 Sum_probs=194.6
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCCCCcEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNL 96 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~-~IP~~~~~L~~L~~L 96 (1137)
.++.|.+..|++++..+. ..+++|++|||++|.+++.+|..++.+ ++|++|+|++|.++ .+|..|+++++|++|
T Consensus 119 ~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l---~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 193 (968)
T PLN00113 119 SLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF---SSLKVLDLGGNVLVGKIPNSLTNLTSLEFL 193 (968)
T ss_pred CCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcC---CCCCEEECccCcccccCChhhhhCcCCCee
Confidence 577777777777655443 456777778888777777777666544 77777777777775 567777777777777
Q ss_pred EccCCCCC-cccccccCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCC
Q 001152 97 KFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1137)
Q Consensus 97 ~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1137)
+|++|.++ .+|..++++++|+.|+|++|.+. .+|..+.++++|++|++++|.+ .+.+|..++++++|+.|++++|
T Consensus 194 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l---~~~~p~~l~~l~~L~~L~L~~n 270 (968)
T PLN00113 194 TLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL---TGPIPSSLGNLKNLQYLFLYQN 270 (968)
T ss_pred eccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCcee---ccccChhHhCCCCCCEEECcCC
Confidence 77777776 56777777777777777777744 5666777777777777777433 3456667777777777777777
Q ss_pred CCc-ccCccccCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccCCcCCCCCcc
Q 001152 175 SIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSL 251 (1137)
Q Consensus 175 ~L~-~IP~~l~~L~~L~~L~Ls~N~L~-~LP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~N~Lsg~~p~ 251 (1137)
.++ .+|..+.++++|+.|+|++|+++ .+|..+.++++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++.+|.
T Consensus 271 ~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~ 350 (968)
T PLN00113 271 KLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350 (968)
T ss_pred eeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCCh
Confidence 776 56777777777777777777776 66777777777777777777776 5677777777777777777777777776
Q ss_pred cccCCCCCCEEEccCCcCCCCCCCCcchh-------hccCCCCCCCC-------CCCcccccccccccCCCc
Q 001152 252 DLCLMHNLQNLNLQYNKLLSYCQVPSWIC-------CNLEGNGKDSS-------NDDFISSSAEMDVYEGPM 309 (1137)
Q Consensus 252 ~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~-------~~l~~n~l~~~-------~~~l~~~~~s~n~l~g~i 309 (1137)
.+..+++|+.|+|++|++++ .+|.+++ +++.+|.+... .+.+...++++|.+.|.+
T Consensus 351 ~l~~~~~L~~L~Ls~n~l~~--~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~ 420 (968)
T PLN00113 351 NLGKHNNLTVLDLSTNNLTG--EIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420 (968)
T ss_pred HHhCCCCCcEEECCCCeeEe--eCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeEC
Confidence 77777777777777777765 3343332 34444443321 224445555566555543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=253.04 Aligned_cols=258 Identities=22% Similarity=0.318 Sum_probs=204.8
Q ss_pred CceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
++++...+-+|.||.||+|.|.. +.|.||. ++. ....-+... ++.|...+..+.|||+..+.+...
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKT--vk~-~AS~iQv~~----~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKT--VKQ-HASQIQVNL----LLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHH--HHh-cccHHHHHH----HHHHHHHHhcCcCCCccceeEEEe
Confidence 46777889999999999998742 2344443 222 122333333 488988899999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE---TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~---~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
++.. ..++++.++.-|.|..+++.++. .....++..+...++.|++.|++|||++||||.||.+
T Consensus 358 e~~~-------------~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAa 424 (563)
T KOG1024|consen 358 EDYA-------------TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAA 424 (563)
T ss_pred eccC-------------cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhh
Confidence 6431 45889999988999999985532 2334677788899999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
.|.+|++. .++||+|=.+++.+......+-... .-....||+||.+.. ..|+.++||||||
T Consensus 425 RNCvIdd~-------LqVkltDsaLSRDLFP~DYhcLGDn--------EnRPvkWMslEal~n----~~yssasDvWsfG 485 (563)
T KOG1024|consen 425 RNCVIDDQ-------LQVKLTDSALSRDLFPGDYHCLGDN--------ENRPVKWMSLEALQN----SHYSSASDVWSFG 485 (563)
T ss_pred hcceehhh-------eeEEeccchhccccCcccccccCCC--------CCCcccccCHHHHhh----hhhcchhhhHHHH
Confidence 99999987 7899999998887665443332111 123458999999986 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001152 1033 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1033 viL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
|++|||+| |+.||...++.++...+..|.+..-+ .+|++++..++.-||..+
T Consensus 486 VllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP---------------------------~NCPDeLf~vMacCWall 538 (563)
T KOG1024|consen 486 VLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP---------------------------FNCPDELFTVMACCWALL 538 (563)
T ss_pred HHHHHHHhcCCCCccccCHHHHHHHHhccceecCC---------------------------CCCcHHHHHHHHHHHhcC
Confidence 99999998 89999999999999999888753211 178889999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 001152 1112 PTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~ 1126 (1137)
|++||+++|++.-|-
T Consensus 539 peeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 539 PEERPSFSQLVICLS 553 (563)
T ss_pred cccCCCHHHHHHHHH
Confidence 999999999987664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-25 Score=229.21 Aligned_cols=212 Identities=34% Similarity=0.499 Sum_probs=173.8
Q ss_pred ecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCC
Q 001152 810 AGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 810 LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 887 (1137)
||+|++|.||++... +..+++|++....... .. ..+.+|+..++.+.|++|+++++++....
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~----~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------- 64 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LL----EELLREIEILKKLNHPNIVKLYGVFEDEN--------- 64 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HH----HHHHHHHHHHHhcCCCCeeeEeeeeecCC---------
Confidence 689999999999997 6788888865332111 12 23478999999999999999999988654
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc-ccccCCC
Q 001152 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL-ERKKADG 966 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~-~~~~~~~ 966 (1137)
..++||||+++++|.+++... ...+++..+..++.+++++++|||+.|++|+||+|.||+++. +
T Consensus 65 -----~~~~~~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~------ 129 (215)
T cd00180 65 -----HLYLVMEYCEGGSLKDLLKEN----EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN------ 129 (215)
T ss_pred -----eEEEEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC------
Confidence 569999999999999998762 136899999999999999999999999999999999999997 5
Q ss_pred CCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 001152 967 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1046 (1137)
Q Consensus 967 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~ 1046 (1137)
+.++|+|||.+........ ......+...|++||.+... ..++.+.|+|++|+++++|
T Consensus 130 -~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~~---~~~~~~~D~~~lg~~~~~l-------- 187 (215)
T cd00180 130 -GKVKLADFGLSKLLTSDKS----------LLKTIVGTPAYMAPEVLLGK---GYYSEKSDIWSLGVILYEL-------- 187 (215)
T ss_pred -CcEEEecCCceEEccCCcc----------hhhcccCCCCccChhHhccc---CCCCchhhhHHHHHHHHHH--------
Confidence 6799999998875543210 01123577799999998651 3678999999999999998
Q ss_pred CCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 001152 1047 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125 (1137)
Q Consensus 1047 ~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L 1125 (1137)
. .+.+++.+|++.+|++||++.++++++
T Consensus 188 ------------------------~---------------------------~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------------P---------------------------ELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------------H---------------------------HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 0 178899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-28 Score=277.88 Aligned_cols=267 Identities=21% Similarity=0.224 Sum_probs=171.7
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCC--CCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTV--DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L--~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~ 95 (1137)
.++.|.++-|++..++ +.++.|+.|+.+++..|+| +|++++.| .|..|+.||||+|+|+++|..+..-+++-+
T Consensus 56 kLEHLs~~HN~L~~vh-GELs~Lp~LRsv~~R~N~LKnsGiP~diF----~l~dLt~lDLShNqL~EvP~~LE~AKn~iV 130 (1255)
T KOG0444|consen 56 KLEHLSMAHNQLISVH-GELSDLPRLRSVIVRDNNLKNSGIPTDIF----RLKDLTILDLSHNQLREVPTNLEYAKNSIV 130 (1255)
T ss_pred hhhhhhhhhhhhHhhh-hhhccchhhHHHhhhccccccCCCCchhc----ccccceeeecchhhhhhcchhhhhhcCcEE
Confidence 4666777777777664 4566666666666666666 34444433 335666667777766666666666666666
Q ss_pred EEccCCCCCccccc-ccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCC----------------------C
Q 001152 96 LKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRP----------------------S 152 (1137)
Q Consensus 96 L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~----------------------~ 152 (1137)
|+||+|+|.+||.. |-+|+.|-.|||++|.+..+|+.+..|..|++|.|++|+++- .
T Consensus 131 LNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT 210 (1255)
T KOG0444|consen 131 LNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT 210 (1255)
T ss_pred EEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch
Confidence 66666666666655 456666666666666666666666666666666666665422 1
Q ss_pred cccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCC
Q 001152 153 VLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLL 232 (1137)
Q Consensus 153 ~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L 232 (1137)
...+|.++-.|.+|..++|+.|.+..+|+.+-++.+|+.|+||+|+|+++....+.+.+|+.|+||.|+|+.+|+.+..|
T Consensus 211 l~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL 290 (1255)
T KOG0444|consen 211 LDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKL 290 (1255)
T ss_pred hhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhh
Confidence 22356666677777777888888777777777777777777777777766666666666777777777777666666666
Q ss_pred CCCCEEeccCCcCC--CCCcccccCCCCCCEEEccCCcCCC----CCCCCcchhhccCCCCCCC
Q 001152 233 QRLENLDLSNNRLT--SLGSLDLCLMHNLQNLNLQYNKLLS----YCQVPSWICCNLEGNGKDS 290 (1137)
Q Consensus 233 ~~L~~LdLS~N~Ls--g~~p~~l~~L~~L~~L~Ls~N~L~~----~~~iP~~~~~~l~~n~l~~ 290 (1137)
++|+.|++.+|+|+ |+| +.++.|.+|+++..++|.|.- +|.-+..-.+.++.|.+-.
T Consensus 291 ~kL~kLy~n~NkL~FeGiP-SGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLiT 353 (1255)
T KOG0444|consen 291 TKLTKLYANNNKLTFEGIP-SGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLIT 353 (1255)
T ss_pred HHHHHHHhccCcccccCCc-cchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccceee
Confidence 66666666666655 443 456666666666666666542 3333333335555554433
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-27 Score=273.39 Aligned_cols=267 Identities=23% Similarity=0.298 Sum_probs=179.2
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCCCCcEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNL 96 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP-~~~~~L~~L~~L 96 (1137)
++++|.+..|.|+++....++-++.|++||||.|.|+.+...+|..- .+|++|+|++|.|+.+- ..|.+|.+|..|
T Consensus 126 hl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~---~ni~~L~La~N~It~l~~~~F~~lnsL~tl 202 (873)
T KOG4194|consen 126 HLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAK---VNIKKLNLASNRITTLETGHFDSLNSLLTL 202 (873)
T ss_pred ceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCC---CCceEEeeccccccccccccccccchheee
Confidence 56677777777777777777777777777777777776665555432 56777777777777774 457777777777
Q ss_pred EccCCCCCccccc-ccCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCC
Q 001152 97 KFFGNEINLFPSE-VGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1137)
Q Consensus 97 ~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~~~~~-~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1137)
.|++|.|+++|.. |.+|++|+.|+|..|.+... +..|.+|.+|+.|.|..|.+..+.. ..|..|.++++|+|..|
T Consensus 203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~D---G~Fy~l~kme~l~L~~N 279 (873)
T KOG4194|consen 203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDD---GAFYGLEKMEHLNLETN 279 (873)
T ss_pred ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccC---cceeeecccceeecccc
Confidence 7777777777654 55577777777777777666 4667777777777777755543332 24556666777777777
Q ss_pred CCcccCc-cccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCcc
Q 001152 175 SIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSL 251 (1137)
Q Consensus 175 ~L~~IP~-~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~ 251 (1137)
+++.+-. ++.+|+.|+.|+||+|.|..| ++++..+++|++|+|++|+|+.+|++ |..|..|+.|+|++|.++.+-..
T Consensus 280 ~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~ 359 (873)
T KOG4194|consen 280 RLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEG 359 (873)
T ss_pred hhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhh
Confidence 7766544 556677777777777777654 45556666777777777777766543 55566777777777777766666
Q ss_pred cccCCCCCCEEEccCCcCCC--------CCCCCcchhhccCCCCCCC
Q 001152 252 DLCLMHNLQNLNLQYNKLLS--------YCQVPSWICCNLEGNGKDS 290 (1137)
Q Consensus 252 ~l~~L~~L~~L~Ls~N~L~~--------~~~iP~~~~~~l~~n~l~~ 290 (1137)
.|..+++|+.|||++|.|+. +..+|..-.+.+.||.+..
T Consensus 360 af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~ 406 (873)
T KOG4194|consen 360 AFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKS 406 (873)
T ss_pred HHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeee
Confidence 66677777777777776654 2235555556666665544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=257.36 Aligned_cols=287 Identities=24% Similarity=0.321 Sum_probs=195.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeE
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 874 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~ 874 (1137)
...|..+++||.|+|++||+|.+. ...||+|- +..+.... ++..|+++|..+. +.||+++.+++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~--i~~ts~p~--------ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKA--IYRTSSPS--------RILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeee--cccccCch--------HHHHHHHHHHHhccchhhhcchhhh
Confidence 345789999999999999999863 34566664 33333221 2477999999997 99999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
...+ +..+||||++.....+++.. ++...+..+++.++.||+|+|.+|||||||||+|
T Consensus 105 rnnd--------------~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsN 162 (418)
T KOG1167|consen 105 RNND--------------QVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSN 162 (418)
T ss_pred ccCC--------------eeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccc
Confidence 8766 67999999998899988865 7789999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccc-cccccc---------------------------------cCCCCCCCc
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFL-HTCCIA---------------------------------HRGIPAPDV 1000 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~-~~~~~~---------------------------------~~~~~~~~~ 1000 (1137)
+|.+... +.-.|+|||+|....... ...... .......-.
T Consensus 163 FL~n~~t------~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~an 236 (418)
T KOG1167|consen 163 FLYNRRT------QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERAN 236 (418)
T ss_pred ccccccc------CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecc
Confidence 9998774 456789999997322111 000000 000011123
Q ss_pred ccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-H----HHHHHH-----H-----HcCC----
Q 001152 1001 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS-E----LEIHDL-----I-----QMGK---- 1061 (1137)
Q Consensus 1001 ~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~-~----~el~~~-----I-----~~g~---- 1061 (1137)
.+||++|+|||++... ..-++++||||.|||+.-++++.+||.... . .++... + ..|.
T Consensus 237 rAGT~GfRaPEvL~k~---~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~ 313 (418)
T KOG1167|consen 237 RAGTPGFRAPEVLFRC---PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLW 313 (418)
T ss_pred cCCCCCCCchHHHhhc---cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeee
Confidence 5899999999999853 455789999999999999999999995421 1 111110 0 1111
Q ss_pred ----CCCchhHHhhhcccccccccccCCC-CCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1062 ----RPRLTDELEALGSCHEHEVAQSGSG-FEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1062 ----~p~l~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
.+.++..........-+.+...... ..........+..+.+++.+|++.||.+|.||+++|+|+||.
T Consensus 314 ~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 314 QKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred ccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 0001100000000000000000000 011111223345789999999999999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-24 Score=228.35 Aligned_cols=214 Identities=32% Similarity=0.454 Sum_probs=170.3
Q ss_pred ceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|.+.+.||.|++|.||++...+ ..+++|+....... ...+ .+.+|+..++.++|+|++++++++....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~----~~~~e~~~~~~~~~~~i~~~~~~~~~~~--- 70 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQRE----EFLREIRILKKLKHPNIVKLYGVFEDPE--- 70 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHH----HHHHHHHHHHhCCCCChhhheeeeecCC---
Confidence 5678999999999999999854 67888875433211 1222 3478999999999999999999987654
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~-ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++... .. +++..+..++.+++.++.|||+.+++|+||+|+||+++.+
T Consensus 71 -----------~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~ 134 (225)
T smart00221 71 -----------PLYLVMEYCEGGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD 134 (225)
T ss_pred -----------ceEEEEeccCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 569999999988999999762 22 8899999999999999999999999999999999999977
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.++|+|||.+......... ......++..|++||.+. ....++.++|||+||+++++|++
T Consensus 135 -------~~~~l~d~g~~~~~~~~~~~---------~~~~~~~~~~~~~pe~~~---~~~~~~~~~Dv~~lG~~~~~l~~ 195 (225)
T smart00221 135 -------GLVKLADFGLARFIHRDLAA---------LLKTVKGTPFYLAPEVLL---GGKGYGEAVDIWSLGVILYELLW 195 (225)
T ss_pred -------CCEEEeeCceeeEecCcccc---------cccceeccCCcCCHhHhc---CCCCCCchhhHHHHHHHHHHHHH
Confidence 68999999988765432100 111345778999999984 23567789999999999999999
Q ss_pred CCCCCCC-CC-HHHHHHHHHcCCC
Q 001152 1041 LQVPYMG-LS-ELEIHDLIQMGKR 1062 (1137)
Q Consensus 1041 G~~Pf~~-~~-~~el~~~I~~g~~ 1062 (1137)
|+.||.. .. ...+.+.+..+..
T Consensus 196 g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 196 GPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred CCCCccccchhHHHHHHHHhcCCc
Confidence 9999977 33 3456666666553
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=235.54 Aligned_cols=265 Identities=19% Similarity=0.247 Sum_probs=187.9
Q ss_pred CCCCCCCC-CceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCccee
Q 001152 795 GLDPGSFP-SLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEM 870 (1137)
Q Consensus 795 ~~~~~~~~-~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkl 870 (1137)
++...++. .|.+.+.||+|.||.+-+|++++ +.+++|.+ ... ....++| .+|..---.|. |.||+.-
T Consensus 16 el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKav--p~p---~tt~~dF----~rEfhY~~~Ls~H~hIi~t 86 (378)
T KOG1345|consen 16 ELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAV--PRP---QTTQADF----VREFHYSFFLSPHQHIIDT 86 (378)
T ss_pred cccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeecc--Ccc---hhhHHHH----HHHhccceeeccchhhhHH
Confidence 34444553 58999999999999999999976 45566543 322 2233344 66766544554 9999977
Q ss_pred eee-EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Q 001152 871 YGH-KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 949 (1137)
Q Consensus 871 lg~-~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrD 949 (1137)
|+. |...+ .++++|||+|.|+|.+-+.. ..+-+...++++.|+++||.|+|++++||||
T Consensus 87 Y~vaFqt~d--------------~YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsknlVHRd 146 (378)
T KOG1345|consen 87 YEVAFQTSD--------------AYVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRD 146 (378)
T ss_pred HHHHhhcCc--------------eEEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccchhhcc
Confidence 765 44444 45899999999999988764 3488889999999999999999999999999
Q ss_pred CCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC-CCCCchhhH
Q 001152 950 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDI 1028 (1137)
Q Consensus 950 LKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~s~ksDV 1028 (1137)
||.+||||-..+ ...|||||||..+..+..-. ..--+..|.|||......++ -...+.+||
T Consensus 147 lK~eNiLif~~d-----f~rvKlcDFG~t~k~g~tV~-------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~ 208 (378)
T KOG1345|consen 147 LKAENILIFDAD-----FYRVKLCDFGLTRKVGTTVK-------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDI 208 (378)
T ss_pred cccceEEEecCC-----ccEEEeeecccccccCceeh-------------hhhhhcccCCcHHHhhccccceEecccccc
Confidence 999999996442 25899999998765443211 11244589999987653322 234788999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHH--HHH--HHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHH
Q 001152 1029 WSYGCLLLELLTLQVPYMGLSELE--IHD--LIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1104 (1137)
Q Consensus 1029 WSLGviL~ELLTG~~Pf~~~~~~e--l~~--~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl 1104 (1137)
|.||+++|..+||++||+....++ ... +...+..+..+..+. ..++.+..+.
T Consensus 209 WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~------------------------~fs~~a~r~F 264 (378)
T KOG1345|consen 209 WQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN------------------------PFSEKALRLF 264 (378)
T ss_pred hheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc------------------------ccCHHHHHHH
Confidence 999999999999999997432221 111 112222333332221 2334577888
Q ss_pred HHhcccCCCCC---CCHHHHHHHHHhhcC
Q 001152 1105 RRCTEENPTER---PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1105 ~~CL~~DP~~R---PSa~EVL~~L~~~~~ 1130 (1137)
++-|.++|.+| .++......+|....
T Consensus 265 kk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 265 KKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred HHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 99999999999 677777778887644
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-26 Score=259.45 Aligned_cols=279 Identities=22% Similarity=0.216 Sum_probs=219.0
Q ss_pred cchhhcccCCCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC
Q 001152 5 NSVEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP 84 (1137)
Q Consensus 5 ~~~~~~~~~~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP 84 (1137)
.+|+..+..--+ .++.|++..|.|+.|+..+|..-.++++|+|++|.|+..-...|..| .+|..|.|++|+|+.+|
T Consensus 138 ~sv~se~L~~l~-alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~l---nsL~tlkLsrNrittLp 213 (873)
T KOG4194|consen 138 SSVTSEELSALP-ALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSL---NSLLTLKLSRNRITTLP 213 (873)
T ss_pred ccccHHHHHhHh-hhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccccccccc---chheeeecccCcccccC
Confidence 444444444443 68889999999999999999998999999999999998887777666 78999999999999998
Q ss_pred c-cccCCCCCcEEEccCCCCCcc-cccccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhc
Q 001152 85 K-SVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIA 161 (1137)
Q Consensus 85 ~-~~~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~ 161 (1137)
. .|.+|++|+.|+|..|+|..+ --.|.+|.+|+.|.|..|.+..+. ..|-.|.++++|+|..|++.... -.++.
T Consensus 214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn---~g~lf 290 (873)
T KOG4194|consen 214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVN---EGWLF 290 (873)
T ss_pred HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhh---ccccc
Confidence 6 577799999999999998865 345888899999999888866544 67888999999999886654332 34678
Q ss_pred CCCCCcEEeccCCCCccc-CccccCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEE
Q 001152 162 GLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSG-LYLLQRLENL 238 (1137)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~L 238 (1137)
+|+.|+.|+|++|.|..| ++.+.-.++|++|+|++|+|+.+| .+|..|.+|+.|+|++|.++.|-+. |..+++|+.|
T Consensus 291 gLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~L 370 (873)
T KOG4194|consen 291 GLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKL 370 (873)
T ss_pred ccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhh
Confidence 888999999999998855 557777888999999999999886 5677788889999999988888655 4558888889
Q ss_pred eccCCcCCCCCcc---cccCCCCCCEEEccCCcCCCC-----CCCCcchhhccCCCCCCC
Q 001152 239 DLSNNRLTSLGSL---DLCLMHNLQNLNLQYNKLLSY-----CQVPSWICCNLEGNGKDS 290 (1137)
Q Consensus 239 dLS~N~Lsg~~p~---~l~~L~~L~~L~Ls~N~L~~~-----~~iP~~~~~~l~~n~l~~ 290 (1137)
||++|.|++.+.. .|..|++|+.|+|.+|+|..+ ..++..-.++|.+|.+..
T Consensus 371 dLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaS 430 (873)
T KOG4194|consen 371 DLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIAS 430 (873)
T ss_pred cCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCccee
Confidence 9999988876643 367788888889998888763 345556666666665554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-25 Score=279.94 Aligned_cols=224 Identities=13% Similarity=0.148 Sum_probs=148.9
Q ss_pred hCCC-CCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 001152 861 ALRH-SCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE 939 (1137)
Q Consensus 861 ~L~H-pNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~y 939 (1137)
.+.| +||+++++++.... .++. .....+++|||+ +++|.+++.. ....+++.+++.|++||++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~----~~~~---~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~ 95 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGN----LDGL---DDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNA 95 (793)
T ss_pred hhhHHHHHHHhhcccCCcc----cccc---ccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHH
Confidence 4456 68888888874322 0111 112467889988 5799999964 23469999999999999999999
Q ss_pred HHhCCeeeccCCCCCeEecccccc------------CCCCCeEEEeecCccccccccccc---cccccCC---CCCCCcc
Q 001152 940 LHSKHIMHRDIKSENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHT---CCIAHRG---IPAPDVC 1001 (1137)
Q Consensus 940 LHs~gIIHrDLKP~NILld~~~~~------------~~~~~~vKL~DFGla~~~~~~~~~---~~~~~~~---~~~~~~~ 1001 (1137)
||++||+||||||+||||+..+.. ....+.+|++|||+++........ ....... .......
T Consensus 96 lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (793)
T PLN00181 96 AHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA 175 (793)
T ss_pred HHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence 999999999999999999653100 011245777788877543210000 0000000 0011124
Q ss_pred cCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccccc
Q 001152 1002 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 1081 (1137)
Q Consensus 1002 ~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~ 1081 (1137)
+||+.|||||++.+ ..|+.++|||||||++|||++|..|+.... .....+.....+. ..
T Consensus 176 ~gt~~Y~APE~~~~----~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~---~~------------ 234 (793)
T PLN00181 176 MEMSWYTSPEEDNG----SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPP---QI------------ 234 (793)
T ss_pred CCCcceEChhhhcc----CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcCh---hh------------
Confidence 68999999999875 467899999999999999999988875321 1222221111110 00
Q ss_pred ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1082 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
....+...+++.+||++||.+||++.||++|+|+..
T Consensus 235 ------------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 235 ------------LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred ------------hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 011223567889999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=214.77 Aligned_cols=168 Identities=24% Similarity=0.297 Sum_probs=126.0
Q ss_pred CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccc
Q 001152 904 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 983 (1137)
Q Consensus 904 gSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~ 983 (1137)
|||.++++.. +..+++..++.|+.||+.||+|||+++ ||+|||++.+ +.+|+ ||++.....
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-------~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-------GLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-------cceee--ccceEeecc
Confidence 6899999752 246999999999999999999999998 9999999877 67888 998865432
Q ss_pred cccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC
Q 001152 984 FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKR 1062 (1137)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~-el~~~I~~g~~ 1062 (1137)
. ...||+.|+|||++.+ ..++.++|||||||++|||+||..||...... .....+.....
T Consensus 62 ~---------------~~~g~~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 122 (176)
T smart00750 62 E---------------QSRVDPYFMAPEVIQG----QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122 (176)
T ss_pred c---------------cCCCcccccChHHhcC----CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence 1 1248899999999975 56789999999999999999999999764332 22222222111
Q ss_pred CCchhHHhhhcccccccccccCCCCCCchhhhhhH--HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1063 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL--SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1063 p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+..+... +. ..... .++.+++.+||+.||.+||++.|+++|+|....
T Consensus 123 ~~~~~~~--------------------~~-~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 123 ADDPRDR--------------------SN-LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cCCcccc--------------------cc-HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 1100000 00 00122 258999999999999999999999999998743
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-25 Score=256.84 Aligned_cols=261 Identities=26% Similarity=0.310 Sum_probs=219.6
Q ss_pred CcccccCCCCCCcccC-CCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCCCCcE
Q 001152 18 IKEKLPSEANKINNEK-NGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRN 95 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~-~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~-~~~L~~L~~ 95 (1137)
.+..+....|++++-. |..+-.+..|++||||+|+|...+. ++...+++.+|+||+|+|.+||.. |.+|+.|-+
T Consensus 79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~----~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLf 154 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPT----NLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLF 154 (1255)
T ss_pred hhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcch----hhhhhcCcEEEEcccCccccCCchHHHhhHhHhh
Confidence 4566666778875543 5678889999999999999986543 344458889999999999999975 678999999
Q ss_pred EEccCCCCCcccccccCCCCCCEEEccCCC--------------------------CCCCcccccCCCCCCEEECCCCCC
Q 001152 96 LKFFGNEINLFPSEVGNLLGLECLQIKISS--------------------------PGVNGFALNKLKGLKELELSKVPP 149 (1137)
Q Consensus 96 L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~--------------------------~~~~~~~~~~L~~L~~L~Ls~n~l 149 (1137)
||||+|+|..+|+.+..|.+|++|.|++|. +..+|.++..|.+|..++||.|
T Consensus 155 LDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N-- 232 (1255)
T KOG0444|consen 155 LDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSEN-- 232 (1255)
T ss_pred hccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhcccccc--
Confidence 999999999999888888788877777764 2334556778889999999984
Q ss_pred CCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCC--ccCc
Q 001152 150 RPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV--ELPS 227 (1137)
Q Consensus 150 n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls--~IP~ 227 (1137)
..+.+|..+.++.+|..|+|++|+|+.+-...+...+|+.|+||+|+|+.+|+.+++|++|+.|++.+|+|+ .||+
T Consensus 233 --~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPS 310 (1255)
T KOG0444|consen 233 --NLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPS 310 (1255)
T ss_pred --CCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCcc
Confidence 446789999999999999999999999988888899999999999999999999999999999999999988 8999
Q ss_pred cccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhccCCCCCCC
Q 001152 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDS 290 (1137)
Q Consensus 228 ~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~ 290 (1137)
+++.|.+|+.+.+++|.|.-+ |..++.+..|+.|.|+.|+|.. +|..|.+.-....++.
T Consensus 311 GIGKL~~Levf~aanN~LElV-PEglcRC~kL~kL~L~~NrLiT---LPeaIHlL~~l~vLDl 369 (1255)
T KOG0444|consen 311 GIGKLIQLEVFHAANNKLELV-PEGLCRCVKLQKLKLDHNRLIT---LPEAIHLLPDLKVLDL 369 (1255)
T ss_pred chhhhhhhHHHHhhccccccC-chhhhhhHHHHHhcccccceee---chhhhhhcCCcceeec
Confidence 999999999999999999976 5689999999999999999976 6666665444444444
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-26 Score=249.59 Aligned_cols=242 Identities=27% Similarity=0.372 Sum_probs=205.2
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEc
Q 001152 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~L 98 (1137)
+.++.+..|.+..+. .++.++..|.+|++++|+++..+|+ ++ .+..++.|+.++|+++.+|++++.+.+|..|+.
T Consensus 47 l~~lils~N~l~~l~-~dl~nL~~l~vl~~~~n~l~~lp~a-ig---~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~ 121 (565)
T KOG0472|consen 47 LQKLILSHNDLEVLR-EDLKNLACLTVLNVHDNKLSQLPAA-IG---ELEALKSLNVSHNKLSELPEQIGSLISLVKLDC 121 (565)
T ss_pred hhhhhhccCchhhcc-HhhhcccceeEEEeccchhhhCCHH-HH---HHHHHHHhhcccchHhhccHHHhhhhhhhhhhc
Confidence 677888899999886 4788999999999999999977665 44 448999999999999999999999999999999
Q ss_pred cCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcc
Q 001152 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1137)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1137)
++|.+.++|++++.+..|+.|+..+|++...|..+..+.+|..|++.+|. ...+|++.-+++.|++|+..+|-++.
T Consensus 122 s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~----l~~l~~~~i~m~~L~~ld~~~N~L~t 197 (565)
T KOG0472|consen 122 SSNELKELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNK----LKALPENHIAMKRLKHLDCNSNLLET 197 (565)
T ss_pred cccceeecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccc----hhhCCHHHHHHHHHHhcccchhhhhc
Confidence 99999999999999999999999999999999999999999999998844 34555555557888888888888888
Q ss_pred cCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcccc-CCCCCCEEeccCCcCCCCCcccccCCC
Q 001152 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLDLCLMH 257 (1137)
Q Consensus 179 IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~-~L~~L~~LdLS~N~Lsg~~p~~l~~L~ 257 (1137)
+|+.++.|.+|..|||.+|+|..+| +|..|..|.+|+++.|+|+.+|.+.. ++.+|..|||..|+|+..|. .++.|.
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pd-e~clLr 275 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPD-EICLLR 275 (565)
T ss_pred CChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCch-HHHHhh
Confidence 8888888888888888888888888 78888888888888888888887766 68888888888888887754 777888
Q ss_pred CCCEEEccCCcCCC
Q 001152 258 NLQNLNLQYNKLLS 271 (1137)
Q Consensus 258 ~L~~L~Ls~N~L~~ 271 (1137)
+|+.||++||.+++
T Consensus 276 sL~rLDlSNN~is~ 289 (565)
T KOG0472|consen 276 SLERLDLSNNDISS 289 (565)
T ss_pred hhhhhcccCCcccc
Confidence 88888888888776
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-22 Score=211.65 Aligned_cols=261 Identities=25% Similarity=0.331 Sum_probs=199.1
Q ss_pred CCCCCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 795 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 795 ~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
.....++.+..+..+|.+..+|..|+++|.+.++++||..+. .......+.| ..|.-.|+-+.||||..+++.+
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr--~~t~risrdf----neefp~lrifshpnilpvlgac 256 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVR--EVTARISRDF----NEEFPALRIFSHPNILPVLGAC 256 (448)
T ss_pred cccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhh--hcchhhcchh----hhhCcceeeecCCchhhhhhhc
Confidence 344455666678889999999999999999999999985433 2222222333 6788888889999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-C-eeeccCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-H-IMHRDIKS 952 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-g-IIHrDLKP 952 (1137)
.... ++.++..||+.|||+..++. ......+..++.+++.+|++|++|||+. . |.---|.+
T Consensus 257 nspp--------------nlv~isq~mp~gslynvlhe---~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns 319 (448)
T KOG0195|consen 257 NSPP--------------NLVIISQYMPFGSLYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNS 319 (448)
T ss_pred cCCC--------------CceEeeeeccchHHHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhccc
Confidence 8643 67999999999999999986 4456788899999999999999999986 3 33557899
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
..++||++.. ..+-.+|--++.. . ....-.|.||+||.++.... ...-.++|+|||.
T Consensus 320 ~hvmidedlt-----arismad~kfsfq--e---------------~gr~y~pawmspealqrkpe-d~n~raadmwsfa 376 (448)
T KOG0195|consen 320 KHVMIDEDLT-----ARISMADTKFSFQ--E---------------VGRAYSPAWMSPEALQRKPE-DLNIRAADMWSFA 376 (448)
T ss_pred ceEEecchhh-----hheecccceeeee--c---------------cccccCcccCCHHHHhcCch-hcchhhhhHHHHH
Confidence 9999998832 2233334322211 0 01246779999999986332 1234789999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHH-HcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I-~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
+++|||.|...||...++++.-..| ..|.++.++. ..+..+..|+.-|+..|
T Consensus 377 illwel~trevpfadlspmecgmkialeglrv~ipp---------------------------gis~hm~klm~icmned 429 (448)
T KOG0195|consen 377 ILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP---------------------------GISRHMNKLMNICMNED 429 (448)
T ss_pred HHHHHhhccccccccCCchhhhhhhhhccccccCCC---------------------------CccHHHHHHHHHHhcCC
Confidence 9999999999999998888876666 5566655543 34455889999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 001152 1112 PTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~~~ 1128 (1137)
|.+||.++.|+-.++..
T Consensus 430 pgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 430 PGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCcCCCcceehhhHHHh
Confidence 99999999998877653
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-24 Score=240.80 Aligned_cols=267 Identities=23% Similarity=0.280 Sum_probs=235.6
Q ss_pred CCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEE
Q 001152 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQ 120 (1137)
Q Consensus 41 ~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~ 120 (1137)
..|+.|+|++|.++...+. +.+|..|++|++.+|+++++|++++.+..++.|+.++|+++.+|+.++.+.+|..|+
T Consensus 45 v~l~~lils~N~l~~l~~d----l~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 45 VDLQKLILSHNDLEVLRED----LKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLD 120 (565)
T ss_pred cchhhhhhccCchhhccHh----hhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhh
Confidence 3688999999999876654 345589999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCC
Q 001152 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMK 200 (1137)
Q Consensus 121 Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~ 200 (1137)
+++|.+...++.++.+..|..|+..+ +.+.++|+.+..+.+|..|++.+|+++.+|+..-+++.|+.||+..|-++
T Consensus 121 ~s~n~~~el~~~i~~~~~l~dl~~~~----N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~ 196 (565)
T KOG0472|consen 121 CSSNELKELPDSIGRLLDLEDLDATN----NQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE 196 (565)
T ss_pred ccccceeecCchHHHHhhhhhhhccc----cccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh
Confidence 99999999999999999999999997 44568899999999999999999999999998777999999999999999
Q ss_pred ccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchh
Q 001152 201 YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1137)
Q Consensus 201 ~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1137)
++|+.++.+.+|..|+|..|+|..+| +|..+..|..|+++.|+|+-++......|++|.+|||..|+|+. +|+.+|
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke---~Pde~c 272 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKE---VPDEIC 272 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccccccc---CchHHH
Confidence 99999999999999999999999999 89999999999999999999987666699999999999999985 899999
Q ss_pred hccCCCCCCCCCCCcccccccccccCCCcccCCCCCcccCCCCCC
Q 001152 281 CNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSGSRHTS 325 (1137)
Q Consensus 281 ~~l~~n~l~~~~~~l~~~~~s~n~l~g~il~~~~~~sf~GN~~lC 325 (1137)
..-+.+.+|.+++.+.+..++.-++ .+-.-...|||.-.
T Consensus 273 lLrsL~rLDlSNN~is~Lp~sLgnl------hL~~L~leGNPlrT 311 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDISSLPYSLGNL------HLKFLALEGNPLRT 311 (565)
T ss_pred HhhhhhhhcccCCccccCCcccccc------eeeehhhcCCchHH
Confidence 8777777777766666655543332 12233556998775
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-20 Score=215.00 Aligned_cols=269 Identities=21% Similarity=0.212 Sum_probs=188.9
Q ss_pred CceEeeeecccCceEEEEEEECCc---cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC----CCcceeeeeEe
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGSA---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH----SCIVEMYGHKI 875 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~~---~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H----pNIVkllg~~~ 875 (1137)
+|.+.++||+|+||.||+|..... .+|+|+.......... .+..|+.++..+.. +++..+++.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--------~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--------VLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--------cchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 899999999999999999998654 5888875433222111 12457888888863 68888888874
Q ss_pred -cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 876 -SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 876 -~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
... ..++||+.+ |.+|.++.... +...++..++.+|+.|++.+|++||+.|++||||||.|
T Consensus 91 ~~~~--------------~~~iVM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 91 STED--------------FNFIVMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPEN 152 (322)
T ss_pred CCCc--------------eeEEEEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHH
Confidence 443 459999988 79999987652 24679999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCcccccc--ccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~--~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
+++.... ......+.|.|||+++... ...... ..........+.||..|+++.+..+ ...+.+.|+||++
T Consensus 153 ~~~g~~~--~~~~~~~~llDfGlar~~~~~~~~~~~--~~~~r~~~~~~rGT~ry~S~~~H~~----~e~~r~DDles~~ 224 (322)
T KOG1164|consen 153 FVVGQSS--RSEVRTLYLLDFGLARRFKYVGDSGGN--LRPPRPQKGLFRGTLRYASINVHLG----IEQGRRDDLESLF 224 (322)
T ss_pred eeecCCC--CcccceEEEEecCCCccccccCCCCcc--cccCCCCccCCCCccccccHHHhCC----CccCCchhhhhHH
Confidence 9998652 0112469999999998332 221110 0011111235669999999998876 5678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
.++.+++.|..||.+.........+........... .....+.++.++...+-..+.
T Consensus 225 Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~ 281 (322)
T KOG1164|consen 225 YMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR-----------------------FGDLKPEEFAKILEYIDSLDY 281 (322)
T ss_pred HHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc-----------------------ccCCChHHHHHHHHHhhccCC
Confidence 999999999999976543322222211110000000 001233456667766667899
Q ss_pred CCCCCHHHHHHHHHhh
Q 001152 1113 TERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~ 1128 (1137)
..+|....+...+...
T Consensus 282 ~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 282 EDKPDYEKLAELLKDV 297 (322)
T ss_pred cCCCCHHHHHHHHHHH
Confidence 9999998888776544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.4e-20 Score=202.13 Aligned_cols=272 Identities=31% Similarity=0.403 Sum_probs=197.0
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCC-CcceeeeeEecCCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~Hp-NIVkllg~~~~~~~~~~ 882 (1137)
|++.+.||.|+||.||++.+. ..+++|+......... .....+.+|+.+++.+.|+ +|+++++++....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~---- 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQDEG---- 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEecCC----
Confidence 778899999999999999988 6677777543332221 1223348899999999988 7999999995443
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
..+++++|+.++++.+++...... ..++...+..++.|++.++.|+|..+++|||+||+||+++..
T Consensus 72 ----------~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~-- 137 (384)
T COG0515 72 ----------SLYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRD-- 137 (384)
T ss_pred ----------EEEEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCC--
Confidence 369999999999999776652110 268999999999999999999999999999999999999977
Q ss_pred cCCCCC-eEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 963 KADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 963 ~~~~~~-~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
. .++++|||.+............. .......||..|+|||.+.+.. ...+....|+||+|++++++++|
T Consensus 138 -----~~~~~l~dfg~~~~~~~~~~~~~~~----~~~~~~~~t~~~~~pe~~~~~~-~~~~~~~~D~~s~g~~~~~~~~~ 207 (384)
T COG0515 138 -----GRVVKLIDFGLAKLLPDPGSTSSIP----ALPSTSVGTPGYMAPEVLLGLS-LAYASSSSDIWSLGITLYELLTG 207 (384)
T ss_pred -----CCeEEEeccCcceecCCCCcccccc----ccccccccccccCCHHHhcCCC-CCCCCchHhHHHHHHHHHHHHhC
Confidence 4 69999999987444322110000 0123557999999999987510 13678999999999999999999
Q ss_pred CCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1042 QVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1042 ~~Pf~~~~~----~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
..||..... ......+.....+......... .. ......+.+++..|+..+|..|.+
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~---~~~~~~~~~~~~~~~~~~~~~r~~ 268 (384)
T COG0515 208 LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS----------------NP---ELISKAASDLLKKLLAKDPKNRLS 268 (384)
T ss_pred CCCCCCCCccccHHHHHHHHHhcCCcccccccCcc----------------cc---chhhHHHHHHHHHHHhcCchhcCC
Confidence 999876552 3444444333322000000000 00 122345889999999999999999
Q ss_pred HHHHHHHHHhh
Q 001152 1118 AGDLYEMFVAR 1128 (1137)
Q Consensus 1118 a~EVL~~L~~~ 1128 (1137)
..+...+.+..
T Consensus 269 ~~~~~~~~~~~ 279 (384)
T COG0515 269 SSSDLSHDLLA 279 (384)
T ss_pred HHHHhhchHhh
Confidence 99888875444
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-23 Score=230.09 Aligned_cols=268 Identities=22% Similarity=0.266 Sum_probs=219.4
Q ss_pred cCCCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeec-CCCCccCc-cccC
Q 001152 12 KSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYK-NVLNLIPK-SVGR 89 (1137)
Q Consensus 12 ~~~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~-N~L~~IP~-~~~~ 89 (1137)
..+-|+.+..|.++.|+|+.|++++|+.+++|+.||||+|+|+.+-|.+|..+ .+|.+|-|.+ |+|+.||. .|++
T Consensus 62 P~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL---~~l~~Lvlyg~NkI~~l~k~~F~g 138 (498)
T KOG4237|consen 62 PANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGL---ASLLSLVLYGNNKITDLPKGAFGG 138 (498)
T ss_pred cccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhh---HhhhHHHhhcCCchhhhhhhHhhh
Confidence 44556679999999999999999999999999999999999999999888655 7777776655 99999996 6999
Q ss_pred CCCCcEEEccCCCCCcc-cccccCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCC---C------Ccccchh
Q 001152 90 YEKLRNLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPR---P------SVLTLLS 158 (1137)
Q Consensus 90 L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~~~~~~~-~~~~L~~L~~L~Ls~n~ln---~------~~~~lp~ 158 (1137)
|..|+.|.+.-|++.-+ ...|..|++|..|.|..|.+..+.. +|..+.+++.+.+..|++- + .....|.
T Consensus 139 L~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~i 218 (498)
T KOG4237|consen 139 LSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPI 218 (498)
T ss_pred HHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchh
Confidence 99999999999999966 4558999999999999999888875 8999999999999987721 1 1112233
Q ss_pred hhcCCCCCcEEec--------------------------cCCCCcccCc-cccCCCCCCEEEccCCCCCcc-chhhcCCC
Q 001152 159 EIAGLKCLTKLSV--------------------------CHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLK 210 (1137)
Q Consensus 159 ~l~~L~~L~~L~L--------------------------s~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~ 210 (1137)
.+++.....-..+ ..+....-|. .|..|++|+.|+|++|+|+.| +.+|..+.
T Consensus 219 etsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a 298 (498)
T KOG4237|consen 219 ETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAA 298 (498)
T ss_pred hcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchh
Confidence 3333322222222 2222233344 578999999999999999977 67889999
Q ss_pred CCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhc
Q 001152 211 ALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282 (1137)
Q Consensus 211 ~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~ 282 (1137)
.|+.|+|..|+|..+-.. |.++.+|+.|+|.+|+|+.+.|..|..+.+|..|+|-.|+|.|.|.+-..-.|.
T Consensus 299 ~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wl 371 (498)
T KOG4237|consen 299 ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWL 371 (498)
T ss_pred hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHH
Confidence 999999999999988765 556999999999999999999999999999999999999999999887655554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-20 Score=201.33 Aligned_cols=219 Identities=23% Similarity=0.288 Sum_probs=170.8
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~ 878 (1137)
..|+++++||+|+||+++.|+. .+..||+|.-..+ ...++. ..|.+..+.|. .+.|..+|-+..+..
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQL-------rdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQL-------RDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc---CCcchH-------HHHHHHHHHHcCCCCCCceeeeccccc
Confidence 3689999999999999999985 6789999964322 223333 34777777775 789988876655443
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
+-.||||++ |.||++++.-+ +..|+.+++..|+.|++.-++|+|++.+|+|||||+|+||.
T Consensus 98 --------------~NiLVidLL-GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG 158 (449)
T KOG1165|consen 98 --------------YNILVIDLL-GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG 158 (449)
T ss_pred --------------hhhhhhhhh-CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence 448999988 79999998764 45799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
... ......+.++|||+|+.+.++.... +.+-..+....||..||+-....| ..-+.+-|+=|||.+++++
T Consensus 159 rp~--~k~~n~IhiiDFGmAK~YrDp~Tkq---HIPYrE~KSLsGTARYMSINTHlG----rEQSRRDDLEaLGHvFmYF 229 (449)
T KOG1165|consen 159 RPG--TKDANVIHIIDFGMAKEYRDPKTKQ---HIPYREHKSLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYF 229 (449)
T ss_pred CCC--CCCCceEEEEeccchhhhcCccccc---cCccccccccccceeeeEeecccc----chhhhhhhHHHhhhhhhhh
Confidence 753 2334568999999999877654322 223334456789999999877766 4567899999999999999
Q ss_pred HhCCCCCCCCCH---HHHHHHHH
Q 001152 1039 LTLQVPYMGLSE---LEIHDLIQ 1058 (1137)
Q Consensus 1039 LTG~~Pf~~~~~---~el~~~I~ 1058 (1137)
|.|..||++... .+-++.|.
T Consensus 230 LRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 230 LRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred ccCCCccccccCcchHHHHHHhc
Confidence 999999998543 44455553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-22 Score=241.38 Aligned_cols=270 Identities=19% Similarity=0.189 Sum_probs=190.1
Q ss_pred CCc-eEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 802 PSL-SSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y-~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..| .....+|.|++|.|+.+... ....+.|.+..+ .. ..+..+.+...+..|+.+-..+.|||++..+..+.+..
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 345 56688999999988877652 233344433222 11 22233333333577888888999999998887776543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
...-+||||++ +|..++.. ...+...++..+++|++.|++|+|..||.|||||++|+++.
T Consensus 395 --------------~~~~~mE~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~ 454 (601)
T KOG0590|consen 395 --------------GILQSMEYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT 454 (601)
T ss_pred --------------cchhhhhcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe
Confidence 12334999998 99999876 24688899999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.. +.+||+|||.+.....+.... .......+|+..|+|||++.+. .......||||.|+++..|
T Consensus 455 ~~-------g~lki~Dfg~~~vf~~~~e~~------~~~~~g~~gS~pY~apE~~~~~---~ydpr~vDiwS~~ii~~~m 518 (601)
T KOG0590|consen 455 EN-------GILKIIDFGAASVFRYPWEKN------IHESSGIVGSDPYLAPEVLTGK---EYDPRAVDVWSCGIIYICM 518 (601)
T ss_pred cC-------CceEEeecCcceeeccCcchh------hhhhcCcccCCcCcCccccccc---ccCcchhhhhhccceEEEE
Confidence 88 799999999886554332211 1112345799999999999862 3445789999999999999
Q ss_pred HhCCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~-~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++|+.||......+.. ............ ..+.......+.+.+.+|.+||++||.+|.|
T Consensus 519 ~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t 578 (601)
T KOG0590|consen 519 ILGRFPWKVAKKSDNSFKTNNYSDQRNIF--------------------EGPNRLLSLLPRETRIIIYRMLQLDPTKRIT 578 (601)
T ss_pred ecCCCccccccccccchhhhccccccccc--------------------cChHHHHHhchhhHHHHHHHHccCChhheec
Confidence 9999999643322111 010000000000 0000111245666889999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001152 1118 AGDLYEMFVART 1129 (1137)
Q Consensus 1118 a~EVL~~L~~~~ 1129 (1137)
+++|++..|++.
T Consensus 579 i~~i~~d~W~~~ 590 (601)
T KOG0590|consen 579 IEQILNDEWIRS 590 (601)
T ss_pred HHHHhhChHhhh
Confidence 999999999984
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-21 Score=237.14 Aligned_cols=224 Identities=21% Similarity=0.276 Sum_probs=178.0
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEc
Q 001152 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~L 98 (1137)
...|.+..++++.++.. + .++|+.|+|++|+|+.++...+ .+|+.|+|++|+|+.||..+. .+|+.|+|
T Consensus 180 ~~~L~L~~~~LtsLP~~-I--p~~L~~L~Ls~N~LtsLP~~l~------~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~L 248 (754)
T PRK15370 180 KTELRLKILGLTTIPAC-I--PEQITTLILDNNELKSLPENLQ------GNIKTLYANSNQLTSIPATLP--DTIQEMEL 248 (754)
T ss_pred ceEEEeCCCCcCcCCcc-c--ccCCcEEEecCCCCCcCChhhc------cCCCEEECCCCccccCChhhh--ccccEEEC
Confidence 45688888888887643 2 2578999999999996544322 578999999999999987664 37999999
Q ss_pred cCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcc
Q 001152 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1137)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1137)
++|+|+.||..+. ++|+.|+|++|++..+|..+. .+|+.|++++|.+.. +|..+. .+|+.|++++|+|+.
T Consensus 249 s~N~L~~LP~~l~--s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt~----LP~~lp--~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 249 SINRITELPERLP--SALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIRT----LPAHLP--SGITHLNVQSNSLTA 318 (754)
T ss_pred cCCccCcCChhHh--CCCCEEECcCCccCccccccC--CCCcEEECCCCcccc----Ccccch--hhHHHHHhcCCcccc
Confidence 9999999998775 589999999999888776543 589999999976654 343332 367888999999998
Q ss_pred cCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCC
Q 001152 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHN 258 (1137)
Q Consensus 179 IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~ 258 (1137)
+|..+. ++|+.|++++|.|+.||..+. ++|+.|+|++|+|+.||..+. ++|+.|+|++|+|+.+|+ .+. ..
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~LP~-~l~--~s 389 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTNLPE-NLP--AA 389 (754)
T ss_pred CCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCCCCH-hHH--HH
Confidence 887553 689999999999999987764 689999999999998887664 689999999999998866 343 36
Q ss_pred CCEEEccCCcCCCC
Q 001152 259 LQNLNLQYNKLLSY 272 (1137)
Q Consensus 259 L~~L~Ls~N~L~~~ 272 (1137)
|+.|++++|+|+.+
T Consensus 390 L~~LdLs~N~L~~L 403 (754)
T PRK15370 390 LQIMQASRNNLVRL 403 (754)
T ss_pred HHHHhhccCCcccC
Confidence 88999999998864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=216.07 Aligned_cols=173 Identities=20% Similarity=0.162 Sum_probs=121.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcce-eeeeEec
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVE-MYGHKIS 876 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVk-llg~~~~ 876 (1137)
...|++.+.||+|+||+||+|.+. +..+|+|+........... .....+.+|+++|++++|+||+. ++++
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~---~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKP---LARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccH---HHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 356999999999999999999874 3556777643111100011 11223589999999999999995 4432
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC-CCCCe
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSENI 955 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDL-KP~NI 955 (1137)
. +.|+||||++|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+||
T Consensus 91 -~--------------~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NI 143 (365)
T PRK09188 91 -G--------------KDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNW 143 (365)
T ss_pred -C--------------CcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceE
Confidence 1 3499999999999962 211 11 1467899999999999999999999 99999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcc
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 1015 (1137)
|++.+ +.+||+|||+|+.+............ .......+++.|+|||++..
T Consensus 144 Lv~~~-------~~ikLiDFGlA~~~~~~~~~~~~~~~--~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 144 LMGPD-------GEAAVIDFQLASVFRRRGALYRIAAY--EDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEcCC-------CCEEEEECccceecccCcchhhhhhh--hhhhhhhccCccCCcccCCh
Confidence 99866 67999999999876543211110000 01124568889999999864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=229.87 Aligned_cols=232 Identities=25% Similarity=0.203 Sum_probs=162.7
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEc
Q 001152 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~L 98 (1137)
...|.+..|+|+.+++. +. ++|+.|+|++|+|+.+ |.. +++|++|+|++|+|+.||.. .++|+.|+|
T Consensus 203 ~~~LdLs~~~LtsLP~~-l~--~~L~~L~L~~N~Lt~L-P~l------p~~Lk~LdLs~N~LtsLP~l---p~sL~~L~L 269 (788)
T PRK15387 203 NAVLNVGESGLTTLPDC-LP--AHITTLVIPDNNLTSL-PAL------PPELRTLEVSGNQLTSLPVL---PPGLLELSI 269 (788)
T ss_pred CcEEEcCCCCCCcCCcc-hh--cCCCEEEccCCcCCCC-CCC------CCCCcEEEecCCccCcccCc---ccccceeec
Confidence 34577788888877653 32 3788888888888864 331 36788888888888888753 357888888
Q ss_pred cCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcc
Q 001152 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1137)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1137)
++|.|+.+|..+ .+|+.|+|++|.+..+|.. +++|+.|+|++|.+.. +|.. ..+|+.|++++|+|+.
T Consensus 270 s~N~L~~Lp~lp---~~L~~L~Ls~N~Lt~LP~~---p~~L~~LdLS~N~L~~----Lp~l---p~~L~~L~Ls~N~L~~ 336 (788)
T PRK15387 270 FSNPLTHLPALP---SGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQLAS----LPAL---PSELCKLWAYNNQLTS 336 (788)
T ss_pred cCCchhhhhhch---hhcCEEECcCCcccccccc---ccccceeECCCCcccc----CCCC---cccccccccccCcccc
Confidence 888888887633 5677888888887777653 4678888888866543 2321 1346677888888888
Q ss_pred cCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCC
Q 001152 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHN 258 (1137)
Q Consensus 179 IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~ 258 (1137)
||.. ..+|+.|+|++|+|+.||.. ..+|+.|++++|+|+.||... .+|+.|+|++|+|+++++ . .++
T Consensus 337 LP~l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~~LP~l~---~~L~~LdLs~N~Lt~LP~-l---~s~ 403 (788)
T PRK15387 337 LPTL---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTSLPALP---SGLKELIVSGNRLTSLPV-L---PSE 403 (788)
T ss_pred cccc---ccccceEecCCCccCCCCCC---CcccceehhhccccccCcccc---cccceEEecCCcccCCCC-c---ccC
Confidence 8752 24788888888888888753 346777888888888887543 567888888888887654 2 357
Q ss_pred CCEEEccCCcCCCCCCCCcch-hhccCCCCCC
Q 001152 259 LQNLNLQYNKLLSYCQVPSWI-CCNLEGNGKD 289 (1137)
Q Consensus 259 L~~L~Ls~N~L~~~~~iP~~~-~~~l~~n~l~ 289 (1137)
|+.|+|++|+|+.++.+|..+ .+++++|.+.
T Consensus 404 L~~LdLS~N~LssIP~l~~~L~~L~Ls~NqLt 435 (788)
T PRK15387 404 LKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT 435 (788)
T ss_pred CCEEEccCCcCCCCCcchhhhhhhhhccCccc
Confidence 888888888887754443322 2444444444
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.3e-21 Score=236.29 Aligned_cols=229 Identities=19% Similarity=0.237 Sum_probs=191.0
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcE
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~ 95 (1137)
++.+..|.+..|+|+.++...+ .+|++|+|++|+|+.+ |..+. .+|+.|+|++|.|+.||..+. .+|+.
T Consensus 198 p~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~LtsL-P~~l~-----~~L~~L~Ls~N~L~~LP~~l~--s~L~~ 266 (754)
T PRK15370 198 PEQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLTSI-PATLP-----DTIQEMELSINRITELPERLP--SALQS 266 (754)
T ss_pred ccCCcEEEecCCCCCcCChhhc---cCCCEEECCCCccccC-Chhhh-----ccccEEECcCCccCcCChhHh--CCCCE
Confidence 3468999999999999976554 4899999999999965 44332 479999999999999998775 48999
Q ss_pred EEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCC
Q 001152 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1137)
Q Consensus 96 L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1137)
|+|++|+|+.||..+. .+|+.|+|++|++..+|..+. .+|+.|++++|.+.. +|..+ .++|+.|++++|.
T Consensus 267 L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt~----LP~~l--~~sL~~L~Ls~N~ 336 (754)
T PRK15370 267 LDLFHNKISCLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLTA----LPETL--PPGLKTLEAGENA 336 (754)
T ss_pred EECcCCccCccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCcccc----CCccc--cccceeccccCCc
Confidence 9999999999998775 589999999999888775443 479999999977653 34333 2579999999999
Q ss_pred CcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCc---cc
Q 001152 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS---LD 252 (1137)
Q Consensus 176 L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p---~~ 252 (1137)
|+.||..+. ++|+.|+|++|+|+.+|..+. ++|+.|+|++|+|+.||..+. ..|+.|++++|+|+++|. ..
T Consensus 337 Lt~LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~ 410 (754)
T PRK15370 337 LTSLPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTNLPENLP--AALQIMQASRNNLVRLPESLPHF 410 (754)
T ss_pred cccCChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCCCCHhHH--HHHHHHhhccCCcccCchhHHHH
Confidence 999998764 799999999999999998774 689999999999999998875 479999999999997753 23
Q ss_pred ccCCCCCCEEEccCCcCCC
Q 001152 253 LCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+..++.+..|+|.+|+|+.
T Consensus 411 ~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 411 RGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred hhcCCCccEEEeeCCCccH
Confidence 3456889999999999864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4e-20 Score=229.45 Aligned_cols=244 Identities=23% Similarity=0.182 Sum_probs=189.1
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L 96 (1137)
+.+..|.+..|+|+.++. ..++|++|+|++|+|+.+ |.. .++|+.|+|++|.|+.+|..+ ++|+.|
T Consensus 222 ~~L~~L~L~~N~Lt~LP~----lp~~Lk~LdLs~N~LtsL-P~l------p~sL~~L~Ls~N~L~~Lp~lp---~~L~~L 287 (788)
T PRK15387 222 AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSL-PVL------PPGLLELSIFSNPLTHLPALP---SGLCKL 287 (788)
T ss_pred cCCCEEEccCCcCCCCCC----CCCCCcEEEecCCccCcc-cCc------ccccceeeccCCchhhhhhch---hhcCEE
Confidence 468899999999999875 358999999999999965 432 268899999999999998743 468899
Q ss_pred EccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCC
Q 001152 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1137)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1137)
+|++|+|+.+|.. +++|+.|+|++|.+..+|..+ .+|+.|++++|.+.. +|.. ..+|+.|+|++|+|
T Consensus 288 ~Ls~N~Lt~LP~~---p~~L~~LdLS~N~L~~Lp~lp---~~L~~L~Ls~N~L~~----LP~l---p~~Lq~LdLS~N~L 354 (788)
T PRK15387 288 WIFGNQLTSLPVL---PPGLQELSVSDNQLASLPALP---SELCKLWAYNNQLTS----LPTL---PSGLQELSVSDNQL 354 (788)
T ss_pred ECcCCcccccccc---ccccceeECCCCccccCCCCc---ccccccccccCcccc----cccc---ccccceEecCCCcc
Confidence 9999999999873 468999999999988777543 357788888866543 3421 24788999999999
Q ss_pred cccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCC
Q 001152 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1137)
Q Consensus 177 ~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L 256 (1137)
+.||.. ..+|+.|++++|+|+.||.. ..+|+.|+|++|+|+.+|... ++|+.|+|++|+|+++|. . .
T Consensus 355 s~LP~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt~LP~l~---s~L~~LdLS~N~LssIP~-l---~ 421 (788)
T PRK15387 355 ASLPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTSLPVLP---SELKELMVSGNRLTSLPM-L---P 421 (788)
T ss_pred CCCCCC---CcccceehhhccccccCccc---ccccceEEecCCcccCCCCcc---cCCCEEEccCCcCCCCCc-c---h
Confidence 998874 35788889999999988854 357899999999999888643 578999999999998753 2 3
Q ss_pred CCCCEEEccCCcCCCCCCCCcchhhccCCCCCCCCCCCcccccccccccCCCcccCC
Q 001152 257 HNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLEND 313 (1137)
Q Consensus 257 ~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~l~~~~~s~n~l~g~il~~~ 313 (1137)
.+|+.|+|++|+|+. ||..++- ...+..+++++|.++|.++..+
T Consensus 422 ~~L~~L~Ls~NqLt~---LP~sl~~----------L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 422 SGLLSLSVYRNQLTR---LPESLIH----------LSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred hhhhhhhhccCcccc---cChHHhh----------ccCCCeEECCCCCCCchHHHHH
Confidence 568889999999874 6665441 2345567777788887765433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-20 Score=205.41 Aligned_cols=215 Identities=22% Similarity=0.331 Sum_probs=149.8
Q ss_pred CCCCcceeeeeEecCCCCCCCCC--------------CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHH
Q 001152 863 RHSCIVEMYGHKISSKWLPSADG--------------NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALF 928 (1137)
Q Consensus 863 ~HpNIVkllg~~~~~~~~~~~~g--------------~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~ 928 (1137)
+|||||+++++|.++-.. .+++ ....+...+|+||..++ .+|..++.. ...+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~-lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKV-LPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhcc-CCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHH
Confidence 599999999988753211 1111 11123457999999997 899999975 2467788889
Q ss_pred HHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCcccccccc-ccccccccCCCCCCCcccCCCcc
Q 001152 929 IAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSF-LHTCCIAHRGIPAPDVCVGTPRW 1007 (1137)
Q Consensus 929 I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~-~~~~~~~~~~~~~~~~~~GT~~Y 1007 (1137)
|+.|+++|+.|||.+||.|||+|++|||+.-+ ++.-..+.|+|||++..-+.- ....+..+ .-...|.-.-
T Consensus 346 ~laQlLEav~hL~~hgvAhRDlKSDNiL~Eld---dD~~P~LVvaDFGCcLAd~~hGlqlpy~S~-----~Vd~GGNa~l 417 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHGVAHRDLKSDNILLELD---DDEIPQLVVADFGCCLADDNHGLQLPYESD-----EVDLGGNAKL 417 (598)
T ss_pred HHHHHHHHHHHHHHccchhhcccccceEEEec---CCCCcEEEEcccceeeeccccccccccccc-----cccCCCccee
Confidence 99999999999999999999999999999776 445578999999987533221 01111111 1122466678
Q ss_pred cchhhhccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHcCCCCCchhHHhhhcccccccccccC
Q 001152 1008 MAPEVLRAMHKPN--LYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL-IQMGKRPRLTDELEALGSCHEHEVAQSG 1084 (1137)
Q Consensus 1008 ~APE~l~~~~~~~--~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~-I~~g~~p~l~~~l~~~~~~~~~~~~~~~ 1084 (1137)
||||+........ ..-.|+|.|+.|.+.||+++...||.+...+.+-.. .+....|.++.
T Consensus 418 mAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~----------------- 480 (598)
T KOG4158|consen 418 MAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPS----------------- 480 (598)
T ss_pred cchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcc-----------------
Confidence 9999987643211 123699999999999999999999986433322111 22222222221
Q ss_pred CCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1085 SGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1085 ~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
.+++.+++++...|+.||.+|++..-
T Consensus 481 ----------~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 481 ----------RVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred ----------cCChHHHHHHHHHhcCCccccCCccH
Confidence 45666999999999999999998643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-22 Score=199.95 Aligned_cols=163 Identities=25% Similarity=0.373 Sum_probs=110.2
Q ss_pred CCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECC
Q 001152 66 GDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELS 145 (1137)
Q Consensus 66 ~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls 145 (1137)
.+.+++.|.|++|+|+.+|+.|..|.+|++|++++|+|+.+|.+++.|++|+.|+++.|.+...|..|+.++.|+.|+|.
T Consensus 31 ~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLT 110 (264)
T ss_pred chhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhcc
Confidence 45788999999999999999999999999999999999999999999999999999988877777666666666666666
Q ss_pred CCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCcc
Q 001152 146 KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225 (1137)
Q Consensus 146 ~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~I 225 (1137)
+|.++. ..+|..|..++.|..|+|+.|.+..+|+.+++|++|+.|.|.+|.|-++|.+++.+++|+.|++.+|+|+.+
T Consensus 111 ynnl~e--~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~vl 188 (264)
T KOG0617|consen 111 YNNLNE--NSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTVL 188 (264)
T ss_pred cccccc--ccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeeec
Confidence 644432 234444444444545555555555455555555555555555555555555555555555555555555544
Q ss_pred Ccccc
Q 001152 226 PSGLY 230 (1137)
Q Consensus 226 P~~l~ 230 (1137)
|++++
T Consensus 189 ppel~ 193 (264)
T KOG0617|consen 189 PPELA 193 (264)
T ss_pred Chhhh
Confidence 44444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.2e-19 Score=183.74 Aligned_cols=212 Identities=19% Similarity=0.227 Sum_probs=161.0
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC-CCcceeeeeEec
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKIS 876 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H-pNIVkllg~~~~ 876 (1137)
....|.++++||.|+||.+|+|.. .+..||+|+-..+.. .++ +..|..+...|+| ..|..+.-|+.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpq-------L~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQ-------LLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---Ccc-------hhHHHHHHHHhccCCCCchhhhhccc
Confidence 456799999999999999999987 468899997433221 222 2557788888874 555556555555
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. .-.+||+++ |.||++++.-+ ...|+..+++-++-|++.-++|+|.+++|||||||+|+|
T Consensus 83 ~~--------------ynvlVMdLL-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFL 143 (341)
T KOG1163|consen 83 KD--------------YNVLVMDLL-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFL 143 (341)
T ss_pred cc--------------cceeeeecc-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCcccee
Confidence 44 338999988 79999988754 346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
..-+. ....+.++|||+|+.+.+..... +-+........||..|.+-....+ ..-+.+-|+=|+|.++.
T Consensus 144 MGlgr----h~~kl~LIDFGLaKky~d~~t~~---HIpyre~r~ltGTaRYASinAh~g----~eqSRRDDmeSvgYvLm 212 (341)
T KOG1163|consen 144 MGLGR----HCNKLYLIDFGLAKKYRDIRTRQ---HIPYREDRNLTGTARYASINAHLG----IEQSRRDDMESVGYVLM 212 (341)
T ss_pred ecccc----ccceEEEEeccchhhhccccccc---cCccccCCccceeeeehhhhhhhh----hhhhhhhhhhhhcceee
Confidence 97552 22468999999998776543221 112222335679999999777654 33468899999999999
Q ss_pred HHHhCCCCCCCCCHH
Q 001152 1037 ELLTLQVPYMGLSEL 1051 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~ 1051 (1137)
.+..|..||++....
T Consensus 213 YfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 213 YFNRGSLPWQGLKAA 227 (341)
T ss_pred eeecCCCcccccchh
Confidence 999999999986543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-21 Score=235.27 Aligned_cols=219 Identities=26% Similarity=0.303 Sum_probs=103.9
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEc
Q 001152 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI 121 (1137)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~L 121 (1137)
+|+++|+|+|++++.+ +|.+.+ .+|+.|...+|+|+.+|..+..+++|+.|.+.+|.++.+|+.+..++.|+.|+|
T Consensus 242 nl~~~dis~n~l~~lp-~wi~~~---~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSNLP-EWIGAC---ANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred cceeeecchhhhhcch-HHHHhc---ccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeee
Confidence 4445555555554433 444333 445555555555555555444445555555555555555554444555555555
Q ss_pred cCCCCCCCcccccC--------------------------CCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCC
Q 001152 122 KISSPGVNGFALNK--------------------------LKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1137)
Q Consensus 122 s~N~~~~~~~~~~~--------------------------L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1137)
..|++...|..+-. +..|+.|++.+|.++... .+.+-+.++|+.|+|++|+
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c---~p~l~~~~hLKVLhLsyNr 394 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSC---FPVLVNFKHLKVLHLSYNR 394 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccc---hhhhccccceeeeeecccc
Confidence 55554444432110 111222233332222211 1123344455555555555
Q ss_pred CcccCc-cccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCccccc
Q 001152 176 IRYLPP-EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1137)
Q Consensus 176 L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~ 254 (1137)
|..+|+ .+.+|..|+.|+||+|+|+.||..+.+|..|++|...+|+|..+| ++.++++|+.+|||.|+|+.+.-..-.
T Consensus 395 L~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~ 473 (1081)
T KOG0618|consen 395 LNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL 473 (1081)
T ss_pred cccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhhhhhhhhC
Confidence 555555 335555555555555555555555555555555555555555555 455555555555555555532211222
Q ss_pred CCCCCCEEEccCCc
Q 001152 255 LMHNLQNLNLQYNK 268 (1137)
Q Consensus 255 ~L~~L~~L~Ls~N~ 268 (1137)
..++|++|||++|.
T Consensus 474 p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 474 PSPNLKYLDLSGNT 487 (1081)
T ss_pred CCcccceeeccCCc
Confidence 22455555555554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-20 Score=225.34 Aligned_cols=260 Identities=20% Similarity=0.197 Sum_probs=184.0
Q ss_pred CceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
.|...+.||.+.|=.|.+|++....++|||+..+.....-..+.+. +.|++ ...++|||++++.-....++
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qr----L~~ik-~~l~~~pn~lPfqk~~~t~k---- 94 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQR----LEEIK-FALMKAPNCLPFQKVLVTDK---- 94 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHH----HHHHH-HHhhcCCcccchHHHHHhhH----
Confidence 6778899999999999999998888999998766544444444443 56666 66778999999877765544
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
..|||-+|+. .+|++.+.. +.-+..-+.+.|+.|++.||..+|..||+|||||.+||||+.-
T Consensus 95 ----------AAylvRqyvk-hnLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-- 156 (1431)
T KOG1240|consen 95 ----------AAYLVRQYVK-HNLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-- 156 (1431)
T ss_pred ----------HHHHHHHHHh-hhhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee--
Confidence 3488899985 899999875 3567888889999999999999999999999999999999976
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc------CCC-CCCchhhHHHHHHHH
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH------KPN-LYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~~~-~~s~ksDVWSLGviL 1035 (1137)
..+.|+||..-++.--+....... ... -++...-..|.|||.+-... ... ..+++.||||+||++
T Consensus 157 -----NW~~LtDFAsFKPtYLPeDNPadf--~fF-FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 157 -----NWLYLTDFASFKPTYLPEDNPADF--TFF-FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred -----chhhhhcccccCCccCCCCCcccc--eEE-EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence 678999997654321111000000 000 01112334899999875411 111 257899999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+||++ |++||.- .++. ..+.+..-....-+..+ ....+++++..|++.||.+
T Consensus 229 aELf~Eg~PlF~L---SQL~-aYr~~~~~~~e~~Le~I-----------------------ed~~~Rnlil~Mi~rdPs~ 281 (1431)
T KOG1240|consen 229 AELFLEGRPLFTL---SQLL-AYRSGNADDPEQLLEKI-----------------------EDVSLRNLILSMIQRDPSK 281 (1431)
T ss_pred HHHHhcCCCcccH---HHHH-hHhccCccCHHHHHHhC-----------------------cCccHHHHHHHHHccCchh
Confidence 99988 5777742 2222 22333211111112211 1123899999999999999
Q ss_pred CCCHHHHHHH
Q 001152 1115 RPTAGDLYEM 1124 (1137)
Q Consensus 1115 RPSa~EVL~~ 1124 (1137)
|.+|++.|+.
T Consensus 282 RlSAedyL~~ 291 (1431)
T KOG1240|consen 282 RLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHh
Confidence 9999999886
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-21 Score=232.46 Aligned_cols=259 Identities=21% Similarity=0.252 Sum_probs=209.2
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~ 97 (1137)
+++.|-.+.|++..+.- ..++|+.|+.++|-|+...+. +- -.+|+++++++|+++.+|++++.+.+|+.|+
T Consensus 200 ~l~~l~c~rn~ls~l~~----~g~~l~~L~a~~n~l~~~~~~-p~----p~nl~~~dis~n~l~~lp~wi~~~~nle~l~ 270 (1081)
T KOG0618|consen 200 NLEVLHCERNQLSELEI----SGPSLTALYADHNPLTTLDVH-PV----PLNLQYLDISHNNLSNLPEWIGACANLEALN 270 (1081)
T ss_pred chhhhhhhhcccceEEe----cCcchheeeeccCcceeeccc-cc----cccceeeecchhhhhcchHHHHhcccceEec
Confidence 56666666666666543 235778888888888744433 21 2489999999999999999999999999999
Q ss_pred ccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccc----hh---------------
Q 001152 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTL----LS--------------- 158 (1137)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~l----p~--------------- 158 (1137)
+.+|+|+.+|..+...++|+.|++.+|.+..+|.....++.|++|+|..|.+..+.... +.
T Consensus 271 ~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~l 350 (1081)
T KOG0618|consen 271 ANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTL 350 (1081)
T ss_pred ccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccc
Confidence 99999999999999999999999999999999999999999999999987653322111 00
Q ss_pred -hh--cCCCCCcEEeccCCCCc-ccCccccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCccCccccCCC
Q 001152 159 -EI--AGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQ 233 (1137)
Q Consensus 159 -~l--~~L~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~ 233 (1137)
.. .....|+.|++.+|.|+ ..-+.|-++..|+.|+|++|+|.++|+. +.+|..|+.|+||+|+|+.||.++.++.
T Consensus 351 p~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~ 430 (1081)
T KOG0618|consen 351 PSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLG 430 (1081)
T ss_pred ccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhh
Confidence 00 12345678899999998 3333467889999999999999999965 5889999999999999999999999999
Q ss_pred CCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCC---CC--CcchhhccCCCC
Q 001152 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC---QV--PSWICCNLEGNG 287 (1137)
Q Consensus 234 ~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~---~i--P~~~~~~l~~n~ 287 (1137)
.|+.|...+|+|...| .+..++.|+.+||+.|.|+... -. |.+-.++++||.
T Consensus 431 ~L~tL~ahsN~l~~fP--e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 431 RLHTLRAHSNQLLSFP--ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred hhHHHhhcCCceeech--hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 9999999999999886 7899999999999999998631 12 445557777776
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=184.49 Aligned_cols=146 Identities=14% Similarity=0.085 Sum_probs=107.9
Q ss_pred eeeecccCceEEEEEEEC-CccEEEEEEecccCCCChH--------H----------HHHhHHhHHHHHHHHHhCCCCCc
Q 001152 807 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSAD--------E----------IRNFEYSCLGEVRMLGALRHSCI 867 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~--------~----------~e~~~~~~lrEi~iL~~L~HpNI 867 (1137)
...||+|++|.||+|... +..||+|+.+......... . .+....+..+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999974 6889999875443211110 0 00112234569999999998887
Q ss_pred ceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCee
Q 001152 868 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVEL-HSKHIM 946 (1137)
Q Consensus 868 Vkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yL-Hs~gII 946 (1137)
.....+... ..+|||||++|+++...+.. ...+++..+..++.||+.+|.|+ |+.||+
T Consensus 82 ~~p~~~~~~----------------~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~gii 140 (190)
T cd05147 82 PCPEPILLK----------------SHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCRLV 140 (190)
T ss_pred CCCcEEEec----------------CCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 544333221 22899999998777654322 24689999999999999999999 699999
Q ss_pred eccCCCCCeEeccccccCCCCCeEEEeecCccccc
Q 001152 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 981 (1137)
Q Consensus 947 HrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~ 981 (1137)
||||||+|||++. +.++|+|||+|...
T Consensus 141 HrDlkP~NIli~~--------~~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYHD--------GKLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEEC--------CcEEEEEccccccC
Confidence 9999999999973 46999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=186.88 Aligned_cols=183 Identities=13% Similarity=0.131 Sum_probs=130.0
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHh--HHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF--EYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~--~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||.|+||.||++...+..+|+|++.-+.... ....+.+ ...+.+|+..+.++.||+|..+.+++.....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~-~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRT-ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCch-HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 579999999999999999988877889999875333211 1111111 0114789999999999999999988765321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ........+|||||++|.+|.++.. +++ ....+|+.+|..+|+.||+|||+||+||+++.
T Consensus 110 ~------~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 110 K------TLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred c------cccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 0 0001124699999999999988632 222 24568999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
+ + ++|+|||......... ....++.. ..++.++|+|+||+++..+
T Consensus 171 ~-------g-i~liDfg~~~~~~e~~----------------------a~d~~vle----r~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 171 N-------G-LRIIDLSGKRCTAQRK----------------------AKDRIDLE----RHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred C-------C-EEEEECCCcccccchh----------------------hHHHHHHH----hHhcccccccceeEeehHH
Confidence 6 6 9999999765432110 00112222 3456799999999987644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-19 Score=211.66 Aligned_cols=237 Identities=23% Similarity=0.275 Sum_probs=182.9
Q ss_pred eecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCCCCC
Q 001152 809 EAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 809 ~LG~GsfG~Vy~a~~-----~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~~~~ 882 (1137)
.+|+|+||.|++++- .+.-+|+|+.+.......... . ...|..++...+ ||.+|++.-.+..+.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~----t~~er~il~~~~~~~f~v~lhyafqt~~---- 70 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--H----TKQERIILAFVHNTPFLVKLHYAFQTDG---- 70 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--c----cccHHHHHhhccCCCceeeeeeeecccc----
Confidence 379999999997653 456677776432222221111 1 145778888888 999999988887665
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
.++++++|..||.|...+.+ ...+++.....+...++-|++++|+.+|+|||+|++||+++.+
T Consensus 71 ----------kl~l~ld~~rgg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-- 133 (612)
T KOG0603|consen 71 ----------KLYLILDFLRGGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-- 133 (612)
T ss_pred ----------chhHhhhhcccchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc--
Confidence 56999999999999988865 3568888888899999999999999999999999999999988
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~ 1042 (1137)
|++++.|||.++....... ..||..|||||++.+ +..++|+||||++++||+||.
T Consensus 134 -----Ghi~~tdfglske~v~~~~--------------~cgt~eymApEI~~g------h~~a~D~ws~gvl~felltg~ 188 (612)
T KOG0603|consen 134 -----GHIKLTDFGLSKEAVKEKI--------------ACGTYEYRAPEIING------HLSAADWWSFGVLAFELLTGT 188 (612)
T ss_pred -----CccccCCchhhhHhHhhhh--------------cccchhhhhhHhhhc------cCCcccchhhhhhHHHHhhCC
Confidence 8999999998876543221 158999999999873 458999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-----C
Q 001152 1043 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-----T 1117 (1137)
Q Consensus 1043 ~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-----S 1117 (1137)
.||.+ ++...|..... ..+. .....+.+++..++..+|..|- -
T Consensus 189 ~pf~~----~~~~~Il~~~~-~~p~---------------------------~l~~~a~~~~~~l~~r~p~nrLg~~~~~ 236 (612)
T KOG0603|consen 189 LPFGG----DTMKRILKAEL-EMPR---------------------------ELSAEARSLFRQLFKRNPENRLGAGPDG 236 (612)
T ss_pred CCCch----HHHHHHhhhcc-CCch---------------------------hhhHHHHHHHHHHHhhCHHHHhccCcch
Confidence 99987 55555544222 1121 3344588899999999999996 4
Q ss_pred HHHHHHHHHhhc
Q 001152 1118 AGDLYEMFVART 1129 (1137)
Q Consensus 1118 a~EVL~~L~~~~ 1129 (1137)
+.|+.+|.++..
T Consensus 237 ~~eik~h~f~~~ 248 (612)
T KOG0603|consen 237 VDEIKQHEFFQS 248 (612)
T ss_pred hHHHhccchhee
Confidence 578888877653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-21 Score=191.68 Aligned_cols=184 Identities=23% Similarity=0.322 Sum_probs=165.7
Q ss_pred ccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhc
Q 001152 82 LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA 161 (1137)
Q Consensus 82 ~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~ 161 (1137)
++| .+.++.+.+.|.||+|+|+.+|+.+.+|.+|++|++.+|++..+|..++.|+.|+.|++.-|.+ ..+|..|+
T Consensus 25 ~~~-gLf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl----~~lprgfg 99 (264)
T KOG0617|consen 25 ELP-GLFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRL----NILPRGFG 99 (264)
T ss_pred hcc-cccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhh----hcCccccC
Confidence 444 3567888999999999999999999999999999999999999999999999999999997555 46788999
Q ss_pred CCCCCcEEeccCCCCc--ccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEe
Q 001152 162 GLKCLTKLSVCHFSIR--YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239 (1137)
Q Consensus 162 ~L~~L~~L~Ls~N~L~--~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~Ld 239 (1137)
.++.|+.|||.+|.+. .+|..|..|+.|+.|+|++|.|+-+|..++++++|+.|.|..|.|-++|.+++.|++|+.|+
T Consensus 100 s~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelh 179 (264)
T KOG0617|consen 100 SFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELH 179 (264)
T ss_pred CCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHh
Confidence 9999999999999998 79999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcCCCCCcccccCCC---CCCEEEccCCcCCC
Q 001152 240 LSNNRLTSLGSLDLCLMH---NLQNLNLQYNKLLS 271 (1137)
Q Consensus 240 LS~N~Lsg~~p~~l~~L~---~L~~L~Ls~N~L~~ 271 (1137)
+.+|+|+-+|| .++++. +=+.+.+.+|+|..
T Consensus 180 iqgnrl~vlpp-el~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 180 IQGNRLTVLPP-ELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred cccceeeecCh-hhhhhhhhhhHHHHhhhhCCCCC
Confidence 99999999988 666654 33556677787754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=192.57 Aligned_cols=254 Identities=20% Similarity=0.202 Sum_probs=153.3
Q ss_pred ceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC----------CCcceee
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH----------SCIVEMY 871 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H----------pNIVkll 871 (1137)
+...+.||.|+++.||.+++.. +..|+|++.... .......+.+ .+|.-....+.+ -.++..+
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~----~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQL----KEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHH----HHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHH----HHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 4677899999999999999955 889999987665 3333344444 555444444322 2333333
Q ss_pred eeEecCCCCCCCCCC---CccccceEEEEEeeccCCCHHHHHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCee
Q 001152 872 GHKISSKWLPSADGN---PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEK--HVSVKLALFIAQDVAAALVELHSKHIM 946 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~---~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~--~ls~~~i~~I~~QIa~gL~yLHs~gII 946 (1137)
+.....+.-+..... ........+++|+-+. ++|.+++.-.+..... .+....+..+..|+++.+++||..||+
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 333221100000000 0111224578898885 8999987654433322 344445567789999999999999999
Q ss_pred eccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc----CCCCC
Q 001152 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KPNLY 1022 (1137)
Q Consensus 947 HrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~~~~~ 1022 (1137)
|+||||+|++++.+ |.++|+||+........... ...+..|.+||...... ....+
T Consensus 168 Hgdi~~~nfll~~~-------G~v~Lg~F~~~~r~g~~~~~-------------~~~~~~~~PPe~~~~~~~~~~~~~~~ 227 (288)
T PF14531_consen 168 HGDIKPENFLLDQD-------GGVFLGDFSSLVRAGTRYRC-------------SEFPVAFTPPELESCAGQFGQNNAPY 227 (288)
T ss_dssp EST-SGGGEEE-TT-------S-EEE--GGGEEETTEEEEG-------------GGS-TTTS-HHHHHHHTSCHHSEEEE
T ss_pred ecccceeeEEEcCC-------CCEEEcChHHHeecCceeec-------------cCCCcccCChhhhhhhcccCccccee
Confidence 99999999999988 89999999977654432110 12446899999875421 12347
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHH
Q 001152 1023 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVD 1102 (1137)
Q Consensus 1023 s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~d 1102 (1137)
+.+.|.|+||+++|.|.++..||..........+ ....+. +.++.+++
T Consensus 228 t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------------------~f~~C~-~~Pe~v~~ 275 (288)
T PF14531_consen 228 TFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------------------------------DFSRCR-DMPEPVQF 275 (288)
T ss_dssp -HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------------------------------GGTTSS----HHHHH
T ss_pred eeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------------------------------cchhcC-CcCHHHHH
Confidence 8999999999999999999999975322110000 011122 55677999
Q ss_pred HHHHhcccCCCCC
Q 001152 1103 VFRRCTEENPTER 1115 (1137)
Q Consensus 1103 Ll~~CL~~DP~~R 1115 (1137)
||..+|+.+|.+|
T Consensus 276 LI~~lL~~~~~~R 288 (288)
T PF14531_consen 276 LIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHT-SSGGGS
T ss_pred HHHHHccCCcccC
Confidence 9999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.2e-18 Score=178.52 Aligned_cols=146 Identities=14% Similarity=0.139 Sum_probs=109.4
Q ss_pred eeeecccCceEEEEEEEC-CccEEEEEEecccCCCCh------------------HHHHHhHHhHHHHHHHHHhCCCCCc
Q 001152 807 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLGALRHSCI 867 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~------------------~~~e~~~~~~lrEi~iL~~L~HpNI 867 (1137)
...||+|++|.||+|.+. ++.||+|+.......... ...+....++.+|++.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999975 789999986654221100 0001112234679999999999988
Q ss_pred ceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHH-HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCe
Q 001152 868 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY-IEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHI 945 (1137)
Q Consensus 868 Vkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~-L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gI 945 (1137)
.....+.... .+|||||++|+++... +.. ..++...+..++.|++.++.++|+ +||
T Consensus 82 ~~p~~~~~~~----------------~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~gi 139 (190)
T cd05145 82 PVPEPILLKK----------------NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGL 139 (190)
T ss_pred CCceEEEecC----------------CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 6544443321 2899999998765443 332 357888999999999999999999 999
Q ss_pred eeccCCCCCeEeccccccCCCCCeEEEeecCcccccc
Q 001152 946 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 982 (1137)
Q Consensus 946 IHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~ 982 (1137)
+||||||+|||++ + +.++|+|||++....
T Consensus 140 vHrDlkP~NIll~-~-------~~~~liDFG~a~~~~ 168 (190)
T cd05145 140 VHGDLSEYNILYH-D-------GKPYIIDVSQAVELD 168 (190)
T ss_pred ecCCCChhhEEEE-C-------CCEEEEEcccceecC
Confidence 9999999999998 4 679999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.9e-17 Score=214.91 Aligned_cols=237 Identities=22% Similarity=0.238 Sum_probs=168.1
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecC-CCCccCccccCCCCCcE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKN-VLNLIPKSVGRYEKLRN 95 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N-~L~~IP~~~~~L~~L~~ 95 (1137)
.+|..|.+..|+|..+.. .+..+++|++|+|++|+..+.+|. +..+++|+.|+|++| .+..+|..|.+|++|+.
T Consensus 611 ~~L~~L~L~~s~l~~L~~-~~~~l~~Lk~L~Ls~~~~l~~ip~----ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~ 685 (1153)
T PLN03210 611 ENLVKLQMQGSKLEKLWD-GVHSLTGLRNIDLRGSKNLKEIPD----LSMATNLETLKLSDCSSLVELPSSIQYLNKLED 685 (1153)
T ss_pred cCCcEEECcCcccccccc-ccccCCCCCEEECCCCCCcCcCCc----cccCCcccEEEecCCCCccccchhhhccCCCCE
Confidence 356666777777766643 456777777777777654444543 334577778888765 45677777777778888
Q ss_pred EEccCC-CCCcccccccCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhh--------------
Q 001152 96 LKFFGN-EINLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSE-------------- 159 (1137)
Q Consensus 96 L~Ls~N-~L~~lP~~l~~L~~L~~L~Ls~N~-~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~-------------- 159 (1137)
|+|++| .++.+|..+ ++++|+.|+|++|. +..+|. ...+|+.|++++|.+. .+|..
T Consensus 686 L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~i~----~lP~~~~l~~L~~L~l~~~ 757 (1153)
T PLN03210 686 LDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD---ISTNISWLDLDETAIE----EFPSNLRLENLDELILCEM 757 (1153)
T ss_pred EeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc---ccCCcCeeecCCCccc----ccccccccccccccccccc
Confidence 888764 466777655 67777777777664 333332 2345666666665432 22221
Q ss_pred ----------------hcCCCCCcEEeccCCC-CcccCccccCCCCCCEEEccCC-CCCccchhhcCCCCCCEEEccCCC
Q 001152 160 ----------------IAGLKCLTKLSVCHFS-IRYLPPEIGCLSNLEQLDLSFN-KMKYLPTEICYLKALISLKVANNK 221 (1137)
Q Consensus 160 ----------------l~~L~~L~~L~Ls~N~-L~~IP~~l~~L~~L~~L~Ls~N-~L~~LP~~l~~L~~L~~L~Ls~N~ 221 (1137)
...+++|+.|+|++|. +..+|..+++|++|+.|+|++| +++.+|..+ ++++|+.|+|++|.
T Consensus 758 ~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~ 836 (1153)
T PLN03210 758 KSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCS 836 (1153)
T ss_pred chhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCC
Confidence 1123578888998885 4589999999999999999986 688999776 78999999999975
Q ss_pred -CCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccC-CcCCC
Q 001152 222 -LVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY-NKLLS 271 (1137)
Q Consensus 222 -Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~-N~L~~ 271 (1137)
+..+|.. .++|+.|+|++|.|+.+| .++..+++|+.|+|++ |+|.+
T Consensus 837 ~L~~~p~~---~~nL~~L~Ls~n~i~~iP-~si~~l~~L~~L~L~~C~~L~~ 884 (1153)
T PLN03210 837 RLRTFPDI---STNISDLNLSRTGIEEVP-WWIEKFSNLSFLDMNGCNNLQR 884 (1153)
T ss_pred cccccccc---ccccCEeECCCCCCccCh-HHHhcCCCCCEEECCCCCCcCc
Confidence 6677753 367899999999999875 5889999999999998 56665
|
syringae 6; Provisional |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=4e-17 Score=173.68 Aligned_cols=200 Identities=14% Similarity=0.067 Sum_probs=137.0
Q ss_pred eEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHH-HhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCCCCC
Q 001152 805 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIR-NFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 805 ~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e-~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~~~~ 882 (1137)
.+...|++|+||+||.+...+..++.+-+.... ...+ -+...+.+|+++|+++. |++|++++++.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~-----~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-------- 71 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAP-----WWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-------- 71 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccch-----hhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc--------
Confidence 356789999999999888766666655432221 1111 11123588999999996 68899998861
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC-CCCCeEecccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI-KSENILIDLER 961 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDL-KP~NILld~~~ 961 (1137)
..++||||+.|.+|...+.. . ...++.|++.+|+++|++||+|||| ||.|||++.+
T Consensus 72 ----------~~~lvmeyI~G~~L~~~~~~-----------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~- 128 (218)
T PRK12274 72 ----------GRHLDRSYLAGAAMYQRPPR-----------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED- 128 (218)
T ss_pred ----------CEEEEEeeecCccHHhhhhh-----------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-
Confidence 34899999999998754321 0 1347889999999999999999999 7999999876
Q ss_pred ccCCCCCeEEEeecCcccccccccccccc-ccCCC--CCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCI-AHRGI--PAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~-~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
+.++|+|||++............ ..+.. ........++.|+.|+.-.-.. ..--...++++.|+-+|.+
T Consensus 129 ------g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~--~~~~~~~~w~~~g~~~~~~ 200 (218)
T PRK12274 129 ------GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK--RTSWIRELWFATGKPVYRF 200 (218)
T ss_pred ------CCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc--cchhHHHHHHHhcchHHHH
Confidence 67999999999754322110000 00000 0000123577888888654311 2223678999999999999
Q ss_pred HhCCCCCCCC
Q 001152 1039 LTLQVPYMGL 1048 (1137)
Q Consensus 1039 LTG~~Pf~~~ 1048 (1137)
+|+..++.++
T Consensus 201 ~~~~~~~~~~ 210 (218)
T PRK12274 201 VTRRVLHWED 210 (218)
T ss_pred HhccCCcccc
Confidence 9999887653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-17 Score=201.96 Aligned_cols=160 Identities=27% Similarity=0.306 Sum_probs=123.0
Q ss_pred HHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCcccccccccccccccc-----CCCCCCCcccCCCccc
Q 001152 934 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH-----RGIPAPDVCVGTPRWM 1008 (1137)
Q Consensus 934 a~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~-----~~~~~~~~~~GT~~Y~ 1008 (1137)
+.+++|||+.||+|||+||+|.+|+.- |++|+.|||+.+.......++.... .........+|||.|+
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~m-------GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyi 225 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSM-------GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYI 225 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeec-------ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCcccc
Confidence 778999999999999999999999977 8999999998864322211111000 0011223457999999
Q ss_pred chhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCC
Q 001152 1009 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1088 (1137)
Q Consensus 1009 APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~ 1088 (1137)
|||++.. +.|++.+|+|++|+|+||.+-|+.||.++.+++++..+......+...
T Consensus 226 aPeVilr----qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~--------------------- 280 (1205)
T KOG0606|consen 226 APEVILR----QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE--------------------- 280 (1205)
T ss_pred Chhhhhh----hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc---------------------
Confidence 9999975 679999999999999999999999999999999988876544322211
Q ss_pred CchhhhhhHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHhhc
Q 001152 1089 KPEAELETLSFLVDVFRRCTEENPTERP---TAGDLYEMFVART 1129 (1137)
Q Consensus 1089 ~~~~~~~~~~~L~dLl~~CL~~DP~~RP---Sa~EVL~~L~~~~ 1129 (1137)
....++++++++.++|+.+|..|- .+-+|-+|-+|+.
T Consensus 281 ----dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 281 ----DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred ----CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 113456799999999999999994 6778888877764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.4e-16 Score=169.11 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=111.7
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~ 887 (1137)
+.||+|++|.||+|.+.+..+++|+...+.......+......++.+|+.++..+.|++|+....++.+..
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--------- 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--------- 72 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC---------
Confidence 57999999999999998889999975433222211122222235688999999999999887666655443
Q ss_pred ccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCC
Q 001152 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGK 967 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~ 967 (1137)
..++||||++|++|.+++... .. .+..++.+++.+|.++|+.|++|||++|.|||++ +
T Consensus 73 -----~~~lv~e~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~------- 130 (211)
T PRK14879 73 -----NFIIVMEYIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G------- 130 (211)
T ss_pred -----CCEEEEEEeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-------
Confidence 348999999999999998651 12 7889999999999999999999999999999998 4
Q ss_pred CeEEEeecCcccc
Q 001152 968 PVVKLCDFDRAVP 980 (1137)
Q Consensus 968 ~~vKL~DFGla~~ 980 (1137)
+.++|+|||.+..
T Consensus 131 ~~~~liDf~~a~~ 143 (211)
T PRK14879 131 GKIYLIDFGLAEF 143 (211)
T ss_pred CCEEEEECCcccC
Confidence 5799999998754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=170.85 Aligned_cols=142 Identities=13% Similarity=0.129 Sum_probs=102.5
Q ss_pred EeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-----CCCCcceeeeeEecCCC
Q 001152 806 SCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-----RHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 806 l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-----~HpNIVkllg~~~~~~~ 879 (1137)
-.+.||+|+||.||. +. ....++|+...... ...+ .+.+|+.+++.+ .||||+++++++.++..
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~----~~~~----~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD----GGDK----EIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEecccc----chHH----HHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 347899999999996 32 23346776543211 1122 348899999999 57999999999987531
Q ss_pred CCCCCCCCccccceEEEEEee--ccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCeeeccCCCCCeE
Q 001152 880 LPSADGNPEHHLLQSAIFMEY--VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL-VELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy--~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL-~yLHs~gIIHrDLKP~NIL 956 (1137)
. ..-..+|||| +++++|.+++.+ ..+++. ..++.|++.++ +|||+++|+||||||+|||
T Consensus 76 ~----------g~v~~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NIL 137 (210)
T PRK10345 76 T----------GYVYDVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNIL 137 (210)
T ss_pred C----------eEEEEEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 0 1123488999 567999999965 235555 35678888888 9999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCcc
Q 001152 957 IDLERKKADGKPVVKLCDFDRA 978 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla 978 (1137)
++..+ .+...++|+||+.+
T Consensus 138 l~~~~---~~~~~~~LiDg~G~ 156 (210)
T PRK10345 138 CQRIS---ESEVIPVVCDNIGE 156 (210)
T ss_pred EeccC---CCCCcEEEEECCCC
Confidence 98541 23357999995533
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=188.50 Aligned_cols=217 Identities=25% Similarity=0.362 Sum_probs=161.4
Q ss_pred HHhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 001152 859 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 938 (1137)
Q Consensus 859 L~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~ 938 (1137)
|+.+.|.|+.+++|.+.+.. +.++|.+||..|+|.+.+.. ....+++--...++++|+.||+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--------------~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ 62 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--------------EMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLA 62 (484)
T ss_pred CcccchhhhhhheeeEecCC--------------ceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHH
Confidence 45688999999999998764 67999999999999999976 3467889999999999999999
Q ss_pred HHHhCCe-eeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc
Q 001152 939 ELHSKHI-MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017 (1137)
Q Consensus 939 yLHs~gI-IHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1017 (1137)
|||+-.| .|+.|++.|.+++.. ..+||.|||+.......... .......-..-|.|||.+.+..
T Consensus 63 ylh~s~i~~hg~l~s~nClvd~~-------w~lklt~~Gl~~~~~~~~~~--------~~~~~~~~~~lw~aPellr~~~ 127 (484)
T KOG1023|consen 63 YLHNSPIGYHGALKSSNCLVDSR-------WVLKLTDFGLNSLLEETAEP--------EAHHPIRKALLWTAPELLRGAL 127 (484)
T ss_pred HHhcCcceeeeeeccccceeeee-------EEEEechhhhcccccccccc--------cccchhHHHHhccCHHHhcccc
Confidence 9998755 899999999999988 89999999987655321000 0011112344799999998642
Q ss_pred CCCC---CCchhhHHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCc
Q 001152 1018 KPNL---YGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 1090 (1137)
Q Consensus 1018 ~~~~---~s~ksDVWSLGviL~ELLTG~~Pf~~----~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 1090 (1137)
.... .+++.||||||++++|+++.+.||.. ..+.++...+..+..+.+...+...
T Consensus 128 ~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~------------------ 189 (484)
T KOG1023|consen 128 SQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELL------------------ 189 (484)
T ss_pred cccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhh------------------
Confidence 2222 57889999999999999999999975 2334566666552221111111100
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1091 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1091 ~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
. ...+++..++.+||..+|.+||++++|-..+....
T Consensus 190 --~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 190 --N-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred --h-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 0 23346899999999999999999999977765543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.9e-16 Score=203.09 Aligned_cols=169 Identities=22% Similarity=0.253 Sum_probs=95.8
Q ss_pred cccCCCCCCcc--cCCCCCCCCCCCCEEEccCCCC------CCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCC
Q 001152 21 KLPSEANKINN--EKNGSVNDDDDDSVIDVSGKTV------DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEK 92 (1137)
Q Consensus 21 ~L~~~~N~i~~--l~~~~f~~l~~L~~LdLs~N~L------~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~ 92 (1137)
.|.+..+.+.. +...+|.++++|+.|.+..+.+ ...+|+.|..+ ..+|+.|++.+|.++.+|..| .+.+
T Consensus 536 ~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~l--p~~Lr~L~~~~~~l~~lP~~f-~~~~ 612 (1153)
T PLN03210 536 GITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYL--PPKLRLLRWDKYPLRCMPSNF-RPEN 612 (1153)
T ss_pred EEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhc--CcccEEEEecCCCCCCCCCcC-CccC
Confidence 34444444433 3446677777777777765532 22344433322 134666666666666666655 3456
Q ss_pred CcEEEccCCCCCcccccccCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEec
Q 001152 93 LRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1137)
Q Consensus 93 L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~-~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~L 171 (1137)
|+.|+|.+|+|..+|..+..+++|+.|+|+++. +..+| .+..+++|+.|+|++ +.....+|..+..|++|+.|++
T Consensus 613 L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~---c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 613 LVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSD---CSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred CcEEECcCccccccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecC---CCCccccchhhhccCCCCEEeC
Confidence 666666666666666666666666666666544 44444 355566666666665 2334455666666666666666
Q ss_pred cCC-CCcccCccccCCCCCCEEEccCC
Q 001152 172 CHF-SIRYLPPEIGCLSNLEQLDLSFN 197 (1137)
Q Consensus 172 s~N-~L~~IP~~l~~L~~L~~L~Ls~N 197 (1137)
++| .++.+|..+ ++++|+.|+|++|
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc 714 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGC 714 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCC
Confidence 653 455555543 4445555554444
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.5e-18 Score=192.88 Aligned_cols=223 Identities=21% Similarity=0.263 Sum_probs=153.8
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCcEEEccC-CCCCccccc-ccCCCCCCE
Q 001152 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKFFG-NEINLFPSE-VGNLLGLEC 118 (1137)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~~L~Ls~-N~L~~lP~~-l~~L~~L~~ 118 (1137)
.-..|+|..|+|+.+++.+|+.+ ++|++|||++|+|+.| |.+|.+|.+|..|-+.+ |+|+.||.. |++|..|+.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l---~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTL---HRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQR 144 (498)
T ss_pred cceEEEeccCCcccCChhhccch---hhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHH
Confidence 45667788888887777777655 7888888888888877 66788887776666655 778888765 777888887
Q ss_pred EEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchh-hhcCCCCCcEEeccCCCCc-------------ccCccc
Q 001152 119 LQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLS-EIAGLKCLTKLSVCHFSIR-------------YLPPEI 183 (1137)
Q Consensus 119 L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~-~l~~L~~L~~L~Ls~N~L~-------------~IP~~l 183 (1137)
|.+.-|++.-+. ..|..|++|..|.+..|.+ ..++. .|..+..++.+.+..|.+- ..|..+
T Consensus 145 LllNan~i~Cir~~al~dL~~l~lLslyDn~~----q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~iet 220 (498)
T KOG4237|consen 145 LLLNANHINCIRQDALRDLPSLSLLSLYDNKI----QSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIET 220 (498)
T ss_pred HhcChhhhcchhHHHHHHhhhcchhcccchhh----hhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhc
Confidence 777777755444 5677777777777776433 33333 5666777777777777621 112222
Q ss_pred cCCCCCCEEEccCCCC--------------------------Cccc-hhhcCCCCCCEEEccCCCCCcc-CccccCCCCC
Q 001152 184 GCLSNLEQLDLSFNKM--------------------------KYLP-TEICYLKALISLKVANNKLVEL-PSGLYLLQRL 235 (1137)
Q Consensus 184 ~~L~~L~~L~Ls~N~L--------------------------~~LP-~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L 235 (1137)
+.+.-..-..|.++++ ...| ..|..|++|+.|+|++|+|+.| +.+|..+..|
T Consensus 221 sgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l 300 (498)
T KOG4237|consen 221 SGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAEL 300 (498)
T ss_pred ccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhh
Confidence 2222222222222222 1223 2467788899999999999877 4567778889
Q ss_pred CEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 236 ~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+.|.|..|+|..+-...|.++..|+.|+|.+|+|++
T Consensus 301 ~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~ 336 (498)
T KOG4237|consen 301 QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITT 336 (498)
T ss_pred hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEE
Confidence 999999999988887788888999999999998887
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.4e-16 Score=164.34 Aligned_cols=138 Identities=21% Similarity=0.269 Sum_probs=105.3
Q ss_pred eecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCCc
Q 001152 809 EAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 888 (1137)
Q Consensus 809 ~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~ 888 (1137)
.||+|+||.||+|.+.+..+++|++..........+......++.+|++++..+.|+++.....++....
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~---------- 70 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD---------- 70 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC----------
Confidence 3899999999999998899999986433222212222222235588999999999887654444444333
Q ss_pred cccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCC
Q 001152 889 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968 (1137)
Q Consensus 889 ~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~ 968 (1137)
..++||||++|++|.+++... . . .++.|++.+|.+||+.|++|||++|.||+++ + +
T Consensus 71 ----~~~lv~e~~~g~~l~~~~~~~-----~-~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-------~ 126 (199)
T TIGR03724 71 ----NKTIVMEYIEGKPLKDVIEEG-----N-D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-------D 126 (199)
T ss_pred ----CCEEEEEEECCccHHHHHhhc-----H-H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-------C
Confidence 348999999999999987541 1 1 7899999999999999999999999999998 4 6
Q ss_pred eEEEeecCcccc
Q 001152 969 VVKLCDFDRAVP 980 (1137)
Q Consensus 969 ~vKL~DFGla~~ 980 (1137)
.++++|||.+..
T Consensus 127 ~~~liDfg~a~~ 138 (199)
T TIGR03724 127 KLYLIDFGLGKY 138 (199)
T ss_pred cEEEEECCCCcC
Confidence 799999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.1e-16 Score=192.94 Aligned_cols=201 Identities=18% Similarity=0.224 Sum_probs=149.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC---CCCcceeeeeEec
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKIS 876 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~---HpNIVkllg~~~~ 876 (1137)
-..|.|.+.||+|+||+||+|... +..+|+|+-+-.... ++ .-=.+++.+|+ -+-|+.+...+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W----Ef-------YI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW----EF-------YICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce----ee-------eehHHHHHhhchhhhcchHHHHHHHcc
Confidence 346889999999999999999874 577888874322211 11 11123444554 2345555544433
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ ..++|+||.+.|||.+++.. .+.+++..+..+..|++.-+++||..+||||||||+|.|
T Consensus 766 ~~--------------~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfl 826 (974)
T KOG1166|consen 766 QN--------------ASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFL 826 (974)
T ss_pred CC--------------cceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeE
Confidence 22 34899999999999999973 567999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
|......+.+..-++|+|||.+..+.-.... ..-...++|-.+-.+|+..| ..++..+|.|.++.+++
T Consensus 827 l~~~~~~~~~~~~l~lIDfG~siDm~lfp~~--------~~F~~~~~td~f~C~EM~~g----rpWtYq~DyfGlAa~~h 894 (974)
T KOG1166|consen 827 LRREICADSDSKGLYLIDFGRSIDMKLFPDG--------TKFKAVWHTDLFDCIEMREG----RPWTYQIDYFGLAATVH 894 (974)
T ss_pred eecccCCCCcccceEEEecccceeeeEcCCC--------cEEeeeeccccchhHHHhcC----CCCchhhhhHHHHHHHH
Confidence 9766433444567999999988654422111 01113457778889999876 78999999999999999
Q ss_pred HHHhCCC
Q 001152 1037 ELLTLQV 1043 (1137)
Q Consensus 1037 ELLTG~~ 1043 (1137)
-||.|++
T Consensus 895 ~mLFG~y 901 (974)
T KOG1166|consen 895 VMLFGKY 901 (974)
T ss_pred HHHHHHH
Confidence 9999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.6e-16 Score=188.68 Aligned_cols=145 Identities=20% Similarity=0.238 Sum_probs=112.9
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
...|...+.||+|+||+||++.+.+..+++|++..+.......+......++.+|+++++.++|++|+..+.++.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-- 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE-- 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--
Confidence 344567899999999999999998877777765433222111111122345689999999999999988776665543
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||+|||++ +
T Consensus 410 ------------~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~ 463 (535)
T PRK09605 410 ------------EKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D 463 (535)
T ss_pred ------------CCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C
Confidence 3489999999999999875 2457899999999999999999999999999993 3
Q ss_pred cccCCCCCeEEEeecCcccc
Q 001152 961 RKKADGKPVVKLCDFDRAVP 980 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~ 980 (1137)
+.++|+|||+++.
T Consensus 464 -------~~~~liDFGla~~ 476 (535)
T PRK09605 464 -------DRLYLIDFGLGKY 476 (535)
T ss_pred -------CcEEEEeCccccc
Confidence 5799999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=8e-16 Score=169.07 Aligned_cols=147 Identities=15% Similarity=0.198 Sum_probs=108.2
Q ss_pred ceEeeeecccCceEEEEEE-E--CCccEEEEEEecccCCCC--------h--------HHHHHhHHhHHHHHHHHHhCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCK-F--GSADAAAKVRTLKVCGSS--------A--------DEIRNFEYSCLGEVRMLGALRH 864 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~-~--~~~~vAVKi~~l~~~~~~--------~--------~~~e~~~~~~lrEi~iL~~L~H 864 (1137)
|.+.+.||+|++|.||+|. . .+..||+|+......... . ...+....++.+|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6788999999999999998 3 568899998654321100 0 0111122345789999999976
Q ss_pred CC--cceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001152 865 SC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS 942 (1137)
Q Consensus 865 pN--IVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs 942 (1137)
.. +.+++++ . ..++||||++|.+|...... ...+....+..++.||+.++++||+
T Consensus 110 ~~i~~p~~~~~---~---------------~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~ 166 (237)
T smart00090 110 AGVPVPKPIAW---R---------------RNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYK 166 (237)
T ss_pred cCCCCCeeeEe---c---------------CceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHh
Confidence 33 3344432 1 22899999998888765422 2345667788999999999999999
Q ss_pred CC-eeeccCCCCCeEeccccccCCCCCeEEEeecCccccc
Q 001152 943 KH-IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 981 (1137)
Q Consensus 943 ~g-IIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~ 981 (1137)
+| |+||||||+||+++ + +.++|+|||.+...
T Consensus 167 ~g~iiH~Dikp~NIli~-~-------~~i~LiDFg~a~~~ 198 (237)
T smart00090 167 EGELVHGDLSEYNILVH-D-------GKVVIIDVSQSVEL 198 (237)
T ss_pred cCCEEeCCCChhhEEEE-C-------CCEEEEEChhhhcc
Confidence 99 99999999999998 4 57999999987643
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.9e-17 Score=182.46 Aligned_cols=251 Identities=22% Similarity=0.194 Sum_probs=176.0
Q ss_pred cccCCCCCCcccC-CCCCCCCCCCCEEEccCCCCCCCCccc-ccCCCCCCCccEEEeecCCCCc-------cCccccCCC
Q 001152 21 KLPSEANKINNEK-NGSVNDDDDDSVIDVSGKTVDFPLIES-YGNRGGDNSVEGLYLYKNVLNL-------IPKSVGRYE 91 (1137)
Q Consensus 21 ~L~~~~N~i~~l~-~~~f~~l~~L~~LdLs~N~L~~~~p~~-~~~l~~L~~L~~L~Ls~N~L~~-------IP~~~~~L~ 91 (1137)
.|.+..++++... ...|..+.+|+.|+|+++.++...... ...+...++|++|+++.|.+.. ++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4666777776332 355667778999999999886531111 1123344778999998887763 334567788
Q ss_pred CCcEEEccCCCCC-cccccccCCCC---CCEEEccCCCCCC-----CcccccCC-CCCCEEECCCCCCCCC-cccchhhh
Q 001152 92 KLRNLKFFGNEIN-LFPSEVGNLLG---LECLQIKISSPGV-----NGFALNKL-KGLKELELSKVPPRPS-VLTLLSEI 160 (1137)
Q Consensus 92 ~L~~L~Ls~N~L~-~lP~~l~~L~~---L~~L~Ls~N~~~~-----~~~~~~~L-~~L~~L~Ls~n~ln~~-~~~lp~~l 160 (1137)
+|+.|+|++|.+. ..+..+..+.+ |+.|+++.|.+.. +...+..+ .+|+.|++++|.+... ...++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 9999999999987 44555555554 9999999888652 22345566 8899999998776532 12345567
Q ss_pred cCCCCCcEEeccCCCCc-----ccCccccCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCCcc-Cccc
Q 001152 161 AGLKCLTKLSVCHFSIR-----YLPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVEL-PSGL 229 (1137)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~-----~IP~~l~~L~~L~~L~Ls~N~L~-----~LP~~l~~L~~L~~L~Ls~N~Ls~I-P~~l 229 (1137)
..+..|+.|++++|.++ .++..+..+++|++|+|++|.++ .++..+..+++|+.|+|++|.++.. +..+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 77888999999999887 24445666679999999999886 3445667788999999999988731 2222
Q ss_pred c-----CCCCCCEEeccCCcCCC--C--CcccccCCCCCCEEEccCCcCCC
Q 001152 230 Y-----LLQRLENLDLSNNRLTS--L--GSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 230 ~-----~L~~L~~LdLS~N~Lsg--~--~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
. ..++|+.|++++|.++. . ....+..+++|++|++++|.++.
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 2 24789999999999872 1 12345566889999999999875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-16 Score=181.04 Aligned_cols=185 Identities=23% Similarity=0.307 Sum_probs=136.5
Q ss_pred eEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEE
Q 001152 893 QSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972 (1137)
Q Consensus 893 ~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL 972 (1137)
++||.|++|...+|.++|.+. ......++...+.|+.|++.|++| +|.+|+|+||.||++..+ ..+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr--~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-------~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR--RTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-------DQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC--CcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-------hhhhh
Confidence 579999999999999999752 333467888999999999999999 999999999999999877 67999
Q ss_pred eecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHH
Q 001152 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSEL 1051 (1137)
Q Consensus 973 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG-~~Pf~~~~~~ 1051 (1137)
+|||+.......... ......+...+||..||+||.+.+ ..|+.|+||||||+|++|+++- ..+|. ..
T Consensus 398 gDFgl~ts~~~~~~~----~~~~a~~t~~~gt~~YmsPEQi~g----~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~ 466 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETV----APAAASHTQQVGTLLYMSPEQIRG----QQYSEKVDIYALGLILAELLIQFSTQFE---RI 466 (516)
T ss_pred hhhhheeecccCCcc----cchhhhhhhcccccccCCHHHHhh----hhhhhhcchhhHHHHHHHHHHHhccHHH---HH
Confidence 999998765543210 001123345689999999999986 6799999999999999999972 22221 11
Q ss_pred HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 001152 1052 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1052 el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~ 1127 (1137)
.....+..+..|... + ...+.-..|+.+++.+.|.+||++.+..-|.|.
T Consensus 467 ~t~~d~r~g~ip~~~--~-------------------------~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 467 ATLTDIRDGIIPPEF--L-------------------------QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HhhhhhhcCCCChHH--h-------------------------hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 223334444433111 0 111224688999999999999988877766653
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.8e-17 Score=189.66 Aligned_cols=201 Identities=30% Similarity=0.404 Sum_probs=143.9
Q ss_pred EEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCC
Q 001152 46 IDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS 125 (1137)
Q Consensus 46 LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~ 125 (1137)
|.|++-++...+-..+. -.|+.....||+.|++.++|..+..+..|+.|.|+.|.|..||..+.+|..|++|+|+.|+
T Consensus 55 l~Ls~rrlk~fpr~a~~--~~ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAAS--YDLTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhhcCCCcccc--ccccchhhhhccccccccCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccch
Confidence 44454444433322222 2334445556666666666655555555666666666666666666666555555555554
Q ss_pred CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchh
Q 001152 126 PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTE 205 (1137)
Q Consensus 126 ~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~ 205 (1137)
+. .+|..++.|+ |+.|-+++|+++.+|..++.+..|..||.+.|.|.++|..
T Consensus 133 lS---------------------------~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~slpsq 184 (722)
T KOG0532|consen 133 LS---------------------------HLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQSLPSQ 184 (722)
T ss_pred hh---------------------------cCChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhhhchHH
Confidence 43 3445566665 7888899999999999888888899999999999999999
Q ss_pred hcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhh
Q 001152 206 ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1137)
Q Consensus 206 l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1137)
++++.+|+.|.+..|++..+|+++..| .|..||+|+|+++.+| ..|.+|+.|++|-|.+|+|.. -|..+|.
T Consensus 185 l~~l~slr~l~vrRn~l~~lp~El~~L-pLi~lDfScNkis~iP-v~fr~m~~Lq~l~LenNPLqS---PPAqIC~ 255 (722)
T KOG0532|consen 185 LGYLTSLRDLNVRRNHLEDLPEELCSL-PLIRLDFSCNKISYLP-VDFRKMRHLQVLQLENNPLQS---PPAQICE 255 (722)
T ss_pred hhhHHHHHHHHHhhhhhhhCCHHHhCC-ceeeeecccCceeecc-hhhhhhhhheeeeeccCCCCC---ChHHHHh
Confidence 999999999999999999999888865 4889999999999875 589999999999999999876 4556663
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.6e-16 Score=176.96 Aligned_cols=223 Identities=23% Similarity=0.231 Sum_probs=172.8
Q ss_pred EEEccCCCCC-CCCcccccCCCCCCCccEEEeecCCCC-----ccCccccCCCCCcEEEccCCCCCc-------cccccc
Q 001152 45 VIDVSGKTVD-FPLIESYGNRGGDNSVEGLYLYKNVLN-----LIPKSVGRYEKLRNLKFFGNEINL-------FPSEVG 111 (1137)
Q Consensus 45 ~LdLs~N~L~-~~~p~~~~~l~~L~~L~~L~Ls~N~L~-----~IP~~~~~L~~L~~L~Ls~N~L~~-------lP~~l~ 111 (1137)
.|+|..+.++ ......|..+ .+|+.|+|+++.++ .|+..+...++|+.|++++|.+.. ++..+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l---~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~ 78 (319)
T cd00116 2 QLSLKGELLKTERATELLPKL---LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLT 78 (319)
T ss_pred ccccccCcccccchHHHHHHH---hhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHH
Confidence 5789999997 4444445444 78999999999995 467778888899999999998873 345678
Q ss_pred CCCCCCEEEccCCCCCC-CcccccCCCC---CCEEECCCCCCCCC-cccchhhhcCC-CCCcEEeccCCCCc-----ccC
Q 001152 112 NLLGLECLQIKISSPGV-NGFALNKLKG---LKELELSKVPPRPS-VLTLLSEIAGL-KCLTKLSVCHFSIR-----YLP 180 (1137)
Q Consensus 112 ~L~~L~~L~Ls~N~~~~-~~~~~~~L~~---L~~L~Ls~n~ln~~-~~~lp~~l~~L-~~L~~L~Ls~N~L~-----~IP 180 (1137)
++++|+.|+|++|.+.. .+..+..+.. |++|++++|.+... ...+...+..+ ++|+.|++++|.++ .++
T Consensus 79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 79 KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred hcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 89999999999998653 4445555555 99999999776531 22334456677 89999999999988 344
Q ss_pred ccccCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCC-----ccCccccCCCCCCEEeccCCcCCCCCc
Q 001152 181 PEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV-----ELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1137)
Q Consensus 181 ~~l~~L~~L~~L~Ls~N~L~-----~LP~~l~~L~~L~~L~Ls~N~Ls-----~IP~~l~~L~~L~~LdLS~N~Lsg~~p 250 (1137)
..+..+.+|+.|+|++|.++ .++..+..+++|+.|+|++|.++ .++..+..+++|+.|++++|.+++...
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~ 238 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHH
Confidence 56677889999999999998 35566777789999999999987 244557778999999999999996433
Q ss_pred ccccC-----CCCCCEEEccCCcCC
Q 001152 251 LDLCL-----MHNLQNLNLQYNKLL 270 (1137)
Q Consensus 251 ~~l~~-----L~~L~~L~Ls~N~L~ 270 (1137)
..+.. .+.|+.|++++|.++
T Consensus 239 ~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 239 AALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHHhccCCCceEEEccCCCCC
Confidence 33322 379999999999986
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.2e-15 Score=155.96 Aligned_cols=143 Identities=17% Similarity=0.163 Sum_probs=105.4
Q ss_pred ceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChH--------------HHHHhHHhHHHHHHHHHhCCCCC--
Q 001152 804 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSAD--------------EIRNFEYSCLGEVRMLGALRHSC-- 866 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~-~~~~vAVKi~~l~~~~~~~~--------------~~e~~~~~~lrEi~iL~~L~HpN-- 866 (1137)
|.+.+.||+|+||.||++.+ .++.+|||+........... ........+.+|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66778999999999999988 46889999865432111000 00011123577899999998874
Q ss_pred cceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Q 001152 867 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 946 (1137)
Q Consensus 867 IVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gII 946 (1137)
+++.++. . ..++||||++|++|...... .....++.+++.++.++|+.||+
T Consensus 97 v~~~~~~----~--------------~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 97 VPKPIDW----N--------------RHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred CCceeec----C--------------CceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCC
Confidence 3444432 1 23899999999998765321 23467889999999999999999
Q ss_pred eccCCCCCeEeccccccCCCCCeEEEeecCcccccc
Q 001152 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 982 (1137)
Q Consensus 947 HrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~ 982 (1137)
||||||+||+++.+ +.++|+|||++....
T Consensus 148 H~Dl~p~Nill~~~-------~~~~liDfg~~~~~~ 176 (198)
T cd05144 148 HGDLSEFNILVDDD-------EKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCCcccEEEcCC-------CcEEEEECCccccCC
Confidence 99999999999876 789999999886443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-16 Score=183.19 Aligned_cols=215 Identities=27% Similarity=0.386 Sum_probs=170.7
Q ss_pred cccccCCCCCCcccCCCCCC-CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEE
Q 001152 19 KEKLPSEANKINNEKNGSVN-DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~-~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~ 97 (1137)
.+.|-+..-+++.-+-+++. ++..-...||+.|++... |+.+..| ..|+.|.|+.|.+..||..+.+|..|++||
T Consensus 52 sg~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~el-p~~~~~f---~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ 127 (722)
T KOG0532|consen 52 SGRLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSEL-PEEACAF---VSLESLILYHNCIRTIPEAICNLEALTFLD 127 (722)
T ss_pred hcccccccchhhcCCCccccccccchhhhhccccccccC-chHHHHH---HHHHHHHHHhccceecchhhhhhhHHHHhh
Confidence 34556666666666655544 566777899999999854 5545555 789999999999999999999999999999
Q ss_pred ccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCc
Q 001152 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1137)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1137)
|+.|+++.+|..++.|+ |+.|-+++|+++.+ |..++.+..|.+|+.+.|.|.
T Consensus 128 ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~~l---------------------------p~~ig~~~tl~~ld~s~nei~ 179 (722)
T KOG0532|consen 128 LSSNQLSHLPDGLCDLP-LKVLIVSNNKLTSL---------------------------PEEIGLLPTLAHLDVSKNEIQ 179 (722)
T ss_pred hccchhhcCChhhhcCc-ceeEEEecCccccC---------------------------CcccccchhHHHhhhhhhhhh
Confidence 99999999999998774 77777776665544 445556677888888999988
Q ss_pred ccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCC
Q 001152 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMH 257 (1137)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~ 257 (1137)
.+|..++.+.+|+.|.+..|++..+|.+++.| .|..||+|.|+++.||-+|.+|+.|++|-|.+|.|+..| ..++..-
T Consensus 180 slpsql~~l~slr~l~vrRn~l~~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqSPP-AqIC~kG 257 (722)
T KOG0532|consen 180 SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQSPP-AQICEKG 257 (722)
T ss_pred hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCCCCh-HHHHhcc
Confidence 89998999999999999999999999888855 488999999999999999999999999999999998764 4555433
Q ss_pred C---CCEEEccCC
Q 001152 258 N---LQNLNLQYN 267 (1137)
Q Consensus 258 ~---L~~L~Ls~N 267 (1137)
. .++|+..-.
T Consensus 258 kVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 258 KVHIFKYLSTQAC 270 (722)
T ss_pred ceeeeeeecchhc
Confidence 2 345555444
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.3e-13 Score=151.90 Aligned_cols=145 Identities=16% Similarity=0.198 Sum_probs=105.0
Q ss_pred eeec-ccCceEEEEEEECCccEEEEEEecccC-----CCChHHHHHhHHhHHHHHHHHHhCCCCCc--ceeeeeEecCCC
Q 001152 808 DEAG-KSVSSSLFRCKFGSADAAAKVRTLKVC-----GSSADEIRNFEYSCLGEVRMLGALRHSCI--VEMYGHKISSKW 879 (1137)
Q Consensus 808 ~~LG-~GsfG~Vy~a~~~~~~vAVKi~~l~~~-----~~~~~~~e~~~~~~lrEi~iL~~L~HpNI--Vkllg~~~~~~~ 879 (1137)
..|| .|+.|+||.+...+..+++|.+..... ............++.+|+.++.++.|++| ++.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 5687 888999999998888999998642211 00000001122356889999999998875 677776543221
Q ss_pred CCCCCCCCccccceEEEEEeeccC-CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~g-gSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. ....++||||++| .+|.+++.. ..++.. .+.||+.+|.+||++||+||||||.|||++
T Consensus 117 ~----------~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~ 176 (239)
T PRK01723 117 L----------FYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD 176 (239)
T ss_pred c----------ceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc
Confidence 0 1134799999997 699988764 235543 367899999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccc
Q 001152 959 LERKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~ 979 (1137)
.+ +.++|+|||.+.
T Consensus 177 ~~-------~~v~LIDfg~~~ 190 (239)
T PRK01723 177 PD-------GKFWLIDFDRGE 190 (239)
T ss_pred CC-------CCEEEEECCCcc
Confidence 76 579999999764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.8e-14 Score=168.17 Aligned_cols=194 Identities=35% Similarity=0.395 Sum_probs=114.7
Q ss_pred EEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCC-CCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCC
Q 001152 72 GLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLL-GLECLQIKISSPGVNGFALNKLKGLKELELSKVPPR 150 (1137)
Q Consensus 72 ~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~-~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln 150 (1137)
.|.+..|.+..-+..+..++.++.|++.+|.++.||...+.+. +|+.|+++.|.+..++..+..+++|+.|++++|++
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l- 175 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDL- 175 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchhhhhhhhhccccccccccCCchh-
Confidence 3445555443333334444455555555555555555544443 55555555555555444455555555555555332
Q ss_pred CCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcccc
Q 001152 151 PSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY 230 (1137)
Q Consensus 151 ~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~ 230 (1137)
..+|...+.++.|+.|++++|+++.||..+..+..|++|.+++|.+..++..+.++.++..|.+++|++..+|..++
T Consensus 176 ---~~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~ 252 (394)
T COG4886 176 ---SDLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIG 252 (394)
T ss_pred ---hhhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeeccchhc
Confidence 23333333566666677777777777665555556777777777666666666667777777777777766666666
Q ss_pred CCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 231 ~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
.+++|+.|++++|+++.+.+ +..+.+|+.|++++|.+..
T Consensus 253 ~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 253 NLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred cccccceecccccccccccc--ccccCccCEEeccCccccc
Confidence 66677777777777776654 6666777777777776654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.7e-15 Score=184.33 Aligned_cols=265 Identities=23% Similarity=0.248 Sum_probs=192.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~ 878 (1137)
-..|.+.+.||+|+|+.|-++... ....+++.+.+..........+. +..|..+-+.+. |+|++.+++...+..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~----i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEH----IDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhh----cCccccccccccccccccccCCccCCCc
Confidence 456788889999999999887763 34455555444443322333333 356788888887 999999999887665
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCCCCeEe
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH-SKHIMHRDIKSENILI 957 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLH-s~gIIHrDLKP~NILl 957 (1137)
..+++++|..|+++.+-+.. ......+...+..++.|+..++.|+| ..++.|+||||+|.++
T Consensus 95 --------------~~~~~~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l 157 (601)
T KOG0590|consen 95 --------------SYLLSLSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL 157 (601)
T ss_pred --------------ccccccCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh
Confidence 45999999999999988731 12225677788899999999999999 9999999999999999
Q ss_pred ccccccCCCCC-eEEEeecCccccccccccccccccCCCCCCCcccC-CCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 958 DLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 958 d~~~~~~~~~~-~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~G-T~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
+.. + .++++|||+|..+....... .......| ++.|+|||...+. ....+..|+||.|+++
T Consensus 158 ~~s-------~~~l~~~df~~At~~~~~~g~~-------~~~~~~~g~s~~y~a~E~~~~~---~~~~~~~d~~S~g~~l 220 (601)
T KOG0590|consen 158 DES-------GSALKIADFGLATAYRNKNGAE-------RSLKDRCGSSPPYGAPEHLSGK---AYRGPSVDVWSLGIVL 220 (601)
T ss_pred ccC-------CCcccCCCchhhccccccCCcc-------eeeecccCCCCCCCCcccccch---hhcCCCcccccccccc
Confidence 987 5 79999999997665421111 11123457 9999999998752 3557899999999999
Q ss_pred HHHHhCCCCCCCCCHHHH--HHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1036 LELLTLQVPYMGLSELEI--HDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el--~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
.-+++|..||......+. ..++..... ... ..........+++.+++..+|
T Consensus 221 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~l~k~l~~~~ 274 (601)
T KOG0590|consen 221 SAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL--------------------------PWNSISDQAHDLLHKILKENP 274 (601)
T ss_pred cccccCCCCccccccccccceeecccccccccC--------------------------ccccCChhhhhcccccccCCc
Confidence 999999999976443321 111111000 000 001233447888999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 001152 1113 TERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~ 1129 (1137)
..|.+.+++..+.|...
T Consensus 275 ~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 275 SNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhccccccccccccccc
Confidence 99999999999998876
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.6e-13 Score=142.72 Aligned_cols=141 Identities=16% Similarity=0.232 Sum_probs=95.8
Q ss_pred eeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHh------------------HHhHHHHHHHHHhCCCCC-
Q 001152 807 CDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNF------------------EYSCLGEVRMLGALRHSC- 866 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~------------------~~~~lrEi~iL~~L~HpN- 866 (1137)
.+.||+|+||.||+|.+. +..||+|+........ .....+ ......|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSF--KKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccch--hhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999986 6889999865432211 111110 001134666666665433
Q ss_pred -cceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHH-HHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 001152 867 -IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-K 943 (1137)
Q Consensus 867 -IVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~-~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~ 943 (1137)
+.++++.. ..++||||++++++.. .+... ... ..+..++.+++.++.++|. .
T Consensus 80 ~~~~~~~~~------------------~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~~ 134 (187)
T cd05119 80 PVPKPIDLN------------------RHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYREA 134 (187)
T ss_pred CCCceEecC------------------CCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhcc
Confidence 33444321 2489999999854432 22211 011 5678899999999999999 9
Q ss_pred CeeeccCCCCCeEeccccccCCCCCeEEEeecCcccccc
Q 001152 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 982 (1137)
Q Consensus 944 gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~ 982 (1137)
||+||||||+||+++ + +.++|+|||.+....
T Consensus 135 ~ivH~Dl~p~Nili~-~-------~~~~liDfg~a~~~~ 165 (187)
T cd05119 135 GLVHGDLSEYNILVD-D-------GKVYIIDVPQAVEID 165 (187)
T ss_pred CcCcCCCChhhEEEE-C-------CcEEEEECccccccc
Confidence 999999999999998 5 679999999886443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.46 E-value=7.7e-14 Score=164.51 Aligned_cols=200 Identities=30% Similarity=0.348 Sum_probs=177.1
Q ss_pred EEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCC-CCcEEEccCCCCCcccccccCCCCCCEEEccC
Q 001152 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYE-KLRNLKFFGNEINLFPSEVGNLLGLECLQIKI 123 (1137)
Q Consensus 45 ~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~-~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~ 123 (1137)
.|+++.|.+...+... ..++.++.|++.+|.++.||+....+. +|+.|++++|++..+|..++++++|+.|+++.
T Consensus 97 ~l~~~~~~~~~~~~~~----~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNISEL----LELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCchhh----hcccceeEEecCCcccccCccccccchhhcccccccccchhhhhhhhhccccccccccCC
Confidence 6888888886555442 334789999999999999999998885 99999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccc
Q 001152 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP 203 (1137)
Q Consensus 124 N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP 203 (1137)
|.+..++.....+.+|+.|++++|. +..+|..+..+..|+.|.+++|.+..++..+.++.++..|.+.+|++..+|
T Consensus 173 N~l~~l~~~~~~~~~L~~L~ls~N~----i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~ 248 (394)
T COG4886 173 NDLSDLPKLLSNLSNLNNLDLSGNK----ISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLP 248 (394)
T ss_pred chhhhhhhhhhhhhhhhheeccCCc----cccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeecc
Confidence 9999999877799999999999854 456666656677799999999987778888899999999999999999999
Q ss_pred hhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccc
Q 001152 204 TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDL 253 (1137)
Q Consensus 204 ~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l 253 (1137)
..++.+++|+.|++++|+++.++. ++.+.+|+.|++++|.++..++...
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred chhccccccceecccccccccccc-ccccCccCEEeccCccccccchhhh
Confidence 999999999999999999999988 8999999999999999999887543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.6e-13 Score=132.27 Aligned_cols=131 Identities=21% Similarity=0.236 Sum_probs=104.0
Q ss_pred EeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC--CCcceeeeeEecCCCCCCC
Q 001152 806 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 806 l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H--pNIVkllg~~~~~~~~~~~ 883 (1137)
+.+.||+|.++.||++...+..+++|+..... . .. .+.+|+.++..++| .+++++++++...+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~--~----~~----~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----- 66 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSRE--K----GA----DREREVAILQLLARKGLPVPKVLASGESDG----- 66 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCC--c----hh----HHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-----
Confidence 45789999999999999988888888753221 1 12 23779999999986 58888888766443
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCCCCeEeccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENILIDLE 960 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~---gIIHrDLKP~NILld~~ 960 (1137)
..+++|||++++.+..+ +......++.+++.+|++||.. +++|||++|.||+++..
T Consensus 67 ---------~~~~v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 67 ---------WSYLLMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred ---------ccEEEEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 45999999987776543 3456677899999999999984 79999999999999875
Q ss_pred cccCCCCCeEEEeecCccc
Q 001152 961 RKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~ 979 (1137)
+.++++|||.+.
T Consensus 126 -------~~~~l~Df~~~~ 137 (155)
T cd05120 126 -------KILGIIDWEYAG 137 (155)
T ss_pred -------cEEEEEeccccc
Confidence 679999999775
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-11 Score=135.16 Aligned_cols=214 Identities=21% Similarity=0.240 Sum_probs=145.6
Q ss_pred HHHHhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 001152 857 RMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 936 (1137)
Q Consensus 857 ~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~g 936 (1137)
.-|-++-|.|||+++.|+.+.++ ....+..++.|||..|++..+|++..+.. ..+......+|+.||+.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~---------~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKY---------EEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHHHHHHHHhhccccc---------ccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhh
Confidence 34556679999999999987652 13347899999999999999999876554 578889999999999999
Q ss_pred HHHHHhC--CeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhc
Q 001152 937 LVELHSK--HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014 (1137)
Q Consensus 937 L~yLHs~--gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1014 (1137)
|.|||+. -|+|+++.-+-|++..+ +.+|++- +.-............ .......+-++|.|||.-.
T Consensus 189 l~yLhs~~PpiihgnlTc~tifiq~n-------gLIkig~-~ap~s~h~s~~~~~~-----~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 189 LSYLHSCDPPIIHGNLTCDTIFIQHN-------GLIKIGS-VAPDSTHPSVNSTRE-----AEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred hhhhhccCCccccCCcchhheeecCC-------ceEEecc-cCccccchhhhhhhH-----hhhhccccCCccccCCcCc
Confidence 9999976 69999999999999977 6777642 111000000000000 0111234667899999743
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 001152 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1093 (1137)
Q Consensus 1015 ~~~~~~~~s~ksDVWSLGviL~ELLTG~~P-f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1137)
. ...+.++|||+||....||..+..- -.+.+.......+...... +.
T Consensus 256 ~----tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~-le--------------------------- 303 (458)
T KOG1266|consen 256 T----TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG-LE--------------------------- 303 (458)
T ss_pred c----cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee-cc---------------------------
Confidence 2 3456899999999999999887543 2322222222222211100 00
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1094 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1094 ~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
...-++++.+|++..|..||+|.+++.|+...
T Consensus 304 ---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 304 ---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred ---CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 00134568899999999999999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.9e-10 Score=122.43 Aligned_cols=142 Identities=13% Similarity=0.111 Sum_probs=102.1
Q ss_pred eeecccCceEEEEEEEC--------CccEEEEEEecccCCCC--------h----------HHHHHhHHhHHHHHHHHHh
Q 001152 808 DEAGKSVSSSLFRCKFG--------SADAAAKVRTLKVCGSS--------A----------DEIRNFEYSCLGEVRMLGA 861 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~--------~~~vAVKi~~l~~~~~~--------~----------~~~e~~~~~~lrEi~iL~~ 861 (1137)
..||.|--+.||.|... +..+|||+++....... . ...+.+..+..+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754 36899999864322111 0 1122334456699999999
Q ss_pred CC--CCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHH-HHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 001152 862 LR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN-YIEKLSETGEKHVSVKLALFIAQDVAAALV 938 (1137)
Q Consensus 862 L~--HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~-~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~ 938 (1137)
+. .-++.+++++ . .-+|||||+.+..+.. .+++ ..++......+..+++.+|.
T Consensus 83 l~~~Gv~vP~pi~~--~----------------~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~ 138 (197)
T cd05146 83 MQKAGIPCPEVVVL--K----------------KHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMK 138 (197)
T ss_pred HHHcCCCCCeEEEe--c----------------CCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHH
Confidence 96 3566677765 2 2289999997654432 2332 23556677788999999999
Q ss_pred HH-HhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccc
Q 001152 939 EL-HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL 981 (1137)
Q Consensus 939 yL-Hs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~ 981 (1137)
.| |..|||||||++.|||++. +.+.|+|||.+...
T Consensus 139 ~l~H~~glVHGDLs~~NIL~~~--------~~v~iIDF~qav~~ 174 (197)
T cd05146 139 QLYKECNLVHADLSEYNMLWHD--------GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHHhCCeecCCCCHHHEEEEC--------CcEEEEECCCceeC
Confidence 99 8999999999999999973 46999999977543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.3e-10 Score=119.92 Aligned_cols=127 Identities=16% Similarity=0.189 Sum_probs=92.2
Q ss_pred eeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcc-eeeeeEecCCCCCCCCC
Q 001152 807 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHKISSKWLPSADG 885 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIV-kllg~~~~~~~~~~~~g 885 (1137)
.+.|+.|.++.||+++..+..+++|+...... .... +.+|+.+++.+.+.+++ +++.+...
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-----~~~~----~~~E~~~l~~l~~~~~~P~~~~~~~~--------- 64 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-----LLIN----RENEAENSKLAAEAGIGPKLYYFDPE--------- 64 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc-----cccC----HHHHHHHHHHHHHhCCCCceEEEeCC---------
Confidence 36789999999999999888899997432210 0111 25688999888755554 55544321
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe-----eeccCCCCCeEeccc
Q 001152 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI-----MHRDIKSENILIDLE 960 (1137)
Q Consensus 886 ~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gI-----IHrDLKP~NILld~~ 960 (1137)
..++||||++|.++... . . ....++.+++++|+.||+.++ +|||++|.||+++ +
T Consensus 65 -------~~~lv~e~i~G~~l~~~--~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 65 -------TGVLITEFIEGSELLTE--D--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred -------CCeEEEEecCCCccccc--c--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 23899999998887543 0 0 112456789999999999875 9999999999998 3
Q ss_pred cccCCCCCeEEEeecCccc
Q 001152 961 RKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~ 979 (1137)
+.++++|||.+.
T Consensus 124 -------~~~~liDf~~a~ 135 (170)
T cd05151 124 -------GRLWLIDWEYAG 135 (170)
T ss_pred -------CeEEEEeccccc
Confidence 468999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.6e-11 Score=140.27 Aligned_cols=257 Identities=22% Similarity=0.193 Sum_probs=175.4
Q ss_pred ceEeeeecc--cCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEec
Q 001152 804 LSSCDEAGK--SVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 876 (1137)
Q Consensus 804 y~l~~~LG~--GsfG~Vy~a~~----~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~ 876 (1137)
+.+.+.+|. |.+|.||.+.. ....+|+|.-+.... ........ ++|+.....++ |+|.|+.+..+..
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k-----~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRK-----LREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCC-Cccccccc-----cchhhcccccCccccccccCccccc
Confidence 456678899 99999998876 235566664222211 11111111 45777777776 9999997777776
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCeeeccCCC
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA----ALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~----gL~yLHs~gIIHrDLKP 952 (1137)
.+ .+++-+|++ +.+|..+.+.. ...++...++.++.+... ||.++|..+|+|-|+||
T Consensus 190 ~~--------------~lfiqtE~~-~~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp 250 (524)
T KOG0601|consen 190 SG--------------ILFIQTELC-GESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKP 250 (524)
T ss_pred CC--------------cceeeeccc-cchhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCCCcccccccch
Confidence 65 568889988 48888887652 234777888888888888 99999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
.||++..+. ...+++|||....+.......... ......|..-|++||...+ .++.+.|||++|
T Consensus 251 ~~i~~~~~~------~s~~~~df~~v~~i~~~~~~~~~~-----~~~r~~~~~~Y~~ke~~~~-----l~~~~~di~sl~ 314 (524)
T KOG0601|consen 251 ANIFTTSDW------TSCKLTDFGLVSKISDGNFSSVFK-----VSKRPEGDCIYAAKELLNG-----LATFASDIFSLG 314 (524)
T ss_pred hheeccccc------ceeecCCcceeEEccCCcccccee-----eeecCCCCceEeChhhhcc-----ccchHhhhcchh
Confidence 999998762 568999999987766543211100 0011146668999999875 678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
.++.+..++..++...-.. ....+..+ +...+.......++...+..|++.+|
T Consensus 315 ev~l~~~l~~~~~~~g~~~-~W~~~r~~--------------------------~ip~e~~~~~s~~l~~~~~~~~d~~~ 367 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNS-SWSQLRQG--------------------------YIPLEFCEGGSSSLRSVTSQMLDEDP 367 (524)
T ss_pred hhhHhhHhhcccccCCCCC-Cccccccc--------------------------cCchhhhcCcchhhhhHHHHhcCcch
Confidence 9999998886665431000 00001000 11111111233446668899999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001152 1113 TERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~ 1128 (1137)
..|++++.+.++....
T Consensus 368 ~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 368 RLRLTAQILTALNVIH 383 (524)
T ss_pred hhhhHHHHHhcccccc
Confidence 9999999998876554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.4e-10 Score=115.72 Aligned_cols=136 Identities=21% Similarity=0.271 Sum_probs=101.0
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcc--eeeeeEecCCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV--EMYGHKISSKWLPSADG 885 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIV--kllg~~~~~~~~~~~~g 885 (1137)
..+++|+-+.||.+.|.+.++++|....+.-..+.-+.+--..+..+|+.++.+++---|. .++++ +.+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~------- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPD------- 72 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCC-------
Confidence 3688999999999999887889997654443333333333345778999999998744443 44444 322
Q ss_pred CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCC
Q 001152 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965 (1137)
Q Consensus 886 ~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~ 965 (1137)
...|+|||++|..|.+.+... ...++..|-.-+.-||..|||||||.++||++..+
T Consensus 73 -------~~~I~me~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~----- 128 (204)
T COG3642 73 -------NGLIVMEYIEGELLKDALEEA------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG----- 128 (204)
T ss_pred -------CCEEEEEEeCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-----
Confidence 348999999988888888761 13456666666778999999999999999999865
Q ss_pred CCCeEEEeecCccc
Q 001152 966 GKPVVKLCDFDRAV 979 (1137)
Q Consensus 966 ~~~~vKL~DFGla~ 979 (1137)
.+.++|||++.
T Consensus 129 ---~i~~IDfGLg~ 139 (204)
T COG3642 129 ---RIYFIDFGLGE 139 (204)
T ss_pred ---cEEEEECCccc
Confidence 48999999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-10 Score=138.59 Aligned_cols=149 Identities=15% Similarity=0.163 Sum_probs=97.2
Q ss_pred eeecccCceEEEEEEE-CCccEEEEEEecccCCC--------------------------ChHHHHHhHH------hHHH
Q 001152 808 DEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGS--------------------------SADEIRNFEY------SCLG 854 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~-~~~~vAVKi~~l~~~~~--------------------------~~~~~e~~~~------~~lr 854 (1137)
+.||.|++|.||+|+. .++.||||+........ ...-.+++.. .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999998 46899999864321100 0011122222 2455
Q ss_pred HHHHHHhCC----CCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHH
Q 001152 855 EVRMLGALR----HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930 (1137)
Q Consensus 855 Ei~iL~~L~----HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~ 930 (1137)
|++.+.+++ |.+-|.+-..+.+.. ...+|||||++|++|.++.... .. .. ....++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-------------~~~vLvmE~i~G~~L~~~~~~~-~~---~~---~~~~ia 262 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRT-------------SERVLTMEWIDGIPLSDIAALD-EA---GL---DRKALA 262 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhc-------------CCceEEEEeECCcccccHHHHH-hc---CC---CHHHHH
Confidence 666666553 322232322332111 1348999999999999876531 11 12 234566
Q ss_pred HHHHH-HHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccc
Q 001152 931 QDVAA-ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 983 (1137)
Q Consensus 931 ~QIa~-gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~ 983 (1137)
.+++. .+..+|..|++|+|+||.||+++.+ +.++++|||++..+..
T Consensus 263 ~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~-------g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 263 ENLARSFLNQVLRDGFFHADLHPGNIFVLKD-------GKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHhCCceeCCCCcccEEECCC-------CcEEEEeCCCeeECCH
Confidence 66666 4788999999999999999999877 7899999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.1e-09 Score=112.95 Aligned_cols=153 Identities=22% Similarity=0.241 Sum_probs=112.4
Q ss_pred EeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCCC
Q 001152 806 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADG 885 (1137)
Q Consensus 806 l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g 885 (1137)
....+-||+-+.|+++.+.++...+|-...+.-..+.-+.+-...+..+|+++|.++.--.|.-..=++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~------- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY------- 83 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-------
Confidence 4568899999999999999999999976555555545555555678899999999987444432222333322
Q ss_pred CCccccceEEEEEeeccC-CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 886 NPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 886 ~~~~~~~~l~LVmEy~~g-gSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
.-.|+|||++| .++.+++...... .........++.+|-..+.-||..+||||||..+||++..++
T Consensus 84 -------~~~i~ME~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~--- 150 (229)
T KOG3087|consen 84 -------GGQIYMEFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG--- 150 (229)
T ss_pred -------CCeEEEEeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC---
Confidence 22799999985 3888888764322 222233367888899999999999999999999999998763
Q ss_pred CCCCeEEEeecCccc
Q 001152 965 DGKPVVKLCDFDRAV 979 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~ 979 (1137)
....+.++|||++.
T Consensus 151 -~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 151 -NQITPILIDFGLSS 164 (229)
T ss_pred -CcCceEEEeecchh
Confidence 23567899999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.7e-11 Score=151.20 Aligned_cols=273 Identities=21% Similarity=0.233 Sum_probs=183.5
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..+++.+.+.+-+-.|+++.++.++-.+. ..+.|+..+..... ..+.+.. .++-.++-..+||-++...-.+.
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~-~~~~~s~----r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR-TNDYESI----RSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhc-ccccccc----CCccCccccCCCCceecccCCCC
Confidence 35778888999999999999998775332 23333321111000 1111111 22223333334566554433322
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
.. ...++||+|+.+++|...++.. ...+..-+......+..+++|||...+.|+|++|+|+
T Consensus 875 ~r--------------sP~~L~~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 875 CR--------------SPLPLVGHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSL 935 (1205)
T ss_pred CC--------------CCcchhhHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccccchhhcccccccch
Confidence 11 1469999999999999998862 2456666667777788999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccc---------------------cccCCCCCCCcccCCCcccchhhhc
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC---------------------IAHRGIPAPDVCVGTPRWMAPEVLR 1014 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~---------------------~~~~~~~~~~~~~GT~~Y~APE~l~ 1014 (1137)
++..+ +..++.|||......-...... .............||+.|.+||...
T Consensus 936 l~~~~-------gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l 1008 (1205)
T KOG0606|consen 936 LIAYD-------GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL 1008 (1205)
T ss_pred hhccc-------CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc
Confidence 99887 7889999984432211100000 0000001123467999999999998
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhh
Q 001152 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094 (1137)
Q Consensus 1015 ~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1137)
+ ...+..+|+|++|++++|.++|..||....+.++++.|..+..++.... .
T Consensus 1009 g----~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~-------------------------~ 1059 (1205)
T KOG0606|consen 1009 G----RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGP-------------------------E 1059 (1205)
T ss_pred c----ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCc-------------------------c
Confidence 7 4567899999999999999999999999999888888776665543321 1
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHH---HHHHHHHhhcC
Q 001152 1095 ETLSFLVDVFRRCTEENPTERPTAG---DLYEMFVARTS 1130 (1137)
Q Consensus 1095 ~~~~~L~dLl~~CL~~DP~~RPSa~---EVL~~L~~~~~ 1130 (1137)
..+.+..+++.+.+..+|.+|-.|. ++-.|.++...
T Consensus 1060 ~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1060 EGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred ccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 2334578889999999999998776 77777777644
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.4e-12 Score=148.48 Aligned_cols=220 Identities=27% Similarity=0.245 Sum_probs=117.9
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCC
Q 001152 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117 (1137)
Q Consensus 38 ~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~ 117 (1137)
..+..++.|+|..|.|.... ..++.+++|+.|+|.+|+|..|...+..+++|++|+|++|.|+.+. .+..++.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~~~~----~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~-~l~~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKIL----NHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLE-GLSTLTLLK 143 (414)
T ss_pred HHhHhHHhhccchhhhhhhh----cccccccceeeeeccccchhhcccchhhhhcchheecccccccccc-chhhccchh
Confidence 34555555666666665411 1234446667777777766666554666667777777777776653 245555566
Q ss_pred EEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCC
Q 001152 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFN 197 (1137)
Q Consensus 118 ~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N 197 (1137)
.|++++|.+..+.. +..+..|+.|++++|.+...... . +..+.+|+.+++..|.+..+. .+..+..+..+++..|
T Consensus 144 ~L~l~~N~i~~~~~-~~~l~~L~~l~l~~n~i~~ie~~--~-~~~~~~l~~l~l~~n~i~~i~-~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 144 ELNLSGNLISDISG-LESLKSLKLLDLSYNRIVDIEND--E-LSELISLEELDLGGNSIREIE-GLDLLKKLVLLSLLDN 218 (414)
T ss_pred hheeccCcchhccC-CccchhhhcccCCcchhhhhhhh--h-hhhccchHHHhccCCchhccc-chHHHHHHHHhhcccc
Confidence 66666666555442 23355566666665443222111 0 244555556666666655432 2233344444455666
Q ss_pred CCCccchhhcCCCC--CCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCC
Q 001152 198 KMKYLPTEICYLKA--LISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270 (1137)
Q Consensus 198 ~L~~LP~~l~~L~~--L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~ 270 (1137)
+++.+- .+..+.. |+.|++++|.+..+|..+..+.++..|++++|++...- .+.....+..+.+..|++.
T Consensus 219 ~i~~~~-~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 219 KISKLE-GLNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLA 290 (414)
T ss_pred cceecc-CcccchhHHHHHHhcccCccccccccccccccccccchhhccccccc--cccccchHHHhccCcchhc
Confidence 655432 1112222 56666666666655555555666666666666666543 2344455555555555544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.7e-11 Score=131.17 Aligned_cols=130 Identities=31% Similarity=0.289 Sum_probs=61.5
Q ss_pred CCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEE
Q 001152 136 LKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISL 215 (1137)
Q Consensus 136 L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L 215 (1137)
+.-|++|+|++|.+ ..+-.++.-++.++.|++++|.|..+-. +..|++|+.||||+|.|+.+-.+--+|.+++.|
T Consensus 283 Wq~LtelDLS~N~I----~~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 283 WQELTELDLSGNLI----TQIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTL 357 (490)
T ss_pred Hhhhhhccccccch----hhhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHhhhhhHhhhcCEeee
Confidence 34445555554322 2222233334445555555555554422 445555555555555555444444444455555
Q ss_pred EccCCCCCccCccccCCCCCCEEeccCCcCCCCCc-ccccCCCCCCEEEccCCcCCC
Q 001152 216 KVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 216 ~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p-~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
.|++|.|..+ +++..|-+|..||+++|+|..... ..+++|+-|+.|.|.+|+|..
T Consensus 358 ~La~N~iE~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 358 KLAQNKIETL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred ehhhhhHhhh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 5555555444 234445555555555555543221 134555555555555555544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.5e-11 Score=139.37 Aligned_cols=255 Identities=22% Similarity=0.139 Sum_probs=175.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~ 877 (1137)
...+|..+..||.|.|+.|+..... ...+.++++.+........+...- +.|+.+...+. |.+++.++..+...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s----l~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS----LGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc----hhhhhHhhHhhcccccCCCCCCcccc
Confidence 4567889999999999999987754 233333332233332222222222 67888888886 99999887776654
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ +.|+--|||+++++...+.- ...+++..++++..|++.++.++|+..++|+|+||+||++
T Consensus 339 r--------------~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i 399 (524)
T KOG0601|consen 339 R--------------QGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILI 399 (524)
T ss_pred c--------------cccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchhhhcccccccceee
Confidence 4 44788999999988776632 2468888999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCccc-chhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~-APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
..++ +..+++|||++..+..... .....-.++ .+|++.. ...+..+.|++|||.-+.
T Consensus 400 ~~~~------~~~~~~~~~~~t~~~~~~~-------------~~~~~~r~~p~~~~~~e---~~~~~~~~~~~sl~~~~~ 457 (524)
T KOG0601|consen 400 SNDG------FFSKLGDFGCWTRLAFSSG-------------VFHHIDRLYPIAEILLE---DYPHLSKADIFSLGLSVD 457 (524)
T ss_pred ccch------hhhhccccccccccceecc-------------cccccccccccchhhcc---cccccccccccccccccc
Confidence 8652 5678999998864332111 112222444 3555543 356779999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+.+++..--... .....|..+..+..+. ...++..+...+...++..||
T Consensus 458 e~~~~~~ls~~~---~~~~~i~~~~~p~~~~----------------------------~~~~~q~~~kv~~~~~~~~~~ 506 (524)
T KOG0601|consen 458 EAITGSPLSESG---VQSLTIRSGDTPNLPG----------------------------LKLQLQVLLKVMINPDRKRRP 506 (524)
T ss_pred ccccCcccCccc---ccceeeecccccCCCc----------------------------hHHhhhhhhhhhcCCccccch
Confidence 999885322211 1122233333333221 123467788899999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
.+.++..|..+...
T Consensus 507 l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 507 SAVELSLHSEFYRD 520 (524)
T ss_pred hhhhhcccchhhhh
Confidence 99999888777643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.6e-10 Score=139.97 Aligned_cols=158 Identities=15% Similarity=0.172 Sum_probs=94.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCC--------------------------CChHHHHHhHHhH
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG--------------------------SSADEIRNFEYSC 852 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~--------------------------~~~~~~e~~~~~~ 852 (1137)
+..|.. +.||.|++|.||+|+.. ++.|||||....... ...+-.+++...+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 344555 78999999999999984 688999996432100 0111223444444
Q ss_pred HHH------HHHHHhCC----CCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC--CCC
Q 001152 853 LGE------VRMLGALR----HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKH 920 (1137)
Q Consensus 853 lrE------i~iL~~L~----HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~--~~~ 920 (1137)
.+| +..+.+++ +.+.+.+-..|.+- ....+|||||++|+.+.++-.- ...+ ...
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-------------st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~ 263 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-------------CSETVMVMERMYGIPVSDVAAL-RAAGTDMKL 263 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-------------CCCceEEEeeecCccHHhHHHH-HhcCCCHHH
Confidence 444 44443332 22223222222211 1145899999999999874321 1111 112
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccc
Q 001152 921 VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS 983 (1137)
Q Consensus 921 ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~ 983 (1137)
+....+..++.||. ..|++|+|+||.||+++.++ ...+.++++|||++..+..
T Consensus 264 la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g---~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 264 LAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDP---PENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCC---CCCCeEEEEecceEEECCH
Confidence 33344444445444 58999999999999998772 1124899999999977654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.8e-11 Score=122.70 Aligned_cols=107 Identities=21% Similarity=0.221 Sum_probs=29.0
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCC-CCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccc-cCCC
Q 001152 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRG-GDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLL 114 (1137)
Q Consensus 37 f~~l~~L~~LdLs~N~L~~~~p~~~~~l~-~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l-~~L~ 114 (1137)
+.+...++.|+|++|.|+.+ .+++ .+.+|+.|+|++|.|+.|+ .|..|++|+.|+|++|.|+.++..+ ..++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I-----e~L~~~l~~L~~L~Ls~N~I~~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp 88 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI-----ENLGATLDKLEVLDLSNNQITKLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLP 88 (175)
T ss_dssp --------------------------S--TT-TT--EEE-TTS--S--T-T----TT--EEE--SS---S-CHHHHHH-T
T ss_pred cccccccccccccccccccc-----cchhhhhcCCCEEECCCCCCcccc-CccChhhhhhcccCCCCCCccccchHHhCC
Confidence 33444566677777766643 1222 3466677777777777664 3666667777777777777665444 2466
Q ss_pred CCCEEEccCCCCCCCc--ccccCCCCCCEEECCCCCC
Q 001152 115 GLECLQIKISSPGVNG--FALNKLKGLKELELSKVPP 149 (1137)
Q Consensus 115 ~L~~L~Ls~N~~~~~~--~~~~~L~~L~~L~Ls~n~l 149 (1137)
+|+.|+|++|++..+. ..+..+++|+.|+|.+|++
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 6666666666654433 2234455555555555444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.1e-11 Score=128.50 Aligned_cols=131 Identities=24% Similarity=0.278 Sum_probs=111.3
Q ss_pred hhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCE
Q 001152 158 SEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237 (1137)
Q Consensus 158 ~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~ 237 (1137)
..+..++.|+.|||++|.|+.|..+..-++.++.|+||+|.|..+-. +..|.+|+.||||+|.|+.+-.+=..|-+++.
T Consensus 278 ~~~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKT 356 (490)
T ss_pred EecchHhhhhhccccccchhhhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHhhhhhHhhhcCEee
Confidence 34455678999999999999999999999999999999999998874 89999999999999999998777677889999
Q ss_pred EeccCCcCCCCCcccccCCCCCCEEEccCCcCCC------CCCCCcchhhccCCCCCCCC
Q 001152 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS------YCQVPSWICCNLEGNGKDSS 291 (1137)
Q Consensus 238 LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~------~~~iP~~~~~~l~~n~l~~~ 291 (1137)
|.|+.|.|..+. .+..|-+|..||+++|++.. +..+|..-.+.+.+|++...
T Consensus 357 L~La~N~iE~LS--GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 357 LKLAQNKIETLS--GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred eehhhhhHhhhh--hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 999999999873 58889999999999999865 34566666666666665543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.6e-11 Score=144.31 Aligned_cols=239 Identities=23% Similarity=0.198 Sum_probs=182.9
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEc
Q 001152 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~L 98 (1137)
+..+.+..|.|..+ ...+..+.+|..|+|..|+|..+... +..+.+|++|+|++|+|+.|. .+..|+.|+.|++
T Consensus 74 l~~l~l~~n~i~~~-~~~l~~~~~l~~l~l~~n~i~~i~~~----l~~~~~L~~L~ls~N~I~~i~-~l~~l~~L~~L~l 147 (414)
T KOG0531|consen 74 LKELNLRQNLIAKI-LNHLSKLKSLEALDLYDNKIEKIENL----LSSLVNLQVLDLSFNKITKLE-GLSTLTLLKELNL 147 (414)
T ss_pred HHhhccchhhhhhh-hcccccccceeeeeccccchhhcccc----hhhhhcchheecccccccccc-chhhccchhhhee
Confidence 33444556666662 34578889999999999999876541 445699999999999999984 4777778999999
Q ss_pred cCCCCCcccccccCCCCCCEEEccCCCCCCCccc-ccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCc
Q 001152 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA-LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1137)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~-~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1137)
++|.|+.++. +..+..|+.+++++|.+..+... ...+.+|+.|++.+|.+.... .+..+..+..+++..|.++
T Consensus 148 ~~N~i~~~~~-~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~-----~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 148 SGNLISDISG-LESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIE-----GLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred ccCcchhccC-CccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhccc-----chHHHHHHHHhhcccccce
Confidence 9999998864 66699999999999997776654 588899999999986653322 3334455666688999988
Q ss_pred ccCccccCCCC--CCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCC---Cccc
Q 001152 178 YLPPEIGCLSN--LEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL---GSLD 252 (1137)
Q Consensus 178 ~IP~~l~~L~~--L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~---~p~~ 252 (1137)
.+-. +..+.. |+.|++++|.+..++..+..+.++..|++.+|++..+. .+.....+..+.+..|.+... ....
T Consensus 222 ~~~~-l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (414)
T KOG0531|consen 222 KLEG-LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNLE-GLERLPKLSELWLNDNKLALSEAISQEY 299 (414)
T ss_pred eccC-cccchhHHHHHHhcccCccccccccccccccccccchhhccccccc-cccccchHHHhccCcchhcchhhhhccc
Confidence 6532 233344 89999999999998878889999999999999998653 244566778888888887732 2212
Q ss_pred -ccCCCCCCEEEccCCcCCC
Q 001152 253 -LCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 253 -l~~L~~L~~L~Ls~N~L~~ 271 (1137)
....+.+..+.+.+|++..
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 300 ITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred cccccccccccccccCcccc
Confidence 5667889999999998866
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.5e-11 Score=134.48 Aligned_cols=204 Identities=19% Similarity=0.140 Sum_probs=127.9
Q ss_pred CCCCccEEEeecCCCCccCc--cccCCCCCcEEEccCCCCCcc---cccccCCCCCCEEEccCCCCCCCc--ccccCCCC
Q 001152 66 GDNSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLF---PSEVGNLLGLECLQIKISSPGVNG--FALNKLKG 138 (1137)
Q Consensus 66 ~L~~L~~L~Ls~N~L~~IP~--~~~~L~~L~~L~Ls~N~L~~l---P~~l~~L~~L~~L~Ls~N~~~~~~--~~~~~L~~ 138 (1137)
++.+|+.+.|.+....-++. -...|++++.|||+.|-|... -.-...|++|+.|+|+.|.+...- ..-..+..
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 34566666666665554442 345666666666666666532 222455666666666666633222 11234566
Q ss_pred CCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCC-CcccCccccCCCCCCEEEccCCCCCccc--hhhcCCCCCCEE
Q 001152 139 LKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-IRYLPPEIGCLSNLEQLDLSFNKMKYLP--TEICYLKALISL 215 (1137)
Q Consensus 139 L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~-L~~IP~~l~~L~~L~~L~Ls~N~L~~LP--~~l~~L~~L~~L 215 (1137)
|+.|.|+.+.++ ...+-.-+..+++|+.|+|..|. +..--.....+..|+.|||++|++-..+ ..++.++.|..|
T Consensus 199 lK~L~l~~CGls--~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 199 LKQLVLNSCGLS--WKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hheEEeccCCCC--HHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 777777775554 22233334567788888888884 2211123345677888888888887666 456788888888
Q ss_pred EccCCCCCc--cCcc-----ccCCCCCCEEeccCCcCCCCCc-ccccCCCCCCEEEccCCcCCC
Q 001152 216 KVANNKLVE--LPSG-----LYLLQRLENLDLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 216 ~Ls~N~Ls~--IP~~-----l~~L~~L~~LdLS~N~Lsg~~p-~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+++.+.+.+ +|+. ...+++|++|+++.|++..... ..+..+++|+.|.+..|.|+.
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 888888884 4654 3457888888888888854321 135556777777777887765
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.3e-10 Score=119.67 Aligned_cols=109 Identities=30% Similarity=0.388 Sum_probs=43.8
Q ss_pred cCCCCCcEEeccCCCCcccCcccc-CCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcccc-CCCCCCEE
Q 001152 161 AGLKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENL 238 (1137)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~IP~~l~-~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~-~L~~L~~L 238 (1137)
.++..++.|+|.+|.|+.|. .++ .+.+|+.|+|++|.|+.|+ .+..++.|+.|+|++|+|+.|+..+. .+++|+.|
T Consensus 16 ~n~~~~~~L~L~~n~I~~Ie-~L~~~l~~L~~L~Ls~N~I~~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQISTIE-NLGATLDKLEVLDLSNNQITKLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQEL 93 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S--T-T----TT--EEE--SS---S-CHHHHHH-TT--EE
T ss_pred cccccccccccccccccccc-chhhhhcCCCEEECCCCCCcccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEE
Confidence 44556788999999998874 455 5789999999999999887 67788999999999999998876664 58999999
Q ss_pred eccCCcCCCCCc-ccccCCCCCCEEEccCCcCCC
Q 001152 239 DLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 239 dLS~N~Lsg~~p-~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+|++|+|..+.. ..+..+++|+.|+|.+|+++.
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 999999986533 246788999999999999865
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.4e-09 Score=135.57 Aligned_cols=104 Identities=23% Similarity=0.339 Sum_probs=57.2
Q ss_pred CcEEeccCCCCc-ccCccccCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccC
Q 001152 166 LTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSN 242 (1137)
Q Consensus 166 L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~-~LP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~ 242 (1137)
++.|+|++|.++ .+|..++.|++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|+ .+|..+++|++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 445555555555 45555555555555555555555 55555555555555555555555 4555555555555555555
Q ss_pred CcCCCCCcccccCC-CCCCEEEccCCcC
Q 001152 243 NRLTSLGSLDLCLM-HNLQNLNLQYNKL 269 (1137)
Q Consensus 243 N~Lsg~~p~~l~~L-~~L~~L~Ls~N~L 269 (1137)
|+|+|.+|..+..+ .++..+++.+|+.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCcc
Confidence 55555555544432 2444555555543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.6e-10 Score=131.29 Aligned_cols=206 Identities=21% Similarity=0.164 Sum_probs=138.0
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC---ccccCCCCCcEEEccCCCCCccccc--ccC
Q 001152 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP---KSVGRYEKLRNLKFFGNEINLFPSE--VGN 112 (1137)
Q Consensus 38 ~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP---~~~~~L~~L~~L~Ls~N~L~~lP~~--l~~ 112 (1137)
+++.+|+.+.|.+..+.....+ +....|++++.|||+.|.|...- .-...|++|+.|+|+.|.+...-++ -..
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~--~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIE--EYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hhHHhhhheeecCccccccchh--hhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence 3556677777777666543322 23345577888888888776432 2345777888888888877633221 235
Q ss_pred CCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccC--ccccCCCC
Q 001152 113 LLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP--PEIGCLSN 188 (1137)
Q Consensus 113 L~~L~~L~Ls~N~~~~--~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP--~~l~~L~~ 188 (1137)
+++|+.|.|+...++. +......+++|+.|+|..|. .-.....+ ..-+..|+.|+|++|.+-..+ ...+.|+.
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~-~~~~~~~~--~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~ 272 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANE-IILIKATS--TKILQTLQELDLSNNNLIDFDQGYKVGTLPG 272 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccc-ccceecch--hhhhhHHhhccccCCcccccccccccccccc
Confidence 6677777777666543 22345567788888888764 12222222 223567888999999888776 35688999
Q ss_pred CCEEEccCCCCCc--cchh-----hcCCCCCCEEEccCCCCCccCc--cccCCCCCCEEeccCCcCCCC
Q 001152 189 LEQLDLSFNKMKY--LPTE-----ICYLKALISLKVANNKLVELPS--GLYLLQRLENLDLSNNRLTSL 248 (1137)
Q Consensus 189 L~~L~Ls~N~L~~--LP~~-----l~~L~~L~~L~Ls~N~Ls~IP~--~l~~L~~L~~LdLS~N~Lsg~ 248 (1137)
|..|+++.+.+.+ +|+. ...+++|++|+++.|++...+. .+..+.+|+.|....|.|+..
T Consensus 273 L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 273 LNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 9999999999984 4544 3457889999999999976653 456678888888889988854
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-10 Score=129.85 Aligned_cols=233 Identities=19% Similarity=0.176 Sum_probs=137.9
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccC-CCCCCCccEEEeecCCCC----ccCccc-------cCCCCCcEEEccCCCCC
Q 001152 37 VNDDDDDSVIDVSGKTVDFPLIESYGN-RGGDNSVEGLYLYKNVLN----LIPKSV-------GRYEKLRNLKFFGNEIN 104 (1137)
Q Consensus 37 f~~l~~L~~LdLs~N~L~~~~p~~~~~-l~~L~~L~~L~Ls~N~L~----~IP~~~-------~~L~~L~~L~Ls~N~L~ 104 (1137)
......++.|+||+|.|...-..++.. +...++|+..++++=..+ .||+.+ -..+.|++|+||.|.|+
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 345567788888888875433222221 233367777777664222 456432 34557888888888886
Q ss_pred -ccccc----ccCCCCCCEEEccCCCCCCCccc--------------ccCCCCCCEEECCCCCCCCCcccch-hhhcCCC
Q 001152 105 -LFPSE----VGNLLGLECLQIKISSPGVNGFA--------------LNKLKGLKELELSKVPPRPSVLTLL-SEIAGLK 164 (1137)
Q Consensus 105 -~lP~~----l~~L~~L~~L~Ls~N~~~~~~~~--------------~~~L~~L~~L~Ls~n~ln~~~~~lp-~~l~~L~ 164 (1137)
.-++. +..++.|+.|.|.+|.++..... ...-+.|+.+...+|.+-+...+.. ..|...+
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~ 185 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHP 185 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcc
Confidence 33332 45677888888877776654421 1223456777777666544433322 2344556
Q ss_pred CCcEEeccCCCCc--cc---CccccCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCCc-----cCccc
Q 001152 165 CLTKLSVCHFSIR--YL---PPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE-----LPSGL 229 (1137)
Q Consensus 165 ~L~~L~Ls~N~L~--~I---P~~l~~L~~L~~L~Ls~N~L~-----~LP~~l~~L~~L~~L~Ls~N~Ls~-----IP~~l 229 (1137)
.|+.+.+..|.|. .+ -..|..++.|+.|||.+|-|+ .+-..+..++.|+.|+++++.|+. +-..+
T Consensus 186 ~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al 265 (382)
T KOG1909|consen 186 TLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDAL 265 (382)
T ss_pred ccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHH
Confidence 7777777777765 11 224566777777777777776 234556667777777777777651 22222
Q ss_pred cC-CCCCCEEeccCCcCCCC----CcccccCCCCCCEEEccCCcC
Q 001152 230 YL-LQRLENLDLSNNRLTSL----GSLDLCLMHNLQNLNLQYNKL 269 (1137)
Q Consensus 230 ~~-L~~L~~LdLS~N~Lsg~----~p~~l~~L~~L~~L~Ls~N~L 269 (1137)
.. .++|+.|.|.+|.++.- ....+...+.|..|+|++|.|
T Consensus 266 ~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 266 KESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred hccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 22 56777777777777632 112344566777777777776
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.3e-09 Score=133.69 Aligned_cols=91 Identities=29% Similarity=0.426 Sum_probs=85.3
Q ss_pred CCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEcc
Q 001152 188 NLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQ 265 (1137)
Q Consensus 188 ~L~~L~Ls~N~L~-~LP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls 265 (1137)
.++.|+|++|.|+ .+|..++.+++|+.|+|++|.|+ .+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3788999999998 89999999999999999999998 899999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCCCcchh
Q 001152 266 YNKLLSYCQVPSWIC 280 (1137)
Q Consensus 266 ~N~L~~~~~iP~~~~ 280 (1137)
+|+|++ .+|..+.
T Consensus 499 ~N~l~g--~iP~~l~ 511 (623)
T PLN03150 499 GNSLSG--RVPAALG 511 (623)
T ss_pred CCcccc--cCChHHh
Confidence 999998 7777664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.5e-08 Score=119.68 Aligned_cols=142 Identities=18% Similarity=0.259 Sum_probs=108.4
Q ss_pred HHHHHHHHhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHH
Q 001152 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQD 932 (1137)
Q Consensus 853 lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~Q 932 (1137)
.+-++.|+.++||||+++++.++.++ ..|||+|.+ .-|..++.. +....+...+.|
T Consensus 57 ~~A~k~lKtlRHP~Il~yL~t~e~~~--------------~~ylvTErV--~Pl~~~lk~--------l~~~~v~~Gl~q 112 (690)
T KOG1243|consen 57 KRAVKRLKTLRHPNILSYLDTTEEEG--------------TLYLVTERV--RPLETVLKE--------LGKEEVCLGLFQ 112 (690)
T ss_pred HHHHHHhhhccCchhhhhhhhhcccC--------------ceEEEeecc--ccHHHHHHH--------hHHHHHHHHHHH
Confidence 56788999999999999999998776 669999998 478888876 335667778999
Q ss_pred HHHHHHHHH-hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchh
Q 001152 933 VAAALVELH-SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011 (1137)
Q Consensus 933 Ia~gL~yLH-s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 1011 (1137)
|+.||.||| +.+++|++|.-+-|+|+.. |..||++|-.+......... . ....--..|..|+
T Consensus 113 Il~AL~FL~~d~~lvHgNv~~~SVfVn~~-------GeWkLggle~v~~~~~~~~~---------~-~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 113 ILAALSFLNDDCNLVHGNVCKDSVFVNES-------GEWKLGGLELVSKASGFNAP---------A-KSLYLIESFDDPE 175 (690)
T ss_pred HHHHHHHHhccCCeeeccEeeeeEEEcCC-------CcEEEeeeEEEeccccCCcc---------c-ccchhhhcccChh
Confidence 999999998 4589999999999999988 88999999877543322110 0 0001112456676
Q ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 1012 ~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
.+.. -.-..|.|-|||+++|++.|
T Consensus 176 ~~~~------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDP------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCc------cccchhhhhHHHHHHHHhCc
Confidence 5432 11457999999999999998
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.3e-08 Score=104.04 Aligned_cols=131 Identities=21% Similarity=0.249 Sum_probs=83.1
Q ss_pred EEEEEEE-CCccEEEEEEecccCCCCh------------------HHHHHhHHhHHHHHHHHHhCCCC--CcceeeeeEe
Q 001152 817 SLFRCKF-GSADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKI 875 (1137)
Q Consensus 817 ~Vy~a~~-~~~~vAVKi~~l~~~~~~~------------------~~~e~~~~~~lrEi~iL~~L~Hp--NIVkllg~~~ 875 (1137)
.||.|.. .+..+|+|+.+........ ........++.+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899987 4678999998654332111 11222344678999999999855 566777553
Q ss_pred cCCCCCCCCCCCccccceEEEEEeecc--CCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCeeeccCCC
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVK--GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVE-LHSKHIMHRDIKS 952 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~--ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~y-LHs~gIIHrDLKP 952 (1137)
.. +|||||++ |..+..+... .++......++.+++..+.. +|..||+||||.+
T Consensus 80 -~~----------------~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~ 135 (188)
T PF01163_consen 80 -RN----------------VIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSE 135 (188)
T ss_dssp -TT----------------EEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-ST
T ss_pred -CC----------------EEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhcCceecCCCh
Confidence 22 89999998 6555543322 12234556778888886665 5799999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCcccc
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVP 980 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~ 980 (1137)
.||+++++ .+.|+|||.+..
T Consensus 136 ~NIlv~~~--------~~~iIDf~qav~ 155 (188)
T PF01163_consen 136 YNILVDDG--------KVYIIDFGQAVD 155 (188)
T ss_dssp TSEEEETT--------CEEE--GTTEEE
T ss_pred hhEEeecc--------eEEEEecCccee
Confidence 99999865 599999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.6e-09 Score=119.00 Aligned_cols=224 Identities=21% Similarity=0.205 Sum_probs=165.6
Q ss_pred CCCCccEEEeecCCCC-----ccCccccCCCCCcEEEccCCCCC----ccccc-------ccCCCCCCEEEccCCCCCCC
Q 001152 66 GDNSVEGLYLYKNVLN-----LIPKSVGRYEKLRNLKFFGNEIN----LFPSE-------VGNLLGLECLQIKISSPGVN 129 (1137)
Q Consensus 66 ~L~~L~~L~Ls~N~L~-----~IP~~~~~L~~L~~L~Ls~N~L~----~lP~~-------l~~L~~L~~L~Ls~N~~~~~ 129 (1137)
.+..++.|+|++|-++ .|-+.+.+.++|+.-++++=..+ .+|+. +-..++|++|+||.|-++.-
T Consensus 28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~ 107 (382)
T KOG1909|consen 28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK 107 (382)
T ss_pred ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence 4478999999999997 35566788889999999875433 55654 34566999999999986654
Q ss_pred c-----ccccCCCCCCEEECCCCCCCCCcccch----------hhhcCCCCCcEEeccCCCCcccCc-----cccCCCCC
Q 001152 130 G-----FALNKLKGLKELELSKVPPRPSVLTLL----------SEIAGLKCLTKLSVCHFSIRYLPP-----EIGCLSNL 189 (1137)
Q Consensus 130 ~-----~~~~~L~~L~~L~Ls~n~ln~~~~~lp----------~~l~~L~~L~~L~Ls~N~L~~IP~-----~l~~L~~L 189 (1137)
+ ..+.+++.|++|+|.++.+...-+... .-++.-+.|+.+...+|++..-+. .|...+.|
T Consensus 108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~l 187 (382)
T KOG1909|consen 108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTL 187 (382)
T ss_pred chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcccc
Confidence 3 346778999999999977654443321 123445679999999999875543 45667899
Q ss_pred CEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCC-----ccCccccCCCCCCEEeccCCcCCCCCccccc-----
Q 001152 190 EQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV-----ELPSGLYLLQRLENLDLSNNRLTSLGSLDLC----- 254 (1137)
Q Consensus 190 ~~L~Ls~N~L~-----~LP~~l~~L~~L~~L~Ls~N~Ls-----~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~----- 254 (1137)
+.+.++.|.|. -+-..+..++.|+.|||..|.|+ .+-..+..+++|+.|+++++.+..-....|.
T Consensus 188 eevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~ 267 (382)
T KOG1909|consen 188 EEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKE 267 (382)
T ss_pred ceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhc
Confidence 99999999987 23456788999999999999987 2345566778899999999999865544442
Q ss_pred CCCCCCEEEccCCcCCC---------CCCCCcchhhccCCCCCC
Q 001152 255 LMHNLQNLNLQYNKLLS---------YCQVPSWICCNLEGNGKD 289 (1137)
Q Consensus 255 ~L~~L~~L~Ls~N~L~~---------~~~iP~~~~~~l~~n~l~ 289 (1137)
..++|++|.|.+|.++. ....|+...+++++|.+.
T Consensus 268 ~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 268 SAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 36899999999999875 224566666666666553
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.2e-08 Score=104.66 Aligned_cols=143 Identities=19% Similarity=0.187 Sum_probs=97.4
Q ss_pred eeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC--CCcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H--pNIVkllg~~~~~~~~~~~~ 884 (1137)
+.|+.|.++.||+++..+ ..+++|+....... .... .+.+|+++++.+.+ .++.+++.+......
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~----~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~----- 71 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAH----DVAREYRVLRALAGTGVPVPKVLALCEDPSV----- 71 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccc----cHHHHHHHHHHhhCCCCCCCCEEEECCCCCc-----
Confidence 578999999999998876 78889874322111 0111 23779999999975 345677766543210
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 942 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs---------------------- 942 (1137)
....++||||++|.++.+.+.. ..++......++.+++++|.+||+
T Consensus 72 ------~~~~~~v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~ 139 (223)
T cd05154 72 ------LGTPFYVMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQV 139 (223)
T ss_pred ------cCCceEEEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHH
Confidence 0134899999998887665421 135666666677777777777763
Q ss_pred ----------------------------------CCeeeccCCCCCeEeccccccCCCCCeEEEeecCccc
Q 001152 943 ----------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 943 ----------------------------------~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~ 979 (1137)
..++|||++|.||+++.+. ...+.|+||+.+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-----~~~~~iID~e~~~ 205 (223)
T cd05154 140 ARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE-----PRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC-----CcEEEEEeccccc
Confidence 2468999999999998720 1568899999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1e-08 Score=130.94 Aligned_cols=201 Identities=21% Similarity=0.240 Sum_probs=136.1
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCC--CCCCCcccccCCCCCCCccEEEeecC-CCCccCccccCCCCCc
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKT--VDFPLIESYGNRGGDNSVEGLYLYKN-VLNLIPKSVGRYEKLR 94 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~--L~~~~p~~~~~l~~L~~L~~L~Ls~N-~L~~IP~~~~~L~~L~ 94 (1137)
....+.+-.|++..+... ...++|++|-+..|. +.....++|..+ +.|.+|||++| .++.+|..|++|-+|+
T Consensus 524 ~~rr~s~~~~~~~~~~~~--~~~~~L~tLll~~n~~~l~~is~~ff~~m---~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 524 SVRRMSLMNNKIEHIAGS--SENPKLRTLLLQRNSDWLLEISGEFFRSL---PLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred heeEEEEeccchhhccCC--CCCCccceEEEeecchhhhhcCHHHHhhC---cceEEEECCCCCccCcCChHHhhhhhhh
Confidence 345556666766665432 233479999999996 555555556544 99999999977 5679999999999999
Q ss_pred EEEccCCCCCcccccccCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccC
Q 001152 95 NLKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1137)
Q Consensus 95 ~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~-~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1137)
+|+|++..++.+|..+++|..|.+|++..+. ...++.....|.+|++|.+-.-. .........++.+|.+|+.|....
T Consensus 599 yL~L~~t~I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~-~~~~~~~l~el~~Le~L~~ls~~~ 677 (889)
T KOG4658|consen 599 YLDLSDTGISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA-LSNDKLLLKELENLEHLENLSITI 677 (889)
T ss_pred cccccCCCccccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc-cccchhhHHhhhcccchhhheeec
Confidence 9999999999999999999999999998877 55556777779999999987633 122233344556666666666644
Q ss_pred CCCcccCccccCCCCC----CEEEccCCCCCccchhhcCCCCCCEEEccCCCCCcc
Q 001152 174 FSIRYLPPEIGCLSNL----EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225 (1137)
Q Consensus 174 N~L~~IP~~l~~L~~L----~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~I 225 (1137)
... .+-..+..++.| +.+.+........+..++.+.+|+.|.+.+..+.++
T Consensus 678 ~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~ 732 (889)
T KOG4658|consen 678 SSV-LLLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGISEI 732 (889)
T ss_pred chh-HhHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCchh
Confidence 433 111112222222 233333344455566677777777777777766533
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=3e-07 Score=103.10 Aligned_cols=149 Identities=16% Similarity=0.152 Sum_probs=97.9
Q ss_pred eEEEEEEECCccEEEEEEecccCCCChHHHHHh-----H-HhHHHHHHHHHhCCCCCc--ceeeeeEecCCCCCCCCCCC
Q 001152 816 SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNF-----E-YSCLGEVRMLGALRHSCI--VEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 816 G~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~-----~-~~~lrEi~iL~~L~HpNI--Vkllg~~~~~~~~~~~~g~~ 887 (1137)
..|+++.+.+..+.||....... ....+.+ . ..+.+|...+.++..-.| +++++++.....
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~---~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~-------- 104 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGW---GEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN-------- 104 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcH---HHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC--------
Confidence 34667788888888886422110 0111110 0 024788888888854333 355666543210
Q ss_pred ccccceEEEEEeeccCC-CHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCC
Q 001152 888 EHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 966 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~gg-SL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~ 966 (1137)
+.....+||||++++. +|.+++.... ....+......++.+++..+.-||..||+|||++++|||++.+.....+
T Consensus 105 -~~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 105 -PATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred -CccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCC
Confidence 0012568999999875 8999986421 1245667788999999999999999999999999999999852000122
Q ss_pred CCeEEEeecCccc
Q 001152 967 KPVVKLCDFDRAV 979 (1137)
Q Consensus 967 ~~~vKL~DFGla~ 979 (1137)
...+.|+||+.+.
T Consensus 181 ~~~~~LIDl~r~~ 193 (268)
T PRK15123 181 DLKLSVIDLHRAQ 193 (268)
T ss_pred CceEEEEECCccc
Confidence 3679999999664
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.9e-08 Score=85.56 Aligned_cols=59 Identities=46% Similarity=0.591 Sum_probs=38.2
Q ss_pred CCCEEEccCCCCCccCc-cccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcC
Q 001152 211 ALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269 (1137)
Q Consensus 211 ~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L 269 (1137)
+|++|+|++|+|+.||. .|..+++|+.|+|++|+|+.+++..|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 56666666666666654 344566666666666666666666666666666666666654
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.5e-06 Score=99.77 Aligned_cols=141 Identities=16% Similarity=0.157 Sum_probs=103.6
Q ss_pred HHHHHHhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccC-CCHHHHHHHhh----------hcCCCCCCH
Q 001152 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLS----------ETGEKHVSV 923 (1137)
Q Consensus 855 Ei~iL~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~g-gSL~~~L~~~~----------~~~~~~ls~ 923 (1137)
=+++++++.|+|||++.++|....+ +...+++|++|+|+ ++|.++.-... ...+...++
T Consensus 323 lve~wkkl~h~NvV~frevf~t~tF----------~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e 392 (655)
T KOG3741|consen 323 LVEAWKKLCHTNVVPFREVFLTYTF----------GDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPE 392 (655)
T ss_pred HHHHHHHhccCceeehhhhhhhhcc----------CcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchH
Confidence 4678999999999999999885432 22378999999985 57877542211 112346788
Q ss_pred HHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccC
Q 001152 924 KLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1003 (1137)
Q Consensus 924 ~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~G 1003 (1137)
..+|.++.|+..||.++|+.|..-+-|.+.+|+++.+ ..++|+..|..-.+....
T Consensus 393 ~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~-------~RIriS~C~i~Dvl~~d~------------------ 447 (655)
T KOG3741|consen 393 EVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK-------MRIRISGCGIMDVLQEDP------------------ 447 (655)
T ss_pred HHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc-------ceEEEecccceeeecCCC------------------
Confidence 9999999999999999999999999999999999976 567777555432222110
Q ss_pred CCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001152 1004 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1043 (1137)
Q Consensus 1004 T~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~ 1043 (1137)
. |.+.+ -++-|.-.||.++..|.||..
T Consensus 448 ----~--~~le~-------~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 448 ----T--EPLES-------QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ----C--cchhH-------HhhhhHHHHHHHHHHHhhccc
Confidence 0 11221 167799999999999999953
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=6.1e-07 Score=96.80 Aligned_cols=110 Identities=23% Similarity=0.264 Sum_probs=84.7
Q ss_pred hHHHHHHHHHhCCCC--CcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCC-CHHHHHHHhhhcCCCCCCHHHHH
Q 001152 851 SCLGEVRMLGALRHS--CIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLAL 927 (1137)
Q Consensus 851 ~~lrEi~iL~~L~Hp--NIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~gg-SL~~~L~~~~~~~~~~ls~~~i~ 927 (1137)
++.+|...+..+..- .+.+.+++....... ....++|||++++. +|.+++... ...+.....
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~----------~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~ 121 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGG----------GYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRR 121 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC----------ceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHH
Confidence 457888888887633 345777776653311 13669999999874 899998762 126667788
Q ss_pred HHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccc
Q 001152 928 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 928 ~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~ 979 (1137)
.++.+++..+.-||.+||+|+|+++.|||++.+. +...+.++||+-++
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~----~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD----GQYRFYLIDLDRMR 169 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC----CceeEEEEcchhce
Confidence 9999999999999999999999999999999872 33579999999664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.3e-10 Score=130.81 Aligned_cols=127 Identities=29% Similarity=0.325 Sum_probs=91.7
Q ss_pred CCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEE
Q 001152 138 GLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLK 216 (1137)
Q Consensus 138 ~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~ 216 (1137)
.|...+.+.|.+ ..+-.++.-++.|+.|+|++|+++.+- .+..|+.|++|||++|+|+.+|.- ...+. |+.|.
T Consensus 165 ~L~~a~fsyN~L----~~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 165 KLATASFSYNRL----VLMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hHhhhhcchhhH----HhHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeee
Confidence 344555555433 233345556777888889999888764 677888889999999998888832 22344 88888
Q ss_pred ccCCCCCccCccccCCCCCCEEeccCCcCCCCCcc-cccCCCCCCEEEccCCcCCC
Q 001152 217 VANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL-DLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 217 Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~-~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
|++|.++++ .++.+|.+|+.|||++|-|.+.-.. .+..|..|..|+|.+|+|.|
T Consensus 239 lrnN~l~tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 239 LRNNALTTL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ecccHHHhh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 999988877 3677888888899999988754321 24567788888999998877
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=7e-08 Score=123.49 Aligned_cols=249 Identities=22% Similarity=0.202 Sum_probs=155.5
Q ss_pred CcccccCCCCC--CcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcE
Q 001152 18 IKEKLPSEANK--INNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1137)
Q Consensus 18 ~l~~L~~~~N~--i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~ 95 (1137)
.+..|=+-.|. +..+....|..++.|.+||||+|.=-+.+|..++.+ -+|++|+|+...++.+|..|.+|..|.+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~L---i~LryL~L~~t~I~~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGEL---VHLRYLDLSDTGISHLPSGLGNLKKLIY 622 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhh---hhhhcccccCCCccccchHHHHHHhhhe
Confidence 57777777776 888888889999999999999987777888887766 8999999999999999999999999999
Q ss_pred EEccCCCCC-cccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCC----cEEe
Q 001152 96 LKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCL----TKLS 170 (1137)
Q Consensus 96 L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L----~~L~ 170 (1137)
|++..+.-- .+|..+..|++|++|.|-..........+..+.+|++|..-....... .+...+..+..| +.+.
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~ 700 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLS 700 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhh
Confidence 999988754 556666779999999986554222233333444444443332211111 111122222222 2333
Q ss_pred ccCCCCcccCccccCCCCCCEEEccCCCCCccch-hhcC------CCCCCEEEccCCCCCccCccccCCCCCCEEeccCC
Q 001152 171 VCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPT-EICY------LKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243 (1137)
Q Consensus 171 Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~-~l~~------L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N 243 (1137)
+..+.....+..++.+.+|+.|.+.+..+.++.. .... +++|..+...+...-..+.+.--.++|+.|.+...
T Consensus 701 ~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~~ 780 (889)
T KOG4658|consen 701 IEGCSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLVSC 780 (889)
T ss_pred hcccccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchhhccCcccEEEEecc
Confidence 3344444566677788888888888877764321 1111 11122111111111122333333577788887766
Q ss_pred cCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 244 ~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
.....|......+..+..+-+..+.+.+
T Consensus 781 ~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 781 RLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred cccccCCCHHHHhhhcccEEeccccccc
Confidence 5544333355556666655555555554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.1e-06 Score=96.69 Aligned_cols=274 Identities=18% Similarity=0.140 Sum_probs=158.0
Q ss_pred EeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCCCC
Q 001152 806 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 806 l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
..+.||+|+.+.+|-.-.- .+.+.||+-.... ... .+.++.|... .||-+-.-+.+=..-- + +.+
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~VAKIYh~Ppp---a~~--------aqk~a~la~~p~~p~~~~rvaWPqa~L-~-G~~ 80 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQVAKIYHAPPP---AAQ--------AQKVAELAATPDAPLLNYRVAWPQATL-H-GGR 80 (637)
T ss_pred CCccccCCccceeeecchh-hchhheeecCCCc---hHH--------HHHHHHhccCCCCcchhhhhcccHHHh-h-CCC
Confidence 4568999999999944322 3445666532221 111 1123445454 3775543222211110 0 111
Q ss_pred CCCccccceEEEEEeeccCC-CHHHHHH-HhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 885 GNPEHHLLQSAIFMEYVKGG-SVKNYIE-KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~gg-SL~~~L~-~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
+. ....+.|+.++|. -+..++. .+++..-....|.-.++.++.++.+.+.||+.|.+-||+.++|+|+.++
T Consensus 81 ~~-----~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-- 153 (637)
T COG4248 81 RG-----KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-- 153 (637)
T ss_pred cc-----ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC--
Confidence 11 1368899998865 2222221 1122334568899999999999999999999999999999999999988
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhc-cccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.|.|.|=..-....... ..---+|...|.+||... ....+-.-+...|.|.||++|++++.|
T Consensus 154 -----~~V~LVdsDsfqi~~ng~-----------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 154 -----SKVVLVDSDSFQINANGT-----------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred -----ceEEEEcccceeeccCCc-----------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence 678888754221111110 011236888999999865 111122345789999999999999987
Q ss_pred -CCCCCCCCH-----HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC--CC
Q 001152 1042 -QVPYMGLSE-----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN--PT 1113 (1137)
Q Consensus 1042 -~~Pf~~~~~-----~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D--P~ 1113 (1137)
.+||.+... .-....|..+....-++. ..-....+.+.| ..-.++++..+..+|+... +.
T Consensus 218 grHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~----------~~g~~p~P~~~P--~~~Lpp~vqAlF~qaF~~~~~~~ 285 (637)
T COG4248 218 GRHPYSGIPLISDAPNPLETDIAHGRFAYASDQ----------RRGLKPPPRSIP--LSMLPPDVQALFQQAFTESGVAT 285 (637)
T ss_pred CCCCCCcccccCCCCCcchhhhhcceeeechhc----------cCCCCCCCCCCC--hhhcCHHHHHHHHHHhcccCCCC
Confidence 999986211 011112222221110000 000000011111 1244566888999999653 56
Q ss_pred CCCCHHHHHHHHHhh
Q 001152 1114 ERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~ 1128 (1137)
-|||++..+..+-..
T Consensus 286 ~RP~a~aW~aAl~al 300 (637)
T COG4248 286 PRPTAKAWVAALDAL 300 (637)
T ss_pred CCCCHHHHHHHHHHH
Confidence 799999887766543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=9.7e-09 Score=122.38 Aligned_cols=126 Identities=29% Similarity=0.302 Sum_probs=106.2
Q ss_pred CCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccC
Q 001152 164 KCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242 (1137)
Q Consensus 164 ~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~ 242 (1137)
..|...+++.|.|..+..++.-++.|+.|+|++|+++.+- .+..|+.|++|||++|.|+.+|.- ...+. |..|.|+|
T Consensus 164 n~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn 241 (1096)
T KOG1859|consen 164 NKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN 241 (1096)
T ss_pred hhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence 4577889999999988888899999999999999999876 888899999999999999999853 33354 99999999
Q ss_pred CcCCCCCcccccCCCCCCEEEccCCcCCCCCCCC------cchhhccCCCCCCCCCC
Q 001152 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVP------SWICCNLEGNGKDSSND 293 (1137)
Q Consensus 243 N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP------~~~~~~l~~n~l~~~~~ 293 (1137)
|.++.+- .+.+|++|+.|||++|-|.+..++- ..+.+.|.||++-..+.
T Consensus 242 N~l~tL~--gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 242 NALTTLR--GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred cHHHhhh--hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 9999885 4889999999999999998866543 33447788888766554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.1e-08 Score=100.54 Aligned_cols=113 Identities=22% Similarity=0.206 Sum_probs=74.5
Q ss_pred hhhcCCCCCcEEeccCCCCcccCccc-cCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCC
Q 001152 158 SEIAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236 (1137)
Q Consensus 158 ~~l~~L~~L~~L~Ls~N~L~~IP~~l-~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~ 236 (1137)
..+.....|+..+|++|.+..+|+.| ..++.++.|+|++|.|+.+|.++..++.|+.|+++.|.|...|.-+..|.+|.
T Consensus 47 y~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~ 126 (177)
T KOG4579|consen 47 YMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLD 126 (177)
T ss_pred HHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccccchHHHHHHHhHH
Confidence 34445556666677777777777766 34456777777777777777777777777777777777777777777677777
Q ss_pred EEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 237 ~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
.|+.-+|.+..++-. +.--..+...++.+|+|.+
T Consensus 127 ~Lds~~na~~eid~d-l~~s~~~al~~lgnepl~~ 160 (177)
T KOG4579|consen 127 MLDSPENARAEIDVD-LFYSSLPALIKLGNEPLGD 160 (177)
T ss_pred HhcCCCCccccCcHH-HhccccHHHHHhcCCcccc
Confidence 777777777766543 3222333444556666655
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=5.1e-08 Score=117.42 Aligned_cols=162 Identities=20% Similarity=0.200 Sum_probs=109.6
Q ss_pred HHHHHHHHHhC-CeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchh
Q 001152 933 VAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011 (1137)
Q Consensus 933 Ia~gL~yLHs~-gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 1011 (1137)
++.|+.|+|.. ++||++|.|++|.++.. +.+||+.|+++......... .........+-...-...|.|||
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~-------~~wkl~Gf~f~v~~~~~~~~-p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNAN-------GDWKLAGFSFCVNANGPTEY-PFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccC-------cceeeccchhhhccCCCCcc-ccccCCCCCChhhccCcccccch
Confidence 44999999965 99999999999999988 78999999988654442221 11222223333445667899999
Q ss_pred hhccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCc
Q 001152 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELL-TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 1090 (1137)
Q Consensus 1012 ~l~~~~~~~~~s~ksDVWSLGviL~ELL-TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~ 1090 (1137)
++.+ ...+.++|+||+||++|.+. .|+.-+....... ......... .. .. ....
T Consensus 180 ~~~~----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~~~-~~----~~-------------~~~s-- 234 (700)
T KOG2137|consen 180 YLLG----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRNLL-NA----GA-------------FGYS-- 234 (700)
T ss_pred hhcc----ccccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhccc-cc----cc-------------cccc--
Confidence 9876 45679999999999999888 4554444322211 111111000 00 00 0000
Q ss_pred hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1091 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1091 ~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
-..+.++++=+.+++..++..||++.++...+++...
T Consensus 235 ---~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 235 ---NNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred ---ccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 1566779999999999999999999999888887643
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.2e-07 Score=81.85 Aligned_cols=58 Identities=26% Similarity=0.314 Sum_probs=27.3
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEccCCC
Q 001152 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNE 102 (1137)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~ 102 (1137)
+|++|+|++|+|+.+.+.+|..+ ++|++|+|++|.|+.+|+ .|.++++|++|+|++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l---~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNL---PNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTG---TTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCC---CCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34455555555544444433322 455555555555554432 34455555555555544
|
... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.3e-06 Score=88.56 Aligned_cols=148 Identities=14% Similarity=0.092 Sum_probs=99.3
Q ss_pred cccCceEEEEEEECCccEEEEEEecccCCCCh-HHHHHhHHhHHHHHHHHHhCCCC--CcceeeeeEecCCCCCCCCCCC
Q 001152 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSA-DEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKISSKWLPSADGNP 887 (1137)
Q Consensus 811 G~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~-~~~e~~~~~~lrEi~iL~~L~Hp--NIVkllg~~~~~~~~~~~~g~~ 887 (1137)
|+||-+.|++....+..+-+|.-.......-. +. =+..+.+|+..|.++..- .+.++..+.....
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~---g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~--------- 94 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPF---GRPTIVREVAVIKELERAGVIVPKIVFGEAVKI--------- 94 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCC---CchHHHHHHHHHHHHHHcCCCCCccceeeeecc---------
Confidence 56888889988887776666642211111100 00 012347899999888632 3445552222111
Q ss_pred ccccceEEEEEeeccC-CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCC
Q 001152 888 EHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADG 966 (1137)
Q Consensus 888 ~~~~~~l~LVmEy~~g-gSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~ 966 (1137)
+...+.+||+|-++| .||.+++.+ ..-.+.+......++.+|+..+.-||+.|+.|+|+.+.||+++.++
T Consensus 95 -~~~~rA~LVTe~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g----- 165 (216)
T PRK09902 95 -EGEWRALLVTEDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG----- 165 (216)
T ss_pred -CCceEEEEEEEeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-----
Confidence 112367999998864 499998865 2223567788889999999999999999999999999999998552
Q ss_pred CCeEEEeecCccc
Q 001152 967 KPVVKLCDFDRAV 979 (1137)
Q Consensus 967 ~~~vKL~DFGla~ 979 (1137)
...++++||.-++
T Consensus 166 ~~~v~lIDlEk~r 178 (216)
T PRK09902 166 KAEAGFLDLEKSR 178 (216)
T ss_pred CeeEEEEEhhccc
Confidence 2459999998554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.9e-06 Score=93.16 Aligned_cols=140 Identities=17% Similarity=0.178 Sum_probs=99.2
Q ss_pred eEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCCh--------------HHHHHhHHhHHHHHHHHHhCCCC--Cc
Q 001152 805 SSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSA--------------DEIRNFEYSCLGEVRMLGALRHS--CI 867 (1137)
Q Consensus 805 ~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~--------------~~~e~~~~~~lrEi~iL~~L~Hp--NI 867 (1137)
.+...||-|--+.||.|... +.++|||.-+.-.++... .........+.+|.++|+.|.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 46689999999999999985 689999975443222100 00111122458899999999754 77
Q ss_pred ceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Q 001152 868 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947 (1137)
Q Consensus 868 Vkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIH 947 (1137)
.+.+++- .-++||||++|--|... +++......++..|+.-+..+-..||||
T Consensus 174 P~P~~~n------------------RHaVvMe~ieG~eL~~~----------r~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 174 PKPIAWN------------------RHAVVMEYIEGVELYRL----------RLDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred CCccccc------------------cceeeeehcccceeecc----------cCcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 7777763 23899999997555442 1233445556666666666666899999
Q ss_pred ccCCCCCeEeccccccCCCCCeEEEeecCccc
Q 001152 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 948 rDLKP~NILld~~~~~~~~~~~vKL~DFGla~ 979 (1137)
||+.+-||+++++ +.+.++||-.+.
T Consensus 226 GDlSefNIlV~~d-------g~~~vIDwPQ~v 250 (304)
T COG0478 226 GDLSEFNILVTED-------GDIVVIDWPQAV 250 (304)
T ss_pred cCCchheEEEecC-------CCEEEEeCcccc
Confidence 9999999999988 779999996543
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=8e-07 Score=103.65 Aligned_cols=33 Identities=21% Similarity=0.275 Sum_probs=24.6
Q ss_pred CCCCEEEccCCCCCccchhhcCCCCCCEEEccCCC
Q 001152 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNK 221 (1137)
Q Consensus 187 ~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~ 221 (1137)
++|++|++++|....+|..+. .+|+.|+++.|.
T Consensus 156 sSLk~L~Is~c~~i~LP~~LP--~SLk~L~ls~n~ 188 (426)
T PRK15386 156 PSLKTLSLTGCSNIILPEKLP--ESLQSITLHIEQ 188 (426)
T ss_pred CcccEEEecCCCcccCccccc--ccCcEEEecccc
Confidence 578888888887776665543 478888888774
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1137 | ||||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 8e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-04 |
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 67/311 (21%), Positives = 111/311 (35%), Gaps = 76/311 (24%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
++ S L++ ++ D KV LKV S + R+F E L H ++ +
Sbjct: 19 NENHSGELWKGRWQGNDIVVKV--LKVRDWSTRKSRDF----NEECPRLRIFSHPNVLPV 72
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
G + P H + ++ GS+ N L E V A+ A
Sbjct: 73 LG---------ACQSPPAPHP---TLITHWMPYGSLYNV---LHEGTNFVVDQSQAVKFA 117
Query: 931 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 988
D+A + LH+ I + S +++ID + ++ D SF
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-------TARISMADVK---FSFQSP- 166
Query: 989 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP-NLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
+ P W+APE L+ KP + D+WS+ LL EL+T +VP+
Sbjct: 167 -----------GRMYAPAWVAPEALQ--KKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
Query: 1048 LSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1106
LS +EI + G RP + H + + +
Sbjct: 214 LSNMEIGMKVALEGLRPTIPP------GISPH---------------------VSKLMKI 246
Query: 1107 CTEENPTERPT 1117
C E+P +RP
Sbjct: 247 CMNEDPAKRPK 257
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-41
Identities = 55/291 (18%), Positives = 98/291 (33%), Gaps = 66/291 (22%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
+R + + + D+++ F EV RH +V G A +P H
Sbjct: 60 IRLIDIERDNEDQLKAF----KREVMAYRQTRHENVVLFMG----------ACMSPPHL- 104
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
AI KG ++ + + + + V IAQ++ + LH+K I+H+D+K
Sbjct: 105 ---AIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
S+N+ D V + DF L S R G +APE
Sbjct: 158 SKNVFYD--------NGKVVITDFG----LFSISGVLQAGRREDKLRIQN-GWLCHLAPE 204
Query: 1012 VLRAMHKPNL-----YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLT 1066
++R + + D+++ G + EL + P+ I + G +P
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP--- 261
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117
+++ + D+ C ERPT
Sbjct: 262 -----------------------NLSQIGMGKEISDILLFCWAFEQEERPT 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 53/268 (19%), Positives = 103/268 (38%), Gaps = 69/268 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV ++ L H IV++YG + + ME+V G + + + +
Sbjct: 73 EVFIMSNLNHPNIVKLYG--LMHNPP--------------RMVMEFVPCGDLYHRLLDKA 116
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKL 972
+ + L + D+A + + +++ I+HRD++S NI + + A K+
Sbjct: 117 ----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP--VCAKV 170
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF + + +H+ +G +WMAPE + A + Y + D +S+
Sbjct: 171 ADFGLS---QQSVHSV----------SGLLGNFQWMAPETIGAEEES--YTEKADTYSFA 215
Query: 1033 CLLLELLTLQVPYMGLSELEI---HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1089
+L +LT + P+ S +I + + + G RP + + C
Sbjct: 216 MILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE------DCPPR----------- 258
Query: 1090 PEAELETLSFLVDVFRRCTEENPTERPT 1117
L +V C +P +RP
Sbjct: 259 ----------LRNVIELCWSGDPKKRPH 276
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 65/312 (20%), Positives = 108/312 (34%), Gaps = 72/312 (23%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G ++R + + A K + I N E ++ L+H I+ +
Sbjct: 16 GIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENV----RQEAKLFAMLKHPNIIAL 71
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
G + + ME+ +GG + + K + + + A
Sbjct: 72 RG----------VCLKEPNL----CLVMEFARGGPLNRVLSG------KRIPPDILVNWA 111
Query: 931 QDVAAALVELHSKH---IMHRDIKSENILIDLERKKAD-GKPVVKLCDFDRAVPLRSFLH 986
+A + LH + I+HRD+KS NILI + + D ++K+ DF
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG---------- 161
Query: 987 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1046
HR G WMAPEV+R + D+WSYG LL ELLT +VP+
Sbjct: 162 LAREWHRT--TKMSAAGAYAWMAPEVIR--ASM--FSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 1047 GLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1105
G+ L + + + + +C E +
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPS------TCPEP---------------------FAKLME 248
Query: 1106 RCTEENPTERPT 1117
C +P RP+
Sbjct: 249 DCWNPDPHSRPS 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 75/310 (24%), Positives = 125/310 (40%), Gaps = 73/310 (23%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G ++ R ++ +D A K+ L A+ + F L EV ++ LRH IV
Sbjct: 46 GAGSFGTVHRAEWHGSDVAVKI--LMEQDFHAERVNEF----LREVAIMKRLRHPNIVLF 99
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
G A P + +I EY+ GS+ + K + + + L +A
Sbjct: 100 MG----------AVTQPPNL----SIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMA 143
Query: 931 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTC 988
DVA + LH+++ I+HR++KS N+L+D K VK+CDF +
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-------KKYTVKVCDFGLS---------- 186
Query: 989 CIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL 1048
+ + GTP WMAPEVLR +P + D++S+G +L EL TLQ P+ L
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLR--DEP--SNEKSDVYSFGVILWELATLQQPWGNL 242
Query: 1049 SELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1107
+ ++ + KR + + + + + C
Sbjct: 243 NPAQVVAAVGFKCKRLEIPR------NLNPQ---------------------VAAIIEGC 275
Query: 1108 TEENPTERPT 1117
P +RP+
Sbjct: 276 WTNEPWKRPS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 65/288 (22%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ L V + +++ F EV +L RH I+ G S+ L
Sbjct: 51 VKMLNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLFMG--YSTA----------PQL 94
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
AI ++ +G S+ +++ E +K + IA+ A + LH+K I+HRD+K
Sbjct: 95 ---AIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
S NI + VK+ DF A + G+ WMAPE
Sbjct: 148 SNNIFL-------HEDNTVKIGDFGLA---TEKSRWSGSHQFEQLS-----GSILWMAPE 192
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDEL 1069
V+R M N Y + D++++G +L EL+T Q+PY ++ + I + + P L
Sbjct: 193 VIR-MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL---S 248
Query: 1070 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117
+ +C + + + C ++ ERP+
Sbjct: 249 KVRSNCPKR---------------------MKRLMAECLKKKRDERPS 275
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 66/312 (21%), Positives = 120/312 (38%), Gaps = 83/312 (26%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G+ + + K+ + D A K ++ S E + F E+R L + H IV++
Sbjct: 17 GRGAFGVVCKAKWRAKDVAIKQ--IE----SESERKAFI----VELRQLSRVNHPNIVKL 66
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
YG + + MEY +GGS+ N + + + A+
Sbjct: 67 YG--ACLNPV--------------CLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWC 108
Query: 931 QDVAAALVELHS---KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 987
+ + LHS K ++HRD+K N+L+ G V+K+CDF A +++ +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV------AGGTVLKICDFGTACDIQTHMTN 162
Query: 988 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
G+ WMAPEV Y + D++S+G +L E++T + P+
Sbjct: 163 NK-------------GSAAWMAPEVFE--GSN--YSEKCDVFSWGIILWEVITRRKPFDE 205
Query: 1048 LS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1105
+ I + G RP L + + + +
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIK------NLPKP---------------------IESLMT 238
Query: 1106 RCTEENPTERPT 1117
RC ++P++RP+
Sbjct: 239 RCWSKDPSQRPS 250
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 66/276 (23%), Positives = 102/276 (36%), Gaps = 64/276 (23%)
Query: 851 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 910
C+ E+ +L L H +++ Y I L I +E G + I
Sbjct: 78 DCIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------NIVLELADAGDLSRMI 123
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
+ + + + + + +AL +HS+ +MHRDIK N+ I A G VV
Sbjct: 124 KHFKKQK-RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-----ATG--VV 175
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1030
KL D R F AH VGTP +M+PE + Y + DIWS
Sbjct: 176 KLGDLGLG---RFFSSKTTAAH-------SLVGTPYYMSPERIH--ENG--YNFKSDIWS 221
Query: 1031 YGCLLLELLTLQVPYMG--LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1088
GCLL E+ LQ P+ G ++ + I+ P L + S
Sbjct: 222 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD------------HYS----- 264
Query: 1089 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
L + C +P +RP +Y++
Sbjct: 265 ---------EELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 56/296 (18%), Positives = 101/296 (34%), Gaps = 60/296 (20%)
Query: 844 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--IFMEYV 901
++ EV+ L L H IV G + P I ME+
Sbjct: 43 RVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFC 102
Query: 902 KGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961
G+++ +IEK + + LAL + + + + +HSK +++RD+K NI +
Sbjct: 103 DKGTLEQWIEK---RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--- 156
Query: 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021
VK+ DF L++ GT R+M+PE + +
Sbjct: 157 --DTK--QVKIGDFGLVTSLKNDGKRTRS-----------KGTLRYMSPEQIS--SQD-- 197
Query: 1022 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 1081
YG EVD+++ G +L ELL + E + ++D
Sbjct: 198 YGKEVDLYALGLILAELLHVCDTAF-----ETSKFFTDLRDGIISDIF------------ 240
Query: 1082 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 1136
+ ++ + P +RP ++ V + S + R
Sbjct: 241 -DKK--------------EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 61/290 (21%), Positives = 107/290 (36%), Gaps = 71/290 (24%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
L+ + E + F+ E ML L+H IV Y W + G + ++
Sbjct: 59 LQDRKLTKSERQRFK----EEAEMLKGLQHPNIVRFYDS-----WESTVKG--KKCIV-- 105
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKS 952
+ E + G++K Y+++ K + + + L LH++ I+HRD+K
Sbjct: 106 -LVTELMTSGTLKTYLKRFKVMKIKVLRS-----WCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1012
+NI I G VK+ D + +GTP +MAPE+
Sbjct: 160 DNIFIT----GPTG--SVKIGDL------------GLATLKRASFAKAVIGTPEFMAPEM 201
Query: 1013 LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEA 1071
Y VD++++G +LE+ T + PY +I+ + G +P D++
Sbjct: 202 YE-----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256
Query: 1072 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
PE + + C +N ER + DL
Sbjct: 257 ------------------PEVK----EII----EGCIRQNKDERYSIKDL 280
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 56/314 (17%), Positives = 108/314 (34%), Gaps = 68/314 (21%)
Query: 818 LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877
+ ++ L + R F L EV+++ L H +++ G +
Sbjct: 26 AIKVTHRETGEVMVMKELI--RFDEETQRTF----LKEVKVMRCLEHPNVLKFIG--VLY 77
Query: 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAAL 937
K + L EY+KGG+++ I+ + + A+D+A+ +
Sbjct: 78 K---------DKRL---NFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGM 121
Query: 938 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGI 995
LHS +I+HRD+ S N L+ + V + DF R + + +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENK-------NVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 996 PAPDV--CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY--MGLSEL 1051
VG P WMAPE++ + Y +VD++S+G +L E++ +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMIN--GRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 1052 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111
+ ++ +C + RC + +
Sbjct: 231 DFGLNVRGFLDR------YCPPNCPPS---------------------FFPITVRCCDLD 263
Query: 1112 PTERPTAGDLYEMF 1125
P +RP+ L
Sbjct: 264 PEKRPSFVKLEHWL 277
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 56/286 (19%), Positives = 93/286 (32%), Gaps = 75/286 (26%)
Query: 849 EYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVK 907
E + L EV L +HS +V + W + H+L I EY GGS+
Sbjct: 54 EQNALREVYAHAVLGQHSHVVRYFSA-----WAE------DDHML---IQNEYCNGGSLA 99
Query: 908 NYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID--------- 958
+ I + + + V L +HS ++H DIK NI I
Sbjct: 100 DAISENYRIM-SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158
Query: 959 ---LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
E A K + K+ D + S P V G R++A EVL+
Sbjct: 159 EEGDEDDWASNKVMFKIGDLGHVTRISS--------------PQVEEGDSRFLANEVLQ- 203
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1075
+ + + DI++ ++ + + I+ G+ PR+ L
Sbjct: 204 ENYT--HLPKADIFALALTVVCAAGAEPLPRNGDQWHE---IRQGRLPRIPQVL------ 252
Query: 1076 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
S ++ + +P RP+A L
Sbjct: 253 -------SQE--------------FTELLKVMIHPDPERRPSAMAL 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 58/268 (21%), Positives = 92/268 (34%), Gaps = 61/268 (22%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ L IV +YG W+ IFME ++GGS+ I+++
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWV--------------NIFMELLEGGSLGQLIKQMG 145
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E L LH++ I+H D+K++N+L+ +DG LCD
Sbjct: 146 CLPEDRALY-----YLGQALEGLEYLHTRRILHGDVKADNVLLS-----SDGS-RAALCD 194
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A+ L+ + D GT MAPEV+ +VDIWS C+
Sbjct: 195 FGHALCLQPDGLGKSLLTG-----DYIPGTETHMAPEVVMG----KPCDAKVDIWSSCCM 245
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
+L +L P+ + I P E P
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIASEPPPIR----------------------EIP---- 279
Query: 1095 ETLS-FLVDVFRRCTEENPTERPTAGDL 1121
+ + + + P R +A +L
Sbjct: 280 PSCAPLTAQAIQEGLRKEPVHRASAMEL 307
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-36
Identities = 69/288 (23%), Positives = 107/288 (37%), Gaps = 66/288 (22%)
Query: 851 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 910
EV +L ++H IV+ + L I M+Y +GG + I
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSL--------------YIVMDYCEGGDLFKRI 114
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
L + AL +H + I+HRDIKS+NI + DG V
Sbjct: 115 NA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-----KDG--TV 164
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1030
+L DF A R T +A C+GTP +++PE+ +KP Y + DIW+
Sbjct: 165 QLGDFGIA---RVLNSTVELAR-------ACIGTPYYLSPEICE--NKP--YNNKSDIWA 210
Query: 1031 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP 1090
GC+L EL TL+ + S + I G P ++ S
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY----S---------------- 250
Query: 1091 EAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSRS 1137
L + + + NP +RP+ + E F+A+ S
Sbjct: 251 -------YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQ 291
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 72/279 (25%), Positives = 106/279 (37%), Gaps = 66/279 (23%)
Query: 851 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 910
+ EV +L L+H IV Y I L I MEY +GG + + I
Sbjct: 51 MLVSEVNLLRELKHPNIVRYYDRIIDRT---------NTTLY---IVMEYCEGGDLASVI 98
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSENILIDLERKKAD 965
K ++ +++ + L + + AL E H + ++HRD+K N+ +D
Sbjct: 99 TKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD------- 150
Query: 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1025
GK VKL DF A R H A VGTP +M+PE + Y +
Sbjct: 151 GKQNVKLGDFGLA---RILNHDTSFAK-------TFVGTPYYMSPEQMN--RMS--YNEK 196
Query: 1026 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1085
DIWS GCLL EL L P+ S+ E+ I+ GK R+ S
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY----S----------- 241
Query: 1086 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
L ++ R RP+ ++ E
Sbjct: 242 ------------DELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 55/276 (19%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKNYI 910
EV +L +L H +V Y WL + ++ I MEY + G++ + I
Sbjct: 52 EVMLLASLNHQYVVRYYAA-----WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
+ + + + AL +HS+ I+HRD+K NI ID V
Sbjct: 107 HS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID-----ESRN--V 155
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVLRAMHKPNLYGLEV 1026
K+ DF A + L + + +P +GT ++A EVL + Y ++
Sbjct: 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG--TGH-YNEKI 212
Query: 1027 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1086
D++S G + E++ G+ + I ++
Sbjct: 213 DMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVS------------------------- 245
Query: 1087 FEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 1121
E P + + R + +P +RP A L
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 61/274 (22%), Positives = 96/274 (35%), Gaps = 48/274 (17%)
Query: 851 SCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI 910
+ EV+ L L H IV + + + L I M+ + ++K+++
Sbjct: 49 KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL--YIQMQLCRKENLKDWM 106
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
+ + L I +A A+ LHSK +MHRD+K NI D VV
Sbjct: 107 NG--RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VV 157
Query: 971 KLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028
K+ DF A+ T VGT +M+PE + Y +VDI
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS----YSHKVDI 213
Query: 1029 WSYGCLLLELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1087
+S G +L ELL P+ E ++ K P L
Sbjct: 214 FSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPL---------------------- 248
Query: 1088 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
+ +V + +P ERP A ++
Sbjct: 249 --FTQKYPCEYVMV---QDMLSPSPMERPEAINI 277
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 61/285 (21%), Positives = 101/285 (35%), Gaps = 53/285 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ LRH I+ +D H Q + Y + GS+ +Y++
Sbjct: 52 ELYNTVMLRHENILGFIA----------SDMTSRHSSTQLWLITHYHEMGSLYDYLQL-- 99
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 966
+ L I +A+ L LH + I HRD+KS+NIL+ +G
Sbjct: 100 ----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-----KNG 150
Query: 967 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE- 1025
+ D AV + + + VGT R+MAPEVL + +
Sbjct: 151 --QCCIADLGLAVMHSQSTNQLDVGNNPR------VGTKRYMAPEVLD--ETIQVDCFDS 200
Query: 1026 ---VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1082
VDIW++G +L E+ V + + + + P D + V
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV--------VCV 252
Query: 1083 SGS--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
TL+ L + + C +NP+ R TA + +
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-35
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 19/220 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISS-PGV 128
L L L P R L+++ + P + GLE L + + + P
Sbjct: 86 LELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPA- 144
Query: 129 NGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
++ L L+EL + ++P + E GL L L + IR LP
Sbjct: 145 ---SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPAS 201
Query: 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA-NNKLVELPSGLYLLQRLENLDLS 241
I L NL+ L + + + L I +L L L + L P L+ L L
Sbjct: 202 IANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK 261
Query: 242 N-NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ + L +L LD+ + L+ L+L+ LS ++PS I
Sbjct: 262 DCSNLLTL-PLDIHRLTQLEKLDLRGCVNLS--RLPSLIA 298
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-27
Identities = 36/198 (18%), Positives = 67/198 (33%), Gaps = 18/198 (9%)
Query: 93 LRNLKFFG-NEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRP 151
NL F G + + + N + ++ +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQ-IETRTGRALKATA 72
Query: 152 SVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKA 211
+L + L + + P + LS+L+ + + + LP +
Sbjct: 73 DLLEDAT----QPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAG 128
Query: 212 LISLKVANNKLVELPSGLYLLQRLENLDLS-NNRLTSL--------GSLDLCLMHNLQNL 262
L +L +A N L LP+ + L RL L + LT L S + + NLQ+L
Sbjct: 129 LETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 263 NLQYNKLLSYCQVPSWIC 280
L++ + S +P+ I
Sbjct: 189 RLEWTGIRS---LPASIA 203
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 35/185 (18%), Positives = 63/185 (34%), Gaps = 43/185 (23%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
+++ L L + +P S+ + L++LK + ++ + +L LE L
Sbjct: 184 NLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEEL--------- 234
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-IRYLPPEIGCLS 187
L+G L G L +L + S + LP +I L+
Sbjct: 235 ------DLRGCTALR-----------NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 188 NLEQLDLSFNKM-KYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
LE+LDL LP+ I L A + V + +L +R
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ---------------HRPV 322
Query: 247 SLGSL 251
+ +
Sbjct: 323 ARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 9/93 (9%), Positives = 19/93 (20%), Gaps = 5/93 (5%)
Query: 179 LPPEIGCLSNLEQLDLS-FNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
S E L ++ + + A+ +
Sbjct: 4 SHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQ---RHYNADRNRWHSAWRQANSNNPQI 60
Query: 238 LDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKL 269
+ L + L+ L L+ L
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPL 93
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 68/286 (23%), Positives = 110/286 (38%), Gaps = 64/286 (22%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ + L+H IV+ G + IFME V GGS+ +
Sbjct: 69 EIALHKHLKHKNIVQYLGSFSE-----------NGFIK---IFMEQVPGGSLSALLRSKW 114
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ + + + Q + L LH I+HRDIK +N+LI+ G V+K+ D
Sbjct: 115 GPLKDNEQT-IGFYTKQ-ILEGLKYLHDNQIVHRDIKGDNVLINTY----SG--VLKISD 166
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F + L P + GT ++MAPE++ P YG DIWS GC
Sbjct: 167 FGTSKRLAGI----------NPCTETFTGTLQYMAPEIID--KGPRGYGKAADIWSLGCT 214
Query: 1035 LLELLTLQVPYMGLSE-LEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
++E+ T + P+ L E + M K P + + + A
Sbjct: 215 IIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA------------------- 255
Query: 1093 ELETLSFLVDVFRRCTEENPTERPTAGDLYE-MFVARTSSSISSRS 1137
+F+ +C E +P +R A DL F+ +S ++
Sbjct: 256 ----KAFI----LKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 60/299 (20%), Positives = 106/299 (35%), Gaps = 81/299 (27%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV L ++H I++ G A+ + + + + GS+ ++++
Sbjct: 68 EVYSLPGMKHENILQFIG----------AEKRGTSVDVDLWLITAFHEKGSLSDFLKA-- 115
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHRDIKSENILIDLERKKA 964
VS IA+ +A L LH I HRDIKS+N+L+
Sbjct: 116 ----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-----N 166
Query: 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR-AMHKPNLYG 1023
+ + DF A+ + + VGT R+MAPEVL A++
Sbjct: 167 NL--TACIADFGLALKFEAGKSAGDTHGQ--------VGTRRYMAPEVLEGAINFQRDAF 216
Query: 1024 LEVDIWSYGCLLLELLTLQVPYMGL----------------SELEIHDLI-QMGKRPRLT 1066
L +D+++ G +L EL + G S ++ +++ KRP L
Sbjct: 217 LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
D +H ++ L + C + + R +AG + E
Sbjct: 277 D------YWQKHAG----------------MAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 64/281 (22%), Positives = 96/281 (34%), Gaps = 75/281 (26%)
Query: 851 SCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 909
L EV + +H C V + W +G L + E G S++ +
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQA-----W---EEGG---ILY---LQTELC-GPSLQQH 146
Query: 910 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 969
E + +D AL LHS+ ++H D+K NI + G
Sbjct: 147 CEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG-----PRG--R 195
Query: 970 VKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029
KL DF V L + +V G PR+MAPE+L+ YG D++
Sbjct: 196 CKLGDFGLLVELGTAGAG-----------EVQEGDPRYMAPELLQ-----GSYGTAADVF 239
Query: 1030 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1088
S G +LE+ +++P+ G L Q P T L S
Sbjct: 240 SLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGL----S-------------- 278
Query: 1089 KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVAR 1128
E L V E +P R TA L + + +
Sbjct: 279 -SE--------LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 44/228 (19%), Positives = 82/228 (35%), Gaps = 28/228 (12%)
Query: 852 CLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE 911
E M H I+ + + + + +H + + + K G++ N IE
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRER-------GAKHEAW---LLLPFFKRGTLWNEIE 122
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
+L + G ++ L++ + L +H+K HRD+K NIL+ +G
Sbjct: 123 RLKDKGN-FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-----DEG--QPV 174
Query: 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL-YGLEVDIWS 1030
L D + A T + APE+ + + D+WS
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQR-CTISYRAPELFSV--QSHCVIDERTDVWS 231
Query: 1031 YGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKR-----PRLTDELEAL 1072
GC+L ++ + PY + + + L + PR + L L
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQL 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 82/288 (28%)
Query: 851 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 908
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 116
Query: 909 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 117 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 163
Query: 969 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 1016
++KL DF A ++ + GT +M PE ++ M
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 210
Query: 1017 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1076
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 249
Query: 1077 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 1123
H + E P + L DV + C + +P +R + +L
Sbjct: 250 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 975 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 1028
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1087
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 1088 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 78/316 (24%), Positives = 115/316 (36%), Gaps = 79/316 (25%)
Query: 820 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISS 877
C A K L+ C +S DE+ E++ + H IV Y
Sbjct: 35 YCAPKKEKVAIKRINLEKCQTSMDELLK-------EIQAMSQCHHPNIVSYYTSFVVKDE 87
Query: 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--------EKHVSVKLALFI 929
W + M+ + GGSV + I+ + G E ++ I
Sbjct: 88 LW----------------LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT-----I 126
Query: 930 AQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCC 989
++V L LH +HRD+K+ NIL+ DG V++ DF + L +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG-----EDGS--VQIADFGVSAFLATGGDITR 179
Query: 990 IAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1049
R VGTP WMAPEV M + Y + DIWS+G +EL T PY
Sbjct: 180 NKVR-----KTFVGTPCWMAPEV---MEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
Query: 1050 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR---- 1105
+++ L P L E + E L FR
Sbjct: 232 PMKVLMLTLQNDPPSL----------------------ETGVQDKEMLKKYGKSFRKMIS 269
Query: 1106 RCTEENPTERPTAGDL 1121
C +++P +RPTA +L
Sbjct: 270 LCLQKDPEKRPTAAEL 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 82/288 (28%)
Query: 851 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 908
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 97
Query: 909 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 98 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 144
Query: 969 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 1016
++KL DF A ++ + GT +M PE ++ M
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GTVNYMPPEAIKDMSSSRENG 191
Query: 1017 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1076
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 230
Query: 1077 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 1123
H + E P + L DV + C + +P +R + +L
Sbjct: 231 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 49/283 (17%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ +RH I+ AD Q + +Y + GS+ +Y++
Sbjct: 81 EIYQTVLMRHENILGFIA----------ADIKGTGSWTQLYLITDYHENGSLYDYLKS-- 128
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSENILIDLERKKADG 966
+ K L +A + L LH++ I HRD+KS+NIL+
Sbjct: 129 ----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-------K 177
Query: 967 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL--YGL 1024
+ D AV S + I VGT R+M PEVL N +
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTR------VGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 1025 EVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1084
D++S+G +L E+ V + E ++ + P D E V
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI--------VCIKK 283
Query: 1085 S--GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
F + E L + + C NP R TA + +
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-33
Identities = 48/288 (16%), Positives = 100/288 (34%), Gaps = 82/288 (28%)
Query: 851 SCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKN 908
S E+ L L+ I+ +Y ++I+ +++ + ME + +
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------YMVMECG-NIDLNS 144
Query: 909 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968
+++K +K + +++ A+ +H I+H D+K N LI
Sbjct: 145 WLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--------DG 191
Query: 969 VVKLCDFDRAVPLRS-----FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM------- 1016
++KL DF A ++ + G +M PE ++ M
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQV-------------GAVNYMPPEAIKDMSSSRENG 238
Query: 1017 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1076
+ + D+WS GC+L + + P+ + +++ L
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-----------------IINQISKL---- 277
Query: 1077 EHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDLYE 1123
H + E P + L DV + C + +P +R + +L
Sbjct: 278 -HAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-32
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 37/277 (13%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E +L L H IV+++ + + H +L ME+ GS+ +E+ S
Sbjct: 57 EFEVLKKLNHKNIVKLFAIE--------EETTTRHKVL----IMEFCPCGSLYTVLEEPS 104
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ L + +DV + L I+HR+IK NI+ DG+ V KL D
Sbjct: 105 NAYG--LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV---IGEDGQSVYKLTD 159
Query: 975 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL----YGLEVDI 1028
F R + + GT ++ P++ YG VD+
Sbjct: 160 FGAARELEDDEQFVSLY-------------GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1087
WS G T +P+ + +++ + + + + + SG
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 1088 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
L V E + + +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-32
Identities = 63/323 (19%), Positives = 102/323 (31%), Gaps = 59/323 (18%)
Query: 820 RCKFGSADAAAKVRTLKVC-GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878
R K + L+ C ++ E+ + H IV I+
Sbjct: 47 RYKPTGEYVTVRRINLEACSNEMVTFLQG-------ELHVSKLFNHPNIVPYRATFIADN 99
Query: 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAA 936
L + ++ GS K+ I G E ++ +I Q V A
Sbjct: 100 EL--------------WVVTSFMAYGSAKDLICTHFMDGMNELAIA-----YILQGVLKA 140
Query: 937 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIP 996
L +H +HR +K+ +ILI DGK V L S +
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS-----VDGK--VYLSGLRSN---LSMISHGQRQRVVHD 190
Query: 997 APDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1056
P V W++PEVL+ + Y + DI+S G EL VP+ + ++
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQG--YDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 1057 IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV--------------D 1102
G P L D ++S + ++ +
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
Query: 1103 VFR----RCTEENPTERPTAGDL 1121
F +C + NP RP+A L
Sbjct: 309 HFHHFVEQCLQRNPDARPSASTL 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 66/299 (22%), Positives = 103/299 (34%), Gaps = 81/299 (27%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ LRH I+ AD Q + +Y + GS+ +Y+ + +
Sbjct: 86 EIYQTVMLRHENILGFIA----------ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 135
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKH--------IMHRDIKSENILIDLERKKADG 966
V+V+ + +A A+ L LH + I HRD+KS+NIL+
Sbjct: 136 ------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------K 182
Query: 967 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR----AMHKPNLY 1022
+ D AV S T IA VGT R+MAPEVL H
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEVLDDSINMKHFE--S 234
Query: 1023 GLEVDIWSYGCLLLELLTL----------QVPYMGL-----SELEIHDLI-QMGKRPRLT 1066
DI++ G + E+ Q+PY L S E+ ++ + RP +
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+ + E L + + R C N R TA + +
Sbjct: 295 NRWQ----------------------SCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 51/301 (16%), Positives = 97/301 (32%), Gaps = 76/301 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
+ + + H I + ++ + MEY GS+ Y+
Sbjct: 57 NIYRVPLMEHDNIARFIV---------GDERVTADGRMEYLLVMEYYPNGSLXKYLSL-- 105
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKH---------IMHRDIKSENILIDLERKKAD 965
+ +A V L LH++ I HRD+ S N+L+ D
Sbjct: 106 ----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-----ND 156
Query: 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR---AMHKPNLY 1022
G + DF ++ L +V GT R+MAPEVL +
Sbjct: 157 G--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEV--GTIRYMAPEVLEGAVNLRDXESA 212
Query: 1023 GLEVDIWSYGCLLLELLT-------------LQVPYMGL-----SELEIHDLI-QMGKRP 1063
+VD+++ G + E+ Q+ + + ++ L+ + +RP
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP 272
Query: 1064 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
+ + + E+ +A + L + C +++ R TA E
Sbjct: 273 KFPE------AWKENSLA---------------VRSLKETIEDCWDQDAEARLTAQXAEE 311
Query: 1124 M 1124
Sbjct: 312 R 312
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 70/270 (25%), Positives = 107/270 (39%), Gaps = 72/270 (26%)
Query: 855 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
E+ ++ ++ IV W + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELW----------------VVMEYLAGGSLTDVVTE 110
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ E ++ + ++ AL LHS ++HRDIKS+NIL+ DG VKL
Sbjct: 111 -TCMDEGQIAA-----VCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKL 157
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF + T + R VGTP WMAPEV+ YG +VDIWS G
Sbjct: 158 TDFGFCAQI-----TPEQSKR-----STMVGTPYWMAPEVV----TRKAYGPKVDIWSLG 203
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
+ +E++ + PY+ + L LI P L +
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP------------------------ 239
Query: 1093 ELETLS-FLVDVFRRCTEENPTERPTAGDL 1121
E LS D RC E + +R +A +L
Sbjct: 240 --EKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 69/270 (25%), Positives = 115/270 (42%), Gaps = 72/270 (26%)
Query: 855 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
EV ++ +H +VEMY W + ME+++GG++ + + +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELW----------------VLMEFLQGGALTDIVSQ 135
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ E+ ++ + + V AL LH++ ++HRDIKS++IL+ L DG+ VKL
Sbjct: 136 VRLN-EEQIAT-----VCEAVLQALAYLHAQGVIHRDIKSDSILLTL-----DGR--VKL 182
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF + + + R VGTP WMAPEV+ Y EVDIWS G
Sbjct: 183 SDFGFCAQI-----SKDVPKR-----KSLVGTPYWMAPEVISRSL----YATEVDIWSLG 228
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
+++E++ + PY S ++ ++ P+L +
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS------------------------ 264
Query: 1093 ELETLS-FLVDVFRRCTEENPTERPTAGDL 1121
+S L D R +P ER TA +L
Sbjct: 265 --HKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 78/311 (25%), Positives = 121/311 (38%), Gaps = 80/311 (25%)
Query: 828 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 885
A K+ L+ ++I+ E+ +L + + YG K + W
Sbjct: 50 VAIKIIDLEEAEDEIEDIQQ-------EITVLSQCDSPYVTKYYGSYLKDTKLW------ 96
Query: 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHI 945
I MEY+ GGS + + + E ++ I +++ L LHS+
Sbjct: 97 ----------IIMEYLGGGSALD-LLEPGPLDETQIAT-----ILREILKGLDYLHSEKK 140
Query: 946 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1005
+HRDIK+ N+L+ G+ VKL DF A L T R + VGTP
Sbjct: 141 IHRDIKAANVLLS-----EHGE--VKLADFGVAGQL-----TDTQIKR-----NTFVGTP 183
Query: 1006 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1065
WMAPEV+ K + Y + DIWS G +EL + P+ L +++ LI P L
Sbjct: 184 FWMAPEVI----KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL 239
Query: 1066 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM- 1124
+ KP L + C + P+ RPTA +L +
Sbjct: 240 EGN------------------YSKP---------LKEFVEACLNKEPSFRPTAKELLKHK 272
Query: 1125 FVARTSSSISS 1135
F+ R + S
Sbjct: 273 FILRNAKKTSY 283
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 65/291 (22%), Positives = 106/291 (36%), Gaps = 64/291 (21%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQ 893
+KV + DE + E+ ML H I YG ++ + L
Sbjct: 54 IKVMDVTGDEEEEIKQ----EINMLKKYSHHRNIATYYGA-----FIKKNPPGMDDQLW- 103
Query: 894 SAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ ME+ GSV + I+ E+ ++ +I +++ L LH ++HRDIK
Sbjct: 104 --LVMEFCGAGSVTDLIKNTKGNTLKEEWIA-----YICREILRGLSHLHQHKVIHRDIK 156
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+N+L+ + + VKL DF + L + R + +GTP WMAPE
Sbjct: 157 GQNVLLT-----ENAE--VKLVDFGVSAQL-----DRTVGRR-----NTFIGTPYWMAPE 199
Query: 1012 VLRAMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
V+ P+ Y + D+WS G +E+ P + + LI PRL
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL----- 254
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
+ K C +N ++RP L
Sbjct: 255 ------------KSKKWSKK---------FQSFIESCLVKNHSQRPATEQL 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 75/298 (25%)
Query: 828 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--HKISSKWLPSADG 885
AAAKV K S +E+ ++ E+ +L H IV++ G + W
Sbjct: 47 AAAKVIETK----SEEELEDYI----VEIEILATCDHPYIVKLLGAYYHDGKLW------ 92
Query: 886 NPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKH 944
I +E+ GG+V + +L E + + + + AL LHSK
Sbjct: 93 ----------IMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VVCRQMLEALNFLHSKR 137
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT 1004
I+HRD+K+ N+L+ +G ++L DF + L R D +GT
Sbjct: 138 IIHRDLKAGNVLMT-----LEGD--IRLADFGVSAKNLKTL-----QKR-----DSFIGT 180
Query: 1005 PRWMAPEV-LRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1063
P WMAPEV + K Y + DIWS G L+E+ ++ P+ L+ + + I P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240
Query: 1064 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
L + S + D + ++NP RP+A L
Sbjct: 241 TL----------------LTPSKWSVE---------FRDFLKIALDKNPETRPSAAQL 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 48/210 (22%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 912
EV + LRH I+ +YG+ + ++ +EY G+V ++K
Sbjct: 59 EVEIQSHLRHPNILRLYGYFHDAT----------------RVYLILEYAPLGTVYRELQK 102
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ ++A AL HSK ++HRDIK EN+L+ + G+ +K+
Sbjct: 103 -----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-----SAGE--LKI 150
Query: 973 CDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
DF +V S C GT ++ PE++ ++ +VD+WS
Sbjct: 151 ADFGWSVHAPSSRRTDLC-------------GTLDYLPPEMIEG----RMHDEKVDLWSL 193
Query: 1032 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
G L E L + P+ + E + I +
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRISRVE 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 68/271 (25%), Positives = 100/271 (36%), Gaps = 72/271 (26%)
Query: 855 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
E+ ++ +V+ YG K + W I MEY GSV + I
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLW----------------IVMEYCGAGSVSDIIRL 117
Query: 913 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
++T E ++ I Q L LH +HRDIK+ NIL++ +G K
Sbjct: 118 RNKTLTEDEIAT-----ILQSTLKGLEYLHFMRKIHRDIKAGNILLN-----TEGH--AK 165
Query: 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
L DF A L T +A R + +GTP WMAPEV+ + Y DIWS
Sbjct: 166 LADFGVAGQL-----TDTMAKR-----NTVIGTPFWMAPEVI----QEIGYNCVADIWSL 211
Query: 1032 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1091
G +E+ + PY + + +I P
Sbjct: 212 GITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP----------------------- 248
Query: 1092 AELETLS-FLVDVFRRCTEENPTERPTAGDL 1121
E S D ++C ++P +R TA L
Sbjct: 249 ---ELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 33/303 (10%), Positives = 69/303 (22%), Gaps = 56/303 (18%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH----------KISSKWLPSAD 884
LKV A+ R+ L E + S+ +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 885 GNPEHHLLQSAIF--MEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVEL 940
+ + M ++ L + + + L
Sbjct: 152 SPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1000
SK ++H +N+ I DG+ + L D + +
Sbjct: 211 QSKGLVHGHFTPDNLFIM-----PDGR--LMLGDVSALWKVGTRGPASS----------- 252
Query: 1001 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 1060
+ E L + ++ W G + + L +P+ ++ +
Sbjct: 253 --VPVTYAPREFLN--ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 1061 KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120
R TD L + + + R + R +
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVK-------------------TLIGRFLNFDRRRRLLPLE 349
Query: 1121 LYE 1123
E
Sbjct: 350 AME 352
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 54/274 (19%), Positives = 107/274 (39%), Gaps = 55/274 (20%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 912
E++++ +++ + G I++ ++ EY++ S+ + E
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNY---------------DEVYIIYEYMENDSILKFDEY 136
Query: 913 ---LSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKP 968
L + + +++ I + V + +H+ K+I HRD+K NIL+D +G+
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-----KNGR- 190
Query: 969 VVKLCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1027
VKL DF + + + GT +M PE ++ + G +VD
Sbjct: 191 -VKLSDFGESEYMVDKKIKGSR-------------GTYEFMPPEFF--SNESSYNGAKVD 234
Query: 1028 IWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG 1086
IWS G L + VP+ +S +E+ + I+ + ++ + +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNN 293
Query: 1087 FEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120
F E D + +NP ER T+ D
Sbjct: 294 FLSNEDI--------DFLKLFLRKNPAERITSED 319
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-28
Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 29/219 (13%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
D L L L+ +P+ L +L N + P +L L + +
Sbjct: 70 DRQAHELELNNLGLSSLPELPP---HLESLVASCNSLTELPELPQSLKSLLVDNNNLKA- 125
Query: 127 GVNGFALNKL-KGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC 185
L+ L L+ L +S L L E+ L + V + S++ LP
Sbjct: 126 ------LSDLPPLLEYLGVSNNQ-----LEKLPELQNSSFLKIIDVDNNSLKKLPDLPP- 173
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
+LE + N+++ LP E+ L L ++ NN L +LP L LE++ NN L
Sbjct: 174 --SLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKKLPD---LPLSLESIVAGNNIL 227
Query: 246 TSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L +L + L + N L + +P +LE
Sbjct: 228 EELP--ELQNLPFLTTIYADNNLLKT---LPDLP-PSLE 260
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 49/234 (20%), Positives = 83/234 (35%), Gaps = 41/234 (17%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
+E L + N L +P + L+ + N + P +L + ++
Sbjct: 131 PLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEEL- 188
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYLPPEIGCL 186
L L L + L ++ L + + + LP E+ L
Sbjct: 189 ---PELQNLPFLTAIYADN--------NSLKKLPDLPLSLESIVAGNNILEELP-ELQNL 236
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L + N +K LP L+ +L V +N L +LP L Q L LD+S N +
Sbjct: 237 PFLTTIYADNNLLKTLPDLPPSLE---ALNVRDNYLTDLPE---LPQSLTFLDVSENIFS 290
Query: 247 -------SLGSLDLC---------LMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+L L+ L +L+ LN+ NKL+ +P+ LE
Sbjct: 291 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE---LPALP-PRLE 340
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 41/233 (17%), Positives = 76/233 (32%), Gaps = 29/233 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
+Y N+L +P L L N + P +L L+ + S
Sbjct: 242 IYADNNLLKTLPDLPP---SLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 298
Query: 133 LNKLKGLKELELSKVPPRPSVLT-------LLSEI-AGLKCLTKLSVCHFSIRYLPPEIG 184
L L E+ + P L L E+ A L +L + +P
Sbjct: 299 LYYLN-ASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLAEVPELPQ 357
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
NL+QL + +N ++ P ++ L N+ L E+P L Q L+ L + N
Sbjct: 358 ---NLKQLHVEYNPLREFPDIPESVEDLRM----NSHLAEVPE---LPQNLKQLHVETNP 407
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297
L + ++++L + +++ + + D
Sbjct: 408 LREFPDI----PESVEDLRMNSERVV---DPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 39/199 (19%), Positives = 66/199 (33%), Gaps = 31/199 (15%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGF 131
+ + L +P + +E P G + +++
Sbjct: 16 PLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD-------- 67
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
+ ELEL+ LS + L L S+ LP L +L
Sbjct: 68 --CLDRQAHELELNN--------LGLSSLPELPPHLESLVASCNSLTELPELPQSLKSLL 117
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
+ + + LP L L V+NN+L +LP L L+ +D+ NN L L
Sbjct: 118 VDNNNLKALSDLP------PLLEYLGVSNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPD 170
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L +L+ + N+L
Sbjct: 171 ----LPPSLEFIAAGNNQL 185
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-16
Identities = 38/208 (18%), Positives = 73/208 (35%), Gaps = 42/208 (20%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
S+E L + N L +P+ L L N + NL L +I S
Sbjct: 258 SLEALNVRDNYLTDLPELPQ---SLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL-- 312
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSVLT-------LLSEI-AGLKCLTKLSVCHFS 175
+ L+EL +S ++P P L L+E+ + L +L V +
Sbjct: 313 ----CDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLAEVPELPQNLKQLHVEYNP 368
Query: 176 IRYLPPEIGCL----------------SNLEQLDLSFNKMKYLPTEICYLKALISLKVAN 219
+R P + NL+QL + N ++ P ++ L++ +
Sbjct: 369 LREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVE---DLRMNS 425
Query: 220 NKLVELPSGLY-LLQRLENLDLSNNRLT 246
++V+ + +LE+ ++
Sbjct: 426 ERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 20/106 (18%), Positives = 40/106 (37%), Gaps = 18/106 (16%)
Query: 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLY------ 230
++ P + L++ + + +P E +K+ A ++ P G
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 231 -------LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L ++ L+L+N L+SL L +L++L N L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPE----LPPHLESLVASCNSL 103
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 69/303 (22%), Positives = 111/303 (36%), Gaps = 74/303 (24%)
Query: 855 EVRMLGALRHSCIVEMYG-----HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 909
E+++L IV YG +IS I ME++ GGS+
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEIS-------------------ICMEHMDGGSLDQV 121
Query: 910 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKP 968
++K E+ + ++ V L L KH IMHRD+K NIL++ +
Sbjct: 122 LKKAGRIPEQILGK-----VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE------ 170
Query: 969 VVKLCDFDRAVPL-RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1027
+KLCDF + L S ++ VGT +M+PE L + Y ++ D
Sbjct: 171 -IKLCDFGVSGQLIDSMANS-------------FVGTRSYMSPERL----QGTHYSVQSD 212
Query: 1028 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1087
IWS G L+E+ + P E+ + + + + + G
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT-PGRPLNKFGMDS 271
Query: 1088 EKPEAELETLSFLV-----------------DVFRRCTEENPTERPTAGDLYEM-FVART 1129
P A E L ++V D +C +NP ER L F+ R+
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
Query: 1130 SSS 1132
+
Sbjct: 332 DAE 334
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 59/276 (21%), Positives = 96/276 (34%), Gaps = 56/276 (20%)
Query: 855 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 913
EV + L H IV+ K + L + E KG V +++K+
Sbjct: 75 EVCFMKKLSGHPNIVQFCSAASIGK---EESDTGQAEFL---LLTELCKGQLV-EFLKKM 127
Query: 914 SETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVK 971
G +S L I A+ +H + I+HRD+K EN+L+ G +K
Sbjct: 128 ESRG--PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-----NQG--TIK 178
Query: 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDV--CVGTPRWMAPEVLRAM-HKPNLYGLEVDI 1028
LCDF A + + A R + TP + PE++ + P G + DI
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP--IGEKQDI 236
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF 1087
W+ GC+L L Q P+ ++L I + + +L
Sbjct: 237 WALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSL--------------- 281
Query: 1088 EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
R + NP ER + ++
Sbjct: 282 ----------------IRAMLQVNPEERLSIAEVVH 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 46/210 (21%), Positives = 78/210 (37%), Gaps = 48/210 (22%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 912
E+ + LRH I+ MY + + I+ +E+ G + ++K
Sbjct: 64 EIEIQSHLRHPNILRMYNY-FHDR---------------KRIYLMLEFAPRGELYKELQK 107
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ + +++A AL H + ++HRDIK EN+L+ G +K+
Sbjct: 108 -----HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-----YKG--ELKI 155
Query: 973 CDFDRAV-PLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
DF +V T C GT ++ PE++ + +VD+W
Sbjct: 156 ADFGWSVHAPSLRRRTMC-------------GTLDYLPPEMIEG----KTHDEKVDLWCA 198
Query: 1032 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
G L E L P+ S E H I
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIVNVD 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 66/295 (22%), Positives = 108/295 (36%), Gaps = 70/295 (23%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V++ + D F L E R+L H IV + G + ++ P +
Sbjct: 144 VKSCR-ETLPPDLKAKF----LQEARILKQYSHPNIVRLIG--VCTQKQP---------I 187
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I ME V+GG ++ + VK L + D AA + L SK +HRD+
Sbjct: 188 Y---IVMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+ N L+ + V+K+ DF + ++ R +P +W APE
Sbjct: 241 ARNCLVTEKN-------VLKISDFGMSREEADGVYAASGGLRQVPV--------KWTAPE 285
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
L Y E D+WS+G LL E +L PY LS + + ++ G R L
Sbjct: 286 ALNY----GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR------LP 335
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
C + + + +C P +RP+ +Y+
Sbjct: 336 CPELCPDA---------------------VFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-27
Identities = 28/218 (12%), Positives = 76/218 (34%), Gaps = 27/218 (12%)
Query: 71 EGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI-------K 122
Y+ + E + + + NL L +++ K
Sbjct: 209 RQFYMGNSPFVAENICEAWENENSEYAQQYKT----EDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 123 ISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSV--CHFS 175
+ + L L ++ + ++ L++ + + + + +
Sbjct: 265 LPT------FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGL-YLLQR 234
+ + + L L+ +N+++ L SL +A N++ E+P+ ++
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 235 LENLDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKLLS 271
+ENL ++N+L + D + + ++ YN++ S
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS 416
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-25
Identities = 43/241 (17%), Positives = 76/241 (31%), Gaps = 37/241 (15%)
Query: 68 NSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLF--------PSEVGNLLGLE 117
VE L N L IP + + F NEI + +
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 118 CL-----QIKISSPGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTK 168
+ QI + + L + L P+ S+ LT
Sbjct: 437 SINLSNNQISKFPKEL----FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 169 LSVCHFSIRYLPPEI--GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV--- 223
+ + + L + L L +DLS+N PT+ L + N +
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGN 552
Query: 224 ----ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
E P G+ L L L + +N + ++ + N+ L+++ N +S S++
Sbjct: 553 RTLREWPEGITLCPSLTQLQIGSNDIR---KVNEKITPNISVLDIKDNPNISI--DLSYV 607
Query: 280 C 280
C
Sbjct: 608 C 608
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-25
Identities = 37/235 (15%), Positives = 75/235 (31%), Gaps = 38/235 (16%)
Query: 69 SVEGLYLYKNVLNL-IPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+ + + I KS K + N I V L L +
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS-IRYLPPEI 183
N + + + + K + LK LT + V + + LP +
Sbjct: 220 --AENICEAWENENSEYAQQYKTED--------LKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 184 GCLSNLEQLDLSFNKMKYLP---------TEICYLKALISLKVANNKLVEL--PSGLYLL 232
L ++ ++++ N+ + + + + + N L + L +
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 233 QRLENLDLSNNRLT----SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
++L L+ N+L + GS L +LNL YN++ +P+ C
Sbjct: 330 KKLGMLECLYNQLEGKLPAFGSE-----IKLASLNLAYNQITE---IPANFCGFT 376
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-21
Identities = 31/239 (12%), Positives = 77/239 (32%), Gaps = 46/239 (19%)
Query: 75 LYKNVLNLIPKSVGRYEKLRNLKFFGNEINL---FPSEVGNLLGLECLQI---------K 122
Y + L +++ + P+ + L ++ + + +
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNC--PNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 123 ISSPGVNGFALNKLKGLKELELSK-----VPPRPSV-----LTLLS-----------EIA 161
+ + ++ + + P S+ L +L
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFG 350
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVA 218
L L++ + I +P G +E L + NK+KY+P + + + ++ +
Sbjct: 351 SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFS 410
Query: 219 NNKL--------VELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N++ L + + +++LSNN+++ L ++NL N L
Sbjct: 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-20
Identities = 33/213 (15%), Positives = 71/213 (33%), Gaps = 30/213 (14%)
Query: 78 NVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPGVNGF-- 131
+ + + + + ++ N+I+ FP E+ L + + ++ N
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 132 ---ALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI 183
L ++L K+ TL L + LS FS P +
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY----LVGID-LSYNSFS--KFPTQP 532
Query: 184 GCLSNLEQLDLSFNK-------MKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236
S L+ + + ++ P I +L L++ +N + ++ + +
Sbjct: 533 LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNIS 590
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LD+ +N S+ +C L Y+K
Sbjct: 591 VLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-16
Identities = 31/203 (15%), Positives = 63/203 (31%), Gaps = 25/203 (12%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEI--------NLFPSEVGNLLGLECL 119
+V + L N ++ + L ++ GN + N L +
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493
Query: 120 QI---KISS-PGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLS 170
+ K++ + F L L ++LS K P +P + L
Sbjct: 494 DLRFNKLTKLS--DDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQR-DAQ 550
Query: 171 VCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP-SGL 229
R P I +L QL + N ++ + +I + L + +N + + S +
Sbjct: 551 GNRTL-REWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISVLDIKDNPNISIDLSYV 607
Query: 230 YLLQRLENLDLSNNRLTSLGSLD 252
L ++ + D
Sbjct: 608 CPYIEAGMYMLFYDKTQDIRGCD 630
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-12
Identities = 25/241 (10%), Positives = 63/241 (26%), Gaps = 73/241 (30%)
Query: 65 GGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRNL-----KFFGNEINLFPSEVGNLLGLEC 118
+ V GL L + +P ++G+ +L L NE P + + E
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
Q + + + S + + S+ +
Sbjct: 138 KQKMR-----MHYQKTFVDYDPREDFSDL----IKDCINSD--------------PQQKS 174
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENL 238
+ Q+ +N + + + L +L
Sbjct: 175 IKKSSRITLKDTQIGQL-----------------------SNNITFVSKAVMRLTKLRQF 211
Query: 239 DLSNNRLTS-----------------LGSLDLCL--MHNLQNLNLQYNKLLSYCQVPSWI 279
+ N+ + + DL + +L ++ + L+ ++P+++
Sbjct: 212 YMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT--KLPTFL 269
Query: 280 C 280
Sbjct: 270 K 270
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-12
Identities = 28/192 (14%), Positives = 59/192 (30%), Gaps = 32/192 (16%)
Query: 124 SSPGVNGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ PGV +LN + L L +VP I L L L++ +
Sbjct: 71 AQPGV---SLNSNGRVTGLSLEGFGASGRVPD---------AIGQLTELEVLALGSHGEK 118
Query: 178 -----YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL------VELP 226
+ P I + EQ Y T + Y + + + +
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMH--YQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
+ + + +N +T + S + + L+ + + ++ +W N E
Sbjct: 177 KSSRITLKDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA 235
Query: 287 GKDSSNDDFISS 298
+ + D +
Sbjct: 236 QQYKTEDLKWDN 247
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 32/200 (16%), Positives = 66/200 (33%), Gaps = 40/200 (20%)
Query: 850 YSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY 909
Y + L ++ Y + S + E G++ N
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFYSAHLFQN--------------GSVLVGELYSYGTLLNA 157
Query: 910 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI----DLERKKAD 965
I T EK + L + A + + ++H I+H DIK +N ++ + + D
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217
Query: 966 GKPVVKLCDFDRAVPLRSF-----LHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1020
+ L D +++ ++ F C T + E+L +KP
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKC-------------ETSGFQCVEMLS--NKP- 261
Query: 1021 LYGLEVDIWSYGCLLLELLT 1040
+ ++D + + +L
Sbjct: 262 -WNYQIDYFGVAATVYCMLF 280
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 59/261 (22%), Positives = 93/261 (35%), Gaps = 44/261 (16%)
Query: 863 RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVS 922
+ V++ S P + I M+ + ++K+++ + +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR--RCSLEDRE 162
Query: 923 VKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVP 980
+ L I +A A+ LHSK +MHRD+K NI D VVK+ DF A+
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-----MDD--VVKVGDFGLVTAMD 215
Query: 981 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
T VGT +M+PE + + Y +VDI+S G +L ELL
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN----YSHKVDIFSLGLILFELLY 271
Query: 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1100
M + I D+ K P L + +
Sbjct: 272 SFSTQMERVRI-ITDVRN-LKFPLL------------------------FTQKYPQEHMM 305
Query: 1101 VDVFRRCTEENPTERPTAGDL 1121
V + +PTERP A D+
Sbjct: 306 V---QDMLSPSPTERPEATDI 323
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-27
Identities = 34/210 (16%), Positives = 72/210 (34%), Gaps = 21/210 (10%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
+ N + I K++ R KL+ + F + V + + + +
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEEL---S 486
Query: 133 LNKLKGLKELELSKVPPRPSVLTLL-SEIAGLKCLTKLSVCH----------FSIRYLPP 181
+ LK L ++EL +T L + L L L++ L
Sbjct: 487 WSNLKDLTDVELY----NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ ++ + +N ++ P + + L L +NK+ L + +L +L
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA-FGTNVKLTDLK 601
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L N++ + ++ L +NKL
Sbjct: 602 LDYNQIEEIPEDFCAFTDQVEGLGFSHNKL 631
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 7e-25
Identities = 35/224 (15%), Positives = 70/224 (31%), Gaps = 33/224 (14%)
Query: 73 LYLY-KNVLNLIPKSVGRYEKLRNLKFFGNEI----------NLFPSEVGNLLGLECLQI 121
+ LY + +P + +L++L N + ++ +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555
Query: 122 ---KISSPGVNGFALNKLKGLKELELS--KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
+ + L K+ L L+ K + L LT L + + I
Sbjct: 556 GYNNLEEFPASAS-LQKMVKLGLLDCVHNK-------VRHLEAFGTNVKLTDLKLDYNQI 607
Query: 177 RYLPPEIG-CLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLVELPSGL---- 229
+P + +E L S NK+KY+P + + S+ + NK+ +
Sbjct: 608 EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 230 --YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
Y + LS N + + + + L N + S
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS 711
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 7e-24
Identities = 38/242 (15%), Positives = 75/242 (30%), Gaps = 41/242 (16%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPS--EVGNLLGLECLQI---KISSP 126
L L N + IP+ + +++ L F N++ P+ ++ + + KI S
Sbjct: 600 LKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSE 659
Query: 127 GVNGFALNKLKGLKELE--------LSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
G N + K P A ++ + + + +
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPT--------ELFATGSPISTIILSNNLMTS 711
Query: 179 LPPE--------IGCLSNLEQLDLSFNKMKYLPTEI--CYLKALISLKVANNKLVELPSG 228
+P L +DL FNK+ L + L L ++ V+ N P+
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQ 771
Query: 229 LYLLQRLENLDLSNNRLTS----LGSL--DLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+L+ + + R L + +L L + N + V +
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK---VDEKLTPQ 828
Query: 283 LE 284
L
Sbjct: 829 LY 830
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 4e-21
Identities = 42/247 (17%), Positives = 78/247 (31%), Gaps = 47/247 (19%)
Query: 68 NSVEGLYLYKNVLNLIPK--SVGRYEKLRNLKFFGNEINLFPSEVG------NLLGLECL 119
+ VEGL N L IP + + ++ F N+I + + +
Sbjct: 619 DQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678
Query: 120 QI---KISSPGVNGFAL-----------NKLKGLKELELSKVPPRPSVLTLLSE------ 159
+ +I FA N + + E L LL+
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 160 ----------IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKM-------KYL 202
L L+ + V + P + S L+ + + +
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798
Query: 203 PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNL 262
PT I +LI L++ +N + ++ L +L LD+++N S+ +C
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMY 856
Query: 263 NLQYNKL 269
L Y+K
Sbjct: 857 VLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 4e-20
Identities = 32/218 (14%), Positives = 74/218 (33%), Gaps = 19/218 (8%)
Query: 65 GGDNSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL---LGLECLQ 120
+ V GL L +P ++G+ +L+ L F + + G+ + +
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT-------KLSVCH 173
L+ + L +L + + E+ +K + ++
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQ-----DAINRNPEMKPIKKDSRISLKDTQIGNLT 434
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQ 233
I ++ I L+ L+ + + + Y + + A + L+
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY---AKQYENEELSWSNLK 491
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L +++L N + L + LQ+LN+ N+ +S
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 24/191 (12%), Positives = 56/191 (29%), Gaps = 30/191 (15%)
Query: 114 LGLECLQIKISSPGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTKL 169
L L K P A+ +L LK L V R L+ + ++
Sbjct: 328 LSLAGFGAKGRVPD----AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 170 SVCHFS-IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228
+ + + L+ +MK + + + N++ +
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKA 443
Query: 229 LYLLQRLENLDLSNNRLTSLGSLDLCL-------------------MHNLQNLNLQYNKL 269
+ L +L+ + +N+ T + +L ++ L
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN 503
Query: 270 LSYCQVPSWIC 280
++ Q+P ++
Sbjct: 504 MT--QLPDFLY 512
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 19/165 (11%), Positives = 44/165 (26%), Gaps = 34/165 (20%)
Query: 166 LTKLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLK-------- 216
+T LS+ F + +P IG L+ L+ L + + +
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 217 ------------------------VANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
N ++ + + + + NR+T +
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISK-A 443
Query: 253 LCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297
+ + LQ + + W N + + + + S
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 49/233 (21%), Positives = 82/233 (35%), Gaps = 53/233 (22%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I +E +++ Y+E+ + + + Q + L LHS +I+HRD+K NI
Sbjct: 95 IAIELC-AATLQEYVEQ----KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 956 LIDLERKKADGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1009
LI A GK + DF S GT W+A
Sbjct: 150 LIS--MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-------------GTEGWIA 194
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE+L K N VDI+S GC+ +++ P+ + + + L+ L E
Sbjct: 195 PEMLSEDCKEN-PTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
E A ++ + +P +RP+A +
Sbjct: 254 KH-----------------EDVIAR--------ELIEKMIAMDPQKRPSAKHV 281
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 66/273 (24%), Positives = 100/273 (36%), Gaps = 79/273 (28%)
Query: 855 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
EVR L LRH ++ G + + W + MEY GS + +E
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAW----------------LVMEYC-LGSASDLLEV 146
Query: 913 LSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
+ E ++ + L LHS +++HRD+K+ NIL+ G VK
Sbjct: 147 HKKPLQEVEIAA-----VTHGALQGLAYLHSHNMIHRDVKAGNILLS-----EPGL--VK 194
Query: 972 LCDFDRAVPL---RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028
L DF A + SF VGTP WMAPEV+ AM Y +VD+
Sbjct: 195 LGDFGSASIMAPANSF-----------------VGTPYWMAPEVILAM-DEGQYDGKVDV 236
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFE 1088
WS G +EL + P ++ + I + P L +
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS-----------------GHWS 279
Query: 1089 KPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
+ + C ++ P +RPT+ L
Sbjct: 280 EY---------FRNFVDSCLQKIPQDRPTSEVL 303
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-27
Identities = 38/256 (14%), Positives = 78/256 (30%), Gaps = 31/256 (12%)
Query: 829 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP- 887
V ++ I+ + + +R+L +++ +++ I L
Sbjct: 107 EVHVPY-FTERPPSNAIKQMK-EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164
Query: 888 --------EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKH--VSVKLALFIAQDVAAAL 937
+ S F+ +++ + E L H + L + V L
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224
Query: 938 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 997
LH ++H ++ +I++D G V L F+ V + +
Sbjct: 225 ASLHHYGLVHTYLRPVDIVLD-----QRGG--VFLTGFEHLVRDGASAVSPI-------- 269
Query: 998 PDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1056
P A +L H P L D W+ G + + +P + L +
Sbjct: 270 -GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW 328
Query: 1057 IQMGKRPRLTDELEAL 1072
I + + AL
Sbjct: 329 I-FRSCKNIPQPVRAL 343
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 33/212 (15%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E++++ L H +V + L D + MEY +GG ++ Y+ +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPND--------LPLLAMEYCEGGDLRKYLNQFE 113
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ + D+++AL LH I+HRD+K ENI++ + + K+ D
Sbjct: 114 NCCG--LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG----PQRLIHKIID 167
Query: 975 F--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
+ + GT +++APE+L Y + VD WS+G
Sbjct: 168 LGYAKELDQGELCTEFV-------------GTLQYLAPELLEQ----KKYTVTVDYWSFG 210
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1064
L E +T P++ + K
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 58/234 (24%), Positives = 83/234 (35%), Gaps = 52/234 (22%)
Query: 896 IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDI 950
I ME + K Y S E+ + I AL L I+HRDI
Sbjct: 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGK-----ITLATVKALNHLKENLKIIHRDI 152
Query: 951 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1010
K NIL+D G +KLCDF + L IA G +MAP
Sbjct: 153 KPSNILLD-----RSGN--IKLCDFGISGQL-----VDSIAKT------RDAGCRPYMAP 194
Query: 1011 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDEL 1069
E + Y + D+WS G L EL T + PY S + + G P+L++
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254
Query: 1070 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
E S P +F+ C ++ ++RP +L +
Sbjct: 255 EREFS---------------PSFI----NFV----NLCLTKDESKRPKYKELLK 285
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 51/236 (21%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 829 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 888
A ++ + + + + + E+ +L L H CI+++ + +
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 213
Query: 889 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 214 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263
Query: 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 1006
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 264 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 306
Query: 1007 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 1061
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 307 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 57/302 (18%), Positives = 113/302 (37%), Gaps = 72/302 (23%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ LK ++ +I F L E + H + ++ G +S + L
Sbjct: 56 VKMLKADIIASSDIEEF----LREAACMKEFDHPHVAKLVG--VSL------RSRAKGRL 103
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKH-VSVKLALFIAQDVAAALVELHSKHIMHRDI 950
+ + ++K G + ++ + ++ + D+A + L S++ +HRD+
Sbjct: 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDL 163
Query: 951 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGT----P 1005
+ N ++ + V + DF + R I + D G P
Sbjct: 164 AARNCMLAEDM-------TVCVADFGLS--------------RKIYSGDYYRQGCASKLP 202
Query: 1006 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1063
+W+A E L NLY + D+W++G + E++T Q PY G+ EI++ + G R
Sbjct: 203 VKWLALESLAD----NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR- 257
Query: 1064 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
++P E + + D+ +C +P +RP+ L
Sbjct: 258 -----------------------LKQPP---ECMEEVYDLMYQCWSADPKQRPSFTCLRM 291
Query: 1124 MF 1125
Sbjct: 292 EL 293
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 49/191 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 912
EV++ L+H I+E+Y + + ++ +E G + Y++
Sbjct: 61 EVKIHCQLKHPSILELYNY-FEDS---------------NYVYLVLEMCHNGEMNRYLKN 104
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
K S A + ++ LHS I+HRD+ N+L+ +K+
Sbjct: 105 RV----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-------IKI 153
Query: 973 CDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029
DF A L+ +T C GTP +++PE+ + +GLE D+W
Sbjct: 154 ADFGLATQLKMPHEKHYTLC-------------GTPNYISPEIATR----SAHGLESDVW 196
Query: 1030 SYGCLLLELLT 1040
S GC+ LL
Sbjct: 197 SLGCMFYTLLI 207
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 73/302 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+T+K+ SS EI F L E + H ++ + G + + P
Sbjct: 67 VKTMKLDNSSQREIEEF----LSEAACMKDFSHPNVIRLLG--VCIEMSSQGIPKP---- 116
Query: 892 LQSAIFMEYVKGGSVKNYI-EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 950
+ + ++K G + Y+ ETG KH+ ++ L D+A + L +++ +HRD+
Sbjct: 117 ---MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173
Query: 951 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV-CVGTP---- 1005
+ N ++ + V + DF + + I + D G
Sbjct: 174 AARNCMLRDDM-------TVCVADFGLS--------------KKIYSGDYYRQGRIAKMP 212
Query: 1006 -RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRP 1063
+W+A E L +Y + D+W++G + E+ T PY G+ E++D + G R
Sbjct: 213 VKWIAIESLAD----RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR- 267
Query: 1064 RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
++PE + L L ++ C +P +RPT L
Sbjct: 268 -----------------------LKQPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRL 301
Query: 1124 MF 1125
Sbjct: 302 QL 303
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 8e-26
Identities = 33/236 (13%), Positives = 73/236 (30%), Gaps = 40/236 (16%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNP---------EHHLLQSAIFMEYVKGGS 905
+R+L +++ +++ I L + S F+ +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 906 VKNYIEKLSETGEKH--VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963
++ + E L H + L + V L LH ++H ++ +I++D
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD----- 240
Query: 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL-------RAM 1016
G V L F+ V + + + + + PE+
Sbjct: 241 QRGG--VFLTGFEHLVRDGARVVSS--------------VSRGFEPPELEARRATISYHR 284
Query: 1017 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL 1072
+ L D W+ G ++ + +P + L + I + + AL
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI-FRSCKNIPQPVRAL 339
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 912
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 65 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 108
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 109 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 156
Query: 973 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029
DF + C GTP ++APEVL + EVD+W
Sbjct: 157 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 199
Query: 1030 SYGCLLLELLT 1040
S GC++ LL
Sbjct: 200 SIGCIMYTLLV 210
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 59/233 (25%), Positives = 93/233 (39%), Gaps = 54/233 (23%)
Query: 896 IFMEYVKGGSVKNYIEKLSETG---EKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIK 951
I ME + K Y + + + E + IA + AL LHSK ++HRD+K
Sbjct: 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGK-----IAVSIVKALEHLHSKLSVIHRDVK 137
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
N+LI+ A G+ VK+CDF + L + A D+ G +MAPE
Sbjct: 138 PSNVLIN-----ALGQ--VKMCDFGISGYLVDDV-----------AKDIDAGCKPYMAPE 179
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELE 1070
+ Y ++ DIWS G ++EL L+ PY + + + P+L +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD-- 237
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
F E + F +C ++N ERPT +L +
Sbjct: 238 ---------------KFSA-----EFVDFT----SQCLKKNSKERPTYPELMQ 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 47/241 (19%), Positives = 88/241 (36%), Gaps = 54/241 (22%)
Query: 896 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953
I +E ++++ +E +S+ K + + + +A+ + LHS I+HRD+K +
Sbjct: 86 IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 954 NILIDLERKKADGKPV------VKLCDF-------DRAVPLRSFLHTCCIAHRGIPAPDV 1000
NIL+ + + + + DF R+ L+
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS----------- 193
Query: 1001 CVGTPRWMAPEVLRAMHKPNL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI 1057
GT W APE+L + +DI+S GC+ +L+ G + I
Sbjct: 194 --GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-DKYSRESNI 250
Query: 1058 QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117
G L+ + H+ + EA D+ + + +P +RPT
Sbjct: 251 IRGIF-----SLDEMKCLHDRSLI--------AEAT--------DLISQMIDHDPLKRPT 289
Query: 1118 A 1118
A
Sbjct: 290 A 290
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 50/191 (26%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 912
E+ + +L H +V +G +F +E + S+ ++
Sbjct: 91 EISIHRSLAHQHVVGFHGF-FEDN---------------DFVFVVLELCRRRSLLELHKR 134
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
K ++ A + + + LH ++HRD+K N+ ++ D + VK+
Sbjct: 135 -----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-----EDLE--VKI 182
Query: 973 CDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029
DF + C GTP ++APEVL + EVD+W
Sbjct: 183 GDFGLATKVEYDGERKKVLC-------------GTPNYIAPEVLSK----KGHSFEVDVW 225
Query: 1030 SYGCLLLELLT 1040
S GC++ LL
Sbjct: 226 SIGCIMYTLLV 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 54/231 (23%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSEN 954
I ME + + K E+ + + + AL L KH ++HRD+K N
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGK-----MTVAIVKALYYLKEKHGVIHRDVKPSN 155
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
IL+D G+ +KLCDF + L A D G +MAPE +
Sbjct: 156 ILLD-----ERGQ--IKLCDFGISGRLVDDK-----------AKDRSAGCAAYMAPERID 197
Query: 1015 AMHKPNL-YGLEVDIWSYGCLLLELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEAL 1072
Y + D+WS G L+EL T Q PY ++ E+ + + P L
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH---- 253
Query: 1073 GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
GF + C ++ +RP L E
Sbjct: 254 ------------MGFSGD---------FQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-25
Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 33/222 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGF 131
L+++ N L +P L+ L N++ P+ L L +++S P
Sbjct: 126 LWIFGNQLTSLPVLPP---GLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLP----- 177
Query: 132 ALNKLKGLKELELSK-----VPPRPSVLTLLSEI--------AGLKCLTKLSVCHFSIRY 178
GL+EL +S +P PS L L A L +L V +
Sbjct: 178 --MLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS 235
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENL 238
LP L++L +S N++ LP L+SL V N+L LP L L +
Sbjct: 236 LPVLPS---ELKELMVSGNRLTSLPMLPS---GLLSLSVYRNQLTRLPESLIHLSSETTV 289
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+L N L+ L + + + ++ + +
Sbjct: 290 NLEGNPLS---ERTLQALREITSAPGYSGPIIRFDMAGASAP 328
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-24
Identities = 50/218 (22%), Positives = 79/218 (36%), Gaps = 34/218 (15%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-P 126
N L + ++ L +P + + L N + P+ L LE +++S P
Sbjct: 40 NGNAVLNVGESGLTTLPDCLPA--HITTLVIPDNNLTSLPALPPELRTLEVSGNQLTSLP 97
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL 186
L L LT L + L KL + + LP
Sbjct: 98 V----LPPGLLELSIFSNP--------LTHLPAL--PSGLCKLWIFGNQLTSLPVLPP-- 141
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L++L +S N++ LP L L NN+L LP L L+ L +S+N+L
Sbjct: 142 -GLQELSVSDNQLASLPALPSELC---KLWAYNNQLTSLPM---LPSGLQELSVSDNQLA 194
Query: 247 SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
SL + L L L N+L +P+ L+
Sbjct: 195 SLPT----LPSELYKLWAYNNRL---TSLPALP-SGLK 224
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-20
Identities = 37/198 (18%), Positives = 64/198 (32%), Gaps = 26/198 (13%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGF 131
L+ Y N L +P L+ L N++ P+ L L +++S P
Sbjct: 166 LWAYNNQLTSLPMLPS---GLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLP----- 217
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
GLKEL +S LT L L +L V + LP L
Sbjct: 218 --ALPSGLKELIVSGNR-----LTSLPV--LPSELKELMVSGNRLTSLPMLPS---GLLS 265
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
L + N++ LP + +L + ++ + N L E + + + + +
Sbjct: 266 LSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQAL--REITSAPGYSGPIIRFDMA 323
Query: 252 D---LCLMHNLQNLNLQY 266
L +
Sbjct: 324 GASAPRETRALHLAAADW 341
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 1e-17
Identities = 38/145 (26%), Positives = 56/145 (38%), Gaps = 22/145 (15%)
Query: 136 LKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLS 195
G L + + S LT L + +T L + ++ LP L L++S
Sbjct: 39 NNGNAVLNVGE-----SGLTTLPD-CLPAHITTLVIPDNNLTSLPALPP---ELRTLEVS 89
Query: 196 FNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255
N++ LP L L L LPSG L L + N+LTSL L
Sbjct: 90 GNQLTSLPVLPPGLLELSIFSNPLTHLPALPSG------LCKLWIFGNQLTSLPV----L 139
Query: 256 MHNLQNLNLQYNKLLSYCQVPSWIC 280
LQ L++ N+L S +P+
Sbjct: 140 PPGLQELSVSDNQLAS---LPALPS 161
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 6/65 (9%)
Query: 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
C L V + L LP L + L + +N LTSL + L L+ L +
Sbjct: 35 RACLNNGNAVLNVGESGLTTLPDC--LPAHITTLVIPDNNLTSLPA----LPPELRTLEV 88
Query: 265 QYNKL 269
N+L
Sbjct: 89 SGNQL 93
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 43/200 (21%), Positives = 78/200 (39%), Gaps = 16/200 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGVN 129
L L N + L L +++ + NL L L + +I
Sbjct: 137 LNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVT-PIANLTDLYSLSLNYNQIEDIS-- 193
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNL 189
L L L + +T ++ +A + L L + + I L P + LS L
Sbjct: 194 --PLASLTSLHYFTAYV-----NQITDITPVANMTRLNSLKIGNNKITDLSP-LANLSQL 245
Query: 190 EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
L++ N++ + + L L L V +N++ ++ L L +L +L L+NN+L +
Sbjct: 246 TWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDISV-LNNLSQLNSLFLNNNQLGNED 303
Query: 250 SLDLCLMHNLQNLNLQYNKL 269
+ + NL L L N +
Sbjct: 304 MEVIGGLTNLTTLFLSQNHI 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 37/207 (17%), Positives = 78/207 (37%), Gaps = 24/207 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISS 125
L K + + + E + L G ++ + L LE L + +I+
Sbjct: 23 EGIRAVLQKASVTDVV-TQEELESITKLVVAGEKVASIQ-GIEYLTNLEYLNLNGNQITD 80
Query: 126 PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS---IRYLPPE 182
L+ L L L + +++I+ L+ LT L + + I + P
Sbjct: 81 IS----PLSNLVKLTNLYIGT--------NKITDISALQNLTNLRELYLNEDNISDISP- 127
Query: 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242
+ L+ + L+L N + + + L L V +K+ ++ + L L +L L+
Sbjct: 128 LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVT-PIANLTDLYSLSLNY 186
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N++ + L + +L N++
Sbjct: 187 NQIEDISPLA--SLTSLHYFTAYVNQI 211
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-22
Identities = 39/203 (19%), Positives = 79/203 (38%), Gaps = 19/203 (9%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
L + ++ + + + L +L N+I S + +L L +I+
Sbjct: 158 NYLTVTESKVKDVT-PIANLTDLYSLSLNYNQIE-DISPLASLTSLHYFTAYVNQITDIT 215
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
+ + L L++ + +T LS +A L LT L + I + + L+
Sbjct: 216 ----PVANMTRLNSLKIGN-----NKITDLSPLANLSQLTWLEIGTNQISDINA-VKDLT 265
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLT 246
L+ L++ N++ + + L L SL + NN+L + L L L LS N +T
Sbjct: 266 KLKMLNVGSNQISDIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 247 SLGSLDLCLMHNLQNLNLQYNKL 269
+ L + + + + +
Sbjct: 325 DIRPLA--SLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 5e-20
Identities = 35/141 (24%), Positives = 63/141 (44%), Gaps = 10/141 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L L K + +T + L+ +TKL V + + I L+NLE
Sbjct: 16 FPDADLAEGIRAVLQK-----ASVTDVVTQEELESITKLVVAGEKVASIQG-IEYLTNLE 69
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L+L+ N++ + + L L +L + NK+ ++ + L L L L L+ + ++ +
Sbjct: 70 YLNLNGNQITDIS-PLSNLVKLTNLYIGTNKITDISA-LQNLTNLRELYLNEDNISDISP 127
Query: 251 LDLCLMHNLQNLNLQYNKLLS 271
L + + +LNL N LS
Sbjct: 128 LAN--LTKMYSLNLGANHNLS 146
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 2e-16
Identities = 39/180 (21%), Positives = 70/180 (38%), Gaps = 21/180 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L L N + I + L + N+I V N+ L L +I SP
Sbjct: 182 LSLNYNQIEDIS-PLASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP- 238
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L L L LE+ + ++ ++ + L L L+V I + + LS
Sbjct: 239 -----LANLSQLTWLEIGT-----NQISDINAVKDLTKLKMLNVGSNQISDISV-LNNLS 287
Query: 188 NLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
L L L+ N++ I L L +L ++ N + ++ L L ++++ D +N +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVIK 346
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 61/235 (25%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ MEY++G ++ YIE +SV A+ + + H I+HRDIK +NI
Sbjct: 88 LVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142
Query: 956 LIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013
LID ++ +K+ DF +A+ + + + +GT ++ +PE
Sbjct: 143 LID-----SNKT--LKIFDFGIAKAL-----------SETSLTQTNHVLGTVQYFSPEQA 184
Query: 1014 RAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDEL 1069
+ G DI+S G +L E+L + P+ G + + I I+ + D +
Sbjct: 185 K--------GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIK-----HIQDSV 229
Query: 1070 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 1123
+ + ++ QS L +V R TE++ R T ++ +
Sbjct: 230 PNVTTDVRKDIPQS----------------LSNVILRATEKDKANRYKTIQEMKD 268
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 829 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 888
A K+ + + + + + E+ +L L H CI+++ + +
Sbjct: 39 AIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA----------ED 88
Query: 889 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948
++++ +E ++GG + + + G K + + A+ LH I+HR
Sbjct: 89 YYIV-----LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 138
Query: 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPR 1006
D+K EN+L+ + + +K+ DF + L S + T C GTP
Sbjct: 139 DLKPENVLLSSQEEDCL----IKITDFGHSKILGETSLMRTLC-------------GTPT 181
Query: 1007 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLSELEIHDLIQMGK 1061
++APEVL ++ Y VD WS G +L L+ P +++ + D I GK
Sbjct: 182 YLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 41/203 (20%), Positives = 74/203 (36%), Gaps = 15/203 (7%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGVN 129
L L N + + + L N I+ G G + + + KI+ +
Sbjct: 85 LDLNNNYVQELLVG----PSIETLHAANNNISRVSCSRGQ--GKKNIYLANNKITM--LR 136
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNL 189
++ L+L + A L L++ + I + ++ + L
Sbjct: 137 DLDEGCRSRVQYLDLKL--NEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKL 193
Query: 190 EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
+ LDLS NK+ ++ E + + + NNKLV + L Q LE+ DL N
Sbjct: 194 KTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT 253
Query: 250 SLDLCLMHN-LQNLNLQYNKLLS 271
D + +Q + Q K L+
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLT 276
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 9/116 (7%)
Query: 157 LSEIAG-LKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTE-ICYLKALI 213
+ EI V S++ + N+++LDLS N + + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +++N L E L L L LDL+NN + L +++ L+ N +
Sbjct: 62 LLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG-----PSIETLHAANNNI 111
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 51/296 (17%), Positives = 97/296 (32%), Gaps = 72/296 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++ L + +F M+ L H +V YG + +
Sbjct: 45 LKVLDKA--HRNYSESF----FEAASMMSKLSHKHLVLNYG--VCVCGDENI-------- 88
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ E+VK GS+ Y++K + +++ L +A+ +AAA+ L ++H ++
Sbjct: 89 ----LVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVC 140
Query: 952 SENILIDLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1010
++NIL+ E + G P +KL D + + D+ W+ P
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGIS--------------ITVLPKDILQERIPWVPP 186
Query: 1011 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1069
E + P L D WS+G L E+ + P L + + L
Sbjct: 187 E---CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ------L 237
Query: 1070 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
A + ++ C + P RP+ +
Sbjct: 238 PAPKAAELA-----------------------NLINNCMDYEPDHRPSFRAIIRDL 270
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEY GG + + K + + ++A F ++ A+ +H +HRDIK +NIL+
Sbjct: 140 MEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM- 1016
D G ++L DF + LR+ V VGTP +++PE+L+A+
Sbjct: 196 D-----RCGH--IRLADFGSCLKLRADGTVRS---------LVAVGTPDYLSPEILQAVG 239
Query: 1017 --HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1063
YG E D W+ G E+ Q P+ S E + I K
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 44/215 (20%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 908
E ++ +V++ + Q + MEY+ GG
Sbjct: 117 WEERDIMAFANSPWVVQL------------------FYAFQDDRYLYMVMEYMPGG---- 154
Query: 909 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968
+ ++ V K A F +V AL +HS +HRD+K +N+L+D G
Sbjct: 155 --DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----KSGH- 206
Query: 969 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028
+KL DF + + C D VGTP +++PEVL++ YG E D
Sbjct: 207 -LKLADFGTCMKMNKEGMVRC---------DTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1063
WS G L E+L P+ S + + I K
Sbjct: 257 WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-24
Identities = 53/275 (19%), Positives = 88/275 (32%), Gaps = 88/275 (32%)
Query: 855 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
E + L + H IV+++ G+P + I MEYV G S+K +
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEH------TDRHGDPVGY-----IVMEYVGGQSLKRSKGQ 177
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ V A+ ++ AL LHS +++ D+K ENI++ E+ +KL
Sbjct: 178 -------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ--------LKL 222
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV---DIW 1029
D I + GTP + APE++R DI+
Sbjct: 223 IDLG-------------AV-SRINSFGYLYGTPGFQAPEIVR--------TGPTVATDIY 260
Query: 1030 SYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK 1089
+ G L L G + + + D L
Sbjct: 261 TVGRTLAALTLDLPTRNGRYVDGLPEDDP---VLKTYDSYGRL----------------- 300
Query: 1090 PEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 1123
RR + +P +R TA ++
Sbjct: 301 --------------LRRAIDPDPRQRFTTAEEMSA 321
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 56/255 (21%), Positives = 92/255 (36%), Gaps = 39/255 (15%)
Query: 829 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG--------------- 872
A K+ K+ + ++ + EVR++ L H I +Y
Sbjct: 55 AIKIMNKNKIRQINPKDVERIK----TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
Query: 873 ------HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA 926
K++ S + ++ I E+ + KL
Sbjct: 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170
Query: 927 LFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 986
I + + +AL LH++ I HRDIK EN L + +KL DF + +
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFS-----TNKSFEIKLVDFGLSKEFYKLNN 225
Query: 987 TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM 1046
GTP ++APEVL ++ YG + D WS G LL LL VP+
Sbjct: 226 GEYYGMTTK------AGTPYFVAPEVLNTTNES--YGPKCDAWSAGVLLHLLLMGAVPFP 277
Query: 1047 GLSELEIHDLIQMGK 1061
G+++ + + K
Sbjct: 278 GVNDADTISQVLNKK 292
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 42/234 (17%), Positives = 83/234 (35%), Gaps = 30/234 (12%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-P 126
N L L + L+ +P ++ ++ L+ N + P +L L+ ++S+ P
Sbjct: 59 NQFSELQLNRLNLSSLPDNLPP--QITVLEITQNALISLPELPASLEYLDACDNRLSTLP 116
Query: 127 GVNGFALNKLKGLKELELS-----KVPPRPSVLTLLS-------EI-AGLKCLTKLSVCH 173
LK L++ +P P++L ++ + L LSV +
Sbjct: 117 -------ELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLPELPTSLEVLSVRN 169
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL----ISLKVANNKLVELPSGL 229
+ +LP +LE LD+S N ++ LP I + N++ +P +
Sbjct: 170 NQLTFLPELPE---SLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRITHIPENI 226
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L + L +N L+S L + + + + L
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPL 280
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 5e-20
Identities = 33/208 (15%), Positives = 63/208 (30%), Gaps = 24/208 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISS-PG 127
S+E L N L+ +P+ L++L N++ + P L + +++ P
Sbjct: 101 SLEYLDACDNRLSTLPELPA---SLKHLDVDNNQLTMLPELPALLEYINADNNQLTMLP- 156
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L+ L + LT L E + L L V + LP
Sbjct: 157 ------ELPTSLEVLSVRNNQ-----LTFLPE--LPESLEALDVSTNLLESLPAVPVRNH 203
Query: 188 NLEQ----LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ E+ N++ ++P I L ++ + +N L L + +
Sbjct: 204 HSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIR--ESLSQQTAQPDYHG 261
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
D + L
Sbjct: 262 PRIYFSMSDGQQNTLHRPLADAVTAWFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 1e-18
Identities = 36/153 (23%), Positives = 65/153 (42%), Gaps = 21/153 (13%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
A +K + + R ++LL E + ++L + ++ LP + +
Sbjct: 32 AWDKWEKQALPGEN----RNEAVSLLKECL-INQFSELQLNRLNLSSLPDNLP--PQITV 84
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
L+++ N + LP L+ L +N+L LP L L++LD+ NN+LT L
Sbjct: 85 LEITQNALISLPELPASLE---YLDACDNRLSTLPE---LPASLKHLDVDNNQLTMLPE- 137
Query: 252 DLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L L+ +N N+L +P +LE
Sbjct: 138 ---LPALLEYINADNNQL---TMLPELP-TSLE 163
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 7e-06
Identities = 18/96 (18%), Positives = 32/96 (33%), Gaps = 10/96 (10%)
Query: 192 LDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGL--YLLQRLENLDLSNNRLTSL 248
+ +N + + + E S L L+ + L L+ L+SL
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSSL 74
Query: 249 GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L + L + N L+S +P +LE
Sbjct: 75 PD---NLPPQITVLEITQNALIS---LPELP-ASLE 103
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 66/297 (22%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ +K S DE F E + + L H +V+ YG + SK P +
Sbjct: 37 VKMIKEGSMSEDE---F----FQEAQTMMKLSHPKLVKFYG--VCSK------EYPIY-- 79
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY+ G + NY+ K + L + DV + L S +HRD+
Sbjct: 80 ----IVTEYISNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ N L+D + VK+ DF R L ++ G P +W A
Sbjct: 132 ARNCLVDRDL-------CVKVSDFGMT---RYVLDDQYVSSVGTKFPV--------KWSA 173
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PEV Y + D+W++G L+ E+ +L ++PY + E+ + G R
Sbjct: 174 PEVFHY----FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------ 223
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L + + + C E P +RPT L
Sbjct: 224 LYRPHLA--------------SDT-------IYQIMYSCWHELPEKRPTFQQLLSSI 259
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 49/188 (26%), Positives = 75/188 (39%), Gaps = 41/188 (21%)
Query: 896 IFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953
+ E V G V LSE A F QD+ + LH + I+HRDIK
Sbjct: 115 MVFELVNQGPVMEVPTLKPLSE--------DQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 954 NILIDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1010
N+L+ DG +K+ DF + + L GTP +MAP
Sbjct: 167 NLLVG-----EDG--HIKIADFGVSNEFKGSDALLSNTV-------------GTPAFMAP 206
Query: 1011 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK-----RPR 1064
E L K + G +D+W+ G L + Q P+M + +H I+ +P
Sbjct: 207 ESLSETRKI--FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPD 264
Query: 1065 LTDELEAL 1072
+ ++L+ L
Sbjct: 265 IAEDLKDL 272
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 76/297 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++T K +S F L E + H IV++ G + ++ NP
Sbjct: 48 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIG--VITE-------NP---- 89
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 90 --VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 143
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 144 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 185
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 186 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 235
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L +C P L + +C +P+ RP +L
Sbjct: 236 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 271
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 33/222 (14%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGV 128
L + N L I + L+NL+ N + + L + +S+
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLST--- 200
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSV-----------LTLLSEIAGLKCLTKLSVC 172
L ++EL+ S V +V LT + + L ++ +
Sbjct: 201 ----LAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLS 256
Query: 173 HFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + + + LE+L +S N++ L + L L +++N L+ +
Sbjct: 257 YNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQ 316
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273
RLENL L +N + +L L H L+NL L +N
Sbjct: 317 FDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNS 355
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 38/176 (21%), Positives = 66/176 (37%), Gaps = 11/176 (6%)
Query: 102 EINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE- 159
E S + + I + + V GF L K + S + L
Sbjct: 9 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN-----STMRKLPAA 63
Query: 160 -IAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLK 216
+ + + L++ I + +++L + FN ++YLP + + L L
Sbjct: 64 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123
Query: 217 VANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ N L LP G++ +L L +SNN L + +LQNL L N+L
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 24/189 (12%)
Query: 95 NLKFFGNEINLFPSEVG------NLLGLECLQI---KISSPGVNGFALNKLKGLKELELS 145
+ F+ I++ +V L + + + + L+ + ++ L L+
Sbjct: 20 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK--LPAALLDSFRQVELLNLN 77
Query: 146 KVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYL 202
+ + A + KL + +IRYLPP + + L L L N + L
Sbjct: 78 D-----LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 203 PTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
P I L +L ++NN L + + L+NL LS+NRLT +DL L+ +L
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIPSLF 189
Query: 261 NLNLQYNKL 269
+ N+ YN L
Sbjct: 190 HANVSYNLL 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 39/270 (14%)
Query: 855 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 913
EV ML + H ++E+ + +L+ E ++GGS+ ++I K
Sbjct: 60 EVEMLYQCQGHRNVLELIE---------FFEEEDRFYLV-----FEKMRGGSILSHIHK- 104
Query: 914 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 973
+H + A + QDVA+AL LH+K I HRD+K ENIL E VK+C
Sbjct: 105 ----RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL--CEHPNQVSP--VKIC 156
Query: 974 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM-HKPNLYGLEVDIWSYG 1032
DFD ++ I+ + P G+ +MAPEV+ A + ++Y D+WS G
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTP---CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
+L LL+ P++G + E++ +E P+
Sbjct: 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK----------YEFPDK 263
Query: 1093 ELETLSFLV-DVFRRCTEENPTERPTAGDL 1121
+ +S D+ + + +R +A +
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 829 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 35 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 78
Query: 888 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 944
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 79 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 125
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1002
I+HR++K EN+L+ KA G VKL DF A+ + H
Sbjct: 126 IVHRNLKPENLLLA---SKAKGAA-VKLADFGLAIEVNDSEAWHGFA------------- 168
Query: 1003 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 169 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 51/242 (21%)
Query: 829 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGN 886
A K+ SA+E++ + L EV +L + H I+++ + + N
Sbjct: 46 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD---------TYETN 96
Query: 887 PEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSK 943
L+ + +K G + +Y+ LSE K I + + + LH
Sbjct: 97 TFFFLV-----FDLMKKGELFDYLTEKVTLSE--------KETRKIMRALLEVICALHKL 143
Query: 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 1001
+I+HRD+K ENIL+ D +KL DF + L L C
Sbjct: 144 NIVHRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKLREVC------------ 184
Query: 1002 VGTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
GTP ++APE++ N YG EVD+WS G ++ LL P+ ++ + +I
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 1060 GK 1061
G
Sbjct: 244 GN 245
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 51/301 (16%), Positives = 107/301 (35%), Gaps = 83/301 (27%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++ L+ +S + L E ++ ++ + + + G I +
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLG--ICLT-------ST---- 90
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+Q + + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 91 VQ--LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1005
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 1006 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 1064
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 1065 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
L C + + R+C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMRKCWMIDADSRPKFRELIIE 272
Query: 1125 F 1125
F
Sbjct: 273 F 273
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/297 (18%), Positives = 105/297 (35%), Gaps = 77/297 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++T++ S ++ F + E ++ L H +V++YG + + P
Sbjct: 37 IKTIREGAMSEED---F----IEEAEVMMKLSHPKLVQLYG--VCLEQAPIC-------- 79
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ E+++ G + +Y+ + + L + DV + L ++HRD+
Sbjct: 80 ----LVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ N L+ + V+K+ DF R L + G P +W +
Sbjct: 132 ARNCLVGENQ-------VIKVSDFGMT---RFVLDDQYTSSTGTKFPV--------KWAS 173
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PEV + Y + D+WS+G L+ E+ + ++PY S E+ + I G R
Sbjct: 174 PEVFSF----SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------ 223
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L + + C E P +RP L
Sbjct: 224 LYKPRLA--------------STH-------VYQIMNHCWRERPEDRPAFSRLLRQL 259
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 77/297 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V++LK S D F L E ++ L+H +V +Y + ++ P +
Sbjct: 42 VKSLKQGSMSPDA---F----LAEANLMKQLQHQRLVRLYA--VVTQ-------EPIY-- 83
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY++ GS+ ++ L +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDF---LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ NIL+ K+ DF A R A G P +W A
Sbjct: 137 AANILVSDTL-------SCKIADFGLA---RLIEDNEYTAREGAKFPI--------KWTA 178
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE + + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R
Sbjct: 179 PEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------ 228
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+ +C PE L + R C +E P +RPT L +
Sbjct: 229 MVRPDNC--------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 82/300 (27%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+T K + D F + E ++ L H IV++ G I + P
Sbjct: 45 VKTCKK-DCTLDNKEKF----MSEAVIMKNLDHPHIVKLIG--IIEE-------EP---- 86
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ I ME G + +Y+E+ + + V + + + A+ L S + +HRDI
Sbjct: 87 --TWIIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIA 140
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
NIL+ VKL DF + R +P +WM+
Sbjct: 141 VRNILVASPE-------CVKLGDFGLS---RYIEDEDYYKASVTRLPI--------KWMS 182
Query: 1010 PEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1065
PE + + D+W + + E+L+ + P+ L ++ +++ G R
Sbjct: 183 PESI-------NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR--- 232
Query: 1066 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L C P L + RC + +P++RP +L
Sbjct: 233 ---LPKPDLC--------------PPV-------LYTLMTRCWDYDPSDRPRFTELVCSL 268
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 52/237 (21%), Positives = 80/237 (33%), Gaps = 71/237 (29%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ M + G + + + + ++ A+ I + + +AL H+ HRD+K ENI
Sbjct: 111 VDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHR----GIPAPDVCVGTPRWMAPE 1011
L+ AD L DF IA + VGT +MAPE
Sbjct: 166 LVS-----ADDF--AYLVDFG-------------IASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 1012 VLRAMHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1067
DI++ C+L E LT PY G D + +
Sbjct: 206 RFS--------ESHATYRADIYALTCVLYECLTGSPPYQG-------DQLSV-------- 242
Query: 1068 ELEALGSCHEHEVAQSGSGFEKPE--AELETLSFLVDVFRRCTEENPTER-PTAGDL 1121
H ++ S +P + V R +NP +R T GDL
Sbjct: 243 ---MGA--HINQAIPRPSTV-RPGIPVAFD------AVIARGMAKNPEDRYVTCGDL 287
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 56/233 (24%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K NI
Sbjct: 93 IVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 147
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
+I A VK+ DF A + ++ + +GT ++++PE R
Sbjct: 148 MIS-----ATNA--VKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQAR- 192
Query: 1016 MHKPNLYGLEV----DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEA 1071
G V D++S GC+L E+LT + P+ G S + + Q + ++
Sbjct: 193 -------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQ-----HVREDPIP 238
Query: 1072 LGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TAGDLYE 1123
S ++ L V + +NP R TA ++
Sbjct: 239 P-SARHEGLSAD----------------LDAVVLKALAKNPENRYQTAAEMRA 274
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
M+Y GG + + K E + ++A F ++ A+ +H H +HRDIK +NIL+
Sbjct: 153 MDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
D +G ++L DF + L G V VGTP +++PE+L+AM
Sbjct: 209 D-----MNGH--IRLADFGSCLKLME---------DGTVQSSVAVGTPDYISPEILQAME 252
Query: 1018 KPNL-YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1063
YG E D WS G + E+L + P+ S +E + I K
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 66/303 (21%), Positives = 110/303 (36%), Gaps = 77/303 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 65 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 108
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 949
I ME + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 109 F---ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 165
Query: 950 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 1005
I + N L+ G+ V K+ DF A R I
Sbjct: 166 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRASYYRKGGCAML 207
Query: 1006 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1062
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 208 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 1063 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1122
++ +C P + + +C + P +RP +
Sbjct: 264 ------MDPPKNC--------------PGP-------VYRIMTQCWQHQPEDRPNFAIIL 296
Query: 1123 EMF 1125
E
Sbjct: 297 ERI 299
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 77/299 (25%)
Query: 829 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887
A K+ R V SS ++ EV +L L H I+++Y +
Sbjct: 66 AIKIIRKTSVSTSSNSKLLE-------EVAVLKLLDHPNIMKLYDFFEDKR--------- 109
Query: 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947
++L+ ME KGG + + I + A I + V + + LH +I+H
Sbjct: 110 NYYLV-----MECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHNIVH 159
Query: 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1005
RD+K EN+L LE K+ D +K+ DF + + GT
Sbjct: 160 RDLKPENLL--LESKEKDAL--IKIVDFGLSAVFENQKKMKERL-------------GTA 202
Query: 1006 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRL 1065
++APEVLR Y + D+WS G +L LL P+ G ++ EI ++ GK
Sbjct: 203 YYIAPEVLRKK-----YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK---- 253
Query: 1066 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTAGDLYE 1123
+ E + +S D+ ++ + + R +A E
Sbjct: 254 ---------------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 51/236 (21%)
Query: 829 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887
A KV I EV +L L H I++++ + +
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFE---------ILEDSS 94
Query: 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1005
RD+K ENIL++ + K D +K+ DF + + + + GT
Sbjct: 145 RDLKPENILLESKEKDCD----IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 1006 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 68/297 (22%), Positives = 111/297 (37%), Gaps = 77/297 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++ +K S DE F + E +++ L H +V++YG + +K P
Sbjct: 53 IKMIKEGSMSEDE---F----IEEAKVMMNLSHEKLVQLYG--VCTK------QRPIF-- 95
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 96 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ N L++ + VVK+ DF + R L + G P RW
Sbjct: 148 ARNCLVNDQG-------VVKVSDFGLS---RYVLDDEYTSSVGSKFPV--------RWSP 189
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PEVL + + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 190 PEVLMY----SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------ 239
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L E + + C E ERPT L
Sbjct: 240 LYRPHLA--------------SEK-------VYTIMYSCWHEKADERPTFKILLSNI 275
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 43/209 (20%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
L E R+L A+ +V++ + L +++ MEYV GG + +++ +
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNL---------YMV-----MEYVAGGEMFSHLRR 134
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
S A F A + LHS +++RD+K EN+LID G +++
Sbjct: 135 -----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-----QQGY--IQV 182
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF A ++ T C GTP +APE++ + K Y VD W+ G
Sbjct: 183 TDFGFAKRVKGRTWTLC-------------GTPEALAPEII--LSKG--YNKAVDWWALG 225
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
L+ E+ P+ ++I++ I GK
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 77/299 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++TLK G + + +F LGE ++G H I+ + G + SK+ P
Sbjct: 78 IKTLKA-GYTEKQRVDF----LGEAGIMGQFSHHNIIRLEG--VISKYKPMM-------- 122
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 123 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 174
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1010
+ NIL++ V K+ DF + L G IP RW AP
Sbjct: 175 ARNILVNSNL-------VCKVSDFGLSRVLEDDPEATYTTSGGKIPI--------RWTAP 219
Query: 1011 EVLRAMHKPNLYGL---EVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1066
E + Y D+WS+G ++ E++T + PY LS E+ I G R
Sbjct: 220 EAI-------SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---- 268
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L C P A + + +C ++ RP D+ +
Sbjct: 269 --LPTPMDC--------------PSA-------IYQLMMQCWQQERARRPKFADIVSIL 304
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 68/297 (22%), Positives = 129/297 (43%), Gaps = 76/297 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TLK +E F L E ++ ++H +V++ G + ++ P +
Sbjct: 43 VKTLKEDTMEVEE---F----LKEAAVMKEIKHPNLVQLLG--VCTR------EPPFY-- 85
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+
Sbjct: 86 ----IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ N L+ +VK+ DF + R AH G P +W A
Sbjct: 139 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFPI--------KWTA 180
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE L N + ++ D+W++G LL E+ T PY G+ ++++L++ R
Sbjct: 181 PESLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ 230
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+E C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 231 MERPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-23
Identities = 46/218 (21%), Positives = 80/218 (36%), Gaps = 56/218 (25%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF----MEYVKGGSVKN 908
E ++ L H V++Y Q + Y K G +
Sbjct: 78 TRERDVMSRLDHPFFVKLYFT------------------FQDDEKLYFGLSYAKNGELLK 119
Query: 909 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968
YI K F ++ +AL LH K I+HRD+K ENIL++ D
Sbjct: 120 YIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-----EDMH- 168
Query: 969 VVKLCDFDRA-----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1023
+++ DF A ++ ++ GT ++++PE+L K
Sbjct: 169 -IQITDFGTAKVLSPESKQARANSFV-------------GTAQYVSPELLT--EKS--AC 210
Query: 1024 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
D+W+ GC++ +L+ P+ +E I I +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-23
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 51/236 (21%)
Query: 829 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887
A KV I EV +L L H I++++ S
Sbjct: 51 AVKVINKASAKNKDTSTILR-------EVELLKKLDHPNIMKLFEILEDSS--------- 94
Query: 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947
+++ E GG + + I K K S A I + V + + +H +I+H
Sbjct: 95 SFYIV-----GELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTP 1005
RD+K ENIL LE K+ D +K+ DF + + + + GT
Sbjct: 145 RDLKPENIL--LESKEKDCD--IKIIDFGLSTCFQQNTKMKDRI-------------GTA 187
Query: 1006 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
++APEVLR Y + D+WS G +L LL+ P+ G +E +I ++ GK
Sbjct: 188 YYIAPEVLR---GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-23
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++TLK S + L E +++ LRH +V++Y
Sbjct: 213 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 254
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 255 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 307
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 308 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 351
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 352 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 401
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
C PE+ L D+ +C + P ERPT L
Sbjct: 402 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 31/170 (18%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
E +KGG + + I + +K S + A + + + LH++ ++HRD+K NIL
Sbjct: 95 TELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149
Query: 958 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
++ +++CDF A LR L T C T ++APEVL
Sbjct: 150 ---VDESGNPESIRICDFGFAKQLRAENGLLMTPC-------------YTANFVAPEVL- 192
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGK 1061
+ Y DIWS G LL +LT P+ + EI I GK
Sbjct: 193 ---ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 58/267 (21%), Positives = 101/267 (37%), Gaps = 69/267 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ ++ +L H I+ +Y + + +L+ ME GG + +
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNT---------DIYLV-----MELCTGGELFERVVH-- 99
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
++ A I +DV +A+ H ++ HRD+K EN L + + +KL D
Sbjct: 100 ---KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP----LKLID 152
Query: 975 FDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
F A + + T GTP +++P+VL LYG E D WS G
Sbjct: 153 FGLAARFKPGKMMRTKV-------------GTPYYVSPQVLE-----GLYGPECDEWSAG 194
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
++ LL P+ ++ E+ I+ G F PE
Sbjct: 195 VMMYVLLCGYPPFSAPTDSEVMLKIREGT-------------------------FTFPEK 229
Query: 1093 ELETLSFLV-DVFRRCTEENPTERPTA 1118
+ +S + RR ++P +R T+
Sbjct: 230 DWLNVSPQAESLIRRLLTKSPKQRITS 256
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 89/313 (28%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V++LK S + I + E+ +L L H IV+ G I ++ GN
Sbjct: 55 VKSLKP-ESGGNHIADL----KKEIEILRNLYHENIVKYKG--ICTE----DGGNG---- 99
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
++ + ME++ GS+K Y+ K + +++K L A + + L S+ +HRD+
Sbjct: 100 IK--LIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1007
+ N+L++ E VK+ DF +A+ +T P W
Sbjct: 154 ARNVLVESEH-------QVKIGDFGLTKAIETDKEYYT---VKDDRDSPV--------FW 195
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 1052
APE L + + + D+WS+G L ELLT + ++
Sbjct: 196 YAPECLMQ----SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 1053 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112
+ + ++ GKR L +C P+ + + R+C E P
Sbjct: 252 LVNTLKEGKR------LPCPPNC--------------PDE-------VYQLMRKCWEFQP 284
Query: 1113 TERPTAGDLYEMF 1125
+ R + +L E F
Sbjct: 285 SNRTSFQNLIEGF 297
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 33/222 (14%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGV 128
L + N L I + L+NL+ N + + L + +S+
Sbjct: 152 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLST--- 206
Query: 129 NGFALNKLKGLKELELS-----KVPPRPSV-----------LTLLSEIAGLKCLTKLSVC 172
L ++EL+ S V +V LT + + L ++ +
Sbjct: 207 ----LAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLS 262
Query: 173 HFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + + + LE+L +S N++ L + L L +++N L+ +
Sbjct: 263 YNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQ 322
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273
RLENL L +N + +L L H L+NL L +N
Sbjct: 323 FDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNS 361
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 38/176 (21%), Positives = 66/176 (37%), Gaps = 11/176 (6%)
Query: 102 EINLFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVPPRPSVLTLLSE- 159
E S + + I + + V GF L K + S + L
Sbjct: 15 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN-----STMRKLPAA 69
Query: 160 -IAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLK 216
+ + + L++ I + +++L + FN ++YLP + + L L
Sbjct: 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129
Query: 217 VANNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ N L LP G++ +L L +SNN L + +LQNL L N+L
Sbjct: 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 71/296 (23%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++ LK G + + R+F L E ++G H I+ + G + ++ G
Sbjct: 82 IKALKA-GYTERQRRDF----LSEASIMGQFDHPNIIRLEG--VVTR------GRLAM-- 126
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY++ GS+ ++ + ++ + + + V A + L +HRD+
Sbjct: 127 ----IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1010
+ N+L+D V K+ DF + L G IP RW AP
Sbjct: 179 ARNVLVDSNL-------VCKVSDFGLSRVLEDDPDAAYTTTGGKIPI--------RWTAP 223
Query: 1011 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1069
E + A + D+WS+G ++ E+L + PY ++ ++ ++ G R L
Sbjct: 224 EAI-AFRT---FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR------L 273
Query: 1070 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
A C P A L + C ++ +RP + +
Sbjct: 274 PAPMGC--------------PHA-------LHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 66/295 (22%), Positives = 127/295 (43%), Gaps = 72/295 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TLK +E L E ++ ++H +V++ G + ++ E
Sbjct: 250 VKTLKEDTMEVEEF-------LKEAAVMKEIKHPNLVQLLG--VCTR---------EPPF 291
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HR++
Sbjct: 292 Y---IITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+ N L+ +VK+ DF + R AH G P +W APE
Sbjct: 346 ARNCLVGENH-------LVKVADFGLS---RLMTGDTYTAHAGAKFP------IKWTAPE 389
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
L N + ++ D+W++G LL E+ T PY G+ ++++L++ R +E
Sbjct: 390 SLAY----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------ME 439
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
C PE + ++ R C + NP++RP+ ++++ F
Sbjct: 440 RPEGC--------------PEK-------VYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 39/209 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ +L +L H I++++ +++ ME +GG + I
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYH---------NMYIV-----METCEGGELLERIVSAQ 115
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
G K +S + + + AL HS+H++H+D+K ENIL + +K+ D
Sbjct: 116 ARG-KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL--FQDTSPHSP--IKIID 170
Query: 975 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
F A +S GT +MAPEV + + DIWS G
Sbjct: 171 FGLAELFKSDEHSTNAA-------------GTALYMAPEVFK-----RDVTFKCDIWSAG 212
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
++ LLT +P+ G S E+ +
Sbjct: 213 VVMYFLLTGCLPFTGTSLEEVQQKATYKE 241
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 50/213 (23%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA----IFMEYVKGGSVKN 908
E++++ L H +V ++ Q + ++ + GG ++
Sbjct: 63 FKELQIMQGLEHPFLVNLWYS------------------FQDEEDMFMVVDLLLGGDLRY 104
Query: 909 YIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968
++++ E+ V LFI + + AL L ++ I+HRD+K +NIL+D G
Sbjct: 105 HLQQNVHFKEETV----KLFICE-LVMALDYLQNQRIIHRDMKPDNILLD-----EHGH- 153
Query: 969 VVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1026
V + DF+ A +P + + T GT +MAPE+ K Y V
Sbjct: 154 -VHITDFNIAAMLPRETQITTMA-------------GTKPYMAPEMFS-SRKGAGYSFAV 198
Query: 1027 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
D WS G ELL + PY S +++
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 91/314 (28%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 44 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 87
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 88 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1007
+ NIL++ E VK+ DF + +P P W
Sbjct: 142 TRNILVENEN-------RVKIGDFGLTKVLPQDKEFFK---VKEPGESPI--------FW 183
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 1051
APE L + + + D+WS+G +L EL T +
Sbjct: 184 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 1052 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111
+ +L++ R L C P+ + + C N
Sbjct: 240 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 272
Query: 1112 PTERPTAGDLYEMF 1125
+RP+ DL
Sbjct: 273 VNQRPSFRDLALRV 286
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 829 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887
AAK+ T K+ ++ E R+ L+H IV ++ S
Sbjct: 58 AAKIINTKKLSARDFQKLER-------EARICRKLQHPNIVRLHD---------SIQEES 101
Query: 888 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 944
H+L+ + V GG + I E SE A Q + ++ HS
Sbjct: 102 FHYLV-----FDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 148
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1002
I+HR++K EN+L+ + K A VKL DF A+ + H
Sbjct: 149 IVHRNLKPENLLLASKAKGAA----VKLADFGLAIEVNDSEAWHGFA------------- 191
Query: 1003 GTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
GTP +++PEVL+ + Y VDIW+ G +L LL P+ + ++ I+ G
Sbjct: 192 GTPGYLSPEVLKK----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 246
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 59/297 (19%), Positives = 107/297 (36%), Gaps = 71/297 (23%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
+++L + ++ F L E ++ L H ++ + G I
Sbjct: 54 IKSLSR-ITEMQQVEAF----LREGLLMRGLNHPNVLALIG--IMLPPEGLP-------- 98
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ + Y+ G + +I +++ +VK + VA + L + +HRD+
Sbjct: 99 ---HVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLA 151
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ N ++D VK+ DF A + + HR +P +W A
Sbjct: 152 ARNCMLDESF-------TVKVADFGLARDILDREYYSVQQHRHARLPV--------KWTA 196
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
E L + + + D+WS+G LL ELLT PY + ++ + G+R
Sbjct: 197 LESL----QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR------ 246
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L C P++ L V ++C E +P RPT L
Sbjct: 247 LPQPEYC--------------PDS-------LYQVMQQCWEADPAVRPTFRVLVGEV 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 50/241 (20%)
Query: 829 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGNP 887
A K+ + S +++ + E +L + H I+ + S + +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID---------SYESSS 173
Query: 888 EHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVELHSKH 944
L+ + ++ G + +Y+ LSE K I + + A+ LH+ +
Sbjct: 174 FMFLV-----FDLMRKGELFDYLTEKVALSE--------KETRSIMRSLLEAVSFLHANN 220
Query: 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCV 1002
I+HRD+K ENIL+ D ++L DF + L L C
Sbjct: 221 IVHRDLKPENILL-------DDNMQIRLSDFGFSCHLEPGEKLRELC------------- 260
Query: 1003 GTPRWMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG 1060
GTP ++APE+L+ YG EVD+W+ G +L LL P+ ++ + +I G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 1061 K 1061
+
Sbjct: 321 Q 321
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 43/209 (20%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV++L L H I+++Y + +L+ E GG + + I
Sbjct: 76 EVQLLKQLDHPNIMKLYE---------FFEDKGYFYLV-----GEVYTGGELFDEIIS-- 119
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
K S A I + V + + +H I+HRD+K EN+L++ + K A+ +++ D
Sbjct: 120 ---RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN----IRIID 172
Query: 975 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
F + + + GT ++APEVL Y + D+WS G
Sbjct: 173 FGLSTHFEASKKMKDKI-------------GTAYYIAPEVLH-----GTYDEKCDVWSTG 214
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
+L LL+ P+ G +E +I ++ GK
Sbjct: 215 VILYILLSGCPPFNGANEYDILKKVEKGK 243
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-22
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 43/209 (20%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
E ML + H I+ M+G ++ + ++ M+Y++GG + + + K
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQI---------FMI-----MDYIEGGELFSLLRK 99
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ +A F A +V AL LHSK I++RD+K ENIL+D +G +K+
Sbjct: 100 -----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-----KNGH--IKI 147
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
DF A + +T C GTP ++APEV+ KP Y +D WS+G
Sbjct: 148 TDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS--TKP--YNKSIDWWSFG 190
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
L+ E+L P+ + ++ ++ I +
Sbjct: 191 ILIYEMLAGYTPFYDSNTMKTYEKILNAE 219
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 64/303 (21%), Positives = 108/303 (35%), Gaps = 77/303 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+TL S + +F L E ++ H IV G +S + LP
Sbjct: 106 VKTLPE-VCSEQDELDF----LMEALIISKFNHQNIVRCIG--VSLQSLP---------R 149
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA--LFIAQDVAAALVELHSKHIMHRD 949
I +E + GG +K+++ + + S+ + L +A+D+A L H +HRD
Sbjct: 150 F---ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 206
Query: 950 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP---- 1005
I + N L+ G+ V K+ DF A R I
Sbjct: 207 IAARNCLLT---CPGPGR-VAKIGDFGMA--------------RDIYRAGYYRKGGCAML 248
Query: 1006 --RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1062
+WM PE ++ + D WS+G LL E+ +L +PY S E+ + + G R
Sbjct: 249 PVKWMPPEAF----MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304
Query: 1063 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1122
+ P+ + + +C + P +RP +
Sbjct: 305 ------------------------MDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIIL 337
Query: 1123 EMF 1125
E
Sbjct: 338 ERI 340
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 911
E+ +L ++H IV + S+ ++L M+ V GG + + I
Sbjct: 56 EIAVLKKIKHENIVTLEDIYESTT---------HYYL-----VMQLVSGGELFDRILERG 101
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
+E K A + Q V +A+ LH I+HRD+K EN+L + + K +
Sbjct: 102 VYTE--------KDASLVIQQVLSAVKYLHENGIVHRDLKPENLL--YLTPEENSK--IM 149
Query: 972 LCDFDRAVPLR-SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1030
+ DF + + + T C GTP ++APEVL KP Y VD WS
Sbjct: 150 ITDFGLSKMEQNGIMSTAC-------------GTPGYVAPEVLA--QKP--YSKAVDCWS 192
Query: 1031 YGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
G + LL P+ +E ++ + I+ G
Sbjct: 193 IGVITYILLCGYPPFYEETESKLFEKIKEGY 223
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 56/215 (26%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 910
EVR++ L H IV+++ I ++ ++ MEY GG V +Y+
Sbjct: 64 EVRIMKILNHPNIVKLF-EVIETE---------------KTLYLIMEYASGGEVFDYLVA 107
Query: 911 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 969
++ E K A + + +A+ H K I+HRD+K+EN+L+D +
Sbjct: 108 HGRMKE--------KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN------- 152
Query: 970 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1026
+K+ DF + L C G P + APE+ + Y G EV
Sbjct: 153 IKIADFGFSNEFTVGGKLDAFC-------------GAPPYAAPELFQG----KKYDGPEV 195
Query: 1027 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
D+WS G +L L++ +P+ G + E+ + + GK
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 62/297 (20%), Positives = 113/297 (38%), Gaps = 71/297 (23%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 58 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 102
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 103 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA 155
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMA 1009
+ N ++D + VK+ DF R + + + +P +WMA
Sbjct: 156 ARNCMLDEKF-------TVKVADFGLARDMYDKEYYSVHNKTGAKLPV--------KWMA 200
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 201 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 250
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L C P+ L +V +C RP+ +L
Sbjct: 251 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-22
Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 71/296 (23%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++TLKV G + + R+F LGE ++G H I+ + G + +K P
Sbjct: 78 IKTLKV-GYTEKQRRDF----LGEASIMGQFDHPNIIRLEG--VVTKSKPVM-------- 122
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY++ GS+ +++ K + +V + + + +A+ + L +HRD+
Sbjct: 123 ----IVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 174
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG-IPAPDVCVGTPRWMAP 1010
+ NILI+ V K+ DF L G IP RW +P
Sbjct: 175 ARNILINSNL-------VCKVSDFGLGRVLEDDPEAAYTTRGGKIPI--------RWTSP 219
Query: 1011 EVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDEL 1069
E + + D+WSYG +L E+++ + PY +S ++ + G R L
Sbjct: 220 EAI----AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR------L 269
Query: 1070 EALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
C P A L + C +++ RP + +
Sbjct: 270 PPPMDC--------------PAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 61/314 (19%), Positives = 112/314 (35%), Gaps = 91/314 (28%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ L+ S+ + +R+F E+ +L +L+H IV+ G S+
Sbjct: 75 VKKLQH--STEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRRN---------- 118
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
L+ + MEY+ GS+++Y++K ++ + L + + L +K +HRD+
Sbjct: 119 LK--LIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1007
+ NIL++ E VK+ DF + +P + P W
Sbjct: 173 TRNILVENEN-------RVKIGDFGLTKVLPQDKEYYK---VKEPGESPI--------FW 214
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL----------------QVPYMGLSEL 1051
APE L + + + D+WS+G +L EL T +
Sbjct: 215 YAPESLTE----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 1052 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111
+ +L++ R L C P+ + + C N
Sbjct: 271 HLIELLKNNGR------LPRPDGC--------------PDE-------IYMIMTECWNNN 303
Query: 1112 PTERPTAGDLYEMF 1125
+RP+ DL
Sbjct: 304 VNQRPSFRDLALRV 317
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-22
Identities = 46/221 (20%), Positives = 76/221 (34%), Gaps = 24/221 (10%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GNEINLFPSEVGNLLGLECLQI---K 122
S+ L L +N L+ +L+ N + + L L+ L
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHST 410
Query: 123 ISSPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ A L+ L L++S GL L L + S +
Sbjct: 411 LKRVTEFS-AFLSLEKLLYLDISYTNTKIDFD--------GIFLGLTSLNTLKMAGNSFK 461
Query: 178 YLPPE--IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQ 233
+NL LDLS +++ + + L L L +++N L+ L S Y L
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274
L LD S NR+ + + +L NL N + C+
Sbjct: 522 SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-19
Identities = 46/225 (20%), Positives = 80/225 (35%), Gaps = 33/225 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFP-----------------SEVGNLLG 115
+ L + + + K ++L ++ FP S +
Sbjct: 290 MSLAGVSIKYLEDVPKHF-KWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348
Query: 116 LECLQI------KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169
L L +S G ++ L+ L+LS + + + GL+ L L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS----FNGAIIMSANFMGLEELQHL 404
Query: 170 SVCHFSIRYLPPE--IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVE-- 224
H +++ + L L LD+S+ K I L +L +LK+A N +
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464
Query: 225 LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L + L LDLS +L + +H LQ LN+ +N L
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-16
Identities = 45/246 (18%), Positives = 83/246 (33%), Gaps = 45/246 (18%)
Query: 132 ALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGC 185
+ + L+ L+LS + GL L+ L + I+ P
Sbjct: 51 SFSNFSELQWLDLSRCEIETIED--------KAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 186 LSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKL--VELPSGLYLLQRLENLDLSN 242
L++LE L K+ L + I L L L VA+N + +LP+ L L ++DLS
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 243 NRLTSLGSLDLCLMHNLQN----LNLQYNKL-----------------LSYCQ----VPS 277
N + ++ DL + L++ N + L +
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMK 222
Query: 278 WICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVS---FSGSRHTSSSISTVSSS 334
NL G ++++E ++E +V+ F + S V
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFH 282
Query: 335 NSRSLT 340
+++
Sbjct: 283 CLANVS 288
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-16
Identities = 25/107 (23%), Positives = 46/107 (42%), Gaps = 3/107 (2%)
Query: 166 LTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLV 223
+ + ++ L S L+ LDLS +++ + + + L L +L + N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 224 ELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
G L LENL +L SL S + + L+ LN+ +N +
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-12
Identities = 38/219 (17%), Positives = 73/219 (33%), Gaps = 28/219 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
L L N + + P S L NL ++ S G L+ L+ L + I S
Sbjct: 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK 144
Query: 128 VNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
+ + + L L ++LS + + L L E + L + I ++ +
Sbjct: 145 LPAY-FSNLTNLVHVDLSYNYIQTITV--NDLQFLRENPQV--NLSLDMSLNPIDFIQDQ 199
Query: 183 IGCLSNLEQLDLSFNKM--KYLPTEICYLKALISLKVANNKLVELPS----------GLY 230
L +L L N + T + L L ++ + + + GL
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ E L+ S + + N+ ++L +
Sbjct: 260 DVTIDE-FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-12
Identities = 33/212 (15%), Positives = 67/212 (31%), Gaps = 30/212 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSV-----GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIK 122
++ + L N + I + + +L N I+ + + L L ++
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 123 --ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+S + L L GL L L E + L
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLI-----------LGEFKDERNLEIFEPSIM------ 255
Query: 181 PEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
E C +++ L++ + L + ++ +A + L + ++L
Sbjct: 256 -EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFK-WQSLS 313
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ +L +LDL L++L L NK
Sbjct: 314 IIRCQLKQFPTLDL---PFLKSLTLTMNKGSI 342
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 23/94 (24%), Positives = 40/94 (42%), Gaps = 4/94 (4%)
Query: 179 LPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLEN 237
L P I + N+ K+ +P +I + ++ ++ N L L S L+
Sbjct: 4 LNPCIEVVPNIT-YQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQW 60
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LDLS + ++ +H+L NL L N + S
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-22
Identities = 57/297 (19%), Positives = 102/297 (34%), Gaps = 76/297 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++T K +S F L E + H IV++ G +
Sbjct: 423 IKTCKN-CTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITENPVW----------- 466
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I ME G ++++++ + + + + A ++ AL L SK +HRDI
Sbjct: 467 ----IIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIA 518
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ N+L+ VKL DF + R + +P +WMA
Sbjct: 519 ARNVLVSSND-------CVKLGDFGLS---RYMEDSTYYKASKGKLPI--------KWMA 560
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE + + D+W +G + E+L P+ G+ ++ I+ G+R
Sbjct: 561 PESINF----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 610
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L +C P L + +C +P+ RP +L
Sbjct: 611 LPMPPNC--------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 646
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-22
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
N++ + N L I + KL ++ N+I + NL L L + +I+
Sbjct: 68 NNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQIT 125
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
L L L LELS ++ +S ++GL L +LS + + L P +
Sbjct: 126 DI----DPLKNLTNLNRLELSSNT-----ISDISALSGLTSLQQLSFGN-QVTDLKP-LA 174
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ LE+LD+S NK+ + + L L SL NN++ ++ L +L L+ L L+ N+
Sbjct: 175 NLTTLERLDISSNKVSDIS-VLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQ 232
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKL 269
L +G+L NL +L+L N++
Sbjct: 233 LKDIGTLASL--TNLTDLDLANNQI 255
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 21/216 (9%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+++ L L N L I ++ L +L N+I+ + L L L++ +IS
Sbjct: 221 TNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQIS 278
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+ L L L LEL++ L +S I+ LK LT L++ +I + P +
Sbjct: 279 NI----SPLAGLTALTNLELNENQ-----LEDISPISNLKNLTYLTLYFNNISDISP-VS 328
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ L++L NK+ + + L + L +N++ +L L L R+ L L++
Sbjct: 329 SLTKLQRLFFYNNKVSDVS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQA 386
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
T+ ++ ++ N L P+ I
Sbjct: 387 WTNA-PVNYKANVSIPNTVKNVTGALI---APATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-19
Identities = 32/181 (17%), Positives = 72/181 (39%), Gaps = 17/181 (9%)
Query: 91 EKLRNLKFFGNEINLFP--SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148
+ + +++ + L+ ++ I S + L L ++ S
Sbjct: 24 AEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSID----GVEYLNNLTQINFSN-- 77
Query: 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICY 208
+ LT ++ + L L + + + I + P + L+NL L L N++ + +
Sbjct: 78 ---NQLTDITPLKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP-LKN 132
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L L L++++N + ++ + L L L+ L N L + L+ L++ NK
Sbjct: 133 LTNLNRLELSSNTISDISA-LSGLTSLQQLSFGNQVTDLKP---LANLTTLERLDISSNK 188
Query: 269 L 269
+
Sbjct: 189 V 189
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-19
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 10/139 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L + L K + +T L +T L I+ + + L+NL
Sbjct: 18 FTDTALAEKMKTVLGK-----TNVTDTVSQTDLDQVTTLQADRLGIKSIDG-VEYLNNLT 71
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
Q++ S N++ + + L L+ + + NN++ ++ L L L L L NN++T +
Sbjct: 72 QINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITDI-- 127
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L + NL L L N +
Sbjct: 128 DPLKNLTNLNRLELSSNTI 146
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-14
Identities = 34/201 (16%), Positives = 66/201 (32%), Gaps = 16/201 (7%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
L L N ++ I + L NL+ N++ + NL L L + IS
Sbjct: 268 TELKLGANQISNIS-PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDIS 325
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
++ L L+ L + ++ +S +A L + LS H I L P + L+
Sbjct: 326 ----PVSSLTKLQRLFFYN-----NKVSDVSSLANLTNINWLSAGHNQISDLTP-LANLT 375
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247
+ QL L+ P ++ + + P+ + D++ N +
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSY 435
Query: 248 LGSLDLCLMHNLQNLNLQYNK 268
+ +
Sbjct: 436 TNEVS-YTFSQPVTIGKGTTT 455
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 29/182 (15%), Positives = 57/182 (31%), Gaps = 14/182 (7%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
++ L L +N L I + + L L + N I+ S V +L L+ L K+S
Sbjct: 287 TALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDI-SPVSSLTKLQRLFFYNNKVS 344
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+L L + L ++ L+ +A L +T+L + + P
Sbjct: 345 DVS----SLANLTNINWLSAGHNQ-----ISDLTPLANLTRITQLGLNDQAWTNAPVNYK 395
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
++ + P I + + N Y + +
Sbjct: 396 ANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTT 455
Query: 245 LT 246
+
Sbjct: 456 FS 457
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-11
Identities = 16/95 (16%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQR 234
I + L+ + L + + L + +L+ + + G+ L
Sbjct: 13 PINQIFT-DTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI-DGVEYLNN 69
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L ++ SNN+LT + L + L ++ + N++
Sbjct: 70 LTQINFSNNQLTDITPLK--NLTKLVDILMNNNQI 102
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 53/240 (22%)
Query: 829 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883
AAK R + EI EV +L + H ++ ++
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIER-------EVSILRQVLHHNVITLHD---------VY 84
Query: 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 943
+ + L+ +E V GG + +++ ++ +S + A + + + LH+K
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVC 1001
I H D+K ENI++ K P +KL DF A +
Sbjct: 135 KIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------------ 179
Query: 1002 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-21
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 73/295 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++TLK S + L E +++ LRH +V++Y
Sbjct: 296 IKTLKPGTMSPEAF-------LQEAQVMKKLRHEKLVQLYAVVSEEPIY----------- 337
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY+ GS+ ++ L K++ + + +A +A+ + + + +HRD++
Sbjct: 338 ----IVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 390
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+ NIL+ V K+ DF A R A +G P +W APE
Sbjct: 391 AANILVGENL-------VCKVADFGLA---RLIEDNEYTARQGAKFP------IKWTAPE 434
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R +
Sbjct: 435 AALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------MP 484
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
C PE+ L D+ +C + P ERPT L
Sbjct: 485 CPPEC--------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-21
Identities = 66/234 (28%), Positives = 95/234 (40%), Gaps = 18/234 (7%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117
IE + + + L L P + + L+ L F N+ SEV +L LE
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPT--LKLKSLKRLTFTSNKGGNAFSEV-DLPSLE 350
Query: 118 CLQI---KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174
L + +S G + LK L+LS V+T+ S GL+ L L H
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS----FNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 175 SIRYLPPEI--GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVE--LPSGL 229
+++ + L NL LD+S + I L +L LK+A N E LP
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L+ L LDLS +L L + +LQ LN+ N+L S VP I L
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS---VPDGIFDRL 517
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-21
Identities = 37/208 (17%), Positives = 70/208 (33%), Gaps = 15/208 (7%)
Query: 69 SVEGLYLYKN--VLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
++E L L+ I + + I N G + L++ +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF-GWQHLEL--VNC 314
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL---PPEI 183
F KLK LK L + + L L L + + +
Sbjct: 315 KFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG--LYLLQRLENLDLS 241
++L+ LDLSFN + + + L+ L L ++ L ++ L+ L LD+S
Sbjct: 370 FGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 242 NNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ + + +L+ L + N
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 5e-17
Identities = 51/230 (22%), Positives = 87/230 (37%), Gaps = 32/230 (13%)
Query: 68 NSVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL-----Q 120
S + L L N L + + +L+ L EI +L L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 121 IKISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
I+ + G A + L L++L + P I LK L +L+V H
Sbjct: 88 IQSLALG----AFSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNL 135
Query: 176 IRYL--PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKAL----ISLKVANNKLVELPSG 228
I+ P L+NLE LDLS NK++ + + L + +SL ++ N + + G
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 229 LYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPS 277
+ RL L L NN + ++ + + L+ L + + +
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-16
Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 19/212 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI--NLFPSEVGNLLGLECLQI--------- 121
L L N +N I + +L L N N+ + + L GLE ++
Sbjct: 182 LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
+ + ++E L+ + + L L ++ S+ +I +
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN--CLTNVSSFSLVSVTIERVKD 299
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLS 241
+ L+L K PT LK+L L +NK S + L LE LDLS
Sbjct: 300 FSY-NFGWQHLELVNCKFGQFPT--LKLKSLKRLTFTSNKGGNAFSEVDL-PSLEFLDLS 355
Query: 242 NNRLTSLG--SLDLCLMHNLQNLNLQYNKLLS 271
N L+ G S +L+ L+L +N +++
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-14
Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 24/192 (12%)
Query: 69 SVEGLYLYKNVLNLI---PKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---- 121
S+E L L +N L+ +S L+ L N + S L LE L
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 122 --KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSI- 176
++S V L+ L L++S + GL L L + S
Sbjct: 408 LKQMSEFSV----FLSLRNLIYLDISHTH-----TRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 177 RYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLY-LLQ 233
P+I L NL LDLS +++ L L +L L +A+N+L +P G++ L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518
Query: 234 RLENLDLSNNRL 245
L+ + L N
Sbjct: 519 SLQKIWLHTNPW 530
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 83/318 (26%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++T+ +S E F L E ++ +V + G + S+ P
Sbjct: 60 IKTVNE-AASMRERIEF----LNEASVMKEFNCHHVVRLLG--VVSQGQP---------T 103
Query: 892 LQSAIFMEYVKGGSVKNYI-----EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 946
L + ME + G +K+Y+ + S+ + +A ++A + L++ +
Sbjct: 104 L---VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160
Query: 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-- 1004
HRD+ + N ++ + VK+ DF R I D
Sbjct: 161 HRDLAARNCMVAEDF-------TVKIGDFGMT--------------RDIYETDYYRKGGK 199
Query: 1005 ---P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQM 1059
P RWM+PE L K ++ D+WS+G +L E+ TL + PY GLS ++ +
Sbjct: 200 GLLPVRWMSPESL----KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 1060 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119
G +KP+ L ++ R C + NP RP+
Sbjct: 256 GGL------------------------LDKPD---NCPDMLFELMRMCWQYNPKMRPSFL 288
Query: 1120 DLYEMFVARTSSSISSRS 1137
++ S
Sbjct: 289 EIISSIKEEMEPGFREVS 306
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 61/243 (25%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 829 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883
AAK R L EI EV +L +RH I+ ++
Sbjct: 34 AAKFIKKRRLSSSRRGVSREEIER-------EVNILREIRHPNIITLHD---------IF 77
Query: 884 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 940
+ + L+ +E V GG + +++ E L+E A + + + L
Sbjct: 78 ENKTDVVLI-----LELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYL 124
Query: 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAP 998
HSK I H D+K ENI+ L K P +KL DF A + +
Sbjct: 125 HSKRIAHFDLKPENIM--LLDKNVPN-PRIKLIDFGIAHKIEAGNEFKNIF--------- 172
Query: 999 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1058
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 173 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224
Query: 1059 MGK 1061
Sbjct: 225 AVN 227
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 911
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 972 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 1025
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 1026 VDIWSYGCLLLELLT 1040
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPGV 128
LYL KN L +P+ + + L+ L+ NEI V L + +++ + S G+
Sbjct: 105 LYLSKNQLKELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 162
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI-GC 185
A +K L + ++ T ++ I LT+L + I +
Sbjct: 163 ENGAFQGMKKLSYIRIAD--------TNITTIPQGLPPSLTELHLDGNKITKVDAASLKG 214
Query: 186 LSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+NL +L LSFN + + L L + NNKLV++P GL + ++ + L NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 245 LTSLGSLDLCL------MHNLQNLNLQYNKL 269
++++GS D C + ++L N +
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 24/207 (11%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGV 128
+ L +PK + L N+I + + NL L L + KIS +
Sbjct: 36 VQCSDLGLEKVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK--I 91
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI-GC 185
+ A L L+ L LSK L E+ K L +L V I + +
Sbjct: 92 SPGAFAPLVKLERLYLSK--------NQLKELPEKMPKTLQELRVHENEITKVRKSVFNG 143
Query: 186 LSNLEQLDLSFNKMK--YLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242
L+ + ++L N +K + +K L +++A+ + +P G L L L L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG--LPPSLTELHLDG 201
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N++T + + L ++NL L L +N +
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSI 228
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 3/87 (3%)
Query: 186 LSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L NL L L NK+ + L L L ++ N+L ELP + + L+ L + N
Sbjct: 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM--PKTLQELRVHENE 132
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+T + ++ + + L N L S
Sbjct: 133 ITKVRKSVFNGLNQMIVVELGTNPLKS 159
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 3/87 (3%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
C +L + S ++ +P ++ L + NNK+ E+ G L+ L L L N
Sbjct: 28 RCQCHLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N+++ + + L+ L L N+L
Sbjct: 86 NKISKISPGAFAPLVKLERLYLSKNQL 112
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 23/140 (16%), Positives = 44/140 (31%), Gaps = 20/140 (14%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISS-P 126
L+L N + + + L L N I+ + N L L + K+ P
Sbjct: 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 256
Query: 127 GVNGFALNKLKGLKELEL-----SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY--L 179
G L K ++ + L S + + + +S+ ++Y +
Sbjct: 257 G----GLADHKYIQVVYLHNNNISAIGS--NDFCPPGYNTKKASYSGVSLFSNPVQYWEI 310
Query: 180 PPEI-GCLSNLEQLDLSFNK 198
P C+ + L K
Sbjct: 311 QPSTFRCVYVRAAVQLGNYK 330
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 68/315 (21%), Positives = 118/315 (37%), Gaps = 96/315 (30%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ LK + ++F E +L L+H IV+ YG + P L
Sbjct: 50 VKALK--DPTLAARKDF----QREAELLTNLQHEHIVKFYG--VCGDGDP---------L 92
Query: 892 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 940
+ + EY+K G + + ++ + + + L IA +A+ +V L
Sbjct: 93 I---MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 149
Query: 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1000
S+H +HRD+ + N L+ +VK+ DF + R + + D
Sbjct: 150 ASQHFVHRDLATRNCLVGANL-------LVKIGDFGMS--------------RDVYSTDY 188
Query: 1001 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 1050
P RWM PE + +Y E D+WS+G +L E+ T + P+ LS
Sbjct: 189 YRVGGHTMLPIRWMPPESI-------MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 1051 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1110
E+ + I G+ LE C P+ + DV C +
Sbjct: 242 TEVIECITQGRV------LERPRVC--------------PKE-------VYDVMLGCWQR 274
Query: 1111 NPTERPTAGDLYEMF 1125
P +R ++Y++
Sbjct: 275 EPQQRLNIKEIYKIL 289
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 55/299 (18%), Positives = 102/299 (34%), Gaps = 78/299 (26%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ LK + L E ++ L + IV M G I E +
Sbjct: 49 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIG--ICEA---------ESWM 93
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 94 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 144
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1007
+ N+L+ + K+ DF +A+ + A P +W
Sbjct: 145 ARNVLLVTQH-------YAKISDFGLSKALRADENYYK---AQTHGKWPV--------KW 186
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1066
APE + + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 187 YAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---- 238
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+ C P + D+ C + RP +
Sbjct: 239 --MGCPAGC--------------PRE-------MYDLMNLCWTYDVENRPGFAAVELRL 274
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-21
Identities = 53/167 (31%), Positives = 78/167 (46%), Gaps = 32/167 (19%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEY+ GG + +I+ + A F A ++ L LHSK I++RD+K +NIL+
Sbjct: 97 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 958 DLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
D DG +K+ DF + + +T C GTP ++APE+L
Sbjct: 152 D-----KDGH--IKIADFGMCKENMLGDAKTNTFC-------------GTPDYIAPEILL 191
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
Y VD WS+G LL E+L Q P+ G E E+ I+M
Sbjct: 192 GQK----YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 46/174 (26%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+++++GG + + K E + + F ++A AL LHS I++RD+K ENIL+
Sbjct: 105 LDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 958 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
D +G +KL DF +A ++ C GT +
Sbjct: 160 D-----EEGH--IKLTDFGLSKESIDHEKKA-------YSFC-------------GTVEY 192
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
MAPEV+ + D WS+G L+ E+LT +P+ G E +I K
Sbjct: 193 MAPEVVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 62/313 (19%), Positives = 114/313 (36%), Gaps = 90/313 (28%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ L+ G D+ R+F E+++L AL IV+ G
Sbjct: 57 VKQLQHSGP--DQQRDF----QREIQILKALHSDFIVKYRGVSYGPGRQS---------- 100
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
L+ + MEY+ G +++++++ + L + + + L S+ +HRD+
Sbjct: 101 LR--LVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA 154
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1007
+ NIL++ E VK+ DF + +PL + P W
Sbjct: 155 ARNILVESEA-------HVKIADFGLAKLLPLDKDYYV---VREPGQSPI--------FW 196
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSEL--------------E 1052
APE L N++ + D+WS+G +L EL T +E
Sbjct: 197 YAPESLSD----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 1053 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112
+ +L++ G+R L A +C P + ++ + C +P
Sbjct: 253 LLELLEEGQR------LPAPPAC--------------PAE-------VHELMKLCWAPSP 285
Query: 1113 TERPTAGDLYEMF 1125
+RP+ L
Sbjct: 286 QDRPSFSALGPQL 298
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 49/301 (16%), Positives = 105/301 (34%), Gaps = 83/301 (27%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++ L+ +S + L E ++ ++ + + + G ++S
Sbjct: 49 IKELRE-ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ----------- 92
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ + + G + +Y+ + + ++ + L +A + L + ++HRD+
Sbjct: 93 ----LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1005
+ N+L+ + VK+ DF A + + A +
Sbjct: 145 ARNVLVKTPQ-------HVKITDFGLA--------------KLLGAEEKEYHAEGGKVPI 183
Query: 1006 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 1064
+WMA E + +Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 184 KWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-- 237
Query: 1065 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
L C + + +C + RP +L
Sbjct: 238 ----LPQPPIC--------------TID-------VYMIMVKCWMIDADSRPKFRELIIE 272
Query: 1125 F 1125
F
Sbjct: 273 F 273
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 98.3 bits (244), Expect = 3e-21
Identities = 49/236 (20%), Positives = 88/236 (37%), Gaps = 22/236 (9%)
Query: 54 DFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL 113
P G +S + L K+ + E+L + + + SE+ +
Sbjct: 312 QLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESC 371
Query: 114 LGLECLQIKISSPGVNGFA-----------------LNKLKGLKELELSKVPPRPSVLTL 156
L+ L+ + + + LK + + + + S L
Sbjct: 372 KELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431
Query: 157 LSEIAG--LKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALIS 214
+ + + L + H + L + L + LDLS N+++ LP + L+ L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEV 490
Query: 215 LKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYNKL 269
L+ ++N L + G+ L RL+ L L NNRL ++ L L LNLQ N L
Sbjct: 491 LQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 26/219 (11%), Positives = 61/219 (27%), Gaps = 3/219 (1%)
Query: 72 GLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF 131
L +++ E+ F + + LL ++ + + +G
Sbjct: 234 WLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGR 293
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
L +L + + + T G + + + L +
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFR 353
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANN-KLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
+LS K L +E+ K L L+ N L+ + + L L + ++L +
Sbjct: 354 CELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 251 LDLC--LMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNG 287
+D + + + +L
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-21
Identities = 55/272 (20%), Positives = 100/272 (36%), Gaps = 69/272 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ +L +L H I++++ K +L+ E+ +GG + I
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKK---------YFYLV-----TEFYEGGELFEQIIN-- 139
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
A I + + + + LH +I+HRDIK ENIL LE K + +K+ D
Sbjct: 140 ---RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL--LENKNSLLN--IKIVD 192
Query: 975 FDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
F + L GT ++APEVL+ Y + D+WS G
Sbjct: 193 FGLSSFFSKDYKLRDRL-------------GTAYYIAPEVLK-----KKYNEKCDVWSCG 234
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092
++ LL P+ G ++ +I ++ GK +
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGK-------------------------YYFDFN 269
Query: 1093 ELETLSFLV-DVFRRCTEENPTERPTAGDLYE 1123
+ + +S ++ + + +R TA +
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 62/297 (20%), Positives = 117/297 (39%), Gaps = 77/297 (25%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+T+K S + L E ++ L+H +V+++ + +K P +
Sbjct: 217 VKTMKPGSMSVEAF-------LAEANVMKTLQHDKLVKLHA--VVTK-------EPIY-- 258
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I E++ GS+ ++ L + + + +A + + ++ +HRD++
Sbjct: 259 ----IITEFMAKGSLLDF---LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ NIL+ V K+ DF A R A G P +W A
Sbjct: 312 AANILVSASL-------VCKIADFGLA---RVIEDNEYTAREGAKFPI--------KWTA 353
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE + + ++ D+WS+G LL+E++T ++PY G+S E+ ++ G R
Sbjct: 354 PEAINF----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------ 403
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+ +C PE L ++ RC + P ERPT + +
Sbjct: 404 MPRPENC--------------PEE-------LYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-21
Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN+++
Sbjct: 84 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 958 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
D DG +K+ DF T C GTP +
Sbjct: 139 D-----KDGH--IKITDFGLCKEGISDGATM-------KTFC-------------GTPEY 171
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
+APEVL N YG VD W G ++ E++ ++P+ + +LI M +
Sbjct: 172 LAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 4e-21
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 46/174 (26%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+EY+ GG + +E+ E A F +++ AL LH K I++RD+K ENI++
Sbjct: 100 LEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML 154
Query: 958 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
+ G VKL DF HT C GT +
Sbjct: 155 N-----HQGH--VKLTDFGLCKESIHDGTVT-------HTFC-------------GTIEY 187
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
MAPE+L + + VD WS G L+ ++LT P+ G + + D I K
Sbjct: 188 MAPEILMR----SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 55/299 (18%), Positives = 100/299 (33%), Gaps = 78/299 (26%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 42 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 85
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ ME GG + ++ + + V + V+ + L K+ +HRD+
Sbjct: 86 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1007
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 138 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 179
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1066
APE + K + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 180 YAPECI-NFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 231
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+E C P L + C +RP + +
Sbjct: 232 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 267
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-21
Identities = 51/240 (21%), Positives = 97/240 (40%), Gaps = 53/240 (22%)
Query: 829 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883
AAK R K +I EV +L ++H ++ ++
Sbjct: 40 AAKFIKKRRTKSSRRGVSREDIER-------EVSILKEIQHPNVITLHE---------VY 83
Query: 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 943
+ + L+ +E V GG + +++ + ++ ++ + A + + + LHS
Sbjct: 84 ENKTDVILI-----LELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSL 133
Query: 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVC 1001
I H D+K ENI+ L + P +K+ DF A + +
Sbjct: 134 QIAHFDLKPENIM--LLDRNVPK-PRIKIIDFGLAHKIDFGNEFKNIF------------ 178
Query: 1002 VGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E +
Sbjct: 179 -GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 55/195 (28%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE--- 911
E+ + L H +V+ YGH + +F+EY GG + + IE
Sbjct: 55 EICINKMLNHENVVKFYGH-RREG----------NIQ---YLFLEYCSGGELFDRIEPDI 100
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
+ E A + A +V LH I HRDIK EN+L+ D + +K
Sbjct: 101 GMPE--------PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-------DERDNLK 145
Query: 972 LCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 1025
+ DF R L+ C GT ++APE+L+ +
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMC-------------GTLPYVAPELLKR----REFHAEP 188
Query: 1026 VDIWSYGCLLLELLT 1040
VD+WS G +L +L
Sbjct: 189 VDVWSCGIVLTAMLA 203
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-21
Identities = 25/205 (12%), Positives = 64/205 (31%), Gaps = 12/205 (5%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KIS 124
S+E L+ N ++ + S G+ +N+ N+I + G ++ L + +I
Sbjct: 100 SIETLHAANNNISRVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
+ L+ L L + + + L L + + ++ PE
Sbjct: 158 TVNFAEL-AASSDTLEHLNLQY-----NFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQ 211
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
+ + + L NK+ + + + + L + N + + ++
Sbjct: 212 SAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + +
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCC 296
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 9/116 (7%)
Query: 157 LSEIAG-LKCLTKLSVCHFSIRYLPPEIG-CLSNLEQLDLSFNKMKYLPTE-ICYLKALI 213
+ EI V S++ + N+++LDLS N + + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +++N L E L L L LDL+NN + L +++ L+ N +
Sbjct: 62 LLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG-----PSIETLHAANNNI 111
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-16
Identities = 27/140 (19%), Positives = 52/140 (37%), Gaps = 19/140 (13%)
Query: 133 LNKLKGLK--ELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNL 189
N+ K K + L + S + +L + + + + + L
Sbjct: 9 GNRYKIEKVTDSSLKQALA--------SLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 190 EQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
E L+LS N + ++ L L +L + NN + EL +E L +NN ++
Sbjct: 61 ELLNLSSNVLYETL-DLESLSTLRTLDLNNNYVQELLV----GPSIETLHAANNNIS--- 112
Query: 250 SLDLCLMHNLQNLNLQYNKL 269
+ +N+ L NK+
Sbjct: 113 RVSCSRGQGKKNIYLANNKI 132
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 33/251 (13%), Positives = 73/251 (29%), Gaps = 32/251 (12%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+++E L L N + + V + KL+ L N++ E + G+ + + K+
Sbjct: 169 DTLEHLNLQYNFIYDVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227
Query: 125 S-PGVNGFALNKLKGLKELELS----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
AL + L+ +L + + +V +++ L
Sbjct: 228 LIEK----ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--------QTVAKQTVKKL 275
Query: 180 PPEIG-CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV--------ELPSGLY 230
+ + + LP + LI+LK + L+ L
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAP--FADRLIALKRKEHALLSGQGSETERLECERE 333
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDS 290
R +D + ++ L + L L+G + +
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393
Query: 291 SNDDFISSSAE 301
+ + E
Sbjct: 394 VGQIELQHATE 404
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 80/297 (26%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 49 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 90
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 91 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ N+L+ + V K+ DF + + +P +W A
Sbjct: 145 ARNVLVSEDN-------VAKVSDFGLT---KE-ASS---TQDTGKLPV--------KWTA 182
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 183 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 232
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
++A C P A + +V + C + RP+ L E
Sbjct: 233 MDAPDGC--------------PPA-------VYEVMKNCWHLDAAMRPSFLQLREQL 268
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-21
Identities = 57/219 (26%), Positives = 86/219 (39%), Gaps = 13/219 (5%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVG--NLLG 115
IE + + + L L P + L+ L F N+ SEV +L
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLK--SLKRLTFTSNKGGNAFSEVDLPSLEF 351
Query: 116 LECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
L+ + +S G + LK L+LS V+T+ S GL+ L L H +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLS----FNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 176 IRYLPPE--IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVE--LPSGLY 230
++ + L NL LD+S + L +L LK+A N E LP
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L LDLS +L L + +LQ LN+ +N
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-19
Identities = 55/219 (25%), Positives = 81/219 (36%), Gaps = 29/219 (13%)
Query: 69 SVEGLYLYKNVLN---LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----Q 120
S+E L L +N L+ +S L+ L N + S L LE L
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 121 IKISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLT--KLSVCH 173
+K S L+ L L++S GL L K++
Sbjct: 408 LKQMSEFS---VFLSLRNLIYLDISHTHTRVAFN--------GIFNGLSSLEVLKMAGNS 456
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYL 231
F +LP L NL LDLS +++ L PT L +L L +++N L +
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 232 LQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKL 269
L L+ LD S N + + +L +L LNL N
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-18
Identities = 35/197 (17%), Positives = 67/197 (34%), Gaps = 13/197 (6%)
Query: 80 LNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGL 139
L+ I + + I + G + L++ + F KLK L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLEL--VNCKFGQFPTLKLKSL 327
Query: 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL---PPEIGCLSNLEQLDLSF 196
K L + + L L L + + + ++L+ LDLSF
Sbjct: 328 KRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 197 NKMKYLPTEICYLKALISLKVANNKLVEL--PSGLYLLQRLENLDLSNNRLTSLGSLDLC 254
N + + + L+ L L ++ L ++ S L+ L LD+S+ +
Sbjct: 383 NGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 255 LMHNLQNLNLQYNKLLS 271
+ +L+ L + N
Sbjct: 443 GLSSLEVLKMAGNSFQE 459
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-16
Identities = 44/251 (17%), Positives = 85/251 (33%), Gaps = 32/251 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFF-------GNEINLFPSEVGNLLGLECLQIK-- 122
L L N + ++ + L + N +N + L L ++
Sbjct: 154 LDLSSNKIQSIYCTDLR---VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 123 ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL--- 179
S V + L GL+ L R + + L+ L L++ F + YL
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 180 ----PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRL 235
CL+N+ L ++ + + Y L++ N K + P+ L+ L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVK-DFSYNFGWQHLELVNCKFGQFPTLK--LKSL 327
Query: 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC-------NLEGNGK 288
+ L ++N+ + S +L+ L+L N L +L NG
Sbjct: 328 KRLTFTSNKGGNAFSEVDL--PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 289 DSSNDDFISSS 299
+ + +F+
Sbjct: 386 ITMSSNFLGLE 396
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-15
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 21/156 (13%)
Query: 127 GVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
+ ++ L+ L+LS + L L+ L + I+ L
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIED--------GAYQSLSHLSTLILTGNPIQSLAL 93
Query: 182 E-IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKL--VELPSGLYLLQRLEN 237
LS+L++L + L I +LK L L VA+N + +LP L LE+
Sbjct: 94 GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQN----LNLQYNKL 269
LDLS+N++ S+ DL ++H + L+L N +
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-15
Identities = 25/109 (22%), Positives = 44/109 (40%), Gaps = 3/109 (2%)
Query: 166 LTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLV 223
L + +R+L L+ LDLS +++ + L L +L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 224 ELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L G L L+ L L SL + + + L+ LN+ +N + S
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-13
Identities = 22/99 (22%), Positives = 39/99 (39%), Gaps = 4/99 (4%)
Query: 173 HFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LY 230
+ +P + + + LDLSFN +++L L L ++ ++ + G
Sbjct: 16 ELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L L L+ N + SL + +LQ L L
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 16/53 (30%), Positives = 23/53 (43%), Gaps = 2/53 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++P L +NLDLS N L LGS LQ L+L ++ +
Sbjct: 16 ELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 47/223 (21%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
ME ++GG + ++ E G++ + + A I +D+ A+ LHS +I HRD+K EN+L
Sbjct: 105 MECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL- 160
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRS-FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1016
K+ D V+KL DF A L T C TP ++APEVL
Sbjct: 161 -YTSKEKD--AVLKLTDFGFAKETTQNALQTPC-------------YTPYYVAPEVLGPE 204
Query: 1017 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH 1076
Y D+WS G ++ LL P+ + I + +
Sbjct: 205 K----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-----------KRRIRLGQ 249
Query: 1077 EHEVAQSGSGFEKPEAELETLSFLV-DVFRRCTEENPTERPTA 1118
+ P E +S + R + +PTER T
Sbjct: 250 ----------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI 282
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 46/179 (25%), Positives = 72/179 (40%), Gaps = 49/179 (27%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
++Y+ GG + ++ + + + ++ AL LH I++RDIK ENIL+
Sbjct: 138 LDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192
Query: 958 DLERKKADGKPVVKLCDF-----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1006
D ++G V L DF +RA + C GT
Sbjct: 193 D-----SNGH--VVLTDFGLSKEFVADETERA-------YDFC-------------GTIE 225
Query: 1007 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE----LEIHDLIQMGK 1061
+MAP+++R + VD WS G L+ ELLT P+ E EI I +
Sbjct: 226 YMAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 890
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 72 VKMLK-DDATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 117
Query: 891 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 939
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 118 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 173 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 211
Query: 1000 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 1052
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 1053 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112
+ L++ G R +KP + L + R C P
Sbjct: 268 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 300
Query: 1113 TERPTAGDLYEMF 1125
++RPT L E
Sbjct: 301 SQRPTFKQLVEDL 313
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 71/311 (22%), Positives = 115/311 (36%), Gaps = 89/311 (28%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ LK S ++F E +L L+H IV +G + ++ P L
Sbjct: 76 VKALKEA--SESARQDF----QREAELLTMLQHQHIVRFFG--VCTEGRP---------L 118
Query: 892 LQSAIFMEYVKGGSVKNY----------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 941
L + EY++ G + + + + + + L +A VAA +V L
Sbjct: 119 L---MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175
Query: 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1001
H +HRD+ + N L+ VVK+ DF + R I + D
Sbjct: 176 GLHFVHRDLATRNCLVGQGL-------VVKIGDFGMS--------------RDIYSTDYY 214
Query: 1002 -VGT----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIH 1054
VG P RWM PE + + E D+WS+G +L E+ T + P+ LS E
Sbjct: 215 RVGGRTMLPIRWMPPESI----LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 1055 DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114
D I G+ LE +C P + + R C + P +
Sbjct: 271 DCITQGRE------LERPRAC--------------PPE-------VYAIMRGCWQREPQQ 303
Query: 1115 RPTAGDLYEMF 1125
R + D++
Sbjct: 304 RHSIKDVHARL 314
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-21
Identities = 67/320 (20%), Positives = 125/320 (39%), Gaps = 97/320 (30%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ LK +S E+R+ L E +L + H ++++YG + P L
Sbjct: 58 VKMLKE-NASPSELRDL----LSEFNVLKQVNHPHVIKLYGA--------CSQDGP---L 101
Query: 892 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 932
L + +EY K GS++ + L E+ +++ + A
Sbjct: 102 L---LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
++ + L ++HRD+ + NIL+ A+G+ +K+ DF +
Sbjct: 159 ISQGMQYLAEMKLVHRDLAARNILV------AEGR-KMKISDFGLS-------------- 197
Query: 993 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 1045
R + D V P +WMA E L ++Y + D+WS+G LL E++TL PY
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFD----HIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 1046 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1105
G+ + +L++ G R E+P+ + +
Sbjct: 254 PGIPPERLFNLLKTGHR------------------------MERPD---NCSEEMYRLML 286
Query: 1106 RCTEENPTERPTAGDLYEMF 1125
+C ++ P +RP D+ +
Sbjct: 287 QCWKQEPDKRPVFADISKDL 306
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 36/174 (20%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
ME + GG + I+K +KH S A +I + + +A+ +H ++HRD+K EN+L
Sbjct: 85 MELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLF 139
Query: 958 DLERKKADGKPVVKLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
+ +K+ DF A L T C T + APE+L
Sbjct: 140 ----TDENDNLEIKIIDFGFARLKPPDNQPLKTPC-------------FTLHYAAPELLN 182
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVP-------YMGLSELEIHDLIQMGK 1061
N Y D+WS G +L +L+ QVP S +EI I+ G
Sbjct: 183 Q----NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-21
Identities = 64/297 (21%), Positives = 109/297 (36%), Gaps = 80/297 (26%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ +K ++A L E ++ LRHS +V++ G + +
Sbjct: 221 VKCIK-NDATAQAF-------LAEASVMTQLRHSNLVQLLG--VIVEEKGGL-------- 262
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY+ GS+ +Y L G + L + DV A+ L + +HRD+
Sbjct: 263 ---YIVTEYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ N+L+ + V K+ DF S +P +W A
Sbjct: 317 ARNVLVSEDN-------VAKVSDFGLTKEASS-------TQDTGKLPV--------KWTA 354
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE LR + + D+WS+G LL E+ + +VPY + ++ ++ G +
Sbjct: 355 PEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------ 404
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
++A C P A + DV + C + RPT L E
Sbjct: 405 MDAPDGC--------------PPA-------VYDVMKNCWHLDAATRPTFLQLREQL 440
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 829 AAKV---RTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883
AAK R + EI EV +L + H I+ ++
Sbjct: 41 AAKFIKKRQSRASRRGVCREEIER-------EVSILRQVLHPNIITLHD---------VY 84
Query: 884 DGNPEHHLLQSAIFMEYVKGGSVKNYI---EKLSETGEKHVSVKLALFIAQDVAAALVEL 940
+ + L+ +E V GG + +++ E LSE + A + + + L
Sbjct: 85 ENRTDVVLI-----LELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPL--RSFLHTCCIAHRGIPAP 998
H+K I H D+K ENI++ K P +KL DF A +
Sbjct: 132 HTKKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--------- 179
Query: 999 DVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQ 1058
GTP ++APE++ ++P GLE D+WS G + LL+ P++G ++ E I
Sbjct: 180 ----GTPEFVAPEIVN--YEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 1059 MGK 1061
Sbjct: 232 AVS 234
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 71/297 (23%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V++L + E+ F L E ++ H ++ + G I + ++G+P
Sbjct: 122 VKSLNR-ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLG--ICLR----SEGSP---- 166
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ + Y+K G ++N+I + +VK + VA + L SK +HRD+
Sbjct: 167 ---LVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 219
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRWMA 1009
+ N ++D + VK+ DF A + G +P +WMA
Sbjct: 220 ARNCMLDEKF-------TVKVADFGLARDMYDKEFDSVHNKTGAKLPV--------KWMA 264
Query: 1010 PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDE 1068
E L+ + + D+WS+G LL EL+T PY ++ +I + G+R
Sbjct: 265 LESLQT----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 314
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
L C P+ L +V +C RP+ +L
Sbjct: 315 LLQPEYC--------------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 67/313 (21%), Positives = 114/313 (36%), Gaps = 91/313 (29%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ LK + + E+ +L L H I++ G A
Sbjct: 65 VKALKA-DAGPQHRSGW----KQEIDILRTLYHEHIIKYKG--CCED----AGAAS---- 109
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
LQ + MEYV GS+++Y+ + + + L AQ + + LH++H +HRD+
Sbjct: 110 LQ--LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLA 161
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1007
+ N+L+D +R +VK+ DF +AVP + P W
Sbjct: 162 ARNVLLDNDR-------LVKIGDFGLAKAVPEGHEYYR---VREDGDSPV--------FW 203
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL---------------QVPYMGLSELE 1052
APE L+ + D+WS+G L ELLT + ++ L
Sbjct: 204 YAPECLKE----YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 1053 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112
+ +L++ G+R L C P + + + C E
Sbjct: 260 LTELLERGER------LPRPDKC--------------PAE-------VYHLMKNCWETEA 292
Query: 1113 TERPTAGDLYEMF 1125
+ RPT +L +
Sbjct: 293 SFRPTFENLIPIL 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 72/313 (23%), Positives = 120/313 (38%), Gaps = 90/313 (28%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 890
V+ LK ++ ++ + + E+ M+ + +H I+ + G ++ +
Sbjct: 106 VKMLK-SDATEKDLSDL----ISEMEMMKMIGKHKNIINLLG--ACTQ---------DGP 149
Query: 891 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 939
L + +EY G+++ Y S E+ +S K + A VA +
Sbjct: 150 LY---VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
L SK +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 207 LASKKCIHRDLAARNVLVTEDN-------VMKIADFGLA--------------RDIHHID 245
Query: 1000 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 1052
T P +WMAPE L +Y + D+WS+G LL E+ TL PY G+ E
Sbjct: 246 YYKKTTNGRLPVKWMAPEAL----FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 1053 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112
+ L++ G R +KP + L + R C P
Sbjct: 302 LFKLLKEGHR------------------------MDKPS---NCTNELYMMMRDCWHAVP 334
Query: 1113 TERPTAGDLYEMF 1125
++RPT L E
Sbjct: 335 SQRPTFKQLVEDL 347
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-20
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 958 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
D ++G +K+ DF T C GTP +
Sbjct: 155 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 187
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 188 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 45/198 (22%), Positives = 74/198 (37%), Gaps = 53/198 (26%)
Query: 855 EVRMLGALRHSC--IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIE 911
EV +L + ++ + W D + + +E + + ++I
Sbjct: 96 EVVLLKKVSSGFSGVIRLLD------WFERPD-----SFV---LILERPEPVQDLFDFIT 141
Query: 912 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968
L E +LA V A+ H+ ++HRDIK ENILIDL R +
Sbjct: 142 ERGALQE--------ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE----- 188
Query: 969 VVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1026
+KL DF A+ + GT + PE +R + Y G
Sbjct: 189 -LKLIDFGSGALLKDTVYTDFD-------------GTRVYSPPEWIRY----HRYHGRSA 230
Query: 1027 DIWSYGCLLLELLTLQVP 1044
+WS G LL +++ +P
Sbjct: 231 AVWSLGILLYDMVCGDIP 248
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 90/313 (28%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 890
V+ LK ++ ++ + + E+ M+ + +H I+ + G P +
Sbjct: 118 VKMLKD-DATEKDLSDL----VSEMEMMKMIGKHKNIINLLGA--------CTQDGPLY- 163
Query: 891 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 939
+ +EY G+++ Y ++ E+ ++ K + +A +
Sbjct: 164 -----VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
L S+ +HRD+ + N+L+ + V+K+ DF A R I D
Sbjct: 219 LASQKCIHRDLAARNVLV------TENN-VMKIADFGLA--------------RDINNID 257
Query: 1000 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE 1052
T P +WMAPE L +Y + D+WS+G L+ E+ TL PY G+ E
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 1053 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112
+ L++ G R +KP + L + R C P
Sbjct: 314 LFKLLKEGHR------------------------MDKPA---NCTNELYMMMRDCWHAVP 346
Query: 1113 TERPTAGDLYEMF 1125
++RPT L E
Sbjct: 347 SQRPTFKQLVEDL 359
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-20
Identities = 65/227 (28%), Positives = 95/227 (41%), Gaps = 29/227 (12%)
Query: 71 EGLYLYKNVLN-LIPKSV-GRYEKLRNLKFFGNEIN-LFPSEVGNLLG-LECLQI---KI 123
E L L N + +P + L+ L NE + P + NL L L +
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 124 SSPGVNGFALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
S P + N L+EL L K+PP S + L + LS + S
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH-------LSFNYLSGT 433
Query: 178 YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRL 235
+P +G LS L L L N ++ +P E+ Y+K L +L + N L E+PSGL L
Sbjct: 434 -IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492
Query: 236 ENLDLSNNRLTSLGSL--DLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ LSNNRLT G + + + NL L L N +P+ +
Sbjct: 493 NWISLSNNRLT--GEIPKWIGRLENLAILKLSNNSF--SGNIPAELG 535
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-17
Identities = 46/211 (21%), Positives = 80/211 (37%), Gaps = 27/211 (12%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L L N + IP +G L L N N P+ + G + + G
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK--IAANFIA-GKRY 575
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCHFSIRYL----PPEIGC 185
+ KE + ++L L L+ + C+ + R P
Sbjct: 576 VYIKNDGMKKECHGAG-----NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 186 LSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNN 243
++ LD+S+N + Y+P EI + L L + +N + +P + L+ L LDLS+N
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 244 RLT-----SLGSLDLCLMHNLQNLNLQYNKL 269
+L ++ +L L ++L N L
Sbjct: 691 KLDGRIPQAMSAL-----TMLTEIDLSNNNL 716
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-16
Identities = 50/233 (21%), Positives = 86/233 (36%), Gaps = 26/233 (11%)
Query: 68 NSVEGLYLYKNVLNL----IPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI-- 121
+ V + L LN+ + S+ L +L + IN S L L +
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL- 179
+S P +L GLK L +S + L +++G L L V S +
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSS-----NTLDFPGKVSGGLKLNSLEVLDLSANSIS 164
Query: 180 ---PPEI---GCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYL 231
L+ L +S NK+ + + L L V++N +P L
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGD 221
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L++LD+S N+L+ S + L+ LN+ N+ +P +L+
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF--VGPIPPLPLKSLQ 272
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 9e-15
Identities = 54/237 (22%), Positives = 84/237 (35%), Gaps = 51/237 (21%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFF---GNEIN-LFPSEVGNLLGLECLQIKI 123
S+E L L N ++ + LK GN+I+ V + LE L +
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDV-- 207
Query: 124 SSPGVNGF-----ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKL--S 170
N F L L+ L++S I+ L L S
Sbjct: 208 ---SSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSR---------AISTCTELKLLNIS 255
Query: 171 VCHFS--IRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICY-LKALISLKVANNKLV-EL 225
F I PP L +L+ L L+ NK +P + L L ++ N +
Sbjct: 256 SNQFVGPI---PPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV 310
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSL---DLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
P LE+L LS+N + G L L M L+ L+L +N+ ++P +
Sbjct: 311 PPFFGSCSLLESLALSSNNFS--GELPMDTLLKMRGLKVLDLSFNEFSG--ELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-14
Identities = 38/220 (17%), Positives = 72/220 (32%), Gaps = 45/220 (20%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L L N L IP + L + N + P +G L L L++ S+ N
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKL--SN---NS 525
Query: 131 F------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178
F L + L L+L+ +P + + K K++ + +
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIP---------AAMF--KQSGKIAANFIAGK- 573
Query: 179 LPPEIGCLSNLEQLDLSFNKMKY---LPTEICYLKALISLKVANNKLV-ELPSGLYLLQR 234
I ++ + N +++ ++ L + +
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633
Query: 235 LENLDLSNNRLT-----SLGSLDLCLMHNLQNLNLQYNKL 269
+ LD+S N L+ +GS+ L LNL +N +
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSM-----PYLFILNLGHNDI 668
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 8e-14
Identities = 47/220 (21%), Positives = 75/220 (34%), Gaps = 43/220 (19%)
Query: 73 LYLYKNVLNL-IPKSVG-RYEKLRNLKFFGNEIN-LFPSEV---GNLLGLECLQIKISSP 126
L + N L+ S G + L L N I+ L+ L I
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI----- 185
Query: 127 GVNGFA----LNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTK--LSVCHF 174
N + +++ L+ L++S +P + L +S
Sbjct: 186 SGNKISGDVDVSRCVNLEFLDVSSNNFSTGIP----------FLGDCSALQHLDISGNKL 235
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLY-L 231
S I + L+ L++S N+ +P LK+L L +A NK E+P L
Sbjct: 236 SGD-FSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 232 LQRLENLDLSNNRLTSLGSL--DLCLMHNLQNLNLQYNKL 269
L LDLS N G++ L++L L N
Sbjct: 293 CDTLTGLDLSGNHFY--GAVPPFFGSCSLLESLALSSNNF 330
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-11
Identities = 51/243 (20%), Positives = 79/243 (32%), Gaps = 59/243 (24%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSP 126
+ L+L N L+ IP S+G KLR+LK + N + P E+ + LE L +
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL----- 473
Query: 127 GVNGF------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAGLKCLTKLSV--C 172
N L+ L + LS ++P I L+ L L +
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP---------KWIGRLENLAILKLSNN 524
Query: 173 HFS--IRYLPPEIGCLSNLEQLDLSFNK---------------MKY------LPTEICYL 209
FS I P E+G +L LDL+ N + I
Sbjct: 525 SFSGNI---PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKND 581
Query: 210 KALISLKVANNKLV---ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
A N L L L ++++ S ++ L++ Y
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 267 NKL 269
N L
Sbjct: 642 NML 644
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-08
Identities = 35/187 (18%), Positives = 55/187 (29%), Gaps = 36/187 (19%)
Query: 65 GGDNSVEGLYLYKNVLNL---IPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQ 120
D + + N+L + + R N + L
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS--IRY 178
+ S N L G + P + + + L L S I
Sbjct: 639 M--SY--------NMLSG----YI------PKEIGSMPYLFILN----LGHNDISGSI-- 672
Query: 179 LPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLE 236
P E+G L L LDLS NK+ +P + L L + ++NN L +P +
Sbjct: 673 -PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG-QFETFP 730
Query: 237 NLDLSNN 243
NN
Sbjct: 731 PAKFLNN 737
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-20
Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 46/174 (26%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
ME+V GG + +I+K + A F A ++ +AL+ LH K I++RD+K +N+L+
Sbjct: 103 MEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 958 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
D +G KL DF T C GTP +
Sbjct: 158 D-----HEGH--CKLADFGMCKEGICNGVTT-------ATFC-------------GTPDY 190
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
+APE+L+ M YG VD W+ G LL E+L P+ +E ++ + I +
Sbjct: 191 IAPEILQEML----YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 57/205 (27%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--ME-YVKGGSVKNYIE 911
E+ +L + H+ I+++ ++ ME + G + +I+
Sbjct: 79 EIAILSRVEHANIIKVL-DIFENQ---------------GFFQLVMEKHGSGLDLFAFID 122
Query: 912 ---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKP 968
+L E LA +I + + +A+ L K I+HRDIK ENI+I
Sbjct: 123 RHPRLDE--------PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI-------AEDF 167
Query: 969 VVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLE 1025
+KL DF A L +T C GT + APEVL N Y G E
Sbjct: 168 TIKLIDFGSAAYLERGKLFYTFC-------------GTIEYCAPEVLMG----NPYRGPE 210
Query: 1026 VDIWSYGCLLLELLTLQVPYMGLSE 1050
+++WS G L L+ + P+ L E
Sbjct: 211 LEMWSLGVTLYTLVFEENPFCELEE 235
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 24/216 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
S L L N L +P V + +L L N ++ + G L+
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 122 KISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI---AGLKCLTKLSVCHFSIR 177
+ + L+ L+ L+ L +SE L+ L L + H R
Sbjct: 89 GVITMSS----NFLGLEQLEHLDFQHSN-----LKQMSEFSVFLSLRNLIYLDISHTHTR 139
Query: 178 YLPPEI-GCLSNLEQLDLSFNKM-KYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQ 233
I LS+LE L ++ N + +I L+ L L ++ +L +L + L
Sbjct: 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 199
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L++S+N SL + +++LQ L+ N +
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 51/188 (27%), Positives = 76/188 (40%), Gaps = 13/188 (6%)
Query: 93 LRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGVNGFALNKLKGLKELELSKVP 148
L+ N++ +L L L L + +S G + LK L+LS
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS--- 86
Query: 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE--IGCLSNLEQLDLSFNKMKYLPTEI 206
V+T+ S GL+ L L H +++ + L NL LD+S + I
Sbjct: 87 -FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145
Query: 207 CY-LKALISLKVANNKLVE--LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLN 263
L +L LK+A N E LP L+ L LDLS +L L + +LQ LN
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205
Query: 264 LQYNKLLS 271
+ +N S
Sbjct: 206 MSHNNFFS 213
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 53/235 (22%), Positives = 79/235 (33%), Gaps = 41/235 (17%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEINLFPSEVGNLLGLECL-----Q 120
+ L L N L+ +LK+ N + S L LE L
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 112
Query: 121 IK-ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCH- 173
+K +S L+ L L++S T GL L L +
Sbjct: 113 LKQMSEFS----VFLSLRNLIYLDISH--------THTRVAFNGIFNGLSSLEVLKMAGN 160
Query: 174 FSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL 231
P+I L NL LDLS +++ L L +L L +++N L + Y
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 232 -LQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L L+ LD S N + + +L +L LNL N + C C
Sbjct: 221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN---------DFACTCEH 266
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 25/117 (21%), Positives = 47/117 (40%), Gaps = 5/117 (4%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEIGC---LSNLEQLDLSFNKMKYLPTEICYLKALISLKV 217
L LTKLS+ + + ++L+ LDLSFN + + + L+ L L
Sbjct: 49 DKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDF 108
Query: 218 ANNKLVELPSG--LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
++ L ++ L+ L LD+S+ + + +L+ L + N
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 56/301 (18%), Positives = 103/301 (34%), Gaps = 83/301 (27%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++ ++ S + + +G+L H+ IV + G S
Sbjct: 47 IKVIED-KSGRQSFQAV----TDHMLAIGSLDHAHIVRLLGLCPGSSLQ----------- 90
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ +Y+ GS+ +++ + + +L L +A + L ++HR++
Sbjct: 91 ----LVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP------ 1005
+ N+L+ V++ DF A +P D +
Sbjct: 143 ARNVLLKSPS-------QVQVADFGVA--------------DLLPPDDKQLLYSEAKTPI 181
Query: 1006 RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPR 1064
+WMA E + Y + D+WSYG + EL+T PY GL E+ DL++ G+R
Sbjct: 182 KWMALESIHF----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-- 235
Query: 1065 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
L C + V +C + RPT +L
Sbjct: 236 ----LAQPQIC--------------TID-------VYMVMVKCWMIDENIRPTFKELANE 270
Query: 1125 F 1125
F
Sbjct: 271 F 271
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-20
Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 18/219 (8%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI----- 121
V+ + + + + L+P S ++ + L L N + + LQ
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
+ S G L LK L L++S R + + + + L++ IR +
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDIS----RNTFHPMPDSCQWPEKMRFLNLSSTGIRVVK 426
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
I LE LD+S N + +L L L ++ NKL LP L L + +
Sbjct: 427 TCI--PQTLEVLDVSNNNLDSFSL---FLPRLQELYISRNKLKTLPDAS-LFPVLLVMKI 480
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
S N+L S+ + +LQ + L N C ++
Sbjct: 481 SRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 519
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-20
Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 17/214 (7%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYE--KLRNLKFFGNEINLFPSEV-GNLLGLECLQI-- 121
D ++ GL + + + +G+ E +R L + S V L ++ + +
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319
Query: 122 -KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP 180
K+ V LK L+ L+LS+ L + L L + +R +
Sbjct: 320 SKVFL--VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQ 377
Query: 181 PEIG---CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
L NL LD+S N +P + + + L +++ + + + + Q LE
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTC--IPQTLEV 435
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LD+SNN L S + LQ L + NKL +
Sbjct: 436 LDVSNNNLDSFSL----FLPRLQELYISRNKLKT 465
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-16
Identities = 37/242 (15%), Positives = 80/242 (33%), Gaps = 17/242 (7%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+++ L L N + I L+ L + IN + +L LE L + +
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 124 SSPGVNGFALNKLKGLKELELS--KVPPRPSVLTLLSEIAGLKCLTKLSVCHF-SIRYLP 180
SS ++ L LK L L L + S L L L + + + +
Sbjct: 87 SS--LSSSWFGPLSSLKYLNLMGNPY----QTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140
Query: 181 PE-IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLY-LLQRLEN 237
L++L +L++ ++ ++ + ++ + L + ++ L +L +
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFIS 297
L+L + L L + + + L + S +F
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 298 SS 299
+
Sbjct: 261 CT 262
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-13
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYL-L 232
S +P + + ++ LDLSFNK+ Y+ + L L + ++++ + + L
Sbjct: 16 SFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSL 73
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LE+LDLS+N L+SL S + +L+ LNL N +
Sbjct: 74 GSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT 112
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 9e-07
Identities = 18/51 (35%), Positives = 30/51 (58%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ +PSGL +++LDLS N++T +G DL NLQ L L+ +++
Sbjct: 14 SRSFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 29/213 (13%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------KISSP 126
LY+ KN L IP ++ L L+ N I P G GL + + +
Sbjct: 107 LYISKNHLVEIPPNL--PSSLVELRIHDNRIRKVPK--GVFSGLRNMNCIEMGGNPLENS 162
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG--LKCLTKLSVCHFSIRYLPPEI- 183
G A + LK L L +S+ L+ I + L +L + H I+ + E
Sbjct: 163 GFEPGAFDGLK-LNYLRISE--------AKLTGIPKDLPETLNELHLDHNKIQAIELEDL 213
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242
S L +L L N+++ + L L L + NNKL +P+GL L+ L+ + L
Sbjct: 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHT 273
Query: 243 NRLTSLGSLDLCLMH------NLQNLNLQYNKL 269
N +T +G D C + ++L N +
Sbjct: 274 NNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV 306
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 47/233 (20%), Positives = 89/233 (38%), Gaps = 49/233 (21%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L L N ++ + K + L L N+I+ +
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK------------------ 96
Query: 128 VNGFALNKLKGLKELELSK-----VPPR-PSVLTLL-------SEI-----AGLKCLTKL 169
A + L+ L++L +SK +PP PS L L ++ +GL+ + +
Sbjct: 97 ----AFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 170 SVCHFSIRYLPPEIGCLS--NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227
+ + E G L L +S K+ +P ++ + L L + +NK+ +
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQAIEL 210
Query: 228 G-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279
L +L L L +N++ + + L + L+ L+L NKL VP+ +
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR---VPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 24/97 (24%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLL 232
++ +P EI + LDL N + L + L+ L +L + NNK+ ++ L
Sbjct: 44 GLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL 101
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
++L+ L +S N L + L +L L + N++
Sbjct: 102 RKLQKLYISKNHLVEIPPN---LPSSLVELRIHDNRI 135
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 25/87 (28%), Positives = 37/87 (42%), Gaps = 3/87 (3%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
GC +L + S +K +P EI L + NN + EL LQ L L L N
Sbjct: 30 GCHCHLRVVQCSDLGLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N+++ + + LQ L + N L
Sbjct: 88 NKISKIHEKAFSPLRKLQKLYISKNHL 114
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-20
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 51/237 (21%)
Query: 829 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887
AA + T K+ ++ E R+ L+H IV ++
Sbjct: 40 AAMIINTKKLSARDHQKLER-------EARICRLLKHPNIVRLHDSISEEG--------- 83
Query: 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947
H+L+ + V GG + I ++ S A Q + A++ H ++H
Sbjct: 84 HHYLI-----FDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVH 133
Query: 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRS---FLHTCCIAHRGIPAPDVCVGT 1004
R++K EN+L+ + K A VKL DF A+ + GT
Sbjct: 134 RNLKPENLLLASKLKGAA----VKLADFGLAIEVEGEQQAWFGFA-------------GT 176
Query: 1005 PRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
P +++PEVLR + YG VD+W+ G +L LL P+ + ++ I+ G
Sbjct: 177 PGYLSPEVLRK----DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E + L+H IVE+ S +++ E++ G + I K
Sbjct: 76 EASICHMLKHPHIVELLETYSSDG---------MLYMV-----FEFMDGADLCFEIVK-R 120
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
S +A + + AL H +I+HRD+K +L+ K + P VKL
Sbjct: 121 ADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA---SKENSAP-VKLGG 176
Query: 975 FDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
F A+ L GTP +MAPEV++ YG VD+W
Sbjct: 177 FGVAIQLGESGLVAGGRV-------------GTPHFMAPEVVKR----EPYGKPVDVWGC 219
Query: 1032 GCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
G +L LL+ +P+ G ++ + + I GK
Sbjct: 220 GVILFILLSGCLPFYG-TKERLFEGIIKGK 248
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 59/242 (24%)
Query: 829 AAKV-RTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGN 886
AAK + + EI + E+ +L + ++ ++ +
Sbjct: 58 AAKFLKKRRRGQDCRAEILH-------EIAVLELAKSCPRVINLHE---------VYENT 101
Query: 887 PEHHLLQSAIFMEYVKGGS-----VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH 941
E L+ +EY GG + E +SE + + + + + LH
Sbjct: 102 SEIILI-----LEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVYYLH 148
Query: 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR--SFLHTCCIAHRGIPAPD 999
+I+H D+K +NIL L G +K+ DF + + L
Sbjct: 149 QNNIVHLDLKPQNIL--LSSIYPLGD--IKIVDFGMSRKIGHACELREIM---------- 194
Query: 1000 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
GTP ++APE+L + P D+W+ G + LLT P++G E + I
Sbjct: 195 ---GTPEYLAPEILN--YDP--ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 1060 GK 1061
Sbjct: 248 VN 249
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-20
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 46/174 (26%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
++Y+ GG + ++++ E+ A F A ++A+AL LHS +I++RD+K ENIL+
Sbjct: 118 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 172
Query: 958 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
D + G + L DF T C GTP +
Sbjct: 173 D-----SQGH--IVLTDFGLCKENIEHNSTT-------STFC-------------GTPEY 205
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
+APEVL Y VD W G +L E+L P+ + E++D I
Sbjct: 206 LAPEVLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 255
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-20
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 15/214 (7%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI----- 121
++E LYL N ++ I G EKL+ L F N I L ++ +L L +
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
I+ F + L + L + ++ L + + P
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST----IQSLWLGTFEDMDDEDISP 245
Query: 182 EI---GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLLQRLEN 237
+ C ++E ++L + + + L L + L ELPSGL L L+
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKK 305
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L LS N+ +L + +L +L+++ N
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-18
Identities = 41/211 (19%), Positives = 75/211 (35%), Gaps = 36/211 (17%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KI 123
SVE + L K+ N+ + + L+ L ++ PS + L L+ L + K
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKF 313
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI 183
+ + + L L + + +
Sbjct: 314 E--NLCQISASNFPSLTHLSIKG-------------------------NTKRLELGTGCL 346
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV---ANNKLVELPSG-LYLLQRLENLD 239
L NL +LDLS + ++ L+ L L+ + N+ + L + +LE LD
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406
Query: 240 LSNNRLTSLGSLD-LCLMHNLQNLNLQYNKL 269
L+ RL + +H L+ LNL ++ L
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-17
Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 24/223 (10%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLK---FFGNEINLFPSEV-GNLLGLECL---- 119
++ L L + + + L +L+ NE +E LE L
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 120 -QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSI 176
++K+ L LK L LS S+L + SE GL L L++
Sbjct: 410 TRLKVKDAQS---PFQNLHLLKVLNLSH-----SLLDISSEQLFDGLPALQHLNLQGNHF 461
Query: 177 RYLPPE----IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL 231
+ + L LE L LSF + + LK + + +++N+L
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274
+ L+L++N ++ + L ++ + +NL+ N L C
Sbjct: 522 HLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-15
Identities = 20/107 (18%), Positives = 42/107 (39%), Gaps = 3/107 (2%)
Query: 166 LTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLV 223
L + + L NL LDL+ ++ ++ + L +L + N L+
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 224 ELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + L++L ++S+ + L L++L L N +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-15
Identities = 42/213 (19%), Positives = 63/213 (29%), Gaps = 38/213 (17%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
NS E L NVL + + R L L +I +
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED----------------- 75
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPE-I 183
L L L+ + L ++E A G K L L I + +
Sbjct: 76 -----TFQSQHRLDTLVLTA-----NPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125
Query: 184 GCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELP----SGLYLLQRLENL 238
LE L L N + + + + L L NN + L S L L L
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS-L 184
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L+ N + + Q+LN + L
Sbjct: 185 NLNGNDIAGIEPGAFDSAV-FQSLNFGGTQNLL 216
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-09
Identities = 15/88 (17%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
+ + + +P + + L+ + N L + + L L LDL+
Sbjct: 10 EKEVNKTYNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRC 67
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
++ + H L L L N L+
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIF 95
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-20
Identities = 50/190 (26%), Positives = 76/190 (40%), Gaps = 48/190 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 911
E+ +L L H I+++ + E L+ +E V GG + + I
Sbjct: 98 EIGVLLRLSHPNIIKLKE------IFETPT---EISLV-----LELVTGGELFDRIVEKG 143
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
SE + A + + A+ LH I+HRD+K EN+L D +K
Sbjct: 144 YYSE--------RDAADAVKQILEAVAYLHENGIVHRDLKPENLL--YATPAPDAP--LK 191
Query: 972 LCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029
+ DF + + + T C GTP + APE+LR YG EVD+W
Sbjct: 192 IADFGLSKIVEHQVLMKTVC-------------GTPGYCAPEILRGCA----YGPEVDMW 234
Query: 1030 SYGCLLLELL 1039
S G + LL
Sbjct: 235 SVGIITYILL 244
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 68/314 (21%), Positives = 119/314 (37%), Gaps = 90/314 (28%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 890
V+ LK G++ E R + E+++L + H +V + G +K P
Sbjct: 62 VKMLKE-GATHSEHRAL----MSELKILIHIGHHLNVVNLLG--ACTK--------PGGP 106
Query: 891 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 939
L+ + +E+ K G++ Y + + ++++ + + VA +
Sbjct: 107 LM---VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
L S+ +HRD+ + NIL+ ++ VVK+CDF A R I
Sbjct: 164 LASRKCIHRDLAARNILL------SEKN-VVKICDFGLA--------------RDIYKDP 202
Query: 1000 VCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE-L 1051
V P +WMAPE + +Y ++ D+WS+G LL E+ +L PY G+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 1052 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111
E ++ G R P+ T + C
Sbjct: 259 EFCRRLKEGTR------------------------MRAPD---YTTPEMYQTMLDCWHGE 291
Query: 1112 PTERPTAGDLYEMF 1125
P++RPT +L E
Sbjct: 292 PSQRPTFSELVEHL 305
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-20
Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 34/221 (15%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEI--NLFPSEVGNLLGLECL-----QIKIS 124
L L KN ++ + + L L NEI L E L + + +
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 125 SPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
+ + + L+ L L + V PS L+ LT L + + +I +
Sbjct: 446 TRN----SFALVPSLQRLMLRRVALKNVDSSPSPFQ------PLRNLTILDLSNNNIANI 495
Query: 180 PPE-IGCLSNLEQLDLSFNKMKYLPTEICY---------LKALISLKVANNKLVELPSGL 229
+ + L LE LDL N + L L L L + +N E+P +
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 230 YL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L L+ +DL N L +L + +L++LNLQ N +
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-19
Identities = 54/233 (23%), Positives = 87/233 (37%), Gaps = 33/233 (14%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL-------QIKI 123
L L N LN + S +L N I LF + L + L + I
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312
Query: 124 SS---PGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTK--LSVCH 173
S P ++ F+ LK L+ L + + + GL L LS
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS--------NMFTGLINLKYLSLSNSF 364
Query: 174 FSIRYLPPEIG---CLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG- 228
S+R L E S L L+L+ NK+ + ++ +L L L + N++ + +G
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 229 -LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
L+ + + LS N+ L L+ +LQ L L+ L + PS
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-19
Identities = 53/227 (23%), Positives = 81/227 (35%), Gaps = 37/227 (16%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
++ L L N L L + RY +L +L N I+ E
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE----------------- 67
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSE--IAGLKCLTKLSVCHFSIRYLPPE-I 183
KL LK L L L+ LS+ A LT+L + SI+ +
Sbjct: 68 -----LCQKLPMLKVLNLQHNE-----LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPS---GLYLLQRLENLD 239
NL LDLS N + L+ L L ++NNK+ L S ++ L+ L+
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
LS+N++ + L L L +L + +C L
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP--SLTEKLCLELANT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-18
Identities = 45/218 (20%), Positives = 79/218 (36%), Gaps = 21/218 (9%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL-----Q 120
+ + ++ + S + L +L N+I + + L+ L+ L
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 121 IKISSPGVNGFALNKLKGLKELELSK-----VPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
+ + F L L L+K + S + L+ L L +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD-----AFSWLGHLEVL-DLGLNEIG 418
Query: 176 IRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKL---VELPSGLYL 231
E L N+ ++ LS+NK L + +L L + L PS
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L LDLSNN + ++ L + L+ L+LQ+N L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-17
Identities = 44/230 (19%), Positives = 78/230 (33%), Gaps = 36/230 (15%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGV 128
+++ L L N + + +LK ++ L N QIK SPG
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLK----KLELS----SN-------QIKEFSPG- 189
Query: 129 NGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG---C 185
+ + L L L+ V PS+ L + LS+ + +
Sbjct: 190 ---CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246
Query: 186 LSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG----------LYLLQR 234
+NL LDLS+N + + +L L + N + L S L L +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+S L + + L++LN++ N + + S + L
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG---IKSNMFTGLI 353
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-17
Identities = 54/250 (21%), Positives = 87/250 (34%), Gaps = 27/250 (10%)
Query: 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GN 101
+ ++ + L E + S+ L L + L+ + K NL N
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 102 EIN-LFPSEVGNLLGLECL-----QIKISSPGVNGFALNKLKGLKELELS----KVPPRP 151
+N + L LE I+ +L+ L ++ L L K
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH----SLHGLFNVRYLNLKRSFTKQSISL 314
Query: 152 SVLTLL--SEIAGLKCLTKLSVCHFSIRYLPPEIGC-LSNLEQLDLSFNKMK--YLPTEI 206
+ L + LKCL L++ I + + L NL+ L LS + L E
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 207 CYLKALISLKV---ANNKLVELPSG-LYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQN 261
A L + NK+ ++ S L LE LDL N + L + + N+
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
Query: 262 LNLQYNKLLS 271
+ L YNK L
Sbjct: 435 IYLSYNKYLQ 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-16
Identities = 47/216 (21%), Positives = 78/216 (36%), Gaps = 28/216 (12%)
Query: 73 LYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPG 127
L L N L L K+ L L N I + + L L + +SS
Sbjct: 78 LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS-- 135
Query: 128 VNGFALNKLKGLKELELS-----KVPPRP-SVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
+L+ L+EL LS + + S L KL + I+ P
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS-------LKKLELSSNQIKEFSP 188
Query: 182 E-IGCLSNLEQLDLSFNKMKYLPTEI----CYLKALISLKVANNKLVELPSGLYL---LQ 233
+ L L L+ ++ TE ++ +L ++N++L + +L
Sbjct: 189 GCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L LDLS N L +G+ + L+ L+YN +
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-14
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 16/147 (10%)
Query: 139 LKELELSKVPPR-PSVLTLL------------SEIAGLKCLTKLSVCHFSIRYLPPE-IG 184
L+L++VP P+ +T+L + LT L V +I L PE
Sbjct: 11 CSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQ 70
Query: 185 CLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
L L+ L+L N++ L + + L L + +N + ++ + + L LDLS+
Sbjct: 71 KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSH 130
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L+S + NLQ L L NK+
Sbjct: 131 NGLSSTKLGTQVQLENLQELLLSNNKI 157
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-12
Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
C + E D S K+ +P ++ + L + +N+L LP+ +L +LD+ N
Sbjct: 2 CTVSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
++ L + L+ LNLQ+N+L
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNEL 85
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 56/192 (29%), Positives = 75/192 (39%), Gaps = 50/192 (26%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---E 911
E+ +LRH IV I + HL AI MEY GG + I
Sbjct: 66 EIINHRSLRHPNIVRFK-EVILTP----------THL---AIIMEYASGGELYERICNAG 111
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
+ SE A F Q + + + HS I HRD+K EN L+D P +K
Sbjct: 112 RFSE--------DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD-----GSPAPRLK 158
Query: 972 LCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEVDI 1028
+CDF ++ L S + GTP ++APEVL Y G D+
Sbjct: 159 ICDFGYSKSSVLHSQPKSTV-------------GTPAYIAPEVLLR----QEYDGKIADV 201
Query: 1029 WSYGCLLLELLT 1040
WS G L +L
Sbjct: 202 WSCGVTLYVMLV 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 65/310 (20%), Positives = 115/310 (37%), Gaps = 75/310 (24%)
Query: 832 VRTLKV-CGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHH 890
V+ LK S + + +F + EV + +L H ++ +YG + P
Sbjct: 51 VKCLKPDVLSQPEAMDDF----IREVNAMHSLDHRNLIRLYG--VVL-------TPP--- 94
Query: 891 LLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 950
++ + E GS+ + + K + H + A VA + L SK +HRD+
Sbjct: 95 -MK--MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147
Query: 951 KSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1008
+ N+L+ + +VK+ DF RA+P + P W
Sbjct: 148 AARNLLL-------ATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVP------FAWC 191
Query: 1009 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLI-QMGKRPRLT 1066
APE L+ + D W +G L E+ T Q P++GL+ +I I + G+R
Sbjct: 192 APESLKT----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---- 243
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1126
L C P+ + +V +C P +RPT L + +
Sbjct: 244 --LPRPEDC--------------PQD-------IYNVMVQCWAHKPEDRPTFVALRDFLL 280
Query: 1127 ARTSSSISSR 1136
+ + +
Sbjct: 281 EAQPTDMRAE 290
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 30/170 (17%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 138 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRS--FLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
+R A +KL DF A S L T C TP ++APEVL
Sbjct: 195 TSKRPNAI----LKLTDFGFAKETTSHNSLTTPC-------------YTPYYVAPEVL-- 235
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 1061
P Y D+WS G ++ LL P+ + I+MG+
Sbjct: 236 --GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 56/194 (28%), Positives = 83/194 (42%), Gaps = 56/194 (28%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 910
E++ L RH I+++Y IS+ + F MEYV GG + +YI
Sbjct: 61 EIQNLKLFRHPHIIKLY-QVISTP---------------TDFFMVMEYVSGGELFDYICK 104
Query: 911 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 969
++ E A + Q + +A+ H ++HRD+K EN+L+D
Sbjct: 105 HGRVEE--------MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN------- 149
Query: 970 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1026
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 192
Query: 1027 DIWSYGCLLLELLT 1040
DIWS G +L LL
Sbjct: 193 DIWSCGVILYALLC 206
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 40/155 (25%), Positives = 59/155 (38%), Gaps = 37/155 (23%)
Query: 896 IFMEY-VKGGSVKNYIE---KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ +E + + +YI L E + V AA+ HS+ ++HRDIK
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGE--------GPSRCFFGQVVAAIQHCHSRGVVHRDIK 166
Query: 952 SENILIDLERKKADGKPVVKLCDFD-RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1010
ENILIDL R KL DF A+ GT + P
Sbjct: 167 DENILIDLRRGC------AKLIDFGSGALLHDEPYTDFD-------------GTRVYSPP 207
Query: 1011 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLTLQVP 1044
E + + Y L +WS G LL +++ +P
Sbjct: 208 EWISR----HQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-19
Identities = 52/227 (22%), Positives = 88/227 (38%), Gaps = 46/227 (20%)
Query: 846 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 905
R E L E ++L + +V + A + L + + GG
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLA----------YAYETKDALCL----VLTLMNGGD 270
Query: 906 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965
+K +I + G+ A+F A ++ L +LH + I++RD+K ENIL+D
Sbjct: 271 LKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD-----DH 322
Query: 966 GKPVVKLCDFDRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1023
G +++ D A VP + GT +MAPEV++ Y
Sbjct: 323 GH--IRISDLGLAVHVPEGQTIKGRV-------------GTVGYMAPEVVKNER----YT 363
Query: 1024 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
D W+ GCLL E++ Q P+ + + + +R E
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVPEE 407
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 2e-19
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 46/174 (26%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
MEYV GG + +I+++ E H A+F A ++A L L SK I++RD+K +N+++
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPH-----AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 958 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
D ++G +K+ DF T C GTP +
Sbjct: 476 D-----SEGH--IKIADFGMCKENIWDGVTT-------KTFC-------------GTPDY 508
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
+APE++ YG VD W++G LL E+L Q P+ G E E+ I
Sbjct: 509 IAPEIIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 68/320 (21%), Positives = 113/320 (35%), Gaps = 97/320 (30%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ LK +SAD +F E ++ + IV++ G A G P +
Sbjct: 82 VKMLKE-EASADMQADF----QREAALMAEFDNPNIVKLLG--------VCAVGKP---M 125
Query: 892 LQSAIFMEYVKGGSVKNY-------------------IEKLSETGEKHVSVKLALFIAQD 932
+ EY+ G + + ++S G +S L IA+
Sbjct: 126 C---LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
VAA + L + +HRD+ + N L+ VVK+ DF +
Sbjct: 183 VAAGMAYLSERKFVHRDLATRNCLVGENM-------VVKIADFGLS-------------- 221
Query: 993 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 1045
R I + D P RWM PE + N Y E D+W+YG +L E+ + PY
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESI----FYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 1046 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1105
G++ E+ ++ G PE L ++ R
Sbjct: 278 YGMAHEEVIYYVRDGNI------------------------LACPE---NCPLELYNLMR 310
Query: 1106 RCTEENPTERPTAGDLYEMF 1125
C + P +RP+ ++ +
Sbjct: 311 LCWSKLPADRPSFCSIHRIL 330
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 60/314 (19%), Positives = 107/314 (34%), Gaps = 95/314 (30%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++TLK + F E + L+H +V + G + +K P
Sbjct: 44 IKTLKD-KAEGPLREEF----RHEAMLRARLQHPNVVCLLG--VVTK------DQP---- 86
Query: 892 LQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVEL 940
++ Y G + + T + + + + +AA + L
Sbjct: 87 --LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144
Query: 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1000
S H++H+D+ + N+L+ + VK+ D R + A D
Sbjct: 145 SSHHVVHKDLATRNVLVYDKL-------NVKISDLGLF--------------REVYAADY 183
Query: 1001 CVGT-----P-RWMAPEVLRAMHKPNLYG---LEVDIWSYGCLLLELLTL-QVPYMGLSE 1050
P RWMAPE + +YG ++ DIWSYG +L E+ + PY G S
Sbjct: 184 YKLLGNSLLPIRWMAPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 1051 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1110
++ ++I+ + L C P + + C E
Sbjct: 237 QDVVEMIRNRQV------LPCPDDC--------------PAW-------VYALMIECWNE 269
Query: 1111 NPTERPTAGDLYEM 1124
P+ RP D++
Sbjct: 270 FPSRRPRFKDIHSR 283
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 50/233 (21%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 829 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 888
AK +KV G+ ++ E+ +L RH I+ ++ S + E
Sbjct: 34 MAKF--VKVKGTDQVLVKK-------EISILNIARHRNILHLHE---------SFESMEE 75
Query: 889 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948
++ E++ G + E+++ + + ++ ++ Q V AL LHS +I H
Sbjct: 76 LVMI-----FEFISGLDI---FERINTSAFELNEREIVSYVHQ-VCEALQFLHSHNIGHF 126
Query: 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1008
DI+ ENI+ + +++ +K+ +F +A L+ G + P +
Sbjct: 127 DIRPENII--YQTRRSS---TIKIIEFGQARQLKP----------GDNFRLLF-TAPEYY 170
Query: 1009 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
APEV + H D+WS G L+ LL+ P++ + +I + I +
Sbjct: 171 APEVHQ--HDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 52/233 (22%), Positives = 87/233 (37%), Gaps = 38/233 (16%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL------Q 120
+ + ++L+ N ++ +P + L L N + + L LE L Q
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS 175
++ P + L L L L + L E+ GL L L + +
Sbjct: 93 LRSVDPA----TFHGLGRLHTLHLDR--------CGLQELGPGLFRGLAALQYLYLQDNA 140
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-L 232
++ LP + L NL L L N++ +P L +L L + N++ + + L
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNLE 284
RL L L N L++L + L + LQ L L N W+C C
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN---------PWVCDCRAR 244
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 23/98 (23%), Positives = 44/98 (44%), Gaps = 5/98 (5%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
++ +P I + +++ L N++ ++P + L L + +N L + + L
Sbjct: 22 GLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79
Query: 233 QRLENLDLSNN-RLTSLGSLDLCLMHNLQNLNLQYNKL 269
LE LDLS+N +L S+ + L L+L L
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 15/82 (18%), Positives = 31/82 (37%), Gaps = 3/82 (3%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGS 250
++ +P I A + + N++ +P+ + L L L +N L + +
Sbjct: 16 TSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 251 LDLCLMHNLQNLNLQYNKLLSY 272
+ L+ L+L N L
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRS 95
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-19
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 33/168 (19%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENIL 956
MEY GG + ++ + E+ S A F ++ +AL LHS+ +++RD+K EN++
Sbjct: 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 957 IDLERKKADGKPVVKLCDF---DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013
+D DG +K+ DF + + + T C GTP ++APEVL
Sbjct: 282 LD-----KDGH--IKITDFGLCKEGIKDGATMKTFC-------------GTPEYLAPEVL 321
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
N YG VD W G ++ E++ ++P+ ++ +LI M +
Sbjct: 322 ED----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 365
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 48/243 (19%), Positives = 75/243 (30%), Gaps = 26/243 (10%)
Query: 64 RGGDNSVEGLYLYKNVL--NLIPKSVGRYEKLRNLKFFGNEIN-------LFPSEVGNLL 114
GG S+E L + + + L+ L I L + L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 115 GLECLQIKISSPGVNGFALNKLKGLKELELSKV--PPRPSVLTLLSEIAGLKCLTKLSVC 172
L ++++ L L L V R + L L + L LS+
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG-LKVLSIA 157
Query: 173 HFSIRYLP-PEIGCLSNLEQLDLSFNKM---KYLPTEICY--LKALISLKVANNKLVELP 226
++ L LDLS N + L + +C L L + N +
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 227 ----SGLYLLQRLENLDLSNNRLTSLGSLDLCL-MHNLQNLNLQYNKLLSYCQVPSWICC 281
+ +L+ LDLS+N L C L +LNL + L VP +
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ---VPKGLPA 274
Query: 282 NLE 284
L
Sbjct: 275 KLS 277
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 44/190 (23%), Positives = 73/190 (38%), Gaps = 20/190 (10%)
Query: 93 LRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF---ALNKLKGLKELELSK--- 146
LRN+ + + + +E+ L + I+ F + L L+LS
Sbjct: 128 LRNVSW--ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 147 VPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL----SNLEQLDLSFNKMKYL 202
+ R + L L L++ + + L L+ LDLS N ++
Sbjct: 186 LGERGLISALCPL--KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243
Query: 203 PTEI--CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
+ L SL ++ L ++P GL +L LDLS NRL S D + +
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLKQVPKGL--PAKLSVLDLSYNRLDRNPSPD--ELPQVG 299
Query: 261 NLNLQYNKLL 270
NL+L+ N L
Sbjct: 300 NLSLKGNPFL 309
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 5e-19
Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 27/245 (11%)
Query: 68 NSVEGLYLYKNVLNLIPK---SVGRYEKLRNLKFFGNEINLFPS----EVGNLLGLECLQ 120
NS++ + N + L+ + + + L N + S + N L+
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 121 -IKISSPG----VNGFALNKLKGLKELELSKVPPRPSVLTL----LSEI-----AGLKC- 165
+ +S G + G N + + L + + AGL
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLIL-AHHIMGAGFGFHNIKDPDQNTFAGLARS 266
Query: 166 -LTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKL 222
+ L + H + L + L +L+ L+L++NK+ + E L L L ++ N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 223 VELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281
EL S Y L ++ +DL N + + + LQ L+L+ N L + +PS
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDI 386
Query: 282 NLEGN 286
L GN
Sbjct: 387 FLSGN 391
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-16
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 21/213 (9%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
V + L KN + +I ++ EKL+ L N + + ++ + K+ +
Sbjct: 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF-IPSIPDIFLSGNKLVTLP 397
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC-- 185
N + L E L + L + + L L + +
Sbjct: 398 KINLTANLIH-LSENRLENLDI-------LYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449
Query: 186 LSNLEQLDLSFNKMKYLP-TEIC-----YLKALISLKVANNKLVELPSGLYL-LQRLENL 238
+LEQL L N ++ TE+C L L L + +N L LP G++ L L L
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L++NRLT L D L NL+ L++ N+LL+
Sbjct: 510 SLNSNRLTVLSHND--LPANLEILDISRNQLLA 540
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-15
Identities = 41/240 (17%), Positives = 77/240 (32%), Gaps = 49/240 (20%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFF---GNEINLFPSEV-GNLLGLECLQI--- 121
++ L L N +N I + L NL+ N + S L + + +
Sbjct: 291 DLKVLNLAYNKINKIADEA--FYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181
I+ + L+ L+ L+L L+ I + + + + + LP
Sbjct: 349 HIAI--IQDQTFKFLEKLQTLDLRD--------NALTTIHFIPSIPDIFLSGNKLVTLPK 398
Query: 182 E----------------------IGCLSNLEQLDLSFNKMKYLPTE--ICYLKALISLKV 217
+ + +L+ L L+ N+ + +L L +
Sbjct: 399 INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458
Query: 218 ANNKLVEL------PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
N L L L+ L L++N L SL + L+ L+L N+L
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV 518
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 4e-14
Identities = 47/194 (24%), Positives = 75/194 (38%), Gaps = 17/194 (8%)
Query: 112 NLLGLECLQI---KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLT 167
L E L + I + V + L+ L+ LEL + + LT+ E L L
Sbjct: 22 VLNTTERLLLSFNYIRT--VTASSFPFLEQLQLLELGS---QYTPLTIDKEAFRNLPNLR 76
Query: 168 KLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYL---PTEICYLKALISLKVANNKLV 223
L + I +L P+ L +L +L L F + LKAL L ++ N++
Sbjct: 77 ILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
Query: 224 ELPSGLYL--LQRLENLDLSNNRLTSLGSLDLCLMH--NLQNLNLQYNKLLSYCQVPSWI 279
L L L+++D S+N++ + +L + L +L N L S V
Sbjct: 137 SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK 196
Query: 280 CCNLEGNGKDSSND 293
C N N D
Sbjct: 197 CMNPFRNMVLEILD 210
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 25/123 (20%), Positives = 52/123 (42%), Gaps = 8/123 (6%)
Query: 165 CLTKLSVCHF-SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKL 222
+++ F ++ +P L+ E+L LSFN ++ + +L+ L L++ +
Sbjct: 4 FDGRIAFYRFCNLTQVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 223 -VELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+ + + L L LDL ++++ L + +L L L + LS +
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCG-LSDAVLKDGYF 119
Query: 281 CNL 283
NL
Sbjct: 120 RNL 122
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 6e-19
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 29/163 (17%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
++ + GG + ++ + S F A ++ L +H++ +++RD+K NIL+
Sbjct: 271 LDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFL-HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1016
D G V++ D A H GT +MAPEVL+
Sbjct: 326 D-----EHGH--VRISDLGLACDFSKKKPHASV-------------GTHGYMAPEVLQKG 365
Query: 1017 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQM 1059
Y D +S GC+L +LL P+ + H++ +M
Sbjct: 366 VA---YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 6e-19
Identities = 55/225 (24%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+E L L +N + I L L+ F N + P+ L L+ L + I
Sbjct: 89 HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI 148
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPP 181
S + +A N++ L+ L+L ++ L+ +SE A GL L L++ ++R +P
Sbjct: 149 ES--IPSYAFNRIPSLRRLDLGELKR----LSYISEGAFEGLSNLRYLNLAMCNLREIP- 201
Query: 182 EIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLD 239
+ L L++LDLS N + + L L L + +++ + + LQ L ++
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L++N LT L +H+L+ ++L +N W C C++
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHHN---------PWNCNCDI 297
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 28/216 (12%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
+ L L++N + +I + L L+ N I G GL L
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI--GAFNGLANLNTLELFDN 122
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHF-S 175
++++ + A L LKEL L + I + L +L +
Sbjct: 123 RLTT--IPNGAFVYLSKLKELWLRN--------NPIESIPSYAFNRIPSLRRLDLGELKR 172
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQ 233
+ Y+ LSNL L+L+ ++ +P + L L L ++ N L + G L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLM 231
Query: 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L+ L + +++ + + +L +NL +N L
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 6e-16
Identities = 51/217 (23%), Positives = 85/217 (39%), Gaps = 29/217 (13%)
Query: 67 DNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECL-----Q 120
N + + L +P + R L N+I + + +L LE L
Sbjct: 42 SNQFSKVICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS 175
I+ G A N L L LEL L+ I L L +L + +
Sbjct: 100 IRTIEIG----AFNGLANLNTLELFD--------NRLTTIPNGAFVYLSKLKELWLRNNP 147
Query: 176 IRYLPPEI-GCLSNLEQLDLS-FNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYLL 232
I +P + +L +LDL ++ Y+ L L L +A L E+P+ L L
Sbjct: 148 IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPN-LTPL 206
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+L+ LDLS N L+++ + +LQ L + +++
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 72/316 (22%), Positives = 115/316 (36%), Gaps = 93/316 (29%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 890
V+ LK + E + E+++L L H IV + G G P
Sbjct: 58 VKMLKP-SAHLTEREAL----MSELKVLSYLGNHMNIVNLLGA--------CTIGGP--- 101
Query: 891 LLQSAIFMEYVKGGSVKNY-------------IEKLSETGEKHVSVKLALFIAQDVAAAL 937
L + EY G + N+ + E E + ++ L + VA +
Sbjct: 102 TL---VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 938 VELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 997
L SK+ +HRD+ + NIL+ R + K+CDF A R I
Sbjct: 159 AFLASKNCIHRDLAARNILLTHGR-------ITKICDFGLA--------------RDIKN 197
Query: 998 PDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSE 1050
V P +WMAPE + +Y E D+WSYG L EL +L PY G+
Sbjct: 198 DSNYVVKGNARLPVKWMAPESI----FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 1051 -LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109
+ + +I+ G R PE + + D+ + C +
Sbjct: 254 DSKFYKMIKEGFR------------------------MLSPE---HAPAEMYDIMKTCWD 286
Query: 1110 ENPTERPTAGDLYEMF 1125
+P +RPT + ++
Sbjct: 287 ADPLKRPTFKQIVQLI 302
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 9e-19
Identities = 53/299 (17%), Positives = 99/299 (33%), Gaps = 78/299 (26%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++ LK G+ + + E +++ L + IV + G + +
Sbjct: 368 IKVLKQ-GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM----------- 411
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ ME GG + ++ + + V + V+ + L K+ +HR++
Sbjct: 412 ----LVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463
Query: 952 SENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRG--IPAPDVCVGTPRW 1007
+ N+L+ K+ DF +A+ +T A P +W
Sbjct: 464 ARNVLLVNRH-------YAKISDFGLSKALGADDSYYT---ARSAGKWPL--------KW 505
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1066
APE + + D+WSYG + E L+ Q PY + E+ I+ GKR
Sbjct: 506 YAPECINF----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 557
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+E C P L + C +RP + +
Sbjct: 558 --MECPPEC--------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQRM 593
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-18
Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 23/210 (10%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
L L N L LIP V L L N+I + + +L L+ L++ +
Sbjct: 85 LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY-- 142
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFSIRYLPPE 182
++ A + L L++L L K L+ I + L L L + H +I +
Sbjct: 143 ISHRAFSGLNSLEQLTLEK--------CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 183 I-GCLSNLEQLDLSFNK-MKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLD 239
L L+ L++S + + Y L SL + + L +P + L L L+
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLN 254
Query: 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
LS N ++++ L + LQ + L +L
Sbjct: 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQL 284
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-18
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+++ L + N L I L L + P+E +L GL L++ I
Sbjct: 129 NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188
Query: 124 SSPGVNGFALNKLKGLKELELSKVP----PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL 179
++ + ++ +L LK LE+S P P+ L L+ LT LS+ H ++ +
Sbjct: 189 NA--IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN-------LTSLSITHCNLTAV 239
Query: 180 PPE-IGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLLQRLE 236
P + L L L+LS+N + + + L L +++ +L + L L
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR 299
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNLE 284
L++S N+LT+L + NL+ L L N C C L
Sbjct: 300 VLNVSGNQLTTLEESVFHSVGNLETLILDSN---------PLACDCRLL 339
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-18
Identities = 48/204 (23%), Positives = 74/204 (36%), Gaps = 22/204 (10%)
Query: 93 LRNLKFFGNEI-NLFPSEVGNLLGLECLQI---KISSPGVNGFALNKLKGLKELELSKVP 148
R L N I L E + LE L++ +S+ V A N L L+ L L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA--VEPGAFNNLFNLRTLGLRS-- 89
Query: 149 PRPSVLTLLSEI-----AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYL 202
L I GL LTKL + I L + L NL+ L++ N + Y+
Sbjct: 90 ------NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI 143
Query: 203 PTEI-CYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260
L +L L + L +P+ L L L L L + + ++ ++ L+
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 261 NLNLQYNKLLSYCQVPSWICCNLE 284
L + + L NL
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLT 227
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-11
Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 4/97 (4%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
+P I + LDL N++K L + L L++ N + + G L
Sbjct: 22 RFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNL 79
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L L +NRL + + NL L++ NK+
Sbjct: 80 FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKI 116
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 13/51 (25%), Positives = 22/51 (43%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ V +P G+ LDL NR+ +L + +L+ L L N +
Sbjct: 20 RKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 68/312 (21%), Positives = 112/312 (35%), Gaps = 89/312 (28%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 890
V+ LK + ADE + E++++ L +H IV + G G P
Sbjct: 81 VKMLKS-TAHADEKEAL----MSELKIMSHLGQHENIVNLLGA--------CTHGGP--- 124
Query: 891 LLQSAIFMEYVKGGSVKNY---------IEKLSETGEKHVSVKLALFIAQDVAAALVELH 941
+L + EY G + N+ + S + L + VA + L
Sbjct: 125 VL---VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC 1001
SK+ +HRD+ + N+L+ +G V K+ DF A R I
Sbjct: 182 SKNCIHRDVAARNVLL------TNGH-VAKIGDFGLA--------------RDIMNDSNY 220
Query: 1002 VGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMG-LSELEI 1053
+ P +WMAPE + +Y ++ D+WSYG LL E+ +L PY G L +
Sbjct: 221 IVKGNARLPVKWMAPESI----FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
Query: 1054 HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113
+ L++ G + +P + + + C PT
Sbjct: 277 YKLVKDGYQ------------------------MAQPA---FAPKNIYSIMQACWALEPT 309
Query: 1114 ERPTAGDLYEMF 1125
RPT +
Sbjct: 310 HRPTFQQICSFL 321
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 34/162 (20%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 89 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV----CVGTPRWMAPEVL 1013
D ++G +KL D+ + G+ D C GTP ++APE+L
Sbjct: 144 D-----SEGH--IKLTDY-------------GMCKEGLRPGDTTSTFC-GTPNYIAPEIL 182
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1055
R YG VD W+ G L+ E++ + P+ + + D
Sbjct: 183 RG----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-18
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 32/171 (18%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
M + GG ++ +I + E A+F + + L LH ++I++RD+K EN+L+
Sbjct: 264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSF---LHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
D DG V++ D AV L++ GTP +MAPE+L
Sbjct: 323 D-----DDGN--VRISDLGLAVELKAGQTKTKGYA-------------GTPGFMAPELLL 362
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL----EIHDLIQMGK 1061
Y VD ++ G L E++ + P+ E E+ +
Sbjct: 363 GEE----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 43/217 (19%), Positives = 68/217 (31%), Gaps = 38/217 (17%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGF 131
L N L + V + L L N + S L L+C K +
Sbjct: 111 LNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL---- 164
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
+ L L+ S + +T L +++ K L +L+ +I L + L
Sbjct: 165 DVTPQTQLTTLDCSF-----NKITEL-DVSQNKLLNRLNCDTNNITKLD--LNQNIQLTF 216
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL--- 248
LD S NK+ + + L L + N L EL L +L L L +
Sbjct: 217 LDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVST--LSKLTTLHCIQTDLLEIDLT 272
Query: 249 ----------------GSLDLCLMHNLQNLNLQYNKL 269
LD+ L L+ Q +
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-17
Identities = 39/171 (22%), Positives = 65/171 (38%), Gaps = 18/171 (10%)
Query: 101 NEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI 160
+ + FP + N ++ + + + +L L L+ S +T ++ I
Sbjct: 10 SFNDWFPDD--NFASEVAAAFEMQA--TDTISEEQLATLTSLDCHN-----SSITDMTGI 60
Query: 161 AGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
L LTKL +I L + +NL L NK+ L + L L L N
Sbjct: 61 EKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYLNCDTN 116
Query: 221 KLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
KL +L L L+ + N LT +D+ L L+ NK ++
Sbjct: 117 KLTKLDVSQ--NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKIT 162
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 37/221 (16%), Positives = 74/221 (33%), Gaps = 32/221 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
+ L N + + V + + L L N I + + L L K++
Sbjct: 170 TQLTTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLT 225
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHF-SIRYL 179
+ L L + S P ++ LS++ L C L ++ + H + Y
Sbjct: 226 E-----IDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYF 280
Query: 180 ---------PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY 230
++ + L LD + L + L+ L + N +L EL +
Sbjct: 281 QAEGCRKIKELDVTHNTQLYLLDCQAAGITELD--LSQNPKLVYLYLNNTELTELD--VS 336
Query: 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L++L N + S + + L N + ++
Sbjct: 337 HNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTIT 375
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 33/198 (16%), Positives = 59/198 (29%), Gaps = 20/198 (10%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGF 131
L N L I V +L N + S + L L C+Q +
Sbjct: 217 LDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLE-----I 269
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQ 191
L L + + L ++ L L I L + L
Sbjct: 270 DLTHNTQLIYFQAEGCRK----IKEL-DVTHNTQLYLLDCQAAGITELD--LSQNPKLVY 322
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
L L+ ++ L + + L SL N + + S + + L N + + ++
Sbjct: 323 LYLNNTELTELD--VSHNTKLKSLSCVNAHIQDFSS-VGKIPALNNNFEAEGQTITMPKE 379
Query: 252 DLCLMHNLQNLNLQYNKL 269
L N + + + L
Sbjct: 380 TLTN--NSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 27/194 (13%), Positives = 61/194 (31%), Gaps = 25/194 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGF 131
N L + S KL L ++ + + L+ + +
Sbjct: 238 FDCSVNPLTELDVS--TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKEL---- 291
Query: 132 ALNKLKGLKELELSK-------VPPRPSVLTL------LSEI--AGLKCLTKLSVCHFSI 176
+ L L+ + P ++ L L+E+ + L LS + I
Sbjct: 292 DVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHI 351
Query: 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236
+ +G + L + + +P E +L ++ V+ + L + + + +
Sbjct: 352 QDFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDG 409
Query: 237 N-LDLSNNRLTSLG 249
D + N +T
Sbjct: 410 GVYDQATNTITWEN 423
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-18
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI------ 121
+E L L +N + I L L+ F N + + PS L L+
Sbjct: 100 HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGA--FEYLSKLRELWLRNN 157
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYL 179
I S + +A N++ L L+L ++ L +SE A GL L L++ +I+ +
Sbjct: 158 PIES--IPSYAFNRVPSLMRLDLGELKK----LEYISEGAFEGLFNLKYLNLGMCNIKDM 211
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLEN 237
P + L LE+L++S N + L +L L V N+++ + L L
Sbjct: 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVE 270
Query: 238 LDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L+L++N L+SL + L L+L +N W C C++
Sbjct: 271 LNLAHNNLSSLPHDLFTPLRYLVELHLHHN---------PWNCDCDI 308
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 44/214 (20%), Positives = 81/214 (37%), Gaps = 24/214 (11%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KI 123
+ L L +N + +I L L+ N I L L L++ +
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 124 SSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHF-SIR 177
+ + A L L+EL L + I + L +L + +
Sbjct: 136 TV--IPSGAFEYLSKLRELWLRN--------NPIESIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 178 YLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL-LQRL 235
Y+ L NL+ L+L +K +P + L L L+++ N E+ G + L L
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+ L + N++++ + + +L LNL +N L
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 9e-12
Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 4/97 (4%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG-LYLL 232
+ +P I SN L+L N ++ + + +L L L++ N + ++ G L
Sbjct: 65 GLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGL 122
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L L+L +N LT + S + L+ L L+ N +
Sbjct: 123 ASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI 159
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 42/259 (16%), Positives = 97/259 (37%), Gaps = 24/259 (9%)
Query: 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYL 75
GP+ + + I + DD+ + + + + NS++ +
Sbjct: 1 GPLGSETITVPTPIKQIFS-------DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIA 53
Query: 76 YKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPGVNGFA 132
+ + + + + + L GN++ + NL L L + K+ ++
Sbjct: 54 NNSDIKSV-QGIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVKD--LSS-- 107
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
L LK LK L L + ++ ++ + L L L + + I + + L+ L+ L
Sbjct: 108 LKDLKKLKSLSLEH-----NGISDINGLVHLPQLESLYLGNNKITDITV-LSRLTKLDTL 161
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
L N++ + + L L +L ++ N + +L L L+ L+ L+L + +
Sbjct: 162 SLEDNQISDIV-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPINH 219
Query: 253 LCLMHNLQNLNLQYNKLLS 271
+ + L++
Sbjct: 220 QSNLVVPNTVKNTDGSLVT 238
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 68/307 (22%), Positives = 117/307 (38%), Gaps = 81/307 (26%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 890
++ +K +S D+ R+F GE+ +L L H I+ + G +
Sbjct: 57 IKRMKE-YASKDDHRDF----AGELEVLCKLGHHPNIINLLGA--------CEHRGYLY- 102
Query: 891 LLQSAIFMEYVKGGSVKNY-----------IEKLSETGEKHVSVKLALFIAQDVAAALVE 939
+ +EY G++ ++ ++ + +S + L A DVA +
Sbjct: 103 -----LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
L K +HRD+ + NIL+ V K+ DF + R +P
Sbjct: 158 LSQKQFIHRDLAARNILVGENY-------VAKIADFGLS---RGQEVYVKKTMGRLPV-- 205
Query: 1000 VCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQ 1058
RWMA E L ++Y D+WSYG LL E+++L PY G++ E+++ +
Sbjct: 206 ------RWMAIESLNY----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 1059 MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118
G R LE +C + + D+ R+C E P ERP+
Sbjct: 256 QGYR------LEKPLNC--------------DDE-------VYDLMRQCWREKPYERPSF 288
Query: 1119 GDLYEMF 1125
+
Sbjct: 289 AQILVSL 295
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 6e-18
Identities = 49/236 (20%), Positives = 74/236 (31%), Gaps = 51/236 (21%)
Query: 62 GNRGGDNSVEGLYLYKNVLN---LIPKSVGRYEKLRNLKFFGNEINLF----PSEVGNLL 114
V L L L IP S+ L L G N P + L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI--NNLVGPIPPAIAKLT 101
Query: 115 GLECLQIKISSPGVNGF------ALNKLKGLKELELS------KVPPRPSVLTLLSEIAG 162
L L I L+++K L L+ S +PP S L L I
Sbjct: 102 QLHYLYI-----THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT- 155
Query: 163 LKCLTKLSVCHFS--IRYLPPEIGCLSNLEQ-LDLSFNKMK-YLPTEICYLKALISLKVA 218
S I P G S L + +S N++ +P L L + ++
Sbjct: 156 ------FDGNRISGAI---PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLS 205
Query: 219 NNKLV-ELPSGLYLLQRLENLDLSNNRLT----SLGSLDLCLMHNLQNLNLQYNKL 269
N L + + + + L+ N L +G NL L+L+ N++
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS-----KNLNGLDLRNNRI 256
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 47/202 (23%), Positives = 75/202 (37%), Gaps = 49/202 (24%)
Query: 83 IPKSVGRYEKLRNLKFFGNEIN---LFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGL 139
+ + + ++ NL G + PS + NL L L I +N L G
Sbjct: 42 LCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI---------GGINNLVG- 91
Query: 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKL--SVCHFS--IRYLPPEIGCLSNLEQLDLS 195
+PP IA L L L + + S I P + + L LD S
Sbjct: 92 ------PIPP---------AIAKLTQLHYLYITHTNVSGAI---PDFLSQIKTLVTLDFS 133
Query: 196 FNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRL-ENLDLSNNRLT-----S 247
+N + LP I L L+ + N++ +P +L ++ +S NRLT +
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 248 LGSLDLCLMHNLQNLNLQYNKL 269
+L NL ++L N L
Sbjct: 194 FANL------NLAFVDLSRNML 209
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 9e-15
Identities = 51/211 (24%), Positives = 75/211 (35%), Gaps = 47/211 (22%)
Query: 73 LYLYKNVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPGVNG 130
L N L+ +P S+ L + F GN I+ P G+ L + IS
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF-TSMTISR----- 183
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK--LSVCHFS--IRYLPPEIGCL 186
N+L G K+PP A L L LS G
Sbjct: 184 ---NRLTG-------KIPP---------TFANLN-LAFVDLSRNMLEGDA---SVLFGSD 220
Query: 187 SNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNR 244
N +++ L+ N + L ++ K L L + NN++ LP GL L+ L +L++S N
Sbjct: 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 245 LT----SLGSLDLCLMHNLQNLNLQYNKLLS 271
L G+L NK L
Sbjct: 280 LCGEIPQGGNLQ-----RFDVSAYANNKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 40/202 (19%), Positives = 68/202 (33%), Gaps = 55/202 (27%)
Query: 69 SVEGLYLYKNVLN-LIPKSVGRYEKL-RNLKFFGNEIN-LFPSEVGNLLGLECLQI---- 121
++ G+ N ++ IP S G + KL ++ N + P NL L + +
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNM 208
Query: 122 ---KISSPGVNGFALNKLKGLKELELSKVPPRPSVLT-LLSEIAGLKCLTKLSVCH--FS 175
S K +++ L+K + L L ++ K L L + +
Sbjct: 209 LEGDASV------LFGSDKNTQKIHLAK-----NSLAFDLGKVGLSKNLNGLDLRNNRIY 257
Query: 176 --IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLL 232
+ P + L L L++SF N L E+P G L
Sbjct: 258 GTL---PQGLTQLKFLHSLNVSF-----------------------NNLCGEIPQGG-NL 290
Query: 233 QRLENLDLSNNRLTSLGSLDLC 254
QR + +NN+ L C
Sbjct: 291 QRFDVSAYANNKCLCGSPLPAC 312
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 46/168 (27%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
+EYV GG + ++++ + E+H A F + +++ AL LH + I++RD+K +N+L+
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 958 DLERKKADGKPVVKLCDF----------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
D ++G +KL D+ D T C GTP +
Sbjct: 187 D-----SEGH--IKLTDYGMCKEGLRPGDTT-------STFC-------------GTPNY 219
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1055
+APE+LR YG VD W+ G L+ E++ + P+ + + D
Sbjct: 220 IAPEILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 38/207 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ ++ L H ++ ++ + + E L +E++ GG + ++++
Sbjct: 98 EISIMNQLHHPKLINLHD---------AFEDKYEMVL-----ILEFLSGGEL---FDRIA 140
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
K ++ ++ Q L +H I+H DIK ENI+ E KKA VK+ D
Sbjct: 141 AEDYKMSEAEVINYMRQ-ACEGLKHMHEHSIVHLDIKPENIM--CETKKAS---SVKIID 194
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A L T + APE++ +P G D+W+ G L
Sbjct: 195 FGLATKLNP----------DEIVKVTT-ATAEFAAPEIVD--REP--VGFYTDMWAIGVL 239
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGK 1061
LL+ P+ G +LE ++
Sbjct: 240 GYVLLSGLSPFAGEDDLETLQNVKRCD 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 8e-18
Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 38/207 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E++ + LRH +V ++ + + + E ++ E++ GG + +
Sbjct: 204 EIQTMSVLRHPTLVNLHD---------AFEDDNEMVMI-----YEFMSGGELFEKV--AD 247
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E +S A+ + V L +H + +H D+K ENI+ +R +KL D
Sbjct: 248 EHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-----LKLID 300
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F L GT + APEV KP G D+WS G L
Sbjct: 301 FGLTAHLDP----------KQSVKVTT-GTAEFAAPEVAE--GKP--VGYYTDMWSVGVL 345
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGK 1061
LL+ P+ G ++ E ++
Sbjct: 346 SYILLSGLSPFGGENDDETLRNVKSCD 372
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-17
Identities = 54/242 (22%), Positives = 86/242 (35%), Gaps = 58/242 (23%)
Query: 844 EIRNFEYSCLGEVRMLGALRHSCIVEMY----GHKISSKWLPSADGNPEHHLLQSAIFME 899
E S E+ +L L+H ++ + H WL +
Sbjct: 57 EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL----------------LFD 100
Query: 900 YVKGGSVKNYIEKLSETGEKHVSVKLAL-----FIAQDVAAALVELHSKHIMHRDIKSEN 954
Y + + + I+ + V+L + Q + + LH+ ++HRD+K N
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-ILDGIHYLHANWVLHRDLKPAN 158
Query: 955 ILIDLERKKADGKPVVKLCDFDRA----VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-A 1009
IL+ E + VK+ D A PL+ D V T W A
Sbjct: 159 ILVMGE---GPERGRVKIADMGFARLFNSPLKPLAD-----------LDPVVVT-FWYRA 203
Query: 1010 PEVL-RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1068
PE+L A H Y +DIW+ GC+ ELLT + + E P D+
Sbjct: 204 PELLLGARH----YTKAIDIWAIGCIFAELLTSEPIFHCRQE------DIKTSNPYHHDQ 253
Query: 1069 LE 1070
L+
Sbjct: 254 LD 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 17/204 (8%)
Query: 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KISSPG 127
GL L N + + + K+ L+ GN + S + L ++ L + +I+
Sbjct: 66 IGLELKDNQITDLA-PLKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDV- 122
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLS 187
L L L+ L L + +T +S +AGL L LS+ + + L P + LS
Sbjct: 123 ---TPLAGLSNLQVLYLDL-----NQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLS 173
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247
L L NK+ + + L LI + + NN++ ++ S L L + L+N +T+
Sbjct: 174 KLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDV-SPLANTSNLFIVTLTNQTITN 231
Query: 248 LGSLDLCLMHNLQNLNLQYNKLLS 271
+ + ++
Sbjct: 232 QPVFYNNNLVVPNVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 10/139 (7%)
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
F L ++ K S +T A L +T LS + + + L+NL
Sbjct: 13 FPDPALANAIKIAAGK-----SNVTDTVTQADLDGITTLSAFGTGVTTIEG-VQYLNNLI 66
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L+L N++ L + L + L+++ N L + S + LQ ++ LDL++ ++T +
Sbjct: 67 GLELKDNQITDLA-PLKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDVT- 123
Query: 251 LDLCLMHNLQNLNLQYNKL 269
L + NLQ L L N++
Sbjct: 124 -PLAGLSNLQVLYLDLNQI 141
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-17
Identities = 58/194 (29%), Positives = 84/194 (43%), Gaps = 56/194 (28%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 910
E++ L RH I+++Y IS+ S IF MEYV GG + +YI
Sbjct: 66 EIQNLKLFRHPHIIKLY-QVISTP---------------SDIFMVMEYVSGGELFDYICK 109
Query: 911 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 969
+L E K + + Q + + + H ++HRD+K EN+L+D
Sbjct: 110 NGRLDE--------KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN------- 154
Query: 970 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1026
K+ DF + + FL T C G+P + APEV+ LY G EV
Sbjct: 155 AKIADFGLSNMMSDGEFLRTSC-------------GSPNYAAPEVISG----RLYAGPEV 197
Query: 1027 DIWSYGCLLLELLT 1040
DIWS G +L LL
Sbjct: 198 DIWSSGVILYALLC 211
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 57/194 (29%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYI-- 910
E+ L LRH I+++Y I++ + I +EY GG + +YI
Sbjct: 59 EISYLKLLRHPHIIKLY-DVITTP---------------TDIVMVIEYA-GGELFDYIVE 101
Query: 911 -EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 969
++++E Q + A+ H I+HRD+K EN+L+D
Sbjct: 102 KKRMTE--------DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN------- 146
Query: 970 VKLCDFDRAVPLR--SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY-GLEV 1026
VK+ DF + + +FL T C G+P + APEV+ LY G EV
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSC-------------GSPNYAAPEVING----KLYAGPEV 189
Query: 1027 DIWSYGCLLLELLT 1040
D+WS G +L +L
Sbjct: 190 DVWSCGIVLYVMLV 203
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 30/182 (16%), Positives = 72/182 (39%), Gaps = 14/182 (7%)
Query: 91 EKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPP 149
+ N + N+ +++ +L + I ++ + G + +K+L ++
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD--LTG--IEYAHNIKDLTINN--- 75
Query: 150 RPSVLTLLSEIAGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEIC 207
T + I+GL L +L + + P + L++L LD+S + + T+I
Sbjct: 76 --IHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 208 YLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267
L + S+ ++ N + L L L++L++ + + ++ L L
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQ 191
Query: 268 KL 269
+
Sbjct: 192 TI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 24/148 (16%), Positives = 53/148 (35%), Gaps = 9/148 (6%)
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
S + K L + S + A + LT +++ + ++ L I
Sbjct: 11 SQDNVNIPDSTFKAYLNGLLGQ----SSTANI--TEAQMNSLTYITLANINVTDLTG-IE 63
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNN 243
N++ L ++ I L L L++ + + L L L LD+S++
Sbjct: 64 YAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+ + + +++L YN ++
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAIT 150
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 28/184 (15%), Positives = 62/184 (33%), Gaps = 23/184 (12%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L ++ I ++ + L + + + + ++ L +P
Sbjct: 28 GLLGQSSTANITEA--QMNSLTYITLANINVTDL-TGIEYAHNIKDLTINNIHATNYNP- 83
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLT--LLSEIAGLKCLTKLSVCHFSIRYLPPE-IG 184
++ L L+ L + +T + ++GL LT L + H + I
Sbjct: 84 -----ISGLSNLERLRIMG-----KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L + +DLS+N + L L SL + + + + G+ +L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY-RGIEDFPKLNQLYAFSQT 192
Query: 245 LTSL 248
+
Sbjct: 193 IGGK 196
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 50/213 (23%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYI---- 910
E+ ++ L H+ ++++Y + + + L MEYV GG + + I
Sbjct: 136 EISVMNQLDHANLIQLYD---------AFESKNDIVL-----VMEYVDGGELFDRIIDES 181
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
L+E + + + + +H +I+H D+K ENIL + A +
Sbjct: 182 YNLTE--------LDTILFMKQICEGIRHMHQMYILHLDLKPENIL--CVNRDAK---QI 228
Query: 971 KLCDFDRAVPL--RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028
K+ DF A R L GTP ++APEV+ + D+
Sbjct: 229 KIIDFGLARRYKPREKLKVNF-------------GTPEFLAPEVVN--YDF--VSFPTDM 271
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGK 1061
WS G + LL+ P++G ++ E + I +
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 304
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 36/151 (23%), Positives = 52/151 (34%), Gaps = 33/151 (21%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ MEY G E L EK V A + L LHS+ I+H+DIK N+
Sbjct: 85 MVMEYCVCGMQ----EMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNL 140
Query: 956 LIDLERKKADGKPVVKLCDF-----DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAP 1010
L+ +K+ T G+P + P
Sbjct: 141 LLTTGGT-------LKISALGVAEALHPFAADDTCRTSQ-------------GSPAFQPP 180
Query: 1011 EVLRAMHKPNLY-GLEVDIWSYGCLLLELLT 1040
E+ + + G +VDIWS G L + T
Sbjct: 181 EIANGLD---TFSGFKVDIWSAGVTLYNITT 208
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 1e-16
Identities = 44/271 (16%), Positives = 98/271 (36%), Gaps = 21/271 (7%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI---KIS 124
NS++ + + + + + + + L GN++ + NL L L + KI
Sbjct: 43 NSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDI-KPLTNLKNLGWLFLDENKIK 100
Query: 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIG 184
++ L LK LK L L + ++ ++ + L L L + + I + +
Sbjct: 101 D--LSS--LKDLKKLKSLSLEH-----NGISDINGLVHLPQLESLYLGNNKITDITV-LS 150
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
L+ L+ L L N++ + + L L +L ++ N + +L L L+ L+ L+L +
Sbjct: 151 RLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQE 208
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDV 304
+ + + L++ P I + + + ++ +
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSLVT----PEIISDDGDYEKPNVKWHLPEFTNEVSFI 264
Query: 305 YEGPMLENDGNVSFSGSRHTSSSISTVSSSN 335
+ P+ F G S +
Sbjct: 265 FYQPVTIGKAKARFHGRVTQPLKEVYTVSYD 295
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 73.2 bits (179), Expect = 3e-13
Identities = 25/117 (21%), Positives = 53/117 (45%), Gaps = 6/117 (5%)
Query: 155 TLLSEIAGLKCLTKLSVCHFSIRYL--PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL 212
T + +I + + + + L++++Q+ + + +K + I YL +
Sbjct: 9 TPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV-QGIQYLPNV 67
Query: 213 ISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L + NKL ++ L L+ L L L N++ L SL L++L+L++N +
Sbjct: 68 TKLFLNGNKLTDI-KPLTNLKNLGWLFLDENKIKDLSSLKDL--KKLKSLSLEHNGI 121
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 11/81 (13%), Positives = 27/81 (33%), Gaps = 4/81 (4%)
Query: 189 LEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL 248
+ + +K + I + + + L ++ + +N+ + S+
Sbjct: 1 MGETITVSTPIKQIFP-DDAFAETIKDNLKKKSVTDA-VTQNELNSIDQIIANNSDIKSV 58
Query: 249 GSLDLCLMHNLQNLNLQYNKL 269
+ N+ L L NKL
Sbjct: 59 QGIQYL--PNVTKLFLNGNKL 77
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 69/324 (21%), Positives = 112/324 (34%), Gaps = 104/324 (32%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHH 890
V+ LK + + E + E++M+ L H IV + G P
Sbjct: 80 VKMLKE-KADSSEREAL----MSELKMMTQLGSHENIVNLLGA--------CTLSGP--- 123
Query: 891 LLQSAIFMEYVKGGSVKNY------------------IEKLSETGEKHVSVKLALFIAQD 932
+ + EY G + NY E ++ + L A
Sbjct: 124 IY---LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 933 VAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH 992
VA + L K +HRD+ + N+L+ + VVK+CDF A
Sbjct: 181 VAKGMEFLEFKSCVHRDLAARNVLVTHGK-------VVKICDFGLA-------------- 219
Query: 993 RGIPAPDVCVGT-----P-RWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPY 1045
R I + V P +WMAPE L +Y ++ D+WSYG LL E+ +L PY
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFE----GIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 1046 MGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE---AELETLSFLV 1101
G+ + + LIQ G + ++P E+
Sbjct: 276 PGIPVDANFYKLIQNGFK------------------------MDQPFYATEEIY------ 305
Query: 1102 DVFRRCTEENPTERPTAGDLYEMF 1125
+ + C + +RP+ +L
Sbjct: 306 IIMQSCWAFDSRKRPSFPNLTSFL 329
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 45/203 (22%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV +L L+H I+E+ + HH + + EY + +K Y++K
Sbjct: 83 EVSLLKELQHRNIIEL--KSV------------IHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ + + F+ Q + + HS+ +HRD+K +N+L+ + V+K+ D
Sbjct: 128 DVSMRVI----KSFLYQ-LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP--VLKIGD 180
Query: 975 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 1029
F RA +P+R F H + T W PE+L Y VDIW
Sbjct: 181 FGLARAFGIPIRQFTHE--------------IIT-LWYRPPEILLGSRH---YSTSVDIW 222
Query: 1030 SYGCLLLELLTLQVPYMGLSELE 1052
S C+ E+L + G SE++
Sbjct: 223 SIACIWAEMLMKTPLFPGDSEID 245
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 57/207 (27%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM--EYVKGGSVKNYIEK 912
E+RML L+H +V + + + + EY +V + +++
Sbjct: 52 EIRMLKQLKHPNLVNLL--------------EVFRR--KRRLHLVFEYCDH-TVLHELDR 94
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+H+ VK Q A+ H + +HRD+K ENILI V+KL
Sbjct: 95 YQRGVPEHL-VKS--ITWQ-TLQAVNFCHKHNCIHRDVKPENILIT-----KHS--VIKL 143
Query: 973 CDFD--RA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 1026
CDF R P + V T RW +PE+L YG V
Sbjct: 144 CDFGFARLLTGPSDYYDDE--------------VAT-RWYRSPELLVGDTQ----YGPPV 184
Query: 1027 DIWSYGCLLLELLTLQVPYM-GLSELE 1052
D+W+ GC+ ELL+ P G S+++
Sbjct: 185 DVWAIGCVFAELLSGV-PLWPGKSDVD 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-16
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 57/207 (27%)
Query: 855 EVRMLGALRHSCIVEMYG--HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
E+++L LRH +V + K +L +F E+V ++ + +E
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYL---------------VF-EFVDH-TILDDLEL 116
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ V V+ ++ Q + + HS +I+HRDIK ENIL+ G VVKL
Sbjct: 117 FPNGLDYQV-VQK--YLFQ-IINGIGFCHSHNIIHRDIKPENILVS-----QSG--VVKL 165
Query: 973 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL-RAMHKPNLYGLEV 1026
CDF R P + V T RW APE+L + YG V
Sbjct: 166 CDFGFARTLAAPGEVYDD--------------EVAT-RWYRAPELLVGDVK----YGKAV 206
Query: 1027 DIWSYGCLLLELLTLQVPYM-GLSELE 1052
D+W+ GCL+ E+ + P G S+++
Sbjct: 207 DVWAIGCLVTEMFMGE-PLFPGDSDID 232
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 52/162 (32%), Positives = 69/162 (42%), Gaps = 15/162 (9%)
Query: 114 LGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173
L L + S L L +L L + + LT L L L L + H
Sbjct: 36 LHLSENLLYTFSLA----TLMPYTRLTQLNLDR-----AELTKLQVDGTLPVLGTLDLSH 86
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLY-L 231
++ LP L L LD+SFN++ LP L L L + N+L LP GL
Sbjct: 87 NQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 232 LQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+LE L L+NN LT L G L+ + NL L LQ N L +
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLN--GLENLDTLLLQENSLYT 186
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 55/222 (24%), Positives = 78/222 (35%), Gaps = 47/222 (21%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L+L +N+L + Y +L L E+
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ-------------------- 71
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
L L L+LS + +L L LT L V + LP L
Sbjct: 72 ----VDGTLPVLGTLDLS----HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 187 SNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
L++L L N++K LP + L L +ANN L ELP+GL L+ L+ L L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L ++ G H L L N P W+C C +
Sbjct: 184 LYTIPKGFFGS---HLLPFAFLHGN--------P-WLCNCEI 213
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNN 243
+++ +++ + LP ++ K L ++ N L + RL L+L
Sbjct: 8 KVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
LT L + L L+L +N+L S
Sbjct: 66 ELTKLQVDG--TLPVLGTLDLSHNQLQS 91
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 6e-16
Identities = 34/123 (27%), Positives = 53/123 (43%), Gaps = 31/123 (25%)
Query: 936 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRA--VPLRSFLHTCCIA 991
L HS++++HRD+K +N+LI+ +G +KL +F RA +P+R +
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLIN-----RNG--ELKLANFGLARAFGIPVRCYSA----- 160
Query: 992 HRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLS 1049
V T W P+VL Y +D+WS GC+ EL P G
Sbjct: 161 ---------EVVT-LWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 1050 ELE 1052
+
Sbjct: 208 VDD 210
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 27/113 (23%), Positives = 51/113 (45%), Gaps = 6/113 (5%)
Query: 157 LSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLK 216
+ GL K ++ S+ L LS ++ + + ++ L + + L L
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS-QKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELH 69
Query: 217 VANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+++N++ +L S L L +LE L ++ NRL +L + L L L N+L
Sbjct: 70 LSHNQISDL-SPLKDLTKLEELSVNRNRLKNLNGIPSA---CLSRLFLDNNEL 118
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 40/202 (19%), Positives = 77/202 (38%), Gaps = 29/202 (14%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL-----QIKISSPG 127
L K + + S ++N + I + + L+ L QI SP
Sbjct: 24 QNLGKQSVTDL-VSQKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQISDLSP- 80
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC--LTKLSVCHFSIRYLPPEIGC 185
L L L+EL +++ L + G+ L++L + + +R +
Sbjct: 81 -----LKDLTKLEELSVNR--------NRLKNLNGIPSACLSRLFLDNNELRDTDS-LIH 126
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
L NLE L + NK+K + + +L L L + N++ GL L+++ +DL+ +
Sbjct: 127 LKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKC 184
Query: 246 TSLGSLDLCLMHNLQNLNLQYN 267
+ + L N +
Sbjct: 185 V---NEPVKYQPELYITNTVKD 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 11/137 (8%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
+L G++ S + L+ + L +L + H I L P + L+ LE+L
Sbjct: 37 QKELSGVQNFNGDN-----SNIQSLAGMQFFTNLKELHLSHNQISDLSP-LKDLTKLEEL 90
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
++ N++K L L L + NN+L + L L+ LE L + NN+L S+ L
Sbjct: 91 SVNRNRLKNL--NGIPSACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKSIVMLG 147
Query: 253 LCLMHNLQNLNLQYNKL 269
+ L+ L+L N++
Sbjct: 148 --FLSKLEVLDLHGNEI 162
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 40/193 (20%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E++++ ++H +V++ + + D E L + +EYV +V +
Sbjct: 82 ELQIMRIVKHPNVVDLKAF-----FYSNGDKKDEVFLN---LVLEYV-PETVYRASRHYA 132
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ + + + L++ Q + +L +HS I HRDIK +N+L+D V+KL D
Sbjct: 133 KLKQTMPMLLIKLYMYQ-LLRSLAYIHSIGICHRDIKPQNLLLDPP------SGVLKLID 185
Query: 975 FDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLEVDIW 1029
F A + + +C R+ APE+ A + Y +DIW
Sbjct: 186 FGSAKILIAGEPNVS------------YICS---RYYRAPELIFGATN----YTTNIDIW 226
Query: 1030 SYGCLLLELLTLQ 1042
S GC++ EL+ Q
Sbjct: 227 STGCVMAELMQGQ 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 67/286 (23%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E++++ +H +VE+ G S+DG+ L ++ Y+ GS+ + +
Sbjct: 80 EIKVMAKCQHENLVELLGF--------SSDGD--DLCL---VY-VYMPNGSLLDRL--SC 123
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
G +S + IAQ A + LH H +HRDIKS NIL+D K+ D
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD-----EAFTA--KISD 176
Query: 975 FD--RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
F RA + + R + VGT +MAPE LR + + DI+S+G
Sbjct: 177 FGLARASEKFAQTV---MTSR------I-VGTTAYMAPEALRG----EIT-PKSDIYSFG 221
Query: 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE--LEA-----LGSCHEHEVAQSGS 1085
+LLE++T E L+ + K +E +E + V
Sbjct: 222 VVLLEIITGLPAVD--EHREPQLLLDI-KEEIEDEEKTIEDYIDKKMNDADSTSVEA--- 275
Query: 1086 GFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 1131
+ V +C E +RP + ++ T+S
Sbjct: 276 --------------MYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 30/151 (19%)
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
A+ E+V K + L++ + ++ + + AL HS IMHRD+K N
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTD---YDI----RFYMYE-ILKALDYCHSMGIMHRDVKPHN 160
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVL 1013
++ID E +K ++L D+ A + R V + R+ PE+L
Sbjct: 161 VMIDHEHRK------LRLIDWGLA---EFYHPGQEYNVR--------VAS-RYFKGPELL 202
Query: 1014 RAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044
Y +D+WS GC+L ++ + P
Sbjct: 203 VDYQM---YDYSLDMWSLGCMLASMIFRKEP 230
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 42/238 (17%), Positives = 76/238 (31%), Gaps = 50/238 (21%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEI-NLFPSEVGNLLG-------LECLQI 121
L L N L+ + S ++ L +L F GN L + + + L
Sbjct: 105 LDLSYNYLSNLSSSW--FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 122 KISSPGVNGFALNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
L L+ELE+ P L ++ ++ L +
Sbjct: 163 TKIQRK----DFAGLTFLEELEIDASDLQSYEP--KSL------KSIQNVSHLILHMKQH 210
Query: 177 RYLPPEI-GCLSNLEQLDLSFNKMKYLP-TEIC--------YLKALISLKVANNKLVELP 226
L S++E L+L + +E+ ++K+ + L ++
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVM 270
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC-CNL 283
L + L L+ S N+L S+ + +LQ + L N W C C
Sbjct: 271 KLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN---------PWDCSCPR 319
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 30/115 (26%), Positives = 49/115 (42%), Gaps = 6/115 (5%)
Query: 161 AGLKCLTKLSV-CHF-SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKV 217
A L C S+ +P + ++ LDLS N++ Y+ L +L +
Sbjct: 26 ASLSCDRNGICKGSSGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVL 83
Query: 218 ANNKLVELPSGL-YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+N + + L LE+LDLS N L++L S + +L LNL N +
Sbjct: 84 TSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT 138
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-15
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 46/206 (22%)
Query: 845 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 904
+ + E++++ L H IV + + S + E +L + ++YV
Sbjct: 87 VLQDKRFKNRELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYV-PE 137
Query: 905 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964
+V S + + + L++ Q + +L +HS I HRDIK +N+L+D +
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIHSFGICHRDIKPQNLLLDPD---- 192
Query: 965 DGKPVVKLCDF------DRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAM 1016
V+KLCDF R P S+ +C R+ APE+ A
Sbjct: 193 --TAVLKLCDFGSAKQLVRGEPNVSY---------------ICS---RYYRAPELIFGAT 232
Query: 1017 HKPNLYGLEVDIWSYGCLLLELLTLQ 1042
Y +D+WS GC+L ELL Q
Sbjct: 233 D----YTSSIDVWSAGCVLAELLLGQ 254
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 31/218 (14%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECL-----QI 121
S + L L N L + + +L+ L EI +L L L I
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 122 KISSPGVNGFALNKLKGLKELEL-----SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176
+ + G + L L++L + + P I LK L +L+V H I
Sbjct: 89 QSLALGA----FSGLSSLQKLVAVETNLASLENFP--------IGHLKTLKELNVAHNLI 136
Query: 177 RYLPPEIGC--LSNLEQLDLSFNKMKYLPTEI-CYLKAL----ISLKVANNKLVELPSGL 229
+ L+NLE LDLS NK++ + L + +SL ++ N + + G
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267
+ RL+ L L N+L S+ + +LQ + L N
Sbjct: 197 FKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 26/113 (23%), Positives = 48/113 (42%), Gaps = 4/113 (3%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVA 218
L L + I+ + LS+L L L+ N ++ L L +L L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCL-MHNLQNLNLQYNKL 269
L L + L+ L+ L++++N + S + + NL++L+L NK+
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 3/100 (3%)
Query: 176 IRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLYL-L 232
+R+L L+ LDLS +++ + L L +L + N + L G + L
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
L+ L L SL + + + L+ LN+ +N + S+
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
+ + LDLSFN +++L + L L ++ ++ + G Y L L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ SL G+ +LQ L L S
Sbjct: 88 IQSLALGAFSGL--SSLQKLVAVETNLAS 114
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 49/203 (24%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ +L L+HS IV++Y + H + + E++ +K ++
Sbjct: 50 EISILKELKHSNIVKLY--------------DVIHTKKRLVLVFEHLDQ-DLKKLLDVCE 94
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E K F+ Q + + H + ++HRD+K +N+LI+ +G +K+ D
Sbjct: 95 GGLESVT-AKS--FLLQ-LLNGIAYCHDRRVLHRDLKPQNLLIN-----REG--ELKIAD 143
Query: 975 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 1029
F RA +P+R + H + T W AP+VL K Y +DIW
Sbjct: 144 FGLARAFGIPVRKYTH--------------EIVT-LWYRAPDVLMGSKK---YSTTIDIW 185
Query: 1030 SYGCLLLELLTLQVPYMGLSELE 1052
S GC+ E++ + G+SE +
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEAD 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 53/205 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIF--MEYVKGGSVKNYIEK 912
E+ +L L H IV + + H + + E+++ +K +++
Sbjct: 69 EISLLKELHHPNIVSLI--------------DVIHS--ERCLTLVFEFMEK-DLKKVLDE 111
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
+ +K+ ++ Q + + H I+HRD+K +N+LI+ +DG +KL
Sbjct: 112 NKTGLQDSQ-IKI--YLYQ-LLRGVAHCHQHRILHRDLKPQNLLIN-----SDG--ALKL 160
Query: 973 CDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVD 1027
DF RA +P+RS+ H V T W AP+VL K Y VD
Sbjct: 161 ADFGLARAFGIPVRSYTH--------------EVVT-LWYRAPDVLMGSKK---YSTSVD 202
Query: 1028 IWSYGCLLLELLTLQVPYMGLSELE 1052
IWS GC+ E++T + + G+++ +
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 27/195 (13%), Positives = 43/195 (22%), Gaps = 73/195 (37%)
Query: 855 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
L + + + H + E+++GGS
Sbjct: 81 RTLRLSRIDKPGVARVLDVVH---------TRAGG-------LVVAEWIRGGS------- 117
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
L E + S A+ Q +AAA H + + + DG V
Sbjct: 118 LQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS-----IDGDVV--- 169
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032
+ P M + DI G
Sbjct: 170 -----------------------------LAYPATMPDANPQD-----------DIRGIG 189
Query: 1033 CLLLELLTLQVPYMG 1047
L LL + P
Sbjct: 190 ASLYALLVNRWPLPE 204
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 45/126 (35%), Positives = 65/126 (51%), Gaps = 38/126 (30%)
Query: 936 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RA--VPLRSFLHTCCIA 991
L LH I+HRD+K N+L+D +G V+KL DF ++ P R++ H
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLD-----ENG--VLKLADFGLAKSFGSPNRAYTH----- 171
Query: 992 HRGIPAPDVCVGTPRWM-APEVL---RAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM- 1046
V T RW APE+L R YG+ VD+W+ GC+L ELL +VP++
Sbjct: 172 ---------QVVT-RWYRAPELLFGARM------YGVGVDMWAVGCILAELLL-RVPFLP 214
Query: 1047 GLSELE 1052
G S+L+
Sbjct: 215 GDSDLD 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 49/203 (24%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
EV +L L+H+ IV + H I H + EY+ +K Y++
Sbjct: 50 EVSLLKDLKHANIVTL--HDI------------IHTEKSLTLVFEYLDK-DLKQYLDDCG 94
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
H VKL F+ Q + L H + ++HRD+K +N+LI+ G +KL D
Sbjct: 95 NIINMHN-VKL--FLFQ-LLRGLAYCHRQKVLHRDLKPQNLLIN-----ERG--ELKLAD 143
Query: 975 F--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIW 1029
F RA +P +++ + V T W P++L Y ++D+W
Sbjct: 144 FGLARAKSIPTKTYDN--------------EVVT-LWYRPPDILLGSTD---YSTQIDMW 185
Query: 1030 SYGCLLLELLTLQVPYMGLSELE 1052
GC+ E+ T + + G + E
Sbjct: 186 GVGCIFYEMATGRPLFPGSTVEE 208
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 47/163 (28%), Positives = 67/163 (41%), Gaps = 42/163 (25%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
E+V ++ Y++K G ++K + Q L LH+ I+HRD+K ENIL+
Sbjct: 98 FEHVDQ-DLRTYLDKAPPPGLPAETIKD--LMRQ-FLRGLDFLHANCIVHRDLKPENILV 153
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEV 1012
+ G VKL DF A R + TP W APEV
Sbjct: 154 T-----SGG--TVKLADFGLA---RIY---------SYQMA----LTPVVVTLWYRAPEV 190
Query: 1013 LRAMHKPNL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1052
L L Y VD+WS GC+ E+ + + G SE +
Sbjct: 191 L-------LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-14
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 56/216 (25%)
Query: 845 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGG 904
IR E + L R L H +V + + + + E L + E+V
Sbjct: 59 IR--EVAVL---RHLETFEHPNVVRL--FDV----CTVSRTDRETKLT---LVFEHVDQ- 103
Query: 905 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964
+ Y++K+ E G ++K + Q + L LHS ++HRD+K +NIL+ +
Sbjct: 104 DLTTYLDKVPEPGVPTETIKD--MMFQ-LLRGLDFLHSHRVVHRDLKPQNILVT-----S 155
Query: 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP----RWM-APEVLRAMHKP 1019
G +KL DF A R + T W APEVL
Sbjct: 156 SG--QIKLADFGLA---RIY---------SFQMA----LTSVVVTLWYRAPEVL------ 191
Query: 1020 NL---YGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1052
L Y VD+WS GC+ E+ + + G S+++
Sbjct: 192 -LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 8e-14
Identities = 51/229 (22%), Positives = 85/229 (37%), Gaps = 60/229 (26%)
Query: 905 SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964
S E + + ++++ + + VA + L S+ +HRD+ + NIL+ +
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--- 230
Query: 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGT-----P-RWMAPEVLRAMHK 1018
VVK+CDF A R I V P +WMAPE +
Sbjct: 231 ----VVKICDFGLA--------------RDIYKDPDYVRKGDARLPLKWMAPETIFD--- 269
Query: 1019 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCH 1076
+Y ++ D+WS+G LL E+ +L PY G+ + E ++ G R + A
Sbjct: 270 -RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------MRAPDYTT 322
Query: 1077 EHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+ C P++RPT +L E
Sbjct: 323 PE---------------------MYQTMLDCWHGEPSQRPTFSELVEHL 350
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-14
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 55/212 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK---GGSVKNYIE 911
E+++L L+H +V + +K P +L+ ++ + G + N +
Sbjct: 66 EIKILQLLKHENVVNLIE-ICRTKASPYNRCKGSIYLV-----FDFCEHDLAGLLSNVLV 119
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
K + + K + + L +H I+HRD+K+ N+LI DG V+K
Sbjct: 120 KFTLSEIKR-------VMQM-LLNGLYYIHRNKILHRDMKAANVLIT-----RDG--VLK 164
Query: 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG-TPR----WM-APEVLRAMHKPNL---- 1021
L DF A R+F + T R W PE+L L
Sbjct: 165 LADFGLA---RAF---------SLAKNSQPNRYTNRVVTLWYRPPELL-------LGERD 205
Query: 1022 YGLEVDIWSYGCLLLELLTLQVPYM-GLSELE 1052
YG +D+W GC++ E+ T P M G +E
Sbjct: 206 YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQH 236
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 52/207 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ ++ L+H IV + + + H + + E++ +K Y++ +
Sbjct: 53 EISLMKELKHENIVRL--YDV------------IHTENKLTLVFEFMDN-DLKKYMDSRT 97
Query: 915 ETGEKH----VSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
VK F Q + L H I+HRD+K +N+LI+ G +
Sbjct: 98 VGNTPRGLELNLVKY--FQWQ-LLQGLAFCHENKILHRDLKPQNLLIN-----KRG--QL 147
Query: 971 KLCDF--DRA--VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLE 1025
KL DF RA +P+ +F V T W AP+VL Y
Sbjct: 148 KLGDFGLARAFGIPVNTFSS--------------EVVT-LWYRAPDVLMGSRT---YSTS 189
Query: 1026 VDIWSYGCLLLELLTLQVPYMGLSELE 1052
+DIWS GC+L E++T + + G ++ E
Sbjct: 190 IDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 53/241 (21%), Positives = 82/241 (34%), Gaps = 53/241 (21%)
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
E + + + S+ L A + L LH I+H D+K ENIL+ K G+ +
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-----KQQGRSGI 241
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1030
K+ DF + ++T I R AP+V +G YG+ +D+WS
Sbjct: 242 KVIDFGSSCYEHQRVYT-YIQSRFYRAPEVILGAR----------------YGMPIDMWS 284
Query: 1031 YGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEH 1078
GC+L ELLT G E + L+ KR + +
Sbjct: 285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTV 344
Query: 1079 EVAQSGSGFEKP-------------------EAELETLSFLVDVFRRCTEENPTERPTAG 1119
GS + +D ++C E +P R T G
Sbjct: 345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404
Query: 1120 D 1120
Sbjct: 405 Q 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 42/242 (17%), Positives = 78/242 (32%), Gaps = 36/242 (14%)
Query: 68 NSVEGLYLYKNVLNLIPKSVGRYEK---------LRNLKFFGNEINLFPSEV----GNLL 114
L L L + + +EK + L GN ++
Sbjct: 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239
Query: 115 GLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRP-SVLTL----LSEI-----AGLK 164
++ L + S + F K + L + + +
Sbjct: 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFT 299
Query: 165 CLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKL 222
L +L++ I + L++L +L+LS N + + + + L L L ++ N +
Sbjct: 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359
Query: 223 VELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC- 280
L +L L L+ L L N+L S+ + +LQ + L N W C
Sbjct: 360 RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN---------PWDCS 410
Query: 281 CN 282
C
Sbjct: 411 CP 412
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 33/232 (14%), Positives = 69/232 (29%), Gaps = 31/232 (13%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEI-NLFPSEV-GNLLGLECL---- 119
++E L L + L+ S ++ L +L+ N I + P+ N+ L
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 120 -QIKISSPGV-NGFALNKLKGLK--ELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175
++K F L+ + L + +T L +
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 176 IRYLPPEI----GCLSNLEQL----------DLSFNKMKYLPTEICY---LKALISLKVA 218
+ + + ++ L K + + ++
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS 283
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+K+ L ++ LE L L+ N + + + +L LNL N L
Sbjct: 284 KSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 30/150 (20%), Positives = 60/150 (40%), Gaps = 14/150 (9%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSN 188
+ ++L+ L+ L++ + + ++ GL L L + + L L+N
Sbjct: 49 SFSRLQDLQFLKVEQQ----TPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLAN 104
Query: 189 LEQLDLSFNKMK--YLPTEI-CYLKALISLKVANNKLVEL-PSGL-YLLQRLENLDLSNN 243
LE L L+ + L L +L L + +N + ++ P+ ++R LDL+ N
Sbjct: 105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164
Query: 244 RLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
++ S+ L + L L L
Sbjct: 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQD 194
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 35/149 (23%), Positives = 56/149 (37%), Gaps = 19/149 (12%)
Query: 144 LSKVPPRPSVLTLL-------SEI-----AGLKCLTKLSVCHFSIRYLPPEIGC--LSNL 189
L +VP P+ + + +E+ + L+ L L V + + LS+L
Sbjct: 22 LHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 190 EQLDLSFNKMKYLPTEICY-LKALISLKVANNKL--VELPSGLYL-LQRLENLDLSNNRL 245
L L +N+ L T L L L + L L + L LE L L +N +
Sbjct: 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 246 TSLGSLDL-CLMHNLQNLNLQYNKLLSYC 273
+ M L+L +NK+ S C
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVKSIC 170
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 43/243 (17%), Positives = 72/243 (29%), Gaps = 52/243 (21%)
Query: 73 LYLYKNVLNL-IPKSVGRY-EKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSP 126
L + + L I + R L LK N+ + L LE L + +
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI--G 184
++G L L+ L L +I+ + P
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDN---------------------------NIKKIQPASFFL 151
Query: 185 CLSNLEQLDLSFNKMKYLPTEICY---LKALISLKVANNKLVELPSGLYL---------L 232
+ LDL+FNK+K + E K L++++ L ++
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSN 292
+ LDLS N + + +Q L + + S N KD N
Sbjct: 212 TSITTLDLSGNGFKESMAKRFF--DAIAGTKIQSLILSNSYNMGSSFGHT---NFKDPDN 266
Query: 293 DDF 295
F
Sbjct: 267 FTF 269
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 47/251 (18%), Positives = 84/251 (33%), Gaps = 66/251 (26%)
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSK--HIMHRDIKSENILIDLERKKADGKP 968
+ L T + VS+ L AQ + AL+ L + I+H D+K ENIL+ +
Sbjct: 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL-----CNPKRS 198
Query: 969 VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028
+K+ DF + L ++ I R +P+V +G P Y L +D+
Sbjct: 199 AIKIVDFGSSCQLGQRIYQY-IQSRFYRSPEVLLGMP----------------YDLAIDM 241
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKR-------------- 1062
WS GC+L+E+ T + + G +E++ ++ +
Sbjct: 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWN 301
Query: 1063 -------------PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109
P LG + + + D+ R +
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG---ESGHTVADYLKFKDLILRMLD 358
Query: 1110 ENPTERPTAGD 1120
+P R
Sbjct: 359 YDPKTRIQPYY 369
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 57/288 (19%), Positives = 99/288 (34%), Gaps = 67/288 (23%)
Query: 853 LGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
L ++ L L H IV++ + + +L + MEYV ++
Sbjct: 67 LQIMQDLAVLHHPNIVQLQ-SYFYT---LGERDRRDIYL---NVVMEYV-PDTLHRCCRN 118
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSENILIDLERKKADGKPVV 970
+ + +F+ Q + ++ LH S ++ HRDIK N+L++ +ADG +
Sbjct: 119 YYRRQVAPPPILIKVFLFQ-LIRSIGCLHLPSVNVCHRDIKPHNVLVN----EADG--TL 171
Query: 971 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWM-APEV-LRAMHKPNLYGLE 1025
KLCDF A P + C + R+ APE+ H Y
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYIC--------------S-RYYRAPELIFGNQH----YTTA 212
Query: 1026 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1085
VDIWS GC+ E++ + + G + I + LG + +
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI-----------VRVLGCPSREVLRKLNP 261
Query: 1086 G-------------FEK--PEAELETLSFLVDVFRRCTEENPTERPTA 1118
+ + L+ D+ + P ER
Sbjct: 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 33/127 (25%), Positives = 56/127 (44%), Gaps = 13/127 (10%)
Query: 161 AGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVA 218
+ K L ++ + + I L P+ L +L L L NK+ LP + L +L L +
Sbjct: 53 SPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112
Query: 219 NNKLVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPS 277
NK+ L + L L L L +N+L ++ + +Q ++L N P
Sbjct: 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN--------P- 163
Query: 278 WIC-CNL 283
+IC C+L
Sbjct: 164 FICDCHL 170
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 23/87 (26%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
+ ++ L N +K +P K L + ++NN++ EL + L+ L +L L N+
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+T L + +LQ L L NK+
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKINC 118
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 38/168 (22%), Positives = 63/168 (37%), Gaps = 47/168 (27%)
Query: 898 MEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957
ME + GG + ++ + G++ + + A I + + A+ LHS +I HRD+K EN+L
Sbjct: 94 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL- 149
Query: 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH 1017
K+ + +KL DF G A E
Sbjct: 150 -YTSKRPNAI--LKLTDF------------------GF-------------AKETTG--- 172
Query: 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMG----LSELEIHDLIQMGK 1061
Y D+WS G ++ LL P+ + I+MG+
Sbjct: 173 --EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 29/138 (21%), Positives = 65/138 (47%), Gaps = 17/138 (12%)
Query: 152 SVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICY-L 209
+VL L L K++ + I + S + ++ L+ N+++ + ++ L
Sbjct: 45 TVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGL 104
Query: 210 KALISLKVANNKLVELPSGLYL-LQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQY 266
++L +L + +N++ + + ++ L + L L +N++T++ G+ D +H+L LNL
Sbjct: 105 ESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD--TLHSLSTLNLLA 162
Query: 267 NKLLSYCQVPSWIC-CNL 283
N + C C L
Sbjct: 163 N---------PFNCNCYL 171
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 18/88 (20%), Positives = 40/88 (45%), Gaps = 3/88 (3%)
Query: 187 SNLEQLDLSFNKMKYLPTEICY--LKALISLKVANNKLVELPSGLYL-LQRLENLDLSNN 243
+L L+ N+ L + L L + +NNK+ ++ G + + + L++N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
RL ++ + +L+ L L+ N++
Sbjct: 92 RLENVQHKMFKGLESLKTLMLRSNRITC 119
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 41/209 (19%), Positives = 71/209 (33%), Gaps = 64/209 (30%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 143 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 181
Query: 1000 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1055
+ V T R+ APEV+ M Y VDIWS GC++ E++ V + G ++ +
Sbjct: 182 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236
Query: 1056 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1091
+ K + E L + + +
Sbjct: 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS--FEKLFPDVLFPADSEHNKLKASQ 294
Query: 1092 AELETLSFLVDVFRRCTEENPTERPTAGD 1120
A D+ + + ++R + +
Sbjct: 295 A--------RDLLSKMLVIDASKRISVDE 315
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 32/192 (16%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
LH +++HRD+K N+LI+ ++ +K+CDF A R +
Sbjct: 128 LHGSNVIHRDLKPSNLLIN-----SNCD--LKVCDFGLA---RIIDESAADNSEPTGQQS 177
Query: 1000 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1055
V T RW APEV+ K Y +D+WS GC+L EL + + G
Sbjct: 178 GMVEFVAT-RWYRAPEVMLTSAK---YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 1056 LI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVDVFRR 1106
LI +G P ++L + S E +S + P + + L +R
Sbjct: 234 LIFGIIGT-PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL----QR 288
Query: 1107 CTEENPTERPTA 1118
+P +R TA
Sbjct: 289 MLVFDPAKRITA 300
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 43/216 (19%), Positives = 78/216 (36%), Gaps = 21/216 (9%)
Query: 69 SVEGLYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEI-NLFPSEV-GNLLGLECLQI---- 121
+ L L +I K + L ++ N++ + ++V NL L ++I
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCH-FSIRY 178
+ +N A L L+ L +S + + L ++ L + +I
Sbjct: 91 NLLY--INPEAFQNLPNLQYLLISN-----TGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 179 LPPEI--GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV-ANNKLVELPSG-LYLLQR 234
+ G L L+ N ++ + L L + NN L ELP+ +
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASG 203
Query: 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270
LD+S R+ SL S L + L+ + K L
Sbjct: 204 PVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 239
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 19/112 (16%), Positives = 45/112 (40%), Gaps = 5/112 (4%)
Query: 166 LTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNK-MKYLPTEI-CYLKALISLKVAN-NK 221
+L +R + +LE++++S N ++ + ++ L L +++ N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 222 LVELPSGLYL-LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
L+ + + L L+ L +SN + L + L++Q N +
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 10/54 (18%), Positives = 21/54 (38%), Gaps = 2/54 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272
+K+ E+PS L + L +L + +L+ + + N +L
Sbjct: 18 ESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 53/318 (16%), Positives = 110/318 (34%), Gaps = 85/318 (26%)
Query: 845 IRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSA--------- 895
+ E+ ++ L H I+++ + ++ P +
Sbjct: 40 VLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNH 99
Query: 896 ---------------IFMEYVKGGSVKNYIEKLSETG----EKHVSVKLALFIAQDVAAA 936
+ MEYV ++ ++ +G +S ++I Q + A
Sbjct: 100 HKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLIS----IYIYQ-LFRA 153
Query: 937 LVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA---VPLRSFLHTCCIAHR 993
+ +HS I HRDIK +N+L++ + D +KLCDF A +P + C
Sbjct: 154 VGFIHSLGICHRDIKPQNLLVNSK----DN--TLKLCDFGSAKKLIPSEPSVAYIC---- 203
Query: 994 GIPAPDVCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELE 1052
+ R+ APE+ M Y +D+WS GC+ EL+ + + G + ++
Sbjct: 204 ----------S-RFYRAPEL---MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID 249
Query: 1053 IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF------EKPEAELETL------SFL 1100
I ++ +G+ + ++ + + + + S
Sbjct: 250 QLVRI-----------IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298
Query: 1101 VDVFRRCTEENPTERPTA 1118
+D+ + P R
Sbjct: 299 IDLLEQILRYEPDLRINP 316
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 36/237 (15%), Positives = 66/237 (27%), Gaps = 71/237 (29%)
Query: 929 IAQDVAAALVELHSKHIMHRDIKSENILI------------------DLERKKADGKPVV 970
++ AL L + H D+K ENIL+ + +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIP---------APDVCVGTPRWMAPEVLRAMHKPNL 1021
KL DF A AP+V +
Sbjct: 202 KLIDFGCA----------TFKSDYHGSIINTRQYRAPEVILNLG---------------- 235
Query: 1022 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEI------------HDLIQMGKRPR----L 1065
+ + D+WS+GC+L EL T + + +E +++ + +
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYV 295
Query: 1066 TDELEALGSCHEHEVAQSGSGFE--KPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120
+ L S + P ++ D + +PT RP+ +
Sbjct: 296 NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 6/117 (5%)
Query: 156 LLSEIAGLKCLTK---LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKAL 212
L+ + A + L + + I + L + +D S N+++ L L+ L
Sbjct: 8 LIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG-FPLLRRL 66
Query: 213 ISLKVANNKLVELPSGL-YLLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
+L V NN++ + GL L L L L+NN L LG LD L + +L L + N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 1/89 (1%)
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
+ +LDL K+ + L ++ ++N++ +L G LL+RL+ L +
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLV 71
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
+NNR+ +G + +L L L N L
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 28/137 (20%), Positives = 48/137 (35%), Gaps = 16/137 (11%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGL----KCLTKLSVCHFSIRYLPPEIGCLSN 188
+EL+L + I L + IR L L
Sbjct: 15 YTNAVRDRELDLRG--------YKIPVIENLGATLDQFDAIDFSDNEIRKLDG-FPLLRR 65
Query: 189 LEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRL 245
L+ L ++ N++ + L L L + NN LVEL L L+ L L + N +
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125
Query: 246 TSLGSLDLCLMHNLQNL 262
T+ L +++ + +
Sbjct: 126 TNKKHYRLYVIYKVPQV 142
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 58/278 (20%), Positives = 101/278 (36%), Gaps = 69/278 (24%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ L RH +V + G + N +L I+ +Y++ G++K ++ S
Sbjct: 85 EIETLSFCRHPHLVSLIGF--------CDERN--EMIL---IY-KYMENGNLKRHLYG-S 129
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ +S + L I A L LH++ I+HRD+KS NIL+ D V K+ D
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL-------DENFVPKITD 182
Query: 975 FD--RAVPLRSFLH--TCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV--DI 1028
F + H T V GT ++ PE L D+
Sbjct: 183 FGISKKGTELDQTHLST------------VVKGTLGYIDPEYFIKGR------LTEKSDV 224
Query: 1029 WSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL------GSCHEHEVAQ 1082
+S+G +L E+L + + E+ +L + +LE + + +
Sbjct: 225 YSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK 284
Query: 1083 SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120
D +C + +RP+ GD
Sbjct: 285 -----------------FGDTAVKCLALSSEDRPSMGD 305
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 26/130 (20%), Positives = 53/130 (40%), Gaps = 15/130 (11%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV---ANNKL 222
+L I + + L + L LS N + +I L + +L++ N +
Sbjct: 27 KVELHGMIPPIEKMDATLSTLKACKHLALSTNNI----EKISSLSGMENLRILSLGRNLI 82
Query: 223 VELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQV------P 276
++ + + LE L +S N++ SL ++ NL+ L + NK+ ++ ++
Sbjct: 83 KKIENLDAVADTLEELWISYNQIASLSGIEKL--VNLRVLYMSNNKITNWGEIDKLAALD 140
Query: 277 SWICCNLEGN 286
L GN
Sbjct: 141 KLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 36/138 (26%), Positives = 61/138 (44%), Gaps = 30/138 (21%)
Query: 133 LNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQL 192
L+ LK K L LS + + +S ++G++ L LS+ I+ + LE+L
Sbjct: 44 LSTLKACKHLALST-----NNIEKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEEL 98
Query: 193 DLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLD 252
+S+N++ L SG+ L L L +SNN++T+ G +D
Sbjct: 99 WISYNQIASL------------------------SGIEKLVNLRVLYMSNNKITNWGEID 134
Query: 253 -LCLMHNLQNLNLQYNKL 269
L + L++L L N L
Sbjct: 135 KLAALDKLEDLLLAGNPL 152
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 21/112 (18%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 997
LHS ++HRD+K NIL++ A+ VK+ DF R+ +
Sbjct: 125 LHSGGLLHRDMKPSNILLN-----AECH--VKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 998 PDVCVGTP--------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
+ P RW APE+L K Y +D+WS GC+L E+L
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTK---YTKGIDMWSLGCILGEILC 226
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 36/194 (18%), Positives = 64/194 (32%), Gaps = 7/194 (3%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
L L L + H IR L + +LE LD+S N+++ + + +L L ++ N
Sbjct: 74 FLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCP--MASLRHLDLSFN 131
Query: 221 KLVELPSGLYL--LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278
LP L +L L LS + L L + +H L + + + S
Sbjct: 132 DFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL 191
Query: 279 ICCNLEGNGKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNS-- 336
N + S M V L+ + + + +
Sbjct: 192 QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTL 251
Query: 337 RSLTARKSSKQWKR 350
++T + WK
Sbjct: 252 LNVTLQHIETTWKC 265
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 1e-11
Identities = 39/223 (17%), Positives = 77/223 (34%), Gaps = 36/223 (16%)
Query: 73 LYLYKNVLNLIPKSVGRY-EKLRNLKFFGNEINLFPSEV-GNLLGLECL-----QIKISS 125
++ V +++ ++ ++ + L S
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 126 PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG----LKCLTKLSVCHFSIRYLPP 181
+ LK L+ L L + L ++A + L L V S+
Sbjct: 370 FQG----CSTLKRLQTLILQRNG-----LKNFFKVALMTKNMSSLETLDVSLNSLNSHAY 420
Query: 182 EIGC--LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ C ++ L+LS N + C + L + NN+++ +P + LQ L+ L+
Sbjct: 421 DRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRIMSIPKDVTHLQALQELN 479
Query: 240 LSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280
+++N+L S+ G D +LQ + L N W C
Sbjct: 480 VASNQLKSVPDGVFDRL--TSLQYIWLHDNP---------WDC 511
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 4e-11
Identities = 24/92 (26%), Positives = 45/92 (48%), Gaps = 9/92 (9%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYL-LQRLENLDLS 241
+ L LS N + L +L L L++++N++ L ++L Q LE LD+S
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108
Query: 242 NNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+NRL ++ + +L++L+L +N
Sbjct: 109 HNRLQNISCCPMA-----SLRHLDLSFNDFDV 135
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 7e-08
Identities = 37/182 (20%), Positives = 68/182 (37%), Gaps = 35/182 (19%)
Query: 69 SVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNL-----LGLECLQIK 122
S L +NV + + + ++L+ L N + F L + +
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLN 413
Query: 123 ISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182
+ + + L LS L+ F R LPP
Sbjct: 414 SLNSHAYDRTCAWAESILVLNLSS--------------------NMLTGSVF--RCLPP- 450
Query: 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLS 241
++ LDL N++ +P ++ +L+AL L VA+N+L +P G++ L L+ + L
Sbjct: 451 -----KVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLH 505
Query: 242 NN 243
+N
Sbjct: 506 DN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 28/232 (12%), Positives = 66/232 (28%), Gaps = 21/232 (9%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKF---FGNEINLFPSEVGNLLGLECLQIKISSPGVN 129
L L N +++P + L L F + L L C+ + + S +
Sbjct: 126 LDLSFNDFDVLPVC-KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHFSIRYLPPEIGC 185
G L+ L V S+ ++ ++ L+ + + + + L +
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE 244
Query: 186 LS-NLEQLDLSFNKMKYLPTEIC------YLKALISLKVANNKLVELPSGLYL------L 232
L+ L+++ ++ + + + L + N + E L
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+ L + N + + L + V +
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 15/51 (29%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L +P L R + L LS N ++ L D+ + L+ L L +N++
Sbjct: 40 NRNLTHVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI 88
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 46/200 (23%), Positives = 77/200 (38%), Gaps = 56/200 (28%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
+HS +++HRD+K N+ I+ E +K+ DF A R +
Sbjct: 136 IHSANVLHRDLKPANLFINTEDLV------LKIGDFGLA--------------RIMDPHY 175
Query: 1000 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1051
+ T +W +P +L + + Y +D+W+ GC+ E+LT + + G EL
Sbjct: 176 SHKGHLSEGLVT-KWYRSPRLLLSPNN---YTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231
Query: 1052 EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--------EKPEAELETL-----S 1098
E LI LE++ HE + + S +P L L
Sbjct: 232 EQMQLI-----------LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 1099 FLVDVFRRCTEENPTERPTA 1118
VD + +P +R TA
Sbjct: 281 EAVDFLEQILTFSPMDRLTA 300
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 43/224 (19%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 929 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 976
+A + AL LH + H D+K ENIL +K+ +++ DF
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 977 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036
A HT +A R P+V + + D+WS GC+L
Sbjct: 188 SATFDHEH-HTTIVATRHYRPPEVILELG----------------WAQPCDVWSIGCILF 230
Query: 1037 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1084
E + E +I ++ + + G E + G
Sbjct: 231 EYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK----GGLVWDENSSDG 286
Query: 1085 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 1120
++ L++ L D+ RR E +P +R T +
Sbjct: 287 RYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 52/197 (26%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
+HS ++HRD+K N+ ++ D + +K+ DF A R +
Sbjct: 142 IHSAGVVHRDLKPGNLAVN-----EDCE--LKILDFGLA--------------RHA-DAE 179
Query: 1000 VC--VGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDL 1056
+ V T RW APEV+ + Y VDIWS GC++ E+LT + + G L+
Sbjct: 180 MTGYVVT-RWYRAPEVILSWMH---YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 235
Query: 1057 I--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDV 1103
I G + ++ L QS + P+A D+
Sbjct: 236 ILKVTGVPGT--EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA--------ADL 285
Query: 1104 FRRCTEENPTERPTAGD 1120
+ E + +R TA
Sbjct: 286 LEKMLELDVDKRLTAAQ 302
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 43/209 (20%), Positives = 72/209 (34%), Gaps = 64/209 (30%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
LHS I+HRD+K NI++ +D +K+ DF A R
Sbjct: 180 LHSAGIIHRDLKPSNIVVK-----SDCT--LKILDFGLA--------------RTAGTSF 218
Query: 1000 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD 1055
+ V T R+ APEV+ M Y VDIWS GC++ E++ ++ + G ++ +
Sbjct: 219 MMTPYVVT-RYYRAPEVILGMG----YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273
Query: 1056 LI------------------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1091
+ K LT L + + +
Sbjct: 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHNKLKASQ 331
Query: 1092 AELETLSFLVDVFRRCTEENPTERPTAGD 1120
A D+ + +P +R + D
Sbjct: 332 A--------RDLLSKMLVIDPAKRISVDD 352
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 40/224 (17%), Positives = 73/224 (32%), Gaps = 53/224 (23%)
Query: 929 IAQDVAAALVELHSKHIMHRDIKSENILI------------DLERKKADGKPVVKLCDFD 976
+A + ++ LHS + H D+K ENIL ++ P +K+ DF
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 977 RAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036
A T ++ R AP+V + + D+WS GC+L+
Sbjct: 183 SATYDDEHHST-LVSTRHYRAPEVILALG----------------WSQPCDVWSIGCILI 225
Query: 1037 ELLTLQVPYMGLSELEI------------HDLIQMGKRPRLTDELEALGSCHEHEVAQSG 1084
E + E +IQ ++ + E + +G
Sbjct: 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH----DRLDWDEHSSAG 281
Query: 1085 SGFEKPEAELETL--------SFLVDVFRRCTEENPTERPTAGD 1120
+ L+ L D+ ++ E +P +R T +
Sbjct: 282 RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 27/86 (31%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 187 SNLEQLDLSFNKMKYLPTEI--CYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243
S LDLS N + L E L L SL +++N L + S + L LDLS+N
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
L +L + L+ L L N +
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNNHI 124
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 38/165 (23%), Positives = 57/165 (34%), Gaps = 25/165 (15%)
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCL 186
+ +L L L LS + L +S A + L L + + L + L
Sbjct: 57 EWTPTRLTNLHSLLLSH-----NHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL 111
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSG----LYLLQRLENLDLS 241
LE L L N + + + L L ++ N++ P L +L LDLS
Sbjct: 112 QALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLS 171
Query: 242 NNRLTSLGSLDLCLMHNL--QNLNLQYNKLLSYCQVPSWIC-CNL 283
+N+L L DL + L L N C C L
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNN---------PLECDCKL 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 48/195 (24%), Positives = 75/195 (38%), Gaps = 48/195 (24%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
+HS I+HRD+K N+ ++ D + +K+ DF A +
Sbjct: 148 IHSADIIHRDLKPSNLAVN-----EDCE--LKILDFGLARHTADEM-------------T 187
Query: 1000 VCVGTPRW-MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 1057
V T RW APE++ Y VDIWS GC++ ELLT + + G ++ LI
Sbjct: 188 GYVAT-RWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243
Query: 1058 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 1105
+G + L+ + S QS + K P A VD+
Sbjct: 244 RLVGTPGA--ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA--------VDLLE 293
Query: 1106 RCTEENPTERPTAGD 1120
+ + +R TA
Sbjct: 294 KMLVLDSDKRITAAQ 308
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 48/195 (24%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
+H+ I+HRD+K N+ ++ D + +K+ DF A S +
Sbjct: 144 IHAAGIIHRDLKPGNLAVN-----EDCE--LKILDFGLARQADSEMTG------------ 184
Query: 1000 VCVGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI- 1057
V T RW APEV+ + Y VDIWS GC++ E++T + + G L+ I
Sbjct: 185 -YVVT-RWYRAPEVILNWMR---YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239
Query: 1058 -QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-----------PEAELETLSFLVDVFR 1105
G P + ++ L S + EK P A V++
Sbjct: 240 KVTGTPPA--EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA--------VNLLE 289
Query: 1106 RCTEENPTERPTAGD 1120
+ + +R TAG+
Sbjct: 290 KMLVLDAEQRVTAGE 304
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 26/111 (23%), Positives = 48/111 (43%), Gaps = 4/111 (3%)
Query: 159 EIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA 218
A ++ L L C + + NLE L L + + + L L L+++
Sbjct: 22 TPAAVRELV-LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN-LPKLPKLKKLELS 79
Query: 219 NNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
N++ L L L +L+LS N+L + +L+ L + L++L+L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 9/109 (8%)
Query: 186 LSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ + +L L K E L L + N L+ + S L L +L+ L+LS N
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSEN 81
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC------NLEGN 286
R+ + + NL +LNL NKL + +L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 32/131 (24%), Positives = 56/131 (42%), Gaps = 8/131 (6%)
Query: 136 LKGLKELELSKVP-PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDL 194
++EL L + L +E L LS+ + + + + L L++L+L
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAE---FVNLEFLSLINVGLISVSN-LPKLPKLKKLEL 78
Query: 195 SFNK-MKYLPTEICYLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRLTSLGSL 251
S N+ L L L L ++ NKL ++ + L L+ L++LDL N +T+L
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDY 138
Query: 252 DLCLMHNLQNL 262
+ L L
Sbjct: 139 RESVFKLLPQL 149
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 22/117 (18%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF--DRAVPLRSFLHTCCIAHRGIPA 997
+H I+HRD+K N L++ D VK+CDF R + +
Sbjct: 145 IHESGIIHRDLKPANCLLN-----QDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 998 PDVCVGTPRWM----------APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044
+ + APE++ Y +DIWS GC+ ELL +
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQEN---YTKSIDIWSTGCIFAELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 45/232 (19%), Positives = 72/232 (31%), Gaps = 65/232 (28%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFD--RAVPLRSFLHTCCIAHRGIPA 997
+HS I+HRD+K N L++ D VK+CDF R V ++
Sbjct: 172 VHSAGILHRDLKPANCLVN-----QDCS--VKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 998 PDVCVGTP--------------RWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042
++ RW APE++ Y +D+WS GC+ ELL +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN---YTEAIDVWSIGCIFAELLNMI 281
Query: 1043 VP----------------YMGLSELEIHDLIQMGKRPRLTDEL----EALGSCHEHEVAQ 1082
LS + D+L LG+ E ++
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341
Query: 1083 SGSGFEKPEAELETLSF-----LVDVFRRCTEE-----------NPTERPTA 1118
E + + L + F + + NP +R T
Sbjct: 342 LEK--EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 4e-11
Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYL-L 232
+ ++P ++ L++S N + L ++I L L L +++N++ L ++
Sbjct: 11 GLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFN 68
Query: 233 QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
Q LE LDLS+N+L + NL++L+L +N +
Sbjct: 69 QELEYLDLSHNKLVKISCHPT---VNLKHLDLSFNAFDA 104
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 40/179 (22%), Positives = 75/179 (41%), Gaps = 13/179 (7%)
Query: 73 LYLYKNVLNLIPKSV-GRYEKLRNLKFFGNEINLFPSEV-GNLLGLECLQI---KISSPG 127
+ ++ + +L F N + E G+L LE L + ++
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
++K L++L++S+ ++ + L + S L I CL
Sbjct: 365 KIAEMTTQMKSLQQLDISQNS-----VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 187 -SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNN 243
++ LDL NK+K +P ++ L+AL L VA+N+L +P G++ L L+ + L N
Sbjct: 420 PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 42/226 (18%), Positives = 70/226 (30%), Gaps = 36/226 (15%)
Query: 69 SVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPG 127
L + +N + L + KLR L N I V
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV----------------- 64
Query: 128 VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP--EIGC 185
+ L+ L+LS + L +S L L + + LP E G
Sbjct: 65 -----FKFNQELEYLDLSH-----NKLVKIS-CHPTVNLKHLDLSFNAFDALPICKEFGN 113
Query: 186 LSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYL----LQRLENLDL 240
+S L+ L LS ++ I +L L V E L + L +
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
+N + + + + NL+ N++ + C I L+ N
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 36/241 (14%), Positives = 73/241 (30%), Gaps = 44/241 (18%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF- 131
L L L + + + E + L + I P F
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179
Query: 132 -----ALNKLKGLKELELSKVPPR---PSVLTLLSEIAGLKCLTKLSVCHFSIRYL---- 179
++ + L+ + V L++L+++ L+ L++ + +
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR 239
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEI------CYLKALISLKVANNKLVELPSGLYL-- 231
++ + + +S K++ LKAL +V ++ S +Y
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299
Query: 232 -----------------------LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
+ +LD SNN LT + + L+ L LQ N+
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359
Query: 269 L 269
L
Sbjct: 360 L 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 13/51 (25%), Positives = 28/51 (54%), Gaps = 2/51 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
N L+ +P L Q+ L++S N ++ L + D+ + L+ L + +N++
Sbjct: 9 KNGLIHVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 37/203 (18%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFA 132
L L N L+ +P + +L L+ L L +++ G+ F
Sbjct: 42 LDLQSNKLSSLPSKA--FHRLTKLRL---------------LYLNDNKLQTLPAGI--F- 81
Query: 133 LNKLKGLKELELS-----KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCL 186
+LK L+ L ++ +P L L +L + ++ LPP + L
Sbjct: 82 -KELKNLETLWVTDNKLQALPIG--------VFDQLVNLAELRLDRNQLKSLPPRVFDSL 132
Query: 187 SNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNR 244
+ L L L +N+++ LP + L +L L++ NN+L +P G + L L+ L L NN+
Sbjct: 133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
Query: 245 LTSLGSLDLCLMHNLQNLNLQYN 267
L + + L+ L LQ N
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 2/87 (2%)
Query: 187 SNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPSGLYL-LQRLENLDLSNNR 244
++ ++LDL NK+ LP++ L L L + +NKL LP+G++ L+ LE L +++N+
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L +L + NL L L N+L S
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRNQLKS 123
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 29/105 (27%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
LH ++HRD+ NIL+ + + +CDF+ A R A
Sbjct: 150 LHEAGVVHRDLHPGNILLA-----DNND--ITICDFNLA--------------REDTADA 188
Query: 1000 VC---VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
V RW APE++ + VD+WS GC++ E+
Sbjct: 189 NKTHYVTH-RWYRAPELVMQFKG---FTKLVDMWSAGCVMAEMFN 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 45/226 (19%), Positives = 74/226 (32%), Gaps = 49/226 (21%)
Query: 922 SVKLALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 980
+ I++ + L +H + I+H DIK EN+L+++ + +K+ D A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKIADLGNA-- 185
Query: 981 LRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040
C + T + +PEVL +G DIWS CL+ EL+T
Sbjct: 186 --------CWYDEHYTNS---IQTREYRSPEVLLGAP----WGCGADIWSTACLIFELIT 230
Query: 1041 LQVPYMGLSELEI------------------HDLIQMGKRPRL--TDELEALGSCHE--- 1077
+ L++ GK R
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290
Query: 1078 --HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
+V F K EA+ + D + +P +R AG L
Sbjct: 291 PLEDVLTEKYKFSKDEAKE-----ISDFLSPMLQLDPRKRADAGGL 331
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 32/207 (15%), Positives = 71/207 (34%), Gaps = 25/207 (12%)
Query: 93 LRNLKFFGNEINLFPSEV-GNLLGLECLQI----KISSPGVNGFALNKLKGLKELELSKV 147
+ LK + PS NL + + + + + + L + +E+
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ--LESHSFYNLSKVTHIEIRNT 90
Query: 148 PPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEIGC--LSNLEQLDLSFN-KMKYL 202
LT + A L L L + + ++ P L+++ N M +
Sbjct: 91 RN----LTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 203 PTEICY--LKALISLKVANNKLVELPSGLYLLQRLENLDLS-NNRLTSL--GSLDLCLMH 257
P ++LK+ NN + + +L+ + L+ N LT + + +
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG-GVYS 205
Query: 258 NLQNLNLQYNKLLSYCQVPSWICCNLE 284
L++ + + +PS +L+
Sbjct: 206 GPSLLDVSQTSVTA---LPSKGLEHLK 229
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 20/110 (18%), Positives = 44/110 (40%), Gaps = 7/110 (6%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVA-NNKLV 223
V I+ +P + + L L ++ +P+ L + + V+ + L
Sbjct: 13 EEDFRVTCKDIQRIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 224 ELPSGLYL-LQRLENLDLSNNR-LTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L S + L ++ ++++ N R LT + L + L+ L + L
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM 119
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 48/196 (24%)
Query: 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPD 999
+HS +++HRD+K N+L++ +K+CDF A R
Sbjct: 144 IHSANVLHRDLKPSNLLLN-----TTCD--LKICDFGLA--------------RVADPDH 182
Query: 1000 VC-------VGTPRWM-APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSEL 1051
V T RW APE++ Y +DIWS GC+L E+L+ + + G L
Sbjct: 183 DHTGFLTEYVAT-RWYRAPEIMLNSKG---YTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
Query: 1052 EIHDLI--QMGKRPRLTDELEALGSCHEHEVAQSGSGFEK-------PEAELETLSFLVD 1102
+ + I +G + ++L + + S K P A+ + L L
Sbjct: 239 DQLNHILGILGSPSQ--EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL-- 294
Query: 1103 VFRRCTEENPTERPTA 1118
+ NP +R
Sbjct: 295 --DKMLTFNPHKRIEV 308
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 23/107 (21%), Positives = 45/107 (42%), Gaps = 4/107 (3%)
Query: 163 LKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222
+K L L + L LE L + + + L L L++++N++
Sbjct: 19 VKELV-LDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRV 76
Query: 223 VELPSGLY-LLQRLENLDLSNNRLTSLGSLD-LCLMHNLQNLNLQYN 267
L L +L+LS N++ L +++ L + NL++L+L
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 23/86 (26%), Positives = 41/86 (47%), Gaps = 3/86 (3%)
Query: 186 LSNLEQLDLSFNKMKYLPTE--ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
S++++L L ++ E + L L N L + + L L +L+ L+LS+N
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDN 74
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKL 269
R++ + NL +LNL NK+
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKI 100
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 31/127 (24%), Positives = 56/127 (44%), Gaps = 6/127 (4%)
Query: 139 LKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNK 198
+KEL L R + L + L LS + + + + L+ L++L+LS N+
Sbjct: 19 VKELVLDNS--RSNEGKLEGLTDEFEELEFLSTINVGLTSIAN-LPKLNKLKKLELSDNR 75
Query: 199 MKYLPTEIC-YLKALISLKVANNKLVELPSGLYL--LQRLENLDLSNNRLTSLGSLDLCL 255
+ + L L ++ NK+ +L + L L+ L++LDL N +T+L +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENV 135
Query: 256 MHNLQNL 262
L L
Sbjct: 136 FKLLPQL 142
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 42/125 (33%), Positives = 68/125 (54%), Gaps = 9/125 (7%)
Query: 154 LTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEI-CYL 209
L LS+ GL LT L++ + ++ L + L+ L L L+ N++ LP + +L
Sbjct: 47 LATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHL 106
Query: 210 KALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQY 266
L L + N+L LPSG++ L +L+ L L+ N+L S+ G+ D + NLQ L+L
Sbjct: 107 TQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD--KLTNLQTLSLST 164
Query: 267 NKLLS 271
N+L S
Sbjct: 165 NQLQS 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 39/161 (24%), Positives = 64/161 (39%), Gaps = 18/161 (11%)
Query: 116 LECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174
+ ++ N ++ V + + G L +S
Sbjct: 24 ANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDISALK- 82
Query: 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLY-LL 232
L+NL L L+ N+++ LP + L L L + N+L LP G++ L
Sbjct: 83 ----------ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKL 132
Query: 233 QRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
L L+L++N+L SL G D + NL L+L YN+L S
Sbjct: 133 TNLTYLNLAHNQLQSLPKGVFD--KLTNLTELDLSYNQLQS 171
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 18/88 (20%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
+ + +L + T+ L ++ + N+ + + G+ L + L L N
Sbjct: 16 DAFAETIKANLKKKSVTDAVTQN-ELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGN 73
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
+L + +L + NL L L N+L S
Sbjct: 74 KLHDISALK--ELTNLTYLILTGNQLQS 99
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 41/186 (22%), Positives = 73/186 (39%), Gaps = 17/186 (9%)
Query: 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSP 126
L K + + + ++I + N+ L K+
Sbjct: 20 ETIKANLKKKSVTDAVTQNEL-NSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDI 78
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCHFSIRYLPPEI- 183
L +L L L L+ + L L L L +L + ++ LP +
Sbjct: 79 SA----LKELTNLTYLILTG-----NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVF 129
Query: 184 GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLS 241
L+NL L+L+ N+++ LP + L L L ++ N+L LP G++ L +L++L L
Sbjct: 130 DKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLY 189
Query: 242 NNRLTS 247
N+L S
Sbjct: 190 QNQLKS 195
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 50/254 (19%), Positives = 72/254 (28%), Gaps = 64/254 (25%)
Query: 925 LALFIAQDVAAALVELHSK-HIMHRDIKSENILIDLE-----------------RKKADG 966
I Q V L LH+K I+H DIK ENIL+ +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 967 KPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV------------CVGTPRWMAPEVLR 1014
V L + L + D+ + T ++ + EVL
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI 266
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----LIQM----GKRP--- 1063
Y DIWS C+ EL T + S E + + GK P
Sbjct: 267 GSG----YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 1064 ----RLTDE----------LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109
+ + E + L EV + + EA D E
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG-----FTDFLLPMLE 377
Query: 1110 ENPTERPTAGDLYE 1123
P +R TA +
Sbjct: 378 LIPEKRATAAECLR 391
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 22/88 (25%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRL 245
++ +L L N+ +P E+ K L + ++NN++ L + + + +L L LS NRL
Sbjct: 31 RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90
Query: 246 TSL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ + D + +L+ L+L N +
Sbjct: 91 RCIPPRTFD--GLKSLRLLSLHGNDISV 116
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 27/111 (24%), Positives = 52/111 (46%), Gaps = 8/111 (7%)
Query: 167 TKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVEL 225
T+L + +P E+ +L +DLS N++ L + + L++L ++ N+L +
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 226 PSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLSYC 273
P + L+ L L L N ++ + G+ + L +L + N L YC
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDL--SALSHLAIGANPL--YC 140
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-09
Identities = 74/314 (23%), Positives = 113/314 (35%), Gaps = 88/314 (28%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ LK + E F EV M+ H ++ + G L
Sbjct: 59 VKRLKEERTQGGE-LQF----QTEVEMISMAVHRNLLRLRGF--------CMTPT--ERL 103
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHR 948
L ++ Y+ GSV + + + E + + IA A L LH I+HR
Sbjct: 104 L---VY-PYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158
Query: 949 DIKSENILID--LERKKAD-GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTP 1005
D+K+ NIL+D E D G + KL D+ + + T V GT
Sbjct: 159 DVKAANILLDEEFEAVVGDFG--LAKLMDYK-----DTHVTT-----------AV-RGTI 199
Query: 1006 RWMAPEVLRAMH-----KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHD----- 1055
+APE K D++ YG +LLEL+T Q + D
Sbjct: 200 GHIAPEY--LSTGKSSEK-------TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 1056 ----LIQMGKRPRLTD-ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1110
L++ K L D +L+ G+ + EV Q L+ V CT+
Sbjct: 251 WVKGLLKEKKLEALVDVDLQ--GNYKDEEVEQ-----------------LIQVALLCTQS 291
Query: 1111 NPTERPTAGDLYEM 1124
+P ERP ++ M
Sbjct: 292 SPMERPKMSEVVRM 305
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 24/168 (14%)
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
E L + + SVK A+ + A + +H K +++RDIK +N LI K +
Sbjct: 93 EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM--I 150
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 1026
+ DF + + H IP + GT R+M+ H G E
Sbjct: 151 YVVDFGMV---KFYRDPVTKQH--IPYREKKNLSGTARYMS----INTHL----GREQSR 197
Query: 1027 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1069
D+ + G + + L +P+ GL + + ++ I K+ EL
Sbjct: 198 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 28/169 (16%)
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
E L + S+K L +A + + + +HSK+ +HRD+K +N L+ L +K +V
Sbjct: 92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK----GNLV 147
Query: 971 KLCDFDRA---VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 1026
+ DF A R+ H ++ + GT R+ + H G+E
Sbjct: 148 YIIDFGLAKKYRDARTHQHIPYRENKNL------TGTARYAS----INTHL----GIEQS 193
Query: 1027 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1069
D+ S G +L+ +P+ GL ++ + ++ I K + L
Sbjct: 194 RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 45/212 (21%), Positives = 76/212 (35%), Gaps = 36/212 (16%)
Query: 93 LRNLKFFGNEIN------LFPSEVGNLLGLECLQI---KISSPGVN--GFALNKLKGLKE 141
L+ L N + L + LE LQ+ +S+ L KE
Sbjct: 115 LQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKE 174
Query: 142 LELSKVPPRPSVLTLLSEI-----AGLKCLTKLSVCHFS---IRYLPPEIGCLSNLEQLD 193
L +S + + +L + L+ L KL C + R L + ++L +L
Sbjct: 175 LTVSNNDINEAGVRVLCQGLKDSPCQLEAL-KLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 194 LSFNK-----MKYL-PTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDLSN 242
L NK M L P + L +L + + +L L + L+ L L+
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293
Query: 243 NRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
N L G+ LC L+ L++L ++
Sbjct: 294 NELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 25/162 (15%)
Query: 132 ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL--------SVCHFSIRYLPPEI 183
L L L+EL LS + L LL E L +L S+ S L +
Sbjct: 108 TLRTLPTLQELHLSDNLLGDAGLQLLCE-GLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166
Query: 184 GCLSNLEQLDLSFNK-----MKYLPTEICYLKA-LISLKVANNKL-----VELPSGLYLL 232
+ ++L +S N ++ L + L +LK+ + + +L +
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226
Query: 233 QRLENLDLSNNRLTSLGSLDLCLM-----HNLQNLNLQYNKL 269
L L L +N+L +G +LC L+ L + +
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-06
Identities = 38/168 (22%), Positives = 55/168 (32%), Gaps = 33/168 (19%)
Query: 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC----LTKLSVCHFSI-----RYLP 180
L + LKEL L+ LL E L L L V S +
Sbjct: 277 CRVLRAKESLKELSLAGNELGDEGARLLCE--TLLEPGCQLESLWVKSCSFTAACCSHFS 334
Query: 181 PEIGCLSNLEQLDLSFNKM---------KYLPTEICYLKALISLKVANNKLVE-----LP 226
+ L +L +S N++ + L L+ L +A+ + + L
Sbjct: 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR---VLWLADCDVSDSSCSSLA 391
Query: 227 SGLYLLQRLENLDLSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
+ L L LDLSNN L G L L + L+ L L
Sbjct: 392 ATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 25/144 (17%), Positives = 47/144 (32%), Gaps = 36/144 (25%)
Query: 139 LKELELSKVP-PRPSVLTLLSEIAGLKCLTKLSVCHFS---IRYLPPEIGCLSNLEQLDL 194
++ L++ LL + + + +L C + + + + L +L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVV-RLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 195 SFNK-----MKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249
N+ + + L L+ + K+ + L L N LT G
Sbjct: 64 RSNELGDVGVHCV---------LQGLQTPSCKI-------------QKLSLQNCCLTGAG 101
Query: 250 SLDLCLM----HNLQNLNLQYNKL 269
L LQ L+L N L
Sbjct: 102 CGVLSSTLRTLPTLQELHLSDNLL 125
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 19/95 (20%), Positives = 40/95 (42%), Gaps = 12/95 (12%)
Query: 187 SNLEQLDLSFNKMKYLP-TEIC-YLKALISLKVANNKL-----VELPSGLYLLQRLENLD 239
+++ LD+ ++ E+ L+ +++ + L ++ S L + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 240 LSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L +N L +G + L +Q L+LQ L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 97
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 29/162 (17%), Positives = 54/162 (33%), Gaps = 9/162 (5%)
Query: 150 RPSVLTLLSEIAGLKCLTKLSVCHF-SIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEI- 206
R L L + G + LT+L + + +++L + L L L + + ++++ +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 207 CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266
+ L L ++ N L L L+ L LS N L C + LQ +
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH----CS-CALRWLQRWEEEG 131
Query: 267 NKLLSYCQVPSWICCNLEGNGKDS-SNDDFISSSAEMDVYEG 307
+ ++ L S V G
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVG 173
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 7e-08
Identities = 92/647 (14%), Positives = 172/647 (26%), Gaps = 209/647 (32%)
Query: 389 LDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAG 448
D S EE II D L LF
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTL--------RLFWT-------------------- 70
Query: 449 LESTGKEGNDECSKHDSSSLSTANGATEQDEGSSSENSKAVCKTKRHSDRDLDNPKPCKS 508
L S +E + + K + + +
Sbjct: 71 LLSKQEEMVQK----------FVEEVLRINYKFLMSPIKTEQR-----QPSMMTRMYIEQ 115
Query: 509 RKSMGENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTG--YEQTPHLDSREVIL 566
R + N +Q ++ Y+ R +P+++L E P + +L
Sbjct: 116 RDRL---YNDNQVFAK--------------YNVSRLQPYLKLRQALLELRPA----KNVL 154
Query: 567 VDR-----KSDEELDAIALSAQALV---------LHLKQLNGLTKDGVIEPVDNLQIALL 612
+D K+ + + + L+LK N + + V+E + L
Sbjct: 155 IDGVLGSGKT--WVALDVCLSYKVQCKMDFKIFWLNLKNCN--SPETVLEMLQKL----- 205
Query: 613 LALFVSDHFGGSDRSG--------IVERTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQ 664
L + SD S I R+ + Y +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL----------------- 248
Query: 665 ILDAVEDI-VLS--DL-C-------EKSLRSIKSKRNSVVVPIGSVQFGVCRH--RAVLL 711
+L V++ + +L C K + S + + + + +++LL
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 712 KYLCDRVE--PPVPC-----------ELVRGYLD-FQPHAWNTILVKKGDSWIRMIVDAC 757
KYL R + P E +R L + W + K + I ++
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN--WKHVNCDKLTTIIESSLNVL 366
Query: 758 RPHDIREEADPEYFIRYIPLYRTIAPFSTESDHSPCSGLDPGSFPSLSSCDE--AGKSVS 815
P + R+ ++ ++ F S H P L F + S K
Sbjct: 367 EPAEYRK------------MFDRLSVFP-PSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 816 SSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875
SL + K T+ + + E + H IV+ Y I
Sbjct: 414 YSL-------VEKQPKESTISI----PSIYLELKVKLENEYAL-----HRSIVDHY--NI 455
Query: 876 SSKWLPSADGNPE----------HHLLQ----------SAIFMEYVKGGSVKNYIE-KLS 914
+ P HHL +F+++ ++E K+
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-------RFLEQKIR 508
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961
+ L Q ++ + +I D K E ++ +
Sbjct: 509 HDSTAWNASGSILNTLQQ-----LKFYKPYICDNDPKYERLVNAILD 550
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 5e-06
Identities = 104/639 (16%), Positives = 190/639 (29%), Gaps = 199/639 (31%)
Query: 174 FSIRYLPPEIGCLSNLEQLDLSFNKM-KYLPTEICYLKALISLKVANNKLVELPSGLYLL 232
P + +EQ D +N + + L+ + L+ L+EL +L
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---QALLELRPAKNVL 154
Query: 233 QRLENLDLSNNRLTSLGS------LDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
++ + LGS LD+CL + +Q ++ W+ NL
Sbjct: 155 --IDGV---------LGSGKTWVALDVCLSYKVQCKM--------DFKI-FWL--NL--- 189
Query: 287 GKDSSNDDFISSSAEMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSLTARKSS- 345
+S + + ML+ + T S +S ++ R S
Sbjct: 190 KNCNSPETVLE-----------MLQK--------LLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 346 KQWKRHHLQQRARQERL------NNSRKWRG-EGHAQ---TSMKEGQRYKSGNLDALASE 395
+ R L+ + + L N++ W + T+ R+K D L++
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT-----RFKQ-VTDFLSAA 284
Query: 396 TPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSCAGLESTGKE 455
T + I LD L E ++LL D + + L E +
Sbjct: 285 TTTH-----ISLDHHSMTLT--PDEVKSLLLKYLDCRPQD---LPREVLTTNPR------ 328
Query: 456 GNDECSKHDSSSLSTANGATEQDEGSSSENSKAV-CKTKRHS-DRDLDNPKPCKSRKSMG 513
LS + +D ++ +N K V C + L+ +P + R
Sbjct: 329 -----------RLSII-AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR---- 372
Query: 514 ENSNASQKYSSVSFCSIEDRLPDGFYDAGRDRPFMQLTGY-EQTPHLDSREVI------- 565
+ + S+ P A P + L+ D V+
Sbjct: 373 ------KMFDR---LSV---FPP---SA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
Query: 566 LVDRKSDEE--------LDAIALSAQALVLH---LKQLNGLTK----DGVIEPVDNLQIA 610
LV+++ E L+ LH + N D + +D
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY--- 472
Query: 611 LLLALFVSDHFGGSDRSGIVERTRKTVSGSNYRKPFVCT--CSTGNSDSANTSQKQILDA 668
+ H + + R ++R F+ + +A+ S IL+
Sbjct: 473 --FYSHIGHHLKNIEHPERMTLFRMVFL--DFR--FLEQKIRHDSTAWNASGS---ILNT 523
Query: 669 VEDIVLSDLCEKSLRSIKSKRNSVVVPIGSVQFGVCRHRAVLLKYLCDRVEPPVPCELVR 728
++ L+ K Y+CD P LV
Sbjct: 524 LQQ----------LKFYK-------------------------PYICD--NDPKYERLVN 546
Query: 729 GYLDFQPHAWNTILVKKGDSWIRMIVDACRPHD-IREEA 766
LDF P ++ K +R+ + A + I EEA
Sbjct: 547 AILDFLPKIEENLICSKYTDLLRIALMA--EDEAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 3e-05
Identities = 69/519 (13%), Positives = 139/519 (26%), Gaps = 179/519 (34%)
Query: 572 DEELDAIALSAQALVLHLKQLNGLTKDGVIEPVDNLQIALLLALFVSDHFGGSDRSGIVE 631
D E + ++ + + + V ++ ++L + D V
Sbjct: 8 DFETGEHQYQYKDILSVFED--AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA---VS 62
Query: 632 RTRKTVSGSNYRKPFVCTCSTGNSDSANTSQKQILDAVEDIVLSD---LCEKSLRSIKSK 688
T + F S + VE+++ + L IK++
Sbjct: 63 GTLRL---------FWTLLSKQEE--------MVQKFVEEVLRINYKFLMSP----IKTE 101
Query: 689 RNSVVVPIGSVQFGVCRHRA-----VLLKYLCDRVEPPVPCELVRGYLDFQPHAWNTILV 743
+ + + + R R V KY R++P + +L + L+ +P +L+
Sbjct: 102 QRQPSMM--TRMYIEQRDRLYNDNQVFAKYNVSRLQPYL--KLRQALLELRPAKN--VLI 155
Query: 744 K----KGDSWIRMIVDACRPHDIREEADPEYFIRYIPLYRTIAP---------FSTESDH 790
G +W + +D C + ++ + D + F ++ L +P + D
Sbjct: 156 DGVLGSGKTW--VALDVCLSYKVQCKMDFKIF--WLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 791 SPCSGLDPGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTL----KVCGSSADEIR 846
+ S D S L + ++ L + K L V +A
Sbjct: 212 NWTSRSDHSSNIKLRI--HSIQAELRRLLKSK-------PYENCLLVLLNVQ--NAKAWN 260
Query: 847 NFEYSCLGEVRML--------------GALRHSCIVEM-------YGHKISSKW------ 879
F SC ++L H + + K+
Sbjct: 261 AFNLSC----KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ 316
Query: 880 -LPS--ADGNPEHHLLQSAIFMEYVKGG-----------------SVKNYIEKLSETGEK 919
LP NP + +I E ++ G +++ + L +
Sbjct: 317 DLPREVLTTNP----RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 920 HVSVKLALF-----I----------------AQDVAAALV-------------------- 938
+ +L++F I V L
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 939 -----------ELHSKHIMHRDIKSENILIDLERKKADG 966
LH + H +I DL D
Sbjct: 433 LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 5e-05
Identities = 71/538 (13%), Positives = 161/538 (29%), Gaps = 159/538 (29%)
Query: 3 LTNSVEITQKSPEGPIKEKLPSEANKINNE------------------KNGSVNDDDDDS 44
L + ++ Q+ P + +++ N+ + + +
Sbjct: 94 LMSPIKTEQRQPSMM-TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 45 VIDV-----SGKTV-------DFPLIESYGNR------GGDNSVEGLYLYKNVL--NLIP 84
V+ + SGKT + + + NS E + L + P
Sbjct: 153 VL-IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 85 KSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE----CLQI--KISSPGV-NGFALNKLK 137
R + N+K I+ +E+ LL + CL + + + N F L
Sbjct: 212 NWTSRSDHSSNIKL---RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL---- 264
Query: 138 GLKELELSKVPPRPSVLTLLSEIA---GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDL 194
K L + T ++ T +S+ H S+ P E ++ L L
Sbjct: 265 SCKIL----------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE------VKSLLL 308
Query: 195 SFNKMKY--LPTEIC----YLKALISLKVANNKLVELPSGLYLLQRLEN-LDLSNNRLTS 247
+ + LP E+ ++I+ + + L +N ++ ++LT+
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDG-----------LATWDNWKHVNCDKLTT 357
Query: 248 LGSLDLCLMHNLQNLNLQ--YNKLLSY---CQVPS------WICCNLEGNGKDSSNDDFI 296
+ ++ L + L+ + +++L + +P+ W ++ + +
Sbjct: 358 I--IESSL-NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIW--FDVIKSDVMVVVNKLH 412
Query: 297 SSSAEMDVYEGPMLENDGNVSFSGSRHTSSSISTVSSSNSRSL--------TARKSSKQW 348
S ++E + S + V N +L K+
Sbjct: 413 KYS---------LVEKQPK-ESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462
Query: 349 KR--------------HHLQQRARQERLNNSRK------WRGEGHAQTSMKEGQRYKSGN 388
HHL+ ER+ R + +++ R+
Sbjct: 463 DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF---------LEQKIRH---- 509
Query: 389 LDALASETPSEEASDIIGLDDDDKQLLSPEAESENLLFSVEDDKIRSGTGLHVENCSC 446
D+ A + + L + + + E L+ ++ D + L +
Sbjct: 510 -DSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTD 566
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 38/110 (34%), Positives = 62/110 (56%), Gaps = 7/110 (6%)
Query: 167 TKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVE 224
T L + S++ LP + L++L QL L NK++ LP + L +L L ++ N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 225 LPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
LP+G++ L +L+ L L+ N+L SL G D + L++L L N+L S
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQSLPDGVFDK--LTQLKDLRLYQNQLKS 138
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 7/111 (6%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVAN 219
L LT+L + ++ LP + L++L L+LS N+++ LP + L L L +
Sbjct: 50 ELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNT 109
Query: 220 NKLVELPSGLY-LLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYN 267
N+L LP G++ L +L++L L N+L S+ G D + +LQ + L N
Sbjct: 110 NQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFD--RLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 35/96 (36%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVELPSGLY-LLQRLEN 237
P I + LDL N +K LP + L +L L + NKL LP+G++ L L
Sbjct: 23 PTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80
Query: 238 LDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
L+LS N+L SL G D + L+ L L N+L S
Sbjct: 81 LNLSTNQLQSLPNGVFDK--LTQLKELALNTNQLQS 114
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 17/87 (19%), Positives = 40/87 (45%), Gaps = 7/87 (8%)
Query: 190 EQLDLSFNKMKYLPTEICY--LKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLT 246
+L L+ N++ + ++ + L L+ L++ N+L + + ++ L L N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 247 SL--GSLDLCLMHNLQNLNLQYNKLLS 271
+ +H L+ LNL N++
Sbjct: 92 EISNKMFL--GLHQLKTLNLYDNQISC 116
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
E L + ++ S+K L IA + + + +HSK++++RD+K EN LI K +
Sbjct: 92 EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV--I 149
Query: 971 KLCDFDRAVPLRSFLHTCCIAHRGIPAPDVC--VGTPRWMAPEVLRAMHKPNLYGLEV-- 1026
+ DF A + ++ H IP + GT R+M+ H G E
Sbjct: 150 HIIDFALA---KEYIDPETKKH--IPYREHKSLTGTARYMS----INTHL----GKEQSR 196
Query: 1027 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1069
D+ + G + + L +P+ GL + E + I KR + L
Sbjct: 197 RDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 911 EKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVV 970
E L + +S+K L +A + + +HSK +HRDIK +N L+ L R+ V
Sbjct: 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR----ANQV 145
Query: 971 KLCDFDRAVPLR---SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV- 1026
+ DF A R + H ++ + GT R+ + H G+E
Sbjct: 146 YIIDFGLAKKYRDTSTHQHIPYRENKNL------TGTARYAS----VNTHL----GIEQS 191
Query: 1027 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1069
D+ S G +L+ L +P+ GL ++ + ++ I K + L
Sbjct: 192 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 162 GLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVAN 219
L L +L + + LP + L+ L LDL N++ LP+ + L L L +
Sbjct: 62 SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCC 121
Query: 220 NKLVELPSGLYLLQRLENLDLSNNRLTSL--GSLDLCLMHNLQNLNLQYN 267
NKL ELP G+ L L +L L N+L S+ G+ D + +L + L N
Sbjct: 122 NKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFD--RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 8/96 (8%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLY-LLQRLEN 237
P I +N + L L N++ L L L L + +N+L LP G++ L +L
Sbjct: 35 PAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV 92
Query: 238 LDLSNNRLTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
LDL N+LT L D + +L+ L + NKL
Sbjct: 93 LDLGTNQLTVLPSAVFDR--LVHLKELFMCCNKLTE 126
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 31/169 (18%), Positives = 60/169 (35%), Gaps = 27/169 (15%)
Query: 910 IEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPV 969
++K+ E K S K L ++ + L +H +H DIK+ N+L++ +
Sbjct: 138 LQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-----Q 192
Query: 970 VKLCDFDRAVPLRSFLHTCCIAHRGIP-APDVC-VGTPRWMAPEVLRAMHKPNLYGLEV- 1026
V L D+ A + H+ P C GT + + H G+
Sbjct: 193 VYLVDYGLA---YRYCPEGV--HKAYAADPKRCHDGTIEFTS----IDAHN----GVAPS 239
Query: 1027 ---DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1069
D+ G +++ LT +P+ + I+ + +
Sbjct: 240 RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 30/168 (17%), Positives = 61/168 (36%), Gaps = 31/168 (18%)
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKL 972
L + + +S + L +A + AL LH +H ++ +ENI +D E + V L
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-----QVTL 202
Query: 973 CDFDRAVPLRSFLHTCCIAHRGIPAPDVC----VGTPRWMAPEVLRAMHKPNLYGLEV-- 1026
+ A + C + + + + G +++ +HK G
Sbjct: 203 AGYGFA---FRY----CPSGKHVAYVEGSRSPHEGDLEFIS----MDLHK----GCGPSR 247
Query: 1027 --DIWSYGCLLLELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDEL 1069
D+ S G +L+ L +P+ +E + + +P
Sbjct: 248 RSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGP 295
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 187 SNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNR 244
S+ +L+L NK++ LP + L L L ++ N++ LP G++ L +L L L N+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 245 LTSL--GSLDLCLMHNLQNLNLQYNKLLS 271
L SL G D + L+ L L N+L S
Sbjct: 88 LQSLPNGVFDK--LTQLKELALDTNQLKS 114
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 6/86 (6%)
Query: 186 LSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNN 243
L+ L +L LS N+++ LP + L L L + NKL LP+G++ L +L+ L L N
Sbjct: 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN 110
Query: 244 RLTSL--GSLDLCLMHNLQNLNLQYN 267
+L S+ G D + +LQ + L N
Sbjct: 111 QLKSVPDGIFD--RLTSLQKIWLHTN 134
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 45/238 (18%), Positives = 75/238 (31%), Gaps = 49/238 (20%)
Query: 68 NSVEGLYLYKNVLN-----LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIK 122
+SV+ + L N + + +++ + L +F E+ L L
Sbjct: 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEI--PEALRLL--- 86
Query: 123 ISSPGVNGFALNKLKGLKELELS--KVPPRPSVLTLLSEIAGLKCLTKLSVCH------- 173
AL K L + LS P + L+ ++ L L + +
Sbjct: 87 -------LQALLKCPKLHTVRLSDNAFGPT-AQEPLIDFLSKHTPLEHLYLHNNGLGPQA 138
Query: 174 -------FSIRYLPPEIGCLSNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNK 221
+ + L + N+ MK + L ++K+ N
Sbjct: 139 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 198
Query: 222 L------VELPSGLYLLQRLENLDLSNNRLTSLGSLDLC--LMHN--LQNLNLQYNKL 269
+ L GL Q L+ LDL +N T LGS L L L+ L L L
Sbjct: 199 IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 19/100 (19%), Positives = 28/100 (28%), Gaps = 17/100 (17%)
Query: 187 SNLEQLDLSFNK-----MKYLPTEICYLKALISLKVANNKL-----VELPSGLYLL--QR 234
L+ LDL N L + L L + + L + L
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275
Query: 235 LENLDLSNNRLTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L+ L L N + L + L L L N+
Sbjct: 276 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 25/134 (18%), Positives = 45/134 (33%), Gaps = 26/134 (19%)
Query: 922 SVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDF---DRA 978
L + + L +H +H DIK+ N+L+ + V L D+ R
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-----QVYLADYGLSYRY 203
Query: 979 VPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV----DIWSYGCL 1034
P + +G GT + + HK G+ + D+ G
Sbjct: 204 CPNGNHKQYQENPRKGH------NGTIEFTS----LDAHK----GVALSRRSDVEILGYC 249
Query: 1035 LLELLTLQVPYMGL 1048
+L L ++P+
Sbjct: 250 MLRWLCGKLPWEQN 263
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 3e-05
Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 24/168 (14%)
Query: 110 VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169
+ + L L+IK ++ LK LE+ SV+ + + L L KL
Sbjct: 168 LDAMPLLNNLKIKGTNNL--SIGKKPRPNLKSLEIISGGLPDSVVEDILG-SDLPNLEKL 224
Query: 170 SVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSG 228
+ Y G ++ F+K + L L + + + +
Sbjct: 225 VLYVGVEDY-----GFDGDMNVFRPLFSKDR--------FPNLKWLGIVDAEEQNVVVEM 271
Query: 229 LY---LLQRLENLDLSNNRLTSLGSLDLC----LMHNLQNLNLQYNKL 269
+L +LE +D+S LT G+ L + +L+ +N++YN L
Sbjct: 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 5/95 (5%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
LDL + + L + L + L +L+LSNNRL L +
Sbjct: 132 LDLKGLRSDPDLVA---QNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDM 188
Query: 252 DLCL--MHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
+ NL+ LNL N+L S ++ LE
Sbjct: 189 SSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 223
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1137 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.95 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.95 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.94 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.94 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.94 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.94 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.94 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.94 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.93 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.93 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.93 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.93 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.92 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.92 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.92 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.92 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.92 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.87 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.84 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.83 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.83 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.82 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.82 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.82 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.82 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.74 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.71 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.71 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.69 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.64 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.63 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.55 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.54 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.54 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.54 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.48 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.48 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.48 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.46 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.45 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.43 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.42 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.39 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.34 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.24 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.23 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.08 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.97 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.95 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.83 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.81 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.8 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.79 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.79 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.78 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.68 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.57 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.44 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.34 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.3 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.18 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.16 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.04 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.03 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.91 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.76 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.4 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.92 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.74 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.64 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.52 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.3 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.21 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.19 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.01 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.93 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.3 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.26 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.1 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.94 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.07 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.04 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.26 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.61 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 80.53 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=467.22 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=215.5
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..++++|++.++||+|+||+||+|++. ++.||||+.... .......+. +.+|+.+|++++|||||++++++.
T Consensus 20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~----~~~E~~il~~l~HpnIV~~~~~~~ 93 (350)
T 4b9d_A 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS--RMSSKEREE----SRREVAVLANMKHPNIVQYRESFE 93 (350)
T ss_dssp CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECT--TSCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehH--HCCHHHHHH----HHHHHHHHHHCCCCCCCcEEEEEE
Confidence 346789999999999999999999985 577999985433 223333344 489999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+++ .+|||||||+||+|.++|.. .....+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 94 ~~~--------------~~yiVmEy~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 156 (350)
T 4b9d_A 94 ENG--------------SLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156 (350)
T ss_dssp ETT--------------EEEEEEECCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGE
T ss_pred ECC--------------EEEEEEeCCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence 776 67999999999999999976 2345689999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
||+.+ +.+||+|||+|+........ ....+||+.|||||++.+ ..|+.++|||||||++
T Consensus 157 Ll~~~-------g~vKl~DFGla~~~~~~~~~----------~~~~~GT~~YmAPE~l~~----~~y~~~~DiwSlGvil 215 (350)
T 4b9d_A 157 FLTKD-------GTVQLGDFGIARVLNSTVEL----------ARACIGTPYYLSPEICEN----KPYNNKSDIWALGCVL 215 (350)
T ss_dssp EECTT-------CCEEECSTTEESCCCHHHHH----------HHHHHSCCTTCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEcccccceeecCCccc----------ccccCCCccccCHHHHCC----CCCCcHHHHHHHHHHH
Confidence 99987 78999999999866532211 113579999999999976 5789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|||+||+.||.+.+..++...+..+..+.++. ..++++.+||.+||+.||++|
T Consensus 216 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~~---------------------------~~s~~~~~li~~~L~~dP~~R 268 (350)
T 4b9d_A 216 YELCTLKHAFEAGSMKNLVLKIISGSFPPVSL---------------------------HYSYDLRSLVSQLFKRNPRDR 268 (350)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHccCChhHC
Confidence 99999999999999999988887766543322 344569999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001152 1116 PTAGDLYEMFVART 1129 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~ 1129 (1137)
||++|+++|+|+..
T Consensus 269 ~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 269 PSVNSILEKGFIAK 282 (350)
T ss_dssp CCHHHHHTSHHHHT
T ss_pred cCHHHHhcCHHhhc
Confidence 99999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=463.20 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=217.5
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|++.++||+|+||+||+|++. +..||||+....... ..+ .+.+|+.+|++++|||||+++++|.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~----~~~~Ei~il~~l~HpnIV~l~~~~~~~~- 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRE----LLFNEVVIMRDYQHENVVEMYNSYLVGD- 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGG----GGHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHH----HHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 45999999999999999999985 577899986544221 122 2478999999999999999999999876
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
++|||||||+||+|.+++.+ ..+++..+..|+.||+.||+|||++|||||||||+||||+.
T Consensus 145 -------------~~~ivmEy~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 205 (346)
T 4fih_A 145 -------------ELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 205 (346)
T ss_dssp -------------EEEEEECCCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred -------------EEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC
Confidence 67999999999999999975 35999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+|+.+..... .....+||+.|||||++.+ ..|+.++|||||||++|||+
T Consensus 206 ~-------g~vKl~DFGla~~~~~~~~----------~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilyeml 264 (346)
T 4fih_A 206 D-------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMV 264 (346)
T ss_dssp T-------CCEEECCCTTCEECCSSSC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEecCcCceecCCCCC----------cccccccCcCcCCHHHHCC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 7899999999986643221 1124579999999999875 57899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|+.||.+.+..++...|.....+.+... ...++++.+||.+||+.||++|||++
T Consensus 265 ~G~~PF~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~s~~~~dli~~~L~~dP~~R~ta~ 319 (346)
T 4fih_A 265 DGEPPYFNEPPLKAMKMIRDNLPPRLKNL-------------------------HKVSPSLKGFLDRLLVRDPAQRATAA 319 (346)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSSCCCCSCG-------------------------GGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HCCCCCCCcCHHHHHHHHHcCCCCCCCcc-------------------------ccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999998888888876554332210 14456799999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001152 1120 DLYEMFVARTSSS 1132 (1137)
Q Consensus 1120 EVL~~L~~~~~ss 1132 (1137)
|+++|+|+....+
T Consensus 320 e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 320 ELLKHPFLAKAGP 332 (346)
T ss_dssp HHTTCGGGGGCCC
T ss_pred HHhcCHhhcCCCC
Confidence 9999999987543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=444.13 Aligned_cols=258 Identities=23% Similarity=0.306 Sum_probs=201.5
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+++|++.+.||+|+||+||+|++. ++.||+|+........ . ....++.+|+.+|++++|||||++++++.++
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-S----DMQGRIEREISYLRLLRHPHIIKLYDVIKSK 85 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-H----HHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 4789999999999999999999984 5789999864332211 1 1223458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..|+||||+ +|+|.+++.+ ...+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 86 ~--------------~~~ivmEy~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl 145 (275)
T 3hyh_A 86 D--------------EIIMVIEYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL 145 (275)
T ss_dssp S--------------EEEEEEECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE
T ss_pred C--------------EEEEEEeCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE
Confidence 6 679999999 6899999976 3469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+|+....... ....+||+.|||||++.+ ...++.++||||+||++|+
T Consensus 146 ~~~-------~~vkl~DFGla~~~~~~~~-----------~~~~~GT~~Y~APE~~~~---~~y~~~~~DiwSlGvily~ 204 (275)
T 3hyh_A 146 DEH-------LNVKIADFGLSNIMTDGNF-----------LKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYV 204 (275)
T ss_dssp CTT-------CCEEECCSSCC--------------------------CTTSCHHHHSS---SSCCCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeecCCCeecCCCCc-----------cCCeeECcccCChhhhcC---CCCCCChhhhHHHHHHHHH
Confidence 987 7899999999976543211 124579999999999976 2345789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|+||+.||.+.+..++...+..+..+ ++. ..++++++|+.+||+.||++|||
T Consensus 205 lltg~~PF~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dP~~R~s 256 (275)
T 3hyh_A 205 MLCRRLPFDDESIPVLFKNISNGVYT-LPK---------------------------FLSPGAAGLIKRMLIVNPLNRIS 256 (275)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCC-CCT---------------------------TSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHccCChhHCcC
Confidence 99999999998888888888765432 111 23456899999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001152 1118 AGDLYEMFVARTSS 1131 (1137)
Q Consensus 1118 a~EVL~~L~~~~~s 1131 (1137)
++|+++|+|++..-
T Consensus 257 ~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 257 IHEIMQDDWFKVDL 270 (275)
T ss_dssp HHHHHHCHHHHTTC
T ss_pred HHHHHcCcccccCC
Confidence 99999999998643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=452.69 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=216.0
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||+||+|++. ++.||+|+...... ..+....++.+|+++|++++|||||+++++|.++
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 104 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 4567999999999999999999985 57799998643211 1111223458999999999999999999999987
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ .+|||||||+||+|.+++++ ...+++..++.|+.||+.||+|||++|||||||||+|||+
T Consensus 105 ~--------------~~yivmEy~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl 165 (311)
T 4aw0_A 105 E--------------KLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 165 (311)
T ss_dssp S--------------EEEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C--------------EEEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE
Confidence 6 67999999999999999986 2469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+|+.+...... ......+||+.|||||++.+ ..|+.++||||+||++||
T Consensus 166 ~~~-------g~vKl~DFGla~~~~~~~~~--------~~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilye 226 (311)
T 4aw0_A 166 NED-------MHIQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLWALGCIIYQ 226 (311)
T ss_dssp CTT-------SCEEECCCTTCEECCTTTTC--------CCBCCCCSCGGGCCHHHHHH----SCBCHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEEEcCCceecCCCCCc--------ccccCcccCcccCCHHHHcC----CCCCcHHHHHHHHHHHHH
Confidence 987 78999999999876432211 11234579999999999986 568999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|..||.+.+..++...|..+... ++. ..++++++||.+||+.||.+|||
T Consensus 227 ml~G~~PF~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~dli~~lL~~dp~~R~t 278 (311)
T 4aw0_A 227 LVAGLPPFRAGNEGLIFAKIIKLEYD-FPE---------------------------KFFPKARDLVEKLLVLDATKRLG 278 (311)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCC-CCT---------------------------TCCHHHHHHHHHHSCSSGGGSTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCC-CCc---------------------------ccCHHHHHHHHHHccCCHhHCcC
Confidence 99999999999999888888765432 111 23456999999999999999999
Q ss_pred HHH------HHHHHHhhcC
Q 001152 1118 AGD------LYEMFVARTS 1130 (1137)
Q Consensus 1118 a~E------VL~~L~~~~~ 1130 (1137)
++| |++|+||..-
T Consensus 279 ~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 279 CEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp SGGGTCHHHHHTSGGGTTC
T ss_pred hHHHcCCHHHHCCCCcCCC
Confidence 987 5788888653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=447.52 Aligned_cols=267 Identities=25% Similarity=0.383 Sum_probs=209.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
....++++.++||+|+||+||+|++.+ .||||+++ .........+.+ .+|+.+|++++|||||++++++.++
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~--~~~~~~~~~~~f----~~E~~il~~l~HpNIV~l~g~~~~~- 104 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILK--VVDPTPEQFQAF----RNEVAVLRKTRHVNILLFMGYMTKD- 104 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECC--CSSCCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEE--ecCCCHHHHHHH----HHHHHHHHhCCCCCEeeEEEEEECC-
Confidence 345678999999999999999999865 58999843 333334444444 8999999999999999999987543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.++||||||+||+|.++++. ....+++.++..|+.|||.||+|||+++||||||||+|||++
T Consensus 105 --------------~~~iVmEy~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~ 166 (307)
T 3omv_A 105 --------------NLAIVTQWCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH 166 (307)
T ss_dssp --------------SCEEEEECCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE
T ss_pred --------------eEEEEEEcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC
Confidence 35999999999999999975 234699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+|+........ ......+||+.|||||++.+. ....|+.++|||||||++|||
T Consensus 167 ~~-------~~~Ki~DFGla~~~~~~~~~--------~~~~~~~GT~~ymAPE~l~~~-~~~~y~~ksDVwS~Gvvl~El 230 (307)
T 3omv_A 167 EG-------LTVKIGDFGLATVKSRWSGS--------QQVEQPTGSVLWMAPEVIRMQ-DNNPFSFQSDVYSYGIVLYEL 230 (307)
T ss_dssp TT-------EEEEECCCSSCBC--------------------CCCCTTSCCHHHHHCC-SSCCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeeccCceecccCCcc--------eeecccccCCCccCHHHhhcc-CCCCCCcHHHhHhHHHHHHHH
Confidence 87 78999999999765432211 111245799999999999752 234689999999999999999
Q ss_pred HhCCCCCCCCCHHH-HHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1039 LTLQVPYMGLSELE-IHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~e-l~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+||+.||.+.+... +...+..+.. |.++. ....+++++.+|+.+||+.||++||
T Consensus 231 ltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~------------------------~~~~~~~~l~~li~~cl~~dP~~RP 286 (307)
T 3omv_A 231 MTGELPYSHINNRDQIIFMVGRGYASPDLSK------------------------LYKNCPKAMKRLVADCVKKVKEERP 286 (307)
T ss_dssp HHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT------------------------SCTTSCHHHHHHHHHHTCSSSTTSC
T ss_pred HHCCCCCCCCChHHHHHHHHhcCCCCCCccc------------------------ccccchHHHHHHHHHHcCCCHhHCc
Confidence 99999998765544 4444444432 11110 0114567799999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001152 1117 TAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~s 1131 (1137)
||.||+++++....+
T Consensus 287 s~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 287 LFPQILSSIELLQHS 301 (307)
T ss_dssp CHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHhcc
Confidence 999999999877543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=446.01 Aligned_cols=258 Identities=23% Similarity=0.337 Sum_probs=203.1
Q ss_pred Cc-eEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 803 SL-SSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 803 ~y-~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+| ++.++||+|+||+||+|.+.. ..||+|+. ..........+. +.+|+.+|++++|||||+++++|.+...
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i--~~~~~~~~~~~~----~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQR----FKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE--EGGGSCHHHHHH----HHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEE--chhhCCHHHHHH----HHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 44 788899999999999999965 45666654 333233333333 4899999999999999999999875310
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeEe
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILI 957 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g--IIHrDLKP~NILl 957 (1137)
....+|||||||+||+|.+++++ ...+++..+..|+.||+.||+|||+++ ||||||||+|||+
T Consensus 100 ----------~~~~~~lvmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl 164 (290)
T 3fpq_A 100 ----------GKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164 (290)
T ss_dssp ----------TEEEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE
T ss_pred ----------CCcEEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE
Confidence 11257999999999999999986 246999999999999999999999998 9999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+... +.+||+|||+|+...... ....+||+.|||||++.+ .|+.++|||||||++||
T Consensus 165 ~~~~------g~vKl~DFGla~~~~~~~------------~~~~~GTp~YmAPE~~~~-----~y~~~~DiwSlGvilye 221 (290)
T 3fpq_A 165 TGPT------GSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLE 221 (290)
T ss_dssp SSTT------SCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHH
T ss_pred ECCC------CCEEEEeCcCCEeCCCCc------------cCCcccCccccCHHHcCC-----CCCcHHHHHHHHHHHHH
Confidence 7421 689999999997533211 124579999999999863 58999999999999999
Q ss_pred HHhCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~-~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|+||+.||.+. ....+...+..+..|... ....++++.+|+.+||+.||++||
T Consensus 222 lltg~~Pf~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~li~~~L~~dP~~R~ 275 (290)
T 3fpq_A 222 MATSEYPYSECQNAAQIYRRVTSGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDERY 275 (290)
T ss_dssp HHHSSCTTTTCSSHHHHHHHHTTTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHCCCCCCCCCcHHHHHHHHHcCCCCCCC--------------------------CccCCHHHHHHHHHHccCChhHCc
Confidence 99999999764 445555555554432111 013345699999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|++|+++|+|++..
T Consensus 276 s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 276 SIKDLLNHAFFQEE 289 (290)
T ss_dssp CHHHHHTSGGGC--
T ss_pred CHHHHhcCccccCC
Confidence 99999999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=464.82 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=217.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|++.++||+|+||+||+|++. +..||||+...... ...+ .+.+|+.+|+.++|||||+++++|.+.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~----~~~~Ei~il~~l~HpnIV~l~~~~~~~~- 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRE----LLFNEVVIMRDYQHENVVEMYNSYLVGD- 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGG----GHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHH----HHHHHHHHHHhCCCCCCCceEEEEEECC-
Confidence 45999999999999999999985 57789988654321 1122 3488999999999999999999999876
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
++|||||||+||+|.++++. ..+++..+..|+.||+.||+|||++|||||||||+||||+.
T Consensus 222 -------------~~~iVmEy~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~ 282 (423)
T 4fie_A 222 -------------ELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 282 (423)
T ss_dssp -------------EEEEEEECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT
T ss_pred -------------EEEEEEeCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC
Confidence 67999999999999999975 35999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+|+.+..... .....+||+.|||||++.+ ..|+.++|||||||++|||+
T Consensus 283 ~-------g~vKl~DFGla~~~~~~~~----------~~~~~~GTp~YmAPEvl~~----~~y~~~~DiWSlGvilyeml 341 (423)
T 4fie_A 283 D-------GRVKLSDFGFCAQVSKEVP----------RRKSLVGTPYWMAPELISR----LPYGPEVDIWSLGIMVIEMV 341 (423)
T ss_dssp T-------CCEEECCCTTCEECCSSCC----------CBCCCEECTTTCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEecCccceECCCCCc----------cccccccCcCcCCHHHHCC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 7899999999986543221 1224679999999999975 57899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|+.||.+.+..++...|.....+.+... ...++++++||.+||+.||++|||++
T Consensus 342 ~G~~PF~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~s~~~~dli~~~L~~dP~~R~ta~ 396 (423)
T 4fie_A 342 DGEPPYFNEPPLKAMKMIRDNLPPRLKNL-------------------------HKVSPSLKGFLDRLLVRDPAQRATAA 396 (423)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCSCT-------------------------TSSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HCCCCCCCcCHHHHHHHHHcCCCCCCccc-------------------------ccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999999888888876554332210 03456699999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001152 1120 DLYEMFVARTSSS 1132 (1137)
Q Consensus 1120 EVL~~L~~~~~ss 1132 (1137)
|+++|+|+....+
T Consensus 397 ell~Hp~~~~~~~ 409 (423)
T 4fie_A 397 ELLKHPFLAKAGP 409 (423)
T ss_dssp HHTTCGGGGGCCC
T ss_pred HHhcCHHhcCCCC
Confidence 9999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=448.09 Aligned_cols=265 Identities=23% Similarity=0.341 Sum_probs=211.7
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
...+|.+.++||+|+||+||+|++. +..||||+.+ . ......++ |.+|+++|++++|||||++++
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~--~--~~~~~~~~----f~~E~~il~~l~HpnIV~l~g 110 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--E--ASESARQD----FQREAELLTMLQHQHIVRFFG 110 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEES--C--CSHHHHHH----HHHHHHHHTTCCCTTBCCEEE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEEC--c--CCHHHHHH----HHHHHHHHHhCCCCCCCcEEE
Confidence 3457899999999999999999974 3568888743 2 12333334 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc----------CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----------GEKHVSVKLALFIAQDVAAALVELHS 942 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~----------~~~~ls~~~i~~I~~QIa~gL~yLHs 942 (1137)
++.+.. ..+||||||++|+|.++++..... ...++++.+++.|+.||+.||+|||+
T Consensus 111 ~~~~~~--------------~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 176 (329)
T 4aoj_A 111 VCTEGR--------------PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176 (329)
T ss_dssp EECSSS--------------SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEECC--------------EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 998765 569999999999999999763211 12469999999999999999999999
Q ss_pred CCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCC
Q 001152 943 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022 (1137)
Q Consensus 943 ~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1022 (1137)
++||||||||+|||++.+ +.+||+|||+++........ .......||+.|||||++.+ ..|
T Consensus 177 ~~iiHRDLKp~NILl~~~-------~~~Ki~DFGla~~~~~~~~~--------~~~~~~~gt~~ymAPE~~~~----~~~ 237 (329)
T 4aoj_A 177 LHFVHRDLATRNCLVGQG-------LVVKIGDFGMSRDIYSTDYY--------RVGGRTMLPIRWMPPESILY----RKF 237 (329)
T ss_dssp TTCCCSCCCGGGEEEETT-------TEEEECCCC------------------------CCCCGGGCCHHHHTT----CCC
T ss_pred CCeecccccHhhEEECCC-------CcEEEcccccceeccCCCcc--------eecCcccccccccChhhhcC----CCC
Confidence 999999999999999988 88999999999865432211 11123569999999999976 578
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001152 1023 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1101 (1137)
Q Consensus 1023 s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1101 (1137)
+.++|||||||++|||+| |+.||.+.+..++...+..+.++..+. .+++++.
T Consensus 238 ~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~---------------------------~~~~~~~ 290 (329)
T 4aoj_A 238 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR---------------------------ACPPEVY 290 (329)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCT---------------------------TCCHHHH
T ss_pred CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------cccHHHH
Confidence 999999999999999999 899999999999888887776544332 3456699
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 001152 1102 DVFRRCTEENPTERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1102 dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ss 1132 (1137)
+|+.+||+.||++||||+||+++|+....++
T Consensus 291 ~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 291 AIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 9999999999999999999999998875543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=445.56 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=214.3
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
+-.+|.+.++||+|+||+||+|++. +..||||+.+ .. .....++ |.+|+++|++++|||||+++|
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~--~~--~~~~~~~----f~~E~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK--DA--SDNARKD----FHREAELLTNLQHEHIVKFYG 82 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEEC--SC--CHHHHHH----HHHHHHHHTTCCCTTBCCEEE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeC--CC--ChHHHHH----HHHHHHHHHhCCCCCCccEEE
Confidence 3457899999999999999999874 3567888743 21 2333334 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--------TGEKHVSVKLALFIAQDVAAALVELHSKH 944 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~--------~~~~~ls~~~i~~I~~QIa~gL~yLHs~g 944 (1137)
++.+.+ ..+||||||++|+|.++++.... .....+++.+++.|+.||+.||+|||+++
T Consensus 83 ~~~~~~--------------~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 148 (299)
T 4asz_A 83 VCVEGD--------------PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH 148 (299)
T ss_dssp EECSSS--------------SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEeeCC--------------EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 998765 56999999999999999986321 22357999999999999999999999999
Q ss_pred eeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCc
Q 001152 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGL 1024 (1137)
Q Consensus 945 IIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ 1024 (1137)
||||||||+|||++.+ +.+||+|||+|+......... ......||+.|||||++.+ ..|+.
T Consensus 149 iiHRDlKp~NILl~~~-------~~~Ki~DFGla~~~~~~~~~~--------~~~~~~gt~~ymAPE~~~~----~~~~~ 209 (299)
T 4asz_A 149 FVHRDLATRNCLVGEN-------LLVKIGDFGMSRDVYSTDYYR--------VGGHTMLPIRWMPPESIMY----RKFTT 209 (299)
T ss_dssp CCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCEE--------ETTTEEECGGGCCHHHHHH----CCCCH
T ss_pred cccCccCHhhEEECCC-------CcEEECCcccceecCCCCcee--------ecCceecChhhcCHHHHcC----CCCCc
Confidence 9999999999999988 789999999998654322110 1123468999999999986 57899
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHH
Q 001152 1025 EVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDV 1103 (1137)
Q Consensus 1025 ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dL 1103 (1137)
++|||||||++|||+| |+.||.+.+..++...+..+..+..+. .+++++.+|
T Consensus 210 k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~~~~l 262 (299)
T 4asz_A 210 ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR---------------------------TCPQEVYEL 262 (299)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHH
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cchHHHHHH
Confidence 9999999999999999 899999999999998888776554332 345569999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1104 FRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1104 l~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+.+||+.||++||||+||++.|....
T Consensus 263 i~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 263 MLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 99999999999999999988887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=442.43 Aligned_cols=265 Identities=20% Similarity=0.313 Sum_probs=216.2
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcce
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVE 869 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVk 869 (1137)
....+.++++.++||+|+||+||+|++. +..||||+. +.... ....++ |.+|+.+|++++|||||+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l--~~~~~-~~~~~~----f~~E~~il~~l~HpNIV~ 93 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAE-GPLREE----FRHEAMLRARLQHPNVVC 93 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEEC--CC-CC-C-CHHH----HHHHHHHHHHCCCTTBCC
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEE--CcccC-hHHHHH----HHHHHHHHHhCCCCCCCC
Confidence 3445677899999999999999999973 356788864 32221 222233 489999999999999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHH
Q 001152 870 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALV 938 (1137)
Q Consensus 870 llg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------~~~~ls~~~i~~I~~QIa~gL~ 938 (1137)
++|++.++. ..+||||||++|+|.++|...... ....+++.++..|+.|||.||+
T Consensus 94 l~g~~~~~~--------------~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~ 159 (308)
T 4gt4_A 94 LLGVVTKDQ--------------PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 159 (308)
T ss_dssp EEEEECSSS--------------SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHH
T ss_pred cceEEEECC--------------EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 999998765 459999999999999999753211 1246999999999999999999
Q ss_pred HHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001152 939 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1018 (1137)
Q Consensus 939 yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1018 (1137)
|||+++||||||||+||||+.+ +.+||+|||+++........ .......||+.|||||++.+
T Consensus 160 yLH~~~iiHRDLK~~NILl~~~-------~~~Ki~DFGlar~~~~~~~~--------~~~~~~~gt~~ymAPE~l~~--- 221 (308)
T 4gt4_A 160 YLSSHHVVHKDLATRNVLVYDK-------LNVKISDLGLFREVYAADYY--------KLLGNSLLPIRWMAPEAIMY--- 221 (308)
T ss_dssp HHHHTTCCCSCCSGGGEEECGG-------GCEEECCSCCBCGGGGGGCB--------CSSSSSCBCGGGCCHHHHHH---
T ss_pred HHHhCCCCCCCccccceEECCC-------CCEEECCcccceeccCCCce--------eEecccccCCcccCHHHHhC---
Confidence 9999999999999999999988 78999999999865432211 11224579999999999986
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001152 1019 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1097 (1137)
Q Consensus 1019 ~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1137)
..|+.++|||||||++|||+| |..||.+.+..++...+..+..+..+. .++
T Consensus 222 -~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~ 273 (308)
T 4gt4_A 222 -GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD---------------------------DCP 273 (308)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCC
T ss_pred -CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------cch
Confidence 578999999999999999998 899999999999998888776544332 345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1098 SFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1098 ~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+++.+|+.+||+.||++||||.||+++|...
T Consensus 274 ~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 274 AWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 6699999999999999999999999999754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=447.91 Aligned_cols=256 Identities=24% Similarity=0.266 Sum_probs=207.9
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
..++|++.+.||+|+||+||+|++. +..||+|+....... ..+.. ++.+|+.+|++++|||||++++++
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--~~~~~----~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK--VRDRV----RTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE--EEECC----------CCCCCCCCTTEECEEEEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC--hHHHH----HHHHHHHHHHHCCCCCCCeEEEEE
Confidence 3468999999999999999999872 356899986433211 11111 347899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+++ .+|||||||+||+|.+++++ ...+++..+..|+.||+.||+|||++||+||||||+|
T Consensus 96 ~~~~--------------~~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 156 (304)
T 3ubd_A 96 QTEG--------------KLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 156 (304)
T ss_dssp EETT--------------EEEEEECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred EECC--------------EEEEEEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 9876 67999999999999999986 2469999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||+|+....... .....+||+.|||||++.+ ..|+.++|||||||+
T Consensus 157 ILl~~~-------g~vKl~DFGla~~~~~~~~----------~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvi 215 (304)
T 3ubd_A 157 ILLDEE-------GHIKLTDFGLSKESIDHEK----------KAYSFCGTVEYMAPEVVNR----RGHTQSADWWSFGVL 215 (304)
T ss_dssp EEECTT-------SCEEEESSEEEEC-----C----------CCCSCCCCGGGCCHHHHHT----SCCCTHHHHHHHHHH
T ss_pred eEEcCC-------CCEEecccccceeccCCCc----------cccccccCcccCCHHHhcc----CCCCCCCcccchHHH
Confidence 999987 7899999999975433211 1224579999999999976 578999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|||+||+.||.+.+..++...|..+..+ ++. ..++++.+||.+||+.||++
T Consensus 216 lyemltG~~PF~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dP~~ 267 (304)
T 3ubd_A 216 MFEMLTGTLPFQGKDRKETMTMILKAKLG-MPQ---------------------------FLSPEAQSLLRMLFKRNPAN 267 (304)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCCCCCcCHHHHHHHHHcCCCC-CCC---------------------------cCCHHHHHHHHHHcccCHHH
Confidence 99999999999999999888888765432 111 34456999999999999999
Q ss_pred CCC-----HHHHHHHHHhhc
Q 001152 1115 RPT-----AGDLYEMFVART 1129 (1137)
Q Consensus 1115 RPS-----a~EVL~~L~~~~ 1129 (1137)
||| ++|+++|+|++.
T Consensus 268 R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 268 RLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp STTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCcCCHHHHHcCccccC
Confidence 998 589999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=444.89 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=206.0
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+..|++.++||+|+||+||+|++. +..||||+...+.. ..+|+.+|+.++|||||++++++.+.
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~E~~il~~l~HpnIV~l~~~~~~~ 122 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------------RVEELVACAGLSSPRIVPLYGAVREG 122 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------------CTHHHHTTTTCCCTTBCCEEEEEEET
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------------HHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3467899999999999999999985 57799998654321 14699999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ .+|||||||+||+|.+++++. ..+++..++.|+.||+.||+|||++|||||||||+||||
T Consensus 123 ~--------------~~~ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 183 (336)
T 4g3f_A 123 P--------------WVNIFMELLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183 (336)
T ss_dssp T--------------EEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE
T ss_pred C--------------EEEEEEeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE
Confidence 6 679999999999999999862 469999999999999999999999999999999999999
Q ss_pred ccccccCCCCC-eEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 958 DLERKKADGKP-VVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 958 d~~~~~~~~~~-~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
+.+ + .+||+|||+|+.+....... ........+||+.|||||++.+ ..|+.++|||||||++|
T Consensus 184 ~~~-------g~~vKl~DFGla~~~~~~~~~~-----~~~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvily 247 (336)
T 4g3f_A 184 SSD-------GSRAALCDFGHALCLQPDGLGK-----SLLTGDYIPGTETHMAPEVVMG----KPCDAKVDIWSSCCMML 247 (336)
T ss_dssp CTT-------SCCEEECCCTTCEEC-----------------CCCCCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHH
T ss_pred eCC-------CCEEEEeeCCCCeEccCCCccc-----ceecCCccccCccccCHHHHCC----CCCCcHHHHHHHHHHHH
Confidence 877 4 59999999998765422111 0011234579999999999986 57899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
||+||+.||.+.+..++...|.....+.. . ....+++++.+||.+||+.||.+||
T Consensus 248 emltG~~Pf~~~~~~~~~~~i~~~~~~~~--~-----------------------~~~~~s~~~~~li~~~L~~dP~~R~ 302 (336)
T 4g3f_A 248 HMLNGCHPWTQYFRGPLCLKIASEPPPIR--E-----------------------IPPSCAPLTAQAIQEGLRKEPVHRA 302 (336)
T ss_dssp HHHHSSCSSTTTCCSCCHHHHHHSCCGGG--G-----------------------SCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHCcCCCCCCCHHHHHHHHHcCCCCch--h-----------------------cCccCCHHHHHHHHHHccCCHhHCc
Confidence 99999999988776666666655432110 0 0014566799999999999999999
Q ss_pred CHHHHHHHHHh
Q 001152 1117 TAGDLYEMFVA 1127 (1137)
Q Consensus 1117 Sa~EVL~~L~~ 1127 (1137)
|+.|++++++.
T Consensus 303 sa~el~~~l~~ 313 (336)
T 4g3f_A 303 SAMELRRKVGK 313 (336)
T ss_dssp CHHHHHHHHHH
T ss_pred CHHHHHHHHHH
Confidence 99999887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=437.77 Aligned_cols=292 Identities=16% Similarity=0.201 Sum_probs=215.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||+||+|++. +..||||+.. .........+ ++++|+.+|+.++|||||++++++.....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~--~~~~~~~~~~----~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP--NAFDVVTNAK----RTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEET--TTTSSHHHHH----HHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEEC--ccccchHHHH----HHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 47999999999999999999985 5778888753 3323233333 34899999999999999999999876432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
+ ....++|||||||+ |+|.+++.. ...+++..++.|++||+.||+|||++|||||||||+|||++.
T Consensus 128 ~--------~~~~~~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~ 193 (398)
T 4b99_A 128 Y--------GEFKSVYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE 193 (398)
T ss_dssp T--------TTCCCEEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred c--------ccCCEEEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC
Confidence 2 11236899999996 789999865 357999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+|+.+...... ........+||+.|||||++.+ ...|+.++||||+||++|||+
T Consensus 194 ~-------~~~Ki~DFGla~~~~~~~~~------~~~~~~~~~GT~~Y~APEv~~~---~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 194 N-------CELKIGDFGMARGLCTSPAE------HQYFMTEYVATRWYRAPELMLS---LHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp T-------CCEEECCCTTCBCC-------------CCCCCSSCCCCTTCCHHHHTT---CSCCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeecceeeecccCccc------cccccccceeChHhcCHHHhcC---CCCCCChhheehhHHHHHHHH
Confidence 7 78999999999865432111 0112235689999999999875 246799999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCC---CCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS---GFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|++||.+.+..+....|...........+................ ...........++++.+||.+||+.||.+||
T Consensus 258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 337 (398)
T 4b99_A 258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI 337 (398)
T ss_dssp HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence 9999999998888887774432211111111000000000000000 0011111224567899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|++|+++|+|+..
T Consensus 338 ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 338 SAAAALRHPFLAK 350 (398)
T ss_dssp CHHHHTTSGGGTT
T ss_pred CHHHHhcCHhhCc
Confidence 9999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=433.91 Aligned_cols=263 Identities=23% Similarity=0.367 Sum_probs=209.6
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC-CCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H-pNIVkllg 872 (1137)
.++|++.++||+|+||+||+|++.+ ..||||+.. .. ....+.+. +.+|+.+|+++.| ||||++++
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~--~~-~~~~~~~~----~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EG-ATHSEHRA----LMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEEC--TT-CCHHHHHH----HHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEc--cc-cChHHHHH----HHHHHHHHHHcCCCCcEEEEEE
Confidence 4679999999999999999999743 347777643 22 12333334 4899999999975 99999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELH 941 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------~~~~ls~~~i~~I~~QIa~gL~yLH 941 (1137)
++.+.+. .++||||||++|+|.++|+..... ....+++..+..|+.|||+||+|||
T Consensus 136 ~~~~~~~-------------~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH 202 (353)
T 4ase_A 136 ACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 202 (353)
T ss_dssp EECCTTS-------------CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCC-------------EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh
Confidence 9875431 459999999999999999864321 1345899999999999999999999
Q ss_pred hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001152 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 942 s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1021 (1137)
+++||||||||+|||++.+ +.+||+|||+|+......... ......||+.|||||++.+ ..
T Consensus 203 ~~~iiHRDLK~~NILl~~~-------~~vKi~DFGlar~~~~~~~~~--------~~~~~~gt~~ymAPE~l~~----~~ 263 (353)
T 4ase_A 203 SRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDYV--------RKGDARLPLKWMAPETIFD----RV 263 (353)
T ss_dssp HTTCCCSCCSGGGEEECGG-------GCEEECCCGGGSCTTTCTTSE--------EETTEEECGGGCCHHHHHH----CC
T ss_pred hCCeecCccCccceeeCCC-------CCEEECcchhhhhcccCCCce--------eeccccccccccCHHHHhc----CC
Confidence 9999999999999999988 789999999998654322110 1123468999999999986 57
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLT-LQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1099 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLT-G~~Pf~~~~-~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1137)
|+.++|||||||++|||+| |+.||.+.. ...+...+..+.++..+. .++++
T Consensus 264 y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~---------------------------~~~~~ 316 (353)
T 4ase_A 264 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD---------------------------YTTPE 316 (353)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT---------------------------TCCHH
T ss_pred CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCc---------------------------cCCHH
Confidence 8999999999999999998 899998765 345556666666544332 34456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1100 LVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1100 L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+.+++.+||+.||++||||.||++||...-
T Consensus 317 ~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 317 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999999987653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=421.30 Aligned_cols=267 Identities=25% Similarity=0.290 Sum_probs=199.5
Q ss_pred CceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
+|.+.++||+|+||+||+|++.++.||||+.... ..+.+ ....|+..+.+++|||||++++++.+++.
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~-------~~~~~--~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~--- 71 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSW--FREAEIYQTVMLRHENILGFIAADNKDNG--- 71 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG-------GHHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS---
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-------chhhH--HHHHHHHHHhcCCCCCCCcEEEEEEecCC---
Confidence 5789999999999999999999999999985322 11111 12456777788999999999999986531
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCCCCC
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIKSEN 954 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~--------gIIHrDLKP~N 954 (1137)
...++|||||||++|+|.++++. ..+++..+.+|+.|++.||+|||++ +||||||||+|
T Consensus 72 -------~~~~~~lV~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~N 138 (303)
T 3hmm_A 72 -------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138 (303)
T ss_dssp -------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGG
T ss_pred -------CceEEEEEecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCccc
Confidence 12367999999999999999976 3589999999999999999999987 99999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC--CCCCCchhhHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYG 1032 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--~~~~s~ksDVWSLG 1032 (1137)
||++.+ +.+||+|||+|+.......... ......+||+.|||||++.+... ...++.++||||||
T Consensus 139 ILl~~~-------~~~Ki~DFGla~~~~~~~~~~~------~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G 205 (303)
T 3hmm_A 139 ILVKKN-------GTCCIADLGLAVRHDSATDTID------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp EEECTT-------SCEEECCCTTCEEEETTTTEES------CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred EEECCC-------CCEEEEeCCCCccccCCCCcee------eecccccccccccCHHHhcccccccCCccChhHhhhhHH
Confidence 999988 7899999999986654322110 11224579999999999975211 12367899999999
Q ss_pred HHHHHHHhCCCCCCCCC---------------HHHHHHHHH-cCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh
Q 001152 1033 CLLLELLTLQVPYMGLS---------------ELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 1096 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~---------------~~el~~~I~-~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1137)
|++|||+||..||.... ..++...+. ...+|.++... ....+
T Consensus 206 vvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~----------------------~~~~~ 263 (303)
T 3hmm_A 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----------------------QSCEA 263 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----------------------GSSHH
T ss_pred HHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccc----------------------cchHH
Confidence 99999999977664211 122222221 12222222211 11255
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1097 LSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1097 ~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
++.+.+|+.+||+.||++||||.||++.|....
T Consensus 264 ~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 264 LRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 677999999999999999999999999987654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=421.95 Aligned_cols=277 Identities=23% Similarity=0.289 Sum_probs=193.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|++. +..||+|+..... .....+ ++.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~----~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELARE----KVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHH----HHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHH----HHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 46899999999999999999985 5778888754332 122223 45899999999999999999999876441
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
.... ........+|+|||||+||+|.++++.. ......++..++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 78 ~~~~--~~~~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~ 153 (299)
T 4g31_A 78 TEKL--QPSSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM 153 (299)
T ss_dssp -----------CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred cccc--cccCCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC
Confidence 1000 0001122579999999999999999762 11224567788999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccc--cCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~--~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+ +.+||+|||+|+............ ..........+||+.|||||++.+ ..|+.++|||||||++||
T Consensus 154 ~-------~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~----~~y~~~~DiwSlGvilye 222 (299)
T 4g31_A 154 D-------DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG----NSYSHKVDIFSLGLILFE 222 (299)
T ss_dssp T-------CCEEECCCCCC--------------------------CCCTTSCHHHHTT----CCCCTHHHHHHHHHHHHH
T ss_pred C-------CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC----CCCCCHHHHHHHHHHHHH
Confidence 7 789999999998765432111000 000011234579999999999976 578999999999999999
Q ss_pred HHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~-~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++ ||..... ......+.....|. .+ ....+.+.+|+.+||+.||.+||
T Consensus 223 ll~---Pf~~~~~~~~~~~~~~~~~~p~---~~------------------------~~~~~~~~~li~~~L~~dP~~Rp 272 (299)
T 4g31_A 223 LLY---PFSTQMERVRTLTDVRNLKFPP---LF------------------------TQKYPCEYVMVQDMLSPSPMERP 272 (299)
T ss_dssp HHS---CCSSHHHHHHHHHHHHTTCCCH---HH------------------------HHHCHHHHHHHHHHTCSSGGGSC
T ss_pred Hcc---CCCCccHHHHHHHHHhcCCCCC---CC------------------------cccCHHHHHHHHHHcCCChhHCc
Confidence 996 7864221 12223333332221 11 13334578899999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|+.|+++|+|+..-
T Consensus 273 s~~eil~h~~~~~~ 286 (299)
T 4g31_A 273 EAINIIENAVFEDL 286 (299)
T ss_dssp CHHHHHTSGGGCCC
T ss_pred CHHHHhcCHhhCCC
Confidence 99999999999753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=438.97 Aligned_cols=261 Identities=21% Similarity=0.268 Sum_probs=216.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+++|++.+.||+|+||+||+|++. +..+|+|+..... ..+.+ .+.+|+.+|+.++|||||+++++|.+..
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----~~~~~----~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKE----TVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHH----HHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----hhhHH----HHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 578999999999999999999985 5678888754321 22223 3488999999999999999999998766
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
++|||||||+||+|.+++.. ....+++.++..|+.||+.||+|||++||+||||||+|||++
T Consensus 228 --------------~~~iv~E~~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~ 289 (573)
T 3uto_A 228 --------------EMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 289 (573)
T ss_dssp --------------EEEEEEECCCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEeecCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhcccc
Confidence 67999999999999999854 134699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+. .+.+||+|||+|+.+...... ...+||+.|||||++.+ ..|+.++|||||||++|||
T Consensus 290 ~~~-----~~~vKl~DFG~a~~~~~~~~~-----------~~~~GT~~y~APEv~~~----~~y~~~~DiWSlGvilyem 349 (573)
T 3uto_A 290 TKR-----SNELKLIDFGLTAHLDPKQSV-----------KVTTGTAEFAAPEVAEG----KPVGYYTDMWSVGVLSYIL 349 (573)
T ss_dssp SSS-----CCCEEECCCSSCEECCTTSEE-----------EEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHHH
T ss_pred CCC-----CCCEEEeeccceeEccCCCce-----------eeeEECccccCHHHhCC----CCCCcHHHHHHHHHHHHHH
Confidence 542 267999999999876543211 13479999999999986 5789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||.+.+..++...|..+........+ ...++++++||.+||+.||.+|||+
T Consensus 350 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~dli~~~L~~dp~~R~t~ 405 (573)
T 3uto_A 350 LSGLSPFGGENDDETLRNVKSCDWNMDDSAF------------------------SGISEDGKDFIRKLLLADPNTRMTI 405 (573)
T ss_dssp HHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG------------------------TTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HHCCCCCCCcCHHHHHHHHHhCCCCCCcccc------------------------cCCCHHHHHHHHHHccCChhHCcCH
Confidence 9999999999999888888765532211111 1345679999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 001152 1119 GDLYEMFVARTSS 1131 (1137)
Q Consensus 1119 ~EVL~~L~~~~~s 1131 (1137)
+|+++|+|+....
T Consensus 406 ~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 406 HQALEHPWLTPGN 418 (573)
T ss_dssp HHHHHSTTTSCCC
T ss_pred HHHhcCcCcCCCC
Confidence 9999999998543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=414.60 Aligned_cols=286 Identities=20% Similarity=0.177 Sum_probs=199.9
Q ss_pred CCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEe
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 875 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~ 875 (1137)
++|++.++||+|+||+||+|++. +..||+|+.. ... .. .++.+|+++|+.+ +|||||+++++|.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~--~~~----~~----~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLI--PTS----HP----IRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEEC--TTS----CH----HHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEc--ccc----CH----HHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 46999999999999999999863 3567777642 211 11 1347899999998 5999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+.+ +.|+||||++||+|.++++ .+++.+++.|+.||+.||+|||++|||||||||+||
T Consensus 91 ~~~--------------~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNi 148 (361)
T 4f9c_A 91 KND--------------HVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNF 148 (361)
T ss_dssp ETT--------------EEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ECC--------------EEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHe
Confidence 776 6799999999999999884 389999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCcccccccccccccc------------------ccCCCCCCCcccCCCcccchhhhcccc
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI------------------AHRGIPAPDVCVGTPRWMAPEVLRAMH 1017 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~------------------~~~~~~~~~~~~GT~~Y~APE~l~~~~ 1017 (1137)
|++.+. +.+||+|||+|+........... ...........+||+.|||||++.+
T Consensus 149 Ll~~~~------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-- 220 (361)
T 4f9c_A 149 LYNRRL------KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-- 220 (361)
T ss_dssp EEETTT------TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT--
T ss_pred EEeCCC------CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC--
Confidence 998652 57999999999755432110000 0000011224579999999999975
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC---------------------CCc--hhHHhhhc
Q 001152 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMG-LSELEIHDLIQMGKR---------------------PRL--TDELEALG 1073 (1137)
Q Consensus 1018 ~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~-~~~~el~~~I~~g~~---------------------p~l--~~~l~~~~ 1073 (1137)
...|+.++||||+||++|||++|+.||.. .+..+....|..... +.. ........
T Consensus 221 -~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 299 (361)
T 4f9c_A 221 -CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLR 299 (361)
T ss_dssp -CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC
T ss_pred -CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhc
Confidence 24689999999999999999999999954 444444444422110 000 00000000
Q ss_pred ccccccccc----cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1074 SCHEHEVAQ----SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1074 ~~~~~~~~~----~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
.. ...... ..............++++++|+.+||+.||++|||++|+++|+|++.
T Consensus 300 ~~-~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 300 GM-DSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp -----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred cc-cccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 00 000000 00000000111245677999999999999999999999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=438.64 Aligned_cols=261 Identities=21% Similarity=0.262 Sum_probs=207.6
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
+.++++|++.++||+|+||+||+|++. +..||+|+........ ............++.+++.++|||||+++++|.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~--~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcch--hhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 557899999999999999999999985 5778999864332110 000111011134467778889999999999999
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+.+ .+|||||||+||+|.++|.+ ...+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 263 ~~~--------------~lylVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI 323 (689)
T 3v5w_A 263 TPD--------------KLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323 (689)
T ss_dssp CSS--------------EEEEEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred ECC--------------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence 876 67999999999999999986 24699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
||+.+ +.+||+|||+|+...... ....+||+.|||||++.. ...|+.++|||||||++
T Consensus 324 Lld~~-------G~vKL~DFGlA~~~~~~~------------~~t~~GTp~YmAPEvl~~---~~~y~~~vDiWSLGvil 381 (689)
T 3v5w_A 324 LLDEH-------GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCML 381 (689)
T ss_dssp EECTT-------SCEEECCCTTCEECSSCC------------CCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHH
T ss_pred EEeCC-------CCEEecccceeeecCCCC------------CCCccCCcCccCHHHHhC---CCCCCcHHHHHHHHHHH
Confidence 99988 889999999998654321 124579999999999963 24689999999999999
Q ss_pred HHHHhCCCCCCCC---CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1036 LELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~---~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
|||++|..||.+. ...++...+..... .++. ..++++++||.+||+.||
T Consensus 382 YEmLtG~~PF~~~~~~~~~~i~~~i~~~~~-~~p~---------------------------~~S~~a~dLI~~lL~~dP 433 (689)
T 3v5w_A 382 FKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPD---------------------------SFSPELRSLLEGLLQRDV 433 (689)
T ss_dssp HHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHTCSCG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHhhcCCCC-CCCc---------------------------cCCHHHHHHHHHHccCCH
Confidence 9999999999753 33344444443321 1111 345569999999999999
Q ss_pred CCCCC-----HHHHHHHHHhhc
Q 001152 1113 TERPT-----AGDLYEMFVART 1129 (1137)
Q Consensus 1113 ~~RPS-----a~EVL~~L~~~~ 1129 (1137)
.+|++ ++||++|+||+.
T Consensus 434 ~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 434 NRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp GGCTTCSSSTHHHHTTSGGGTT
T ss_pred hHCCCCCCCCHHHHhcCccccC
Confidence 99998 899999999974
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=386.33 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=214.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
..+.+|++.+.||+|+||.||+|++ .+..||+|+..... ......+. +.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ--LNPTSLQK----LFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc--CCHHHHHH----HHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 3467899999999999999999998 45789999864332 22333333 4889999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ ..++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 86 ~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIl 146 (328)
T 3fe3_A 86 EK--------------TLYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL 146 (328)
T ss_dssp SS--------------EEEEEECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CC--------------EEEEEEECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEE
Confidence 65 679999999999999999762 46999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++........ .....||+.|+|||++.+. ...+.++|||||||++|
T Consensus 147 l~~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ 205 (328)
T 3fe3_A 147 LDAD-------MNIKIADFGFSNEFTVGGK-----------LDAFCGAPPYAAPELFQGK---KYDGPEVDVWSLGVILY 205 (328)
T ss_dssp ECTT-------SCEEECSTTCCGGGSSSCG-----------GGTTSSSGGGCCHHHHHTC---CCCSHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeeccCceecCCCCc-----------cccccCCcceeCcccccCC---CcCCchhhhhhhHHHHH
Confidence 9887 7899999999875543211 1234699999999999862 33468999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|++|..||.+.+..++...+..+.... +. ..++++.+|+.+||+.||.+||
T Consensus 206 ell~g~~pf~~~~~~~~~~~i~~~~~~~-p~---------------------------~~s~~~~~li~~~L~~dP~~R~ 257 (328)
T 3fe3_A 206 TLVSGSLPFDGQNLKELRERVLRGKYRI-PF---------------------------YMSTDCENLLKRFLVLNPIKRG 257 (328)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCC-CT---------------------------TSCHHHHHHHHHHCCSSTTTSC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCC-CC---------------------------CCCHHHHHHHHHHCCCChhHCc
Confidence 9999999999988888888776654321 11 2345589999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|++|+++|+|+...
T Consensus 258 t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 258 TLEQIMKDRWINAG 271 (328)
T ss_dssp CHHHHTTCTTTTTT
T ss_pred CHHHHhcCHhhcCC
Confidence 99999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=380.54 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=212.1
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||+||+|.+ .+..||+|+........ .+ .+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----KE----LIINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC----HH----HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH----HH----HHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 45799999999999999999987 45778888865443211 12 2378999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 91 --------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~ 150 (297)
T 3fxz_A 91 --------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (297)
T ss_dssp --------------EEEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC
Confidence 67999999999999999976 3589999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 151 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el 209 (297)
T 3fxz_A 151 MD-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEM 209 (297)
T ss_dssp TT-------CCEEECCCTTCEECCSTTC----------CBCCCCSCGGGCCHHHHHC----SCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCceecCCccc----------ccCCccCCcCccChhhhcC----CCCCcHHHHHHHHHHHHHH
Confidence 87 7899999999876543221 1123469999999999976 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||.+.........+.....+.+.. ....++.+.+++.+||+.||.+|||+
T Consensus 210 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~Rps~ 264 (297)
T 3fxz_A 210 IEGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLEMDVEKRGSA 264 (297)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHHCSCCCSC-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCCC-------------------------ccccCHHHHHHHHHHccCChhHCcCH
Confidence 99999999887776665554333222110 01345669999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001152 1119 GDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ss~ 1133 (1137)
+|+++|+|++...+.
T Consensus 265 ~ell~h~~~~~~~~~ 279 (297)
T 3fxz_A 265 KELLQHQFLKIAKPL 279 (297)
T ss_dssp HHHTTCGGGGGCCCG
T ss_pred HHHhhChhhcccCcc
Confidence 999999999876544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=380.49 Aligned_cols=259 Identities=21% Similarity=0.279 Sum_probs=213.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||+||+|.+. +..+|+|+.... ....+. +.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~----~~~E~~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVL----VKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHH----HHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHH----HHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence 467999999999999999999985 466888875422 222223 478999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 75 --------------~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~ 136 (321)
T 1tki_A 75 --------------ELVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp --------------EEEEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEeCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 67999999999999999864 234699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+. .+.+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 137 ~~~-----~~~~kl~Dfg~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 196 (321)
T 1tki_A 137 TRR-----SSTIKIIEFGQARQLKPGDNF-----------RLLFTAPEYYAPEVHQH----DVVSTATDMWSLGTLVYVL 196 (321)
T ss_dssp SSS-----CCCEEECCCTTCEECCTTCEE-----------EEEESCGGGSCHHHHTT----CEECHHHHHHHHHHHHHHH
T ss_pred cCC-----CCCEEEEECCCCeECCCCCcc-----------ccccCChhhcCcHHhcC----CCCCchhhHHHHHHHHHHH
Confidence 631 278999999999765432211 13468999999999875 4578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||.+....++...+..+........+ ...++++.+|+.+||+.||.+|||+
T Consensus 197 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~Rpt~ 252 (321)
T 1tki_A 197 LSGINPFLAETNQQIIENIMNAEYTFDEEAF------------------------KEISIEAMDFVDRLLVKERKSRMTA 252 (321)
T ss_dssp HHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCcCCCHHHHHHHHHcCCCCCChhhh------------------------ccCCHHHHHHHHHHcCCChhHCcCH
Confidence 9999999998888888887665543222111 1345669999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
.|+++|+|+...
T Consensus 253 ~e~l~hp~~~~~ 264 (321)
T 1tki_A 253 SEALQHPWLKQK 264 (321)
T ss_dssp HHHHHSHHHHSC
T ss_pred HHHhcChhhccC
Confidence 999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=386.97 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=214.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+.|++.+.||+|+||+||+|++. +..+|+|+........... ......+.+|+.+|++++||||+++++++.+..
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~- 88 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVCREEIEREVSILRQVLHPNIITLHDVYENRT- 88 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc--hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC-
Confidence 46999999999999999999985 5779999865443221110 001123478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 89 -------------~~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 150 (361)
T 2yab_A 89 -------------DVVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150 (361)
T ss_dssp -------------EEEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred -------------EEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeC
Confidence 67999999999999999864 346999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
++ .....+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 151 ~~---~~~~~vkl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~~ll 212 (361)
T 2yab_A 151 KN---IPIPHIKLIDFGLAHEIEDGVE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 212 (361)
T ss_dssp TT---SSSCCEEECCCSSCEECCTTCC-----------CCCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CC---CCccCEEEEecCCceEcCCCCc-----------cccCCCCccEECchHHcC----CCCCccccHHHHHHHHHHHH
Confidence 62 1113799999999976543211 123469999999999875 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||.+.+..+....+..+........+ ...++++.+||.+||+.||.+|||+.
T Consensus 213 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~R~t~~ 268 (361)
T 2yab_A 213 SGASPFLGDTKQETLANITAVSYDFDEEFF------------------------SQTSELAKDFIRKLLVKETRKRLTIQ 268 (361)
T ss_dssp HSCCSSCCSSHHHHHHHHHTTCCCCCHHHH------------------------TTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhcCCCCCchhc------------------------cCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 999999998888888888765532211111 13456699999999999999999999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
|+++|+|+..
T Consensus 269 e~l~hp~~~~ 278 (361)
T 2yab_A 269 EALRHPWITP 278 (361)
T ss_dssp HHHTSTTTSC
T ss_pred HHhcCcCcCC
Confidence 9999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=380.31 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=211.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
++.+|++.+.||+|+||.||+|++. +..+|+|+...... ........+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence 4678999999999999999999985 57799998643311 0111122347899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..|+||||++||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 78 ~--------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 138 (337)
T 1o6l_A 78 D--------------RLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138 (337)
T ss_dssp S--------------EEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred C--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE
Confidence 5 67999999999999999976 2468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 139 ~~~-------g~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~e 197 (337)
T 1o6l_A 139 DKD-------GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYE 197 (337)
T ss_dssp CTT-------SCEEECCCTTCBCSCCTTC----------CBCCCEECGGGCCGGGGSS----SCBCTTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeccchhhcccCCC----------cccccccChhhCChhhhcC----CCCCchhhcccchhHHHH
Confidence 987 7899999999875332111 1124579999999999875 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP- 1116 (1137)
|++|..||.+.+..++...+...... ++. ..++++.+||.+||+.||.+||
T Consensus 198 ll~g~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~lL~~dP~~R~g 249 (337)
T 1o6l_A 198 MMCGRLPFYNQDHERLFELILMEEIR-FPR---------------------------TLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSTTTSTT
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHhhcCHHHhcC
Confidence 99999999988888777777554321 111 2345699999999999999999
Q ss_pred ----CHHHHHHHHHhhc
Q 001152 1117 ----TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 ----Sa~EVL~~L~~~~ 1129 (1137)
+++||++|+|+..
T Consensus 250 ~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 250 GGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CSTTTHHHHHTSGGGTT
T ss_pred CCCCCHHHHHcCCCcCC
Confidence 9999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=385.34 Aligned_cols=259 Identities=24% Similarity=0.301 Sum_probs=208.7
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeE
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 874 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~ 874 (1137)
...+.+|++.+.||+|+||+||+|++. +..+|+|+...... ........+.+|+.+++.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-----LQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh-----cchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 345789999999999999999999985 56789998653311 1111122347899999988 599999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+.+ ..|+||||++||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 94 ~~~~--------------~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 154 (353)
T 3txo_A 94 QTPD--------------RLFFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDN 154 (353)
T ss_dssp ECSS--------------EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EeCC--------------EEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHH
Confidence 8766 679999999999999999762 469999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 155 ILl~~~-------g~ikL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 213 (353)
T 3txo_A 155 VLLDHE-------GHCKLADFGMCKEGICNGV----------TTATFCGTPDYIAPEILQE----MLYGPAVDWWAMGVL 213 (353)
T ss_dssp EEECTT-------SCEEECCCTTCBCSCC-------------------CCGGGCCHHHHHH----HHCTTHHHHHHHHHH
T ss_pred EEECCC-------CCEEEccccceeecccCCc----------cccccCCCcCeEChhhcCC----CCcCCccCCCcchHH
Confidence 999987 7899999999875332111 1124579999999999976 457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|||++|..||.+.+..++...+..+.... +. ..++++.+|+.+||+.||.+
T Consensus 214 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-p~---------------------------~~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 214 LYEMLCGHAPFEAENEDDLFEAILNDEVVY-PT---------------------------WLHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-CT---------------------------TSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CC---------------------------CCCHHHHHHHHHHhhhCHHH
Confidence 999999999999999888888886654321 11 23345899999999999999
Q ss_pred CCCH------HHHHHHHHhhc
Q 001152 1115 RPTA------GDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa------~EVL~~L~~~~ 1129 (1137)
||++ +||++|+|+..
T Consensus 266 R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 266 RLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp STTSGGGTCTHHHHTSGGGTT
T ss_pred ccCCcccCCHHHHhhCCcccC
Confidence 9998 99999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=381.00 Aligned_cols=260 Identities=25% Similarity=0.307 Sum_probs=213.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|.+. +..+|+|+..... ......+. +.+|+.+++.++|||||++++++.+.+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~----~~~E~~il~~l~hpnIv~~~~~~~~~~- 101 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQK----LEREARICRKLQHPNIVRLHDSIQEES- 101 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc--CCHHHHHH----HHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 46999999999999999999985 5678888864332 23333344 488999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 102 -------------~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 163 (362)
T 2bdw_A 102 -------------FHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 163 (362)
T ss_dssp -------------EEEEEECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESC
T ss_pred -------------EEEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 67999999999999998865 346999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+. ..+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 164 ~~----~~~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll 224 (362)
T 2bdw_A 164 KA----KGAAVKLADFGLAIEVNDSEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYILL 224 (362)
T ss_dssp SS----TTCCEEECCCTTCBCCTTCCS-----------CCCSCSCTTTCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCCEEEeecCcceEecCCcc-----------cccCCCCccccCHHHHcc----CCCCchhhHHHHHHHHHHHH
Confidence 52 125699999999876543211 123469999999999875 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||.+.+..++...+..+........+ ...++++.+|+.+||+.||.+|||+.
T Consensus 225 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~R~t~~ 280 (362)
T 2bdw_A 225 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEW------------------------DTVTPEAKSLIDSMLTVNPKKRITAD 280 (362)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTGG------------------------GGSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCcccc------------------------cCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999999998888888887665532211111 13456699999999999999999999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
|+++|+|+..
T Consensus 281 e~l~hp~~~~ 290 (362)
T 2bdw_A 281 QALKVPWICN 290 (362)
T ss_dssp HHTTSHHHHT
T ss_pred HHhcCcccCC
Confidence 9999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=373.33 Aligned_cols=288 Identities=19% Similarity=0.228 Sum_probs=209.6
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.-..+|++.++||+|+||+||+|++. +..+|+|+...... .. .....+.+|+.++++++||||+++++++.+.
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DE----GIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc--cc----hhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 34678999999999999999999984 57789998643321 11 1122347899999999999999999999866
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||++ ++|.+++.. ....+++..+..|+.||+.||+|||++||+||||||+|||+
T Consensus 92 ~--------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~ 152 (311)
T 3niz_A 92 R--------------CLTLVFEFME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152 (311)
T ss_dssp S--------------CEEEEEECCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred C--------------EEEEEEcCCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE
Confidence 5 5699999997 688888865 23469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++....... ......||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 153 ~~~-------~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ 212 (311)
T 3niz_A 153 NSD-------GALKLADFGLARAFGIPVR----------SYTHEVVTLWYRAPDVLMG---SKKYSTSVDIWSIGCIFAE 212 (311)
T ss_dssp CTT-------CCEEECCCTTCEETTSCCC-------------CCCCCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEccCcCceecCCCcc----------cccCCcccCCcCCHHHhcC---CCCCCchHHhHHHHHHHHH
Confidence 987 7899999999976543211 1123468999999999875 2467899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc--ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE--HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|++|+.||.+....+....+........+..+........ ....+..............++++.+|+.+||+.||.+|
T Consensus 213 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 292 (311)
T 3niz_A 213 MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292 (311)
T ss_dssp HHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTS
T ss_pred HHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHC
Confidence 9999999987665555444422111111111111000000 00000000000111122456779999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 001152 1116 PTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~s 1131 (1137)
||++|+++|+|++.-.
T Consensus 293 pt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 293 ISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCHHHHHTSGGGTTSC
T ss_pred CCHHHHhcCcccccCC
Confidence 9999999999998643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=374.37 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=211.8
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
.++.+|++.+.||+|+||.||+|+.. +..+|+|+...... ........+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 35678999999999999999999985 57789998643211 000111234789999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. ..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 78 ~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 138 (318)
T 1fot_A 78 AQ--------------QIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 138 (318)
T ss_dssp SS--------------EEEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred CC--------------EEEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE
Confidence 65 67999999999999999976 346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 139 l~~~-------g~~kL~Dfg~a~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 194 (318)
T 1fot_A 139 LDKN-------GHIKITDFGFAKYVPDVT-------------YTLCGTPDYIAPEVVST----KPYNKSIDWWSFGILIY 194 (318)
T ss_dssp ECTT-------SCEEECCCSSCEECSSCB-------------CCCCSCTTTCCHHHHTT----CCBCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEeecCcceecCCcc-------------ccccCCccccCHhHhcC----CCCCcccchhhhHHHHH
Confidence 9877 789999999997643311 13469999999999875 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
||++|..||.+.+..+....+...... ++. ..++++.+++.+||+.||.+||
T Consensus 195 ell~g~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 195 EMLAGYTPFYDSNTMKTYEKILNAELR-FPP---------------------------FFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSCTTTCT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCC-CCC---------------------------CCCHHHHHHHHHHhccCHHHcC
Confidence 999999999988888877777654321 111 2345699999999999999999
Q ss_pred -----CHHHHHHHHHhhc
Q 001152 1117 -----TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 -----Sa~EVL~~L~~~~ 1129 (1137)
+++||++|+|+..
T Consensus 247 ~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 247 GNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp TSSTTTTHHHHTSGGGSS
T ss_pred CCcCCCHHHHhcCccccC
Confidence 9999999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=363.36 Aligned_cols=258 Identities=25% Similarity=0.295 Sum_probs=210.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
-.+.+|++.+.||+|+||.||+|.+.. ..+|+|+.... ..........+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH-----HHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecc-----ccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 356789999999999999999999864 56888875432 11222233456889999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. ..++||||+++++|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 81 ~~--------------~~~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nil 141 (279)
T 3fdn_A 81 AT--------------RVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141 (279)
T ss_dssp SS--------------EEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEE
T ss_pred CC--------------EEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEE
Confidence 65 679999999999999999762 45899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 142 i~~~-------~~~~l~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 198 (279)
T 3fdn_A 142 LGSA-------GELKIADFGWSVHAPSSR------------RTDLCGTLDYLPPEMIEG----RMHDEKVDLWSLGVLCY 198 (279)
T ss_dssp ECTT-------SCEEECSCCEESCC--------------------CCCCTTCCHHHHTT----CCCCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEeccccccCCccc------------ccccCCCCCccCHhHhcc----CCCCccchhHhHHHHHH
Confidence 9877 789999999885443221 113468999999999875 56789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|++|..||......+....+....... +. ..++.+.+|+.+||+.||.+||
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 250 (279)
T 3fdn_A 199 EFLVGKPPFEANTYQETYKRISRVEFTF-PD---------------------------FVTEGARDLISRLLKHNPSQRP 250 (279)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHHTCCCC-CT---------------------------TSCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHCCCCCCCCcHHHHHHHHHhCCCCC-CC---------------------------cCCHHHHHHHHHHhccChhhCC
Confidence 9999999999888777777665433211 10 2345589999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001152 1117 TAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~s 1131 (1137)
|++||++|+|+...+
T Consensus 251 s~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 251 MLREVLEHPWITANS 265 (279)
T ss_dssp CHHHHHHCHHHHHHC
T ss_pred CHHHHhhCccccCCc
Confidence 999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=371.43 Aligned_cols=261 Identities=27% Similarity=0.449 Sum_probs=205.1
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
...+|++.+.||+|+||+||+|++.+..+|+|+.... .......+. +.+|+.++++++||||+++++++.+..
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~~- 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQ--DFHAERVNE----FLREVAIMKRLRHPNIVLFMGAVTQPP- 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCC--CCSHHHHHH----HHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred ChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCC--CCCHHHHHH----HHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 4578999999999999999999999999999986432 223333344 488999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeEe
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILI 957 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g--IIHrDLKP~NILl 957 (1137)
..++||||+++++|.+++..... ...+++..++.|+.||+.||+|||++| |+||||||+|||+
T Consensus 108 -------------~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll 172 (309)
T 3p86_A 108 -------------NLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172 (309)
T ss_dssp -------------CCEEEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE
T ss_pred -------------ceEEEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE
Confidence 45999999999999999975211 124999999999999999999999999 9999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 173 ~~~-------~~~kL~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~e 231 (309)
T 3p86_A 173 DKK-------YTVKVCDFGLSRLKASTFL----------SSKSAAGTPEWMAPEVLRD----EPSNEKSDVYSFGVILWE 231 (309)
T ss_dssp CTT-------CCEEECCCC---------------------------CCTTSCHHHHTT----CCCCTTHHHHHHHHHHHH
T ss_pred eCC-------CcEEECCCCCCcccccccc----------ccccCCCCccccChhhhcC----CCCCchhhHHHHHHHHHH
Confidence 887 7899999999875433211 1123469999999999975 567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++|..||.+....+....+.... ...++. ..++++.+|+.+||+.||.+||
T Consensus 232 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~~Rp 284 (309)
T 3p86_A 232 LATLQQPWGNLNPAQVVAAVGFKCKRLEIPR---------------------------NLNPQVAAIIEGCWTNEPWKRP 284 (309)
T ss_dssp HHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc---------------------------cCCHHHHHHHHHHccCChhhCc
Confidence 999999999888877776664322 222111 3445699999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|++|+++.+.....
T Consensus 285 s~~~ll~~L~~~~~ 298 (309)
T 3p86_A 285 SFATIMDLLRPLIK 298 (309)
T ss_dssp CHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHH
Confidence 99999998776543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=374.63 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=212.5
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChH--HHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSAD--EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~--~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
..|++.+.||+|+||.||+|.+. +..+|+|+........... ..+ .+.+|+.+|+.++||||+++++++.+.
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE----DIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHH----HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHH----HHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 45899999999999999999985 5779999865443221111 122 347899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+++++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||+
T Consensus 87 ~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll 147 (326)
T 2y0a_A 87 T--------------DVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147 (326)
T ss_dssp S--------------EEEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred C--------------EEEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEE
Confidence 5 67999999999999999864 3469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+. .....+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 148 ~~~~---~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ 209 (326)
T 2y0a_A 148 LDRN---VPKPRIKIIDFGLAHKIDFGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYI 209 (326)
T ss_dssp SCSS---SSSCCEEECCCTTCEECCTTSC-----------CCCCCSCTTTCCHHHHTT----CCCCTHHHHHHHHHHHHH
T ss_pred ecCC---CCCCCEEEEECCCCeECCCCCc-----------cccccCCcCcCCceeecC----CCCCcHHHHHHHHHHHHH
Confidence 8762 1123799999999976543211 123469999999999875 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|..||.+....+....+............ ...++.+.+|+.+||+.||.+|||
T Consensus 210 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~Rpt 265 (326)
T 2y0a_A 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYF------------------------SNTSALAKDFIRRLLVKDPKKRMT 265 (326)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc------------------------ccCCHHHHHHHHHHccCChhhCCC
Confidence 99999999988887777777554432211111 134566999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001152 1118 AGDLYEMFVARTS 1130 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ 1130 (1137)
+.|+++|+|+...
T Consensus 266 ~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 266 IQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHSTTTSCC
T ss_pred HHHHhcCCCccCC
Confidence 9999999999743
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=374.75 Aligned_cols=260 Identities=25% Similarity=0.283 Sum_probs=204.2
Q ss_pred CCCCCCceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
.....+|++.+.||+|+||.||+|++ .+..+|+|+.............. .+.+|+.+|+.++||||+++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA----HTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHH----HHHHHHHHHHhCCCCCccceeE
Confidence 34567899999999999999999997 35778999864332211122222 2378999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
++...+ ..|+||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||
T Consensus 89 ~~~~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp 149 (327)
T 3a62_A 89 AFQTGG--------------KLYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKP 149 (327)
T ss_dssp EEECSS--------------CEEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCT
T ss_pred EEEcCC--------------EEEEEEeCCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCH
Confidence 998765 56999999999999999976 24689999999999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
+|||++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++||||||
T Consensus 150 ~Nill~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG 208 (327)
T 3a62_A 150 ENIMLNHQ-------GHVKLTDFGLCKESIHDGT----------VTHTFCGTIEYMAPEILMR----SGHNRAVDWWSLG 208 (327)
T ss_dssp TTEEECTT-------SCEEECCCSCC--------------------CTTSSCCTTSCHHHHTT----SCCCTHHHHHHHH
T ss_pred HHeEECCC-------CcEEEEeCCcccccccCCc----------cccccCCCcCccCHhhCcC----CCCCCcccchhHH
Confidence 99999977 7899999999875432211 1123469999999999875 4678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
|++|+|++|..||.+.+..+....+...... ++. ..++++.+++.+||+.||
T Consensus 209 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~L~~dp 260 (327)
T 3a62_A 209 ALMYDMLTGAPPFTGENRKKTIDKILKCKLN-LPP---------------------------YLTQEARDLLKKLLKRNA 260 (327)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCT---------------------------TSCHHHHHHHHHHSCSCG
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-CCC---------------------------CCCHHHHHHHHHHHhcCH
Confidence 9999999999999988887777777554321 111 234569999999999999
Q ss_pred CCCC-----CHHHHHHHHHhhc
Q 001152 1113 TERP-----TAGDLYEMFVART 1129 (1137)
Q Consensus 1113 ~~RP-----Sa~EVL~~L~~~~ 1129 (1137)
.+|| +++|+++|+|+..
T Consensus 261 ~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 261 ASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp GGSTTSSTTTHHHHHHSGGGSS
T ss_pred hhccCCCCCCHHHHHcCCcccC
Confidence 9999 8999999999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=389.12 Aligned_cols=261 Identities=25% Similarity=0.307 Sum_probs=212.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|.+. +..+|+|+...+. ....+.+ .+.+|+.+++.++|||||++++++.+.+
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~--~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~- 83 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK--LSARDHQ----KLEREARICRLLKHPNIVRLHDSISEEG- 83 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS--CHHHHHH----HHHHHHHHHHHCCBTTBCCEEEEEECSS-
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc--CCHHHHH----HHHHHHHHHHhCCCcCCCeEEEEEEECC-
Confidence 46999999999999999999984 5778888754332 2222333 3488999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 84 -------------~~~lv~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~ 145 (444)
T 3soa_A 84 -------------HHYLIFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLAS 145 (444)
T ss_dssp -------------EEEEEECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESB
T ss_pred -------------EEEEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 67999999999999999876 346999999999999999999999999999999999999985
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+. ..+.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 146 ~~----~~~~vkL~DFG~a~~~~~~~~~----------~~~~~gt~~Y~APE~l~~----~~~~~~~DIwSlGvilyell 207 (444)
T 3soa_A 146 KL----KGAAVKLADFGLAIEVEGEQQA----------WFGFAGTPGYLSPEVLRK----DPYGKPVDLWACGVILYILL 207 (444)
T ss_dssp SS----TTCCEEECCCSSCBCCCTTCCB----------CCCSCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred cC----CCCcEEEccCceeEEecCCCce----------eecccCCcccCCHHHhcC----CCCCCccccHHHHHHHHHHH
Confidence 41 1267999999999765432211 123469999999999875 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||.+.+..++...+..+........+ ...++++.+|+.+||+.||.+|||+.
T Consensus 208 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~Rpta~ 263 (444)
T 3soa_A 208 VGYPPFWDEDQHRLYQQIKAGAYDFPSPEW------------------------DTVTPEAKDLINKMLTINPSKRITAA 263 (444)
T ss_dssp HSSCSCCCSSHHHHHHHHHHTCCCCCTTTT------------------------TTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hCCCCCCCccHHHHHHHHHhCCCCCCcccc------------------------ccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 999999998888888888766532211111 13456699999999999999999999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
|+++|+|+..
T Consensus 264 e~L~hp~~~~ 273 (444)
T 3soa_A 264 EALKHPWISH 273 (444)
T ss_dssp HHHHSCTTHH
T ss_pred HHhcCccccC
Confidence 9999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=376.33 Aligned_cols=266 Identities=25% Similarity=0.312 Sum_probs=210.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~-~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.+|++.+.||+|+||+||+|.+. +..+|+|+........ .....+ .+.+|+.+++.++||||+++++++.+.+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE----DLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHH----HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHH----HHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 46999999999999999999984 5789999865332111 001122 3478999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..|+||||+++++|.+++..... ....+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 100 --------------~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~ 164 (351)
T 3c0i_A 100 --------------MLYMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA 164 (351)
T ss_dssp --------------EEEEEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------EEEEEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEe
Confidence 67999999999999998875432 234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+. ....+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 165 ~~~----~~~~vkl~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 226 (351)
T 3c0i_A 165 SKE----NSAPVKLGGFGVAIQLGESGL----------VAGGRVGTPHFMAPEVVKR----EPYGKPVDVWGCGVILFIL 226 (351)
T ss_dssp SSS----TTCCEEECCCTTCEECCTTSC----------BCCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred cCC----CCCcEEEecCcceeEecCCCe----------eecCCcCCcCccCHHHHcC----CCCCchHhhHHHHHHHHHH
Confidence 652 124599999999976543211 1123469999999999875 4678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||.+. ..++...+..+.....+..+ ...++++.+|+.+||+.||++|||+
T Consensus 227 l~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~R~s~ 281 (351)
T 3c0i_A 227 LSGCLPFYGT-KERLFEGIIKGKYKMNPRQW------------------------SHISESAKDLVRRMLMLDPAERITV 281 (351)
T ss_dssp HHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHCCCCCCCc-HHHHHHHHHcCCCCCCcccc------------------------ccCCHHHHHHHHHHCCCChhHCcCH
Confidence 9999999874 44555555554432222111 1345669999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001152 1119 GDLYEMFVART 1129 (1137)
Q Consensus 1119 ~EVL~~L~~~~ 1129 (1137)
.|+++|+|+..
T Consensus 282 ~e~l~hp~~~~ 292 (351)
T 3c0i_A 282 YEALNHPWLKE 292 (351)
T ss_dssp HHHHTSHHHHT
T ss_pred HHHhcChhhcC
Confidence 99999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=364.65 Aligned_cols=285 Identities=19% Similarity=0.236 Sum_probs=208.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|++.+.||+|+||+||+|++. +..+|+|+...... .....+. +.+|+.++++++||||+++++++.+..
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSS----ALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHH----HHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchH----HHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 468999999999999999999985 46789998654432 2222223 378999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||++ ++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 75 --------------~~~lv~e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~ 135 (292)
T 3o0g_A 75 --------------KLTLVFEFCD-QDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp --------------EEEEEEECCS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEecCC-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 6799999997 577776654 134699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 136 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 195 (292)
T 3o0g_A 136 RN-------GELKLANFGLARAFGIPVR----------CYSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_dssp TT-------SCEEECCCTTCEECCSCCS----------CCCSCCSCGGGCCHHHHTT---CSCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccceecCCccc----------cccCCccccCCcChHHHcC---CCCcCchHHHHHHHHHHHHH
Confidence 87 7899999999976543211 1123468999999999875 23578999999999999999
Q ss_pred HhCCCC-CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccc-cccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1039 LTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH-EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1039 LTG~~P-f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
++|..| |.+.+..+....+...........+......... ..................++++.+|+.+||+.||++||
T Consensus 196 ~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 275 (292)
T 3o0g_A 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC
Confidence 998877 4555655555555332111111111100000000 00000000011111224667799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|++|+++|+|+..-
T Consensus 276 t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 276 SAEEALQHPYFSDF 289 (292)
T ss_dssp CHHHHHTSGGGTTC
T ss_pred CHHHHhcCcccccC
Confidence 99999999999854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=366.74 Aligned_cols=282 Identities=19% Similarity=0.255 Sum_probs=207.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+.+|++.+.||+|+||+||+|++. +..+|+|+....... . .....+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~--~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--E----GIPSTTIREISILKELKHSNIVKLYDVIHTKK- 73 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG--G----CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-
T ss_pred CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc--c----ccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-
Confidence 368999999999999999999985 577899876433211 1 11123478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 74 -------------~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 135 (288)
T 1ob3_A 74 -------------RLVLVFEHLD-QDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (288)
T ss_dssp -------------CEEEEEECCS-EEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred -------------eEEEEEEecC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 5699999997 5999988752 246899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 136 ~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~ 195 (288)
T 1ob3_A 136 E-------GELKIADFGLARAFGIPVR----------KYTHEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMV 195 (288)
T ss_dssp T-------SCEEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeECccccccCcccc----------ccccccccccccCchheeC---CCCCCcHHHHHHHHHHHHHHH
Confidence 7 7899999999876543211 1113468999999999874 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcC--CCCCch-hHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMG--KRPRLT-DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g--~~p~l~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|..||.+....+....+... ..+... ......... ..... ..............++++.+|+.+||+.||++||
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 273 (288)
T 1ob3_A 196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY-DPNFT-VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273 (288)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC-CTTCC-CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc-ccccc-cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCC
Confidence 999999988777666555321 111100 000000000 00000 0000001111124567799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|++|+++|+|+..
T Consensus 274 t~~e~l~hp~f~~ 286 (288)
T 1ob3_A 274 TAKQALEHAYFKE 286 (288)
T ss_dssp CHHHHHTSGGGGC
T ss_pred CHHHHhcCcchhh
Confidence 9999999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=371.29 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=210.7
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|...+.||+|+||.||+|++. +..||||+...... ...+. +.+|+.++++++||||+++++++...+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~-- 115 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRREL----LFNEVVIMRDYQHFNVVEMYKSYLVGE-- 115 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHH----HHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHH----HHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 3678889999999999999985 67899998653321 11222 378999999999999999999998765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 116 ------------~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 116 ------------ELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp ------------EEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred ------------EEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 67999999999999998864 369999999999999999999999999999999999999877
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 178 -------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~el~~ 236 (321)
T 2c30_A 178 -------GRVKLSDFGFCAQISKDVP----------KRKSLVGTPYWMAPEVISR----SLYATEVDIWSLGIMVIEMVD 236 (321)
T ss_dssp -------CCEEECCCTTCEECCSSSC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHHH
T ss_pred -------CcEEEeeeeeeeecccCcc----------ccccccCCccccCHhhhcC----CCCCchhhHHHHHHHHHHHHh
Confidence 7899999999876543211 1123469999999999875 568899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||......+....+.....+.+... ...++.+.+++.+||+.||.+|||++|
T Consensus 237 g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 237 GEPPYFSDSPVQAMKRLRDSPPPKLKNS-------------------------HKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp SSCTTTTSCHHHHHHHHHHSSCCCCTTG-------------------------GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCcCcc-------------------------ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999998888777777765543332210 134556999999999999999999999
Q ss_pred HHHHHHhhcCC
Q 001152 1121 LYEMFVARTSS 1131 (1137)
Q Consensus 1121 VL~~L~~~~~s 1131 (1137)
+++|+|+....
T Consensus 292 ll~hp~~~~~~ 302 (321)
T 2c30_A 292 LLDHPFLLQTG 302 (321)
T ss_dssp HHTSGGGGGCC
T ss_pred HhcChhhccCC
Confidence 99999998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=360.34 Aligned_cols=265 Identities=25% Similarity=0.302 Sum_probs=215.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.++|++.+.||+|+||.||+|.+. +..+|+|+..... ......+. +.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQK----LEREARICRKLQHPNIVRLHDSIQEES 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc--CCHHHHHH----HHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence 367999999999999999999985 5678998865433 22333333 488999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 79 --------------~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~ 139 (284)
T 3kk8_A 79 --------------FHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 139 (284)
T ss_dssp --------------EEEEEECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred --------------EEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEe
Confidence 66999999999999998876 24699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+. ..+.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 140 ~~~----~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 200 (284)
T 3kk8_A 140 SKA----KGAAVKLADFGLAIEVNDSEA-----------WHGFAGTPGYLSPEVLKK----DPYSKPVDIWACGVILYIL 200 (284)
T ss_dssp SSS----TTCCEEECCCTTCEECCSSCB-----------CCCSCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred cCC----CCCcEEEeeceeeEEcccCcc-----------ccCCCCCcCCcCchhhcC----CCCCcccchHHHHHHHHHH
Confidence 652 124599999999876543221 123469999999999875 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||.+....+....+..+......... ...++++.+++.+||+.||.+|||+
T Consensus 201 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~li~~~l~~dp~~Rps~ 256 (284)
T 3kk8_A 201 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW------------------------DTVTPEAKSLIDSMLTVNPKKRITA 256 (284)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT------------------------TTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHCCCCCCCCchhHHHHHHHhccccCCchhh------------------------cccCHHHHHHHHHHcccChhhCCCH
Confidence 9999999998888887777655432211100 1345669999999999999999999
Q ss_pred HHHHHHHHhhcCCCC
Q 001152 1119 GDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ss~ 1133 (1137)
+|+++|+|+......
T Consensus 257 ~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 257 DQALKVPWICNRERV 271 (284)
T ss_dssp HHHTTSHHHHSCCCG
T ss_pred HHHhcCccccCChhH
Confidence 999999999865443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=377.35 Aligned_cols=255 Identities=24% Similarity=0.295 Sum_probs=213.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
..+.+|++.+.||+|+||.||+|++. +..+|+|+...... ........+.+|+.+++.++||||+++++++.+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh-----ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 45789999999999999999999985 57789998643211 111112234789999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. ..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 113 ~~--------------~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 173 (350)
T 1rdq_E 113 NS--------------NLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp SS--------------EEEEEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CC--------------EEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEE
Confidence 65 679999999999999999862 35999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 174 l~~~-------g~~kL~DFg~a~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 229 (350)
T 1rdq_E 174 IDQQ-------GYIQVTDFGFAKRVKGRT-------------WTLCGTPEALAPEIILS----KGYNKAVDWWALGVLIY 229 (350)
T ss_dssp ECTT-------SCEEECCCTTCEECSSCB-------------CCCEECGGGCCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEcccccceeccCCc-------------ccccCCccccCHHHhcC----CCCCCcCCEecccHhHh
Confidence 9887 789999999997654321 13469999999999875 56889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
||++|..||.+.+..++...+..+... ++. ..++++.+++.+||+.||.+||
T Consensus 230 ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~lL~~dp~~R~ 281 (350)
T 1rdq_E 230 EMAAGYPPFFADQPIQIYEKIVSGKVR-FPS---------------------------HFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TCCHHHHHHHHHHSCSCTTTCT
T ss_pred HHhhCCCCCCCCCHHHHHHHHHcCCCC-CCC---------------------------CCCHHHHHHHHHHhhcCHHhcc
Confidence 999999999998888888887665421 111 2345699999999999999999
Q ss_pred C-----HHHHHHHHHhhc
Q 001152 1117 T-----AGDLYEMFVART 1129 (1137)
Q Consensus 1117 S-----a~EVL~~L~~~~ 1129 (1137)
+ ++||++|+|+..
T Consensus 282 ~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 282 GNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp TSSTTTTHHHHTSGGGTT
T ss_pred CCccCCHHHHHhCcCcCC
Confidence 8 999999999964
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=368.70 Aligned_cols=268 Identities=24% Similarity=0.243 Sum_probs=204.7
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCCh------------------HHHHHhHHhHHHHHHH
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSA------------------DEIRNFEYSCLGEVRM 858 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~------------------~~~e~~~~~~lrEi~i 858 (1137)
..+.+|++.+.||+|+||.||+|++. +..||+|+.......... ........++.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45689999999999999999999984 577899986443211100 0001112345889999
Q ss_pred HHhCCCCCcceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 001152 859 LGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALV 938 (1137)
Q Consensus 859 L~~L~HpNIVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~ 938 (1137)
+++++||||+++++++.+... ...++||||+++++|.+++. ...+++..++.++.||+.||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~------------~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~ 151 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNE------------DHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIE 151 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSS------------SEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEcCCC------------CEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHH
Confidence 999999999999999986321 16799999999999987643 246999999999999999999
Q ss_pred HHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001152 939 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1018 (1137)
Q Consensus 939 yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1018 (1137)
|||++||+||||||+|||++.+ +.+||+|||++......... .....||+.|+|||++.+..
T Consensus 152 ~lH~~~ivH~Dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~- 213 (298)
T 2zv2_A 152 YLHYQKIIHRDIKPSNLLVGED-------GHIKIADFGVSNEFKGSDAL----------LSNTVGTPAFMAPESLSETR- 213 (298)
T ss_dssp HHHHTTEECCCCCGGGEEECTT-------SCEEECCCTTCEECSSSSCE----------ECCCCSCGGGCCGGGCCTTC-
T ss_pred HHHHCCeeccCCCHHHEEECCC-------CCEEEecCCCcccccccccc----------ccCCcCCccccChhhhccCC-
Confidence 9999999999999999999887 78999999999765432211 11346999999999987521
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001152 1019 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1098 (1137)
Q Consensus 1019 ~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1137)
...++.++|||||||++|+|++|..||.......+...+......... ....++
T Consensus 214 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~ 267 (298)
T 2zv2_A 214 KIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD--------------------------QPDIAE 267 (298)
T ss_dssp CCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--------------------------SSCCCH
T ss_pred CCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC--------------------------ccccCH
Confidence 112478999999999999999999999988777766666543321100 013445
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1099 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1099 ~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
++.+++.+||+.||++|||+.|+++|+|+.
T Consensus 268 ~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 268 DLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 699999999999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=378.52 Aligned_cols=258 Identities=26% Similarity=0.329 Sum_probs=210.4
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEe
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 875 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~ 875 (1137)
..+.+|++.+.||+|+||.||+|++. +..+|+|+...... ..+.....+.+|..++..+ +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-----hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 45789999999999999999999985 46788887643211 0011112347789999877 8999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+.. ..|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 89 ~~~--------------~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 149 (345)
T 1xjd_A 89 TKE--------------NLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149 (345)
T ss_dssp CSS--------------EEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred eCC--------------EEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhE
Confidence 765 679999999999999999762 4699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 150 ll~~~-------g~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 208 (345)
T 1xjd_A 150 LLDKD-------GHIKIADFGMCKENMLGDA----------KTNTFCGTPDYIAPEILLG----QKYNHSVDWWSFGVLL 208 (345)
T ss_dssp EECTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeEChhhhhcccCCC----------cccCCCCCcccCChhhhcC----CCCCChhhhHHHHHHH
Confidence 99987 7899999999875432111 1124579999999999975 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|||++|..||.+.+..++...+..+.. .++. ..++++.+|+.+||+.||.+|
T Consensus 209 ~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~lL~~dp~~R 260 (345)
T 1xjd_A 209 YEMLIGQSPFHGQDEEELFHSIRMDNP-FYPR---------------------------WLEKEAKDLLVKLFVREPEKR 260 (345)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCc---------------------------ccCHHHHHHHHHHhcCCHhHc
Confidence 999999999999888888887765432 1111 234568999999999999999
Q ss_pred CCHH-HHHHHHHhhc
Q 001152 1116 PTAG-DLYEMFVART 1129 (1137)
Q Consensus 1116 PSa~-EVL~~L~~~~ 1129 (1137)
|++. +|++|+|+..
T Consensus 261 ~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 261 LGVRGDIRQHPLFRE 275 (345)
T ss_dssp BTTBSCGGGSGGGTT
T ss_pred CCChHHHHcCccccC
Confidence 9998 9999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=372.94 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=206.7
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeee
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGH 873 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~ 873 (1137)
.+..+.+|++.+.||+|+||.||+|++. +..+|+|+...... ......+. +.+|+.+++++ +|||||+++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~----~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDW----VQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHH----HHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHH----HHHHHHHHHhcCCCCccCeEEEE
Confidence 3456788999999999999999999985 46788888654332 12233333 47899999988 79999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+.+.. ..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 79 ~~~~~--------------~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 139 (345)
T 3a8x_A 79 FQTES--------------RLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 139 (345)
T ss_dssp EECSS--------------EEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred EEeCC--------------EEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH
Confidence 98765 679999999999999999762 46999999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 140 NIll~~~-------g~~kL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~ 198 (345)
T 3a8x_A 140 NVLLDSE-------GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGV 198 (345)
T ss_dssp GEEECTT-------SCEEECCGGGCBCSCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHH
T ss_pred HEEECCC-------CCEEEEeccccccccCCCC----------cccccCCCccccCccccCC----CCCChHHhHHHHHH
Confidence 9999987 7899999999875332111 1124579999999999975 56889999999999
Q ss_pred HHHHHHhCCCCCCCC---------CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHH
Q 001152 1034 LLLELLTLQVPYMGL---------SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVF 1104 (1137)
Q Consensus 1034 iL~ELLTG~~Pf~~~---------~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl 1104 (1137)
++|||++|..||... ....+...+..... .++ ...++++.+|+
T Consensus 199 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~p---------------------------~~~s~~~~~li 250 (345)
T 3a8x_A 199 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIP---------------------------RSLSVKAASVL 250 (345)
T ss_dssp HHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHH
T ss_pred HHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-CCC---------------------------CCCCHHHHHHH
Confidence 999999999999652 22223333332221 111 03445699999
Q ss_pred HHhcccCCCCCCCH------HHHHHHHHhhc
Q 001152 1105 RRCTEENPTERPTA------GDLYEMFVART 1129 (1137)
Q Consensus 1105 ~~CL~~DP~~RPSa------~EVL~~L~~~~ 1129 (1137)
.+||+.||.+||++ +|+++|+|+..
T Consensus 251 ~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 251 KSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999985 89999999964
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=377.17 Aligned_cols=262 Identities=22% Similarity=0.362 Sum_probs=210.0
Q ss_pred CCCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 870 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~---------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkl 870 (1137)
..+|++.+.||+|+||.||+|++.+ ..||+|+.. .. ......+. +.+|+.+++.+ +|||||++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~----~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DD-ATEKDLSD----LVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECC--TT-CBHHHHHH----HHHHHHHHHHSCCCTTBCCE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEec--CC-cCHHHHHH----HHHHHHHHHHhcCCCCEeeE
Confidence 4679999999999999999998731 347777643 22 12333333 48999999999 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001152 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 939 (1137)
Q Consensus 871 lg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------~~~~ls~~~i~~I~~QIa~gL~y 939 (1137)
++++.+.+ ..|+||||+++|+|.+++...... ....+++..++.|+.||+.||+|
T Consensus 153 ~~~~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 218 (370)
T 2psq_A 153 LGACTQDG--------------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218 (370)
T ss_dssp EEEECSSS--------------SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEccCC--------------CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 99998765 459999999999999999863211 12458999999999999999999
Q ss_pred HHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 940 LHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
||++||+||||||+|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+
T Consensus 219 LH~~~ivHrDlkp~NIll~~~-------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~---- 279 (370)
T 2psq_A 219 LASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDINNIDYY--------KKTTNGRLPVKWMAPEALFD---- 279 (370)
T ss_dssp HHHTTEECSCCCGGGEEECTT-------CCEEECCCSSCEETTCCCTT--------CTTTTTTSCGGGCCHHHHHT----
T ss_pred HHhCCeeccccchhhEEECCC-------CCEEEccccCCcccCcccce--------ecccCCCcccceECHhHhcC----
Confidence 999999999999999999887 78999999999765432211 11123357889999999875
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001152 1020 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1098 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1137)
..++.++|||||||++|||++ |..||.+....++...+..+..+..+. .+++
T Consensus 280 ~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 332 (370)
T 2psq_A 280 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NCTN 332 (370)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---------------------------TSCH
T ss_pred CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC---------------------------CCCH
Confidence 568999999999999999999 999999887777777776655433221 3445
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1099 FLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1099 ~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
++.+++.+||+.||.+|||+.|+++++....
T Consensus 333 ~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 333 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 6999999999999999999999999988753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=381.22 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=203.9
Q ss_pred CCCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...+++|++.+.||+|+||.||+|.+ .+..||+|+..... ........++.+|+.+++.++||||+++++++.
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL-----LKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH-----ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 44678999999999999999999998 45779999864321 111122234588999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
... ..++||||+ +|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 80 ~~~--------------~~~lv~E~~-~g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 139 (336)
T 3h4j_B 80 TPT--------------DIVMVIEYA-GGELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENL 139 (336)
T ss_dssp CSS--------------EEEEEECCC-CEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTE
T ss_pred eCC--------------EEEEEEECC-CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhE
Confidence 765 679999999 6899998876 24699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++........ .....||+.|+|||++.+. ...+.++|||||||++
T Consensus 140 ll~~~-------~~~kl~DFG~s~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il 198 (336)
T 3h4j_B 140 LLDDN-------LNVKIADFGLSNIMTDGNF-----------LKTSCGSPNYAAPEVINGK---LYAGPEVDVWSCGIVL 198 (336)
T ss_dssp EECTT-------CCEEECCSSCTBTTTTSBT-----------TCCCTTSTTTSCGGGSCCS---GGGCHHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEEEeccceeccCCcc-----------cccccCCcCcCCHHHHcCC---CCCCCccchhHHHHHH
Confidence 99977 7899999999875543211 1234699999999998752 2347899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|+|++|..||.+.....+...+..+. ... ....++++.+|+.+||+.||.+|
T Consensus 199 ~~ll~g~~Pf~~~~~~~~~~~i~~~~-------------------------~~~---p~~~s~~~~~li~~~L~~dP~~R 250 (336)
T 3h4j_B 199 YVMLVGRLPFDDEFIPNLFKKVNSCV-------------------------YVM---PDFLSPGAQSLIRRMIVADPMQR 250 (336)
T ss_dssp HHHHHSSCSSBCSSSTTCBCCCCSSC-------------------------CCC---CTTSCHHHHHHHHTTSCSSGGGS
T ss_pred HHHHhCCCCCCCccHHHHHHHHHcCC-------------------------CCC---cccCCHHHHHHHHHHcCCChhHC
Confidence 99999999997643221111110000 000 01345679999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001152 1116 PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ 1130 (1137)
||++|+++|+|+...
T Consensus 251 pt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 251 ITIQEIRRDPWFNVN 265 (336)
T ss_dssp CCHHHHTTCHHHHTT
T ss_pred cCHHHHHhChhhccC
Confidence 999999999999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=358.57 Aligned_cols=263 Identities=23% Similarity=0.281 Sum_probs=211.6
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|.+.. ..+|+|+...... . ..+. +.+|+.++++++||||+++++++.+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~---~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~- 79 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-E---DVDR----FKQEIEIMKSLDHPNIIRLYETFEDNT- 79 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-S---CHHH----HHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-c---hHHH----HHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 469999999999999999999865 4567776533221 1 1222 478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||+..
T Consensus 80 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~ 141 (277)
T 3f3z_A 80 -------------DIYLVMELCTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLT 141 (277)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred -------------eEEEEEeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEec
Confidence 67999999999999998876 245899999999999999999999999999999999999933
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ ...+.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|+
T Consensus 142 ~----~~~~~~~l~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l~ 201 (277)
T 3f3z_A 142 D----SPDSPLKLIDFGLAARFKPGKM-----------MRTKVGTPYYVSPQVLEG-----LYGPECDEWSAGVMMYVLL 201 (277)
T ss_dssp S----STTCCEEECCCTTCEECCTTSC-----------BCCCCSCTTTCCHHHHTT-----CBCTTHHHHHHHHHHHHHH
T ss_pred C----CCCCcEEEEecccceeccCccc-----------hhccCCCCCccChHHhcc-----cCCchhhehhHHHHHHHHH
Confidence 2 1127899999999876543221 123469999999999864 4789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||......+....+..+......... ...++.+.+++.+||+.||.+|||+.
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~li~~~l~~dp~~R~s~~ 257 (277)
T 3f3z_A 202 CGYPPFSAPTDSEVMLKIREGTFTFPEKDW------------------------LNVSPQAESLIRRLLTKSPKQRITSL 257 (277)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCHHHH------------------------TTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCchhh------------------------hcCCHHHHHHHHHHccCChhhCcCHH
Confidence 999999998888888777665543322111 13456699999999999999999999
Q ss_pred HHHHHHHhhcCCCCCC
Q 001152 1120 DLYEMFVARTSSSISS 1135 (1137)
Q Consensus 1120 EVL~~L~~~~~ss~s~ 1135 (1137)
|+++|+|+......+.
T Consensus 258 ~~l~h~~~~~~~~~~~ 273 (277)
T 3f3z_A 258 QALEHEWFEKQLSSSP 273 (277)
T ss_dssp HHTTSHHHHHHHCCSG
T ss_pred HHhcCHHHhccccccc
Confidence 9999999986544443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=364.58 Aligned_cols=285 Identities=22% Similarity=0.278 Sum_probs=208.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|++.+.||+|+||+||+|.+. +..+|+|+.... .......+ .+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVIKK----IALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC--CC-HHHHH----HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc--ccchHHHH----HHHHHHHHHHhCCCCCccchhheeecCC
Confidence 468999999999999999999985 567888875322 22222222 3478999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+||+++
T Consensus 76 --------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~ 136 (311)
T 4agu_A 76 --------------RLHLVFEYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136 (311)
T ss_dssp --------------EEEEEEECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------eEEEEEEeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc
Confidence 67999999999999988764 34699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 137 ~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l 196 (311)
T 4agu_A 137 KH-------SVIKLCDFGFARLLTGPSDY----------YDDEVATRWYRSPELLVG---DTQYGPPVDVWAIGCVFAEL 196 (311)
T ss_dssp TT-------SCEEECCCTTCEECC----------------------GGGCCHHHHHT---CSCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeCCCchhccCcccc----------cCCCcCCccccChHHHhc---CCCCCcchhhHHHHHHHHHH
Confidence 77 78999999999765432211 123468999999999874 24678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhh---cccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEAL---GSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
++|..||.+....+....+........+...... ........................++++.+|+.+||+.||.+|
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (311)
T 4agu_A 197 LSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTER 276 (311)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhc
Confidence 9999999988877766655432222222111110 0000000000000000001112566779999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001152 1116 PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ 1130 (1137)
||++|+++|+|+...
T Consensus 277 pt~~ell~hp~f~~~ 291 (311)
T 4agu_A 277 LTCEQLLHHPYFENI 291 (311)
T ss_dssp CCHHHHHTSGGGTTC
T ss_pred CCHHHHhcChHHHhc
Confidence 999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=370.08 Aligned_cols=264 Identities=19% Similarity=0.320 Sum_probs=211.1
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
...+|++.+.||+|+||.||+|.+. +..||||+.... ......+. +.+|+.+++.++||||+++++++
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~ 119 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG---YTERQRRD----FLSEASIMGQFDHPNIIRLEGVV 119 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT---CCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC---CCHHHHHH----HHHHHHHHHhCCCCCCCcEEEEE
Confidence 4567999999999999999999984 234888875322 12333333 48999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+.. ..++||||+++++|.++++. ....+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 120 ~~~~--------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 181 (325)
T 3kul_A 120 TRGR--------------LAMIVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARN 181 (325)
T ss_dssp CGGG--------------CCEEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EeCC--------------ccEEEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence 8765 45999999999999999965 23469999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||+++.......... ......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 182 Ill~~~-------~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~i 243 (325)
T 3kul_A 182 VLVDSN-------LVCKVSDFGLSRVLEDDPDAAY-------TTTGGKIPIRWTAPEAIAF----RTFSSASDVWSFGVV 243 (325)
T ss_dssp EEECTT-------CCEEECCCSSCEECC----CCE-------ECC---CCGGGSCHHHHHH----CEECHHHHHHHHHHH
T ss_pred EEECCC-------CCEEECCCCcccccccCcccee-------eccCCCCcccccCHhHhcC----CCCCcHHHHHHHHHH
Confidence 999877 7899999999986544321110 0112346788999999976 467899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|+|++ |..||.+....++...+..+.....+. .+++.+.+|+.+||+.||.
T Consensus 244 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~ 296 (325)
T 3kul_A 244 MWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM---------------------------GCPHALHQLMLDCWHKDRA 296 (325)
T ss_dssp HHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCC---------------------------CcCHHHHHHHHHHccCChh
Confidence 999999 999999988888888776654333221 3445699999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCCC
Q 001152 1114 ERPTAGDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~ss~ 1133 (1137)
+|||+.||++.+........
T Consensus 297 ~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 297 QRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp GSCCHHHHHHHHHHHHHSCC
T ss_pred hCcCHHHHHHHHHHHHhCcc
Confidence 99999999999988754443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=360.89 Aligned_cols=263 Identities=24% Similarity=0.320 Sum_probs=206.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
-.+|++.+.||+|+||.||+|++. +..+|+|+...... ......+ ++.+|+.++++++||||+++++++.+.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~----~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLK----RFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHH----HHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHH----HHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 367999999999999999999974 56788987643322 2223333 3489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 85 --------------~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~ 145 (294)
T 4eqm_A 85 --------------CYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145 (294)
T ss_dssp --------------EEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred --------------eEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 679999999999999999762 3699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 146 ~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 205 (294)
T 4eqm_A 146 SN-------KTLKIFDFGIAKALSETSLT---------QTNHVLGTVQYFSPEQAKG----EATDECTDIYSIGIVLYEM 205 (294)
T ss_dssp TT-------SCEEECCCSSSTTC----------------------CCSSCCHHHHHT----CCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEeCCCcccccccccc---------ccCccccCccccCHhHhcC----CCCCchHhHHHHHHHHHHH
Confidence 77 78999999999765432111 1123469999999999876 5678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-C
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-T 1117 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-S 1117 (1137)
++|+.||.+....+..........+....... ...++.+.+++.+||+.||.+|| +
T Consensus 206 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~l~~li~~~l~~dp~~R~~~ 262 (294)
T 4eqm_A 206 LVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR-----------------------KDIPQSLSNVILRATEKDKANRYKT 262 (294)
T ss_dssp HHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSC-----------------------TTSCHHHHHHHHHHSCSSGGGSCSS
T ss_pred HhCCCCCCCCChHHHHHHHhhccCCCcchhcc-----------------------cCCCHHHHHHHHHHhcCCHhHcccc
Confidence 99999999888776665555444333222110 14456799999999999999999 7
Q ss_pred HHHHHHHHHhhcC
Q 001152 1118 AGDLYEMFVARTS 1130 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ 1130 (1137)
++++.+.+.....
T Consensus 263 ~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 263 IQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHHHHHHTSSS
T ss_pred HHHHHHHHHHHHh
Confidence 7777777766543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=374.59 Aligned_cols=259 Identities=24% Similarity=0.294 Sum_probs=210.4
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeE
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 874 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~ 874 (1137)
...+.+|++.+.||+|+||.||+|++.. ..+|+|+...... ........+.+|..++..+ +||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 4467899999999999999999999965 5688887643311 0111122347899999988 699999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+.+ ..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 91 ~~~~--------------~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 151 (353)
T 2i0e_A 91 QTMD--------------RLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 151 (353)
T ss_dssp ECSS--------------EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EcCC--------------EEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHH
Confidence 8765 679999999999999999762 369999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 152 Ill~~~-------g~vkL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 210 (353)
T 2i0e_A 152 VMLDSE-------GHIKIADFGMCKENIWDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVL 210 (353)
T ss_dssp EEECTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBSTHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEEeCCcccccccCCc----------ccccccCCccccChhhhcC----CCcCCcccccchHHH
Confidence 999987 7899999999875332111 1124579999999999875 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|||++|..||.+.+..++...+...... ++. ..++++.+|+.+||+.||.+
T Consensus 211 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~lL~~dP~~ 262 (353)
T 2i0e_A 211 LYEMLAGQAPFEGEDEDELFQSIMEHNVA-YPK---------------------------SMSKEAVAICKGLMTKHPGK 262 (353)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSCTTS
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhCCCC-CCC---------------------------CCCHHHHHHHHHHhhcCHHH
Confidence 99999999999998888888887654321 111 23456999999999999999
Q ss_pred CC-----CHHHHHHHHHhhc
Q 001152 1115 RP-----TAGDLYEMFVART 1129 (1137)
Q Consensus 1115 RP-----Sa~EVL~~L~~~~ 1129 (1137)
|| ++++|++|+|+..
T Consensus 263 R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 263 RLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp CTTCSTTHHHHHHTSGGGTT
T ss_pred cCCCCCCCHHHHhcCccccC
Confidence 99 4799999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=373.31 Aligned_cols=260 Identities=24% Similarity=0.282 Sum_probs=203.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
-+.+|++.+.||+|+||+||+|.+. +..||+|+...+... ...+ .+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~----~~~~E~~~l~~l~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPE----NIKKEICINKMLNHENVVKFYGHRREG 77 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---chHH----HHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 4678999999999999999999985 577899986433221 1112 347899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..++||||+++++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 78 ~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll 138 (323)
T 3tki_A 78 N--------------IQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138 (323)
T ss_dssp S--------------EEEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C--------------eEEEEEEcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE
Confidence 5 67999999999999998854 3469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++......... .......||+.|+|||++.+. ..++.++|||||||++|+
T Consensus 139 ~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ 200 (323)
T 3tki_A 139 DER-------DNLKISDFGLATVFRYNNRE--------RLLNKMCGTLPYVAPELLKRR---EFHAEPVDVWSCGIVLTA 200 (323)
T ss_dssp CTT-------CCEEECCCTTCEECEETTEE--------CCBCSCCSCGGGSCHHHHHCS---SBCHHHHHHHHHHHHHHH
T ss_pred eCC-------CCEEEEEeeccceeccCCcc--------cccCCCccCcCccCcHHhccC---CCCCCcccHHHHHHHHHH
Confidence 987 78999999999765432211 111234699999999999752 334789999999999999
Q ss_pred HHhCCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~e-l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++|..||....... ....+...... .. .....++.+.+|+.+||+.||.+||
T Consensus 201 ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~-------------------------~~~~~~~~~~~li~~~L~~dP~~R~ 254 (323)
T 3tki_A 201 MLAGELPWDQPSDSCQEYSDWKEKKTY-LN-------------------------PWKKIDSAPLALLHKILVENPSARI 254 (323)
T ss_dssp HHHSSCSCSSSCTTSHHHHHHHTTCTT-ST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHhCCCCCCCCchHHHHHHHHhccccc-CC-------------------------ccccCCHHHHHHHHHHccCChhhCc
Confidence 999999997654321 22222211110 00 0013456689999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|++|+++|+|+..
T Consensus 255 t~~eil~h~~~~~ 267 (323)
T 3tki_A 255 TIPDIKKDRWYNK 267 (323)
T ss_dssp CHHHHTTCTTTTC
T ss_pred CHHHHhhChhhcc
Confidence 9999999999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=369.11 Aligned_cols=283 Identities=21% Similarity=0.265 Sum_probs=205.1
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
..+|++.++||+|+||+||+|++.+..||||++... ...... ..+|+.++++++|||||++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~~- 92 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ-----DKQSWQ----NEYEVYSLPGMKHENILQFIGAEKRGTS- 92 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG-----GHHHHH----HHHHHHTSTTCCCTTBCCEEEEEEEECS-
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecC-----chHHHH----HHHHHHHHhcCCCCCchhhcceeccCCC-
Confidence 467999999999999999999999999999986432 122222 2569999999999999999999986441
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CeeeccC
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK----------HIMHRDI 950 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~----------gIIHrDL 950 (1137)
...+.++||||+++|+|.++++. ..+++..++.|+.||+.||+|||+. ||+||||
T Consensus 93 ---------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dl 157 (322)
T 3soc_A 93 ---------VDVDLWLITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDI 157 (322)
T ss_dssp ---------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCC
T ss_pred ---------CCceEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCC
Confidence 12257999999999999999976 3599999999999999999999999 9999999
Q ss_pred CCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC-CCCCCchhhHH
Q 001152 951 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIW 1029 (1137)
Q Consensus 951 KP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~s~ksDVW 1029 (1137)
||+|||++.+ +.+||+|||+++........ .......||+.|+|||++.+... ...++.++|||
T Consensus 158 kp~Nill~~~-------~~~kL~DFg~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 222 (322)
T 3soc_A 158 KSKNVLLKNN-------LTACIADFGLALKFEAGKSA--------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222 (322)
T ss_dssp SGGGEEECTT-------CCEEECCCTTCEEECTTSCC--------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHH
T ss_pred ChHhEEECCC-------CeEEEccCCcccccccccCc--------cccccCccCccccCHhhcccccccCcCCCccchhH
Confidence 9999999877 78999999999765432211 11123469999999999875211 12456789999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHH-HHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001152 1030 SYGCLLLELLTLQVPYMGLSELEIHDL-IQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1108 (1137)
Q Consensus 1030 SLGviL~ELLTG~~Pf~~~~~~el~~~-I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL 1108 (1137)
||||++|||+||+.||.+......... ......+.......... .................++++.+|+.+||
T Consensus 223 slG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (322)
T 3soc_A 223 AMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV------HKKKRPVLRDYWQKHAGMAMLCETIEECW 296 (322)
T ss_dssp HHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHT------TSCCCCCCCGGGGSSHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhh------cccCCCCccccccccchHHHHHHHHHHHc
Confidence 999999999999999975322110000 00011111110000000 00000000011111255677999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhc
Q 001152 1109 EENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1109 ~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+.||++|||+.||++.+....
T Consensus 297 ~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 297 DHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CSSGGGSCCHHHHHHHHHHHH
T ss_pred cCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999988754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=358.33 Aligned_cols=261 Identities=25% Similarity=0.431 Sum_probs=200.4
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+.+|++.+.||+|+||.||+|.+.+..+|+|+............. ..+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTI----ENVRQEAKLFAMLKHPNIIALRGVCLKEP- 79 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CH----HHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred chhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHH----HHHHHHHHHHHhcCCCCEeeEEEEEecCC-
Confidence 5678999999999999999999999999999985443222111122 33488999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCCCCeE
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH---IMHRDIKSENIL 956 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g---IIHrDLKP~NIL 956 (1137)
..++||||+++++|.+++.. ..+++..++.|+.||+.||+|||++| |+||||||+|||
T Consensus 80 -------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil 140 (271)
T 3dtc_A 80 -------------NLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140 (271)
T ss_dssp --------------CEEEEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEE
T ss_pred -------------ceEEEEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEE
Confidence 45999999999999998853 46999999999999999999999999 899999999999
Q ss_pred ecccccc-CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 957 IDLERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 957 ld~~~~~-~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
++.+... ....+.+||+|||++........ ....||+.|+|||++.+ ..++.++||||||+++
T Consensus 141 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l 204 (271)
T 3dtc_A 141 ILQKVENGDLSNKILKITDFGLAREWHRTTK------------MSAAGAYAWMAPEVIRA----SMFSKGSDVWSYGVLL 204 (271)
T ss_dssp ESSCCSSSCCSSCCEEECCCCC-------------------------CCGGGSCHHHHHH----CCCSHHHHHHHHHHHH
T ss_pred EecccccccccCcceEEccCCcccccccccc------------cCCCCccceeCHHHhcc----CCCCchhhHHHHHHHH
Confidence 9864210 11237799999999875443211 13368999999999876 4688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCC-CchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+|++|+.||.+.........+...... ..+ ..+++.+.+++.+||+.||.+
T Consensus 205 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 257 (271)
T 3dtc_A 205 WELLTGEVPFRGIDGLAVAYGVAMNKLALPIP---------------------------STCPEPFAKLMEDCWNPDPHS 257 (271)
T ss_dssp HHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC---------------------------TTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC---------------------------cccCHHHHHHHHHHhcCCccc
Confidence 9999999999988777666655443321 111 134556999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 001152 1115 RPTAGDLYEMFVA 1127 (1137)
Q Consensus 1115 RPSa~EVL~~L~~ 1127 (1137)
|||+.|+++++..
T Consensus 258 Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 258 RPSFTNILDQLTT 270 (271)
T ss_dssp SCCHHHHHHHHHC
T ss_pred CcCHHHHHHHHhc
Confidence 9999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=372.61 Aligned_cols=266 Identities=25% Similarity=0.367 Sum_probs=219.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~ 878 (1137)
.+|++.+.||+|+||.||+|.+. +..||||+.............+.+...+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 46999999999999999999985 67899998765544444555556666778999999999 7999999999998665
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 174 --------------~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 174 --------------FMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234 (365)
T ss_dssp --------------EEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------EEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 67999999999999999976 24699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC--CCCCCchhhHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK--PNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--~~~~s~ksDVWSLGviL~ 1036 (1137)
.+ +.+||+|||++........ .....||+.|+|||++.+... ...++.++|||||||++|
T Consensus 235 ~~-------~~ikl~DfG~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 296 (365)
T 2y7j_A 235 DN-------MQIRLSDFGFSCHLEPGEK-----------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296 (365)
T ss_dssp TT-------CCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHH
T ss_pred CC-------CCEEEEecCcccccCCCcc-----------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHH
Confidence 87 7899999999876543221 113469999999999875311 235789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|++|..||...........+..+........+. ..++.+.+++.+||+.||.+||
T Consensus 297 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------------------------~~~~~~~~li~~~L~~dP~~Rp 352 (365)
T 2y7j_A 297 TLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD------------------------DRSSTVKDLISRLLQVDPEARL 352 (365)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS------------------------SSCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc------------------------cCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999888777777776554332211110 3345699999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001152 1117 TAGDLYEMFVAR 1128 (1137)
Q Consensus 1117 Sa~EVL~~L~~~ 1128 (1137)
|++|+++|+|+.
T Consensus 353 s~~ell~hp~f~ 364 (365)
T 2y7j_A 353 TAEQALQHPFFE 364 (365)
T ss_dssp CHHHHHHSGGGC
T ss_pred CHHHHhcCcccC
Confidence 999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=366.35 Aligned_cols=288 Identities=21% Similarity=0.291 Sum_probs=198.4
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
+..+|++.+.||+|+||+||+|.+. +..||+|+....... ...+ .+.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---GTPS----TAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTT---CSCH----HHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc---ccHH----HHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 3568999999999999999999875 577888886543321 1112 237899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
+ ..++||||++ ++|.+++..... .....+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 76 ~--------------~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl 140 (317)
T 2pmi_A 76 N--------------KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLL 140 (317)
T ss_dssp T--------------EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred C--------------eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeE
Confidence 5 6799999998 699999876422 12245899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+++....... ......||+.|+|||++.+ ...++.++|||||||++|
T Consensus 141 ~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 200 (317)
T 2pmi_A 141 INKR-------GQLKLGDFGLARAFGIPVN----------TFSSEVVTLWYRAPDVLMG---SRTYSTSIDIWSCGCILA 200 (317)
T ss_dssp ECTT-------CCEEECCCSSCEETTSCCC----------CCCCCCSCCTTCCHHHHTT---CCCCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEECcCccceecCCCcc----------cCCCCcccccccCchHhhC---CCCCCcHHHHHHHHHHHH
Confidence 9987 7899999999976543211 1123468999999999874 246789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcC--CCCC-chhHHhhhcccccccccccCCCCC----CchhhhhhHHHHHHHHHHhcc
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMG--KRPR-LTDELEALGSCHEHEVAQSGSGFE----KPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g--~~p~-l~~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
+|++|+.||.+....+....+... ..+. ............ ........... .+......++++.+|+.+||+
T Consensus 201 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 279 (317)
T 2pmi_A 201 EMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN-PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ 279 (317)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC-TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSC
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc-cccccccchhHHHhhcccccccCCHHHHHHHHHHCC
Confidence 999999999988877766666331 1111 111111100000 00000000000 000011345679999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001152 1110 ENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1110 ~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
.||++|||++|+++|+|+...
T Consensus 280 ~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 280 LNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp SSGGGSCCHHHHTTSGGGGGG
T ss_pred CCcccCCCHHHHhCChhhhcc
Confidence 999999999999999999854
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=380.84 Aligned_cols=258 Identities=21% Similarity=0.343 Sum_probs=204.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEe
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKI 875 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~ 875 (1137)
..+.+|++.++||+|+||.||+|++. +..+|+|+.+...... ....+ .+.+|+.++.++ +|||||++++++.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~-~~~~~----~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND-DEDID----WVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CC----HHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-HHHHH----HHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 45788999999999999999999985 4678888865433221 12222 247799999887 7999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+.. ..++||||++||+|..++.. ...+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 124 ~~~--------------~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NI 184 (396)
T 4dc2_A 124 TES--------------RLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184 (396)
T ss_dssp CSS--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred ECC--------------EEEEEEEcCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHE
Confidence 765 67999999999999999976 24699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 185 Ll~~~-------g~ikL~DFGla~~~~~~~~----------~~~~~~gt~~Y~aPE~l~~----~~~~~~~DiwslGvll 243 (396)
T 4dc2_A 185 LLDSE-------GHIKLTDYGMCKEGLRPGD----------TTSTFCGTPNYIAPEILRG----EDYGFSVDWWALGVLM 243 (396)
T ss_dssp EECTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCBCGGGCCHHHHTT----CCBCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEeecceeeecccCCC----------ccccccCCcccCCchhhcC----CCCChHHHHHHHHHHH
Confidence 99987 7899999999975322111 1124579999999999976 5689999999999999
Q ss_pred HHHHhCCCCCCCCC---------HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001152 1036 LELLTLQVPYMGLS---------ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1106 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~---------~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~ 1106 (1137)
|||++|..||.... ...+...+..... .++. ..++++.+||.+
T Consensus 244 yell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~~li~~ 295 (396)
T 4dc2_A 244 FEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPR---------------------------SLSVKAASVLKS 295 (396)
T ss_dssp HHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHH
T ss_pred HHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-CCCC---------------------------cCCHHHHHHHHH
Confidence 99999999996422 1223333333221 1111 344569999999
Q ss_pred hcccCCCCCCCH------HHHHHHHHhhc
Q 001152 1107 CTEENPTERPTA------GDLYEMFVART 1129 (1137)
Q Consensus 1107 CL~~DP~~RPSa------~EVL~~L~~~~ 1129 (1137)
||+.||.+||++ +||++|+||..
T Consensus 296 lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 296 FLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp HTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred HhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 999999999984 89999999964
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=359.08 Aligned_cols=261 Identities=22% Similarity=0.296 Sum_probs=205.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||+||+|.+. +..+|+|+......... .+. +.+|+.++++++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~~- 93 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP---MEQ----IEAEIEVLKSLDHPNIIKIFEVFEDYH- 93 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC---HHH----HHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh---HHH----HHHHHHHHHhCCCchHHhHHHheecCC-
Confidence 56999999999999999999985 46788887654432211 222 378999999999999999999998665
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++...... ...+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 94 -------------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~ 159 (285)
T 3is5_A 94 -------------NMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD 159 (285)
T ss_dssp -------------EEEEEECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESS
T ss_pred -------------eEEEEEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEec
Confidence 679999999999999998764333 256999999999999999999999999999999999999964
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+. ..+.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 160 ~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~il~~ll 219 (285)
T 3is5_A 160 TS----PHSPIKIIDFGLAELFKSDEH-----------STNAAGTALYMAPEVFKR-----DVTFKCDIWSAGVVMYFLL 219 (285)
T ss_dssp SS----TTCCEEECCCCCCCC---------------------CTTGGGCCHHHHTT-----CCCHHHHHHHHHHHHHHHH
T ss_pred CC----CCCCEEEEeeecceecCCccc-----------CcCcccccCcCChHHhcc-----CCCcccCeehHHHHHHHHH
Confidence 31 226799999999975443211 123468999999999853 5789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|+.||.+....++...+.......... ....++++.+|+.+||+.||.+|||+.
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ 274 (285)
T 3is5_A 220 TGCLPFTGTSLEEVQQKATYKEPNYAVE-------------------------CRPLTPQAVDLLKQMLTKDPERRPSAA 274 (285)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCC---------------------------CCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHhhhccCCcccccc-------------------------cCcCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999999888777766654433211100 002345689999999999999999999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
||++|+|++.
T Consensus 275 e~l~hp~f~~ 284 (285)
T 3is5_A 275 QVLHHEWFKQ 284 (285)
T ss_dssp HHHTSGGGGC
T ss_pred HHhcCHHhhc
Confidence 9999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=379.46 Aligned_cols=260 Identities=20% Similarity=0.279 Sum_probs=211.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.++|++.+.||+|+||.||+|.+. +..+|+|+..... ..+.. .+.+|+.+|+.++|||||++++++.+..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~----~~~~E~~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKY----TVKNEISIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHH----HHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHH----HHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence 467999999999999999999985 4668888754221 22222 3488999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 122 --------------~~~lv~E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~ 183 (387)
T 1kob_A 122 --------------EMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 183 (387)
T ss_dssp --------------EEEEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEcCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEe
Confidence 67999999999999998864 234699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+. .+.+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 184 ~~~-----~~~vkL~DFG~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el 243 (387)
T 1kob_A 184 TKK-----ASSVKIIDFGLATKLNPDEIV-----------KVTTATAEFAAPEIVDR----EPVGFYTDMWAIGVLGYVL 243 (387)
T ss_dssp STT-----CCCEEECCCTTCEECCTTSCE-----------EEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHHH
T ss_pred cCC-----CCceEEEecccceecCCCcce-----------eeeccCCCccCchhccC----CCCCCcccEeeHhHHHHHH
Confidence 542 267999999999765432111 13368999999999875 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||.+.+..+....+........... ....++++.+||.+||+.||.+|||+
T Consensus 244 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~Rpt~ 299 (387)
T 1kob_A 244 LSGLSPFAGEDDLETLQNVKRCDWEFDEDA------------------------FSSVSPEAKDFIKNLLQKEPRKRLTV 299 (387)
T ss_dssp HHSCCSSCCSSHHHHHHHHHHCCCCCCSST------------------------TTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCccc------------------------cccCCHHHHHHHHHHcCCChhHCcCH
Confidence 999999999888777777755432211100 01345669999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
.|+++|+|+...
T Consensus 300 ~ell~hp~~~~~ 311 (387)
T 1kob_A 300 HDALEHPWLKGD 311 (387)
T ss_dssp HHHHTSTTTSSC
T ss_pred HHHhhCccccCC
Confidence 999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=384.01 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=212.0
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.++||+|+||+||+|++. +..+|+|+..... ...+.....+.+|+.+++.++|||||++++++.+.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-----MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhh-----hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3568999999999999999999985 4678888754321 00111112347899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..|+||||++||+|.++++. ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 142 ~--------------~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl 201 (410)
T 3v8s_A 142 R--------------YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201 (410)
T ss_dssp S--------------EEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred C--------------EEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE
Confidence 5 67999999999999999875 358999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++........ .....+||+.|+|||++.+......++.++|||||||++||
T Consensus 202 ~~~-------g~ikL~DFG~a~~~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilye 265 (410)
T 3v8s_A 202 DKS-------GHLKLADFGTCMKMNKEGMV---------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265 (410)
T ss_dssp CTT-------SCEEECCCTTCEECCTTSEE---------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeccceeEeeccCCcc---------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHH
Confidence 987 78999999999765432211 11245799999999999863222237899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKR-PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE-- 1114 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~-p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~-- 1114 (1137)
|++|..||.+.+..+....+..+.. ..++. ....++++.+||.+||+.+|.+
T Consensus 266 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-------------------------~~~~s~~~~~li~~lL~~~~~rlg 320 (410)
T 3v8s_A 266 MLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-------------------------DNDISKEAKNLICAFLTDREVRLG 320 (410)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT-------------------------TCCCCHHHHHHHHHHSSCGGGCTT
T ss_pred HHhCCCCCCCCChhhHHHHHHhccccccCCC-------------------------cccccHHHHHHHHHHccChhhhCC
Confidence 9999999999888888777754210 00110 0034556999999999999988
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
||+++||++|+|++..
T Consensus 321 R~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 321 RNGVEEIKRHLFFKND 336 (410)
T ss_dssp SSCHHHHHTSGGGCCS
T ss_pred CCCHHHHhcCccccCC
Confidence 9999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=370.60 Aligned_cols=283 Identities=20% Similarity=0.255 Sum_probs=210.4
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-----CCCcceeeeeE
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----HSCIVEMYGHK 874 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-----HpNIVkllg~~ 874 (1137)
.+|++.++||+|+||+||+|++ .+..||+|+.... ....+. +.+|+.+++.+. |||||++++++
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~----~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-----KKYTRS----AKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----HHHHHH----HHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-----hhhhhh----hHHHHHHHHHhcccCCCCCCeeccccee
Confidence 6799999999999999999998 4567899985321 222222 367999999986 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
...+ ..++||||+ +++|.+++... ....+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 106 ~~~~--------------~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 167 (360)
T 3llt_A 106 MYYD--------------HMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPEN 167 (360)
T ss_dssp EETT--------------EEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eECC--------------eeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCccc
Confidence 8765 679999999 89999999862 23459999999999999999999999999999999999
Q ss_pred eEecccccc------------------CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccc
Q 001152 955 ILIDLERKK------------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAM 1016 (1137)
Q Consensus 955 ILld~~~~~------------------~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 1016 (1137)
||++..... ....+.+||+|||++....... ....||+.|+|||++.+
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-------------~~~~gt~~y~aPE~~~~- 233 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-------------GSIINTRQYRAPEVILN- 233 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-------------CSCCSCGGGCCHHHHTT-
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-------------cCccCcccccCcHHHcC-
Confidence 999752000 0113789999999987543211 13468999999999976
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc-ccccc-----cCCCCC--
Q 001152 1017 HKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQ-----SGSGFE-- 1088 (1137)
Q Consensus 1017 ~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~-~~~~~-----~~~~~~-- 1088 (1137)
..++.++|||||||++|+|++|+.||......+....+.....+.............. ..... ......
T Consensus 234 ---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 310 (360)
T 3llt_A 234 ---LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASS 310 (360)
T ss_dssp ---CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSC
T ss_pred ---CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccc
Confidence 5688999999999999999999999998888777777655443332222211110000 00000 000000
Q ss_pred ----------CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1089 ----------KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1089 ----------~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
.+.......+.+.+|+.+||+.||.+|||++|+++|+|++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 311 INSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 0111112336788999999999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=370.12 Aligned_cols=275 Identities=23% Similarity=0.243 Sum_probs=209.9
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCC-CChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~-~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.+|++.+.||+|+||+||+|.+.. ..+|+|+....... ......+ ++.+|+.++++++||||+++++++.+..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE----RIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHH----HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHH----HHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 469999999999999999999854 56888876433211 1112222 3488999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------------------------------CCCCCCH
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------------------------------GEKHVSV 923 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------------------------------~~~~ls~ 923 (1137)
..++||||+++|+|.+++...... ....+++
T Consensus 102 --------------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (345)
T 3hko_A 102 --------------YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167 (345)
T ss_dssp --------------EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHH
T ss_pred --------------eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccH
Confidence 679999999999999988521110 1223567
Q ss_pred HHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccC
Q 001152 924 KLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1003 (1137)
Q Consensus 924 ~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~G 1003 (1137)
..++.|+.||+.||+|||++||+||||||+|||++.+. .+.+||+|||++.......... ........|
T Consensus 168 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-----~~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~g 236 (345)
T 3hko_A 168 KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK-----SFEIKLVDFGLSKEFYKLNNGE------YYGMTTKAG 236 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS-----SCCEEECCCTTCEEGGGTTCC--------------CC
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCC-----CceEEEeeccccccccccCccc------cccccccCC
Confidence 88999999999999999999999999999999998652 1479999999997654322110 011124469
Q ss_pred CCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccccccc
Q 001152 1004 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 1083 (1137)
Q Consensus 1004 T~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~ 1083 (1137)
|+.|+|||++.+ ....++.++|||||||++|+|++|+.||.+....+....+............
T Consensus 237 t~~y~aPE~~~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------- 300 (345)
T 3hko_A 237 TPYFVAPEVLNT--TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY-------------- 300 (345)
T ss_dssp CGGGCCHHHHTC--SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGG--------------
T ss_pred CccccCchhhcc--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCccc--------------
Confidence 999999999875 2356889999999999999999999999988887777776554422111110
Q ss_pred CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001152 1084 GSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1084 ~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~s 1131 (1137)
...++++.+|+.+||+.||.+|||+.|+++|+|+....
T Consensus 301 ----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 301 ----------NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp ----------GGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred ----------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 13456799999999999999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=355.87 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=210.5
Q ss_pred CCCceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~-~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|+||.||+|.+ .+..+|+|+..... ... +. +.+|+.++++++||||+++++++.+..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~---~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~- 78 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSE---ED----FIEEAEVMMKLSHPKLVQLYGVCLEQA- 78 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCH---HH----HHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCH---HH----HHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 46799999999999999999998 45678888854321 111 22 378999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+||+++.
T Consensus 79 -------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~ 141 (269)
T 4hcu_A 79 -------------PICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 141 (269)
T ss_dssp -------------SEEEEEECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred -------------ceEEEEEeCCCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcC
Confidence 56999999999999999975 2346999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 142 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~ll 201 (269)
T 4hcu_A 142 N-------QVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEVF 201 (269)
T ss_dssp G-------GCEEECCTTGGGGBCCHHHH---------STTSTTCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEeccccccccccccccc---------cccCcccccccCCHHHhcC----CCCCchhhhHHHHHHHHHHh
Confidence 7 78999999998765432211 0112357889999999976 46889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||......+....+..+..+..+. ..++++.+++.+||+.||.+|||+
T Consensus 202 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~Rps~ 254 (269)
T 4hcu_A 202 SEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWRERPEDRPAF 254 (269)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cCCCCCCCCCCHHHHHHHHhcCccCCCCC---------------------------cCCHHHHHHHHHHccCCcccCcCH
Confidence 9 999999988888887776654332221 234559999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
.|+++++.....
T Consensus 255 ~~ll~~l~~l~~ 266 (269)
T 4hcu_A 255 SRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=376.90 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=208.3
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...+.+|++.+.||+|+||.||+|.+.. ..+|+|+...... ........+.+|+.+|+.++|||||++++++.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-----VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc-----ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3457889999999999999999999854 5688887543211 11111234588999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+.. ..|+||||++||+|..++.. ...+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 86 ~~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 146 (384)
T 4fr4_A 86 DEE--------------DMFMVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNI 146 (384)
T ss_dssp CSS--------------EEEEEECCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred eCC--------------EEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHe
Confidence 765 67999999999999999975 34699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||+++....... .....||+.|+|||++.+. ....++.++|||||||++
T Consensus 147 ll~~~-------g~vkL~DFG~a~~~~~~~~-----------~~~~~gt~~Y~aPE~~~~~-~~~~~~~~~DiwSlG~il 207 (384)
T 4fr4_A 147 LLDEH-------GHVHITDFNIAAMLPRETQ-----------ITTMAGTKPYMAPEMFSSR-KGAGYSFAVDWWSLGVTA 207 (384)
T ss_dssp EECTT-------SCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCGGGTCCC-SSCCBCTTHHHHHHHHHH
T ss_pred EECCC-------CCEEEeccceeeeccCCCc-----------eeccCCCccccCCeeeccC-CCCCCCccceeechHHHH
Confidence 99987 7899999999976543211 1245799999999998742 124588999999999999
Q ss_pred HHHHhCCCCCCCC---CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1036 LELLTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~---~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
|+|++|..||... ...++...+...... ++. ..++++.+||.+||+.||
T Consensus 208 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~p~---------------------------~~s~~~~~li~~lL~~dP 259 (384)
T 4fr4_A 208 YELLRGRRPYHIRSSTSSKEIVHTFETTVVT-YPS---------------------------AWSQEMVSLLKKLLEPNP 259 (384)
T ss_dssp HHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHSCSSG
T ss_pred HHHHhCCCCCCCCCCccHHHHHHHHhhcccC-CCC---------------------------cCCHHHHHHHHHHhcCCH
Confidence 9999999999753 333444444332211 110 334569999999999999
Q ss_pred CCCCC-HHHHHHHHHhhc
Q 001152 1113 TERPT-AGDLYEMFVART 1129 (1137)
Q Consensus 1113 ~~RPS-a~EVL~~L~~~~ 1129 (1137)
.+||+ +++|++|+|+..
T Consensus 260 ~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 260 DQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp GGSCCSHHHHHTSGGGTT
T ss_pred hHhcccHHHHHcChhhhc
Confidence 99998 999999999964
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=364.06 Aligned_cols=291 Identities=21% Similarity=0.219 Sum_probs=207.7
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L---~HpNIVkllg~~~ 875 (1137)
..+|++.+.||+|+||+||+|++ .+..||+|+............ ....+.+|+.+++.+ .||||+++++++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGG---LPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSC---CCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccc---cchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 46899999999999999999996 457899998654432211110 111225677776666 4999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
.... ......++||||+. ++|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 85 ~~~~---------~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 151 (308)
T 3g33_A 85 TSRT---------DREIKVTLVFEHVD-QDLRTYLDK---APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 151 (308)
T ss_dssp ECCS---------SSEEEEEEEEECCC-CBHHHHHHT---CCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTE
T ss_pred ccCC---------CCceeEEEEehhhh-cCHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 6431 11235799999997 699999976 2334599999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 152 l~~~~-------~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 209 (308)
T 3g33_A 152 LVTSG-------GTVKLADFGLARIYSYQMA-----------LTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGCIF 209 (308)
T ss_dssp EECTT-------SCEEECSCSCTTTSTTCCC-----------SGGGGCCCSSCCHHHHHT----SCCCSTHHHHHHHHHH
T ss_pred EEcCC-------CCEEEeeCccccccCCCcc-----------cCCccccccccCchHHcC----CCCCchHHHHHHHHHH
Confidence 99877 7899999999875543211 124578999999999975 4688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|+|++|..||.+....+....+...........+........... ...............++++.+|+.+||+.||++|
T Consensus 210 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 288 (308)
T 3g33_A 210 AEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF-PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKR 288 (308)
T ss_dssp HHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGS-CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcccccc-CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccC
Confidence 999999999999888777666633211111111110000000000 0000000111122556789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001152 1116 PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ 1130 (1137)
||+.|+++|+|+...
T Consensus 289 ~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 289 ISAFRALQHSYLHKD 303 (308)
T ss_dssp CCHHHHHTSTTC---
T ss_pred CCHHHHhcCccccCC
Confidence 999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=376.93 Aligned_cols=296 Identities=20% Similarity=0.226 Sum_probs=210.5
Q ss_pred CCCCceEeeeeccc--CceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 800 SFPSLSSCDEAGKS--VSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 800 ~~~~y~l~~~LG~G--sfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...+|++.++||+| +||.||+|++. +..||+|+..... ......+ .+.+|+.+++.++|||||++++++.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVT----FLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc--cChHHHH----HHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 45789999999999 99999999985 5778898865432 2233333 3488999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+.+ ..++||||+++++|.+++... ....+++..+..|+.||+.||+|||++||+||||||+||
T Consensus 97 ~~~--------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NI 159 (389)
T 3gni_B 97 ADN--------------ELWVVTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 159 (389)
T ss_dssp ETT--------------EEEEEEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred ECC--------------EEEEEEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 765 679999999999999999762 224699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||.+............ .........||+.|+|||++.+ ....++.++|||||||++
T Consensus 160 ll~~~-------~~~kl~dfg~~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DiwslG~il 227 (389)
T 3gni_B 160 LISVD-------GKVYLSGLRSNLSMISHGQRQRV---VHDFPKYSVKVLPWLSPEVLQQ--NLQGYDAKSDIYSVGITA 227 (389)
T ss_dssp EECTT-------CCEEECCGGGCEECEETTEECSC---BCCCCTTCTTTGGGSCHHHHST--TSSCBCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEcccccceeeccccccccc---cccccccccccccccCHHHHhc--cCCCCCcHhHHHHHHHHH
Confidence 99877 78999999988654332211100 0011223479999999999975 224688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhc---------cccc----ccccc-----cCCCCCCchhhhhhH
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG---------SCHE----HEVAQ-----SGSGFEKPEAELETL 1097 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~---------~~~~----~~~~~-----~~~~~~~~~~~~~~~ 1097 (1137)
|+|++|+.||.+....+....+..+..+.+........ .... ..... ..............+
T Consensus 228 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 307 (389)
T 3gni_B 228 CELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307 (389)
T ss_dssp HHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------CC
T ss_pred HHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccC
Confidence 99999999998765554444333222211110000000 0000 00000 000000001122456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1098 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1098 ~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+++.+|+.+||+.||.+|||++|+++|+|+...
T Consensus 308 ~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 308 PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 789999999999999999999999999999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=356.32 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=210.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
..+++|++.+.||+|+||.||+|++.. ..+|+|+..... ........++.+|+.+++.++||||+++++++.+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ-----LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc-----cchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 356789999999999999999999864 568888754321 1111223345889999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ ..++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+
T Consensus 86 ~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 146 (284)
T 2vgo_A 86 RK--------------RIYLMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL 146 (284)
T ss_dssp SS--------------EEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred CC--------------EEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence 65 679999999999999999762 35899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++||||||+++|
T Consensus 147 ~~~~-------~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 203 (284)
T 2vgo_A 147 MGYK-------GELKIADFGWSVHAPSLR------------RRTMCGTLDYLPPEMIEG----KTHDEKVDLWCAGVLCY 203 (284)
T ss_dssp ECTT-------CCEEECCCTTCEECSSSC------------BCCCCSCGGGCCHHHHTT----CCBCTTHHHHHHHHHHH
T ss_pred EcCC-------CCEEEecccccccCcccc------------cccccCCCCcCCHHHhcc----CCCCcccchhhHHHHHH
Confidence 9877 789999999886543211 113468999999999875 46789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|++|..||......+....+...... ++. ..++.+.+++.+||+.||.+||
T Consensus 204 ~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~li~~~l~~~p~~Rp 255 (284)
T 2vgo_A 204 EFLVGMPPFDSPSHTETHRRIVNVDLK-FPP---------------------------FLSDGSKDLISKLLRYHPPQRL 255 (284)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTTCCC-CCT---------------------------TSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHCCCCCCCCCHhHHHHHHhccccC-CCC---------------------------cCCHHHHHHHHHHhhcCHhhCC
Confidence 999999999987777766666543221 110 2345689999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|++|+++|+|+...
T Consensus 256 s~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 256 PLKGVMEHPWVKAN 269 (284)
T ss_dssp CHHHHHTCHHHHHH
T ss_pred CHHHHhhCHHHHhh
Confidence 99999999999854
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=366.85 Aligned_cols=266 Identities=23% Similarity=0.370 Sum_probs=212.6
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
...+|++.+.||+|+||.||+|++.+ ..||+|+.... . .....+ .+.+|+.++++++||||+++++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~-~~~~~~----~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--A-SADMQA----DFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--C-CHHHHH----HHHHHHHHHHTCCCTTBCCEEE
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc--c-CHHHHH----HHHHHHHHHHhCCCCCEEEEEE
Confidence 34679999999999999999999853 56888874322 1 222233 3489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-------------------CCCCCCHHHHHHHHHHH
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------------GEKHVSVKLALFIAQDV 933 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-------------------~~~~ls~~~i~~I~~QI 933 (1137)
++.+.+ ..++||||+++++|.+++...... ....+++..++.|+.||
T Consensus 118 ~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 118 VCAVGK--------------PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp EECSSS--------------SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred EEccCC--------------ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 998765 459999999999999999863211 12569999999999999
Q ss_pred HHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhh
Q 001152 934 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013 (1137)
Q Consensus 934 a~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 1013 (1137)
+.||+|||++||+||||||+|||++.+ +.+||+|||++......... .......+|+.|+|||++
T Consensus 184 ~~~l~~LH~~~ivH~Dlkp~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~ 248 (343)
T 1luf_A 184 AAGMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYY--------KADGNDAIPIRWMPPESI 248 (343)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCB--------C----CCBCGGGCCHHHH
T ss_pred HHHHHHHHhCCeecCCCCcceEEECCC-------CeEEEeecCCCcccccCccc--------cccCCCcccceecChhhh
Confidence 999999999999999999999999987 78999999998765432211 111234578899999998
Q ss_pred ccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchh
Q 001152 1014 RAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092 (1137)
Q Consensus 1014 ~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1137)
.+ ..++.++|||||||++|+|++ |..||.+....++...+..+..+..+.
T Consensus 249 ~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------- 299 (343)
T 1luf_A 249 FY----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE------------------------- 299 (343)
T ss_dssp HH----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT-------------------------
T ss_pred cc----CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCC-------------------------
Confidence 76 468899999999999999999 999999988888887776655433221
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 001152 1093 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1093 ~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ss 1132 (1137)
.+++++.+++.+||+.||.+|||+.+|++++.......
T Consensus 300 --~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 300 --NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred --CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 33456999999999999999999999999998875533
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=373.55 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=201.5
Q ss_pred eEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCC
Q 001152 805 SSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 805 ~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~ 882 (1137)
...+.||+|+||.||+|.+. +..||+|+..... ....+. +.+|+.+|++++|||||++++++.+.+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~----~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 159 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEE----VKNEISVMNQLDHANLIQLYDAFESKN---- 159 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHH----HHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHH----HHHHHHHHHhCCCCCCCeEEEEEEECC----
Confidence 44678999999999999984 5678888864321 223333 488999999999999999999998765
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
..++||||+++++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||+..+.
T Consensus 160 ----------~~~lv~E~~~~~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~- 224 (373)
T 2x4f_A 160 ----------DIVLVMEYVDGGELFDRIIDE----SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD- 224 (373)
T ss_dssp ----------EEEEEEECCTTCEEHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT-
T ss_pred ----------EEEEEEeCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC-
Confidence 679999999999999988751 24689999999999999999999999999999999999995331
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~ 1042 (1137)
.+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 225 ----~~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~ 285 (373)
T 2x4f_A 225 ----AKQIKIIDFGLARRYKPREK-----------LKVNFGTPEFLAPEVVNY----DFVSFPTDMWSVGVIAYMLLSGL 285 (373)
T ss_dssp ----TTEEEECCCSSCEECCTTCB-----------CCCCCSSCTTCCHHHHTT----CBCCHHHHHHHHHHHHHHHHHSS
T ss_pred ----CCcEEEEeCCCceecCCccc-----------cccccCCCcEeChhhccC----CCCCcHHhHHHHHHHHHHHHhCC
Confidence 16899999999976543221 113469999999999865 56889999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001152 1043 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1122 (1137)
Q Consensus 1043 ~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL 1122 (1137)
.||.+.+..+....+........... ....++++.+|+.+||+.||.+|||++|++
T Consensus 286 ~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~li~~~L~~dp~~Rps~~e~l 341 (373)
T 2x4f_A 286 SPFLGDNDAETLNNILACRWDLEDEE------------------------FQDISEEAKEFISKLLIKEKSWRISASEAL 341 (373)
T ss_dssp CTTCCSSHHHHHHHHHHTCCCSCSGG------------------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHhccCCCChhh------------------------hccCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999888877777755432211110 013456799999999999999999999999
Q ss_pred HHHHhhc
Q 001152 1123 EMFVART 1129 (1137)
Q Consensus 1123 ~~L~~~~ 1129 (1137)
+|+|+..
T Consensus 342 ~hp~~~~ 348 (373)
T 2x4f_A 342 KHPWLSD 348 (373)
T ss_dssp HSHHHHC
T ss_pred cCcCcCC
Confidence 9999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=371.14 Aligned_cols=256 Identities=24% Similarity=0.266 Sum_probs=204.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~ 878 (1137)
++|++.+.||+|+||.||+|.+. +..+|+|+...... .. .+|++++.++ +||||+++++++.+..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~----~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DP----TEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CC----HHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------Ch----HHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 56999999999999999999985 56788988643321 11 4588888888 6999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+.
T Consensus 90 --------------~~~lv~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~ 150 (342)
T 2qr7_A 90 --------------YVYVVTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYV 150 (342)
T ss_dssp --------------EEEEEECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred --------------EEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEe
Confidence 67999999999999999875 34699999999999999999999999999999999999986
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+. ...+.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 151 ~~~---~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el 213 (342)
T 2qr7_A 151 DES---GNPESIRICDFGFAKQLRAENGL----------LMTPCYTANFVAPEVLER----QGYDAACDIWSLGVLLYTM 213 (342)
T ss_dssp SSS---CSGGGEEECCCTTCEECBCTTCC----------BCCSSCCSSCCCHHHHHH----HHHHHHHHHHHHHHHHHHH
T ss_pred cCC---CCcCeEEEEECCCcccCcCCCCc----------eeccCCCccccCHHHhcC----CCCCCccCeeeHhHHHHHH
Confidence 541 12246999999999765432111 123468999999999876 3477999999999999999
Q ss_pred HhCCCCCCC---CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1039 LTLQVPYMG---LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1039 LTG~~Pf~~---~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
++|..||.+ ....++...+..+........+ ...++++.+|+.+||+.||.+|
T Consensus 214 l~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~R 269 (342)
T 2qr7_A 214 LTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW------------------------NSVSDTAKDLVSKMLHVDPHQR 269 (342)
T ss_dssp HHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT------------------------TTSCHHHHHHHHHHTCSSTTTS
T ss_pred hcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc------------------------ccCCHHHHHHHHHHCCCChhHC
Confidence 999999975 3556666777655432211000 1345669999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001152 1116 PTAGDLYEMFVART 1129 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~ 1129 (1137)
||+.|+++|+|+..
T Consensus 270 ~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 270 LTAALVLRHPWIVH 283 (342)
T ss_dssp CCHHHHTTSHHHHT
T ss_pred cCHHHHhcCCeecC
Confidence 99999999999964
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=367.86 Aligned_cols=291 Identities=21% Similarity=0.248 Sum_probs=206.2
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...+++|++.++||+|+||+||+|.+. +..||+|+.... .......+. +.+|+.++++++||||+++++++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE--HEEEGVPGT----AIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCC--C------------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccc--ccccccchh----HHHHHHHHHHcCCCCcceEEEEEe
Confidence 345788999999999999999999874 567888875332 222222223 378999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+.. ..++||||++ ++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 104 ~~~--------------~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NI 163 (329)
T 3gbz_A 104 HNH--------------RLHLIFEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163 (329)
T ss_dssp ETT--------------EEEEEEECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred cCC--------------EEEEEEecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHE
Confidence 765 6799999997 699999976 24699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+. ....+.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++
T Consensus 164 ll~~~~--~~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il 228 (329)
T 3gbz_A 164 LLSVSD--ASETPVLKIGDFGLARAFGIPIR----------QFTHEIITLWYRPPEILLG---SRHYSTSVDIWSIACIW 228 (329)
T ss_dssp EEEC-------CCEEEECCTTHHHHHC---------------------CCTTCCHHHHTT---CCCCCTHHHHHHHHHHH
T ss_pred EEecCC--CCccceEEECcCCCccccCCccc----------ccCCCcCCccccCHHHhcC---CCCCCcHHHHHHHHHHH
Confidence 996542 12236799999999976543211 1123468999999999875 24578999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCC----chhhhhhHHHHHHHHHHhcccC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK----PEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
|+|++|..||.+....+....+...........+...... ....+....+.. .......++++.+|+.+||+.|
T Consensus 229 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 306 (329)
T 3gbz_A 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL--PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306 (329)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSS
T ss_pred HHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh--hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCC
Confidence 9999999999988877766655322111101001100000 000000011110 1111235678999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCC
Q 001152 1112 PTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~~~~~s 1131 (1137)
|.+|||++|+++|+|+....
T Consensus 307 P~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 307 PVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp GGGSCCHHHHHTSGGGSSSC
T ss_pred hhhCCCHHHHhCCcccCCCC
Confidence 99999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=385.25 Aligned_cols=284 Identities=17% Similarity=0.235 Sum_probs=206.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||+||+|.+. +..||+|+.... .......+ ++.+|+.+|+.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~----~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAK----RAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG--GGSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc--ccChHHHH----HHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 478999999999999999999985 567888875422 22223333 3489999999999999999999997654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.. ....+.|+||||++ ++|.+.+.. .+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 135 ~~--------~~~~~~~lv~E~~~-~~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 135 TL--------EEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198 (464)
T ss_dssp ST--------TTCCEEEEEEECCS-EEHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred cc--------ccCCeEEEEEeCCC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe
Confidence 21 11236899999997 567776642 489999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++...... .....+||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 199 ~~-------~~~kl~DFG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el 256 (464)
T 3ttj_A 199 SD-------CTLKILDFGLARTAGTSF-----------MMTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 256 (464)
T ss_dssp TT-------SCEEECCCCCC-----CC-----------CC----CCCTTCCHHHHTT----CCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEEEEeeeecCCCc-----------ccCCCcccccccCHHHHcC----CCCCHHHHHHHHHHHHHHH
Confidence 87 789999999997654321 1124579999999999986 4688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCC---C------------CCchhhhhhHHHHHHH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSG---F------------EKPEAELETLSFLVDV 1103 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~---~------------~~~~~~~~~~~~L~dL 1103 (1137)
++|+.||.+.+..+....+........+..+......... ....... . .........++++.+|
T Consensus 257 l~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 335 (464)
T 3ttj_A 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN-YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 335 (464)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH-HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh-HhhcccccCCCChHHhCcccccccccccccccCHHHHHH
Confidence 9999999998887777666433222222211111000000 0000000 0 0011122336789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1104 FRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1104 l~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+.+||+.||.+|||++|+++|+|+..
T Consensus 336 l~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 336 LSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHcCCChhhCCCHHHHhcChhhhh
Confidence 99999999999999999999999973
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=364.23 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=212.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||+|++. +..+|+|+............ .....+.+|+.++++++||||+++++++.+..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 88 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRG--VSREEIEREVSILRQVLHHNVITLHDVYENRT- 88 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSS--BCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccc--hhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 45999999999999999999985 57799998654432221110 01123478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 89 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~ 150 (321)
T 2a2a_A 89 -------------DVVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150 (321)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred -------------EEEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEec
Confidence 67999999999999999975 346899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
++ .....+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 151 ~~---~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 212 (321)
T 2a2a_A 151 KN---IPIPHIKLIDFGLAHEIEDGVE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 212 (321)
T ss_dssp TT---SSSCCEEECCCTTCEECCTTCC-----------CCCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CC---CCcCCEEEccCccceecCcccc-----------ccccCCCCCccCcccccC----CCCCCccccHHHHHHHHHHH
Confidence 62 1112799999999876543211 123469999999999875 56789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||.+....+....+......... .. ....++.+.+++.+||+.||.+|||++
T Consensus 213 ~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~-----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ 268 (321)
T 2a2a_A 213 SGASPFLGDTKQETLANITSVSYDFDE-EF-----------------------FSHTSELAKDFIRKLLVKETRKRLTIQ 268 (321)
T ss_dssp HSCCSSCCSSHHHHHHHHHTTCCCCCH-HH-----------------------HTTCCHHHHHHHHTTSCSSTTTSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHhcccccCh-hh-----------------------hcccCHHHHHHHHHHcCCChhhCcCHH
Confidence 999999988888777777654432211 11 113456699999999999999999999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
|+++|+|+..
T Consensus 269 e~l~hp~~~~ 278 (321)
T 2a2a_A 269 EALRHPWITP 278 (321)
T ss_dssp HHHHSTTTSC
T ss_pred HHhcCccccC
Confidence 9999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=386.24 Aligned_cols=269 Identities=22% Similarity=0.292 Sum_probs=213.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCC-----hHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSS-----ADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~-----~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
..+|++.++||+|+||+||+|.+. +..+|+|+......... ....+.....+.+|+.+|++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 367999999999999999999985 46789998654322110 11112233456899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+.+.. ..++||||+++|+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+
T Consensus 115 ~~~~~--------------~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~ 175 (504)
T 3q5i_A 115 FEDKK--------------YFYLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPE 175 (504)
T ss_dssp EECSS--------------EEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEcCC--------------EEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHH
Confidence 98765 67999999999999999876 246999999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.++ ....+||+|||++........ .....||+.|+|||++.+ .++.++|||||||
T Consensus 176 Nil~~~~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~ 235 (504)
T 3q5i_A 176 NILLENKN----SLLNIKIVDFGLSSFFSKDYK-----------LRDRLGTAYYIAPEVLKK-----KYNEKCDVWSCGV 235 (504)
T ss_dssp GEEESSTT----CCSSEEECCCTTCEECCTTSC-----------BCCCCSCTTTCCHHHHTT-----CBCTHHHHHHHHH
T ss_pred HEEEecCC----CCccEEEEECCCCEEcCCCCc-----------cccccCCcCCCCHHHhcc-----CCCchHHHHHHHH
Confidence 99998662 123699999999976543211 113469999999999863 5789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1034 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1034 iL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
++|+|++|..||.+....++...+..+........+. ..++++.+|+.+||+.||.
T Consensus 236 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------------------------~~s~~~~~li~~~L~~dp~ 291 (504)
T 3q5i_A 236 IMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK------------------------NISDEAKELIKLMLTYDYN 291 (504)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT------------------------TSCHHHHHHHHHHTCSSTT
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC------------------------CCCHHHHHHHHHHcCCChh
Confidence 9999999999999999888888887765432221111 3456699999999999999
Q ss_pred CCCCHHHHHHHHHhhcCCC
Q 001152 1114 ERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~ss 1132 (1137)
+|||++|+++|+|++....
T Consensus 292 ~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 292 KRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp TSCCHHHHHTSHHHHHTCC
T ss_pred HCCCHHHHhcCHhhhhchh
Confidence 9999999999999986543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=364.69 Aligned_cols=267 Identities=23% Similarity=0.259 Sum_probs=204.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.++|++.+.||+|+||.||+|++. +..||+|+...... ...... .++.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFY----LRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHH----HHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHH----HHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 467999999999999999999974 57788888643322 112222 34588999999999999999999987643
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. .....|+||||+++++|.++++. ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 86 ~----------~~~~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 150 (311)
T 3ork_A 86 P----------AGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150 (311)
T ss_dssp T----------TEEEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred C----------CCcccEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 1 11245999999999999999976 23699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++.......... .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 151 ~~-------~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l 212 (311)
T 3ork_A 151 AT-------NAVKVMDFGIARAIADSGNSV-------TQTAAVIGTAQYLSPEQARG----DSVDARSDVYSLGCVLYEV 212 (311)
T ss_dssp TT-------SCEEECCCSCC-------------------------CCTTCCHHHHHT----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeccCccccccccccc-------ccccccCcCcccCCHHHhcC----CCCCchHhHHHHHHHHHHH
Confidence 87 789999999997654322110 11123468999999999976 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|+.||.+....+....+.......... . ....++++.+++.+||+.||.+||++
T Consensus 213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-----------------------~~~~~~~l~~li~~~l~~dP~~R~~~ 268 (311)
T 3ork_A 213 LTGEPPFTGDSPVSVAYQHVREDPIPPSA-R-----------------------HEGLSADLDAVVLKALAKNPENRYQT 268 (311)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCCHHH-H-----------------------STTCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred HhCCCCCCCCChHHHHHHHhcCCCCCccc-c-----------------------cCCCCHHHHHHHHHHHhcCHhhChhh
Confidence 99999999888777666554433221110 0 01345679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001152 1119 GDLYEMFVART 1129 (1137)
Q Consensus 1119 ~EVL~~L~~~~ 1129 (1137)
.+++.+.|+..
T Consensus 269 ~~~l~~~l~~~ 279 (311)
T 3ork_A 269 AAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=371.44 Aligned_cols=290 Identities=22% Similarity=0.232 Sum_probs=206.9
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|++. +..||+|+........ ..+.....+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch---hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3578999999999999999999985 5678888754322111 1112223457899999999999999999999865
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||++ ++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 85 ~--------------~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 145 (346)
T 1ua2_A 85 S--------------NISLVFDFME-TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 145 (346)
T ss_dssp T--------------CCEEEEECCS-EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred C--------------ceEEEEEcCC-CCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE
Confidence 5 4599999998 589888864 23468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++....... ......||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 146 ~~~-------~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~e 205 (346)
T 1ua2_A 146 DEN-------GVLKLADFGLAKSFGSPNR----------AYTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILAE 205 (346)
T ss_dssp CTT-------CCEEECCCGGGSTTTSCCC----------CCCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEEecccceeccCCcc----------cCCcccccccccCchHhhC---CCCCCchhhhHhHHHHHHH
Confidence 887 7899999999876543211 1123468999999999864 2457899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|..||.+....+....+...........+...........................++++.+|+.+||+.||.+|||
T Consensus 206 ll~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 285 (346)
T 1ua2_A 206 LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285 (346)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC
Confidence 99999999988877776666332111111111100000000000000000001111245678999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001152 1118 AGDLYEMFVARTSS 1131 (1137)
Q Consensus 1118 a~EVL~~L~~~~~s 1131 (1137)
++|+++|+|+....
T Consensus 286 ~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 286 ATQALKMKYFSNRP 299 (346)
T ss_dssp HHHHHTSGGGTSSS
T ss_pred HHHHhcChhhhcCC
Confidence 99999999998643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=373.25 Aligned_cols=268 Identities=21% Similarity=0.339 Sum_probs=213.7
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCccee
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkl 870 (1137)
.....+|++.+.||+|+||+||+|++. +..||||+.. .. ........ +.+|+.++++++|||||++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~----~~~E~~~l~~l~hpnIv~~ 139 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EV-CSEQDELD----FLMEALIISKFNHQNIVRC 139 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECC--SS-CCHHHHHH----HHHHHHHHHHCCCTTBCCE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecc--cc-cChhhHHH----HHHHHHHHHhCCCCCCCeE
Confidence 344578999999999999999999963 2457888642 22 12333333 4889999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 001152 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948 (1137)
Q Consensus 871 lg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~--~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHr 948 (1137)
++++.+.. ..++||||+++|+|.++++..... ....+++..++.|+.||+.||+|||++||+||
T Consensus 140 ~~~~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 205 (367)
T 3l9p_A 140 IGVSLQSL--------------PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 205 (367)
T ss_dssp EEEECSSS--------------SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEecCC--------------CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 99998765 459999999999999999874321 12469999999999999999999999999999
Q ss_pred cCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhH
Q 001152 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028 (1137)
Q Consensus 949 DLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1028 (1137)
||||+|||++.++ ....+||+|||+++........ .......||+.|+|||++.+ ..++.++||
T Consensus 206 Dlkp~NIll~~~~----~~~~~kL~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Dv 269 (367)
T 3l9p_A 206 DIAARNCLLTCPG----PGRVAKIGDFGMARDIYRAGYY--------RKGGCAMLPVKWMPPEAFME----GIFTSKTDT 269 (367)
T ss_dssp CCCGGGEEESCSS----TTCCEEECCCHHHHHHHHHSSC--------TTCCGGGSCGGGCCHHHHHH----CCCCHHHHH
T ss_pred CCChhhEEEecCC----CCceEEECCCcccccccccccc--------ccCCCcCCcccEECHHHhcC----CCCCcHHHH
Confidence 9999999998552 1146999999999755332111 11123468899999999976 568899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001152 1029 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1107 (1137)
Q Consensus 1029 WSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~C 1107 (1137)
|||||++|||++ |..||.+....++...+..+..+..+. .+++.+.+|+.+|
T Consensus 270 wslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~ 322 (367)
T 3l9p_A 270 WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---------------------------NCPGPVYRIMTQC 322 (367)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHH
Confidence 999999999998 999999988888888887665433221 3345599999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhc
Q 001152 1108 TEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1108 L~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
|+.||.+|||+.+|+++++...
T Consensus 323 l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 323 WQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHHHHHHh
Confidence 9999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=375.24 Aligned_cols=294 Identities=19% Similarity=0.237 Sum_probs=202.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~ 877 (1137)
+.+|++.+.||+|+||.||+|.+. +..||+|+.. .........+. +.+|+.+++.+. |||||++++++...
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~--~~~~~~~~~~~----~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF--DAFQNSTDAQR----TFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEEC--C--CCHHHHHH----HHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEec--ccccChHHHHH----HHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 568999999999999999999985 5678888643 22222333333 378999999998 99999999999754
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+. ...|+||||++ ++|..+++. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 82 ~~------------~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 142 (388)
T 3oz6_A 82 ND------------RDVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142 (388)
T ss_dssp TS------------SCEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CC------------CEEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE
Confidence 31 15799999997 799999876 368999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCcccccccccccccc-----------ccCCCCCCCcccCCCcccchhhhccccCCCCCCchh
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI-----------AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1026 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~-----------~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ks 1026 (1137)
+.+ +.+||+|||+++........... ...........+||+.|+|||++.+ ...++.++
T Consensus 143 ~~~-------~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~ 212 (388)
T 3oz6_A 143 NAE-------CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG---STKYTKGI 212 (388)
T ss_dssp CTT-------CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT---CCCCCTHH
T ss_pred cCC-------CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC---CCCCCChh
Confidence 987 78999999999765431110000 0000111234579999999999875 25688999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccc----c------ccCCCCCCch-----
Q 001152 1027 DIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEV----A------QSGSGFEKPE----- 1091 (1137)
Q Consensus 1027 DVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~----~------~~~~~~~~~~----- 1091 (1137)
|||||||++|||++|+.||.+.+..+....+...........+........... . ........+.
T Consensus 213 DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (388)
T 3oz6_A 213 DMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292 (388)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhc
Confidence 999999999999999999999888777766643221111111111000000000 0 0000000000
Q ss_pred ----hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1092 ----AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1092 ----~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
....+++++.+|+.+||+.||.+|||++|+++|+|+..
T Consensus 293 ~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334 (388)
T ss_dssp HHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred ccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHH
Confidence 00144667999999999999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=374.59 Aligned_cols=259 Identities=23% Similarity=0.290 Sum_probs=204.9
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHH-HHhCCCCCcceeeeeE
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRM-LGALRHSCIVEMYGHK 874 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~i-L~~L~HpNIVkllg~~ 874 (1137)
.....+|++.+.||+|+||.||+|++.. ..+|+|+........ ....+. +.+|..+ ++.++|||||++++++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~----~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKH----IMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHH----HHHHHHHHHHhCCCCCCCCEEEEE
Confidence 3456789999999999999999999854 568888865443221 112222 3567666 5678999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+.+ ..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 109 ~~~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 169 (373)
T 2r5t_A 109 QTAD--------------KLYFVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPEN 169 (373)
T ss_dssp ECSS--------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred EeCC--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHH
Confidence 8765 67999999999999999976 2468999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 170 Ill~~~-------g~ikL~DFG~a~~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~i 228 (373)
T 2r5t_A 170 ILLDSQ-------GHIVLTDFGLCKENIEHN----------STTSTFCGTPEYLAPEVLHK----QPYDRTVDWWCLGAV 228 (373)
T ss_dssp EEECTT-------SCEEECCCCBCGGGBCCC----------CCCCSBSCCCCCCCHHHHTT----CCCCTHHHHHHHHHH
T ss_pred EEECCC-------CCEEEeeCccccccccCC----------CccccccCCccccCHHHhCC----CCCCchhhhHHHHHH
Confidence 999987 789999999987533211 11224579999999999875 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|||++|..||.+.+..++...+...... ++. ..++++.+|+.+||+.||.+
T Consensus 229 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~~~---------------------------~~~~~~~~li~~lL~~dp~~ 280 (373)
T 2r5t_A 229 LYEMLYGLPPFYSRNTAEMYDNILNKPLQ-LKP---------------------------NITNSARHLLEGLLQKDRTK 280 (373)
T ss_dssp HHHHHHSSCTTCCSBHHHHHHHHHHSCCC-CCS---------------------------SSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhcccC-CCC---------------------------CCCHHHHHHHHHHcccCHHh
Confidence 99999999999998888888777654321 110 23456899999999999999
Q ss_pred CCCH----HHHHHHHHhhc
Q 001152 1115 RPTA----GDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa----~EVL~~L~~~~ 1129 (1137)
||++ .++++|+|+..
T Consensus 281 R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 281 RLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp STTTTTTHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHhCCccccC
Confidence 9986 79999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=385.45 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=213.4
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...+.+|.+.+.||+|+||.||+|++. +..||+|+...... ........+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-----RSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH-----HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-----cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345688999999999999999999985 67899998643211 11112234588999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
... ..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 87 ~~~--------------~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NI 147 (476)
T 2y94_A 87 TPS--------------DIFMVMEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV 147 (476)
T ss_dssp CSS--------------EEEEEEECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGE
T ss_pred ECC--------------EEEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHE
Confidence 765 67999999999999999864 34699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++........ .....||+.|+|||++.+. ..++.++|||||||++
T Consensus 148 ll~~~-------~~vkL~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil 206 (476)
T 2y94_A 148 LLDAH-------MNAKIADFGLSNMMSDGEF-----------LRTSCGSPNYAAPEVISGR---LYAGPEVDIWSSGVIL 206 (476)
T ss_dssp EECTT-------CCEEECCCSSCEECCTTCC-----------BCCCCSCSTTCCHHHHTTC---CBCSHHHHHHHHHHHH
T ss_pred EEecC-------CCeEEEeccchhhcccccc-----------ccccCCCcCeEChhhccCC---CCCCCcceehhhHHHH
Confidence 99987 7899999999976543211 1134699999999999752 2347899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|+|++|..||.+.....+...+..+.... +. ..++++.+|+.+||+.||.+|
T Consensus 207 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~-p~---------------------------~~s~~~~~Li~~~L~~dP~~R 258 (476)
T 2y94_A 207 YALLCGTLPFDDDHVPTLFKKICDGIFYT-PQ---------------------------YLNPSVISLLKHMLQVDPMKR 258 (476)
T ss_dssp HHHHHSSCSSCCSSSHHHHHHHHTTCCCC-CT---------------------------TCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhhCCCCCCCCCHHHHHHHHhcCCcCC-Cc---------------------------cCCHHHHHHHHHHcCCCchhC
Confidence 99999999999887777777776554211 10 234568999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001152 1116 PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ 1130 (1137)
||++||++|+|+...
T Consensus 259 pt~~eil~hp~~~~~ 273 (476)
T 2y94_A 259 ATIKDIREHEWFKQD 273 (476)
T ss_dssp CCHHHHHTCHHHHTT
T ss_pred cCHHHHHhCHHhhhc
Confidence 999999999999754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=352.58 Aligned_cols=261 Identities=22% Similarity=0.355 Sum_probs=209.8
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+.+|++.+.||+|+||+||+|++.+..+|+|++... .......+. +.+|+.++++++||||+++++++.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVR--DWSTRKSRD----FNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCT--TCCHHHHHH----HHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccc--ccCHHHHHH----HHHHHHHHHhcCCCchhheEEEEccC
Confidence 345788999999999999999999999999999986543 222333333 48899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENI 955 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g--IIHrDLKP~NI 955 (1137)
.. ...++||||+++|+|.+++.. .....+++..++.|+.||+.||+|||++| |+||||||+||
T Consensus 80 ~~------------~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Ni 144 (271)
T 3kmu_A 80 PA------------PHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSV 144 (271)
T ss_dssp TS------------SSCEEEEECCTTCBHHHHHHS---CSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGE
T ss_pred CC------------CCeEeeecccCCCcHHHHHhh---cccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceE
Confidence 21 156999999999999999975 22336999999999999999999999999 99999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.++|+|||++..... ....||+.|+|||++.+.. ...++.++|||||||++
T Consensus 145 l~~~~-------~~~~l~~~~~~~~~~~---------------~~~~~t~~y~aPE~~~~~~-~~~~~~~~Di~slG~il 201 (271)
T 3kmu_A 145 MIDED-------MTARISMADVKFSFQS---------------PGRMYAPAWVAPEALQKKP-EDTNRRSADMWSFAVLL 201 (271)
T ss_dssp EECTT-------SCEEEEGGGSCCTTSC---------------TTCBSCGGGSCHHHHHSCG-GGSCHHHHHHHHHHHHH
T ss_pred EEcCC-------cceeEEeccceeeecc---------------cCccCCccccChhhhccCC-CCCCCchhhHHHHHHHH
Confidence 99977 7799998887653221 1235899999999987521 12344589999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHc-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~-g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+|++|+.||.+....+....+.. +..+.++. ..++++.+++.+||+.||.+
T Consensus 202 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~ 254 (271)
T 3kmu_A 202 WELVTREVPFADLSNMEIGMKVALEGLRPTIPP---------------------------GISPHVSKLMKICMNEDPAK 254 (271)
T ss_dssp HHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhCCCCccccChHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhh
Confidence 999999999998887776655533 32322221 34456999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001152 1115 RPTAGDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~ 1129 (1137)
|||++|+++.+....
T Consensus 255 Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 255 RPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCCHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHhh
Confidence 999999999987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=356.73 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=200.9
Q ss_pred CCceEeeeecccCceEEEEEEECCc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGSA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|++.+.||+|+||+||+|.+..+ .+|+|+.. .........+. +.+|+.++++++||||+++++++.....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~--~~~~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ--DRKLTKSERQR----FKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE--GGGSCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEec--chhhCHHHHHH----HHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 3479999999999999999998654 46666543 32223333333 4889999999999999999999875320
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeEe
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILI 957 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g--IIHrDLKP~NILl 957 (1137)
.....++||||+++++|.+++... ..+++..++.|+.||+.||+|||++| |+||||||+|||+
T Consensus 100 ----------~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~ 164 (290)
T 1t4h_A 100 ----------GKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164 (290)
T ss_dssp ----------SCEEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE
T ss_pred ----------CCceEEEEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEE
Confidence 122679999999999999999762 46899999999999999999999999 9999999999999
Q ss_pred c-cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 958 D-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 958 d-~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
+ .+ +.+||+|||++........ ....||+.|+|||++.+ .++.++|||||||++|
T Consensus 165 ~~~~-------~~~kl~Dfg~~~~~~~~~~------------~~~~~t~~y~aPE~~~~-----~~~~~~Di~slG~~l~ 220 (290)
T 1t4h_A 165 TGPT-------GSVKIGDLGLATLKRASFA------------KAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCML 220 (290)
T ss_dssp SSTT-------SCEEECCTTGGGGCCTTSB------------EESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeeCCCccccccccc------------ccccCCcCcCCHHHHhc-----cCCCcchHHHHHHHHH
Confidence 7 44 6899999999864433211 13468999999998863 4789999999999999
Q ss_pred HHHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~-~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
+|++|..||.... .......+..+..+.. .....++++.+++.+||+.||.+|
T Consensus 221 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~R 274 (290)
T 1t4h_A 221 EMATSEYPYSECQNAAQIYRRVTSGVKPAS--------------------------FDKVAIPEVKEIIEGCIRQNKDER 274 (290)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHhCCCCCCCcCcHHHHHHHHhccCCccc--------------------------cCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999998743 3444444433322110 011234569999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001152 1116 PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ 1130 (1137)
||++|+++|+|+...
T Consensus 275 ps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 275 YSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHTSGGGC--
T ss_pred CCHHHHhhCcccccC
Confidence 999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=361.16 Aligned_cols=294 Identities=20% Similarity=0.225 Sum_probs=210.4
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|++. +..||+|+........ ..+ .+.+|+.++++++||||+++++++.....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVD----VQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS---CHH----HHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc---hHH----HHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 46999999999999999999986 5779999864322111 122 23789999999999999999999876441
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
...++||||+++++|.+++.... ....+++..++.|+.||+.||+|||++||+||||||+|||+..
T Consensus 82 ------------~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 147 (319)
T 4euu_A 82 ------------RHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147 (319)
T ss_dssp ------------CCEEEEEECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred ------------ceEEEEEeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEec
Confidence 15699999999999999998632 2234999999999999999999999999999999999999822
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc----CCCCCCchhhHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH----KPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~~~~~s~ksDVWSLGviL 1035 (1137)
. ....+.+||+|||+++........ ....||+.|+|||++.... ....++.++|||||||++
T Consensus 148 ~---~~~~~~~kL~Dfg~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 213 (319)
T 4euu_A 148 G---EDGQSVYKLTDFGAARELEDDEQF-----------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (319)
T ss_dssp C---TTSCEEEEECCCTTCEECCTTCCB-----------CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred c---CCCCceEEEccCCCceecCCCCce-----------eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence 2 112267999999999765432211 1346999999999986310 125688999999999999
Q ss_pred HHHHhCCCCCCCCC----HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001152 1036 LELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~----~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
|||++|..||.... ..++...+..+..+............ ......... .........++.+.+++.+||+.|
T Consensus 214 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~d 290 (319)
T 4euu_A 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG--PIDWSGDMP-VSCSLSRGLQVLLTPVLANILEAD 290 (319)
T ss_dssp HHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTC--CEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred HHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCC--ccccCccCC-cccccchhHHHHhHHHHHHhccCC
Confidence 99999999996422 23444445443332211111110000 000000000 011122467788999999999999
Q ss_pred CCCCCCHHHHHHHHHhhcCCCC
Q 001152 1112 PTERPTAGDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~~~~~ss~ 1133 (1137)
|++|||++|+++|+........
T Consensus 291 P~~R~s~~ell~h~~d~~~~~~ 312 (319)
T 4euu_A 291 QEKCWGFDQFFAETSDILHRGN 312 (319)
T ss_dssp TTTSCCHHHHHHHHHHHTC---
T ss_pred hhhhccHHHhhhccHHHhhcCC
Confidence 9999999999999998765443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=384.99 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=205.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
....+|++.+.||+|+||.||+|++. +..||+|+........ ..... .+.+|+.+++.++||||+++++++.+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~----~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVA----HTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh-hHHHH----HHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 34678999999999999999999984 5679999865332111 12222 23789999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCe
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENI 955 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NI 955 (1137)
.+ ..++||||+++|+|.+++.. ...+++..+..|+.||+.||+|||+ +||+||||||+||
T Consensus 220 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NI 280 (446)
T 4ejn_A 220 HD--------------RLCFVMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 280 (446)
T ss_dssp TT--------------EEEEEECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGE
T ss_pred CC--------------EEEEEEeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHE
Confidence 66 67999999999999999976 2469999999999999999999998 9999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 281 ll~~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il 339 (446)
T 4ejn_A 281 MLDKD-------GHIKITDFGLCKEGIKDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVM 339 (446)
T ss_dssp EECSS-------SCEEECCCCCCCTTCC---------------CCSSSCGGGCCHHHHHT----SCCCTHHHHHHHHHHH
T ss_pred EECCC-------CCEEEccCCCceeccCCCc----------ccccccCCccccCHhhcCC----CCCCCccchhhhHHHH
Confidence 99987 7899999999875332211 1124579999999999875 5689999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|||++|..||.+.+..++...+...... ++. ..++++.+||.+||+.||.+|
T Consensus 340 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~~~~~~~li~~~L~~dP~~R 391 (446)
T 4ejn_A 340 YEMMCGRLPFYNQDHEKLFELILMEEIR-FPR---------------------------TLGPEAKSLLSGLLKKDPKQR 391 (446)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCc---------------------------cCCHHHHHHHHHHcccCHHHh
Confidence 9999999999988888877777554321 111 234569999999999999999
Q ss_pred C-----CHHHHHHHHHhhc
Q 001152 1116 P-----TAGDLYEMFVART 1129 (1137)
Q Consensus 1116 P-----Sa~EVL~~L~~~~ 1129 (1137)
| +++|+++|+|+..
T Consensus 392 ~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 392 LGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp TTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHHhCccccC
Confidence 9 9999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=366.77 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=187.7
Q ss_pred CceEe---eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEec
Q 001152 803 SLSSC---DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 876 (1137)
Q Consensus 803 ~y~l~---~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~ 876 (1137)
+|++. +.||+|+||+||+|.+. +..+|+|+.... ... .+.+|+.+++.+. ||||+++++++.+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~----~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEA----NTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHH----HHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhh----hHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 45554 78999999999999985 567888885322 112 2367999999997 9999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. ..++||||+++++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 78 ~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 138 (325)
T 3kn6_A 78 QL--------------HTFLVMELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL 138 (325)
T ss_dssp SS--------------EEEEEECCCCSCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CC--------------EEEEEEEccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEE
Confidence 65 67999999999999999976 356999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.++ ....+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 139 l~~~~----~~~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il~ 200 (325)
T 3kn6_A 139 FTDEN----DNLEIKIIDFGFARLKPPDNQ----------PLKTPCFTLHYAAPELLNQ----NGYDESCDLWSLGVILY 200 (325)
T ss_dssp EEC--------CEEEECCCTTCEECCC------------------------------------CCCCHHHHHHHHHHHHH
T ss_pred EecCC----CcccEEEeccccceecCCCCC----------cccccCCCcCccCHHHhcC----CCCCCccchHHHHHHHH
Confidence 98652 114799999999975443211 1123468999999999875 56889999999999999
Q ss_pred HHHhCCCCCCCCCH-------HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001152 1037 ELLTLQVPYMGLSE-------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~-------~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
+|++|..||.+... .++...+..+..+..... ....++++.+|+.+||+
T Consensus 201 ~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~ 256 (325)
T 3kn6_A 201 TMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA------------------------WKNVSQEAKDLIQGLLT 256 (325)
T ss_dssp HHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH------------------------HHTSCHHHHHHHHHHHC
T ss_pred HHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc------------------------ccCCCHHHHHHHHHHCC
Confidence 99999999976432 344444444332211111 11456679999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcCCCC
Q 001152 1110 ENPTERPTAGDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1110 ~DP~~RPSa~EVL~~L~~~~~ss~ 1133 (1137)
.||.+|||++|+++|+|+......
T Consensus 257 ~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 257 VDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp CCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred CChhHCCCHHHHhcChhhccCccC
Confidence 999999999999999999865443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=352.55 Aligned_cols=256 Identities=23% Similarity=0.308 Sum_probs=209.3
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|+||.||+|++.+ ..+|+|+..... ... +. +.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~---~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~- 76 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSE---DE----FFQEAQTMMKLSHPKLVKFYGVCSKEY- 76 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCH---HH----HHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcH---HH----HHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence 4679999999999999999999865 478998864322 111 22 378999999999999999999997655
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+||+++.
T Consensus 77 -------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~ 139 (268)
T 3sxs_A 77 -------------PIYIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR 139 (268)
T ss_dssp -------------SEEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT
T ss_pred -------------ceEEEEEccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC
Confidence 569999999999999999762 235999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 140 ~-------~~~~l~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 199 (268)
T 3sxs_A 140 D-------LCVKVSDFGMTRYVLDDQYVS---------SVGTKFPVKWSAPEVFHY----FKYSSKSDVWAFGILMWEVF 199 (268)
T ss_dssp T-------CCEEECCTTCEEECCTTCEEE---------CCSCCCCGGGCCHHHHHH----SEEETTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEccCccceecchhhhhc---------ccCCCcCcccCCHHHHhc----cCCchhhhhHHHHHHHHHHH
Confidence 7 789999999987654332111 112346778999999876 45789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||......+....+..+.....+. ..++.+.+++.+||+.||.+|||+
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps~ 252 (268)
T 3sxs_A 200 SLGKMPYDLYTNSEVVLKVSQGHRLYRPH---------------------------LASDTIYQIMYSCWHELPEKRPTF 252 (268)
T ss_dssp TTTCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHTTCSSGGGSCCH
T ss_pred cCCCCCccccChHHHHHHHHcCCCCCCCC---------------------------cChHHHHHHHHHHcCCChhhCcCH
Confidence 9 999999888887777776554332221 233458999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
.|+++++.....
T Consensus 253 ~~ll~~L~~l~~ 264 (268)
T 3sxs_A 253 QQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHGGGCC
T ss_pred HHHHHHHHHhhh
Confidence 999999987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=385.66 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=207.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.++||+|+||+||+|++. +..+|+|+....... ....+ .+.+|+.+++.++|||||++++++.+..
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~- 109 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNS----KLLEEVAVLKLLDHPNIMKLYDFFEDKR- 109 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTH----HHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHH----HHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 36999999999999999999985 467888886433211 11122 3478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 110 -------------~~~lv~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 171 (494)
T 3lij_A 110 -------------NYYLVMECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES 171 (494)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred -------------EEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeC
Confidence 679999999999999988762 46999999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
.. ..+.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 172 ~~----~~~~~kl~DfG~a~~~~~~~~-----------~~~~~gt~~y~aPE~l~~-----~~~~~~DiwslG~il~~ll 231 (494)
T 3lij_A 172 KE----KDALIKIVDFGLSAVFENQKK-----------MKERLGTAYYIAPEVLRK-----KYDEKCDVWSIGVILFILL 231 (494)
T ss_dssp SS----TTCCEEECCCTTCEECBTTBC-----------BCCCCSCTTTCCHHHHTT-----CBCTHHHHHHHHHHHHHHH
T ss_pred CC----CCCcEEEEECCCCeECCCCcc-----------ccccCCCcCeeCHHHHcc-----cCCCchhHHHHHHHHHHHH
Confidence 42 125699999999976543221 113469999999999863 5889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||.+....++...+..+........+ ...++.+.+|+.+||+.||.+|||+.
T Consensus 232 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~s~~ 287 (494)
T 3lij_A 232 AGYPPFGGQTDQEILRKVEKGKYTFDSPEW------------------------KNVSEGAKDLIKQMLQFDSQRRISAQ 287 (494)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCSGGG------------------------TTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCchhc------------------------ccCCHHHHHHHHHHCCCChhhCccHH
Confidence 999999999888888888766543221111 13456699999999999999999999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
|+++|+|++.
T Consensus 288 e~l~hp~~~~ 297 (494)
T 3lij_A 288 QALEHPWIKE 297 (494)
T ss_dssp HHHTCHHHHH
T ss_pred HHhcCccccc
Confidence 9999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=356.60 Aligned_cols=265 Identities=26% Similarity=0.355 Sum_probs=212.7
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|++. +..+|+|+.... .......+. +.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG--SMTEAEKQM----LVSEVNLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECT--TCCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcc--cCCHHHHHH----HHHHHHHHHhcCCCCCCeEEEEEecC
Confidence 4678999999999999999999985 467888875433 222333333 48899999999999999999988643
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCC
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKS 952 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g-----IIHrDLKP 952 (1137)
.. ...++||||+++++|.+++..... ....+++..++.|+.||+.||+|||++| |+||||||
T Consensus 78 ~~------------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p 144 (279)
T 2w5a_A 78 TN------------TTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP 144 (279)
T ss_dssp GG------------TEEEEEEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSG
T ss_pred CC------------ceEEEEEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccch
Confidence 21 167999999999999999986432 2346999999999999999999999999 99999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
+|||++.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++||||||
T Consensus 145 ~NIl~~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 203 (279)
T 2w5a_A 145 ANVFLDGK-------QNVKLGDFGLARILNHDTSF----------AKTFVGTPYYMSPEQMNR----MSYNEKSDIWSLG 203 (279)
T ss_dssp GGEEECSS-------SCEEECCCCHHHHC---CHH----------HHHHHSCCTTCCHHHHHC----C-CCHHHHHHHHH
T ss_pred hhEEEcCC-------CCEEEecCchheeecccccc----------ccccCCCccccChHHhcc----CCCCchhhHHHHH
Confidence 99999877 78999999998765432111 012358999999999875 4678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
+++|+|++|..||......++...+..+..+.++. ..++++.+++.+||+.||
T Consensus 204 ~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p 256 (279)
T 2w5a_A 204 CLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---------------------------RYSDELNEIITRMLNLKD 256 (279)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc---------------------------ccCHHHHHHHHHHcCCCc
Confidence 99999999999999888887777776665443321 234569999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001152 1113 TERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~s 1131 (1137)
.+|||+.||++++|+....
T Consensus 257 ~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 257 YHRPSVEEILENPLILEHH 275 (279)
T ss_dssp GGSCCHHHHHTSTTCCGGG
T ss_pred ccCCCHHHHHhChhhhhhc
Confidence 9999999999999987653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=368.06 Aligned_cols=284 Identities=19% Similarity=0.222 Sum_probs=205.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|++.+.||+|+||+||+|++. +..||+|+...... .... ..+.+|+.+++.++||||+++++++.+..
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAP----CTAIREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------C----CCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccc----hhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 468999999999999999999985 56788887643321 1111 12256999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||++ ++|.+++... ...+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 74 --------------~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~ 134 (324)
T 3mtl_A 74 --------------SLTLVFEYLD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN 134 (324)
T ss_dssp --------------CEEEEEECCS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC
T ss_pred --------------EEEEEecccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC
Confidence 5699999997 7999988762 34699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++........ ......||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 135 ~~-------~~~kl~Dfg~a~~~~~~~~----------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l 194 (324)
T 3mtl_A 135 ER-------GELKLADFGLARAKSIPTK----------TYDNEVVTLWYRPPDILLG---STDYSTQIDMWGVGCIFYEM 194 (324)
T ss_dssp TT-------CCEEECSSSEEECC----------------------CGGGCCHHHHTT---CCCCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccCcccccccCCcc----------ccccccCcccccChhhhcC---CCCCCcHHHHHHHHHHHHHH
Confidence 87 7899999999875443211 1123468999999999875 24678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccc-cc-ccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VA-QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
++|..||.+....+....+...........+.......... .. ...............++++.+|+.+||+.||.+||
T Consensus 195 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 274 (324)
T 3mtl_A 195 ATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI 274 (324)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC
Confidence 99999999988877766664322111111111000000000 00 00000000111124567799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|++|+++|+|+...
T Consensus 275 t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 275 SAEDAMKHPFFLSL 288 (324)
T ss_dssp CHHHHTTSGGGGGG
T ss_pred CHHHHhcChhhhhc
Confidence 99999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=370.90 Aligned_cols=285 Identities=19% Similarity=0.218 Sum_probs=206.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|.+. +..||+|+. .......... .++.+|+.+++.++||||+++++++.....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~--~~~~~~~~~~----~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFA----KRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEEC--SSTTSSHHHH----HHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEe--CccccCHHHH----HHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 57999999999999999999985 566888763 2222222222 345899999999999999999999876532
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ......|+||||+ +++|.++++. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 99 ~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 163 (367)
T 1cm8_A 99 L--------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 163 (367)
T ss_dssp T--------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c--------ccCceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcC
Confidence 1 1122569999999 7999999875 35899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++..... ....++|+.|+|||++.+ ...++.++|||||||++|||+
T Consensus 164 ~-------~~~kl~Dfg~a~~~~~~-------------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell 220 (367)
T 1cm8_A 164 D-------CELKILDFGLARQADSE-------------MTGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEMI 220 (367)
T ss_dssp T-------CCEEECCCTTCEECCSS-------------CCSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEeeecccccccc-------------cCcCcCCCCcCCHHHHhC---CCCCChhhhHHHHHHHHHHHH
Confidence 7 78999999999764321 113468999999999875 246889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccccccc---CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS---GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||.+.+..+....+...........+.............. .............++.+.+|+.+||+.||.+||
T Consensus 221 ~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~ 300 (367)
T 1cm8_A 221 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300 (367)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCC
Confidence 99999999888777666643222111111111100000000000 000011111124567799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|++|+++|+|+..-
T Consensus 301 t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 301 TAGEALAHPYFESL 314 (367)
T ss_dssp CHHHHHHSGGGTTT
T ss_pred CHHHHhcChHHHhh
Confidence 99999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=385.69 Aligned_cols=263 Identities=27% Similarity=0.324 Sum_probs=213.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.++||+|+||+||+|++. +..||+|+........ ...+ .+.+|+.++++++|||||++++++.+..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~- 94 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTS----TILREVELLKKLDHPNIMKLFEILEDSS- 94 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHH----HHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHH----HHHHHHHHHHhCCCCCcCeEEEEEEcCC-
Confidence 56999999999999999999985 5779999864332111 1122 3478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 95 -------------~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 156 (486)
T 3mwu_A 95 -------------SFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (486)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESS
T ss_pred -------------EEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 679999999999999988762 46999999999999999999999999999999999999975
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
.. ..+.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 157 ~~----~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll 216 (486)
T 3mwu_A 157 KE----KDCDIKIIDFGLSTCFQQNTK-----------MKDRIGTAYYIAPEVLRG-----TYDEKCDVWSAGVILYILL 216 (486)
T ss_dssp SS----TTCCEEECSCSCTTTBCCC---------------CCTTGGGGCCGGGGGS-----CCCHHHHHHHHHHHHHHHH
T ss_pred CC----CCCCEEEEECCcCeECCCCCc-----------cCCCcCCCCCCCHHHhCC-----CCCchhhHHHHHHHHHHHH
Confidence 41 226799999999875543211 123469999999999874 4889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||.+....++...+..+..+.....+ ...++++.+|+.+||+.||.+|||+.
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~t~~ 272 (486)
T 3mwu_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQW------------------------RTISDDAKDLIRKMLTFHPSLRITAT 272 (486)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCSCSGGG------------------------GGSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCccc------------------------CCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999999998888888888765533211111 13456799999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 001152 1120 DLYEMFVARTSSSI 1133 (1137)
Q Consensus 1120 EVL~~L~~~~~ss~ 1133 (1137)
|+++|+|+......
T Consensus 273 ~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 273 QCLEHPWIQKYSSE 286 (486)
T ss_dssp HHHHCHHHHHTCCC
T ss_pred HHhcCHhhccCccc
Confidence 99999999865443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=363.08 Aligned_cols=280 Identities=24% Similarity=0.277 Sum_probs=200.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|++.+.||+|+||.||+|++. +..||+|+...... ....+ .+.+|+.+|++++|||||++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR---ELARE----KVMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST---TTHHH----HHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc---hhHHH----HHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 356999999999999999999985 57799998654321 22222 3488999999999999999999986543
Q ss_pred CCC-----------C--------------------------------CCCCCccccceEEEEEeeccCCCHHHHHHHhhh
Q 001152 879 WLP-----------S--------------------------------ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE 915 (1137)
Q Consensus 879 ~~~-----------~--------------------------------~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~ 915 (1137)
... . ..-.........++||||+++++|.+++...
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-- 155 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-- 155 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC--
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc--
Confidence 100 0 0000001122479999999999999999763
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccc--cC
Q 001152 916 TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA--HR 993 (1137)
Q Consensus 916 ~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~--~~ 993 (1137)
......++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++............ ..
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-------~~~kL~DfG~a~~~~~~~~~~~~~~~~~ 228 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-------DVVKVGDFGLVTAMDQDEEEQTVLTPMP 228 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-------CCEEECCCTTCEECSCC-----------
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-------CCEEEeecCcccccccchhhcccccccc
Confidence 222356777899999999999999999999999999999999977 789999999998665432110000 00
Q ss_pred CCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhc
Q 001152 994 GIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1073 (1137)
Q Consensus 994 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~ 1073 (1137)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..|+.. .......+.....+.
T Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~--------- 293 (332)
T 3qd2_B 229 AYATHTGQVGTKLYMSPEQIHG----NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPL--------- 293 (332)
T ss_dssp ---CCCSCC-CGGGSCHHHHHC----CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCH---------
T ss_pred ccccccccCCCcCccChHHhcC----CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCc---------
Confidence 0011234569999999999975 5688999999999999999998766531 222233333322211
Q ss_pred ccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1074 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1074 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
.....++++.+++.+||+.||.+|||++|+++|+|+..
T Consensus 294 ------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 294 ------------------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp ------------------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ------------------ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 11134456899999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=366.35 Aligned_cols=290 Identities=21% Similarity=0.269 Sum_probs=213.5
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 796 LDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 796 ~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
+....+.+|++.+.||+|+||.||+|++. +..||+|++... .......+ .+.+|+.++++++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~ 92 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES--DDDKMVKK----IAMREIKLLKQLRHENLVNLLEV 92 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC--SSCHHHHH----HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC--CCchHHHH----HHHHHHHHHhhCCCCCEeeEEEE
Confidence 55667889999999999999999999986 567888875432 22222222 34789999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+.+.. ..++||||+++++|..++.. ...+++..+..|+.||+.||+|||++||+||||||+
T Consensus 93 ~~~~~--------------~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~ 153 (331)
T 4aaa_A 93 CKKKK--------------RWYLVFEFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPE 153 (331)
T ss_dssp EEETT--------------EEEEEEECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred eecCC--------------EEEEEEecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChh
Confidence 98765 67999999998888887654 246999999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.+ +.+||+|||++......... .....||+.|+|||++.+ ...++.++|||||||
T Consensus 154 Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~Di~slG~ 213 (331)
T 4aaa_A 154 NILVSQS-------GVVKLCDFGFARTLAAPGEV----------YDDEVATRWYRAPELLVG---DVKYGKAVDVWAIGC 213 (331)
T ss_dssp GEEECTT-------SCEEECCCTTC----------------------CCCCCTTCCHHHHTT---CTTCCTHHHHHHHHH
T ss_pred eEEEcCC-------CcEEEEeCCCceeecCCccc----------cCCCcCCccccCcccccC---CCCcchHHHHHHHHH
Confidence 9999887 78999999998755432211 123468999999999875 236789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhH---HhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhccc
Q 001152 1034 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE---LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1110 (1137)
Q Consensus 1034 iL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~---l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~ 1110 (1137)
++|+|++|..||.+....+....+........+.. +...........................++++.+|+.+||+.
T Consensus 214 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 293 (331)
T 4aaa_A 214 LVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHI 293 (331)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhcc
Confidence 99999999999998877766655533222222211 111100000111110111111111235677899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhcC
Q 001152 1111 NPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1111 DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
||.+|||++|+++|+|+...
T Consensus 294 dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 294 DPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp SGGGSCCGGGGGGSHHHHGG
T ss_pred CcccCCCHHHHhcCchhccC
Confidence 99999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.82 Aligned_cols=265 Identities=24% Similarity=0.303 Sum_probs=209.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||+|++. +..+|+|+............ .....+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRG--VSREEIEREVNILREIRHPNIITLHDIFENKT- 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS--BCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccc--hHHHHHHHHHHHHHhCCCCCeeehhheecCCC-
Confidence 35899999999999999999985 57899998654432221110 01123478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 82 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 143 (283)
T 3bhy_A 82 -------------DVVLILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 143 (283)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred -------------eEEEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEec
Confidence 67999999999999999976 246899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+. .....+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 144 ~~---~~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 205 (283)
T 3bhy_A 144 KN---VPNPRIKLIDFGIAHKIEAGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 205 (283)
T ss_dssp SS---SSSCCEEECCCTTCEECC-------------------CCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred CC---CCCCceEEEecccceeccCCCc-----------ccccCCCcCccCcceecC----CCCCcchhhhhHHHHHHHHH
Confidence 62 1224799999999876543211 113468999999999875 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||.+....+....+........... ....++.+.+++.+||+.||.+|||+.
T Consensus 206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ 261 (283)
T 3bhy_A 206 SGASPFLGETKQETLTNISAVNYDFDEEY------------------------FSNTSELAKDFIRRLLVKDPKRRMTIA 261 (283)
T ss_dssp HSSCTTCCSSHHHHHHHHHTTCCCCCHHH------------------------HTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred HCCCCCCCcchHHHHHHhHhcccCCcchh------------------------cccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 99999998887777776655443221111 113456699999999999999999999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
|+++|+|+..
T Consensus 262 ~~l~h~~~~~ 271 (283)
T 3bhy_A 262 QSLEHSWIKA 271 (283)
T ss_dssp HHHHCHHHHH
T ss_pred HHHhCHHHHH
Confidence 9999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=351.31 Aligned_cols=260 Identities=23% Similarity=0.279 Sum_probs=204.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+.+|++.+.||+|+||.||+|.+. +..+|+|+..... ........++.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK-----IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc-----ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 4678999999999999999999985 5789999864321 11112223458899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 84 ~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 144 (276)
T 2h6d_A 84 T--------------DFFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL 144 (276)
T ss_dssp S--------------EEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE
T ss_pred C--------------eEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE
Confidence 5 679999999999999999762 358999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++........ .....||+.|+|||++.+. ...+.++||||||+++|+
T Consensus 145 ~~~-------~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~~l~~ 203 (276)
T 2h6d_A 145 DAH-------MNAKIADFGLSNMMSDGEF-----------LRTSCGSPNYAAPEVISGR---LYAGPEVDIWSCGVILYA 203 (276)
T ss_dssp CTT-------SCEEECCCCGGGCCCC------------------------CCTGGGTTS---CCCHHHHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeecccccccCCCcc-----------eecccCCccccCHHHHcCC---CCCCccchHHHHHHHHHH
Confidence 877 7899999999876543211 1134689999999998752 234689999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|..||......++...+..+... ++. ..++.+.+++.+||+.||.+|||
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps 255 (276)
T 2h6d_A 204 LLCGTLPFDDEHVPTLFKKIRGGVFY-IPE---------------------------YLNRSVATLLMHMLQVDPLKRAT 255 (276)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhCCCCCCCCcHHHHHHHhhcCccc-Cch---------------------------hcCHHHHHHHHHHccCChhhCCC
Confidence 99999999988777777666554321 110 23445899999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 001152 1118 AGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ss 1132 (1137)
++|+++|+|+....+
T Consensus 256 ~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 256 IKDIREHEWFKQDLP 270 (276)
T ss_dssp HHHHHHSHHHHTTCC
T ss_pred HHHHHhChhhccCch
Confidence 999999999986543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=354.28 Aligned_cols=261 Identities=21% Similarity=0.286 Sum_probs=212.2
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
++....+|++.+.||+|+||.||+|.+. +..+|+|+....... .....+. +.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREK----MSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHH----HHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc-CHHHHHH----HHHHHHHHHhCCCCCEeeeeeee
Confidence 3455678999999999999999999986 467888876433221 2223333 48899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+.+ ..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 85 ~~~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N 145 (294)
T 2rku_A 85 EDND--------------FVFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 145 (294)
T ss_dssp ECSS--------------EEEEEEECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ccCC--------------EEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence 8765 67999999999999998876 2468999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||++
T Consensus 146 il~~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~ 204 (294)
T 2rku_A 146 LFLNED-------LEVKIGDFGLATKVEYDGE----------RKKVLCGTPNYIAPEVLSK----KGHSFEVDVWSIGCI 204 (294)
T ss_dssp EEECTT-------CCEEECCCTTCEECCSTTC----------CBCCCCSCCSSCCHHHHTT----SCBCTHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEEeccCceecccCcc----------ccccccCCCCcCCcchhcc----CCCCchhhHHHHHHH
Confidence 999977 7899999999876542211 1123468999999999875 457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+|++|..||......+....+...... ++. ..++.+.+++.+||+.||++
T Consensus 205 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~li~~~l~~~p~~ 256 (294)
T 2rku_A 205 MYTLLVGKPPFETSCLKETYLRIKKNEYS-IPK---------------------------HINPVAASLIQKMLQTDPTA 256 (294)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHTTCCC-CCT---------------------------TSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHhhccCC-Ccc---------------------------ccCHHHHHHHHHHcccChhh
Confidence 99999999999987777666655443321 110 23445899999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
|||++|+++|+|+...
T Consensus 257 Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 257 RPTINELLNDEFFTSG 272 (294)
T ss_dssp SCCGGGGGGSHHHHTS
T ss_pred CcCHHHHhhChheecC
Confidence 9999999999999854
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=365.19 Aligned_cols=301 Identities=17% Similarity=0.209 Sum_probs=212.8
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
..+.+|++.+.||+|+||+||+|++. +..||+|+....... ..... .+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPI----TALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCH----HHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchH----HHHHHHHHHHhccCCCcccHhheeec
Confidence 35688999999999999999999984 567888875333221 11112 23789999999999999999999886
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
...... ......++||||++ ++|.+.+.. ....+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus 88 ~~~~~~------~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 156 (351)
T 3mi9_A 88 KASPYN------RCKGSIYLVFDFCE-HDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL 156 (351)
T ss_dssp C--------------CEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cccccc------cCCceEEEEEeccC-CCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEE
Confidence 431100 01226799999997 688887764 2346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+++......... ........||+.|+|||++.+ ...++.++|||||||++|
T Consensus 157 ~~~~-------~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 220 (351)
T 3mi9_A 157 ITRD-------GVLKLADFGLARAFSLAKNSQ------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLWGAGCIMA 220 (351)
T ss_dssp ECTT-------SCEEECCCTTCEECCCCSSSS------CCCCCSSCSCGGGCCHHHHTT---CCSCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEccchhccccccccccc------ccccCCcccccCccCchhhcC---CCCCCcHhHHHHHHHHHH
Confidence 9987 789999999997654322110 111224468999999999875 245789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCC---CCchhHHhhhcccccccccccC-CCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKR---PRLTDELEALGSCHEHEVAQSG-SGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~---p~l~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
+|++|..||.+....+....+..... +..................... ............++.+.+|+.+||+.||
T Consensus 221 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 300 (351)
T 3mi9_A 221 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 300 (351)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSG
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCCh
Confidence 99999999999887776666633221 1111111110000000000000 0000000011235678999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCC
Q 001152 1113 TERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~ss 1132 (1137)
.+|||++|+++|+|+.....
T Consensus 301 ~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 301 AQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp GGSCCHHHHHTSGGGGSSSC
T ss_pred hhCCCHHHHhCCCCcCCCCC
Confidence 99999999999999986543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=385.33 Aligned_cols=261 Identities=24% Similarity=0.323 Sum_probs=213.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|++. +..+|||+........ ....+. +.+|+.++++++|||||++++++.+..
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~- 99 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKES----LLREVQLLKQLDHPNIMKLYEFFEDKG- 99 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHH----HHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHH----HHHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence 46999999999999999999985 5789999864432211 112223 478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+.+++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 100 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 161 (484)
T 3nyv_A 100 -------------YFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES 161 (484)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred -------------EEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEec
Confidence 67999999999999999875 356999999999999999999999999999999999999964
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
. ...+.+||+|||++......... ....||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 162 ~----~~~~~~kl~Dfg~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll 221 (484)
T 3nyv_A 162 K----SKDANIRIIDFGLSTHFEASKKM-----------KDKIGTAYYIAPEVLHG-----TYDEKCDVWSTGVILYILL 221 (484)
T ss_dssp S----STTCCEEECCTTHHHHBCCCCSH-----------HHHTTGGGTCCHHHHHT-----CCCTHHHHHHHHHHHHHHH
T ss_pred C----CCCCcEEEEeeeeeEEccccccc-----------ccCCCCccccCceeecC-----CCCCcceeHHHHHHHHHHH
Confidence 3 11278999999998765432211 13469999999999874 5789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||.+.+..++...+..+........+ ...++++.+|+.+||+.||.+|||+.
T Consensus 222 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~s~~ 277 (484)
T 3nyv_A 222 SGCPPFNGANEYDILKKVEKGKYTFELPQW------------------------KKVSESAKDLIRKMLTYVPSMRISAR 277 (484)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSGGG------------------------GGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCCccc------------------------ccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 999999999988888888766532211111 13456799999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001152 1120 DLYEMFVARTS 1130 (1137)
Q Consensus 1120 EVL~~L~~~~~ 1130 (1137)
|+++|+|+...
T Consensus 278 e~l~h~~~~~~ 288 (484)
T 3nyv_A 278 DALDHEWIQTY 288 (484)
T ss_dssp HHHTSHHHHHH
T ss_pred HHhhChhhccc
Confidence 99999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=365.21 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=208.5
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|++.+.||+|+||+||+|++. +..||+|+...... ......+ .+.+|+.++++++|||||++++++....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~- 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQ----DIIKEVRFLQKLRHPNTIQYRGCYLREH- 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHH----HHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHH----HHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 34899999999999999999974 56788887543321 1122223 3489999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||++ |+|.+++... ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 128 -------------~~~lv~e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 189 (348)
T 1u5q_A 128 -------------TAWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 189 (348)
T ss_dssp -------------EEEEEEECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred -------------eEEEEEecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence 6799999997 7898888642 246999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++...... ....||+.|+|||++.+. ....++.++|||||||++|||+
T Consensus 190 ~-------~~~kL~DfG~a~~~~~~--------------~~~~gt~~y~aPE~~~~~-~~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 190 P-------GLVKLGDFGSASIMAPA--------------NSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp T-------TEEEECCCTTCBSSSSB--------------CCCCSCGGGCCHHHHHTT-SSCCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeeccCceecCCC--------------CcccCCcceeCHhhhccc-cCCCCCcHHHHHHHHHHHHHHH
Confidence 7 78999999998654321 134699999999998632 1356889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||.+.+..+....+.....+.... ...++.+.+|+.+||+.||.+|||++
T Consensus 248 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dP~~Rps~~ 301 (348)
T 1u5q_A 248 ERKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTSE 301 (348)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCCC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCC--------------------------CCCCHHHHHHHHHHcccChhhCcCHH
Confidence 9999998887776666665444332110 03345689999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001152 1120 DLYEMFVARTSSS 1132 (1137)
Q Consensus 1120 EVL~~L~~~~~ss 1132 (1137)
++++|+|+....+
T Consensus 302 ~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 302 VLLKHRFVLRERP 314 (348)
T ss_dssp HHTTCHHHHSCCC
T ss_pred HHhhChhhhccCC
Confidence 9999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=380.50 Aligned_cols=268 Identities=20% Similarity=0.284 Sum_probs=200.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|.+. +..||+|+...+...............+.+|+.+|++++|||||++++++...
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-- 212 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 212 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS--
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 67999999999999999999985 46899998765433222211112222458899999999999999999997643
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 213 -------------~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~ 274 (419)
T 3i6u_A 213 -------------DYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 274 (419)
T ss_dssp -------------EEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred -------------ceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEec
Confidence 46999999999999888754 356999999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
++ ....+||+|||+++....... .....||+.|+|||++.+. ....++.++|||||||++|+|+
T Consensus 275 ~~----~~~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~~~~DiwslG~il~~ll 338 (419)
T 3i6u_A 275 QE----EDCLIKITDFGHSKILGETSL-----------MRTLCGTPTYLAPEVLVSV-GTAGYNRAVDCWSLGVILFICL 338 (419)
T ss_dssp SS----SSCCEEECCSSTTTSCC----------------------CTTCCTTTTC-----CTTHHHHHHHHHHHHHHHHH
T ss_pred CC----CcceEEEeecccceecCCCcc-----------ccccCCCCCccCceeeecC-CCCCCCchhhhHhHHHHHHHHH
Confidence 42 125699999999976543211 1234699999999998632 1246789999999999999999
Q ss_pred hCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~-~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+|..||..... ..+...+..+.....+..+ ...++.+.+|+.+||+.||.+|||+
T Consensus 339 tg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~Rps~ 394 (419)
T 3i6u_A 339 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVW------------------------AEVSEKALDLVKKLLVVDPKARFTT 394 (419)
T ss_dssp HSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH------------------------TTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HCCCCCCCCcchHHHHHHHhcCCCCCCchhh------------------------cccCHHHHHHHHHHccCChhHCcCH
Confidence 99999976432 2344445554433322211 1345669999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001152 1119 GDLYEMFVART 1129 (1137)
Q Consensus 1119 ~EVL~~L~~~~ 1129 (1137)
+|+++|+|+..
T Consensus 395 ~e~l~hp~~~~ 405 (419)
T 3i6u_A 395 EEALRHPWLQD 405 (419)
T ss_dssp HHHHHSGGGCC
T ss_pred HHHhCCcccCC
Confidence 99999999964
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.98 Aligned_cols=266 Identities=22% Similarity=0.279 Sum_probs=207.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|++.+.||+|+||.||+|.+. +..+|+|+.......... .....+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIP----NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHST----THHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccc----hhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 468999999999999999999984 467888886433211101 11234588999999999999999999986432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. ...++||||++++ |.+++... ....+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 80 ~------------~~~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~ 143 (305)
T 2wtk_C 80 K------------QKMYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143 (305)
T ss_dssp --------------CEEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred C------------CeEEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc
Confidence 1 1579999999855 88877652 345699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++......... .......||+.|+|||++.+. ...++.++||||||+++|+|
T Consensus 144 ~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~l 206 (305)
T 2wtk_C 144 TG-------GTLKISALGVAEALHPFAAD--------DTCRTSQGSPAFQPPEIANGL--DTFSGFKVDIWSAGVTLYNI 206 (305)
T ss_dssp TT-------CCEEECCCTTCEECCTTCSS--------CEECCCCSCGGGCCHHHHTCC--SCEESHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEeeccccccccCccccc--------cccccCCCCCCCcChhhccCc--ccCCcchhhHHHHHHHHHHH
Confidence 77 78999999998765432111 001134589999999998752 23347899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||.+....+....+..+..+. +. .+++.+.+++.+||+.||.+|||+
T Consensus 207 ~~g~~p~~~~~~~~~~~~i~~~~~~~-~~---------------------------~~~~~l~~li~~~l~~dp~~Rps~ 258 (305)
T 2wtk_C 207 TTGLYPFEGDNIYKLFENIGKGSYAI-PG---------------------------DCGPPLSDLLKGMLEYEPAKRFSI 258 (305)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCC-CS---------------------------SSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhCCCCCCCchHHHHHHHHhcCCCCC-CC---------------------------ccCHHHHHHHHHHccCChhhCCCH
Confidence 99999999888777777765543211 10 234568999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 001152 1119 GDLYEMFVARTSS 1131 (1137)
Q Consensus 1119 ~EVL~~L~~~~~s 1131 (1137)
+|+++|+|+....
T Consensus 259 ~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 259 RQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHSHHHHSCC
T ss_pred HHHhcCcccccCC
Confidence 9999999998653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.80 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=206.7
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
...+|++.+.||+|+||+||+|.+.+ ..+|+|+..... ... +. +.+|+.++++++||||+++++++.+..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~---~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSE---DE----FIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCH---HH----HHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCH---HH----HHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 45689999999999999999999865 578998864321 111 22 378999999999999999999997655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 93 --------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~ 154 (283)
T 3gen_A 93 --------------PIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 154 (283)
T ss_dssp --------------SEEEEECCCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC
T ss_pred --------------CeEEEEeccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc
Confidence 569999999999999999752 24599999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 155 ~~-------~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~~l 214 (283)
T 3gen_A 155 DQ-------GVVKVSDFGLSRYVLDDEYTS---------SVGSKFPVRWSPPEVLMY----SKFSSKSDIWAFGVLMWEI 214 (283)
T ss_dssp TT-------SCEEECSTTGGGGBCCHHHHS---------TTSTTSCGGGCCHHHHHH----CCCSHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEcccccccccccccccc---------ccCCccCcccCCHHHhcc----CCCCchhhHHHHHHHHHHH
Confidence 77 789999999997654322110 112347788999999986 4688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++ |..||......+....+..+.....+. ..++.+.+++.+||+.||.+|||
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps 267 (283)
T 3gen_A 215 YSLGKMPYERFTNSETAEHIAQGLRLYRPH---------------------------LASEKVYTIMYSCWHEKADERPT 267 (283)
T ss_dssp HTTTCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGGSCC
T ss_pred HhCCCCCccccChhHHHHHHhcccCCCCCC---------------------------cCCHHHHHHHHHHccCChhHCcC
Confidence 98 999999888888877776654332221 22345899999999999999999
Q ss_pred HHHHHHHHHhh
Q 001152 1118 AGDLYEMFVAR 1128 (1137)
Q Consensus 1118 a~EVL~~L~~~ 1128 (1137)
++|+++++...
T Consensus 268 ~~~ll~~L~~~ 278 (283)
T 3gen_A 268 FKILLSNILDV 278 (283)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=355.00 Aligned_cols=266 Identities=24% Similarity=0.353 Sum_probs=199.3
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHh--CCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~--L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||+||+|++.+..||||++... ..+. +.+|.+++.. ++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~----~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-------DEKS----WFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-------GHHH----HHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-------cchh----hHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 457999999999999999999999999999986422 1122 2456666665 78999999999976532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeeccC
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--------SKHIMHRDI 950 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLH--------s~gIIHrDL 950 (1137)
. .....++||||+++|+|.++++. ..+++..++.|+.||+.||+||| ++||+||||
T Consensus 76 ~----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 139 (301)
T 3q4u_A 76 H----------SSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDL 139 (301)
T ss_dssp T----------TEEEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCC
T ss_pred C----------CCceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCC
Confidence 1 12367999999999999999954 46999999999999999999999 999999999
Q ss_pred CCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCC--CCCchhhH
Q 001152 951 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEVDI 1028 (1137)
Q Consensus 951 KP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~--~~s~ksDV 1028 (1137)
||+|||++.+ +.+||+|||+++.......... .......||+.|+|||++.+..... .++.++||
T Consensus 140 kp~Nill~~~-------~~~kl~Dfg~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dv 206 (301)
T 3q4u_A 140 KSKNILVKKN-------GQCCIADLGLAVMHSQSTNQLD------VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206 (301)
T ss_dssp CGGGEEECTT-------SCEEECCCTTCEEEETTTTEEE------CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHH
T ss_pred ChHhEEEcCC-------CCEEEeeCCCeeeccccccccc------ccccccccccceeChhhhcCcCCCCcccCCchhhH
Confidence 9999999977 7899999999976543322110 1112346999999999997621111 34579999
Q ss_pred HHHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHH-cCCCCCchhHHhhhcccccccccccCCCCCCchh
Q 001152 1029 WSYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092 (1137)
Q Consensus 1029 WSLGviL~ELLTG----------~~Pf~~~~-----~~el~~~I~-~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1137)
|||||++|||++| ..||.... ...+...+. ....+.++.. ..
T Consensus 207 wslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~ 264 (301)
T 3q4u_A 207 WAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR----------------------WF 264 (301)
T ss_dssp HHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG----------------------GG
T ss_pred HHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChh----------------------hc
Confidence 9999999999999 88885421 122222221 1112221111 11
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1093 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1093 ~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
....++++.+|+.+||+.||.+|||+.||++.+...
T Consensus 265 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 265 SDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp GSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 125677899999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=369.30 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=212.2
Q ss_pred CCCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 870 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~---------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkl 870 (1137)
..+|++.+.||+|+||+||+|++.+ ..+|+|+.... ......+. +.+|+++++++ +|||||++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD----LISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHH----HHHHHHHHHHhcCCchhhhh
Confidence 4679999999999999999999732 45888875422 22333333 48899999999 89999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001152 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 939 (1137)
Q Consensus 871 lg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------~~~~ls~~~i~~I~~QIa~gL~y 939 (1137)
++++...+ ..++||||+++|+|.+++...... ....+++..++.|+.||+.||+|
T Consensus 141 ~~~~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 206 (382)
T 3tt0_A 141 LGACTQDG--------------PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206 (382)
T ss_dssp EEEECSSS--------------SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred eeeeccCC--------------ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 99998765 459999999999999999873211 12459999999999999999999
Q ss_pred HHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 940 LHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
||++||+||||||+|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+
T Consensus 207 LH~~~ivH~Dlkp~NIll~~~-------~~~kL~DFG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~---- 267 (382)
T 3tt0_A 207 LASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD---- 267 (382)
T ss_dssp HHHTTCCCSCCCGGGEEECTT-------CCEEECSCSCCCCSSCCCTT--------CCCTTCCCGGGGSCHHHHHS----
T ss_pred HHhCCEecCCCCcceEEEcCC-------CcEEEcccCccccccccccc--------ccccCCCCCcceeCHHHhcC----
Confidence 999999999999999999877 78999999999765432211 11123357889999999975
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001152 1020 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1098 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1137)
..++.++|||||||++|+|++ |..||.+....++...+..+..+..+. .+++
T Consensus 268 ~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 320 (382)
T 3tt0_A 268 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS---------------------------NCTN 320 (382)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS---------------------------SCCH
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCH
Confidence 568899999999999999999 999999988888888777655433221 3345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1099 FLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1099 ~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
++.+|+.+||+.||++|||++||++++....
T Consensus 321 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 321 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 6999999999999999999999999998763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=358.46 Aligned_cols=261 Identities=21% Similarity=0.360 Sum_probs=208.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
..+|++.+.||+|+||.||+|.+. +..+|+|+.. .. ......+. +.+|+.++++++||||++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~----~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--EN-ASPSELRD----LLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECC--TT-CCHHHHHH----HHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEecc--CC-CCHHHHHH----HHHHHHHHhhCCCCceeeEEEE
Confidence 467999999999999999999872 2567888743 21 22333334 4889999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-------------------CCCCCCHHHHHHHHHHHH
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-------------------GEKHVSVKLALFIAQDVA 934 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-------------------~~~~ls~~~i~~I~~QIa 934 (1137)
+.+.+ ..++||||+++++|.+++...... ....+++..++.|+.||+
T Consensus 95 ~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 160 (314)
T 2ivs_A 95 CSQDG--------------PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160 (314)
T ss_dssp ECSSS--------------SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHH
T ss_pred EecCC--------------ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHH
Confidence 98765 459999999999999999863221 123489999999999999
Q ss_pred HHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhc
Q 001152 935 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014 (1137)
Q Consensus 935 ~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1014 (1137)
.||+|||++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||++.
T Consensus 161 ~~l~~lH~~~ivH~dikp~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 161 QGMQYLAEMKLVHRDLAARNILVAEG-------RKMKISDFGLSRDVYEEDSYV--------KRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEEETT-------TEEEECCCTTCEECTTTSCEE--------CSSCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHCCCcccccchheEEEcCC-------CCEEEccccccccccccccce--------eccCCCCcccccChhhhc
Confidence 99999999999999999999999977 789999999997654322110 112335788999999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 001152 1015 AMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1093 (1137)
Q Consensus 1015 ~~~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1137)
+ ..++.++|||||||++|+|++ |..||.+....++...+..+..+..+.
T Consensus 226 ~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------- 275 (314)
T 2ivs_A 226 D----HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPD-------------------------- 275 (314)
T ss_dssp H----CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT--------------------------
T ss_pred C----CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCc--------------------------
Confidence 6 457899999999999999999 999999887777776666554332221
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1094 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1094 ~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
.+++++.+++.+||+.||.+|||+.|+++++...
T Consensus 276 -~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 276 -NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3445699999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=373.90 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=208.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||.||+|++. +..||+|+.. .. ......+. +.+|+.+|++++|||||++++++....
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~--~~-~~~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR--ET-LPPDLKAK----FLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECC--TT-SCHHHHTT----TTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcc--cc-CCHHHHHH----HHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 357999999999999999999995 5678888743 21 12233333 488999999999999999999997665
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++|+|.++++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 186 --------------~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~ 247 (377)
T 3cbl_A 186 --------------PIYIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT 247 (377)
T ss_dssp --------------SCEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------CcEEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc
Confidence 459999999999999999762 23589999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|||
T Consensus 248 ~~-------~~~kl~DfG~s~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~el 308 (377)
T 3cbl_A 248 EK-------NVLKISDFGMSREEADGVYA--------ASGGLRQVPVKWTAPEALNY----GRYSSESDVWSFGILLWET 308 (377)
T ss_dssp TT-------CCEEECCGGGCEECTTSEEE--------CCSSCCEEEGGGSCHHHHHH----CEEEHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEECcCCCceecCCCcee--------ecCCCCCCCcCcCCHhHhcc----CCCCchhhHHHHHHHHHHH
Confidence 77 78999999998754332111 00112235678999999875 4578999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++ |..||.+....++...+..+.....+. .+++++.+|+.+||+.||++|||
T Consensus 309 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rps 361 (377)
T 3cbl_A 309 FSLGASPYPNLSNQQTREFVEKGGRLPCPE---------------------------LCPDAVFRLMEQCWAYEPGQRPS 361 (377)
T ss_dssp HTTSCCSSTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCchhCcC
Confidence 98 999999988888777776655433221 34456999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001152 1118 AGDLYEMFVAR 1128 (1137)
Q Consensus 1118 a~EVL~~L~~~ 1128 (1137)
+++|++.+...
T Consensus 362 ~~~i~~~L~~i 372 (377)
T 3cbl_A 362 FSTIYQELQSI 372 (377)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=368.90 Aligned_cols=259 Identities=24% Similarity=0.280 Sum_probs=195.2
Q ss_pred CCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||.||+|++.+ ..||+|+..... ..+. +.+|+.++++++||||+++++++.+..
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~- 121 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKI----VRTEIGVLLRLSHPNIIKLKEIFETPT- 121 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECSS-
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHH----HHHHHHHHHhCCCCCCcceeeeEecCC-
Confidence 569999999999999999999964 568888754221 1122 377999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 122 -------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~ 183 (349)
T 2w4o_A 122 -------------EISLVLELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYAT 183 (349)
T ss_dssp -------------EEEEEECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESS
T ss_pred -------------eEEEEEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEec
Confidence 67999999999999999865 346999999999999999999999999999999999999975
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
. ...+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 184 ~----~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell 244 (349)
T 2w4o_A 184 P----APDAPLKIADFGLSKIVEHQVL-----------MKTVCGTPGYCAPEILRG----CAYGPEVDMWSVGIITYILL 244 (349)
T ss_dssp S----STTCCEEECCCC---------------------------CGGGSCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred C----CCCCCEEEccCccccccCcccc-----------cccccCCCCccCHHHhcC----CCCCcccchHHHHHHHHHHH
Confidence 2 1127899999999875543211 123468999999999875 46889999999999999999
Q ss_pred hCCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~~e-l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+|..||......+ +...+........... ....+.++.+|+.+||+.||++|||+
T Consensus 245 ~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~ 300 (349)
T 2w4o_A 245 CGFEPFYDERGDQFMFRRILNCEYYFISPW------------------------WDEVSLNAKDLVRKLIVLDPKKRLTT 300 (349)
T ss_dssp HSSCTTCCTTCHHHHHHHHHTTCCCCCTTT------------------------TTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred hCCCCCCCCcccHHHHHHHHhCCCccCCch------------------------hhhCCHHHHHHHHHHccCChhhCcCH
Confidence 9999997655443 4555544332211100 01345569999999999999999999
Q ss_pred HHHHHHHHhhcCCC
Q 001152 1119 GDLYEMFVARTSSS 1132 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ss 1132 (1137)
.|+++|+|+.....
T Consensus 301 ~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 301 FQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHSTTTTSTTC
T ss_pred HHHhcCcccCCCcc
Confidence 99999999986543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=366.90 Aligned_cols=258 Identities=24% Similarity=0.283 Sum_probs=193.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||+||+|++. +..||+|+..... ... +. +.+|+.+++.++||||+++++++.+.
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~---~~----~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AID---EN----VQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSC---HH----HHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--ccc---HH----HHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 4578999999999999999999985 5678888754321 111 22 37899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+++|+|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 89 ~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill 149 (361)
T 3uc3_A 89 T--------------HLAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL 149 (361)
T ss_dssp S--------------EEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEE
T ss_pred C--------------EEEEEEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 5 67999999999999999876 2369999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+. .+.+||+|||+++...... ......||+.|+|||++.+. ...+.++|||||||++|+
T Consensus 150 ~~~~-----~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~e 210 (361)
T 3uc3_A 150 DGSP-----APRLKICDFGYSKSSVLHS-----------QPKSTVGTPAYIAPEVLLRQ---EYDGKIADVWSCGVTLYV 210 (361)
T ss_dssp CSSS-----SCCEEECCCCCC--------------------------CTTSCHHHHHCS---SCCHHHHHHHHHHHHHHH
T ss_pred cCCC-----CceEEEeecCccccccccC-----------CCCCCcCCCCcCChhhhcCC---CCCCCeeeeehhHHHHHH
Confidence 8662 1459999999986432211 11234699999999998752 233455999999999999
Q ss_pred HHhCCCCCCCCCH----HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1038 LLTLQVPYMGLSE----LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~----~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
|++|+.||.+... ......+...... ++. ....++++.+|+.+||+.||.
T Consensus 211 ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~s~~~~~li~~~L~~dP~ 264 (361)
T 3uc3_A 211 MLVGAYPFEDPEEPRDYRKTIQRILSVKYS-IPD-------------------------DIRISPECCHLISRIFVADPA 264 (361)
T ss_dssp HHHSSCSCC----CCCHHHHHHHHHTTCCC-CCT-------------------------TSCCCHHHHHHHHHHSCSCTT
T ss_pred HHhCCCCCCCCccHHHHHHHHHHHhcCCCC-CCC-------------------------cCCCCHHHHHHHHHHccCChh
Confidence 9999999976433 2233333222110 000 013345699999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001152 1114 ERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~ 1130 (1137)
+|||+.|+++|+|+...
T Consensus 265 ~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 265 TRISIPEIKTHSWFLKN 281 (361)
T ss_dssp TSCCHHHHHTSHHHHTT
T ss_pred HCcCHHHHHhCcchhcC
Confidence 99999999999999654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=379.72 Aligned_cols=267 Identities=23% Similarity=0.280 Sum_probs=211.2
Q ss_pred CCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.++||+|+||+||+|++.. ..+|+|+..... ...+.....+.+|+.++..++|||||++++++.+..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-----MLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH-----hhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 4679999999999999999999864 668888754221 111111123578999999999999999999998766
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..|+||||++||+|.+++.+. ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 148 --------------~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~ 209 (437)
T 4aw2_A 148 --------------NLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209 (437)
T ss_dssp --------------EEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc
Confidence 679999999999999999752 34699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~E 1037 (1137)
.+ +.+||+|||+++........ .....+||+.|+|||++.... ....++.++|||||||++||
T Consensus 210 ~~-------g~vkL~DFGla~~~~~~~~~---------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~e 273 (437)
T 4aw2_A 210 MN-------GHIRLADFGSCLKLMEDGTV---------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273 (437)
T ss_dssp TT-------SCEEECCCTTCEECCTTSCE---------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEcchhhhhhcccCCCc---------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHH
Confidence 87 78999999999765432211 112347999999999987311 12467899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC--
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE-- 1114 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~-- 1114 (1137)
|++|+.||.+.+..+....+.... ...++. .....++++.+||.+||..+|++
T Consensus 274 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~------------------------~~~~~s~~~~dLi~~lL~~~~~r~~ 329 (437)
T 4aw2_A 274 MLYGETPFYAESLVETYGKIMNHKERFQFPT------------------------QVTDVSENAKDLIRRLICSREHRLG 329 (437)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS------------------------SCCCSCHHHHHHHHTTSSCGGGCTT
T ss_pred HHhCCCCCCCCChhHHHHhhhhccccccCCc------------------------ccccCCHHHHHHHHHHhcccccccC
Confidence 999999999988888777764311 001110 00134566999999999988888
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
||+++|+++|+|+..-
T Consensus 330 r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 330 QNGIEDFKKHPFFSGI 345 (437)
T ss_dssp TTTTHHHHTSGGGTTC
T ss_pred CCCHHHHhCCCccCCC
Confidence 9999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.65 Aligned_cols=263 Identities=22% Similarity=0.236 Sum_probs=201.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~ 877 (1137)
..+|++.+.||+|+||+||+|.+. +..+|+|+..... ........ +.+|+.++..+ +||||+++++++.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQN----ALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC--TTSHHHHH----HHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc--cccHHHHH----HHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 356999999999999999999985 6788898854332 22222333 37899999999 899999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..++||||+++++|.+++...... ...+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 84 ~--------------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~ 148 (289)
T 1x8b_A 84 D--------------HMLIQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFI 148 (289)
T ss_dssp T--------------EEEEEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred C--------------eEEEEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEE
Confidence 5 679999999999999999864332 2468999999999999999999999999999999999999
Q ss_pred ccccc------------cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCch
Q 001152 958 DLERK------------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1025 (1137)
Q Consensus 958 d~~~~------------~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~k 1025 (1137)
+.+.. .......+||+|||.+....... ...||+.|+|||++.+ ...++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------------~~~gt~~y~aPE~~~~---~~~~~~~ 211 (289)
T 1x8b_A 149 SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--------------VEEGDSRFLANEVLQE---NYTHLPK 211 (289)
T ss_dssp C--------------------CCCEEECCCTTCEETTCSC--------------CCCCCGGGCCHHHHTT---CCTTHHH
T ss_pred cCCCCCcccccccccccccCCceEEEEcccccccccCCcc--------------ccCCCccccChhHhcC---CCCCCch
Confidence 85420 00123579999999987654321 2358999999999875 2356789
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHH
Q 001152 1026 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1105 (1137)
Q Consensus 1026 sDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~ 1105 (1137)
+|||||||++|+|++|..|+.... ....+..+..+.++. ..++++.+++.
T Consensus 212 ~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~ 261 (289)
T 1x8b_A 212 ADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIPQ---------------------------VLSQEFTELLK 261 (289)
T ss_dssp HHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCCCCSS---------------------------CCCHHHHHHHH
T ss_pred hhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCCCCCc---------------------------ccCHHHHHHHH
Confidence 999999999999999988775432 233444443332221 33456999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhcCC
Q 001152 1106 RCTEENPTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1106 ~CL~~DP~~RPSa~EVL~~L~~~~~s 1131 (1137)
+||+.||.+|||+.|+++|+|+...+
T Consensus 262 ~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 262 VMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHhCCCcccCCCHHHHhhChHhhhhc
Confidence 99999999999999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=357.05 Aligned_cols=262 Identities=22% Similarity=0.324 Sum_probs=185.2
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+.+|++.+.||+|+||.||+|++ .+..+|+|+..... ........++.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-----MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh-----hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence 467899999999999999999997 45789999864321 11112223458899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 84 ~--------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili 145 (278)
T 3cok_A 84 N--------------YVYLVLEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL 145 (278)
T ss_dssp S--------------EEEEEEECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE
T ss_pred C--------------eEEEEEecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 5 67999999999999999875 23569999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++......... .....||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 146 ~~~-------~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 204 (278)
T 3cok_A 146 TRN-------MNIKIADFGLATQLKMPHEK----------HYTLCGTPNYISPEIATR----SAHGLESDVWSLGCMFYT 204 (278)
T ss_dssp CTT-------CCEEECCCTTCEECC------------------------------------------CTHHHHHHHHHHH
T ss_pred cCC-------CCEEEEeecceeeccCCCCc----------ceeccCCCCcCCcchhcC----CCCCchhhHHHHHHHHHH
Confidence 877 78999999998765432111 113468999999999875 467899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|..||......+....+..... .. ....+.++.+++.+||+.||.+|||
T Consensus 205 l~~g~~p~~~~~~~~~~~~~~~~~~-------------------------~~---~~~~~~~~~~li~~~l~~dp~~Rps 256 (278)
T 3cok_A 205 LLIGRPPFDTDTVKNTLNKVVLADY-------------------------EM---PSFLSIEAKDLIHQLLRRNPADRLS 256 (278)
T ss_dssp HHHSSCSSCCCSCC-----CCSSCC-------------------------CC---CTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHhCCCCCCChhHHHHHHHHhhccc-------------------------CC---ccccCHHHHHHHHHHcccCHhhCCC
Confidence 9999999976543322221110000 00 0134456899999999999999999
Q ss_pred HHHHHHHHHhhcCCCC
Q 001152 1118 AGDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ss~ 1133 (1137)
++++++|+|+......
T Consensus 257 ~~~~l~h~~~~~~~~~ 272 (278)
T 3cok_A 257 LSSVLDHPFMSRNSST 272 (278)
T ss_dssp HHHHTTSTTTC-----
T ss_pred HHHHhcCccccCCCCc
Confidence 9999999999865443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.70 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=194.8
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||+||+|++ .+..+|+|+.... .. ...... .+..+...++.++||||+++++++.+.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~-~~~~~~---~~~~~~~~~~~~~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VN-SQEQKR---LLMDLDISMRTVDCPFTVTFYGALFRE 78 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----C-HHHHHH---HHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecc--cC-cHHHHH---HHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence 356899999999999999999998 4577888875422 11 222111 124455568888999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCeE
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENIL 956 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrDLKP~NIL 956 (1137)
+ ..++||||++ |+|.+++...... ...+++..++.|+.||+.||+|||++ ||+||||||+|||
T Consensus 79 ~--------------~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil 142 (290)
T 3fme_A 79 G--------------DVWICMELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVL 142 (290)
T ss_dssp S--------------SEEEEEECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCE
T ss_pred C--------------CEEEEEehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEE
Confidence 5 5699999997 6998888764333 35799999999999999999999998 9999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++........ .....||+.|+|||++........++.++|||||||++|
T Consensus 143 ~~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 204 (290)
T 3fme_A 143 INAL-------GQVKMCDFGISGYLVDDVA-----------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204 (290)
T ss_dssp ECTT-------CCEEBCCC--------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecCCccccccccc-----------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHH
Confidence 9877 7899999999876543221 113369999999999743223457889999999999999
Q ss_pred HHHhCCCCCCC-CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLTG~~Pf~~-~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
+|++|..||.. .........+.....+..+. ...++++.+++.+||+.||.+|
T Consensus 205 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~R 258 (290)
T 3fme_A 205 ELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA--------------------------DKFSAEFVDFTSQCLKKNSKER 258 (290)
T ss_dssp HHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT--------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHCCCCccccCchHHHHHHHhccCCCCccc--------------------------ccCCHHHHHHHHHHhhcChhhC
Confidence 99999999975 33333333333322222110 1344569999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001152 1116 PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ 1130 (1137)
||++|+++|+|+...
T Consensus 259 pt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 259 PTYPELMQHPFFTLH 273 (290)
T ss_dssp CCHHHHTTSHHHHHH
T ss_pred cCHHHHHhCcccccC
Confidence 999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=365.86 Aligned_cols=279 Identities=23% Similarity=0.310 Sum_probs=207.5
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
....+|++.+.||+|+||+||+|.+. +..+|+|+..... .....+ ++.+|+.++++++||||+++++++..
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRN----QIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHH----HHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHH----HHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 34568999999999999999999996 5678888764332 222223 34899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCe
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 955 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrDLKP~NI 955 (1137)
.+ ..++||||+++++|.+++... ..+++..+..|+.||+.||+|||++ ||+||||||+||
T Consensus 103 ~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni 163 (360)
T 3eqc_A 103 DG--------------EISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163 (360)
T ss_dssp TT--------------EEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred CC--------------EEEEEEECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHE
Confidence 65 679999999999999999762 3689999999999999999999986 999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++........ ....||+.|+|||++.+ ..++.++|||||||++
T Consensus 164 l~~~~-------~~~kl~Dfg~~~~~~~~~~------------~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 220 (360)
T 3eqc_A 164 LVNSR-------GEIKLCDFGVSGQLIDSMA------------NSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSL 220 (360)
T ss_dssp EECTT-------CCEEECCCCCCHHHHHHC----------------CCCCTTCCHHHHTT----CCCSHHHHHHHHHHHH
T ss_pred EECCC-------CCEEEEECCCCcccccccc------------cCCCCCCCeECHHHHcC----CCCCchhhHHHHHHHH
Confidence 99987 7899999999875533211 13468999999999875 5688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCC---CCCchhHHhhhccccc----------------ccccccCCCCCCchhhhhh
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGK---RPRLTDELEALGSCHE----------------HEVAQSGSGFEKPEAELET 1096 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~---~p~l~~~l~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~ 1096 (1137)
|+|++|..||......++...+.... ....+........... ........ ........
T Consensus 221 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 297 (360)
T 3eqc_A 221 VEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP---PKLPSGVF 297 (360)
T ss_dssp HHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCC---CCCCTTTS
T ss_pred HHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC---CCCCcccc
Confidence 99999999998877666544331110 0000000000000000 00000000 00011135
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1097 LSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1097 ~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
++++.+|+.+||+.||.+|||++|+++|+|+..
T Consensus 298 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 298 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred cHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 667999999999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=369.80 Aligned_cols=294 Identities=18% Similarity=0.177 Sum_probs=207.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||+||+|.+. +..||+|+....... . .+|+.+|+.++|||||++++++....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~----~~E~~il~~l~hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------K----NRELDIMKVLDHVNIIKLVDYFYTTG 73 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------C----CHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------H----HHHHHHHHHcCCCCccchhheeeecC
Confidence 467999999999999999999984 577899875432111 1 35999999999999999999986532
Q ss_pred CCCCC-----------CC-------------CCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHH
Q 001152 879 WLPSA-----------DG-------------NPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVA 934 (1137)
Q Consensus 879 ~~~~~-----------~g-------------~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa 934 (1137)
..... .+ .........++||||++ ++|.+.+...... ...+++..++.|+.||+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLF 151 (383)
T ss_dssp ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHH
Confidence 10000 00 00012235799999998 7999888764433 35799999999999999
Q ss_pred HHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhc
Q 001152 935 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014 (1137)
Q Consensus 935 ~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1014 (1137)
.||+|||++||+||||||+|||++.+. +.+||+|||+++....... .....||+.|+|||++.
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~------~~~kl~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~ 214 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKD------NTLKLCDFGSAKKLIPSEP-----------SVAYICSRFYRAPELML 214 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTT------TEEEECCCTTCEECCTTSC-----------CCCCCCCSSCCCHHHHT
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCC------CcEEEEECCCCcccCCCCC-----------CcCcccCCCccCHHHhc
Confidence 999999999999999999999997431 7899999999976543221 12346899999999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhcc-cccccccccCCCCCCchh
Q 001152 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGS-CHEHEVAQSGSGFEKPEA 1092 (1137)
Q Consensus 1015 ~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g-~~p~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~ 1092 (1137)
+ ...++.++|||||||++|+|++|+.||.+....+....+... ..+... .+..... .............-....
T Consensus 215 ~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (383)
T 3eb0_A 215 G---ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKE-QMIRMNPHYTEVRFPTLKAKDWRKIL 290 (383)
T ss_dssp T---CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH-HHHHHCTTC--CCCCCCCCCCHHHHS
T ss_pred C---CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH-HHHHhCcccccccCCccCcccHHhhC
Confidence 5 245889999999999999999999999998877766665332 222211 1111100 000000000000000001
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1093 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1093 ~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
....++++.+|+.+||+.||.+|||+.|+++|+|+..
T Consensus 291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 1245677999999999999999999999999999963
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=377.96 Aligned_cols=298 Identities=18% Similarity=0.183 Sum_probs=194.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|.+. +..||+|+.. .........+. +.+|+.+|+.++|||||++++++.....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~--~~~~~~~~~~~----~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL--RVFEDLIDCKR----ILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEEC--STTSSHHHHHH----HHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEec--hhhcCHHHHHH----HHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 67999999999999999999875 4678888643 22223333333 4899999999999999999999865431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
......|+||||+. ++|.++++. ...+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 127 ---------~~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~ 191 (458)
T 3rp9_A 127 ---------EKFDELYVVLEIAD-SDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ 191 (458)
T ss_dssp ---------TTCCCEEEEECCCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred ---------ccCceEEEEEeccc-cchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECC
Confidence 01226899999985 899999875 356999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccc-----------------cCCCCCCCcccCCCcccchhhhccccCCCCC
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA-----------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~-----------------~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1022 (1137)
+ +.+||+|||+++............ ..........+||+.|+|||++.. ...+
T Consensus 192 ~-------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~ 261 (458)
T 3rp9_A 192 D-------CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL---QENY 261 (458)
T ss_dssp T-------CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT---CCCC
T ss_pred C-------CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC---CCCC
Confidence 7 789999999998654322110000 000011234578999999998753 2568
Q ss_pred CchhhHHHHHHHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHHHcCCCCCchhHHhh
Q 001152 1023 GLEVDIWSYGCLLLELLT-----------LQVPYMGLSE--------------------LEIHDLIQMGKRPRLTDELEA 1071 (1137)
Q Consensus 1023 s~ksDVWSLGviL~ELLT-----------G~~Pf~~~~~--------------------~el~~~I~~g~~p~l~~~l~~ 1071 (1137)
+.++|||||||++|||++ |.++|.+... .+....+...........+..
T Consensus 262 ~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~ 341 (458)
T 3rp9_A 262 TEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341 (458)
T ss_dssp CTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHT
T ss_pred CcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhh
Confidence 999999999999999999 6777765431 111222211110011111111
Q ss_pred hcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1072 LGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1072 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
........... ..............++++.+||.+||+.||.+|||++|+++|+|+..-
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 342 LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp SSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 00000000000 001111111223456789999999999999999999999999999754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=362.74 Aligned_cols=257 Identities=19% Similarity=0.311 Sum_probs=201.6
Q ss_pred CCCCceEeeeecccCceEEEEEEECC--ccE----EEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS--ADA----AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~v----AVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
...+|++.+.||+|+||+||+|++.. ..+ |+|.. .... .... ..++.+|+.++++++||||++++++
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~--~~~~-~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REAT-SPKA----NKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------C----HHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeec--cccc-CHHH----HHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 34679999999999999999999843 333 44432 2111 1112 2334889999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+.+. ..++||||+++|+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+
T Consensus 86 ~~~~---------------~~~~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~ 146 (327)
T 3poz_A 86 CLTS---------------TVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 146 (327)
T ss_dssp EESS---------------SEEEEEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EecC---------------CeEEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChh
Confidence 9864 348999999999999999762 346999999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||
T Consensus 147 NIll~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~ 207 (327)
T 3poz_A 147 NVLVKTP-------QHVKITDFGLAKLLGAEEKE--------YHAEGGKVPIKWMALESILH----RIYTHQSDVWSYGV 207 (327)
T ss_dssp GEEEEET-------TEEEECCTTHHHHHTTTCC---------------CCCGGGSCHHHHHH----CCCCHHHHHHHHHH
T ss_pred eEEECCC-------CCEEEccCcceeEccCCccc--------ccccCCCccccccChHHhcc----CCCCchhhhhhhHH
Confidence 9999987 78999999999765432211 11112357889999999986 56889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1034 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1034 iL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
++|||++ |..||.+....++...+..+.....+. .++.++.+++.+||+.||
T Consensus 208 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p 260 (327)
T 3poz_A 208 TVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMVKCWMIDA 260 (327)
T ss_dssp HHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TBCHHHHHHHHHHTCSCG
T ss_pred HHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCCh
Confidence 9999999 999999887777776666554332221 334569999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001152 1113 TERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~ 1128 (1137)
.+|||+.|+++++...
T Consensus 261 ~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 261 DSRPKFRELIIEFSKM 276 (327)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHH
Confidence 9999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.92 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=195.6
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
...+|++.+.||+|+||.||+|.+.. ..+|+|+ .... ......+ ++.+|+.++++++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~--~~~~-~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT--CKNC-TSDSVRE----KFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEE--CTTT-TSHHHHH----HHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEe--cccc-CCHHHHH----HHHHHHHHHHhCCCCccceEEEEE
Confidence 34679999999999999999999843 2355554 3322 1222223 348899999999999999999997
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+. ..++||||+++++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 86 ~~~---------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 146 (281)
T 1mp8_A 86 TEN---------------PVWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 146 (281)
T ss_dssp CSS---------------SCEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ccC---------------ccEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHH
Confidence 532 35899999999999999975 23469999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 147 il~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~ 206 (281)
T 1mp8_A 147 VLVSSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVC 206 (281)
T ss_dssp EEEEET-------TEEEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHHHHHHH
T ss_pred EEECCC-------CCEEECccccccccCccccc---------ccccCCCcccccChhhccc----CCCCCccCchHHHHH
Confidence 999987 78999999999765432211 1112357789999999975 468899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|+|++ |..||.+....+....+..+..+..+. .+++.+.+++.+||+.||.
T Consensus 207 l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~ 259 (281)
T 1mp8_A 207 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPS 259 (281)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChh
Confidence 999997 999999877777777776554332221 3455699999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001152 1114 ERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~ 1128 (1137)
+|||+.|+++++...
T Consensus 260 ~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 260 RRPRFTELKAQLSTI 274 (281)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=361.22 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=202.9
Q ss_pred CCCCceEeeeecccCceEEEEEEECC--cc----EEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS--AD----AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~----vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
...+|++.+.||+|+||+||+|.+.. .. +|+|+..... .....+. +.+|+.++++++||||++++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~---~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~ 83 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQA----VTDHMLAIGSLDHAHIVRLLGL 83 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT---SCSCBCS----CCHHHHHHHTCCCTTBCCEEEE
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc---cHHHHHH----HHHHHHHHhcCCCCCcCeEEEE
Confidence 45689999999999999999999843 33 5555432111 1111222 3679999999999999999998
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+.+. ..++||||+++|+|.+++... ...+++..+..|+.||+.||+|||++||+||||||+
T Consensus 84 ~~~~---------------~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~ 144 (325)
T 3kex_A 84 CPGS---------------SLQLVTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAAR 144 (325)
T ss_dssp ECBS---------------SEEEEEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSST
T ss_pred EcCC---------------ccEEEEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchh
Confidence 8643 468999999999999998752 246899999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||
T Consensus 145 Nil~~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~ 205 (325)
T 3kex_A 145 NVLLKSP-------SQVQVADFGVADLLPPDDKQ--------LLYSEAKTPIKWMALESIHF----GKYTHQSDVWSYGV 205 (325)
T ss_dssp TEEESSS-------SCEEECSCSGGGGSCCCTTC--------CC-----CCTTTSCHHHHHH----CCCCHHHHHHHHHH
T ss_pred eEEECCC-------CeEEECCCCcccccCccccc--------ccccCCCCcccccChHHhcc----CCCChhhHhHHhHH
Confidence 9999877 78999999999865432211 11123468889999999976 46889999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1034 LLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1034 iL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
++|+|++ |..||.+....++...+..+..+..+. .++.++.+++.+||+.||
T Consensus 206 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~dp 258 (325)
T 3kex_A 206 TVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ---------------------------ICTIDVYMVMVKCWMIDE 258 (325)
T ss_dssp HHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT---------------------------TBCTTTTHHHHHHTCSCT
T ss_pred HHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC---------------------------cCcHHHHHHHHHHcCCCh
Confidence 9999999 999999877777777776654433222 122337889999999999
Q ss_pred CCCCCHHHHHHHHHhhc
Q 001152 1113 TERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~ 1129 (1137)
.+|||+.|+++++....
T Consensus 259 ~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 259 NIRPTFKELANEFTRMA 275 (325)
T ss_dssp TTSCCHHHHHHHHHHHT
T ss_pred hhCcCHHHHHHHHHHHH
Confidence 99999999999987653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.89 Aligned_cols=276 Identities=22% Similarity=0.289 Sum_probs=198.8
Q ss_pred CCCceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~------~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
-.+|++.+.||+|+||+||+|++ .+..||+|+.... .....+. +.+|+.++++++||||+++++++
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRD----FEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHH----HHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHH----HHHHHHHHHhCCCCCEeeEEEEE
Confidence 46799999999999999999985 3567888875321 2333333 48899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
...+. ...++||||+++++|.+++... ...+++..+..|+.||+.||+|||++||+||||||+|
T Consensus 81 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N 144 (295)
T 3ugc_A 81 YSAGR------------RNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 144 (295)
T ss_dssp CHHHH------------TSCEEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ecCCC------------CceEEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhh
Confidence 65321 1469999999999999999762 2359999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||++.......... .......+|..|+|||++.+ ..++.++||||||++
T Consensus 145 il~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~ 206 (295)
T 3ugc_A 145 ILVENE-------NRVKIGDFGLTKVLPQDKEFF-------KVKEPGESPIFWYAPESLTE----SKFSVASDVWSFGVV 206 (295)
T ss_dssp EEEEET-------TEEEECCCCSCC--------------------CTTCGGGGCCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CeEEEccCcccccccCCccee-------eeccCCCCccceeCcHHhcC----CCCChHHHHHHHHHH
Confidence 999987 789999999997654322110 11123357778999999976 468899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+|++|..||.... .+....+.... ......... ...... ..... ....+++++.+++.+||+.||.+
T Consensus 207 l~~l~~g~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~----~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~dp~~ 275 (295)
T 3ugc_A 207 LYELFTYIEKSKSPP-AEFMRMIGNDK--QGQMIVFHL----IELLKN-NGRLP---RPDGCPDEIYMIMTECWNNNVNQ 275 (295)
T ss_dssp HHHHHHTTCTTCSHH-HHHHHHHCTTC--CTHHHHHHH----HHHHHT-TCCCC---CCTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHHhcccccCCCh-HHHHhhhcCcc--ccchhHHHH----HHHHhc-cCcCC---CCcCcCHHHHHHHHHHcCCChhh
Confidence 999999999986532 22222221111 100000000 000000 00000 01145677999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001152 1115 RPTAGDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~ 1129 (1137)
|||+.|+++.+....
T Consensus 276 Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 276 RPSFRDLALRVDQIR 290 (295)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHH
Confidence 999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=366.19 Aligned_cols=263 Identities=23% Similarity=0.358 Sum_probs=204.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
..+|++.+.||+|+||.||+|++. +..||||+.... ......+. +.+|+++++++ +|||||++++
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRA----LMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHHH----HHHHHHHHHhhcCCcceeeeee
Confidence 467999999999999999999852 256888875322 12333333 48999999999 6999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC-----------------------------------
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG----------------------------------- 917 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~----------------------------------- 917 (1137)
++.+.+. ..++||||+++|+|.++++......
T Consensus 94 ~~~~~~~-------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (359)
T 3vhe_A 94 ACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQ 160 (359)
T ss_dssp EECSTTS-------------CCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------
T ss_pred eeecCCC-------------ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccc
Confidence 9876441 3699999999999999997632100
Q ss_pred --------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEE
Q 001152 918 --------------------------EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971 (1137)
Q Consensus 918 --------------------------~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vK 971 (1137)
...+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-------~~~k 233 (359)
T 3vhe_A 161 SSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-------NVVK 233 (359)
T ss_dssp -----------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-------GCEE
T ss_pred cccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-------CcEE
Confidence 1228999999999999999999999999999999999999987 7899
Q ss_pred EeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 001152 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSE 1050 (1137)
Q Consensus 972 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~ 1050 (1137)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+...
T Consensus 234 l~Dfg~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 234 ICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp ECCCGGGSCTTSCTTC--------EEC--CEECGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred EEeccceeeecccccc--------hhccccCCCceeEChhhhcC----CCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 9999999765432211 01123468889999999876 568899999999999999998 9999987553
Q ss_pred -HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1051 -LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1051 -~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
..+...+..+..+..+. ..++++.+++.+||+.||.+|||+.||++|+....
T Consensus 302 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 302 DEEFCRRLKEGTRMRAPD---------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp SHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 33444444433322221 23456999999999999999999999999997653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=360.51 Aligned_cols=267 Identities=20% Similarity=0.318 Sum_probs=193.2
Q ss_pred CCCceEeeeecccCceEEEEEEECCc-----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSA-----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~-----~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..+|++.+.||+|+||+||+|++... .||+|+.... .......+. +.+|+.++++++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD--IIASSDIEE----FLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHH----HHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccc--ccCHHHHHH----HHHHHHHHHHCCCCceehhhceee
Confidence 46799999999999999999997543 5788874322 212233333 489999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
..... ......++||||+++++|.+++...... ....+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 96 ~~~~~--------~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~N 167 (323)
T 3qup_A 96 RSRAK--------GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARN 167 (323)
T ss_dssp CC---------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ccccc--------cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcce
Confidence 65421 0112359999999999999999764321 22369999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 168 Ili~~~-------~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 228 (323)
T 3qup_A 168 CMLAED-------MTVCVADFGLSRKIYSGDYY--------RQGCASKLPVKWLALESLAD----NLYTVHSDVWAFGVT 228 (323)
T ss_dssp EEECTT-------SCEEECCCCC-------------------------CCGGGCCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEeeccccccccccccc--------cccccccCcccccCchhhcC----CCCCCccchhhHHHH
Confidence 999877 78999999999765432211 11113357789999999876 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|+|++ |..||.+....++...+..+..+..+. ..++++.+++.+||+.||.
T Consensus 229 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~ 281 (323)
T 3qup_A 229 MWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP---------------------------ECMEEVYDLMYQCWSADPK 281 (323)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGG
T ss_pred HHHHHhCCCCCccccChHHHHHHHhcCCCCCCCC---------------------------ccCHHHHHHHHHHccCChh
Confidence 999999 999999887777777766554332221 3345699999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001152 1114 ERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~ 1127 (1137)
+|||+.++++.+..
T Consensus 282 ~Rps~~~l~~~l~~ 295 (323)
T 3qup_A 282 QRPSFTCLRMELEN 295 (323)
T ss_dssp GSCCHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHH
Confidence 99996555554443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=374.38 Aligned_cols=267 Identities=24% Similarity=0.255 Sum_probs=211.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|++. +..||+|+..... ...+.....+.+|+.++..++||||+++++++.+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-----MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 3568999999999999999999985 5778999854221 11111123458899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..|+||||++||+|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 134 ~--------------~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl 195 (412)
T 2vd5_A 134 N--------------YLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195 (412)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred C--------------EEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee
Confidence 5 679999999999999999762 2369999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc---CCCCCCchhhHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~s~ksDVWSLGvi 1034 (1137)
+.+ +.+||+|||+++........ .....+||+.|+|||++.... ....++.++|||||||+
T Consensus 196 d~~-------g~vkL~DFGla~~~~~~~~~---------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvi 259 (412)
T 2vd5_A 196 DRC-------GHIRLADFGSCLKLRADGTV---------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259 (412)
T ss_dssp CTT-------SCEEECCCTTCEECCTTSCE---------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHH
T ss_pred cCC-------CCEEEeechhheeccCCCcc---------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHH
Confidence 987 78999999999765432211 012347999999999987311 12457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|||++|+.||.+.+..+....+.... ...++ ......++++++||.+||. +|.
T Consensus 260 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p------------------------~~~~~~s~~~~dli~~lL~-~p~ 314 (412)
T 2vd5_A 260 AYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP------------------------LVDEGVPEEARDFIQRLLC-PPE 314 (412)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----------------------------CCCHHHHHHHHTTSS-CGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC------------------------ccccCCCHHHHHHHHHHcC-Chh
Confidence 999999999999988888777765321 00000 0011345679999999999 999
Q ss_pred CC---CCHHHHHHHHHhhcC
Q 001152 1114 ER---PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1114 ~R---PSa~EVL~~L~~~~~ 1130 (1137)
+| |+++||++|+||..-
T Consensus 315 ~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 315 TRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp GCTTTTTHHHHHTSGGGTTC
T ss_pred hcCCCCCHHHHhcCCCcCCC
Confidence 98 699999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=354.83 Aligned_cols=259 Identities=24% Similarity=0.242 Sum_probs=208.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|++. +..+|+|+...... ...+ .+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDS----SLENEIAVLKKIKHENIVTLEDIYESTT- 79 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchH----HHHHHHHHHHhCCCCCeeehhhhcccCC-
Confidence 46999999999999999999985 57789998653221 1112 2478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||++..
T Consensus 80 -------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~ 141 (304)
T 2jam_A 80 -------------HYYLVMQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLT 141 (304)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESS
T ss_pred -------------EEEEEEEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 679999999999999998762 36899999999999999999999999999999999999942
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ ...+.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 142 ~----~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 201 (304)
T 2jam_A 142 P----EENSKIMITDFGLSKMEQNGI------------MSTACGTPGYVAPEVLAQ----KPYSKAVDCWSIGVITYILL 201 (304)
T ss_dssp S----STTCCEEBCSCSTTCCCCCBT------------THHHHSCCCBCCTTTBSS----CSCCHHHHHHHHHHHHHHHH
T ss_pred C----CCCCCEEEccCCcceecCCCc------------cccccCCCCccChHHhcc----CCCCchhhHHHHHHHHHHHH
Confidence 1 112789999999886533211 113468999999999875 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||......++...+..+........ ....++++.+++.+||+.||.+|||++
T Consensus 202 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ 257 (304)
T 2jam_A 202 CGYPPFYEETESKLFEKIKEGYYEFESPF------------------------WDDISESAKDFICHLLEKDPNERYTCE 257 (304)
T ss_dssp HSSCTTTTSCHHHHHHHHHHCCCCCCTTT------------------------TTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCccc------------------------cccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999998888877777766543211100 013456699999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001152 1120 DLYEMFVARTSS 1131 (1137)
Q Consensus 1120 EVL~~L~~~~~s 1131 (1137)
|+++|+|+....
T Consensus 258 ~~l~h~~~~~~~ 269 (304)
T 2jam_A 258 KALSHPWIDGNT 269 (304)
T ss_dssp HHHTSHHHHSSC
T ss_pred HHhcCccccCCC
Confidence 999999998654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=355.12 Aligned_cols=256 Identities=28% Similarity=0.413 Sum_probs=210.9
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
-..|++.+.||+|+||.||+|.+. +..||+|+....... ...+. +.+|+.+++.++||||+++++++....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIED----IQQEITVLSQCDSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---TTHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---HHHHH----HHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 356999999999999999999874 577899986544321 12223 478999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 94 --------------~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 153 (303)
T 3a7i_A 94 --------------KLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 153 (303)
T ss_dssp --------------EEEEEEECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------eEEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC
Confidence 67999999999999999854 4699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 154 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 212 (303)
T 3a7i_A 154 EH-------GEVKLADFGVAGQLTDTQI----------KRNTFVGTPFWMAPEVIKQ----SAYDSKADIWSLGITAIEL 212 (303)
T ss_dssp TT-------SCEEECCCTTCEECBTTBC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccceecCcccc----------ccCccCCCcCccCHHHHhc----CCCCchhhhHHHHHHHHHH
Confidence 77 7899999999876543211 1123468999999999875 4678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||......+....+.....+.++. ..+..+.+++.+||+.||.+|||+
T Consensus 213 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~~Rps~ 265 (303)
T 3a7i_A 213 ARGEPPHSELHPMKVLFLIPKNNPPTLEG---------------------------NYSKPLKEFVEACLNKEPSFRPTA 265 (303)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHSCCCCCCS---------------------------SCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred ccCCCCCCCcCHHHHHHHhhcCCCCCCcc---------------------------ccCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999888777766665544332221 234559999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 001152 1119 GDLYEMFVARTSS 1131 (1137)
Q Consensus 1119 ~EVL~~L~~~~~s 1131 (1137)
.|+++|+|+....
T Consensus 266 ~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 266 KELLKHKFILRNA 278 (303)
T ss_dssp HHHTTCHHHHHHC
T ss_pred HHHhhChhhhcCC
Confidence 9999999997543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=360.14 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=212.3
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
++....+|++.+.||+|+||.||+|.+. +..+|+|+...... ......+. +.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREK----MSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHH----HHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHH----HHHHHHHHHhCCCCCCCeEEEEE
Confidence 3445678999999999999999999985 46788887643322 12233333 48899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+.+ ..++||||+++++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 111 ~~~~--------------~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 171 (335)
T 2owb_A 111 EDND--------------FVFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 171 (335)
T ss_dssp ECSS--------------EEEEEECCCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ecCC--------------eEEEEEecCCCCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchh
Confidence 8765 67999999999999999876 2468999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 172 Il~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~i 230 (335)
T 2owb_A 172 LFLNED-------LEVKIGDFGLATKVEYDGE----------RKKVLCGTPNYIAPEVLSK----KGHSFEVDVWSIGCI 230 (335)
T ss_dssp EEECTT-------CCEEECCCTTCEECCSTTC----------CBCCCCSCCSSCCHHHHHT----SCBCTHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEeeccCceecccCcc----------cccccCCCccccCHHHhcc----CCCCchhhHHHHHHH
Confidence 999977 7899999999876542211 1123468999999999875 457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+|++|+.||......+....+...... ++. ..++.+.+|+.+||+.||.+
T Consensus 231 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~li~~~l~~dp~~ 282 (335)
T 2owb_A 231 MYTLLVGKPPFETSCLKETYLRIKKNEYS-IPK---------------------------HINPVAASLIQKMLQTDPTA 282 (335)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHHTCCC-CCT---------------------------TSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHCcCCCCCCCHHHHHHHHhcCCCC-CCc---------------------------cCCHHHHHHHHHHccCChhH
Confidence 99999999999987777666665443321 110 23445899999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
|||++|+++|+|+...
T Consensus 283 Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 283 RPTINELLNDEFFTSG 298 (335)
T ss_dssp SCCGGGGGGSHHHHTS
T ss_pred CcCHHHHhcCccccCC
Confidence 9999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=356.50 Aligned_cols=251 Identities=25% Similarity=0.247 Sum_probs=195.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~ 878 (1137)
.+|++.++||+|+||+||+|++. +..||||+... ........... ..|+..+.++ +||||+++++++.+..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~----~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS--PFRGPKDRARK----LAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESS--SCCSHHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecc--cccChHHHHHH----HHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 56999999999999999999985 57788887432 22223332222 5566666555 8999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 131 --------------~~~lv~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 131 --------------ILYLQTELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191 (311)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------EEEEEEecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 679999999 68999988762 24699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|||
T Consensus 192 ~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~el 248 (311)
T 3p1a_A 192 PR-------GRCKLGDFGLLVELGTAGA-----------GEVQEGDPRYMAPELLQG-----SYGTAADVFSLGLTILEV 248 (311)
T ss_dssp GG-------GCEEECCCTTCEECC-----------------CCCCCGGGCCGGGGGT-----CCSTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccceeeeecccCCC-----------CcccCCCccccCHhHhcC-----CCCchhhHHHHHHHHHHH
Confidence 88 7899999999876543221 123469999999999864 578999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..|+.+.. ....+..+.. +.. .....++++.+++.+||+.||++|||+
T Consensus 249 ~~g~~~~~~~~---~~~~~~~~~~---~~~-----------------------~~~~~~~~l~~li~~~L~~dP~~Rpt~ 299 (311)
T 3p1a_A 249 ACNMELPHGGE---GWQQLRQGYL---PPE-----------------------FTAGLSSELRSVLVMMLEPDPKLRATA 299 (311)
T ss_dssp HHTCCCCSSHH---HHHHHTTTCC---CHH-----------------------HHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HhCCCCCCCcc---HHHHHhccCC---Ccc-----------------------cccCCCHHHHHHHHHHcCCChhhCcCH
Confidence 99977765422 2222222211 111 111455679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001152 1119 GDLYEMFVART 1129 (1137)
Q Consensus 1119 ~EVL~~L~~~~ 1129 (1137)
+|+++|+|++.
T Consensus 300 ~ell~hp~~~~ 310 (311)
T 3p1a_A 300 EALLALPVLRQ 310 (311)
T ss_dssp HHHHTSGGGSC
T ss_pred HHHHhCccccC
Confidence 99999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=363.45 Aligned_cols=285 Identities=17% Similarity=0.209 Sum_probs=205.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||.||+|.+. +..||+|+.... .......+. +.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~----~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP--FQNQTHAKR----AYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT--TSSHHHHHH----HHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc--cCChHHHHH----HHHHHHHHHhcCCCCccceEEeecccc
Confidence 468999999999999999999985 567888875432 222333333 488999999999999999999987654
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.. ......++||||++ ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 98 ~~--------~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 98 SL--------EEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 161 (371)
T ss_dssp ST--------TTCCEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cc--------ccccceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 21 11236799999997 688888753 489999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 162 ~~-------~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el 219 (371)
T 2xrw_A 162 SD-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEM 219 (371)
T ss_dssp TT-------SCEEECCCCC---------------------------CTTCCHHHHTT----CCCCTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEEeecccccccccc-----------cCCceecCCccCHHHhcC----CCCCchHhHHHHHHHHHHH
Confidence 87 7899999999975543211 123468999999999975 4688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccc-----------ccccccccCCC---CCCchhhhhhHHHHHHHH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-----------HEHEVAQSGSG---FEKPEAELETLSFLVDVF 1104 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~-----------~~~~~~~~~~~---~~~~~~~~~~~~~L~dLl 1104 (1137)
++|..||.+.+..+....+........+..+...... ........... ..........++++.+|+
T Consensus 220 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 299 (371)
T 2xrw_A 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 299 (371)
T ss_dssp HHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHH
Confidence 9999999998887777777554433322221111000 00000000000 000111223467899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1105 RRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1105 ~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
.+||+.||.+|||++|+++|+|+..
T Consensus 300 ~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 300 SKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHCcCChhhCCCHHHHhCCcchhh
Confidence 9999999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=349.66 Aligned_cols=273 Identities=25% Similarity=0.352 Sum_probs=218.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCC-CChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeE
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCG-SSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 874 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~-~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~ 874 (1137)
....+|++.+.||+|+||.||+|.+. +..||+|+....... ....+.+.....+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34678999999999999999999985 467899986544321 223344444556789999999996 99999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.... ..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 94 ~~~~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 154 (298)
T 1phk_A 94 ETNT--------------FFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 154 (298)
T ss_dssp ECSS--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ccCC--------------eEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence 8665 67999999999999999976 2468999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc--CCCCCCchhhHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVWSLG 1032 (1137)
|+++.+ +.+||+|||++........ .....||+.|+|||++.+.. ....++.++||||||
T Consensus 155 il~~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 216 (298)
T 1phk_A 155 ILLDDD-------MNIKLTDFGFSCQLDPGEK-----------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216 (298)
T ss_dssp EEECTT-------CCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred EEEcCC-------CcEEEecccchhhcCCCcc-----------cccccCCccccCHHHhccccccccccCCcccccHhHH
Confidence 999877 7899999999876543211 11346899999999986321 124578999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
+++|+|++|..||......+....+..+........ ....++.+.+++.+||+.||
T Consensus 217 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~l~~li~~~l~~dp 272 (298)
T 1phk_A 217 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE------------------------WDDYSDTVKDLVSRFLVVQP 272 (298)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT------------------------GGGSCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc------------------------ccccCHHHHHHHHHHccCCc
Confidence 999999999999998887777777655443211110 01345669999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCCC
Q 001152 1113 TERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~ss 1132 (1137)
.+|||++|+++|+|+.....
T Consensus 273 ~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 273 QKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp GGSCCHHHHTTSGGGCTTC-
T ss_pred ccCCCHHHHHhChHhhhccc
Confidence 99999999999999986543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=356.13 Aligned_cols=274 Identities=26% Similarity=0.325 Sum_probs=198.7
Q ss_pred CCCceEe-eeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEec
Q 001152 801 FPSLSSC-DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 876 (1137)
Q Consensus 801 ~~~y~l~-~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~ 876 (1137)
-..|++. +.||+|+||.||+|.+ .+..||+|+..... . ...+ ++.+|+.++.++ +||||+++++++.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~--~~~~----~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--G--HIRS----RVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--S--CCHH----HHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--c--hhHH----HHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3568885 7899999999999997 45789999864331 1 1112 347899999985 69999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ ..++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 83 ~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 143 (316)
T 2ac3_A 83 ED--------------RFYLVFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143 (316)
T ss_dssp TT--------------EEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CC--------------EEEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence 65 679999999999999999762 46899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC-CCCCCchhhHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK-PNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~s~ksDVWSLGviL 1035 (1137)
++.++ ....+||+|||++............ .........||+.|+|||++.+... ...++.++|||||||++
T Consensus 144 ~~~~~----~~~~~kl~Dfg~~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 216 (316)
T 2ac3_A 144 CEHPN----QVSPVKICDFDLGSGIKLNGDCSPI---STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216 (316)
T ss_dssp ESCSS----SSCSEEECCTTCCC----------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHH
T ss_pred EccCC----CcCceEEEEccCccccccCCccccc---cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHH
Confidence 98762 1134999999998755422111000 0011123469999999999864100 12467899999999999
Q ss_pred HHHHhCCCCCCCCCH---------------HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001152 1036 LELLTLQVPYMGLSE---------------LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1100 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~---------------~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1100 (1137)
|+|++|..||.+... ..+...+..+........ ....++++
T Consensus 217 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~ 272 (316)
T 2ac3_A 217 YILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD------------------------WAHISCAA 272 (316)
T ss_dssp HHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHH------------------------HTTSCHHH
T ss_pred HHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchh------------------------cccCCHHH
Confidence 999999999976432 223344443332111110 01345679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 001152 1101 VDVFRRCTEENPTERPTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1101 ~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ss 1132 (1137)
.+|+.+||+.||.+|||++|+++|+|+....+
T Consensus 273 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 273 KDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred HHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 99999999999999999999999999986433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=361.84 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=197.0
Q ss_pred CCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC--CCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H--pNIVkllg~~~~~~ 878 (1137)
.+|++.+.||+|+||.||+|.+. +..||+|+..... ......+. +.+|+.+|++++| |||+++++++....
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~----~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDS----YRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT--CCHHHHHH----HHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc--cchHHHHH----HHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 46999999999999999999874 4678999865432 22333334 4889999999986 99999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++|||| .+++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 83 --------------~~~lv~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~ 142 (343)
T 3dbq_A 83 --------------YIYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 142 (343)
T ss_dssp --------------EEEEEECC-CSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred --------------EEEEEEeC-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE
Confidence 67999995 57999999986 34699999999999999999999999999999999999996
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-------CCCCCCchhhHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSY 1031 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~s~ksDVWSL 1031 (1137)
. +.+||+|||+++........ .......||+.|+|||++.+.. ....++.++|||||
T Consensus 143 ~--------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diwsl 206 (343)
T 3dbq_A 143 D--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206 (343)
T ss_dssp T--------TEEEECCCSSSCCC--------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHH
T ss_pred C--------CcEEEeecccccccCccccc--------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHH
Confidence 3 57999999999765432211 1112446999999999986411 12467899999999
Q ss_pred HHHHHHHHhCCCCCCCCCH-HHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001152 1032 GCLLLELLTLQVPYMGLSE-LEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1032 GviL~ELLTG~~Pf~~~~~-~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
||++|+|++|..||..... ......+.... ...++ ...++++.+|+.+||+
T Consensus 207 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~L~ 259 (343)
T 3dbq_A 207 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---------------------------DIPEKDLQDVLKCCLK 259 (343)
T ss_dssp HHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC---------------------------CCSCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc---------------------------ccCCHHHHHHHHHHcC
Confidence 9999999999999976432 22222222211 11110 0223458999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001152 1110 ENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1110 ~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
.||.+|||+.|+++|+|+...
T Consensus 260 ~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 260 RDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp SSTTTSCCHHHHHTSHHHHSC
T ss_pred CChhHCCCHHHHHhCcccccc
Confidence 999999999999999999754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=376.24 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=209.4
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
...+|++.+.||+|+||.||+|.+.+..||||+.+... ..+. +.+|+.+|++++|||||++++++.+...
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~------~~~~----~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA------TAQA----FLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT------TSHH----HHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch------HHHH----HHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 45679999999999999999999999999999864221 1223 4889999999999999999999875431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.++++.. +...+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 261 -------------~~~iv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~ 324 (450)
T 1k9a_A 261 -------------GLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 324 (450)
T ss_dssp -------------CEEEEEECCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred -------------ceEEEEEecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC
Confidence 469999999999999999862 3345799999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++...... ....+++.|+|||++.+ ..++.++|||||||++|||+
T Consensus 325 ~-------~~~kl~DfG~a~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~el~ 380 (450)
T 1k9a_A 325 D-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIY 380 (450)
T ss_dssp T-------SCEEECCCTTCEECC-------------------CCCTTTSCHHHHHS----SCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeeCCCcccccccc-------------cCCCCCcceeCHHHhcC----CCCCcHHHHHHHHHHHHHHH
Confidence 7 789999999987433211 12247889999999975 56899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||.+....++...+..+..+..+. .+++++.+||.+||+.||.+|||+
T Consensus 381 t~g~~P~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dp~~Rpt~ 433 (450)
T 1k9a_A 381 SFGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPAVYDVMKNCWHLDAATRPTF 433 (450)
T ss_dssp TTTCCSSTTSCTTTHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhHCcCH
Confidence 8 999999877777777776654433221 345669999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
.++++.+.....
T Consensus 434 ~~l~~~L~~i~~ 445 (450)
T 1k9a_A 434 LQLREQLEHIRT 445 (450)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999877643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=351.81 Aligned_cols=265 Identities=24% Similarity=0.405 Sum_probs=196.5
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.-.+|++.++||+|+||+||+|++.+ .+|+|+.... .......+.+ .+|+.++++++||||++++++....
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~--~~~~~~~~~~----~~E~~~l~~l~h~~iv~~~~~~~~~-- 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT--APTPQQLQAF----KNEVGVLRKTRHVNILLFMGYSTAP-- 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCS--SCCHHHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEecc--CCCHHHHHHH----HHHHHHHHhCCCCcEEEEEeeccCC--
Confidence 34579999999999999999999765 4888886433 2333444444 8899999999999999999975432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 93 -------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~ 155 (289)
T 3og7_A 93 -------------QLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE 155 (289)
T ss_dssp -------------SCEEEEECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred -------------ccEEEEEecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 35999999999999999864 2356999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++......... .......||+.|+|||++... ....++.++||||||+++|+|+
T Consensus 156 ~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~el~ 219 (289)
T 3og7_A 156 D-------NTVKIGDFGLATEKSRWSGS--------HQFEQLSGSILWMAPEVIRMQ-DSNPYSFQSDVYAFGIVLYELM 219 (289)
T ss_dssp T-------TEEEECCCC--------------------------CCCTTCCHHHHC-----CCSCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEccceecccccccccc--------ccccccCCCccccCchhhccc-CCCCCCcccchHHHHHHHHHHH
Confidence 7 78999999998754432111 111234689999999998632 2356789999999999999999
Q ss_pred hCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~-~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+|+.||..... ..+...+..+........ ....+++++.+|+.+||+.||.+|||+
T Consensus 220 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~ 276 (289)
T 3og7_A 220 TGQLPYSNINNRDQIIEMVGRGSLSPDLSK-----------------------VRSNCPKRMKRLMAECLKKKRDERPSF 276 (289)
T ss_dssp HSSCTTSSCCCHHHHHHHHHHTSCCCCTTS-----------------------SCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCccccchHHHHHHHhcccccCcchhh-----------------------ccccCCHHHHHHHHHHccCChhhCCCH
Confidence 99999987544 344444444332211100 011455679999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001152 1119 GDLYEMFVART 1129 (1137)
Q Consensus 1119 ~EVL~~L~~~~ 1129 (1137)
.|+++.+....
T Consensus 277 ~ell~~L~~l~ 287 (289)
T 3og7_A 277 PRILAEIEELA 287 (289)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHHh
Confidence 99999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=373.01 Aligned_cols=262 Identities=24% Similarity=0.256 Sum_probs=194.6
Q ss_pred CCCceEe-eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHH-hCCCCCcceeeeeEec
Q 001152 801 FPSLSSC-DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG-ALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 801 ~~~y~l~-~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~-~L~HpNIVkllg~~~~ 876 (1137)
+.+|.+. +.||+|+||+||+|.+. +..||+|+.... .. +.+|+.++. ..+||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~----~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PK----ARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hh----HHHHHHHHHHhcCCCCcceEeEEEee
Confidence 5678776 78999999999999985 467899875311 11 256888874 4579999999999865
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. .....+|+||||++||+|.+++.. .+...+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 127 ~~----------~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nil 193 (400)
T 1nxk_A 127 LY----------AGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193 (400)
T ss_dssp EE----------TTEEEEEEEEECCCSEEHHHHHHC---C---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred cc----------cCCcEEEEEEEeCCCCcHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEE
Confidence 11 011267999999999999999975 22346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+. ..+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 194 l~~~~----~~~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ 254 (400)
T 1nxk_A 194 YTSKR----PNAILKLTDFGFAKETTSHNS-----------LTTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 254 (400)
T ss_dssp ESSSS----TTCCEEECCCTTCEECC----------------------CTTCCGGGSCC----CCSSSHHHHHHHHHHHH
T ss_pred EecCC----CCccEEEEecccccccCCCCc-----------cccCCCCCCccCHhhcCC----CCCCCcccHHHHHHHHH
Confidence 98631 127899999999975443211 123468999999999865 57889999999999999
Q ss_pred HHHhCCCCCCCCCHHH----HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1037 ELLTLQVPYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~e----l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
+|++|..||.+..... ....+..+....... ....+++++.+||.+||+.||
T Consensus 255 ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP 310 (400)
T 1nxk_A 255 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP------------------------EWSEVSEEVKMLIRNLLKTEP 310 (400)
T ss_dssp HHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT------------------------TTTTSCHHHHHHHHTTSCSSG
T ss_pred HHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc------------------------ccccCCHHHHHHHHHHCCCCh
Confidence 9999999997644321 223333322111000 001345679999999999999
Q ss_pred CCCCCHHHHHHHHHhhcCC
Q 001152 1113 TERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~s 1131 (1137)
.+|||+.|+++|+|+....
T Consensus 311 ~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 311 TQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp GGSCCHHHHHHSHHHHTTT
T ss_pred hHCcCHHHHhcCccccCCC
Confidence 9999999999999998643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=372.95 Aligned_cols=284 Identities=23% Similarity=0.239 Sum_probs=206.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|++. +..||||+...... . ..+|+++|+.++|||||++++++.....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~----~~~E~~il~~l~hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------F----KNRELQIMRKLDHCNIVRLRYFFYSSGE 121 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------S----CCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------h----HHHHHHHHHHcCCCCccceeeEEeccCC
Confidence 46999999999999999999984 57788887532211 1 1469999999999999999999865321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. .....+++||||++ ++|.+.+..... ....+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 122 ~--------~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~ 191 (420)
T 1j1b_A 122 K--------KDEVYLNLVLDYVP-ETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 191 (420)
T ss_dssp T--------TTEEEEEEEEECCC-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET
T ss_pred C--------CcceeEEeehhccc-ccHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC
Confidence 0 11225789999997 578777765332 2357999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+. +.+||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|||+
T Consensus 192 ~~------~~~kl~DFG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell 251 (420)
T 1j1b_A 192 DT------AVLKLCDFGSAKQLVRGEP-----------NVSYICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAELL 251 (420)
T ss_dssp TT------TEEEECCCTTCEECCTTCC-----------CCSCCSCTTSCCHHHHTT---CSSCCTHHHHHHHHHHHHHHH
T ss_pred CC------CeEEeccchhhhhcccCCC-----------ceeeeeCCCcCCHHHHcC---CCCCCchhhhHHHHHHHHHHH
Confidence 52 5789999999976543211 113468999999999875 246889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcC-CCCCchhHHhhhccc-ccccccccCCCCCCc-hhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMG-KRPRLTDELEALGSC-HEHEVAQSGSGFEKP-EAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g-~~p~l~~~l~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||.+.+..+....+... ..+. ...+...... ......+.. ..... ......++++.+|+.+||+.||.+||
T Consensus 252 ~G~~pf~~~~~~~~l~~i~~~lg~p~-~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~ 329 (420)
T 1j1b_A 252 LGQPIFPGDSGVDQLVEIIKVLGTPT-REQIREMNPNYTEFKFPQIK-AHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329 (420)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCSCC-HHHHHHHCSCCCCCCCCCCC-CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCC-HHHHHhhChhhhhhccCccC-CCCHHHhcCCCCCHHHHHHHHHhccCChhHCC
Confidence 999999988776665555332 2222 1111111000 000000000 00000 01124467899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|+.|+++|+|+..
T Consensus 330 t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 330 TPLEACAHSFFDE 342 (420)
T ss_dssp CHHHHHTSGGGGG
T ss_pred CHHHHhCCHhhcc
Confidence 9999999999964
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=344.85 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=209.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|+||.||+|.+. +..+|+|+..... ... +. +.+|+.++++++||||+++++++.+.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~---~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 76 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSE---ED----FIEEAEVMMKLSHPKLVQLYGVCLEQA- 76 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCH---HH----HHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCH---HH----HHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence 467999999999999999999984 4678898864322 111 22 378999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 77 -------------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~ 139 (267)
T 3t9t_A 77 -------------PICLVTEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 139 (267)
T ss_dssp -------------SCEEEECCCTTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG
T ss_pred -------------CeEEEEeCCCCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECC
Confidence 459999999999999999762 246899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 140 ~-------~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 199 (267)
T 3t9t_A 140 N-------QVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEVF 199 (267)
T ss_dssp G-------GCEEECCTTGGGGBCCHHHH---------STTSTTCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEccccccccccccccc---------ccccccccccccChhhhcC----CCccchhchhhhHHHHHHHh
Confidence 7 78999999998765432111 0112357889999999975 46789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||......+....+..+..+..+. ..++.+.+++.+||+.||.+|||+
T Consensus 200 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps~ 252 (267)
T 3t9t_A 200 SEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWRERPEDRPAF 252 (267)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccCCCCCCCCCHHHHHHHHhcCCcCCCCc---------------------------cCcHHHHHHHHHHccCChhhCcCH
Confidence 9 899999888887777776654322221 234458999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
.++++++.....
T Consensus 253 ~~ll~~L~~l~~ 264 (267)
T 3t9t_A 253 SRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999987643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=385.59 Aligned_cols=259 Identities=23% Similarity=0.315 Sum_probs=208.4
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
....+|++.+.||+|+||.||+|++. +..||+|+...... ........+.+|+.+|+.++|||||++++++.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh-----hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 35678999999999999999999984 57788988643211 111112234789999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ ..|+||||++||+|.+++.. .+...+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus 256 ~~--------------~l~lVmEy~~gg~L~~~l~~---~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNIL 318 (576)
T 2acx_A 256 KD--------------ALCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318 (576)
T ss_dssp SS--------------EEEEEECCCCSCBHHHHHHS---SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CC--------------EEEEEEEcCCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEE
Confidence 65 67999999999999999875 23345999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+++........ ...+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 319 ld~~-------g~vKL~DFGla~~~~~~~~~-----------~~~~GT~~Y~APEvl~~----~~~~~~~DiwSLGvily 376 (576)
T 2acx_A 319 LDDH-------GHIRISDLGLAVHVPEGQTI-----------KGRVGTVGYMAPEVVKN----ERYTFSPDWWALGCLLY 376 (576)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTCCE-----------ECCCSCGGGCCHHHHTT----CEESSHHHHHHHHHHHH
T ss_pred EeCC-------CCeEEEecccceecccCccc-----------cccCCCccccCHHHHcC----CCCCccchHHHHHHHHH
Confidence 9987 78999999999765432111 13469999999999975 46889999999999999
Q ss_pred HHHhCCCCCCCCC----HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1037 ELLTLQVPYMGLS----ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~----~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
||++|..||.+.. ..++...+..... .++ ...++++.+||.+||+.||
T Consensus 377 eLltG~~PF~~~~~~~~~~~i~~~i~~~~~-~~p---------------------------~~~s~~~~dLI~~lL~~dP 428 (576)
T 2acx_A 377 EMIAGQSPFQQRKKKIKREEVERLVKEVPE-EYS---------------------------ERFSPQARSLCSQLLCKDP 428 (576)
T ss_dssp HHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHHTCSSG
T ss_pred HHHhCCCCCcccccchhHHHHHHHhhcccc-cCC---------------------------ccCCHHHHHHHHHhccCCH
Confidence 9999999998643 3444444443221 111 1344569999999999999
Q ss_pred CCCC-----CHHHHHHHHHhhc
Q 001152 1113 TERP-----TAGDLYEMFVART 1129 (1137)
Q Consensus 1113 ~~RP-----Sa~EVL~~L~~~~ 1129 (1137)
.+|| +++||++|+|+..
T Consensus 429 ~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 429 AERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp GGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHcCCCCCCCHHHHHhChhhcc
Confidence 9999 8999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=348.40 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=206.7
Q ss_pred CCceEee-eecccCceEEEEEEE----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 802 PSLSSCD-EAGKSVSSSLFRCKF----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 802 ~~y~l~~-~LG~GsfG~Vy~a~~----~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
.+|.+.+ .||+|+||.||+|.+ .+..||+|+.... ......+. +.+|+.++++++||||+++++++..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~ 81 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEE----MMREAQIMHQLDNPYIVRLIGVCQA 81 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHH----HHHHHHHHHhCCCCCEeEEEEEecC
Confidence 4577776 999999999999986 3456888875432 12333333 4889999999999999999999843
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
. ..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 82 ~---------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 142 (287)
T 1u59_A 82 E---------------ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 142 (287)
T ss_dssp S---------------SEEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred C---------------CcEEEEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEE
Confidence 2 46999999999999999864 2346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++|||||||++|
T Consensus 143 i~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 204 (287)
T 1u59_A 143 LVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTMW 204 (287)
T ss_dssp EEET-------TEEEECCCTTCEECTTCSCEE-------CCCCSSCCCGGGCCHHHHHH----CEECHHHHHHHHHHHHH
T ss_pred EcCC-------CCEEECcccceeeeccCccee-------eccccccccccccCHHHhcc----CCCCchhhHHHHHHHHH
Confidence 9977 789999999997654322110 11123357889999999875 45789999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
+|++ |..||......++...+..+..+..+. .+++++.+++.+||+.||.+|
T Consensus 205 ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~R 257 (287)
T 1u59_A 205 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWEDR 257 (287)
T ss_dssp HHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGGS
T ss_pred HHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC---------------------------CcCHHHHHHHHHHcCCChhhC
Confidence 9998 999999888777777776655433221 344569999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001152 1116 PTAGDLYEMFVAR 1128 (1137)
Q Consensus 1116 PSa~EVL~~L~~~ 1128 (1137)
|++.+++++++..
T Consensus 258 ps~~~l~~~l~~~ 270 (287)
T 1u59_A 258 PDFLTVEQRMRAC 270 (287)
T ss_dssp CCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHH
Confidence 9999999999876
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=367.10 Aligned_cols=263 Identities=22% Similarity=0.265 Sum_probs=204.1
Q ss_pred CCCCCCceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceee
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 871 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkll 871 (1137)
...+.+|++.+.||+|+||.||+|++ .+..||+|+.............+.+ .+|+.+++.+ +||||++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~----~~E~~~l~~l~~h~~iv~~~ 125 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLH 125 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGC----CCHHHHHHHHHTCTTBCCEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHH----HHHHHHHHHccCCCceeEEE
Confidence 34567899999999999999999998 4578999986432211111112222 6699999999 599999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLK 951 (1137)
+++.... ..++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+|||||
T Consensus 126 ~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk 186 (355)
T 1vzo_A 126 YAFQTET--------------KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK 186 (355)
T ss_dssp EEEEETT--------------EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred EEEeeCc--------------eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 9998765 679999999999999999762 368999999999999999999999999999999
Q ss_pred CCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001152 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031 (1137)
Q Consensus 952 P~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1031 (1137)
|+|||++.+ +.+||+|||+++........ ......||+.|+|||++.+ ....++.++|||||
T Consensus 187 p~NIll~~~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~--~~~~~~~~~Dvwsl 248 (355)
T 1vzo_A 187 LENILLDSN-------GHVVLTDFGLSKEFVADETE---------RAYDFCGTIEYMAPDIVRG--GDSGHDKAVDWWSL 248 (355)
T ss_dssp GGGEEECTT-------SCEEESCSSEEEECCGGGGG---------GGCGGGSCCTTCCHHHHTT--CC---CTHHHHHHH
T ss_pred HHHEEECCC-------CcEEEeeCCCCeecccCCCC---------cccCcccCcCccChhhhcC--CCCCCCchhhHHHH
Confidence 999999887 78999999998765432111 0113469999999999975 22457899999999
Q ss_pred HHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001152 1032 GCLLLELLTLQVPYMGL----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1107 (1137)
Q Consensus 1032 GviL~ELLTG~~Pf~~~----~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~C 1107 (1137)
||++|+|++|..||... ....+...+..... .++ ...++.+.+|+.+|
T Consensus 249 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~~ 300 (355)
T 1vzo_A 249 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-PYP---------------------------QEMSALAKDLIQRL 300 (355)
T ss_dssp HHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-CCC---------------------------TTSCHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC-CCC---------------------------cccCHHHHHHHHHH
Confidence 99999999999999743 22333333332221 111 13345689999999
Q ss_pred cccCCCCCC-----CHHHHHHHHHhhc
Q 001152 1108 TEENPTERP-----TAGDLYEMFVART 1129 (1137)
Q Consensus 1108 L~~DP~~RP-----Sa~EVL~~L~~~~ 1129 (1137)
|+.||.+|| +++|+++|+|+..
T Consensus 301 L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 301 LMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp TCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred hhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 999999999 9999999999974
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=348.26 Aligned_cols=267 Identities=21% Similarity=0.318 Sum_probs=204.3
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 796 LDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 796 ~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
++.....+|++.+.||+|+||+||+|++. +..+|+|+............. ....++.+|+.++++++||||++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI-EKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHH-CCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHH-HHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 34445678999999999999999999984 577888875443322222211 111345889999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIK 951 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g--IIHrDLK 951 (1137)
+.+.. ++||||+++++|.+++.. ....+++..++.++.||+.||+|||++| |+|||||
T Consensus 92 ~~~~~----------------~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dik 151 (287)
T 4f0f_A 92 MHNPP----------------RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLR 151 (287)
T ss_dssp ETTTT----------------EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCS
T ss_pred ecCCC----------------eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCC
Confidence 86543 799999999999998865 2346999999999999999999999999 9999999
Q ss_pred CCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001152 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031 (1137)
Q Consensus 952 P~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1031 (1137)
|+|||++.+. ......+||+|||+++...... ....||+.|+|||++.+ ....++.++|||||
T Consensus 152 p~Nil~~~~~--~~~~~~~kl~Dfg~~~~~~~~~-------------~~~~g~~~y~aPE~~~~--~~~~~~~~~Di~sl 214 (287)
T 4f0f_A 152 SPNIFLQSLD--ENAPVCAKVADFGLSQQSVHSV-------------SGLLGNFQWMAPETIGA--EEESYTEKADTYSF 214 (287)
T ss_dssp GGGEEESCCC--TTCSCCEEECCCTTCBCCSSCE-------------ECCCCCCTTSCGGGSSC--SSCEECHHHHHHHH
T ss_pred cceEEEeccC--CCCceeEEeCCCCccccccccc-------------cccCCCccccCchhhcc--CCCCcCchhhHHHH
Confidence 9999998762 1222459999999986433211 13468999999999854 23457899999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHH--HHHHHHc-CCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001152 1032 GCLLLELLTLQVPYMGLSELE--IHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1108 (1137)
Q Consensus 1032 GviL~ELLTG~~Pf~~~~~~e--l~~~I~~-g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL 1108 (1137)
||++|+|++|..||......+ ....+.. ...+.++. .+++++.+++.+||
T Consensus 215 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l 267 (287)
T 4f0f_A 215 AMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE---------------------------DCPPRLRNVIELCW 267 (287)
T ss_dssp HHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCT---------------------------TSCHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCc---------------------------ccCHHHHHHHHHHh
Confidence 999999999999997654322 2333322 22222111 34566999999999
Q ss_pred ccCCCCCCCHHHHHHHHHh
Q 001152 1109 EENPTERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1109 ~~DP~~RPSa~EVL~~L~~ 1127 (1137)
+.||.+|||++|+++.+..
T Consensus 268 ~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 268 SGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CSSGGGSCCHHHHHHHHHT
T ss_pred cCChhhCcCHHHHHHHHHh
Confidence 9999999999999998864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=368.96 Aligned_cols=259 Identities=21% Similarity=0.345 Sum_probs=197.1
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
...+|++.+.||+|+||.||+|++. +..||+|+.... . .....+. +.+|+.++++++||||+++++++
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~-~~~~~~~----~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--Y-TEKQRRD----FLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--C-CHHHHHH----HHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--c-CHHHHHH----HHHHHHHHHhCCCCCCCeEEEEE
Confidence 3457999999999999999999874 356888874322 1 2333333 48999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+.. ..++||||+++++|.++++. ....+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 116 ~~~~--------------~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 177 (373)
T 2qol_A 116 TKSK--------------PVMIVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177 (373)
T ss_dssp CSSS--------------SCEEEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeCC--------------ceEEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence 8665 45999999999999999975 23469999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||+++......... .......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 178 Ill~~~-------~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~SlG~i 239 (373)
T 2qol_A 178 ILINSN-------LVCKVSDFGLGRVLEDDPEAA-------YTTRGGKIPIRWTSPEAIAY----RKFTSASDVWSYGIV 239 (373)
T ss_dssp EEECTT-------CCEEECCC-----------------------------CTTSCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEECcCccccccccCCccc-------eeccCCCcCCCccChhhhcc----CCcCchhcHHHHHHH
Confidence 999877 789999999997654322110 00112235778999999976 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|||++ |..||......++...+..+.....+. .++..+.+++.+||+.||.
T Consensus 240 l~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dp~ 292 (373)
T 2qol_A 240 LWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM---------------------------DCPAALYQLMLDCWQKDRN 292 (373)
T ss_dssp HHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCT---------------------------TCBHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cccHHHHHHHHHHhCcChh
Confidence 999998 999999888887777765543221111 3445699999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001152 1114 ERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~ 1128 (1137)
+||++.+|++.+...
T Consensus 293 ~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 293 NRPKFEQIVSILDKL 307 (373)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999988765
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=369.16 Aligned_cols=285 Identities=21% Similarity=0.234 Sum_probs=204.6
Q ss_pred CCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.+|++.+.||+|+||+||+|++.. ..+|+|....+... ..+|+.+++.++|||||++++++......
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------------~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------------KNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 469999999999999999999854 55777754322111 13589999999999999999998764310
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec-c
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID-L 959 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld-~ 959 (1137)
......++||||++ +++...+..... ....+++..++.|+.||+.||+|||++||+||||||+|||++ .
T Consensus 108 --------~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~ 177 (394)
T 4e7w_A 108 --------KDEVFLNLVLEYVP-ETVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP 177 (394)
T ss_dssp --------SSCEEEEEEEECCS-EEHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT
T ss_pred --------CCceEEEEEeeccC-ccHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCC
Confidence 11225789999998 455555543222 235799999999999999999999999999999999999998 4
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|||+
T Consensus 178 ~-------~~~kL~DFG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell 236 (394)
T 4e7w_A 178 S-------GVLKLIDFGSAKILIAGEP-----------NVSYICSRYYRAPELIFG---ATNYTTNIDIWSTGCVMAELM 236 (394)
T ss_dssp T-------TEEEECCCTTCEECCTTCC-----------CCSSCSCGGGCCHHHHTT---CSSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CcEEEeeCCCcccccCCCC-----------CcccccCcCccCHHHHcC---CCCCCcHHHHHHHHHHHHHHH
Confidence 5 7899999999976543211 123468999999999875 245889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhc-ccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALG-SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+|+.||.+.+..+....+...........+.... .......................++++.+|+.+||+.||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (394)
T 4e7w_A 237 QGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA 316 (394)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH
Confidence 9999999988777666653322111111111110 000000000000000000112356789999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001152 1119 GDLYEMFVART 1129 (1137)
Q Consensus 1119 ~EVL~~L~~~~ 1129 (1137)
.|+++|+|+..
T Consensus 317 ~e~l~hp~f~~ 327 (394)
T 4e7w_A 317 IEALCHPFFDE 327 (394)
T ss_dssp HHHHTSGGGST
T ss_pred HHHhcChhhhh
Confidence 99999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=371.44 Aligned_cols=298 Identities=19% Similarity=0.231 Sum_probs=201.8
Q ss_pred CCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||.||+|.+.. ..||+|+.. .........+ ++.+|+.+|+.++||||+++++++....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~--~~~~~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN--RMFEDLIDCK----RILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEC--STTTSHHHHH----HHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeC--chhcChHHHH----HHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 3679999999999999999999854 567777643 3223333333 3489999999999999999999987653
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.. .....|+||||+. ++|.++++. ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 99 ~~---------~~~~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~ 163 (432)
T 3n9x_A 99 LL---------KFDELYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN 163 (432)
T ss_dssp TT---------TCCCEEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CC---------cCCeEEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC
Confidence 11 1236799999996 799999875 34699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccc------------cCCCCCCCcccCCCcccchhhhccccCCCCCCchh
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA------------HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1026 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~------------~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ks 1026 (1137)
.+ +.+||+|||+++............ ..........+||+.|+|||++.. ...++.++
T Consensus 164 ~~-------~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~~~ 233 (432)
T 3n9x_A 164 QD-------CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL---QENYTKSI 233 (432)
T ss_dssp TT-------CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT---CSCCCTHH
T ss_pred CC-------CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc---CCCCCccc
Confidence 87 789999999998664322110000 000001234579999999999753 25689999
Q ss_pred hHHHHHHHHHHHHhCCCC-----------CCCCC-----------------HHHHHHHHH-cCCCCCchhHHhhhccccc
Q 001152 1027 DIWSYGCLLLELLTLQVP-----------YMGLS-----------------ELEIHDLIQ-MGKRPRLTDELEALGSCHE 1077 (1137)
Q Consensus 1027 DVWSLGviL~ELLTG~~P-----------f~~~~-----------------~~el~~~I~-~g~~p~l~~~l~~~~~~~~ 1077 (1137)
|||||||++|||++|..| |.+.+ ..+....+. ....|. ...+........
T Consensus 234 DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~-~~~~~~~~~~~~ 312 (432)
T 3n9x_A 234 DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT-EDDLKNINKPEV 312 (432)
T ss_dssp HHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCC-HHHHHTCCCHHH
T ss_pred ccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCC-HHHHHhccCHHH
Confidence 999999999999985444 43322 112222221 111111 111111000000
Q ss_pred ccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1078 HEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1078 ~~~~~---~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
..... ..............++++.+||.+||+.||.+|||++|+++|+|+..-
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 00000 000011111112467789999999999999999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=350.66 Aligned_cols=301 Identities=21% Similarity=0.237 Sum_probs=206.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|.+. +..||+|+.... .....+. +.+|+.++++++||||+++++++.....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKH----ALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHH----HHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHH----HHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 57999999999999999999986 567888875422 2333333 4889999999999999999999865321
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
....+..........++||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT 155 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 00000000112237899999997 799998854 46899999999999999999999999999999999999974
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
++ +.+||+|||++.......... .......+|+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 156 ~~------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 156 ED------LVLKIGDFGLARIMDPHYSHK-------GHLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp TT------TEEEECCCTTCBCC---------------CCCGGGSCCTTCCHHHHHC---TTCCCHHHHHHHHHHHHHHHH
T ss_pred CC------CeEEEccCccccccCCCcccc-------cccccccccccccCcHHhcC---cccCCchhhhHhHHHHHHHHH
Confidence 31 689999999997654321110 11123457899999999864 246889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCC--CCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGF--EKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
+|+.||.+....+....+.............................. .........++++.+++.+||+.||.+|||
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 999999988877776666443322211111111000000000000000 001111245778999999999999999999
Q ss_pred HHHHHHHHHhhcCCCC
Q 001152 1118 AGDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ss~ 1133 (1137)
++|+++|+|+......
T Consensus 300 ~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 300 AEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHTSHHHHTTCC-
T ss_pred HHHHhCCcccccccCc
Confidence 9999999999865443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=392.66 Aligned_cols=259 Identities=24% Similarity=0.292 Sum_probs=211.9
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeE
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHK 874 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~ 874 (1137)
...+.+|++.++||+|+||.||+|++.. ..||+|+....... .+.....+..|..++..+ +||||+++++++
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-----HTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-----cHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 3467899999999999999999999854 56899986533110 111112347799999988 599999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+.+ .+||||||++||+|.++++.. ..+++..++.|+.||+.||+|||++|||||||||+|
T Consensus 412 ~~~~--------------~~~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~N 472 (674)
T 3pfq_A 412 QTMD--------------RLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 472 (674)
T ss_dssp BCSS--------------EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTT
T ss_pred EeCC--------------EEEEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhh
Confidence 8765 679999999999999999862 469999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
|||+.+ +.+||+|||+++....... ......||+.|+|||++.+ ..|+.++|||||||+
T Consensus 473 ILl~~~-------g~ikL~DFGla~~~~~~~~----------~~~~~~GT~~Y~APE~l~~----~~~~~~~DvwSlGvi 531 (674)
T 3pfq_A 473 VMLDSE-------GHIKIADFGMCKENIWDGV----------TTKTFCGTPDYIAPEIIAY----QPYGKSVDWWAFGVL 531 (674)
T ss_dssp EEECSS-------SCEEECCCTTCEECCCTTC----------CBCCCCSCSSSCCHHHHTC----CCBSTHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEeecceeeccccCCc----------ccccccCCCcccCHhhhcC----CCCCccceEechHHH
Confidence 999987 7899999999975332211 1124579999999999975 578999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|||++|..||.+.+..++...|...... ++. ..++++.+||.+||+.||.+
T Consensus 532 lyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~lL~~dP~~ 583 (674)
T 3pfq_A 532 LYEMLAGQAPFEGEDEDELFQSIMEHNVA-YPK---------------------------SMSKEAVAICKGLMTKHPGK 583 (674)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHSSCCC-CCT---------------------------TSCHHHHHHHHHHSCSSSTT
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHhCCCC-CCc---------------------------cCCHHHHHHHHHHccCCHHH
Confidence 99999999999999988888888764421 111 33456999999999999999
Q ss_pred CCCH-----HHHHHHHHhhc
Q 001152 1115 RPTA-----GDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa-----~EVL~~L~~~~ 1129 (1137)
||++ +||++|+||..
T Consensus 584 R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 584 RLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp CTTCSTTHHHHHHSSGGGSS
T ss_pred CCCCCCCcHHHHhcCccccC
Confidence 9997 99999999964
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=372.58 Aligned_cols=281 Identities=21% Similarity=0.244 Sum_probs=204.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC------CCCCcceeeee
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL------RHSCIVEMYGH 873 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L------~HpNIVkllg~ 873 (1137)
.+|++.+.||+|+||+||+|.+. +..||||+.... ....+ .+.+|+.+++.+ .|+||++++++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~----~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHR----QAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHH----HHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHH----HHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 57999999999999999999985 467888875321 22222 236788888776 57799999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
+.... +.++||||+. ++|.+++... ....+++..++.|+.||+.||+|||++||+||||||+
T Consensus 168 ~~~~~--------------~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~ 229 (429)
T 3kvw_A 168 FTFRN--------------HICMTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229 (429)
T ss_dssp EEETT--------------EEEEEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGG
T ss_pred cccCC--------------eEEEEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 98765 6799999996 7999998762 2345999999999999999999999999999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.+.. ..+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||
T Consensus 230 NILl~~~~~-----~~vkL~DFG~a~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~ 287 (429)
T 3kvw_A 230 NILLKQQGR-----SGIKVIDFGSSCYEHQRV-------------YTYIQSRFYRAPEVILG----ARYGMPIDMWSLGC 287 (429)
T ss_dssp GEEESSTTS-----CCEEECCCTTCEETTCCC-------------CSSCSCGGGCCHHHHHT----BCCCTHHHHHHHHH
T ss_pred HeEEccCCC-----cceEEeecccceecCCcc-------------cccCCCCCccChHHHhC----CCCCchHHHHhHHH
Confidence 999997721 339999999986543211 13468999999999986 46899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccc----ccccc-----------------------c-cCC
Q 001152 1034 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH----EHEVA-----------------------Q-SGS 1085 (1137)
Q Consensus 1034 iL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~----~~~~~-----------------------~-~~~ 1085 (1137)
++|||++|..||.+.+..+....+...........+....... ..... . ...
T Consensus 288 il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (429)
T 3kvw_A 288 ILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGP 367 (429)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECS
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCC
Confidence 9999999999999988877666653322111111111000000 00000 0 000
Q ss_pred CCCCc---hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001152 1086 GFEKP---EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1086 ~~~~~---~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~s 1131 (1137)
..... ......++.+.+||.+||+.||++|||++|+++|+|++...
T Consensus 368 ~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 368 PESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp TTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred ccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 00000 00112356799999999999999999999999999998653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=355.69 Aligned_cols=270 Identities=24% Similarity=0.352 Sum_probs=205.4
Q ss_pred ceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
|...+.||+|+||.||+|.+.+..+|+|+.............+ ++.+|+.++++++||||+++++++.+.+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~~~~~----- 103 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ----QFDQEIKVMAKCQHENLVELLGFSSDGD----- 103 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHH----HHHHHHHHHHHCCCTTBCCEEEEECSSS-----
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHH----HHHHHHHHHHhcCCCCeEEEEEEEecCC-----
Confidence 4566899999999999999988999999865332222222223 3488999999999999999999998765
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
..++||||+++++|.+++.... ....+++..+..|+.||+.||+|||++||+||||||+||+++.+
T Consensus 104 ---------~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~--- 169 (307)
T 2nru_A 104 ---------DLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA--- 169 (307)
T ss_dssp ---------SCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---
T ss_pred ---------ceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC---
Confidence 4599999999999999997532 23469999999999999999999999999999999999999877
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1043 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~ 1043 (1137)
+.+||+|||++.......... ......||+.|+|||++.+ .++.++||||||+++|+|++|..
T Consensus 170 ----~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-----~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 170 ----FTAKISDFGLARASEKFAQTV--------MTSRIVGTTAYMAPEALRG-----EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp ----CCEEECCCTTCEECCSCSSCE--------ECSSCCSCGGGCCHHHHTT-----EECTHHHHHHHHHHHHHHHHCCC
T ss_pred ----CcEEEeecccccccccccccc--------cccccCCCcCcCChHHhcC-----CCCccchhHHHHHHHHHHHHCCC
Confidence 789999999987654322110 1123468999999999864 46799999999999999999999
Q ss_pred CCCCCCHHH----HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1044 PYMGLSELE----IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1044 Pf~~~~~~e----l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
||......+ +...+.... ..+...+. . .........++.+.+++.+||+.||.+|||+.
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----------~-----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 295 (307)
T 2nru_A 233 AVDEHREPQLLLDIKEEIEDEE-KTIEDYID-----------K-----KMNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295 (307)
T ss_dssp SBCTTBSSSBTTHHHHHHHTTS-CCHHHHSC-----------S-----SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CcccCcchHHHHHHHHHhhhhh-hhhhhhcc-----------c-----cccccchHHHHHHHHHHHHHcCCCcccCcCHH
Confidence 997643322 222222111 11111100 0 00111235677899999999999999999999
Q ss_pred HHHHHHHhhcC
Q 001152 1120 DLYEMFVARTS 1130 (1137)
Q Consensus 1120 EVL~~L~~~~~ 1130 (1137)
+|++++.....
T Consensus 296 ~l~~~L~~l~~ 306 (307)
T 2nru_A 296 KVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHHhc
Confidence 99999987654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=358.80 Aligned_cols=267 Identities=21% Similarity=0.288 Sum_probs=201.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|.+. +..||+|+...................+.+|+.++++++||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 46999999999999999999985 46788888643322111111111122358899999999999999999998643
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 88 -------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 88 -------------DYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 149 (322)
T ss_dssp -------------SEEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred -------------ceEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEec
Confidence 35999999999999998864 346999999999999999999999999999999999999986
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
++ ....+||+|||++......... ....||+.|+|||++.+. ....++.++|||||||++|+|+
T Consensus 150 ~~----~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~~l~ 213 (322)
T 2ycf_A 150 QE----EDCLIKITDFGHSKILGETSLM-----------RTLCGTPTYLAPEVLVSV-GTAGYNRAVDCWSLGVILFICL 213 (322)
T ss_dssp SS----SSCCEEECCCTTCEECCCCHHH-----------HHHHSCCTTCCHHHHHHT-TTTTCTTHHHHHHHHHHHHHHH
T ss_pred CC----CCCeEEEccCccceeccccccc-----------ccccCCcCccCchhhccC-CCCCCCchhhHHHHHHHHHHHH
Confidence 52 1246999999998765432111 123689999999998531 1246789999999999999999
Q ss_pred hCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~-~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+|..||..... ..+...+..+.....+... ...++.+.+++.+||+.||.+|||+
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~li~~~l~~dP~~Rps~ 269 (322)
T 2ycf_A 214 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVW------------------------AEVSEKALDLVKKLLVVDPKARFTT 269 (322)
T ss_dssp HSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred hCCCCCcccchHHHHHHHHHhCccccCchhh------------------------hhcCHHHHHHHHHHcccCHhhCCCH
Confidence 99999976432 2334444444332222111 1345669999999999999999999
Q ss_pred HHHHHHHHhh
Q 001152 1119 GDLYEMFVAR 1128 (1137)
Q Consensus 1119 ~EVL~~L~~~ 1128 (1137)
+|+++|+|+.
T Consensus 270 ~~~l~h~~~~ 279 (322)
T 2ycf_A 270 EEALRHPWLQ 279 (322)
T ss_dssp HHHHTSGGGC
T ss_pred HHHhhCcCcC
Confidence 9999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=355.09 Aligned_cols=260 Identities=21% Similarity=0.331 Sum_probs=203.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCc------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFGSA------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~~------~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
....+|++.+.||+|+||.||+|.+... .||+|+.... ....... .+.+|+.+++.++||||+++++
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRV----DFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHH----HHHHHHHHHHTCCCTTBCCEEE
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC---CCHHHHH----HHHHHHHHHHhCCCCCCCcEEE
Confidence 3456799999999999999999987432 3788875322 1222323 3488999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
++.... ..++||||+++++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||
T Consensus 114 ~~~~~~--------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 175 (333)
T 1mqb_A 114 VISKYK--------------PMMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175 (333)
T ss_dssp EECSSS--------------SEEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEecCC--------------CcEEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 987655 56999999999999999976 234699999999999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
+|||++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||
T Consensus 176 ~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG 237 (333)
T 1mqb_A 176 RNILVNSN-------LVCKVSDFGLSRVLEDDPEAT-------YTTSGGKIPIRWTAPEAISY----RKFTSASDVWSFG 237 (333)
T ss_dssp GGEEECTT-------CCEEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHHHHH
T ss_pred heEEECCC-------CcEEECCCCcchhhccccccc-------cccCCCCccccccCchhccc----CCCCchhhhHHHH
Confidence 99999877 789999999997654322110 01112346789999999875 5688999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001152 1033 CLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1033 viL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
|++|+|++ |..||......++...+..+..+..+. .+++.+.+++.+||+.|
T Consensus 238 ~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~ 290 (333)
T 1mqb_A 238 IVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM---------------------------DCPSAIYQLMMQCWQQE 290 (333)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCBHHHHHHHHHHTCSS
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcc---------------------------cCCHHHHHHHHHHcCCC
Confidence 99999999 999999888888877776654322211 33456999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 001152 1112 PTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~~~ 1128 (1137)
|.+||++.++++++...
T Consensus 291 p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 291 RARRPKFADIVSILDKL 307 (333)
T ss_dssp TTTSCCHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHH
Confidence 99999999999998765
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=356.27 Aligned_cols=269 Identities=24% Similarity=0.369 Sum_probs=204.7
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEec
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 876 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~ 876 (1137)
...+|++.+.||+|+||.||+|++ .+..||+|+..... . ..+. +.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~---~~~~----~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--D---EEEE----IKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--S---TTHH----HHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--c---cHHH----HHHHHHHHHhccCCCCeeeeeeEEee
Confidence 356799999999999999999998 45788999864332 1 1122 37899999999 79999999999986
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.... ......++||||+++++|.+++... ....+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 93 ~~~~--------~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl 161 (326)
T 2x7f_A 93 KNPP--------GMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 161 (326)
T ss_dssp CC----------CCCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred ccCc--------cccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEE
Confidence 4310 0112679999999999999999863 2246899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL 1035 (1137)
++.+ +.+||+|||++........ ......||+.|+|||++.... ....++.++|||||||++
T Consensus 162 ~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 224 (326)
T 2x7f_A 162 LTEN-------AEVKLVDFGVSAQLDRTVG----------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224 (326)
T ss_dssp ECTT-------CCEEECCCTTTC-----------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHH
T ss_pred EcCC-------CCEEEeeCcCceecCcCcc----------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHH
Confidence 9877 7899999999876543211 112346899999999986321 124678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|+|++|..||...........+.....+.... ...++.+.+++.+||..||.+|
T Consensus 225 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dp~~R 278 (326)
T 2x7f_A 225 IEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS--------------------------KKWSKKFQSFIESCLVKNHSQR 278 (326)
T ss_dssp HHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC--------------------------SCSCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHhCCCCCCCCcHHHHHHHhhcCccccCCc--------------------------cccCHHHHHHHHHHhccChhhC
Confidence 99999999998877766665554433222110 0334569999999999999999
Q ss_pred CCHHHHHHHHHhhcCC
Q 001152 1116 PTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~s 1131 (1137)
|+++++++|+|+....
T Consensus 279 ps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 279 PATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCHHHHHTSHHHHCCT
T ss_pred CCHHHHhhChHHhhCc
Confidence 9999999999998654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=356.21 Aligned_cols=264 Identities=25% Similarity=0.376 Sum_probs=207.3
Q ss_pred CCCCCCCCCceEeeeecccCceEEEEEEEC--CccE--EEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcce
Q 001152 795 GLDPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADA--AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVE 869 (1137)
Q Consensus 795 ~~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~v--AVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVk 869 (1137)
.++...+.+|++.+.||+|+||.||+|++. +..+ ++|+.. ... .....+ ++.+|+.+++++ +||||++
T Consensus 18 ~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~--~~~-~~~~~~----~~~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYA-SKDDHR----DFAGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEE--CC-------C----HHHHHHHHHTTCCCCTTBCC
T ss_pred ccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeec--ccc-chHHHH----HHHHHHHHHHhccCCCchhh
Confidence 466677889999999999999999999974 3434 555533 211 122222 348899999999 8999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHH
Q 001152 870 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALV 938 (1137)
Q Consensus 870 llg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-----------~~~~~ls~~~i~~I~~QIa~gL~ 938 (1137)
+++++.+.+ ..++||||+++++|.+++..... .....+++..++.|+.||+.||+
T Consensus 91 ~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 156 (327)
T 1fvr_A 91 LLGACEHRG--------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 156 (327)
T ss_dssp EEEEEEETT--------------EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHH
T ss_pred hceeeeeCC--------------ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 999998765 67999999999999999976310 11246999999999999999999
Q ss_pred HHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC
Q 001152 939 ELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1018 (1137)
Q Consensus 939 yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 1018 (1137)
|||++||+||||||+|||++.+ +.+||+|||+++....... .....+++.|+|||++.+
T Consensus 157 ~LH~~~ivH~dlkp~NIl~~~~-------~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~--- 215 (327)
T 1fvr_A 157 YLSQKQFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVK-----------KTMGRLPVRWMAIESLNY--- 215 (327)
T ss_dssp HHHHTTEECSCCSGGGEEECGG-------GCEEECCTTCEESSCEECC-----------C----CCTTTCCHHHHHH---
T ss_pred HHHhCCccCCCCccceEEEcCC-------CeEEEcccCcCcccccccc-----------ccCCCCCccccChhhhcc---
Confidence 9999999999999999999887 7899999999864332111 113357889999999875
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001152 1019 PNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1097 (1137)
Q Consensus 1019 ~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1137)
..++.++|||||||++|+|++ |..||.+....++...+..+..+..+. ..+
T Consensus 216 -~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 267 (327)
T 1fvr_A 216 -SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL---------------------------NCD 267 (327)
T ss_dssp -CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCT---------------------------TBC
T ss_pred -ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCC---------------------------CCC
Confidence 457899999999999999998 999999888777776665443222111 344
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1098 SFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1098 ~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+.+.+++.+||+.||.+|||++|+++++...
T Consensus 268 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 268 DEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 5699999999999999999999999998875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=350.51 Aligned_cols=263 Identities=20% Similarity=0.330 Sum_probs=198.6
Q ss_pred CCCCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCccee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~---------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkl 870 (1137)
...+|++.+.||+|+||+||+|.+.. ..+|+|+..... .... .++.+|+.++++++||||+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~----~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYS----ESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGH----HHHHHHHHHHHTSCCTTBCCE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHH----HHHHHHHHHHHhCCCCCEeEE
Confidence 45679999999999999999998753 348888753221 1122 335889999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Q 001152 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDI 950 (1137)
Q Consensus 871 lg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDL 950 (1137)
++++.+.+ ..++||||+++++|.+++... ...+++..++.|+.||+.||+|||++||+||||
T Consensus 78 ~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 139 (289)
T 4fvq_A 78 YGVCVCGD--------------ENILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEENTLIHGNV 139 (289)
T ss_dssp EEEECCTT--------------CCEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEEEEeCC--------------CCEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCc
Confidence 99998765 459999999999999999862 234899999999999999999999999999999
Q ss_pred CCCCeEecccccc-CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHH
Q 001152 951 KSENILIDLERKK-ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029 (1137)
Q Consensus 951 KP~NILld~~~~~-~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVW 1029 (1137)
||+|||++.+... ....+.+||+|||++....... ...||+.|+|||++.+ ...++.++|||
T Consensus 140 kp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------------~~~~~~~y~aPE~~~~---~~~~~~~~Diw 202 (289)
T 4fvq_A 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--------------ILQERIPWVPPECIEN---PKNLNLATDKW 202 (289)
T ss_dssp CGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHH--------------HHHHTTTTSCHHHHHC---GGGCCHHHHHH
T ss_pred CcceEEEecCCcccccccceeeeccCcccccccCcc--------------ccCCcCcccCHHHhCC---CCCCCchhHHH
Confidence 9999999877310 0112339999999986543221 2357889999999874 24578999999
Q ss_pred HHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001152 1030 SYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1108 (1137)
Q Consensus 1030 SLGviL~ELLTG-~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL 1108 (1137)
||||++|+|++| ..||................ .++. ..++++.+++.+||
T Consensus 203 slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~--~~~~---------------------------~~~~~l~~li~~~l 253 (289)
T 4fvq_A 203 SFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH--QLPA---------------------------PKAAELANLINNCM 253 (289)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--CCCC---------------------------CSSCTTHHHHHHHS
T ss_pred HHHHHHHHHHcCCCCCccccchHHHHHHhhccC--CCCC---------------------------CCCHHHHHHHHHHc
Confidence 999999999995 55555555444433333211 1110 11223889999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhcCCCCC
Q 001152 1109 EENPTERPTAGDLYEMFVARTSSSIS 1134 (1137)
Q Consensus 1109 ~~DP~~RPSa~EVL~~L~~~~~ss~s 1134 (1137)
+.||.+|||+.|+++++...-++..+
T Consensus 254 ~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 254 DYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp CSSGGGSCCHHHHHHHHHTCC-----
T ss_pred CCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 99999999999999999988765544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=367.02 Aligned_cols=284 Identities=19% Similarity=0.236 Sum_probs=195.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|.+. +..||+|+. ..........+. +.+|+.+++.++||||+++++++.....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~--~~~~~~~~~~~~----~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKR----TYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEEC--SSTTSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEe--CccccCHHHHHH----HHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 68999999999999999999975 466777763 332222333333 4889999999999999999999875421
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ......++||||+ +++|.++++. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 103 ~--------~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~ 167 (367)
T 2fst_X 103 L--------EEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167 (367)
T ss_dssp G--------GGCCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred c--------ccCCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC
Confidence 1 1122569999999 6999998864 36999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++...... ....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 168 ~-------~~~kL~DFG~a~~~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell 224 (367)
T 2fst_X 168 D-------CELKILDFGLARHTADEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 224 (367)
T ss_dssp T-------CCEEECC----------------------------CCCTTCCHHHHTT---CCSCCTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEeeccccccccccC-------------CCcCcCcCccChHHHcC---CcCCCchhhHHHHHHHHHHHH
Confidence 7 789999999987543211 13468999999999874 246889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||.+.+..+....+...........+............+.. ............++.+.+|+.+||+.||.+||
T Consensus 225 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~ 304 (367)
T 2fst_X 225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304 (367)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc
Confidence 999999998887776666432211111111111000000000000 01111111224567799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|++|+++|+|+..
T Consensus 305 t~~e~L~hp~~~~ 317 (367)
T 2fst_X 305 TAAQALAHAYFAQ 317 (367)
T ss_dssp CHHHHHTSGGGTT
T ss_pred CHHHHhcChhhhh
Confidence 9999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=349.41 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=198.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||+||+|.+. +..+|+|+.. . ......+. +.+|+.++++++||||+++++++.+..
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~--~--~~~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI--R--FDEETQRT----FLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEES--C--CCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEec--c--CCHHHHHH----HHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 467999999999999999999985 4667777642 1 12333333 489999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.++++. ....+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 81 --------------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~ 142 (310)
T 3s95_A 81 --------------RLNFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR 142 (310)
T ss_dssp --------------EEEEEEECCTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC
T ss_pred --------------eeEEEEEecCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC
Confidence 67999999999999999976 234699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccc----cCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA----HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~----~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
.+ +.+||+|||++............. ...........||+.|+|||++.+ ..++.++|||||||+
T Consensus 143 ~~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~ 211 (310)
T 3s95_A 143 EN-------KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING----RSYDEKVDVFSFGIV 211 (310)
T ss_dssp TT-------SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT----CCCCTHHHHHHHHHH
T ss_pred CC-------CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC----CCCCcHHHHHHHHHH
Confidence 87 789999999997654322110000 000001114579999999999975 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+|++|..||.......... ........... ....+++.+.+++.+||+.||++
T Consensus 212 l~el~~g~~~~~~~~~~~~~~------~~~~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~dP~~ 266 (310)
T 3s95_A 212 LCEIIGRVNADPDYLPRTMDF------GLNVRGFLDRY-------------------CPPNCPPSFFPITVRCCDLDPEK 266 (310)
T ss_dssp HHHHHHTCCSSTTTSCBCTTS------SBCHHHHHHHT-------------------CCTTCCTTHHHHHHHHTCSSGGG
T ss_pred HHHHhcCCCCCcchhhhHHHH------hhhhhcccccc-------------------CCCCCCHHHHHHHHHHccCChhh
Confidence 999999999986532110000 00000000000 00133445899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001152 1115 RPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~ 1128 (1137)
|||+.++++.+...
T Consensus 267 Rps~~~l~~~L~~l 280 (310)
T 3s95_A 267 RPSFVKLEHWLETL 280 (310)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999988765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=347.05 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=202.1
Q ss_pred CCCCceEeeeecccCceEEEEEEECC---c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS---A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~---~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
...+|++.+.||+|+||.||+|.+.. . .+|+|+.. ... .....+ ++.+|+.+++.++||||+++++++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK--KDC-TLDNKE----KFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECC--TTS-CHHHHH----HHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecc--ccc-CchHHH----HHHHHHHHHHhCCCCCcceEEEEE
Confidence 45689999999999999999998743 2 36777633 221 223333 348899999999999999999997
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+. ..++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 83 ~~~---------------~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 143 (281)
T 3cc6_A 83 EEE---------------PTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRN 143 (281)
T ss_dssp CSS---------------SCEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred cCC---------------CCEEEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccce
Confidence 643 238999999999999999762 2458999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
|+++.+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++||||||++
T Consensus 144 il~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 203 (281)
T 3cc6_A 144 ILVASP-------ECVKLGDFGLSRYIEDEDYY---------KASVTRLPIKWMSPESINF----RRFTTASDVWMFAVC 203 (281)
T ss_dssp EEEEET-------TEEEECCCCGGGCC------------------CCCCCGGGCCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEECCC-------CcEEeCccCCCccccccccc---------ccccCCCCcceeCchhhcc----CCCCchhccHHHHHH
Confidence 999987 78999999998765432211 1123357889999999875 468899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|+|++ |..||......+....+..+..+..+. .+++.+.+++.+||+.||.
T Consensus 204 l~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~ 256 (281)
T 3cc6_A 204 MWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD---------------------------LCPPVLYTLMTRCWDYDPS 256 (281)
T ss_dssp HHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHHHHccCCch
Confidence 999998 999998776666666665544322211 2345699999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001152 1114 ERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~ 1128 (1137)
+|||+.|+++++...
T Consensus 257 ~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 257 DRPRFTELVCSLSDV 271 (281)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.79 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=204.5
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
....+|++.+.||+|+||.||+|.+. +..||+|+..... ..+. +.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQE----IIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHH----HHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHH----HHHHHHHHHhCCCCCCccEEEEEEe
Confidence 34567999999999999999999985 5778888764321 1122 3789999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. ..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 96 ~~--------------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil 157 (314)
T 3com_A 96 NT--------------DLWIVMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL 157 (314)
T ss_dssp TT--------------EEEEEEECCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CC--------------EEEEEeecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEE
Confidence 65 679999999999999998741 246999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||+++|
T Consensus 158 ~~~~-------~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~ 216 (314)
T 3com_A 158 LNTE-------GHAKLADFGVAGQLTDTMA----------KRNTVIGTPFWMAPEVIQE----IGYNCVADIWSLGITAI 216 (314)
T ss_dssp ECTT-------CCEEECCCTTCEECBTTBS----------CBCCCCSCGGGCCHHHHSS----SCBCTTHHHHHHHHHHH
T ss_pred ECCC-------CCEEEeecccchhhhhhcc----------ccCccCCCCCccChhhcCC----CCCCccccHHHHHHHHH
Confidence 9877 7899999999876543211 1123468999999999875 46789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|++|..||...........+.....+.+.. ....++.+.+++.+||+.||.+||
T Consensus 217 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rp 271 (314)
T 3com_A 217 EMAEGKPPYADIHPMRAIFMIPTNPPPTFRK-------------------------PELWSDNFTDFVKQCLVKSPEQRA 271 (314)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHTCSCTTTSC
T ss_pred HHHhCCCCCCCCChHHHHHHHhcCCCcccCC-------------------------cccCCHHHHHHHHHHccCChhhCc
Confidence 9999999998877766555554433222110 013355699999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001152 1117 TAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~s 1131 (1137)
|+.++++|+|+....
T Consensus 272 t~~~ll~~~~~~~~~ 286 (314)
T 3com_A 272 TATQLLQHPFVRSAK 286 (314)
T ss_dssp CHHHHTTSHHHHTCC
T ss_pred CHHHHHhCHHHhcCC
Confidence 999999999998654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=357.39 Aligned_cols=261 Identities=19% Similarity=0.318 Sum_probs=200.6
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEE--ecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVR--TLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~--~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
....+|++.+.||+|+||+||+|.+. +..+++|+. ...... .....+. +.+|+.++++++||||+++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKE----ILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHH----HHHHHHHHTTCCBTTBCCCCEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHH----HHHHHHHHHhCCCCCeeEEEEEE
Confidence 34578999999999999999999984 344544332 121111 1112223 47899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
... ..++||||+++|+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 87 ~~~---------------~~~~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 147 (327)
T 3lzb_A 87 LTS---------------TVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 147 (327)
T ss_dssp ESS---------------SEEEEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ecC---------------CceEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHH
Confidence 864 358999999999999999762 3469999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 148 Il~~~~-------~~~kL~DfG~a~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~i 208 (327)
T 3lzb_A 148 VLVKTP-------QHVKITDFGLAKLLGAEEKE--------YHAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVT 208 (327)
T ss_dssp EEEEET-------TEEEECCTTC------------------------CCCGGGSCHHHHHH----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEccCcceeEccCcccc--------ccccCCCccccccCHHHHcC----CCCChHHHHHHHHHH
Confidence 999887 78999999999765432211 11112357889999999986 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|+|++ |..||.+....++...+..+.....+. .++.++.+++.+||+.||.
T Consensus 209 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~ 261 (327)
T 3lzb_A 209 VWELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMRKCWMIDAD 261 (327)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TBCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCChh
Confidence 999999 999999887777777766554332221 3345699999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001152 1114 ERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~ 1129 (1137)
+|||+.|+++.+....
T Consensus 262 ~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 262 SRPKFRELIIEFSKMA 277 (327)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHH
Confidence 9999999999987653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=353.53 Aligned_cols=262 Identities=21% Similarity=0.343 Sum_probs=209.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
..+|++.+.||+|+||.||+|.+. +..+|+|+.. .. ....... ++.+|+.+++.++||||++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~--~~-~~~~~~~----~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EA-ASMRERI----EFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECC--TT-SCHHHHH----HHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecc--cc-cCHHHHH----HHHHHHHHHHhcCCCCEeeeEEE
Confidence 357999999999999999999874 3567777643 21 1222222 34889999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----GEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHr 948 (1137)
+.+.. ..++||||+++++|.++++..... ....+++..++.|+.||+.||+|||++||+||
T Consensus 97 ~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 162 (322)
T 1p4o_A 97 VSQGQ--------------PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162 (322)
T ss_dssp ECSSS--------------SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred EccCC--------------ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 97665 459999999999999999764321 12357999999999999999999999999999
Q ss_pred cCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhH
Q 001152 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDI 1028 (1137)
Q Consensus 949 DLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDV 1028 (1137)
||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||++.+ ..++.++||
T Consensus 163 dikp~NIli~~~-------~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di 223 (322)
T 1p4o_A 163 DLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYR--------KGGKGLLPVRWMSPESLKD----GVFTTYSDV 223 (322)
T ss_dssp CCSGGGEEECTT-------CCEEECCTTCCCGGGGGGCEE--------GGGSSEECGGGCCHHHHHH----CCCCHHHHH
T ss_pred CCccceEEEcCC-------CeEEECcCccccccccccccc--------cccCCCCCCCccChhhhcc----CCCCchhhH
Confidence 999999999977 789999999987654322110 0112357889999999876 468899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001152 1029 WSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1107 (1137)
Q Consensus 1029 WSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~C 1107 (1137)
|||||++|+|++ |..||.+....++...+..+..+..+. .+++.+.+++.+|
T Consensus 224 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~ 276 (322)
T 1p4o_A 224 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD---------------------------NCPDMLFELMRMC 276 (322)
T ss_dssp HHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCC---------------------------CCCHHHHHHHHHH
Confidence 999999999999 899999888887777776554332221 3445699999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhc
Q 001152 1108 TEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1108 L~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
|+.||.+|||+.|+++++....
T Consensus 277 l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 277 WQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp TCSSGGGSCCHHHHHHHHGGGS
T ss_pred cCCCcccCcCHHHHHHHHHHhh
Confidence 9999999999999999987753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=353.03 Aligned_cols=264 Identities=21% Similarity=0.220 Sum_probs=201.3
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~ 878 (1137)
.+|++.+.||+|+||.||+|++ .+..||+|+...+... + ++.+|+.+++++ +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~----~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA------P----QLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS------C----CHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch------H----HHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 5799999999999999999996 4578999986433211 1 237799999999 8999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 79 --------------~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~ 139 (330)
T 2izr_A 79 --------------YNAMVLELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG 139 (330)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred --------------ccEEEEEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec
Confidence 679999999 89999999862 34799999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+.. .....+||+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 140 ~~~~--~~~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el 210 (330)
T 2izr_A 140 RPGN--KTQQVIHIIDFALAKEYIDPETKKH---IPYREHKSLTGTARYMSINTHLG----KEQSRRDDLEALGHMFMYF 210 (330)
T ss_dssp CGGG--TCTTSEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred cCCC--CCCceEEEEEcccceeeecCCCCcc---ccccccCCcCCCccccChHHHcC----CCCCchhHHHHHHHHHHHH
Confidence 7721 1122399999999986544321110 01111235579999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1039 LTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1039 LTG~~Pf~~~~---~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
++|..||.+.. ..+....+.....+.....+ ....+ ++.+++.+||+.||.+|
T Consensus 211 l~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~-----------------------~~~~p-~~~~li~~~l~~~p~~R 266 (330)
T 2izr_A 211 LRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL-----------------------CENFP-EMATYLRYVRRLDFFEK 266 (330)
T ss_dssp HHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHH-----------------------TTTCH-HHHHHHHHHHHCCTTCC
T ss_pred hcCCCCccccccccHHHHHHHHHhhhccCCHHHH-----------------------hccCh-HHHHHHHHHHhCCCCCC
Confidence 99999998743 33333333221111100000 01234 79999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001152 1116 PTAGDLYEMFVA 1127 (1137)
Q Consensus 1116 PSa~EVL~~L~~ 1127 (1137)
|++++|++.+..
T Consensus 267 P~~~~l~~~l~~ 278 (330)
T 2izr_A 267 PDYDYLRKLFTD 278 (330)
T ss_dssp CCHHHHHHHHHH
T ss_pred CCHHHHHHHHHH
Confidence 999999987754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=365.94 Aligned_cols=260 Identities=21% Similarity=0.316 Sum_probs=198.4
Q ss_pred CCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--CCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~--HpNIVkllg~~~~~~ 878 (1137)
.+|++.+.||+|+||.||+|.+. +..||||+..... ......+. +.+|+.+|++++ |||||++++++...+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~--~~~~~~~~----~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDS----YRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT--CCHHHHHH----HHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc--ccHHHHHH----HHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 35999999999999999999875 4678999865432 22333334 489999999997 599999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||| +.+++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 130 --------------~~~lv~E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~ 189 (390)
T 2zmd_A 130 --------------YIYMVME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 189 (390)
T ss_dssp --------------EEEEEEE-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES
T ss_pred --------------EEEEEEe-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE
Confidence 5799999 557999999986 24689999999999999999999999999999999999995
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-------CCCCCCchhhHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSY 1031 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~s~ksDVWSL 1031 (1137)
+ +.+||+|||+++........ ......+||+.|+|||++.+.. ....++.++|||||
T Consensus 190 -~-------~~~kl~DFG~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl 253 (390)
T 2zmd_A 190 -D-------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253 (390)
T ss_dssp -S-------SCEEECCCSSSCCC-----------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred -C-------CeEEEEecCccccccCCCcc--------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence 3 57999999999765432111 1112446999999999987421 11368899999999
Q ss_pred HHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCC-CchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001152 1032 GCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRP-RLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1032 GviL~ELLTG~~Pf~~~~-~~el~~~I~~g~~p-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
||++|||++|+.||.... .......+...... .++. ..++++.+|+.+||+
T Consensus 254 Gvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~li~~~L~ 306 (390)
T 2zmd_A 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD---------------------------IPEKDLQDVLKCCLK 306 (390)
T ss_dssp HHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC---------------------------CSCHHHHHHHHHHTC
T ss_pred HHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc---------------------------cchHHHHHHHHHHcc
Confidence 999999999999997643 23333333322110 0000 123458999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001152 1110 ENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1110 ~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
.||.+|||+.|+++|+|+...
T Consensus 307 ~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 307 RDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp SSTTTSCCHHHHHTSHHHHSC
T ss_pred cChhhCCCHHHHhhCcCcccc
Confidence 999999999999999999754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=359.67 Aligned_cols=289 Identities=18% Similarity=0.218 Sum_probs=211.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|.+. +..||+|+.. .. ......+ ++.+|+.++++++||||+++++++.....
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~~-~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--PF-EHQTYCQ----RTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC--CT-TCHHHHH----HHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEec--cc-cCcHHHH----HHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 47999999999999999999985 4567887643 21 1122223 34889999999999999999999876431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. .....++||||+. ++|.++++. ..+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 100 ~---------~~~~~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 163 (364)
T 3qyz_A 100 E---------QMKDVYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163 (364)
T ss_dssp T---------TCCCEEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c---------ccceEEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC
Confidence 1 1225799999997 799999875 35999999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++.......... .......||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 164 ~-------~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell 226 (364)
T 3qyz_A 164 T-------CDLKICDFGLARVADPDHDHT-------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEML 226 (364)
T ss_dssp T-------CCEEECCCTTCEECCGGGCBC-------CTTCCCCSCGGGCCHHHHHT---BCSCSTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEeCcceEecCCCCCcc-------ccccccccccCCCCCHHhcC---CCCCCcchhHHHHHHHHHHHH
Confidence 7 789999999997654322110 11123479999999998764 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccc-cccc--CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||.+....+....+...........+.......... .... .............++++.+|+.+||+.||.+||
T Consensus 227 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 306 (364)
T 3qyz_A 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306 (364)
T ss_dssp HSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred HCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC
Confidence 9999999877766666553322111111111100000000 0000 000111111224567799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|++|+++|+|+...
T Consensus 307 t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 307 EVEQALAHPYLEQY 320 (364)
T ss_dssp CHHHHHTSGGGTTT
T ss_pred CHHHHhcCcchhhc
Confidence 99999999999854
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=347.86 Aligned_cols=262 Identities=24% Similarity=0.289 Sum_probs=204.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|++.+.||+|+||.||+|.+. +..+|+|+....... ...+ .+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPE----NIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT---THHH----HHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch---hhhH----HHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 357999999999999999999985 577899886543321 1222 3478999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 79 --------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 139 (276)
T 2yex_A 79 --------------IQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139 (276)
T ss_dssp --------------EEEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------EEEEEEEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc
Confidence 66999999999999998754 34699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||.+......... .......||+.|+|||++.+. ..++.++||||||+++|+|
T Consensus 140 ~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l 201 (276)
T 2yex_A 140 ER-------DNLKISDFGLATVFRYNNRE--------RLLNKMCGTLPYVAPELLKRR---EFHAEPVDVWSCGIVLTAM 201 (276)
T ss_dssp TT-------CCEEECCCTTCEECEETTEE--------CCBCCCCSCGGGCCGGGGTCS---SBCHHHHHHHHHHHHHHHH
T ss_pred cC-------CCEEEeeCCCccccCCCcch--------hcccCCccccCccChHHHhcC---CCCCCcchHHHHHHHHHHH
Confidence 77 78999999998765432211 011234689999999998751 2347899999999999999
Q ss_pred HhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~-el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++|..||...... .....+..... ... .....++.+.+++.+||+.||.+|||
T Consensus 202 ~~g~~p~~~~~~~~~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps 255 (276)
T 2yex_A 202 LAGELPWDQPSDSCQEYSDWKEKKT-YLN-------------------------PWKKIDSAPLALLHKILVENPSARIT 255 (276)
T ss_dssp HHSSCCCSCSCTTSHHHHHHHTTCT-TST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HhCCCCCCCCchHHHHHHHhhhccc-ccC-------------------------chhhcCHHHHHHHHHHCCCCchhCCC
Confidence 9999999765432 12222222111 000 00134566899999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 001152 1118 AGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ss 1132 (1137)
++|+++|+|+.....
T Consensus 256 ~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 256 IPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHTTCTTTTCCCC
T ss_pred HHHHhcCccccChhh
Confidence 999999999986543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=352.39 Aligned_cols=277 Identities=20% Similarity=0.238 Sum_probs=203.2
Q ss_pred CCCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEe
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKI 875 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~ 875 (1137)
....+|++.+.||+|+||+||+|.+ .+..||+|+.... ..+. +.+|+.++++++ ||||+++++++.
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~----~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKK----IKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHH----HHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHH----HHHHHHHHHHcCCCCCEEEeeeeec
Confidence 3457899999999999999999987 4577888885321 1122 378999999997 999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+... ...++||||+++++|.++++. +++..+..|+.||+.||+|||++||+||||||+||
T Consensus 102 ~~~~------------~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Ni 161 (330)
T 3nsz_A 102 DPVS------------RTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNV 161 (330)
T ss_dssp CTTT------------CCEEEEEECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred cCCC------------CceEEEEeccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 6431 157999999999999998743 88999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.++ ..+||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++
T Consensus 162 l~~~~~------~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il 221 (330)
T 3nsz_A 162 MIDHEH------RKLRLIDWGLAEFYHPGQE-----------YNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCML 221 (330)
T ss_dssp EEETTT------TEEEECCCTTCEECCTTCC-----------CCSCCSCGGGCCHHHHTT---CCCCCTHHHHHHHHHHH
T ss_pred EEcCCC------CEEEEEeCCCceEcCCCCc-----------cccccccccccChhhhcC---CCcCCchhhHHHHHHHH
Confidence 998662 3799999999975543211 123468999999999864 24688999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHH-------------HcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001152 1036 LELLTLQVPYMGL-SELEIHDLI-------------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1101 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~-~~~el~~~I-------------~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1101 (1137)
|+|++|..||... ...+....+ ....... ...+........ ................++++.
T Consensus 222 ~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 297 (330)
T 3nsz_A 222 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL-DPRFNDILGRHS---RKRWERFVHSENQHLVSPEAL 297 (330)
T ss_dssp HHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC-CTHHHHHHCCCC---CCCGGGGCCTTTGGGCCHHHH
T ss_pred HHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc-ccchhhhhhhcc---ccchhhhccccccccCCHHHH
Confidence 9999999999542 332222222 1111110 000000000000 000000111111224677899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1102 DVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1102 dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+|+.+||+.||.+|||++|+++|+|+...
T Consensus 298 ~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 298 DFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 99999999999999999999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=359.34 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=205.7
Q ss_pred CceEe-eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCC
Q 001152 803 SLSSC-DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 878 (1137)
Q Consensus 803 ~y~l~-~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~ 878 (1137)
+|.+. +.||+|+||+||+|.+. +..||+|+....... ..... .+.+|+.+++.+. ||||+++++++.+..
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~----~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG--QDCRA----EILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT--EECHH----HHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHH----HHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 46776 89999999999999985 578999986543221 11222 3478999999996 799999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 103 --------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~ 165 (327)
T 3lm5_A 103 --------------EIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165 (327)
T ss_dssp --------------EEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred --------------eEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEe
Confidence 67999999999999998753 2235699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
... ..+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 166 ~~~----~~~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l 226 (327)
T 3lm5_A 166 SIY----PLGDIKIVDFGMSRKIGHACE-----------LREIMGTPEYLAPEILNY----DPITTATDMWNIGIIAYML 226 (327)
T ss_dssp CBT----TBCCEEECCGGGCEEC--------------------CCCGGGCCHHHHTT----CCCCTHHHHHHHHHHHHHH
T ss_pred cCC----CCCcEEEeeCccccccCCccc-----------cccccCCcCccCCeeecC----CCCCchhhHHHHHHHHHHH
Confidence 731 126799999999976543211 113469999999999875 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||.+....+....+........... ....++.+.+++.+||+.||.+|||+
T Consensus 227 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~ 282 (327)
T 3lm5_A 227 LTHTSPFVGEDNQETYLNISQVNVDYSEET------------------------FSSVSQLATDFIQSLLVKNPEKRPTA 282 (327)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTTT------------------------TTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HhCCCCCCCCCchHHHHHHHhcccccCchh------------------------hcccCHHHHHHHHHHcCCChhhCcCH
Confidence 999999998888777766655432211110 01345669999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001152 1119 GDLYEMFVART 1129 (1137)
Q Consensus 1119 ~EVL~~L~~~~ 1129 (1137)
+|+++|+|++.
T Consensus 283 ~~ll~h~~~~~ 293 (327)
T 3lm5_A 283 EICLSHSWLQQ 293 (327)
T ss_dssp HHHTTCGGGCC
T ss_pred HHHhCCHhhcc
Confidence 99999999964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=352.69 Aligned_cols=263 Identities=28% Similarity=0.435 Sum_probs=206.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
-.+|++.+.||+|+||.||+|.+. +..+|+|+..... ....+. +.+|+.+++.++||||+++++++....
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELED----YIVEIEILATCDHPYIVKLLGAYYHDG 89 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHH----HHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHH----HHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence 467999999999999999999996 5678888753221 112223 478999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 90 --------------~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (302)
T 2j7t_A 90 --------------KLWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 151 (302)
T ss_dssp --------------CEEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC
T ss_pred --------------eEEEEEEeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC
Confidence 569999999999999998752 24699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~E 1037 (1137)
.+ +.+||+|||++......... .....||+.|+|||++.... ....++.++||||||+++|+
T Consensus 152 ~~-------~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 214 (302)
T 2j7t_A 152 LE-------GDIRLADFGVSAKNLKTLQK----------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214 (302)
T ss_dssp TT-------SCEEECCCHHHHHHHHHHHC---------------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEECCCCccccccccc----------cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHH
Confidence 77 78999999987543221110 11346899999999985211 13567899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|..||...+.......+.....+.... ....+..+.+++.+||+.||.+|||
T Consensus 215 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rps 269 (302)
T 2j7t_A 215 MAQIEPPHHELNPMRVLLKIAKSDPPTLLT-------------------------PSKWSVEFRDFLKIALDKNPETRPS 269 (302)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCCCSS-------------------------GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HhcCCCCCccCCHHHHHHHHhccCCcccCC-------------------------ccccCHHHHHHHHHHcccChhhCCC
Confidence 999999999888777666665544332110 0134556999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001152 1118 AGDLYEMFVARTSS 1131 (1137)
Q Consensus 1118 a~EVL~~L~~~~~s 1131 (1137)
++++++|+|+....
T Consensus 270 ~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 270 AAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHTTSTTTTTCC
T ss_pred HHHHhcChHHhhhc
Confidence 99999999998643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=352.71 Aligned_cols=253 Identities=25% Similarity=0.469 Sum_probs=196.6
Q ss_pred CCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
....+|++.+.||+|+||+||+|++.+..+|+|+.. . ....+. +.+|+.++++++||||+++++++.+.
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~--~----~~~~~~----~~~E~~~l~~l~hp~iv~~~~~~~~~- 73 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE--S----ESERKA----FIVELRQLSRVNHPNIVKLYGACLNP- 73 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECS--S----TTHHHH----HHHHHHHHHHCCCTTBCCEEEBCTTT-
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEec--C----hhHHHH----HHHHHHHHhcCCCCCcCeEEEEEcCC-
Confidence 456789999999999999999999999999999742 1 122233 48899999999999999999987632
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCCCCe
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---KHIMHRDIKSENI 955 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs---~gIIHrDLKP~NI 955 (1137)
.++||||+++++|.+++... .....+++..++.++.||+.||+|||+ +||+||||||+||
T Consensus 74 ---------------~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NI 136 (307)
T 2eva_A 74 ---------------VCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136 (307)
T ss_dssp ---------------TEEEEECCTTCBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGE
T ss_pred ---------------cEEEEEcCCCCCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHE
Confidence 38999999999999999752 112357899999999999999999999 8999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+. ..+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++
T Consensus 137 ll~~~~------~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 193 (307)
T 2eva_A 137 LLVAGG------TVLKICDFGTACDIQTHM-------------TNNKGSAAWMAPEVFEG----SNYSEKCDVFSWGIIL 193 (307)
T ss_dssp EEETTT------TEEEECCCCC-------------------------CCTTSSCHHHHTC----CCCCTHHHHHHHHHHH
T ss_pred EEeCCC------CEEEEccccccccccccc-------------ccCCCCCceEChhhhCC----CCCCcHHHHHHHHHHH
Confidence 998762 248999999986543211 12358999999999875 5688999999999999
Q ss_pred HHHHhCCCCCCCCC--HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1036 LELLTLQVPYMGLS--ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~--~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
|+|++|+.||.... ...+...+..+..+.... ..++.+.+++.+||+.||.
T Consensus 194 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~ 246 (307)
T 2eva_A 194 WEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK---------------------------NLPKPIESLMTRCWSKDPS 246 (307)
T ss_dssp HHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHCCCCchhhCccHHHHHHHHhcCCCCCccc---------------------------ccCHHHHHHHHHHhcCChh
Confidence 99999999997532 233333344333322211 3445699999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001152 1114 ERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~ 1129 (1137)
+|||++|+++++....
T Consensus 247 ~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 247 QRPSMEEIVKIMTHLM 262 (307)
T ss_dssp GSCCHHHHHHHHHHHG
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999988653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=375.04 Aligned_cols=257 Identities=21% Similarity=0.370 Sum_probs=210.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|+||.||+|.+. +..||||+.+... . ..+. +.+|+.+|++++|||||++++++.. .
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~---~~~~----~~~E~~~l~~l~h~~iv~l~~~~~~-~- 255 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--M---SVEA----FLAEANVMKTLQHDKLVKLHAVVTK-E- 255 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--B---CHHH----HHHHHHHHTTCCCTTBCCEEEEECS-S-
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--c---cHHH----HHHHHHHHhhCCCCCEeeEEEEEeC-C-
Confidence 457999999999999999999996 4678998854321 1 1233 4889999999999999999999863 2
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.++++... ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 256 -------------~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~ 319 (454)
T 1qcf_A 256 -------------PIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA 319 (454)
T ss_dssp -------------SCEEEECCCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT
T ss_pred -------------ccEEEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC
Confidence 3599999999999999997532 235889999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++........ ......+|+.|+|||++.. ..++.++|||||||++|||+
T Consensus 320 ~-------~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~ 379 (454)
T 1qcf_A 320 S-------LVCKIADFGLARVIEDNEYT---------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLMEIV 379 (454)
T ss_dssp T-------CCEEECSTTGGGGBCCHHHH---------TTCSSSSCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CcEEEeeCCCceEcCCCcee---------ccCCCcccccccCHHHhcc----CCCCcHHHHHhHHHHHHHHH
Confidence 7 78999999999765432111 0112346789999999975 46889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
| |..||.+....++...+..+.....+. .+++++.+|+.+||+.||++|||+
T Consensus 380 t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dp~~RPt~ 432 (454)
T 1qcf_A 380 TYGRIPYPGMSNPEVIRALERGYRMPRPE---------------------------NCPEELYNIMMRCWKNRPEERPTF 432 (454)
T ss_dssp TTSCCSSTTCCHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhHCcCH
Confidence 9 999999988888888776654332221 345569999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 001152 1119 GDLYEMFVARTSS 1131 (1137)
Q Consensus 1119 ~EVL~~L~~~~~s 1131 (1137)
++|++.+......
T Consensus 433 ~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 433 EYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHHTSSSS
T ss_pred HHHHHHHHHHHhc
Confidence 9999999887554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=351.69 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=204.6
Q ss_pred CCCceEeeeecccCceEEEEEEE-------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~-------~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
..+|++.+.||+|+||.||+|++ .+..||+|+.... ......+. +.+|+.+++++ +||||+++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREA----LMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc---hhHHHHHH----HHHHHHHHhhcccCCCeeeEEE
Confidence 46799999999999999999986 2357888875322 12223333 48899999999 8999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------------cCCCCCCHHHHHHHHHHHHHHHHH
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------TGEKHVSVKLALFIAQDVAAALVE 939 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-------------~~~~~ls~~~i~~I~~QIa~gL~y 939 (1137)
++...+ ..++||||+++|+|.+++..... .....+++..++.++.||+.||+|
T Consensus 95 ~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 160 (313)
T 1t46_A 95 ACTIGG--------------PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160 (313)
T ss_dssp EECSSS--------------SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred EEecCC--------------CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 998765 45999999999999999986321 112358999999999999999999
Q ss_pred HHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 940 LHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
||++||+||||||+|||++.+ +.+||+|||++......... .......+|+.|+|||++.+
T Consensus 161 lH~~~i~H~dlkp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~---- 221 (313)
T 1t46_A 161 LASKNCIHRDLAARNILLTHG-------RITKICDFGLARDIKNDSNY--------VVKGNARLPVKWMAPESIFN---- 221 (313)
T ss_dssp HHHTTCCCSCCSGGGEEEETT-------TEEEECCCGGGSCTTSCTTS--------EECSSSEECGGGCCHHHHHH----
T ss_pred HHHCCeecCCCccceEEEcCC-------CCEEEccccccccccccccc--------eeccCCCCcceeeChHHhcC----
Confidence 999999999999999999877 78999999998765443211 01123357789999999876
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001152 1020 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1097 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~e-l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1137)
..++.++|||||||++|+|++ |..||.+..... ....+..+..+..+ ...+
T Consensus 222 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 274 (313)
T 1t46_A 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP---------------------------EHAP 274 (313)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC---------------------------TTSC
T ss_pred CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCc---------------------------ccCC
Confidence 468899999999999999999 999998755433 33333333221111 0344
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1098 SFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1098 ~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+.+.+++.+||+.||.+|||+.|+++++.....
T Consensus 275 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 275 AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 569999999999999999999999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=358.68 Aligned_cols=264 Identities=25% Similarity=0.340 Sum_probs=203.1
Q ss_pred CCCCceEeeeecccCceEEEEEEE-------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKF-------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 871 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~-------~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkll 871 (1137)
...+|++.+.||+|+||.||+|++ .+..||+|+..... ..... .++.+|+.+++++ +||||++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~----~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSER----EALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------C----HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHH----HHHHHHHHHHHhhcCCCCeeeEE
Confidence 346799999999999999999997 22468888754221 11222 2348899999999 899999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------------------CCCCCCHHHHHHHHHHH
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------GEKHVSVKLALFIAQDV 933 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~------------------~~~~ls~~~i~~I~~QI 933 (1137)
+++...+ ..++||||+++|+|.+++...... ....+++..++.|+.||
T Consensus 116 ~~~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 116 GACTLSG--------------PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp EEECSSS--------------SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred EEEeeCC--------------ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 9998765 459999999999999999763211 01348999999999999
Q ss_pred HHHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhh
Q 001152 934 AAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVL 1013 (1137)
Q Consensus 934 a~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 1013 (1137)
+.||+|||++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||++
T Consensus 182 ~~aL~~LH~~~ivH~Dikp~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~t~~y~aPE~~ 246 (344)
T 1rjb_A 182 AKGMEFLEFKSCVHRDLAARNVLVTHG-------KVVKICDFGLARDIMSDSNYV--------VRGNARLPVKWMAPESL 246 (344)
T ss_dssp HHHHHHHHHTTEEETTCSGGGEEEETT-------TEEEECCCGGGSCGGGCTTSE--------EETTEEECGGGCCHHHH
T ss_pred HHHHHHHHhCCcccCCCChhhEEEcCC-------CcEEeCCCccCcccccCccce--------eccCccCccCccCHHHh
Confidence 999999999999999999999999977 789999999997654322110 11234578899999998
Q ss_pred ccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCch
Q 001152 1014 RAMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1091 (1137)
Q Consensus 1014 ~~~~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~e-l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 1091 (1137)
.+ ..++.++|||||||++|+|+| |..||.+..... ....+..+..+..+.
T Consensus 247 ~~----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------ 298 (344)
T 1rjb_A 247 FE----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF------------------------ 298 (344)
T ss_dssp HH----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCT------------------------
T ss_pred cc----CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCC------------------------
Confidence 76 468899999999999999998 999998765433 333334333222111
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1092 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1092 ~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
..++++.+|+.+||+.||.+|||+.||+++++....
T Consensus 299 ---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 299 ---YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 334569999999999999999999999999988754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=379.57 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=209.5
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
....+|++.+.||+|+||.||+|++. +..+|+|+...... ........+.+|+.++++++||||+++++++.+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-----KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh-----hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence 45678999999999999999999984 57789988643211 111112345789999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.. ..|+||||++||+|.+++..... ....+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus 257 ~~--------------~l~lVmE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NIL 321 (543)
T 3c4z_A 257 KT--------------DLCLVMTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL 321 (543)
T ss_dssp SS--------------EEEEEECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CC--------------EEEEEEEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEE
Confidence 65 67999999999999999875321 2346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 322 l~~~-------g~vkL~DFGla~~~~~~~~----------~~~~~~GT~~Y~APE~l~~----~~~~~~~DiwSlGvily 380 (543)
T 3c4z_A 322 LDDD-------GNVRISDLGLAVELKAGQT----------KTKGYAGTPGFMAPELLLG----EEYDFSVDYFALGVTLY 380 (543)
T ss_dssp ECTT-------SCEEECCCTTCEECCTTCC----------CBCCCCSCTTTSCHHHHTT----CCBCTHHHHHHHHHHHH
T ss_pred EeCC-------CCEEEeecceeeeccCCCc----------ccccccCCccccChhhhcC----CCCChHHhcCcchHHHH
Confidence 9987 7899999999976543211 1123479999999999975 56889999999999999
Q ss_pred HHHhCCCCCCCC----CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1037 ELLTLQVPYMGL----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1037 ELLTG~~Pf~~~----~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
||++|..||.+. ...++...+...... ++. ..++++.+|+.+||+.||
T Consensus 381 elltG~~PF~~~~~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~lL~~dP 432 (543)
T 3c4z_A 381 EMIAARGPFRARGEKVENKELKQRVLEQAVT-YPD---------------------------KFSPASKDFCEALLQKDP 432 (543)
T ss_dssp HHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHSCSSG
T ss_pred HHHhCCCCCCCCccchhHHHHHHHHhhcccC-CCc---------------------------ccCHHHHHHHHHhccCCH
Confidence 999999999764 334455555433211 110 344569999999999999
Q ss_pred CCCCC-----HHHHHHHHHhhc
Q 001152 1113 TERPT-----AGDLYEMFVART 1129 (1137)
Q Consensus 1113 ~~RPS-----a~EVL~~L~~~~ 1129 (1137)
.+||+ +++|++|+|+..
T Consensus 433 ~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 433 EKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp GGSCCCBTTBSHHHHTSGGGTT
T ss_pred hHCCCCcccCHHHHHcCccccC
Confidence 99995 589999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=354.14 Aligned_cols=297 Identities=19% Similarity=0.213 Sum_probs=208.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.+.||+|+||.||+|++. +..||+|+.. .. ....... ++.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~-~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PF-DKPLFAL----RTLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC--CC-SSHHHHH----HHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeec--cc-ccchHHH----HHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 468999999999999999999986 5678888753 21 1222222 3478999999999999999999876542
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
+. .....++||||+. ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 83 ~~---------~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~ 146 (353)
T 2b9h_A 83 FE---------NFNEVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146 (353)
T ss_dssp ST---------TCCCEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cC---------ccceEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc
Confidence 11 1226799999997 799999875 3699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++........................||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 147 ~~-------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l 216 (353)
T 2b9h_A 147 SN-------CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT---SAKYSRAMDVWSCGCILAEL 216 (353)
T ss_dssp TT-------CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS---CCCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc---CCCccchhhHHHHHHHHHHH
Confidence 77 789999999998655322111000000011123468999999998764 25688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHc-CCCCCchhHHhhhcccc-cccccccC--CCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCH-EHEVAQSG--SGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~-g~~p~l~~~l~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
++|..||.+.+..+....+.. ...+............. ........ ............++++.+|+.+||+.||.+
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 296 (353)
T 2b9h_A 217 FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296 (353)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGG
T ss_pred HhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCccc
Confidence 999999998877665554422 11111110000000000 00000000 000001111256678999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
|||++|+++|+|+...
T Consensus 297 Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 297 RITAKEALEHPYLQTY 312 (353)
T ss_dssp SCCHHHHHTSGGGTTT
T ss_pred CCCHHHHhcCcccccc
Confidence 9999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=350.81 Aligned_cols=285 Identities=20% Similarity=0.222 Sum_probs=207.1
Q ss_pred CCCceEeeeecccCceEEEEEEE---CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCC------Ccceee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF---GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS------CIVEMY 871 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~---~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~Hp------NIVkll 871 (1137)
..+|++.+.||+|+||+||+|.+ .+..||+|+.... ....+ .+.+|+.+++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~----~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCE----AARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHH----HHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhH----HHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 36899999999999999999987 3567899885321 22222 347899999888765 499999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLK 951 (1137)
+++...+ +.++||||+ +++|.+++.. .+...+++..+..|+.||+.||+|||++||+|||||
T Consensus 84 ~~~~~~~--------------~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 145 (339)
T 1z57_A 84 EWFEHHG--------------HICIVFELL-GLSTYDFIKE---NGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLK 145 (339)
T ss_dssp EEEEETT--------------EEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred cccccCC--------------cEEEEEcCC-CCCHHHHHHh---cCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 9998765 679999999 7999999976 233468999999999999999999999999999999
Q ss_pred CCCeEecccccc------------CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 952 SENILIDLERKK------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 952 P~NILld~~~~~------------~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
|+|||++.+... ....+.+||+|||++...... .....||+.|+|||++.+
T Consensus 146 p~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------~~~~~gt~~y~aPE~~~~---- 208 (339)
T 1z57_A 146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-------------HSTLVSTRHYRAPEVILA---- 208 (339)
T ss_dssp GGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-------------CCSSCSCGGGCCHHHHTT----
T ss_pred HHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-------------cccccCCccccChHHhhC----
Confidence 999999864100 000267999999998753321 113468999999999875
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc---cc------------ccccC
Q 001152 1020 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE---HE------------VAQSG 1084 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~---~~------------~~~~~ 1084 (1137)
..++.++|||||||++|||++|..||...+..+....+.....+.....+........ .. .....
T Consensus 209 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (339)
T 1z57_A 209 LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC 288 (339)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC
Confidence 4688999999999999999999999998877766555533222211111111000000 00 00000
Q ss_pred CCC-CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1085 SGF-EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1085 ~~~-~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
... .........++++.+|+.+||+.||.+|||++|+++|+|+..
T Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred cchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 000 000011245678999999999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.06 Aligned_cols=264 Identities=22% Similarity=0.331 Sum_probs=202.0
Q ss_pred CCCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~---~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
..+|++.+.||+|+||+||+|++.. ..++++++..... ......+. +.+|+.++++++||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQ----FLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHH----HHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHH----HHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 4568999999999999999999742 3333343333332 22333333 48899999999999999999986543
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+. ..++||||+++++|.++++. ....+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 99 ~~-------------~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~ 161 (298)
T 3f66_A 99 EG-------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML 161 (298)
T ss_dssp SS-------------CCEEEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CC-------------ceEEEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE
Confidence 31 45999999999999999965 23468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++.......... ........+|+.|+|||.+.+ ..++.++||||||+++|+
T Consensus 162 ~~~-------~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 224 (298)
T 3f66_A 162 DEK-------FTVKVADFGLARDMYDKEYYS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWE 224 (298)
T ss_dssp CTT-------CCEEECSCGGGCCCSCGGGCB------C-----CCBCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred CCC-------CCEEECcccccccccccchhc------cccccCCCCCccccChHHhcC----CCCChHHHHHHHHHHHHH
Confidence 877 789999999997654322111 011123457889999999976 568899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++ +.+||......+....+..+..+..+. ..++.+.+++.+||+.||.+||
T Consensus 225 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 277 (298)
T 3f66_A 225 LMTRGAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAEMRP 277 (298)
T ss_dssp HHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCccCCHHHHHHHHhcCCCCCCCc---------------------------cCCHHHHHHHHHHcCCChhhCc
Confidence 999 677777766666666665544332221 2345699999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
|+.|+++.+.....
T Consensus 278 s~~ell~~L~~~~~ 291 (298)
T 3f66_A 278 SFSELVSRISAIFS 291 (298)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHH
Confidence 99999999887643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.96 Aligned_cols=267 Identities=25% Similarity=0.417 Sum_probs=200.6
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
....+.+|++.+.||+|+||.||+|.+. +..+|+|+...... ......+. +.+|+.++++++||||+++++++
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARAD----CIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHH----HHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHH----HHHHHHHHHhCCCCCEeeEEEEE
Confidence 3456788999999999999999999974 57788887643221 22333333 48899999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
...+ ..++||||+++++|.+++...... ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 102 ~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~N 166 (310)
T 2wqm_A 102 IEDN--------------ELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166 (310)
T ss_dssp EETT--------------EEEEEEECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred EcCC--------------cEEEEEecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHH
Confidence 8765 679999999999999999764332 3569999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
|+++.+ +.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||++
T Consensus 167 Il~~~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~i 225 (310)
T 2wqm_A 167 VFITAT-------GVVKLGDLGLGRFFSSKTT----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCL 225 (310)
T ss_dssp EEECTT-------SCEEECCC----------------------------CCSSCCHHHHTT----CCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEEeccceeeecCCCc----------cccccCCCeeEeChHHhCC----CCCCchhhHHHHHHH
Confidence 999877 7899999999875543211 1113468999999999875 568899999999999
Q ss_pred HHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1035 LLELLTLQVPYMGL--SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~--~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
+|+|++|..||.+. ....+...+.....+.... ...++++.+++.+||+.||
T Consensus 226 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dp 279 (310)
T 2wqm_A 226 LYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS--------------------------DHYSEELRQLVNMCINPDP 279 (310)
T ss_dssp HHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCT--------------------------TTSCHHHHHHHHHHTCSSG
T ss_pred HHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcc--------------------------cccCHHHHHHHHHHcCCCh
Confidence 99999999999753 3344445554433322110 1345569999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001152 1113 TERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~ 1130 (1137)
.+|||+.+|++++.....
T Consensus 280 ~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 280 EKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHHHH
Confidence 999999999999887644
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=355.26 Aligned_cols=261 Identities=22% Similarity=0.367 Sum_probs=208.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 870 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~---------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkl 870 (1137)
..+|++.+.||+|+||.||+|++. +..||+|+.... ......+. +.+|+.+++++ +||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD----LVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC---CcHHHHHH----HHHHHHHHHHhhcCCCEeeE
Confidence 467999999999999999999974 245888874322 12333333 48899999999 89999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHH
Q 001152 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVE 939 (1137)
Q Consensus 871 lg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------~~~~ls~~~i~~I~~QIa~gL~y 939 (1137)
++++.+.+ ..++||||+++++|.+++...... ....+++..++.|+.||+.||+|
T Consensus 107 ~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 172 (334)
T 2pvf_A 107 LGACTQDG--------------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172 (334)
T ss_dssp EEEECSSS--------------CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEccCC--------------ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 99998765 459999999999999999863211 12358999999999999999999
Q ss_pred HHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 940 LHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
||++||+||||||+|||++.+ +.+||+|||++.......... ......+|+.|+|||++.+
T Consensus 173 LH~~~ivH~Dlkp~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---- 233 (334)
T 2pvf_A 173 LASQKCIHRDLAARNVLVTEN-------NVMKIADFGLARDINNIDYYK--------KTTNGRLPVKWMAPEALFD---- 233 (334)
T ss_dssp HHHTTEECSCCSGGGEEECTT-------CCEEECCCTTCEECTTTSSEE--------CCSCCCCCGGGCCHHHHHH----
T ss_pred HHhCCeeCCCCccceEEEcCC-------CCEEEcccccccccccccccc--------ccCCCCcccceeChHHhcC----
Confidence 999999999999999999877 789999999997654322110 1112357889999999876
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001152 1020 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1098 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1137)
..++.++|||||||++|+|++ |..||.+....++...+..+..+..+. .+++
T Consensus 234 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 286 (334)
T 2pvf_A 234 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA---------------------------NCTN 286 (334)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT---------------------------TCCH
T ss_pred CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCc---------------------------cCCH
Confidence 457899999999999999999 999999888888777776654332221 3345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1099 FLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1099 ~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
++.+++.+||+.||.+|||+.|+++++...
T Consensus 287 ~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 699999999999999999999999998865
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=357.01 Aligned_cols=293 Identities=19% Similarity=0.180 Sum_probs=200.6
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
..+.+|++.+.||+|+||+||+|++. +..||+|+........ . +..+|+..++.++||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~----~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-----N----RELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-----C----HHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-----H----HHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 34688999999999999999999985 5678888753322111 1 12567788889999999999999876
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCCCC
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDIKSEN 954 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLH--s~gIIHrDLKP~N 954 (1137)
.... .......++||||++ ++|...+..... ....+++..+..++.||+.||.||| ++||+||||||+|
T Consensus 91 ~~~~-------~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~N 161 (360)
T 3e3p_A 91 LGER-------DRRDIYLNVVMEYVP-DTLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN 161 (360)
T ss_dssp ECSS-------CTTCEEEEEEEECCS-CBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGG
T ss_pred cccc-------cccceeEEEEeeccc-ccHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHH
Confidence 4310 011225789999998 577666654332 2357899999999999999999999 9999999999999
Q ss_pred eEecc-ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 955 ILIDL-ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 955 ILld~-~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
||++. + +.+||+|||++........ .....||+.|+|||++.+ ...++.++|||||||
T Consensus 162 Ill~~~~-------~~~kl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~ 220 (360)
T 3e3p_A 162 VLVNEAD-------GTLKLCDFGSAKKLSPSEP-----------NVAYICSRYYRAPELIFG---NQHYTTAVDIWSVGC 220 (360)
T ss_dssp EEEETTT-------TEEEECCCTTCBCCCTTSC-----------CCSTTSCGGGCCHHHHTT---CSSCCTHHHHHHHHH
T ss_pred EEEeCCC-------CcEEEeeCCCceecCCCCC-----------cccccCCcceeCHHHHcC---CCCCCcHHHHHHHHH
Confidence 99986 4 7899999999976543221 123468999999999864 245789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCC----chhhhhhHHHHHHHHHHhcc
Q 001152 1034 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEK----PEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1034 iL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
++|+|++|..||.+.+..+....+...........+.................... +......++++.+|+.+||+
T Consensus 221 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 300 (360)
T 3e3p_A 221 IFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300 (360)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTC
T ss_pred HHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhc
Confidence 99999999999999888777666643222221111111100000000000000000 01111357789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcC
Q 001152 1110 ENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1110 ~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
.||.+|||+.|+++|+|+...
T Consensus 301 ~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 301 YLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGGGG
T ss_pred cCccccCCHHHHhcCcccccc
Confidence 999999999999999999854
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=355.13 Aligned_cols=270 Identities=21% Similarity=0.347 Sum_probs=210.0
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcc
Q 001152 796 LDPGSFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV 868 (1137)
Q Consensus 796 ~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIV 868 (1137)
+......+|++.+.||+|+||.||+|++. +..||+|+.. .. ........ +.+|+.++++++||||+
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~--~~-~~~~~~~~----~~~E~~~l~~l~h~~iv 96 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EV-CSEQDELD----FLMEALIISKFNHQNIV 96 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECC--SS-CCHHHHHH----HHHHHHHHHHCCCTTBC
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEec--cc-cchhhHHH----HHHHHHHHhhCCCCCCC
Confidence 44455678999999999999999999853 3468888743 21 12333333 48899999999999999
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Q 001152 869 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET--GEKHVSVKLALFIAQDVAAALVELHSKHIM 946 (1137)
Q Consensus 869 kllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~--~~~~ls~~~i~~I~~QIa~gL~yLHs~gII 946 (1137)
++++++.... ..++||||+++++|.+++...... ....+++..++.++.||+.||.|||++||+
T Consensus 97 ~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~ 162 (327)
T 2yfx_A 97 RCIGVSLQSL--------------PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFI 162 (327)
T ss_dssp CEEEEECSSS--------------SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred eEEEEEcCCC--------------CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCee
Confidence 9999998765 459999999999999999873221 114589999999999999999999999999
Q ss_pred eccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchh
Q 001152 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEV 1026 (1137)
Q Consensus 947 HrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ks 1026 (1137)
||||||+|||++.++ ....+||+|||++......... .......+|+.|+|||++.+ ..++.++
T Consensus 163 H~dlkp~NIli~~~~----~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~ 226 (327)
T 2yfx_A 163 HRDIAARNCLLTCPG----PGRVAKIGDFGMARDIYRASYY--------RKGGCAMLPVKWMPPEAFME----GIFTSKT 226 (327)
T ss_dssp CSCCCGGGEEESCSS----TTCCEEECCCHHHHHHHC--------------CCGGGSCGGGCCHHHHHH----CCCCHHH
T ss_pred cCcCCHhHEEEecCC----CcceEEECcccccccccccccc--------ccCCCcCCCcceeCHhHhcC----CCCCchh
Confidence 999999999998541 1256999999998754332211 11123468899999999876 4688999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHH
Q 001152 1027 DIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1105 (1137)
Q Consensus 1027 DVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~ 1105 (1137)
|||||||++|+|++ |..||......++...+..+..+..+. .+++.+.+++.
T Consensus 227 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~ 279 (327)
T 2yfx_A 227 DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK---------------------------NCPGPVYRIMT 279 (327)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCC---------------------------CCCHHHHHHHH
Confidence 99999999999998 999999888887777776655433221 33456999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1106 RCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1106 ~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+||+.||.+||++.+|++++|...
T Consensus 280 ~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 280 QCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=362.95 Aligned_cols=255 Identities=22% Similarity=0.230 Sum_probs=199.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|.+. +..||+|+..................++.+|+.++++++||||+++++++.+.+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~- 102 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG- 102 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC-
Confidence 57999999999999999999874 567888886544322110000001112367999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCC-CHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGG-SVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~gg-SL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+.+| +|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 103 -------------~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 164 (335)
T 3dls_A 103 -------------FFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA 164 (335)
T ss_dssp -------------EEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred -------------EEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc
Confidence 679999999766 99999875 34699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++........ .....||+.|+|||++.+ ...++.++|||||||++|+|
T Consensus 165 ~~-------~~~kL~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~el 223 (335)
T 3dls_A 165 ED-------FTIKLIDFGSAAYLERGKL-----------FYTFCGTIEYCAPEVLMG---NPYRGPELEMWSLGVTLYTL 223 (335)
T ss_dssp TT-------SCEEECCCTTCEECCTTCC-----------BCEECSCGGGCCHHHHTT---CCBCSHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeecccceECCCCCc-----------eeccCCCccccChhhhcC---CCCCCCcccchhHHHHHHHH
Confidence 87 7899999999976543221 123469999999999875 23348899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||..... .+.... . . ....++++.+|+.+||+.||.+|||+
T Consensus 224 ~~g~~pf~~~~~-----~~~~~~--~------------------------~---~~~~~~~l~~li~~~L~~dP~~Rps~ 269 (335)
T 3dls_A 224 VFEENPFCELEE-----TVEAAI--H------------------------P---PYLVSKELMSLVSGLLQPVPERRTTL 269 (335)
T ss_dssp HHSSCSCSSGGG-----GTTTCC--C------------------------C---SSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HhCCCchhhHHH-----HHhhcc--C------------------------C---CcccCHHHHHHHHHHccCChhhCcCH
Confidence 999999965211 000000 0 0 00244569999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
+|+++|+|+...
T Consensus 270 ~ell~hp~~~~~ 281 (335)
T 3dls_A 270 EKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHCTTTTCC
T ss_pred HHHhcCccccCC
Confidence 999999998653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=350.07 Aligned_cols=267 Identities=24% Similarity=0.357 Sum_probs=195.4
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC--CCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L--~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|++.+..||||++.... ... ..+|.+++... +||||+++++++.....
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-------~~~----~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-------EAS----WFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-------HHH----HHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-------cch----hhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 579999999999999999999999999999864221 111 14455555554 89999999999876531
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCC
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------HIMHRDIK 951 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~--------gIIHrDLK 951 (1137)
.....++||||+++|+|.++++. ..+++..++.|+.||+.||+|||++ ||+|||||
T Consensus 106 ----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dik 169 (337)
T 3mdy_A 106 ----------SWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169 (337)
T ss_dssp ----------GGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCC
T ss_pred ----------CCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccc
Confidence 11267999999999999999976 3599999999999999999999998 99999999
Q ss_pred CCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC--CCchhhHH
Q 001152 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL--YGLEVDIW 1029 (1137)
Q Consensus 952 P~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~--~s~ksDVW 1029 (1137)
|+|||++.+ +.+||+|||++.......... ........||+.|+|||++.+...... ++.++|||
T Consensus 170 p~Nill~~~-------~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diw 236 (337)
T 3mdy_A 170 SKNILVKKN-------GTCCIADLGLAVKFISDTNEV------DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMY 236 (337)
T ss_dssp GGGEEECTT-------SCEEECCCTTCEECC---------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHH
T ss_pred hHHEEECCC-------CCEEEEeCCCceeeccccccc------cCCCCCCccCcceeChhhcccccCCccccCccccchH
Confidence 999999877 789999999997654322110 011124469999999999975221110 01259999
Q ss_pred HHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHH-cCCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 001152 1030 SYGCLLLELLTL----------QVPYMGLS-----ELEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1093 (1137)
Q Consensus 1030 SLGviL~ELLTG----------~~Pf~~~~-----~~el~~~I~-~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1137)
||||++|||++| +.||.... .......+. ....+.++..+ ..
T Consensus 237 slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~ 294 (337)
T 3mdy_A 237 SFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW----------------------SS 294 (337)
T ss_dssp HHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----------------------GG
T ss_pred HHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccc----------------------hh
Confidence 999999999999 66665321 111222221 11111111111 11
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1094 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1094 ~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
..+++++.+|+.+||+.||.+|||+.||++++.....
T Consensus 295 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 295 DECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp SHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 2677889999999999999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=343.41 Aligned_cols=267 Identities=16% Similarity=0.170 Sum_probs=204.0
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~ 877 (1137)
-.+|++.+.||+|+||.||+|.+ .+..||+|+...... .+ .+.+|+.+++.+ +|+||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~----~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------AP----QLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SC----CHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cH----HHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 35799999999999999999996 467889997542211 11 236799999999 699999999998766
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+ +++|.+++... ...+++..+..|+.||+.||+|||++||+||||||+|||+
T Consensus 79 ~--------------~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 139 (298)
T 1csn_A 79 L--------------HNVLVIDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139 (298)
T ss_dssp T--------------EEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred c--------------eeEEEEEec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe
Confidence 5 679999999 89999999762 2459999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+. ......+||+|||++........... ..........||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 140 ~~~~--~~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~e 210 (298)
T 1csn_A 140 GRPN--SKNANMIYVVDFGMVKFYRDPVTKQH---IPYREKKNLSGTARYMSINTHLG----REQSRRDDLEALGHVFMY 210 (298)
T ss_dssp CCSS--STTTTCEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred ccCC--CCCCCeEEEEECcccccccccccccc---ccccCccCCCCCcccCCchhhcC----CCCChHHHHHHHHHHHHH
Confidence 8762 12224599999999986654322110 01112234579999999999875 568899999999999999
Q ss_pred HHhCCCCCCCC---CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1038 LLTLQVPYMGL---SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1038 LLTG~~Pf~~~---~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|++|+.||.+. ...+....+.....+..... ....+++++.+++.+||+.||.+
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~ 267 (298)
T 1csn_A 211 FLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE-----------------------LCAGFPEEFYKYMHYARNLAFDA 267 (298)
T ss_dssp HHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-----------------------HTTTSCHHHHHHHHHHHHCCTTC
T ss_pred HHcCCCCcchhhccccHHHHHHHHhhccCccHHH-----------------------HHhhCcHHHHHHHHHHhcCCccc
Confidence 99999999873 33334433322111000000 01144567999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001152 1115 RPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~ 1128 (1137)
||++++|++.+...
T Consensus 268 RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 268 TPDYDYLQGLFSKV 281 (298)
T ss_dssp CCCHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHH
Confidence 99999999988765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=358.89 Aligned_cols=278 Identities=22% Similarity=0.278 Sum_probs=205.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
...+|++.+.||+|+||+||+|++. +..||+|+.... . ....+. +.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~--~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--S--SQGIEE----FETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--C--SSHHHH----HHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--C--hHHHHH----HHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 3568999999999999999999985 577888864322 1 222333 378999999999999999999987655
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++++|.+++... ......+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 109 --------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 109 --------------EMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD 173 (321)
T ss_dssp --------------CCEEEEECCTTCBTGGGSSSS-CCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC
T ss_pred --------------eEEEEEEcCCCCcHHHHHhcc-CCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC
Confidence 459999999999999988642 12224699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 174 ~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~el 234 (321)
T 2qkw_B 174 EN-------FVPKITDFGISKKGTELDQT--------HLSTVVKGTLGYIDPEYFIK----GRLTEKSDVYSFGVVLFEV 234 (321)
T ss_dssp TT-------CCEEECCCTTCEECSSSSCC--------CCBCCCEEETTTCCHHHHHH----CBCCTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeeccccccccccccc--------ccccccCCCccccCHHHhcC----CCCCcccchHhHHHHHHHH
Confidence 77 78999999998754332111 11123458999999999876 4678999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|+.||.+..+.+....+.. ........ ...+..............+..+.+++.+||+.||++|||+
T Consensus 235 l~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 303 (321)
T 2qkw_B 235 LCARSAIVQSLPREMVNLAEW--------AVESHNNG---QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303 (321)
T ss_dssp HHCCTTCSCSSSSSCCCHHHH--------THHHHTTT---CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred HhCCCcccccCcHHHHHHHHH--------hhhccccc---cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCH
Confidence 999999976432211100000 00000000 0000000000111223677889999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
.||+++++....
T Consensus 304 ~ell~~L~~~l~ 315 (321)
T 2qkw_B 304 GDVLWKLEYALR 315 (321)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHhh
Confidence 999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=346.66 Aligned_cols=256 Identities=22% Similarity=0.393 Sum_probs=207.8
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|.+. +..+|+|+.... ....+. +.+|+.++++++||||+++++++.+.
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHH----HHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHH----HHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3567999999999999999999996 456777765321 122333 37899999999999999999998766
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+++++|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+||++
T Consensus 82 ~--------------~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~ 144 (288)
T 3kfa_A 82 P--------------PFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 144 (288)
T ss_dssp S--------------SEEEEEECCTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE
T ss_pred C--------------CEEEEEEcCCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE
Confidence 5 56999999999999999976 334569999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++.......... .....+|+.|+|||++.+ ..++.++||||||+++|+
T Consensus 145 ~~~-------~~~~l~Dfg~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 204 (288)
T 3kfa_A 145 GEN-------HLVKVADFGLSRLMTGDTYTA---------HAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWE 204 (288)
T ss_dssp CGG-------GCEEECCCCGGGTSCSSSSEE---------ETTEEECGGGCCHHHHHH----CCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEEccCccceeccCCcccc---------ccCCccccCcCChhhhcc----CCCCchhhHHHHHHHHHH
Confidence 887 789999999987654322111 112356789999999976 468899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++ |..||.+....++...+.....+..+. .+++.+.+++.+||+.||.+||
T Consensus 205 ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~~Rp 257 (288)
T 3kfa_A 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPE---------------------------GCPEKVYELMRACWQWNPSDRP 257 (288)
T ss_dssp HHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCCCCHHHHHHHHhccCCCCCCC---------------------------CCCHHHHHHHHHHhCCChhhCc
Confidence 999 999998877776666665543322211 3445699999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001152 1117 TAGDLYEMFVAR 1128 (1137)
Q Consensus 1117 Sa~EVL~~L~~~ 1128 (1137)
|++|+++.+...
T Consensus 258 s~~~~~~~l~~~ 269 (288)
T 3kfa_A 258 SFAEIHQAFETM 269 (288)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999987653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.43 Aligned_cols=277 Identities=23% Similarity=0.356 Sum_probs=194.5
Q ss_pred CCCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.+.||+|+||.||+|.+ .+..||+|+...... ....+ .+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMD----ELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEEESS
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHH----HHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 457899999999999999999987 456788886432211 11122 347899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~---~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
+ ..++||||+++++|.+++...... ....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 86 ~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N 151 (303)
T 2vwi_A 86 D--------------ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151 (303)
T ss_dssp S--------------CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred C--------------CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 5 569999999999999999754322 23469999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
|+++.+ +.+||+|||++.......... .........||+.|+|||++.+. ..++.++|||||||+
T Consensus 152 il~~~~-------~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~i 216 (303)
T 2vwi_A 152 ILLGED-------GSVQIADFGVSAFLATGGDIT-----RNKVRKTFVGTPCWMAPEVMEQV---RGYDFKADIWSFGIT 216 (303)
T ss_dssp EEECTT-------CCEEECCCHHHHHCC--------------------CCCTTCCHHHHHHH---HCCCTHHHHHHHHHH
T ss_pred EEEcCC-------CCEEEEeccchheeccCCCcc-----chhhhcccCCCccccCHHHhccc---cCCCchhhHHHHHHH
Confidence 999877 789999999987554321110 00111234699999999998642 247899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+|++|..||.................+......... ......++++.+++.+||+.||.+
T Consensus 217 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~dp~~ 278 (303)
T 2vwi_A 217 AIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK------------------EMLKKYGKSFRKMISLCLQKDPEK 278 (303)
T ss_dssp HHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----------------------CCCCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHhCCCCCccCchhhHHHHHhccCCCccccccccc------------------hhhhhhhHHHHHHHHHHccCChhh
Confidence 99999999999887665555444443333222111100 000134566999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
|||+.|+++|+|+...
T Consensus 279 Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 279 RPTAAELLRHKFFQKA 294 (303)
T ss_dssp SCCHHHHHTSTTC---
T ss_pred CcCHHHHhhChhhhcC
Confidence 9999999999999754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=348.42 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=200.8
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
...+|++.+.||+|+||.||+|++.+..+|+|+..... ..+. +.+|+.++++++||||+++++++.+..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~- 87 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA------TAQA----FLAEASVMTQLRHSNLVQLLGVIVEEK- 87 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--------HH----HHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh------HHHH----HHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 46789999999999999999999999999999853221 1222 478999999999999999999876432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
...++||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 88 ------------~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~ 152 (278)
T 1byg_A 88 ------------GGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 152 (278)
T ss_dssp -------------CCEEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred ------------CceEEEEecCCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeC
Confidence 14599999999999999997632 224889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++....... ....+++.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 153 ~-------~~~~l~Dfg~~~~~~~~~-------------~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~l~ 208 (278)
T 1byg_A 153 D-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIY 208 (278)
T ss_dssp T-------SCEEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CcEEEeeccccccccccc-------------cCCCccccccCHHHhCC----CCCCchhcHHHHHHHHHHHH
Confidence 7 789999999887543321 12357889999999875 56889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||......++...+..+..+..+. .+++.+.+++.+||+.||.+|||+
T Consensus 209 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps~ 261 (278)
T 1byg_A 209 SFGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPAVYEVMKNCWHLDAAMRPSF 261 (278)
T ss_dssp TTSCCSCTTSCGGGHHHHHTTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHhcCCCCCCcc---------------------------cCCHHHHHHHHHHhcCChhhCCCH
Confidence 8 999998877666666554443222111 345569999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001152 1119 GDLYEMFVART 1129 (1137)
Q Consensus 1119 ~EVL~~L~~~~ 1129 (1137)
.|+++.+....
T Consensus 262 ~~l~~~L~~i~ 272 (278)
T 1byg_A 262 LQLREQLEHIK 272 (278)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999987653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=347.40 Aligned_cols=262 Identities=27% Similarity=0.326 Sum_probs=211.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|++. +..+|+|+....... ....+. +.+|+.++++++||||+++++++.+..
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTST----ILREVELLKKLDHPNIMKLFEILEDSS- 94 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHH----HHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHH----HHHHHHHHHhccCCCccEEEEEEeCCC-
Confidence 57999999999999999999984 578999986543322 112223 478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 95 -------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~ 156 (287)
T 2wei_A 95 -------------SFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (287)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred -------------eEEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEec
Confidence 679999999999999988752 36899999999999999999999999999999999999976
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+. ..+.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|+
T Consensus 157 ~~----~~~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~~l~~l~ 216 (287)
T 2wei_A 157 KE----KDCDIKIIDFGLSTCFQQNTK-----------MKDRIGTAYYIAPEVLRG-----TYDEKCDVWSAGVILYILL 216 (287)
T ss_dssp SS----TTCCEEECSTTGGGTBCCCSS-----------CSCHHHHHTTCCHHHHTT-----CCCTHHHHHHHHHHHHHHH
T ss_pred CC----CcccEEEeccCcceeecCCCc-----------cccccCcccccChHHhcC-----CCCCchhhHhHHHHHHHHH
Confidence 52 125799999999875443211 113358889999999864 4789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||.+....++...+..+......... ...++++.+++.+||+.||.+|||+.
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~li~~~l~~dp~~Rps~~ 272 (287)
T 2wei_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQW------------------------RTISDDAKDLIRKMLTFHPSLRITAT 272 (287)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSGGG------------------------TTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCchhh------------------------hhcCHHHHHHHHHHcccChhhCcCHH
Confidence 999999998888877777665432111000 13455699999999999999999999
Q ss_pred HHHHHHHhhcCCC
Q 001152 1120 DLYEMFVARTSSS 1132 (1137)
Q Consensus 1120 EVL~~L~~~~~ss 1132 (1137)
|+++|+|+....+
T Consensus 273 ell~hp~~~~~~~ 285 (287)
T 2wei_A 273 QCLEHPWIQKYSS 285 (287)
T ss_dssp HHHHSHHHHHHCC
T ss_pred HHhcCHHHhcccc
Confidence 9999999986543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.92 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=204.2
Q ss_pred CCCceEee-eecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 801 FPSLSSCD-EAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~-~LG~GsfG~Vy~a~~~----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..+|++.+ .||+|+||+||+|.+. +..+|+|+.... .......+ ++.+|+.+++.++||||+++++++.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKD----ELLAEANVMQQLDNPYIVRMIGICE 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHH----HHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccc--ccCHHHHH----HHHHHHHHHHhCCCCCEEEEEEEEC
Confidence 35688888 9999999999999652 356888875432 11122223 3488999999999999999999984
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
. + ..++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 89 ~-~--------------~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Ni 148 (291)
T 1xbb_A 89 A-E--------------SWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 148 (291)
T ss_dssp S-S--------------SEEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred C-C--------------CcEEEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceE
Confidence 3 2 46999999999999999976 24699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||+++
T Consensus 149 l~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 210 (291)
T 1xbb_A 149 LLVTQ-------HYAKISDFGLSKALRADENYY-------KAQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLM 210 (291)
T ss_dssp EEEET-------TEEEECCCTTCEECCTTCSEE-------EC----CCCGGGCCHHHHHH----CEEEHHHHHHHHHHHH
T ss_pred EEeCC-------CcEEEccCCcceeeccCCCcc-------cccccCCCCceeeChHHhcc----CCCChhhhHHHHHHHH
Confidence 99987 789999999997654322110 01112346789999999976 4578999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+|++ |..||.+....++...+..+..+..+. .+++.+.+++.+||+.||.+
T Consensus 211 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~~ 263 (291)
T 1xbb_A 211 WEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDVEN 263 (291)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhh
Confidence 99999 999999988888877776655433221 34456999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001152 1115 RPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~ 1128 (1137)
||++.++++.+...
T Consensus 264 Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 264 RPGFAAVELRLRNY 277 (291)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999887653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=345.19 Aligned_cols=280 Identities=23% Similarity=0.340 Sum_probs=200.7
Q ss_pred CCCCCC--CCceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCc
Q 001152 796 LDPGSF--PSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI 867 (1137)
Q Consensus 796 ~~~~~~--~~y~l~~~LG~GsfG~Vy~a~~------~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNI 867 (1137)
+++..+ .+|++.+.||+|+||.||+|++ .+..+|+|+...... ....+ .+.+|+.+++.++||||
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~----~~~~E~~~l~~l~h~~i 85 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIA----DLKKEIEILRNLYHENI 85 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHH----HHHHHHHHHHTCCCTTB
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhHH----HHHHHHHHHHhCCCCCe
Confidence 344444 3589999999999999999995 457788988643321 11122 34789999999999999
Q ss_pred ceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Q 001152 868 VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947 (1137)
Q Consensus 868 Vkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIH 947 (1137)
+++++++..... ...++||||+++++|.+++... ...+++..++.|+.||+.||+|||++||+|
T Consensus 86 ~~~~~~~~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 149 (302)
T 4e5w_A 86 VKYKGICTEDGG------------NGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQYVH 149 (302)
T ss_dssp CCEEEEEEC---------------CCEEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred eeeeeEEecCCC------------ceEEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCCccc
Confidence 999999986531 1579999999999999999652 246999999999999999999999999999
Q ss_pred ccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhh
Q 001152 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1027 (1137)
Q Consensus 948 rDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1027 (1137)
|||||+|||++.+ +.+||+|||++.......... .......||..|+|||++.+ ..++.++|
T Consensus 150 ~dikp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~D 211 (302)
T 4e5w_A 150 RDLAARNVLVESE-------HQVKIGDFGLTKAIETDKEYY-------TVKDDRDSPVFWYAPECLMQ----SKFYIASD 211 (302)
T ss_dssp SCCSGGGEEEEET-------TEEEECCCTTCEECCTTCCEE-------ECCCCTTCCGGGCCHHHHHH----CEEEHHHH
T ss_pred CCCchheEEEcCC-------CCEEECcccccccccCCCcce-------eccCCCCCCccccCCeeecC----CCCCcchh
Confidence 9999999999887 789999999997655432110 01123468889999999876 45779999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001152 1028 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1107 (1137)
Q Consensus 1028 VWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~C 1107 (1137)
||||||++|+|++|..|+.. ................. ..... ..... .... ......++++.+|+.+|
T Consensus 212 i~slG~il~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~--~~~~~----~~~~~-~~~~---~~~~~~~~~l~~li~~~ 279 (302)
T 4e5w_A 212 VWSFGVTLHELLTYCDSDSS--PMALFLKMIGPTHGQMT--VTRLV----NTLKE-GKRL---PCPPNCPDEVYQLMRKC 279 (302)
T ss_dssp HHHHHHHHHHHHTTTCGGGS--HHHHHHHHHCSCCGGGH--HHHHH----HHHHT-TCCC---CCCTTCCHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHccCCCcc--hhhHHhhccCCcccccC--HHHHH----HHHhc-cCCC---CCCCCCCHHHHHHHHHH
Confidence 99999999999999998753 21111111111100000 00000 00000 0000 01114566799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhh
Q 001152 1108 TEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1108 L~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
|+.||.+|||+.|+++.+...
T Consensus 280 l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 280 WEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp TCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHH
Confidence 999999999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=347.97 Aligned_cols=267 Identities=22% Similarity=0.346 Sum_probs=201.8
Q ss_pred CCCceEeeeecccCceEEEEEEECC-----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..+|++.+.||+|+||.||+|++.. ..+|+|+.. .........+.+ .+|+.++++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK--LDNSSQREIEEF----LSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC-----CCCHHHHHHH----HHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEe--ccccchhHHHHH----HHHHHHHhcCCCCCeeeeeEEEe
Confidence 3579999999999999999998742 357888743 322333344444 88999999999999999999988
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-TGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
+.... .....++||||+++++|.+++..... .....+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 107 ~~~~~---------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N 177 (313)
T 3brb_A 107 EMSSQ---------GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN 177 (313)
T ss_dssp C----------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGG
T ss_pred ecccc---------CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence 64411 11246999999999999999864321 234579999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||++......... .......+++.|+|||.+.+ ..++.++||||||++
T Consensus 178 Ili~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 238 (313)
T 3brb_A 178 CMLRDD-------MTVCVADFGLSKKIYSGDYY--------RQGRIAKMPVKWIAIESLAD----RVYTSKSDVWAFGVT 238 (313)
T ss_dssp EEECTT-------SCEEECSCSCC------------------------CCGGGSCHHHHHS----SCCCHHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEeecCcceeccccccc--------CcccccCCCccccCchhhcC----CCccchhhhHHHHHH
Confidence 999877 78999999998765432211 11123457889999999875 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|+|++ |..||.+....++...+..+..+..+. .+++.+.+++.+||+.||.
T Consensus 239 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dp~ 291 (313)
T 3brb_A 239 MWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE---------------------------DCLDELYEIMYSCWRTDPL 291 (313)
T ss_dssp HHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBT---------------------------TCCHHHHHHHHHTTCSSGG
T ss_pred HHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCc---------------------------cccHHHHHHHHHHcCCChh
Confidence 999999 899998877777777666554433221 3445699999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 001152 1114 ERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~ 1128 (1137)
+|||+.++++++...
T Consensus 292 ~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 292 DRPTFSVLRLQLEKL 306 (313)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHH
Confidence 999999999998765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=372.35 Aligned_cols=270 Identities=13% Similarity=0.119 Sum_probs=190.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHH---HHHHhCCCCCcceee----
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEV---RMLGALRHSCIVEMY---- 871 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi---~iL~~L~HpNIVkll---- 871 (1137)
..+|++.+.||+|+||.||+|++. +..||||+........ ....+. +.+|+ .++++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~----~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQ----MKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC-TTHHHH----HHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc-hHHHHH----HHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 457999999999999999999974 6789999865432222 222333 47899 455566799999998
Q ss_pred ---eeEecCCCCC---CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001152 872 ---GHKISSKWLP---SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG--EKHVSVKLALFIAQDVAAALVELHSK 943 (1137)
Q Consensus 872 ---g~~~~~~~~~---~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~--~~~ls~~~i~~I~~QIa~gL~yLHs~ 943 (1137)
+++.+.+... ...+.........++||||+ +|+|.+++....... ...+++..++.|+.||+.||+|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 5544332000 00000001112379999999 589999998642211 13455688889999999999999999
Q ss_pred CeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc------
Q 001152 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH------ 1017 (1137)
Q Consensus 944 gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------ 1017 (1137)
||+||||||+|||++.+ +.+||+|||+++...... ....| +.|+|||++.+..
T Consensus 226 ~ivHrDikp~NIll~~~-------~~~kL~DFG~a~~~~~~~-------------~~~~g-~~y~aPE~~~~~~~~~~~~ 284 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQR-------GGVFLTGFEHLVRDGARV-------------VSSVS-RGFEPPELEARRATISYHR 284 (377)
T ss_dssp TEECSCCCGGGEEECTT-------CCEEECCGGGCEETTCEE-------------ECCCC-TTCCCHHHHHHHTSTHHHH
T ss_pred CeecCCCCHHHEEEcCC-------CCEEEEechhheecCCcc-------------cCCCC-cCccChhhhcccccccccc
Confidence 99999999999999977 789999999997533211 12357 8999999998620
Q ss_pred -CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhh
Q 001152 1018 -KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELET 1096 (1137)
Q Consensus 1018 -~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1137)
....++.++|||||||++|||++|+.||.+....+....+... . ...
T Consensus 285 ~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------------~---------~~~ 332 (377)
T 3byv_A 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS-----------------------C---------KNI 332 (377)
T ss_dssp CCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS-----------------------C---------CCC
T ss_pred cccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh-----------------------c---------cCC
Confidence 0015889999999999999999999999754322111111000 0 134
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1097 LSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1097 ~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
++++.+|+.+||+.||.+|||+.|+++|+|+..
T Consensus 333 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 333 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 556999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=348.65 Aligned_cols=287 Identities=21% Similarity=0.235 Sum_probs=207.2
Q ss_pred CCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeeEe
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 875 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L---~HpNIVkllg~~~ 875 (1137)
.+|++.+.||+|+||.||+|++. +..||+|+......... ... .+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~~----~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPL----STIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBC----THHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--CCc----hhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 67999999999999999999983 46789998654432211 111 225677776665 8999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
.... ......++||||++ |+|.+++... ....+++..+..++.||+.||+|||++||+||||||+||
T Consensus 85 ~~~~---------~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Ni 151 (326)
T 1blx_A 85 VSRT---------DRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151 (326)
T ss_dssp EEEC---------SSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred eccc---------CCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHe
Confidence 3210 01226799999998 7999999762 234599999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||++
T Consensus 152 li~~~-------~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 209 (326)
T 1blx_A 152 LVTSS-------GQIKLADFGLARIYSFQMAL-----------TSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCIF 209 (326)
T ss_dssp EECTT-------CCEEECSCCSCCCCCGGGGG-----------CCCCCCCTTCCHHHHTT----CCCCTHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEecCcccccccCCCCc-----------cccccccceeCHHHHhc----CCCCcchhHHHHHHHH
Confidence 99877 78999999998765432111 13468999999999875 4688999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|+|++|..||.+....+....+...........+............ ..............++.+.+|+.+||+.||.+|
T Consensus 210 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 288 (326)
T 1blx_A 210 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH-SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288 (326)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSC-CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTS
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhc-ccCcchhhhccccCCHHHHHHHHHHcCCCcccC
Confidence 9999999999988877766665432111111111000000000000 000000111112456779999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001152 1116 PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ 1130 (1137)
||+.|+++|+|+...
T Consensus 289 pt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 289 ISAYSALSHPYFQDL 303 (326)
T ss_dssp CCHHHHHTSGGGTTC
T ss_pred CCHHHHhcCcccccc
Confidence 999999999999743
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=358.79 Aligned_cols=285 Identities=24% Similarity=0.255 Sum_probs=201.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--------CCCccee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--------HSCIVEM 870 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~--------HpNIVkl 870 (1137)
..+|++.++||+|+||+||+|++. +..||+|+.... ....+ .+.+|+.+++.++ ||||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~----~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTE----TALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHH----HHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchH----HHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 367999999999999999999884 567888875321 22223 3488999999985 7889999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-Ceeecc
Q 001152 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRD 949 (1137)
Q Consensus 871 lg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrD 949 (1137)
++++..... .....++||||+ +++|.+++.. .....+++..++.|+.||+.||+|||++ ||+|||
T Consensus 107 ~~~~~~~~~----------~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrD 172 (397)
T 1wak_A 107 LDDFKISGV----------NGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTD 172 (397)
T ss_dssp EEEEEEEET----------TEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCC
T ss_pred ecceeecCC----------CCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 999874210 122689999999 5777777765 2234699999999999999999999998 999999
Q ss_pred CCCCCeEeccccc------------------------------------------cCCCCCeEEEeecCccccccccccc
Q 001152 950 IKSENILIDLERK------------------------------------------KADGKPVVKLCDFDRAVPLRSFLHT 987 (1137)
Q Consensus 950 LKP~NILld~~~~------------------------------------------~~~~~~~vKL~DFGla~~~~~~~~~ 987 (1137)
|||+|||++.++. .......+||+|||++.......
T Consensus 173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-- 250 (397)
T 1wak_A 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-- 250 (397)
T ss_dssp CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS--
T ss_pred CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC--
Confidence 9999999986520 00011379999999987654321
Q ss_pred cccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHH--c
Q 001152 988 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS------ELEIHDLIQ--M 1059 (1137)
Q Consensus 988 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~------~~el~~~I~--~ 1059 (1137)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+ ..+....+. .
T Consensus 251 -----------~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 315 (397)
T 1wak_A 251 -----------TEDIQTRQYRSLEVLIG----SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315 (397)
T ss_dssp -----------CSCCSCGGGCCHHHHHT----SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHH
T ss_pred -----------ccCCCCCcccCChhhcC----CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhc
Confidence 13368999999999986 458899999999999999999999997643 222222221 1
Q ss_pred CCCCCchhHHhhhcccccccccc-----cCCCCCC----------chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 001152 1060 GKRPRLTDELEALGSCHEHEVAQ-----SGSGFEK----------PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124 (1137)
Q Consensus 1060 g~~p~l~~~l~~~~~~~~~~~~~-----~~~~~~~----------~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~ 1124 (1137)
+..+. .+............. ....... .......++.+.+||.+||+.||++|||++||++|
T Consensus 316 ~~~p~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 316 GKVPR---KLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CSCCH---HHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCCCh---HHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 21111 100000000000000 0000000 01123567789999999999999999999999999
Q ss_pred HHhh
Q 001152 1125 FVAR 1128 (1137)
Q Consensus 1125 L~~~ 1128 (1137)
+|+.
T Consensus 393 p~~~ 396 (397)
T 1wak_A 393 PWLN 396 (397)
T ss_dssp GGGG
T ss_pred cccc
Confidence 9986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=352.29 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=203.5
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMY 871 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkll 871 (1137)
...+|++.+.||+|+||.||+|.+.+ ..+|+|+.... ......+. +.+|+.+++++ +||||++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST---AHADEKEA----LMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc---cChHHHHH----HHHHHHHHHhhcCCCCeeeEE
Confidence 35789999999999999999999843 25788875322 12233333 48899999999 799999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc---------CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET---------GEKHVSVKLALFIAQDVAAALVELHS 942 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~---------~~~~ls~~~i~~I~~QIa~gL~yLHs 942 (1137)
+++...+ ..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+
T Consensus 117 ~~~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 117 GACTHGG--------------PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp EEECSSS--------------SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCC--------------ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 9998765 459999999999999999764321 12458999999999999999999999
Q ss_pred CCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCC
Q 001152 943 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022 (1137)
Q Consensus 943 ~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 1022 (1137)
+||+||||||+|||++.+ +.+||+|||++......... .......+|+.|+|||++.+ ..+
T Consensus 183 ~~ivH~Dlkp~NIl~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~ 243 (333)
T 2i1m_A 183 KNCIHRDVAARNVLLTNG-------HVAKIGDFGLARDIMNDSNY--------IVKGNARLPVKWMAPESIFD----CVY 243 (333)
T ss_dssp TTEECSCCSGGGCEEEGG-------GEEEBCCCGGGCCGGGCTTS--------EECSSCEECGGGSCHHHHHH----CCC
T ss_pred CCcccCCcccceEEECCC-------CeEEECccccccccccccce--------eecCCCCCCccccCHHHhcc----CCC
Confidence 999999999999999987 78999999999765432211 01123357889999999876 468
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001152 1023 GLEVDIWSYGCLLLELLT-LQVPYMGLSELEIH-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1100 (1137)
Q Consensus 1023 s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~-~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1100 (1137)
+.++|||||||++|+|++ |..||.+....... ..+..+..+..+. ..++.+
T Consensus 244 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l 296 (333)
T 2i1m_A 244 TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA---------------------------FAPKNI 296 (333)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCT---------------------------TCCHHH
T ss_pred ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCC---------------------------CCCHHH
Confidence 899999999999999998 99999875443333 3333322211110 234568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1101 VDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1101 ~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
.+++.+||+.||.+|||+.||++++...
T Consensus 297 ~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 297 YSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=352.25 Aligned_cols=275 Identities=23% Similarity=0.330 Sum_probs=202.0
Q ss_pred CCCceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~------~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
-.+|++.+.||+|+||.||+|++ .+..||+|+.... .....+. +.+|+.++++++||||+++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRD----FQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHH----HHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHH----HHHHHHHHHhcCCCceeEEEEEE
Confidence 35799999999999999999995 3466888875322 2333333 48899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
...+. ...++||||+++++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 94 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~N 157 (327)
T 3lxl_A 94 YGPGR------------QSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARN 157 (327)
T ss_dssp ECSSS------------CEEEEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ecCCC------------ceEEEEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhh
Confidence 75331 1679999999999999999763 2358999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 158 Il~~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 219 (327)
T 3lxl_A 158 ILVESE-------AHVKIADFGLAKLLPLDKDYY-------VVREPGQSPIFWYAPESLSD----NIFSRQSDVWSFGVV 219 (327)
T ss_dssp EEEEET-------TEEEECCGGGCEECCTTCSEE-------ECSSCCCSCGGGSCHHHHHH----CEEEHHHHHHHHHHH
T ss_pred EEECCC-------CCEEEcccccceecccCCccc-------eeeccCCccccccCHHHhcc----CCCChHHhHHHHHHH
Confidence 999987 789999999997654322111 01123458889999999876 457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+|++|+.||.................+......... .. .... .....+++++.+|+.+||+.||.+
T Consensus 220 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~---~~~~~~~~~l~~li~~~l~~dP~~ 287 (327)
T 3lxl_A 220 LYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL--------EE-GQRL---PAPPACPAEVHELMKLCWAPSPQD 287 (327)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH--------HT-TCCC---CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh--------hc-ccCC---CCCCcccHHHHHHHHHHcCCChhh
Confidence 99999999999753222111100110111001000000 00 0000 001245677999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001152 1115 RPTAGDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~ 1129 (1137)
|||++|+++++....
T Consensus 288 Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 288 RPSFSALGPQLDMLW 302 (327)
T ss_dssp SCCHHHHHHHHHHC-
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999988753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=343.27 Aligned_cols=259 Identities=21% Similarity=0.325 Sum_probs=202.0
Q ss_pred CceEeeeecccCceEEEEEEECC--c---cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGS--A---DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~--~---~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.|.+.++||+|+||+||+|.+.. . .+|+|+. .. .......+. +.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~--~~-~~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SR-ITEMQQVEA----FLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEE--TT-CCSHHHHHH----HHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeec--cc-cccHHHHHH----HHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 46778999999999999998732 2 4666664 22 222333334 48899999999999999999998765
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+. ..++||||+.+++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 95 ~~-------------~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili 157 (298)
T 3pls_A 95 EG-------------LPHVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157 (298)
T ss_dssp SS-------------CCEEEECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CC-------------CcEEEEecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 41 34899999999999999975 23568999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++.......... ........+|+.|+|||.+.+ ..++.++|||||||++|+
T Consensus 158 ~~~-------~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 220 (298)
T 3pls_A 158 DES-------FTVKVADFGLARDILDREYYS------VQQHRHARLPVKWTALESLQT----YRFTTKSDVWSFGVLLWE 220 (298)
T ss_dssp CTT-------CCEEECCTTSSCTTTTGGGGC------SCCSSCTTCGGGGSCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred cCC-------CcEEeCcCCCcccccCCcccc------cccCcCCCCCccccChhhhcc----CCCChhhchhhHHHHHHH
Confidence 877 789999999997654322111 111223468889999999975 568899999999999999
Q ss_pred HHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG-~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++| .+||......++...+..+.....+. ..++.+.+++.+||+.||.+||
T Consensus 221 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rp 273 (298)
T 3pls_A 221 LLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE---------------------------YCPDSLYQVMQQCWEADPAVRP 273 (298)
T ss_dssp HHHTSCCTTTTSCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhhCCCCCCccCCHHHHHHHhhcCCCCCCCc---------------------------cchHHHHHHHHHHccCChhhCc
Confidence 9994 55566666666666665554332211 2345699999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|+.++++.+....
T Consensus 274 s~~~ll~~l~~~~ 286 (298)
T 3pls_A 274 TFRVLVGEVEQIV 286 (298)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999987753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=356.12 Aligned_cols=295 Identities=16% Similarity=0.154 Sum_probs=207.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCCh---HHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSA---DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~---~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
..+|++.+.||+|+||.||+|.+. +..||+|+.......... ........++.+|+.++++++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 357999999999999999999874 577999986443222110 1111222345899999999999999999999865
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
... ......++||||++ |+|.+++.. ....+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 101 ~~~---------~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 101 FEE---------PAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL 166 (362)
T ss_dssp CCT---------TTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred ccC---------CCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEE
Confidence 321 11236899999997 799988864 2346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++........ .....||+.|+|||++.+ ...++.++|||||||++|
T Consensus 167 ~~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ 225 (362)
T 3pg1_A 167 LADN-------NDITICDFNLAREDTADAN-----------KTHYVTHRWYRAPELVMQ---FKGFTKLVDMWSAGCVMA 225 (362)
T ss_dssp ECTT-------CCEEECCTTC--------------------------CGGGCCHHHHTT---CTTCCTHHHHHHHHHHHH
T ss_pred EcCC-------CCEEEEecCcccccccccc-----------cceecccceecCcHHhcC---CCCCCcHhHHHhHHHHHH
Confidence 9877 7899999999874433211 123468999999999874 246889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHc-CCCCCchhHHhhhcccccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~-g~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
+|++|+.||.+....+....+.. ...+..................... ............++.+.+|+.+||+.||
T Consensus 226 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 305 (362)
T 3pg1_A 226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305 (362)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCCh
Confidence 99999999998887776666533 2222222111000000000000000 0001111223456779999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001152 1113 TERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~ 1130 (1137)
.+|||++|+++|+|+..-
T Consensus 306 ~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 306 QRRISTEQALRHPYFESL 323 (362)
T ss_dssp GGSCCHHHHHTSGGGTTT
T ss_pred hhCCCHHHHHcCchhhhc
Confidence 999999999999999754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=349.11 Aligned_cols=263 Identities=23% Similarity=0.359 Sum_probs=203.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
..+|++.+.||+|+||+||+|++. +..||+|+.... ......+. +.+|+.+++++ +||||+++++
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRA----LMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC---CCcHHHHH----HHHHHHHHHhcccCCCeeeEEE
Confidence 467999999999999999999852 356888875422 12333333 48899999999 6999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELH 941 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------~~~~ls~~~i~~I~~QIa~gL~yLH 941 (1137)
++...+. ..++||||+++++|.+++...... ....+++..++.++.||+.||+|||
T Consensus 99 ~~~~~~~-------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 165 (316)
T 2xir_A 99 ACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165 (316)
T ss_dssp EECCTTS-------------CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCC-------------ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH
Confidence 9876431 469999999999999999763211 0123899999999999999999999
Q ss_pred hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001152 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 942 s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1021 (1137)
++||+||||||+|||++.+ +.+||+|||+++........ .......+|+.|+|||++.+ ..
T Consensus 166 ~~~i~H~dikp~Nil~~~~-------~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~----~~ 226 (316)
T 2xir_A 166 SRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RV 226 (316)
T ss_dssp HTTCCCSCCSGGGEEECGG-------GCEEECCCGGGSCTTTCTTS--------EEETTEEECGGGCCHHHHHH----CC
T ss_pred hCCcccccCccceEEECCC-------CCEEECCCccccccccCccc--------eeccCCCcceeecCchhhcc----cc
Confidence 9999999999999999877 78999999998765432111 01113457889999999876 56
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLT-LQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1099 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~-~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1137)
++.++|||||||++|+|++ |..||.+... ..+...+..+.....+. ..++.
T Consensus 227 ~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 279 (316)
T 2xir_A 227 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD---------------------------YTTPE 279 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT---------------------------TCCHH
T ss_pred ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCC---------------------------CCCHH
Confidence 8899999999999999998 9999987543 33444444443322211 23456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1100 LVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1100 L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+.+++.+||+.||.+|||+.||++++....
T Consensus 280 l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 280 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=372.62 Aligned_cols=256 Identities=22% Similarity=0.390 Sum_probs=208.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..+|++.++||+|+||.||+|.+. +..||||+. +.... ..+. +.+|+.+|++++|||||++++++....
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~--~~~~~---~~~~----~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTM---EVEE----FLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEEC--CSSSS---CHHH----HHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEe--cCccc---chHH----HHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 457899999999999999999996 456777764 32221 1233 388999999999999999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++|+|.++++. .....+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 290 --------------~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 352 (495)
T 1opk_A 290 --------------PFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG 352 (495)
T ss_dssp --------------SCEEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------cEEEEEEccCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC
Confidence 45999999999999999976 2335689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++........ ......+++.|+|||++.+ ..++.++|||||||++|||
T Consensus 353 ~~-------~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwSlG~~l~el 412 (495)
T 1opk_A 353 EN-------HLVKVADFGLSRLMTGDTYT---------AHAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWEI 412 (495)
T ss_dssp GG-------GCEEECCTTCEECCTTCCEE---------CCTTCCCCGGGCCHHHHHH----CEECHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEeecccceeccCCcee---------ecCCCcCCcceeCHhHHhc----CCCCcHHhHHhHHHHHHHH
Confidence 87 78999999999765432211 1112346789999999976 4678999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++ |..||.+.+..++...+..+.....+. .+++.+.+|+.+||+.||.+|||
T Consensus 413 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~RPs 465 (495)
T 1opk_A 413 ATYGMSPYPGIDLSQVYELLEKDYRMERPE---------------------------GCPEKVYELMRACWQWNPSDRPS 465 (495)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCcChhHCcC
Confidence 99 999999887777777666544322211 34556999999999999999999
Q ss_pred HHHHHHHHHhhc
Q 001152 1118 AGDLYEMFVART 1129 (1137)
Q Consensus 1118 a~EVL~~L~~~~ 1129 (1137)
+.+|++.+....
T Consensus 466 ~~el~~~L~~~~ 477 (495)
T 1opk_A 466 FAEIHQAFETMF 477 (495)
T ss_dssp HHHHHHHHHTSC
T ss_pred HHHHHHHHHHHH
Confidence 999999987653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=351.35 Aligned_cols=273 Identities=22% Similarity=0.275 Sum_probs=203.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|+||.||+|++. +..||+|+........ . ..++.+|+.+++.++||||+++++++....
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 100 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG---G----ELQFQTEVEMISMAVHRNLLRLRGFCMTPT- 100 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------C----CCHHHHHHHGGGTCCCTTBCCCCEEECCSS-
T ss_pred hhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch---H----HHHHHHHHHHHHhccCCCccceEEEEecCC-
Confidence 467999999999999999999874 5789999854322111 1 113478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCCCCeE
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---HIMHRDIKSENIL 956 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~---gIIHrDLKP~NIL 956 (1137)
..++||||+++++|.+++.... .....+++..+..|+.||+.||+|||++ ||+||||||+|||
T Consensus 101 -------------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil 166 (326)
T 3uim_A 101 -------------ERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166 (326)
T ss_dssp -------------CCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred -------------ceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence 4599999999999999997632 2234699999999999999999999999 9999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 167 ~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~ 226 (326)
T 3uim_A 167 LDEE-------FEAVVGDFGLAKLMDYKDTH---------VTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLL 226 (326)
T ss_dssp ECTT-------CCEEECCCSSCEECCSSSSC---------EECCCCSCGGGCCHHHHHH----SEECHHHHHHHHHHHHH
T ss_pred ECCC-------CCEEeccCccccccCccccc---------ccccccCCcCccCHHHhcc----CCCCccccchhHHHHHH
Confidence 9977 78999999999765432211 1123459999999999876 45789999999999999
Q ss_pred HHHhCCCCCCCC-----CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001152 1037 ELLTLQVPYMGL-----SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1037 ELLTG~~Pf~~~-----~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
+|++|..||... .......++....... ..................++.+.+++.+||+.|
T Consensus 227 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 292 (326)
T 3uim_A 227 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--------------KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292 (326)
T ss_dssp HHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC--------------CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhCCCcccccccccccchhHHHHHHHHhhch--------------hhhhhcChhhccccCHHHHHHHHHHHHHHhCcC
Confidence 999999999521 1111111111111000 000000000111122366788999999999999
Q ss_pred CCCCCCHHHHHHHHHhhc
Q 001152 1112 PTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~~~~ 1129 (1137)
|.+|||+.||+++|+...
T Consensus 293 P~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 293 PMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp GGGSCCHHHHHHHHHTSS
T ss_pred CccCCCHHHHHHHhcCcc
Confidence 999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=370.37 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=204.8
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.++||+|+||.||+|.+.+ ..||||+.... ... .+. +.+|+.+|++++||||+++++++.+ .
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~---~~~----~~~E~~~l~~l~hp~iv~~~~~~~~-~- 251 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSE-E- 251 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECS-S-
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccC--CCC---HHH----HHHHHHHHHhCCCCCEeeEEEEEcC-C-
Confidence 4569999999999999999999975 56888874322 211 223 3789999999999999999999864 2
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.++++... ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 252 -------------~~~iv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~ 315 (452)
T 1fmk_A 252 -------------PIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 315 (452)
T ss_dssp -------------SCEEEECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred -------------ceEEEehhhcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECC
Confidence 3599999999999999997521 235899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 316 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~el~ 375 (452)
T 1fmk_A 316 N-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELT 375 (452)
T ss_dssp G-------GCEEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEECCCccceecCCCcee---------cccCCcccccccCHhHHhc----CCCCccccHHhHHHHHHHHH
Confidence 7 78999999999765432111 1112346789999999876 46889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||.+....++...+..+.....+. .+++.+.+|+.+||+.||++|||+
T Consensus 376 t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rpt~ 428 (452)
T 1fmk_A 376 TKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERPTF 428 (452)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHccCChhhCcCH
Confidence 9 999999988888888777655433221 345569999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
++|++.+.....
T Consensus 429 ~~l~~~L~~~~~ 440 (452)
T 1fmk_A 429 EYLQAFLEDYFT 440 (452)
T ss_dssp HHHHHHHHTTTS
T ss_pred HHHHHHHHHHhc
Confidence 999999887644
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=361.56 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=194.3
Q ss_pred CCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
..|++.+.||+|+||+||+|++. +..+.|+++.++... .....+. +.+|+.++++++||||+++++++...+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~----~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQ----FLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHH----HHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHH----HHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 35788999999999999999873 233333333343322 2233334 488999999999999999999875432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. ..++||||+++|+|.++++. ....+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 164 ~-------------~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 226 (373)
T 3c1x_A 164 G-------------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 226 (373)
T ss_dssp S-------------CCEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred C-------------CeEEEEECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC
Confidence 1 45899999999999999975 234689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++......... ........+|+.|+|||++.+ ..++.++|||||||++|||
T Consensus 227 ~~-------~~~kL~DFG~a~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlG~il~el 289 (373)
T 3c1x_A 227 EK-------FTVKVADFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWEL 289 (373)
T ss_dssp TT-------CCEEECCC---------------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccccccccccccc------ccccCCCCCcccccChHHhcC----CCCCcHHHHHHHHHHHHHH
Confidence 77 789999999997654321110 011123357889999999976 5688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++ |.+||......++...+..+..+..+. .+++.+.+++.+||+.||++|||
T Consensus 290 lt~~~~p~~~~~~~~~~~~~~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dp~~RPs 342 (373)
T 3c1x_A 290 MTRGAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAEMRPS 342 (373)
T ss_dssp HTTSCCSCTTSCSSCHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCcCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhhCcC
Confidence 99 788887766655655565544322211 34456999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001152 1118 AGDLYEMFVARTS 1130 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ 1130 (1137)
+.|+++++.....
T Consensus 343 ~~ell~~L~~i~~ 355 (373)
T 3c1x_A 343 FSELVSRISAIFS 355 (373)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999987643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=358.42 Aligned_cols=283 Identities=19% Similarity=0.194 Sum_probs=206.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|.+.+.||+|+||.||+|.+. +..||+|+.... .......+ ++.+|+.+++.++||||+++++++.....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP--FQSEIFAK----RAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST--TSSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccc--ccchhHHH----HHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 57999999999999999999985 567888875322 22222223 34889999999999999999999986542
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ......++||||+. ++|.+++. ..+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 116 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 179 (371)
T 4exu_A 116 L--------RNFYDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 179 (371)
T ss_dssp S--------TTCCCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred c--------ccceeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC
Confidence 1 11224599999997 78888763 24999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++...... ....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 180 ~-------~~~kL~Dfg~a~~~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~ 236 (371)
T 4exu_A 180 D-------CELKILDFGLARHADAEM-------------TGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEML 236 (371)
T ss_dssp T-------CCEEECSTTCC---------------------CTTCCCTTSCHHHHSC---CSCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEecCcccccccCc-------------CCcccCccccCHHHhcC---CCCCCcHHhHHHHHHHHHHHH
Confidence 7 789999999987543321 13468999999999874 246889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|..||.+.+..+....+........................+.. ............++++.+|+.+||+.||.+||
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 316 (371)
T 4exu_A 237 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 316 (371)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC
Confidence 999999998877776666332211111111110000000000000 00001111124567899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|++|+++|+|+..
T Consensus 317 t~~ell~hp~f~~ 329 (371)
T 4exu_A 317 TAAQALTHPFFEP 329 (371)
T ss_dssp CHHHHHTSGGGTT
T ss_pred CHHHHhcCccccc
Confidence 9999999999974
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=340.59 Aligned_cols=262 Identities=22% Similarity=0.292 Sum_probs=200.4
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|.+. +..+|+|+..... +.+ .+|+.++++++||||+++++++....+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~----~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKA----EREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGG----HHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHH----HHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 46899999999999999999985 6788999864321 122 679999999999999999998864221
Q ss_pred CCCC--CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 880 LPSA--DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 880 ~~~~--~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
.+.. ...........++||||+++++|.+++.... ...+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL 155 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE
Confidence 0000 0000011235799999999999999997632 2469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 156 ~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 213 (284)
T 2a19_B 156 VDT-------KQVKIGDFGLVTSLKNDGK-----------RTRSKGTLRYMSPEQISS----QDYGKEVDLYALGLILAE 213 (284)
T ss_dssp EET-------TEEEECCCTTCEESSCCSC-----------CCCCCSCCTTSCHHHHHC----SCCCTHHHHHHHHHHHHH
T ss_pred cCC-------CCEEECcchhheecccccc-----------ccccCCcccccChhhhcc----CCCcchhhhHHHHHHHHH
Confidence 987 7899999999876543211 113468999999999875 467899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|..||.. .......+.....+ ...++.+.+++.+||+.||.+|||
T Consensus 214 l~~~~~~~~~--~~~~~~~~~~~~~~------------------------------~~~~~~~~~li~~~l~~dp~~Rps 261 (284)
T 2a19_B 214 LLHVCDTAFE--TSKFFTDLRDGIIS------------------------------DIFDKKEKTLLQKLLSKKPEDRPN 261 (284)
T ss_dssp HHSCCSSHHH--HHHHHHHHHTTCCC------------------------------TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhcCCcchh--HHHHHHHhhccccc------------------------------ccCCHHHHHHHHHHccCChhhCcC
Confidence 9999988742 12222222221111 023445899999999999999999
Q ss_pred HHHHHHHHHhhcCCC
Q 001152 1118 AGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ss 1132 (1137)
+.|++++++......
T Consensus 262 ~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 262 TSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHHHHHHHHHTC--
T ss_pred HHHHHHHHHHHhhCC
Confidence 999999999986644
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=342.72 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=205.1
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|+||.||+|.+.+ ..+|+|+..... .. .+. +.+|+.++++++||||+++++++...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~---~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~-- 80 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MS---PDA----FLAEANLMKQLQHQRLVRLYAVVTQE-- 80 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--cc---HHH----HHHHHHHHHhCCCcCcceEEEEEcCC--
Confidence 3679999999999999999999865 578888754221 11 222 37899999999999999999987643
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 81 -------------~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~ 144 (279)
T 1qpc_A 81 -------------PIYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 144 (279)
T ss_dssp -------------SCEEEEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred -------------CcEEEEecCCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC
Confidence 3489999999999999986421 135899999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++......... ......+|+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 145 ~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~el~ 204 (279)
T 1qpc_A 145 T-------LSCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIV 204 (279)
T ss_dssp T-------SCEEECCCTTCEECSSSCEE---------CCTTCCCCTTTSCHHHHHH----CEECHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEECCCcccccccCcccc---------cccCCCCccCccChhhhcc----CCCCchhhhHHHHHHHHHHH
Confidence 7 78999999999765432211 1112357889999999875 45789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||.+....++...+..+..+..+. .+++++.+++.+||+.||++|||+
T Consensus 205 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~~p~~Rps~ 257 (279)
T 1qpc_A 205 THGRIPYPGMTNPEVIQNLERGYRMVRPD---------------------------NCPEELYQLMRLCWKERPEDRPTF 257 (279)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCcccCHHHHHHHHhcccCCCCcc---------------------------cccHHHHHHHHHHhccChhhCCCH
Confidence 9 999999888877777776554322211 334569999999999999999999
Q ss_pred HHHHHHHHhh
Q 001152 1119 GDLYEMFVAR 1128 (1137)
Q Consensus 1119 ~EVL~~L~~~ 1128 (1137)
+++++.+...
T Consensus 258 ~~l~~~l~~~ 267 (279)
T 1qpc_A 258 DYLRSVLEDF 267 (279)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999987654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=362.36 Aligned_cols=291 Identities=20% Similarity=0.254 Sum_probs=187.2
Q ss_pred ceE-eeeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 804 LSS-CDEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 804 y~l-~~~LG~GsfG~Vy~a~~~----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
|++ .++||+|+||+||+|++. +..||+|+.. ..... + .+.+|+.+|+.++|||||++++++....
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~--~~~~~----~----~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGIS----M----SACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECS--SSSCC----H----HHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEEC--CCCCC----H----HHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 555 468999999999999964 4678888743 22211 1 2378999999999999999999996532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET----GEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~----~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
. ...++||||+. ++|.+++...... ....+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 92 ~------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~N 158 (405)
T 3rgf_A 92 D------------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPAN 158 (405)
T ss_dssp T------------TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred C------------CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHH
Confidence 1 16799999996 7898888643321 12359999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||+..+ ....+.+||+|||+++........ ........||+.|+|||++.+ ...++.++|||||||+
T Consensus 159 Ill~~~---~~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~i 225 (405)
T 3rgf_A 159 ILVMGE---GPERGRVKIADMGFARLFNSPLKP-------LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCI 225 (405)
T ss_dssp EEECCS---STTTTCEEECCTTCCC-----------------------CCCTTCCHHHHTT---CCSCCHHHHHHHHHHH
T ss_pred eEEecC---CCCCCcEEEEECCCceecCCCCcc-------cccCCCceecCcccCchhhcC---CCcccchhhhHHHHHH
Confidence 999432 112278999999999765432111 011124579999999999875 2458899999999999
Q ss_pred HHHHHhCCCCCCCCCHH---------HHHHHH-HcCCCCCchhHHhhhccccccc-c-cccC-CCCCCch-------hhh
Q 001152 1035 LLELLTLQVPYMGLSEL---------EIHDLI-QMGKRPRLTDELEALGSCHEHE-V-AQSG-SGFEKPE-------AEL 1094 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~---------el~~~I-~~g~~p~l~~~l~~~~~~~~~~-~-~~~~-~~~~~~~-------~~~ 1094 (1137)
+|+|++|..||.+.... +....+ .....+... .+.......... . .... ..+.... ...
T Consensus 226 l~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (405)
T 3rgf_A 226 FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK-DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304 (405)
T ss_dssp HHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTT-TCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTC
T ss_pred HHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChh-hcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCC
Confidence 99999999999764431 222232 111111100 000000000000 0 0000 0000000 000
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001152 1095 ETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1095 ~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~s 1131 (1137)
..++.+.+||.+||+.||.+|||++|+++|+|+....
T Consensus 305 ~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp CTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 1245689999999999999999999999999998653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=355.34 Aligned_cols=282 Identities=14% Similarity=0.123 Sum_probs=200.6
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHH----hHHhHHHHHHHHHhCCCCCcce
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRN----FEYSCLGEVRMLGALRHSCIVE 869 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~----~~~~~lrEi~iL~~L~HpNIVk 869 (1137)
-.+|++.+.||+|+||.||+|.+.. ..||+|+....... ...+.+. ....+.+|+..+..++||||++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 3579999999999999999999843 57899986433210 0011111 1112356777888899999999
Q ss_pred eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Q 001152 870 MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRD 949 (1137)
Q Consensus 870 llg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrD 949 (1137)
+++++..... .....++||||+ +++|.+++.. ....+++..++.|+.||+.||+|||++||+|||
T Consensus 113 ~~~~~~~~~~----------~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrD 177 (364)
T 3op5_A 113 YWGSGLHDKN----------GKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGD 177 (364)
T ss_dssp EEEEEEEEET----------TEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEeeeeeccC----------CcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEec
Confidence 9999876421 112579999999 8999999976 235699999999999999999999999999999
Q ss_pred CCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHH
Q 001152 950 IKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIW 1029 (1137)
Q Consensus 950 LKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVW 1029 (1137)
|||+|||++.+. .+.+||+|||+++.......... ..........||+.|+|||++.+ ..++.++|||
T Consensus 178 lkp~Nill~~~~-----~~~~kl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~ 245 (364)
T 3op5_A 178 IKASNLLLNYKN-----PDQVYLVDYGLAYRYCPEGVHKA---YAADPKRCHDGTIEFTSIDAHNG----VAPSRRGDLE 245 (364)
T ss_dssp CCGGGEEEESSC-----TTCEEECCCTTCEESSGGGCCCC---SSCCSSCCCCCCTTTCCHHHHTT----CCCCHHHHHH
T ss_pred CCHHHEEEecCC-----CCeEEEEECCcceecccCCcccc---cccCcccccCCCCCccCHHHhCC----CCCCchhhHH
Confidence 999999998321 17899999999976654321110 01111234569999999999875 4689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001152 1030 SYGCLLLELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1108 (1137)
Q Consensus 1030 SLGviL~ELLTG~~Pf~~~~-~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL 1108 (1137)
||||++|||++|+.||.+.. .............+.+...+... .. ...+++++.+++..||
T Consensus 246 slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~-------~~~~~~~~~~li~~cl 307 (364)
T 3op5_A 246 ILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKC-----------FP-------AANAPGEIAKYMETVK 307 (364)
T ss_dssp HHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHH-----------SC-------TTCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHh-----------cc-------cccCHHHHHHHHHHHh
Confidence 99999999999999998532 22222222111111111111100 00 0134667999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhh
Q 001152 1109 EENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1109 ~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+.||.+||++++|++.+...
T Consensus 308 ~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 308 LLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp TCCTTCCCCHHHHHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHH
Confidence 99999999999999887654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=347.32 Aligned_cols=264 Identities=23% Similarity=0.244 Sum_probs=197.5
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
...+.+|++.+.||+|+||.||+|.+. +..||+|+...... ........+.+|+.++++++||||+++++++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-----SDPVFRTRMQREARTAGRLQEPHVVPIHDFGE 104 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-----GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-----cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 445789999999999999999999985 56788887532211 11122234588999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
..+ ..++||||+++++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 105 ~~~--------------~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NI 165 (309)
T 2h34_A 105 IDG--------------QLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165 (309)
T ss_dssp ETT--------------EEEEEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eCC--------------eEEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHE
Confidence 765 679999999999999999762 3689999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++||||||+++
T Consensus 166 l~~~~-------~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 225 (309)
T 2h34_A 166 LVSAD-------DFAYLVDFGIASATTDEKLT---------QLGNTVGTLYYMAPERFSE----SHATYRADIYALTCVL 225 (309)
T ss_dssp EECTT-------SCEEECSCCC-------------------------CCGGGCCGGGTCC--------CCCHHHHHHHHH
T ss_pred EEcCC-------CCEEEecCccCccccccccc---------cccccCCCcCccCHHHHcC----CCCCchHhHHHHHHHH
Confidence 99877 78999999998755432111 1123468999999999875 4678999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|+|++|..||.+.....+...+..... .... .....++++.+++.+||+.||.+|
T Consensus 226 ~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~------------------------~~~~~~~~l~~li~~~l~~dP~~R 280 (309)
T 2h34_A 226 YECLTGSPPYQGDQLSVMGAHINQAIP-RPST------------------------VRPGIPVAFDAVIARGMAKNPEDR 280 (309)
T ss_dssp HHHHHSSCSSCSCHHHHHHHHHHSCCC-CGGG------------------------TSTTCCTHHHHHHHHHTCSSGGGS
T ss_pred HHHHHCCCCCCCchHHHHHHHhccCCC-Cccc------------------------cCCCCCHHHHHHHHHhccCCHHHH
Confidence 999999999987665544444433221 1100 001344569999999999999999
Q ss_pred C-CHHHHHHHHHhhcC
Q 001152 1116 P-TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 P-Sa~EVL~~L~~~~~ 1130 (1137)
| +++++++.+.....
T Consensus 281 p~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 281 YVTCGDLSAAAHAALA 296 (309)
T ss_dssp CSSHHHHHHHHHHTCC
T ss_pred HHhHHHHHHHHHHHHH
Confidence 9 99999999887643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=342.62 Aligned_cols=260 Identities=26% Similarity=0.359 Sum_probs=197.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..|.....||+|+||.||+|.+. +..||+|+..... ....+. +.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~- 92 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQP----LHEEIALHKHLKHKNIVQYLGSFSENG- 92 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HH----HHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHH----HHHHHHHHHhCCCCCEeeEeeEEEeCC-
Confidence 44555568999999999999985 4567888654221 112222 478999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++++|.+++... .....+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 93 -------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 157 (295)
T 2clq_A 93 -------------FIKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 157 (295)
T ss_dssp -------------EEEEEEECCSEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred -------------cEEEEEEeCCCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC
Confidence 679999999999999999762 22346789999999999999999999999999999999999986
Q ss_pred -ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 960 -ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 960 -~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
+ +.+||+|||++........ ......||+.|+|||++.+. ...++.++||||||+++|+|
T Consensus 158 ~~-------~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~l 218 (295)
T 2clq_A 158 YS-------GVLKISDFGTSKRLAGINP----------CTETFTGTLQYMAPEIIDKG--PRGYGKAADIWSLGCTIIEM 218 (295)
T ss_dssp TT-------CCEEECCTTTCEESCC---------------CCCCCCGGGCCHHHHHHG--GGGCSHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEeecccccccCCCCC----------cccccCCCccccChhhhcCC--CCCCCcHHHHHHHHHHHHHH
Confidence 4 6899999999876543211 11234689999999998752 13478999999999999999
Q ss_pred HhCCCCCCCCCHHHH-H-HHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1039 LTLQVPYMGLSELEI-H-DLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el-~-~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
++|..||........ . ........+.++ ...++++.+++.+||+.||++||
T Consensus 219 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~li~~~l~~dp~~Rp 271 (295)
T 2clq_A 219 ATGKPPFYELGEPQAAMFKVGMFKVHPEIP---------------------------ESMSAEAKAFILKCFEPDPDKRA 271 (295)
T ss_dssp HHTSCTTGGGSSHHHHHHHHHHHCCCCCCC---------------------------TTSCHHHHHHHHHTTCSSTTTSC
T ss_pred HHCCCCccCCCchhHHHHhhcccccccccc---------------------------ccCCHHHHHHHHHHccCChhhCC
Confidence 999999975432221 1 111111111111 13455699999999999999999
Q ss_pred CHHHHHHHHHhhcCC
Q 001152 1117 TAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~s 1131 (1137)
|++|+++|+|+....
T Consensus 272 s~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 272 CANDLLVDEFLKVSS 286 (295)
T ss_dssp CHHHHHTSGGGCC--
T ss_pred CHHHHhcChhhhhcc
Confidence 999999999998543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=349.18 Aligned_cols=291 Identities=20% Similarity=0.231 Sum_probs=197.8
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+.+|++.+.||+|+||.||+|++.+..||+|++.... ...+ ....|+..+..++||||+++++++...
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-------~~~~--~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-------RQNF--INEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-------HHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-------hhhH--HHHHHHHHHHhccCcchhhheeccccc
Confidence 4467899999999999999999999999999999865321 1111 012344445568999999999876542
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------Ceeec
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK---------HIMHR 948 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~---------gIIHr 948 (1137)
.. ......++||||+++|+|.+++.. ...++..+..|+.||+.||+|||++ ||+||
T Consensus 80 ~~---------~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~ 144 (336)
T 3g2f_A 80 TA---------DGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR 144 (336)
T ss_dssp CT---------TSCEEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECS
T ss_pred cc---------CCCceEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeec
Confidence 21 012267999999999999999976 2468999999999999999999999 99999
Q ss_pred cCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC---CCCCCch
Q 001152 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK---PNLYGLE 1025 (1137)
Q Consensus 949 DLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---~~~~s~k 1025 (1137)
||||+|||++.+ +.+||+|||+++........... ..........||+.|+|||++.+... ...++.+
T Consensus 145 Dikp~Nill~~~-------~~~kL~DFG~a~~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 215 (336)
T 3g2f_A 145 DLNSRNVLVKND-------GTCVISDFGLSMRLTGNRLVRPG--EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215 (336)
T ss_dssp SCSGGGEEECTT-------SCEEECCCTTCEECSSSSCC-----------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH
T ss_pred ccccceEEEcCC-------CcEEEeeccceeecccccccCcc--ccccccccCCCccceeCchhhcCCcccccccccccc
Confidence 999999999977 78999999999765432211000 00011224469999999999875211 0235679
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCH-HH--HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCch---hhhhhHHH
Q 001152 1026 VDIWSYGCLLLELLTLQVPYMGLSE-LE--IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE---AELETLSF 1099 (1137)
Q Consensus 1026 sDVWSLGviL~ELLTG~~Pf~~~~~-~e--l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 1099 (1137)
+|||||||++|||++|..||..... .+ .......+..+......... .........+. ....++++
T Consensus 216 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
T 3g2f_A 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV--------SREKQRPKFPEAWKENSLAVRS 287 (336)
T ss_dssp HHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHH--------TTSCCCCCCCTTCCCCSHHHHH
T ss_pred cchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhh--------cccccCCCCCcccccccchHHH
Confidence 9999999999999999777643211 00 00000111111111000000 00000000000 01246778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1100 LVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1100 L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+.+|+.+||+.||.+|||+.||++.+....
T Consensus 288 l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 288 LKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 999999999999999999999999887754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=358.04 Aligned_cols=283 Identities=19% Similarity=0.222 Sum_probs=212.4
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHH---------HHHhHHhHHHHHHHHHhCCCCCccee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADE---------IRNFEYSCLGEVRMLGALRHSCIVEM 870 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~---------~e~~~~~~lrEi~iL~~L~HpNIVkl 870 (1137)
.+.+|++.+.||+|+||.||+|.+.+..||+|+............ .......+.+|+.++++++||||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 457899999999999999999999889999998754422111000 00000234889999999999999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHH------HHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 001152 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNY------IEKLSETGEKHVSVKLALFIAQDVAAALVELHS-K 943 (1137)
Q Consensus 871 lg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~------L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~ 943 (1137)
++++.+.+ ..++||||+++++|.++ +.. .....+++..++.|+.||+.||+|||+ +
T Consensus 109 ~~~~~~~~--------------~~~lv~e~~~~~~L~~~~~~~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 171 (348)
T 2pml_X 109 EGIITNYD--------------EVYIIYEYMENDSILKFDEYFFVLDK---NYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171 (348)
T ss_dssp SEEEESSS--------------EEEEEEECCTTCBSSEESSSEESSCS---SSCCCCCHHHHHHHHHHHHHHHHHHHHTS
T ss_pred EEEEeeCC--------------eEEEEEeccCCCcHHHHHHHhhhhhh---ccccCCCHHHHHHHHHHHHHHHHHHhccC
Confidence 99998765 67999999999999998 432 224579999999999999999999999 9
Q ss_pred CeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCC
Q 001152 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1023 (1137)
Q Consensus 944 gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s 1023 (1137)
||+||||||+|||++.+ +.+||+|||.+........ ....||+.|+|||++.+. ..++
T Consensus 172 ~i~H~dl~p~Nil~~~~-------~~~kl~dfg~~~~~~~~~~------------~~~~~~~~y~aPE~~~~~---~~~~ 229 (348)
T 2pml_X 172 NICHRDVKPSNILMDKN-------GRVKLSDFGESEYMVDKKI------------KGSRGTYEFMPPEFFSNE---SSYN 229 (348)
T ss_dssp CEECCCCCGGGEEECTT-------SCEEECCCTTCEECBTTEE------------CSSCSCGGGCCGGGGSSC---CCEE
T ss_pred CEeecCCChHhEEEcCC-------CcEEEeccccccccccccc------------cCCCCCcCccCchhhcCC---CCCC
Confidence 99999999999999887 7899999999876543211 134689999999998752 2444
Q ss_pred c-hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001152 1024 L-EVDIWSYGCLLLELLTLQVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1101 (1137)
Q Consensus 1024 ~-ksDVWSLGviL~ELLTG~~Pf~~~~~-~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1101 (1137)
. ++|||||||++|+|++|..||..... .++...+..+.... +..... .................++++.
T Consensus 230 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~ 300 (348)
T 2pml_X 230 GAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY-PLDRNH--------FLYPLTNKKSTCSNNFLSNEDI 300 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCC-CCSSSS--------STTTTCC--------CCCHHHH
T ss_pred cchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCC-ccchhh--------hhccccccccccchhhcCHHHH
Confidence 5 99999999999999999999987665 66666665543221 100000 0000000000011124567799
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1102 DVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1102 dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
+|+.+||+.||.+|||++|+++|+|+...
T Consensus 301 ~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 301 DFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=348.17 Aligned_cols=269 Identities=22% Similarity=0.321 Sum_probs=198.0
Q ss_pred ceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 804 LSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~------~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
|++.+.||+|+||+||++.+ .+..||+|+.... ......+. +.+|+.++++++||||+++++++.+.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSG----WKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHH----HHHHHHHHHhCCCcchhhEEEEEecC
Confidence 49999999999999999876 3567889886432 12333333 48899999999999999999999864
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+. ...++||||+++++|.+++.. ..+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 106 ~~------------~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~ 167 (318)
T 3lxp_A 106 GA------------ASLQLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL 167 (318)
T ss_dssp TT------------TEEEEEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CC------------ceEEEEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE
Confidence 31 167999999999999999865 349999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++|||||||++|+
T Consensus 168 ~~~-------~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 229 (318)
T 3lxp_A 168 DND-------RLVKIGDFGLAKAVPEGHEYY-------RVREDGDSPVFWYAPECLKE----YKFYYASDVWSFGVTLYE 229 (318)
T ss_dssp CTT-------CCEEECCGGGCEECCTTCSEE-------EC---CCCCGGGCCHHHHHH----CEEEHHHHHHHHHHHHHH
T ss_pred cCC-------CCEEECCcccccccccccccc-------ccccCCCCCceeeChHHhcC----CCCCcHHHHHHHHHHHHH
Confidence 877 789999999997654422110 01123458889999999976 457799999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchh-HHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTD-ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++|..||...... ... ........... .+... ... .... .....+++++.+|+.+||+.||.+||
T Consensus 230 ll~g~~p~~~~~~~-~~~-~~~~~~~~~~~~~~~~~-------~~~-~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rp 296 (318)
T 3lxp_A 230 LLTHCDSSQSPPTK-FLE-LIGIAQGQMTVLRLTEL-------LER-GERL---PRPDKCPAEVYHLMKNCWETEASFRP 296 (318)
T ss_dssp HHTTTCGGGSHHHH-HHH-HHCSCCHHHHHHHHHHH-------HHT-TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCcccccchh-hhh-hhcccccchhHHHHHHH-------Hhc-ccCC---CCCccccHHHHHHHHHHcCCCcccCc
Confidence 99999999753211 111 00000000000 00000 000 0000 00114566799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001152 1117 TAGDLYEMFVAR 1128 (1137)
Q Consensus 1117 Sa~EVL~~L~~~ 1128 (1137)
|++|+++.+...
T Consensus 297 s~~ell~~L~~l 308 (318)
T 3lxp_A 297 TFENLIPILKTV 308 (318)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999988765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=342.70 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=198.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC---Cc--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG---SA--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~---~~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..+|++.+.||+|+||+||+|++. +. .||+|+....... .....+ ++.+|+.++++++||||+++++++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMD----DFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHH----HHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHH----HHHHHHHHHHhCCCCCcccEEEEEc
Confidence 457999999999999999999863 22 3677764322111 112223 3488999999999999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
... .++||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 92 ~~~---------------~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Ni 152 (291)
T 1u46_A 92 TPP---------------MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 152 (291)
T ss_dssp SSS---------------CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred cCC---------------ceeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheE
Confidence 543 48999999999999999763 24589999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++.......... .......+|+.|+|||++.+ ..++.++||||||+++
T Consensus 153 li~~~-------~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~il 214 (291)
T 1u46_A 153 LLATR-------DLVKIGDFGLMRALPQNDDHY-------VMQEHRKVPFAWCAPESLKT----RTFSHASDTWMFGVTL 214 (291)
T ss_dssp EEEET-------TEEEECCCTTCEECCC-CCEE-------EC-----CCGGGCCHHHHHH----CEEEHHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEccccccccccccccch-------hhhccCCCCceeeCchhhcC----CCCCchhhHHHHHHHH
Confidence 99987 789999999987654322110 01123357889999999876 4578999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+|++ |..||.+....++...+......... ...+++++.+++.+||+.||.+
T Consensus 215 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~~p~~ 268 (291)
T 1u46_A 215 WEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--------------------------PEDCPQDIYNVMVQCWAHKPED 268 (291)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--------------------------CcCcCHHHHHHHHHHccCCccc
Confidence 99999 99999988888777776543321100 0134556999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 001152 1115 RPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~s 1131 (1137)
|||+.++++++......
T Consensus 269 Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 269 RPTFVALRDFLLEAQPT 285 (291)
T ss_dssp SCCHHHHHHHHHHHC--
T ss_pred CcCHHHHHHHHHHhCcc
Confidence 99999999999877543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=345.60 Aligned_cols=267 Identities=27% Similarity=0.362 Sum_probs=203.5
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHh--CCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGA--LRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~--L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|++.+..||+|++... ..+. +.+|++++.. ++||||+++++++.....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------~~~~----~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERS----WFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-------GHHH----HHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-------hHHH----HHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 57999999999999999999999999999986322 1222 3678888887 789999999999886531
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeeccCC
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--------SKHIMHRDIK 951 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLH--------s~gIIHrDLK 951 (1137)
.....++||||+++|+|.+++.. ..+++..++.++.||+.||+||| ++||+|||||
T Consensus 111 ----------~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk 174 (342)
T 1b6c_B 111 ----------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174 (342)
T ss_dssp ----------SCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCS
T ss_pred ----------ccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCC
Confidence 11257999999999999999976 35899999999999999999999 8999999999
Q ss_pred CCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCC--CCCchhhHH
Q 001152 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN--LYGLEVDIW 1029 (1137)
Q Consensus 952 P~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~--~~s~ksDVW 1029 (1137)
|+|||++.+ +.+||+|||++........... .......||+.|+|||++.+..... .++.++|||
T Consensus 175 p~NIll~~~-------~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~ 241 (342)
T 1b6c_B 175 SKNILVKKN-------GTCCIADLGLAVRHDSATDTID------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 241 (342)
T ss_dssp GGGEEECTT-------SCEEECCCTTCEEEETTTTEEE------ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHH
T ss_pred HHHEEECCC-------CCEEEEECCCceeccccccccc------cccccCCcCcccCCHhhhcccccccccccCCcccHH
Confidence 999999887 7899999999976544321100 0112346999999999987522111 233789999
Q ss_pred HHHHHHHHHHhC----------CCCCCCC-----CHHHHHHHHHc-CCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 001152 1030 SYGCLLLELLTL----------QVPYMGL-----SELEIHDLIQM-GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1093 (1137)
Q Consensus 1030 SLGviL~ELLTG----------~~Pf~~~-----~~~el~~~I~~-g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1137)
||||++|||++| ..||... ....+...+.. ...+.++..+ ..
T Consensus 242 slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~ 299 (342)
T 1b6c_B 242 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----------------------QS 299 (342)
T ss_dssp HHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----------------------GT
T ss_pred HHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc----------------------cc
Confidence 999999999999 7888653 22333333322 1222222111 11
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1094 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1094 ~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
..+++.+.+|+.+||+.||++|||+.||++++.....
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 300 CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp SHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 2566789999999999999999999999999987643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=354.71 Aligned_cols=281 Identities=20% Similarity=0.260 Sum_probs=205.7
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCC-----cceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSC-----IVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpN-----IVkllg 872 (1137)
..+|++.+.||+|+||+||+|.+. +..||+|+.... ....+ .+.+|+.+++.++ |++ |+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~----~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLN----QAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHH----HHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHH----HHHHHHHHHHHHHhcccccceeEEEeee
Confidence 578999999999999999999985 467888875421 22222 2367888888886 554 899999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELH--SKHIMHRDI 950 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLH--s~gIIHrDL 950 (1137)
++...+ +.++||||++ ++|.+++... ....+++..+..|+.||+.||.||| +.||+||||
T Consensus 124 ~~~~~~--------------~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDl 185 (382)
T 2vx3_A 124 HFMFRN--------------HLCLVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDL 185 (382)
T ss_dssp EEEETT--------------EEEEEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCC
T ss_pred eeccCC--------------ceEEEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCC
Confidence 988765 6799999996 6999999862 2245899999999999999999999 469999999
Q ss_pred CCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHH
Q 001152 951 KSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWS 1030 (1137)
Q Consensus 951 KP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWS 1030 (1137)
||+|||++.+. .+.+||+|||+++...... ....||+.|+|||++.+ ..++.++||||
T Consensus 186 kp~NIll~~~~-----~~~~kL~DFG~a~~~~~~~-------------~~~~~t~~y~aPE~~~~----~~~~~~~DiwS 243 (382)
T 2vx3_A 186 KPENILLCNPK-----RSAIKIVDFGSSCQLGQRI-------------YQYIQSRFYRSPEVLLG----MPYDLAIDMWS 243 (382)
T ss_dssp SGGGEEESSTT-----SCCEEECCCTTCEETTCCC-------------CSSCSCGGGCCHHHHTT----CCCCTHHHHHH
T ss_pred CcccEEEecCC-----CCcEEEEeccCceeccccc-------------ccccCCccccChHHHcC----CCCCcHHHHHH
Confidence 99999996431 1679999999997654311 13468999999999976 46889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcc-------cccccc-----cccCCCCCCc--------
Q 001152 1031 YGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS-------CHEHEV-----AQSGSGFEKP-------- 1090 (1137)
Q Consensus 1031 LGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~-------~~~~~~-----~~~~~~~~~~-------- 1090 (1137)
|||++|||++|+.||.+.+..+....+...........+...+. .....+ ......+..+
T Consensus 244 lG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 323 (382)
T 2vx3_A 244 LGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNI 323 (382)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHH
Confidence 99999999999999999888777766644322111111110000 000000 0000000000
Q ss_pred ----------------hhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1091 ----------------EAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1091 ----------------~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
.......+++.+||.+||+.||++|||++|+++|+|+...
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 324 LGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 0011234579999999999999999999999999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=345.94 Aligned_cols=286 Identities=17% Similarity=0.173 Sum_probs=204.7
Q ss_pred CCCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC------cceee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC------IVEMY 871 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~---~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpN------IVkll 871 (1137)
..+|++.+.||+|+||+||+|.+.. ..||+|+.... ....+ .+.+|+.+++.++|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~----~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----GKYRE----AARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-----HHHHH----HHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-----ccchh----HHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 3689999999999999999999843 56888885321 22222 3478999999987665 88999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLK 951 (1137)
+++.... +.++||||+ +++|.+++.. .....+++..++.|+.||+.||+|||++||+|||||
T Consensus 89 ~~~~~~~--------------~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlk 150 (355)
T 2eu9_A 89 DWFNFHG--------------HMCIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLK 150 (355)
T ss_dssp EEEEETT--------------EEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred eeeeeCC--------------eEEEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 9888665 679999999 5788887765 223469999999999999999999999999999999
Q ss_pred CCCeEeccccc------------cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 952 SENILIDLERK------------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 952 P~NILld~~~~------------~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
|+|||++.... .....+.+||+|||+++...... ....||+.|+|||++.+
T Consensus 151 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~---- 213 (355)
T 2eu9_A 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-------------TTIVATRHYRPPEVILE---- 213 (355)
T ss_dssp GGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-------------CSSCSCGGGCCHHHHTT----
T ss_pred HHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc-------------cCCcCCCcccCCeeeec----
Confidence 99999943210 00123789999999987533211 13469999999999975
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccc----ccc-----------ccccC
Q 001152 1020 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCH----EHE-----------VAQSG 1084 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~----~~~-----------~~~~~ 1084 (1137)
..++.++|||||||++|||++|..||......+....+.....+.....+....... ... .....
T Consensus 214 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
T 2eu9_A 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293 (355)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccC
Confidence 568899999999999999999999999877766555553322221111111100000 000 00000
Q ss_pred CCC-CCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1085 SGF-EKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1085 ~~~-~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
... .........++++.+|+.+||+.||.+|||++|+++|+|+...
T Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred CcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 000 0000012446689999999999999999999999999999853
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=341.62 Aligned_cols=278 Identities=20% Similarity=0.284 Sum_probs=196.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|++. +..+|+|+.... ....+. +.+|+.++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~----~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLST----ILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHH----HHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 46899999999999999999974 577888875322 223333 4889999999999999999999876431
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
+...- .........++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 77 ~~~~~-~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 77 FVKPM-TAVKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCC-------CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred hhhhh-cccccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC
Confidence 10000 001123378999999999999999976 2346889999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccc----cCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIA----HRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~----~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
+ +.+||+|||++............. ...........||+.|+|||++.+ ...++.++|||||||++
T Consensus 152 ~-------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il 221 (303)
T 1zy4_A 152 S-------RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG---TGHYNEKIDMYSLGIIF 221 (303)
T ss_dssp T-------SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS---CSCCCTHHHHHHHHHHH
T ss_pred C-------CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC---CCCCcchhhHHHHHHHH
Confidence 7 789999999987654321100000 000011224468999999999874 23678999999999999
Q ss_pred HHHHhCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLTLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~-~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+|++ ||... ...+....+..... .++.. .....++.+.+++.+||+.||.+
T Consensus 222 ~~l~~---p~~~~~~~~~~~~~~~~~~~-~~~~~-----------------------~~~~~~~~~~~li~~~l~~dp~~ 274 (303)
T 1zy4_A 222 FEMIY---PFSTGMERVNILKKLRSVSI-EFPPD-----------------------FDDNKMKVEKKIIRLLIDHDPNK 274 (303)
T ss_dssp HHHHS---CCSSHHHHHHHHHHHHSTTC-CCCTT-----------------------CCTTTSHHHHHHHHHHTCSSGGG
T ss_pred HHHHh---ccCCchhHHHHHHhcccccc-ccCcc-----------------------ccccchHHHHHHHHHHHhcCccc
Confidence 99998 56432 22333334433221 11110 01134556899999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
|||++++++|+|+...
T Consensus 275 Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 275 RPGARTLLNSGWLPVK 290 (303)
T ss_dssp SCCHHHHHHSSCSCCC
T ss_pred CcCHHHHhCCCCcCCC
Confidence 9999999999999643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.87 Aligned_cols=269 Identities=21% Similarity=0.290 Sum_probs=206.5
Q ss_pred CCCCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.....+|++.+.||+|+||.||+|++.+ .+|+|+...... .....+.+ .+|+.++++++||||+++++++.+.
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~--~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERD--NEDQLKAF----KREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSC--CCCCCCCC----CTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCC--CHHHHHHH----HHHHHHHhcCCCCCEeEEEEEEecC
Confidence 3456789999999999999999999875 588887543322 12222223 6789999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+++++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 102 ~--------------~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~ 163 (319)
T 2y4i_B 102 P--------------HLAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY 163 (319)
T ss_dssp S--------------CEEEECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE
T ss_pred C--------------ceEEEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE
Confidence 5 56999999999999999865 23468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-----CCCCCCchhhHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-----KPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-----~~~~~s~ksDVWSLG 1032 (1137)
+ + +.+||+|||++.......... .........||+.|+|||++.+.. ....++.++||||||
T Consensus 164 ~-~-------~~~~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG 230 (319)
T 2y4i_B 164 D-N-------GKVVITDFGLFSISGVLQAGR-----REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230 (319)
T ss_dssp C----------CCEECCCSCCC---------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHH
T ss_pred e-C-------CCEEEeecCCccccccccccc-----cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHH
Confidence 7 3 579999999986543211110 011122345889999999987521 124578999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
|++|+|++|..||.......+...+..+..+..... ..++++.+++.+||+.||
T Consensus 231 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~l~~li~~~l~~~p 284 (319)
T 2y4i_B 231 TIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI--------------------------GMGKEISDILLFCWAFEQ 284 (319)
T ss_dssp HHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCS--------------------------SCCTTHHHHHHHHHCSST
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcC--------------------------CCCHHHHHHHHHHhcCCh
Confidence 999999999999998888877777766554332210 123348999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001152 1113 TERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~ 1130 (1137)
.+|||+.++++.+.....
T Consensus 285 ~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 285 EERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp TTSCCHHHHHHHHTTC--
T ss_pred hhCcCHHHHHHHHHHHHH
Confidence 999999999999887643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=356.80 Aligned_cols=289 Identities=20% Similarity=0.230 Sum_probs=208.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||+||+|++. +..||+|+........ ..+ .+.+|+.++++++||||+++++++.....
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~----~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVD----VQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS---CHH----HHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc---hHH----HHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 46999999999999999999986 5779999864322111 122 23789999999999999999999876441
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
...++||||+++|+|.++++... ....+++..++.|+.||+.||+|||++||+||||||+|||+..
T Consensus 82 ------------~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 147 (396)
T 4eut_A 82 ------------RHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147 (396)
T ss_dssp ------------CCEEEEECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE
T ss_pred ------------CeeEEEEecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEee
Confidence 15699999999999999997532 1234999999999999999999999999999999999999832
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccC----CCCCCchhhHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK----PNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~----~~~~s~ksDVWSLGviL 1035 (1137)
+ ..+.+.+||+|||+++........ ....||+.|+|||++.+... ...++.++|||||||++
T Consensus 148 ~---~~~~~~~kL~DFG~a~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il 213 (396)
T 4eut_A 148 G---EDGQSVYKLTDFGAARELEDDEQF-----------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (396)
T ss_dssp C---TTSCEEEEECCGGGCEECCCGGGS-----------SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred c---CCCceeEEEecCCCceEccCCCcc-----------ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence 2 112267999999999765432211 13469999999999864110 02467899999999999
Q ss_pred HHHHhCCCCCCC----CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccC
Q 001152 1036 LELLTLQVPYMG----LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEEN 1111 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~----~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~D 1111 (1137)
|||++|+.||.. ....++...+..+..+............. ..+.. .. ..........++.+.+++.+||+.|
T Consensus 214 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~-~~~~~-~~-~~~~~l~~~~~~~l~~ll~~~L~~d 290 (396)
T 4eut_A 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP-IDWSG-DM-PVSCSLSRGLQVLLTPVLANILEAD 290 (396)
T ss_dssp HHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCC-EEEES-SC-CTTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred HHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCC-cccCc-cC-CcccccchHHHhhchHHHHHhhccC
Confidence 999999999964 23344555555554332221111100000 00000 00 0011122367788999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 001152 1112 PTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1112 P~~RPSa~EVL~~L~~~ 1128 (1137)
|++||+++|+++++..+
T Consensus 291 P~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 291 QEKCWGFDQFFAETSDI 307 (396)
T ss_dssp TTTSCCHHHHHHHHHHH
T ss_pred hhhhccHHHHHHHHHHH
Confidence 99999999999988765
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=351.93 Aligned_cols=283 Identities=18% Similarity=0.192 Sum_probs=205.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|.+.+.||+|+||.||+|.+. +..||+|+... ........+ ++.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--PFQSEIFAK----RAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESS--TTSSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecc--cccchHHHH----HHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 57999999999999999999985 56788887532 222222223 34889999999999999999999876542
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ......++||||+. ++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 98 ~--------~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~ 161 (353)
T 3coi_A 98 L--------RNFYDFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 161 (353)
T ss_dssp G--------GGCCCCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT
T ss_pred c--------ccceeEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC
Confidence 1 11224699999997 78887763 24999999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||++....... ....+|+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 162 ~-------~~~kl~Dfg~~~~~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~ 218 (353)
T 3coi_A 162 D-------CELKILDFGLARHADAEM-------------TGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEML 218 (353)
T ss_dssp T-------CCEEECSTTCTTC---------------------CCSBCCSCHHHHSC---CSCCCTTHHHHHHHHHHHHHH
T ss_pred C-------CcEEEeecccccCCCCCc-------------cccccCcCcCCHHHHhC---cCCCCchhhHHHHHHHHHHHH
Confidence 7 789999999987543211 13468999999999874 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccc---cCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ---SGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|..||.+.+..+....+........................+ ..............++++.+|+.+||+.||.+||
T Consensus 219 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp 298 (353)
T 3coi_A 219 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298 (353)
T ss_dssp HSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC
Confidence 9999999888777666553321111111110000000000000 0000001111125567899999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|++|+++|+|+..
T Consensus 299 t~~e~l~hp~f~~ 311 (353)
T 3coi_A 299 TAAQALTHPFFEP 311 (353)
T ss_dssp CHHHHHTSGGGTT
T ss_pred CHHHHhcCcchhh
Confidence 9999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=373.22 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=209.1
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.++||+|+||.||+|.+.+ ..||||+.+... .. .+. +.+|+.+|++++|||||++++++.+ .
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~---~~~----~~~E~~~l~~l~hpniv~~~~~~~~-~- 334 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSE-E- 334 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SC---HHH----HHHHHHHHHHCCCTTBCCEEEEECS-S-
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CC---HHH----HHHHHHHHHhCCCCCEeeEEEEEee-c-
Confidence 4579999999999999999999975 568888754322 11 223 3889999999999999999999865 2
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..+|||||+++|+|.++++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 335 -------------~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~ 398 (535)
T 2h8h_A 335 -------------PIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 398 (535)
T ss_dssp -------------SCEEEECCCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred -------------cceEeeehhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcC
Confidence 3599999999999999997521 235899999999999999999999999999999999999988
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||+
T Consensus 399 ~-------~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwSlGv~l~el~ 458 (535)
T 2h8h_A 399 N-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELT 458 (535)
T ss_dssp G-------GCEEECCTTSTTTCCCHHHH---------TTCSTTSCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHT
T ss_pred C-------CcEEEcccccceecCCCcee---------cccCCcCcccccCHHHhcc----CCCCchhhHHHHHHHHHHHH
Confidence 7 78999999999765432111 0112346789999999876 46889999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+ |..||.+....++...+..+.+...+. .+++.+.+||.+||+.||++|||+
T Consensus 459 t~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~RPt~ 511 (535)
T 2h8h_A 459 TKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERPTF 511 (535)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCChhHCcCH
Confidence 9 999999988888888776654332221 345569999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
++|++.|.....
T Consensus 512 ~~l~~~L~~~~~ 523 (535)
T 2h8h_A 512 EYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHHHHTSSC
T ss_pred HHHHHHHHHHhh
Confidence 999999987644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=377.82 Aligned_cols=249 Identities=21% Similarity=0.334 Sum_probs=199.7
Q ss_pred eeecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
++||+|+||.||+|.+. +..||||+.+... ......+ .+.+|+.+|++++|||||++++++...
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~------ 442 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKD----ELLAEANVMQQLDNPYIVRMIGICEAE------ 442 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHH----HHHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEecC------
Confidence 48999999999999762 3568888754332 1122223 348999999999999999999998643
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
..++||||+++|+|.++++. ...+++..++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus 443 ---------~~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~--- 505 (635)
T 4fl3_A 443 ---------SWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--- 505 (635)
T ss_dssp ---------SEEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---
T ss_pred ---------CEEEEEEccCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC---
Confidence 35899999999999999976 3469999999999999999999999999999999999999987
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQ 1042 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~ 1042 (1137)
+.+||+|||+++......... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |+
T Consensus 506 ----~~~kL~DFGla~~~~~~~~~~-------~~~~~~~~t~~y~APE~~~~----~~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 506 ----HYAKISDFGLSKALRADENYY-------KAQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp ----TEEEECCTTHHHHTTC--------------------CGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----CCEEEEEcCCccccccCcccc-------ccccCCCCceeeeChhhhcC----CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 789999999997654322110 11112346789999999976 568999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001152 1043 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1122 (1137)
Q Consensus 1043 ~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL 1122 (1137)
.||.+....++...+..+..+..+. .+++++.+||.+||+.||++||++++|+
T Consensus 571 ~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPs~~~l~ 623 (635)
T 4fl3_A 571 KPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDVENRPGFAAVE 623 (635)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 9999999888888887766543332 3455699999999999999999999999
Q ss_pred HHHHh
Q 001152 1123 EMFVA 1127 (1137)
Q Consensus 1123 ~~L~~ 1127 (1137)
+.+..
T Consensus 624 ~~L~~ 628 (635)
T 4fl3_A 624 LRLRN 628 (635)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=374.80 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=200.3
Q ss_pred CCceEee-eecccCceEEEEEEEC----CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 802 PSLSSCD-EAGKSVSSSLFRCKFG----SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 802 ~~y~l~~-~LG~GsfG~Vy~a~~~----~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
.++.+.+ .||+|+||.||+|.+. +..||||+.+.. .. ....+. +.+|+.+|++++|||||++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~-~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TE-KADTEE----MMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC--CS-STTHHH----HHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC--CC-hHHHHH----HHHHHHHHHhCCCCCEeeEEEEecc
Confidence 3455555 8999999999999873 245777774322 11 222333 3889999999999999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
+ ..++||||+++|+|.+++.. ....+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 408 ~---------------~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL 468 (613)
T 2ozo_A 408 E---------------ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468 (613)
T ss_dssp S---------------SEEEEEECCTTCBHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred C---------------CeEEEEEeCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEE
Confidence 3 46999999999999999864 2346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+++......... .......+|+.|+|||++.+ ..++.++|||||||++|
T Consensus 469 l~~~-------~~vkL~DFGla~~~~~~~~~~-------~~~~~~~~~~~y~APE~~~~----~~~~~~sDvwSlGv~l~ 530 (613)
T 2ozo_A 469 LVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTMW 530 (613)
T ss_dssp EEET-------TEEEECCCSTTTTCC---------------------CCTTSCHHHHHH----CCCCHHHHHHHHHHHHH
T ss_pred EcCC-------CcEEEeeccCcccccCCCcee-------eeccCCCCccceeCHhhhcC----CCCCcHHHHHHHHHHHH
Confidence 9987 789999999997654322110 01112245689999999976 56899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
||++ |..||.+....++...+..+.....+. .+++++.+||.+||+.||++|
T Consensus 531 ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~R 583 (613)
T 2ozo_A 531 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWEDR 583 (613)
T ss_dssp HHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSTTTS
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCChhHC
Confidence 9998 999999988888888887766443322 345569999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001152 1116 PTAGDLYEMFVA 1127 (1137)
Q Consensus 1116 PSa~EVL~~L~~ 1127 (1137)
|++.+|++.|..
T Consensus 584 Ps~~~l~~~L~~ 595 (613)
T 2ozo_A 584 PDFLTVEQRMRA 595 (613)
T ss_dssp CCHHHHHHHHHH
T ss_pred cCHHHHHHHHHH
Confidence 999999776554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=349.33 Aligned_cols=287 Identities=19% Similarity=0.242 Sum_probs=203.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-----------CCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HSC 866 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-----------HpN 866 (1137)
...+|++.+.||+|+||+||+|++. +..||+|+.... ....+. +.+|+.+++++. |||
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~----~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEA----AEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHH----HHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhh----hhHHHHHHHHhhcccccchhccccch
Confidence 3468999999999999999999974 577888875421 222223 377999988886 899
Q ss_pred cceeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-Ce
Q 001152 867 IVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HI 945 (1137)
Q Consensus 867 IVkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gI 945 (1137)
|+++++++.... ......++||||+ +++|.+++... ....+++..+..|+.||+.||+|||++ ||
T Consensus 88 i~~~~~~~~~~~----------~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~i 153 (373)
T 1q8y_A 88 ILKLLDHFNHKG----------PNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCGI 153 (373)
T ss_dssp BCCCCEEEEEEE----------TTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred HHHHHHHhhccC----------CCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCCE
Confidence 999999987643 1123679999999 89999999863 234599999999999999999999998 99
Q ss_pred eeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCch
Q 001152 946 MHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1025 (1137)
Q Consensus 946 IHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~k 1025 (1137)
+||||||+|||++.++. ....+.+||+|||++....... ....||+.|+|||++.+ ..++.+
T Consensus 154 vH~Dikp~NIll~~~~~-~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~t~~y~aPE~~~~----~~~~~~ 215 (373)
T 1q8y_A 154 IHTDIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEHY-------------TNSIQTREYRSPEVLLG----APWGCG 215 (373)
T ss_dssp ECSCCSGGGEEEEEEET-TTTEEEEEECCCTTCEETTBCC-------------CSCCSCGGGCCHHHHHT----CCCCTH
T ss_pred EecCCChHHeEEeccCC-CcCcceEEEcccccccccCCCC-------------CCCCCCccccCcHHHhC----CCCCch
Confidence 99999999999965421 1122579999999997654321 12368999999999976 468899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHc--CCCCCchhHHhhhcccc-----cccccccCCCCCC---
Q 001152 1026 VDIWSYGCLLLELLTLQVPYMGLSE------LEIHDLIQM--GKRPRLTDELEALGSCH-----EHEVAQSGSGFEK--- 1089 (1137)
Q Consensus 1026 sDVWSLGviL~ELLTG~~Pf~~~~~------~el~~~I~~--g~~p~l~~~l~~~~~~~-----~~~~~~~~~~~~~--- 1089 (1137)
+|||||||++|||++|..||..... .+....+.. +..| ..+....... .............
T Consensus 216 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (373)
T 1q8y_A 216 ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP---SYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 292 (373)
T ss_dssp HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCC---HHHHHHCTTHHHHBCC--CBSSCCCCCBCCH
T ss_pred HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCC---HHHHhccchhhhhcCCcchhcccccccccch
Confidence 9999999999999999999986432 222222211 1111 1110000000 0000000000000
Q ss_pred -------chhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1090 -------PEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1090 -------~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
.......++++.+||.+||+.||.+|||++||++|+|+...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 293 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 00113567889999999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=335.41 Aligned_cols=263 Identities=17% Similarity=0.160 Sum_probs=194.7
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
-.+|++.+.||+|+||.||+|++ .+..||+|+....... + ++.+|+.+++.++|++++..+.++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------P----QLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------C----CHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------h----HHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 36799999999999999999996 4577888875433211 1 2377999999999988887777664432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe-
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI- 957 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl- 957 (1137)
...++||||+ +++|.+++... ...+++..+..|+.||+.||+|||++||+||||||+|||+
T Consensus 78 -------------~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 139 (296)
T 4hgt_A 78 -------------DYNVMVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp -------------TEEEEEEECC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred -------------CceEEEEEcc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeee
Confidence 1679999999 89999999752 3469999999999999999999999999999999999999
Q ss_pred --ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 958 --DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 958 --d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
+.+ +.+||+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++
T Consensus 140 ~~~~~-------~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il 205 (296)
T 4hgt_A 140 LGKKG-------NLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVL 205 (296)
T ss_dssp CGGGT-------TCEEECCCTTCEECBCTTTCCB---CCCCCSCCCCSCGGGCCHHHHTT----CCCCHHHHHHHHHHHH
T ss_pred ccCCC-------CeEEEecCccceeccCcccCcc---CCCCcccccCCCccccchHHhcC----CCCCchhHHHHHHHHH
Confidence 444 7899999999986654322110 01112234579999999999876 4688999999999999
Q ss_pred HHHHhCCCCCCCCCHH---HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1036 LELLTLQVPYMGLSEL---EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~---el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
|+|++|+.||.+.... +....+.....+... +......++++.+++.+||+.||
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p 262 (296)
T 4hgt_A 206 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----------------------EVLCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----------------------HHHTTTSCHHHHHHHHHHHTSCT
T ss_pred HHHhcCCCCCcccchhhhhhhhhhhhcccccchh-----------------------hhhhccCCHHHHHHHHHHHhcCC
Confidence 9999999999764321 111111110000000 00011345679999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 001152 1113 TERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~ 1128 (1137)
++|||+++|++.+...
T Consensus 263 ~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 263 DDKPDYSYLRQLFRNL 278 (296)
T ss_dssp TCCCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHH
Confidence 9999999999987664
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=350.90 Aligned_cols=281 Identities=13% Similarity=0.081 Sum_probs=197.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC-----CccEEEEEEecccCCCChHHHHH----hHHhHHHHHHHHHhCCCCCcceee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-----SADAAAKVRTLKVCGSSADEIRN----FEYSCLGEVRMLGALRHSCIVEMY 871 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-----~~~vAVKi~~l~~~~~~~~~~e~----~~~~~lrEi~iL~~L~HpNIVkll 871 (1137)
-.+|++.+.||+|+||.||+|.+. +..+|+|+....... ...+.+. ....+.+|+.+++.++||||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-LFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CH-HHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcc-hHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 367999999999999999999984 366888875433210 0111111 112357889999999999999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLK 951 (1137)
+++.... ......++||||+ +++|.+++... ..+++..++.|+.||+.||+|||++||+|||||
T Consensus 115 ~~~~~~~----------~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 178 (345)
T 2v62_A 115 GSGLTEF----------KGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIK 178 (345)
T ss_dssp EEEEEES----------SSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred ccccccc----------CCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcC
Confidence 9987621 0112689999999 89999998652 369999999999999999999999999999999
Q ss_pred CCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHH
Q 001152 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031 (1137)
Q Consensus 952 P~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSL 1031 (1137)
|+|||++.+.. +.+||+|||+++.......... ..........||+.|+|||++.+ ..++.++|||||
T Consensus 179 p~NIll~~~~~-----~~~kL~Dfg~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~sl 246 (345)
T 2v62_A 179 AANLLLGYKNP-----DQVYLADYGLSYRYCPNGNHKQ---YQENPRKGHNGTIEFTSLDAHKG----VALSRRSDVEIL 246 (345)
T ss_dssp GGGEEEESSST-----TSEEECCCTTCEESSGGGCCCC---CCCCGGGCSCSCTTTCCHHHHHT----CCCCHHHHHHHH
T ss_pred HHHEEEccCCC-----CcEEEEeCCCceeccccccccc---chhccccccCCCccccCHHHhcC----CCCCchhhHHHH
Confidence 99999987621 3899999999976643221100 00011124579999999999876 468999999999
Q ss_pred HHHHHHHHhCCCCCCC--CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001152 1032 GCLLLELLTLQVPYMG--LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1032 GviL~ELLTG~~Pf~~--~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
||++|||++|+.||.+ .......... ....+.++..+... . .....++++.+++.+||+
T Consensus 247 G~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----------~-------~~~~~~~~l~~li~~~l~ 307 (345)
T 2v62_A 247 GYCMLRWLCGKLPWEQNLKDPVAVQTAK-TNLLDELPQSVLKW-----------A-------PSGSSCCEIAQFLVCAHS 307 (345)
T ss_dssp HHHHHHHHHSSCTTGGGTTCHHHHHHHH-HHHHHTTTHHHHHH-----------S-------CTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCccccccccHHHHHHH-HhhcccccHHHHhh-----------c-------cccccHHHHHHHHHHHhh
Confidence 9999999999999964 2222222211 11111111111110 0 001345679999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhc
Q 001152 1110 ENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1110 ~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
.||++|||+++|++.+....
T Consensus 308 ~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 308 LAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp CCTTCCCCHHHHHHHHCTTC
T ss_pred cCcccCCCHHHHHHHHhccC
Confidence 99999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=335.00 Aligned_cols=266 Identities=17% Similarity=0.169 Sum_probs=197.7
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
-.+|++.+.||+|+||.||+|++ .+..||+|+....... + ++.+|+.+++.++|++++..+.++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------P----QLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC------C----HHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch------h----HHHHHHHHHHHhhcCCCCCccccccCCC
Confidence 36799999999999999999997 4678899975433211 1 2377999999999988887776664432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
...++||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 78 -------------~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~ 139 (296)
T 3uzp_A 78 -------------DYNVMVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp -------------TEEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred -------------CceEEEEEec-CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEe
Confidence 1679999999 89999999752 24699999999999999999999999999999999999995
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+. ..+.+||+|||++........... ..........||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 140 ~~~----~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~l 208 (296)
T 3uzp_A 140 LGK----KGNLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVLMYF 208 (296)
T ss_dssp CGG----GTTCEEECCCTTCEECBCTTTCCB---CCCCCSCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred cCC----CCCeEEEeeCCCcccccccccccc---cccccccccccccccCChhhhcC----CCCCcchhhHHHHHHHHHH
Confidence 211 116899999999986654322110 01111234579999999999876 5688999999999999999
Q ss_pred HhCCCCCCCCCH---HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1039 LTLQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1039 LTG~~Pf~~~~~---~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
++|+.||.+... .+....+.......... .....+++++.+++.+||+.||.+|
T Consensus 209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~R 265 (296)
T 3uzp_A 209 NLGSLPWQGLKAATKRQKYERISEKKMSTPIE-----------------------VLCKGYPSEFATYLNFCRSLRFDDK 265 (296)
T ss_dssp HHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-----------------------HHTTTSCHHHHHHHHHHHTSCTTCC
T ss_pred HhCCCCCCCcCchhhhhhhhhhcccccCCchH-----------------------HHHhhCCHHHHHHHHHHHhcCcCcC
Confidence 999999976322 11222221110000000 0011445679999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 001152 1116 PTAGDLYEMFVAR 1128 (1137)
Q Consensus 1116 PSa~EVL~~L~~~ 1128 (1137)
||+++|++.+...
T Consensus 266 ps~~~l~~~l~~~ 278 (296)
T 3uzp_A 266 PDYSYLRQLFRNL 278 (296)
T ss_dssp CCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHH
Confidence 9999999887764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=348.41 Aligned_cols=267 Identities=23% Similarity=0.333 Sum_probs=183.5
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHH-HHHhCCCCCcceeeeeEec
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVR-MLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~-iL~~L~HpNIVkllg~~~~ 876 (1137)
...+|++.+.||+|+||.||+|.+. +..||+|+..... ....... +.+|+. +++.++||||+++++++..
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~----~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQ----LLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHH----HHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHH----HHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4578999999999999999999986 5778888764321 1222222 255655 6777899999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCe
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 955 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrDLKP~NI 955 (1137)
.+ ..++||||++ ++|.+++..........+++..+..++.|++.||.|||++ ||+||||||+||
T Consensus 93 ~~--------------~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NI 157 (327)
T 3aln_A 93 EG--------------DCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNI 157 (327)
T ss_dssp SS--------------EEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGE
T ss_pred CC--------------ceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHE
Confidence 65 6799999997 6999888754444456799999999999999999999998 999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||++........ .....||+.|+|||++........++.++|||||||++
T Consensus 158 ll~~~-------~~~kl~Dfg~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 219 (327)
T 3aln_A 158 LLDRS-------GNIKLCDFGISGQLVDSIA-----------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219 (327)
T ss_dssp EEETT-------TEEEECCCSSSCC-----------------------------------------CCSHHHHHHHHHHH
T ss_pred EEcCC-------CCEEEccCCCceecccccc-----------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHH
Confidence 99877 7899999999876543211 11236899999999985322235688999999999999
Q ss_pred HHHHhCCCCCCCCCHH-HHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLTLQVPYMGLSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~-el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+|++|..||...... +....+..+..+.+.. ......++.+.+|+.+||+.||.+
T Consensus 220 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~ 276 (327)
T 3aln_A 220 YELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN-----------------------SEEREFSPSFINFVNLCLTKDESK 276 (327)
T ss_dssp HHHHHSCCCSSCC-------CCCCCSCCCCCCC-----------------------CSSCCCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC-----------------------cccccCCHHHHHHHHHHhhCChhh
Confidence 9999999999764321 1111111111111100 000134567999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001152 1115 RPTAGDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~ 1129 (1137)
|||+.||++|+|+..
T Consensus 277 Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 277 RPKYKELLKHPFILM 291 (327)
T ss_dssp SCCHHHHTTSHHHHH
T ss_pred CcCHHHHHhChHHHH
Confidence 999999999999964
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=340.28 Aligned_cols=278 Identities=18% Similarity=0.172 Sum_probs=201.7
Q ss_pred CCCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
-.+|++.+.||+|+||.||+|++ .+..||+|+.... .....+. +.+|+.+++.++||||+++++++....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREE----AQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHH----HHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHH----HHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 35799999999999999999997 4577899975432 1333333 488999999999999999999987422
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
. .....++||||+++++|.+++...... ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 100 ~----------~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~ 168 (317)
T 2buj_A 100 G----------AKHEAWLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG 168 (317)
T ss_dssp T----------TEEEEEEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred C----------CCceeEEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc
Confidence 0 122679999999999999999864333 35799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||++.............. .........||+.|+|||++.+.. ...++.++|||||||++|+|
T Consensus 169 ~~-------~~~kl~dfg~~~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el 239 (317)
T 2buj_A 169 DE-------GQPVLMDLGSMNQACIHVEGSRQAL-TLQDWAAQRCTISYRAPELFSVQS-HCVIDERTDVWSLGCVLYAM 239 (317)
T ss_dssp TT-------SCEEECCCSSCEESCEEEESHHHHH-HHHHHHHHHSCGGGCCGGGSSCCS-EEEECTHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEEecCcchhcccccccccccc-cccccccccCCcccCCHhHhccCC-CcCCCchhhHHHHHHHHHHH
Confidence 77 7899999998865432110000000 000001234789999999986421 12367899999999999999
Q ss_pred HhCCCCCCCCCH--HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1039 LTLQVPYMGLSE--LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1039 LTG~~Pf~~~~~--~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
++|..||..... ..+...+........ ....++++.+++.+||+.||.+||
T Consensus 240 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~dp~~Rp 292 (317)
T 2buj_A 240 MFGEGPYDMVFQKGDSVALAVQNQLSIPQ---------------------------SPRHSSALWQLLNSMMTVDPHQRP 292 (317)
T ss_dssp HHSSCTTHHHHHTTSCHHHHHHCC--CCC---------------------------CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HhCCCChhhhhcccchhhHHhhccCCCCc---------------------------cccCCHHHHHHHHHHhhcChhhCC
Confidence 999999953100 011111111110000 013456699999999999999999
Q ss_pred CHHHHHHHHHhhcCCCC
Q 001152 1117 TAGDLYEMFVARTSSSI 1133 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ss~ 1133 (1137)
|++++++++.....+..
T Consensus 293 s~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 293 HIPLLLSQLEALQPPAP 309 (317)
T ss_dssp CHHHHHHHHHHTCCCCC
T ss_pred CHHHHHHHhhhcCCCCC
Confidence 99999999998876544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=339.83 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=196.3
Q ss_pred CCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--CCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~--HpNIVkllg~~~~~~ 878 (1137)
.+|++.+.||+|+||.||+|.+. +..+|+|+..... ......+. +.+|+.++++++ ||||+++++++....
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~----~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDS----YRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS--CCHHHHHH----HHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc--ccccchHH----HHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 46999999999999999999985 4678999865432 22333333 488999999997 599999999998765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||| +.+++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 102 --------------~~~lv~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 161 (313)
T 3cek_A 102 --------------YIYMVME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 161 (313)
T ss_dssp --------------EEEEEEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred --------------EEEEEEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE
Confidence 6799999 557999999986 34689999999999999999999999999999999999996
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-------CCCCCCchhhHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-------KPNLYGLEVDIWSY 1031 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~s~ksDVWSL 1031 (1137)
. +.+||+|||++......... .......||+.|+|||++.+.. ....++.++|||||
T Consensus 162 ~--------~~~kL~Dfg~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 162 D--------GMLKLIDFGIANQMQPDTTS--------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp T--------TEEEECCCSSSCC----------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred C--------CeEEEeeccccccccCcccc--------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 3 57999999999765432211 1112346899999999986421 11367899999999
Q ss_pred HHHHHHHHhCCCCCCCCCH-HHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001152 1032 GCLLLELLTLQVPYMGLSE-LEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1032 GviL~ELLTG~~Pf~~~~~-~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
||++|+|++|..||..... ......+.... ...++ ...++++.+++.+||+
T Consensus 226 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~l~~li~~~l~ 278 (313)
T 3cek_A 226 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP---------------------------DIPEKDLQDVLKCCLK 278 (313)
T ss_dssp HHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC---------------------------CCSCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc---------------------------ccchHHHHHHHHHHcc
Confidence 9999999999999976432 22222222211 10100 0224468999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhcCC
Q 001152 1110 ENPTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1110 ~DP~~RPSa~EVL~~L~~~~~s 1131 (1137)
.||.+|||++|+++|+|+....
T Consensus 279 ~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 279 RDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp SSTTTSCCHHHHHTSHHHHCC-
T ss_pred CCcccCcCHHHHhcCccccCCC
Confidence 9999999999999999998653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.27 Aligned_cols=263 Identities=23% Similarity=0.355 Sum_probs=188.1
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
..+.+|++.+.||+|+||.||+|.+. +..||+|+..... . ...... .+..+..+++.++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~-~~~~~~---~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--N-KEENKR---ILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS--C-HHHHHH---HHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc--c-chHHHH---HHHHHHHHHHhcCCCceeeEEEEEec
Confidence 35678999999999999999999985 5788999864332 1 222222 12445567888899999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCCe
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK-HIMHRDIKSENI 955 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~-gIIHrDLKP~NI 955 (1137)
.+ ..++||||+ ++.+..+.... ...+++..+..++.||+.||+|||++ ||+||||||+||
T Consensus 96 ~~--------------~~~lv~e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Ni 156 (318)
T 2dyl_A 96 NT--------------DVFIAMELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156 (318)
T ss_dssp SS--------------EEEEEECCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGE
T ss_pred CC--------------cEEEEEecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHE
Confidence 65 679999999 56666655431 24689999999999999999999995 999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGvi 1034 (1137)
|++.+ +.+||+|||++........ .....||+.|+|||++.... ....++.++|||||||+
T Consensus 157 l~~~~-------~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 218 (318)
T 2dyl_A 157 LLDER-------GQIKLCDFGISGRLVDDKA-----------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218 (318)
T ss_dssp EECTT-------SCEEECCCTTC-------------------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred EECCC-------CCEEEEECCCchhccCCcc-----------ccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence 99877 7899999999875543211 11346899999999985311 12467899999999999
Q ss_pred HHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLTLQVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~-~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|+|++|..||.. ....+....+.....+.++.. ...++++.+++.+||+.||.
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~~l~~dp~ 273 (318)
T 2dyl_A 219 LVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH-------------------------MGFSGDFQSFVKDCLTKDHR 273 (318)
T ss_dssp HHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS-------------------------SCCCHHHHHHHHHHTCSCTT
T ss_pred HHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc-------------------------CCCCHHHHHHHHHHccCChh
Confidence 9999999999986 344555555554443322210 02445699999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001152 1114 ERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~ 1129 (1137)
+|||++|+++|+|+..
T Consensus 274 ~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 274 KRPKYNKLLEHSFIKR 289 (318)
T ss_dssp TSCCHHHHTTSHHHHH
T ss_pred HCcCHHHHhhCHHHHh
Confidence 9999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=347.57 Aligned_cols=266 Identities=14% Similarity=0.114 Sum_probs=198.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC----------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcce-
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG----------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVE- 869 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~----------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVk- 869 (1137)
-.+|++.+.||+|+||.||+|++. +..+|+|+.... + .+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~----~~~~E~~~l~~l~h~niv~~ 107 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------G----RLFNEQNFFQRAAKPLQVNK 107 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------S----THHHHHHHHHHHCCHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------c----hHHHHHHHHHHhcccchhhh
Confidence 367999999999999999999985 467999985422 1 2377999999999999998
Q ss_pred --------------eeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHH
Q 001152 870 --------------MYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAA 935 (1137)
Q Consensus 870 --------------llg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~ 935 (1137)
+++++...+ ...++||||+ +++|.+++... ....+++..++.|+.||+.
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~~~-------------~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~ 170 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVHQD-------------KYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLD 170 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEETT-------------TEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHH
T ss_pred hhhhccCCccCccchhhccccCC-------------cEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHH
Confidence 455554321 2679999999 89999999862 1246999999999999999
Q ss_pred HHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcc
Q 001152 936 ALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015 (1137)
Q Consensus 936 gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 1015 (1137)
||+|||++||+||||||+|||++.+.. ..+||+|||+++........... .........||+.|+|||++.+
T Consensus 171 ~L~~LH~~~ivH~Dikp~NIl~~~~~~-----~~~kl~Dfg~a~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 171 ALEFLHENEYVHGNVTAENIFVDPEDQ-----SQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHTTCBCSCCCGGGEEEETTEE-----EEEEECCGGGCBCSSGGGCCCCC---CTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHhCCccCCCCCHHHEEEcCCCC-----ceEEEecCcceeeccCCCccccc---cccccccccCCccccCHHHHcc
Confidence 999999999999999999999997721 27999999999766543211100 0011224479999999999875
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHc--CCCCCchhHHhhhcccccccccccCCCCCCch
Q 001152 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGL--SELEIHDLIQM--GKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1091 (1137)
Q Consensus 1016 ~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~--~~~el~~~I~~--g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 1091 (1137)
..++.++|||||||++|+|++|+.||... ....+...... ...+.+.... .
T Consensus 243 ----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~------ 297 (352)
T 2jii_A 243 ----CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPC---------------G------ 297 (352)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTT---------------S------
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhc---------------c------
Confidence 46889999999999999999999999764 33333332211 1111110000 0
Q ss_pred hhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1092 AELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1092 ~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
.....++++.+|+.+||+.||.+|||+++|++.+....
T Consensus 298 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 298 HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 00133567999999999999999999999999987653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=342.09 Aligned_cols=273 Identities=21% Similarity=0.279 Sum_probs=183.4
Q ss_pred CCceEeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~ 878 (1137)
.+|++.++||+|+||.||+|++ .+..||+|+.... .....+. +.+|+.+++++. ||||+++++++....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRA----IIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHH----HHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHH----HHHHHHHHHHhccCCChhhccccccccc
Confidence 3799999999999999999998 4578899975322 1233333 488999999996 999999999986432
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeE
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENIL 956 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g--IIHrDLKP~NIL 956 (1137)
.. ........++||||+. |+|.+++..... ...+++..++.|+.||+.||+|||++| |+||||||+|||
T Consensus 100 ~~------~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl 170 (337)
T 3ll6_A 100 EE------SDTGQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170 (337)
T ss_dssp TT------STTSSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCE
T ss_pred cc------cccCCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEE
Confidence 11 0012236899999996 899999876432 346999999999999999999999999 999999999999
Q ss_pred eccccccCCCCCeEEEeecCcccccccccccccccc--CCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAH--RGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~--~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
++.+ +.+||+|||+++............. ..........||+.|+|||++... ....++.++|||||||+
T Consensus 171 ~~~~-------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~~Dv~slG~i 242 (337)
T 3ll6_A 171 LSNQ-------GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-SNFPIGEKQDIWALGCI 242 (337)
T ss_dssp ECTT-------SCEEBCCCTTCBCCSSCC-------------------------------CC-TTSCSSHHHHHHHHHHH
T ss_pred ECCC-------CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-ccCCCChHHhHHHHHHH
Confidence 9987 7899999999976543221100000 000011134589999999998421 23567899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+|++|+.||............ ...... ...++.+.+|+.+||+.||.+
T Consensus 243 l~el~~g~~p~~~~~~~~~~~~~---~~~~~~---------------------------~~~~~~~~~li~~~l~~~p~~ 292 (337)
T 3ll6_A 243 LYLLCFRQHPFEDGAKLRIVNGK---YSIPPH---------------------------DTQYTVFHSLIRAMLQVNPEE 292 (337)
T ss_dssp HHHHHHSSCCC---------------CCCCTT---------------------------CCSSGGGHHHHHHHSCSSGGG
T ss_pred HHHHHhCCCCCcchhHHHhhcCc---ccCCcc---------------------------cccchHHHHHHHHHccCChhh
Confidence 99999999999754332221111 000000 012233889999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001152 1115 RPTAGDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~ 1129 (1137)
|||+.|++++++...
T Consensus 293 Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 293 RLSIAEVVHQLQEIA 307 (337)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999998764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=348.08 Aligned_cols=265 Identities=24% Similarity=0.261 Sum_probs=176.6
Q ss_pred CCCceEee-eecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 801 FPSLSSCD-EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~-~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.++|++.+ .||+|+||+||+|.+. +..||+|+.... ....+ .....++.+.||||+++++++...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~-------e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQ-------EVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHH-------HHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHH-------HHHHHHHhcCCCChHHHHHHHhhc
Confidence 36799854 6999999999999986 578999985321 11111 122345677899999999998752
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
.. .....++||||+++|+|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 95 ~~----------~~~~~~lv~e~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll 161 (336)
T 3fhr_A 95 HH----------GKRCLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLY 161 (336)
T ss_dssp ET----------TEEEEEEEEECCTTEEHHHHHHT---C-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred cC----------CCceEEEEEeccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 20 11257999999999999999976 233469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.++ ..+.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 162 ~~~~----~~~~~kl~Dfg~~~~~~~~~------------~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~il~~ 221 (336)
T 3fhr_A 162 TSKE----KDAVLKLTDFGFAKETTQNA------------LQTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVIMYI 221 (336)
T ss_dssp SCSS----TTCCEEECCCTTCEEC--------------------------------------CHHHHHHHHHHHHHHHHH
T ss_pred EecC----CCceEEEeccccceeccccc------------cccCCCCcCccChhhhCC----CCCCchhhHHHHHHHHHH
Confidence 8642 12669999999987544321 113468999999999864 467899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|..||................... .. .... ......++++.+|+.+||+.||.+|||
T Consensus 222 l~~g~~pf~~~~~~~~~~~~~~~~~~~---~~----------------~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt 281 (336)
T 3fhr_A 222 LLCGFPPFYSNTGQAISPGMKRRIRLG---QY----------------GFPN-PEWSEVSEDAKQLIRLLLKTDPTERLT 281 (336)
T ss_dssp HHHSSCCC----------------------------------------CCCT-TTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHCCCCCCCccchhhhhhHHHhhhcc---cc----------------ccCc-hhhccCCHHHHHHHHHHCCCChhHCcC
Confidence 999999997654433221111100000 00 0000 000145667999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001152 1118 AGDLYEMFVARTS 1130 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ 1130 (1137)
++|+++|+|+...
T Consensus 282 ~~ell~hp~~~~~ 294 (336)
T 3fhr_A 282 ITQFMNHPWINQS 294 (336)
T ss_dssp HHHHHHSHHHHTG
T ss_pred HHHHhcCcccccc
Confidence 9999999999854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=341.13 Aligned_cols=275 Identities=23% Similarity=0.312 Sum_probs=199.5
Q ss_pred CCCceEeeeecccCceEEEEEEE------CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKF------GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~------~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
..+|++.+.||+|+||.||+|++ .+..||+|+.... .....+. +.+|+.++++++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRD----FEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHH----HHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHH----HHHHHHHHHhCCCCCeeeEEEEE
Confidence 45699999999999999999985 3567888875321 1233333 48899999999999999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
..... ...++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 112 ~~~~~------------~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N 175 (326)
T 2w1i_A 112 YSAGR------------RNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 175 (326)
T ss_dssp CC----------------CCEEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EecCC------------CceEEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcce
Confidence 75431 1469999999999999999762 2469999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.+ +.+||+|||++.......... .......++..|+|||++.+ ..++.++|||||||+
T Consensus 176 Ili~~~-------~~~kL~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~i 237 (326)
T 2w1i_A 176 ILVENE-------NRVKIGDFGLTKVLPQDKEYY-------KVKEPGESPIFWYAPESLTE----SKFSVASDVWSFGVV 237 (326)
T ss_dssp EEEEET-------TEEEECCCTTCEECCSSCSEE-------ECSSCCSCCGGGCCHHHHHH----CEEEHHHHHHHHHHH
T ss_pred EEEcCC-------CcEEEecCcchhhcccccccc-------ccccCCCCceeEECchhhcC----CCCCchhhHHHHHHH
Confidence 999987 789999999997654332110 00112357788999999876 457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCch-hHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLT-DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|+|++|..||.... .+....+......... ..+... +.. ..... ....+++++.+++.+||+.||.
T Consensus 238 l~el~tg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-------~~~-~~~~~---~~~~~~~~l~~li~~cl~~dP~ 305 (326)
T 2w1i_A 238 LYELFTYIEKSKSPP-AEFMRMIGNDKQGQMIVFHLIEL-------LKN-NGRLP---RPDGCPDEIYMIMTECWNNNVN 305 (326)
T ss_dssp HHHHHHTTCGGGSHH-HHHHHHHCTTCCTHHHHHHHHHH-------HHT-TCCCC---CCTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHHHhcCCCCCCCH-HHHHHhhccccchhhhHHHHHHH-------hhc-CCCCC---CCCcccHHHHHHHHHHcCCChh
Confidence 999999999986421 1111111111000000 000000 000 00000 0114567799999999999999
Q ss_pred CCCCHHHHHHHHHhhc
Q 001152 1114 ERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~ 1129 (1137)
+|||+.||++.+....
T Consensus 306 ~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 306 QRPSFRDLALRVDQIR 321 (326)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999887653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=351.95 Aligned_cols=277 Identities=12% Similarity=0.048 Sum_probs=182.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC--CCCCcceee------
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL--RHSCIVEMY------ 871 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L--~HpNIVkll------ 871 (1137)
..|++.+.||+|+||+||+|++. +..||+|+....... .....+ .+.+|+.+++.+ +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~----~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSELE----RLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-HHHHHH----HHHHHHHHHHHHHC----------CBCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-cccHHH----HHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 45899999999999999999985 567899986543211 122222 346775444444 699988755
Q ss_pred -eeEecCCC---CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHH------HHHHHHHHHHHHHHH
Q 001152 872 -GHKISSKW---LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLA------LFIAQDVAAALVELH 941 (1137)
Q Consensus 872 -g~~~~~~~---~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i------~~I~~QIa~gL~yLH 941 (1137)
+++..... ....++.......+.|+||||++ ++|.+++.... ..+.+..+ ..|+.||+.||+|||
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 34333221 00000000111235899999998 99999998642 23444555 677899999999999
Q ss_pred hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001152 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 942 s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1021 (1137)
++||+||||||+|||++.+ +.+||+|||+++....... ...+|+.|+|||++.+ ....
T Consensus 212 ~~~ivHrDikp~NIll~~~-------~~~kL~DFG~a~~~~~~~~-------------~~~~t~~y~aPE~~~~--~~~~ 269 (371)
T 3q60_A 212 SKGLVHGHFTPDNLFIMPD-------GRLMLGDVSALWKVGTRGP-------------ASSVPVTYAPREFLNA--STAT 269 (371)
T ss_dssp HTTEEETTCSGGGEEECTT-------SCEEECCGGGEEETTCEEE-------------GGGSCGGGCCHHHHTC--SEEE
T ss_pred HCCCccCcCCHHHEEECCC-------CCEEEEecceeeecCCCcc-------------CccCCcCCcChhhccC--CCCC
Confidence 9999999999999999987 7899999999976543211 2347799999999964 1246
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLV 1101 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1101 (1137)
++.++|||||||++|+|++|+.||.+....... .+. .. ............+. ....++.+.
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---------~~~----~~-----~~~~~~~~~~~~~~-~~~~~~~~~ 330 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG---------SWK----RP-----SLRVPGTDSLAFGS-CTPLPDFVK 330 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT---------CCC----BC-----CTTSCCCCSCCCTT-SSCCCHHHH
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCccccc---------chh----hh-----hhhhccccccchhh-ccCCCHHHH
Confidence 789999999999999999999999764321000 000 00 00000000000110 114567799
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1102 DVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1102 dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+|+.+||+.||++|||+.|+++|+|+..
T Consensus 331 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 331 TLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp HHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 9999999999999999999999999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=348.37 Aligned_cols=256 Identities=14% Similarity=0.151 Sum_probs=191.3
Q ss_pred CCceEeeeecccCceEEEEEE-------ECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC---CCCcceee
Q 001152 802 PSLSSCDEAGKSVSSSLFRCK-------FGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMY 871 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~-------~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~---HpNIVkll 871 (1137)
.+|++.+.||+|+||+||+|. ..+..||+|+.... .. .++ .+|+.+++.++ |+||++++
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~---~~~----~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NP---WEF----YIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CH---HHH----HHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----Ch---hHH----HHHHHHHHHhhhhhhhhhhhhh
Confidence 569999999999999999994 24578999985322 11 122 56778888887 99999999
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLK 951 (1137)
+++...+ ..++||||+++|+|.+++..........+++..++.|+.||+.||+|||++||+|||||
T Consensus 134 ~~~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiK 199 (365)
T 3e7e_A 134 SAHLFQN--------------GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIK 199 (365)
T ss_dssp EEEECSS--------------CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred eeeecCC--------------CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCC
Confidence 9998765 56999999999999999987554445679999999999999999999999999999999
Q ss_pred CCCeEeccccc----cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhh
Q 001152 952 SENILIDLERK----KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1027 (1137)
Q Consensus 952 P~NILld~~~~----~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1027 (1137)
|+|||++.+.. .....+.+||+|||+++......... ......||+.|+|||++.+ ..++.++|
T Consensus 200 p~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~----~~~~~~~D 267 (365)
T 3e7e_A 200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT--------IFTAKCETSGFQCVEMLSN----KPWNYQID 267 (365)
T ss_dssp GGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTE--------EECCSSCTTSCCCHHHHTT----CCBSTHHH
T ss_pred HHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCc--------eeeeecCCCCCCChHHhcC----CCCCcccc
Confidence 99999987100 01113789999999997554221110 1123469999999999976 45899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHh
Q 001152 1028 IWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRC 1107 (1137)
Q Consensus 1028 VWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~C 1107 (1137)
||||||++|||+||+.||....... .......... ...+.+.+++..|
T Consensus 268 iwslG~il~elltg~~pf~~~~~~~-------------------------~~~~~~~~~~-------~~~~~~~~~~~~~ 315 (365)
T 3e7e_A 268 YFGVAATVYCMLFGTYMKVKNEGGE-------------------------CKPEGLFRRL-------PHLDMWNEFFHVM 315 (365)
T ss_dssp HHHHHHHHHHHHHSSCCCEEEETTE-------------------------EEECSCCTTC-------SSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCccccCCCCc-------------------------eeechhcccc-------CcHHHHHHHHHHH
Confidence 9999999999999999996421100 0000000000 2345688999999
Q ss_pred cccCCCCCC-CHHHHHHHHH
Q 001152 1108 TEENPTERP-TAGDLYEMFV 1126 (1137)
Q Consensus 1108 L~~DP~~RP-Sa~EVL~~L~ 1126 (1137)
|+.+|.+|+ ++.++.+.+.
T Consensus 316 l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 316 LNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp HCCCCTTCCCCHHHHHHHHH
T ss_pred cCCCCCCcchHHHHHHHHHH
Confidence 999999984 6666655443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=339.00 Aligned_cols=253 Identities=21% Similarity=0.244 Sum_probs=191.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC----CCCCcceeeeeE
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL----RHSCIVEMYGHK 874 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L----~HpNIVkllg~~ 874 (1137)
..+|++.+.||+|+||.||+|++. +..||+|+....... ..........+.+|+.++.++ +||||+++++++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVL--GWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccc--ccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 467999999999999999999984 567888875433211 111001112236799999998 899999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEee-ccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEY-VKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSE 953 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy-~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~ 953 (1137)
...+ ..++|||| +.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 108 ~~~~--------------~~~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 168 (312)
T 2iwi_A 108 ETQE--------------GFMLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDE 168 (312)
T ss_dssp -------------------CEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGG
T ss_pred ecCC--------------eEEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChh
Confidence 7655 45999999 788999999976 235899999999999999999999999999999999
Q ss_pred CeEec-cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 954 NILID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 954 NILld-~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
||+++ .+ +.+||+|||++........ ....||+.|+|||++.+. ...+.++||||||
T Consensus 169 Nil~~~~~-------~~~kl~dfg~~~~~~~~~~------------~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG 226 (312)
T 2iwi_A 169 NILIDLRR-------GCAKLIDFGSGALLHDEPY------------TDFDGTRVYSPPEWISRH---QYHALPATVWSLG 226 (312)
T ss_dssp GEEEETTT-------TEEEECCCSSCEECCSSCB------------CCCCSCTTTSCHHHHHHS---CBCHHHHHHHHHH
T ss_pred hEEEeCCC-------CeEEEEEcchhhhcccCcc------------cccCCcccccCceeeecC---CCCCccchHHHHH
Confidence 99998 45 7899999999876543211 134589999999998752 2345699999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCC
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENP 1112 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP 1112 (1137)
|++|+|++|+.||.... .+..... .++ ...++.+.+++.+||+.||
T Consensus 227 ~il~~l~~g~~pf~~~~------~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~~p 272 (312)
T 2iwi_A 227 ILLYDMVCGDIPFERDQ------EILEAEL-HFP---------------------------AHVSPDCCALIRRCLAPKP 272 (312)
T ss_dssp HHHHHHHHSSCSCCSHH------HHHHTCC-CCC---------------------------TTSCHHHHHHHHHHTCSST
T ss_pred HHHHHHHHCCCCCCChH------HHhhhcc-CCc---------------------------ccCCHHHHHHHHHHccCCh
Confidence 99999999999997521 1111110 000 0334568999999999999
Q ss_pred CCCCCHHHHHHHHHhhcC
Q 001152 1113 TERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1113 ~~RPSa~EVL~~L~~~~~ 1130 (1137)
++|||++|+++|+|+...
T Consensus 273 ~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 273 SSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TTSCCHHHHHHSTTTCC-
T ss_pred hhCcCHHHHhcChhhcCc
Confidence 999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=342.85 Aligned_cols=253 Identities=21% Similarity=0.226 Sum_probs=198.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--CCCcceeeeeEec
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKIS 876 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~--HpNIVkllg~~~~ 876 (1137)
..+|++.+.||+|+||.||+|.+. +..||+|+.......... .. ....++.+|+.++++++ ||||+++++++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~-~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG-EL-PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEE-EC-TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhh-hh-hhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 467999999999999999999984 577888886544322100 00 00112367999999996 5999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccC-CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~g-gSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
.+ ..++||||+.+ ++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 120 ~~--------------~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 180 (320)
T 3a99_A 120 PD--------------SFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 180 (320)
T ss_dssp SS--------------EEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CC--------------cEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHE
Confidence 65 67999999976 899999976 24689999999999999999999999999999999999
Q ss_pred Eec-cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 956 LID-LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 956 Lld-~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
|++ .+ +.+||+|||++........ ....||+.|+|||++.+. ..++.++|||||||+
T Consensus 181 ll~~~~-------~~~kL~Dfg~~~~~~~~~~------------~~~~gt~~y~aPE~~~~~---~~~~~~~Di~slG~i 238 (320)
T 3a99_A 181 LIDLNR-------GELKLIDFGSGALLKDTVY------------TDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGIL 238 (320)
T ss_dssp EEETTT-------TEEEECCCTTCEECCSSCB------------CCCCSCGGGSCHHHHHHS---CBCHHHHHHHHHHHH
T ss_pred EEeCCC-------CCEEEeeCccccccccccc------------cCCCCCccCCChHHhccC---CCCCccchHHhHHHH
Confidence 998 44 6899999999876543211 134689999999998752 334789999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|||++|+.||.... .+..... .++ ...++++.+|+.+||+.||.+
T Consensus 239 l~el~~g~~pf~~~~------~~~~~~~-~~~---------------------------~~~~~~~~~li~~~l~~dp~~ 284 (320)
T 3a99_A 239 LYDMVCGDIPFEHDE------EIIRGQV-FFR---------------------------QRVSSECQHLIRWCLALRPSD 284 (320)
T ss_dssp HHHHHHSSCSCCSHH------HHHHCCC-CCS---------------------------SCCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHCCCCCCChh------hhhcccc-ccc---------------------------ccCCHHHHHHHHHHccCChhh
Confidence 999999999997521 1111111 000 033456999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
|||++||++|+|+...
T Consensus 285 Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 285 RPTFEEIQNHPWMQDV 300 (320)
T ss_dssp SCCHHHHHTSGGGSSC
T ss_pred CcCHHHHhcCHhhcCc
Confidence 9999999999999754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=369.43 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=203.1
Q ss_pred CCCceEeeeecccCceEEEEEEECC---c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS---A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~---~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..+|++.+.||+|+||.||+|.+.. . .+|+|+ .+.. ......+ .+.+|+.++++++|||||++++++.
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~--~~~~-~~~~~~~----~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT--CKNC-TSDSVRE----KFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEE--CSST-TCHHHHH----HHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEE--eccc-CCHHHHH----HHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4679999999999999999999843 2 345554 3322 1222223 3489999999999999999999985
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+. ..++||||+++|+|.++++. ....+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 462 ~~---------------~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NI 522 (656)
T 2j0j_A 462 EN---------------PVWIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 522 (656)
T ss_dssp SS---------------SCEEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred cC---------------ceEEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhE
Confidence 32 35999999999999999975 234689999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||+++........ ......+|+.|+|||++.+ ..++.++|||||||++
T Consensus 523 Ll~~~-------~~vkL~DFG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il 582 (656)
T 2j0j_A 523 LVSSN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCM 582 (656)
T ss_dssp EEEET-------TEEEECCCCCCCSCCC-------------------CCGGGCCHHHHHH----CCCCHHHHHHHHHHHH
T ss_pred EEeCC-------CCEEEEecCCCeecCCCcce---------eccCCCCCcceeCHHHhcC----CCCCchhhHHHHHHHH
Confidence 99987 78999999999765432211 1112357789999999976 4688999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|||++ |..||.+....++...+..+..+..+. .+++.+.+++.+||+.||.+
T Consensus 583 ~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~~l~~dP~~ 635 (656)
T 2j0j_A 583 WEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPSR 635 (656)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cccHHHHHHHHHHcCCChhH
Confidence 99997 999999988888888776655433221 34456999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001152 1115 RPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~ 1128 (1137)
|||+.||++.+...
T Consensus 636 RPs~~el~~~L~~i 649 (656)
T 2j0j_A 636 RPRFTELKAQLSTI 649 (656)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999988754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=356.91 Aligned_cols=261 Identities=22% Similarity=0.305 Sum_probs=191.0
Q ss_pred CceEeeeecccCceE-EEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSS-LFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~-Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~ 880 (1137)
+|++.+.||+|+||+ ||++...++.||||+...+. ... +.+|+.+|+.+ +|||||++++++.+..
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-------~~~----~~~E~~~l~~l~~HpnIv~l~~~~~~~~-- 91 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-------FSF----ADREVQLLRESDEHPNVIRYFCTEKDRQ-- 91 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-------EEE----CHHHHHHHHHSCCCTTBCCEEEEEEETT--
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-------HHH----HHHHHHHHHhccCCCCcCeEEEEEecCC--
Confidence 589999999999998 55566678899999753221 111 26799999999 7999999999988765
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..|+||||++ |+|.+++... ...+.+..++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus 92 ------------~~~lv~E~~~-g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~ 154 (432)
T 3p23_A 92 ------------FQYIAIELCA-ATLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMP 154 (432)
T ss_dssp ------------EEEEEEECCS-EEHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCC
T ss_pred ------------EEEEEEECCC-CCHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecC
Confidence 6799999996 7999999752 2335555678999999999999999999999999999999654
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+ ..+...+||+|||+++......... .......||+.|+|||++.+.. ...++.++|||||||++|||++
T Consensus 155 ~--~~~~~~~kL~DFG~a~~~~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~-~~~~t~~~DiwSlG~il~ellt 224 (432)
T 3p23_A 155 N--AHGKIKAMISDFGLCKKLAVGRHSF-------SRRSGVPGTEGWIAPEMLSEDC-KENPTYTVDIFSAGCVFYYVIS 224 (432)
T ss_dssp B--TTTBCCEEECCTTEEECC-------------------CCSCTTSCCGGGTSCC----CCCTHHHHHHHHHHHHHHHT
T ss_pred C--CCCceeEEEecccceeeccCCCcce-------eeccccCCCcCccChhhhhccc-ccCCCcHHHHHHHHHHHHHHHc
Confidence 2 1233568999999997654322110 1112346999999999987421 2456789999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 -LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 -G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|..||...........+......... .....+..+.+|+.+||+.||.+|||++
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ 279 (432)
T 3p23_A 225 EGSHPFGKSLQRQANILLGACSLDCLH-------------------------PEKHEDVIARELIEKMIAMDPQKRPSAK 279 (432)
T ss_dssp TSCBTTBSTTTHHHHHHTTCCCCTTSC-------------------------TTCHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCcchhhHHHHHHHhccCCccccC-------------------------ccccccHHHHHHHHHHHhCCHhhCCCHH
Confidence 99999754443332221111110000 0113455689999999999999999999
Q ss_pred HHHHHHHhh
Q 001152 1120 DLYEMFVAR 1128 (1137)
Q Consensus 1120 EVL~~L~~~ 1128 (1137)
||++|+|+.
T Consensus 280 evl~hp~f~ 288 (432)
T 3p23_A 280 HVLKHPFFW 288 (432)
T ss_dssp HHHTSTTTC
T ss_pred HHHhCcccc
Confidence 999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=351.18 Aligned_cols=271 Identities=20% Similarity=0.259 Sum_probs=189.1
Q ss_pred CceEeeeecccCceEEEEE-EECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRC-KFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a-~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~ 880 (1137)
.|.+.+.||+|+||+||.+ ...+..||||+...+. .+. +.+|+.+++++ +|||||++++++.+..
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-------~~~----~~~E~~~l~~l~~HpnIv~~~~~~~~~~-- 82 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-------CDI----ALMEIKLLTESDDHPNVIRYYCSETTDR-- 82 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-------HHH----HHHHHHHHHHHTTSTTBCCEEEEEECSS--
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-------HHH----HHHHHHHHHhccCCCCcCeEEEEEecCC--
Confidence 3567789999999999754 4467889999864321 122 37799999876 7999999999988665
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGE--KHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~--~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||++ |+|.+++........ ...++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 83 ------------~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~ 149 (434)
T 2rio_A 83 ------------FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVS 149 (434)
T ss_dssp ------------EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred ------------eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEe
Confidence 6799999996 799999976221110 0113345678999999999999999999999999999997
Q ss_pred cccc------cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc---CCCCCCchhhHH
Q 001152 959 LERK------KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH---KPNLYGLEVDIW 1029 (1137)
Q Consensus 959 ~~~~------~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~s~ksDVW 1029 (1137)
.++. .....+.+||+|||+++.......... .......||+.|+|||++.+.. ....++.++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 223 (434)
T 2rio_A 150 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR------TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223 (434)
T ss_dssp CCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHH
T ss_pred cCcccccccccCCCceEEEEcccccceecCCCCccce------eeecCCCCCCCccCHHHhccccccccccCcchhhhhH
Confidence 6420 012236899999999986654221100 0112346999999999987521 124688999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhc
Q 001152 1030 SYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCT 1108 (1137)
Q Consensus 1030 SLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL 1108 (1137)
||||++|||++ |..||......+ ..+..+....... . .......++++.+|+.+||
T Consensus 224 SlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~--~-------------------~~~~~~~~~~~~~li~~~L 280 (434)
T 2rio_A 224 SMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEM--K-------------------CLHDRSLIAEATDLISQMI 280 (434)
T ss_dssp HHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCC--T-------------------TCCCHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccc--c-------------------ccccccchHHHHHHHHHHh
Confidence 99999999999 999997644332 2222222110000 0 0001245678999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhh
Q 001152 1109 EENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1109 ~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+.||.+|||+.||++|+|+.
T Consensus 281 ~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 281 DHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp CSSGGGSCCHHHHHTSGGGS
T ss_pred hCChhhCCCHHHHHhCCccC
Confidence 99999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=348.07 Aligned_cols=265 Identities=19% Similarity=0.219 Sum_probs=196.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcc-eeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIV-kllg~~~~~ 877 (1137)
-.+|++.++||+|+||.||+|++. +..||||+....... + ++.+|+.+++.++|++++ .+..++...
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~----~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------P----QLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------C----CHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------H----HHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 467999999999999999999974 678999975543221 1 236799999999975554 554444444
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..+|||||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+||||
T Consensus 76 ~--------------~~~lvme~~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl 136 (483)
T 3sv0_A 76 D--------------YNVLVMDLL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136 (483)
T ss_dssp T--------------EEEEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred C--------------EEEEEEECC-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEE
Confidence 3 569999999 89999999752 2469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+. ..+.+||+|||+++......... ...........||+.|+|||++.+ ..++.++|||||||++||
T Consensus 137 ~~~~----~~~~vkL~DFGla~~~~~~~~~~---~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~~sDvwSlGvil~e 205 (483)
T 3sv0_A 137 GLGR----RANQVYIIDFGLAKKYRDTSTHQ---HIPYRENKNLTGTARYASVNTHLG----IEQSRRDDLESLGYVLMY 205 (483)
T ss_dssp CCGG----GTTCEEECCCTTCEECBCTTTCC---BCCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHH
T ss_pred ecCC----CCCeEEEEeCCcceeccCCcccc---ccccccccccCCCccccCHHHhcC----CCCChHHHHHHHHHHHHH
Confidence 4210 11789999999998665432211 001112235579999999999876 568899999999999999
Q ss_pred HHhCCCCCCCCCH---HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1038 LLTLQVPYMGLSE---LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~---~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|++|+.||.+... .+.+..+........... ....+++++.+|+.+||+.||++
T Consensus 206 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-----------------------l~~~~p~~l~~li~~cl~~dP~~ 262 (483)
T 3sv0_A 206 FLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA-----------------------LCRGYPTEFASYFHYCRSLRFDD 262 (483)
T ss_dssp HHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH-----------------------HHTTSCHHHHHHHHHHHTCCTTC
T ss_pred HHhCCCCCccccchhHHHHHHHHhhccccccHHH-----------------------HhcCCcHHHHHHHHHHhcCChhh
Confidence 9999999987433 333333321110000000 11144567999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001152 1115 RPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~ 1128 (1137)
||++.+|++.+...
T Consensus 263 RPs~~el~~~L~~l 276 (483)
T 3sv0_A 263 KPDYSYLKRLFRDL 276 (483)
T ss_dssp CCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999998876653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=323.66 Aligned_cols=244 Identities=23% Similarity=0.255 Sum_probs=180.9
Q ss_pred CCCCceEe-eeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHH-HhCCCCCcceeeeeEe
Q 001152 800 SFPSLSSC-DEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRML-GALRHSCIVEMYGHKI 875 (1137)
Q Consensus 800 ~~~~y~l~-~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL-~~L~HpNIVkllg~~~ 875 (1137)
.+.+|.+. +.||+|+||.||+|.+. +..||+|+.... .. +.+|+.++ +..+||||+++++++.
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~----~~~e~~~~~~~~~h~~i~~~~~~~~ 81 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PK----ARREVELHWRASQCPHIVRIVDVYE 81 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HH----HHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HH----HHHHHHHHHHhccCCCchhHHhhhh
Confidence 35678887 78999999999999984 567899875311 11 25688887 5568999999999987
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
... ......++||||+++++|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 82 ~~~----------~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 148 (299)
T 3m2w_A 82 NLY----------AGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 148 (299)
T ss_dssp EEE----------TTEEEEEEEECCCCSCBHHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred hhc----------CCCceEEEEEeecCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 511 011267999999999999999986 2334699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+. ..+.+||+|||++..... ..++.++|||||||++
T Consensus 149 l~~~~~----~~~~~kl~Dfg~a~~~~~------------------------------------~~~~~~~DiwslG~il 188 (299)
T 3m2w_A 149 LYTSKR----PNAILKLTDFGFAKETTG------------------------------------EKYDKSCDMWSLGVIM 188 (299)
T ss_dssp EESSSS----TTCCEEECCCTTCEECTT------------------------------------CGGGGHHHHHHHHHHH
T ss_pred EEecCC----CCCcEEEecccccccccc------------------------------------ccCCchhhHHHHHHHH
Confidence 998731 126899999998743210 2345899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCc-hhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKP-EAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|+|++|..||.+.........+.. .+. . .....+ ......++++.+++.+||+.||.+
T Consensus 189 ~el~tg~~pf~~~~~~~~~~~~~~----~~~---------------~--~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 247 (299)
T 3m2w_A 189 YILLCGYPPFYSNHGLAISPGMKT----RIR---------------M--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 247 (299)
T ss_dssp HHHHHSSCSCCC-------CCSCC----SSC---------------T--TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHCCCCCCCCcchhhhHHHHH----HHh---------------h--ccccCCchhcccCCHHHHHHHHHHcccChhh
Confidence 999999999976543322111100 000 0 000001 011245677999999999999999
Q ss_pred CCCHHHHHHHHHhhcC
Q 001152 1115 RPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~ 1130 (1137)
|||++|+++|+|+...
T Consensus 248 Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 248 RMTITEFMNHPWIMQS 263 (299)
T ss_dssp SCCHHHHHTSHHHHTG
T ss_pred CCCHHHHhcChhhccc
Confidence 9999999999999755
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=339.68 Aligned_cols=271 Identities=16% Similarity=0.113 Sum_probs=186.6
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCC----ChHHHHHhHHhHHHHHHHHHhCC---------CCCc
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGS----SADEIRNFEYSCLGEVRMLGALR---------HSCI 867 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~----~~~~~e~~~~~~lrEi~iL~~L~---------HpNI 867 (1137)
..+|++.+.||+|+||+||+|++.+..||+|+........ .....+. +.+|+.+++.++ ||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~----~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEE----ILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHH----HHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHH----HHHHHHHHHHHHHhhccccccCCch
Confidence 3579999999999999999999998999999876543211 1111122 377888888775 6676
Q ss_pred ceeeeeEecCCCC----------------CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHH
Q 001152 868 VEMYGHKISSKWL----------------PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQ 931 (1137)
Q Consensus 868 Vkllg~~~~~~~~----------------~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~ 931 (1137)
|++++.+...... ...+..........|+||||+++|++.+.+.+ ..+++..++.|+.
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~ 168 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILH 168 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHH
Confidence 6666654311000 00000000012368999999999977666532 3589999999999
Q ss_pred HHHHHHHHHH-hCCeeeccCCCCCeEecccccc-------------CCCCCeEEEeecCccccccccccccccccCCCCC
Q 001152 932 DVAAALVELH-SKHIMHRDIKSENILIDLERKK-------------ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPA 997 (1137)
Q Consensus 932 QIa~gL~yLH-s~gIIHrDLKP~NILld~~~~~-------------~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~ 997 (1137)
||+.||+||| ++||+||||||+|||++.++.. ......+||+|||+|+.....
T Consensus 169 qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------- 235 (336)
T 2vuw_A 169 QLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------- 235 (336)
T ss_dssp HHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------------
T ss_pred HHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------------
Confidence 9999999999 9999999999999999976200 000128999999999765431
Q ss_pred CCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHcC-CCCCchhHHhhhcc
Q 001152 998 PDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL-LLELLTLQVPYMGLSE-LEIHDLIQMG-KRPRLTDELEALGS 1074 (1137)
Q Consensus 998 ~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi-L~ELLTG~~Pf~~~~~-~el~~~I~~g-~~p~l~~~l~~~~~ 1074 (1137)
..+||+.|+|||++.+ . .+.++||||+|++ .+++++|..||..... ......+... ....
T Consensus 236 --~~~gt~~y~aPE~~~g----~-~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 298 (336)
T 2vuw_A 236 --IVVFCDVSMDEDLFTG----D-GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT---------- 298 (336)
T ss_dssp --EEECCCCTTCSGGGCC----C-SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS----------
T ss_pred --cEEEeecccChhhhcC----C-CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc----------
Confidence 2369999999999985 2 2789999998777 7778889998853111 1122222211 1100
Q ss_pred cccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHhh
Q 001152 1075 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY-EMFVAR 1128 (1137)
Q Consensus 1075 ~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL-~~L~~~ 1128 (1137)
..........++++.+||.+||+.| |++|++ +|+|++
T Consensus 299 ------------~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 299 ------------KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ------------CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ------------ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0011122367788999999999976 999999 999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=361.16 Aligned_cols=292 Identities=19% Similarity=0.179 Sum_probs=199.0
Q ss_pred CCCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 797 DPGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 797 ~~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
+...+.+|++.+.||+|+||+||+|.+. +..||+|+.... ......+. +.+|+.++++++||||+++++++
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~----~~~Ei~iL~~L~HpnIV~l~~v~ 81 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRER----WCLEIQIMKKLNHPNVVSAREVP 81 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHH----HHHHHHHHHHCCBTTBCCEEECC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHH----HHHHHHHHHhCCCCCCCceeeee
Confidence 3445788999999999999999999974 577888874322 12333333 48899999999999999999987
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
...... ......++||||+++|+|.+++... .....+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 82 ~~~~~~--------~~~~~~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~N 151 (676)
T 3qa8_A 82 DGLQKL--------APNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 151 (676)
T ss_dssp TTTCCC--------CTTSSCCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTT
T ss_pred cccccc--------cCCCeEEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHH
Confidence 652211 0112569999999999999999762 222368999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.++ ....+||+|||.+........ .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 152 ILl~~~g----~~~~vKL~DFG~a~~~~~~~~-----------~~~~~gt~~Y~APE~l~~----~~~s~ksDIwSLGvi 212 (676)
T 3qa8_A 152 IVLQPGP----QRLIHKIIDLGYAKELDQGEL-----------CTEFVGTLQYLAPELLEQ----KKYTVTVDYWSFGTL 212 (676)
T ss_dssp EEEECCS----SSCEEEECSCCCCCBTTSCCC-----------CCCCCSCCTTCSSCSSCC----SCCSTTHHHHHHHHH
T ss_pred eEeecCC----CceeEEEcccccccccccccc-----------cccccCCcccCChHHhcc----CCCCchhHHHHHHHH
Confidence 9998662 124699999999976543211 123469999999999875 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+|++|..||......... ...... .............. ...-..............++.+.+++.+||..||.+
T Consensus 213 LyeLltG~~Pf~~~~~~~~~--~~~i~~-~~~~~~~~~~~l~g-~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~k 288 (676)
T 3qa8_A 213 AFECITGFRPFLPNWQPVQW--HGKVRE-KSNEHIVVYDDLTG-AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ 288 (676)
T ss_dssp HHHHHSSCSSCCSSCHHHHS--STTCC-------CCSCCCCSS-SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC-
T ss_pred HHHHHHCCCCCCcccchhhh--hhhhhc-ccchhhhhhhhhcc-ccccccccCCchhhchhhhHHHHHHHHHHccCCHhh
Confidence 99999999999764332110 000000 00000000000000 000000000111122357888999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001152 1115 RPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~ 1128 (1137)
|||++|+++|+|+.
T Consensus 289 RPTa~elL~hp~F~ 302 (676)
T 3qa8_A 289 RGTDPQNPNVGCFQ 302 (676)
T ss_dssp --CCTTCCCCTTHH
T ss_pred CcCHHHHhcCHHHH
Confidence 99999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=340.01 Aligned_cols=269 Identities=14% Similarity=0.127 Sum_probs=187.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC-CCccee-------
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEM------- 870 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H-pNIVkl------- 870 (1137)
...|.+.+.||+|+||+||+|++. ++.||||+....... .....+ .+.+|+.+++.++| +|....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-~~~~~~----~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIK----QMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCH----HHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-cHHHHH----HHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 345889999999999999999986 688999986532211 112223 34889999999987 332211
Q ss_pred --eeeEecCCCC---CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001152 871 --YGHKISSKWL---PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE--TGEKHVSVKLALFIAQDVAAALVELHSK 943 (1137)
Q Consensus 871 --lg~~~~~~~~---~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~--~~~~~ls~~~i~~I~~QIa~gL~yLHs~ 943 (1137)
++........ ....+.........+++|+++ +++|.++++.... .....+++..++.|+.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111110000 000000001123568888876 5999999864321 2234688899999999999999999999
Q ss_pred CeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc------
Q 001152 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH------ 1017 (1137)
Q Consensus 944 gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------ 1017 (1137)
||+||||||+|||++.+ +.+||+|||+++...... ....| +.|+|||++.+..
T Consensus 231 ~iiHrDiKp~NILl~~~-------~~~kL~DFG~a~~~~~~~-------------~~~~g-~~y~aPE~~~~~~~~~~~~ 289 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQR-------GGVFLTGFEHLVRDGASA-------------VSPIG-RGFAPPETTAERMLPFGQH 289 (413)
T ss_dssp TEECSCCCGGGEEECTT-------CCEEECCGGGCEETTEEE-------------CCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred CcccCCcccceEEEecC-------CeEEEEeccceeecCCcc-------------ccCCC-CceeCchhhhccccccccc
Confidence 99999999999999988 779999999987654321 12357 8999999994321
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001152 1018 KPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1097 (1137)
Q Consensus 1018 ~~~~~s~ksDVWSLGviL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1137)
....++.++|||||||++|||++|+.||......+....+ +. .. ...+
T Consensus 290 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~-----------~~------------~~---------~~~~ 337 (413)
T 3dzo_A 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI-----------FR------------SC---------KNIP 337 (413)
T ss_dssp CCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG-----------GS------------SC---------CCCC
T ss_pred cCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH-----------Hh------------hc---------ccCC
Confidence 2345788999999999999999999999764322111110 00 00 0234
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1098 SFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1098 ~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+.+.+|+.+||+.||.+||++.++++|+|+.
T Consensus 338 ~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 338 QPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 5699999999999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=315.06 Aligned_cols=233 Identities=14% Similarity=0.085 Sum_probs=177.6
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.+.||+|+||.||+|++. +..||+|+...... ......+. +.+|+.++++++||||+++++++.+.+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~----~~~e~~~l~~l~hp~iv~~~~~~~~~~- 104 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQE----TLSRTLRLSRIDKPGVARVLDVVHTRA- 104 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHH----HHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHH----HHHHHHHHhcCCCCCcceeeEEEEECC-
Confidence 67999999999999999999986 57788887532221 11222333 488999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..|+||||++|++|.++++. .....++.+|+.||+.||+|||++||+||||||+|||++.
T Consensus 105 -------------~~~lv~e~~~g~~L~~~l~~-------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~ 164 (286)
T 3uqc_A 105 -------------GGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI 164 (286)
T ss_dssp -------------EEEEEEECCCEEEHHHHHTT-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET
T ss_pred -------------cEEEEEEecCCCCHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC
Confidence 67999999999999999853 1356678999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+++| |++| ++.++|||||||++|+|+
T Consensus 165 ~-------g~~kl~~~~------------------------------~~~~-----------~~~~~Di~slG~il~ell 196 (286)
T 3uqc_A 165 D-------GDVVLAYPA------------------------------TMPD-----------ANPQDDIRGIGASLYALL 196 (286)
T ss_dssp T-------SCEEECSCC------------------------------CCTT-----------CCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEecc------------------------------ccCC-----------CCchhHHHHHHHHHHHHH
Confidence 7 778887443 2222 458999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
||+.||.+.+..+.............. .........++++.+++.+||+.||.+| |+.
T Consensus 197 tg~~Pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~ 254 (286)
T 3uqc_A 197 VNRWPLPEAGVRSGLAPAERDTAGQPI---------------------EPADIDRDIPFQISAVAARSVQGDGGIR-SAS 254 (286)
T ss_dssp HSEECSCCCSBCCCSEECCBCTTSCBC---------------------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHH
T ss_pred HCCCCCCcCCcchhhHHHHHHhccCCC---------------------ChhhcccCCCHHHHHHHHHHcccCCccC-CHH
Confidence 999999864332110000000000000 0001112456779999999999999999 999
Q ss_pred HHHHHHHhhcC
Q 001152 1120 DLYEMFVARTS 1130 (1137)
Q Consensus 1120 EVL~~L~~~~~ 1130 (1137)
|+++.+.....
T Consensus 255 el~~~L~~~~~ 265 (286)
T 3uqc_A 255 TLLNLMQQATA 265 (286)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHHhc
Confidence 99999988643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=351.93 Aligned_cols=242 Identities=23% Similarity=0.257 Sum_probs=186.3
Q ss_pred CCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.+|++.+.||+|+||+||+|.+. +..||+|+.. .. ......+ .+.+|+.++++++|||||++++++...+
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~--~~-~~~~~~~----~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLV--HS-GDAEAQA----MAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESC--SS-CCHHHHH----HHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeC--cc-CCHHHHH----HHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 68999999999999999999984 5678888642 21 1222223 3488999999999999999999998754
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
.. .....||||||++|++|.+++.. .+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 153 ~~---------~~~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~ 216 (681)
T 2pzi_A 153 RH---------GDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT 216 (681)
T ss_dssp TT---------SCEEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CC---------CCceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe
Confidence 21 11236999999999999987643 599999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ .+||+|||+++..... ....||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 217 ~~--------~~kl~DFG~a~~~~~~--------------~~~~gt~~y~aPE~~~~-----~~~~~sDi~slG~~l~~l 269 (681)
T 2pzi_A 217 EE--------QLKLIDLGAVSRINSF--------------GYLYGTPGFQAPEIVRT-----GPTVATDIYTVGRTLAAL 269 (681)
T ss_dssp SS--------CEEECCCTTCEETTCC--------------SCCCCCTTTSCTTHHHH-----CSCHHHHHHHHHHHHHHH
T ss_pred CC--------cEEEEecccchhcccC--------------CccCCCccccCHHHHcC-----CCCCceehhhhHHHHHHH
Confidence 54 6999999998765432 13469999999999875 247999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||.+.... . .+. .......++.+.+|+.+||+.||.+||+.
T Consensus 270 ~~g~~~~~~~~~~--------~-~~~-------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~ 315 (681)
T 2pzi_A 270 TLDLPTRNGRYVD--------G-LPE-------------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTT 315 (681)
T ss_dssp HSCCCEETTEECS--------S-CCT-------------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSS
T ss_pred HhCCCCCcccccc--------c-ccc-------------------------cccccccCHHHHHHHhhhccCChhhCCCH
Confidence 9999888642100 0 000 00011334568999999999999999987
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
.+++.+.+.
T Consensus 316 ~~~l~~~l~ 324 (681)
T 2pzi_A 316 AEEMSAQLT 324 (681)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 777666554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=349.58 Aligned_cols=289 Identities=20% Similarity=0.215 Sum_probs=163.3
Q ss_pred cccccCCCCCCcccCCCCCCC--CCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCCCCcE
Q 001152 19 KEKLPSEANKINNEKNGSVND--DDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRN 95 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~--l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~-~IP~~~~~L~~L~~ 95 (1137)
++.|.+..|++++..+..+.. +++|++|+|++|++++.+|..|+.+ ++|+.|+|++|.++ .+|..|+++++|++
T Consensus 370 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 446 (768)
T 3rgz_A 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC---SELVSLHLSFNYLSGTIPSSLGSLSKLRD 446 (768)
T ss_dssp CSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGC---TTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred CcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcC---CCCCEEECcCCcccCcccHHHhcCCCCCE
Confidence 333444444443333333333 4445555555555554454444333 55555555555554 44555555555555
Q ss_pred EEccCCCCC-cccccccCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccC
Q 001152 96 LKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1137)
Q Consensus 96 L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1137)
|+|++|.++ .+|..++.+++|+.|+|++|.+. .+|..+.++++|+.|+|++|.+ .+.+|.+++.+++|++|++++
T Consensus 447 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l---~~~~p~~~~~l~~L~~L~L~~ 523 (768)
T 3rgz_A 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL---TGEIPKWIGRLENLAILKLSN 523 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC---CSCCCGGGGGCTTCCEEECCS
T ss_pred EECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCcc---CCcCChHHhcCCCCCEEECCC
Confidence 555555554 44555555555555555555533 4445555555555555555332 233445555555555555555
Q ss_pred CCCc-ccCccccCCCCCCEEEccCCCCC-ccchhh---------------------------------------------
Q 001152 174 FSIR-YLPPEIGCLSNLEQLDLSFNKMK-YLPTEI--------------------------------------------- 206 (1137)
Q Consensus 174 N~L~-~IP~~l~~L~~L~~L~Ls~N~L~-~LP~~l--------------------------------------------- 206 (1137)
|+++ .+|..++.+++|++|+|++|+++ .+|..+
T Consensus 524 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 603 (768)
T 3rgz_A 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603 (768)
T ss_dssp SCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGG
T ss_pred CcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchh
Confidence 5555 45555555555555555555554 444322
Q ss_pred -------------------------cCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCC
Q 001152 207 -------------------------CYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260 (1137)
Q Consensus 207 -------------------------~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~ 260 (1137)
+.+++|+.|+|++|+|+ .||.+++++++|+.|+|++|+|+|.+|..|+++++|+
T Consensus 604 ~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~ 683 (768)
T 3rgz_A 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN 683 (768)
T ss_dssp GGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred hhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCC
Confidence 22345566666666665 5566666666666666666666666666666666666
Q ss_pred EEEccCCcCCCCCCCCcchhhccCCCCCCCCCCCcccccccccccCCCc-----ccCCCCCcccCCCCCC
Q 001152 261 NLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPM-----LENDGNVSFSGSRHTS 325 (1137)
Q Consensus 261 ~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~l~~~~~s~n~l~g~i-----l~~~~~~sf~GN~~lC 325 (1137)
.|||++|+|++ .+|..+. ....+..+++++|.++|+| +.+|...+|.|||+||
T Consensus 684 ~LdLs~N~l~g--~ip~~l~----------~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lc 741 (768)
T 3rgz_A 684 ILDLSSNKLDG--RIPQAMS----------ALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741 (768)
T ss_dssp EEECCSSCCEE--CCCGGGG----------GCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEE
T ss_pred EEECCCCcccC--cCChHHh----------CCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhc
Confidence 66666666665 4555443 1235777888888888876 6778899999999999
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=324.64 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=234.6
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCCCCcE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLRN 95 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~-~IP~~~~~L~~L~~ 95 (1137)
+.++.|.+..|+++...+..|.++++|++|+|++|++++.+|..|+.+ ++|+.|+|++|.++ .+|..|..+++|++
T Consensus 394 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l---~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 470 (768)
T 3rgz_A 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL---SKLRDLKLWLNMLEGEIPQELMYVKTLET 470 (768)
T ss_dssp CCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC---TTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred CCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcC---CCCCEEECCCCcccCcCCHHHcCCCCceE
Confidence 479999999999999999999999999999999999999999988766 89999999999998 78999999999999
Q ss_pred EEccCCCCC-cccccccCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccC
Q 001152 96 LKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1137)
Q Consensus 96 L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1137)
|+|++|+++ .+|..++++++|++|+|++|.+. .+|..+..+++|+.|+|++| ...+.+|..++.+++|+.|++++
T Consensus 471 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N---~l~~~~p~~l~~l~~L~~L~Ls~ 547 (768)
T 3rgz_A 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN---SFSGNIPAELGDCRSLIWLDLNT 547 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS---CCEEECCGGGGGCTTCCEEECCS
T ss_pred EEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCC---cccCcCCHHHcCCCCCCEEECCC
Confidence 999999998 78999999999999999999966 78889999999999999995 45567899999999999999999
Q ss_pred CCCc-ccCccc---------------------------------------------------------------------
Q 001152 174 FSIR-YLPPEI--------------------------------------------------------------------- 183 (1137)
Q Consensus 174 N~L~-~IP~~l--------------------------------------------------------------------- 183 (1137)
|.++ .+|..+
T Consensus 548 N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~ 627 (768)
T 3rgz_A 548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627 (768)
T ss_dssp SEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCS
T ss_pred CccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchh
Confidence 9987 666543
Q ss_pred -cCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCC
Q 001152 184 -GCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260 (1137)
Q Consensus 184 -~~L~~L~~L~Ls~N~L~-~LP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~ 260 (1137)
+.+++|+.|+|++|+|+ .+|.+|+++++|+.|+|++|+|+ .||..++++++|+.|||++|+|+|.+|..+..+++|+
T Consensus 628 ~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~ 707 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707 (768)
T ss_dssp CSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCS
T ss_pred hhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence 34578999999999999 89999999999999999999999 8999999999999999999999999999999999999
Q ss_pred EEEccCCcCCCCCCCCcc
Q 001152 261 NLNLQYNKLLSYCQVPSW 278 (1137)
Q Consensus 261 ~L~Ls~N~L~~~~~iP~~ 278 (1137)
+|+|++|+|+| .||..
T Consensus 708 ~L~ls~N~l~g--~iP~~ 723 (768)
T 3rgz_A 708 EIDLSNNNLSG--PIPEM 723 (768)
T ss_dssp EEECCSSEEEE--ECCSS
T ss_pred EEECcCCcccc--cCCCc
Confidence 99999999998 66654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-28 Score=276.32 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=138.0
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L 96 (1137)
+.++.|.+..|+|+.+.+.+|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|.|+.+|..+. ++|++|
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~Ls~n~l~~l~~~~~--~~L~~L 126 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPL---VKLERLYLSKNQLKELPEKMP--KTLQEL 126 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTC---TTCCEEECCSSCCSBCCSSCC--TTCCEE
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCC---CCCCEEECCCCcCCccChhhc--ccccEE
Confidence 345556666666666665566666666666666666665555544333 566666666666666655443 456666
Q ss_pred EccCCCCCcccc-cccCCCCCCEEEccCCCCC---CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEecc
Q 001152 97 KFFGNEINLFPS-EVGNLLGLECLQIKISSPG---VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172 (1137)
Q Consensus 97 ~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~~~---~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls 172 (1137)
+|++|.|+.++. .+.++++|+.|+|++|.+. ..+..+..+++|++|++++|.+.. +|..+. ++|+.|+++
T Consensus 127 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~----l~~~~~--~~L~~L~l~ 200 (330)
T 1xku_A 127 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT----IPQGLP--PSLTELHLD 200 (330)
T ss_dssp ECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS----CCSSCC--TTCSEEECT
T ss_pred ECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc----CCcccc--ccCCEEECC
Confidence 666666655533 3555666666666666543 333445556666666666544332 232222 456666666
Q ss_pred CCCCccc-CccccCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCc
Q 001152 173 HFSIRYL-PPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1137)
Q Consensus 173 ~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p 250 (1137)
+|+++.+ |..|..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++|+|+.+|.++..+++|+.|+|++|+|+++++
T Consensus 201 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~~~ 280 (330)
T 1xku_A 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGS 280 (330)
T ss_dssp TSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCccCh
Confidence 6666544 345556666666666666666443 24555666666666666666666666666666666666666666555
Q ss_pred ccccCC------CCCCEEEccCCcCCC
Q 001152 251 LDLCLM------HNLQNLNLQYNKLLS 271 (1137)
Q Consensus 251 ~~l~~L------~~L~~L~Ls~N~L~~ 271 (1137)
..|+.. ..|+.|+|++|++..
T Consensus 281 ~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 281 NDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp TSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred hhcCCcccccccccccceEeecCcccc
Confidence 554332 455566666666544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-29 Score=277.82 Aligned_cols=254 Identities=22% Similarity=0.227 Sum_probs=222.8
Q ss_pred ccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc---CccccCCCCCcEE
Q 001152 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI---PKSVGRYEKLRNL 96 (1137)
Q Consensus 20 ~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I---P~~~~~L~~L~~L 96 (1137)
..+....+.++.++...+ ++|++|+|++|+|+...+..|.. +++|++|+|++|.++.+ |..+..+++|++|
T Consensus 10 ~~l~c~~~~l~~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~---l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L 83 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTGIP---SSATRLELESNKLQSLPHGVFDK---LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83 (306)
T ss_dssp TEEECCSSCCSSCCSCCC---TTCCEEECCSSCCCCCCTTTTTT---CTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEE
T ss_pred CEEEcCCCCcccCCCCCC---CCCCEEECCCCccCccCHhHhhc---cccCCEEECCCCccCcccCcccccccccccCEE
Confidence 357788888999876443 68999999999999777665654 49999999999999865 6778889999999
Q ss_pred EccCCCCCcccccccCCCCCCEEEccCCCCCCCc--ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCC
Q 001152 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNG--FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1137)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~--~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1137)
+|++|.++.+|..+.++++|++|+|++|.+...+ ..+..+++|++|++++|.+ ....+..+..+++|+.|++++|
T Consensus 84 ~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l---~~~~~~~~~~l~~L~~L~l~~n 160 (306)
T 2z66_A 84 DLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT---RVAFNGIFNGLSSLEVLKMAGN 160 (306)
T ss_dssp ECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCC---EECSTTTTTTCTTCCEEECTTC
T ss_pred ECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcC---CccchhhcccCcCCCEEECCCC
Confidence 9999999999999999999999999999977766 4789999999999999654 4455667889999999999999
Q ss_pred CCcc--cCccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeccCCcCCCCCc
Q 001152 175 SIRY--LPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGS 250 (1137)
Q Consensus 175 ~L~~--IP~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdLS~N~Lsg~~p 250 (1137)
.++. +|..+..+++|++|+|++|+|+.+ |..+..+++|+.|+|++|+++.+|. .+..+++|+.|+|++|+|++.++
T Consensus 161 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (306)
T 2z66_A 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240 (306)
T ss_dssp EEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSS
T ss_pred ccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCH
Confidence 9985 788999999999999999999976 6789999999999999999998865 68889999999999999999999
Q ss_pred ccccCCC-CCCEEEccCCcCCCCCCCCcchhhc
Q 001152 251 LDLCLMH-NLQNLNLQYNKLLSYCQVPSWICCN 282 (1137)
Q Consensus 251 ~~l~~L~-~L~~L~Ls~N~L~~~~~iP~~~~~~ 282 (1137)
..+..++ +|+.|+|++|+|+|.|.+..+..|.
T Consensus 241 ~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l 273 (306)
T 2z66_A 241 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWI 273 (306)
T ss_dssp SSCCCCCTTCCEEECTTCCEECSGGGHHHHHHH
T ss_pred HHHHhhhccCCEEEccCCCeecccChHHHHHHH
Confidence 8999985 9999999999999988876655553
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=287.38 Aligned_cols=224 Identities=21% Similarity=0.243 Sum_probs=156.3
Q ss_pred CCCCEEEccCCCCCC--CCcccccCCCCCCCccEEEeec-CCCC-ccCccccCCCCCcEEEccCCCCC-cccccccCCCC
Q 001152 41 DDDSVIDVSGKTVDF--PLIESYGNRGGDNSVEGLYLYK-NVLN-LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLG 115 (1137)
Q Consensus 41 ~~L~~LdLs~N~L~~--~~p~~~~~l~~L~~L~~L~Ls~-N~L~-~IP~~~~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~ 115 (1137)
..++.|+|++|+|++ .+|..|+.+ ++|++|+|++ |.++ .+|..|+++++|++|+|++|.|+ .+|..|+++++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l---~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~ 126 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANL---PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGC---TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTT
T ss_pred ceEEEEECCCCCccCCcccChhHhCC---CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCC
Confidence 467777777777776 666666544 7777777773 6665 56777777777777777777776 66777777777
Q ss_pred CCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCC-CCcEEeccCCCCc-ccCccccCCCCCCEE
Q 001152 116 LECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLK-CLTKLSVCHFSIR-YLPPEIGCLSNLEQL 192 (1137)
Q Consensus 116 L~~L~Ls~N~~~-~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~-~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L 192 (1137)
|++|+|++|.+. .+|..+..+++|++|++++|. ..+.+|..+..++ +|+.|++++|+++ .+|..+..++ |++|
T Consensus 127 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~---l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L 202 (313)
T 1ogq_A 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR---ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV 202 (313)
T ss_dssp CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC---CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEE
T ss_pred CCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc---ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEE
Confidence 777777777755 566667777777777777743 3345666677776 7777777777776 6666666665 7777
Q ss_pred EccCCCCC-ccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 193 DLSFNKMK-YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 193 ~Ls~N~L~-~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+|++|+|+ .+|..|..+++|+.|+|++|+++..++.+..+++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++
T Consensus 203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 77777776 45666677777777777777777544446667777777777777776666677777777777777777765
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=283.69 Aligned_cols=247 Identities=17% Similarity=0.177 Sum_probs=221.5
Q ss_pred CCcccccCCCCCCcc--cCCCCCCCCCCCCEEEccC-CCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccccCCCC
Q 001152 17 PIKEKLPSEANKINN--EKNGSVNDDDDDSVIDVSG-KTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEK 92 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~--l~~~~f~~l~~L~~LdLs~-N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~-~IP~~~~~L~~ 92 (1137)
..+..|.+..|+|++ ..+..|.++++|++|+|++ |++.+.+|..|+.+ ++|++|+|++|.++ .+|..|.++++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l---~~L~~L~Ls~n~l~~~~p~~~~~l~~ 126 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL---TQLHYLYITHTNVSGAIPDFLSQIKT 126 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGC---TTCSEEEEEEECCEEECCGGGGGCTT
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcC---CCCCEEECcCCeeCCcCCHHHhCCCC
Confidence 368889999999998 6788999999999999995 99999999888766 99999999999998 78999999999
Q ss_pred CcEEEccCCCCC-cccccccCCCCCCEEEccCCCCC-CCcccccCCC-CCCEEECCCCCCCCCcccchhhhcCCCCCcEE
Q 001152 93 LRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLK-GLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169 (1137)
Q Consensus 93 L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~L~-~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L 169 (1137)
|++|+|++|.|+ .+|..++++++|++|+|++|.+. .+|..+..+. +|+.|++++|. ..+.+|..+..++ |+.|
T Consensus 127 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~---l~~~~~~~~~~l~-L~~L 202 (313)
T 1ogq_A 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR---LTGKIPPTFANLN-LAFV 202 (313)
T ss_dssp CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE---EEEECCGGGGGCC-CSEE
T ss_pred CCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCe---eeccCChHHhCCc-ccEE
Confidence 999999999998 78999999999999999999977 7888899998 99999999954 4457788888887 9999
Q ss_pred eccCCCCc-ccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccCCcCCC
Q 001152 170 SVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTS 247 (1137)
Q Consensus 170 ~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~N~Lsg 247 (1137)
++++|.++ .+|..|..+++|+.|+|++|+++..+..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++
T Consensus 203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 99999998 5667889999999999999999966666889999999999999999 889999999999999999999998
Q ss_pred CCcccccCCCCCCEEEccCCcCCC
Q 001152 248 LGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 248 ~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
.+|. ...+++|+.|++++|+.-|
T Consensus 283 ~ip~-~~~l~~L~~l~l~~N~~lc 305 (313)
T 1ogq_A 283 EIPQ-GGNLQRFDVSAYANNKCLC 305 (313)
T ss_dssp ECCC-STTGGGSCGGGTCSSSEEE
T ss_pred cCCC-CccccccChHHhcCCCCcc
Confidence 8885 4889999999999998443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=290.61 Aligned_cols=250 Identities=20% Similarity=0.200 Sum_probs=197.1
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCc
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLR 94 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~ 94 (1137)
++.++.|.+..|+|+.+.+..|.++++|++|+|++|.|++..|..|..+ ++|++|+|++|.|+.+|. .|.++++|+
T Consensus 31 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 107 (477)
T 2id5_A 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNL---FNLRTLGLRSNRLKLIPLGVFTGLSNLT 107 (477)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCSCCTTSSTTCTTCC
T ss_pred CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCC---ccCCEEECCCCcCCccCcccccCCCCCC
Confidence 4579999999999999999999999999999999999999888777655 999999999999999986 478999999
Q ss_pred EEEccCCCCCcc-cccccCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEecc
Q 001152 95 NLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172 (1137)
Q Consensus 95 ~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~~~~~-~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls 172 (1137)
+|+|++|.|+.+ |..|.++++|+.|+|++|.+..+ +..|..+++|+.|+|++|.+.. ..+..+..+++|+.|+++
T Consensus 108 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---~~~~~l~~l~~L~~L~l~ 184 (477)
T 2id5_A 108 KLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS---IPTEALSHLHGLIVLRLR 184 (477)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS---CCHHHHTTCTTCCEEEEE
T ss_pred EEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc---cChhHhcccCCCcEEeCC
Confidence 999999999966 66799999999999999997654 4678999999999999966543 223457888899999999
Q ss_pred CCCCcccCc-cccCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeccCCcCCCCC
Q 001152 173 HFSIRYLPP-EIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLG 249 (1137)
Q Consensus 173 ~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~-~LP~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdLS~N~Lsg~~ 249 (1137)
+|.++.++. .|..+++|+.|+|++|.+. .+|..+....+|+.|+|++|+|+.+|. .+..+++|+.|+|++|+|++++
T Consensus 185 ~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 264 (477)
T 2id5_A 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIE 264 (477)
T ss_dssp SCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEEC
T ss_pred CCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccC
Confidence 998886655 6777777777777776543 566555555566666666666666663 4556666666666666666666
Q ss_pred cccccCCCCCCEEEccCCcCCC
Q 001152 250 SLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 250 p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+..|..+++|+.|+|++|++++
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~~ 286 (477)
T 2id5_A 265 GSMLHELLRLQEIQLVGGQLAV 286 (477)
T ss_dssp TTSCTTCTTCCEEECCSSCCSE
T ss_pred hhhccccccCCEEECCCCccce
Confidence 6666666666666666666655
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-28 Score=287.53 Aligned_cols=253 Identities=20% Similarity=0.181 Sum_probs=200.7
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCc-ccccCCCCCCCccEEEeecCCCCcc-CccccCCCCC
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLI-ESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKL 93 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p-~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L 93 (1137)
++.++.|.+..|+|+.+.+..|.++++|++|+|++|.+.+.++ ..| .++++|++|+|++|.++.+ |..|.++++|
T Consensus 29 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~---~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 105 (455)
T 3v47_A 29 PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF---RGLSSLIILKLDYNQFLQLETGAFNGLANL 105 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTT---TTCTTCCEEECTTCTTCEECTTTTTTCTTC
T ss_pred CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccc---cccccCCEEeCCCCccCccChhhccCcccC
Confidence 3578999999999999999999999999999999999876554 344 4558999999999999866 6789999999
Q ss_pred cEEEccCCCCCc-cccc--ccCCCCCCEEEccCCCCCCC-ccc-ccCCCCCCEEECCCCCCCCCcccc------------
Q 001152 94 RNLKFFGNEINL-FPSE--VGNLLGLECLQIKISSPGVN-GFA-LNKLKGLKELELSKVPPRPSVLTL------------ 156 (1137)
Q Consensus 94 ~~L~Ls~N~L~~-lP~~--l~~L~~L~~L~Ls~N~~~~~-~~~-~~~L~~L~~L~Ls~n~ln~~~~~l------------ 156 (1137)
++|+|++|.|+. +|.. |.++++|++|+|++|.+... |.. +.++++|++|++++|.+.......
T Consensus 106 ~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L 185 (455)
T 3v47_A 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185 (455)
T ss_dssp CEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEE
T ss_pred CEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccc
Confidence 999999999984 4554 88899999999999987665 443 788899999999887654332110
Q ss_pred -------------------------------------------hhhhc--------------------------------
Q 001152 157 -------------------------------------------LSEIA-------------------------------- 161 (1137)
Q Consensus 157 -------------------------------------------p~~l~-------------------------------- 161 (1137)
|..+.
T Consensus 186 ~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~ 265 (455)
T 3v47_A 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265 (455)
T ss_dssp ECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCC
T ss_pred ccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCc
Confidence 11000
Q ss_pred -------CCCCCcEEeccCCCCcc-cCccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCcc-CccccC
Q 001152 162 -------GLKCLTKLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYL 231 (1137)
Q Consensus 162 -------~L~~L~~L~Ls~N~L~~-IP~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~ 231 (1137)
.+++|+.|++++|.++. +|..|+.+++|++|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+ |..+..
T Consensus 266 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 345 (455)
T 3v47_A 266 NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFEN 345 (455)
T ss_dssp TTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTT
T ss_pred ccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcC
Confidence 01356666666666663 456788889999999999999865 56788899999999999999866 566788
Q ss_pred CCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 232 L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+++|+.|+|++|+|++++|..|..+++|++|+|++|+|++
T Consensus 346 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 346 LDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred cccCCEEECCCCcccccChhhccccccccEEECCCCcccc
Confidence 9999999999999999888888999999999999999886
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-28 Score=275.42 Aligned_cols=240 Identities=18% Similarity=0.242 Sum_probs=125.2
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCcEEE
Q 001152 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLK 97 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~~L~ 97 (1137)
+..+.+..+.++.++...+ ++|++|+|++|+|++..+..|..+ ++|++|+|++|.++.+ |..|.++++|++|+
T Consensus 35 l~~l~~~~~~l~~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 35 LRVVQCSDLGLKAVPKEIS---PDTTLLDLQNNDISELRKDDFKGL---QHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp TTEEECCSSCCSSCCSCCC---TTCCEEECCSSCCCEECTTTTTTC---TTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred CCEEECCCCCccccCCCCC---CCCeEEECCCCcCCccCHhHhhCC---CCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 4445555555555543322 455555555555555544444333 5555555555555544 34555555555555
Q ss_pred ccCCCCCcccccccCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCC
Q 001152 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1137)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~-~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1137)
|++|.|+.+|..+. ++|++|+|++|.+..++. .+..+++|+.|++++|.+.. .+..|..+..+ +|+.|++++|++
T Consensus 109 L~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 109 ISKNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN-SGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CCSSCCCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG-GGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCCCcCCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc-CCCCcccccCC-ccCEEECcCCCC
Confidence 55555555555443 455555555555444442 35555555555555543321 12233344444 555555555555
Q ss_pred cccCccccCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeccCCcCCCCCccccc
Q 001152 177 RYLPPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1137)
Q Consensus 177 ~~IP~~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdLS~N~Lsg~~p~~l~ 254 (1137)
+.+|..+. ++|+.|+|++|+++.++ ..+..+++|+.|+|++|+|+.++. .+..+++|+.|+|++|+|+.+++ .+.
T Consensus 185 ~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~l~ 261 (332)
T 2ft3_A 185 TGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPA-GLP 261 (332)
T ss_dssp SSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCT-TGG
T ss_pred CccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecCh-hhh
Confidence 55555433 45555555555555443 345555555555555555554432 45555555555555555554432 455
Q ss_pred CCCCCCEEEccCCcCCC
Q 001152 255 LMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 255 ~L~~L~~L~Ls~N~L~~ 271 (1137)
.+++|+.|+|++|+|+.
T Consensus 262 ~l~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 262 DLKLLQVVYLHTNNITK 278 (332)
T ss_dssp GCTTCCEEECCSSCCCB
T ss_pred cCccCCEEECCCCCCCc
Confidence 55555555555555554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-27 Score=281.24 Aligned_cols=253 Identities=20% Similarity=0.299 Sum_probs=222.7
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCCCCcEEE
Q 001152 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLK 97 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP-~~~~~L~~L~~L~ 97 (1137)
...+....++++.++.+.. +++++|+|++|+|++..+..|..+ ++|+.|+|++|.|+.++ ..|.++++|++|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l---~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~ 118 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGIS---TNTRLLNLHENQIQIIKVNSFKHL---RHLEILQLSRNHIRTIEIGAFNGLANLNTLE 118 (440)
T ss_dssp SCEEECCSCCCSSCCSCCC---TTCSEEECCSCCCCEECTTTTSSC---SSCCEEECCSSCCCEECGGGGTTCSSCCEEE
T ss_pred CCEEEeCCCCcCcCCCCCC---CCCcEEEccCCcCCeeCHHHhhCC---CCCCEEECCCCcCCccChhhccCCccCCEEE
Confidence 4567778888998876544 689999999999999888777655 99999999999999886 5799999999999
Q ss_pred ccCCCCCcccc-cccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchh-hhcCCCCCcEEeccCC
Q 001152 98 FFGNEINLFPS-EVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLS-EIAGLKCLTKLSVCHF 174 (1137)
Q Consensus 98 Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~-~l~~L~~L~~L~Ls~N 174 (1137)
|++|+|+.+|. .|.++++|+.|+|++|.+..++ ..|..+++|+.|+|++| +....++. .|.++++|+.|++++|
T Consensus 119 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~---~~l~~i~~~~~~~l~~L~~L~L~~n 195 (440)
T 3zyj_A 119 LFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL---KRLSYISEGAFEGLSNLRYLNLAMC 195 (440)
T ss_dssp CCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC---TTCCEECTTTTTTCSSCCEEECTTS
T ss_pred CCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCC---CCcceeCcchhhcccccCeecCCCC
Confidence 99999999876 5899999999999999987766 47899999999999984 33444444 6889999999999999
Q ss_pred CCcccCccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeccCCcCCCCCccc
Q 001152 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLD 252 (1137)
Q Consensus 175 ~L~~IP~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~LdLS~N~Lsg~~p~~ 252 (1137)
+|+.+|. +..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+ |..|.++++|+.|+|++|+|+++++..
T Consensus 196 ~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 274 (440)
T 3zyj_A 196 NLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274 (440)
T ss_dssp CCSSCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTT
T ss_pred cCccccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhH
Confidence 9999985 78999999999999999976 67899999999999999999977 556888999999999999999999988
Q ss_pred ccCCCCCCEEEccCCcCCCCCCCCcchhh
Q 001152 253 LCLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1137)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1137)
|..+++|+.|+|++|+|.|.|.+-....|
T Consensus 275 ~~~l~~L~~L~L~~Np~~CdC~l~~l~~~ 303 (440)
T 3zyj_A 275 FTPLHHLERIHLHHNPWNCNCDILWLSWW 303 (440)
T ss_dssp TSSCTTCCEEECCSSCEECSSTTHHHHHH
T ss_pred hccccCCCEEEcCCCCccCCCCchHHHHH
Confidence 99999999999999999999987655444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-29 Score=307.85 Aligned_cols=263 Identities=15% Similarity=0.201 Sum_probs=219.8
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCC--------------------------------------------
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTV-------------------------------------------- 53 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L-------------------------------------------- 53 (1137)
.+..|.+..|++++..+.+|.++++|++|||++|.+
T Consensus 82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~ 161 (636)
T 4eco_A 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL 161 (636)
T ss_dssp CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred CEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHH
Confidence 578899999999988889999999999999998843
Q ss_pred ----------------------------------CCCCcccccCCCCCCCccEEEeecCCCCc-----------------
Q 001152 54 ----------------------------------DFPLIESYGNRGGDNSVEGLYLYKNVLNL----------------- 82 (1137)
Q Consensus 54 ----------------------------------~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~----------------- 82 (1137)
++ +|..|+.+ ++|++|+|++|.|+.
T Consensus 162 ~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l---~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~ 237 (636)
T 4eco_A 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRL---TKLRQFYMGNSPFVAENICEAWENENSEYAQQ 237 (636)
T ss_dssp HHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGC---TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHH
T ss_pred HHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcc---cCCCEEECcCCccccccccccccccccchhcc
Confidence 34 56655544 899999999999987
Q ss_pred -cCcccc--CCCCCcEEEccCCCCC-cccccccCCCCCCEEEccCCC-CCC--CcccccCC------CCCCEEECCCCCC
Q 001152 83 -IPKSVG--RYEKLRNLKFFGNEIN-LFPSEVGNLLGLECLQIKISS-PGV--NGFALNKL------KGLKELELSKVPP 149 (1137)
Q Consensus 83 -IP~~~~--~L~~L~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~-~~~--~~~~~~~L------~~L~~L~Ls~n~l 149 (1137)
+|..|+ ++++|++|+|++|.+. .+|..|+++++|++|+|++|. +.. +|..+..| ++|++|++++|.+
T Consensus 238 ~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l 317 (636)
T 4eco_A 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317 (636)
T ss_dssp HTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCC
T ss_pred cCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcC
Confidence 999988 9999999999999876 789899999999999999997 763 77777666 8999999998654
Q ss_pred CCCcccchh--hhcCCCCCcEEeccCCCCc-ccCccccCCCCCCEEEccCCCCCccchhhcCCCC-CCEEEccCCCCCcc
Q 001152 150 RPSVLTLLS--EIAGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKA-LISLKVANNKLVEL 225 (1137)
Q Consensus 150 n~~~~~lp~--~l~~L~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~-L~~L~Ls~N~Ls~I 225 (1137)
. .+|. .++++++|+.|++++|+++ .+| .|+.+++|++|+|++|+|+.+|..++.+++ |+.|+|++|+|+.+
T Consensus 318 ~----~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~~l 392 (636)
T 4eco_A 318 K----TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYI 392 (636)
T ss_dssp S----SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCSSC
T ss_pred C----ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCccc
Confidence 3 6777 8889999999999999998 899 888899999999999999999988999988 99999999999999
Q ss_pred CccccCCC--CCCEEeccCCcCCCCCccccc-------CCCCCCEEEccCCcCCCCCC-----CCcchhhccCCCCCC
Q 001152 226 PSGLYLLQ--RLENLDLSNNRLTSLGSLDLC-------LMHNLQNLNLQYNKLLSYCQ-----VPSWICCNLEGNGKD 289 (1137)
Q Consensus 226 P~~l~~L~--~L~~LdLS~N~Lsg~~p~~l~-------~L~~L~~L~Ls~N~L~~~~~-----iP~~~~~~l~~n~l~ 289 (1137)
|..+..+. +|+.|+|++|+|++.+|..|. .+++|+.|+|++|+|+.++. ++....+++++|.+.
T Consensus 393 p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~ 470 (636)
T 4eco_A 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470 (636)
T ss_dssp CSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS
T ss_pred chhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC
Confidence 98877754 899999999999998887787 78899999999999886331 233334556666555
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=277.54 Aligned_cols=284 Identities=17% Similarity=0.148 Sum_probs=146.3
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCCCCcEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRNL 96 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~-~~~L~~L~~L 96 (1137)
.++.|.+..|+|+.+.+.+|.++++|++|+|++|.|++..|..|+.+ ++|++|+|++|.|+.+|.. |.++++|++|
T Consensus 70 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV---PLLTVLVLERNDLSSLPRGIFHNTPKLTTL 146 (390)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC---TTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCC---CCCCEEECCCCccCcCCHHHhcCCCCCcEE
Confidence 45556666666666666666666666666666666665555544333 5666666666666666544 3556666666
Q ss_pred EccCCCCCccc-ccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCC---------------cccchhhh
Q 001152 97 KFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPS---------------VLTLLSEI 160 (1137)
Q Consensus 97 ~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~---------------~~~lp~~l 160 (1137)
+|++|.|+.++ ..+.++++|+.|+|++|.+...+ +..+++|+.|++++|.+... +..+|..
T Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~- 223 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGP- 223 (390)
T ss_dssp ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECC-
T ss_pred ECCCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeecccccccccCCCCcceEEECCCCeeeecccc-
Confidence 66666665443 33556666666666666544432 34444555554444332210 0000100
Q ss_pred cCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEe
Q 001152 161 AGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239 (1137)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~Ld 239 (1137)
..++|+.|++++|.++.+ ..+..+++|++|+|++|.|+.+ |..|..+++|+.|+|++|+|+.+|..+..+++|+.|+
T Consensus 224 -~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~ 301 (390)
T 3o6n_A 224 -VNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLD 301 (390)
T ss_dssp -CCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEE
T ss_pred -ccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEE
Confidence 112344444444444433 2344445555555555555433 4444555555555555555555544444455555555
Q ss_pred ccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhccCCCCCCCCCCCcccccccccccCCCc----ccCCCC
Q 001152 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPM----LENDGN 315 (1137)
Q Consensus 240 LS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~l~~~~~s~n~l~g~i----l~~~~~ 315 (1137)
|++|+|+++++ .+..+++|+.|+|++|+|+.+ | ....+.+...+++.|.+.+.- +..+..
T Consensus 302 L~~n~l~~~~~-~~~~l~~L~~L~L~~N~i~~~---~------------~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~ 365 (390)
T 3o6n_A 302 LSHNHLLHVER-NQPQFDRLENLYLDHNSIVTL---K------------LSTHHTLKNLTLSHNDWDCNSLRALFRNVAR 365 (390)
T ss_dssp CCSSCCCCCGG-GHHHHTTCSEEECCSSCCCCC---C------------CCTTCCCSEEECCSSCEEHHHHHHHTTTCCT
T ss_pred CCCCcceecCc-cccccCcCCEEECCCCcccee---C------------chhhccCCEEEcCCCCccchhHHHHHHHHHh
Confidence 55555554432 344455555555555554431 0 112234555666666665532 566677
Q ss_pred CcccCCCCCC
Q 001152 316 VSFSGSRHTS 325 (1137)
Q Consensus 316 ~sf~GN~~lC 325 (1137)
..+.+++..|
T Consensus 366 ~~~~~~~~~c 375 (390)
T 3o6n_A 366 PAVDDADQHC 375 (390)
T ss_dssp TTBCCCCSCC
T ss_pred hcccccCcee
Confidence 7778888888
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=292.67 Aligned_cols=128 Identities=16% Similarity=0.139 Sum_probs=74.0
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCcEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNL 96 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~~L 96 (1137)
.+..|.+..|+|+.+.+.+|.++++|++|||++|+|++..|..|+.+ ++|++|+|++|.++.+ |..|+++++|++|
T Consensus 33 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l---~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 109 (606)
T 3vq2_A 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGL---HHLSNLILTGNPIQSFSPGSFSGLTSLENL 109 (606)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC---TTCCEEECTTCCCCCCCTTSSTTCTTCCEE
T ss_pred CcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhch---hhcCEeECCCCcccccChhhcCCcccCCEE
Confidence 45666666666666666666666666666666666665555544333 5666666666666654 4456666666666
Q ss_pred EccCCCCCccc-ccccCCCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCC
Q 001152 97 KFFGNEINLFP-SEVGNLLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVP 148 (1137)
Q Consensus 97 ~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~~~~--~~~~~~~L~~L~~L~Ls~n~ 148 (1137)
+|++|.|+.+| ..++++++|++|+|++|.+.. +|..+.++++|++|++++|.
T Consensus 110 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~ 164 (606)
T 3vq2_A 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164 (606)
T ss_dssp ECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred EccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence 66666665543 345555666666665555442 34555555555555555543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=292.92 Aligned_cols=280 Identities=18% Similarity=0.170 Sum_probs=156.8
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCCCCcEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRNL 96 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~-~~~L~~L~~L 96 (1137)
.+..|.+..|.|+.+.+.+|.++++|++|+|++|.|++.+|..|+.+ ++|++|+|++|.|+.+|.. |+++++|++|
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 152 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV---PLLTVLVLERNDLSSLPRGIFHNTPKLTTL 152 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC---TTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCC---CCCCEEEeeCCCCCCCCHHHhccCCCCCEE
Confidence 46666666666666666666666666666666666666665544433 6666666666666666554 4666666666
Q ss_pred EccCCCCCccc-ccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCC
Q 001152 97 KFFGNEINLFP-SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1137)
Q Consensus 97 ~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1137)
+|++|.|+.+| ..|+++++|+.|+|++|.+..++ +..+++|+.|++++|.+.. +....+|+.|++++|.
T Consensus 153 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n~l~~--------l~~~~~L~~L~ls~n~ 222 (597)
T 3oja_B 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLST--------LAIPIAVEELDASHNS 222 (597)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSSCCSE--------EECCTTCSEEECCSSC
T ss_pred EeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccCcccc--------ccCCchhheeeccCCc
Confidence 66666666443 34666666666666666654443 3445555555555543321 1122334444444444
Q ss_pred CcccC--------------------ccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCccccCCCC
Q 001152 176 IRYLP--------------------PEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQR 234 (1137)
Q Consensus 176 L~~IP--------------------~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~ 234 (1137)
++.+| ..++.+++|+.|+|++|.|+.+ |..|+.+++|+.|+|++|.|+.+|..+..+++
T Consensus 223 l~~~~~~~~~~L~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~ 302 (597)
T 3oja_B 223 INVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPT 302 (597)
T ss_dssp CCEEECSCCSCCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTT
T ss_pred ccccccccCCCCCEEECCCCCCCCChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCC
Confidence 44333 3344555555555555555532 44455555555555555555555554544555
Q ss_pred CCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhccCCCCCCCCCCCcccccccccccCCCc----c
Q 001152 235 LENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPM----L 310 (1137)
Q Consensus 235 L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~l~~~~~s~n~l~g~i----l 310 (1137)
|+.|+|++|.|+++++ .+..+++|+.|+|++|+|+++ | ....+.+...++++|.+.+.. +
T Consensus 303 L~~L~Ls~N~l~~i~~-~~~~l~~L~~L~L~~N~l~~~---~------------~~~~~~L~~L~l~~N~~~~~~~~~~~ 366 (597)
T 3oja_B 303 LKVLDLSHNHLLHVER-NQPQFDRLENLYLDHNSIVTL---K------------LSTHHTLKNLTLSHNDWDCNSLRALF 366 (597)
T ss_dssp CCEEECCSSCCCCCGG-GHHHHTTCSEEECCSSCCCCC---C------------CCTTCCCSEEECCSSCEEHHHHHHHT
T ss_pred CcEEECCCCCCCccCc-ccccCCCCCEEECCCCCCCCc---C------------hhhcCCCCEEEeeCCCCCChhHHHHH
Confidence 5555555555554432 444555555555555555441 1 112345666777777777643 6
Q ss_pred cCCCCCcccCCCCCCc
Q 001152 311 ENDGNVSFSGSRHTSS 326 (1137)
Q Consensus 311 ~~~~~~sf~GN~~lC~ 326 (1137)
..+....+.+++.+|.
T Consensus 367 ~~~~~~~~~~~~~~C~ 382 (597)
T 3oja_B 367 RNVARPAVDDADQHCK 382 (597)
T ss_dssp TTCCTTTBCCCCCCCC
T ss_pred HHHhhhccccccccCC
Confidence 7777888889999993
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=282.09 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=221.2
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCCCCcEEE
Q 001152 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLK 97 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP-~~~~~L~~L~~L~ 97 (1137)
...+....+.++.++.+.. ++|++|+|++|+|++..+..|..+ ++|+.|+|++|.|+.++ ..|.++++|++|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 129 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP---SNTRYLNLMENNIQMIQADTFRHL---HHLEVLQLGRNSIRQIEVGAFNGLASLNTLE 129 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC---TTCSEEECCSSCCCEECTTTTTTC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcEEEECCCCcCccCCCCC---CCccEEECcCCcCceECHHHcCCC---CCCCEEECCCCccCCcChhhccCcccCCEEE
Confidence 4567777888888875433 689999999999999988877655 99999999999999885 6799999999999
Q ss_pred ccCCCCCccccc-ccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchh-hhcCCCCCcEEeccCC
Q 001152 98 FFGNEINLFPSE-VGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLS-EIAGLKCLTKLSVCHF 174 (1137)
Q Consensus 98 Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~-~l~~L~~L~~L~Ls~N 174 (1137)
|++|+|+.+|.. |.++++|++|+|++|.+..++ ..|.++++|+.|++++| +....++. .|.++++|++|+|++|
T Consensus 130 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~---~~l~~i~~~~~~~l~~L~~L~L~~n 206 (452)
T 3zyi_A 130 LFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL---KKLEYISEGAFEGLFNLKYLNLGMC 206 (452)
T ss_dssp CCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC---TTCCEECTTTTTTCTTCCEEECTTS
T ss_pred CCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCC---CCccccChhhccCCCCCCEEECCCC
Confidence 999999988765 889999999999999988766 47899999999999983 33444544 5889999999999999
Q ss_pred CCcccCccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeccCCcCCCCCccc
Q 001152 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLD 252 (1137)
Q Consensus 175 ~L~~IP~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~LdLS~N~Lsg~~p~~ 252 (1137)
+|+.+|. +..+++|+.|+|++|+|+.+ |..|.++++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+++++..
T Consensus 207 ~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 285 (452)
T 3zyi_A 207 NIKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285 (452)
T ss_dssp CCSSCCC-CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTS
T ss_pred ccccccc-ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHH
Confidence 9999975 78999999999999999966 77899999999999999999966 567888999999999999999999988
Q ss_pred ccCCCCCCEEEccCCcCCCCCCCCcchh
Q 001152 253 LCLMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1137)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1137)
|..+++|+.|+|++|+|.|.|.+-....
T Consensus 286 ~~~l~~L~~L~L~~Np~~CdC~~~~l~~ 313 (452)
T 3zyi_A 286 FTPLRYLVELHLHHNPWNCDCDILWLAW 313 (452)
T ss_dssp STTCTTCCEEECCSSCEECSTTTHHHHH
T ss_pred hccccCCCEEEccCCCcCCCCCchHHHH
Confidence 9999999999999999999998764433
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=291.19 Aligned_cols=299 Identities=18% Similarity=0.128 Sum_probs=215.8
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L 96 (1137)
+.++.|.+..|+|+.+.+.+|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|.|+.||.. .+++|++|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~lp~~--~l~~L~~L 126 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFN---QDLEYLDVSHNRLQNISCC--PMASLRHL 126 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTC---TTCCEEECTTSCCCEECSC--CCTTCSEE
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCC---CCCCEEECCCCcCCccCcc--ccccCCEE
Confidence 579999999999999999999999999999999999998888776554 8999999999999999877 78999999
Q ss_pred EccCCCCCcc--cccccCCCCCCEEEccCCCCCCCcccccCCCCC--CEEECCCCCC--CCCcccchhhhcC--------
Q 001152 97 KFFGNEINLF--PSEVGNLLGLECLQIKISSPGVNGFALNKLKGL--KELELSKVPP--RPSVLTLLSEIAG-------- 162 (1137)
Q Consensus 97 ~Ls~N~L~~l--P~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L--~~L~Ls~n~l--n~~~~~lp~~l~~-------- 162 (1137)
+|++|+|+.+ |..|+++++|++|+|++|.+.. ..+..+++| +.|++++|.+ ... .|..+..
T Consensus 127 ~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~L~~n~l~~~~~---~~~~l~~l~~~~l~l 201 (562)
T 3a79_B 127 DLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ--LDLLPVAHLHLSCILLDLVSYHIKGG---ETESLQIPNTTVLHL 201 (562)
T ss_dssp ECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT--TTTGGGTTSCEEEEEEEESSCCCCSS---SCCEEEECCEEEEEE
T ss_pred ECCCCCccccCchHhhcccCcccEEecCCCcccc--CchhhhhhceeeEEEeeccccccccc---CcccccccCcceEEE
Confidence 9999999865 4789999999999999988654 235555555 7777777655 111 1111111
Q ss_pred -------------------------------------------------------------------------CCCCcEE
Q 001152 163 -------------------------------------------------------------------------LKCLTKL 169 (1137)
Q Consensus 163 -------------------------------------------------------------------------L~~L~~L 169 (1137)
..+|++|
T Consensus 202 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L 281 (562)
T 3a79_B 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281 (562)
T ss_dssp EECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEE
T ss_pred EecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEE
Confidence 1145556
Q ss_pred eccCCCCc-ccCccc-----------------------------------------------------cCCCCCCEEEcc
Q 001152 170 SVCHFSIR-YLPPEI-----------------------------------------------------GCLSNLEQLDLS 195 (1137)
Q Consensus 170 ~Ls~N~L~-~IP~~l-----------------------------------------------------~~L~~L~~L~Ls 195 (1137)
++++|.++ .+|..+ ..+++|++|+|+
T Consensus 282 ~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~ 361 (562)
T 3a79_B 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361 (562)
T ss_dssp EEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECC
T ss_pred EEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECC
Confidence 66666655 555543 566778888888
Q ss_pred CCCCCc-cchhhcCCCCCCEEEccCCCCCccC---ccccCCCCCCEEeccCCcCCC-CCcccccCCCCCCEEEccCCcCC
Q 001152 196 FNKMKY-LPTEICYLKALISLKVANNKLVELP---SGLYLLQRLENLDLSNNRLTS-LGSLDLCLMHNLQNLNLQYNKLL 270 (1137)
Q Consensus 196 ~N~L~~-LP~~l~~L~~L~~L~Ls~N~Ls~IP---~~l~~L~~L~~LdLS~N~Lsg-~~p~~l~~L~~L~~L~Ls~N~L~ 270 (1137)
+|+++. +|..++++++|+.|+|++|+|+.+| ..+..+++|+.|+|++|++++ +++..+..+++|+.|+|++|+|+
T Consensus 362 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~ 441 (562)
T 3a79_B 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441 (562)
T ss_dssp SSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCC
T ss_pred CCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCC
Confidence 888874 6777788888888888888887554 457778888888888888887 55555777788888888888876
Q ss_pred CC--CCC-CcchhhccCCCCCCCCC------CCcccccccccccCCCc------ccCCCCCcccCCCCCC
Q 001152 271 SY--CQV-PSWICCNLEGNGKDSSN------DDFISSSAEMDVYEGPM------LENDGNVSFSGSRHTS 325 (1137)
Q Consensus 271 ~~--~~i-P~~~~~~l~~n~l~~~~------~~l~~~~~s~n~l~g~i------l~~~~~~sf~GN~~lC 325 (1137)
+. ..+ +....+++++|.+..-+ +.+...++++|.+..-. +..+....++||+..|
T Consensus 442 ~~~~~~l~~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c 511 (562)
T 3a79_B 442 GSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 511 (562)
T ss_dssp GGGGSSCCTTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCC
T ss_pred cchhhhhcCcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCC
Confidence 51 123 23444667777655432 34566677777776421 2334455678999998
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=273.30 Aligned_cols=224 Identities=19% Similarity=0.175 Sum_probs=197.4
Q ss_pred CCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEE
Q 001152 40 DDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECL 119 (1137)
Q Consensus 40 l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L 119 (1137)
...++.|+|++|+|+ .+|..++. +++|++|+|++|.|+.+|..|+++++|++|+|++|.|+.+|..++++++|++|
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~---l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFR---LSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPASIASLNRLREL 155 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGG---GTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEE
T ss_pred ccceeEEEccCCCch-hcChhhhh---CCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEE
Confidence 478999999999998 45554544 48999999999999999999999999999999999999999999999999999
Q ss_pred EccCCC-CCCCccccc---------CCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCC
Q 001152 120 QIKISS-PGVNGFALN---------KLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNL 189 (1137)
Q Consensus 120 ~Ls~N~-~~~~~~~~~---------~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L 189 (1137)
+|++|+ .+.+|..+. ++++|++|+|++|.+. .+|..+..+++|+.|++++|+++.+|..++.+++|
T Consensus 156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~----~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L 231 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR----SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKL 231 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC----CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTC
T ss_pred ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC----cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCC
Confidence 999865 677776654 4999999999986554 67788899999999999999999999989999999
Q ss_pred CEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCC
Q 001152 190 EQLDLSFNKMK-YLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1137)
Q Consensus 190 ~~L~Ls~N~L~-~LP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N 267 (1137)
++|+|++|++. .+|..++.+++|+.|+|++|.+. .+|..+.++++|+.|+|++|++.+.+|..+.+|++|+.+++..|
T Consensus 232 ~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~ 311 (328)
T 4fcg_A 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311 (328)
T ss_dssp CEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGG
T ss_pred CEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHH
Confidence 99999998776 78888999999999999998765 88989999999999999999999988989999999999999988
Q ss_pred cCCC
Q 001152 268 KLLS 271 (1137)
Q Consensus 268 ~L~~ 271 (1137)
.+..
T Consensus 312 ~~~~ 315 (328)
T 4fcg_A 312 LQAQ 315 (328)
T ss_dssp GSCC
T ss_pred HHHH
Confidence 7765
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.4e-28 Score=290.74 Aligned_cols=303 Identities=18% Similarity=0.186 Sum_probs=177.0
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCCCCcE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRN 95 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~-~~~L~~L~~ 95 (1137)
+.++.|.+..|+|+.+.+.+|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|.++.+|+. |+++++|++
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 102 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSL---GSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTC---TTCCEEECTTSCCCSCCHHHHTTCTTCCE
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccc---ccCCEEECCCCccCccCHHHhccCCCCcE
Confidence 457777777777777777777777777777777777777666555433 6777777777777766543 777777777
Q ss_pred EEccCCCCCc--ccccccCCCCCCEEEccCCC-CCCCc-ccccCC-----------------------------------
Q 001152 96 LKFFGNEINL--FPSEVGNLLGLECLQIKISS-PGVNG-FALNKL----------------------------------- 136 (1137)
Q Consensus 96 L~Ls~N~L~~--lP~~l~~L~~L~~L~Ls~N~-~~~~~-~~~~~L----------------------------------- 136 (1137)
|+|++|.|+. +|..++++++|++|+|++|. ++.++ ..+.++
T Consensus 103 L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n 182 (549)
T 2z81_A 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182 (549)
T ss_dssp EECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECS
T ss_pred EECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccC
Confidence 7777777763 35566666677777666665 33333 233333
Q ss_pred -------------CCCCEEECCCCCCCCCc--------------------------------------------------
Q 001152 137 -------------KGLKELELSKVPPRPSV-------------------------------------------------- 153 (1137)
Q Consensus 137 -------------~~L~~L~Ls~n~ln~~~-------------------------------------------------- 153 (1137)
++|++|++++|.+....
T Consensus 183 ~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~ 262 (549)
T 2z81_A 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262 (549)
T ss_dssp BSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCE
T ss_pred cccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccccc
Confidence 34444444444332210
Q ss_pred ------------------------------------------------------------ccchhhh-cCCCCCcEEecc
Q 001152 154 ------------------------------------------------------------LTLLSEI-AGLKCLTKLSVC 172 (1137)
Q Consensus 154 ------------------------------------------------------------~~lp~~l-~~L~~L~~L~Ls 172 (1137)
..+|..+ ..+++|+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls 342 (549)
T 2z81_A 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLS 342 (549)
T ss_dssp EECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECC
T ss_pred ccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEcc
Confidence 0011122 234555555555
Q ss_pred CCCCcc-cCc---cccCCCCCCEEEccCCCCCccc---hhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcC
Q 001152 173 HFSIRY-LPP---EIGCLSNLEQLDLSFNKMKYLP---TEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245 (1137)
Q Consensus 173 ~N~L~~-IP~---~l~~L~~L~~L~Ls~N~L~~LP---~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~L 245 (1137)
+|+++. +|. .++.+++|++|+|++|+|+.+| ..+..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+|
T Consensus 343 ~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l 422 (549)
T 2z81_A 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGI 422 (549)
T ss_dssp SSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCC
T ss_pred CCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCc
Confidence 555552 221 2445555555555555555544 235556666666666666666666565566666666666666
Q ss_pred CCCCcccccCCCCCCEEEccCCcCCCCC-CCCcchhhccCCCCCCCC-----CCCcccccccccccCCCc------ccCC
Q 001152 246 TSLGSLDLCLMHNLQNLNLQYNKLLSYC-QVPSWICCNLEGNGKDSS-----NDDFISSSAEMDVYEGPM------LEND 313 (1137)
Q Consensus 246 sg~~p~~l~~L~~L~~L~Ls~N~L~~~~-~iP~~~~~~l~~n~l~~~-----~~~l~~~~~s~n~l~g~i------l~~~ 313 (1137)
+.++.. + .++|+.|+|++|+|+++. .+|....+++++|.+..- .+.+...++++|.+.+.+ +..+
T Consensus 423 ~~l~~~-~--~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 499 (549)
T 2z81_A 423 RVVKTC-I--PQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499 (549)
T ss_dssp SCCCTT-S--CTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTC
T ss_pred ccccch-h--cCCceEEECCCCChhhhcccCChhcEEECCCCccCcCCCcccCccCCEEecCCCccCCcCHHHHhcCccc
Confidence 554331 1 145556666666555532 345555566777766532 235666778888888754 2344
Q ss_pred CCCcccCCCCCC
Q 001152 314 GNVSFSGSRHTS 325 (1137)
Q Consensus 314 ~~~sf~GN~~lC 325 (1137)
....++||+..|
T Consensus 500 ~~L~l~~N~~~~ 511 (549)
T 2z81_A 500 QKIWLHTNPWDC 511 (549)
T ss_dssp CEEECCSSCBCC
T ss_pred CEEEecCCCccC
Confidence 555778999888
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=290.29 Aligned_cols=301 Identities=17% Similarity=0.111 Sum_probs=210.9
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L 96 (1137)
+.++.|.+..|+|+.+.+.+|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|+|+.||.. .+++|++|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~lp~~--~l~~L~~L 95 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFN---QELEYLDLSHNKLVKISCH--PTVNLKHL 95 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTC---TTCCEEECCSSCCCEEECC--CCCCCSEE
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcc---cCCCEEecCCCceeecCcc--ccCCccEE
Confidence 589999999999999999999999999999999999999888877655 9999999999999999887 89999999
Q ss_pred EccCCCCCc--ccccccCCCCCCEEEccCCCCCCCcccccCCCCC--CEEECCCCCCCCCcccchhhhcC----------
Q 001152 97 KFFGNEINL--FPSEVGNLLGLECLQIKISSPGVNGFALNKLKGL--KELELSKVPPRPSVLTLLSEIAG---------- 162 (1137)
Q Consensus 97 ~Ls~N~L~~--lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L--~~L~Ls~n~ln~~~~~lp~~l~~---------- 162 (1137)
+|++|.|+. +|..|+++++|++|+|++|.+.. ..+..+++| +.|++++|.+.. .+..|..+..
T Consensus 96 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~l~~n~l~~-~~~~~~~l~~l~~~~l~l~l 172 (520)
T 2z7x_B 96 DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK--SSVLPIAHLNISKVLLVLGETYG-EKEDPEGLQDFNTESLHIVF 172 (520)
T ss_dssp ECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG--GGGGGGTTSCEEEEEEEECTTTT-SSCCTTTTTTCCEEEEEEEC
T ss_pred eccCCccccccchhhhccCCcceEEEecCcccch--hhccccccceeeEEEeecccccc-cccccccccccccceEEEEe
Confidence 999999985 67899999999999999988654 345566666 666666654400 0011111111
Q ss_pred -------------------------------------------------------------------------CCCCcEE
Q 001152 163 -------------------------------------------------------------------------LKCLTKL 169 (1137)
Q Consensus 163 -------------------------------------------------------------------------L~~L~~L 169 (1137)
+++|++|
T Consensus 173 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L 252 (520)
T 2z7x_B 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252 (520)
T ss_dssp CSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEE
T ss_pred ccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEE
Confidence 1134444
Q ss_pred eccCCCCc-ccCccc-----------------------------------------------------cCCCCCCEEEcc
Q 001152 170 SVCHFSIR-YLPPEI-----------------------------------------------------GCLSNLEQLDLS 195 (1137)
Q Consensus 170 ~Ls~N~L~-~IP~~l-----------------------------------------------------~~L~~L~~L~Ls 195 (1137)
++++|+++ .+|..+ ..+++|++|+|+
T Consensus 253 ~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls 332 (520)
T 2z7x_B 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332 (520)
T ss_dssp EEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECC
T ss_pred EeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeE
Confidence 44444444 344333 466677777777
Q ss_pred CCCCCc-cchhhcCCCCCCEEEccCCCCCc---cCccccCCCCCCEEeccCCcCCC-CCcccccCCCCCCEEEccCCcCC
Q 001152 196 FNKMKY-LPTEICYLKALISLKVANNKLVE---LPSGLYLLQRLENLDLSNNRLTS-LGSLDLCLMHNLQNLNLQYNKLL 270 (1137)
Q Consensus 196 ~N~L~~-LP~~l~~L~~L~~L~Ls~N~Ls~---IP~~l~~L~~L~~LdLS~N~Lsg-~~p~~l~~L~~L~~L~Ls~N~L~ 270 (1137)
+|+++. +|..++.+++|+.|+|++|+++. +|..+..+++|+.|+|++|++++ +++..+..+++|+.|+|++|+++
T Consensus 333 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~ 412 (520)
T 2z7x_B 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412 (520)
T ss_dssp SSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCC
T ss_pred CCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCC
Confidence 777774 67777777777777777777774 34567777777777777777777 44444677777777777777775
Q ss_pred CC--CCC-CcchhhccCCCCCCCCC------CCcccccccccccCCCc------ccCCCCCcccCCCCCC
Q 001152 271 SY--CQV-PSWICCNLEGNGKDSSN------DDFISSSAEMDVYEGPM------LENDGNVSFSGSRHTS 325 (1137)
Q Consensus 271 ~~--~~i-P~~~~~~l~~n~l~~~~------~~l~~~~~s~n~l~g~i------l~~~~~~sf~GN~~lC 325 (1137)
+. ..+ +....+++++|.+..-+ +.+...++++|.+..-. +.++....++||+..|
T Consensus 413 ~~~~~~l~~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c 482 (520)
T 2z7x_B 413 DTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 482 (520)
T ss_dssp GGGGGSCCTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cchhhhhcccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcc
Confidence 41 122 23334566666655322 24555666777666321 2334445677999888
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=302.06 Aligned_cols=246 Identities=17% Similarity=0.193 Sum_probs=171.4
Q ss_pred CCcccccCCCCCCccc-----------------CCCCCC--CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeec
Q 001152 17 PIKEKLPSEANKINNE-----------------KNGSVN--DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYK 77 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l-----------------~~~~f~--~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~ 77 (1137)
+.++.|.+..|+|++. .|..+. ++++|++|+|++|++.+.+|..|+.+ ++|++|+|++
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~Ls~ 282 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL---PEMQLINVAC 282 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC---SSCCEEECTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC---CCCCEEECcC
Confidence 4688888889999884 567777 89999999999999998888766554 8889999999
Q ss_pred CC-CC--ccCccccCC------CCCcEEEccCCCCCcccc--cccCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECC
Q 001152 78 NV-LN--LIPKSVGRY------EKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELS 145 (1137)
Q Consensus 78 N~-L~--~IP~~~~~L------~~L~~L~Ls~N~L~~lP~--~l~~L~~L~~L~Ls~N~~~-~~~~~~~~L~~L~~L~Ls 145 (1137)
|+ ++ .+|..+++| ++|++|+|++|+|+.+|. .++++++|+.|+|++|.+. .+| .+..+++|+.|+++
T Consensus 283 n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~ 361 (636)
T 4eco_A 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA 361 (636)
T ss_dssp CTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECC
T ss_pred CCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECC
Confidence 87 87 488888776 888999999998888888 8888888888888888877 677 77778888888888
Q ss_pred CCCCCCCcccchhhhcCCCC-CcEEeccCCCCcccCccccCCC--CCCEEEccCCCCC-ccchhhc-------CCCCCCE
Q 001152 146 KVPPRPSVLTLLSEIAGLKC-LTKLSVCHFSIRYLPPEIGCLS--NLEQLDLSFNKMK-YLPTEIC-------YLKALIS 214 (1137)
Q Consensus 146 ~n~ln~~~~~lp~~l~~L~~-L~~L~Ls~N~L~~IP~~l~~L~--~L~~L~Ls~N~L~-~LP~~l~-------~L~~L~~ 214 (1137)
+|.+ ..+|..+..+++ |+.|++++|.++.+|..+..++ +|++|+|++|+|+ .+|..|. .+++|+.
T Consensus 362 ~N~l----~~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~ 437 (636)
T 4eco_A 362 YNQI----TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437 (636)
T ss_dssp SSEE----EECCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEE
T ss_pred CCcc----ccccHhhhhhcccCcEEEccCCcCcccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCE
Confidence 7443 266777777777 7777777777777777655443 5666666666655 3444444 4455555
Q ss_pred EEccCCCCCccCcccc-CCCCCCEEeccCCcCCCCCcccccCCC-------CCCEEEccCCcCC
Q 001152 215 LKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLDLCLMH-------NLQNLNLQYNKLL 270 (1137)
Q Consensus 215 L~Ls~N~Ls~IP~~l~-~L~~L~~LdLS~N~Lsg~~p~~l~~L~-------~L~~L~Ls~N~L~ 270 (1137)
|+|++|+|+.+|..++ .+++|+.|+|++|+|+.+++..+..+. +|+.|+|++|+|+
T Consensus 438 L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 501 (636)
T 4eco_A 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501 (636)
T ss_dssp EECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC
T ss_pred EECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC
Confidence 5555555555554433 255555555555555544433322221 4555555555554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=284.35 Aligned_cols=249 Identities=18% Similarity=0.208 Sum_probs=194.6
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCcE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRN 95 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~~ 95 (1137)
+.++.|.+..|+|+.+.+.+|.++++|++|+|++|+|++..+..|.. +++|++|+|++|.++.+ |..|.++++|++
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~---l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 132 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTG---LSNLTKLDISENKIVILLDYMFQDLYNLKS 132 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTT---CTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccC---CCCCCEEECCCCccccCChhHccccccCCE
Confidence 47999999999999999999999999999999999999887766654 48999999999999866 567899999999
Q ss_pred EEccCCCCCcc-cccccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccC
Q 001152 96 LKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1137)
Q Consensus 96 L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1137)
|+|++|.|+.+ |..|.++++|+.|+|++|.+..++ ..+..+++|+.|+|++|.+.. ..+..+..+++|+.|++++
T Consensus 133 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~---~~~~~~~~l~~L~~L~l~~ 209 (477)
T 2id5_A 133 LEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA---IRDYSFKRLYRLKVLEISH 209 (477)
T ss_dssp EEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE---ECTTCSCSCTTCCEEEEEC
T ss_pred EECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE---eChhhcccCcccceeeCCC
Confidence 99999999866 557889999999999999877666 458888999999998865533 2334567777777777777
Q ss_pred CCCc-ccCccccCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeccCCcCCCCCc
Q 001152 174 FSIR-YLPPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGS 250 (1137)
Q Consensus 174 N~L~-~IP~~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdLS~N~Lsg~~p 250 (1137)
|.+. .+|..+....+|+.|+|++|+|+.+| ..+..+++|+.|+|++|.|+.+|. .+..+++|+.|+|++|+|++++|
T Consensus 210 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 289 (477)
T 2id5_A 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP 289 (477)
T ss_dssp CTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECT
T ss_pred CccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECH
Confidence 6544 66665555567777777777777776 356677777777777777776543 46667777777777777777777
Q ss_pred ccccCCCCCCEEEccCCcCCC
Q 001152 251 LDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 251 ~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
..|..+++|+.|+|++|+|+.
T Consensus 290 ~~~~~l~~L~~L~L~~N~l~~ 310 (477)
T 2id5_A 290 YAFRGLNYLRVLNVSGNQLTT 310 (477)
T ss_dssp TTBTTCTTCCEEECCSSCCSC
T ss_pred HHhcCcccCCEEECCCCcCce
Confidence 777777777777777777765
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=304.77 Aligned_cols=249 Identities=16% Similarity=0.176 Sum_probs=186.6
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCC-CCC-CCcccccCC----CCCCCccEEEeecCCCCccCc--ccc
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKT-VDF-PLIESYGNR----GGDNSVEGLYLYKNVLNLIPK--SVG 88 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~-L~~-~~p~~~~~l----~~L~~L~~L~Ls~N~L~~IP~--~~~ 88 (1137)
+.++.|.+..|++....|..|.++++|++|+|++|+ |++ .+|..++.+ ..+++|+.|+|++|.|+.||. .|+
T Consensus 491 ~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~ 570 (876)
T 4ecn_A 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQ 570 (876)
T ss_dssp TTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHT
T ss_pred CCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhh
Confidence 478999999999988889999999999999999998 998 788766543 455699999999999999998 899
Q ss_pred CCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCC-CCEEECCCCCCCCCcccchhhhcCCCC--
Q 001152 89 RYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKG-LKELELSKVPPRPSVLTLLSEIAGLKC-- 165 (1137)
Q Consensus 89 ~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~-L~~L~Ls~n~ln~~~~~lp~~l~~L~~-- 165 (1137)
++++|+.|+|++|.|+.|| .|+++++|+.|+|++|.+..+|..+..+++ |+.|+|++|.+. .+|..+..+..
T Consensus 571 ~L~~L~~L~Ls~N~l~~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~----~lp~~~~~~~~~~ 645 (876)
T 4ecn_A 571 KMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK----YIPNIFNAKSVYV 645 (876)
T ss_dssp TCTTCCEEECTTSCCCBCC-CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC----SCCSCCCTTCSSC
T ss_pred cCCCCCEEECCCCCcccch-hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC----cCchhhhccccCC
Confidence 9999999999999999999 899999999999999998888888999998 999999997654 45555554433
Q ss_pred CcEEeccCCCCcccCc----ccc--CCCCCCEEEccCCCCCccchhhc-CCCCCCEEEccCCCCCccCccccCCC-----
Q 001152 166 LTKLSVCHFSIRYLPP----EIG--CLSNLEQLDLSFNKMKYLPTEIC-YLKALISLKVANNKLVELPSGLYLLQ----- 233 (1137)
Q Consensus 166 L~~L~Ls~N~L~~IP~----~l~--~L~~L~~L~Ls~N~L~~LP~~l~-~L~~L~~L~Ls~N~Ls~IP~~l~~L~----- 233 (1137)
|+.|++++|+|+..++ .+. .+++|+.|+|++|+|+.+|..+. .+++|+.|+|++|+|+.||..++...
T Consensus 646 L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~ 725 (876)
T 4ecn_A 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725 (876)
T ss_dssp EEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCT
T ss_pred CCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhcccccccc
Confidence 6677777776653222 222 23366666666666666665553 56666666666666666666544322
Q ss_pred ---CCCEEeccCCcCCCCCccccc--CCCCCCEEEccCCcCCC
Q 001152 234 ---RLENLDLSNNRLTSLGSLDLC--LMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 234 ---~L~~LdLS~N~Lsg~~p~~l~--~L~~L~~L~Ls~N~L~~ 271 (1137)
+|+.|+|++|+|+.++ ..+. .+++|+.|+|++|+|++
T Consensus 726 nl~~L~~L~Ls~N~L~~lp-~~l~~~~l~~L~~L~Ls~N~L~~ 767 (876)
T 4ecn_A 726 NTYLLTTIDLRFNKLTSLS-DDFRATTLPYLSNMDVSYNCFSS 767 (876)
T ss_dssp TGGGCCEEECCSSCCCCCC-GGGSTTTCTTCCEEECCSSCCSS
T ss_pred ccCCccEEECCCCCCccch-HHhhhccCCCcCEEEeCCCCCCc
Confidence 6666666666666443 3444 66666666666666665
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-27 Score=287.40 Aligned_cols=131 Identities=16% Similarity=0.109 Sum_probs=115.3
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCc
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLR 94 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~ 94 (1137)
|+.++.|++..|+|+.+.+.+|.++++|++|||++|+|+++.+.+|.++ ++|++|+|++|+|+.+|. .|.+|++|+
T Consensus 51 p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L---~~L~~L~Ls~N~l~~l~~~~f~~L~~L~ 127 (635)
T 4g8a_A 51 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL---SHLSTLILTGNPIQSLALGAFSGLSSLQ 127 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC---TTCCEEECTTCCCCEECGGGGTTCTTCC
T ss_pred CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCC---CCCCEEEccCCcCCCCCHHHhcCCCCCC
Confidence 4579999999999999999999999999999999999999888777555 999999999999999985 589999999
Q ss_pred EEEccCCCCCcccc-cccCCCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCCC
Q 001152 95 NLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPP 149 (1137)
Q Consensus 95 ~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~~~~--~~~~~~~L~~L~~L~Ls~n~l 149 (1137)
+|+|++|+|+.+|. .|++|++|++|+|++|.+.. .|..+..+++|++|++++|.+
T Consensus 128 ~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 185 (635)
T 4g8a_A 128 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 185 (635)
T ss_dssp EEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred EEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccc
Confidence 99999999998876 48999999999999998764 456788899999998887653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-27 Score=288.62 Aligned_cols=267 Identities=18% Similarity=0.165 Sum_probs=218.1
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCc
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLR 94 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~ 94 (1137)
++.++.|.+..|+|+.+.+.+|.++++|++|||++|+|++..|..|+.+ ++|++|+|++|.++.+ |..|+++++|+
T Consensus 32 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 108 (606)
T 3t6q_A 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQ---HRLDTLVLTANPLIFMAETALSGPKALK 108 (606)
T ss_dssp CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTC---TTCCEEECTTCCCSEECTTTTSSCTTCC
T ss_pred CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCc---cccCeeeCCCCcccccChhhhccccccc
Confidence 4579999999999999999999999999999999999999888877655 9999999999999976 67899999999
Q ss_pred EEEccCCCCCcc-cccccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCc--EEe
Q 001152 95 NLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT--KLS 170 (1137)
Q Consensus 95 ~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~--~L~ 170 (1137)
+|+|++|.|+.+ |..++++++|++|+|++|.+..++ ..+..+++|+.|++++|.+. ...|..+..+++|+ .|+
T Consensus 109 ~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~l~L~ 185 (606)
T 3t6q_A 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH---YLSKEDMSSLQQATNLSLN 185 (606)
T ss_dssp EEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC---EECHHHHHTTTTCCSEEEE
T ss_pred EeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc---ccChhhhhhhcccceeEEe
Confidence 999999999988 677999999999999999987753 45556999999999996553 34466788888888 889
Q ss_pred ccCCCCcccCccccCCC----------------------------------------------------CCCEEEccCCC
Q 001152 171 VCHFSIRYLPPEIGCLS----------------------------------------------------NLEQLDLSFNK 198 (1137)
Q Consensus 171 Ls~N~L~~IP~~l~~L~----------------------------------------------------~L~~L~Ls~N~ 198 (1137)
+++|.++.+++...... +|+.|+|++|.
T Consensus 186 l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~ 265 (606)
T 3t6q_A 186 LNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265 (606)
T ss_dssp CTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCC
T ss_pred cCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCc
Confidence 99999886655322211 56778888888
Q ss_pred CCccchh-hcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC------
Q 001152 199 MKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS------ 271 (1137)
Q Consensus 199 L~~LP~~-l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~------ 271 (1137)
++.+|.. |..+++|+.|+|++|+++.+|..+..+++|+.|+|++|++++++|..+..+++|+.|++++|.+.+
T Consensus 266 l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 345 (606)
T 3t6q_A 266 FFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345 (606)
T ss_dssp CSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSST
T ss_pred cCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhh
Confidence 8877644 788888888888888888888888888888888888888888888788888888888888888764
Q ss_pred CCCCCcchhhccCCCCC
Q 001152 272 YCQVPSWICCNLEGNGK 288 (1137)
Q Consensus 272 ~~~iP~~~~~~l~~n~l 288 (1137)
+..++....+++++|.+
T Consensus 346 ~~~l~~L~~L~l~~n~l 362 (606)
T 3t6q_A 346 LENLENLRELDLSHDDI 362 (606)
T ss_dssp TTTCTTCCEEECCSSCC
T ss_pred hhccCcCCEEECCCCcc
Confidence 22333344445555544
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=302.28 Aligned_cols=266 Identities=17% Similarity=0.183 Sum_probs=225.5
Q ss_pred CCcccccCCCCCCccc-----------------CCCCCC--CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeec
Q 001152 17 PIKEKLPSEANKINNE-----------------KNGSVN--DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYK 77 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l-----------------~~~~f~--~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~ 77 (1137)
+.++.|.+..|+|++. .|..+. ++++|++|+|++|++.+.+|..|+.+ ++|+.|+|++
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L---~~L~~L~Ls~ 524 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL---PELQSLNIAC 524 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC---SSCCEEECTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC---CCCCEEECcC
Confidence 4789999999999992 456666 99999999999999999999888766 9999999999
Q ss_pred CC-CC--ccCccccCCC-------CCcEEEccCCCCCcccc--cccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECC
Q 001152 78 NV-LN--LIPKSVGRYE-------KLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELS 145 (1137)
Q Consensus 78 N~-L~--~IP~~~~~L~-------~L~~L~Ls~N~L~~lP~--~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls 145 (1137)
|+ |+ .+|..|++++ +|++|+|++|+|+.||. .|+++++|+.|+|++|.+..+| .+..+++|+.|+|+
T Consensus 525 N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~l~~lp-~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLD 603 (876)
T ss_dssp CTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSCCCBCC-CCCTTSEESEEECC
T ss_pred CCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCCcccch-hhcCCCcceEEECc
Confidence 98 88 4898777666 99999999999999999 8999999999999999988888 89999999999999
Q ss_pred CCCCCCCcccchhhhcCCCC-CcEEeccCCCCcccCccccCCCC--CCEEEccCCCCCcc-c---hhhc--CCCCCCEEE
Q 001152 146 KVPPRPSVLTLLSEIAGLKC-LTKLSVCHFSIRYLPPEIGCLSN--LEQLDLSFNKMKYL-P---TEIC--YLKALISLK 216 (1137)
Q Consensus 146 ~n~ln~~~~~lp~~l~~L~~-L~~L~Ls~N~L~~IP~~l~~L~~--L~~L~Ls~N~L~~L-P---~~l~--~L~~L~~L~ 216 (1137)
+|.+. .+|..+.++++ |+.|+|++|.|+.+|..+..++. |+.|+|++|+|+.. | ..+. .+++|+.|+
T Consensus 604 ~N~l~----~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~ 679 (876)
T 4ecn_A 604 YNQIE----EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679 (876)
T ss_dssp SSCCS----CCCTTSCEECTTCCEEECCSSCCCSCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEE
T ss_pred CCccc----cchHHHhhccccCCEEECcCCCCCcCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEE
Confidence 96654 67888999999 99999999999999998877764 99999999999743 3 2333 456999999
Q ss_pred ccCCCCCccCcccc-CCCCCCEEeccCCcCCCCCcccccCC-------CCCCEEEccCCcCCCCC------CCCcchhhc
Q 001152 217 VANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSLDLCLM-------HNLQNLNLQYNKLLSYC------QVPSWICCN 282 (1137)
Q Consensus 217 Ls~N~Ls~IP~~l~-~L~~L~~LdLS~N~Lsg~~p~~l~~L-------~~L~~L~Ls~N~L~~~~------~iP~~~~~~ 282 (1137)
|++|+|+.+|..++ .+++|+.|+|++|+|+.+++..+..+ ++|+.|+|++|+|+.++ .+|....++
T Consensus 680 Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~ 759 (876)
T 4ecn_A 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMD 759 (876)
T ss_dssp CCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGSTTTCTTCCEEE
T ss_pred ccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCccchHHhhhccCCCcCEEE
Confidence 99999999998876 79999999999999997776444433 39999999999998632 233334456
Q ss_pred cCCCCCCC
Q 001152 283 LEGNGKDS 290 (1137)
Q Consensus 283 l~~n~l~~ 290 (1137)
+++|.+..
T Consensus 760 Ls~N~L~~ 767 (876)
T 4ecn_A 760 VSYNCFSS 767 (876)
T ss_dssp CCSSCCSS
T ss_pred eCCCCCCc
Confidence 66666654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-26 Score=261.88 Aligned_cols=242 Identities=19% Similarity=0.227 Sum_probs=212.6
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCcEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNL 96 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~~L 96 (1137)
.++.+.+..+.++.++.... ++|++|+|++|+|++..+..|+.+ ++|++|+|++|.++.+ |..|.++++|++|
T Consensus 32 ~l~~l~~~~~~l~~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (330)
T 1xku_A 32 HLRVVQCSDLGLEKVPKDLP---PDTALLDLQNNKITEIKDGDFKNL---KNLHTLILINNKISKISPGAFAPLVKLERL 105 (330)
T ss_dssp ETTEEECTTSCCCSCCCSCC---TTCCEEECCSSCCCCBCTTTTTTC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCeEEEecCCCccccCccCC---CCCeEEECCCCcCCEeChhhhccC---CCCCEEECCCCcCCeeCHHHhcCCCCCCEE
Confidence 56778888889988865432 689999999999999888766555 9999999999999987 7789999999999
Q ss_pred EccCCCCCcccccccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCC
Q 001152 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1137)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1137)
+|++|.|+.+|..+. ++|+.|++++|.+..++ ..+.++++|+.|++++|.+.. .+..+..+.++++|+.|++++|.
T Consensus 106 ~Ls~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~~l~~L~~L~l~~n~ 182 (330)
T 1xku_A 106 YLSKNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS-SGIENGAFQGMKKLSYIRIADTN 182 (330)
T ss_dssp ECCSSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG-GGBCTTGGGGCTTCCEEECCSSC
T ss_pred ECCCCcCCccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc-cCcChhhccCCCCcCEEECCCCc
Confidence 999999999998876 79999999999977666 468999999999999976632 33556788999999999999999
Q ss_pred CcccCccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeccCCcCCCCCcccc
Q 001152 176 IRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDL 253 (1137)
Q Consensus 176 L~~IP~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdLS~N~Lsg~~p~~l 253 (1137)
++.+|..+. ++|++|+|++|+++.+ |..+..+++|+.|+|++|.++.++. .+..+++|+.|+|++|+|+.++ ..+
T Consensus 183 l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp-~~l 259 (330)
T 1xku_A 183 ITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP-GGL 259 (330)
T ss_dssp CCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCC-TTT
T ss_pred cccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCC-hhh
Confidence 999998664 8999999999999966 6789999999999999999997754 7888999999999999999775 479
Q ss_pred cCCCCCCEEEccCCcCCC
Q 001152 254 CLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 254 ~~L~~L~~L~Ls~N~L~~ 271 (1137)
..+++|++|+|++|+|++
T Consensus 260 ~~l~~L~~L~l~~N~i~~ 277 (330)
T 1xku_A 260 ADHKYIQVVYLHNNNISA 277 (330)
T ss_dssp TTCSSCCEEECCSSCCCC
T ss_pred ccCCCcCEEECCCCcCCc
Confidence 999999999999999987
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-27 Score=264.77 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=220.2
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcE
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~ 95 (1137)
++.++.|.+..|+|+.+.+.+|.++++|++|+|++|+|++..|..|+.+ ++|++|+|++|.|+.+|..+. ++|++
T Consensus 53 ~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~l~~~~~--~~L~~ 127 (332)
T 2ft3_A 53 SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL---RKLQKLYISKNHLVEIPPNLP--SSLVE 127 (332)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTC---TTCCEEECCSSCCCSCCSSCC--TTCCE
T ss_pred CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCc---CCCCEEECCCCcCCccCcccc--ccCCE
Confidence 3579999999999999999999999999999999999999888877655 999999999999999998776 79999
Q ss_pred EEccCCCCCccccc-ccCCCCCCEEEccCCCCC---CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEec
Q 001152 96 LKFFGNEINLFPSE-VGNLLGLECLQIKISSPG---VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1137)
Q Consensus 96 L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~~~---~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~L 171 (1137)
|+|++|.|+.+|.. |.++++|+.|+|++|.+. ..+..+..+ +|+.|++++|.+.. +|..+. ++|+.|++
T Consensus 128 L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~----l~~~~~--~~L~~L~l 200 (332)
T 2ft3_A 128 LRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG----IPKDLP--ETLNELHL 200 (332)
T ss_dssp EECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS----CCSSSC--SSCSCCBC
T ss_pred EECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc----cCcccc--CCCCEEEC
Confidence 99999999988765 899999999999999975 556677777 99999999976654 454443 68999999
Q ss_pred cCCCCcccC-ccccCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCC
Q 001152 172 CHFSIRYLP-PEIGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249 (1137)
Q Consensus 172 s~N~L~~IP-~~l~~L~~L~~L~Ls~N~L~~LP~-~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~ 249 (1137)
++|.++.++ ..|..+++|+.|+|++|+|+.++. .+..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+|++++
T Consensus 201 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~~~~ 280 (332)
T 2ft3_A 201 DHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVG 280 (332)
T ss_dssp CSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCCBCC
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCCccC
Confidence 999999776 578999999999999999997764 789999999999999999999999999999999999999999998
Q ss_pred cccccCC------CCCCEEEccCCcCCCCCCCCcch
Q 001152 250 SLDLCLM------HNLQNLNLQYNKLLSYCQVPSWI 279 (1137)
Q Consensus 250 p~~l~~L------~~L~~L~Ls~N~L~~~~~iP~~~ 279 (1137)
+..|..+ ..|+.|+|++|++......|..+
T Consensus 281 ~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~ 316 (332)
T 2ft3_A 281 VNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF 316 (332)
T ss_dssp TTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGG
T ss_pred hhHccccccccccccccceEeecCcccccccCcccc
Confidence 8777654 67999999999987543334333
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-27 Score=284.31 Aligned_cols=130 Identities=16% Similarity=0.116 Sum_probs=104.0
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCCCCcE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRN 95 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP-~~~~~L~~L~~ 95 (1137)
+.++.|.+..|+|+.+.+.+|.++++|++|||++|+|++..+..|+.+ ++|++|+|++|.++.+| ..|.++++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL---SHLSTLILTGNPIQSLALGAFSGLSSLQK 104 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTC---TTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCc---hhCCEEeCcCCcCCccCHhhhcCcccccc
Confidence 468888888888888888888888888888888888888777666544 88888888888888775 56888888888
Q ss_pred EEccCCCCCcccc-cccCCCCCCEEEccCCCCCC--CcccccCCCCCCEEECCCCCC
Q 001152 96 LKFFGNEINLFPS-EVGNLLGLECLQIKISSPGV--NGFALNKLKGLKELELSKVPP 149 (1137)
Q Consensus 96 L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~~~~--~~~~~~~L~~L~~L~Ls~n~l 149 (1137)
|+|++|.++.+|. .++++++|++|+|++|.+.. +|..+.++++|++|++++|.+
T Consensus 105 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l 161 (570)
T 2z63_A 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (570)
T ss_dssp EECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCC
T ss_pred ccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcc
Confidence 8888888887765 57888888888888887664 467788888888888877654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-26 Score=285.07 Aligned_cols=288 Identities=18% Similarity=0.166 Sum_probs=240.7
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCcEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNL 96 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~~L 96 (1137)
.++.|.+..|+++.+.+..|.++++|++|+|++|+++. +|..+ .++++|++|+|++|.++.+ |..+.++++|++|
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-lp~~l---~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 330 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGL---VGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSC-CCSSC---CSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEE
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccCC-CChhh---cccccCCEEECccCCcCcCchhhhhccCcCCEE
Confidence 57889999999999999999999999999999999994 55545 4559999999999999977 5689999999999
Q ss_pred EccCCCCC-ccccc-ccCCCCCCEEEccCCCCCCC---cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEec
Q 001152 97 KFFGNEIN-LFPSE-VGNLLGLECLQIKISSPGVN---GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1137)
Q Consensus 97 ~Ls~N~L~-~lP~~-l~~L~~L~~L~Ls~N~~~~~---~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~L 171 (1137)
+|++|.+. .+|.. +.++++|+.|+|++|.+... +..+..+++|++|++++|.+ ....|..+..+++|+.|++
T Consensus 331 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l---~~~~~~~~~~l~~L~~L~l 407 (606)
T 3t6q_A 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP---LSLKTEAFKECPQLELLDL 407 (606)
T ss_dssp ECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSC---EEECTTTTTTCTTCSEEEC
T ss_pred ECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcC---CcCCHHHhcCCccCCeEEC
Confidence 99999997 77665 89999999999999997765 56789999999999999544 4455778899999999999
Q ss_pred cCCCCccc-Cc-cccCCCCCCEEEccCCCCCc-cchhhcCCCCCCEEEccCCCCCc--cC--ccccCCCCCCEEeccCCc
Q 001152 172 CHFSIRYL-PP-EIGCLSNLEQLDLSFNKMKY-LPTEICYLKALISLKVANNKLVE--LP--SGLYLLQRLENLDLSNNR 244 (1137)
Q Consensus 172 s~N~L~~I-P~-~l~~L~~L~~L~Ls~N~L~~-LP~~l~~L~~L~~L~Ls~N~Ls~--IP--~~l~~L~~L~~LdLS~N~ 244 (1137)
++|.++.+ |. .+..+++|++|+|++|.++. .|..+..+++|+.|+|++|+++. +| ..+..+++|+.|+|++|+
T Consensus 408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~ 487 (606)
T 3t6q_A 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487 (606)
T ss_dssp TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence 99999854 44 48999999999999999995 46778999999999999999984 33 568889999999999999
Q ss_pred CCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhccCCCCCCCCCCCcccccccccccCCCc------ccCCCCCcc
Q 001152 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPM------LENDGNVSF 318 (1137)
Q Consensus 245 Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~l~~~~~s~n~l~g~i------l~~~~~~sf 318 (1137)
+++++|..|..+++|+.|+|++|++++ ..|..+.. ...+ ..++++|.+.+.. +..+....+
T Consensus 488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~l~~----------l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l 554 (606)
T 3t6q_A 488 LSSIDQHAFTSLKMMNHVDLSHNRLTS--SSIEALSH----------LKGI-YLNLASNHISIILPSLLPILSQQRTINL 554 (606)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCG--GGGGGGTT----------CCSC-EEECCSSCCCCCCGGGHHHHHTSSEEEC
T ss_pred cCccChhhhccccCCCEEECCCCccCc--CChhHhCc----------cccc-EEECcCCcccccCHhhcccCCCCCEEeC
Confidence 999999899999999999999999987 23333321 1223 4455555555433 345566778
Q ss_pred cCCCCCC
Q 001152 319 SGSRHTS 325 (1137)
Q Consensus 319 ~GN~~lC 325 (1137)
+|||..|
T Consensus 555 ~~N~~~c 561 (606)
T 3t6q_A 555 RQNPLDC 561 (606)
T ss_dssp TTCCEEC
T ss_pred CCCCccc
Confidence 8999998
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-27 Score=268.57 Aligned_cols=209 Identities=24% Similarity=0.267 Sum_probs=195.2
Q ss_pred CCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001152 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1137)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n 147 (1137)
.+++.|+|++|.|+.||..++++++|++|+|++|.|+.+|..++++++|++|+|++|.+..+|..+..+++|++|+|++|
T Consensus 81 ~~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n 160 (328)
T 4fcg_A 81 PGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRAC 160 (328)
T ss_dssp TTCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEE
T ss_pred cceeEEEccCCCchhcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCC
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999994
Q ss_pred CCCCCcccchhhhc---------CCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEcc
Q 001152 148 PPRPSVLTLLSEIA---------GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVA 218 (1137)
Q Consensus 148 ~ln~~~~~lp~~l~---------~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls 218 (1137)
. ..+.+|..+. ++++|+.|++++|+|+.+|..++.+++|++|+|++|+|+.+|..++.+++|+.|+|+
T Consensus 161 ~---~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls 237 (328)
T 4fcg_A 161 P---ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLR 237 (328)
T ss_dssp T---TCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECT
T ss_pred C---CccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECc
Confidence 4 4455666554 499999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCC-ccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhh
Q 001152 219 NNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1137)
Q Consensus 219 ~N~Ls-~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1137)
+|.+. .+|..++.+++|+.|+|++|++.+.+|..+..+++|+.|+|++|++.+ .+|.++.-
T Consensus 238 ~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~--~iP~~l~~ 299 (328)
T 4fcg_A 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS--RLPSLIAQ 299 (328)
T ss_dssp TCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC--CCCGGGGG
T ss_pred CCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchh--hccHHHhh
Confidence 99877 889999999999999999999999999999999999999999999988 78888763
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-26 Score=258.90 Aligned_cols=271 Identities=18% Similarity=0.236 Sum_probs=198.4
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~ 97 (1137)
.++.|.+..|.++.+. .|..+++|++|+|++|++++..+ + .++++|++|+|++|.++.+| .|.++++|++|+
T Consensus 45 ~L~~L~l~~~~i~~~~--~~~~~~~L~~L~l~~n~i~~~~~--~---~~l~~L~~L~L~~n~i~~~~-~~~~l~~L~~L~ 116 (347)
T 4fmz_A 45 SITKLVVAGEKVASIQ--GIEYLTNLEYLNLNGNQITDISP--L---SNLVKLTNLYIGTNKITDIS-ALQNLTNLRELY 116 (347)
T ss_dssp TCSEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--G---TTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEE
T ss_pred cccEEEEeCCccccch--hhhhcCCccEEEccCCccccchh--h---hcCCcCCEEEccCCcccCch-HHcCCCcCCEEE
Confidence 5778888888888874 47888889999999988887654 4 44588889999888888875 588888899999
Q ss_pred ccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCc
Q 001152 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1137)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1137)
|++|.++.+|. +.++++|+.|++++|........+..+++|++|++++|.+.... . +..+++|+.|++++|.++
T Consensus 117 l~~n~i~~~~~-~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~----~-~~~l~~L~~L~l~~n~l~ 190 (347)
T 4fmz_A 117 LNEDNISDISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVT----P-IANLTDLYSLSLNYNQIE 190 (347)
T ss_dssp CTTSCCCCCGG-GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCG----G-GGGCTTCSEEECTTSCCC
T ss_pred CcCCcccCchh-hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcCCch----h-hccCCCCCEEEccCCccc
Confidence 99888888876 88888888888888864444445788888888888886554322 2 677888888888888888
Q ss_pred ccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCC
Q 001152 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMH 257 (1137)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~ 257 (1137)
.++. +..+++|+.|++++|.++.++. +..+++|+.|+|++|.++.+|. +..+++|+.|+|++|.++++ + .+..++
T Consensus 191 ~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~ 265 (347)
T 4fmz_A 191 DISP-LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI-N-AVKDLT 265 (347)
T ss_dssp CCGG-GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC-G-GGTTCT
T ss_pred cccc-ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC-h-hHhcCC
Confidence 7766 6777888888888888887664 7777888888888888887766 77788888888888888876 2 577788
Q ss_pred CCCEEEccCCcCCCCC---CCCcchhhccCCCCCCC-------CCCCcccccccccccCC
Q 001152 258 NLQNLNLQYNKLLSYC---QVPSWICCNLEGNGKDS-------SNDDFISSSAEMDVYEG 307 (1137)
Q Consensus 258 ~L~~L~Ls~N~L~~~~---~iP~~~~~~l~~n~l~~-------~~~~l~~~~~s~n~l~g 307 (1137)
+|+.|++++|+++.+. .+|....+++++|.+.. ..+.+...+++.|.+.+
T Consensus 266 ~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 266 KLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp TCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred CcCEEEccCCccCCChhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 8888888888777632 22333334455554432 12344445555555444
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-27 Score=271.49 Aligned_cols=283 Identities=17% Similarity=0.155 Sum_probs=211.5
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCCCCcE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRN 95 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP-~~~~~L~~L~~ 95 (1137)
+.++.+.+..|.|+.+++..|.++++|++|+|++|.|++..+..|..+ ++|++|+|++|.++.+| ..|.++++|++
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA---HTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCC---CCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 367888899999999999889999999999999999998887766554 99999999999999886 46899999999
Q ss_pred EEccCCCCCccccc-ccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCC--------
Q 001152 96 LKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC-------- 165 (1137)
Q Consensus 96 L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~-------- 165 (1137)
|+|++|.|+.+|.. |.++++|++|+|++|.+..++ ..+..+++|++|++++|.+.... +..+++
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~------~~~l~~L~~L~l~~ 195 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD------LSLIPSLFHANVSY 195 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC------GGGCTTCSEEECCS
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc------cccccccceeeccc
Confidence 99999999999887 589999999999999977654 56899999999999998765432 233444
Q ss_pred -----------CcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCcc-CccccCCC
Q 001152 166 -----------LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL-PSGLYLLQ 233 (1137)
Q Consensus 166 -----------L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~ 233 (1137)
|+.|++++|.++.+|.. .+++|+.|+|++|+++.++ .+..+++|+.|+|++|.++.+ |..+..++
T Consensus 196 n~l~~~~~~~~L~~L~l~~n~l~~~~~~--~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 272 (390)
T 3o6n_A 196 NLLSTLAIPIAVEELDASHNSINVVRGP--VNVELTILKLQHNNLTDTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272 (390)
T ss_dssp SCCSEEECCSSCSEEECCSSCCCEEECC--CCSSCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCEEESGGGTTCS
T ss_pred ccccccCCCCcceEEECCCCeeeecccc--ccccccEEECCCCCCcccH-HHcCCCCccEEECCCCcCCCcChhHccccc
Confidence 45555555555554442 2357777777777777654 677777888888888887754 66677778
Q ss_pred CCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhccCCCCCCCCCCCcccccccccccCCCc---c
Q 001152 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPM---L 310 (1137)
Q Consensus 234 ~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~l~~~~~s~n~l~g~i---l 310 (1137)
+|+.|+|++|+|++++. .+..+++|+.|+|++|+++. +|..+... +.+...++++|.+..-. +
T Consensus 273 ~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~L~~n~l~~---~~~~~~~l----------~~L~~L~L~~N~i~~~~~~~~ 338 (390)
T 3o6n_A 273 RLERLYISNNRLVALNL-YGQPIPTLKVLDLSHNHLLH---VERNQPQF----------DRLENLYLDHNSIVTLKLSTH 338 (390)
T ss_dssp SCCEEECCSSCCCEEEC-SSSCCTTCCEEECCSSCCCC---CGGGHHHH----------TTCSEEECCSSCCCCCCCCTT
T ss_pred cCCEEECCCCcCcccCc-ccCCCCCCCEEECCCCccee---cCcccccc----------CcCCEEECCCCccceeCchhh
Confidence 88888888888877643 55677788888888887765 34333211 22333334444333322 4
Q ss_pred cCCCCCcccCCCCCC
Q 001152 311 ENDGNVSFSGSRHTS 325 (1137)
Q Consensus 311 ~~~~~~sf~GN~~lC 325 (1137)
.++....++||+.-|
T Consensus 339 ~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 339 HTLKNLTLSHNDWDC 353 (390)
T ss_dssp CCCSEEECCSSCEEH
T ss_pred ccCCEEEcCCCCccc
Confidence 455566778999888
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=282.60 Aligned_cols=305 Identities=16% Similarity=0.120 Sum_probs=208.7
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCCCCcE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRN 95 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP-~~~~~L~~L~~ 95 (1137)
+.++.|.+..|+|+.+.+.+|.++++|++|+|++|.|++..|..|+.+ ++|++|+|++|.++.+| ..|+++++|++
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 132 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL---TSLENLVAVETKLASLESFPIGQLITLKK 132 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTC---TTCCEEECTTSCCCCSSSSCCTTCTTCCE
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCc---ccCCEEEccCCccccccccccCCCCCCCE
Confidence 368888888888888888888888888888888888888877766544 78888888888887775 56778888888
Q ss_pred EEccCCCCC--cccccccCCCCCCEEEccCCCCCCCc-ccc---------------------------------------
Q 001152 96 LKFFGNEIN--LFPSEVGNLLGLECLQIKISSPGVNG-FAL--------------------------------------- 133 (1137)
Q Consensus 96 L~Ls~N~L~--~lP~~l~~L~~L~~L~Ls~N~~~~~~-~~~--------------------------------------- 133 (1137)
|+|++|.++ .+|..|+++++|++|+|++|.+..++ ..+
T Consensus 133 L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~ 212 (606)
T 3vq2_A 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212 (606)
T ss_dssp EECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEE
T ss_pred EeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeecc
Confidence 888888876 46777888888888777777643321 101
Q ss_pred --------------------------------------------------------------------------------
Q 001152 134 -------------------------------------------------------------------------------- 133 (1137)
Q Consensus 134 -------------------------------------------------------------------------------- 133 (1137)
T Consensus 213 ~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l 292 (606)
T 3vq2_A 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSL 292 (606)
T ss_dssp SCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEE
T ss_pred CCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEe
Confidence
Q ss_pred ------------------------------------------------------cCCCCCCEEECCCCCCCCCcccchhh
Q 001152 134 ------------------------------------------------------NKLKGLKELELSKVPPRPSVLTLLSE 159 (1137)
Q Consensus 134 ------------------------------------------------------~~L~~L~~L~Ls~n~ln~~~~~lp~~ 159 (1137)
..+++|++|++++|.+.. ...+|..
T Consensus 293 ~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~-~~~~~~~ 371 (606)
T 3vq2_A 293 AGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSF-SGCCSYS 371 (606)
T ss_dssp ESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEE-EEECCHH
T ss_pred cCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCC-Ccchhhh
Confidence 012223333333322110 0112566
Q ss_pred hcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccc--hhhcCCCCCCEEEccCCCCC-ccCccccCCCCCC
Q 001152 160 IAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLV-ELPSGLYLLQRLE 236 (1137)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP--~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~ 236 (1137)
+..+++|+.|++++|.++.+|..+..+++|+.|+|++|+++.++ ..+..+++|+.|+|++|.++ .+|..+..+++|+
T Consensus 372 ~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 451 (606)
T 3vq2_A 372 DLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451 (606)
T ss_dssp HHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred hccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCC
Confidence 77788888888888888888877888888888888888887554 36777778888888888777 3566677777777
Q ss_pred EEeccCCcCCC-CCcccccCCCCCCEEEccCCcCCCC-----CCCCcchhhccCCCCCCCC-------CCCccccccccc
Q 001152 237 NLDLSNNRLTS-LGSLDLCLMHNLQNLNLQYNKLLSY-----CQVPSWICCNLEGNGKDSS-------NDDFISSSAEMD 303 (1137)
Q Consensus 237 ~LdLS~N~Lsg-~~p~~l~~L~~L~~L~Ls~N~L~~~-----~~iP~~~~~~l~~n~l~~~-------~~~l~~~~~s~n 303 (1137)
.|+|++|++++ .+|..+..+++|+.|+|++|++++. ..++..-.+++++|.+... ...+...++++|
T Consensus 452 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 531 (606)
T 3vq2_A 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531 (606)
T ss_dssp EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTS
T ss_pred EEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCC
Confidence 77777777776 3556677777777777777777652 2334444466666655542 235666777777
Q ss_pred ccCCCc--cc----CCCCCcccCCCCCC
Q 001152 304 VYEGPM--LE----NDGNVSFSGSRHTS 325 (1137)
Q Consensus 304 ~l~g~i--l~----~~~~~sf~GN~~lC 325 (1137)
.+..-. +. .+....++|||..|
T Consensus 532 ~l~~~p~~~~~l~~~L~~l~l~~N~~~c 559 (606)
T 3vq2_A 532 RIETSKGILQHFPKSLAFFNLTNNSVAC 559 (606)
T ss_dssp CCCCEESCGGGSCTTCCEEECCSCCCCC
T ss_pred cCcccCHhHhhhcccCcEEEccCCCccc
Confidence 776321 22 24455788999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-28 Score=298.67 Aligned_cols=191 Identities=15% Similarity=0.112 Sum_probs=129.3
Q ss_pred eeecccCceEEEEEEE--CCccEEEEEEecccCCC--ChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEecCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGS--SADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~--~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~~~~~~~ 882 (1137)
...+.|+.|.+..++. -+..+++|++....... .....+...+.+.+|+++|+++ .|+||++++++++++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~---- 315 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ---- 315 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS----
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC----
Confidence 4567777777665543 57889999976553322 2333333344579999999999 5999999999999876
Q ss_pred CCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccc
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~ 962 (1137)
+.||||||++|++|.++|.+ ...+++. +|+.||+.||+|+|++|||||||||+|||++.+
T Consensus 316 ----------~~yLVMEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-- 375 (569)
T 4azs_A 316 ----------SGWLVMEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-- 375 (569)
T ss_dssp ----------EEEEEEECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT--
T ss_pred ----------EEEEEEecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC--
Confidence 67999999999999999976 2456654 589999999999999999999999999999987
Q ss_pred cCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001152 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042 (1137)
Q Consensus 963 ~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~ 1042 (1137)
+.+||+|||+|+....... .....+||+.|||||++.+ .+..++|+||+|+++++|.++.
T Consensus 376 -----g~vKL~DFGlAr~~~~~~~----------~~~t~vGTp~YmAPE~l~g-----~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 376 -----QHARLIDFGSIVTTPQDCS----------WPTNLVQSFFVFVNELFAE-----NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp -----SCEEECCCTTEESCC---C----------CSHHHHHHHHHHHHHHC----------------------CCCCTTH
T ss_pred -----CCEEEeecccCeeCCCCCc----------cccCceechhhccHHHhCC-----CCCCcccccccccchhhhcccc
Confidence 7899999999986543221 1224579999999999875 3567899999999988776553
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=278.19 Aligned_cols=243 Identities=21% Similarity=0.216 Sum_probs=159.2
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc--cCccccCCCCCc
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL--IPKSVGRYEKLR 94 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~--IP~~~~~L~~L~ 94 (1137)
+.++.|.+..|+|+.+.+.+|.++++|++|||++|+|++ +|.. .+++|++|+|++|.++. +|..|+++++|+
T Consensus 45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~-----~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~ 118 (520)
T 2z7x_B 45 SKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH-----PTVNLKHLDLSFNAFDALPICKEFGNMSQLK 118 (520)
T ss_dssp TTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC-----CCCCCSEEECCSSCCSSCCCCGGGGGCTTCC
T ss_pred ccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc-----ccCCccEEeccCCccccccchhhhccCCcce
Confidence 368888899999998888888999999999999988884 4432 45788888888888875 567788888888
Q ss_pred EEEccCCCCCc--------------------------ccccccCCC----------------------------------
Q 001152 95 NLKFFGNEINL--------------------------FPSEVGNLL---------------------------------- 114 (1137)
Q Consensus 95 ~L~Ls~N~L~~--------------------------lP~~l~~L~---------------------------------- 114 (1137)
+|+|++|.|+. +|..+.++.
T Consensus 119 ~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 198 (520)
T 2z7x_B 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198 (520)
T ss_dssp EEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEE
T ss_pred EEEecCcccchhhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccc
Confidence 88887776641 122222211
Q ss_pred -------------------------------------------------CCCEEEccCCCCC-CCcccc-----------
Q 001152 115 -------------------------------------------------GLECLQIKISSPG-VNGFAL----------- 133 (1137)
Q Consensus 115 -------------------------------------------------~L~~L~Ls~N~~~-~~~~~~----------- 133 (1137)
+|+.|+|++|.+. .+|..+
T Consensus 199 ~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L 278 (520)
T 2z7x_B 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKAL 278 (520)
T ss_dssp ECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEE
T ss_pred ccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCcee
Confidence 3444444444322 222211
Q ss_pred ------------------------------------------cCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEec
Q 001152 134 ------------------------------------------NKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1137)
Q Consensus 134 ------------------------------------------~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~L 171 (1137)
..+++|++|++++|.+. ..+|..+..+++|+.|++
T Consensus 279 ~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~---~~~~~~~~~l~~L~~L~L 355 (520)
T 2z7x_B 279 SIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT---DTVFENCGHLTELETLIL 355 (520)
T ss_dssp EEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCC---TTTTTTCCCCSSCCEEEC
T ss_pred EeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccC---hhhhhhhccCCCCCEEEc
Confidence 46667777777775443 335566777777777777
Q ss_pred cCCCCcc---cCccccCCCCCCEEEccCCCCCc-cchh-hcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccCCcC
Q 001152 172 CHFSIRY---LPPEIGCLSNLEQLDLSFNKMKY-LPTE-ICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRL 245 (1137)
Q Consensus 172 s~N~L~~---IP~~l~~L~~L~~L~Ls~N~L~~-LP~~-l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~N~L 245 (1137)
++|+++. +|..++.+++|++|+|++|+++. +|.. +..+++|+.|+|++|+++ .+|..+. ++|+.|+|++|+|
T Consensus 356 ~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l 433 (520)
T 2z7x_B 356 QMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI 433 (520)
T ss_dssp CSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCC
T ss_pred cCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCcc
Confidence 7777774 34556777777777777777775 7654 555666666666666665 4454443 5666666666666
Q ss_pred CCCCcccccCCCCCCEEEccCCcCCC
Q 001152 246 TSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 246 sg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+.+++ .+..+++|+.|+|++|+|+.
T Consensus 434 ~~ip~-~~~~l~~L~~L~L~~N~l~~ 458 (520)
T 2z7x_B 434 KSIPK-QVVKLEALQELNVASNQLKS 458 (520)
T ss_dssp CCCCG-GGGGCTTCCEEECCSSCCCC
T ss_pred cccch-hhhcCCCCCEEECCCCcCCc
Confidence 64433 44466666666666666654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-26 Score=278.83 Aligned_cols=243 Identities=21% Similarity=0.196 Sum_probs=173.6
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC--ccccCCCCCc
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP--KSVGRYEKLR 94 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP--~~~~~L~~L~ 94 (1137)
+.++.|.+..|+|+.+.+.+|.++++|++|||++|+|+. +|.. .+++|++|+|++|+++.+| ..|+++++|+
T Consensus 76 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~-----~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~ 149 (562)
T 3a79_B 76 SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC-----PMASLRHLDLSFNDFDVLPVCKEFGNLTKLT 149 (562)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC-----CCTTCSEEECCSSCCSBCCCCGGGGGCTTCC
T ss_pred CCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc-----ccccCCEEECCCCCccccCchHhhcccCccc
Confidence 479999999999999999999999999999999999985 4432 4589999999999999764 6899999999
Q ss_pred EEEccCCCCCcc--------------------------cccccCCC----------------------------------
Q 001152 95 NLKFFGNEINLF--------------------------PSEVGNLL---------------------------------- 114 (1137)
Q Consensus 95 ~L~Ls~N~L~~l--------------------------P~~l~~L~---------------------------------- 114 (1137)
+|+|++|.|+.. |..+.++.
T Consensus 150 ~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 229 (562)
T 3a79_B 150 FLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229 (562)
T ss_dssp EEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEE
T ss_pred EEecCCCccccCchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEeccc
Confidence 999999987531 11111111
Q ss_pred -----------------------------------------------CCCEEEccCCCCC-CCcccc-------------
Q 001152 115 -----------------------------------------------GLECLQIKISSPG-VNGFAL------------- 133 (1137)
Q Consensus 115 -----------------------------------------------~L~~L~Ls~N~~~-~~~~~~------------- 133 (1137)
+|++|++++|.+. .+|..+
T Consensus 230 ~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~ 309 (562)
T 3a79_B 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309 (562)
T ss_dssp CCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEE
T ss_pred ccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheeh
Confidence 2333333333322 233222
Q ss_pred ----------------------------------------cCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccC
Q 001152 134 ----------------------------------------NKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1137)
Q Consensus 134 ----------------------------------------~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1137)
..+++|++|++++|.+. ..+|..+.++++|+.|++++
T Consensus 310 ~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~---~~~~~~~~~l~~L~~L~L~~ 386 (562)
T 3a79_B 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT---DSVFQGCSTLKRLQTLILQR 386 (562)
T ss_dssp EEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCC---TTTTTTCCSCSSCCEEECCS
T ss_pred hhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccc---cchhhhhcccCCCCEEECCC
Confidence 56677888888885543 34566777888888888888
Q ss_pred CCCcccC---ccccCCCCCCEEEccCCCCCc-cchh-hcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccCCcCCC
Q 001152 174 FSIRYLP---PEIGCLSNLEQLDLSFNKMKY-LPTE-ICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTS 247 (1137)
Q Consensus 174 N~L~~IP---~~l~~L~~L~~L~Ls~N~L~~-LP~~-l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~N~Lsg 247 (1137)
|+++.+| ..+..+++|++|+|++|+++. +|.. +..+++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+.
T Consensus 387 N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ 464 (562)
T 3a79_B 387 NGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS 464 (562)
T ss_dssp SCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCC
T ss_pred CCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcc
Confidence 8888654 457788888888888888875 7754 566777777777777776 4555443 567777777777776
Q ss_pred CCcccccCCCCCCEEEccCCcCCC
Q 001152 248 LGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 248 ~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+++ .+..+++|+.|+|++|+|+.
T Consensus 465 ip~-~~~~l~~L~~L~L~~N~l~~ 487 (562)
T 3a79_B 465 IPK-DVTHLQALQELNVASNQLKS 487 (562)
T ss_dssp CCT-TTTSSCCCSEEECCSSCCCC
T ss_pred cCh-hhcCCCCCCEEECCCCCCCC
Confidence 554 44477777777777777764
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=254.99 Aligned_cols=229 Identities=21% Similarity=0.229 Sum_probs=184.2
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEccCCCCCcc-cccccCCCCCCEEEc
Q 001152 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLECLQI 121 (1137)
Q Consensus 44 ~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~L 121 (1137)
.++++++++++..+.. + .++|++|+|++|.++.+|. .|.++++|++|+|++|.|+.+ |..|.++++|++|+|
T Consensus 14 ~~~~c~~~~l~~ip~~-~-----~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 87 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVG-I-----PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87 (285)
T ss_dssp CEEECCSSCCSSCCTT-C-----CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred eEEEcCcCCcccCCcC-C-----CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeC
Confidence 5677777777755332 1 2567777777777777653 577777788888877777765 566777777888888
Q ss_pred cCCC-CCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCC
Q 001152 122 KISS-PGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNK 198 (1137)
Q Consensus 122 s~N~-~~~~-~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~ 198 (1137)
++|. +..+ +..+..+++|++|++++|.+.. ..|..+.++++|++|++++|+++.+|. .|..+++|+.|+|++|+
T Consensus 88 ~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~---~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 164 (285)
T 1ozn_A 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE---LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (285)
T ss_dssp CSCTTCCCCCTTTTTTCTTCCEEECTTSCCCC---CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCCCccccCHHHhcCCcCCCEEECCCCcCCE---ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCc
Confidence 7775 5555 4567778888888888755433 335567889999999999999998876 47899999999999999
Q ss_pred CCccch-hhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCC
Q 001152 199 MKYLPT-EICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVP 276 (1137)
Q Consensus 199 L~~LP~-~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP 276 (1137)
|+.+|. .+..+++|+.|+|++|.++.+ |..+..+++|+.|+|++|+|+++++..+..+++|+.|+|++|+|.|.|.+.
T Consensus 165 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~ 244 (285)
T 1ozn_A 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (285)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH
Confidence 998876 488999999999999999966 788999999999999999999999888999999999999999999988766
Q ss_pred cchhh
Q 001152 277 SWICC 281 (1137)
Q Consensus 277 ~~~~~ 281 (1137)
....|
T Consensus 245 ~~~~~ 249 (285)
T 1ozn_A 245 PLWAW 249 (285)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 44443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=270.88 Aligned_cols=244 Identities=18% Similarity=0.214 Sum_probs=133.3
Q ss_pred ccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCCCCcEEEccC
Q 001152 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLKFFG 100 (1137)
Q Consensus 22 L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP-~~~~~L~~L~~L~Ls~ 100 (1137)
.....|+++.++...+ ++|++|+|++|+|++..+..|.. +++|++|+|++|.++.++ ..|.++++|++|+|++
T Consensus 36 c~~~~~~l~~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 36 CKGSSGSLNSIPSGLT---EAVKSLDLSNNRITYISNSDLQR---CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp EECCSTTCSSCCTTCC---TTCCEEECTTSCCCEECTTTTTT---CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eeCCCCCccccccccc---ccCcEEECCCCcCcccCHHHhcc---CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 3444445554443222 24555555555555444333322 245555555555555442 3355555555555555
Q ss_pred CCCCccccc-ccCCCCCCEEEccCCCCCCCcc--cccCCCCCCEEECCCCCCCCCcccc-hhhhcCCCCCcEEeccCCCC
Q 001152 101 NEINLFPSE-VGNLLGLECLQIKISSPGVNGF--ALNKLKGLKELELSKVPPRPSVLTL-LSEIAGLKCLTKLSVCHFSI 176 (1137)
Q Consensus 101 N~L~~lP~~-l~~L~~L~~L~Ls~N~~~~~~~--~~~~L~~L~~L~Ls~n~ln~~~~~l-p~~l~~L~~L~~L~Ls~N~L 176 (1137)
|+|+.+|.. |.++++|++|+|++|.+..++. .+..+++|++|++++|. ....+ +..+.++++|+.|++++|.+
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD---TFTKIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp SCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS---SCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCc---cccccCHHHccCCCCCCEEECCCCCc
Confidence 555544443 4455555555555555444443 34455555555555421 11111 23344455555555555555
Q ss_pred ccc-CccccCCCCCCEEEccCCCCCccchhh-cCCCCCCEEEccCCCCCc------------------------------
Q 001152 177 RYL-PPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVE------------------------------ 224 (1137)
Q Consensus 177 ~~I-P~~l~~L~~L~~L~Ls~N~L~~LP~~l-~~L~~L~~L~Ls~N~Ls~------------------------------ 224 (1137)
+.+ |..+..+++|++|+|++|+++.+|..+ ..+++|+.|+|++|.++.
T Consensus 187 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l 266 (353)
T 2z80_A 187 QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266 (353)
T ss_dssp CEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHH
T ss_pred CccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcch
Confidence 432 344455555555555555555444332 224455555555554443
Q ss_pred --cCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001152 225 --LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1137)
Q Consensus 225 --IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1137)
+|..+..+++|+.|+|++|+|+.+++..|..+++|+.|+|++|+|.|.|+
T Consensus 267 ~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 267 FQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 56677889999999999999998877667899999999999999998553
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=284.54 Aligned_cols=292 Identities=16% Similarity=0.165 Sum_probs=200.9
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNL 96 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L 96 (1137)
.+..+.+..|.++.+++..|.++++|++|+|++|.|++.+|..|+.+ ++|+.|+|++|.|+.+|+ .|+++++|++|
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA---HTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCC---CCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 56777888999999999999999999999999999999888777555 999999999999998865 57999999999
Q ss_pred EccCCCCCccccc-ccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCC
Q 001152 97 KFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1137)
Q Consensus 97 ~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1137)
+|++|.|+.+|.. |+++++|++|+|++|.+..++ ..|..+++|+.|+|++|.+... .+..+++|+.|++++|
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV------DLSLIPSLFHANVSYN 202 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC------CGGGCTTCSEEECCSS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc------ChhhhhhhhhhhcccC
Confidence 9999999999877 589999999999999976655 5799999999999999776543 2556889999999999
Q ss_pred CCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCccccc
Q 001152 175 SIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1137)
Q Consensus 175 ~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~ 254 (1137)
.++.++ ..++|+.|+|++|.|+.+|..+. ++|+.|+|++|.|+.+ ..+..+++|+.|+|++|.|++++|..|.
T Consensus 203 ~l~~l~----~~~~L~~L~ls~n~l~~~~~~~~--~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 275 (597)
T 3oja_B 203 LLSTLA----IPIAVEELDASHNSINVVRGPVN--VELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFV 275 (597)
T ss_dssp CCSEEE----CCTTCSEEECCSSCCCEEECSCC--SCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred cccccc----CCchhheeeccCCcccccccccC--CCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhc
Confidence 998543 23455566666655554443321 3444444444444432 2344444444444444444444444444
Q ss_pred CCCCCCEEEccCCcCCCCC----CCCcchhhccCCCCCCCCC------CCcccccccccccCCCc---ccCCCCCcccCC
Q 001152 255 LMHNLQNLNLQYNKLLSYC----QVPSWICCNLEGNGKDSSN------DDFISSSAEMDVYEGPM---LENDGNVSFSGS 321 (1137)
Q Consensus 255 ~L~~L~~L~Ls~N~L~~~~----~iP~~~~~~l~~n~l~~~~------~~l~~~~~s~n~l~g~i---l~~~~~~sf~GN 321 (1137)
.+++|+.|+|++|.|++++ .+|..-.+++++|.+...+ +.|...++++|.+.+.. +..+....++||
T Consensus 276 ~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N 355 (597)
T 3oja_B 276 KMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHN 355 (597)
T ss_dssp TCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSS
T ss_pred CccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCCccCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeCC
Confidence 4444444444444444321 1233333444444433221 23445556666655433 344555677899
Q ss_pred CCCC
Q 001152 322 RHTS 325 (1137)
Q Consensus 322 ~~lC 325 (1137)
+.-|
T Consensus 356 ~~~~ 359 (597)
T 3oja_B 356 DWDC 359 (597)
T ss_dssp CEEH
T ss_pred CCCC
Confidence 9888
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=278.32 Aligned_cols=283 Identities=19% Similarity=0.207 Sum_probs=202.6
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc--cCccccCCCCCc
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL--IPKSVGRYEKLR 94 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~--IP~~~~~L~~L~ 94 (1137)
+.++.|.+..|+|+.+.+.+|.++++|++|||++|+|++.+|..|+.+ ++|++|+|++|.++. +|..|+++++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 126 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPL---SSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTC---TTCCEEECTTCCCSSSCSSCSCTTCTTCC
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccC---CCCcEEECCCCcccccchhhhhhccCCcc
Confidence 368888888888888888888888888888888888888877766544 777778887777774 355666667777
Q ss_pred EEEccCCC-CCcccc-cccC------------------------------------------------CCCCCEEEccCC
Q 001152 95 NLKFFGNE-INLFPS-EVGN------------------------------------------------LLGLECLQIKIS 124 (1137)
Q Consensus 95 ~L~Ls~N~-L~~lP~-~l~~------------------------------------------------L~~L~~L~Ls~N 124 (1137)
+|+|++|. ++.+|. .|.+ +++|+.|+|++|
T Consensus 127 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n 206 (549)
T 2z81_A 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206 (549)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESC
T ss_pred EEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCC
Confidence 77776665 344432 2332 344555555554
Q ss_pred CCCCC---------------------------------------------------------------------------
Q 001152 125 SPGVN--------------------------------------------------------------------------- 129 (1137)
Q Consensus 125 ~~~~~--------------------------------------------------------------------------- 129 (1137)
.+...
T Consensus 207 ~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L 286 (549)
T 2z81_A 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV 286 (549)
T ss_dssp BCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEE
T ss_pred ccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccc
Confidence 43221
Q ss_pred ---------------------------------------cccc-cCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEE
Q 001152 130 ---------------------------------------GFAL-NKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKL 169 (1137)
Q Consensus 130 ---------------------------------------~~~~-~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L 169 (1137)
|..+ ..+++|+.|++++|.+.......+..++.+++|+.|
T Consensus 287 ~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L 366 (549)
T 2z81_A 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366 (549)
T ss_dssp EEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEE
T ss_pred cccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEE
Confidence 1111 357888888998866543222223347789999999
Q ss_pred eccCCCCcccCc---cccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCC
Q 001152 170 SVCHFSIRYLPP---EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246 (1137)
Q Consensus 170 ~Ls~N~L~~IP~---~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Ls 246 (1137)
++++|+|+.+|. .+..+++|++|+|++|+|+.+|..++.+++|++|+|++|+|+.+|..+. ++|+.|+|++|+|+
T Consensus 367 ~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~--~~L~~L~Ls~N~l~ 444 (549)
T 2z81_A 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIP--QTLEVLDVSNNNLD 444 (549)
T ss_dssp ECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSCCCTTSC--TTCSEEECCSSCCS
T ss_pred EccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCcccccchhc--CCceEEECCCCChh
Confidence 999999998763 5889999999999999999999999999999999999999999887664 68899999999988
Q ss_pred CCCcccccCCCCCCEEEccCCcCCCCCC---CCcchhhccCCCCCCCCCC-------CcccccccccccCCC
Q 001152 247 SLGSLDLCLMHNLQNLNLQYNKLLSYCQ---VPSWICCNLEGNGKDSSND-------DFISSSAEMDVYEGP 308 (1137)
Q Consensus 247 g~~p~~l~~L~~L~~L~Ls~N~L~~~~~---iP~~~~~~l~~n~l~~~~~-------~l~~~~~s~n~l~g~ 308 (1137)
+.+ ..+++|+.|+|++|+|+.++. +|....+++++|.+...++ .+...+++.|.+.+.
T Consensus 445 ~~~----~~l~~L~~L~Ls~N~l~~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 445 SFS----LFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp CCC----CCCTTCCEEECCSSCCSSCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred hhc----ccCChhcEEECCCCccCcCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 864 467889999999998876432 2333446677776665443 334445555555443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-26 Score=290.92 Aligned_cols=290 Identities=19% Similarity=0.186 Sum_probs=217.2
Q ss_pred CCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCC-cccccCCCCCCCccEEEeecCCCCcc-CccccCCCC
Q 001152 15 EGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPL-IESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEK 92 (1137)
Q Consensus 15 ~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~-p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~ 92 (1137)
.++.++.|.+..|+|+.+.+.+|.++++|++|||++|.+.+.+ |..|+ ++++|++|+|++|.|+.+ |..|.++++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~---~L~~L~~L~Ls~N~l~~~~p~~~~~l~~ 98 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFR---NLPNLRILDLGSSKIYFLHPDAFQGLFH 98 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTS---SCTTCCEEECTTCCCCEECTTSSCSCSS
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhc---CCCCCCEEECCCCcCcccCHhHccCCcc
Confidence 3457889999999999998888999999999999888665555 55554 448888888888888866 678888888
Q ss_pred CcEEEccCCCCCc-cccc--ccCCCCCCEEEccCCCCCCCc--ccccCCCCCCEEECCCCCCCCCccc------------
Q 001152 93 LRNLKFFGNEINL-FPSE--VGNLLGLECLQIKISSPGVNG--FALNKLKGLKELELSKVPPRPSVLT------------ 155 (1137)
Q Consensus 93 L~~L~Ls~N~L~~-lP~~--l~~L~~L~~L~Ls~N~~~~~~--~~~~~L~~L~~L~Ls~n~ln~~~~~------------ 155 (1137)
|++|+|++|.++. +|.. |+++++|++|+|++|.+...+ ..|.++++|++|+|++|.+......
T Consensus 99 L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~ 178 (844)
T 3j0a_A 99 LFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178 (844)
T ss_dssp CCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCC
T ss_pred cCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccce
Confidence 8888888888874 5554 888888888888888865543 4678888888888887765332110
Q ss_pred -----------chhhhc---------------------------------------------------------------
Q 001152 156 -----------LLSEIA--------------------------------------------------------------- 161 (1137)
Q Consensus 156 -----------lp~~l~--------------------------------------------------------------- 161 (1137)
.|..++
T Consensus 179 L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~ 258 (844)
T 3j0a_A 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258 (844)
T ss_dssp CEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGT
T ss_pred EECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChh
Confidence 000000
Q ss_pred ---C--CCCCcEEeccCCCCccc-CccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCcc-CccccCCC
Q 001152 162 ---G--LKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL-PSGLYLLQ 233 (1137)
Q Consensus 162 ---~--L~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~ 233 (1137)
+ .++|+.|++++|.+..+ |..|..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+ |..+..++
T Consensus 259 ~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 338 (844)
T 3j0a_A 259 TFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLP 338 (844)
T ss_dssp TTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCT
T ss_pred hhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCC
Confidence 1 14577777777777744 45678888999999999998855 56788899999999999999866 66788899
Q ss_pred CCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhccCCCCCCCCC---CCcccccccccccCC
Q 001152 234 RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSN---DDFISSSAEMDVYEG 307 (1137)
Q Consensus 234 ~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~---~~l~~~~~s~n~l~g 307 (1137)
+|+.|+|++|+|+++++..|..+++|+.|+|++|.|+++..+|....+.+++|.+...+ ..+...+++.|.+.+
T Consensus 339 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~ 415 (844)
T 3j0a_A 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLEN 415 (844)
T ss_dssp TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCS
T ss_pred CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCcccc
Confidence 99999999999998888888889999999999999988777777666777777665422 123344555555554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-26 Score=267.29 Aligned_cols=295 Identities=14% Similarity=0.110 Sum_probs=196.6
Q ss_pred cccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccC-ccccCCCCCcEEEc
Q 001152 21 KLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIP-KSVGRYEKLRNLKF 98 (1137)
Q Consensus 21 ~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~-~IP-~~~~~L~~L~~L~L 98 (1137)
.+....+.++.++. + .++|++|||++|+|++..|..|+.+ ++|++|+|++|.+. .+| ..|.++++|++|+|
T Consensus 14 ~~~c~~~~l~~lp~--l--~~~l~~L~Ls~n~i~~~~~~~~~~l---~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L 86 (455)
T 3v47_A 14 NAICINRGLHQVPE--L--PAHVNYVDLSLNSIAELNETSFSRL---QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86 (455)
T ss_dssp EEECCSSCCSSCCC--C--CTTCCEEECCSSCCCEECTTTTSSC---TTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred ccCcCCCCcccCCC--C--CCccCEEEecCCccCcCChhHhccC---ccccEEECcCCcccceECcccccccccCCEEeC
Confidence 46667778888876 2 2789999999999999888877655 99999999999997 674 57999999999999
Q ss_pred cCCCCCcc-cccccCCCCCCEEEccCCCCCC-Ccc--cccCCCCCCEEECCCCCCCCCcccchhh-hcCCCCCcEEeccC
Q 001152 99 FGNEINLF-PSEVGNLLGLECLQIKISSPGV-NGF--ALNKLKGLKELELSKVPPRPSVLTLLSE-IAGLKCLTKLSVCH 173 (1137)
Q Consensus 99 s~N~L~~l-P~~l~~L~~L~~L~Ls~N~~~~-~~~--~~~~L~~L~~L~Ls~n~ln~~~~~lp~~-l~~L~~L~~L~Ls~ 173 (1137)
++|.++.+ |..|+++++|++|+|++|.+.. .+. .+..+++|++|+|++|.+... .|.. +.++++|++|++++
T Consensus 87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~---~~~~~~~~l~~L~~L~L~~ 163 (455)
T 3v47_A 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI---QPASFFLNMRRFHVLDLTF 163 (455)
T ss_dssp TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSC---CCCGGGGGCTTCCEEECTT
T ss_pred CCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCcc---CcccccCCCCcccEEeCCC
Confidence 99999966 7889999999999999999764 233 388999999999999765433 3444 78899999999999
Q ss_pred CCCccc-CccccC----------------------------------CCCCCEEEccCCCCC-ccchhhcC---------
Q 001152 174 FSIRYL-PPEIGC----------------------------------LSNLEQLDLSFNKMK-YLPTEICY--------- 208 (1137)
Q Consensus 174 N~L~~I-P~~l~~----------------------------------L~~L~~L~Ls~N~L~-~LP~~l~~--------- 208 (1137)
|.++.+ |..+.. +++|+.|+|++|+++ .+|..+..
T Consensus 164 n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~ 243 (455)
T 3v47_A 164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243 (455)
T ss_dssp CCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEE
T ss_pred CcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceee
Confidence 998855 334433 245666666666654 22222211
Q ss_pred ------------------------------CCCCCEEEccCCCCCc-cCccccCCCCCCEEeccCCcCCCCCcccccCCC
Q 001152 209 ------------------------------LKALISLKVANNKLVE-LPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMH 257 (1137)
Q Consensus 209 ------------------------------L~~L~~L~Ls~N~Ls~-IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~ 257 (1137)
.++|+.|+|++|.++. +|..+..+++|+.|+|++|+|++++|..|..++
T Consensus 244 L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 323 (455)
T 3v47_A 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT 323 (455)
T ss_dssp EECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred EeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcc
Confidence 1345555555555542 234444555555555555555555544555555
Q ss_pred CCCEEEccCCcCCCC-----CCCCcchhhccCCCCCCCC-------CCCcccccccccccCCCc------ccCCCCCccc
Q 001152 258 NLQNLNLQYNKLLSY-----CQVPSWICCNLEGNGKDSS-------NDDFISSSAEMDVYEGPM------LENDGNVSFS 319 (1137)
Q Consensus 258 ~L~~L~Ls~N~L~~~-----~~iP~~~~~~l~~n~l~~~-------~~~l~~~~~s~n~l~g~i------l~~~~~~sf~ 319 (1137)
+|+.|+|++|.++++ ..++....+++++|.+... .+.+...++++|.+.+-. +..+....++
T Consensus 324 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 403 (455)
T 3v47_A 324 HLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 403 (455)
T ss_dssp TCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred cCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEcc
Confidence 555555555554431 1223333344444433321 234555666666666522 3345556778
Q ss_pred CCCCCC
Q 001152 320 GSRHTS 325 (1137)
Q Consensus 320 GN~~lC 325 (1137)
||+..|
T Consensus 404 ~N~l~~ 409 (455)
T 3v47_A 404 TNPWDC 409 (455)
T ss_dssp SSCBCC
T ss_pred CCCccc
Confidence 999888
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-25 Score=255.07 Aligned_cols=255 Identities=19% Similarity=0.203 Sum_probs=183.7
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L 96 (1137)
+.++.|.+..|+|+.+.+ |.++++|++|+|++|.++.. + .| .++++|++|+|++|.++.+|. +..+++|++|
T Consensus 66 ~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~-~-~~---~~l~~L~~L~l~~n~i~~~~~-~~~l~~L~~L 137 (347)
T 4fmz_A 66 TNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI-S-AL---QNLTNLRELYLNEDNISDISP-LANLTKMYSL 137 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GG---TTCTTCSEEECTTSCCCCCGG-GTTCTTCCEE
T ss_pred CCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc-h-HH---cCCCcCCEEECcCCcccCchh-hccCCceeEE
Confidence 479999999999999876 99999999999999999874 2 34 455999999999999998877 8889999999
Q ss_pred EccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCC
Q 001152 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1137)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1137)
+|++|.....+..+..+++|+.|++++|.+...+. +..+++|+.|++++|.+... +. +..+++|+.|++++|.+
T Consensus 138 ~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l~~~----~~-~~~l~~L~~L~l~~n~l 211 (347)
T 4fmz_A 138 NLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQIEDI----SP-LASLTSLHYFTAYVNQI 211 (347)
T ss_dssp ECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTSCCCCC----GG-GGGCTTCCEEECCSSCC
T ss_pred ECCCCCCcccccchhhCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCCccccc----cc-ccCCCccceeecccCCC
Confidence 99999655444458888899999998888776665 77888888888888665432 22 55666777777777776
Q ss_pred cccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCC
Q 001152 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1137)
Q Consensus 177 ~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L 256 (1137)
+.++. +..+++|+.|+|++|+++.+|. +..+++|+.|+|++|.++.++ .+..+++|+.|+|++|+++++ + .+..+
T Consensus 212 ~~~~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~l~~n~l~~~-~-~~~~l 286 (347)
T 4fmz_A 212 TDITP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDI-S-VLNNL 286 (347)
T ss_dssp CCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC-G-GGGGC
T ss_pred CCCch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCCh-hHhcCCCcCEEEccCCccCCC-h-hhcCC
Confidence 65554 5666677777777777766664 666667777777777666653 466666677777777766665 2 46666
Q ss_pred CCCCEEEccCCcCCCC-----CCCCcchhhccCCCCCCC
Q 001152 257 HNLQNLNLQYNKLLSY-----CQVPSWICCNLEGNGKDS 290 (1137)
Q Consensus 257 ~~L~~L~Ls~N~L~~~-----~~iP~~~~~~l~~n~l~~ 290 (1137)
++|+.|+|++|++++. ..+|....+++++|.+..
T Consensus 287 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp TTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred CCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 6677777777766542 123444445555555443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-25 Score=265.12 Aligned_cols=227 Identities=19% Similarity=0.156 Sum_probs=187.7
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L 96 (1137)
+.++.|.+..|+|+.++ .|..+++|++|+|++|+|++. | ++.+++|++|+|++|.|+.+| |+++++|++|
T Consensus 42 ~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~n~l~~~-~-----~~~l~~L~~L~Ls~N~l~~~~--~~~l~~L~~L 111 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDMT--GIEKLTGLTKLICTSNNITTL-D-----LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYL 111 (457)
T ss_dssp TTCCEEECCSSCCCCCT--TGGGCTTCSEEECCSSCCSCC-C-----CTTCTTCSEEECCSSCCSCCC--CTTCTTCCEE
T ss_pred CCCCEEEccCCCcccCh--hhcccCCCCEEEccCCcCCeE-c-----cccCCCCCEEECcCCCCceee--cCCCCcCCEE
Confidence 36788889999999874 688899999999999999885 2 345588999999999998886 8889999999
Q ss_pred EccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCC
Q 001152 97 KFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSI 176 (1137)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L 176 (1137)
+|++|+|+.+| ++++++|+.|+|++|.+..++ +..+++|++|++++|.. .+.+ .+..+++|+.|++++|+|
T Consensus 112 ~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l~--l~~l~~L~~L~l~~n~~---~~~~--~~~~l~~L~~L~ls~n~l 182 (457)
T 3bz5_A 112 NCDTNKLTKLD--VSQNPLLTYLNCARNTLTEID--VSHNTQLTELDCHLNKK---ITKL--DVTPQTQLTTLDCSFNKI 182 (457)
T ss_dssp ECCSSCCSCCC--CTTCTTCCEEECTTSCCSCCC--CTTCTTCCEEECTTCSC---CCCC--CCTTCTTCCEEECCSSCC
T ss_pred ECCCCcCCeec--CCCCCcCCEEECCCCccceec--cccCCcCCEEECCCCCc---cccc--ccccCCcCCEEECCCCcc
Confidence 99999998886 888999999999999877764 78889999999998642 3333 367788999999999999
Q ss_pred cccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCC
Q 001152 177 RYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1137)
Q Consensus 177 ~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L 256 (1137)
+.+| ++.+++|+.|+|++|+|+.++ ++.+++|+.|+|++|+|+.+| ++.+++|+.|+|++|+|+++++ ..+
T Consensus 183 ~~l~--l~~l~~L~~L~l~~N~l~~~~--l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~~---~~l 253 (457)
T 3bz5_A 183 TELD--VSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDV---STL 253 (457)
T ss_dssp CCCC--CTTCTTCCEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCCC---TTC
T ss_pred ceec--cccCCCCCEEECcCCcCCeec--cccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcCH---HHC
Confidence 9887 788899999999999999874 888899999999999999888 7888999999999999998764 455
Q ss_pred CCCCEEEccCCcCCC
Q 001152 257 HNLQNLNLQYNKLLS 271 (1137)
Q Consensus 257 ~~L~~L~Ls~N~L~~ 271 (1137)
++|+.|++++|+|..
T Consensus 254 ~~L~~L~l~~n~L~~ 268 (457)
T 3bz5_A 254 SKLTTLHCIQTDLLE 268 (457)
T ss_dssp TTCCEEECTTCCCSC
T ss_pred CCCCEEeccCCCCCE
Confidence 666666666666654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-25 Score=266.33 Aligned_cols=236 Identities=22% Similarity=0.277 Sum_probs=132.3
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L 96 (1137)
+.++.|.+..|+|+.+.+ |.++++|++|+|++|.+++..+ ++ ++++|++|+|++|.++.+|. +.++++|++|
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~---~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L 139 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LA---NLTNLTGLTLFNNQITDIDP-LKNLTNLNRL 139 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GT---TCTTCCEEECCSSCCCCCGG-GTTCTTCSEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hc---CCCCCCEEECCCCCCCCChH-HcCCCCCCEE
Confidence 357777777777777765 7777777777777777776554 33 34777777777777777655 6777777777
Q ss_pred EccCCCCCcccc--------------------cccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccc
Q 001152 97 KFFGNEINLFPS--------------------EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTL 156 (1137)
Q Consensus 97 ~Ls~N~L~~lP~--------------------~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~l 156 (1137)
+|++|.++.+|. .+.++++|+.|++++|.+..++ .+..+++|++|++++|.+....
T Consensus 140 ~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~--- 215 (466)
T 1o6v_A 140 ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS-VLAKLTNLESLIATNNQISDIT--- 215 (466)
T ss_dssp EEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCG---
T ss_pred ECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCCh-hhccCCCCCEEEecCCcccccc---
Confidence 777777665543 1233344444444444433332 2344444444444443332211
Q ss_pred hhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCC
Q 001152 157 LSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236 (1137)
Q Consensus 157 p~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~ 236 (1137)
| ++.+++|+.|++++|.++.++ .+..+++|+.|+|++|+++.++. +..+++|+.|+|++|.++.+|. +..+++|+
T Consensus 216 ~--~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~ 290 (466)
T 1o6v_A 216 P--LGILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP-LAGLTALT 290 (466)
T ss_dssp G--GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG-GTTCTTCS
T ss_pred c--ccccCCCCEEECCCCCcccch-hhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc-ccCCCccC
Confidence 1 334445555555555554442 34455555555555555554443 5555555555555555555544 55555555
Q ss_pred EEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 237 ~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
.|+|++|+++++++ +..+++|+.|+|++|++++
T Consensus 291 ~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~ 323 (466)
T 1o6v_A 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323 (466)
T ss_dssp EEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSC
T ss_pred eEEcCCCcccCchh--hcCCCCCCEEECcCCcCCC
Confidence 55555555555543 4555555555555555554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-25 Score=277.43 Aligned_cols=306 Identities=20% Similarity=0.138 Sum_probs=161.0
Q ss_pred CcccccCCCCCCcccCCCCCCCCCC--CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCc
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDD--DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLR 94 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~--L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~ 94 (1137)
.++.|.+..|+++.+.+.+|.++.. |++|||++|++++..|..|+.+ ++|++|+|++|.++.+ |..|.++++|+
T Consensus 223 ~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 299 (680)
T 1ziw_A 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWL---PQLEYFFLEYNNIQHLFSHSLHGLFNVR 299 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTC---TTCCEEECCSCCBSEECTTTTTTCTTCC
T ss_pred cccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCc---ccccEeeCCCCccCccChhhhcCCCCcc
Confidence 3445555555555555555554433 5555555555554444433322 4555555555555433 23344444444
Q ss_pred EEEccCCCCC------cccc----cccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCC--------------
Q 001152 95 NLKFFGNEIN------LFPS----EVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPP-------------- 149 (1137)
Q Consensus 95 ~L~Ls~N~L~------~lP~----~l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~l-------------- 149 (1137)
+|+|++|... .+|. .|..+++|+.|+|++|.+..++ ..|.++++|++|++++|.+
T Consensus 300 ~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~ 379 (680)
T 1ziw_A 300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379 (680)
T ss_dssp EEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGT
T ss_pred EEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccc
Confidence 4444433222 2221 2333444444444444422221 2233333444443333210
Q ss_pred -----------CCCcccchhhhcCCCCCcEEeccCCCCc-ccC-ccccCCCCCCEEEccCCCCC----------------
Q 001152 150 -----------RPSVLTLLSEIAGLKCLTKLSVCHFSIR-YLP-PEIGCLSNLEQLDLSFNKMK---------------- 200 (1137)
Q Consensus 150 -----------n~~~~~lp~~l~~L~~L~~L~Ls~N~L~-~IP-~~l~~L~~L~~L~Ls~N~L~---------------- 200 (1137)
+......|..+..+++|+.|++++|.++ .+| ..|..+++|++|+|++|+++
T Consensus 380 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L 459 (680)
T 1ziw_A 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459 (680)
T ss_dssp TSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEE
T ss_pred cCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccc
Confidence 1112223444555555555555555554 344 24455555555555555443
Q ss_pred -----------ccchhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCc--------ccccCCCCCC
Q 001152 201 -----------YLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGS--------LDLCLMHNLQ 260 (1137)
Q Consensus 201 -----------~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p--------~~l~~L~~L~ 260 (1137)
.+|..|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|+|+++++ ..|..+++|+
T Consensus 460 ~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~ 539 (680)
T 1ziw_A 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539 (680)
T ss_dssp ECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCC
T ss_pred hhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCC
Confidence 3456666777777777777777766543 5667777777777777775422 2356777777
Q ss_pred EEEccCCcCCCCC-----CCCcchhhccCCCCCCCCC-------CCcccccccccccCCCc-------ccCCCCCcccCC
Q 001152 261 NLNLQYNKLLSYC-----QVPSWICCNLEGNGKDSSN-------DDFISSSAEMDVYEGPM-------LENDGNVSFSGS 321 (1137)
Q Consensus 261 ~L~Ls~N~L~~~~-----~iP~~~~~~l~~n~l~~~~-------~~l~~~~~s~n~l~g~i-------l~~~~~~sf~GN 321 (1137)
.|+|++|+|+.++ .++....+++++|.+...+ ..+...++++|.+++.. +.++....++||
T Consensus 540 ~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N 619 (680)
T 1ziw_A 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTC
T ss_pred EEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCC
Confidence 7777777776532 2334444667777665433 34556677788777754 345566678899
Q ss_pred CCCCc
Q 001152 322 RHTSS 326 (1137)
Q Consensus 322 ~~lC~ 326 (1137)
|+.|.
T Consensus 620 ~~~c~ 624 (680)
T 1ziw_A 620 PFDCT 624 (680)
T ss_dssp CCCBC
T ss_pred CcccC
Confidence 99993
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-25 Score=264.41 Aligned_cols=265 Identities=18% Similarity=0.103 Sum_probs=171.4
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNL 96 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L 96 (1137)
+.++.|.+..|+|+.++ |..+++|++|+|++|+|++. + ++++++|++|+|++|.|+.+| ++.+++|++|
T Consensus 64 ~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~~-~-----~~~l~~L~~L~L~~N~l~~l~--~~~l~~L~~L 132 (457)
T 3bz5_A 64 TGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTNL-D-----VTPLTKLTYLNCDTNKLTKLD--VSQNPLLTYL 132 (457)
T ss_dssp TTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSCC-C-----CTTCTTCCEEECCSSCCSCCC--CTTCTTCCEE
T ss_pred CCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCcee-e-----cCCCCcCCEEECCCCcCCeec--CCCCCcCCEE
Confidence 47889999999999983 88999999999999999885 2 455689999999999999886 8899999999
Q ss_pred EccCCCCCcccccccCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCC
Q 001152 97 KFFGNEINLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1137)
Q Consensus 97 ~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~-~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1137)
+|++|+|+.+| ++++++|+.|++++|. ++.+ .+..+++|+.|++++|.+.. +| +..+++|+.|++++|+
T Consensus 133 ~l~~N~l~~l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~----l~--l~~l~~L~~L~l~~N~ 202 (457)
T 3bz5_A 133 NCARNTLTEID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE----LD--VSQNKLLNRLNCDTNN 202 (457)
T ss_dssp ECTTSCCSCCC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC----CC--CTTCTTCCEEECCSSC
T ss_pred ECCCCccceec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce----ec--cccCCCCCEEECcCCc
Confidence 99999998875 7778888888888774 4444 36677777777777765543 22 4556666666666666
Q ss_pred CcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcc-c-------------------------
Q 001152 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-L------------------------- 229 (1137)
Q Consensus 176 L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~-l------------------------- 229 (1137)
++.++ ++.+++|++|+|++|+|+.+| ++.+++|+.|+|++|+|+.+|.. +
T Consensus 203 l~~~~--l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~ 278 (457)
T 3bz5_A 203 ITKLD--LNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLI 278 (457)
T ss_dssp CSCCC--CTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCC
T ss_pred CCeec--cccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCC
Confidence 66552 556666666666666666655 55566666666666666544421 1
Q ss_pred ----cCCCCCCEEeccCCcCCCCCcc--------cccCCCCCCEEEccCCcCCCC--CCCCcchhhccCCCCCCCCCCCc
Q 001152 230 ----YLLQRLENLDLSNNRLTSLGSL--------DLCLMHNLQNLNLQYNKLLSY--CQVPSWICCNLEGNGKDSSNDDF 295 (1137)
Q Consensus 230 ----~~L~~L~~LdLS~N~Lsg~~p~--------~l~~L~~L~~L~Ls~N~L~~~--~~iP~~~~~~l~~n~l~~~~~~l 295 (1137)
+.+++|+.|+|++|.+.+.+|. .+..+++|+.|+|++|+|+++ ..++....+++++|.+.. .+.+
T Consensus 279 ~~~~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l~l~~l~~L~~L~l~~N~l~~-l~~L 357 (457)
T 3bz5_A 279 YFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHIQD-FSSV 357 (457)
T ss_dssp EEECTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCSEEECCSSCCCB-CTTG
T ss_pred cccccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcccccccccCCcCcEEECCCCCCCC-cccc
Confidence 1224444444444443332221 234445666666666666653 122333344555555543 2334
Q ss_pred ccccccccccCC
Q 001152 296 ISSSAEMDVYEG 307 (1137)
Q Consensus 296 ~~~~~s~n~l~g 307 (1137)
.....+.|.+.|
T Consensus 358 ~~L~l~~n~l~g 369 (457)
T 3bz5_A 358 GKIPALNNNFEA 369 (457)
T ss_dssp GGSSGGGTSEEE
T ss_pred ccccccCCcEEe
Confidence 444444555544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=291.30 Aligned_cols=282 Identities=15% Similarity=0.073 Sum_probs=223.1
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCcE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRN 95 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~~ 95 (1137)
+.++.|.+..|.|..+.+..|..+++|++|+|++|+|++..|..|..+ ++|++|+|++|.|+.+ |..|..+++|++
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 342 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGL---DNLQVLNLSYNLLGELYSSNFYGLPKVAY 342 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTC---SSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCC---CCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence 467888888888888888888888888888888888888877766544 8888888888888866 567888888888
Q ss_pred EEccCCCCCcccc-cccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCC
Q 001152 96 LKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF 174 (1137)
Q Consensus 96 L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N 174 (1137)
|+|++|.|+.++. .|.++++|+.|+|++|.+..++. +++|+.|++++|.+. .+|.. ..+|+.|++++|
T Consensus 343 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~----~~~L~~L~l~~N~l~----~l~~~---~~~l~~L~ls~N 411 (844)
T 3j0a_A 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF----IPSIPDIFLSGNKLV----TLPKI---NLTANLIHLSEN 411 (844)
T ss_dssp EECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS----CCSCSEEEEESCCCC----CCCCC---CTTCCEEECCSC
T ss_pred EECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccC----CCCcchhccCCCCcc----ccccc---ccccceeecccC
Confidence 8888888887754 47888888888888888765443 778888888886664 33332 456888999999
Q ss_pred CCcccCc--cccCCCCCCEEEccCCCCCccch--hhcCCCCCCEEEccCCCCCcc------CccccCCCCCCEEeccCCc
Q 001152 175 SIRYLPP--EIGCLSNLEQLDLSFNKMKYLPT--EICYLKALISLKVANNKLVEL------PSGLYLLQRLENLDLSNNR 244 (1137)
Q Consensus 175 ~L~~IP~--~l~~L~~L~~L~Ls~N~L~~LP~--~l~~L~~L~~L~Ls~N~Ls~I------P~~l~~L~~L~~LdLS~N~ 244 (1137)
+++.++. .+..+++|+.|+|++|+|+.++. .+..+++|+.|+|++|.++.+ |..+..+++|+.|+|++|+
T Consensus 412 ~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~ 491 (844)
T 3j0a_A 412 RLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491 (844)
T ss_dssp CCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHH
T ss_pred ccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCc
Confidence 9987765 45689999999999999996653 356689999999999999743 3457789999999999999
Q ss_pred CCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhccCCCCCCCCCCCcccccccccccCCCcc---cCCCCCcccCC
Q 001152 245 LTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPML---ENDGNVSFSGS 321 (1137)
Q Consensus 245 Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~l~~~~~s~n~l~g~il---~~~~~~sf~GN 321 (1137)
|++++|..|..+++|+.|+|++|+|+++ |... ....+...++++|.+.+.+. ..+....++||
T Consensus 492 l~~~~~~~~~~l~~L~~L~Ls~N~l~~l---~~~~-----------~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~N 557 (844)
T 3j0a_A 492 LNSLPPGVFSHLTALRGLSLNSNRLTVL---SHND-----------LPANLEILDISRNQLLAPNPDVFVSLSVLDITHN 557 (844)
T ss_dssp HTTCCTTSSSSCCSCSEEEEESCCCSSC---CCCC-----------CCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEE
T ss_pred ccccChhHccchhhhheeECCCCCCCcc---Chhh-----------hhccccEEECCCCcCCCCChhHhCCcCEEEecCC
Confidence 9999998899999999999999999873 2211 11567788889999988774 34555577899
Q ss_pred CCCCc
Q 001152 322 RHTSS 326 (1137)
Q Consensus 322 ~~lC~ 326 (1137)
|+.|.
T Consensus 558 p~~C~ 562 (844)
T 3j0a_A 558 KFICE 562 (844)
T ss_dssp CCCCS
T ss_pred Ccccc
Confidence 99993
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-25 Score=276.73 Aligned_cols=253 Identities=23% Similarity=0.195 Sum_probs=181.3
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCC--CcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCC
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFP--LIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKL 93 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~--~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L 93 (1137)
+.++.|.+..|+|+.+.+..|.++++|++|+|++|.++.. ....|..+ ..++|+.|+|++|+++.+ |..|..+++|
T Consensus 329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L 407 (680)
T 1ziw_A 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL-AHSPLHILNLTKNKISKIESDAFSWLGHL 407 (680)
T ss_dssp TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGG-TTSCCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhccc-ccCcCceEECCCCCCCeEChhhhhCCCCC
Confidence 3688888888888888888888888888888888865432 22223222 124677788888878765 4567788888
Q ss_pred cEEEccCCCCC-ccc-ccccCCCCCCEEEccCCCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEe
Q 001152 94 RNLKFFGNEIN-LFP-SEVGNLLGLECLQIKISSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLS 170 (1137)
Q Consensus 94 ~~L~Ls~N~L~-~lP-~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~ 170 (1137)
++|+|++|.++ .+| ..+.++++|+.|+|++|.+. ..+..|..+++|+.|++++|.+.. .+.+|..+..+++|+.|+
T Consensus 408 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~p~~~~~l~~L~~L~ 486 (680)
T 1ziw_A 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN-VDSSPSPFQPLRNLTILD 486 (680)
T ss_dssp CEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBC-TTCSSCTTTTCTTCCEEE
T ss_pred CEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccc-cccCCcccccCCCCCEEE
Confidence 88888888886 465 45777888888888887743 334567777777777777765532 245666777777788888
Q ss_pred ccCCCCcccCc-cccCCCCCCEEEccCCCCCccch---------hhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEe
Q 001152 171 VCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPT---------EICYLKALISLKVANNKLVELPSG-LYLLQRLENLD 239 (1137)
Q Consensus 171 Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~---------~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~Ld 239 (1137)
+++|+|+.+|+ .|..+++|++|+|++|+|+.++. .+..+++|+.|+|++|+|+.||.. |.++++|+.|+
T Consensus 487 Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 566 (680)
T 1ziw_A 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeE
Confidence 88887776665 46777778888888887775432 256777778888888877777754 66677778888
Q ss_pred ccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 240 LSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 240 LS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
|++|+|+++++..|..+++|+.|+|++|+|++
T Consensus 567 Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ 598 (680)
T 1ziw_A 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCCCB
T ss_pred CCCCCCCcCCHhHhCCCCCCCEEECCCCcCCc
Confidence 88887777777667777777777777777776
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=272.22 Aligned_cols=306 Identities=17% Similarity=0.165 Sum_probs=224.5
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcE
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRN 95 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~ 95 (1137)
+.++.|.+..|+|+.+.+.+|.++++|++|+|++|.|++..|..|+.+ ++|++|+|++|.++.+|. .|+++++|++
T Consensus 52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~l~~~~~~~l~~L~~ 128 (570)
T 2z63_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL---SSLQKLVAVETNLASLENFPIGHLKTLKE 128 (570)
T ss_dssp SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC---TTCCEEECTTSCCCCSTTCSCTTCTTCCE
T ss_pred CCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCc---cccccccccccccccCCCccccccccccE
Confidence 378889999999999988899999999999999999988877766544 888888888888888875 5888888888
Q ss_pred EEccCCCCCc--ccccccCCCCCCEEEccCCCCCCCc-ccccCCCCC----CEEECCCCCCCCC----------------
Q 001152 96 LKFFGNEINL--FPSEVGNLLGLECLQIKISSPGVNG-FALNKLKGL----KELELSKVPPRPS---------------- 152 (1137)
Q Consensus 96 L~Ls~N~L~~--lP~~l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L----~~L~Ls~n~ln~~---------------- 152 (1137)
|+|++|.++. +|..|+++++|+.|++++|.+..++ ..+..+.+| ..|++++|.+...
T Consensus 129 L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~ 208 (570)
T 2z63_A 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208 (570)
T ss_dssp EECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEE
T ss_pred EecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecc
Confidence 8888888874 6888888888888888888754432 233333333 3333333221100
Q ss_pred --------------------------------------------------------------------------------
Q 001152 153 -------------------------------------------------------------------------------- 152 (1137)
Q Consensus 153 -------------------------------------------------------------------------------- 152 (1137)
T Consensus 209 ~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~ 288 (570)
T 2z63_A 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288 (570)
T ss_dssp SCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEE
T ss_pred cccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEE
Confidence
Q ss_pred -----cccchhhh------------------------------------------cCCCCCcEEeccCCCCccc---Ccc
Q 001152 153 -----VLTLLSEI------------------------------------------AGLKCLTKLSVCHFSIRYL---PPE 182 (1137)
Q Consensus 153 -----~~~lp~~l------------------------------------------~~L~~L~~L~Ls~N~L~~I---P~~ 182 (1137)
...+|..+ ..+++|+.|++++|.++.+ |..
T Consensus 289 l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 368 (570)
T 2z63_A 289 LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368 (570)
T ss_dssp EESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHH
T ss_pred ecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCcccccccc
Confidence 00011100 3567888889999988855 567
Q ss_pred ccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccC--ccccCCCCCCEEeccCCcCCCCCcccccCCCCCC
Q 001152 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP--SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQ 260 (1137)
Q Consensus 183 l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP--~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~ 260 (1137)
+..+++|++|+|++|.++.+|..+..+++|+.|+|++|.++.++ ..+..+++|+.|+|++|++++.+|..+..+++|+
T Consensus 369 ~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 448 (570)
T 2z63_A 369 DFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448 (570)
T ss_dssp HHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred ccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCc
Confidence 78888999999999998888777888889999999998888553 3577888889999999988888888888888888
Q ss_pred EEEccCCcCCC------CCCCCcchhhccCCCCCCCC-------CCCcccccccccccCCCc------ccCCCCCcccCC
Q 001152 261 NLNLQYNKLLS------YCQVPSWICCNLEGNGKDSS-------NDDFISSSAEMDVYEGPM------LENDGNVSFSGS 321 (1137)
Q Consensus 261 ~L~Ls~N~L~~------~~~iP~~~~~~l~~n~l~~~-------~~~l~~~~~s~n~l~g~i------l~~~~~~sf~GN 321 (1137)
.|+|++|+++. +..+|..-.+++++|.+... .+.+...++++|.+.+.. +..+....++||
T Consensus 449 ~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 528 (570)
T 2z63_A 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528 (570)
T ss_dssp EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred EEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCC
Confidence 88888888762 33455555567777765543 245677778888887754 233445577899
Q ss_pred CCCC
Q 001152 322 RHTS 325 (1137)
Q Consensus 322 ~~lC 325 (1137)
+..|
T Consensus 529 ~~~~ 532 (570)
T 2z63_A 529 PWDC 532 (570)
T ss_dssp CBCC
T ss_pred cccC
Confidence 9888
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-25 Score=261.15 Aligned_cols=237 Identities=20% Similarity=0.239 Sum_probs=201.6
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-----------
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK----------- 85 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~----------- 85 (1137)
+.++.|.+..|+++.+.+ |.++++|++|+|++|++++..+ + .++++|++|+|++|.++.+|.
T Consensus 90 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~---~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~ 162 (466)
T 1o6v_A 90 TKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L---KNLTNLNRLELSSNTISDISALSGLTSLQQLS 162 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--G---TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEE
T ss_pred ccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--H---cCCCCCCEEECCCCccCCChhhccCCcccEee
Confidence 478888888999988876 8889999999999998887654 3 445888888888887776542
Q ss_pred ---------cccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccc
Q 001152 86 ---------SVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTL 156 (1137)
Q Consensus 86 ---------~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~l 156 (1137)
.+.++++|++|+|++|.++.++. +.++++|+.|++++|.+...+. +..+++|+.|++++|.+...
T Consensus 163 l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~---- 236 (466)
T 1o6v_A 163 FGNQVTDLKPLANLTTLERLDISSNKVSDISV-LAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI---- 236 (466)
T ss_dssp EEESCCCCGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC----
T ss_pred cCCcccCchhhccCCCCCEEECcCCcCCCChh-hccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccc----
Confidence 26677889999999999998864 8899999999999999776655 78899999999999776543
Q ss_pred hhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCC
Q 001152 157 LSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236 (1137)
Q Consensus 157 p~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~ 236 (1137)
..+..+++|+.|++++|.++.++. +..+++|+.|+|++|+++.+|. +..+++|+.|+|++|+++.+|. +..+++|+
T Consensus 237 -~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~ 312 (466)
T 1o6v_A 237 -GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP-ISNLKNLT 312 (466)
T ss_dssp -GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG-GGGCTTCS
T ss_pred -hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh-hcCCCCCC
Confidence 357789999999999999997766 8889999999999999998876 8889999999999999998876 78899999
Q ss_pred EEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCC
Q 001152 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272 (1137)
Q Consensus 237 ~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1137)
.|+|++|++++.+| +..+++|+.|++++|+++++
T Consensus 313 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 313 YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp EEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred EEECcCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence 99999999999876 78899999999999998874
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-25 Score=246.62 Aligned_cols=219 Identities=21% Similarity=0.270 Sum_probs=194.8
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCCCCcEEEccCCCCCcc---cccccCCCCCCE
Q 001152 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRNLKFFGNEINLF---PSEVGNLLGLEC 118 (1137)
Q Consensus 43 L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~-~~~L~~L~~L~Ls~N~L~~l---P~~l~~L~~L~~ 118 (1137)
-+.+++++++++..+...+ ++|++|+|++|.++.+|.. |.++++|++|+|++|.|+.+ |..+..+++|++
T Consensus 9 ~~~l~c~~~~l~~ip~~~~------~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 82 (306)
T 2z66_A 9 GTEIRCNSKGLTSVPTGIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82 (306)
T ss_dssp TTEEECCSSCCSSCCSCCC------TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred CCEEEcCCCCcccCCCCCC------CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence 3579999999987654322 6899999999999999875 78999999999999999855 677888999999
Q ss_pred EEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccch--hhhcCCCCCcEEeccCCCCcc-cCccccCCCCCCEEEcc
Q 001152 119 LQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLL--SEIAGLKCLTKLSVCHFSIRY-LPPEIGCLSNLEQLDLS 195 (1137)
Q Consensus 119 L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp--~~l~~L~~L~~L~Ls~N~L~~-IP~~l~~L~~L~~L~Ls 195 (1137)
|+|++|.+..++..+..+++|++|++++|.+. .++ ..+..+++|++|++++|.++. +|..+..+++|++|+|+
T Consensus 83 L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 158 (306)
T 2z66_A 83 LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK----QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 158 (306)
T ss_dssp EECCSCSEEEEEEEEETCTTCCEEECTTSEEE----SSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECT
T ss_pred EECCCCccccChhhcCCCCCCCEEECCCCccc----ccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECC
Confidence 99999998888888999999999999996543 333 468889999999999999984 45678999999999999
Q ss_pred CCCCCc--cchhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 196 FNKMKY--LPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 196 ~N~L~~--LP~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+|.++. +|..+..+++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+++++..+..+++|+.|+|++|++++
T Consensus 159 ~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 237 (306)
T 2z66_A 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 237 (306)
T ss_dssp TCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCB
T ss_pred CCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcc
Confidence 999985 799999999999999999999976 6778899999999999999999998889999999999999999987
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=262.30 Aligned_cols=245 Identities=21% Similarity=0.174 Sum_probs=192.6
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCC-CCCCccccc----CCCCCCCccEEEeecCCCC-ccCccc--cC
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTV-DFPLIESYG----NRGGDNSVEGLYLYKNVLN-LIPKSV--GR 89 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L-~~~~p~~~~----~l~~L~~L~~L~Ls~N~L~-~IP~~~--~~ 89 (1137)
.++.+.+..|++ .++. .+... |+.|+|++|.| .+.+|..+. .+.++++|++|+|++|.++ .+|..+ ..
T Consensus 44 ~L~~l~l~~n~l-~~p~-~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 119 (312)
T 1wwl_A 44 SLEYLLKRVDTE-ADLG-QFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119 (312)
T ss_dssp ECTTHHHHCCTT-CCCH-HHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCC
T ss_pred CceeEeeccccc-ccHH-HHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhc
Confidence 467777777888 4433 22222 88888999888 445555443 0013488999999999998 678876 88
Q ss_pred CCCCcEEEccCCCCCcccccccCC-----CCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhh--c
Q 001152 90 YEKLRNLKFFGNEINLFPSEVGNL-----LGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEI--A 161 (1137)
Q Consensus 90 L~~L~~L~Ls~N~L~~lP~~l~~L-----~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l--~ 161 (1137)
+++|++|+|++|+|+.+|..++.+ ++|++|+|++|.+..++ ..+..+++|++|+|++|.+.... .+|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER-GLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHH-HHHHHSCTT
T ss_pred CCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcch-HHHHHHHhc
Confidence 999999999999999888877776 89999999999977766 78889999999999996643221 134444 7
Q ss_pred CCCCCcEEeccCCCCcccC---c-cccCCCCCCEEEccCCCCCccc--hhhcCCCCCCEEEccCCCCCccCccccCCCCC
Q 001152 162 GLKCLTKLSVCHFSIRYLP---P-EIGCLSNLEQLDLSFNKMKYLP--TEICYLKALISLKVANNKLVELPSGLYLLQRL 235 (1137)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~IP---~-~l~~L~~L~~L~Ls~N~L~~LP--~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L 235 (1137)
.+++|++|++++|+|+.+| . .+..+++|++|+|++|+|+.++ ..+..+++|+.|+|++|+|+.||..+. ++|
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L 276 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKL 276 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC--SEE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc--CCc
Confidence 8899999999999998544 3 3367899999999999998654 456678999999999999999998887 889
Q ss_pred CEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 236 ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 236 ~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+.|+|++|+|+++ |. +..+++|+.|+|++|+|++
T Consensus 277 ~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 277 SVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp EEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred eEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 9999999999998 43 8899999999999999876
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-24 Score=255.98 Aligned_cols=276 Identities=23% Similarity=0.229 Sum_probs=121.9
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~ 97 (1137)
.++.|.+..|+|+.++ .|.++++|++|+|++|+|++ +|..+ .+|++|+|++|.++.+| .|+++++|++|+
T Consensus 132 ~L~~L~L~~n~l~~lp--~~~~l~~L~~L~l~~N~l~~-lp~~~------~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~ 201 (454)
T 1jl5_A 132 LLEYLGVSNNQLEKLP--ELQNSSFLKIIDVDNNSLKK-LPDLP------PSLEFIAAGNNQLEELP-ELQNLPFLTAIY 201 (454)
T ss_dssp TCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSC-CCCCC------TTCCEEECCSSCCSSCC-CCTTCTTCCEEE
T ss_pred CCCEEECcCCCCCCCc--ccCCCCCCCEEECCCCcCcc-cCCCc------ccccEEECcCCcCCcCc-cccCCCCCCEEE
Confidence 4455555555555443 35555555555555555554 22211 24555555555555554 355555555555
Q ss_pred ccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCc
Q 001152 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1137)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1137)
|++|+++.+|... .+|+.|++++|.+..+| .+..+++|++|++++|.+.. +|.. +++|+.|++++|+++
T Consensus 202 l~~N~l~~l~~~~---~~L~~L~l~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~----l~~~---~~~L~~L~l~~N~l~ 270 (454)
T 1jl5_A 202 ADNNSLKKLPDLP---LSLESIVAGNNILEELP-ELQNLPFLTTIYADNNLLKT----LPDL---PPSLEALNVRDNYLT 270 (454)
T ss_dssp CCSSCCSSCCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS----CCSC---CTTCCEEECCSSCCS
T ss_pred CCCCcCCcCCCCc---CcccEEECcCCcCCccc-ccCCCCCCCEEECCCCcCCc----cccc---ccccCEEECCCCccc
Confidence 5555555444322 34555555555544444 25555555555555544332 2211 234555555555555
Q ss_pred ccCccccCCCCCCEEEccCCCCCccch---hh-------------cCC-CCCCEEEccCCCCCccCccccCCCCCCEEec
Q 001152 178 YLPPEIGCLSNLEQLDLSFNKMKYLPT---EI-------------CYL-KALISLKVANNKLVELPSGLYLLQRLENLDL 240 (1137)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~~LP~---~l-------------~~L-~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdL 240 (1137)
.+|.. +++|++|+|++|+|+.+|. .+ ..+ ++|+.|+|++|+++.+|.. +++|+.|+|
T Consensus 271 ~l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~L 344 (454)
T 1jl5_A 271 DLPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL---PPRLERLIA 344 (454)
T ss_dssp CCCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCCC---CTTCCEEEC
T ss_pred ccCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccccccc---CCcCCEEEC
Confidence 44432 2445555555555553321 11 112 3666666666666666654 366777777
Q ss_pred cCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhc----cCCCCCCCCCCCcccccccccccCC--CcccCCC
Q 001152 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN----LEGNGKDSSNDDFISSSAEMDVYEG--PMLENDG 314 (1137)
Q Consensus 241 S~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~----l~~n~l~~~~~~l~~~~~s~n~l~g--~il~~~~ 314 (1137)
++|+|+++++ .+++|+.|+|++|++++++.+|.++.-. +.+..+. ....+...++++|.+.| .++..+.
T Consensus 345 ~~N~l~~lp~----~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~-~~~~L~~L~ls~N~l~~~~~iP~sl~ 419 (454)
T 1jl5_A 345 SFNHLAEVPE----LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPE-LPQNLKQLHVETNPLREFPDIPESVE 419 (454)
T ss_dssp CSSCCSCCCC----CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC----------------------------------
T ss_pred CCCccccccc----hhhhccEEECCCCCCCcCCCChHHHHhhhhccccccccc-ccCcCCEEECCCCcCCccccchhhHh
Confidence 7777776543 3567777777777777766666665421 1111111 12456777777777776 5555555
Q ss_pred CCcccCCCCCC
Q 001152 315 NVSFSGSRHTS 325 (1137)
Q Consensus 315 ~~sf~GN~~lC 325 (1137)
.-.+.+|...|
T Consensus 420 ~L~~~~~~~~~ 430 (454)
T 1jl5_A 420 DLRMNSERVVD 430 (454)
T ss_dssp -----------
T ss_pred heeCcCcccCC
Confidence 55555554444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.7e-26 Score=257.35 Aligned_cols=238 Identities=17% Similarity=0.132 Sum_probs=201.3
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEc
Q 001152 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~L 98 (1137)
+.-+.+..+++.......+..+++|++|||++|+|++..|..|..+ ++|++|+|++|.++.+++ |..+++|++|+|
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~L 87 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPF---TKLELLNLSSNVLYETLD-LESLSTLRTLDL 87 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTC---TTCCEEECTTSCCEEEEE-ETTCTTCCEEEC
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCC---CcCCEEECCCCcCCcchh-hhhcCCCCEEEC
Confidence 4445566777777767777888899999999999999888878655 899999999999997765 999999999999
Q ss_pred cCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcc
Q 001152 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1137)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1137)
++|.|+.+|. +++|+.|++++|.+..++. ..+++|++|++++|.+... .+..+..+++|+.|++++|.++.
T Consensus 88 s~n~l~~l~~----~~~L~~L~l~~n~l~~~~~--~~~~~L~~L~l~~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~ 158 (317)
T 3o53_A 88 NNNYVQELLV----GPSIETLHAANNNISRVSC--SRGQGKKNIYLANNKITML---RDLDEGCRSRVQYLDLKLNEIDT 158 (317)
T ss_dssp CSSEEEEEEE----CTTCCEEECCSSCCSEEEE--CCCSSCEEEECCSSCCCSG---GGBCTGGGSSEEEEECTTSCCCE
T ss_pred cCCccccccC----CCCcCEEECCCCccCCcCc--cccCCCCEEECCCCCCCCc---cchhhhccCCCCEEECCCCCCCc
Confidence 9999987764 3899999999999776653 4578899999999766443 34467788999999999999996
Q ss_pred cC-ccc-cCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCC
Q 001152 179 LP-PEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1137)
Q Consensus 179 IP-~~l-~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L 256 (1137)
++ ..+ ..+++|++|+|++|+|+.+|. ...+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+|+++++ .+..+
T Consensus 159 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l~~-~~~~l 236 (317)
T 3o53_A 159 VNFAELAASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEK-ALRFS 236 (317)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEEEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECT-TCCCC
T ss_pred ccHHHHhhccCcCCEEECCCCcCccccc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccchhh-HhhcC
Confidence 54 455 478999999999999998874 445899999999999999999889999999999999999998754 78999
Q ss_pred CCCCEEEccCCcCCC
Q 001152 257 HNLQNLNLQYNKLLS 271 (1137)
Q Consensus 257 ~~L~~L~Ls~N~L~~ 271 (1137)
++|+.|+|++|++.|
T Consensus 237 ~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 237 QNLEHFDLRGNGFHC 251 (317)
T ss_dssp TTCCEEECTTCCCBH
T ss_pred CCCCEEEccCCCccC
Confidence 999999999999985
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-26 Score=260.85 Aligned_cols=241 Identities=17% Similarity=0.128 Sum_probs=211.2
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcE
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~ 95 (1137)
.+.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++.++ | ..+++|++|+|++|.|+.+|. +++|++
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~---~~l~~L~~L~Ls~n~l~~l~~----~~~L~~ 103 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--L---ESLSTLRTLDLNNNYVQELLV----GPSIET 103 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--E---TTCTTCCEEECCSSEEEEEEE----CTTCCE
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--h---hhcCCCCEEECcCCccccccC----CCCcCE
Confidence 3479999999999999999999999999999999999988665 4 455999999999999998873 389999
Q ss_pred EEccCCCCCcccccccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhh-cCCCCCcEEeccC
Q 001152 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEI-AGLKCLTKLSVCH 173 (1137)
Q Consensus 96 L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l-~~L~~L~~L~Ls~ 173 (1137)
|+|++|.|+.++.. .+++|+.|+|++|.+..++ ..+..+++|++|++++|.+.. ..+..+ ..+++|+.|++++
T Consensus 104 L~l~~n~l~~~~~~--~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~~l~~L~~L~L~~ 178 (317)
T 3o53_A 104 LHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT---VNFAELAASSDTLEHLNLQY 178 (317)
T ss_dssp EECCSSCCSEEEEC--CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE---EEGGGGGGGTTTCCEEECTT
T ss_pred EECCCCccCCcCcc--ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc---ccHHHHhhccCcCCEEECCC
Confidence 99999999987654 4789999999999987765 578899999999999966543 334455 4789999999999
Q ss_pred CCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCC-CCCccc
Q 001152 174 FSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT-SLGSLD 252 (1137)
Q Consensus 174 N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Ls-g~~p~~ 252 (1137)
|.|+.+|.. ..+++|++|+|++|+|+.+|..+..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|.++ +.++..
T Consensus 179 N~l~~~~~~-~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 257 (317)
T 3o53_A 179 NFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (317)
T ss_dssp SCCCEEECC-CCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHHHHHHH
T ss_pred CcCcccccc-cccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCcCHHHH
Confidence 999988654 458999999999999999998999999999999999999999999999999999999999999 777888
Q ss_pred ccCCCCCCEEEccCC-cCCC
Q 001152 253 LCLMHNLQNLNLQYN-KLLS 271 (1137)
Q Consensus 253 l~~L~~L~~L~Ls~N-~L~~ 271 (1137)
+..+++|+.|++++| .+++
T Consensus 258 ~~~~~~L~~l~l~~~~~l~~ 277 (317)
T 3o53_A 258 FSKNQRVQTVAKQTVKKLTG 277 (317)
T ss_dssp HHTCHHHHHHHHHHHHHHHS
T ss_pred HhccccceEEECCCchhccC
Confidence 999999999999954 3444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-26 Score=271.85 Aligned_cols=220 Identities=18% Similarity=0.148 Sum_probs=182.9
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCC
Q 001152 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGL 116 (1137)
Q Consensus 37 f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L 116 (1137)
....++|++|+|++|+|++.+|..|+.+ ++|++|+|++|.|+.+++ |..+++|++|+|++|.|+.+|.. ++|
T Consensus 30 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~~~----~~L 101 (487)
T 3oja_A 30 RQSAWNVKELDLSGNPLSQISAADLAPF---TKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG----PSI 101 (487)
T ss_dssp STTGGGCCEEECCSSCCCCCCGGGGTTC---TTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEEEC----TTC
T ss_pred cccCCCccEEEeeCCcCCCCCHHHHhCC---CCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCCCC----CCc
Confidence 3455589999999999999888777655 899999999999986655 88899999999999999877643 789
Q ss_pred CEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcc-cCcccc-CCCCCCEEEc
Q 001152 117 ECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY-LPPEIG-CLSNLEQLDL 194 (1137)
Q Consensus 117 ~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~-IP~~l~-~L~~L~~L~L 194 (1137)
+.|+|++|.+..++. ..+++|+.|+|++|.+.. ..|..++.+++|+.|+|++|.|+. +|..+. .+++|++|+|
T Consensus 102 ~~L~L~~N~l~~~~~--~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L 176 (487)
T 3oja_A 102 ETLHAANNNISRVSC--SRGQGKKNIYLANNKITM---LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (487)
T ss_dssp CEEECCSSCCCCEEE--CCCSSCEEEECCSSCCCS---GGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CEEECcCCcCCCCCc--cccCCCCEEECCCCCCCC---CCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence 999999998777664 457889999999866543 345567788999999999999985 556665 7899999999
Q ss_pred cCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 195 SFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 195 s~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
++|.|+.+|. +..+++|+.|+|++|.|+.+|+.+..+++|+.|+|++|.|+++++ .+..+++|+.|+|++|++.|
T Consensus 177 s~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp~-~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 177 QYNFIYDVKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEK-ALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp TTSCCCEEEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECT-TCCCCTTCCEEECTTCCBCH
T ss_pred CCCccccccc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccch-hhccCCCCCEEEcCCCCCcC
Confidence 9999998864 446899999999999999998888889999999999999998765 68889999999999999985
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=266.28 Aligned_cols=237 Identities=17% Similarity=0.130 Sum_probs=179.1
Q ss_pred CCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCC
Q 001152 14 PEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKL 93 (1137)
Q Consensus 14 ~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L 93 (1137)
...+.+..|.+..|+|+.+.+.+|.++++|++|+|++|.|++.+| ++.+++|++|+|++|.|+.+|.. ++|
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-----l~~l~~L~~L~Ls~N~l~~l~~~----~~L 101 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-----LESLSTLRTLDLNNNYVQELLVG----PSI 101 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-----CTTCTTCCEEECCSSEEEEEEEC----TTC
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-----cccCCCCCEEEecCCcCCCCCCC----CCc
Confidence 344468888888888888888888888888888888888877655 34558888888888888777643 678
Q ss_pred cEEEccCCCCCcccccccCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhc-CCCCCcEEec
Q 001152 94 RNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIA-GLKCLTKLSV 171 (1137)
Q Consensus 94 ~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~-~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~-~L~~L~~L~L 171 (1137)
++|+|++|.|+.+|.. .+++|+.|+|++|.+... |..+..+++|+.|+|++|.+. +..|..+. .+++|+.|+|
T Consensus 102 ~~L~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~---~~~~~~l~~~l~~L~~L~L 176 (487)
T 3oja_A 102 ETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID---TVNFAELAASSDTLEHLNL 176 (487)
T ss_dssp CEEECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCC---EEEGGGGGGGTTTCCEEEC
T ss_pred CEEECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCC---CcChHHHhhhCCcccEEec
Confidence 8888888888876543 467788888888886655 456777888888888885443 33455654 6788888888
Q ss_pred cCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCC-CCCc
Q 001152 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT-SLGS 250 (1137)
Q Consensus 172 s~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Ls-g~~p 250 (1137)
++|.|+.+|.. ..+++|++|+|++|+|+.+|+.++.+++|+.|+|++|.|+.||..+..+++|+.|+|++|.++ +.+|
T Consensus 177 s~N~l~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~~ 255 (487)
T 3oja_A 177 QYNFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLR 255 (487)
T ss_dssp TTSCCCEEECC-CCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred CCCcccccccc-ccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcchH
Confidence 88888877553 457888888888888888877788888888888888888888888888888888888888887 5555
Q ss_pred ccccCCCCCCEEEcc
Q 001152 251 LDLCLMHNLQNLNLQ 265 (1137)
Q Consensus 251 ~~l~~L~~L~~L~Ls 265 (1137)
..+..++.|+.|+++
T Consensus 256 ~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 256 DFFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHHTTCHHHHHHHHH
T ss_pred HHHHhCCCCcEEecc
Confidence 667777777766665
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-25 Score=242.84 Aligned_cols=248 Identities=20% Similarity=0.190 Sum_probs=205.4
Q ss_pred ccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCcEEEc
Q 001152 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKF 98 (1137)
Q Consensus 20 ~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~~L~L 98 (1137)
..+....+.++.++... .++|++|+|++|+|++..+..|..+ ++|++|+|++|.++.+ |..|.++++|++|+|
T Consensus 14 ~~~~c~~~~l~~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 87 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGI---PAASQRIFLHGNRISHVPAASFRAC---RNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87 (285)
T ss_dssp CEEECCSSCCSSCCTTC---CTTCSEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred eEEEcCcCCcccCCcCC---CCCceEEEeeCCcCCccCHHHcccC---CCCCEEECCCCccceeCHhhcCCccCCCEEeC
Confidence 45777888888886533 4689999999999999887767555 9999999999999987 678999999999999
Q ss_pred cCCC-CCcc-cccccCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCC
Q 001152 99 FGNE-INLF-PSEVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1137)
Q Consensus 99 s~N~-L~~l-P~~l~~L~~L~~L~Ls~N~~~~~-~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1137)
++|. ++.+ |..|.++++|++|+|++|.+..+ +..+..+++|++|++++|.+... .+..+..+++|+.|++++|+
T Consensus 88 ~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~~~~l~~L~~L~l~~n~ 164 (285)
T 1ozn_A 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL---PDDTFRDLGNLTHLFLHGNR 164 (285)
T ss_dssp CSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC---CTTTTTTCTTCCEEECCSSC
T ss_pred CCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccccc---CHhHhccCCCccEEECCCCc
Confidence 9997 8877 67799999999999999997766 56789999999999999765432 23457889999999999999
Q ss_pred CcccCc-cccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCccc
Q 001152 176 IRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLD 252 (1137)
Q Consensus 176 L~~IP~-~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~~ 252 (1137)
|+.+|. .|..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|.++...+..
T Consensus 165 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~ 244 (285)
T 1ozn_A 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (285)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH
Confidence 998887 589999999999999999966 78899999999999999999988754 888999999999999998654421
Q ss_pred ccCCCCCCEEEccCCcCCCCCCCCcch
Q 001152 253 LCLMHNLQNLNLQYNKLLSYCQVPSWI 279 (1137)
Q Consensus 253 l~~L~~L~~L~Ls~N~L~~~~~iP~~~ 279 (1137)
..+..|+.+..+.|.+.| ..|..+
T Consensus 245 -~~~~~l~~~~~~~~~~~c--~~p~~l 268 (285)
T 1ozn_A 245 -PLWAWLQKFRGSSSEVPC--SLPQRL 268 (285)
T ss_dssp -HHHHHHHHCCSEECCCBE--EESGGG
T ss_pred -HHHHHHHhcccccCcccc--CCchHh
Confidence 112334555567777765 455543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-24 Score=253.38 Aligned_cols=224 Identities=21% Similarity=0.264 Sum_probs=199.9
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCc
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLR 94 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~ 94 (1137)
++.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..+..|..+ ++|++|+|++|+|+.+|. .|..+++|+
T Consensus 63 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 139 (440)
T 3zyj_A 63 STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGL---ANLNTLELFDNRLTTIPNGAFVYLSKLK 139 (440)
T ss_dssp CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTC---SSCCEEECCSSCCSSCCTTTSCSCSSCC
T ss_pred CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCC---ccCCEEECCCCcCCeeCHhHhhccccCc
Confidence 3578999999999999999999999999999999999999888877655 999999999999999986 699999999
Q ss_pred EEEccCCCCCcccc-cccCCCCCCEEEccCCC-CCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEec
Q 001152 95 NLKFFGNEINLFPS-EVGNLLGLECLQIKISS-PGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1137)
Q Consensus 95 ~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~-~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~L 171 (1137)
+|+|++|.|+.+|. .|.++++|+.|+|++|+ +..++ ..|.++++|++|+|++|.+. .+| .+..+++|+.|+|
T Consensus 140 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~----~~~-~~~~l~~L~~L~L 214 (440)
T 3zyj_A 140 ELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR----EIP-NLTPLIKLDELDL 214 (440)
T ss_dssp EEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS----SCC-CCTTCSSCCEEEC
T ss_pred eeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc----ccc-ccCCCcccCEEEC
Confidence 99999999998866 58999999999999854 66555 47899999999999997665 344 4788999999999
Q ss_pred cCCCCccc-CccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCC
Q 001152 172 CHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTS 247 (1137)
Q Consensus 172 s~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg 247 (1137)
++|.|+.+ |..|..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|.+..
T Consensus 215 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 99999976 66899999999999999999966 56789999999999999999988765 5679999999999998863
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-24 Score=253.94 Aligned_cols=224 Identities=21% Similarity=0.235 Sum_probs=199.5
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCCCCc
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLR 94 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~-~~~L~~L~ 94 (1137)
++.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..+..|..+ ++|++|+|++|.|+.+|.. |.++++|+
T Consensus 74 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 150 (452)
T 3zyi_A 74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGL---ASLNTLELFDNWLTVIPSGAFEYLSKLR 150 (452)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC---TTCCEEECCSSCCSBCCTTTSSSCTTCC
T ss_pred CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCc---ccCCEEECCCCcCCccChhhhcccCCCC
Confidence 3579999999999999999999999999999999999999888777554 9999999999999999764 89999999
Q ss_pred EEEccCCCCCcccc-cccCCCCCCEEEccCC-CCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEec
Q 001152 95 NLKFFGNEINLFPS-EVGNLLGLECLQIKIS-SPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1137)
Q Consensus 95 ~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N-~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~L 171 (1137)
+|+|++|.|+.+|. .|.++++|+.|+|++| .++.++ ..|.++++|++|+|++|.+.. +| .+..+++|+.|+|
T Consensus 151 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~----~~-~~~~l~~L~~L~L 225 (452)
T 3zyi_A 151 ELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD----MP-NLTPLVGLEELEM 225 (452)
T ss_dssp EEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS----CC-CCTTCTTCCEEEC
T ss_pred EEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc----cc-cccccccccEEEC
Confidence 99999999998876 5899999999999984 466666 468999999999999977654 33 5788999999999
Q ss_pred cCCCCccc-CccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCC
Q 001152 172 CHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTS 247 (1137)
Q Consensus 172 s~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg 247 (1137)
++|.|+.+ |..|..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|.+..
T Consensus 226 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp TTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred cCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 99999976 56899999999999999999966 67789999999999999999988765 5679999999999998764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=251.52 Aligned_cols=225 Identities=19% Similarity=0.114 Sum_probs=190.3
Q ss_pred cccccCCCCCCcccCCCC-CC-------CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCC
Q 001152 19 KEKLPSEANKINNEKNGS-VN-------DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRY 90 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~-f~-------~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L 90 (1137)
++.|.+..|+|+.+.... +. ++++|++|+|++|+|++.+|..+. ++.+++|++|+|++|+|+.+|..+..+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL-EATGPDLNILNLRNVSWATRDAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS-SCCSCCCSEEEEESCBCSSSSSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH-HhcCCCccEEEccCCCCcchhHHHHHH
Confidence 788899999997654333 22 689999999999999998887541 245699999999999999889888877
Q ss_pred -----CCCcEEEccCCCCCccc-ccccCCCCCCEEEccCCCCCC---Cccc--ccCCCCCCEEECCCCCCCCCcccch-h
Q 001152 91 -----EKLRNLKFFGNEINLFP-SEVGNLLGLECLQIKISSPGV---NGFA--LNKLKGLKELELSKVPPRPSVLTLL-S 158 (1137)
Q Consensus 91 -----~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~~~~---~~~~--~~~L~~L~~L~Ls~n~ln~~~~~lp-~ 158 (1137)
++|++|+|++|+|+.+| ..|+++++|++|+|++|.+.. .+.. +..+++|++|+|++|.+.... .++ .
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~ 222 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS-GVCSA 222 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHH-HHHHH
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchH-HHHHH
Confidence 89999999999999776 779999999999999998543 1223 389999999999998775332 333 3
Q ss_pred hhcCCCCCcEEeccCCCCcccC--ccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCC
Q 001152 159 EIAGLKCLTKLSVCHFSIRYLP--PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLE 236 (1137)
Q Consensus 159 ~l~~L~~L~~L~Ls~N~L~~IP--~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~ 236 (1137)
.+..+++|+.|++++|+|+.++ ..+..+++|++|+|++|+|+.+|..+. ++|+.|+|++|+|+.+|. +..+++|+
T Consensus 223 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L~~L~Ls~N~l~~~p~-~~~l~~L~ 299 (312)
T 1wwl_A 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDRNPS-PDELPQVG 299 (312)
T ss_dssp HHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC--SEEEEEECCSSCCCSCCC-TTTSCEEE
T ss_pred HHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc--CCceEEECCCCCCCCChh-HhhCCCCC
Confidence 4468899999999999999654 356778999999999999999998887 899999999999999987 88999999
Q ss_pred EEeccCCcCCCC
Q 001152 237 NLDLSNNRLTSL 248 (1137)
Q Consensus 237 ~LdLS~N~Lsg~ 248 (1137)
.|+|++|+|++.
T Consensus 300 ~L~L~~N~l~~~ 311 (312)
T 1wwl_A 300 NLSLKGNPFLDS 311 (312)
T ss_dssp EEECTTCTTTCC
T ss_pred EEeccCCCCCCC
Confidence 999999999874
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=252.93 Aligned_cols=224 Identities=20% Similarity=0.217 Sum_probs=190.0
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEccCCCCCcc-cccccCCCC
Q 001152 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLF-PSEVGNLLG 115 (1137)
Q Consensus 38 ~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~ 115 (1137)
...+...+.|+++|+++.++...+ ++|++|+|++|.++.+|. .|.++++|++|+|++|.|+.+ |..|.++++
T Consensus 28 ~~C~~~~~c~~~~~~l~~iP~~~~------~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 101 (353)
T 2z80_A 28 LSCDRNGICKGSSGSLNSIPSGLT------EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101 (353)
T ss_dssp CEECTTSEEECCSTTCSSCCTTCC------TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred CCCCCCeEeeCCCCCccccccccc------ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCC
Confidence 344566679999999997654322 589999999999999976 799999999999999999977 556999999
Q ss_pred CCEEEccCCCCCCCccc-ccCCCCCCEEECCCCCCCCCcccchh--hhcCCCCCcEEeccCC-CCcccC-ccccCCCCCC
Q 001152 116 LECLQIKISSPGVNGFA-LNKLKGLKELELSKVPPRPSVLTLLS--EIAGLKCLTKLSVCHF-SIRYLP-PEIGCLSNLE 190 (1137)
Q Consensus 116 L~~L~Ls~N~~~~~~~~-~~~L~~L~~L~Ls~n~ln~~~~~lp~--~l~~L~~L~~L~Ls~N-~L~~IP-~~l~~L~~L~ 190 (1137)
|++|+|++|.+..++.. +.++++|++|++++|.+. .+|. .+..+++|+.|++++| .++.++ ..|..+++|+
T Consensus 102 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~----~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~ 177 (353)
T 2z80_A 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK----TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE 177 (353)
T ss_dssp CCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS----SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEE
T ss_pred CCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc----ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCC
Confidence 99999999998887755 899999999999997654 4454 6788999999999999 578775 5789999999
Q ss_pred EEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCcccc-CCCCCCEEeccCCcCCCCCcc-----------------
Q 001152 191 QLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLY-LLQRLENLDLSNNRLTSLGSL----------------- 251 (1137)
Q Consensus 191 ~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~~l~-~L~~L~~LdLS~N~Lsg~~p~----------------- 251 (1137)
+|+|++|+++.+ |..+..+++|+.|+|++|+++.+|..+. .+++|+.|+|++|++++.++.
T Consensus 178 ~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~ 257 (353)
T 2z80_A 178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR 257 (353)
T ss_dssp EEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEE
T ss_pred EEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccc
Confidence 999999999965 8899999999999999999999987654 489999999999999986533
Q ss_pred --------------cccCCCCCCEEEccCCcCCC
Q 001152 252 --------------DLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 252 --------------~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
.+..+++|+.|+|++|+|+.
T Consensus 258 ~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~ 291 (353)
T 2z80_A 258 NVKITDESLFQVMKLLNQISGLLELEFSRNQLKS 291 (353)
T ss_dssp SCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC
T ss_pred cccccCcchhhhHHHHhcccCCCEEECCCCCCCc
Confidence 35567777777777777764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-23 Score=257.28 Aligned_cols=147 Identities=18% Similarity=0.132 Sum_probs=121.5
Q ss_pred CCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEccCCC
Q 001152 24 SEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNE 102 (1137)
Q Consensus 24 ~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~ 102 (1137)
-...+++.++.+ + -+++++|||++|+|+++.+..|..+ ++|++|+|++|+|+.||+ .|.+|++|++|+|++|+
T Consensus 38 c~~~~l~~vP~~-l--p~~~~~LdLs~N~i~~l~~~~f~~l---~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 38 CMELNFYKIPDN-L--PFSTKNLDLSFNPLRHLGSYSFFSF---PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp CTTSCCSSCCSS-S--CTTCCEEECTTSCCCEECTTTTTTC---TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CCCCCcCccCCC-C--CcCCCEEEeeCCCCCCCCHHHHhCC---CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 345567777642 1 1479999999999999888777655 999999999999999975 69999999999999999
Q ss_pred CCcccc-cccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcc
Q 001152 103 INLFPS-EVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1137)
Q Consensus 103 L~~lP~-~l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1137)
|+.+|. .|.+|++|++|+|++|.+..++ ..|.+|++|++|+|++|.+... .+|..++.+++|++|++++|+|+.
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~--~~~~~~~~l~~L~~L~L~~N~l~~ 187 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF--KLPEYFSNLTNLEHLDLSSNKIQS 187 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC--CCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccC--CCchhhccchhhhhhcccCccccc
Confidence 999976 5899999999999999988776 4699999999999999766432 346667778888888888777653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=236.15 Aligned_cols=204 Identities=25% Similarity=0.258 Sum_probs=146.1
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEccCCCCCccc-ccccCCCCCCEE
Q 001152 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECL 119 (1137)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L 119 (1137)
+|++|+|++|+|++..+..|..+ ++|++|+|++|.++.+|. .|.++++|++|+|++|.|+.++ ..|.++++|+.|
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSF---PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTC---TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred CccEEECCCCcccccCHhHhccc---cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEE
Confidence 45556666665555544433332 555566665555555543 4555555556666555555443 335555555555
Q ss_pred EccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcc--cCccccCCCCCCEEEccCC
Q 001152 120 QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY--LPPEIGCLSNLEQLDLSFN 197 (1137)
Q Consensus 120 ~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~--IP~~l~~L~~L~~L~Ls~N 197 (1137)
++++|.+..++ +..+..+++|++|++++|.++. +|..+..+++|++|+|++|
T Consensus 106 ~l~~n~l~~~~--------------------------~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N 159 (276)
T 2z62_A 106 VAVETNLASLE--------------------------NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159 (276)
T ss_dssp ECTTSCCCCST--------------------------TCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred ECCCCCccccC--------------------------chhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCC
Confidence 55544432221 1236677888899999998885 6888999999999999999
Q ss_pred CCCccc-hhhcCCCCCC----EEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCC
Q 001152 198 KMKYLP-TEICYLKALI----SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272 (1137)
Q Consensus 198 ~L~~LP-~~l~~L~~L~----~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1137)
+|+.+| ..+..+++|+ .|+|++|.++.+|.......+|+.|+|++|+|+++++..|..+++|+.|+|++|+|+|.
T Consensus 160 ~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp CCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred CCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 999775 4566666665 89999999999988888777999999999999999987889999999999999999997
Q ss_pred CC
Q 001152 273 CQ 274 (1137)
Q Consensus 273 ~~ 274 (1137)
|+
T Consensus 240 c~ 241 (276)
T 2z62_A 240 CP 241 (276)
T ss_dssp TT
T ss_pred CC
Confidence 75
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=257.53 Aligned_cols=266 Identities=18% Similarity=0.142 Sum_probs=178.8
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCC----------CCccEEEeecCCCCccCccc
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGD----------NSVEGLYLYKNVLNLIPKSV 87 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L----------~~L~~L~Ls~N~L~~IP~~~ 87 (1137)
.++.|.+..|+|..+ |.+|.++++|++|+|++|+++|.+|..++.+..+ .+|++|+|++|.++.+|..
T Consensus 12 ~L~~L~l~~n~l~~i-P~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~- 89 (454)
T 1jl5_A 12 FLQEPLRHSSNLTEM-PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL- 89 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC-
T ss_pred cchhhhcccCchhhC-ChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC-
Confidence 577888889999655 5678999999999999999988888877655211 1248888988888888763
Q ss_pred cCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCc
Q 001152 88 GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT 167 (1137)
Q Consensus 88 ~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~ 167 (1137)
.++|++|+|++|.++.+|.. +++|+.|++++|.+..++..+ ++|++|++++|.+. .+| .++++++|+
T Consensus 90 --~~~L~~L~l~~n~l~~lp~~---~~~L~~L~l~~n~l~~l~~~~---~~L~~L~L~~n~l~----~lp-~~~~l~~L~ 156 (454)
T 1jl5_A 90 --PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSDLP---PLLEYLGVSNNQLE----KLP-ELQNSSFLK 156 (454)
T ss_dssp --CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCSCC---TTCCEEECCSSCCS----SCC-CCTTCTTCC
T ss_pred --cCCCCEEEccCCcCCccccc---cCCCcEEECCCCccCcccCCC---CCCCEEECcCCCCC----CCc-ccCCCCCCC
Confidence 35788888888888888864 367888888888876655332 67888888886554 255 478888888
Q ss_pred EEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCC
Q 001152 168 KLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247 (1137)
Q Consensus 168 ~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg 247 (1137)
+|++++|+++.+|..+ .+|++|+|++|+++.+| .++++++|+.|+|++|+++.+|... ++|+.|+|++|+++.
T Consensus 157 ~L~l~~N~l~~lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~n~l~~ 229 (454)
T 1jl5_A 157 IIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKKLPDLP---LSLESIVAGNNILEE 229 (454)
T ss_dssp EEECCSSCCSCCCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSSCCCCC---TTCCEEECCSSCCSS
T ss_pred EEECCCCcCcccCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECCCCcCCcCCCCc---CcccEEECcCCcCCc
Confidence 8888888888887643 47888888888888887 6888888888888888888777543 478888888888886
Q ss_pred CCcccccCCCCCCEEEccCCcCCCCCCCCcc-hhhccCCCCCCCC---CCCcccccccccccCC
Q 001152 248 LGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW-ICCNLEGNGKDSS---NDDFISSSAEMDVYEG 307 (1137)
Q Consensus 248 ~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~-~~~~l~~n~l~~~---~~~l~~~~~s~n~l~g 307 (1137)
++ .+..+++|+.|++++|++++++..+.. ..+++++|.+..- ...+...++++|.+.+
T Consensus 230 lp--~~~~l~~L~~L~l~~N~l~~l~~~~~~L~~L~l~~N~l~~l~~~~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 230 LP--ELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSG 291 (454)
T ss_dssp CC--CCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSE
T ss_pred cc--ccCCCCCCCEEECCCCcCCcccccccccCEEECCCCcccccCcccCcCCEEECcCCccCc
Confidence 54 377888888888888888875544332 2355666655442 2345556666666665
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-23 Score=236.32 Aligned_cols=210 Identities=25% Similarity=0.263 Sum_probs=151.9
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCcEEEccCCCCCcccccccCCCC
Q 001152 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKFFGNEINLFPSEVGNLLG 115 (1137)
Q Consensus 37 f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~ 115 (1137)
+.++++++.|++++|+|+..++..+ ++|+.|+|++|.|+.+ |..|.++++|++|+|++|.|+.+|.. +.+++
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~~------~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~ 78 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPV 78 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC------TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTT
T ss_pred ccccCCccEEECCCCCCCcCCCCCC------CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCc
Confidence 4455566666666666654433211 3556666666666654 33456666666666666666655443 44455
Q ss_pred CCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEc
Q 001152 116 LECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDL 194 (1137)
Q Consensus 116 L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~L 194 (1137)
|+.|+|++|.+. .+|..+..+++|+.|++++|+|+.+|. .|..+++|++|+|
T Consensus 79 L~~L~Ls~N~l~---------------------------~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 79 LGTLDLSHNQLQ---------------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (290)
T ss_dssp CCEEECCSSCCS---------------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred CCEEECCCCcCC---------------------------cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence 555555444432 344556678888999999999998875 6899999999999
Q ss_pred cCCCCCccchh-hcCCCCCCEEEccCCCCCccCccc-cCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCC
Q 001152 195 SFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGL-YLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272 (1137)
Q Consensus 195 s~N~L~~LP~~-l~~L~~L~~L~Ls~N~Ls~IP~~l-~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1137)
++|+|+.+|.. |..+++|+.|+|++|+|+.+|..+ ..+++|+.|+|++|+|+.+++ .+..+.+|+.|+|++|+|.|.
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~-~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPK-GFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCCCSEEECCSCCBCCS
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccCh-hhcccccCCeEEeCCCCccCc
Confidence 99999988755 578999999999999999998765 569999999999999998765 677888999999999999998
Q ss_pred CCCCcchhh
Q 001152 273 CQVPSWICC 281 (1137)
Q Consensus 273 ~~iP~~~~~ 281 (1137)
|.+.....|
T Consensus 211 c~~~~l~~w 219 (290)
T 1p9a_G 211 CEILYFRRW 219 (290)
T ss_dssp GGGHHHHHH
T ss_pred CccHHHHHH
Confidence 876544333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-23 Score=256.39 Aligned_cols=239 Identities=24% Similarity=0.201 Sum_probs=151.8
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~ 97 (1137)
.+..|.+..|+|+.++. .+++|++|||++|+|+++.+ .+++|++|+|++|.|+.+|. .+++|+.|+
T Consensus 62 ~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~lp~-------~l~~L~~L~Ls~N~l~~l~~---~l~~L~~L~ 127 (622)
T 3g06_A 62 HITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSLPV-------LPPGLLELSIFSNPLTHLPA---LPSGLCKLW 127 (622)
T ss_dssp TCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSCCCC-------CCTTCCEEEECSCCCCCCCC---CCTTCCEEE
T ss_pred CCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCcCCC-------CCCCCCEEECcCCcCCCCCC---CCCCcCEEE
Confidence 45555555666555544 34556666666666554322 22555666666666665554 344566666
Q ss_pred ccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCc
Q 001152 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1137)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1137)
|++|+|+.+|.. +++|++|+|++|.+..+|. .+.+|+.|++++|.+.. +| ..+++|+.|++++|.|+
T Consensus 128 L~~N~l~~lp~~---l~~L~~L~Ls~N~l~~l~~---~~~~L~~L~L~~N~l~~----l~---~~~~~L~~L~Ls~N~l~ 194 (622)
T 3g06_A 128 IFGNQLTSLPVL---PPGLQELSVSDNQLASLPA---LPSELCKLWAYNNQLTS----LP---MLPSGLQELSVSDNQLA 194 (622)
T ss_dssp CCSSCCSCCCCC---CTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC----CC---CCCTTCCEEECCSSCCS
T ss_pred CCCCCCCcCCCC---CCCCCEEECcCCcCCCcCC---ccCCCCEEECCCCCCCC----Cc---ccCCCCcEEECCCCCCC
Confidence 666666655543 2556666666666554443 23455556665544432 23 23477888888888888
Q ss_pred ccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCC
Q 001152 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMH 257 (1137)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~ 257 (1137)
.+|.. +++|+.|+|++|.|+.+|.. +++|+.|+|++|+|+.|| ..+++|+.|+|++|+|+.+++ .++
T Consensus 195 ~l~~~---~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~~lp~----~~~ 261 (622)
T 3g06_A 195 SLPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLTSLPM----LPS 261 (622)
T ss_dssp CCCCC---CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC----CCT
T ss_pred CCCCc---cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCCcCCc----ccc
Confidence 77763 46788888888888877743 477889999999988888 446788999999999987765 568
Q ss_pred CCCEEEccCCcCCCCCCCCcchhhccCCCCCCCCCCCcccccccccccCCCc
Q 001152 258 NLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPM 309 (1137)
Q Consensus 258 ~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~l~~~~~s~n~l~g~i 309 (1137)
+|+.|+|++|+|+. ||..+.. .+.+...++++|.+.+.+
T Consensus 262 ~L~~L~Ls~N~L~~---lp~~l~~----------l~~L~~L~L~~N~l~~~~ 300 (622)
T 3g06_A 262 GLLSLSVYRNQLTR---LPESLIH----------LSSETTVNLEGNPLSERT 300 (622)
T ss_dssp TCCEEECCSSCCCS---CCGGGGG----------SCTTCEEECCSCCCCHHH
T ss_pred cCcEEeCCCCCCCc---CCHHHhh----------ccccCEEEecCCCCCCcC
Confidence 89999999998874 5655442 233445555555555544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-23 Score=228.08 Aligned_cols=201 Identities=26% Similarity=0.362 Sum_probs=153.3
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEccCCCCCccccc-ccCCCCCCEE
Q 001152 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECL 119 (1137)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L 119 (1137)
+++++++++|+|+.++ ..+. ++|+.|+|++|.|+.+|. .|.++++|++|+|++|.|+.+|.. |.++++|++|
T Consensus 17 ~~~~l~~~~~~l~~ip-~~~~-----~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L 90 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIP-SNIP-----ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETL 90 (270)
T ss_dssp TTTEEECTTSCCSSCC-SCCC-----TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEE
T ss_pred CCCEEEccCCCCCccC-CCCC-----CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEE
Confidence 4566777777666533 2121 456667777776666654 566666677777777666666554 3556666666
Q ss_pred EccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCC
Q 001152 120 QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNK 198 (1137)
Q Consensus 120 ~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~ 198 (1137)
+|++|.+..++ +..+..+++|+.|++++|+++.+|. .|..+++|++|+|++|+
T Consensus 91 ~l~~n~l~~~~--------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 91 WVTDNKLQALP--------------------------IGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp ECCSSCCCCCC--------------------------TTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCcCC--------------------------HhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCc
Confidence 66555433222 2345678889999999999997766 57899999999999999
Q ss_pred CCccchh-hcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001152 199 MKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1137)
Q Consensus 199 L~~LP~~-l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1137)
|+.+|.. |..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|.|.|.
T Consensus 145 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 145 LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred CCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 9988865 78899999999999999988765 7789999999999999999998889999999999999999999876
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=264.30 Aligned_cols=201 Identities=18% Similarity=0.176 Sum_probs=144.7
Q ss_pred eEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCCC
Q 001152 805 SSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 805 ~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~~ 884 (1137)
...+.||+|+||.||+|.+.+..+++|....+.........+....++.+|++++++++||||+++..++...+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~------ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD------ 412 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT------
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC------
Confidence 44578999999999999988899999986544333222223333456799999999999999995555544433
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccccccC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKA 964 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~~ 964 (1137)
+.||||||++|++|.++++. +..|+.||+.||+|||++||+||||||+|||++.
T Consensus 413 --------~~~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----- 466 (540)
T 3en9_A 413 --------NKRIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----- 466 (540)
T ss_dssp --------TTEEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----
T ss_pred --------ccEEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----
Confidence 34999999999999998853 5689999999999999999999999999999984
Q ss_pred CCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 001152 965 DGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP 1044 (1137)
Q Consensus 965 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~P 1044 (1137)
.+||+|||+++............. .......||+.|||||++.+.. ..|+..+|+|+..+-..+.+.++.+
T Consensus 467 ----~~kL~DFGla~~~~~~~~~~~~~~---~~~~~~~GT~~y~APEv~~~~~--~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 467 ----DLYIIDFGLGKISNLDEDKAVDLI---VFKKAVLSTHHEKFDEIWERFL--EGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp ----SEEECCCTTCEECCCHHHHHHHHH---HHHHHHHHHCGGGHHHHHHHHH--HHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred ----eEEEEECccCEECCCccccccchh---hhhhhhcCCCCcCCHHHHHHHH--HHHHHHHhHHHHHHHHHHHHHhccc
Confidence 499999999987654221100000 0011357999999999997522 3467889999999888887777766
Q ss_pred CC
Q 001152 1045 YM 1046 (1137)
Q Consensus 1045 f~ 1046 (1137)
|.
T Consensus 538 Y~ 539 (540)
T 3en9_A 538 YV 539 (540)
T ss_dssp CC
T ss_pred cC
Confidence 63
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-23 Score=225.92 Aligned_cols=206 Identities=18% Similarity=0.188 Sum_probs=168.6
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCCCCc
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLR 94 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP-~~~~~L~~L~ 94 (1137)
++.++.|.+..|+|+.+.+..|.++++|++|+|++|+|++..+..|..+ ++|++|+|++|.++.++ ..|.++++|+
T Consensus 27 ~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (276)
T 2z62_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL---SHLSTLILTGNPIQSLALGAFSGLSSLQ 103 (276)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTC---TTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCC---cCCCEEECCCCccCccChhhhcCCcccc
Confidence 3579999999999999999999999999999999999998887766544 99999999999999876 5799999999
Q ss_pred EEEccCCCCCcccc-cccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccC
Q 001152 95 NLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH 173 (1137)
Q Consensus 95 ~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~ 173 (1137)
+|+|++|.++.++. .++++++|+.|+|++|.+... .+|..+..+++|+.|++++
T Consensus 104 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-------------------------~l~~~~~~l~~L~~L~Ls~ 158 (276)
T 2z62_A 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF-------------------------KLPEYFSNLTNLEHLDLSS 158 (276)
T ss_dssp EEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC-------------------------CCCGGGGGCTTCCEEECCS
T ss_pred EEECCCCCccccCchhcccCCCCCEEECcCCcccee-------------------------cCchhhccCCCCCEEECCC
Confidence 99999999998865 588888888888887775431 1344566667777777777
Q ss_pred CCCcccCc-cccCCCCCC----EEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCC
Q 001152 174 FSIRYLPP-EIGCLSNLE----QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTS 247 (1137)
Q Consensus 174 N~L~~IP~-~l~~L~~L~----~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg 247 (1137)
|+++.+|. .+..+.+|+ .|+|++|+|+.+|..+....+|+.|+|++|+|+.+|.. +..+++|+.|+|++|.+++
T Consensus 159 N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp SCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred CCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 77776653 455555555 78899999988887776767899999999999988766 4678999999999998886
Q ss_pred CC
Q 001152 248 LG 249 (1137)
Q Consensus 248 ~~ 249 (1137)
..
T Consensus 239 ~c 240 (276)
T 2z62_A 239 SC 240 (276)
T ss_dssp CT
T ss_pred cC
Confidence 43
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-22 Score=228.00 Aligned_cols=197 Identities=19% Similarity=0.225 Sum_probs=168.4
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~ 97 (1137)
.+..+.+..|+|+.++...+ +++++|+|++|+|++..+..|..+ ++|+.|+|++|.|+.+|.. ..+++|++|+
T Consensus 11 ~l~~l~~~~~~l~~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~-~~l~~L~~L~ 83 (290)
T 1p9a_G 11 SHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPY---TRLTQLNLDRAELTKLQVD-GTLPVLGTLD 83 (290)
T ss_dssp TCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSEEEGGGGTTC---TTCCEEECTTSCCCEEECC-SCCTTCCEEE
T ss_pred CccEEECCCCCCCcCCCCCC---CCCCEEEcCCCcCCccCHHHhhcC---CCCCEEECCCCccCcccCC-CCCCcCCEEE
Confidence 68889999999999986654 689999999999999888877655 9999999999999998765 8899999999
Q ss_pred ccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCc
Q 001152 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1137)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1137)
|++|+|+.+|..+..+++|++|+|++|.+..++ |..|.++++|++|+|++|+|+
T Consensus 84 Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~--------------------------~~~~~~l~~L~~L~L~~N~l~ 137 (290)
T 1p9a_G 84 LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP--------------------------LGALRGLGELQELYLKGNELK 137 (290)
T ss_dssp CCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCC--------------------------SSTTTTCTTCCEEECTTSCCC
T ss_pred CCCCcCCcCchhhccCCCCCEEECCCCcCcccC--------------------------HHHHcCCCCCCEEECCCCCCC
Confidence 999999999998999999999999888765443 234566777888888888888
Q ss_pred ccCc-cccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCC
Q 001152 178 YLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247 (1137)
Q Consensus 178 ~IP~-~l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg 247 (1137)
.+|. .|..+++|+.|+|++|+|+.+|.. |..+++|+.|+|++|+|+.||..++.+.+|+.|+|++|.+..
T Consensus 138 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccC
Confidence 7776 457888999999999999988865 467899999999999999999998888899999999998874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=9.5e-23 Score=230.31 Aligned_cols=195 Identities=22% Similarity=0.286 Sum_probs=123.3
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCC
Q 001152 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGL 116 (1137)
Q Consensus 37 f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L 116 (1137)
+.++++|++|+|++|+++.. + .+. .+++|++|+|++|.++.+|. +..+++|++|+|++|.|+.+| .+.++++|
T Consensus 37 ~~~l~~L~~L~l~~~~i~~l-~-~~~---~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~-~~~~l~~L 109 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTTI-E-GVQ---YLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS-AIAGLQSI 109 (308)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGG---GCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG-GGTTCTTC
T ss_pred HHHcCCcCEEEeeCCCccCc-h-hhh---ccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCch-hhcCCCCC
Confidence 34455666666666666543 2 122 23566666666666665555 666666666666666666554 35555555
Q ss_pred CEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccC
Q 001152 117 ECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSF 196 (1137)
Q Consensus 117 ~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~ 196 (1137)
+.|+|++|.+..++ .+..+++|+.|++++|.++.+|. +..+++|++|+|++
T Consensus 110 ~~L~l~~n~l~~~~----------------------------~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~ 160 (308)
T 1h6u_A 110 KTLDLTSTQITDVT----------------------------PLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGN 160 (308)
T ss_dssp CEEECTTSCCCCCG----------------------------GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCS
T ss_pred CEEECCCCCCCCch----------------------------hhcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccC
Confidence 55555555433322 25566667777777777766655 66677777777777
Q ss_pred CCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 197 NKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 197 N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
|+|+.+|. +..+++|+.|+|++|+++.+|. +..+++|+.|+|++|+|+++++ +..+++|+.|+|++|+|++
T Consensus 161 n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 161 AQVSDLTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp SCCCCCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CcCCCChh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 77776665 6677777777777777776664 6667777777777777777653 6677777777777777765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=6.3e-23 Score=231.40 Aligned_cols=228 Identities=19% Similarity=0.123 Sum_probs=181.2
Q ss_pred CCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCccc--cCCCCCcEEEccCCCCCc-cc----cccc
Q 001152 40 DDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPKSV--GRYEKLRNLKFFGNEINL-FP----SEVG 111 (1137)
Q Consensus 40 l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~-~IP~~~--~~L~~L~~L~Ls~N~L~~-lP----~~l~ 111 (1137)
...++.|++.++.++...-..+..+..+++|++|+|++|.++ .+|..+ ..+++|++|+|++|.|+. +| ..+.
T Consensus 63 ~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~ 142 (310)
T 4glp_A 63 ALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW 142 (310)
T ss_dssp SCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred hcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence 335788899888875321111111122367999999999998 557777 899999999999999984 33 3456
Q ss_pred CCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccc-hhhhcCCCCCcEEeccCCCCcccCcc----ccC
Q 001152 112 NLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTL-LSEIAGLKCLTKLSVCHFSIRYLPPE----IGC 185 (1137)
Q Consensus 112 ~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~l-p~~l~~L~~L~~L~Ls~N~L~~IP~~----l~~ 185 (1137)
.+++|++|+|++|.+...+ ..+..+++|++|+|++|.+....+.. +..+..+++|++|++++|+|+.+|.. ++.
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~ 222 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAA 222 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHH
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhc
Confidence 7999999999999976655 67889999999999997653221111 12236889999999999999877663 578
Q ss_pred CCCCCEEEccCCCCCcc-chhhcCC---CCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCE
Q 001152 186 LSNLEQLDLSFNKMKYL-PTEICYL---KALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQN 261 (1137)
Q Consensus 186 L~~L~~L~Ls~N~L~~L-P~~l~~L---~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~ 261 (1137)
+++|++|+|++|+|+.+ |..++.+ ++|++|+|++|+|+.||..+. ++|+.|+|++|+|++++. +..+++|+.
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~~~--~~~l~~L~~ 298 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRAPQ--PDELPEVDN 298 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSCCC--TTSCCCCSC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCCch--hhhCCCccE
Confidence 89999999999999966 8888776 699999999999999999886 899999999999999843 788999999
Q ss_pred EEccCCcCCC
Q 001152 262 LNLQYNKLLS 271 (1137)
Q Consensus 262 L~Ls~N~L~~ 271 (1137)
|+|++|+|+.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999875
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-22 Score=246.91 Aligned_cols=226 Identities=22% Similarity=0.179 Sum_probs=196.1
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcE
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~ 95 (1137)
.+.++.|.+..|+|+.++. .+++|++|+|++|+|++..+ .+++|+.|+|++|+|+.||.. +++|++
T Consensus 80 l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~l~~-------~l~~L~~L~L~~N~l~~lp~~---l~~L~~ 145 (622)
T 3g06_A 80 PPELRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLTSLPVL---PPGLQE 145 (622)
T ss_dssp CTTCCEEEECSCCCSCCCC----CCTTCCEEEECSCCCCCCCC-------CCTTCCEEECCSSCCSCCCCC---CTTCCE
T ss_pred CCCCCEEEcCCCcCCcCCC----CCCCCCEEECcCCcCCCCCC-------CCCCcCEEECCCCCCCcCCCC---CCCCCE
Confidence 4589999999999999876 78999999999999998654 237899999999999999975 478999
Q ss_pred EEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCC
Q 001152 96 LKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1137)
Q Consensus 96 L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1137)
|+|++|+|+.+|.. +.+|+.|+|++|.+..+| ..+++|+.|++++|.+.. +|.. +++|+.|++++|.
T Consensus 146 L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~~l~---~~~~~L~~L~Ls~N~l~~----l~~~---~~~L~~L~L~~N~ 212 (622)
T 3g06_A 146 LSVSDNQLASLPAL---PSELCKLWAYNNQLTSLP---MLPSGLQELSVSDNQLAS----LPTL---PSELYKLWAYNNR 212 (622)
T ss_dssp EECCSSCCSCCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC----CCCC---CTTCCEEECCSSC
T ss_pred EECcCCcCCCcCCc---cCCCCEEECCCCCCCCCc---ccCCCCcEEECCCCCCCC----CCCc---cchhhEEECcCCc
Confidence 99999999999864 468999999999988887 567899999999977654 3332 4789999999999
Q ss_pred CcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccC
Q 001152 176 IRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255 (1137)
Q Consensus 176 L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~ 255 (1137)
|+.+|.. +++|+.|+|++|+|+.+| ..+++|+.|+|++|+|+.||. .+++|+.|+|++|+|+.++ ..|..
T Consensus 213 l~~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~~lp-~~l~~ 282 (622)
T 3g06_A 213 LTSLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLTRLP-ESLIH 282 (622)
T ss_dssp CSSCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCCSCC-GGGGG
T ss_pred ccccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCCcCC-HHHhh
Confidence 9999864 588999999999999999 557899999999999999998 6789999999999999775 57999
Q ss_pred CCCCCEEEccCCcCCCCCCCCcchh
Q 001152 256 MHNLQNLNLQYNKLLSYCQVPSWIC 280 (1137)
Q Consensus 256 L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1137)
+++|+.|+|++|+|++ .+|..+.
T Consensus 283 l~~L~~L~L~~N~l~~--~~~~~l~ 305 (622)
T 3g06_A 283 LSSETTVNLEGNPLSE--RTLQALR 305 (622)
T ss_dssp SCTTCEEECCSCCCCH--HHHHHHH
T ss_pred ccccCEEEecCCCCCC--cCHHHHH
Confidence 9999999999999987 4455444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-22 Score=225.97 Aligned_cols=193 Identities=18% Similarity=0.216 Sum_probs=151.3
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~ 97 (1137)
.+..|.+..|+|+.+. .+..+++|++|+|++|+|++..+ + ..+++|++|+|++|.|+.+| .+..+++|++|+
T Consensus 42 ~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~~~~--~---~~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~ 113 (308)
T 1h6u_A 42 GITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP--L---KNLTKITELELSGNPLKNVS-AIAGLQSIKTLD 113 (308)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--G---TTCCSCCEEECCSCCCSCCG-GGTTCTTCCEEE
T ss_pred CcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCCChh--H---ccCCCCCEEEccCCcCCCch-hhcCCCCCCEEE
Confidence 6889999999999985 68999999999999999998765 4 45599999999999999986 699999999999
Q ss_pred ccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCc
Q 001152 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1137)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1137)
|++|.|+.+|. +..+++|+.|+|++|.+..++. +..+++|+.|++++|+++
T Consensus 114 l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~----------------------------l~~l~~L~~L~l~~n~l~ 164 (308)
T 1h6u_A 114 LTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP----------------------------LAGLTNLQYLSIGNAQVS 164 (308)
T ss_dssp CTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG----------------------------GGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc----------------------------ccCCCCccEEEccCCcCC
Confidence 99999999876 8999999999998887654442 344556666666666666
Q ss_pred ccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCc
Q 001152 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1137)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p 250 (1137)
.+|. +..+++|+.|+|++|+|+.+|. +..+++|+.|+|++|+++.+|+ +..+++|+.|+|++|++++.+.
T Consensus 165 ~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 165 DLTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp CCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEECCCE
T ss_pred CChh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeeecCCe
Confidence 6655 6667777777777777776664 6667777777777777776663 6667777777777777766543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-21 Score=215.88 Aligned_cols=199 Identities=23% Similarity=0.302 Sum_probs=164.9
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-ccCCCCCcEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VGRYEKLRNL 96 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~-~~~L~~L~~L 96 (1137)
....+.+..++|+.++.... ++|+.|+|++|+|++..+..|..+ ++|++|+|++|.|+.+|.. |.++++|++|
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~l---~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L 90 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIP---ADTKKLDLQSNKLSSLPSKAFHRL---TKLRLLYLNDNKLQTLPAGIFKELKNLETL 90 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCC---TTCSEEECCSSCCSCCCTTSSSSC---TTCCEEECCSSCCSCCCTTTTSSCTTCCEE
T ss_pred CCCEEEccCCCCCccCCCCC---CCCCEEECcCCCCCeeCHHHhcCC---CCCCEEECCCCccCeeChhhhcCCCCCCEE
Confidence 46779999999999875432 689999999999999887766555 9999999999999999875 6889999999
Q ss_pred EccCCCCCccccc-ccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCC
Q 001152 97 KFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFS 175 (1137)
Q Consensus 97 ~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~ 175 (1137)
+|++|.|+.+|.. |.++++|+.|+|++|.+..++ +..|..+++|++|++++|.
T Consensus 91 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------------------------~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 91 WVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLP--------------------------PRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp ECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCC--------------------------TTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCcCCHhHcccccCCCEEECCCCccCeeC--------------------------HHHhCcCcCCCEEECCCCc
Confidence 9999999988764 678888888888877754433 2235667788888888888
Q ss_pred CcccCcc-ccCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCCC
Q 001152 176 IRYLPPE-IGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSL 248 (1137)
Q Consensus 176 L~~IP~~-l~~L~~L~~L~Ls~N~L~~LP~-~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~ 248 (1137)
|+.+|.. |..+++|+.|+|++|+|+.+|. .|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|.+...
T Consensus 145 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 145 LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 8887764 7888999999999999998875 478889999999999999988765 66789999999999988754
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.3e-22 Score=224.57 Aligned_cols=203 Identities=17% Similarity=0.133 Sum_probs=169.8
Q ss_pred CCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc-cC----ccccCCCCCcEEEccCCCCCccc-ccccCC
Q 001152 40 DDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL-IP----KSVGRYEKLRNLKFFGNEINLFP-SEVGNL 113 (1137)
Q Consensus 40 l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~-IP----~~~~~L~~L~~L~Ls~N~L~~lP-~~l~~L 113 (1137)
+++|++|+|++|++++..|..+.. ..+++|++|+|++|.++. +| ..+..+++|++|+|++|.|+.+| ..|+++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~-~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLE-ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSS-CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred cCceeEEEeeCCEeccchhhhhhh-ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 456999999999999999886611 455999999999999984 33 34568999999999999999765 678999
Q ss_pred CCCCEEEccCCCCCC---C--cccccCCCCCCEEECCCCCCCCCcccchhh-hcCCCCCcEEeccCCCCccc-CccccCC
Q 001152 114 LGLECLQIKISSPGV---N--GFALNKLKGLKELELSKVPPRPSVLTLLSE-IAGLKCLTKLSVCHFSIRYL-PPEIGCL 186 (1137)
Q Consensus 114 ~~L~~L~Ls~N~~~~---~--~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~-l~~L~~L~~L~Ls~N~L~~I-P~~l~~L 186 (1137)
++|++|+|++|.+.. + +..+..+++|++|+|++|.+.... ..+.. +..+++|++|+|++|+|+.+ |..++.+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPT-GVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHH-HHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchH-HHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 999999999998542 2 233478999999999998774322 22333 57889999999999999965 8877776
Q ss_pred ---CCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCC
Q 001152 187 ---SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTS 247 (1137)
Q Consensus 187 ---~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg 247 (1137)
++|++|+|++|+|+.+|..+. ++|+.|+|++|+|+.+|. +..+++|+.|+|++|+|+.
T Consensus 248 ~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRAPQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSCCC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCCch-hhhCCCccEEECcCCCCCC
Confidence 699999999999999998875 799999999999999876 7889999999999999985
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-23 Score=243.11 Aligned_cols=237 Identities=19% Similarity=0.164 Sum_probs=193.8
Q ss_pred CCCCCCCCCCEEEccCCCCCCCCccccc-CCCCCCCccEEEeecCCCC----ccCccc-------cCCCCCcEEEccCCC
Q 001152 35 GSVNDDDDDSVIDVSGKTVDFPLIESYG-NRGGDNSVEGLYLYKNVLN----LIPKSV-------GRYEKLRNLKFFGNE 102 (1137)
Q Consensus 35 ~~f~~l~~L~~LdLs~N~L~~~~p~~~~-~l~~L~~L~~L~Ls~N~L~----~IP~~~-------~~L~~L~~L~Ls~N~ 102 (1137)
..+..+++|++|+|++|+|+...+..+. .+..+++|++|+|++|.+. .+|..+ ..+++|++|+|++|.
T Consensus 26 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 105 (386)
T 2ca6_A 26 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105 (386)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence 3456788999999999999887555432 2456699999999997665 445544 788999999999999
Q ss_pred CCc-----ccccccCCCCCCEEEccCCCCCCCc-----ccccCC---------CCCCEEECCCCCCC-CCcccchhhhcC
Q 001152 103 INL-----FPSEVGNLLGLECLQIKISSPGVNG-----FALNKL---------KGLKELELSKVPPR-PSVLTLLSEIAG 162 (1137)
Q Consensus 103 L~~-----lP~~l~~L~~L~~L~Ls~N~~~~~~-----~~~~~L---------~~L~~L~Ls~n~ln-~~~~~lp~~l~~ 162 (1137)
|+. +|..+.++++|++|+|++|.++..+ ..+..+ ++|++|+|++|.+. .....+...+..
T Consensus 106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 185 (386)
T 2ca6_A 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185 (386)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh
Confidence 985 7888999999999999999875332 233344 89999999997765 233333467788
Q ss_pred CCCCcEEeccCCCCc------ccCccccCCCCCCEEEccCCCC-----CccchhhcCCCCCCEEEccCCCCCc-----cC
Q 001152 163 LKCLTKLSVCHFSIR------YLPPEIGCLSNLEQLDLSFNKM-----KYLPTEICYLKALISLKVANNKLVE-----LP 226 (1137)
Q Consensus 163 L~~L~~L~Ls~N~L~------~IP~~l~~L~~L~~L~Ls~N~L-----~~LP~~l~~L~~L~~L~Ls~N~Ls~-----IP 226 (1137)
+++|+.|++++|+|+ .+|..+..+++|+.|+|++|.| ..+|..+..+++|+.|+|++|.|+. +|
T Consensus 186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 265 (386)
T 2ca6_A 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265 (386)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence 999999999999998 2454788999999999999999 4689999999999999999999984 57
Q ss_pred ccc--cCCCCCCEEeccCCcCCC----CCcccc-cCCCCCCEEEccCCcCCC
Q 001152 227 SGL--YLLQRLENLDLSNNRLTS----LGSLDL-CLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 227 ~~l--~~L~~L~~LdLS~N~Lsg----~~p~~l-~~L~~L~~L~Ls~N~L~~ 271 (1137)
..+ +.+++|+.|+|++|.|++ .+|..+ .++++|+.|+|++|++++
T Consensus 266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 777 449999999999999998 345566 678999999999999987
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-22 Score=220.65 Aligned_cols=200 Identities=23% Similarity=0.275 Sum_probs=127.5
Q ss_pred CCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001152 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1137)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n 147 (1137)
++|+.|++++|.++.++ .+..+++|++|+|++|.|+.++ .+.++++|++|+|++|.+..++
T Consensus 41 ~~L~~L~l~~~~i~~~~-~l~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~L~~n~l~~~~----------------- 101 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKLHDIS-ALKELTNLTYLILTGNQLQSLP----------------- 101 (272)
T ss_dssp TTCCEEECTTSCCCCCT-TGGGCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECTTSCCCCCC-----------------
T ss_pred cceeeeeeCCCCccccc-ccccCCCCcEEECCCCCCCCch-hhcCCCCCCEEECCCCccCccC-----------------
Confidence 55555555555555543 2555555555555555555543 4455555555555544433222
Q ss_pred CCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCcc
Q 001152 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVEL 225 (1137)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~Ls~N~Ls~I 225 (1137)
+..+..+++|++|++++|+++.+|. .|+.+++|++|+|++|+|+.+|.. ++.+++|+.|+|++|+|+.+
T Consensus 102 ---------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 102 ---------NGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp ---------TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ---------hhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence 2234566777777777777776655 357777888888888887766644 56778888888888888766
Q ss_pred Ccc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhccCCCCCCCCCCCcccccccccc
Q 001152 226 PSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDV 304 (1137)
Q Consensus 226 P~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~l~~~~~s~n~ 304 (1137)
|.. +..+++|+.|+|++|+|+++++..+..+++|+.|+|++|++.|. +| .+..++...|.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~--~~-----------------~l~~l~~~~n~ 233 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT--CP-----------------GIRYLSEWINK 233 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC--TT-----------------TTHHHHHHHHH
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc--Cc-----------------HHHHHHHHHHh
Confidence 554 46678888888888888887776677788888888888887762 22 23344455566
Q ss_pred cCCCcccCCC
Q 001152 305 YEGPMLENDG 314 (1137)
Q Consensus 305 l~g~il~~~~ 314 (1137)
+.|.++..++
T Consensus 234 ~~g~ip~~~~ 243 (272)
T 3rfs_A 234 HSGVVRNSAG 243 (272)
T ss_dssp TGGGBBCTTS
T ss_pred CCCcccCccc
Confidence 6666655444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=217.13 Aligned_cols=199 Identities=23% Similarity=0.224 Sum_probs=143.7
Q ss_pred CccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001152 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1137)
Q Consensus 69 ~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ 148 (1137)
.+..+++..+.+..+ ..+..+++|+.|++++|.++.++. +..+++|++ |++++|.
T Consensus 20 ~l~~l~l~~~~~~~~-~~~~~l~~L~~L~l~~~~i~~~~~-l~~l~~L~~-----------------------L~l~~n~ 74 (272)
T 3rfs_A 20 ETIKANLKKKSVTDA-VTQNELNSIDQIIANNSDIKSVQG-IQYLPNVRY-----------------------LALGGNK 74 (272)
T ss_dssp HHHHHHHTCSCTTSE-ECHHHHTTCCEEECTTSCCCCCTT-GGGCTTCCE-----------------------EECTTSC
T ss_pred HHHHHHhcCcccccc-cccccccceeeeeeCCCCcccccc-cccCCCCcE-----------------------EECCCCC
Confidence 344444555544433 123445556666666666555442 444455554 4555443
Q ss_pred CCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCccC
Q 001152 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELP 226 (1137)
Q Consensus 149 ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~Ls~N~Ls~IP 226 (1137)
+.. + ..+..+++|++|++++|.++.+|. .|..+++|++|+|++|+|+.+|.. |+.+++|++|+|++|+|+.+|
T Consensus 75 l~~----~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 149 (272)
T 3rfs_A 75 LHD----I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLP 149 (272)
T ss_dssp CCC----C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCC----c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccC
Confidence 332 1 257788999999999999998876 468999999999999999988755 789999999999999999887
Q ss_pred cc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhccCCCCCCCCCCCccccccccccc
Q 001152 227 SG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVY 305 (1137)
Q Consensus 227 ~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~l~~~~~s~n~l 305 (1137)
.. +..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|+++. |..+. ..+.+...+++.|.+
T Consensus 150 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~----------~l~~L~~L~l~~N~~ 217 (272)
T 3rfs_A 150 KGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVP--DGVFD----------RLTSLQYIWLHDNPW 217 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC--TTTTT----------TCTTCCEEECCSSCB
T ss_pred HHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccC--HHHHh----------CCcCCCEEEccCCCc
Confidence 65 578999999999999999999988899999999999999998732 21111 234556666666766
Q ss_pred CCCc
Q 001152 306 EGPM 309 (1137)
Q Consensus 306 ~g~i 309 (1137)
.+..
T Consensus 218 ~~~~ 221 (272)
T 3rfs_A 218 DCTC 221 (272)
T ss_dssp CCCT
T ss_pred cccC
Confidence 6653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-21 Score=212.00 Aligned_cols=193 Identities=15% Similarity=0.126 Sum_probs=141.1
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCC-CCccCc-cccCCCCCcEEEccC-CCCCcccc-cccCCCCCC
Q 001152 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV-LNLIPK-SVGRYEKLRNLKFFG-NEINLFPS-EVGNLLGLE 117 (1137)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~-L~~IP~-~~~~L~~L~~L~Ls~-N~L~~lP~-~l~~L~~L~ 117 (1137)
+|++|+|++|+|++..+..|..+ ++|++|+|++|. ++.+|. .|.++++|++|+|++ |.|+.+|. .|.++++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l---~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~ 108 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNL---PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK 108 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTC---TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCC
T ss_pred cccEEEEeCCcceEECHHHccCC---CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCC
Confidence 67777777777776666555443 777777777775 777664 567777777777776 77776653 466666777
Q ss_pred EEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCc---EEeccCC-CCcccCc-cccCCCCCC-E
Q 001152 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT---KLSVCHF-SIRYLPP-EIGCLSNLE-Q 191 (1137)
Q Consensus 118 ~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~---~L~Ls~N-~L~~IP~-~l~~L~~L~-~ 191 (1137)
.|+|++|.+..+|. +..+++|+ .|++++| .++.+|. .|..+++|+ .
T Consensus 109 ~L~l~~n~l~~lp~----------------------------~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~ 160 (239)
T 2xwt_C 109 FLGIFNTGLKMFPD----------------------------LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160 (239)
T ss_dssp EEEEEEECCCSCCC----------------------------CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEE
T ss_pred EEeCCCCCCccccc----------------------------cccccccccccEEECCCCcchhhcCcccccchhcceeE
Confidence 77666665444332 33445555 8888888 8887776 478888899 9
Q ss_pred EEccCCCCCccchhhcCCCCCCEEEccCCC-CCccCc-cccCC-CCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCc
Q 001152 192 LDLSFNKMKYLPTEICYLKALISLKVANNK-LVELPS-GLYLL-QRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268 (1137)
Q Consensus 192 L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~-Ls~IP~-~l~~L-~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~ 268 (1137)
|+|++|+|+.+|......++|+.|+|++|+ |+.+|. .+..+ ++|+.|+|++|+|+++++. .+++|+.|++++|.
T Consensus 161 L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 161 LKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW 237 (239)
T ss_dssp EECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred EEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence 999999998888766555889999999995 888865 46678 8899999999999988764 57788889888764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.1e-22 Score=213.21 Aligned_cols=177 Identities=16% Similarity=0.194 Sum_probs=139.1
Q ss_pred CccEEEeecCCCCccCc-cccCCCCCcEEEccCCC-CCcccc-cccCCCCCCEEEccC-CCCCCCcccccCCCCCCEEEC
Q 001152 69 SVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNE-INLFPS-EVGNLLGLECLQIKI-SSPGVNGFALNKLKGLKELEL 144 (1137)
Q Consensus 69 ~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~-L~~lP~-~l~~L~~L~~L~Ls~-N~~~~~~~~~~~L~~L~~L~L 144 (1137)
+|++|+|++|+|+.+|. .|.++++|++|+|++|. ++.+|. .|.++++|++|+|++ |.+..++
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~-------------- 97 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID-------------- 97 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC--------------
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC--------------
Confidence 56666666666666654 46666666666666664 665544 355555555555554 4432211
Q ss_pred CCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCC---EEEccCC-CCCccch-hhcCCCCCC-EEEcc
Q 001152 145 SKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE---QLDLSFN-KMKYLPT-EICYLKALI-SLKVA 218 (1137)
Q Consensus 145 s~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~---~L~Ls~N-~L~~LP~-~l~~L~~L~-~L~Ls 218 (1137)
+..|.++++|++|++++|.++.+|. |..+++|+ +|+|++| +++.+|. .|..+++|+ .|+|+
T Consensus 98 ------------~~~f~~l~~L~~L~l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~ 164 (239)
T 2xwt_C 98 ------------PDALKELPLLKFLGIFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164 (239)
T ss_dssp ------------TTSEECCTTCCEEEEEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECC
T ss_pred ------------HHHhCCCCCCCEEeCCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcC
Confidence 2356778899999999999999998 88899998 9999999 9998875 488999999 99999
Q ss_pred CCCCCccCccccCCCCCCEEeccCCc-CCCCCcccccCC-CCCCEEEccCCcCCCC
Q 001152 219 NNKLVELPSGLYLLQRLENLDLSNNR-LTSLGSLDLCLM-HNLQNLNLQYNKLLSY 272 (1137)
Q Consensus 219 ~N~Ls~IP~~l~~L~~L~~LdLS~N~-Lsg~~p~~l~~L-~~L~~L~Ls~N~L~~~ 272 (1137)
+|+++.||...+..++|+.|+|++|+ |+++++..|..+ ++|+.|+|++|+|+.+
T Consensus 165 ~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l 220 (239)
T 2xwt_C 165 NNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL 220 (239)
T ss_dssp SCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC
T ss_pred CCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC
Confidence 99999999887777899999999995 999998889999 9999999999999873
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.9e-21 Score=210.19 Aligned_cols=179 Identities=21% Similarity=0.294 Sum_probs=140.7
Q ss_pred CccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccc-cccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001152 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1137)
Q Consensus 69 ~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n 147 (1137)
+.+++++++|.++.+|..+. ++|+.|+|++|.|+.++. .|.++++|++|+|++|.+..++
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~----------------- 75 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS----------------- 75 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC-----------------
T ss_pred CCeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccC-----------------
Confidence 45677777777777776655 467777777777775543 4666666666666665543222
Q ss_pred CCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCcc
Q 001152 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVEL 225 (1137)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~Ls~N~Ls~I 225 (1137)
+..|..+++|++|+|++|+|+.+|. .|..+++|++|+|++|+|+.+|.. |..+++|+.|+|++|+|+.+
T Consensus 76 ---------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 146 (251)
T 3m19_A 76 ---------AGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI 146 (251)
T ss_dssp ---------TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ---------HhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence 2345667788888888888887765 568899999999999999988765 58899999999999999988
Q ss_pred Cc-cccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCC-CCC
Q 001152 226 PS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY-CQV 275 (1137)
Q Consensus 226 P~-~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~-~~i 275 (1137)
|. .+..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|.|. |.+
T Consensus 147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~ 198 (251)
T 3m19_A 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEI 198 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTTH
T ss_pred CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcccc
Confidence 77 588899999999999999999988899999999999999999986 543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-21 Score=236.81 Aligned_cols=185 Identities=19% Similarity=0.238 Sum_probs=105.9
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEc
Q 001152 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI 121 (1137)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~L 121 (1137)
+|+.|+|++|+|++ +|..+ + ++|+.|+|++|.|+.|| ..+++|++|+|++|+|+.||. +.+ +|+.|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~---~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--P---PQITVLEITQNALISLP---ELPASLEYLDACDNRLSTLPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--C---TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhH--c---CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCCcch-hhc--CCCEEEC
Confidence 56666666666665 33222 1 45666666666666666 334566666666666666655 443 5555555
Q ss_pred cCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCc
Q 001152 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY 201 (1137)
Q Consensus 122 s~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~ 201 (1137)
++|.++.+|. .+++|+.|++++|.|+.||. .+++|+.|+|++|+|+.
T Consensus 128 s~N~l~~lp~------------------------------~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 128 DNNQLTMLPE------------------------------LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp CSSCCSCCCC------------------------------CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC
T ss_pred CCCcCCCCCC------------------------------cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC
Confidence 5555443332 34556666666666666655 35566666666666666
Q ss_pred cchhhcCCCCCCEEEccCCCCCccCccccCCCCC-------CEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001152 202 LPTEICYLKALISLKVANNKLVELPSGLYLLQRL-------ENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1137)
Q Consensus 202 LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L-------~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1137)
+|. |. ++|+.|+|++|+|+.||. +.. +| +.|+|++|+|+.+++ .+..+++|+.|+|++|+|++ .
T Consensus 175 lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~-~l~~l~~L~~L~L~~N~l~~--~ 245 (571)
T 3cvr_A 175 LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRITHIPE-NILSLDPTCTIILEDNPLSS--R 245 (571)
T ss_dssp CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCCCCCG-GGGGSCTTEEEECCSSSCCH--H
T ss_pred cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcceecCH-HHhcCCCCCEEEeeCCcCCC--c
Confidence 665 44 566666666666666665 443 45 666666666665543 45556666666666666665 4
Q ss_pred CCcchh
Q 001152 275 VPSWIC 280 (1137)
Q Consensus 275 iP~~~~ 280 (1137)
+|..+.
T Consensus 246 ~p~~l~ 251 (571)
T 3cvr_A 246 IRESLS 251 (571)
T ss_dssp HHHHHH
T ss_pred CHHHHH
Confidence 454444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.9e-21 Score=231.89 Aligned_cols=180 Identities=22% Similarity=0.245 Sum_probs=130.9
Q ss_pred CCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEec
Q 001152 92 KLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1137)
Q Consensus 92 ~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~L 171 (1137)
+|+.|+|++|.|+.||..+. ++|+.|+|++|.+..+| ..+++|+.|+|++|.+.. +|. +.+ +|+.|+|
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~--~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~----ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLP--PQITVLEITQNALISLP---ELPASLEYLDACDNRLST----LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCC--TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC----CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCccCHhHc--CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCC----cch-hhc--CCCEEEC
Confidence 55556666665555555442 45566666655555544 335666666666654433 343 433 7999999
Q ss_pred cCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcc
Q 001152 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251 (1137)
Q Consensus 172 s~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~ 251 (1137)
++|.|+.||. .+++|+.|+|++|+|+.+|. .+++|+.|+|++|+|+.||. +. ++|+.|+|++|+|+.+++
T Consensus 128 s~N~l~~lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~~lp~- 197 (571)
T 3cvr_A 128 DNNQLTMLPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLESLPA- 197 (571)
T ss_dssp CSSCCSCCCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCSSCCC-
T ss_pred CCCcCCCCCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCCchhh-
Confidence 9999999998 68999999999999999997 67899999999999999998 66 899999999999997765
Q ss_pred cccCCCCC-------CEEEccCCcCCCCCCCCcchhhccCCCCCCCCCCCcccccccccccCCCc
Q 001152 252 DLCLMHNL-------QNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSSAEMDVYEGPM 309 (1137)
Q Consensus 252 ~l~~L~~L-------~~L~Ls~N~L~~~~~iP~~~~~~l~~n~l~~~~~~l~~~~~s~n~l~g~i 309 (1137)
|.. +| +.|+|++|+|+. ||..+.. .+.+...++++|.+++.+
T Consensus 198 -~~~--~L~~~~~~L~~L~Ls~N~l~~---lp~~l~~----------l~~L~~L~L~~N~l~~~~ 246 (571)
T 3cvr_A 198 -VPV--RNHHSEETEIFFRCRENRITH---IPENILS----------LDPTCTIILEDNPLSSRI 246 (571)
T ss_dssp -CC----------CCEEEECCSSCCCC---CCGGGGG----------SCTTEEEECCSSSCCHHH
T ss_pred -HHH--hhhcccccceEEecCCCccee---cCHHHhc----------CCCCCEEEeeCCcCCCcC
Confidence 544 77 999999999985 6665542 234555566666666654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=7e-22 Score=229.45 Aligned_cols=234 Identities=15% Similarity=0.126 Sum_probs=192.8
Q ss_pred CCcccccCCCCCCcccCC----CCCCCCCCCCEEEccCC---CCCCCCccccc----CCCCCCCccEEEeecCCCCc---
Q 001152 17 PIKEKLPSEANKINNEKN----GSVNDDDDDSVIDVSGK---TVDFPLIESYG----NRGGDNSVEGLYLYKNVLNL--- 82 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~----~~f~~l~~L~~LdLs~N---~L~~~~p~~~~----~l~~L~~L~~L~Ls~N~L~~--- 82 (1137)
+.++.|.+..|+|+...+ ..|..+++|++|+|++| ++++.+|..+. .+..+++|++|+|++|.|+.
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 469999999999988754 34889999999999996 45556665442 12456999999999999986
Q ss_pred --cCccccCCCCCcEEEccCCCCCc-----ccccccCC---------CCCCEEEccCCCCC--CCc---ccccCCCCCCE
Q 001152 83 --IPKSVGRYEKLRNLKFFGNEINL-----FPSEVGNL---------LGLECLQIKISSPG--VNG---FALNKLKGLKE 141 (1137)
Q Consensus 83 --IP~~~~~L~~L~~L~Ls~N~L~~-----lP~~l~~L---------~~L~~L~Ls~N~~~--~~~---~~~~~L~~L~~ 141 (1137)
+|..|..+++|++|+|++|.|+. ++..+..+ ++|++|+|++|.++ ..+ ..+..+++|++
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 78889999999999999999973 34444445 89999999999976 333 35678999999
Q ss_pred EECCCCCCCC--CcccchhhhcCCCCCcEEeccCCCC-----cccCccccCCCCCCEEEccCCCCCc-----cchhh--c
Q 001152 142 LELSKVPPRP--SVLTLLSEIAGLKCLTKLSVCHFSI-----RYLPPEIGCLSNLEQLDLSFNKMKY-----LPTEI--C 207 (1137)
Q Consensus 142 L~Ls~n~ln~--~~~~lp~~l~~L~~L~~L~Ls~N~L-----~~IP~~l~~L~~L~~L~Ls~N~L~~-----LP~~l--~ 207 (1137)
|+|++|.+.. ....+|..+..+++|+.|+|++|.| ..+|..+..+++|++|+|++|+|+. +|..+ +
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~ 271 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTC
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhc
Confidence 9999976642 1113444788999999999999999 5678889999999999999999983 57777 4
Q ss_pred CCCCCCEEEccCCCCCc-----cCccc-cCCCCCCEEeccCCcCCCCCc
Q 001152 208 YLKALISLKVANNKLVE-----LPSGL-YLLQRLENLDLSNNRLTSLGS 250 (1137)
Q Consensus 208 ~L~~L~~L~Ls~N~Ls~-----IP~~l-~~L~~L~~LdLS~N~Lsg~~p 250 (1137)
.+++|+.|+|++|.|+. +|..+ .++++|+.|+|++|+|++..+
T Consensus 272 ~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp SSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred cCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 49999999999999997 89888 568999999999999998875
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.83 E-value=1e-21 Score=226.58 Aligned_cols=247 Identities=13% Similarity=0.112 Sum_probs=188.0
Q ss_pred ccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCc----ccccCCCCCC-CccEEEeecCCCCcc-CccccCC-----
Q 001152 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLI----ESYGNRGGDN-SVEGLYLYKNVLNLI-PKSVGRY----- 90 (1137)
Q Consensus 22 L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p----~~~~~l~~L~-~L~~L~Ls~N~L~~I-P~~~~~L----- 90 (1137)
..+..|++++..+..+...++|++|||++|.|++..+ ..|..+ + +|++|+|++|.|+.. +..|..+
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~---~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~ 79 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANT---PASVTSLNLSGNSLGFKNSDELVQILAAIP 79 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTC---CTTCCEEECCSSCGGGSCHHHHHHHHHTSC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhC---CCceeEEECcCCCCCHHHHHHHHHHHhccC
Confidence 3466788888877777777789999999999988877 555544 7 899999999999865 4556554
Q ss_pred CCCcEEEccCCCCCccc-cc----ccCC-CCCCEEEccCCCCCCCcc-c----ccC-CCCCCEEECCCCCCCCCc-ccch
Q 001152 91 EKLRNLKFFGNEINLFP-SE----VGNL-LGLECLQIKISSPGVNGF-A----LNK-LKGLKELELSKVPPRPSV-LTLL 157 (1137)
Q Consensus 91 ~~L~~L~Ls~N~L~~lP-~~----l~~L-~~L~~L~Ls~N~~~~~~~-~----~~~-L~~L~~L~Ls~n~ln~~~-~~lp 157 (1137)
++|++|+|++|.|+..+ .. +..+ ++|+.|+|++|.++..+. . +.. .++|++|+|++|.+.... ..++
T Consensus 80 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~ 159 (362)
T 3goz_A 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI 159 (362)
T ss_dssp TTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred CCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH
Confidence 89999999999998543 33 4455 899999999999766553 2 334 368999999997654322 2455
Q ss_pred hhhcCCC-CCcEEeccCCCCcccCc-----cccCC-CCCCEEEccCCCCCc-----cchhhcC-CCCCCEEEccCCCCCc
Q 001152 158 SEIAGLK-CLTKLSVCHFSIRYLPP-----EIGCL-SNLEQLDLSFNKMKY-----LPTEICY-LKALISLKVANNKLVE 224 (1137)
Q Consensus 158 ~~l~~L~-~L~~L~Ls~N~L~~IP~-----~l~~L-~~L~~L~Ls~N~L~~-----LP~~l~~-L~~L~~L~Ls~N~Ls~ 224 (1137)
..+..++ +|+.|+|++|+|+..+. .+..+ ++|++|+|++|.|+. ++..+.. .++|+.|+|++|.|+.
T Consensus 160 ~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 239 (362)
T 3goz_A 160 QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239 (362)
T ss_dssp HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCC
T ss_pred HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCc
Confidence 5666665 89999999999985543 34455 599999999999986 7777766 4589999999999986
Q ss_pred cCc-----cccCCCCCCEEeccCCcCCCCCcc-------cccCCCCCCEEEccCCcCCC
Q 001152 225 LPS-----GLYLLQRLENLDLSNNRLTSLGSL-------DLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 225 IP~-----~l~~L~~L~~LdLS~N~Lsg~~p~-------~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
++. .+..+++|+.|+|++|.+.++.+. .+..+++|+.|||++|++..
T Consensus 240 ~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 240 PSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp CCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 543 346688999999999997766543 46678889999999999876
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.5e-20 Score=211.88 Aligned_cols=235 Identities=16% Similarity=0.125 Sum_probs=169.3
Q ss_pred cccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC-ccCc-cccCCCCCcE-EE
Q 001152 21 KLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN-LIPK-SVGRYEKLRN-LK 97 (1137)
Q Consensus 21 ~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~-~IP~-~~~~L~~L~~-L~ 97 (1137)
.+....++|+.|+.+- .+++++|+|++|+|+.+.+.+|.++ ++|++|+|++|++. .||. .|.+|++|.. +.
T Consensus 13 ~v~C~~~~Lt~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l---~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 13 VFLCQESKVTEIPSDL---PRNAIELRFVLTKLRVIQKGAFSGF---GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp EEEEESTTCCSCCTTC---CTTCSEEEEESCCCSEECTTSSTTC---TTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred EEEecCCCCCccCcCc---CCCCCEEEccCCcCCCcCHHHHcCC---CCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 3455667777776433 2568888888888887666655444 88888888888874 5664 5778877654 66
Q ss_pred ccCCCCCccc-ccccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchh-hhcCCC-CCcEEeccC
Q 001152 98 FFGNEINLFP-SEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLS-EIAGLK-CLTKLSVCH 173 (1137)
Q Consensus 98 Ls~N~L~~lP-~~l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~-~l~~L~-~L~~L~Ls~ 173 (1137)
+.+|+|+.+| ..|.++++|++|++++|.+..++ ..+....++..|++.++ +.+..++. .+..+. .|+.|+|++
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~---~~i~~l~~~~f~~~~~~l~~L~L~~ 163 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN---INIHTIERNSFVGLSFESVILWLNK 163 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC---TTCCEECTTSSTTSBSSCEEEECCS
T ss_pred ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccc---cccccccccchhhcchhhhhhcccc
Confidence 6678888774 45788888888888888876655 34555666777777652 23334433 344443 588899999
Q ss_pred CCCcccCccccCCCCCCEEEccC-CCCCccch-hhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccC-CcCCCCCc
Q 001152 174 FSIRYLPPEIGCLSNLEQLDLSF-NKMKYLPT-EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN-NRLTSLGS 250 (1137)
Q Consensus 174 N~L~~IP~~l~~L~~L~~L~Ls~-N~L~~LP~-~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~-N~Lsg~~p 250 (1137)
|+|+.||..+....+|+.|+|++ |.++.||. .|..+++|+.|+|++|+|+.||... +.+|+.|.+.+ +.++.+|
T Consensus 164 N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~--~~~L~~L~~l~~~~l~~lP- 240 (350)
T 4ay9_X 164 NGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRARSTYNLKKLP- 240 (350)
T ss_dssp SCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS--CTTCCEEECTTCTTCCCCC-
T ss_pred ccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh--hccchHhhhccCCCcCcCC-
Confidence 99999988777778899999974 78889985 4688999999999999999998743 45666666544 4566665
Q ss_pred ccccCCCCCCEEEccCCc
Q 001152 251 LDLCLMHNLQNLNLQYNK 268 (1137)
Q Consensus 251 ~~l~~L~~L~~L~Ls~N~ 268 (1137)
.+..+++|+.+++.++.
T Consensus 241 -~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 241 -TLEKLVALMEASLTYPS 257 (350)
T ss_dssp -CTTTCCSCCEEECSCHH
T ss_pred -CchhCcChhhCcCCCCc
Confidence 47888999999997654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.82 E-value=3.3e-22 Score=236.47 Aligned_cols=252 Identities=17% Similarity=0.095 Sum_probs=179.0
Q ss_pred CCcccccCCCCCCcccCCCCC-CCCC----CCCEEEccCCCCCC----CCcccccCCCCCCCccEEEeecCCCCcc-Ccc
Q 001152 17 PIKEKLPSEANKINNEKNGSV-NDDD----DDSVIDVSGKTVDF----PLIESYGNRGGDNSVEGLYLYKNVLNLI-PKS 86 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f-~~l~----~L~~LdLs~N~L~~----~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~ 86 (1137)
+.++.|.+..|+|+......+ ..+. +|++|+|++|+|+. .++..+.. +++|++|+|++|.++.. +..
T Consensus 56 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~---~~~L~~L~Ls~n~i~~~~~~~ 132 (461)
T 1z7x_W 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT---LPTLQELHLSDNLLGDAGLQL 132 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTS---CTTCCEEECCSSBCHHHHHHH
T ss_pred CCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHcc---CCceeEEECCCCcCchHHHHH
Confidence 478899999998877544222 2344 69999999998874 44555544 48899999999988732 222
Q ss_pred c-----cCCCCCcEEEccCCCCCc-----ccccccCCCCCCEEEccCCCCCCCc-cccc-----CCCCCCEEECCCCCCC
Q 001152 87 V-----GRYEKLRNLKFFGNEINL-----FPSEVGNLLGLECLQIKISSPGVNG-FALN-----KLKGLKELELSKVPPR 150 (1137)
Q Consensus 87 ~-----~~L~~L~~L~Ls~N~L~~-----lP~~l~~L~~L~~L~Ls~N~~~~~~-~~~~-----~L~~L~~L~Ls~n~ln 150 (1137)
+ ..+++|++|+|++|.++. ++..+..+++|+.|+|++|.++..+ ..+. .+++|++|++++|.+.
T Consensus 133 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~ 212 (461)
T 1z7x_W 133 LCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212 (461)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCB
T ss_pred HHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCc
Confidence 2 235679999999998873 4666777889999999888755432 1121 3568899999886654
Q ss_pred CCc-ccchhhhcCCCCCcEEeccCCCCccc------CccccCCCCCCEEEccCCCCCc-----cchhhcCCCCCCEEEcc
Q 001152 151 PSV-LTLLSEIAGLKCLTKLSVCHFSIRYL------PPEIGCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKVA 218 (1137)
Q Consensus 151 ~~~-~~lp~~l~~L~~L~~L~Ls~N~L~~I------P~~l~~L~~L~~L~Ls~N~L~~-----LP~~l~~L~~L~~L~Ls 218 (1137)
... ..++..+..+++|+.|++++|.++.. +..+..+++|++|+|++|+|+. +|..+..+++|+.|+|+
T Consensus 213 ~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls 292 (461)
T 1z7x_W 213 SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLA 292 (461)
T ss_dssp TTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECT
T ss_pred HHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECC
Confidence 321 12566777888888999998888742 2223467888999999988885 67778888888999999
Q ss_pred CCCCCc-----cCccccC-CCCCCEEeccCCcCCCC----CcccccCCCCCCEEEccCCcCCC
Q 001152 219 NNKLVE-----LPSGLYL-LQRLENLDLSNNRLTSL----GSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 219 ~N~Ls~-----IP~~l~~-L~~L~~LdLS~N~Lsg~----~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+|.++. +...+.. .++|+.|+|++|.+++. .+..+..+++|+.|+|++|+++.
T Consensus 293 ~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~ 355 (461)
T 1z7x_W 293 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED 355 (461)
T ss_dssp TCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHH
T ss_pred CCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccc
Confidence 888872 2222222 36888888888888865 34456677888888888888765
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.3e-21 Score=219.76 Aligned_cols=241 Identities=18% Similarity=0.176 Sum_probs=139.1
Q ss_pred CcccccCCCCCCcccCCCCCCCC--CCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc--cCccccCCCCC
Q 001152 18 IKEKLPSEANKINNEKNGSVNDD--DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL--IPKSVGRYEKL 93 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l--~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~--IP~~~~~L~~L 93 (1137)
....+.+..|++. +..+..+ ++++.|+|++|.+++.++.. ..+++|++|+|++|.++. +|..+..+++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~----~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L 120 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEH----FSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSC----CCCBCCCEEECTTCEECHHHHHHHHTTBCCC
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhh----ccCCCCCEEEccCCCcCHHHHHHHHhhCCCC
Confidence 3555666665554 3344444 66777777777776665542 234667777777776652 56666667777
Q ss_pred cEEEccCCCCC-cccccccCCCCCCEEEccCC-CCCC--CcccccCCCCCCEEECCCC-CCCCCcccchhhhcCCC-CCc
Q 001152 94 RNLKFFGNEIN-LFPSEVGNLLGLECLQIKIS-SPGV--NGFALNKLKGLKELELSKV-PPRPSVLTLLSEIAGLK-CLT 167 (1137)
Q Consensus 94 ~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N-~~~~--~~~~~~~L~~L~~L~Ls~n-~ln~~~~~lp~~l~~L~-~L~ 167 (1137)
++|+|++|.++ .+|..++++++|++|+|++| .++. ++..+..+++|++|++++| .+.. ..++..+..++ +|+
T Consensus 121 ~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~--~~~~~~~~~l~~~L~ 198 (336)
T 2ast_B 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE--KHVQVAVAHVSETIT 198 (336)
T ss_dssp SEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH--HHHHHHHHHSCTTCC
T ss_pred CEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh--HHHHHHHHhcccCCC
Confidence 77777777666 45666666777777777666 3442 3444566666666666664 3221 11344555666 666
Q ss_pred EEeccCCC--Cc--ccCccccCCCCCCEEEccCCC-CC-ccchhhcCCCCCCEEEccCCC-CC-ccCccccCCCCCCEEe
Q 001152 168 KLSVCHFS--IR--YLPPEIGCLSNLEQLDLSFNK-MK-YLPTEICYLKALISLKVANNK-LV-ELPSGLYLLQRLENLD 239 (1137)
Q Consensus 168 ~L~Ls~N~--L~--~IP~~l~~L~~L~~L~Ls~N~-L~-~LP~~l~~L~~L~~L~Ls~N~-Ls-~IP~~l~~L~~L~~Ld 239 (1137)
.|++++|. ++ .+|..+..+++|+.|+|++|. ++ ..+..++.+++|+.|+|++|. ++ .....+.++++|+.|+
T Consensus 199 ~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~ 278 (336)
T 2ast_B 199 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 278 (336)
T ss_dssp EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred EEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEe
Confidence 66666663 32 455555566666666666666 44 445566666666666666664 22 1112355566666666
Q ss_pred ccCCcCCCCCcccccCC-CCCCEEEccCCcCCC
Q 001152 240 LSNNRLTSLGSLDLCLM-HNLQNLNLQYNKLLS 271 (1137)
Q Consensus 240 LS~N~Lsg~~p~~l~~L-~~L~~L~Ls~N~L~~ 271 (1137)
|++| ++ ...+..+ .+|..|++++|+|++
T Consensus 279 l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~ 307 (336)
T 2ast_B 279 VFGI-VP---DGTLQLLKEALPHLQINCSHFTT 307 (336)
T ss_dssp CTTS-SC---TTCHHHHHHHSTTSEESCCCSCC
T ss_pred ccCc-cC---HHHHHHHHhhCcceEEecccCcc
Confidence 6666 22 2222222 224555566666665
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.82 E-value=2.6e-22 Score=237.35 Aligned_cols=290 Identities=14% Similarity=0.104 Sum_probs=178.3
Q ss_pred CcccccCCCCCCcccC----CCCCCCCCCCCEEEccCCCCCCCCcccc-cCCCCCC-CccEEEeecCCCC-----ccCcc
Q 001152 18 IKEKLPSEANKINNEK----NGSVNDDDDDSVIDVSGKTVDFPLIESY-GNRGGDN-SVEGLYLYKNVLN-----LIPKS 86 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~----~~~f~~l~~L~~LdLs~N~L~~~~p~~~-~~l~~L~-~L~~L~Ls~N~L~-----~IP~~ 86 (1137)
.++.|.+..|+|+... +..|..+++|++|||++|.|+...+..+ ..+.... +|++|+|++|.++ .+|..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 5677777777776442 3456666777777777777765433322 2231111 5777777777776 35666
Q ss_pred ccCCCCCcEEEccCCCCCcc-cccc-----cCCCCCCEEEccCCCCCCC-----cccccCCCCCCEEECCCCCCCCCcc-
Q 001152 87 VGRYEKLRNLKFFGNEINLF-PSEV-----GNLLGLECLQIKISSPGVN-----GFALNKLKGLKELELSKVPPRPSVL- 154 (1137)
Q Consensus 87 ~~~L~~L~~L~Ls~N~L~~l-P~~l-----~~L~~L~~L~Ls~N~~~~~-----~~~~~~L~~L~~L~Ls~n~ln~~~~- 154 (1137)
|..+++|++|+|++|.|+.. +..+ ..+++|+.|+|++|.++.. +..+..+++|++|++++|.+.....
T Consensus 109 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 188 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 188 (461)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHH
Confidence 77777777777777777622 2222 2355677777777765542 3445566777888877754322111
Q ss_pred cchhhhc-CCCCCcEEeccCCCCcc-----cCccccCCCCCCEEEccCCCCCcc-----chhh-cCCCCCCEEEccCCCC
Q 001152 155 TLLSEIA-GLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKYL-----PTEI-CYLKALISLKVANNKL 222 (1137)
Q Consensus 155 ~lp~~l~-~L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~~L-----P~~l-~~L~~L~~L~Ls~N~L 222 (1137)
.+...+. .+++|+.|++++|.++. +|..+..+++|+.|+|++|.|+.. ...+ ..+++|+.|+|++|.+
T Consensus 189 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l 268 (461)
T 1z7x_W 189 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268 (461)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCC
Confidence 1111111 35577788888887774 466667778888888888877632 2233 3577888888888888
Q ss_pred Cc-----cCccccCCCCCCEEeccCCcCCCCCcccccC-----CCCCCEEEccCCcCCCCC---------CCCcchhhcc
Q 001152 223 VE-----LPSGLYLLQRLENLDLSNNRLTSLGSLDLCL-----MHNLQNLNLQYNKLLSYC---------QVPSWICCNL 283 (1137)
Q Consensus 223 s~-----IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~-----L~~L~~L~Ls~N~L~~~~---------~iP~~~~~~l 283 (1137)
+. +|..+..+++|+.|+|++|.++...+..+.. .++|+.|+|++|.+++.+ ..+....+++
T Consensus 269 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 348 (461)
T 1z7x_W 269 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 348 (461)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred CHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEc
Confidence 75 6777777788888888888877544433332 257888888888876521 1233444556
Q ss_pred CCCCCCCC------------CCCcccccccccccCC
Q 001152 284 EGNGKDSS------------NDDFISSSAEMDVYEG 307 (1137)
Q Consensus 284 ~~n~l~~~------------~~~l~~~~~s~n~l~g 307 (1137)
++|.+... ...+...++++|.+.+
T Consensus 349 s~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 349 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp CSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred cCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 66654321 2355566666666553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-20 Score=208.85 Aligned_cols=170 Identities=21% Similarity=0.235 Sum_probs=84.0
Q ss_pred CCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001152 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1137)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n 147 (1137)
++|+.|++++|.++.+|. +..+++|++|+|++|+|+.++. +.++++|+.|+|++|.+..++. +..+++|++|++++|
T Consensus 46 ~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~n 122 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLSS-LKDLKKLKSLSLEHN 122 (291)
T ss_dssp HTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGGG-GTTCTTCCEEECTTS
T ss_pred CcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCChh-hccCCCCCEEECCCC
Confidence 445555555555554432 4445555555555555554444 4555555555555444333221 333333333333333
Q ss_pred CCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001152 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1137)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1137)
.+... ..+..+++|+.|++++|+++.+ ..+..+++|+.|+|++|+|+.++. +..+++|+.|+|++|.|+.+|.
T Consensus 123 ~i~~~-----~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~l~~ 195 (291)
T 1h6t_A 123 GISDI-----NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDLRA 195 (291)
T ss_dssp CCCCC-----GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBCGG
T ss_pred cCCCC-----hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCCChh
Confidence 22221 1344455555555555555554 344555555555555555555543 5555555555555555555543
Q ss_pred cccCCCCCCEEeccCCcCCCC
Q 001152 228 GLYLLQRLENLDLSNNRLTSL 248 (1137)
Q Consensus 228 ~l~~L~~L~~LdLS~N~Lsg~ 248 (1137)
+..+++|+.|+|++|+++..
T Consensus 196 -l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 196 -LAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp -GTTCTTCSEEEEEEEEEECC
T ss_pred -hccCCCCCEEECcCCcccCC
Confidence 55555555555555555543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-19 Score=196.39 Aligned_cols=175 Identities=22% Similarity=0.275 Sum_probs=134.2
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEccCCCCCcccc-cccCCCCCCEE
Q 001152 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECL 119 (1137)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L 119 (1137)
+.+++|+++|.++..++. +. ++|+.|+|++|.|+.++. .|.++++|++|+|++|.|+.++. .|.++++|++|
T Consensus 15 ~~~~l~~~~~~l~~~p~~-~~-----~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 88 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSG-IP-----ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTL 88 (251)
T ss_dssp GGTEEECTTCCCSSCCSC-CC-----TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCeEEecCCCCccccCCC-CC-----CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEE
Confidence 457788888888865543 21 578888888888887754 68888888888888888886644 47778888888
Q ss_pred EccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCcc-ccCCCCCCEEEccCCC
Q 001152 120 QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNK 198 (1137)
Q Consensus 120 ~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~ 198 (1137)
+|++|.+..++ +..|..+++|++|+|++|+|+.+|.. |..+++|++|+|++|+
T Consensus 89 ~L~~n~l~~~~--------------------------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 142 (251)
T 3m19_A 89 GLANNQLASLP--------------------------LGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQ 142 (251)
T ss_dssp ECTTSCCCCCC--------------------------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcccccC--------------------------hhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCc
Confidence 88777654433 12345567778888888888877764 5788888999999998
Q ss_pred CCccch-hhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeccCCcCCCC
Q 001152 199 MKYLPT-EICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSL 248 (1137)
Q Consensus 199 L~~LP~-~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdLS~N~Lsg~ 248 (1137)
|+.+|. .|..+++|+.|+|++|+|+.+|. .+..+++|+.|+|++|.|++.
T Consensus 143 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 143 LQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 888775 57888889999999999887765 577788999999999998876
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.82 E-value=7.7e-21 Score=219.17 Aligned_cols=224 Identities=16% Similarity=0.128 Sum_probs=178.7
Q ss_pred EEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-----ccccCCC-CCcEEEccCCCCCcc-cccccCC----
Q 001152 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-----KSVGRYE-KLRNLKFFGNEINLF-PSEVGNL---- 113 (1137)
Q Consensus 45 ~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP-----~~~~~L~-~L~~L~Ls~N~L~~l-P~~l~~L---- 113 (1137)
+++|++|++++.+|..+... ++|++|+|++|.|+.++ ..|..++ +|++|+|++|.|+.. +..+..+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~---~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~ 78 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIP---HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSC---TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTS
T ss_pred ccccccccchHHHHHHHhCC---CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhcc
Confidence 57899999999999877554 67999999999999876 5678898 899999999999855 5556654
Q ss_pred -CCCCEEEccCCCCCCCccc-----ccCC-CCCCEEECCCCCCCCCccc-chhhhcC-CCCCcEEeccCCCCc-----cc
Q 001152 114 -LGLECLQIKISSPGVNGFA-----LNKL-KGLKELELSKVPPRPSVLT-LLSEIAG-LKCLTKLSVCHFSIR-----YL 179 (1137)
Q Consensus 114 -~~L~~L~Ls~N~~~~~~~~-----~~~L-~~L~~L~Ls~n~ln~~~~~-lp~~l~~-L~~L~~L~Ls~N~L~-----~I 179 (1137)
++|++|+|++|.++..+.. +..+ ++|++|+|++|.+...... +...+.. .++|++|+|++|.|+ .+
T Consensus 79 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp CTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 9999999999997755532 5555 8999999999765433321 1223444 369999999999998 34
Q ss_pred CccccCCC-CCCEEEccCCCCCccc-h----hhcCC-CCCCEEEccCCCCCc-----cCccccC-CCCCCEEeccCCcCC
Q 001152 180 PPEIGCLS-NLEQLDLSFNKMKYLP-T----EICYL-KALISLKVANNKLVE-----LPSGLYL-LQRLENLDLSNNRLT 246 (1137)
Q Consensus 180 P~~l~~L~-~L~~L~Ls~N~L~~LP-~----~l~~L-~~L~~L~Ls~N~Ls~-----IP~~l~~-L~~L~~LdLS~N~Ls 246 (1137)
+..+..++ +|++|+|++|+|+..+ . .+..+ ++|+.|+|++|.|+. +|..+.. .++|+.|+|++|+|+
T Consensus 159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 55566666 9999999999998543 3 44555 599999999999997 7777776 459999999999999
Q ss_pred CCCcc----cccCCCCCCEEEccCCcCCC
Q 001152 247 SLGSL----DLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 247 g~~p~----~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+.++. .+..+++|+.|+|++|.+..
T Consensus 239 ~~~~~~l~~~~~~l~~L~~L~L~~n~l~~ 267 (362)
T 3goz_A 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKN 267 (362)
T ss_dssp CCCHHHHHHTTTTTTTCSEEEEEHHHHTT
T ss_pred cHHHHHHHHHHhcCCCccEEEeccCCccc
Confidence 87763 34678999999999999654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=208.10 Aligned_cols=219 Identities=19% Similarity=0.103 Sum_probs=179.1
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcc-cccCCCCCCCccE-EEeecCCCCccC-ccccCCCC
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIE-SYGNRGGDNSVEG-LYLYKNVLNLIP-KSVGRYEK 92 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~-~~~~l~~L~~L~~-L~Ls~N~L~~IP-~~~~~L~~ 92 (1137)
+++++.|.+..|+|+.|++++|.++++|++|||++|++.+.+|. .|. ++++|.. +.++.|+|+.|| ..|..+++
T Consensus 29 ~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~---~L~~l~~~l~~~~N~l~~l~~~~f~~l~~ 105 (350)
T 4ay9_X 29 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS---NLPKLHEIRIEKANNLLYINPEAFQNLPN 105 (350)
T ss_dssp CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBC---SCTTCCEEEEEEETTCCEECTTSBCCCTT
T ss_pred CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhh---cchhhhhhhcccCCcccccCchhhhhccc
Confidence 35799999999999999999999999999999999999776654 454 4477665 677889999985 57899999
Q ss_pred CcEEEccCCCCCccccc-ccCCCCCCEEEccC-CCCCCCc-ccccCCC-CCCEEECCCCCCCCCcccchhhhcCCCCCcE
Q 001152 93 LRNLKFFGNEINLFPSE-VGNLLGLECLQIKI-SSPGVNG-FALNKLK-GLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168 (1137)
Q Consensus 93 L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~-N~~~~~~-~~~~~L~-~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~ 168 (1137)
|++|++++|+|+.+|.. +....++..|++.. |.+..++ ..|..+. .|+.|+|++|.+ ..+|..+....+|+.
T Consensus 106 L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i----~~i~~~~f~~~~L~~ 181 (350)
T 4ay9_X 106 LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI----QEIHNSAFNGTQLDE 181 (350)
T ss_dssp CCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC----CEECTTSSTTEEEEE
T ss_pred cccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc----cCCChhhccccchhH
Confidence 99999999999988654 56777888898865 4566655 4566664 688999999655 356666667788999
Q ss_pred Eecc-CCCCcccCc-cccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCC-CCCccCccccCCCCCCEEeccCCc
Q 001152 169 LSVC-HFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN-KLVELPSGLYLLQRLENLDLSNNR 244 (1137)
Q Consensus 169 L~Ls-~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N-~Ls~IP~~l~~L~~L~~LdLS~N~ 244 (1137)
|++. +|.++.||. .|..+++|++|+|++|+|+.||... +.+|+.|.+.++ .++.+|. +.++++|+.++++++.
T Consensus 182 l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~--~~~L~~L~~l~~~~l~~lP~-l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRARSTYNLKKLPT-LEKLVALMEASLTYPS 257 (350)
T ss_dssp EECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS--CTTCCEEECTTCTTCCCCCC-TTTCCSCCEEECSCHH
T ss_pred HhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh--hccchHhhhccCCCcCcCCC-chhCcChhhCcCCCCc
Confidence 9997 588999997 5799999999999999999999643 567777776554 5889994 8889999999998764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.6e-20 Score=210.17 Aligned_cols=180 Identities=23% Similarity=0.218 Sum_probs=135.0
Q ss_pred cEEEeecCCCCccCccccCCCCCcEEEccCCCCCccccc-cc-CCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001152 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE-VG-NLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1137)
Q Consensus 71 ~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~-l~-~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ 148 (1137)
+.+++++|.|+.||..+.. .|+.|+|++|+|+.+|.. +. ++++|+.|+|++|.+..++
T Consensus 21 ~~l~c~~~~l~~iP~~~~~--~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~------------------ 80 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFIS------------------ 80 (361)
T ss_dssp TEEECCSSCCSSCCSSCCT--TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEEC------------------
T ss_pred CEEEeCCCCcCccCccCCC--CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccC------------------
Confidence 4667777777777765543 466777777777766543 33 5566666665555433222
Q ss_pred CCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccC
Q 001152 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELP 226 (1137)
Q Consensus 149 ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP 226 (1137)
+..|.++++|++|+|++|+|+.+|. .|..+++|++|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|
T Consensus 81 --------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 152 (361)
T 2xot_A 81 --------SEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152 (361)
T ss_dssp --------TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred --------hhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC
Confidence 2345567778888888888887765 578889999999999999866 567888999999999999999998
Q ss_pred ccc----cCCCCCCEEeccCCcCCCCCcccccCCCC--CCEEEccCCcCCCCCCCCcc
Q 001152 227 SGL----YLLQRLENLDLSNNRLTSLGSLDLCLMHN--LQNLNLQYNKLLSYCQVPSW 278 (1137)
Q Consensus 227 ~~l----~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~--L~~L~Ls~N~L~~~~~iP~~ 278 (1137)
..+ ..+++|+.|+|++|+|+++++..+..++. |+.|+|++|+|.|.|.+-.+
T Consensus 153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l~~~ 210 (361)
T 2xot_A 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQL 210 (361)
T ss_dssp GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHHHHH
T ss_pred HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCcHHH
Confidence 775 46899999999999999998888888887 48999999999998876544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.8e-19 Score=199.27 Aligned_cols=191 Identities=24% Similarity=0.226 Sum_probs=167.8
Q ss_pred CCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001152 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1137)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n 147 (1137)
..+..+.+..+.++.+. .+..+++|+.|++++|.++.+|. +..+++|+.|+|++|.+..++. +..+++|+.|++++|
T Consensus 24 ~~~~~~~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 24 AETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHHHHTTCSCTTSEE-CHHHHHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred HHHHHHHhcCCCccccc-chhhcCcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCC
Confidence 34555667777776552 34678899999999999999975 8999999999999999888777 999999999999997
Q ss_pred CCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001152 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1137)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1137)
.+.. ++ .+..+++|+.|++++|+++.++ .+..+++|+.|+|++|+|+.+ ..+..+++|+.|+|++|+|+.++.
T Consensus 101 ~l~~----~~-~l~~l~~L~~L~L~~n~i~~~~-~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 101 KVKD----LS-SLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp CCCC----GG-GGTTCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred cCCC----Ch-hhccCCCCCEEECCCCcCCCCh-hhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh
Confidence 7644 33 4889999999999999999884 688999999999999999998 589999999999999999998876
Q ss_pred cccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 228 ~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+..+++|+.|+|++|+|++++ .+..+++|+.|+|++|+++.
T Consensus 174 -l~~l~~L~~L~L~~N~i~~l~--~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 174 -LAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -GTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEEEEEEC
T ss_pred -hcCCCccCEEECCCCcCCCCh--hhccCCCCCEEECcCCcccC
Confidence 899999999999999999974 48999999999999999876
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=8e-20 Score=204.20 Aligned_cols=152 Identities=16% Similarity=0.143 Sum_probs=112.8
Q ss_pred CceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCC----hH------HHHHhHHhHHHHHHHHHhCCCCCcceee
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSS----AD------EIRNFEYSCLGEVRMLGALRHSCIVEMY 871 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~----~~------~~e~~~~~~lrEi~iL~~L~HpNIVkll 871 (1137)
.|.+.+.||+|+||.||+|.+. +..+|+|+......... .. .......++.+|+.+|++++ | ++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 3667899999999999999993 57899998643321110 00 00012234589999999999 4 6666
Q ss_pred eeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 001152 872 GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951 (1137)
Q Consensus 872 g~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLK 951 (1137)
+++... ..++||||++|++|.+ +.. .....++.||+.||+|||++||+|||||
T Consensus 168 ~~~~~~---------------~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~giiHrDlk 220 (282)
T 1zar_A 168 KVYAWE---------------GNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRGIVHGDLS 220 (282)
T ss_dssp CEEEEE---------------TTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eEEecc---------------ceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCCCEeCCCC
Confidence 655432 3499999999999987 421 2245799999999999999999999999
Q ss_pred CCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcc
Q 001152 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015 (1137)
Q Consensus 952 P~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 1015 (1137)
|+|||++ + +.+||+|||+++. +..|+|||++..
T Consensus 221 p~NILl~-~-------~~vkl~DFG~a~~-----------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 221 QYNVLVS-E-------EGIWIIDFPQSVE-----------------------VGEEGWREILER 253 (282)
T ss_dssp TTSEEEE-T-------TEEEECCCTTCEE-----------------------TTSTTHHHHHHH
T ss_pred HHHEEEE-C-------CcEEEEECCCCeE-----------------------CCCCCHHHHHHH
Confidence 9999999 6 7899999998752 236789998764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=221.95 Aligned_cols=171 Identities=20% Similarity=0.236 Sum_probs=90.3
Q ss_pred CCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001152 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1137)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n 147 (1137)
++|+.|+|++|.|+.+| .|..|++|+.|+|++|.|+.+|. +.+|++|+.|+|++|.+..++ .+..|++|+.|+|++|
T Consensus 43 ~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N 119 (605)
T 1m9s_A 43 NSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKDLS-SLKDLKKLKSLSLEHN 119 (605)
T ss_dssp TTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCT-TSTTCTTCCEEECTTS
T ss_pred CCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCCCh-hhccCCCCCEEEecCC
Confidence 45555555555555554 35555555555555555555544 555555555555555444332 2334444444444443
Q ss_pred CCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001152 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1137)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1137)
.+... ..+..|++|+.|+|++|.|+.+ ..+..|++|+.|+|++|+|+.++. +..+++|+.|+|++|+|+.+|
T Consensus 120 ~l~~l-----~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l~- 191 (605)
T 1m9s_A 120 GISDI-----NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDLR- 191 (605)
T ss_dssp CCCCC-----GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBCG-
T ss_pred CCCCC-----ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCCh-
Confidence 33221 1344555555666666655555 345555666666666666655543 555666666666666665553
Q ss_pred cccCCCCCCEEeccCCcCCCCC
Q 001152 228 GLYLLQRLENLDLSNNRLTSLG 249 (1137)
Q Consensus 228 ~l~~L~~L~~LdLS~N~Lsg~~ 249 (1137)
.+..|++|+.|+|++|.|++.+
T Consensus 192 ~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 192 ALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp GGTTCTTCSEEECCSEEEECCC
T ss_pred HHccCCCCCEEEccCCcCcCCc
Confidence 3555566666666666665544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.9e-20 Score=209.73 Aligned_cols=231 Identities=16% Similarity=0.134 Sum_probs=189.3
Q ss_pred CCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCC-CcccccCCCCCCCccEEEeecCCCC-ccCccccCCCCCc
Q 001152 17 PIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFP-LIESYGNRGGDNSVEGLYLYKNVLN-LIPKSVGRYEKLR 94 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~-~p~~~~~l~~L~~L~~L~Ls~N~L~-~IP~~~~~L~~L~ 94 (1137)
+.+..+.+..|.|..+.+. +..+++|++|+|++|.+++. ++..+..+ ++|++|+|++|.++ .+|..|..+++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~---~~L~~L~L~~~~l~~~~~~~l~~~~~L~ 145 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQC---SKLQNLSLEGLRLSDPIVNTLAKNSNLV 145 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTB---CCCSEEECTTCBCCHHHHHHHTTCTTCS
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhC---CCCCEEeCcCcccCHHHHHHHhcCCCCC
Confidence 3688899999999998776 55799999999999999876 66666554 99999999999998 6788899999999
Q ss_pred EEEccCC-CCC--cccccccCCCCCCEEEccCC-CCCC--CcccccCCC-CCCEEECCCCCCCCCcccchhhhcCCCCCc
Q 001152 95 NLKFFGN-EIN--LFPSEVGNLLGLECLQIKIS-SPGV--NGFALNKLK-GLKELELSKVPPRPSVLTLLSEIAGLKCLT 167 (1137)
Q Consensus 95 ~L~Ls~N-~L~--~lP~~l~~L~~L~~L~Ls~N-~~~~--~~~~~~~L~-~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~ 167 (1137)
+|+|++| .++ .+|..+.++++|+.|+|++| .++. ++..+..++ +|++|++++|.+.-....+|..+..+++|+
T Consensus 146 ~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~ 225 (336)
T 2ast_B 146 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 225 (336)
T ss_dssp EEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCS
T ss_pred EEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCC
Confidence 9999999 788 47888999999999999999 7764 456788999 999999999642122256777788999999
Q ss_pred EEeccCCC-Cc-ccCccccCCCCCCEEEccCCC-CC-ccchhhcCCCCCCEEEccCCCCCccCcc-ccCC-CCCCEEecc
Q 001152 168 KLSVCHFS-IR-YLPPEIGCLSNLEQLDLSFNK-MK-YLPTEICYLKALISLKVANNKLVELPSG-LYLL-QRLENLDLS 241 (1137)
Q Consensus 168 ~L~Ls~N~-L~-~IP~~l~~L~~L~~L~Ls~N~-L~-~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L-~~L~~LdLS 241 (1137)
.|++++|. ++ ..+..+..+++|+.|+|++|. +. .....++++++|+.|+|++| +|.. +..+ .+|..|+++
T Consensus 226 ~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~----i~~~~~~~l~~~l~~L~l~ 301 (336)
T 2ast_B 226 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI----VPDGTLQLLKEALPHLQIN 301 (336)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS----SCTTCHHHHHHHSTTSEES
T ss_pred EEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc----cCHHHHHHHHhhCcceEEe
Confidence 99999999 66 667788999999999999995 33 11236888999999999999 4432 3333 346777799
Q ss_pred CCcCCCCCcccccC
Q 001152 242 NNRLTSLGSLDLCL 255 (1137)
Q Consensus 242 ~N~Lsg~~p~~l~~ 255 (1137)
+|+|++..|..++.
T Consensus 302 ~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 302 CSHFTTIARPTIGN 315 (336)
T ss_dssp CCCSCCTTCSSCSS
T ss_pred cccCccccCCcccc
Confidence 99999999876654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4e-19 Score=218.69 Aligned_cols=190 Identities=20% Similarity=0.172 Sum_probs=164.4
Q ss_pred ccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCC
Q 001152 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGN 101 (1137)
Q Consensus 22 L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N 101 (1137)
+.+..+.+..+. .+..+++|+.|+|++|.|.... .+ ..|++|+.|+|++|.|+.+|+ |..|++|+.|+|++|
T Consensus 26 l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~l~--~l---~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N 97 (605)
T 1m9s_A 26 DNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQ--GI---QYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDEN 97 (605)
T ss_dssp HHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCCCT--TG---GGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSS
T ss_pred HhccCCCccccc--chhcCCCCCEEECcCCCCCCCh--HH---ccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCC
Confidence 344555665553 4678899999999999998753 24 445999999999999999877 999999999999999
Q ss_pred CCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc
Q 001152 102 EINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181 (1137)
Q Consensus 102 ~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~ 181 (1137)
.|+.+| .+..|++|+.|+|++|.+..++ .+..|++|+.|+|++|.+... ..+..|++|+.|+|++|.|+.+++
T Consensus 98 ~l~~l~-~l~~l~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l-----~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 98 KIKDLS-SLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI-----TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp CCCCCT-TSTTCTTCCEEECTTSCCCCCG-GGGGCTTCSEEECCSSCCCCC-----GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCCh-hhccCCCCCEEEecCCCCCCCc-cccCCCccCEEECCCCccCCc-----hhhcccCCCCEEECcCCcCCCchh
Confidence 999887 6999999999999999988764 588999999999999877653 468899999999999999998876
Q ss_pred cccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcc
Q 001152 182 EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228 (1137)
Q Consensus 182 ~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~ 228 (1137)
+..+++|+.|+|++|+|+.+| .+..|++|+.|+|++|.|+..|..
T Consensus 171 -l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 171 -LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp -GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEECCSEEEECCCCC
T ss_pred -hccCCCCCEEECcCCCCCCCh-HHccCCCCCEEEccCCcCcCCccc
Confidence 899999999999999999986 699999999999999999876643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-18 Score=187.03 Aligned_cols=121 Identities=19% Similarity=0.231 Sum_probs=102.4
Q ss_pred hcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCCcc-CccccCCCCCC
Q 001152 160 IAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVEL-PSGLYLLQRLE 236 (1137)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~-~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~ 236 (1137)
|..+++|+.|+|++|+|+.+|. .|..+++|++|+|++|+|+.+|. .|..+++|++|+|++|+|+.+ |..+..+++|+
T Consensus 53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 132 (220)
T 2v70_A 53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR 132 (220)
T ss_dssp GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence 3456667777777777776665 78888999999999999997765 478899999999999999977 67788899999
Q ss_pred EEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchh
Q 001152 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1137)
Q Consensus 237 ~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1137)
.|+|++|+|++++|..|..+++|+.|+|++|+|.|.|.+.....
T Consensus 133 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~l~~ 176 (220)
T 2v70_A 133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAWLGE 176 (220)
T ss_dssp EEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGGHHHHH
T ss_pred EEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCchHHHHH
Confidence 99999999999999899999999999999999999887654433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.3e-18 Score=185.01 Aligned_cols=122 Identities=24% Similarity=0.284 Sum_probs=100.7
Q ss_pred hcCCCCCcEEeccCCCCccc-CccccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCcc-CccccCCCCCC
Q 001152 160 IAGLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVEL-PSGLYLLQRLE 236 (1137)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~ 236 (1137)
|..+++|+.|+|++|+|+.+ |..|..+++|++|+|++|+|+.+|.. |..+++|+.|+|++|+|+.+ |..|..+++|+
T Consensus 52 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 131 (220)
T 2v9t_B 52 FSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLN 131 (220)
T ss_dssp STTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCC
Confidence 34455666777777777755 56788888888889998988888765 57789999999999999977 55688899999
Q ss_pred EEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhh
Q 001152 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1137)
Q Consensus 237 ~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1137)
.|+|++|+|+++++..|..+++|+.|+|++|+|.|.|.+.....+
T Consensus 132 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l~~l~~~ 176 (220)
T 2v9t_B 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHLKWLADY 176 (220)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHH
T ss_pred EEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCccHHHHHH
Confidence 999999999999988899999999999999999999887555444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.1e-18 Score=184.03 Aligned_cols=116 Identities=29% Similarity=0.342 Sum_probs=98.1
Q ss_pred hhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCccCccccCCCCCC
Q 001152 159 EIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLE 236 (1137)
Q Consensus 159 ~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~ 236 (1137)
.|.++++|+.|+|++|+|+.+|. .|..+++|++|+|++|+|+.+|.. |..+++|+.|+|++|+|+.||..+..+++|+
T Consensus 59 ~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~ 138 (229)
T 3e6j_A 59 VFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLT 138 (229)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCS
T ss_pred HhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCC
Confidence 34456667777777777777765 457888899999999999888754 5789999999999999999999999999999
Q ss_pred EEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001152 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1137)
Q Consensus 237 ~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1137)
.|+|++|+|+++++..|..+++|+.|+|++|+|.|.|.
T Consensus 139 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 139 HLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred EEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 99999999999988789999999999999999998664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-21 Score=236.60 Aligned_cols=196 Identities=23% Similarity=0.212 Sum_probs=147.8
Q ss_pred CCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCC-------------CC-cccccccCCCCCCEEE-
Q 001152 56 PLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNE-------------IN-LFPSEVGNLLGLECLQ- 120 (1137)
Q Consensus 56 ~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~-------------L~-~lP~~l~~L~~L~~L~- 120 (1137)
....++.++..++.|+.|+|++|+|+.||.+|++|++|+.|++++|. +. .+|..+++|++|+.|+
T Consensus 337 ~~~~~~~d~~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~ 416 (567)
T 1dce_A 337 RPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP 416 (567)
T ss_dssp CSEEEEECCSTTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCG
T ss_pred CchhhhcccccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcc
Confidence 33344444556688888899998888888888888888888887764 22 3344455555555555
Q ss_pred ccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCC
Q 001152 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMK 200 (1137)
Q Consensus 121 Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~ 200 (1137)
++.|. +.+|..+.+++| .+..+|. ..|+.|+|++|.|+.||. |+.+++|+.|+|++|+|+
T Consensus 417 l~~n~----------~~~L~~l~l~~n----~i~~l~~-----~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~ 476 (567)
T 1dce_A 417 MRAAY----------LDDLRSKFLLEN----SVLKMEY-----ADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR 476 (567)
T ss_dssp GGHHH----------HHHHHHHHHHHH----HHHHHHH-----TTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC
T ss_pred hhhcc----------cchhhhhhhhcc----cccccCc-----cCceEEEecCCCCCCCcC-ccccccCcEeecCccccc
Confidence 33222 122223333331 1222222 248889999999999987 899999999999999999
Q ss_pred ccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCC-cccccCCCCCCEEEccCCcCCCC
Q 001152 201 YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG-SLDLCLMHNLQNLNLQYNKLLSY 272 (1137)
Q Consensus 201 ~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~-p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1137)
.||..|+.+++|+.|+|++|+|+.|| .++.+++|+.|+|++|+|++++ |..|..|++|+.|+|++|+|++.
T Consensus 477 ~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 477 ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 99999999999999999999999998 8889999999999999999986 77899999999999999998874
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.2e-18 Score=181.29 Aligned_cols=92 Identities=18% Similarity=0.172 Sum_probs=48.2
Q ss_pred hcCCCCCcEEeccCCCCcccCcc-ccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCccCccccCCCCCCE
Q 001152 160 IAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGLYLLQRLEN 237 (1137)
Q Consensus 160 l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~ 237 (1137)
+..+++|++|++++|+|+.+|.. |..+++|++|+|++|+|+.+|.. +..+++|+.|+|++|.+. +.+++|+.
T Consensus 96 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~------~~~~~l~~ 169 (208)
T 2o6s_A 96 FDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD------CTCPGIRY 169 (208)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC------CCTTTTHH
T ss_pred hcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee------cCCCCHHH
Confidence 34455555555555555554442 45555555555555555555433 455555555555555433 22345555
Q ss_pred EeccCCcCCCCCcccccCCC
Q 001152 238 LDLSNNRLTSLGSLDLCLMH 257 (1137)
Q Consensus 238 LdLS~N~Lsg~~p~~l~~L~ 257 (1137)
|+++.|+++|.+|.+++.++
T Consensus 170 L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 170 LSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp HHHHHHHCTTTBBCTTSSBC
T ss_pred HHHHHHhCCceeeccCcccc
Confidence 55555555555555544443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=6.6e-19 Score=194.52 Aligned_cols=167 Identities=22% Similarity=0.192 Sum_probs=77.9
Q ss_pred CccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001152 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1137)
Q Consensus 69 ~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ 148 (1137)
+++.|+|++|.++.++ .+..+++|++|+|++|.|+.+| .+..+++|+.|+|++|.+..++.
T Consensus 20 ~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~----------------- 80 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP----------------- 80 (263)
T ss_dssp HHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-----------------
T ss_pred HHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh-----------------
Confidence 3444445555555444 3444455555555555555444 34444444444444444332222
Q ss_pred CCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcc
Q 001152 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG 228 (1137)
Q Consensus 149 ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~ 228 (1137)
+..+++|+.|++++|+|+.+|.... ++|++|+|++|+|+.+| .+..+++|+.|+|++|+|+.+| .
T Consensus 81 -----------l~~l~~L~~L~L~~N~l~~l~~~~~--~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~~-~ 145 (263)
T 1xeu_A 81 -----------LKDLTKLEELSVNRNRLKNLNGIPS--ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSIV-M 145 (263)
T ss_dssp -----------GTTCSSCCEEECCSSCCSCCTTCCC--SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBCG-G
T ss_pred -----------hccCCCCCEEECCCCccCCcCcccc--CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCCh-H
Confidence 3333444444444444444433211 44555555555555443 3444555555555555555443 3
Q ss_pred ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 229 LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 229 l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++
T Consensus 146 l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 146 LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp GGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred HccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 44455555555555555544 234455555555555555443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=192.09 Aligned_cols=149 Identities=24% Similarity=0.272 Sum_probs=124.8
Q ss_pred CCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcE
Q 001152 89 RYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTK 168 (1137)
Q Consensus 89 ~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~ 168 (1137)
++.+|..|+|++|.++.++ .+..+++|+.|++++|.+.. ++ .+..+++|+.
T Consensus 17 ~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~---------------------------l~-~l~~l~~L~~ 67 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQS---------------------------LA-GMQFFTNLKE 67 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCC---------------------------CT-TGGGCTTCCE
T ss_pred HHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCccc---------------------------ch-HHhhCCCCCE
Confidence 4556777788888888776 56667777777776655332 22 4567888999
Q ss_pred EeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCC
Q 001152 169 LSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSL 248 (1137)
Q Consensus 169 L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~ 248 (1137)
|++++|+|+.+|. +..+++|++|+|++|+|+.+|.... ++|+.|+|++|+|+.+| .+..+++|+.|+|++|+|+++
T Consensus 68 L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~l~~~~~--~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~ 143 (263)
T 1xeu_A 68 LHLSHNQISDLSP-LKDLTKLEELSVNRNRLKNLNGIPS--ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSI 143 (263)
T ss_dssp EECCSSCCCCCGG-GTTCSSCCEEECCSSCCSCCTTCCC--SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBC
T ss_pred EECCCCccCCChh-hccCCCCCEEECCCCccCCcCcccc--CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCC
Confidence 9999999998888 9999999999999999999885433 89999999999999986 589999999999999999998
Q ss_pred CcccccCCCCCCEEEccCCcCCCC
Q 001152 249 GSLDLCLMHNLQNLNLQYNKLLSY 272 (1137)
Q Consensus 249 ~p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1137)
+ .+..+++|+.|+|++|+|+++
T Consensus 144 ~--~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 144 V--MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp G--GGGGCTTCCEEECTTSCCCBC
T ss_pred h--HHccCCCCCEEECCCCcCcch
Confidence 4 689999999999999999874
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=9.8e-18 Score=177.56 Aligned_cols=169 Identities=20% Similarity=0.176 Sum_probs=102.4
Q ss_pred CccEEEeecCCCCccCc-cccCCCCCcEEEccCCCCCccccc-ccCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEECC
Q 001152 69 SVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELELS 145 (1137)
Q Consensus 69 ~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~~~~~~~-~~~~L~~L~~L~Ls 145 (1137)
+|++|+|++|.|+.+|. .|..+++|++|+|++|+|+.+|.. |.++++|++|+|++|.+..++. .+..+++|++|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44444444444444433 234444444444444444444332 3444444444444444433332 24455555555555
Q ss_pred CCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCcc-ccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCC-
Q 001152 146 KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV- 223 (1137)
Q Consensus 146 ~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls- 223 (1137)
+|.+.. ..+..+..+++|+.|++++|.|+.+|.. +..+++|+.|+|++|.+. +.+++|++|+++.|+++
T Consensus 109 ~N~l~~---~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~------~~~~~l~~L~~~~n~~~g 179 (208)
T 2o6s_A 109 TNQLQS---LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD------CTCPGIRYLSEWINKHSG 179 (208)
T ss_dssp SSCCCC---CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC------CCTTTTHHHHHHHHHCTT
T ss_pred CCcCcc---cCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee------cCCCCHHHHHHHHHhCCc
Confidence 543322 1123466788899999999999888774 788999999999999765 34568899999999998
Q ss_pred ccCccccCCCCCCEEeccCCcCCCCCc
Q 001152 224 ELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1137)
Q Consensus 224 ~IP~~l~~L~~L~~LdLS~N~Lsg~~p 250 (1137)
.||.+++.++. ++..+...+.++
T Consensus 180 ~ip~~~~~l~~----~~~~C~~~~~~~ 202 (208)
T 2o6s_A 180 VVRNSAGSVAP----DSAKCSGSGKPV 202 (208)
T ss_dssp TBBCTTSSBCT----TCSBBTTTCCBG
T ss_pred eeeccCccccC----CccccccCCCcc
Confidence 88998887765 444555444444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.8e-17 Score=176.50 Aligned_cols=153 Identities=22% Similarity=0.256 Sum_probs=115.2
Q ss_pred ccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcc-cccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001152 70 VEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLF-PSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1137)
Q Consensus 70 L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ 148 (1137)
.+.++.++|.++.||..+. ++|++|+|++|.|+.+ |..|.++++|+.|+|++|.+..++
T Consensus 21 ~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~------------------ 80 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALP------------------ 80 (229)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC------------------
T ss_pred CCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcC------------------
Confidence 4567777777777776554 5777777777777755 455666666666666666543332
Q ss_pred CCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001152 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1137)
Q Consensus 149 ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1137)
+..|..+++|+.|+|++|+|+.+|. .|..+++|++|+|++|+|+.+|..+..+++|+.|+|++|+|+.+|.
T Consensus 81 --------~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 81 --------VGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp --------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred --------hhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCH
Confidence 1234567778888888888887776 4678899999999999999999889899999999999999998875
Q ss_pred c-ccCCCCCCEEeccCCcCCCCCc
Q 001152 228 G-LYLLQRLENLDLSNNRLTSLGS 250 (1137)
Q Consensus 228 ~-l~~L~~L~~LdLS~N~Lsg~~p 250 (1137)
. +..+++|+.|+|++|.+++..+
T Consensus 153 ~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 153 GAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TTTTTCTTCCEEECTTSCBCTTBG
T ss_pred HHHhCCCCCCEEEeeCCCccCCcc
Confidence 4 7778999999999999886643
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=8.4e-19 Score=220.52 Aligned_cols=194 Identities=19% Similarity=0.065 Sum_probs=88.9
Q ss_pred CCCCCEEEccCCCCCCCCcccccCCCCCC--CccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCC
Q 001152 40 DDDDSVIDVSGKTVDFPLIESYGNRGGDN--SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117 (1137)
Q Consensus 40 l~~L~~LdLs~N~L~~~~p~~~~~l~~L~--~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~ 117 (1137)
.+.+..|+|++|.+.......+..+ .|. +|..+++..|.+...|..|..+++|+.|+|++|.|..||..++++++|+
T Consensus 172 ~~~~~~l~L~~n~~~~~~~~~l~~l-~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~ 250 (727)
T 4b8c_D 172 TPLTPKIELFANGKDEANQALLQHK-KLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLT 250 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCSCCCGGGGGCCSCS
T ss_pred CCccceEEeeCCCCCcchhhHhhcC-ccCcccccCccccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCC
Confidence 3557777787777766432211111 111 1222333334444344556666666666666666666666555555555
Q ss_pred EEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCC
Q 001152 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFN 197 (1137)
Q Consensus 118 ~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N 197 (1137)
+|+|++|.+. .+|..|++|++|++|+|++|.|+.||..|+.|++|++|+|++|
T Consensus 251 ~L~Ls~N~l~---------------------------~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N 303 (727)
T 4b8c_D 251 RLYLNGNSLT---------------------------ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDN 303 (727)
T ss_dssp CCBCTTSCCS---------------------------CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSS
T ss_pred EEEeeCCcCc---------------------------ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCC
Confidence 5555544433 3455566677777777777777777777777777777777777
Q ss_pred CCCccchhhcCCCCCCEEEccCCCCC-ccCccccCCC-CCCEEeccCCcCCCCCcccccCCCCCCEEEccCC
Q 001152 198 KMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQ-RLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1137)
Q Consensus 198 ~L~~LP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~-~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N 267 (1137)
.|+.||..|+.|++|+.|+|++|.|+ .+|..+..+. .+..|+|++|.+++.+|. .|..|++++|
T Consensus 304 ~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n 369 (727)
T 4b8c_D 304 MVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTD 369 (727)
T ss_dssp CCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------
T ss_pred CCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecc
Confidence 77777777777777777777777777 4455554322 122367777777777663 4556666665
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-17 Score=175.31 Aligned_cols=152 Identities=16% Similarity=0.207 Sum_probs=102.7
Q ss_pred cCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCc
Q 001152 88 GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLT 167 (1137)
Q Consensus 88 ~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~ 167 (1137)
..+++|+.|+|++|.|+.+| .+..+++|+.|++++|.+... ..+..+++|+
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~----------------------------~~l~~l~~L~ 91 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNY----------------------------NPISGLSNLE 91 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCC----------------------------GGGTTCTTCC
T ss_pred hhcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcc----------------------------hhhhcCCCCC
Confidence 44555666666666666555 455555555555554432211 2345566677
Q ss_pred EEeccCCCCcc-cCccccCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCC-CCccCccccCCCCCCEEeccCCc
Q 001152 168 KLSVCHFSIRY-LPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNK-LVELPSGLYLLQRLENLDLSNNR 244 (1137)
Q Consensus 168 ~L~Ls~N~L~~-IP~~l~~L~~L~~L~Ls~N~L~-~LP~~l~~L~~L~~L~Ls~N~-Ls~IP~~l~~L~~L~~LdLS~N~ 244 (1137)
+|++++|.++. .|..++.+++|++|+|++|+++ ..|..++.+++|+.|+|++|+ ++.+| .+..+++|+.|+|++|+
T Consensus 92 ~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBC
T ss_pred EEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCC
Confidence 77777777763 5667777888888888888887 466777788888888888887 77776 57778888888888888
Q ss_pred CCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 245 LTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 245 Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+++++ .+..+++|+.|++++|++..
T Consensus 171 i~~~~--~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 171 VHDYR--GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCCCT--TGGGCSSCCEEEECBC----
T ss_pred CcChH--HhccCCCCCEEEeeCcccCC
Confidence 88764 57778888888888887643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-17 Score=183.74 Aligned_cols=142 Identities=15% Similarity=0.123 Sum_probs=103.8
Q ss_pred ceEeeeecccCceEEEEEEE--CCcc--EEEEEEecccCCCChH----------------HHHHhHHhHHHHHHHHHhCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKF--GSAD--AAAKVRTLKVCGSSAD----------------EIRNFEYSCLGEVRMLGALR 863 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~--~~~~--vAVKi~~l~~~~~~~~----------------~~e~~~~~~lrEi~iL~~L~ 863 (1137)
|++.+.||+|+||.||+|.+ .+.. +|||+.+......... .......++.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998 6778 9999864432111000 01112235688999999999
Q ss_pred CCCc--ceeeeeEecCCCCCCCCCCCccccceEEEEEeeccC-C----CHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHH
Q 001152 864 HSCI--VEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG-G----SVKNYIEKLSETGEKHVSVKLALFIAQDVAAA 936 (1137)
Q Consensus 864 HpNI--Vkllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~g-g----SL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~g 936 (1137)
|++| ..++++ . ..+|||||+.+ | +|.++... .++..+..++.||+.|
T Consensus 129 ~~~i~~p~~~~~--~----------------~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~ 182 (258)
T 1zth_A 129 EAGVSVPQPYTY--M----------------KNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVEN 182 (258)
T ss_dssp HTTCCCCCEEEE--E----------------TTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc--C----------------CCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHH
Confidence 8865 344432 1 23899999942 3 67665422 2345678899999999
Q ss_pred HHHHH-hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCcccc
Q 001152 937 LVELH-SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 980 (1137)
Q Consensus 937 L~yLH-s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~ 980 (1137)
|.||| +.||+||||||+|||++. .++|+|||+|..
T Consensus 183 l~~lH~~~givHrDlkp~NILl~~---------~~~liDFG~a~~ 218 (258)
T 1zth_A 183 VKRLYQEAELVHADLSEYNIMYID---------KVYFIDMGQAVT 218 (258)
T ss_dssp HHHHHHTSCEECSSCSTTSEEESS---------SEEECCCTTCEE
T ss_pred HHHHHHHCCEEeCCCCHHHEEEcC---------cEEEEECccccc
Confidence 99999 999999999999999974 499999999864
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=9.7e-20 Score=222.68 Aligned_cols=203 Identities=18% Similarity=0.180 Sum_probs=160.3
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCC-------------CC-ccCccccCCCCCcEEE-ccCC
Q 001152 37 VNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV-------------LN-LIPKSVGRYEKLRNLK-FFGN 101 (1137)
Q Consensus 37 f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~-------------L~-~IP~~~~~L~~L~~L~-Ls~N 101 (1137)
+..+++|+.|+|++|+|+ .+|..++.+ ++|+.|++++|. +. .+|..+++|++|+.|+ ++.|
T Consensus 345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l---~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n 420 (567)
T 1dce_A 345 SATDEQLFRCELSVEKST-VLQSELESC---KELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420 (567)
T ss_dssp CSTTTTSSSCCCCHHHHH-HHHHHHHHH---HHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHH
T ss_pred cccCccceeccCChhhHH-hhHHHHHHH---HHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhc
Confidence 367889999999999997 567777766 899999997774 33 5577889999999999 7877
Q ss_pred CCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc
Q 001152 102 EINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP 181 (1137)
Q Consensus 102 ~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~ 181 (1137)
.+..++. +.++.|.+..++. ..|+.|+|++|.+.. +|. ++.|++|+.|+|++|.|+.||.
T Consensus 421 ~~~~L~~----------l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~----lp~-~~~l~~L~~L~Ls~N~l~~lp~ 480 (567)
T 1dce_A 421 YLDDLRS----------KFLLENSVLKMEY-----ADVRVLHLAHKDLTV----LCH-LEQLLLVTHLDLSHNRLRALPP 480 (567)
T ss_dssp HHHHHHH----------HHHHHHHHHHHHH-----TTCSEEECTTSCCSS----CCC-GGGGTTCCEEECCSSCCCCCCG
T ss_pred ccchhhh----------hhhhcccccccCc-----cCceEEEecCCCCCC----CcC-ccccccCcEeecCcccccccch
Confidence 6654433 2333333222221 136777777755433 454 7888899999999999999999
Q ss_pred cccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCcc--CccccCCCCCCEEeccCCcCCCCCccc---ccCC
Q 001152 182 EIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL--PSGLYLLQRLENLDLSNNRLTSLGSLD---LCLM 256 (1137)
Q Consensus 182 ~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~I--P~~l~~L~~L~~LdLS~N~Lsg~~p~~---l~~L 256 (1137)
.|+.+++|+.|+|++|+|+.|| .|+.+++|+.|+|++|+|+.+ |..++.+++|+.|+|++|+|++.+|.. +..+
T Consensus 481 ~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~l 559 (567)
T 1dce_A 481 ALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 559 (567)
T ss_dssp GGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHC
T ss_pred hhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHC
Confidence 9999999999999999999998 899999999999999999977 889999999999999999999987732 2348
Q ss_pred CCCCEEEc
Q 001152 257 HNLQNLNL 264 (1137)
Q Consensus 257 ~~L~~L~L 264 (1137)
++|+.|+|
T Consensus 560 p~L~~L~l 567 (567)
T 1dce_A 560 PSVSSILT 567 (567)
T ss_dssp TTCSEEEC
T ss_pred cccCccCC
Confidence 89999875
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.5e-17 Score=171.40 Aligned_cols=150 Identities=19% Similarity=0.254 Sum_probs=95.4
Q ss_pred CCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001152 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1137)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n 147 (1137)
++|+.|+|++|.++.+| .+..+++|++|+|++|.++.++ .+..+++|++|+|++|.+..
T Consensus 44 ~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~------------------- 102 (197)
T 4ezg_A 44 NSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTS------------------- 102 (197)
T ss_dssp HTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBG-------------------
T ss_pred CCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCc-------------------
Confidence 66777777777777777 5777777777777777666554 56667777777776665332
Q ss_pred CCCCCcccchhhhcCCCCCcEEeccCCCCc-ccCccccCCCCCCEEEccCCC-CCccchhhcCCCCCCEEEccCCCCCcc
Q 001152 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIR-YLPPEIGCLSNLEQLDLSFNK-MKYLPTEICYLKALISLKVANNKLVEL 225 (1137)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~-L~~LP~~l~~L~~L~~L~Ls~N~Ls~I 225 (1137)
..|..+..+++|++|++++|+++ ..|..++.+++|++|+|++|+ ++.+| .+..+++|+.|+|++|+++.+
T Consensus 103 -------~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~ 174 (197)
T 4ezg_A 103 -------DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY 174 (197)
T ss_dssp -------GGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC
T ss_pred -------ccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh
Confidence 11223444555666666666665 345556666666777777666 66665 566667777777777777666
Q ss_pred CccccCCCCCCEEeccCCcCCC
Q 001152 226 PSGLYLLQRLENLDLSNNRLTS 247 (1137)
Q Consensus 226 P~~l~~L~~L~~LdLS~N~Lsg 247 (1137)
| .+..+++|+.|+|++|++.+
T Consensus 175 ~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 175 R-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp T-TGGGCSSCCEEEECBC----
T ss_pred H-HhccCCCCCEEEeeCcccCC
Confidence 5 56666777777777776653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.71 E-value=7.3e-17 Score=173.28 Aligned_cols=149 Identities=21% Similarity=0.276 Sum_probs=100.5
Q ss_pred cEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccc-cccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCC
Q 001152 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPP 149 (1137)
Q Consensus 71 ~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~l 149 (1137)
+.+++++|.|+.||..+. ++|+.|+|++|+|+.+|. .|.++++|+.|+|++|.+..
T Consensus 14 ~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~--------------------- 70 (220)
T 2v9t_B 14 NIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE--------------------- 70 (220)
T ss_dssp TEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCE---------------------
T ss_pred CEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCC---------------------
Confidence 456666666666665544 456666666666665543 35555555555555444321
Q ss_pred CCCcccchhhhcCCCCCcEEeccCCCCcccCcc-ccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCc
Q 001152 150 RPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE-IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPS 227 (1137)
Q Consensus 150 n~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~-l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1137)
..|..|.++++|++|+|++|+|+.+|.. |..+++|++|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+|.
T Consensus 71 -----~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 71 -----LAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145 (220)
T ss_dssp -----ECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred -----cCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECH
Confidence 1234556667777777777777777764 57788888888888888866 4567788888888888888887765
Q ss_pred c-ccCCCCCCEEeccCCcCCC
Q 001152 228 G-LYLLQRLENLDLSNNRLTS 247 (1137)
Q Consensus 228 ~-l~~L~~L~~LdLS~N~Lsg 247 (1137)
. +..+++|+.|+|++|.+..
T Consensus 146 ~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 146 GTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp TTTTTCTTCCEEECCSSCEEC
T ss_pred HHHhCCCCCCEEEeCCCCcCC
Confidence 4 6678888888888888764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.9e-17 Score=188.28 Aligned_cols=172 Identities=23% Similarity=0.232 Sum_probs=122.2
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-cc-CCCCCcEEEccCCCCCcccc-cccCCCCCCEEE
Q 001152 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS-VG-RYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQ 120 (1137)
Q Consensus 44 ~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~-~~-~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~ 120 (1137)
+++++++|+|+.++.. +. ..|+.|+|++|+|+.+|.. |. ++++|++|+|++|+|+.+|. .|.++++|++|+
T Consensus 21 ~~l~c~~~~l~~iP~~-~~-----~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~ 94 (361)
T 2xot_A 21 NILSCSKQQLPNVPQS-LP-----SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLD 94 (361)
T ss_dssp TEEECCSSCCSSCCSS-CC-----TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CEEEeCCCCcCccCcc-CC-----CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEE
Confidence 5889999998875432 22 4588999999999988654 55 88999999999999998764 588888888888
Q ss_pred ccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCccc-CccccCCCCCCEEEccCCCC
Q 001152 121 IKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKM 199 (1137)
Q Consensus 121 Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~L 199 (1137)
|++|.+..++. ..|.++++|+.|+|++|+|+.+ |..|..+++|+.|+|++|+|
T Consensus 95 Ls~N~l~~~~~--------------------------~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 148 (361)
T 2xot_A 95 LSSNHLHTLDE--------------------------FLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI 148 (361)
T ss_dssp CCSSCCCEECT--------------------------TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCcCCcCCH--------------------------HHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcC
Confidence 88777544331 2344566666777777777655 44667777777777777777
Q ss_pred Cccchhh----cCCCCCCEEEccCCCCCccCc-cccCCCC--CCEEeccCCcCCC
Q 001152 200 KYLPTEI----CYLKALISLKVANNKLVELPS-GLYLLQR--LENLDLSNNRLTS 247 (1137)
Q Consensus 200 ~~LP~~l----~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~--L~~LdLS~N~Lsg 247 (1137)
+.+|..+ ..+++|+.|+|++|+|+.+|. .+..++. |+.|+|++|.+..
T Consensus 149 ~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 149 SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 7777554 457777777777777777764 3555665 3677888887763
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-16 Score=170.15 Aligned_cols=151 Identities=16% Similarity=0.193 Sum_probs=89.2
Q ss_pred cEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccc--cccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001152 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1137)
Q Consensus 71 ~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~--~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ 148 (1137)
+.|++++|.|+.||..+.. .+++|+|++|+|+.++. .|.++++|+.|+|++|.+..++
T Consensus 14 ~~l~~s~n~l~~iP~~~~~--~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~------------------ 73 (220)
T 2v70_A 14 TTVDCSNQKLNKIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIE------------------ 73 (220)
T ss_dssp TEEECCSSCCSSCCSCCCT--TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEEC------------------
T ss_pred CEeEeCCCCcccCccCCCC--CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEEC------------------
Confidence 3556666666666554432 34566666666655422 2555666666665555433222
Q ss_pred CCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCcc-
Q 001152 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVEL- 225 (1137)
Q Consensus 149 ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~I- 225 (1137)
+..|.++++|+.|+|++|+|+.+|. .|..+++|++|+|++|+|+.+ |..|..+++|+.|+|++|+|+.+
T Consensus 74 --------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 145 (220)
T 2v70_A 74 --------EGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVA 145 (220)
T ss_dssp --------TTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBC
T ss_pred --------HHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEEC
Confidence 1133445555566666666665554 356666777777777777655 45566677777777777777755
Q ss_pred CccccCCCCCCEEeccCCcCCCCC
Q 001152 226 PSGLYLLQRLENLDLSNNRLTSLG 249 (1137)
Q Consensus 226 P~~l~~L~~L~~LdLS~N~Lsg~~ 249 (1137)
|..|..+++|+.|+|++|.|++..
T Consensus 146 ~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 146 PGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp TTTTTTCTTCCEEECCSCCEECSG
T ss_pred HHHhcCCCCCCEEEecCcCCcCCC
Confidence 556666777777777777776543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.6e-18 Score=213.78 Aligned_cols=195 Identities=22% Similarity=0.123 Sum_probs=122.2
Q ss_pred CCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001152 68 NSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1137)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n 147 (1137)
+.++.|.|..|.+..+|..+ |+.|+|+.|.|..+ ++..|.+...+..+..+..|+.|+|++|
T Consensus 173 ~~~~~l~L~~n~~~~~~~~~-----l~~l~Ls~~~i~~~-------------~~~~n~~~~~~~~~~~l~~L~~L~Ls~n 234 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQAL-----LQHKKLSQYSIDED-------------DDIENRMVMPKDSKYDDQLWHALDLSNL 234 (727)
T ss_dssp -------------------------------------------------------------------CCCCCCEEECTTS
T ss_pred CccceEEeeCCCCCcchhhH-----hhcCccCcccccCc-------------cccccceecChhhhccCCCCcEEECCCC
Confidence 45777888888777765443 34455555555432 2334444555666777777777888775
Q ss_pred CCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc
Q 001152 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS 227 (1137)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~ 227 (1137)
.+. .+|..+..|++|+.|+|++|.|+.||..|+.|++|++|+|++|+|+.||..|+.|++|++|+|++|.|+.||.
T Consensus 235 ~l~----~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~lp~ 310 (727)
T 4b8c_D 235 QIF----NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVTTLPW 310 (727)
T ss_dssp CCS----CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCCCCCS
T ss_pred CCC----CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCCccCh
Confidence 443 5666777899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCEEeccCCcCCCCCcccccCCCC-CCEEEccCCcCCCCCCCCcchh-hccCCC
Q 001152 228 GLYLLQRLENLDLSNNRLTSLGSLDLCLMHN-LQNLNLQYNKLLSYCQVPSWIC-CNLEGN 286 (1137)
Q Consensus 228 ~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~-L~~L~Ls~N~L~~~~~iP~~~~-~~l~~n 286 (1137)
.|+.|++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++ .+|..+. +.++.|
T Consensus 311 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~--~~p~~l~~l~l~~n 369 (727)
T 4b8c_D 311 EFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI--PLPHERRFIEINTD 369 (727)
T ss_dssp STTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC--CCCCC---------
T ss_pred hhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC--cCccccceeEeecc
Confidence 9999999999999999999999987765432 2358899999998 7777665 334443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=6.8e-16 Score=162.04 Aligned_cols=134 Identities=19% Similarity=0.295 Sum_probs=113.1
Q ss_pred CEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCcc--ccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEE
Q 001152 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE--IGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLK 216 (1137)
Q Consensus 140 ~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~--l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~ 216 (1137)
+.|++++|.+ ..+|..+. .+|+.|++++|+|+.+|.. |+.+++|++|+|++|+|+.+ |..|..+++|+.|+
T Consensus 11 ~~l~~s~~~l----~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 84 (192)
T 1w8a_A 11 TTVDCTGRGL----KEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp TEEECTTSCC----SSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CEEEcCCCCc----CcCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEE
Confidence 4566666443 33444443 2789999999999988763 89999999999999999976 77899999999999
Q ss_pred ccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcch
Q 001152 217 VANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI 279 (1137)
Q Consensus 217 Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~ 279 (1137)
|++|+|+.+|.. +..+++|+.|+|++|+|++++|..|..+++|+.|+|++|+|+|.|.+....
T Consensus 85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~ 148 (192)
T 1w8a_A 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA 148 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH
Confidence 999999977654 888999999999999999999999999999999999999999987765443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.63 E-value=8.5e-17 Score=196.27 Aligned_cols=253 Identities=16% Similarity=-0.004 Sum_probs=150.7
Q ss_pred CCcccccCCCCCCcccCC----CCCCCCCCCCEEEccCCCCCCCCccc------------------------ccCCCCCC
Q 001152 17 PIKEKLPSEANKINNEKN----GSVNDDDDDSVIDVSGKTVDFPLIES------------------------YGNRGGDN 68 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~~l~~----~~f~~l~~L~~LdLs~N~L~~~~p~~------------------------~~~l~~L~ 68 (1137)
+.++.|.+..|.++.+.. ..+.++++|++|+|++|.+.+ ++.. +..+..++
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~ 270 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCT
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccc
Confidence 367777777777764432 234466777777777776654 2222 23344445
Q ss_pred CccEEEeecCCCCccCccccCCCCCcEEEccCCCCC--cccccccCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECC
Q 001152 69 SVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEIN--LFPSEVGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELS 145 (1137)
Q Consensus 69 ~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~--~lP~~l~~L~~L~~L~Ls~N~-~~~~~~~~~~L~~L~~L~Ls 145 (1137)
+|+.|+++++....+|..+..+++|++|+|++|.++ .++..+.++++|+.|+|+++. ...++..+..+++|++|+++
T Consensus 271 ~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~ 350 (592)
T 3ogk_B 271 KLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIE 350 (592)
T ss_dssp TCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEE
T ss_pred cccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEee
Confidence 666666666555567777777888888888888876 333446777788888777221 11122334567778888887
Q ss_pred C--------CCCCCCcc-cchhhhcCCCCCcEEeccCCCCc-ccCccccC-CCCCCEEEcc----CCCCCccc------h
Q 001152 146 K--------VPPRPSVL-TLLSEIAGLKCLTKLSVCHFSIR-YLPPEIGC-LSNLEQLDLS----FNKMKYLP------T 204 (1137)
Q Consensus 146 ~--------n~ln~~~~-~lp~~l~~L~~L~~L~Ls~N~L~-~IP~~l~~-L~~L~~L~Ls----~N~L~~LP------~ 204 (1137)
+ +..+.... .++..+..+++|+.|+++.|.++ ..+..++. +++|+.|+|+ .|+++..| .
T Consensus 351 ~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~ 430 (592)
T 3ogk_B 351 RGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRS 430 (592)
T ss_dssp CCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHH
T ss_pred cCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHH
Confidence 3 00011111 12222345777777777777776 33344443 7777888775 66776533 2
Q ss_pred hhcCCCCCCEEEccCC--CCC-ccCcccc-CCCCCCEEeccCCcCCCC-CcccccCCCCCCEEEccCCcCC
Q 001152 205 EICYLKALISLKVANN--KLV-ELPSGLY-LLQRLENLDLSNNRLTSL-GSLDLCLMHNLQNLNLQYNKLL 270 (1137)
Q Consensus 205 ~l~~L~~L~~L~Ls~N--~Ls-~IP~~l~-~L~~L~~LdLS~N~Lsg~-~p~~l~~L~~L~~L~Ls~N~L~ 270 (1137)
.+..+++|+.|+|+++ .++ ..+..++ .+++|+.|+|++|++++. .+..+..+++|+.|+|++|+|+
T Consensus 431 ~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 431 LLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp HHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred HHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence 3555777777777643 355 3333343 367777777777777642 2334466777777777777764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.63 E-value=8.7e-16 Score=174.57 Aligned_cols=222 Identities=12% Similarity=0.104 Sum_probs=139.7
Q ss_pred CCCCCEEEccCCCCC--CCCcccc---------------cCCCC--------CCCccEEEeecCCCCccCc-cccCCCCC
Q 001152 40 DDDDSVIDVSGKTVD--FPLIESY---------------GNRGG--------DNSVEGLYLYKNVLNLIPK-SVGRYEKL 93 (1137)
Q Consensus 40 l~~L~~LdLs~N~L~--~~~p~~~---------------~~l~~--------L~~L~~L~Ls~N~L~~IP~-~~~~L~~L 93 (1137)
+++|++|||++|+|. ......+ ..|.+ +++|+.|+|.+ .++.|++ .|.++++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 788999999999988 1111000 11233 46677777766 5666654 46667777
Q ss_pred cEEEccCCCCCccccc-ccCCCCCCEEEccCCC-----CCCCcccccCCCCCC-EEECCCCCC-----------------
Q 001152 94 RNLKFFGNEINLFPSE-VGNLLGLECLQIKISS-----PGVNGFALNKLKGLK-ELELSKVPP----------------- 149 (1137)
Q Consensus 94 ~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~-----~~~~~~~~~~L~~L~-~L~Ls~n~l----------------- 149 (1137)
+.|+|++|.++.|+.. |.++.+|..|.+..+. ..+....|.++.+|+ .+.+.....
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~ 206 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF 206 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence 7777777776666443 5555555555444311 112223344444444 222221000
Q ss_pred ----CCCcccchhhh-cCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccc-hhhcCCCCCC-EEEccCCC
Q 001152 150 ----RPSVLTLLSEI-AGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALI-SLKVANNK 221 (1137)
Q Consensus 150 ----n~~~~~lp~~l-~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~-~L~Ls~N~ 221 (1137)
......-...+ ..+++|+.|+|++|+++.||. .|..+++|+.|+|.+| ++.|+ ..|.+|.+|+ .|+|.+ .
T Consensus 207 l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~ 284 (329)
T 3sb4_A 207 LTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-S 284 (329)
T ss_dssp EEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-T
T ss_pred EEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-c
Confidence 00000000011 137788888888888888877 6788888888888887 87776 4577888888 888888 7
Q ss_pred CCccC-ccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEc
Q 001152 222 LVELP-SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264 (1137)
Q Consensus 222 Ls~IP-~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~L 264 (1137)
++.|+ ..|.+|++|+.|+|++|+++.+.+..|.++++|+.|+.
T Consensus 285 l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 285 VTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred ceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 88886 45667888888888888888888888888888888764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-15 Score=159.71 Aligned_cols=136 Identities=21% Similarity=0.256 Sum_probs=115.0
Q ss_pred CEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEcc
Q 001152 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVA 218 (1137)
Q Consensus 140 ~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls 218 (1137)
+.+++++|.+. .+|..+. ++|+.|++++|+|+.+|..|..+++|++|+|++|+|+.++ ..|.++++|+.|+|+
T Consensus 13 ~~l~~~~~~l~----~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls 86 (193)
T 2wfh_A 13 TVVRCSNKGLK----VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86 (193)
T ss_dssp TEEECTTSCCS----SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCCC----cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECC
Confidence 34555554332 3343332 4789999999999999999999999999999999999886 568999999999999
Q ss_pred CCCCCccCc-cccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhh
Q 001152 219 NNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1137)
Q Consensus 219 ~N~Ls~IP~-~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1137)
+|+|+.+|. .|..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|.|.|.+.....|
T Consensus 87 ~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~ 150 (193)
T 2wfh_A 87 YNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDW 150 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHH
T ss_pred CCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHH
Confidence 999998865 588899999999999999999988899999999999999999998886555444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3.5e-15 Score=152.47 Aligned_cols=133 Identities=20% Similarity=0.128 Sum_probs=70.1
Q ss_pred CCccEEEeecCCCC--ccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECC
Q 001152 68 NSVEGLYLYKNVLN--LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELS 145 (1137)
Q Consensus 68 ~~L~~L~Ls~N~L~--~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls 145 (1137)
++|+.|+|++|.++ .+|..+..+++|++|+|++|.|+.+ ..+..+++|++|+|++|.+..
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~----------------- 85 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFG----------------- 85 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCS-----------------
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCch-----------------
Confidence 45666666666665 5666566666666666666666555 444444444444444443222
Q ss_pred CCCCCCCcccchhhhcCCCCCcEEeccCCCCcccC--ccccCCCCCCEEEccCCCCCccch----hhcCCCCCCEEEccC
Q 001152 146 KVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLP--PEIGCLSNLEQLDLSFNKMKYLPT----EICYLKALISLKVAN 219 (1137)
Q Consensus 146 ~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP--~~l~~L~~L~~L~Ls~N~L~~LP~----~l~~L~~L~~L~Ls~ 219 (1137)
.+|..+..+++|+.|++++|.|+.+| ..+..+++|++|+|++|.|+.+|. .+..+++|+.|++++
T Consensus 86 ---------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~ 156 (168)
T 2ell_A 86 ---------GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD 156 (168)
T ss_dssp ---------CCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred ---------HHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence 12223333455555555555555444 345555555555555555555443 445555555555555
Q ss_pred CCCCccCc
Q 001152 220 NKLVELPS 227 (1137)
Q Consensus 220 N~Ls~IP~ 227 (1137)
|.+..+|.
T Consensus 157 n~~~~~~~ 164 (168)
T 2ell_A 157 REDQEAPD 164 (168)
T ss_dssp TTSCBCCS
T ss_pred CChhhccc
Confidence 55555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.8e-14 Score=165.21 Aligned_cols=228 Identities=11% Similarity=0.107 Sum_probs=187.1
Q ss_pred CCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-ccccCCCCCcEEEccCCCCCc
Q 001152 27 NKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP-KSVGRYEKLRNLKFFGNEINL 105 (1137)
Q Consensus 27 N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP-~~~~~L~~L~~L~Ls~N~L~~ 105 (1137)
|+++.|...+|.+. +|+.++|..| ++.+...+|.+. +|+.+.|.+ .++.|+ ..|.++++|+.|+|.+|.++.
T Consensus 122 ~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~----~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~ 194 (401)
T 4fdw_A 122 NSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS----TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITK 194 (401)
T ss_dssp TTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC----CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSE
T ss_pred CccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC----CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceE
Confidence 57899999999985 8999999877 777777667553 699999986 688886 479999999999999999999
Q ss_pred ccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccch-hhhcCCCCCcEEeccCCCCcccCc-cc
Q 001152 106 FPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLL-SEIAGLKCLTKLSVCHFSIRYLPP-EI 183 (1137)
Q Consensus 106 lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp-~~l~~L~~L~~L~Ls~N~L~~IP~-~l 183 (1137)
||.......+|+.+.|..|-..+...+|.++.+|+.|++..+ . ..++ .+|.+ .+|+.+.+ .|.++.|+. .|
T Consensus 195 I~~~aF~~~~L~~l~lp~~l~~I~~~aF~~~~~L~~l~l~~~----l-~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF 267 (401)
T 4fdw_A 195 LPASTFVYAGIEEVLLPVTLKEIGSQAFLKTSQLKTIEIPEN----V-STIGQEAFRE-SGITTVKL-PNGVTNIASRAF 267 (401)
T ss_dssp ECTTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCCEECCTT----C-CEECTTTTTT-CCCSEEEE-ETTCCEECTTTT
T ss_pred echhhEeecccCEEEeCCchheehhhHhhCCCCCCEEecCCC----c-cCcccccccc-CCccEEEe-CCCccEEChhHh
Confidence 988766679999999985533344478999999999999862 2 2333 34555 78999999 566788866 78
Q ss_pred cCCCCCCEEEccCCCCC-----ccc-hhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCcccccCC
Q 001152 184 GCLSNLEQLDLSFNKMK-----YLP-TEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLM 256 (1137)
Q Consensus 184 ~~L~~L~~L~Ls~N~L~-----~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L 256 (1137)
.++++|+.|+|.+|.+. .|+ ..|.+|++|+.+.|. |.++.|+.. |.+|++|+.|+|.+| ++.+.+..|.++
T Consensus 268 ~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~ 345 (401)
T 4fdw_A 268 YYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT 345 (401)
T ss_dssp TTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS
T ss_pred hCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC
Confidence 99999999999998876 565 568889999999999 559999765 667999999999665 888888899999
Q ss_pred CCCCEEEccCCcCCC
Q 001152 257 HNLQNLNLQYNKLLS 271 (1137)
Q Consensus 257 ~~L~~L~Ls~N~L~~ 271 (1137)
+|+.|++.+|.+..
T Consensus 346 -~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 346 -GIKEVKVEGTTPPQ 359 (401)
T ss_dssp -CCCEEEECCSSCCB
T ss_pred -CCCEEEEcCCCCcc
Confidence 99999999998755
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.4e-16 Score=192.28 Aligned_cols=239 Identities=17% Similarity=0.047 Sum_probs=122.4
Q ss_pred cccccCCCCC-CcccCC-CCCCCCCCCCEEEccCCCCCCC----CcccccCCCCCCCccEEEeecCCCC-----ccCccc
Q 001152 19 KEKLPSEANK-INNEKN-GSVNDDDDDSVIDVSGKTVDFP----LIESYGNRGGDNSVEGLYLYKNVLN-----LIPKSV 87 (1137)
Q Consensus 19 l~~L~~~~N~-i~~l~~-~~f~~l~~L~~LdLs~N~L~~~----~p~~~~~l~~L~~L~~L~Ls~N~L~-----~IP~~~ 87 (1137)
++.|.+..+. ++.... ..+.++++|++|+|++|.+++. ++..+.. +++|+.|+|++|.++ .++..+
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~---~~~L~~L~L~~n~~~~~~~~~l~~~~ 216 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQH---NTSLEVLNFYMTEFAKISPKDLETIA 216 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHH---CCCCCEEECTTCCCSSCCHHHHHHHH
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhc---CCCccEEEeeccCCCccCHHHHHHHH
Confidence 6666665554 111100 1123566777777777766554 2222332 366777777777665 233344
Q ss_pred cCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCC----CCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCC
Q 001152 88 GRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP----GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGL 163 (1137)
Q Consensus 88 ~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~----~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L 163 (1137)
.++++|+.|+|++|.+..+|..+.++++|+.|+++.... ......+..+++|+.|+++++ ....+|..+..+
T Consensus 217 ~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~----~~~~l~~~~~~~ 292 (592)
T 3ogk_B 217 RNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM----GPNEMPILFPFA 292 (592)
T ss_dssp HHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC----CTTTGGGGGGGG
T ss_pred hhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCcccc----chhHHHHHHhhc
Confidence 566777777777777766666666667777766653221 112233445555666665542 223344444555
Q ss_pred CCCcEEeccCCCCc--ccCccccCCCCCCEEEccCCCCC--ccchhhcCCCCCCEEEcc-----------CCCCC--ccC
Q 001152 164 KCLTKLSVCHFSIR--YLPPEIGCLSNLEQLDLSFNKMK--YLPTEICYLKALISLKVA-----------NNKLV--ELP 226 (1137)
Q Consensus 164 ~~L~~L~Ls~N~L~--~IP~~l~~L~~L~~L~Ls~N~L~--~LP~~l~~L~~L~~L~Ls-----------~N~Ls--~IP 226 (1137)
++|++|++++|.++ .++..+..+++|+.|+|+ |.+. .++..+..+++|+.|+|+ .|.++ .++
T Consensus 293 ~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~ 371 (592)
T 3ogk_B 293 AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLI 371 (592)
T ss_dssp GGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHH
T ss_pred CCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHH
Confidence 56666666666554 122223555555555555 3333 233333445555555555 24444 222
Q ss_pred ccccCCCCCCEEeccCCcCCCCCcccccC-CCCCCEEEcc
Q 001152 227 SGLYLLQRLENLDLSNNRLTSLGSLDLCL-MHNLQNLNLQ 265 (1137)
Q Consensus 227 ~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~-L~~L~~L~Ls 265 (1137)
.-+..+++|+.|+|+.|++++.....+.. +++|+.|+|+
T Consensus 372 ~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~ 411 (592)
T 3ogk_B 372 ALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411 (592)
T ss_dssp HHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEE
T ss_pred HHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEe
Confidence 22333555555555555555443333433 5555555553
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.9e-15 Score=172.44 Aligned_cols=148 Identities=19% Similarity=0.185 Sum_probs=101.8
Q ss_pred ceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCC--------------hHHHHHhHHhHHHHHHHHHhCCCCCcc
Q 001152 804 LSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSS--------------ADEIRNFEYSCLGEVRMLGALRHSCIV 868 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~--------------~~~~e~~~~~~lrEi~iL~~L~HpNIV 868 (1137)
|++...||.|++|.||+|... +..+|||+.+....... .........++.+|...|.++.+..+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 789999999999999999974 57899999754322110 011112222345677778777655443
Q ss_pred --eeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Q 001152 869 --EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 946 (1137)
Q Consensus 869 --kllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gII 946 (1137)
..+++ . ..+|||||++|++|..+. ....+..++.||+.+|.|||++|||
T Consensus 177 vp~p~~~--~----------------~~~LVME~i~G~~L~~l~-----------~~~~~~~l~~qll~~l~~lH~~gIV 227 (397)
T 4gyi_A 177 VPEPIAQ--S----------------RHTIVMSLVDALPMRQVS-----------SVPDPASLYADLIALILRLAKHGLI 227 (397)
T ss_dssp CCCEEEE--E----------------TTEEEEECCSCEEGGGCC-----------CCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCeeeec--c----------------CceEEEEecCCccHhhhc-----------ccHHHHHHHHHHHHHHHHHHHCCCc
Confidence 22222 1 127999999988875432 1123457889999999999999999
Q ss_pred eccCCCCCeEeccccccCCCC---CeEEEeecCcccc
Q 001152 947 HRDIKSENILIDLERKKADGK---PVVKLCDFDRAVP 980 (1137)
Q Consensus 947 HrDLKP~NILld~~~~~~~~~---~~vKL~DFGla~~ 980 (1137)
||||||.|||++.+....... ..+.|+||+-+..
T Consensus 228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999999999999874211111 1388999997654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.56 E-value=7.4e-15 Score=150.01 Aligned_cols=138 Identities=17% Similarity=0.097 Sum_probs=108.2
Q ss_pred CCCCCCEEEccCCCCC-CCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCc-ccccccCCCCC
Q 001152 39 DDDDDSVIDVSGKTVD-FPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINL-FPSEVGNLLGL 116 (1137)
Q Consensus 39 ~l~~L~~LdLs~N~L~-~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~-lP~~l~~L~~L 116 (1137)
..++|+.|+|++|+|+ +.+|..+..+ ++|++|+|++|.|+.+ ..|..+++|++|+|++|.|+. +|..+.++++|
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l---~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 97 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEF---VNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNL 97 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGG---GGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTC
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhC---CCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCC
Confidence 3478999999999998 7778766555 9999999999999988 789999999999999999997 78777789999
Q ss_pred CEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc----cccCCCCCCEE
Q 001152 117 ECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP----EIGCLSNLEQL 192 (1137)
Q Consensus 117 ~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~----~l~~L~~L~~L 192 (1137)
++|+|++|.+..++. +..+..+++|+.|++++|.++.+|. .+..+++|++|
T Consensus 98 ~~L~Ls~N~l~~~~~-------------------------~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L 152 (168)
T 2ell_A 98 THLNLSGNKLKDIST-------------------------LEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152 (168)
T ss_dssp CEEECBSSSCCSSGG-------------------------GGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEE
T ss_pred CEEeccCCccCcchh-------------------------HHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEe
Confidence 999998887665441 1244556666667777777766665 56677777777
Q ss_pred EccCCCCCccchh
Q 001152 193 DLSFNKMKYLPTE 205 (1137)
Q Consensus 193 ~Ls~N~L~~LP~~ 205 (1137)
++++|.+.++|.+
T Consensus 153 ~l~~n~~~~~~~~ 165 (168)
T 2ell_A 153 DGYDREDQEAPDS 165 (168)
T ss_dssp TTEETTSCBCCSS
T ss_pred cCCCCChhhcccc
Confidence 7777777766643
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1e-13 Score=162.53 Aligned_cols=248 Identities=8% Similarity=0.057 Sum_probs=198.5
Q ss_pred hhhcccCCCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc
Q 001152 7 VEITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS 86 (1137)
Q Consensus 7 ~~~~~~~~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~ 86 (1137)
+.-.++..+ .+..+.+..| |+.|...+|.+. +|+.|+|.. .++.+...+|. ++.+|+.|+|.+|.++.||..
T Consensus 127 I~~~aF~~~--~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~---~c~~L~~l~l~~n~l~~I~~~ 198 (401)
T 4fdw_A 127 IPKDAFRNS--QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFY---YCYNLKKADLSKTKITKLPAS 198 (401)
T ss_dssp ECTTTTTTC--CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTT---TCTTCCEEECTTSCCSEECTT
T ss_pred ehHhhcccC--CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhh---CcccCCeeecCCCcceEechh
Confidence 334455554 4788887655 999999999994 799999986 77776666664 459999999999999999876
Q ss_pred ccCCCCCcEEEccCCCCCcccc-cccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCC
Q 001152 87 VGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKC 165 (1137)
Q Consensus 87 ~~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~ 165 (1137)
.....+|+.|.|.+ .++.|+. .|.++++|+.|.|..|-..+-..+|.+ .+|+.+.+.+ +....-...|.+|++
T Consensus 199 aF~~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~l~~I~~~aF~~-~~L~~i~lp~----~i~~I~~~aF~~c~~ 272 (401)
T 4fdw_A 199 TFVYAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPENVSTIGQEAFRE-SGITTVKLPN----GVTNIASRAFYYCPE 272 (401)
T ss_dssp TTTTCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTTCCEECTTTTTT-CCCSEEEEET----TCCEECTTTTTTCTT
T ss_pred hEeecccCEEEeCC-chheehhhHhhCCCCCCEEecCCCccCcccccccc-CCccEEEeCC----CccEEChhHhhCCCC
Confidence 44468999999985 4888865 488999999999987643334466777 8999999954 222222457889999
Q ss_pred CcEEeccCCCCc-----ccCc-cccCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCE
Q 001152 166 LTKLSVCHFSIR-----YLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLEN 237 (1137)
Q Consensus 166 L~~L~Ls~N~L~-----~IP~-~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~ 237 (1137)
|+.|.+.+|.+. .|+. .|..+++|+.|+|. |.++.|+ ..|.+|++|+.|.|..| ++.|+. .|.++ +|+.
T Consensus 273 L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~ 349 (401)
T 4fdw_A 273 LAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKE 349 (401)
T ss_dssp CCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCE
T ss_pred CCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCE
Confidence 999999998876 5665 78999999999999 5699886 56788999999999655 888865 46678 9999
Q ss_pred EeccCCcCCCCCcccccCCC-CCCEEEccCCcCCC
Q 001152 238 LDLSNNRLTSLGSLDLCLMH-NLQNLNLQYNKLLS 271 (1137)
Q Consensus 238 LdLS~N~Lsg~~p~~l~~L~-~L~~L~Ls~N~L~~ 271 (1137)
|+|++|.+..+.+..|..++ .+..|++..|.+..
T Consensus 350 l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~~ 384 (401)
T 4fdw_A 350 VKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVEK 384 (401)
T ss_dssp EEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHHH
T ss_pred EEEcCCCCcccccccccCCCCCccEEEeCHHHHHH
Confidence 99999999999888888885 78999999887543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.54 E-value=8.8e-15 Score=153.56 Aligned_cols=125 Identities=22% Similarity=0.227 Sum_probs=64.3
Q ss_pred cEEEeecCCCCccCccccCCCCCcEEEccCCCCCccccc--ccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCC
Q 001152 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE--VGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVP 148 (1137)
Q Consensus 71 ~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~--l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ 148 (1137)
+.|++++|.|+.||..+.. +|++|+|++|+|+.+|.. |+++++|++|+|++|.+..+
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~------------------- 69 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI------------------- 69 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCB-------------------
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCc-------------------
Confidence 4566666666666665543 666666666666655432 44444444444444432221
Q ss_pred CCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCC
Q 001152 149 PRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLV 223 (1137)
Q Consensus 149 ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls 223 (1137)
.|..|.++++|+.|+|++|+|+.+|. .|..+++|++|+|++|+|+.+ |..|..+++|+.|+|++|.++
T Consensus 70 -------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 139 (192)
T 1w8a_A 70 -------EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp -------CTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred -------CHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence 12334444455555555555554433 345555555555555555533 444455555555555555554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.54 E-value=7.7e-15 Score=146.87 Aligned_cols=127 Identities=25% Similarity=0.249 Sum_probs=97.6
Q ss_pred CCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCc-cchhhcCCCCCCEE
Q 001152 137 KGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY-LPTEICYLKALISL 215 (1137)
Q Consensus 137 ~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~-LP~~l~~L~~L~~L 215 (1137)
++|+.|++++|.+.. +.+|..+..+++|+.|++++|.++.+ ..++.+++|++|+|++|+|+. +|..+..+++|+.|
T Consensus 17 ~~l~~L~l~~n~l~~--~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBT--TBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCCh--hHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 456666666643320 24555667778888888888888877 667888888888888888886 77777778888888
Q ss_pred EccCCCCCccC--ccccCCCCCCEEeccCCcCCCCCc---ccccCCCCCCEEEccC
Q 001152 216 KVANNKLVELP--SGLYLLQRLENLDLSNNRLTSLGS---LDLCLMHNLQNLNLQY 266 (1137)
Q Consensus 216 ~Ls~N~Ls~IP--~~l~~L~~L~~LdLS~N~Lsg~~p---~~l~~L~~L~~L~Ls~ 266 (1137)
+|++|+++.+| ..+..+++|+.|+|++|.+++.++ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 88888888765 778888888888888888888876 5678888888888764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.7e-14 Score=149.19 Aligned_cols=64 Identities=28% Similarity=0.436 Sum_probs=31.2
Q ss_pred ccCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCC
Q 001152 183 IGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLT 246 (1137)
Q Consensus 183 l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Ls 246 (1137)
|..+++|++|+|++|+|+.+| ..|..+++|+.|+|++|+|+.+|.. +..+++|+.|+|++|.+.
T Consensus 74 f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 74 FSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp TTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 444444444444444444443 2344455555555555555544442 344555555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.53 E-value=6.8e-14 Score=144.22 Aligned_cols=128 Identities=27% Similarity=0.336 Sum_probs=106.3
Q ss_pred CEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEc
Q 001152 140 KELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKV 217 (1137)
Q Consensus 140 ~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~L 217 (1137)
+.++++++.+. .+|..+ .++|+.|++++|+++.+|. .|..+++|++|+|++|+|+.+|.. +..+++|+.|+|
T Consensus 10 ~~l~~~~~~l~----~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 83 (177)
T 2o6r_A 10 TEIRCNSKGLT----SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYL 83 (177)
T ss_dssp TEEECCSSCCS----SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CEEEecCCCCc----cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEEC
Confidence 45555553332 333332 3578999999999998876 568999999999999999988755 688999999999
Q ss_pred cCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCC
Q 001152 218 ANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYC 273 (1137)
Q Consensus 218 s~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~ 273 (1137)
++|+|+.+|.. +..+++|+.|+|++|+|+++++..+..+++|+.|+|++|+|.+.|
T Consensus 84 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 84 HENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 99999988765 678999999999999999998877889999999999999999854
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=4.6e-14 Score=145.36 Aligned_cols=107 Identities=27% Similarity=0.324 Sum_probs=98.5
Q ss_pred CcEEeccCCCCcccCccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCC
Q 001152 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243 (1137)
Q Consensus 166 L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N 243 (1137)
.+.|++++|.|+.||..+. ++|++|+|++|+|+.+ |..|..+++|++|+|++|+|+.+|.. |..+++|+.|+|++|
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 5789999999999998764 8999999999999988 56789999999999999999999876 578999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001152 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1137)
Q Consensus 244 ~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1137)
+|+++++..|..+++|+.|+|++|+|+|.|.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999999889999999999999999999764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.8e-14 Score=148.64 Aligned_cols=105 Identities=25% Similarity=0.241 Sum_probs=82.0
Q ss_pred CCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhh-cCCCCCCEEEccCCCCCccCc--cccCCCCCCEEecc
Q 001152 165 CLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPS--GLYLLQRLENLDLS 241 (1137)
Q Consensus 165 ~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l-~~L~~L~~L~Ls~N~Ls~IP~--~l~~L~~L~~LdLS 241 (1137)
+|+.|++++|.|+.+ ..|..+++|++|+|++|+|+.+|..+ ..+++|+.|+|++|+|+.+|. .+..+++|+.|+|+
T Consensus 43 ~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~ 121 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL 121 (176)
T ss_dssp CCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECC
T ss_pred CCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEec
Confidence 777888888888776 56777888888888888888777554 778888888888888888776 67778888888888
Q ss_pred CCcCCCCCcc---cccCCCCCCEEEccCCcCC
Q 001152 242 NNRLTSLGSL---DLCLMHNLQNLNLQYNKLL 270 (1137)
Q Consensus 242 ~N~Lsg~~p~---~l~~L~~L~~L~Ls~N~L~ 270 (1137)
+|.++..++. .+..+++|+.|++++|.+.
T Consensus 122 ~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 122 RNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp SSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 8888876543 3778888888888888754
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=2.7e-14 Score=147.40 Aligned_cols=133 Identities=20% Similarity=0.235 Sum_probs=98.8
Q ss_pred cccCCCCCcEEEccCCCCCcccccccCCC-CCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCC
Q 001152 86 SVGRYEKLRNLKFFGNEINLFPSEVGNLL-GLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLK 164 (1137)
Q Consensus 86 ~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~-~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~ 164 (1137)
.+.++.+|+.|+|++|+|+.+|. +..+. +|++|+|++|.+..+ ..+..++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i~~-~~~~~~~L~~L~Ls~N~l~~~----------------------------~~l~~l~ 64 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVIEN-LGATLDQFDAIDFSDNEIRKL----------------------------DGFPLLR 64 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSCCC-GGGGTTCCSEEECCSSCCCEE----------------------------CCCCCCS
T ss_pred hcCCcCCceEEEeeCCCCchhHH-hhhcCCCCCEEECCCCCCCcc----------------------------cccccCC
Confidence 45667788888888888887754 44443 677777666654322 2455677
Q ss_pred CCcEEeccCCCCcccCccc-cCCCCCCEEEccCCCCCccch--hhcCCCCCCEEEccCCCCCccCcc----ccCCCCCCE
Q 001152 165 CLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPT--EICYLKALISLKVANNKLVELPSG----LYLLQRLEN 237 (1137)
Q Consensus 165 ~L~~L~Ls~N~L~~IP~~l-~~L~~L~~L~Ls~N~L~~LP~--~l~~L~~L~~L~Ls~N~Ls~IP~~----l~~L~~L~~ 237 (1137)
+|+.|++++|.|+.+|+.+ ..+++|++|+|++|+|+.+|. .+..+++|+.|+|++|.++.+|.. +..+++|+.
T Consensus 65 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~ 144 (176)
T 1a9n_A 65 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRV 144 (176)
T ss_dssp SCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSE
T ss_pred CCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccce
Confidence 7888888888888777654 778888888888888888876 778888888888888888888775 777888888
Q ss_pred EeccCCcCCC
Q 001152 238 LDLSNNRLTS 247 (1137)
Q Consensus 238 LdLS~N~Lsg 247 (1137)
||++.|.+..
T Consensus 145 Ld~~~n~~~~ 154 (176)
T 1a9n_A 145 LDFQKVKLKE 154 (176)
T ss_dssp ETTEECCHHH
T ss_pred eCCCcCCHHH
Confidence 8888887653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.4e-13 Score=142.34 Aligned_cols=107 Identities=26% Similarity=0.347 Sum_probs=98.2
Q ss_pred CcEEeccCCCCcccCccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCC
Q 001152 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNN 243 (1137)
Q Consensus 166 L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N 243 (1137)
-+.+++++|+|+.||..+. ++|++|+|++|+|+.+ |..|.++++|+.|+|++|+|+.||.. |..+++|+.|+|++|
T Consensus 14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 3689999999999999765 8999999999999977 56789999999999999999999887 478999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001152 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1137)
Q Consensus 244 ~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1137)
+|+++++..|..+++|+.|+|++|+|.+.|.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 9999998779999999999999999999664
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.6e-13 Score=139.81 Aligned_cols=90 Identities=31% Similarity=0.363 Sum_probs=64.5
Q ss_pred cCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEEccCCCCCccCccc-cCCCCCCE
Q 001152 161 AGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLKVANNKLVELPSGL-YLLQRLEN 237 (1137)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~Ls~N~Ls~IP~~l-~~L~~L~~ 237 (1137)
..+++|++|++++|+|+.+|. .|..+++|++|+|++|+|+.+|.. +..+++|+.|+|++|+|+.+|..+ ..+++|+.
T Consensus 49 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 128 (177)
T 2o6r_A 49 DKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQK 128 (177)
T ss_dssp TTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred cCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCE
Confidence 345556666666666666655 356777788888888888776654 567788888888888888777654 56788888
Q ss_pred EeccCCcCCCCCc
Q 001152 238 LDLSNNRLTSLGS 250 (1137)
Q Consensus 238 LdLS~N~Lsg~~p 250 (1137)
|+|++|.+++..|
T Consensus 129 L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 129 IWLHTNPWDCSCP 141 (177)
T ss_dssp EECCSSCBCCCHH
T ss_pred EEecCCCeeccCc
Confidence 8888888887654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.48 E-value=4.1e-14 Score=141.58 Aligned_cols=128 Identities=18% Similarity=0.054 Sum_probs=63.7
Q ss_pred CCCCEEEccCCCCC-CCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCc-ccccccCCCCCCE
Q 001152 41 DDDSVIDVSGKTVD-FPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINL-FPSEVGNLLGLEC 118 (1137)
Q Consensus 41 ~~L~~LdLs~N~L~-~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~-lP~~l~~L~~L~~ 118 (1137)
++|+.|+|++|+++ +.+|..+..+ ++|+.|+|++|.|+.+ ..|..+++|++|+|++|.|+. +|..+.++++|++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l---~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEF---EELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTC---TTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhc---CCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 44555555555554 4444433322 5555555555555544 445555555555555555553 4444444555555
Q ss_pred EEccCCCCCCCc--ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEecc
Q 001152 119 LQIKISSPGVNG--FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVC 172 (1137)
Q Consensus 119 L~Ls~N~~~~~~--~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls 172 (1137)
|+|++|.+..++ ..+..+++|++|++++|.+..........+..+++|+.|+++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555544433 445555555555555543322111111245556666666654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-15 Score=185.70 Aligned_cols=201 Identities=15% Similarity=0.110 Sum_probs=125.6
Q ss_pred CCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecC-CCCc--cCccccCCCCCcEEEccCCCCCc-----cccc
Q 001152 38 NDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKN-VLNL--IPKSVGRYEKLRNLKFFGNEINL-----FPSE 109 (1137)
Q Consensus 38 ~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N-~L~~--IP~~~~~L~~L~~L~Ls~N~L~~-----lP~~ 109 (1137)
..+++|++|+|++|.+++..+..+.. .+++|++|+|++| .++. ++..+.++++|++|+|++|.++. ++.-
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~--~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~ 179 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAK--SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHF 179 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHH--HCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGS
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHH--hCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHH
Confidence 46789999999999988776665541 2489999999998 6664 55556689999999999998763 2333
Q ss_pred ccCCCCCCEEEccCCCCCCCcc----cccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCC-------CCcc
Q 001152 110 VGNLLGLECLQIKISSPGVNGF----ALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHF-------SIRY 178 (1137)
Q Consensus 110 l~~L~~L~~L~Ls~N~~~~~~~----~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N-------~L~~ 178 (1137)
...+++|+.|+|++|....... .+..+++|+.|+++++ .....+|..+..+++|+.|+++.+ .+..
T Consensus 180 ~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~---~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~ 256 (594)
T 2p1m_B 180 PDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA---VPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG 256 (594)
T ss_dssp CTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT---SCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH
T ss_pred hhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC---CcHHHHHHHHhcCCcceEcccccccCccchhhHHH
Confidence 3477899999999887222222 2345799999999985 234446777777888888875444 2333
Q ss_pred cCccccCCCCCCEE-EccCCCCCccchhhcCCCCCCEEEccCCCCC--ccCccccCCCCCCEEeccCC
Q 001152 179 LPPEIGCLSNLEQL-DLSFNKMKYLPTEICYLKALISLKVANNKLV--ELPSGLYLLQRLENLDLSNN 243 (1137)
Q Consensus 179 IP~~l~~L~~L~~L-~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls--~IP~~l~~L~~L~~LdLS~N 243 (1137)
++..+.++++|+.| .+.++....+|..+..+++|+.|+|++|.++ .++..+..+++|+.|+|++|
T Consensus 257 l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 324 (594)
T 2p1m_B 257 LSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324 (594)
T ss_dssp HHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred HHHHHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc
Confidence 44444555555555 3333333334433344455555555555544 12222334455555555544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.45 E-value=3.9e-16 Score=164.36 Aligned_cols=110 Identities=26% Similarity=0.263 Sum_probs=78.6
Q ss_pred hhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCc--cccCCCCCC
Q 001152 159 EIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPS--GLYLLQRLE 236 (1137)
Q Consensus 159 ~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~--~l~~L~~L~ 236 (1137)
.+..+++|+.|++++|.|+.+|..+..+++|++|+|++|+|+.+| .+..+++|+.|+|++|+|+.+|. .+..+++|+
T Consensus 65 ~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~ 143 (198)
T 1ds9_A 65 SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143 (198)
T ss_dssp CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCS
T ss_pred ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCC
Confidence 445566666777777777777766666677777777777777776 57777777788888777776654 577777888
Q ss_pred EEeccCCcCCCCCccc----------ccCCCCCCEEEccCCcCCC
Q 001152 237 NLDLSNNRLTSLGSLD----------LCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 237 ~LdLS~N~Lsg~~p~~----------l~~L~~L~~L~Ls~N~L~~ 271 (1137)
.|+|++|.+++.+|.. +..+++|+.|| +|+++.
T Consensus 144 ~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 144 DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp EEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred EEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 8888888777665532 67788888776 666654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.43 E-value=5.3e-16 Score=163.36 Aligned_cols=113 Identities=21% Similarity=0.164 Sum_probs=53.8
Q ss_pred ccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhc
Q 001152 82 LIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA 161 (1137)
Q Consensus 82 ~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~ 161 (1137)
.+|..|..+++|++|+|++|.|+.+| .+.++++|+.|+|++|.+..+|.. +.
T Consensus 39 ~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~~l~~~---------------------------~~ 90 (198)
T 1ds9_A 39 KMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKKIENL---------------------------DA 90 (198)
T ss_dssp CCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEECSCSSH---------------------------HH
T ss_pred hhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcccccch---------------------------hh
Confidence 33445555555555555555555555 455555555555554443322221 22
Q ss_pred CCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccch--hhcCCCCCCEEEccCCCCC
Q 001152 162 GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPT--EICYLKALISLKVANNKLV 223 (1137)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~--~l~~L~~L~~L~Ls~N~Ls 223 (1137)
.+++|+.|++++|+|+.+| .+..+++|++|+|++|+|+.+|. .+..+++|+.|+|++|.++
T Consensus 91 ~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 91 VADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred cCCcCCEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccc
Confidence 2233444444444444443 34444455555555555554432 4445555555555555554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.3e-14 Score=176.89 Aligned_cols=231 Identities=16% Similarity=0.116 Sum_probs=164.9
Q ss_pred CCCCCCCCCEEEccCCCCC---CCCcccc--------cC-CCCCCCccEEEeecCCCCc-cCcccc-CCCCCcEEEccCC
Q 001152 36 SVNDDDDDSVIDVSGKTVD---FPLIESY--------GN-RGGDNSVEGLYLYKNVLNL-IPKSVG-RYEKLRNLKFFGN 101 (1137)
Q Consensus 36 ~f~~l~~L~~LdLs~N~L~---~~~p~~~--------~~-l~~L~~L~~L~Ls~N~L~~-IP~~~~-~L~~L~~L~Ls~N 101 (1137)
.+..+++|+.|+|+++... +..|..+ .. ...+++|++|+|++|.++. .+..+. .+++|++|+|++|
T Consensus 61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~ 140 (594)
T 2p1m_B 61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC 140 (594)
T ss_dssp HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence 4567788999999997532 1222111 11 1234789999999998873 345554 6889999999998
Q ss_pred -CCCc--ccccccCCCCCCEEEccCCCCCCC-----cccccCCCCCCEEECCCCCCCCCc-ccchhhhcCCCCCcEEecc
Q 001152 102 -EINL--FPSEVGNLLGLECLQIKISSPGVN-----GFALNKLKGLKELELSKVPPRPSV-LTLLSEIAGLKCLTKLSVC 172 (1137)
Q Consensus 102 -~L~~--lP~~l~~L~~L~~L~Ls~N~~~~~-----~~~~~~L~~L~~L~Ls~n~ln~~~-~~lp~~l~~L~~L~~L~Ls 172 (1137)
.++. ++..+.++++|++|+|++|.+... +..+..+++|+.|+++++. .... ..+..-+..+++|+.|+++
T Consensus 141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~ 219 (594)
T 2p1m_B 141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLN 219 (594)
T ss_dssp EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECC
T ss_pred CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecC
Confidence 6663 666666899999999998874432 2334467799999999865 1121 2233334567999999999
Q ss_pred CC-CCcccCccccCCCCCCEEEccCC-------CCCccchhhcCCCCCCEE-EccCCCCCccCccccCCCCCCEEeccCC
Q 001152 173 HF-SIRYLPPEIGCLSNLEQLDLSFN-------KMKYLPTEICYLKALISL-KVANNKLVELPSGLYLLQRLENLDLSNN 243 (1137)
Q Consensus 173 ~N-~L~~IP~~l~~L~~L~~L~Ls~N-------~L~~LP~~l~~L~~L~~L-~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N 243 (1137)
+| .++.+|..+..+++|+.|+++.+ .+..++..+.++++|+.| .+.++....+|..+..+++|+.|+|++|
T Consensus 220 ~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~ 299 (594)
T 2p1m_B 220 RAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYA 299 (594)
T ss_dssp TTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTC
T ss_pred CCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCC
Confidence 88 55577888888999999996554 445677788999999999 5555554567776667899999999999
Q ss_pred cCCCCCcc-cccCCCCCCEEEccCC
Q 001152 244 RLTSLGSL-DLCLMHNLQNLNLQYN 267 (1137)
Q Consensus 244 ~Lsg~~p~-~l~~L~~L~~L~Ls~N 267 (1137)
.+++.... .+..+++|+.|+|++|
T Consensus 300 ~l~~~~l~~~~~~~~~L~~L~l~~~ 324 (594)
T 2p1m_B 300 TVQSYDLVKLLCQCPKLQRLWVLDY 324 (594)
T ss_dssp CCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred CCCHHHHHHHHhcCCCcCEEeCcCc
Confidence 97753222 3568899999999988
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.39 E-value=3.5e-13 Score=153.01 Aligned_cols=214 Identities=12% Similarity=0.015 Sum_probs=160.0
Q ss_pred CCcccccCCCCCCc--------------------ccCCCCCCC--------CCCCCEEEccCCCCCCCCcccccCCCCCC
Q 001152 17 PIKEKLPSEANKIN--------------------NEKNGSVND--------DDDDSVIDVSGKTVDFPLIESYGNRGGDN 68 (1137)
Q Consensus 17 ~~l~~L~~~~N~i~--------------------~l~~~~f~~--------l~~L~~LdLs~N~L~~~~p~~~~~l~~L~ 68 (1137)
+.++.|++..|+|. .|+..+|.+ +++|+.|+|.+ +++.+.+.+|.+ ++
T Consensus 49 ~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~---~~ 124 (329)
T 3sb4_A 49 PSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKG---CD 124 (329)
T ss_dssp TTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTT---CT
T ss_pred ccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhc---Cc
Confidence 35777888877777 778889999 99999999999 888877766654 49
Q ss_pred CccEEEeecCCCCccCc-cccCCCCCcEEEccCCC----CCcc-cccccCCCCCC-------------------------
Q 001152 69 SVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNE----INLF-PSEVGNLLGLE------------------------- 117 (1137)
Q Consensus 69 ~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~----L~~l-P~~l~~L~~L~------------------------- 117 (1137)
+|+.|+|++|.++.|++ .|.++.+|..|.+..+. +..+ +..|.++.+|+
T Consensus 125 ~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~ 204 (329)
T 3sb4_A 125 NLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDI 204 (329)
T ss_dssp TCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGC
T ss_pred ccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCcccc
Confidence 99999999999999865 68887778777776532 2223 12244444444
Q ss_pred -EEEccCCCCCCCccc-ccCCCCCCEEECCCCCCCCCcccch-hhhcCCCCCcEEeccCCCCcccCc-cccCCCCCC-EE
Q 001152 118 -CLQIKISSPGVNGFA-LNKLKGLKELELSKVPPRPSVLTLL-SEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLE-QL 192 (1137)
Q Consensus 118 -~L~Ls~N~~~~~~~~-~~~L~~L~~L~Ls~n~ln~~~~~lp-~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~-~L 192 (1137)
.+.+.++-....... ...+++|+.|+|++|.+ ..+| ..|.+|.+|+.|+|.+| ++.|+. .|.++++|+ .|
T Consensus 205 ~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i----~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l 279 (329)
T 3sb4_A 205 NFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNA----TTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTL 279 (329)
T ss_dssp SEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCC----CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred ceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCc----ceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEE
Confidence 333222210000001 11378999999998543 3444 46889999999999998 888887 789999999 99
Q ss_pred EccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEec
Q 001152 193 DLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDL 240 (1137)
Q Consensus 193 ~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdL 240 (1137)
+|.+ .++.|+ ..|.+|++|+.|+|++|.++.|+. .|.++++|+.|+.
T Consensus 280 ~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 280 ELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 9998 888886 678999999999999999999976 5777999999874
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=2.1e-12 Score=147.27 Aligned_cols=111 Identities=23% Similarity=0.220 Sum_probs=98.6
Q ss_pred EEeccCC-CCcccCccccCCCCCCEEEccC-CCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeccCC
Q 001152 168 KLSVCHF-SIRYLPPEIGCLSNLEQLDLSF-NKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNN 243 (1137)
Q Consensus 168 ~L~Ls~N-~L~~IP~~l~~L~~L~~L~Ls~-N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdLS~N 243 (1137)
.++++++ +|+.||. |..+++|+.|+|++ |+|+.+| ..|+.|++|+.|+|++|+|+.+|+ .|.+|++|+.|+|++|
T Consensus 12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 5788888 9999999 99999999999996 9999887 578999999999999999997765 6788999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchh
Q 001152 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1137)
Q Consensus 244 ~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1137)
+|+++++..|..++ |+.|+|++|+|.|.|.+.....
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~ 126 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQR 126 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHH
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHH
Confidence 99999987777776 9999999999999887654433
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.24 E-value=2.7e-11 Score=124.53 Aligned_cols=106 Identities=25% Similarity=0.291 Sum_probs=86.3
Q ss_pred CCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCccc-CccccCCCCCCEEEccCCCCCccchh-hcCCCCCCEEE
Q 001152 139 LKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYL-PPEIGCLSNLEQLDLSFNKMKYLPTE-ICYLKALISLK 216 (1137)
Q Consensus 139 L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~I-P~~l~~L~~L~~L~Ls~N~L~~LP~~-l~~L~~L~~L~ 216 (1137)
.+.|++++|.+. .+|..+ .++|+.|+|++|+|+.+ |..|..+++|++|+|++|+|+.+|.. |..+++|+.|+
T Consensus 11 ~~~l~~s~n~l~----~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~ 84 (170)
T 3g39_A 11 GTTVDCSGKSLA----SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLS 84 (170)
T ss_dssp TTEEECTTSCCS----SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCEEEeCCCCcC----ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEE
Confidence 345666654432 344443 26789999999999987 55789999999999999999988865 58899999999
Q ss_pred ccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCc
Q 001152 217 VANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGS 250 (1137)
Q Consensus 217 Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p 250 (1137)
|++|+|+.+|.. +..+++|+.|+|++|.|+...+
T Consensus 85 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 85 LNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999999998875 7789999999999999997754
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.6e-11 Score=125.32 Aligned_cols=82 Identities=22% Similarity=0.295 Sum_probs=41.8
Q ss_pred CCccEEEeecCCCCcc-CccccCCCCCcEEEccCCCCCccccc-ccCCCCCCEEEccCCCCCCCcc-cccCCCCCCEEEC
Q 001152 68 NSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVNGF-ALNKLKGLKELEL 144 (1137)
Q Consensus 68 ~~L~~L~Ls~N~L~~I-P~~~~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~~~~~~~-~~~~L~~L~~L~L 144 (1137)
++|++|+|++|+|+.+ |..|.++++|++|+|++|+|+.+|.. |.++++|++|+|++|.+..++. .|..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 3455555555555544 23455555555555555555555443 3455555555555555444443 2555555555555
Q ss_pred CCCCC
Q 001152 145 SKVPP 149 (1137)
Q Consensus 145 s~n~l 149 (1137)
++|++
T Consensus 113 ~~N~~ 117 (174)
T 2r9u_A 113 YNNPW 117 (174)
T ss_dssp CSSCB
T ss_pred CCCCc
Confidence 55444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.9e-12 Score=150.23 Aligned_cols=163 Identities=20% Similarity=0.185 Sum_probs=86.4
Q ss_pred CCcEEEccCCCCCcc-----ccccc-CCCCCCEEEccCCCCCCCc--ccccCCCCCCEEECCCCCCCCCccc-chhhh-c
Q 001152 92 KLRNLKFFGNEINLF-----PSEVG-NLLGLECLQIKISSPGVNG--FALNKLKGLKELELSKVPPRPSVLT-LLSEI-A 161 (1137)
Q Consensus 92 ~L~~L~Ls~N~L~~l-----P~~l~-~L~~L~~L~Ls~N~~~~~~--~~~~~L~~L~~L~Ls~n~ln~~~~~-lp~~l-~ 161 (1137)
.|+.|+|++|.|+.. ...+. +.++|+.|+|++|.++..+ .....+.+|+.|+|++|.+...... +...+ .
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 455666666665522 11122 1245555555555543211 1122334455555555443221111 11112 2
Q ss_pred CCCCCcEEeccCCCCcc-----cCccccCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCCc-----cC
Q 001152 162 GLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE-----LP 226 (1137)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~-----~LP~~l~~L~~L~~L~Ls~N~Ls~-----IP 226 (1137)
..++|+.|+|++|.|+. ++..+..+++|++|+|++|.|+ .|+..+..+++|+.|+|++|.|+. ++
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~ 232 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA 232 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHH
Confidence 34567777777777653 3444556667777777777776 234556666677777777777762 33
Q ss_pred ccccCCCCCCEEeccCCcCCCCCccccc
Q 001152 227 SGLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1137)
Q Consensus 227 ~~l~~L~~L~~LdLS~N~Lsg~~p~~l~ 254 (1137)
..+...++|+.|+|++|.|+......+.
T Consensus 233 ~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 233 RAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp HHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred HHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 4455566777777777777654444443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=2.3e-10 Score=125.04 Aligned_cols=139 Identities=14% Similarity=0.119 Sum_probs=106.3
Q ss_pred CCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~ 879 (1137)
+..|++...++.|+.+.||++...+..+++|+........ . . .+.+|+.+++.+. |..+.++++++...+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~-~---~----~~~~E~~~l~~l~~~~~vP~v~~~~~~~~- 83 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT-T---Y----DVEREKDMMLWLEGKLPVPKVLHFERHDG- 83 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS-T---T----CHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC-H---H----HHHHHHHHHHHHhcCCCCCeEEEEEecCC-
Confidence 4568899999999999999999877889999854321111 1 1 2377999999986 677889998887654
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS----------------- 942 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs----------------- 942 (1137)
..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 84 -------------~~~lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~ 140 (263)
T 3tm0_A 84 -------------WSNLLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140 (263)
T ss_dssp -------------EEEEEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHH
T ss_pred -------------ceEEEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHH
Confidence 5699999999999876521 112234778899999999998
Q ss_pred ------------------------------------------CCeeeccCCCCCeEeccccccCCCCCeEEEeecCcc
Q 001152 943 ------------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRA 978 (1137)
Q Consensus 943 ------------------------------------------~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla 978 (1137)
..++|||++|.|||++.+ ..+.|+||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-------~~~~lIDwe~a 211 (263)
T 3tm0_A 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-------KVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-------EEEEECCCTTC
T ss_pred HHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-------cEEEEEEchhc
Confidence 458999999999999754 45679999965
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.1e-11 Score=143.68 Aligned_cols=158 Identities=20% Similarity=0.242 Sum_probs=100.2
Q ss_pred CCccEEEeecCCCCccC-----cccc-CCCCCcEEEccCCCCCc--ccccccCCCCCCEEEccCCCCCCCcc-cc-----
Q 001152 68 NSVEGLYLYKNVLNLIP-----KSVG-RYEKLRNLKFFGNEINL--FPSEVGNLLGLECLQIKISSPGVNGF-AL----- 133 (1137)
Q Consensus 68 ~~L~~L~Ls~N~L~~IP-----~~~~-~L~~L~~L~Ls~N~L~~--lP~~l~~L~~L~~L~Ls~N~~~~~~~-~~----- 133 (1137)
+.|+.|+|++|.|+... ..+. ..++|+.|+|++|.|+. +..-...+++|+.|+|++|.++..+. .+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 34566666666665321 1122 12456666666666652 11112234456666666665543331 11
Q ss_pred cCCCCCCEEECCCCCCCCC-cccchhhhcCCCCCcEEeccCCCCcc-----cCccccCCCCCCEEEccCCCCCc-----c
Q 001152 134 NKLKGLKELELSKVPPRPS-VLTLLSEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----L 202 (1137)
Q Consensus 134 ~~L~~L~~L~Ls~n~ln~~-~~~lp~~l~~L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~~-----L 202 (1137)
....+|++|+|++|.+... ...++..+..+++|++|+|++|.|+. |+..+...++|+.|+|++|.|+. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 2356677777777554321 12355566788899999999999873 35567778899999999999983 4
Q ss_pred chhhcCCCCCCEEEccCCCCCcc
Q 001152 203 PTEICYLKALISLKVANNKLVEL 225 (1137)
Q Consensus 203 P~~l~~L~~L~~L~Ls~N~Ls~I 225 (1137)
+..+..+++|++|+|++|.|+..
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHH
Confidence 56677789999999999999843
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.2e-10 Score=132.67 Aligned_cols=127 Identities=19% Similarity=0.161 Sum_probs=94.3
Q ss_pred EEECCCCCCCCCcccchhhhcCCCCCcEEeccC-CCCcccCc-cccCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEc
Q 001152 141 ELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCH-FSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKV 217 (1137)
Q Consensus 141 ~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~-N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~L 217 (1137)
.++++++ +.+..+|. |..+++|+.|+|++ |+|+.+|. .|+.|++|++|+|++|+|+.+| ..|.+|++|+.|+|
T Consensus 12 ~v~~~~~---n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 12 GLRCTRD---GALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp CEECCSS---CCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred EEEcCCC---CCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 3455552 13345777 88888999999996 99998875 7899999999999999999775 56799999999999
Q ss_pred cCCCCCccCccccCCCCCCEEeccCCcCCCCCc-ccccCCCCCCEEEccCCcCCC
Q 001152 218 ANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 218 s~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p-~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
++|+|+.+|..++....|+.|+|++|.|...-. .+|..+.......+..+.++|
T Consensus 88 ~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C 142 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQC 142 (347)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCC
T ss_pred CCCccceeCHHHcccCCceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCC
Confidence 999999998876664459999999999986432 123332222333344555665
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.97 E-value=9.5e-09 Score=119.49 Aligned_cols=244 Identities=12% Similarity=0.104 Sum_probs=122.2
Q ss_pred cccCCCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecC-----------
Q 001152 10 TQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKN----------- 78 (1137)
Q Consensus 10 ~~~~~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N----------- 78 (1137)
.++..+. .|+.+.+. ++|+.|...+|.++.+|+.++|..+ ++.+....|.+. .+|+.+.+..+
T Consensus 65 ~AF~~c~-~L~~i~lp-~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c---~~L~~i~~p~~l~~i~~~aF~~ 138 (394)
T 4fs7_A 65 AAFQGCR-KVTEIKIP-STVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGC---YALKSILLPLMLKSIGVEAFKG 138 (394)
T ss_dssp TTTTTCT-TEEEEECC-TTCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTC---TTCCCCCCCTTCCEECTTTTTT
T ss_pred HHhhCCC-CceEEEeC-CCccCcchhHhhCCCCCcEEEeCCC-ceEccchhhccc---ccchhhcccCceeeecceeeec
Confidence 3455554 57777665 4588888888888888888888654 433333333222 33333322211
Q ss_pred ----------CCCccC-ccccCCCCCcEEEccCCCCCcccc-cccCCCCCCEEEccCCC---------------------
Q 001152 79 ----------VLNLIP-KSVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKISS--------------------- 125 (1137)
Q Consensus 79 ----------~L~~IP-~~~~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N~--------------------- 125 (1137)
.+..+. ..|.++++|+.+.|.++ +..|+. .|.++.+|+.+.+..|-
T Consensus 139 ~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~~~~I~~~~F~~~~~L~~i~~~~ 217 (394)
T 4fs7_A 139 CDFKEITIPEGVTVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRNLKIIRDYCFAECILLENMEFPN 217 (394)
T ss_dssp CCCSEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCTTCCBCCCCT
T ss_pred ccccccccCccccccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCCceEeCchhhccccccceeecCC
Confidence 011111 12444455555555432 223322 23444444444443221
Q ss_pred -CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcc--------------------cCc-cc
Q 001152 126 -PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY--------------------LPP-EI 183 (1137)
Q Consensus 126 -~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~--------------------IP~-~l 183 (1137)
...++..+....+|+.+.+... ....-...+.++..|+.+.+..+...- +|. .|
T Consensus 218 ~~~~i~~~~~~~~~l~~i~ip~~----~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~~~~F 293 (394)
T 4fs7_A 218 SLYYLGDFALSKTGVKNIIIPDS----FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVPEKTF 293 (394)
T ss_dssp TCCEECTTTTTTCCCCEEEECTT----CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEECTTTT
T ss_pred CceEeehhhcccCCCceEEECCC----ceecccccccccccceeEEcCCCcceeeccccccccccceeccCceeeccccc
Confidence 1111222233345666655431 111111234455566666555443221 222 34
Q ss_pred cCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeccCCcCCCCCcccccCCCCCCE
Q 001152 184 GCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQN 261 (1137)
Q Consensus 184 ~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~ 261 (1137)
..+.+|+.+.+..| ++.|+ .+|.++.+|+.++|..+ ++.|+. .|.++.+|+.++|..| ++.+...+|.++.+|+.
T Consensus 294 ~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~ 370 (394)
T 4fs7_A 294 YGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKK 370 (394)
T ss_dssp TTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCE
T ss_pred cccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCE
Confidence 55566666666543 55554 34566677777777533 666643 3555677777777655 66666666777777777
Q ss_pred EEccCC
Q 001152 262 LNLQYN 267 (1137)
Q Consensus 262 L~Ls~N 267 (1137)
++|..|
T Consensus 371 i~lp~~ 376 (394)
T 4fs7_A 371 VELPKR 376 (394)
T ss_dssp EEEEGG
T ss_pred EEECCC
Confidence 766544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.4e-08 Score=116.14 Aligned_cols=249 Identities=8% Similarity=0.095 Sum_probs=153.9
Q ss_pred cccCCCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCC---CCCCCcccccCCCCCCCccEEEeecCCCCccCc-
Q 001152 10 TQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKT---VDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK- 85 (1137)
Q Consensus 10 ~~~~~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~---L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~- 85 (1137)
.++.+....++.+.+- +.++.|...+|.++.+|+.+.++.|. ++.+-..+|. ++.+|+.+.+.++ ++.|+.
T Consensus 57 ~aF~~~~~~L~sI~iP-~svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~---~c~~L~~i~~~~~-~~~I~~~ 131 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIP-DTVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFM---FCSELTDIPILDS-VTEIDSE 131 (394)
T ss_dssp TTTTTCCSCCCEEEEC-TTCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTT---TCTTCCBCGGGTT-CSEECTT
T ss_pred hhccCCCCcCEEEEEC-CCeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhch---hcccceeeccCCc-cceehhh
Confidence 3455543346666554 35899999999999999999998774 4444444443 3366666666554 666653
Q ss_pred cccCCCCCcEEEccCCCCCcccc-cccCCCCCCEEEccCC----------------------CCCCCcccccCCCCCCEE
Q 001152 86 SVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQIKIS----------------------SPGVNGFALNKLKGLKEL 142 (1137)
Q Consensus 86 ~~~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~Ls~N----------------------~~~~~~~~~~~L~~L~~L 142 (1137)
.|..+.+|+.+.|.. .+..|+. .|.++.+|+.+.+..+ ........|..+.+|...
T Consensus 132 aF~~c~~L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 132 AFHHCEELDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDSVTAIEERAFTGTALTQIHIPAKVTRIGTNAFSECFALSTI 210 (394)
T ss_dssp TTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCCCSEEEECTTCCEECTTTTTTCTTCCEE
T ss_pred hhhhhcccccccccc-eeeeecccceecccccccccccceeeEeccccccccceeEEEECCcccccccchhhhcccccee
Confidence 466666677776653 2333332 2444555555555432 221222233444444443
Q ss_pred ECCCCCCC-------------------------CCcccch--------hhhcCCCCCcEEeccCCCCcccCc-cccCCCC
Q 001152 143 ELSKVPPR-------------------------PSVLTLL--------SEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSN 188 (1137)
Q Consensus 143 ~Ls~n~ln-------------------------~~~~~lp--------~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~ 188 (1137)
....+... ...-.+| .+|.++..|+.+.+..+-. .|.. .|.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~ 289 (394)
T 4gt6_A 211 TSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPA 289 (394)
T ss_dssp EECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTT
T ss_pred cccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccc-eecCcccccccc
Confidence 32221100 0001122 2456677788887765543 3444 6778888
Q ss_pred CCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccC
Q 001152 189 LEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1137)
Q Consensus 189 L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~ 266 (1137)
|+.+.+. +.++.|+ ..|.++.+|+.+.|..| ++.|.. .|.++.+|+.+.|..+ ++.+...+|.++.+|+.+++.+
T Consensus 290 L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~ 366 (394)
T 4gt6_A 290 LQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSG 366 (394)
T ss_dssp CCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESS
T ss_pred cccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECC
Confidence 8888885 5677776 45677889999998754 777865 4667889999998654 7888788888999999999888
Q ss_pred Cc
Q 001152 267 NK 268 (1137)
Q Consensus 267 N~ 268 (1137)
|.
T Consensus 367 ~~ 368 (394)
T 4gt6_A 367 SR 368 (394)
T ss_dssp CH
T ss_pred ce
Confidence 75
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.83 E-value=5.4e-09 Score=113.00 Aligned_cols=134 Identities=14% Similarity=0.123 Sum_probs=92.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCc--ceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI--VEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNI--Vkllg~~~~~ 877 (1137)
+..|.+....+.|..+.||++... +..+++|+.... ... .+.+|+.+++.+.+.++ .+++++....
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~----~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALN----ELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-------cch----hhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 455666555556677999999864 466999985321 111 23678999998865454 4688877654
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH------------- 944 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g------------- 944 (1137)
+ ..++||||++|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 88 ~--------------~~~~v~e~i~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~ 140 (264)
T 1nd4_A 88 G--------------RDWLLLGEVPGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHR 140 (264)
T ss_dssp S--------------CEEEEEECCSSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHH
T ss_pred C--------------CCEEEEEecCCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 3 469999999988884 11 011 1245667777777777543
Q ss_pred ---------------------------------------------eeeccCCCCCeEeccccccCCCCCeEEEeecCccc
Q 001152 945 ---------------------------------------------IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 945 ---------------------------------------------IIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~ 979 (1137)
++|||++|.|||++.+ ..+.|+|||.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-------~~~~liD~~~a~ 213 (264)
T 1nd4_A 141 IERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-------RFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-------EEEEECCCTTCE
T ss_pred HHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-------cEEEEEcchhcc
Confidence 9999999999999765 456799999763
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.81 E-value=9.4e-08 Score=110.13 Aligned_cols=239 Identities=12% Similarity=0.059 Sum_probs=133.1
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~ 97 (1137)
+++.+-+. ..|+.|...+|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+..| ++.|+.......+|+.+.
T Consensus 47 ~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c----~l~~i~~~~~-l~~I~~~aF~~~~L~~i~ 119 (379)
T 4h09_A 47 RISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT----KLQSYTGMER-VKKFGDYVFQGTDLDDFE 119 (379)
T ss_dssp GCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC----CCCEEEECTT-CCEECTTTTTTCCCSEEE
T ss_pred CCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC----CCceEECCce-eeEeccceeccCCccccc
Confidence 34444443 4588999999999999999999754 776666666543 6888888765 888876433335799998
Q ss_pred ccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCC---------------------------
Q 001152 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPR--------------------------- 150 (1137)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln--------------------------- 150 (1137)
|..+ ++.+......-.+|+.+.+..+-.......|....+|+.+.+..+...
T Consensus 120 lp~~-~~~i~~~~F~~~~l~~~~~~~~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (379)
T 4h09_A 120 FPGA-TTEIGNYIFYNSSVKRIVIPKSVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTE 198 (379)
T ss_dssp CCTT-CCEECTTTTTTCCCCEEEECTTCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSE
T ss_pred CCCc-cccccccccccceeeeeeccceeeccccchhcccccccccccccccceeecccceecccccceeccccccccccc
Confidence 8654 444433322233455544433322222234444555554444321110
Q ss_pred -----CCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCC
Q 001152 151 -----PSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLV 223 (1137)
Q Consensus 151 -----~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls 223 (1137)
.........+..+.+|+.+.+..+ +..|+. .+..+..|+.+.+..+ ++.|. ..|.++.+|+.+.+..+ ++
T Consensus 199 ~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~ 275 (379)
T 4h09_A 199 FTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK 275 (379)
T ss_dssp EECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS
T ss_pred cccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce
Confidence 000001122334455555555433 333333 4555666666666554 55553 34455666666666433 55
Q ss_pred ccCcc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCC
Q 001152 224 ELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1137)
Q Consensus 224 ~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N 267 (1137)
.|+.. |.++.+|+.+.|.+|.++.+....|.++.+|+.+.|..|
T Consensus 276 ~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 276 TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 55543 444666666666666666666666666666666666543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.80 E-value=6.3e-09 Score=119.26 Aligned_cols=147 Identities=15% Similarity=0.181 Sum_probs=103.7
Q ss_pred EeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--CCCcceeeeeEecCCCCCCC
Q 001152 806 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 806 l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~--HpNIVkllg~~~~~~~~~~~ 883 (1137)
-.+.|+.|.++.||++...+..+++|+....... ...... .+.+|+.+++.+. +..+.++++++.+....
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~-~~~~~~----~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~--- 113 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSK-LLPSAH----AIEREYRVMDALAGTDVPVAKMYALCEDESVI--- 113 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT---
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCC-CCCcHH----HHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc---
Confidence 4578999999999999987777888763200110 011111 2377999999997 45577888887654311
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------------------- 942 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs--------------------- 942 (1137)
...++||||++|..+.+.. ...++......++.++++.|..||+
T Consensus 114 --------g~~~~vme~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3dxp_A 114 --------GRAFYIMEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQ 178 (359)
T ss_dssp --------SSCEEEEECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHH
T ss_pred --------CCeEEEEEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHH
Confidence 1358999999988774311 1246788888999999999999997
Q ss_pred -------------------------------------CCeeeccCCCCCeEeccccccCCCCCeEEEeecCcccc
Q 001152 943 -------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 980 (1137)
Q Consensus 943 -------------------------------------~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~ 980 (1137)
..++|||+++.|||++.+.. ..+.|+||+.+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-----~v~~viDwe~a~~ 248 (359)
T 3dxp_A 179 IERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-----RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-----CEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-----cEEEEECcccccc
Confidence 35899999999999986621 2468999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.79 E-value=2.8e-09 Score=123.07 Aligned_cols=151 Identities=17% Similarity=0.188 Sum_probs=77.5
Q ss_pred ccCCCCCCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhc--CCCCCcEEeccC--CC------Ccc
Q 001152 110 VGNLLGLECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIA--GLKCLTKLSVCH--FS------IRY 178 (1137)
Q Consensus 110 l~~L~~L~~L~Ls~N~-~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~--~L~~L~~L~Ls~--N~------L~~ 178 (1137)
+..+++|+.|.|++|. +.. +. + .+.+|+.|+|..+.++ ......+. .+++|+.|+|+. |. +..
T Consensus 168 l~~~P~L~~L~L~g~~~l~l-~~-~-~~~~L~~L~L~~~~l~---~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~ 241 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNLSI-GK-K-PRPNLKSLEIISGGLP---DSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV 241 (362)
T ss_dssp HHTCTTCCEEEEECCBTCBC-CS-C-BCTTCSEEEEECSBCC---HHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred HhcCCCCcEEEEeCCCCcee-cc-c-cCCCCcEEEEecCCCC---hHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence 4445555555555442 211 11 1 2555666666543221 11122222 456666666542 11 111
Q ss_pred cCccc--cCCCCCCEEEccCCCCC-ccchhhc---CCCCCCEEEccCCCCCc-----cCccccCCCCCCEEeccCCcCCC
Q 001152 179 LPPEI--GCLSNLEQLDLSFNKMK-YLPTEIC---YLKALISLKVANNKLVE-----LPSGLYLLQRLENLDLSNNRLTS 247 (1137)
Q Consensus 179 IP~~l--~~L~~L~~L~Ls~N~L~-~LP~~l~---~L~~L~~L~Ls~N~Ls~-----IP~~l~~L~~L~~LdLS~N~Lsg 247 (1137)
+...+ ..+++|++|+|++|.+. ..+..+. .+++|+.|+|+.|.|+. |+..+..+++|+.|+|++|.|+.
T Consensus 242 l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 11112 24677777777777776 2232332 36677777777777763 44445556777777777777764
Q ss_pred CCcccccC-CCCCCEEEccCCc
Q 001152 248 LGSLDLCL-MHNLQNLNLQYNK 268 (1137)
Q Consensus 248 ~~p~~l~~-L~~L~~L~Ls~N~ 268 (1137)
..-..+.. + ...+++++|+
T Consensus 322 ~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 322 EMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHHC--CSEEECCSBC
T ss_pred HHHHHHHHHc--CCEEEecCCc
Confidence 32222322 2 3456777665
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.79 E-value=3.3e-08 Score=114.92 Aligned_cols=221 Identities=14% Similarity=0.181 Sum_probs=151.6
Q ss_pred CCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEccCCCC-
Q 001152 26 ANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEI- 103 (1137)
Q Consensus 26 ~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~L- 103 (1137)
.+.+..+...+|.++.+|+.++|..+. ..+....| .++.+|+.+.|..| ++.|+. .|.++..|+.+.+.++..
T Consensus 147 ~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F---~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~ 221 (394)
T 4fs7_A 147 PEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLF---SGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY 221 (394)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTT---TTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE
T ss_pred CccccccchhhhcccCCCcEEecCCcc-ceeccccc---cCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE
Confidence 345566778889999999999997653 33444444 44578888888877 777754 577777777777655432
Q ss_pred --------------------Cccc-ccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcC
Q 001152 104 --------------------NLFP-SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAG 162 (1137)
Q Consensus 104 --------------------~~lP-~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~ 162 (1137)
+.|. ..+.++..|+.+.+..+........|..+..|+.+.+..+. + ....+..
T Consensus 222 i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~----i--~~~~F~~ 295 (394)
T 4fs7_A 222 LGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVI----V--PEKTFYG 295 (394)
T ss_dssp ECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSE----E--CTTTTTT
T ss_pred eehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCcee----e--ccccccc
Confidence 1111 12344555555555554444444455555666655554311 1 1134678
Q ss_pred CCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEe
Q 001152 163 LKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLD 239 (1137)
Q Consensus 163 L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~Ld 239 (1137)
+.+|+.+.+..+ ++.|+. .|.++++|+.++|.. .++.|+ .+|.+|.+|+.+.|..| ++.|+. .|.++.+|+.++
T Consensus 296 ~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~-~v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 372 (394)
T 4fs7_A 296 CSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPY-LVEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVE 372 (394)
T ss_dssp CTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEE
T ss_pred cccccccccccc-cceechhhhcCCCCCCEEEeCC-cccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEE
Confidence 889999998765 777866 788999999999975 488885 57889999999999877 888865 477899999999
Q ss_pred ccCCcCCCCCcccccCCCCCCEE
Q 001152 240 LSNNRLTSLGSLDLCLMHNLQNL 262 (1137)
Q Consensus 240 LS~N~Lsg~~p~~l~~L~~L~~L 262 (1137)
|..| ++.. ...|.++++|+.+
T Consensus 373 lp~~-~~~~-~~~F~~c~~L~~I 393 (394)
T 4fs7_A 373 LPKR-LEQY-RYDFEDTTKFKWI 393 (394)
T ss_dssp EEGG-GGGG-GGGBCTTCEEEEE
T ss_pred ECCC-CEEh-hheecCCCCCcEE
Confidence 9866 4433 3578888888765
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.78 E-value=1.1e-07 Score=110.46 Aligned_cols=232 Identities=10% Similarity=0.113 Sum_probs=149.9
Q ss_pred CCcccCCCCCCCCC-CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCC---CCccCc-cccCCCCCcEEEccCCC
Q 001152 28 KINNEKNGSVNDDD-DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV---LNLIPK-SVGRYEKLRNLKFFGNE 102 (1137)
Q Consensus 28 ~i~~l~~~~f~~l~-~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~---L~~IP~-~~~~L~~L~~L~Ls~N~ 102 (1137)
.++.|...+|.+.. .|+.+.|-.+ ++.+-..+|. ++++|+.+.+..|. ++.|+. .|.++.+|+.+.+..+
T Consensus 50 ~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~---~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~- 124 (394)
T 4gt6_A 50 PVSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFY---NCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS- 124 (394)
T ss_dssp EEEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTT---TCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-
T ss_pred eeeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhh---CCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-
Confidence 47899999999985 6999999754 7766666664 45999999998874 778864 6888999999888754
Q ss_pred CCcccc-cccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCC---------CCC-cccch--------hhhcCC
Q 001152 103 INLFPS-EVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPP---------RPS-VLTLL--------SEIAGL 163 (1137)
Q Consensus 103 L~~lP~-~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~l---------n~~-~~~lp--------~~l~~L 163 (1137)
++.|+. .|.++.+|+.+.+..+........|..+.+|+.+.+..+-. +.+ .-.+| ..+..+
T Consensus 125 ~~~I~~~aF~~c~~L~~i~lp~~~~~I~~~~F~~c~~L~~i~~~~~~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c 204 (394)
T 4gt6_A 125 VTEIDSEAFHHCEELDTVTIPEGVTSVADGMFSYCYSLHTVTLPDSVTAIEERAFTGTALTQIHIPAKVTRIGTNAFSEC 204 (394)
T ss_dssp CSEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCCCSEEEECTTCCEECTTTTTTC
T ss_pred cceehhhhhhhhcccccccccceeeeecccceecccccccccccceeeEeccccccccceeEEEECCcccccccchhhhc
Confidence 777755 47889999999997655444556788888898888865210 000 00111 123334
Q ss_pred CCCcEEeccCCCCc-----------------------------ccCc--------cccCCCCCCEEEccCCCCCccc-hh
Q 001152 164 KCLTKLSVCHFSIR-----------------------------YLPP--------EIGCLSNLEQLDLSFNKMKYLP-TE 205 (1137)
Q Consensus 164 ~~L~~L~Ls~N~L~-----------------------------~IP~--------~l~~L~~L~~L~Ls~N~L~~LP-~~ 205 (1137)
..|.......+... .+|. .|..+.+|+.+.+..+. ..|. ..
T Consensus 205 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~-~~I~~~a 283 (394)
T 4gt6_A 205 FALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSV-VSIGTGA 283 (394)
T ss_dssp TTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTC-CEECTTT
T ss_pred cccceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEeccccc-ceecCcc
Confidence 44443332221111 1222 34455666666665433 2332 45
Q ss_pred hcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCC
Q 001152 206 ICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1137)
Q Consensus 206 l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N 267 (1137)
|.++.+|+.+.+. +.++.|+.. |.++.+|+.++|..| ++.+...+|.++.+|+.+.|..|
T Consensus 284 F~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s 344 (394)
T 4gt6_A 284 FMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS 344 (394)
T ss_dssp TTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT
T ss_pred cccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc
Confidence 5667777777774 456667654 445777777777654 66666667777777777777544
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.68 E-value=2.7e-08 Score=111.36 Aligned_cols=196 Identities=18% Similarity=0.207 Sum_probs=117.5
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCc--ceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCI--VEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNI--Vkllg~~~~~~~~~~~~ 884 (1137)
+.++.|.+..||++. ..+++|+... ..... ++.+|+++|+.+. +..| .+++........
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~------~~~~~----~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~----- 87 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH------SRGST----NLFNEVNILKRIHNKLPLPIPEVVFTGMPSET----- 87 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS------HHHHH----HHHHHHHHHHHHTTSSSSCCCCEEEECCCCSS-----
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC------cchHH----HHHHHHHHHHHHHhcCCCCCCceEeecCCCCC-----
Confidence 458999999999764 5688887421 11222 3478999998884 4333 344444322221
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 942 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs---------------------- 942 (1137)
....|+|||+++|.+|...... .++..++..++.|++..|..||+
T Consensus 88 ------~~~~~~vm~~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~ 154 (304)
T 3sg8_A 88 ------YQMSFAGFTKIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDN 154 (304)
T ss_dssp ------CSCSCEEEECCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHH
T ss_pred ------CCcceEEEcccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHH
Confidence 1134899999999888754332 36777788888888888888885
Q ss_pred ------------------------------------CCeeeccCCCCCeEeccccccCCCCCeEEEeecCcccccccccc
Q 001152 943 ------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLH 986 (1137)
Q Consensus 943 ------------------------------------~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~ 986 (1137)
..++|||++|.||+++.+. ...+.|+||+.+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-----~~~~~~iD~~~~~~~~~~~D 229 (304)
T 3sg8_A 155 KKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-----NTICGIIDFGDAAISDPDND 229 (304)
T ss_dssp HHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-----TEEEEECCCTTCEEECTTHH
T ss_pred HHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-----CCEEEEEeCCCCccCChHHH
Confidence 1379999999999998731 14678999998764322110
Q ss_pred ccccccCCC-CCC---CcccCCCcccc-hhhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 001152 987 TCCIAHRGI-PAP---DVCVGTPRWMA-PEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045 (1137)
Q Consensus 987 ~~~~~~~~~-~~~---~~~~GT~~Y~A-PE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~Pf 1045 (1137)
......... ... ..+.....+.. |+.... .....+.|++|.++|.+.+|..+|
T Consensus 230 l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r------~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 230 FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK------YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH------HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH------HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000000000 000 00000001111 222221 113468999999999999998776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.57 E-value=3.6e-08 Score=113.75 Aligned_cols=81 Identities=20% Similarity=0.229 Sum_probs=58.5
Q ss_pred CCCCCcEEeccCCCCc-ccCccc---cCCCCCCEEEccCCCCCc-----cchhhcCCCCCCEEEccCCCCCc-cCccccC
Q 001152 162 GLKCLTKLSVCHFSIR-YLPPEI---GCLSNLEQLDLSFNKMKY-----LPTEICYLKALISLKVANNKLVE-LPSGLYL 231 (1137)
Q Consensus 162 ~L~~L~~L~Ls~N~L~-~IP~~l---~~L~~L~~L~Ls~N~L~~-----LP~~l~~L~~L~~L~Ls~N~Ls~-IP~~l~~ 231 (1137)
.+++|+.|+|.+|.++ ..+..+ ..+++|++|+|+.|.|+. ++..+..+++|+.|+|++|.|+. .=..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 4678899999888876 232222 357899999999999983 55556678899999999998872 2222332
Q ss_pred -CCCCCEEeccCCc
Q 001152 232 -LQRLENLDLSNNR 244 (1137)
Q Consensus 232 -L~~L~~LdLS~N~ 244 (1137)
+ ...++++.|+
T Consensus 330 al--g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL--PMKIDVSDSQ 341 (362)
T ss_dssp HC--CSEEECCSBC
T ss_pred Hc--CCEEEecCCc
Confidence 2 4678999988
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.44 E-value=4.4e-06 Score=96.09 Aligned_cols=242 Identities=11% Similarity=0.082 Sum_probs=160.4
Q ss_pred hhcccCCCCCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCcc-
Q 001152 8 EITQKSPEGPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKS- 86 (1137)
Q Consensus 8 ~~~~~~~~~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~- 86 (1137)
.-.++..+. .|+.+.+. +.++.|...+|.+. +|+.+.+..+ ++.+...+|.. .+|+.+.|..+ ++.+...
T Consensus 61 g~~aF~~C~-~L~~I~lp-~~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~----~~L~~i~lp~~-~~~i~~~~ 131 (379)
T 4h09_A 61 GEANFNSCY-NMTKVTVA-STVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG----TDLDDFEFPGA-TTEIGNYI 131 (379)
T ss_dssp CTTTTTTCT-TCCEEEEC-TTCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT----CCCSEEECCTT-CCEECTTT
T ss_pred HHHHhhCCC-CCCEEEeC-CcceEechhhhcCC-CCceEECCce-eeEeccceecc----CCcccccCCCc-cccccccc
Confidence 334555654 67777775 45888989999887 6777777644 55444444432 36788887655 4444432
Q ss_pred ccCCCCCcEEEccCCCCCccc-ccccCCCCCCE------------------------------------EEccCCCCCCC
Q 001152 87 VGRYEKLRNLKFFGNEINLFP-SEVGNLLGLEC------------------------------------LQIKISSPGVN 129 (1137)
Q Consensus 87 ~~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~------------------------------------L~Ls~N~~~~~ 129 (1137)
|.+ .+|+.+.+..+ ++.+. ..+.++.+|+. +.+..+.....
T Consensus 132 F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 209 (379)
T 4h09_A 132 FYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVT 209 (379)
T ss_dssp TTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEEC
T ss_pred ccc-ceeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEe
Confidence 322 23444444322 22221 12333334433 33332222223
Q ss_pred cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccch-hhc
Q 001152 130 GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPT-EIC 207 (1137)
Q Consensus 130 ~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~-~l~ 207 (1137)
...+....+|+.+.+.. +....-...+.++..|+.+.+..+ ++.|.. .|.++.+|+.+.+.. .++.++. .|.
T Consensus 210 ~~~f~~~~~l~~i~~~~----~~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~i~~~aF~ 283 (379)
T 4h09_A 210 AYGFSYGKNLKKITITS----GVTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKTVPYLLCS 283 (379)
T ss_dssp TTTTTTCSSCSEEECCT----TCCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCSEECTTTTT
T ss_pred ecccccccccceeeecc----ceeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-cceeccccccc
Confidence 34566677888888765 222222345778899999999776 677765 678899999999975 5777764 578
Q ss_pred CCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCC
Q 001152 208 YLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYN 267 (1137)
Q Consensus 208 ~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N 267 (1137)
++.+|+.+.|.+|.++.|+.. |.++.+|+.+.|..| ++.+...+|.++.+|+.+.|..|
T Consensus 284 ~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 284 GCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp TCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred cccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 899999999999999999754 667999999999765 88888888999999999998665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.34 E-value=1.3e-07 Score=98.36 Aligned_cols=115 Identities=14% Similarity=0.072 Sum_probs=85.0
Q ss_pred chhhhcCCCCCcEEeccCC-CCcc-----cCccccCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCCc
Q 001152 156 LLSEIAGLKCLTKLSVCHF-SIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE 224 (1137)
Q Consensus 156 lp~~l~~L~~L~~L~Ls~N-~L~~-----IP~~l~~L~~L~~L~Ls~N~L~-----~LP~~l~~L~~L~~L~Ls~N~Ls~ 224 (1137)
+...+...+.|+.|+|++| .|+. +...+...++|++|+|++|.|. .|...+...++|++|+|++|.|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3345566788888888888 7762 3445666788899999999887 345566667889999999998873
Q ss_pred -----cCccccCCCCCCEEec--cCCcCCCCC----cccccCCCCCCEEEccCCcCC
Q 001152 225 -----LPSGLYLLQRLENLDL--SNNRLTSLG----SLDLCLMHNLQNLNLQYNKLL 270 (1137)
Q Consensus 225 -----IP~~l~~L~~L~~LdL--S~N~Lsg~~----p~~l~~L~~L~~L~Ls~N~L~ 270 (1137)
|...+...++|+.|+| ++|.|+... ...+...++|+.|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 5666777788999999 788888532 223455688999999998864
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.34 E-value=9.8e-08 Score=105.38 Aligned_cols=94 Identities=21% Similarity=0.182 Sum_probs=53.4
Q ss_pred EeccCCCCcccCccc----cCCCCCCEEEccCCCCCcc---chhhcCCCCCCEEEccCCCCCccCccccCCC--CCCEEe
Q 001152 169 LSVCHFSIRYLPPEI----GCLSNLEQLDLSFNKMKYL---PTEICYLKALISLKVANNKLVELPSGLYLLQ--RLENLD 239 (1137)
Q Consensus 169 L~Ls~N~L~~IP~~l----~~L~~L~~L~Ls~N~L~~L---P~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~--~L~~Ld 239 (1137)
++++.|+...++..+ .++++|+.|+|++|+|+.+ |..+..+++|+.|+|++|+|+.+ ..+..+. +|+.|+
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~ 226 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELW 226 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEE
Confidence 455556544433311 3566677777777776643 34455666777777777776655 2233333 667777
Q ss_pred ccCCcCCCCCc-------ccccCCCCCCEEE
Q 001152 240 LSNNRLTSLGS-------LDLCLMHNLQNLN 263 (1137)
Q Consensus 240 LS~N~Lsg~~p-------~~l~~L~~L~~L~ 263 (1137)
|++|.|++..| ..+..+++|+.||
T Consensus 227 L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 227 LDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp CTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred ccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 77777665433 1245566666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.18 E-value=6.6e-07 Score=93.10 Aligned_cols=112 Identities=14% Similarity=0.116 Sum_probs=70.7
Q ss_pred CCCCCCEEECCCC-CCCCC-cccchhhhcCCCCCcEEeccCCCCcc-----cCccccCCCCCCEEEccCCCCCc-----c
Q 001152 135 KLKGLKELELSKV-PPRPS-VLTLLSEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----L 202 (1137)
Q Consensus 135 ~L~~L~~L~Ls~n-~ln~~-~~~lp~~l~~L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~~-----L 202 (1137)
..+.|++|+|++| .+... ...+...+...++|++|+|++|.|+. |...+...++|++|+|++|.|+. |
T Consensus 34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l 113 (185)
T 1io0_A 34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 113 (185)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence 3444455555543 33211 11233445566777777777777762 33344555678888888888872 5
Q ss_pred chhhcCCCCCCEEEc--cCCCCCc-----cCccccCCCCCCEEeccCCcCC
Q 001152 203 PTEICYLKALISLKV--ANNKLVE-----LPSGLYLLQRLENLDLSNNRLT 246 (1137)
Q Consensus 203 P~~l~~L~~L~~L~L--s~N~Ls~-----IP~~l~~L~~L~~LdLS~N~Ls 246 (1137)
...+...++|+.|+| ++|.|+. |...+...++|+.|+|++|.+.
T Consensus 114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 566777778888888 7788872 4445556678888888888765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.16 E-value=3.4e-07 Score=101.07 Aligned_cols=78 Identities=24% Similarity=0.210 Sum_probs=63.5
Q ss_pred cCCCCCcEEeccCCCCcccC---ccccCCCCCCEEEccCCCCCccchhhcCCC--CCCEEEccCCCCC-ccCc-------
Q 001152 161 AGLKCLTKLSVCHFSIRYLP---PEIGCLSNLEQLDLSFNKMKYLPTEICYLK--ALISLKVANNKLV-ELPS------- 227 (1137)
Q Consensus 161 ~~L~~L~~L~Ls~N~L~~IP---~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~--~L~~L~Ls~N~Ls-~IP~------- 227 (1137)
.++++|+.|+|++|+|+.|+ ..+..+++|+.|+|++|+|+.+. .+..+. +|+.|+|++|.|. .+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~-~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSER-ELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGG-GGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCch-hhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 56889999999999998654 56678999999999999999773 454444 9999999999998 5663
Q ss_pred cccCCCCCCEEe
Q 001152 228 GLYLLQRLENLD 239 (1137)
Q Consensus 228 ~l~~L~~L~~Ld 239 (1137)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 256789999886
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=4.7e-05 Score=85.35 Aligned_cols=137 Identities=16% Similarity=0.149 Sum_probs=86.8
Q ss_pred eeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCC---CcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS---CIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~Hp---NIVkllg~~~~~~~~~~~~ 884 (1137)
+.++.|....||+. +..+++|+.. ...... ++.+|+++|+.+.+. .+.+++.+.....
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~------~~~~~~----~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~------ 85 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPK------SQQGAD----ELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD------ 85 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEES------SHHHHH----HHHHHHHHHHHHTTTCSSBCCCEEEEEECTT------
T ss_pred eecCCCcceeEEEE---CCEEEEEecC------CchHHH----HHHHHHHHHHHHHhcCCCCCCCeEeecccCC------
Confidence 56789999999988 6778888731 112222 347899999999742 2446666654211
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS---------------------- 942 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs---------------------- 942 (1137)
...++||||++|.+|....-. .++......++.++++.|..||+
T Consensus 86 -------g~~~~v~e~i~G~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~ 151 (306)
T 3tdw_A 86 -------GNPFVGYRKVQGQILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILL 151 (306)
T ss_dssp -------SCEEEEEECCCSEECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHH
T ss_pred -------CceEEEEeccCCeECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHH
Confidence 135899999998887663211 13344444444444444444443
Q ss_pred --------------------------------------CCeeeccCCCCCeEeccccccCCCCCeEEEeecCcccc
Q 001152 943 --------------------------------------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 980 (1137)
Q Consensus 943 --------------------------------------~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~ 980 (1137)
..++|||++|.||+++.+. .....+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~---~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 152 LSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS---RQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC---SSCCEEEECCCTTCEE
T ss_pred HHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCC---CCCceEEEEehhhcCC
Confidence 1469999999999998620 0113457999997753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=5.5e-05 Score=82.43 Aligned_cols=130 Identities=15% Similarity=0.136 Sum_probs=86.5
Q ss_pred eecccCce-EEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCCCCCCC
Q 001152 809 EAGKSVSS-SLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 809 ~LG~GsfG-~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~~~~~~ 884 (1137)
.+..|.+| .||+.... +..+++|+.... .... +.+|..+|+.+. +--+.++++++.+.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~----~~~E~~~l~~l~~~vPVP~v~~~~~~~~------ 93 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VAND----VTDEMVRLNWLTAFMPLPTIKHFIRTPD------ 93 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHH----HHHHHHHHHHHTTTSCCCCEEEEEEETT------
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhH----HHHHHHHHHHhccCCCcCeEEEEEEECC------
Confidence 44556555 68987764 456888875321 1222 367899998886 333568888877654
Q ss_pred CCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK--------------------- 943 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~--------------------- 943 (1137)
..++|||+++|.++.+..... ......++.+++..|..||..
T Consensus 94 --------~~~lvme~l~G~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~ 156 (272)
T 4gkh_A 94 --------DAWLLTTAIPGKTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSR 156 (272)
T ss_dssp --------EEEEEEECCCSEEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHH
T ss_pred --------eEEEEEEeeCCccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHH
Confidence 569999999988887765431 112234555566666666631
Q ss_pred -------------------------------------CeeeccCCCCCeEeccccccCCCCCeEEEeecCccc
Q 001152 944 -------------------------------------HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 944 -------------------------------------gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~ 979 (1137)
.++|||+.+.|||++.+ ..+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-------~~~~viDwe~a~ 222 (272)
T 4gkh_A 157 MNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-------KLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-------EEEEECCCTTCE
T ss_pred HHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-------eEEEEEECcccc
Confidence 26899999999999865 456699999663
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=1.1e-05 Score=79.40 Aligned_cols=70 Identities=20% Similarity=0.180 Sum_probs=59.6
Q ss_pred CEEEccCCCCC--ccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhhccC
Q 001152 213 ISLKVANNKLV--ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284 (1137)
Q Consensus 213 ~~L~Ls~N~Ls--~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~~l~ 284 (1137)
..++.+++.|+ .||..+. .+|+.|+|++|+|+.+++..|..+++|+.|+|++|+|.|.|.+-.+..|...
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~~ 82 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAG 82 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHHT
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHHh
Confidence 47888888888 8887654 5799999999999999998899999999999999999999987666665443
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=9.5e-05 Score=84.14 Aligned_cols=85 Identities=11% Similarity=-0.015 Sum_probs=51.6
Q ss_pred Eeeee-cccCceEEEEEEEC--------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-C--CCcceeeee
Q 001152 806 SCDEA-GKSVSSSLFRCKFG--------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H--SCIVEMYGH 873 (1137)
Q Consensus 806 l~~~L-G~GsfG~Vy~a~~~--------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-H--pNIVkllg~ 873 (1137)
..+.| +.|....+|+.... +..+++|+.......... ... .+.+|+.+++.+. + -.+.+++++
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~-~~~----~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF-PTY----RLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS-SCC----CHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC-chh----HHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 45678 89999999998765 556777763221100000 001 2366888888885 3 346678877
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCH
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSV 906 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL 906 (1137)
..+.... ...++||||++|..+
T Consensus 99 ~~~~~~~-----------g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 99 ETTGDVL-----------GTPFFLMDYVEGVVP 120 (357)
T ss_dssp ECSSTTT-----------SSCEEEEECCCCBCC
T ss_pred ccCCCcc-----------CCceEEEEecCCCCh
Confidence 6543211 134899999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0019 Score=72.36 Aligned_cols=30 Identities=20% Similarity=0.339 Sum_probs=25.8
Q ss_pred CCeeeccCCCCCeEeccccccCCCCCeEEEeecCccc
Q 001152 943 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 943 ~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~ 979 (1137)
.++||||+++.|||++.+ +.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~-------~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-------EQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGG-------GCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCC-------CcEEEEehhhcc
Confidence 579999999999999766 568999999763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00034 Score=81.00 Aligned_cols=82 Identities=12% Similarity=0.002 Sum_probs=46.1
Q ss_pred EeeeecccCceEEEEEEE--CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC--CCcc-eeeeeEecCCCC
Q 001152 806 SCDEAGKSVSSSLFRCKF--GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIV-EMYGHKISSKWL 880 (1137)
Q Consensus 806 l~~~LG~GsfG~Vy~a~~--~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H--pNIV-kllg~~~~~~~~ 880 (1137)
-.+.||.|.++.||+++. .+..+++|.........+ +.......++..|+++|+.+.. |..+ +++.+. ..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~-~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~-- 108 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVG-ESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE-- 108 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT--
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccC-CCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CC--
Confidence 346899999999999964 456788886432111000 0000011233668888887742 4333 555432 22
Q ss_pred CCCCCCCccccceEEEEEeeccCC
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGG 904 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~gg 904 (1137)
..++||||+++.
T Consensus 109 ------------~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 ------------MAVTVMEDLSHL 120 (397)
T ss_dssp ------------TTEEEECCCTTS
T ss_pred ------------ccEEEEEeCCCc
Confidence 238999999863
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0028 Score=74.04 Aligned_cols=32 Identities=9% Similarity=0.351 Sum_probs=26.9
Q ss_pred HhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCcccc
Q 001152 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 980 (1137)
Q Consensus 941 Hs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~ 980 (1137)
+...++|||++|.|||++.+ + ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~-------~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD-------S-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS-------C-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCC-------C-CEEEeCccccc
Confidence 35679999999999999865 3 89999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0052 Score=68.18 Aligned_cols=71 Identities=13% Similarity=0.145 Sum_probs=43.1
Q ss_pred eeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCc-ceeeeeEecCCCCCCCCC
Q 001152 807 CDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKISSKWLPSADG 885 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNI-Vkllg~~~~~~~~~~~~g 885 (1137)
.+.|+.|....+|++ ..+++|+..... ..... ..+|+.+++.+....+ .+++++..+.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~-----~~~~~----r~~E~~~l~~l~~~g~~P~~~~~~~~~-------- 81 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT-----EEYIN----RANEAVAAREAAKAGVSPEVLHVDPAT-------- 81 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC---------CCC----HHHHHHHHHHHHHTTSSCCEEEECTTT--------
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc-----cceeC----HHHHHHHHHHHHHcCCCCceEEEECCC--------
Confidence 678999999999999 678888754221 11101 1347777777652233 3565543221
Q ss_pred CCccccceEEEEEeec-cCCCH
Q 001152 886 NPEHHLLQSAIFMEYV-KGGSV 906 (1137)
Q Consensus 886 ~~~~~~~~l~LVmEy~-~ggSL 906 (1137)
-++||||+ +|.+|
T Consensus 82 --------~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 82 --------GVMVTRYIAGAQTM 95 (301)
T ss_dssp --------CCEEEECCTTCEEC
T ss_pred --------CEEEEeecCCCccC
Confidence 27899999 65444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.002 Score=63.00 Aligned_cols=54 Identities=28% Similarity=0.340 Sum_probs=24.5
Q ss_pred EEEccCCCCC--ccchhhcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCC
Q 001152 191 QLDLSFNKMK--YLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLT 246 (1137)
Q Consensus 191 ~L~Ls~N~L~--~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Ls 246 (1137)
.++.+++.|+ .+|..+. .+|+.|+|++|+|+.||.. |..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 3444444444 4443321 2344555555555555433 233455555555555443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.025 Score=63.63 Aligned_cols=76 Identities=12% Similarity=0.044 Sum_probs=55.6
Q ss_pred EeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC---CCCcceeeeeEecCCCCCC
Q 001152 806 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR---HSCIVEMYGHKISSKWLPS 882 (1137)
Q Consensus 806 l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~---HpNIVkllg~~~~~~~~~~ 882 (1137)
-.+.|+.|.+..+|+....+..+++|+.... ... .+.+|++.|+.+. ...+.+++++....+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-------~~~----~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g---- 104 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-------YRS----MFRAEADQLALLAKTNSINVPLVYGIGNSQG---- 104 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-------GHH----HHHHHHHHHHHHHHTTSSBCCCEEEEEECSS----
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-------cHH----HHHHHHHHHHHHHhhCCCCcceEEEEeecCC----
Confidence 3467899999999999987788888875421 112 2367888888885 255778888766443
Q ss_pred CCCCCccccceEEEEEeeccCCCH
Q 001152 883 ADGNPEHHLLQSAIFMEYVKGGSV 906 (1137)
Q Consensus 883 ~~g~~~~~~~~l~LVmEy~~ggSL 906 (1137)
..++||||++|..+
T Consensus 105 ----------~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 105 ----------HSFLLLEALNKSKN 118 (312)
T ss_dssp ----------EEEEEEECCCCCCC
T ss_pred ----------ceEEEEEeccCCCC
Confidence 56999999998753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0015 Score=68.56 Aligned_cols=109 Identities=15% Similarity=0.124 Sum_probs=72.2
Q ss_pred hcCCCCCcEEeccCC-CCcc-----cCccccCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCC-----
Q 001152 160 IAGLKCLTKLSVCHF-SIRY-----LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV----- 223 (1137)
Q Consensus 160 l~~L~~L~~L~Ls~N-~L~~-----IP~~l~~L~~L~~L~Ls~N~L~-----~LP~~l~~L~~L~~L~Ls~N~Ls----- 223 (1137)
+.+-+.|+.|+|++| .|.. |-..+..-+.|+.|+|++|+|. .|-..+..-+.|+.|+|++|.|+
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 344567888888875 7652 3334555567888888888887 34455666678888888888887
Q ss_pred ccCccccCCCCCCEEeccCCcC---CCC----CcccccCCCCCCEEEccCCc
Q 001152 224 ELPSGLYLLQRLENLDLSNNRL---TSL----GSLDLCLMHNLQNLNLQYNK 268 (1137)
Q Consensus 224 ~IP~~l~~L~~L~~LdLS~N~L---sg~----~p~~l~~L~~L~~L~Ls~N~ 268 (1137)
.|-..+..-+.|+.|+|++|.. ... +...+..-+.|..|+|+.|.
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 2334455556788899886533 321 12234455678888887765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.30 E-value=0.02 Score=63.81 Aligned_cols=149 Identities=15% Similarity=0.129 Sum_probs=76.3
Q ss_pred EeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC--cceeeeeEecCCCCCCC
Q 001152 806 SCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC--IVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 806 l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpN--IVkllg~~~~~~~~~~~ 883 (1137)
-.+.|+.|....+|++...+..+++|+..... .. +. +..|+.++..+.... +.+++... +...+.
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~---~~---~~----l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~-- 92 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRV---EK---ND----LPFFLGLMQHLAAKGLSCPLPLPRK-DGELLG-- 92 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC------C---CH----HHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCE--
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCCC---CH---HH----HHHHHHHHHHHHHCCCCCCcccCCC-CCCEEE--
Confidence 45678889999999998876678888754211 01 11 244777777664212 23333221 000000
Q ss_pred CCCCccccceEEEEEeeccCCCHH-----------HH---HHHhhhc-CCCC---CC---HHHHHH------------HH
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVK-----------NY---IEKLSET-GEKH---VS---VKLALF------------IA 930 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~-----------~~---L~~~~~~-~~~~---ls---~~~i~~------------I~ 930 (1137)
......++||+|++|..+. .. ++..... .... .. |..... +.
T Consensus 93 -----~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~ 167 (322)
T 2ppq_A 93 -----ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 167 (322)
T ss_dssp -----EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred -----EECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhH
Confidence 0011458999999976431 11 2221100 0000 11 111000 01
Q ss_pred HHHHHHHHHHHh-------CCeeeccCCCCCeEeccccccCCCCCeEEEeecCccc
Q 001152 931 QDVAAALVELHS-------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 931 ~QIa~gL~yLHs-------~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~ 979 (1137)
..+...+++++. .++||+|+.+.|||++.+ ..+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~-------~~~~lIDf~~a~ 216 (322)
T 2ppq_A 168 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGD-------ELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETT-------EEEEECCCTTCE
T ss_pred HHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCC-------ceEEEecchhcc
Confidence 123445555552 369999999999999865 345799998664
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0033 Score=65.96 Aligned_cols=87 Identities=13% Similarity=0.070 Sum_probs=43.1
Q ss_pred CCCCCCCCEEEccCC-CCCCCCcc-cccCCCCCCCccEEEeecCCCC-----ccCccccCCCCCcEEEccCCCCC-----
Q 001152 37 VNDDDDDSVIDVSGK-TVDFPLIE-SYGNRGGDNSVEGLYLYKNVLN-----LIPKSVGRYEKLRNLKFFGNEIN----- 104 (1137)
Q Consensus 37 f~~l~~L~~LdLs~N-~L~~~~p~-~~~~l~~L~~L~~L~Ls~N~L~-----~IP~~~~~L~~L~~L~Ls~N~L~----- 104 (1137)
+.+.+.|+.|+|++| +|...--. ....+..-+.|+.|+|++|.|+ .|-..+..-+.|+.|+|++|.|+
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 445566677777664 55321100 1111222355666666666665 22333444456666666666665
Q ss_pred cccccccCCCCCCEEEccC
Q 001152 105 LFPSEVGNLLGLECLQIKI 123 (1137)
Q Consensus 105 ~lP~~l~~L~~L~~L~Ls~ 123 (1137)
.|-..+..-+.|+.|+|++
T Consensus 117 ala~aL~~N~tL~~L~L~n 135 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADN 135 (197)
T ss_dssp HHHHHTTTTCCCSEEECCC
T ss_pred HHHHHHhhCCceeEEECCC
Confidence 2233344444455555543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0019 Score=66.64 Aligned_cols=81 Identities=14% Similarity=0.174 Sum_probs=46.4
Q ss_pred CCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCC-CCc-cCccccCC----CCCCEEeccCC-cCCCCCcccccCCCCC
Q 001152 188 NLEQLDLSFNKMKYL-PTEICYLKALISLKVANNK-LVE-LPSGLYLL----QRLENLDLSNN-RLTSLGSLDLCLMHNL 259 (1137)
Q Consensus 188 ~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~-Ls~-IP~~l~~L----~~L~~LdLS~N-~Lsg~~p~~l~~L~~L 259 (1137)
+|+.|||+++.|+.. -..+..+++|+.|+|+++. |+. -=..+..+ ++|+.|+|+++ ++|...-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 566777777666521 1245566777777777764 552 11223332 35777777775 3663222345667777
Q ss_pred CEEEccCCc
Q 001152 260 QNLNLQYNK 268 (1137)
Q Consensus 260 ~~L~Ls~N~ 268 (1137)
+.|+|++.+
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 777777764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.18 E-value=0.013 Score=65.85 Aligned_cols=35 Identities=34% Similarity=0.468 Sum_probs=26.3
Q ss_pred CCeeeccCCCCCeEeccccccCCCCCeEEEeecCcccc
Q 001152 943 KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 980 (1137)
Q Consensus 943 ~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~ 980 (1137)
..++|||+.+.|||++.+. .+...+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~---~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPER---EGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTS---CGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCc---CCCCCeEEEeCCCcCc
Confidence 4799999999999997631 0113589999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.01 E-value=0.045 Score=60.08 Aligned_cols=75 Identities=19% Similarity=0.162 Sum_probs=49.0
Q ss_pred eEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-C--CCcceeeeeEecCCCC
Q 001152 805 SSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H--SCIVEMYGHKISSKWL 880 (1137)
Q Consensus 805 ~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-H--pNIVkllg~~~~~~~~ 880 (1137)
.-.+.+|.|..+.||+++.. ++.+.+|+...... . . .. .+.+|++.|+.+. . --+.+++++. ..
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~-~--~~----~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~-- 85 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-A-L--DG----LFRAEALGLDWLGRSFGSPVPQVAGWD--DR-- 85 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-C-C--TT----HHHHHHHHHHHHTCSTTCCSCCEEEEE--TT--
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-c-h--hh----HHHHHHHHHHHHHhhCCCCcceEEecc--Cc--
Confidence 45678999999999999985 57888886432211 1 1 11 1367889998885 2 2344555542 22
Q ss_pred CCCCCCCccccceEEEEEeeccCCC
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGS 905 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggS 905 (1137)
++||||++++.
T Consensus 86 --------------~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 --------------TLAMEWVDERP 96 (288)
T ss_dssp --------------EEEEECCCCCC
T ss_pred --------------eEEEEeecccC
Confidence 79999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.058 Score=63.83 Aligned_cols=72 Identities=17% Similarity=0.133 Sum_probs=46.0
Q ss_pred eeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcc-eeeeeEecCCCCCCC
Q 001152 807 CDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHKISSKWLPSA 883 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIV-kllg~~~~~~~~~~~ 883 (1137)
.+.|+.|-...+|++...+ ..+++|+.... ... . .. ..+|..+++.+...+++ ++++.+. +
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~-~~~-~--id-----R~~E~~vl~~L~~~gl~P~ll~~~~--~----- 176 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPK-TDE-I--IN-----REREKKISCILYNKNIAKKIYVFFT--N----- 176 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC--CCS-C--SC-----HHHHHHHHHHHTTSSSBCCEEEEET--T-----
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCC-hhh-h--cC-----HHHHHHHHHHHHhcCCCCCEEEEeC--C-----
Confidence 4678889999999999876 77888875321 110 0 00 03588899988755554 6776652 2
Q ss_pred CCCCccccceEEEEEeeccCCC
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGS 905 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggS 905 (1137)
.+||||++|.+
T Consensus 177 -----------G~v~e~I~G~~ 187 (458)
T 2qg7_A 177 -----------GRIEEFMDGYA 187 (458)
T ss_dssp -----------EEEEECCCSEE
T ss_pred -----------eEEEEeeCCcc
Confidence 46999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.30 E-value=0.042 Score=63.44 Aligned_cols=143 Identities=17% Similarity=0.229 Sum_probs=78.1
Q ss_pred eeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecC
Q 001152 808 DEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISS 877 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~---------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~ 877 (1137)
+.|..|-...+|++... +..+++++. ... .. ..... .+|.++++.+. +.-..++++++.
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~-g~~-~~---~~~~~----~rE~~vl~~L~~~gv~P~ll~~~~-- 124 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLY-GAI-LQ---GVDSL----VLESVMFAILAERSLGPQLYGVFP-- 124 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEEC-C----C---CHHHH----HHHHHHHHHHHHTTSSCCEEEEET--
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEEC-CCc-cc---hHHHH----HHHHHHHHHHHhcCCCCeEEEEcC--
Confidence 56777888889998874 256777763 111 11 11122 56888888886 322346666543
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHH--------------HHHHHhhhcC---CCCC--CHHHHHHHHHHHHH---
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVK--------------NYIEKLSETG---EKHV--SVKLALFIAQDVAA--- 935 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~--------------~~L~~~~~~~---~~~l--s~~~i~~I~~QIa~--- 935 (1137)
+ .+||||++|.+|. +.+.+..... .... -+.++.++..++..
T Consensus 125 ~----------------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~ 188 (379)
T 3feg_A 125 E----------------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPP 188 (379)
T ss_dssp T----------------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCC
T ss_pred C----------------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccC
Confidence 1 4899999875432 2222222111 1112 24566666655532
Q ss_pred ----------------HHHHHHh--------CCeeeccCCCCCeEeccccccCCCCCeEEEeecCcccc
Q 001152 936 ----------------ALVELHS--------KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 980 (1137)
Q Consensus 936 ----------------gL~yLHs--------~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~ 980 (1137)
.+..|.+ ..++|+|+.+.|||++.+. ...+.+.|+||..+..
T Consensus 189 ~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~---~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 189 TGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEP---ENADSLMLVDFEYSSY 254 (379)
T ss_dssp CSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC------CCEEECCCTTCEE
T ss_pred cccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCC---CccCcEEEEecccCCc
Confidence 2333332 2589999999999998651 1124689999997753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.26 E-value=0.12 Score=54.92 Aligned_cols=100 Identities=15% Similarity=0.099 Sum_probs=62.6
Q ss_pred CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeEeccccccCCCCCeEEEeecCcccccc
Q 001152 904 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR 982 (1137)
Q Consensus 904 gSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~ 982 (1137)
-||.++|+.+ +.++++++++.++.|.+.+|.-+-. +.-..+=+-|..|++..+ |.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-------G~V~f~~-~~s~--- 97 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-------GAVTLAP-AADD--- 97 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-------SCEEECC-C------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-------Cceeccc-cccc---
Confidence 3899999863 3579999999999999999877621 111122234578888877 6675542 1110
Q ss_pred ccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 001152 983 SFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQ 1042 (1137)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~ 1042 (1137)
.....+.|||... ...+.+.=|||||++||.-+--.
T Consensus 98 -------------------~~~~~~~~pe~~~-----~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -------------------AGEPPPVAGKLGY-----SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ----------------------------CCSS-----SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -------------------ccccCCCChhhcc-----ccchHHHHHHHHHHHHHHHhhcC
Confidence 0112566888753 24568899999999999887543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.10 E-value=0.015 Score=59.84 Aligned_cols=79 Identities=11% Similarity=0.103 Sum_probs=38.9
Q ss_pred CCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCC-CCcc-CccccCC----CCCcEEEccCCC-CC--ccccccc
Q 001152 41 DDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNV-LNLI-PKSVGRY----EKLRNLKFFGNE-IN--LFPSEVG 111 (1137)
Q Consensus 41 ~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~-L~~I-P~~~~~L----~~L~~L~Ls~N~-L~--~lP~~l~ 111 (1137)
..|+.|||+++.|+.. .+..+.++++|++|+|+++. |+.- =..|..+ ++|++|+|+++. || .+ ..+.
T Consensus 61 ~~L~~LDLs~~~Itd~---GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl-~~L~ 136 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSI---GFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI-IALH 136 (176)
T ss_dssp CCEEEEEEESCCCCGG---GGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH-HHGG
T ss_pred ceEeEEeCcCCCccHH---HHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH-HHHh
Confidence 3566666666665432 23333455666666666653 4421 1223333 246666666653 55 12 1244
Q ss_pred CCCCCCEEEccC
Q 001152 112 NLLGLECLQIKI 123 (1137)
Q Consensus 112 ~L~~L~~L~Ls~ 123 (1137)
++++|+.|+|++
T Consensus 137 ~~~~L~~L~L~~ 148 (176)
T 3e4g_A 137 HFRNLKYLFLSD 148 (176)
T ss_dssp GCTTCCEEEEES
T ss_pred cCCCCCEEECCC
Confidence 455555555543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.94 E-value=0.088 Score=59.94 Aligned_cols=72 Identities=11% Similarity=0.193 Sum_probs=41.1
Q ss_pred eeeecccCceEEEEEEECC----------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCC-cceeeeeEe
Q 001152 807 CDEAGKSVSSSLFRCKFGS----------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSC-IVEMYGHKI 875 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~~----------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpN-IVkllg~~~ 875 (1137)
.+.|+.|....+|++...+ ..+++|+.... ...... ...|..+++.+.... +.++++..
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~~----~~~E~~~l~~L~~~g~~P~~~~~~- 107 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-----VDELYN----TISEFEVYKTMSKYKIAPQLLNTF- 107 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-----GGGTSC----HHHHHHHHHHHHHTTSSCCEEEEE-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-----ccceec----HHHHHHHHHHHHhcCCCCceEEec-
Confidence 4578888889999998754 56777764211 111111 145778888776333 34666543
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCC
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGS 905 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggS 905 (1137)
.+ ++||||++|.+
T Consensus 108 -~~----------------~~v~e~i~G~~ 120 (369)
T 3c5i_A 108 -NG----------------GRIEEWLYGDP 120 (369)
T ss_dssp -TT----------------EEEEECCCSEE
T ss_pred -CC----------------cEEEEEecCCc
Confidence 22 78999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.69 E-value=0.18 Score=59.01 Aligned_cols=70 Identities=16% Similarity=0.259 Sum_probs=45.4
Q ss_pred eeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCc-ceeeeeEec
Q 001152 807 CDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKIS 876 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~---------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNI-Vkllg~~~~ 876 (1137)
.+.|+.|-...||++... +..+++|+.... .. .+.+ .+|+.+++.+...++ .++++.+.
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~--~~~l----i~E~~~l~~L~~~g~~P~l~~~~~- 146 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET--ESHL----VAESVIFTLLSERHLGPKLYGIFS- 146 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC--HHHH----HHHHHHHHHHHHTTSSSCEEEEET-
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc--HHHH----HHHHHHHHHHHhCCCCCcEEEEeC-
Confidence 467888999999999874 356888875211 11 0122 468888888863344 46666542
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCC
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGG 904 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~gg 904 (1137)
+ .+||||++|.
T Consensus 147 -~----------------g~v~e~l~G~ 157 (429)
T 1nw1_A 147 -G----------------GRLEEYIPSR 157 (429)
T ss_dssp -T----------------EEEECCCCEE
T ss_pred -C----------------CEEEEEeCCc
Confidence 2 4899999863
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.45 E-value=0.18 Score=55.95 Aligned_cols=79 Identities=14% Similarity=0.041 Sum_probs=43.5
Q ss_pred eeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCC--CcceeeeeEecCCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS--CIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~Hp--NIVkllg~~~~~~~~~~~~ 884 (1137)
..++ |....||++... +..+++|+..... .... . +..|+.++..+... .+++++.. +...+.
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~---~----~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~--- 96 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTAD---Q----ILEEHQFALQLVNDEVPVAAPVAF--NGQTLL--- 96 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHH---H----HHHHHHHHHHHHHTTCSBCCCCCB--TTBSCE---
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHH---H----HHHHHHHHHHHHHcCCeecceeec--CCcEEE---
Confidence 3566 888899998764 3478899853111 1111 2 24577777777521 24455543 111100
Q ss_pred CCCccccceEEEEEeeccCCC
Q 001152 885 GNPEHHLLQSAIFMEYVKGGS 905 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggS 905 (1137)
......++||||++|..
T Consensus 97 ----~~~g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 97 ----NHQGFYFAVFPSVGGRQ 113 (328)
T ss_dssp ----EETTEEEEEEECCCCEE
T ss_pred ----EECCEEEEEEEecCCCC
Confidence 00114588999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.07 E-value=0.77 Score=51.71 Aligned_cols=30 Identities=27% Similarity=0.492 Sum_probs=25.8
Q ss_pred CeeeccCCCCCeEeccccccCCCCCeEEEeecCcccc
Q 001152 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 980 (1137)
Q Consensus 944 gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~ 980 (1137)
.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~-------~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNE-------ESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGG-------GCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCC-------CeEEEEECCCCee
Confidence 68999999999999866 5689999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.04 E-value=0.49 Score=55.34 Aligned_cols=72 Identities=11% Similarity=0.148 Sum_probs=44.7
Q ss_pred eeeecccCceEEEEEEEC---------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCc-ceeeeeEec
Q 001152 807 CDEAGKSVSSSLFRCKFG---------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCI-VEMYGHKIS 876 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~---------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNI-Vkllg~~~~ 876 (1137)
.+.+..|-...+|++... +..+++++.. ... ...-. ..+|..+++.+.-..| .++++.+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g-~~t----~~~id----R~~E~~~l~~L~~~gi~P~l~~~~-- 143 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYG-KHV----GKFYD----SKVELDVFRYLSNINIAPNIIADF-- 143 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECC-CCC-----CCCC----HHHHHHHHHHHHHTTSSCCEEEEE--
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECC-CCc----chhcC----HHHHHHHHHHHHhcCCCCCEEEEc--
Confidence 466778888999999876 4667777642 211 11101 1457788887763233 4666532
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCC
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGS 905 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggS 905 (1137)
.+ ++||||++|..
T Consensus 144 ~~----------------~~I~efI~G~~ 156 (424)
T 3mes_A 144 PE----------------GRIEEFIDGEP 156 (424)
T ss_dssp TT----------------EEEEECCCSEE
T ss_pred CC----------------CEEEEEeCCcc
Confidence 22 78999999764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.61 E-value=2.1 Score=49.32 Aligned_cols=35 Identities=29% Similarity=0.357 Sum_probs=25.6
Q ss_pred eeeccCCCCCeEeccccccCCCCCeEEEeecCcccc
Q 001152 945 IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVP 980 (1137)
Q Consensus 945 IIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~ 980 (1137)
++|+|+.+.|||+..+.. ......+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~-~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRE-NSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGG-GCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcc-cCcCCeEEEechHhccC
Confidence 679999999999965321 11225799999998854
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=80.53 E-value=0.61 Score=51.78 Aligned_cols=43 Identities=30% Similarity=0.422 Sum_probs=37.8
Q ss_pred ccchhhhHHHHHHHhhhccCCCCccccccccccc----CCCccceeEEe
Q 001152 700 QFGVCRHRAVLLKYLCDRVEPPVPCELVRGYLDF----QPHAWNTILVK 744 (1137)
Q Consensus 700 ~~g~~~hr~~l~k~~~d~~~~~~~~~~~~g~~~~----~~~~~~~~~~~ 744 (1137)
..|+|++-|.||-.||-.++ ||||.|-||..- ..|||..+-+.
T Consensus 177 ~~G~C~d~A~l~val~Ra~G--IPAR~VsGy~~~~~~~~~HAW~Evyl~ 223 (293)
T 3isr_A 177 RAGVCRDFAHLGIALCRALS--IPARYFTGYAFKLNPPDFHACFEAYIG 223 (293)
T ss_dssp CEECHHHHHHHHHHHHHHTT--CCEEEEEEEETTCSSCCEEEEEEEEET
T ss_pred CcEehHHHHHHHHHHHHHCC--CCEEEEEEECCCCCCCCeEEEEEEEEC
Confidence 47999999999999999999 999999999853 46999877664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1137 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-34 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-30 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-11 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 65/315 (20%), Positives = 123/315 (39%), Gaps = 64/315 (20%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G ++++ K+ D A K+ L V + +++ F EV +L RH I+
Sbjct: 17 GSGSFGTVYKGKWHG-DVAVKM--LNVTAPTPQQLQAF----KNEVGVLRKTRHVNILLF 69
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
G+ + + I ++ +G S+ +++ + E + + IA
Sbjct: 70 MGYSTAPQLA---------------IVTQWCEGSSLYHHLHII----ETKFEMIKLIDIA 110
Query: 931 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 990
+ A + LH+K I+HRD+KS NI + VK+ DF A + +
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFL-------HEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 991 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1050
G+ WMAPEV+R M N Y + D++++G +L EL+T Q+PY ++
Sbjct: 164 EQ--------LSGSILWMAPEVIR-MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214
Query: 1051 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEE 1110
+ + +G+ D + +C + + + C ++
Sbjct: 215 RDQIIFM-VGRGYLSPDLSKVRSNCPKA---------------------MKRLMAECLKK 252
Query: 1111 NPTERPTAGDLYEMF 1125
ERP +
Sbjct: 253 KRDERPLFPQILASI 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-38
Identities = 69/314 (21%), Positives = 118/314 (37%), Gaps = 67/314 (21%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G +++ + A + + S +E+ ++ + E+ +L + H IV++
Sbjct: 21 GDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDY----MVEIDILASCDHPNIVKL 74
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
L I +E+ GG+V + +L E+ ++ +
Sbjct: 75 LDAFYYENNL--------------WILIEFCAGGAVDAVMLEL----ERPLTESQIQVVC 116
Query: 931 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 990
+ AL LH I+HRD+K+ NIL DG +KL DF +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFT-----LDG--DIKLADFGVS----------AK 159
Query: 991 AHRGIPAPDVCVGTPRWMAPEVLRA-MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLS 1049
R I D +GTP WMAPEV+ K Y + D+WS G L+E+ ++ P+ L+
Sbjct: 160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219
Query: 1050 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109
+ + I + P L +P S D ++C E
Sbjct: 220 PMRVLLKIAKSEPPTL----------------------AQPS---RWSSNFKDFLKKCLE 254
Query: 1110 ENPTERPTAGDLYE 1123
+N R T L +
Sbjct: 255 KNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 74/318 (23%), Positives = 115/318 (36%), Gaps = 70/318 (22%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G + + S + L + E + + EV +L L+H IV
Sbjct: 13 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML----VSEVNLLRELKHPNIVRY 68
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
Y I L I MEY +GG + + I K ++ +++ + L +
Sbjct: 69 YDRIIDRT---------NTTLY---IVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVM 115
Query: 931 QDVAAALVELHSKH-----IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFL 985
+ AL E H + ++HRD+K N+ +D GK VKL DF A
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-------GKQNVKLGDFGLA------- 161
Query: 986 HTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPY 1045
I + VGTP +M+PE + M Y + DIWS GCLL EL L P+
Sbjct: 162 ---RILNHDTSFAKAFVGTPYYMSPEQMNRMS----YNEKSDIWSLGCLLYELCALMPPF 214
Query: 1046 MGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFR 1105
S+ E+ I+ GK R+ + L ++
Sbjct: 215 TAFSQKELAGKIREGKFRRIPYRY--------------------SDE-------LNEIIT 247
Query: 1106 RCTEENPTERPTAGDLYE 1123
R RP+ ++ E
Sbjct: 248 RMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 67/317 (21%), Positives = 115/317 (36%), Gaps = 73/317 (23%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G+ ++++ L+ + E + F E ML L+H IV
Sbjct: 18 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF----KEEAEMLKGLQHPNIVRF 73
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
Y W + G L+ E + G++K Y+++ K + +K+
Sbjct: 74 YDS-----WESTVKGKKCIVLV-----TELMTSGTLKTYLKR-----FKVMKIKVLRSWC 118
Query: 931 QDVAAALVELHSKH--IMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLR-SFLHT 987
+ + L LH++ I+HRD+K +NI I VK+ D A R SF
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFIT------GPTGSVKIGDLGLATLKRASFAKA 172
Query: 988 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMG 1047
GTP +MAPE+ Y VD++++G +LE+ T + PY
Sbjct: 173 VI-------------GTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYPYSE 214
Query: 1048 LSEL-EIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1106
+I+ + G +P D++ PE + ++
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKVAI------------------PEVK--------EIIEG 248
Query: 1107 CTEENPTERPTAGDLYE 1123
C +N ER + DL
Sbjct: 249 CIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 52/294 (17%), Positives = 99/294 (33%), Gaps = 70/294 (23%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V+ LK + L E ++ L + IV M G + W+
Sbjct: 39 VKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIGICEAESWM----------- 83
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
+ ME + G + Y+++ +HV K + + V+ + L + +HRD+
Sbjct: 84 ----LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 134
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+ N+L+ + K+ DF + LR+ + +W APE
Sbjct: 135 ARNVLL-------VTQHYAKISDFGLSKALRADENYYKAQTH-------GKWPVKWYAPE 180
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
+ + + D+WS+G L+ E + Q PY G+ E+ +++ G+R
Sbjct: 181 CINYYK----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC- 235
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
P + D+ C + RP +
Sbjct: 236 -------------------PRE-------MYDLMNLCWTYDVENRPGFAAVELR 263
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 68/311 (21%), Positives = 115/311 (36%), Gaps = 66/311 (21%)
Query: 828 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887
A K+ L++ + ++I E+++L IV YG S +
Sbjct: 34 MARKLIHLEIKPAIRNQIIR-------ELQVLHECNSPYIVGFYGAFYSDGEI------- 79
Query: 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-IM 946
+I ME++ GGS+ ++K + ++ ++ V L L KH IM
Sbjct: 80 -------SICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1006
HRD+K NIL++ + +KLCDF + L + VGT
Sbjct: 128 HRDVKPSNILVN-------SRGEIKLCDFGVSGQLIDSMAN------------SFVGTRS 168
Query: 1007 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLI--------- 1057
+M+PE L+ H Y ++ DIWS G L+E+ + P E+ +
Sbjct: 169 YMSPERLQGTH----YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 1058 ------QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEE 1110
+ RP + +++ E+ P+ S D +C +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 1111 NPTERPTAGDL 1121
NP ER L
Sbjct: 285 NPAERADLKQL 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 3e-36
Identities = 59/272 (21%), Positives = 98/272 (36%), Gaps = 68/272 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E ++ LRHS +V++ G + K L I EY+ GS+ +Y+
Sbjct: 50 EASVMTQLRHSNLVQLLGVIVEEK----------GGLY---IVTEYMAKGSLVDYLRS-- 94
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
G + L + DV A+ L + +HRD+ + N+L+ D V K+ D
Sbjct: 95 -RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-----EDN--VAKVSD 146
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F S T +W APE LR + + D+WS+G L
Sbjct: 147 FGLTKEASSTQDTGK-------------LPVKWTAPEALREKK----FSTKSDVWSFGIL 189
Query: 1035 LLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1093
L E+ + +VPY + ++ ++ G + D P A
Sbjct: 190 LWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC--------------------PPA- 228
Query: 1094 LETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+ +V + C + RP+ L E
Sbjct: 229 ------VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (341), Expect = 7e-36
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 64/299 (21%)
Query: 828 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWLPSADGN 886
A + SA+E++ + L EV +L + H I+++ ++ +
Sbjct: 32 AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF------ 85
Query: 887 PEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIM 946
+ + +K G + +Y+ + + +S K I + + + LH +I+
Sbjct: 86 --------FLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1006
HRD+K ENIL+ D +KL DF + L GTP
Sbjct: 133 HRDLKPENILL-------DDDMNIKLTDFGFSCQLDPGEKL-----------REVCGTPS 174
Query: 1007 WMAPEVLRAMHKPNL--YGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPR 1064
++APE++ N YG EVD+WS G ++ LL P+ ++ + +I G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 1065 LTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
+ E + + D+ R P +R TA +
Sbjct: 235 GSPEWDDYSDT------------------------VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 8e-36
Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 71/298 (23%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
LKV + E E+ EV + LRH I+ +YG+ + +
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY------------- 82
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
+ +EY G+V ++K + ++A AL HSK ++HRDIK EN
Sbjct: 83 -LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
+L+ +K+ DF +V S T GT ++ PE++
Sbjct: 137 LLL-------GSAGELKIADFGWSVHAPSSRRTT------------LCGTLDYLPPEMIE 177
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1074
+ +VD+WS G L E L + P+ + E + I D +
Sbjct: 178 GRM----HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDFV----- 227
Query: 1075 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM-FVARTSS 1131
E D+ R + NP++RP ++ E ++ SS
Sbjct: 228 ---------------TEG-------ARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (337), Expect = 6e-35
Identities = 66/289 (22%), Positives = 100/289 (34%), Gaps = 67/289 (23%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
+K S + + EVR L LRH ++ G + EH
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----------EHTAW-- 91
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
+ MEY G + +K + + L LHS +++HRD+K+ N
Sbjct: 92 -LVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
IL+ +VKL DF A PA GTP WMAPEV+
Sbjct: 146 ILL-------SEPGLVKLGDF-------------GSASIMAPANSFV-GTPYWMAPEVIL 184
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1074
AM + Y +VD+WS G +EL + P ++ + I + P L
Sbjct: 185 AMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG------ 237
Query: 1075 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
E + C ++ P +RPT+ L +
Sbjct: 238 -------------HWSEY-------FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 133 bits (335), Expect = 2e-34
Identities = 48/270 (17%), Positives = 83/270 (30%), Gaps = 64/270 (23%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E++ + LRH +V ++ + + E++ GG + +
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFEDDNEM--------------VMIYEFMSGGELFEKVAD-- 116
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+S A+ + V L +H + +H D+K ENI+ +KL D
Sbjct: 117 --EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-----TKRSNELKLID 169
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F L GT + APEV G D+WS G L
Sbjct: 170 FGLTAHLDPKQSVKV-----------TTGTAEFAAPEVAEGKP----VGYYTDMWSVGVL 214
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
LL+ P+ G ++ E ++ + ++
Sbjct: 215 SYILLSGLSPFGGENDDETLRNVKSCD-------------------------WNMDDSAF 249
Query: 1095 ETLSF-LVDVFRRCTEENPTERPTAGDLYE 1123
+S D R+ +P R T E
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-34
Identities = 63/295 (21%), Positives = 110/295 (37%), Gaps = 69/295 (23%)
Query: 829 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 888
A K+ +K + I+ E+ + L H +V+ YGH+
Sbjct: 34 AVKIVDMKRAVDCPENIKK-------EICINKMLNHENVVKFYGHRREGNIQ-------- 78
Query: 889 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948
+F+EY GG + + IE + + A + A +V LH I HR
Sbjct: 79 ------YLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1008
DIK EN+L+ D + +K+ DF L T + + GT ++
Sbjct: 128 DIKPENLLL-------DERDNLKISDFG--------LATVFRYNNRERLLNKMCGTLPYV 172
Query: 1009 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1068
APE+L+ + + VD+WS G +L +L ++P+ S+ K+ L
Sbjct: 173 APELLK---RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--- 226
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
P +++ S + + + ENP+ R T D+ +
Sbjct: 227 --------------------NPWKKID--SAPLALLHKILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 4e-34
Identities = 66/268 (24%), Positives = 102/268 (38%), Gaps = 68/268 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ ++ ++ IV + L + MEY+ GGS+ + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDEL--------------WVVMEYLAGGSLTDVVTE-- 110
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ + ++ AL LHS ++HRDIKS+NIL+ DG VKL D
Sbjct: 111 ----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-----MDGS--VKLTD 159
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F + VGTP WMAPEV+ YG +VDIWS G +
Sbjct: 160 FGFCAQITPEQSKR----------STMVGTPYWMAPEVVTRKA----YGPKVDIWSLGIM 205
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
+E++ + PY+ + L LI P L +
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-------------------------- 239
Query: 1095 ETLS-FLVDVFRRCTEENPTERPTAGDL 1121
E LS D RC + + +R +A +L
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-34
Identities = 49/287 (17%), Positives = 91/287 (31%), Gaps = 69/287 (24%)
Query: 839 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 898
G+ + + E +++ L + IV + G + + + M
Sbjct: 47 GTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAEALM---------------LVM 87
Query: 899 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958
E GG + ++ + + V + V+ + L K+ +HRD+ + N+L+
Sbjct: 88 EMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL- 142
Query: 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1018
+ K+ DF + L + G +W APE +
Sbjct: 143 ------VNRHYAKISDFGLSKALGADDSYYTARSAG-------KWPLKWYAPECINFRK- 188
Query: 1019 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 1077
+ D+WSYG + E L+ Q PY + E+ I+ GKR E
Sbjct: 189 ---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-------- 237
Query: 1078 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
P L + C +RP + +
Sbjct: 238 ------------PPE-------LYALMSDCWIYKWEDRPDFLTVEQR 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 130 bits (329), Expect = 1e-33
Identities = 51/284 (17%), Positives = 96/284 (33%), Gaps = 65/284 (22%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ ++ L H ++ ++ + + +E++ GG + + I
Sbjct: 76 EISIMNQLHHPKLINLHDAFEDKYEM--------------VLILEFLSGGELFDRIAA-- 119
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ +S + + L +H I+H DIK ENI+ + VK+ D
Sbjct: 120 --EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE-----TKKASSVKIID 172
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A L T + APE++ G D+W+ G L
Sbjct: 173 FGLATKLNPDEIVKV-----------TTATAEFAAPEIVDREP----VGFYTDMWAIGVL 217
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
LL+ P+ G +LE ++ +E E
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCD-------------------------WEFDEDAF 252
Query: 1095 ETLSF-LVDVFRRCTEENPTERPTAGDLYEM-FVARTSSSISSR 1136
++S D + ++ P +R T D E ++ S+++SR
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (324), Expect = 2e-33
Identities = 55/315 (17%), Positives = 119/315 (37%), Gaps = 69/315 (21%)
Query: 824 GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883
G + ++TLK G + + R+F L E ++G H ++ + G S +
Sbjct: 51 GKREIFVAIKTLKS-GYTEKQRRDF----LSEASIMGQFDHPNVIHLEGVVTKSTPV--- 102
Query: 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSK 943
I E+++ GS+ +++ + + +V + + + +AA + L
Sbjct: 103 -----------MIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADM 147
Query: 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVG 1003
+ +HRD+ + NIL++ ++ V K+ DF + L
Sbjct: 148 NYVHRDLAARNILVN-----SNL--VCKVSDFGLSRFLEDDTSDPTYTSAL-----GGKI 195
Query: 1004 TPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKR 1062
RW APE ++ + D+WSYG ++ E+++ + PY ++ ++ + I+ R
Sbjct: 196 PIRWTAPEAIQYRK----FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 1063 PRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1122
++ S L + C +++ RP G +
Sbjct: 252 L---------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 1123 EMF--VARTSSSISS 1135
+ R +S+ +
Sbjct: 285 NTLDKMIRNPNSLKA 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 60/295 (20%), Positives = 110/295 (37%), Gaps = 73/295 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
V++LK S D E ++ L+H +V +Y
Sbjct: 42 VKSLKQGSMSPDAFLA-------EANLMKQLQHQRLVRLYAVVTQEPIY----------- 83
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY++ GS+ ++++ +++ L +A +A + + ++ +HRD++
Sbjct: 84 ----IITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+ NIL+ K+ DF A I A + +W APE
Sbjct: 137 AANILV-------SDTLSCKIADFGLA---------RLIEDNEYTAREGAKFPIKWTAPE 180
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
+ + ++ D+WS+G LL E++T ++PY G++ E+ ++ G R D
Sbjct: 181 AINYGT----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC- 235
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
PE L + R C +E P +RPT L +
Sbjct: 236 -------------------PEE-------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 7e-33
Identities = 62/294 (21%), Positives = 106/294 (36%), Gaps = 73/294 (24%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++ +K S DE E +++ L H +V++YG + +
Sbjct: 33 IKMIKEGSMSEDEFIE-------EAKVMMNLSHEKLVQLYGVCTKQRPIF---------- 75
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY+ G + NY+ + + L + +DV A+ L SK +HRD+
Sbjct: 76 ----IITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+ N L+ + + VVK+ DF + + +T + RW PE
Sbjct: 128 ARNCLV-------NDQGVVKVSDFGLSRYVLDDEYTSSVG---------SKFPVRWSPPE 171
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
VL + + DIW++G L+ E+ +L ++PY + E + I G R
Sbjct: 172 VLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------- 220
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
+P E + + C E ERPT L
Sbjct: 221 -----------------YRPHLASEK---VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 58/295 (19%), Positives = 98/295 (33%), Gaps = 37/295 (12%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
+K+ S + E E+ LRH I+ AD Q
Sbjct: 31 VKIFSSREERSWFRE----AEIYQTVMLRHENILGFIA----------ADNKDNGTWTQL 76
Query: 895 AIFMEYVKGGSVKNYIEK--LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952
+ +Y + GS+ +Y+ + ++ G +++ A +A + I HRD+KS
Sbjct: 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEV 1012
+NIL+ + D AV S T IA VGT R+MAPEV
Sbjct: 137 KNILV-------KKNGTCCIADLGLAVRHDSATDTIDIAPNHR------VGTKRYMAPEV 183
Query: 1013 LR--AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELE 1070
L K DI++ G + E+ + ++ + P + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+ E L + + R C N R TA + +
Sbjct: 244 VVCEQKLRP------NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 58/286 (20%), Positives = 97/286 (33%), Gaps = 39/286 (13%)
Query: 839 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 898
G ++ + L E+++L L H I+ + + ++
Sbjct: 34 GHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--------------SLVF 79
Query: 899 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958
++++ + H L LH I+HRD+K N+L+D
Sbjct: 80 DFMETDLEVIIKDNSLVLTPSH-----IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 134
Query: 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1018
V+KL DF A S V T + APE+L
Sbjct: 135 -------ENGVLKLADFGLAKSFGSPNRAYTH----------QVVTRWYRAPELLFGARM 177
Query: 1019 PNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1078
YG+ VD+W+ GC+L ELL G S+L+ I ++ + S ++
Sbjct: 178 ---YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 1079 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
+S G L+D+ + NP R TA +M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 5e-32
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 70/292 (23%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
+K F L E +++ LRH +V++Y
Sbjct: 46 IKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSEEPIY-------------- 87
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
I EY+ GS+ ++++ K++ + + +A +A+ + + + +HRD+++ N
Sbjct: 88 -IVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 143
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
IL+ V K+ DF A + +T A +W APE
Sbjct: 144 ILV-------GENLVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAAL 187
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALG 1073
+ ++ D+WS+G LL EL T +VPY G+ E+ D ++ G R E
Sbjct: 188 YGR----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---- 239
Query: 1074 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
PE+ L D+ +C + P ERPT L
Sbjct: 240 ----------------PES-------LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 8e-32
Identities = 52/316 (16%), Positives = 105/316 (33%), Gaps = 74/316 (23%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G + + + D A ++T++ S ++ E ++ L H +V++
Sbjct: 14 GSGQFGLVHLGYWLNKDKVA-IKTIREGAMSEEDFIE-------EAEVMMKLSHPKLVQL 65
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
YG + + + E+++ G + +Y+ + + L +
Sbjct: 66 YGVCLEQAPI--------------CLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMC 107
Query: 931 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 990
DV + L ++HRD+ + N L+ V+K+ DF + +T
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVG-------ENQVIKVSDFGMTRFVLDDQYTSST 160
Query: 991 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 1049
+W +PEV Y + D+WS+G L+ E+ + ++PY S
Sbjct: 161 G---------TKFPVKWASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPYENRS 207
Query: 1050 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109
E+ + I G R + + + C +
Sbjct: 208 NSEVVEDISTGFRLYKPRLAS---------------------------THVYQIMNHCWK 240
Query: 1110 ENPTERPTAGDLYEMF 1125
E P +RP L
Sbjct: 241 ERPEDRPAFSRLLRQL 256
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 8e-32
Identities = 58/306 (18%), Positives = 106/306 (34%), Gaps = 84/306 (27%)
Query: 840 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 899
+SAD +F E ++ + IV++ G K + + E
Sbjct: 55 ASADMQADF----QREAALMAEFDNPNIVKLLGVCAVGKPM--------------CLLFE 96
Query: 900 YVKGGSVKNYIEKL-------------------SETGEKHVSVKLALFIAQDVAAALVEL 940
Y+ G + ++ + S G +S L IA+ VAA + L
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 941 HSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDV 1000
+ +HRD+ + N L+ VVK+ DF + + S + +
Sbjct: 157 SERKFVHRDLATRNCLV-------GENMVVKIADFGLSRNIYSADYYKADGN-------- 201
Query: 1001 CVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQM 1059
RWM PE + Y E D+W+YG +L E+ + + PY G++ E+ ++
Sbjct: 202 DAIPIRWMPPESIFYNR----YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257
Query: 1060 GKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119
G + P L ++ R C + P +RP+
Sbjct: 258 GNILACPENC--------------------PLE-------LYNLMRLCWSKLPADRPSFC 290
Query: 1120 DLYEMF 1125
++ +
Sbjct: 291 SIHRIL 296
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 8e-32
Identities = 56/316 (17%), Positives = 99/316 (31%), Gaps = 64/316 (20%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G + R ++ + +K + EV + +L H ++ +
Sbjct: 17 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 76
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
YG ++ + E GS+ + + K + H + A
Sbjct: 77 YGVVLTPPMK---------------MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYA 117
Query: 931 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 990
VA + L SK +HRD+ + N+L+ +VK+ DF L +
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRD-------LVKIGDFGLMRALPQNDDHYVM 170
Query: 991 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLS 1049
W APE L+ + D W +G L E+ T Q P++GL+
Sbjct: 171 QEH-------RKVPFAWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLN 219
Query: 1050 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109
+I I +PE + + +V +C
Sbjct: 220 GSQILHKIDKEGER-----------------------LPRPEDCPQD---IYNVMVQCWA 253
Query: 1110 ENPTERPTAGDLYEMF 1125
P +RPT L +
Sbjct: 254 HKPEDRPTFVALRDFL 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (311), Expect = 9e-32
Identities = 59/292 (20%), Positives = 120/292 (41%), Gaps = 69/292 (23%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
+K E+ F L E ++ ++H +V++ G
Sbjct: 47 VKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPPF-------------- 88
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
I E++ G++ +Y L E + VS + L++A +++A+ L K+ +HRD+ + N
Sbjct: 89 YIITEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
L+ + +VK+ DF + + +T +W APE L
Sbjct: 146 CLVG-----ENH--LVKVADFGLSRLMTGDTYTAHAG---------AKFPIKWTAPESLA 189
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQV-PYMGLSELEIHDLIQMGKRPRLTDELEALG 1073
+ ++ D+W++G LL E+ T + PY G+ ++++L++ R
Sbjct: 190 YNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------- 235
Query: 1074 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
E+PE E + ++ R C + NP++RP+ ++++ F
Sbjct: 236 --------------ERPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-31
Identities = 52/287 (18%), Positives = 95/287 (33%), Gaps = 66/287 (22%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
+K+ N E ++ L H V++Y + L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL-------------- 83
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
+ Y K G + YI K F ++ +AL LH K I+HRD+K EN
Sbjct: 84 YFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
IL+ + +++ DF A + VGT ++++PE+L
Sbjct: 139 ILL-------NEDMHIQITDFGTA--------KVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1074
D+W+ GC++ +L+ P+ +E I I + ++
Sbjct: 184 EKS----ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFF---- 234
Query: 1075 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDL 1121
P+A D+ + + T+R ++
Sbjct: 235 ---------------PKA--------RDLVEKLLVLDATKRLGCEEM 258
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-30
Identities = 48/270 (17%), Positives = 96/270 (35%), Gaps = 36/270 (13%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+++L RH I+ + + P ++ + ++ G + ++
Sbjct: 56 EIKILLRFRHENIIGINDIIRA----------PTIEQMKDVYLVTHLMGADLYKLLKT-- 103
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+H+S + + L +HS +++HRD+K N+L+ + +K+CD
Sbjct: 104 ----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL-------NTTCDLKICD 152
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A V T + APE++ Y +DIWS GC+
Sbjct: 153 FGLARVADPDHDHTGFLTE-------YVATRWYRAPEIMLNSKG---YTKSIDIWSVGCI 202
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
L E+L+ + + G L+ + I ++L + + S K
Sbjct: 203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 262
Query: 1095 ETLSF---LVDVFRRCTEENPTERPTAGDL 1121
+ +D+ + NP +R
Sbjct: 263 LFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 56/314 (17%), Positives = 106/314 (33%), Gaps = 71/314 (22%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G+ + RC S+ + +KV G+ ++ E+ +L RH I+ +
Sbjct: 14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK-------EISILNIARHRNILHL 66
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
+ S + L + E++ G + I ++ + +
Sbjct: 67 HESFESMEEL--------------VMIFEFISGLDIFERINT----SAFELNEREIVSYV 108
Query: 931 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 990
V AL LHS +I H DI+ ENI+ +K+ +F +A L+ +
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQ-----TRRSSTIKIIEFGQARQLKPGDNF--- 160
Query: 991 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSE 1050
+ P + APEV + D+WS G L+ LL+ P++ +
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDV----VSTATDMWSLGTLVYVLLSGINPFLAETN 208
Query: 1051 LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTE 1109
+I + I + + E + +S +D R
Sbjct: 209 QQIIENIMNAE-------------------------YTFDEEAFKEISIEAMDFVDRLLV 243
Query: 1110 ENPTERPTAGDLYE 1123
+ R TA + +
Sbjct: 244 KERKSRMTASEALQ 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-30
Identities = 59/265 (22%), Positives = 94/265 (35%), Gaps = 54/265 (20%)
Query: 858 MLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETG 917
A + IV + + LL I ME + GG + + I+ G
Sbjct: 58 HWRASQCPHIVRIVDVYENL-------YAGRKCLL---IVMECLDGGELFSRIQD---RG 104
Query: 918 EKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDR 977
++ + + A I + + A+ LHS +I HRD+K EN+L ++KL DF
Sbjct: 105 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT----SKRPNAILKLTDFGF 160
Query: 978 AVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037
A S + TP ++APEVL Y D+WS G ++
Sbjct: 161 AKETTSHNSLTTPCY-----------TPYYVAPEVLGPEK----YDKSCDMWSLGVIMYI 205
Query: 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1097
LL P+ L I ++ R +E P E +
Sbjct: 206 LLCGYPPFYSNHGLAISPGMKTRIRM---------------------GQYEFPNPEWSEV 244
Query: 1098 SF-LVDVFRRCTEENPTERPTAGDL 1121
S + + R + PT+R T +
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 56/299 (18%), Positives = 102/299 (34%), Gaps = 72/299 (24%)
Query: 828 AAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNP 887
A ++T K C +S F L E + H IV++ G I+ +
Sbjct: 36 LAVAIKTCKNC-TSDSVREKF----LQEALTMRQFDHPHIVKLIGV-ITENPVW------ 83
Query: 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947
I ME G ++++++ + + + + A ++ AL L SK +H
Sbjct: 84 --------IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
RDI + N+L+ VKL DF + + + +W
Sbjct: 132 RDIAARNVLVS-------SNDCVKLGDFGLSRYMEDSTYYKA---------SKGKLPIKW 175
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLT 1066
MAPE + + D+W +G + E+L P+ G+ ++ I+ G+R +
Sbjct: 176 MAPESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231
Query: 1067 DELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
P L + +C +P+ RP +L
Sbjct: 232 PNC--------------------PPT-------LYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (300), Expect = 3e-30
Identities = 58/280 (20%), Positives = 96/280 (34%), Gaps = 64/280 (22%)
Query: 843 DEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVK 902
+ E S E+ +L ++H IV + S L + M+ V
Sbjct: 45 KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL--------------YLIMQLVS 90
Query: 903 GGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962
GG + + I + + + + A + V A+ LH I+HRD+K EN+L
Sbjct: 91 GGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL-- 143
Query: 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022
D + + DF + G C GTP ++APEVL Y
Sbjct: 144 --DEDSKIMISDF----------GLSKMEDPGSVLSTAC-GTPGYVAPEVLAQKP----Y 186
Query: 1023 GLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQ 1082
VD WS G + LL P+ ++ ++ + I +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE--------------------- 225
Query: 1083 SGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 1121
+E + +S D R E++P +R T
Sbjct: 226 ----YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-30
Identities = 68/319 (21%), Positives = 116/319 (36%), Gaps = 81/319 (25%)
Query: 820 RCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKISSK 878
R K A ++ +K +S D+ R+F GE+ +L L H I+ + G
Sbjct: 30 RIKKDGLRMDAAIKRMKE-YASKDDHRDF----AGELEVLCKLGHHPNIINLLGACEHRG 84
Query: 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-----------LSETGEKHVSVKLAL 927
+L + +EY G++ +++ K ++ + +S + L
Sbjct: 85 YL--------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 928 FIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHT 987
A DVA + L K +HRD+ + NIL+ V K+ DF + ++
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVG-------ENYVAKIADFGLSRGQEVYVKK 183
Query: 988 CCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYM 1046
RWMA E L Y D+WSYG LL E+++L PY
Sbjct: 184 TM-----------GRLPVRWMAIESLNYSV----YTTNSDVWSYGVLLWEIVSLGGTPYC 228
Query: 1047 GLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1106
G++ E+++ + G R + + D+ R+
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCD---------------------------DEVYDLMRQ 261
Query: 1107 CTEENPTERPTAGDLYEMF 1125
C E P ERP+ +
Sbjct: 262 CWREKPYERPSFAQILVSL 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-30
Identities = 51/286 (17%), Positives = 101/286 (35%), Gaps = 31/286 (10%)
Query: 840 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 899
+E F + L E+++L L+H +V + + + + + +
Sbjct: 44 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY------LVFD 97
Query: 900 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959
+ + L ++ + Q + L +H I+HRD+K+ N+LI
Sbjct: 98 FCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT- 151
Query: 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019
DG V+KL DF A ++ + V T + PE+L
Sbjct: 152 ----RDG--VLKLADFGLARAFSLAKNSQPNRYTNR------VVTLWYRPPELLLGERD- 198
Query: 1020 NLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE 1079
YG +D+W GC++ E+ T G +E LI + + + +E
Sbjct: 199 --YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256
Query: 1080 VAQSGSGFEKPEAELETLSFL----VDVFRRCTEENPTERPTAGDL 1121
+ G ++ + +D+ + +P +R + D
Sbjct: 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (294), Expect = 1e-29
Identities = 65/294 (22%), Positives = 104/294 (35%), Gaps = 60/294 (20%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
+KV + +F E + AL H IV +Y +
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA----------ETPAGPLP 86
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
I MEYV G ++++ + E ++ K A+ + D AL H I+HRD+K N
Sbjct: 87 YIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 141
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
I+I VK+ DF A + ++ +GT ++++PE R
Sbjct: 142 IMIS-------ATNAVKVMDFGIARAIADSGNSVTQTAA-------VIGTAQYLSPEQAR 187
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1074
D++S GC+L E+LT + P+ G S + +
Sbjct: 188 GDS----VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---------- 233
Query: 1075 CHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERP-TAGDLYEMFV 1126
P A E LS L V + +NP R TA ++ V
Sbjct: 234 ---------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 66/292 (22%), Positives = 105/292 (35%), Gaps = 76/292 (26%)
Query: 855 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIE-- 911
E+ M+ + +H I+ + G L + +EY G+++ Y++
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPL--------------YVIVEYASKGNLREYLQAR 113
Query: 912 ---------KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERK 962
S E+ +S K + A VA + L SK +HRD+ + N+L+
Sbjct: 114 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---- 169
Query: 963 KADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLY 1022
V+K+ DF A + + + +WMAPE L Y
Sbjct: 170 ---EDNVMKIADFGLARDIHHIDYYKKTTN--------GRLPVKWMAPEALFDRI----Y 214
Query: 1023 GLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVA 1081
+ D+WS+G LL E+ TL PY G+ E+ L++ G R
Sbjct: 215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC------------ 262
Query: 1082 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF---VARTS 1130
L + R C P++RPT L E VA TS
Sbjct: 263 --------TNE-------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-29
Identities = 54/295 (18%), Positives = 103/295 (34%), Gaps = 69/295 (23%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++TLK + + LGE ++G H I+ + G K +
Sbjct: 41 IKTLKAGYTEKQRVD-----FLGEAGIMGQFSHHNIIRLEGVISKYKPMM---------- 85
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIK 951
I EY++ G++ ++ + + SV + + + +AA + L + + +HRD+
Sbjct: 86 ----IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137
Query: 952 SENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPE 1011
+ NIL+ + V K+ DF + L G RW APE
Sbjct: 138 ARNILV-------NSNLVCKVSDFGLSRVLEDDPEATYTTSGG-------KIPIRWTAPE 183
Query: 1012 VLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYM-GLSELEIHDLIQMGKRPRLTDELE 1070
+ + D+WS+G ++ E++T LS E+ I G R
Sbjct: 184 AISYRKFTS----ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-------- 231
Query: 1071 ALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
++ S + + +C ++ RP D+ +
Sbjct: 232 -------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-29
Identities = 61/298 (20%), Positives = 105/298 (35%), Gaps = 66/298 (22%)
Query: 840 SSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFME 899
+ E+ F L E ++ H ++ + G + E L + +
Sbjct: 67 TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICL----------RSEGSPL---VVLP 109
Query: 900 YVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959
Y+K G ++N+I + +VK + VA + L SK +HRD+ + N ++
Sbjct: 110 YMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML-- 163
Query: 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019
D K VK+ DF A + G +WMA E L+
Sbjct: 164 -----DEKFTVKVADFGLARDMYDKEFDSVHNKTG------AKLPVKWMALESLQTQK-- 210
Query: 1020 NLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEH 1078
+ + D+WS+G LL EL+T PY ++ +I + G+R +
Sbjct: 211 --FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--------- 259
Query: 1079 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTSSSISSR 1136
P+ L +V +C RP+ +L A S+ I
Sbjct: 260 -----------PDP-------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 1e-28
Identities = 40/271 (14%), Positives = 86/271 (31%), Gaps = 49/271 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E ++ ++ + + ++++ + ME + +
Sbjct: 52 ESKIYKMMQGGVGIPTIRWCGA---------EGDYNV----MVMELLGPSLEDLFNFC-- 96
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ S+K L +A + + + +HSK+ +HRD+K +N L+ L +V + D
Sbjct: 97 ---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG----KKGNLVYIID 149
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A R I + GT R+ + + D+ S G +
Sbjct: 150 FGLAKKYRDARTHQHIPY---RENKNLTGTARYASINTHLGIE----QSRRDDLESLGYV 202
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
L+ +P+ GL + +++ +E L + E
Sbjct: 203 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE--------------- 247
Query: 1095 ETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
C ++P L ++F
Sbjct: 248 -----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 56/296 (18%), Positives = 108/296 (36%), Gaps = 65/296 (21%)
Query: 829 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPE 888
AAK +K + + EV +L ++H ++ ++ + +
Sbjct: 39 AAKF--IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV-------- 88
Query: 889 HHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHR 948
+ +E V GG + +++ + ++ ++ + A + + + LHS I H
Sbjct: 89 ------ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 949 DIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWM 1008
D+K ENI++ + KP +K+ DF A + GTP ++
Sbjct: 138 DLKPENIMLL---DRNVPKPRIKIIDFGLAHKIDFGNEFKN-----------IFGTPEFV 183
Query: 1009 APEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDE 1068
APE++ GLE D+WS G + LL+ P++G ++ E +
Sbjct: 184 APEIVNYEP----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN------- 232
Query: 1069 LEALGSCHEHEVAQSGSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDLYE 1123
+E + S D RR ++P +R T D +
Sbjct: 233 ------------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 47/288 (16%), Positives = 98/288 (34%), Gaps = 70/288 (24%)
Query: 839 GSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFM 898
+S + L E ++ ++ + + + G ++S +
Sbjct: 49 ATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTSTVQ---------------LIT 89
Query: 899 EYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958
+ + G + +Y+ + + ++ + L +A + L + ++HRD+ + N+L+
Sbjct: 90 QLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 145
Query: 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHK 1018
VK+ DF A L + + +WMA E +
Sbjct: 146 -------TPQHVKITDFGLAKLLGAEEKEYHA--------EGGKVPIKWMALESILHRI- 189
Query: 1019 PNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE 1077
Y + D+WSYG + EL+T PY G+ EI +++ G+R
Sbjct: 190 ---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------------- 232
Query: 1078 HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+P + + +C + RP +L F
Sbjct: 233 ----------PQPPICTIDV---YMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 61/264 (23%), Positives = 92/264 (34%), Gaps = 68/264 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
+ + A H + M+ + + L MEY+ GG + +I+
Sbjct: 53 KRVLSLAWEHPFLTHMFCTFQTKENL--------------FFVMEYLNGGDLMYHIQS-- 96
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ A F A ++ L LHSK I++RD+K +NIL+D +K+ D
Sbjct: 97 ---CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-------KDGHIKIAD 146
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F GTP ++APE+L Y VD WS+G L
Sbjct: 147 FGMCKENMLGDAKTN----------TFCGTPDYIAPEILLGQK----YNHSVDWWSFGVL 192
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
L E+L Q P+ G E E+ I+M P LE EA
Sbjct: 193 LYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRWLE-------------------KEA-- 230
Query: 1095 ETLSFLVDVFRRCTEENPTERPTA 1118
D+ + P +R
Sbjct: 231 ------KDLLVKLFVREPEKRLGV 248
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 61/291 (20%), Positives = 98/291 (33%), Gaps = 81/291 (27%)
Query: 855 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 912
E++M+ L H IV + G S + + EY G + NY+
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTLSGPI--------------YLIFEYCCYGDLLNYLRSK 135
Query: 913 -----------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
E ++ + L A VA + L K +HRD+ + N+
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
L+ VVK+CDF A + S + + +WMAPE L
Sbjct: 196 LV-------THGKVVKICDFGLARDIMSDSNYVVRGN--------ARLPVKWMAPESLFE 240
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELE-IHDLIQMGKRPRLTDELEALG 1073
Y ++ D+WSYG LL E+ +L PY G+ + LIQ G +
Sbjct: 241 GI----YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA---- 292
Query: 1074 SCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
E + + + C + +RP+ +L
Sbjct: 293 ----------------TEE-------IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 6e-28
Identities = 53/268 (19%), Positives = 96/268 (35%), Gaps = 38/268 (14%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
+R L H +V ++ S+ + + E+V L
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSR---------TDRETKLTLVFEHVDQD----LTTYLD 106
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ E V + + + L LHS ++HRD+K +NIL+ + G+ +
Sbjct: 107 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-----SSGQIKLADFG 161
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
R + L + T + APEVL Y VD+WS GC+
Sbjct: 162 LARIYSFQMALTSVV-------------VTLWYRAPEVLLQSS----YATPVDLWSVGCI 204
Query: 1035 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1093
E+ + + G S+++ I + P D + + ++S EK +
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 1094 LETLSFLVDVFRRCTEENPTERPTAGDL 1121
++ L D+ +C NP +R +A
Sbjct: 265 IDEL--GKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (280), Expect = 1e-27
Identities = 38/230 (16%), Positives = 72/230 (31%), Gaps = 33/230 (14%)
Query: 896 IFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955
+ + + G S+++ ++ + SVK A+ + A + +H K +++RDIK +N
Sbjct: 77 VLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132
Query: 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRA 1015
LI K + + DF R + I + GT R+M+
Sbjct: 133 LIGRPNSKNANM--IYVVDFGMVKFYRDPVTKQHIPY---REKKNLSGTARYMSINT--- 184
Query: 1016 MHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC 1075
H D+ + G + + L +P+ GL + + + L L +
Sbjct: 185 -HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 1076 HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
E P L +F
Sbjct: 244 FPEE--------------------FYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 53/300 (17%), Positives = 103/300 (34%), Gaps = 71/300 (23%)
Query: 832 VRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHL 891
++T+ S + I L E ++ +V + G +
Sbjct: 55 IKTVNEAASMRERIE-----FLNEASVMKEFNCHHVVRLLGVVSQGQPTL---------- 99
Query: 892 LQSAIFMEYVKGGSVKNYIEKLSETGEKHV-----SVKLALFIAQDVAAALVELHSKHIM 946
+ ME + G +K+Y+ L + S+ + +A ++A + L++ +
Sbjct: 100 ----VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155
Query: 947 HRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPR 1006
HRD+ + N ++ VK+ DF + + R
Sbjct: 156 HRDLAARNCMVA-------EDFTVKIGDFG--------MTRDIYETDYYRKGGKGLLPVR 200
Query: 1007 WMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRL 1065
WM+PE L+ ++ D+WS+G +L E+ TL + PY GLS ++ + G
Sbjct: 201 WMSPESLK----DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 1066 TDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
D + L ++ R C + NP RP+ ++
Sbjct: 257 PDNCPDM---------------------------LFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 109 bits (273), Expect = 7e-27
Identities = 52/277 (18%), Positives = 101/277 (36%), Gaps = 40/277 (14%)
Query: 846 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 905
+ + E+ +L L+HS IV++Y + K L + E++
Sbjct: 41 EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV--------------LVFEHLDQDL 86
Query: 906 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965
K E + A + + H + ++HRD+K +N+LI+
Sbjct: 87 KKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN------- 134
Query: 966 GKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLE 1025
+ +K+ DF A + + T + AP+VL K Y
Sbjct: 135 REGELKIADFGLARAFGIPVRKYT----------HEIVTLWYRAPDVLMGSKK---YSTT 181
Query: 1026 VDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGS 1085
+DIWS GC+ E++ + G+SE + I + + +++ +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 1086 GFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 1121
E+ L+ L +D+ + + +P +R TA
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-26
Identities = 60/268 (22%), Positives = 97/268 (36%), Gaps = 31/268 (11%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E++++ L H IV + + S + E +L + ++YV +
Sbjct: 63 ELQIMRKLDHCNIVRLRYF-----FYSSGEKKDEVYL---NLVLDYVPETVYRVARHYSR 114
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
++ + V + +L +HS I HRDIK +N+L+D V+KLCD
Sbjct: 115 A--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD------PDTAVLKLCD 166
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A L RG P + A Y +D+WS GC+
Sbjct: 167 FGSAKQLV----------RGEPNVSYICSRYYRAPELIFGATD----YTSSIDVWSAGCV 212
Query: 1035 LLELLTLQVPYMGLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1093
L ELL Q + G S ++ I ++ P E + E + Q +
Sbjct: 213 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 1094 LETLSFLVDVFRRCTEENPTERPTAGDL 1121
T + + R E PT R T +
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 4e-26
Identities = 56/287 (19%), Positives = 102/287 (35%), Gaps = 76/287 (26%)
Query: 855 EVRMLGAL-RHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK- 912
E+++L L H IV + G + EY G + N++ +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPT--------------LVITEYCCYGDLLNFLRRK 121
Query: 913 ------------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960
+ E E + ++ L + VA + L SK+ +HRD+ + NIL+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-- 179
Query: 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1020
+ K+CDF A +++ + + +WMAPE +
Sbjct: 180 -----HGRITKICDFGLARDIKNDSNYVVKGN--------ARLPVKWMAPESIFNCV--- 223
Query: 1021 LYGLEVDIWSYGCLLLELLTLQVPYMGLSELE--IHDLIQMGKRPRLTDELEALGSCHEH 1078
Y E D+WSYG L EL +L ++ + +I+ G R + A
Sbjct: 224 -YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE------ 276
Query: 1079 EVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMF 1125
+ D+ + C + +P +RPT + ++
Sbjct: 277 ---------------------MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (266), Expect = 1e-25
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 46/241 (19%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
+KV E ML + H I+ M+G ++ +
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI-------------- 79
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
+ M+Y++GG + + + K A F A +V AL LHSK I++RD+K EN
Sbjct: 80 FMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLALEYLHSKDIIYRDLKPEN 134
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
IL+D +G +K+ DF A + +T C GTP ++APEV+
Sbjct: 135 ILLD-----KNGH--IKITDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVS 174
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKR---PRLTDELEA 1071
Y +D WS+G L+ E+L P+ + ++ ++ I + P ++++
Sbjct: 175 TKP----YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
Query: 1072 L 1072
L
Sbjct: 231 L 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 51/279 (18%), Positives = 99/279 (35%), Gaps = 39/279 (13%)
Query: 844 EIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKG 903
E + + E+ +L L H IV++ + L + E++
Sbjct: 40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY--------------LVFEFLH- 84
Query: 904 GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963
++ + + + + + L + L HS ++HRD+K +N+LI
Sbjct: 85 ---QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI------ 135
Query: 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1023
+ + +KL DF A + T V T + APE+L Y
Sbjct: 136 -NTEGAIKLADFGLARAFGVPVRTYT----------HEVVTLWYRAPEILLGCKY---YS 181
Query: 1024 LEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS 1083
VDIWS GC+ E++T + + G SE++ I + S +++ +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 1084 GSGFEKPEAELETLS-FLVDVFRRCTEENPTERPTAGDL 1121
+ + L + + +P +R +A
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 5e-25
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+R+L +RH ++ + + M ++ G + ++
Sbjct: 67 ELRLLKHMRHENVIGLLDVFT--------PDETLDDFTDFYLVMPFM-GTDLGKLMKH-- 115
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ + F+ + L +H+ I+HRD+K N+ + + +K+ D
Sbjct: 116 ----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV-------NEDCELKILD 164
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A S + T + APEV+ + Y VDIWS GC+
Sbjct: 165 FGLARQADSEMTGYV-------------VTRWYRAPEVILNWMR---YTQTVDIWSVGCI 208
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE- 1093
+ E++T + + G L+ I + ++ L S + EK +
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 1094 -LETLS-FLVDVFRRCTEENPTERPTAGDL 1121
L S V++ + + +R TAG+
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (263), Expect = 6e-25
Identities = 46/265 (17%), Positives = 86/265 (32%), Gaps = 66/265 (24%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
+ ++ IV M + L + ++ + GG + ++ +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKL--------------SFILDLMNGGDLHYHLSQHG 102
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
E F A ++ L +H++ +++RD+K NIL+ D V++ D
Sbjct: 103 VFSEAD-----MRFYAAEIILGLEHMHNRFVVYRDLKPANILL-------DEHGHVRISD 150
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
A + GT +MAPEVL+ Y D +S GC+
Sbjct: 151 LGLACDFSKKKPHASV------------GTHGYMAPEVLQKGVA---YDSSADWFSLGCM 195
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
L +LL P+ + H++ +M + E+ S S PE
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------------ELPDSFS----PELR- 237
Query: 1095 ETLSFLVDVFRRCTEENPTERPTAG 1119
+ + + R
Sbjct: 238 -------SLLEGLLQRDVNRRLGCL 255
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 7e-25
Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 68/285 (23%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
+K+ ++ + E R+L RH + + + L
Sbjct: 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC------------- 81
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
MEY GG + ++ + E+ + + A F ++ +AL LHS+ +++RDIK EN
Sbjct: 82 -FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
+++ D +K+ DF S T GTP ++APEVL
Sbjct: 136 LML-------DKDGHIKITDFGLCKEGISDGATMKT----------FCGTPEYLAPEVLE 178
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGS 1074
YG VD W G ++ E++ ++P+ + +LI M + R L
Sbjct: 179 DND----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLS---- 229
Query: 1075 CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119
PEA + +++P +R G
Sbjct: 230 ---------------PEA--------KSLLAGLLKKDPKQRLGGG 251
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-24
Identities = 52/272 (19%), Positives = 94/272 (34%), Gaps = 77/272 (28%)
Query: 855 EVRMLGALR--HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS-VKNYIE 911
EV +L + S ++ + + +E + + ++I
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSF--------------VLILERPEPVQDLFDFIT 102
Query: 912 KLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVK 971
+ + +LA V A+ H+ ++HRDIK ENILIDL R + +K
Sbjct: 103 E-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE------LK 151
Query: 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
L DF L+ ++T GT + PE +R +G +WS
Sbjct: 152 LIDFGSGALLKDTVYTD------------FDGTRVYSPPEWIRYHRY---HGRSAAVWSL 196
Query: 1032 GCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1091
G LL +++ +P+ E+ + R R++ E +
Sbjct: 197 GILLYDMVCGDIPFEHDEEIIRGQVFF---RQRVSSECQ--------------------- 232
Query: 1092 AELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123
+ R C P++RPT ++
Sbjct: 233 ----------HLIRWCLALRPSDRPTFEEIQN 254
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-24
Identities = 50/270 (18%), Positives = 97/270 (35%), Gaps = 41/270 (15%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+R+L ++H ++ + ++ L + ++ G + N ++
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSL---------EEFNDVYLVTHLMGADLNNIVKC-- 115
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ ++ F+ + L +HS I+HRD+K N+ ++ +K+ D
Sbjct: 116 ----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-------EDCELKILD 164
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A + T + APE++ Y VDIWS GC+
Sbjct: 165 FGLARHTDDEMTGYVA-------------TRWYRAPEIMLNWMH---YNQTVDIWSVGCI 208
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
+ ELLT + + G ++ LI + L+ + S QS + K
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 268
Query: 1095 ETLSF---LVDVFRRCTEENPTERPTAGDL 1121
+ VD+ + + +R TA
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 3e-24
Identities = 50/313 (15%), Positives = 108/313 (34%), Gaps = 45/313 (14%)
Query: 811 GKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEM 870
G+ ++F+ K ++ +++ + L E+ +L L+H IV +
Sbjct: 11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LREICLLKELKHKNIVRL 66
Query: 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIA 930
+ S K L + E+ ++K ++ + ++
Sbjct: 67 HDVLHSDKKLT--------------LVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 931 QDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCI 990
+ L HS++++HRD+K +N+LI + +KL +F
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLI-------NRNGELKLANFG----------LARA 150
Query: 991 AHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVP-YMGLS 1049
+ V T + P+VL Y +D+WS GC+ EL P + G
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 1050 ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCT 1108
+ I ++ ++ +++ + L+ D+ +
Sbjct: 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLL 267
Query: 1109 EENPTERPTAGDL 1121
+ NP +R +A +
Sbjct: 268 KCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (251), Expect = 1e-23
Identities = 51/278 (18%), Positives = 94/278 (33%), Gaps = 51/278 (18%)
Query: 855 EVRMLGALR-HSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKL 913
E+++L LR I+ + +P A+ E+V K + L
Sbjct: 79 EIKILENLRGGPNIITLADIVK----------DPVSRTP--ALVFEHVNNTDFKQLYQTL 126
Query: 914 SETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLC 973
++ F ++ AL HS IMHRD+K N++ID E +K ++L
Sbjct: 127 TD--------YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK------LRLI 172
Query: 974 DFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033
D+ A V + + PE+ + +Y +D+WS GC
Sbjct: 173 DWGLAEFYHPGQEYNV-----------RVASRYFKGPEL---LVDYQMYDYSLDMWSLGC 218
Query: 1034 LLLELLTLQVPYM-GLSELEIHDLI-QMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE 1091
+L ++ + P+ G + I ++ L D ++ + +
Sbjct: 219 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 278
Query: 1092 AELETLSF--------LVDVFRRCTEENPTERPTAGDL 1121
E S +D + + R TA +
Sbjct: 279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 8e-23
Identities = 58/292 (19%), Positives = 97/292 (33%), Gaps = 66/292 (22%)
Query: 829 AAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHS-CIVEMYGHKISSKWLPSADGNP 887
A KV A + E ++L +R S +V ++ + L
Sbjct: 56 AMKVLKKATIVQKAKTTEHT----RTERQVLEHIRQSPFLVTLHYAFQTETKLH------ 105
Query: 888 EHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947
+ ++Y+ GG + ++ + E V + + ++ AL LH I++
Sbjct: 106 --------LILDYINGGELFTHLSQRERFTEHEVQIYVG-----EIVLALEHLHKLGIIY 152
Query: 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRW 1007
RDIK ENIL+D V L DF + + G +
Sbjct: 153 RDIKLENILLD-------SNGHVVLTDFGLSKEFVADETERAYDFCGTI---------EY 196
Query: 1008 MAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTD 1067
MAP+++R + VD WS G L+ ELLT P+ E I
Sbjct: 197 MAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---- 250
Query: 1068 ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119
+P E + D+ +R ++P +R G
Sbjct: 251 --------------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 1e-22
Identities = 61/283 (21%), Positives = 103/283 (36%), Gaps = 71/283 (25%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK-- 912
E+++L + H V L A P L+ + +E+ K G++ Y+
Sbjct: 66 ELKILIHIGHHLNV---------VNLLGACTKPGGPLM---VIVEFCKFGNLSTYLRSKR 113
Query: 913 ---------LSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963
+ + ++++ + + VA + L S+ +HRD+ + NIL+
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----- 168
Query: 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYG 1023
K VVK+CDF A + +WMAPE + Y
Sbjct: 169 --EKNVVKICDFGLARDIYKDPDYVRKGD--------ARLPLKWMAPETIFDRV----YT 214
Query: 1024 LEVDIWSYGCLLLELLTLQV-PYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVA 1081
++ D+WS+G LL E+ +L PY G+ E ++ G R R D
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT----------- 263
Query: 1082 QSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEM 1124
PE + C P++RPT +L E
Sbjct: 264 --------PE--------MYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 1e-21
Identities = 47/281 (16%), Positives = 92/281 (32%), Gaps = 52/281 (18%)
Query: 855 EVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS 914
E+ ++ + H I+ + K L + ME + + +L
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQ--------DVYLVMELMDANLCQVIQMELD 117
Query: 915 ETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCD 974
+ ++ + + LHS I+HRD+K NI++ +K+ D
Sbjct: 118 H--------ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-------KSDCTLKILD 162
Query: 975 FDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034
F A + V T + APEV+ M Y VDIWS GC+
Sbjct: 163 FGLARTAGTSFMMTPY-----------VVTRYYRAPEVILGMG----YKENVDIWSVGCI 207
Query: 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAEL 1094
+ E++ ++ + G ++ + + + ++ L + V +L
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 1095 ETLSF--------------LVDVFRRCTEENPTERPTAGDL 1121
S D+ + +P +R + D
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.1 bits (233), Expect = 4e-21
Identities = 47/229 (20%), Positives = 81/229 (35%), Gaps = 43/229 (18%)
Query: 835 LKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQS 894
+K+ L E R+L A+ +V++ + L + S
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 895 AIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954
+ S A F A + LHS +++RD+K EN
Sbjct: 131 HLRRI-------------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014
+LI D + +++ DF A ++ T C GTP +APE++
Sbjct: 172 LLI-------DQQGYIQVTDFGFAKRVKGRTWTLC-------------GTPEALAPEIIL 211
Query: 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQVPYMGLSELEIHDLIQMGKRP 1063
+ Y VD W+ G L+ E+ P+ ++I++ I GK
Sbjct: 212 SKG----YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.0 bits (201), Expect = 5e-17
Identities = 48/290 (16%), Positives = 96/290 (33%), Gaps = 46/290 (15%)
Query: 855 EVRMLGALRHSCIVEMY--GHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEK 912
E+++L + + + G K L +H + + + V +N +
Sbjct: 59 EIKLLQRVNDADNTKEDSMGANHILKLLDH-----FNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 913 LSETGEKHVSVKLALFIAQDVAAALVELHSKH-IMHRDIKSENILIDLERKKADGKPVVK 971
+ + + + + I++ + L +H + I+H DIK EN+L+++ + +K
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIK 172
Query: 972 LCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSY 1031
+ D A T + +PEVL +G DIWS
Sbjct: 173 IADLGNACWYDEHYTNSI-------------QTREYRSPEVLLGAP----WGCGADIWST 215
Query: 1032 GCLLLELLTLQVPYMG-------------------LSELEIHDLIQMGKRPRLTDELEAL 1072
CL+ EL+T + L EL + L + L
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275
Query: 1073 GSCHEHEVAQSGSGFEKPEAELETLSF-LVDVFRRCTEENPTERPTAGDL 1121
+ + + + + + + D + +P +R AG L
Sbjct: 276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.3 bits (176), Expect = 7e-14
Identities = 47/197 (23%), Positives = 78/197 (39%), Gaps = 17/197 (8%)
Query: 73 LYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPS--EVGNLLGLECLQIKISSPGVNG 130
L N ++ I +G L L GN++ + + NL L+ +IS+
Sbjct: 202 LIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLA--- 257
Query: 131 FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLE 190
L+ L L EL+L ++ +S +AGL + + I L NL
Sbjct: 258 -PLSGLTKLTELKLGANQ-----ISNISPLAGLTA-LTNLELNENQLEDISPISNLKNLT 310
Query: 191 QLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGS 250
L L FN + + + L L L ANNK+ ++ S L L + L +N+++ L
Sbjct: 311 YLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSDVSS-LANLTNINWLSAGHNQISDL-- 366
Query: 251 LDLCLMHNLQNLNLQYN 267
L + + L L
Sbjct: 367 TPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.9 bits (154), Expect = 4e-11
Identities = 37/176 (21%), Positives = 73/176 (41%), Gaps = 16/176 (9%)
Query: 96 LKFFGNEINLFPSEVG--NLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSV 153
L N+I+ NL L ++ G L L L +L+L+ +
Sbjct: 202 LIATNNQISDITPLGILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLAN-----NQ 252
Query: 154 LTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALI 213
++ L+ ++GL LT+L + I + P G + + I LK L
Sbjct: 253 ISNLAPLSGLTKLTELKLGANQISNISPLAGLTAL--TNLELNENQLEDISPISNLKNLT 310
Query: 214 SLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269
L + N + ++ + L +L+ L +NN+++ + SL + N+ L+ +N++
Sbjct: 311 YLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDVSSL--ANLTNINWLSAGHNQI 363
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 1e-07
Identities = 28/163 (17%), Positives = 60/163 (36%), Gaps = 10/163 (6%)
Query: 58 IESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117
++ G ++ L L N ++ + + KL LK N+I+ G L
Sbjct: 231 LKDIGTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNISPLAG--LTAL 287
Query: 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177
+ + ++ LK L L L + ++ +S ++ L L +L + +
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYF-----NNISDISPVSSLTKLQRLFFANNKVS 342
Query: 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANN 220
+ L+N+ L N++ L + L + L + +
Sbjct: 343 D-VSSLANLTNINWLSAGHNQISDLT-PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 4e-04
Identities = 25/112 (22%), Positives = 49/112 (43%), Gaps = 4/112 (3%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ + L+NLE L + N++ + + L L L + N+L ++ + L
Sbjct: 182 ISSNKVSDISVLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGT-LAS 239
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L L +LDL+NN++++L L + L L L N++ + +
Sbjct: 240 LTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTN 289
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 5e-04
Identities = 15/98 (15%), Positives = 38/98 (38%), Gaps = 4/98 (4%)
Query: 186 LSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRL 245
L+ + L + ++ L + +L+ + + G+ L L ++ SNN+L
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQL 78
Query: 246 TSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
T + L + L ++ + N++ + +
Sbjct: 79 TDI--TPLKNLTKLVDILMNNNQIADITPLANLTNLTG 114
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 65.2 bits (157), Expect = 1e-11
Identities = 22/93 (23%), Positives = 40/93 (43%), Gaps = 10/93 (10%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYL 231
+ S + +LE+L++S NK+ LP L+ L + N L E+P L
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAEVPE---L 322
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
Q L+ L + N L + ++++L +
Sbjct: 323 PQNLKQLHVEYNPLREFPD----IPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 61.0 bits (146), Expect = 3e-10
Identities = 26/74 (35%), Positives = 38/74 (51%), Gaps = 7/74 (9%)
Query: 206 ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQ 265
+L L V+NNKL+ELP+ L RLE L S N L + L NL+ L+++
Sbjct: 280 CDLPPSLEELNVSNNKLIELPA---LPPRLERLIASFNHLAEVPEL----PQNLKQLHVE 332
Query: 266 YNKLLSYCQVPSWI 279
YN L + +P +
Sbjct: 333 YNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 12/100 (12%)
Query: 187 SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246
N EQ +++ ++++ C + L++ N L LP L LE+L S N LT
Sbjct: 20 GNGEQREMAVSRLR-----DCLDRQAHELELNNLGLSSLPE---LPPHLESLVASCNSLT 71
Query: 247 SLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGN 286
L L +L++L + N L + +P + N
Sbjct: 72 ELPE----LPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 107
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 1e-06
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 7/99 (7%)
Query: 185 CL-SNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNN 243
CL +L+L+ + LP +L+ SL + N L ELP L Q L++L + NN
Sbjct: 35 CLDRQAHELELNNLGLSSLPELPPHLE---SLVASCNSLTELPE---LPQSLKSLLVDNN 88
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
L +L L L + + N I
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDV 127
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 6/117 (5%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
+L + + + LP +LE L S N + LP LK SL V NN L L
Sbjct: 40 AHELELNNLGLSSLPELPP---HLESLVASCNSLTELPELPQSLK---SLLVDNNNLKAL 93
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
LL+ L + +L L + + ++ N +L+ L N
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 59.7 bits (144), Expect = 3e-11
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 3/112 (2%)
Query: 154 LTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALI 213
LT+L + L +T L + H +R LPP + L LE L S N ++ + + L L
Sbjct: 10 LTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD-GVANLPRLQ 68
Query: 214 SLKVANNKLVELP--SGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLN 263
L + NN+L + L RL L+L N L + L L +++
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 57.8 bits (139), Expect = 1e-10
Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 2/105 (1%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239
+ L + LDLS N+++ LP + L+ L L+ ++N L + L RL+ L
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGV-ANLPRLQELL 71
Query: 240 LSNNRLTSLGSLD-LCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
L NNRL ++ L L LNLQ N L + + L
Sbjct: 72 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.2 bits (147), Expect = 2e-10
Identities = 48/238 (20%), Positives = 86/238 (36%), Gaps = 37/238 (15%)
Query: 76 YKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLG-LECLQIKISSPGVNGFALN 134
+ + P + KL L N++ P ++ L L + +I+ + F
Sbjct: 64 NNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL 123
Query: 135 KLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDL 194
+ EL P S G+K L+ + + +I +P G +L +L L
Sbjct: 124 NQMIVVEL---GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ--GLPPSLTELHL 178
Query: 195 SFNKMK-YLPTEICYLKALISLK------------------------VANNKLVELPSGL 229
NK+ + L L L + NNKLV++P GL
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL 238
Query: 230 YLLQRLENLDLSNNRLTSLGSLDLCLMH------NLQNLNLQYNKLLSYCQVPSWICC 281
+ ++ + L NN ++++GS D C + ++L N + + PS C
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.3 bits (124), Expect = 1e-07
Identities = 45/210 (21%), Positives = 81/210 (38%), Gaps = 16/210 (7%)
Query: 80 LNLIPKSVGRYEKLRNLKFFGNEI-NLFPSEVGNLLGLECLQIKISS-PGVNGFALNKLK 137
L +PK + L N+I + + NL L L + + ++ A L
Sbjct: 22 LEKVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLV 79
Query: 138 GLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSF 196
L+ L LSK + L L E +L V I + + L+ + ++L
Sbjct: 80 KLERLYLSK-----NQLKELPEKMPKTL-QELRVHENEITKVRKSVFNGLNQMIVVELGT 133
Query: 197 NKMKYL---PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDL 253
N +K +K L +++A+ + +P GL L L L N++T + + L
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASL 191
Query: 254 CLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
++NL L L +N + + +L
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 28/148 (18%), Positives = 51/148 (34%), Gaps = 11/148 (7%)
Query: 166 LTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLV 223
L + + I + + L NL L L NK+ + P L L L ++ N+L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 224 ELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWI---- 279
ELP + + L+ L + N +T + ++ + + L N L S
Sbjct: 93 ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 280 ---CCNLEGNGKDSSNDDFISSSAEMDV 304
+ + S E+ +
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLTELHL 178
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.8 bits (107), Expect = 2e-05
Identities = 22/101 (21%), Positives = 41/101 (40%), Gaps = 3/101 (2%)
Query: 184 GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSN 242
C +L + S ++ +P ++ L + NNK+ E+ G L+ L L L N
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 64
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNL 283
N+++ + + L+ L L N+L + L
Sbjct: 65 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL 105
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 58.3 bits (140), Expect = 4e-10
Identities = 27/197 (13%), Positives = 59/197 (29%), Gaps = 65/197 (32%)
Query: 846 RNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGS 905
S E R L L+ + ++Y + +A+ ME +
Sbjct: 55 VLAIRSARNEFRALQKLQGLAVPKVYAWE------------------GNAVLMELIDAKE 96
Query: 906 VKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKKAD 965
+ + + + + + + + + I+H D+ N+L+
Sbjct: 97 LYRVRVENPDE------------VLDMILEEVAKFYHRGIVHGDLSQYNVLVS------- 137
Query: 966 GKPVVKLCDFDRAVPL-----RSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPN 1020
+ + + DF ++V + R L DV ++ +
Sbjct: 138 -EEGIWIIDFPQSVEVGEEGWREIL-----------ERDVRN---------IITYFSRT- 175
Query: 1021 LYGLEVDIWSYGCLLLE 1037
Y E DI S +L+
Sbjct: 176 -YRTEKDINSAIDRILQ 191
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (135), Expect = 8e-09
Identities = 15/102 (14%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 188 NLEQLDLSFNKM--KYLPTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDL 240
+++ LD+ ++ + L+ +++ + L ++ S L + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+N L +G + + +Q L + C +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL 104
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 20/90 (22%), Positives = 27/90 (30%), Gaps = 23/90 (25%)
Query: 185 CLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNR 244
S L L L+ + ++ L + L L LDLSNN
Sbjct: 367 PGSVLRVLWLADCDVS------------------DSSCSSLAATLLANHSLRELDLSNNC 408
Query: 245 LTSLGSLDLC--LMHN---LQNLNLQYNKL 269
L G L L + L+ L L
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYW 438
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (120), Expect = 1e-07
Identities = 28/128 (21%), Positives = 48/128 (37%), Gaps = 10/128 (7%)
Query: 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVEL 225
L +L + L + + Q L ++ P ++ + L ++ L
Sbjct: 1 LNELK--PEQVEQLKLIMSKRYDGSQQALDLKGLRSDP-DLVAQNIDVVLNRRSSMAATL 57
Query: 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCL--MHNLQNLNLQYNKL-----LSYCQVPSW 278
+ L +L+LSNNRL L + + NL+ LNL N+L L +
Sbjct: 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117
Query: 279 ICCNLEGN 286
L+GN
Sbjct: 118 EELWLDGN 125
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 9e-06
Identities = 24/95 (25%), Positives = 40/95 (42%), Gaps = 3/95 (3%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV---ELPSGLYLLQRLE 236
P++ + L+ + L + L+SL ++NN+L ++ S + L+
Sbjct: 35 DPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94
Query: 237 NLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271
L+LS N L S LD L+ L L N L
Sbjct: 95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 16/60 (26%), Positives = 24/60 (40%), Gaps = 3/60 (5%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL-DLCLMHNLQNLNLQYNKLLSYCQVPS 277
N LP GL L+ L +L++S N L G + + NK L +P+
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLC--GEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.0 bits (102), Expect = 6e-05
Identities = 25/84 (29%), Positives = 36/84 (42%), Gaps = 1/84 (1%)
Query: 172 CHFSIRYLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVELPSGLY 230
S+ + ++G NL LDL N++ LP + LK L SL V+ N L
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288
Query: 231 LLQRLENLDLSNNRLTSLGSLDLC 254
LQR + +NN+ L C
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.0 bits (97), Expect = 3e-04
Identities = 14/58 (24%), Positives = 20/58 (34%), Gaps = 1/58 (1%)
Query: 165 CLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL 222
L LP + L L L++SFN + + L+ ANNK
Sbjct: 247 NGLDLRNNRIYGT-LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 16/70 (22%), Positives = 24/70 (34%), Gaps = 2/70 (2%)
Query: 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
E+ + + + + L LP L + L LS N L + L L LNL
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 265 QYNKLLSYCQ 274
+L
Sbjct: 63 DRAELTKLQV 72
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.003
Identities = 12/58 (20%), Positives = 21/58 (36%)
Query: 180 PPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLEN 237
+ L NL+ L L N + +P L + N + LY + L++
Sbjct: 165 AGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQD 222
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (103), Expect = 4e-05
Identities = 46/236 (19%), Positives = 82/236 (34%), Gaps = 7/236 (2%)
Query: 68 NSVEGLYLYKNVL-NLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126
+ + ++L+ N + ++ S L L N + + L L +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCL 186
+ GL L + GL L L + +++ LP +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 187 S-NLEQLDLSFNKMKYLPTEICY-LKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNN 243
NL L L N++ +P L +L L + N++ + P L RL L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 244 RLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCNLEGNGKDSSNDDFISSS 299
L++L + L + LQ L L N + C+ + L+ S+ + S
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKF--RGSSSEVPCSL 264
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 11/100 (11%), Positives = 32/100 (32%), Gaps = 5/100 (5%)
Query: 188 NLEQLDLSFNKMKYLPTEICYLKALISLKVANNKL-----VELPSGLYLLQRLENLDLSN 242
+L+ ++ K + + ++ + ++ N + L + + LE + S+
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+ + L L+ KL + +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 108
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 9/78 (11%), Positives = 21/78 (26%), Gaps = 4/78 (5%)
Query: 210 KALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLM----HNLQNLNLQ 265
K+L + + + L ++ + LS N + + + L +L+
Sbjct: 8 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 266 YNKLLSYCQVPSWICCNL 283
L
Sbjct: 68 DIFTGRVKDEIPEALRLL 85
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 19/94 (20%), Positives = 39/94 (41%), Gaps = 1/94 (1%)
Query: 192 LDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSL 251
LDL+ + T + +I+ + + + + + + R++++DLSN+ +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 64
Query: 252 D-LCLMHNLQNLNLQYNKLLSYCQVPSWICCNLE 284
L LQNL+L+ +L NL
Sbjct: 65 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.001
Identities = 24/140 (17%), Positives = 41/140 (29%), Gaps = 25/140 (17%)
Query: 142 LELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKY 201
L+L+ P V L + + + E ++ +DLS +
Sbjct: 5 LDLTGKNLHPDVTGRLLS----QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNS---- 56
Query: 202 LPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQN 261
++ L L +L+NL L RL+ L NL
Sbjct: 57 -----------------VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVR 99
Query: 262 LNLQYNKLLSYCQVPSWICC 281
LNL S + + +
Sbjct: 100 LNLSGCSGFSEFALQTLLSS 119
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 4e-04
Identities = 22/102 (21%), Positives = 43/102 (42%), Gaps = 1/102 (0%)
Query: 181 PEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDL 240
+ +LDL K+ + L ++ ++N++ +L G LL+RL+ L +
Sbjct: 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLV 70
Query: 241 SNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICCN 282
+NNR+ +G + +L L L N L+ +
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK 112
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.002
Identities = 23/134 (17%), Positives = 46/134 (34%), Gaps = 1/134 (0%)
Query: 151 PSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLK 210
++ ++ +L + + I + L + +D S N+++ L +
Sbjct: 5 AELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRR 64
Query: 211 ALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLC-LMHNLQNLNLQYNKL 269
L N L L L L+NN L LG LD + +L L + N +
Sbjct: 65 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124
Query: 270 LSYCQVPSWICCNL 283
+ ++ +
Sbjct: 125 TNKKHYRLYVIYKV 138
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 10/75 (13%), Positives = 26/75 (34%), Gaps = 3/75 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
I + + + + L ++ + +N+ + S+ + + N+ L L NK
Sbjct: 23 FAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNGNK 79
Query: 269 LLSYCQVPSWICCNL 283
L + +
Sbjct: 80 LTDIKPLANLKNLGW 94
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 16/59 (27%), Positives = 28/59 (47%), Gaps = 3/59 (5%)
Query: 206 ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNL 264
+ L L +LK +NK+ ++ L L L + L NN+++ + L NL + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSPLANT--SNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 10/75 (13%), Positives = 26/75 (34%), Gaps = 3/75 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L I + + + + + L + L +T++ + +NL L L+ N+
Sbjct: 18 LANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTIEGVQYL--NNLIGLELKDNQ 74
Query: 269 LLSYCQVPSWICCNL 283
+ + +
Sbjct: 75 ITDLAPLKNLTKITE 89
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 165 CLTKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPTEICYLKALISLKV-ANNKL 222
+ ++ LP ++ S LD+S ++ LP+ L+ L L+ + L
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG--LENLKKLRARSTYNL 235
Query: 223 VELPS 227
+LP+
Sbjct: 236 KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.002
Identities = 11/39 (28%), Positives = 16/39 (41%)
Query: 232 LQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLL 270
LD+S R+ SL S L + L+ + K L
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 10/64 (15%), Positives = 23/64 (35%), Gaps = 2/64 (3%)
Query: 219 NNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSW 278
+K+ E+PS L + L +L + +L+ + + N +L + +
Sbjct: 17 ESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74
Query: 279 ICCN 282
Sbjct: 75 SNLP 78
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 0.001
Identities = 10/74 (13%), Positives = 25/74 (33%), Gaps = 3/74 (4%)
Query: 209 LKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNK 268
L + + + + S L ++ L + S+ ++ +NL +N N+
Sbjct: 17 LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSIDGVEYL--NNLTQINFSNNQ 73
Query: 269 LLSYCQVPSWICCN 282
L + +
Sbjct: 74 LTDITPLKNLTKLV 87
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1137 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.93 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.84 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.69 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.65 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.6 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.56 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.41 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.37 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.34 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.33 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.33 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.25 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.24 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.13 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.33 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.08 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.96 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.43 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.11 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.02 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.69 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.59 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.1 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.68 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=439.99 Aligned_cols=257 Identities=25% Similarity=0.301 Sum_probs=215.8
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
++++|++.+.||+|+||+||+|++. +..||+|+..... ........++.+|+.+|+.++|||||++++++.++
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH-----ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 3678999999999999999999985 4678999754321 11122234458899999999999999999999976
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..|+|||||++|+|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 79 ~--------------~~~ivmEy~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill 139 (263)
T d2j4za1 79 T--------------RVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 139 (263)
T ss_dssp S--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred C--------------EEEEEEeecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee
Confidence 6 67999999999999999976 2469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+|+...... .....||+.|||||++.+ ..++.++|||||||++||
T Consensus 140 ~~~-------~~~kl~DFG~a~~~~~~~------------~~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvilye 196 (263)
T d2j4za1 140 GSA-------GELKIADFGWSVHAPSSR------------RTTLCGTLDYLPPEMIEG----RMHDEKVDLWSLGVLCYE 196 (263)
T ss_dssp CTT-------SCEEECCCCSCSCCCCCC------------CEETTEEGGGCCHHHHTT----CCCCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEeecccceeeecCCCc------------ccccCCCCcccCHHHHcC----CCCCchhhhhhHhHHHHH
Confidence 987 789999999997654321 123469999999999986 568999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|+.||.+.+..++...+...... ++. ..++++.+|+.+||+.||++|||
T Consensus 197 ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dp~~R~t 248 (263)
T d2j4za1 197 FLVGKPPFEANTYQETYKRISRVEFT-FPD---------------------------FVTEGARDLISRLLKHNPSQRPM 248 (263)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTTCCC-CCT---------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCC-CCc---------------------------cCCHHHHHHHHHHccCCHhHCcC
Confidence 99999999998888888877665422 111 23456999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 001152 1118 AGDLYEMFVARTSS 1131 (1137)
Q Consensus 1118 a~EVL~~L~~~~~s 1131 (1137)
++|+++|+|+...+
T Consensus 249 ~~eil~hp~~~~~s 262 (263)
T d2j4za1 249 LREVLEHPWITANS 262 (263)
T ss_dssp HHHHHTCHHHHHHC
T ss_pred HHHHHcCcCcCCcC
Confidence 99999999998654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=437.44 Aligned_cols=258 Identities=25% Similarity=0.432 Sum_probs=213.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.++||+|+||+||+|++. +..||+|+....... ..+. +.+|+.+|++++|||||++++++.+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~- 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKEL----IINEILVMRENKNPNIVNYLDSYLVGD- 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHH----HHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh----HHHH----HHHHHHHHHhCCCCCEeeEeEEEEECC-
Confidence 46999999999999999999974 678999986544221 1222 488999999999999999999998876
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
+.|+|||||+||+|.+++.+ ..+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 91 -------------~~~ivmEy~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 151 (293)
T d1yhwa1 91 -------------ELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (293)
T ss_dssp -------------EEEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred -------------EEEEEEEecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC
Confidence 67999999999999998765 35999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+|+.+..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|+
T Consensus 152 ~-------~~vkl~DFG~a~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyeml 210 (293)
T d1yhwa1 152 D-------GSVKLTDFGFCAQITPEQS----------KRSTMVGTPYWMAPEVVTR----KAYGPKVDIWSLGIMAIEMI 210 (293)
T ss_dssp T-------CCEEECCCTTCEECCSTTC----------CBCCCCSCGGGCCHHHHSS----SCBCTHHHHHHHHHHHHHHH
T ss_pred C-------CcEeeccchhheeeccccc----------cccccccCCCccChhhhcC----CCCCchhceehHhHHHHHHh
Confidence 7 7899999999986543221 1124579999999999976 56889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|..||.+.+..+....+.....+.+.. ....++++++||.+||+.||.+|||++
T Consensus 211 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ 265 (293)
T d1yhwa1 211 EGEPPYLNENPLRALYLIATNGTPELQN-------------------------PEKLSAIFRDFLNRCLDMDVEKRGSAK 265 (293)
T ss_dssp HSSCTTTTSCHHHHHHHHHHHCSCCCSS-------------------------GGGSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCC-------------------------cccCCHHHHHHHHHHccCChhHCcCHH
Confidence 9999999888777666664433322211 013456699999999999999999999
Q ss_pred HHHHHHHhhcCCCC
Q 001152 1120 DLYEMFVARTSSSI 1133 (1137)
Q Consensus 1120 EVL~~L~~~~~ss~ 1133 (1137)
|+++|+|++...+.
T Consensus 266 eil~Hp~~~~~~~~ 279 (293)
T d1yhwa1 266 ELLQHQFLKIAKPL 279 (293)
T ss_dssp HHTTCGGGGGCCCG
T ss_pred HHhcCHhhCCCCCC
Confidence 99999999865443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=434.45 Aligned_cols=260 Identities=24% Similarity=0.284 Sum_probs=205.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+++|++.+.||+|+||+||+|++. +..||+|+...+.. ....+ ++.+|+.+|++++|||||++++++.+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~----~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPE----NIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHH----HHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence 568999999999999999999985 56799998654321 11222 3488999999999999999999998876
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..|||||||++|+|.++++. ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 77 --------------~~~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~ 137 (271)
T d1nvra_ 77 --------------IQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137 (271)
T ss_dssp --------------EEEEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred --------------eeEEEEeccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC
Confidence 67999999999999998854 34799999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+|+........ ......+||+.|||||++.+ ...++.++|||||||++|||
T Consensus 138 ~~-------~~~KL~DFG~a~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~---~~~~~~~~DiwSlGvilyem 199 (271)
T d1nvra_ 138 ER-------DNLKISDFGLATVFRYNNRE--------RLLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTAM 199 (271)
T ss_dssp TT-------CCEEECCCTTCEECEETTEE--------CCBCCCCSCGGGSCTHHHHC---SSBCHHHHHHHHHHHHHHHH
T ss_pred CC-------CCEEEccchhheeeccCCcc--------ccccceeeCcCccCHhHhcC---CCCCCCceeeeHhHHHHHHH
Confidence 77 78999999999866433211 11124579999999999975 23457889999999999999
Q ss_pred HhCCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LTLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~e-l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
+||+.||....... ....+....... . .....++++.+|+.+||+.||++|||
T Consensus 200 l~G~~pf~~~~~~~~~~~~~~~~~~~~-~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t 253 (271)
T d1nvra_ 200 LAGELPWDQPSDSCQEYSDWKEKKTYL-N-------------------------PWKKIDSAPLALLHKILVENPSARIT 253 (271)
T ss_dssp HHSSCSCSSSSTTSHHHHHHHTTCTTS-T-------------------------TGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCC-C-------------------------ccccCCHHHHHHHHHHcCCChhHCcC
Confidence 99999997654322 222222211110 0 01134567899999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 001152 1118 AGDLYEMFVARTS 1130 (1137)
Q Consensus 1118 a~EVL~~L~~~~~ 1130 (1137)
++|+++|+|+...
T Consensus 254 ~~eil~hpwf~~~ 266 (271)
T d1nvra_ 254 IPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHTTCTTTTCC
T ss_pred HHHHhcCHhhCcC
Confidence 9999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=432.12 Aligned_cols=260 Identities=27% Similarity=0.366 Sum_probs=205.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.++|++.+.||+|+||+||+|++. +..||+|+.... .....+.+. +.+|+++|++++|||||++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG--SMTEAEKQM----LVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCT--TSCHHHHHH----HHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChh--hCCHHHHHH----HHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 467999999999999999999985 567888875432 333334333 489999999999999999999987532
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCCC
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH-----IMHRDIKSE 953 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g-----IIHrDLKP~ 953 (1137)
. ..+|+|||||++|+|.+++.+..+. ...+++..++.|+.||+.||+|||++| |+||||||+
T Consensus 77 ~------------~~~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~ 143 (269)
T d2java1 77 N------------TTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143 (269)
T ss_dssp --------------CEEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG
T ss_pred C------------CEEEEEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchh
Confidence 1 1579999999999999999765433 357999999999999999999999876 999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGC 1033 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGv 1033 (1137)
|||++.+ +.+||+|||+|+....... ......||+.|||||++.+ ..|+.++|||||||
T Consensus 144 NIll~~~-------~~vkl~DFG~a~~~~~~~~----------~~~~~~gt~~Y~APE~l~~----~~~~~~~DIwSlGv 202 (269)
T d2java1 144 NVFLDGK-------QNVKLGDFGLARILNHDTS----------FAKAFVGTPYYMSPEQMNR----MSYNEKSDIWSLGC 202 (269)
T ss_dssp GEEECTT-------SCEEECCHHHHHHC---------------------CCCSCCCHHHHTT----CCCCHHHHHHHHHH
T ss_pred hcCcCCC-------CcEEEeeccceeecccCCC----------ccccCCCCcccCCHHHHcC----CCCChHHHHHhhCH
Confidence 9999987 7899999999986543221 1124579999999999975 56899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1034 LLLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1034 iL~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
++|||+||+.||.+.+..++...+..+..+.++. .+++++.+|+.+||+.||.
T Consensus 203 ilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~s~~l~~li~~~L~~dp~ 255 (269)
T d2java1 203 LLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---------------------------RYSDELNEIITRMLNLKDY 255 (269)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHHcCCChh
Confidence 9999999999999999888888887766544332 3345699999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001152 1114 ERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~ 1127 (1137)
+|||++|+++|+|.
T Consensus 256 ~Rps~~ell~hp~i 269 (269)
T d2java1 256 HRPSVEEILENPLI 269 (269)
T ss_dssp GSCCHHHHHTSTTC
T ss_pred HCcCHHHHHhCCcC
Confidence 99999999999984
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=432.45 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=214.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+.|++.+.||+|+||+||+|++. +..||+|+..... ....+.+ .+|+++|++++|||||++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~----~~E~~il~~l~HpnIv~l~~~~~~~~- 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDY----MVEIDILASCDHPNIVKLLDAFYYEN- 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGT----HHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHH----HHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence 35899999999999999999985 4678888754321 2233444 88999999999999999999998766
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++|||||++|+|.+++.+. ...+++..+..|+.||+.||+|||++||+||||||+|||++.
T Consensus 83 -------------~~~lvmEy~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~ 145 (288)
T d2jfla1 83 -------------NLWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 145 (288)
T ss_dssp -------------EEEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred -------------eEEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC
Confidence 679999999999999998652 246999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc-CCCCCCchhhHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH-KPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~s~ksDVWSLGviL~EL 1038 (1137)
+ +.+||+|||+|+........ .....||+.|+|||++.... ....|+.++|||||||++|||
T Consensus 146 ~-------~~~Kl~DFG~a~~~~~~~~~----------~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyem 208 (288)
T d2jfla1 146 D-------GDIKLADFGVSAKNTRTIQR----------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208 (288)
T ss_dssp T-------SCEEECCCTTCEECHHHHHH----------HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHH
T ss_pred C-------CCEEEEechhhhccCCCccc----------ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHH
Confidence 7 78999999999765432111 11346999999999986422 235689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+||+.||.+.+..++...+..+..+.+... ...++++.+|+.+||+.||.+|||+
T Consensus 209 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~s~~~~~li~~~L~~dp~~R~t~ 263 (288)
T d2jfla1 209 AEIEPPHHELNPMRVLLKIAKSEPPTLAQP-------------------------SRWSSNFKDFLKKCLEKNVDARWTT 263 (288)
T ss_dssp HHSSCTTTTSCGGGHHHHHHHSCCCCCSSG-------------------------GGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCCCCCcc-------------------------ccCCHHHHHHHHHHccCChhHCcCH
Confidence 999999999888888877776654432210 1445679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
+|+++|+|+...
T Consensus 264 ~ell~hp~~~~~ 275 (288)
T d2jfla1 264 SQLLQHPFVTVD 275 (288)
T ss_dssp HHHTTSGGGCCC
T ss_pred HHHhcCcccCCC
Confidence 999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=425.02 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=202.3
Q ss_pred ceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 804 LSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
|++.++||+|+||+||+|++.. ..||+|+.... .....+.+. +.+|+++|++++|||||++++++.+...
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~--~~~~~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~~-- 82 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR--KLTKSERQR----FKEEAEMLKGLQHPNIVRFYDSWESTVK-- 82 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG--GSCHHHHHH----HHHHHHHHTTCCCTTBCCEEEEEEEESS--
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh--hCCHHHHHH----HHHHHHHHHhCCCCCeeeEEEEEeeccc--
Confidence 4788899999999999999865 45677764332 223333334 4899999999999999999999875320
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCCeEecc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKH--IMHRDIKSENILIDL 959 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~g--IIHrDLKP~NILld~ 959 (1137)
....+|+||||+++|+|.+++.+. ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 83 --------~~~~~~ivmE~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~ 149 (270)
T d1t4ha_ 83 --------GKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 149 (270)
T ss_dssp --------SCEEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS
T ss_pred --------cCCEEEEEEeCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC
Confidence 122679999999999999999762 46999999999999999999999998 999999999999974
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+. +.+||+|||+|+...... ....+||+.|||||++.+ .++.++|||||||++|||+
T Consensus 150 ~~------~~~Kl~DFGla~~~~~~~------------~~~~~GT~~Y~aPE~~~~-----~~~~~~DIwSlGvilyel~ 206 (270)
T d1t4ha_ 150 PT------GSVKIGDLGLATLKRASF------------AKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLEMA 206 (270)
T ss_dssp TT------SCEEECCTTGGGGCCTTS------------BEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHHHH
T ss_pred CC------CCEEEeecCcceeccCCc------------cCCcccCccccCHHHhCC-----CCCCcCchhhHHHHHHHHH
Confidence 31 689999999997543221 123579999999999864 5899999999999999999
Q ss_pred hCCCCCCCC-CHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TLQVPYMGL-SELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~-~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+|+.||.+. +..++...+..+..+... ....++++.+|+.+||+.||++|||+
T Consensus 207 ~g~~Pf~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~dp~~R~s~ 260 (270)
T d1t4ha_ 207 TSEYPYSECQNAAQIYRRVTSGVKPASF--------------------------DKVAIPEVKEIIEGCIRQNKDERYSI 260 (270)
T ss_dssp HSSCTTTTCSSHHHHHHHHTTTCCCGGG--------------------------GGCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HCCCCCCCcccHHHHHHHHHcCCCCccc--------------------------CccCCHHHHHHHHHHccCCHhHCcCH
Confidence 999999764 445555555544332110 11344569999999999999999999
Q ss_pred HHHHHHHHhh
Q 001152 1119 GDLYEMFVAR 1128 (1137)
Q Consensus 1119 ~EVL~~L~~~ 1128 (1137)
+|+++|+|++
T Consensus 261 ~ell~Hp~fk 270 (270)
T d1t4ha_ 261 KDLLNHAFFQ 270 (270)
T ss_dssp HHHHTSGGGC
T ss_pred HHHhCCcccC
Confidence 9999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=427.42 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=207.1
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+..+|++.++||+|+||+||+|++.+ .||||+... ........+.+ .+|+.+|++++|||||++++++.+.
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~--~~~~~~~~~~~----~~E~~~l~~l~HpnIv~~~~~~~~~-- 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNV--TAPTPQQLQAF----KNEVGVLRKTRHVNILLFMGYSTAP-- 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCC--SSCCTTHHHHH----HHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEc--ccCCHHHHHHH----HHHHHHHHhCCCCCEeeeeEEEecc--
Confidence 34678999999999999999999765 599998543 33333344444 8999999999999999999987543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
+.++|||||++|+|.+++.. ....+++..+..|+.||++||+|||+++||||||||+|||++.
T Consensus 77 -------------~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~ 139 (276)
T d1uwha_ 77 -------------QLAIVTQWCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE 139 (276)
T ss_dssp -------------SCEEEEECCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred -------------EEEEEEecCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcC
Confidence 35999999999999999975 2346999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+|+........ .......||+.|||||++.+. ....|+.++|||||||++|||+
T Consensus 140 ~-------~~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~~-~~~~~~~~sDiwS~Gv~l~el~ 203 (276)
T d1uwha_ 140 D-------LTVKIGDFGLATVKSRWSGS--------HQFEQLSGSILWMAPEVIRMQ-DKNPYSFQSDVYAFGIVLYELM 203 (276)
T ss_dssp T-------SSEEECCCCCSCC--------------------CCCCGGGCCHHHHTTC-SSCCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEccccceeeccccCCc--------ccccccccCcccCCHHHHhcc-cCCCCCchhhhhhhHHHHHHHH
Confidence 7 78999999999765432211 111245799999999998752 2346899999999999999999
Q ss_pred hCCCCCCCCCHHH-HHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TLQVPYMGLSELE-IHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~~e-l~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
||+.||.+..... +...+..+..+..... ....+++++.+|+.+||+.||++||||
T Consensus 204 tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~-----------------------~~~~~~~~l~~li~~cl~~dp~~RPt~ 260 (276)
T d1uwha_ 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSK-----------------------VRSNCPKAMKRLMAECLKKKRDERPLF 260 (276)
T ss_dssp HSSCTTTTCCCHHHHHHHHHHTSCCCCGGG-----------------------SCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCChHHHHHHHHhcCCCCCcchh-----------------------ccccchHHHHHHHHHHcCCCHhHCcCH
Confidence 9999998865543 4444454432221110 011456779999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
+||+++|+....
T Consensus 261 ~~il~~Le~l~~ 272 (276)
T d1uwha_ 261 PQILASIELLAR 272 (276)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999988754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-47 Score=431.99 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=212.0
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
.|++.++||+|+||+||+|++. +..||||+...... ......+ .+.+|+.+|++++|||||++++++.+++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~~~-- 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQ----DIIKEVRFLQKLRHPNTIQYRGCYLREH-- 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHH----HHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHH----HHHHHHHHHHHCCCCCEeeEEEEEEECC--
Confidence 3899999999999999999985 46688887543221 1122223 3489999999999999999999998766
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
..|+|||||++|+|..++.. ...+++..++.|+.||+.||+|||++|||||||||+|||++.+
T Consensus 89 ------------~~~iv~E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~ 151 (309)
T d1u5ra_ 89 ------------TAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151 (309)
T ss_dssp ------------EEEEEEECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred ------------EEEEEEEecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC
Confidence 67999999999999876654 3569999999999999999999999999999999999999987
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
+.+||+|||+|...... ....||+.|||||++.+. ....|+.++|||||||++|||++
T Consensus 152 -------~~~Kl~DFG~a~~~~~~--------------~~~~GT~~Y~APE~~~~~-~~~~y~~~~DiwSlGvilyel~~ 209 (309)
T d1u5ra_ 152 -------GLVKLGDFGSASIMAPA--------------NSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAE 209 (309)
T ss_dssp -------TEEEECCCTTCBSSSSB--------------CCCCSCGGGCCHHHHTTT-TSCCBCTHHHHHHHHHHHHHHHH
T ss_pred -------CCEEEeecccccccCCC--------------CccccCccccCHHHHhcc-CCCCcCchhhhhhHHHHHHHHHH
Confidence 78999999999754321 134699999999998752 13468899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
|..||.+....+....+..+..+.+.. ...++++.+|+.+||+.||.+|||++|
T Consensus 210 g~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~e 263 (309)
T d1u5ra_ 210 RKPPLFNMNAMSALYHIAQNESPALQS--------------------------GHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (309)
T ss_dssp SSCTTTTSCHHHHHHHHHHSCCCCCSC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCC--------------------------CCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 999999888888777776655433221 034556999999999999999999999
Q ss_pred HHHHHHhhcCCC
Q 001152 1121 LYEMFVARTSSS 1132 (1137)
Q Consensus 1121 VL~~L~~~~~ss 1132 (1137)
+++|+|+....+
T Consensus 264 ll~Hp~~~~~~~ 275 (309)
T d1u5ra_ 264 LLKHRFVLRERP 275 (309)
T ss_dssp HTTCHHHHSCCC
T ss_pred HHhCHHhcCCCC
Confidence 999999986543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=424.78 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=216.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||+||+|++. +..||||+........... ......+.+|+.+|++++|||||++++++.+.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKT- 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 46999999999999999999985 5789999865443222111 111223488999999999999999999998766
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
+.|||||||++|+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 87 -------------~~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~ 148 (293)
T d1jksa_ 87 -------------DVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148 (293)
T ss_dssp -------------EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred -------------EEEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEec
Confidence 679999999999999999762 46999999999999999999999999999999999999987
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
++ .....+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 149 ~~---~~~~~vkl~DfG~a~~~~~~~~-----------~~~~~~t~~y~APE~~~~----~~~~~~~DiwSlGvilyell 210 (293)
T d1jksa_ 149 RN---VPKPRIKIIDFGLAHKIDFGNE-----------FKNIFGTPEFVAPEIVNY----EPLGLEADMWSIGVITYILL 210 (293)
T ss_dssp SS---SSSCCEEECCCTTCEECTTSCB-----------CSCCCCCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHHHH
T ss_pred CC---CcccceEecchhhhhhcCCCcc-----------ccccCCCCcccCHHHHcC----CCCCCcccchhhhHHHHHHH
Confidence 62 2234699999999976543221 123469999999999975 56899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|+.||.+.+..++...+..+......... ...++++.+||.+||+.||.+|||++
T Consensus 211 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~R~s~~ 266 (293)
T d1jksa_ 211 SGASPFLGDTKQETLANVSAVNYEFEDEYF------------------------SNTSALAKDFIRRLLVKDPKKRMTIQ 266 (293)
T ss_dssp HSSCSSCCSSHHHHHHHHHTTCCCCCHHHH------------------------TTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCchhc------------------------CCCCHHHHHHHHHHccCChhHCcCHH
Confidence 999999999988888888766543222111 14456799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
|+++|+|++.
T Consensus 267 eil~hp~~~~ 276 (293)
T d1jksa_ 267 DSLQHPWIKP 276 (293)
T ss_dssp HHHHSTTTCC
T ss_pred HHhcCcccCC
Confidence 9999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=425.90 Aligned_cols=258 Identities=21% Similarity=0.270 Sum_probs=209.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
.++|++.+.||+|+||+||+|++. +..||||+...... ..+.....+.+|+.+|++++|||||++++++.+++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-----cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence 357999999999999999999985 56799998643211 11111234588999999999999999999998766
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 82 --------------~~~ivmEy~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~ 142 (288)
T d1uu3a_ 82 --------------KLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 142 (288)
T ss_dssp --------------EEEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------EEEEEEEccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC
Confidence 67999999999999999876 24699999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+|+.+...... ......+||+.|+|||++.+ ..|+.++|||||||++|||
T Consensus 143 ~~-------~~vkl~DFG~a~~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~----~~~~~~~DiwSlGvilyel 203 (288)
T d1uu3a_ 143 ED-------MHIQITDFGTAKVLSPESKQ--------ARANSFVGTAQYVSPELLTE----KSACKSSDLWALGCIIYQL 203 (288)
T ss_dssp TT-------SCEEECCCTTCEECC------------------CCCCGGGCCHHHHHT----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------ceEEecccccceecccCCcc--------cccccccCCccccCceeecc----CCCCcccceehhhHHHHHH
Confidence 87 78999999999866432211 11124579999999999976 5789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|+.||.+.+..++...+..+... ++. ..++++++||.+||+.||.+|||+
T Consensus 204 l~g~~Pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~~li~~~L~~dP~~R~t~ 255 (288)
T d1uu3a_ 204 VAGLPPFRAGNEYLIFQKIIKLEYD-FPE---------------------------KFFPKARDLVEKLLVLDATKRLGC 255 (288)
T ss_dssp HHSSCSSCCSSHHHHHHHHHTTCCC-CCT---------------------------TCCHHHHHHHHTTSCSSGGGSTTS
T ss_pred hhCCCCCCCcCHHHHHHHHHcCCCC-CCc---------------------------cCCHHHHHHHHHHccCCHhHCcCH
Confidence 9999999998888888888665421 111 234568999999999999999999
Q ss_pred HHH------HHHHHhhc
Q 001152 1119 GDL------YEMFVART 1129 (1137)
Q Consensus 1119 ~EV------L~~L~~~~ 1129 (1137)
+|+ ++|+|+..
T Consensus 256 ~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 256 EEMEGYGPLKAHPFFES 272 (288)
T ss_dssp GGGTCHHHHHTSGGGTT
T ss_pred HHHcCCHHHHcCCccCC
Confidence 884 66777653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-47 Score=429.64 Aligned_cols=261 Identities=23% Similarity=0.220 Sum_probs=201.7
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+.|++.+.||+|+||+||+|++. +..||||+...+... .. ...+.+|+.+|++++|||||++++++.+++
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 80 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GK----EGSMENEIAVLHKIKHPNIVALDDIYESGG- 80 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 35999999999999999999985 567899986433221 11 123478999999999999999999998766
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..|||||||+||+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||+..
T Consensus 81 -------------~~~lvmE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~ 142 (307)
T d1a06a_ 81 -------------HLYLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 142 (307)
T ss_dssp -------------EEEEEECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred -------------EEEEEEeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecc
Confidence 67999999999999999975 357999999999999999999999999999999999999964
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
. ...+.+||+|||+++....... ....+||+.|||||++.+ ..|+.++|||||||++|||+
T Consensus 143 ~----~~~~~vkl~DFG~a~~~~~~~~-----------~~~~~GT~~y~APE~~~~----~~~~~~~DiwSlGvilyell 203 (307)
T d1a06a_ 143 L----DEDSKIMISDFGLSKMEDPGSV-----------LSTACGTPGYVAPEVLAQ----KPYSKAVDCWSIGVIAYILL 203 (307)
T ss_dssp S----STTCCEEECCC-----------------------------CTTSCHHHHTT----CCCCTHHHHHHHHHHHHHHH
T ss_pred c----CCCceEEEeccceeEEccCCCe-----------eeeeeeCccccCcHHHcC----CCCCcHHHhhhhhHHHHHHH
Confidence 2 1127899999999976543211 123579999999999976 56899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
+|+.||.+....++...+..+........ ....++++.+|+.+||+.||++|||++
T Consensus 204 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ 259 (307)
T d1a06a_ 204 CGYPPFYDENDAKLFEQILKAEYEFDSPY------------------------WDDISDSAKDFIRHLMEKDPEKRFTCE 259 (307)
T ss_dssp HSSCSCCCSSHHHHHHHHHTTCCCCCTTT------------------------TTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hCCCCCCCCCHHHHHHHHhccCCCCCCcc------------------------ccCCCHHHHHHHHHHccCCHhHCcCHH
Confidence 99999999888888888876553221110 014456799999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 001152 1120 DLYEMFVARTSS 1131 (1137)
Q Consensus 1120 EVL~~L~~~~~s 1131 (1137)
|+++|+|+....
T Consensus 260 eil~hp~~~~~~ 271 (307)
T d1a06a_ 260 QALQHPWIAGDT 271 (307)
T ss_dssp HHHHSTTTTSSC
T ss_pred HHhcCHhhCCCC
Confidence 999999997543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=433.38 Aligned_cols=280 Identities=23% Similarity=0.306 Sum_probs=204.2
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
-++|++.++||+|+||+||+|++. +..||+|+...+. . .... .++.+|+.+|++++|||||+++++|.+..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~-~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--K-PAIR----NQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--C-TTHH----HHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--C-HHHH----HHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357999999999999999999985 5678888754332 1 1222 23489999999999999999999998766
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCCeEe
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMHRDIKSENILI 957 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIHrDLKP~NILl 957 (1137)
+.|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||+
T Consensus 78 --------------~~~iVmEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl 138 (322)
T d1s9ja_ 78 --------------EISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138 (322)
T ss_dssp --------------EEEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE
T ss_pred --------------EEEEEEEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE
Confidence 679999999999999999762 469999999999999999999997 599999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+|+....... ...+||+.|+|||++.+ ..|+.++||||+||++||
T Consensus 139 ~~~-------~~vkl~DFGla~~~~~~~~------------~~~~GT~~Y~APEvl~~----~~y~~~~DiWSlGvil~e 195 (322)
T d1s9ja_ 139 NSR-------GEIKLCDFGVSGQLIDSMA------------NSFVGTRSYMSPERLQG----THYSVQSDIWSMGLSLVE 195 (322)
T ss_dssp CTT-------CCEEECCCCCCHHHHHHTC---------------CCSSCCCCHHHHHC----SCCCTTHHHHHHHHHHHH
T ss_pred CCC-------CCEEEeeCCCccccCCCcc------------ccccCCccccCchHHcC----CCCCcHHHHHHHHHHHHH
Confidence 887 7899999999986543211 24579999999999986 578999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHH---HcCCCCCchhHHhhhcccccccccccC-------------CCCCCchhhhhhHHHHH
Q 001152 1038 LLTLQVPYMGLSELEIHDLI---QMGKRPRLTDELEALGSCHEHEVAQSG-------------SGFEKPEAELETLSFLV 1101 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I---~~g~~p~l~~~l~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~L~ 1101 (1137)
|++|+.||.+.+..+..... ..+.....+.................. ....+.......+.++.
T Consensus 196 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 275 (322)
T d1s9ja_ 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275 (322)
T ss_dssp HHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHH
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHH
Confidence 99999999875543321111 111100000000000000000000000 00000001113457799
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1102 DVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1102 dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+|+.+||+.||.+||||+|+++|+|++.
T Consensus 276 dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 276 DFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 9999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.6e-47 Score=433.61 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=215.3
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+++|++.+.||+|+||+||+|++. +..||||+.... .....+. +.+|+.+|++++|||||++++++.+.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKET----VRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHH----HHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHH----HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 568999999999999999999985 567888875322 1223333 489999999999999999999998766
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
+.|||||||+||+|.+++.+ ....+++..+..|+.||+.||+|||++|||||||||+|||++
T Consensus 97 --------------~~~ivmE~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~ 158 (350)
T d1koaa2 97 --------------EMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 158 (350)
T ss_dssp --------------EEEEEECCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEcCCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeec
Confidence 67999999999999999854 134699999999999999999999999999999999999997
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+. .+.+||+|||+++.+...... ....||+.|||||++.+ ..++.++|||||||++|+|
T Consensus 159 ~~~-----~~~vkL~DFG~a~~~~~~~~~-----------~~~~gT~~Y~aPEv~~~----~~~~~~~DiwSlGvilyel 218 (350)
T d1koaa2 159 TKR-----SNELKLIDFGLTAHLDPKQSV-----------KVTTGTAEFAAPEVAEG----KPVGYYTDMWSVGVLSYIL 218 (350)
T ss_dssp STT-----SCCEEECCCTTCEECCTTSCE-----------EEECSCTTTCCHHHHHT----CCBCHHHHHHHHHHHHHHH
T ss_pred cCC-----CCeEEEeecchheeccccccc-----------ceecCcccccCHHHHcC----CCCChhHhhhhhhHHHHHH
Confidence 542 267999999999865543211 23579999999999986 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|+.||.+.+..++...+..+........ ....++++++||.+||+.||++|||+
T Consensus 219 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R~t~ 274 (350)
T d1koaa2 219 LSGLSPFGGENDDETLRNVKSCDWNMDDSA------------------------FSGISEDGKDFIRKLLLADPNTRMTI 274 (350)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCSCCGG------------------------GGGCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCccc------------------------ccCCCHHHHHHHHHHccCChhHCcCH
Confidence 999999999888888888866543221111 11445679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
+|+++|+|+...
T Consensus 275 ~eil~hp~~~~~ 286 (350)
T d1koaa2 275 HQALEHPWLTPG 286 (350)
T ss_dssp HHHHHSTTTSCT
T ss_pred HHHhcCcccCCC
Confidence 999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-46 Score=422.67 Aligned_cols=267 Identities=19% Similarity=0.326 Sum_probs=204.9
Q ss_pred CCCCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~---~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
...+|++.++||+|+||+||+|++.. ..++|+++.+.... .....+. +.+|+.+|++++|||||++++++.+
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~----~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRD----FLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHH----HHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHH----HHHHHHHHHhCCCCCCccEEEEEee
Confidence 34679999999999999999999843 33455554444322 2333344 4899999999999999999999987
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ ..++|||||++|+|.+++.. ....+++.++..|+.||++||+|||+++|+||||||+|||
T Consensus 99 ~~--------------~~~iv~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 99 ST--------------PVMIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL 160 (299)
T ss_dssp SS--------------SCEEEEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CC--------------EEEEEEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEE
Confidence 65 45999999999999998875 2346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+++.......... ........||+.|||||++.+ ..++.++|||||||++|
T Consensus 161 l~~~-------~~~Kl~DFGla~~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~----~~~~~~sDvwS~Gvvl~ 224 (299)
T d1jpaa_ 161 VNSN-------LVCKVSDFGLSRFLEDDTSDPT-----YTSALGGKIPIRWTAPEAIQY----RKFTSASDVWSYGIVMW 224 (299)
T ss_dssp ECTT-------CCEEECCC----------------------------CGGGSCHHHHHS----CCCCHHHHHHHHHHHHH
T ss_pred ECCC-------CcEEECCcccceEccCCCCcce-----eeecccccCCccccCHHHHhc----CCCCcccccccchHHHH
Confidence 9987 7899999999986654321110 001112357899999999875 57899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
||+| |..||.+....++...+..+.++..+. .+++++.+|+.+||+.||++|
T Consensus 225 el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~~P~~R 277 (299)
T d1jpaa_ 225 EVMSYGERPYWDMTNQDVINAIEQDYRLPPPM---------------------------DCPSALHQLMLDCWQKDRNHR 277 (299)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cchHHHHHHHHHHcCCCHhHC
Confidence 9998 899999999888888887765443321 345569999999999999999
Q ss_pred CCHHHHHHHHHhhcCCC
Q 001152 1116 PTAGDLYEMFVARTSSS 1132 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ss 1132 (1137)
|||+||+++|....+.+
T Consensus 278 Ps~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 278 PKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp CCHHHHHHHHHHHHHSG
T ss_pred cCHHHHHHHHHHHhcCh
Confidence 99999999987654433
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-46 Score=414.76 Aligned_cols=268 Identities=25% Similarity=0.364 Sum_probs=222.1
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCC-ChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEec
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGS-SADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKIS 876 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~-~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~ 876 (1137)
..+|++.+.||+|+||+||+|++. ++.+|||+........ .....+....++.+|+.+|++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999984 5789999865544332 33444556667799999999997 9999999999997
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
++ +.|||||||++|+|.++++. ...+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus 82 ~~--------------~~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil 142 (277)
T d1phka_ 82 NT--------------FFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 142 (277)
T ss_dssp SS--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred Cc--------------ceEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE
Confidence 76 67999999999999999976 246999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhcccc--CCCCCCchhhHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMH--KPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~s~ksDVWSLGvi 1034 (1137)
++.+ +.+||+|||+++....... .....||+.|+|||++.+.. ....++.++||||+||+
T Consensus 143 l~~~-------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvi 204 (277)
T d1phka_ 143 LDDD-------MNIKLTDFGFSCQLDPGEK-----------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 204 (277)
T ss_dssp ECTT-------CCEEECCCTTCEECCTTCC-----------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred EcCC-------CCeEEccchheeEccCCCc-----------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchh
Confidence 9887 7899999999986654221 12346999999999987532 23457899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1035 LLELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+|++|+.||.+.+..+....+..+........ ....++++++|+.+||+.||.+
T Consensus 205 lyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~~p~~ 260 (277)
T d1phka_ 205 MYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE------------------------WDDYSDTVKDLVSRFLVVQPQK 260 (277)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT------------------------GGGSCHHHHHHHHHHCCSSGGG
T ss_pred hhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc------------------------cccCCHHHHHHHHHHccCChhH
Confidence 9999999999999888888877766543211110 1145677999999999999999
Q ss_pred CCCHHHHHHHHHhhc
Q 001152 1115 RPTAGDLYEMFVART 1129 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~ 1129 (1137)
|||++||++|+|++.
T Consensus 261 R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 261 RYTAEEALAHPFFQQ 275 (277)
T ss_dssp SCCHHHHTTSGGGCT
T ss_pred CcCHHHHHcCHHHHH
Confidence 999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=426.20 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=215.8
Q ss_pred CCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
.++++|++.+.||+|+||.||+|++. +..||+|+...... ..+....++.+|+.+|++++|||||++++++.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 36788999999999999999999984 57899998643311 111112345889999999999999999999998
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
.+ .+|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 77 ~~--------------~~~iv~ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL 137 (337)
T d1o6la_ 77 HD--------------RLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SS--------------EEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred cc--------------ccccceeccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeE
Confidence 76 67999999999999999886 246899999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+|+....... .....+||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 138 l~~~-------g~vkl~DFG~a~~~~~~~~----------~~~~~~GT~~Y~aPE~~~~----~~y~~~~DiwSlGvily 196 (337)
T d1o6la_ 138 LDKD-------GHIKITDFGLCKEGISDGA----------TMKTFCGTPEYLAPEVLED----NDYGRAVDWWGLGVVMY 196 (337)
T ss_dssp ECTT-------SCEEECCCTTCBCSCCTTC----------CBCCCEECGGGCCGGGGSS----SCBCTTHHHHHHHHHHH
T ss_pred ecCC-------CCEEEeecccccccccCCc----------ccccceeCHHHhhhhhccC----CCCChhhcccchhhHHH
Confidence 9987 7899999999976543221 1124579999999999976 57899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
||++|+.||.+.+..++...+..+... ++. ..++++.+||.+||++||.+||
T Consensus 197 eml~G~~pf~~~~~~~~~~~i~~~~~~-~p~---------------------------~~s~~~~dli~~~L~~dP~~R~ 248 (337)
T d1o6la_ 197 EMMCGRLPFYNQDHERLFELILMEEIR-FPR---------------------------TLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCC-CCT---------------------------TSCHHHHHHHHHHTCSSTTTST
T ss_pred HHHHCCCCCCCcCHHHHHHHHhcCCCC-CCc---------------------------cCCHHHHHHHHhhccCCchhhc
Confidence 999999999999988888887665422 221 3345689999999999999999
Q ss_pred C-----HHHHHHHHHhhc
Q 001152 1117 T-----AGDLYEMFVART 1129 (1137)
Q Consensus 1117 S-----a~EVL~~L~~~~ 1129 (1137)
+ ++|+++|+|+..
T Consensus 249 ~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 249 GGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp TCSTTTHHHHHTSGGGTT
T ss_pred ccccccHHHHHcCccccc
Confidence 4 999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-46 Score=430.06 Aligned_cols=260 Identities=20% Similarity=0.279 Sum_probs=214.6
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+++|++.+.||+|+||+||+|++. +..||+|+..... ..+.+ ++.+|+.+|++++|||||++++++.+++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKY----TVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHH----HHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHH----HHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 467999999999999999999984 5778999754321 22222 3488999999999999999999998766
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
+.|||||||+||+|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+|||++
T Consensus 100 --------------~~~ivmE~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~ 161 (352)
T d1koba_ 100 --------------EMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 161 (352)
T ss_dssp --------------EEEEEEECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEEcCCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccc
Confidence 67999999999999987754 234699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
... .+.+||+|||+|+........ ....||+.|+|||++.+ ..|+.++|||||||++|+|
T Consensus 162 ~~~-----~~~vkL~DFGla~~~~~~~~~-----------~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvilyel 221 (352)
T d1koba_ 162 TKK-----ASSVKIIDFGLATKLNPDEIV-----------KVTTATAEFAAPEIVDR----EPVGFYTDMWAIGVLGYVL 221 (352)
T ss_dssp STT-----CCCEEECCCTTCEECCTTSCE-----------EEECSSGGGCCHHHHTT----CCBCHHHHHHHHHHHHHHH
T ss_pred ccC-----CCeEEEeecccceecCCCCce-----------eeccCcccccCHHHHcC----CCCCCccchHHHHHHHHHH
Confidence 432 278999999999876542211 23469999999999975 5689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+||..||.+.+..++...+..+..+..... ....++++.+||.+||+.||.+|||+
T Consensus 222 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dp~~R~s~ 277 (352)
T d1koba_ 222 LSGLSPFAGEDDLETLQNVKRCDWEFDEDA------------------------FSSVSPEAKDFIKNLLQKEPRKRLTV 277 (352)
T ss_dssp HHSCCSSCCSSHHHHHHHHHHCCCCCCSST------------------------TTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCccc------------------------ccCCCHHHHHHHHHHccCChhHCcCH
Confidence 999999999888888888876553221110 01445679999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
+|+++|+|++..
T Consensus 278 ~eil~Hp~~~~~ 289 (352)
T d1koba_ 278 HDALEHPWLKGD 289 (352)
T ss_dssp HHHHTSTTTSSC
T ss_pred HHHhcCHhhCCC
Confidence 999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-46 Score=421.70 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=213.8
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
++.+|++.+.||+|+||+||+|++. +..||||+...... .......++.+|+.+|++++|||||++++++.+.
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 4678999999999999999999985 57899998643321 1111123458899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..|+|||||+||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 77 ~--------------~~~ivmE~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl 137 (316)
T d1fota_ 77 Q--------------QIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 137 (316)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred C--------------eeeeEeeecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE
Confidence 6 67999999999999999876 3568999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+|+...... ....||+.|||||++.+ ..|+.++|||||||++|+
T Consensus 138 ~~~-------g~vkL~DFG~a~~~~~~~-------------~~~~Gt~~Y~APE~l~~----~~y~~~~DiwSlGvilye 193 (316)
T d1fota_ 138 DKN-------GHIKITDFGFAKYVPDVT-------------YTLCGTPDYIAPEVVST----KPYNKSIDWWSFGILIYE 193 (316)
T ss_dssp CTT-------SCEEECCCSSCEECSSCB-------------CCCCSCTTTCCHHHHTT----CCBCTTHHHHHHHHHHHH
T ss_pred cCC-------CCEEEecCccceEecccc-------------ccccCcccccCHHHHcC----CCCCchhhccccchhHHH
Confidence 987 789999999997654321 13479999999999975 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP- 1116 (1137)
|+||+.||.+.+..++...+..+.... +. ..++++.+++.+||+.||.+||
T Consensus 194 mltG~~Pf~~~~~~~~~~~i~~~~~~~-p~---------------------------~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 194 MLAGYTPFYDSNTMKTYEKILNAELRF-PP---------------------------FFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHCCCCC-CT---------------------------TSCHHHHHHHHHHTCSCTTTCTT
T ss_pred HHhCCCCCCCcCHHHHHHHHHcCCCCC-CC---------------------------CCCHHHHHHHHHHhhhCHHhccc
Confidence 999999999999888888886654321 11 2345689999999999999996
Q ss_pred ----CHHHHHHHHHhhc
Q 001152 1117 ----TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 ----Sa~EVL~~L~~~~ 1129 (1137)
|++|+++|+|++.
T Consensus 246 ~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 246 NLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp SSTTTTHHHHTSGGGSS
T ss_pred cchhhHHHHHcCccccc
Confidence 9999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=412.33 Aligned_cols=255 Identities=21% Similarity=0.349 Sum_probs=202.3
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.+.||+|+||+||+|++.+ ..||||+. +..... .++ +.+|++++++++|||||+++|++.+.+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i--~~~~~~---~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~~- 73 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMS---EED----FIEEAEVMMKLSHPKLVQLYGVCLEQA- 73 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEEC--CSSSSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEE--CCCcCc---HHH----HHHHHHHHHhcCCCCcccccceeccCC-
Confidence 3579999999999999999999964 66888874 332222 223 388999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.+++.. ....+++..+..|+.||+.||+|||+++|+||||||+|||++.
T Consensus 74 -------------~~~lv~E~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~ 136 (263)
T d1sm2a_ 74 -------------PICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136 (263)
T ss_dssp -------------SCEEEEECCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG
T ss_pred -------------ceEEEEEecCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecC
Confidence 45999999999999999875 2356899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 137 ~-------~~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~----~~~~~k~DVwS~Gvil~el~ 196 (263)
T d1sm2a_ 137 N-------QVIKVSDFGMTRFVLDDQYT---------SSTGTKFPVKWASPEVFSF----SRYSSKSDVWSFGVLMWEVF 196 (263)
T ss_dssp G-------GCEEECSCC---------------------------CTTSCCHHHHTT----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCeEecccchheeccCCCce---------eecceecCcccCChHHhcC----CCCCchhhhcchHHHHHHHH
Confidence 8 78999999999765432211 1123468999999999975 56899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
| |.+||...+..++...+..+..+..+. .+++++.+|+.+||+.||++|||+
T Consensus 197 t~~~~~~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~~p~~Rps~ 249 (263)
T d1sm2a_ 197 SEGKIPYENRSNSEVVEDISTGFRLYKPR---------------------------LASTHVYQIMNHCWKERPEDRPAF 249 (263)
T ss_dssp TTSCCTTCSCCHHHHHHHHHHTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCCCHHHHHHHHHhcCCCCCcc---------------------------ccCHHHHHHHHHHccCCHhHCcCH
Confidence 9 577777778888888887765443321 334569999999999999999999
Q ss_pred HHHHHHHHhhc
Q 001152 1119 GDLYEMFVART 1129 (1137)
Q Consensus 1119 ~EVL~~L~~~~ 1129 (1137)
+||+++|....
T Consensus 250 ~~il~~L~~i~ 260 (263)
T d1sm2a_ 250 SRLLRQLAEIA 260 (263)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=421.51 Aligned_cols=284 Identities=22% Similarity=0.224 Sum_probs=207.0
Q ss_pred EeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 806 SCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 806 l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
..++||+|+||+||+|++. ++.||||+........ ..+.+..++.+|+.+|++++|||||++++++.+++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~----- 73 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS----- 73 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhh---hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-----
Confidence 4689999999999999984 5679999754332211 11223345689999999999999999999998776
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
+.|+||||+.++++..+... ...+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 74 ---------~~~ivmE~~~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~--- 136 (299)
T d1ua2a_ 74 ---------NISLVFDFMETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN--- 136 (299)
T ss_dssp ---------CCEEEEECCSEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---
T ss_pred ---------ceeehhhhhcchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC---
Confidence 45999999987766655432 4579999999999999999999999999999999999999987
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTLQV 1043 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG~~ 1043 (1137)
+.+||+|||+++....... .....+||+.|+|||++.+ ...|+.++|||||||++|||+||..
T Consensus 137 ----~~~KL~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 137 ----GVLKLADFGLAKSFGSPNR----------AYTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp ----CCEEECCCGGGSTTTSCCC----------CCCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ----CccccccCccccccCCCcc----------cccceecChhhccHHHHcc---CCCCChhhhhhhcchHHHHHHhCcC
Confidence 7899999999976543221 1224579999999999874 2468999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 001152 1044 PYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLYE 1123 (1137)
Q Consensus 1044 Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~ 1123 (1137)
||.+.+..+....+...........+...........................++++.+|+.+||+.||++||||+|+++
T Consensus 200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 99998888877776432211111111100000000000000111111111245678999999999999999999999999
Q ss_pred HHHhhcCC
Q 001152 1124 MFVARTSS 1131 (1137)
Q Consensus 1124 ~L~~~~~s 1131 (1137)
|+|++..+
T Consensus 280 Hp~f~~~p 287 (299)
T d1ua2a_ 280 MKYFSNRP 287 (299)
T ss_dssp SGGGTSSS
T ss_pred CHhhCCCC
Confidence 99998654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=421.14 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=215.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+++|++.+.||+|+||+||+|.+. +..||+|+...+ ..+.. .+.+|+++|+.++|||||++++++.+.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-----~~~~~----~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQV----LVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHH----HHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-----cccHH----HHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 578999999999999999999985 567888885433 12222 2478999999999999999999998776
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
+.|+|||||+||+|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+|||++
T Consensus 75 --------------~~~lvmE~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~ 136 (321)
T d1tkia_ 75 --------------ELVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp --------------EEEEEECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------EEEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeec
Confidence 67999999999999999864 234699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+. ...+||+|||+++........ ....+|+.|+|||.+.+ ..|+.++|||||||++|+|
T Consensus 137 ~~~-----~~~ikl~DFG~~~~~~~~~~~-----------~~~~~t~~y~ape~~~~----~~~~~~~DiWSlGvily~l 196 (321)
T d1tkia_ 137 TRR-----SSTIKIIEFGQARQLKPGDNF-----------RLLFTAPEYYAPEVHQH----DVVSTATDMWSLGTLVYVL 196 (321)
T ss_dssp SSS-----CCCEEECCCTTCEECCTTCEE-----------EEEESCGGGSCHHHHTT----CEECHHHHHHHHHHHHHHH
T ss_pred CCC-----ceEEEEcccchhhccccCCcc-----------cccccccccccchhccC----CCCCchhhcccHHHHHHHH
Confidence 652 267999999999765432211 13468999999999875 5688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
++|..||.+.+..++...|..+........+ ...++++.+|+.+||+.||.+|||+
T Consensus 197 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dp~~R~s~ 252 (321)
T d1tkia_ 197 LSGINPFLAETNQQIIENIMNAEYTFDEEAF------------------------KEISIEAMDFVDRLLVKERKSRMTA 252 (321)
T ss_dssp HHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH------------------------TTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCChhhc------------------------cCCCHHHHHHHHHHccCChhHCcCH
Confidence 9999999999998888888765533221111 1345669999999999999999999
Q ss_pred HHHHHHHHhhcC
Q 001152 1119 GDLYEMFVARTS 1130 (1137)
Q Consensus 1119 ~EVL~~L~~~~~ 1130 (1137)
+|+++|+|+...
T Consensus 253 ~eil~hp~~~~~ 264 (321)
T d1tkia_ 253 SEALQHPWLKQK 264 (321)
T ss_dssp HHHHHSHHHHSC
T ss_pred HHHhcCHhhccC
Confidence 999999999743
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=412.07 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=205.9
Q ss_pred CCceEee-eecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEec
Q 001152 802 PSLSSCD-EAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKIS 876 (1137)
Q Consensus 802 ~~y~l~~-~LG~GsfG~Vy~a~~~~----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~ 876 (1137)
++|.+.+ +||+|+||+||+|.+.. ..||||+.+ .. ......+. +.+|+++|++++|||||++++++.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~--~~-~~~~~~~~----~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK--QG-TEKADTEE----MMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEEC--SS-CCHHHHHH----HHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEC--hh-cCHHHHHH----HHHHHHHHHhCCCCCEeeEeeeecc
Confidence 3467777 49999999999998742 357777643 22 22333444 4899999999999999999999864
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
+ ..|+||||+++|+|.+++.. ....+++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 81 ~---------------~~~lvmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nil 141 (285)
T d1u59a_ 81 E---------------ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 141 (285)
T ss_dssp S---------------SEEEEEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred C---------------eEEEEEEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhee
Confidence 3 35999999999999998754 2346999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+ +.+||+|||+++......... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 142 l~~~-------~~~Kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwS~Gv~l~ 203 (285)
T d1u59a_ 142 LVNR-------HYAKISDFGLSKALGADDSYY-------TARSAGKWPLKWYAPECINF----RKFSSRSDVWSYGVTMW 203 (285)
T ss_dssp EEET-------TEEEECCCTTCEECTTCSCEE-------CCCCSSCCCGGGCCHHHHHH----CEECHHHHHHHHHHHHH
T ss_pred eccC-------Cceeeccchhhhccccccccc-------ccccccccCccccChHHHhC----CCCCccchhhcchHHHH
Confidence 9987 789999999998765432211 11123468999999999976 46889999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1037 ELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1037 ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
||+| |+.||.+.+..++...+..+.++..+. .+++++.+|+.+||+.||++|
T Consensus 204 E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~~p~~R 256 (285)
T d1u59a_ 204 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---------------------------ECPPELYALMSDCWIYKWEDR 256 (285)
T ss_dssp HHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------cCCHHHHHHHHHHcCCCHhHC
Confidence 9998 899999988888888888777654432 345569999999999999999
Q ss_pred CCHHHHHHHHH
Q 001152 1116 PTAGDLYEMFV 1126 (1137)
Q Consensus 1116 PSa~EVL~~L~ 1126 (1137)
|||.+|++.|.
T Consensus 257 Ps~~~i~~~L~ 267 (285)
T d1u59a_ 257 PDFLTVEQRMR 267 (285)
T ss_dssp CCHHHHHHHHH
T ss_pred cCHHHHHHHHH
Confidence 99999965543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=404.65 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=211.8
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.++|++.++||+|+||+||+|++.+ ..||||+.+.. .... +++ ++|+.++++++|||||+++|++.+++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~---~~~----~~Ev~~~~~l~HpnIv~~~g~~~~~~- 72 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSE---DEF----IEEAKVMMNLSHEKLVQLYGVCTKQR- 72 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCH---HHH----HHHHHHHHTCCCTTBCCEEEEECCSS-
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCH---HHH----HHHHHHHHhcCCCceeeEEEEEeeCC-
Confidence 3578899999999999999999964 57999985432 2212 233 88999999999999999999998765
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|..++... ...+++..+.+|+.||++||+|||++||+||||||+|||++.
T Consensus 73 -------------~~~iv~Ey~~~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~ 135 (258)
T d1k2pa_ 73 -------------PIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 135 (258)
T ss_dssp -------------SEEEEEECCTTEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT
T ss_pred -------------ceEEEEEccCCCcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC
Confidence 579999999999999997652 346899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~DfG~a~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~----~~~~~ksDiwS~G~~l~el~ 195 (258)
T d1k2pa_ 136 Q-------GVVKVSDFGLSRYVLDDEYT---------SSVGSKFPVRWSPPEVLMY----SKFSSKSDIWAFGVLMWEIY 195 (258)
T ss_dssp T-------CCEEECCCSSCCBCSSSSCC---------CCCCSCCCGGGCCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CcEEECcchhheeccCCCce---------eecccCCCCCcCCcHHhcC----CCCCcceeecccchhhHhHH
Confidence 7 78999999999765432211 1123468999999999986 56899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
| |+.||.+.+..++...+..+.++..+. .+++++.+|+.+||+.||++|||+
T Consensus 196 t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPt~ 248 (258)
T d1k2pa_ 196 SLGKMPYERFTNSETAEHIAQGLRLYRPH---------------------------LASEKVYTIMYSCWHEKADERPTF 248 (258)
T ss_dssp TTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred hcCCCCCCCCCHHHHHHHHHhCCCCCCcc---------------------------cccHHHHHHHHHHccCCHhHCcCH
Confidence 8 899999999999888887766544332 334569999999999999999999
Q ss_pred HHHHHHHHh
Q 001152 1119 GDLYEMFVA 1127 (1137)
Q Consensus 1119 ~EVL~~L~~ 1127 (1137)
+||++||..
T Consensus 249 ~eil~~L~d 257 (258)
T d1k2pa_ 249 KILLSNILD 257 (258)
T ss_dssp HHHHHHHHC
T ss_pred HHHHHHhhC
Confidence 999999854
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=407.51 Aligned_cols=245 Identities=21% Similarity=0.342 Sum_probs=198.5
Q ss_pred eeecccCceEEEEEEECC----ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCCCC
Q 001152 808 DEAGKSVSSSLFRCKFGS----ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLPSA 883 (1137)
Q Consensus 808 ~~LG~GsfG~Vy~a~~~~----~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~~~ 883 (1137)
++||+|+||+||+|.+.. ..||||+.+.. .......+ ++.+|+.+|++++|||||++++++..+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~----~~~~E~~il~~l~HpnIv~~~g~~~~~------ 80 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKD----ELLAEANVMQQLDNPYIVRMIGICEAE------ 80 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHH----HHHHHHHHHHTCCCTTBCCEEEEEESS------
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChh--hCCHHHHH----HHHHHHHHHHhCCCCCCceEEEEeccC------
Confidence 479999999999998732 45888875322 22222223 358999999999999999999998643
Q ss_pred CCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccccc
Q 001152 884 DGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLERKK 963 (1137)
Q Consensus 884 ~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~~~ 963 (1137)
..+|||||+++|+|.++++. ...+++..+..|+.||+.||+|||+++|+||||||+|||++.+
T Consensus 81 ---------~~~lvmE~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~--- 143 (277)
T d1xbba_ 81 ---------SWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ--- 143 (277)
T ss_dssp ---------SEEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---
T ss_pred ---------CEEEEEEcCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc---
Confidence 35899999999999999876 3469999999999999999999999999999999999999988
Q ss_pred CCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 001152 964 ADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT-LQ 1042 (1137)
Q Consensus 964 ~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT-G~ 1042 (1137)
+.+||+|||+++......... .......||+.|+|||++.+ ..++.++|||||||++|||+| |+
T Consensus 144 ----~~~kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~y~APE~l~~----~~~~~~sDiwS~Gv~l~ellt~g~ 208 (277)
T d1xbba_ 144 ----HYAKISDFGLSKALRADENYY-------KAQTHGKWPVKWYAPECINY----YKFSSKSDVWSFGVLMWEAFSYGQ 208 (277)
T ss_dssp ----TEEEECCCTTCEECCTTCSEE-------EC----CCCGGGCCHHHHHH----CEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ----Ccccccchhhhhhcccccccc-------ccccccCCCceecCchhhcC----CCCCchhhhccchhhhhHHhhCCC
Confidence 789999999998654332111 11123468999999999976 568899999999999999998 89
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 001152 1043 VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGDLY 1122 (1137)
Q Consensus 1043 ~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL 1122 (1137)
.||.+.+..++...+..+.++..+. .+++++.+|+.+||+.||++|||+++|+
T Consensus 209 ~Pf~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~~~~li~~cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 209 KPYRGMKGSEVTAMLEKGERMGCPA---------------------------GCPREMYDLMNLCWTYDVENRPGFAAVE 261 (277)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 9999988888888888776554432 3445699999999999999999999995
Q ss_pred H
Q 001152 1123 E 1123 (1137)
Q Consensus 1123 ~ 1123 (1137)
+
T Consensus 262 ~ 262 (277)
T d1xbba_ 262 L 262 (277)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-45 Score=421.69 Aligned_cols=254 Identities=24% Similarity=0.289 Sum_probs=213.6
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
.+++|++.+.||+|+||+||+|++. +..||||+...... .......++.+|+.+|+.++|||||++++++.+.
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHHcCCCcEeecccccccc
Confidence 4689999999999999999999985 57899998543211 1111123458999999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
. ..++||||+.+|+|..++... ..+++..++.|+.||+.||.|||++|||||||||+|||+
T Consensus 114 ~--------------~~~~v~e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl 174 (350)
T d1rdqe_ 114 S--------------NLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174 (350)
T ss_dssp S--------------EEEEEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred c--------------ccccccccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc
Confidence 6 679999999999999998762 469999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+|+...... ....||+.|||||++.+ ..++.++|||||||++||
T Consensus 175 ~~~-------g~ikL~DFG~a~~~~~~~-------------~~~~Gt~~Y~APE~~~~----~~~~~~~DiwSlGvilye 230 (350)
T d1rdqe_ 175 DQQ-------GYIQVTDFGFAKRVKGRT-------------WTLCGTPEALAPEIILS----KGYNKAVDWWALGVLIYE 230 (350)
T ss_dssp CTT-------SCEEECCCTTCEECSSCB-------------CCCEECGGGCCHHHHTT----CCBCTHHHHHHHHHHHHH
T ss_pred CCC-------CCEEeeeceeeeeccccc-------------ccccCccccCCHHHHcC----CCCCccccccchhHHHHH
Confidence 887 789999999998654321 13469999999999976 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP- 1116 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP- 1116 (1137)
|+||+.||.+.+...+...+..+.... +. ..++++.+|+.+||+.||.+|+
T Consensus 231 mltG~~Pf~~~~~~~~~~~i~~~~~~~-p~---------------------------~~s~~~~~li~~~L~~dP~kR~~ 282 (350)
T d1rdqe_ 231 MAAGYPPFFADQPIQIYEKIVSGKVRF-PS---------------------------HFSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCC-CT---------------------------TCCHHHHHHHHHHSCSCTTTCTT
T ss_pred HHhCCCCCCCcCHHHHHHHHhcCCCCC-Cc---------------------------cCCHHHHHHHHHHhhhCHHhccc
Confidence 999999999988888888886654321 11 3345699999999999999994
Q ss_pred ----CHHHHHHHHHhhc
Q 001152 1117 ----TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 ----Sa~EVL~~L~~~~ 1129 (1137)
|++|+++|+||+.
T Consensus 283 ~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 283 NLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp SSTTTTHHHHTSGGGTT
T ss_pred cccccHHHHHcCccccC
Confidence 9999999999964
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=406.28 Aligned_cols=260 Identities=21% Similarity=0.340 Sum_probs=202.7
Q ss_pred CCCceEeeeecccCceEEEEEEECC------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeE
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHK 874 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~ 874 (1137)
...|++.++||+|+||+||+|.+.. ..||||+.. ... ......+ +++|+.+|++++|||||+++|++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~--~~~-~~~~~~~----~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK--AGY-TEKQRVD----FLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEEC--TTC-CHHHHHH----HHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEEC--ccc-ChHHHHH----HHHHHHHHHhcCCCCEeeeeEEE
Confidence 4568999999999999999999743 246777643 222 2333333 48999999999999999999999
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
.+.. ..++||||+.++++.+++.. ....+++..+..|+.||+.||+|||+++|+||||||+|
T Consensus 79 ~~~~--------------~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~N 140 (283)
T d1mqba_ 79 SKYK--------------PMMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN 140 (283)
T ss_dssp CSSS--------------SEEEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ecCC--------------ceEEEEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccccccccCccccce
Confidence 8765 56999999999999998865 23569999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
|||+.+ +.+||+|||+++......... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 141 ILl~~~-------~~~Kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~----~~~~~~sDI~S~Gvi 202 (283)
T d1mqba_ 141 ILVNSN-------LVCKVSDFGLSRVLEDDPEAT-------YTTSGGKIPIRWTAPEAISY----RKFTSASDVWSFGIV 202 (283)
T ss_dssp EEECTT-------CCEEECCCCC------------------------CCCGGGSCHHHHHS----CCCCHHHHHHHHHHH
T ss_pred EEECCC-------CeEEEcccchhhcccCCCccc-------eEeccCCCCccccCHHHHcc----CCCCCcccccccHHH
Confidence 999987 789999999998654322111 11123468999999999875 578999999999999
Q ss_pred HHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1035 LLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1035 L~ELLTG-~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
+|||+++ .+|+......++...+..+.++..+. .+++++.+|+.+||+.||+
T Consensus 203 l~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~~p~ 255 (283)
T d1mqba_ 203 MWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM---------------------------DCPSAIYQLMMQCWQQERA 255 (283)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---------------------------TCBHHHHHHHHHHTCSSTT
T ss_pred HHHHHhCCCCccccCCHHHHHHHHhccCCCCCch---------------------------hhHHHHHHHHHHHCcCCHh
Confidence 9999995 55566677777888887766544332 3445699999999999999
Q ss_pred CCCCHHHHHHHHHhhcC
Q 001152 1114 ERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~ 1130 (1137)
+||||.||++.|.....
T Consensus 256 ~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 256 RRPKFADIVSILDKLIR 272 (283)
T ss_dssp TSCCHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHhh
Confidence 99999999998876543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-45 Score=408.34 Aligned_cols=256 Identities=22% Similarity=0.393 Sum_probs=207.9
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
...+|++.++||+|+||+||+|++. +..||||+. +.... ..++ +.+|+++|++++|||||++++++.+.
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i--~~~~~---~~~~----~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTM---EVEE----FLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEEC--CTTCS---CHHH----HHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEE--CCccc---hHHH----HHHHHHHHHhCCCCCEecCCccEeeC
Confidence 3467999999999999999999985 456888863 33222 2233 48899999999999999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..++||||+++|+|.+++.. .....+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 86 ~--------------~~~iv~E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl 148 (287)
T d1opja_ 86 P--------------PFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 148 (287)
T ss_dssp S--------------SCEEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C--------------eeEEEeecccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE
Confidence 5 45999999999999999976 334579999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+|+......... .....||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 149 ~~~-------~~~Kl~DFG~a~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~----~~~~~k~DiwS~Gv~l~e 208 (287)
T d1opja_ 149 GEN-------HLVKVADFGLSRLMTGDTYTA---------HAGAKFPIKWTAPESLAY----NKFSIKSDVWAFGVLLWE 208 (287)
T ss_dssp CGG-------GCEEECCCCCTTTCCSSSSEE---------ETTEEECGGGCCHHHHHH----CCCSHHHHHHHHHHHHHH
T ss_pred CCC-------CcEEEccccceeecCCCCcee---------eccccccccccChHHHcC----CCCCchhhhhhHHHHHHH
Confidence 988 789999999998654432111 113358899999999886 568999999999999999
Q ss_pred HHhCCCC-CCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1038 LLTLQVP-YMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1038 LLTG~~P-f~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
|++|..| |.+.+..++...+..+..+..+. .+++++.+|+.+||+.||++||
T Consensus 209 ll~~~~p~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rp 261 (287)
T d1opja_ 209 IATYGMSPYPGIDLSQVYELLEKDYRMERPE---------------------------GCPEKVYELMRACWQWNPSDRP 261 (287)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhCCCCCCCcchHHHHHHHHhcCCCCCCCc---------------------------cchHHHHHHHHHHcCCCHhHCc
Confidence 9996555 55566666776666655443332 3445699999999999999999
Q ss_pred CHHHHHHHHHhh
Q 001152 1117 TAGDLYEMFVAR 1128 (1137)
Q Consensus 1117 Sa~EVL~~L~~~ 1128 (1137)
|++||++.+...
T Consensus 262 s~~ei~~~L~~~ 273 (287)
T d1opja_ 262 SFAEIHQAFETM 273 (287)
T ss_dssp CHHHHHHHHHHT
T ss_pred CHHHHHHHHHHH
Confidence 999999987654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=408.21 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=205.1
Q ss_pred CCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
..+|++.++||+|+||+||+|++.+ +.||||+.. ..... .+. +.+|+.+|++++|||||++++++.++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~--~~~~~---~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~-- 80 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMS---PDA----FLAEANLMKQLQHQRLVRLYAVVTQE-- 80 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEEC--TTSSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEc--cCcCC---HHH----HHHHHHHHHhCCCCCEeEEEeeeccC--
Confidence 4679999999999999999999965 679999753 22221 223 48899999999999999999987543
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
..++||||+++|+|.+++.... ...+++..++.|+.||++||+|||+++|+||||||+||||+.
T Consensus 81 -------------~~~iv~Ey~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~ 144 (272)
T d1qpca_ 81 -------------PIYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 144 (272)
T ss_dssp -------------SCEEEEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred -------------CeEEEEEeCCCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeec
Confidence 3489999999999999875422 235899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+|+........ ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 145 ~-------~~~Kl~DFGla~~~~~~~~~---------~~~~~~gt~~y~APE~~~~----~~~~~~sDvwS~Gvvl~ell 204 (272)
T d1qpca_ 145 T-------LSCKIADFGLARLIEDNEYT---------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIV 204 (272)
T ss_dssp T-------SCEEECCCTTCEECSSSCEE---------CCTTCCCCTTTSCHHHHHH----CEECHHHHHHHHHHHHHHHH
T ss_pred c-------cceeeccccceEEccCCccc---------cccccCCcccccChHHHhC----CCCCchhhhhhhHHHHHHHH
Confidence 7 78999999999866432211 1123468999999999976 46889999999999999999
Q ss_pred hC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG-~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
|| .+||......++...+..+..+..+. .+++++.+|+.+||+.||++|||+
T Consensus 205 t~~~~~~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~cl~~~P~~Rpt~ 257 (272)
T d1qpca_ 205 THGRIPYPGMTNPEVIQNLERGYRMVRPD---------------------------NCPEELYQLMRLCWKERPEDRPTF 257 (272)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCCCcc---------------------------cChHHHHHHHHHHcCCCHhHCcCH
Confidence 95 55666777777888887765544332 344569999999999999999999
Q ss_pred HHHHHHHH
Q 001152 1119 GDLYEMFV 1126 (1137)
Q Consensus 1119 ~EVL~~L~ 1126 (1137)
+||++.|.
T Consensus 258 ~ei~~~L~ 265 (272)
T d1qpca_ 258 DYLRSVLE 265 (272)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 99998553
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=418.06 Aligned_cols=259 Identities=25% Similarity=0.330 Sum_probs=201.0
Q ss_pred CCCceEeeeecccCceEEEEEEECCc-------cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGSA-------DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~~-------~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
.++|++.++||+|+||+||+|++.+. .||+|+.. .... .... ..+.+|+.+|.++ +|||||++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~--~~~~-~~~~----~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--EKAD-SSER----EALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEEC--C-------C----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEec--cccC-HHHH----HHHHHHHHHHHHhcCCCcEeEEEE
Confidence 35799999999999999999997431 35666532 2111 1122 2348899999998 7999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc------------------CCCCCCHHHHHHHHHHHH
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET------------------GEKHVSVKLALFIAQDVA 934 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~------------------~~~~ls~~~i~~I~~QIa 934 (1137)
++.+.+ ..++|||||++|+|.++++..... ....+++..++.|+.||+
T Consensus 109 ~~~~~~--------------~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 174 (325)
T d1rjba_ 109 ACTLSG--------------PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 174 (325)
T ss_dssp EECSSS--------------SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHH
T ss_pred EEeeCC--------------eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHH
Confidence 998766 459999999999999999763211 123589999999999999
Q ss_pred HHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhc
Q 001152 935 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014 (1137)
Q Consensus 935 ~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1014 (1137)
.||+|||+++||||||||+|||++.+ +.+||+|||+|+......... ......||+.|||||++.
T Consensus 175 ~gl~yLH~~~IiHRDlKp~Nill~~~-------~~~Kl~DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~l~ 239 (325)
T d1rjba_ 175 KGMEFLEFKSCVHRDLAARNVLVTHG-------KVVKICDFGLARDIMSDSNYV--------VRGNARLPVKWMAPESLF 239 (325)
T ss_dssp HHHHHHHHTTEEETTCSGGGEEEETT-------TEEEECCCGGGSCGGGCTTSE--------EETTEEECGGGCCHHHHH
T ss_pred HHHHHHHhCCeeeccCchhccccccC-------CeEEEeeccccccccCCCcee--------eeccccCCCccCChHHHc
Confidence 99999999999999999999999987 889999999997654432110 112346899999999987
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchh
Q 001152 1015 AMHKPNLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEA 1092 (1137)
Q Consensus 1015 ~~~~~~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el-~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1137)
+ ..++.++|||||||++|||+| |..||.+.+..+. ...+..+.++..+.
T Consensus 240 ~----~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~------------------------- 290 (325)
T d1rjba_ 240 E----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF------------------------- 290 (325)
T ss_dssp H----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCT-------------------------
T ss_pred C----CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCC-------------------------
Confidence 6 578999999999999999998 8999987655443 44444444332221
Q ss_pred hhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 001152 1093 ELETLSFLVDVFRRCTEENPTERPTAGDLYEMFV 1126 (1137)
Q Consensus 1093 ~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~ 1126 (1137)
.+++++.+||.+||+.||++|||++||++||.
T Consensus 291 --~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 291 --YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 34566999999999999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-45 Score=423.24 Aligned_cols=262 Identities=20% Similarity=0.257 Sum_probs=203.9
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
++++|++.+.||+|+||+||+|++. +..||+|+....... ....+....+..+|+.+++.++|||||++++++.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~--~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcc--hhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 5789999999999999999999985 577899985432110 111111111113457778888899999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..|+|||||+||+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||+
T Consensus 80 ~--------------~~~ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl 140 (364)
T d1omwa3 80 D--------------KLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 140 (364)
T ss_dssp S--------------EEEEEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred C--------------EEEEEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE
Confidence 6 67999999999999999976 2468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+|+...... .....||+.|+|||++.. ...|+.++|||||||++||
T Consensus 141 ~~~-------g~iKl~DFGla~~~~~~~------------~~~~~GT~~y~APE~~~~---~~~~~~~~DiwSlGvilye 198 (364)
T d1omwa3 141 DEH-------GHVRISDLGLACDFSKKK------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFK 198 (364)
T ss_dssp CSS-------SCEEECCCTTCEECSSSC------------CCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHHHH
T ss_pred cCC-------CcEEEeeeceeeecCCCc------------ccccccccccchhHHhhc---CCCCCcccchhHHHHHHHH
Confidence 987 789999999997654321 123479999999999864 2468999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|+||+.||.+....+.............. .....++++.+||.+||+.||.+|||
T Consensus 199 mltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t 253 (364)
T d1omwa3 199 LLRGHSPFRQHKTKDKHEIDRMTLTMAVE-------------------------LPDSFSPELRSLLEGLLQRDVNRRLG 253 (364)
T ss_dssp HHHSSCSSCSSCSSCHHHHHHHSSSCCCC-------------------------CCSSSCHHHHHHHHHHTCSSTTTSTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHhcccCCCC-------------------------CCCCCCHHHHHHHHHHcccCHHHhCC
Confidence 99999999865433332222221111000 00134566999999999999999999
Q ss_pred -----HHHHHHHHHhhc
Q 001152 1118 -----AGDLYEMFVART 1129 (1137)
Q Consensus 1118 -----a~EVL~~L~~~~ 1129 (1137)
|+|+++|+|++.
T Consensus 254 ~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 254 CLGRGAQEVKESPFFRS 270 (364)
T ss_dssp TSSSTHHHHHTSGGGTT
T ss_pred CcccCHHHHHcCccccC
Confidence 899999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=414.07 Aligned_cols=256 Identities=27% Similarity=0.356 Sum_probs=210.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHH-hCCCCCcceeeeeEecC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLG-ALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~-~L~HpNIVkllg~~~~~ 877 (1137)
+++|++.+.||+|+||+||+|++. ++.||||+........ ....+ .+.+|+.++. .++|||||++++++.++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~----~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVE----CTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHH----HHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHH----HHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence 468999999999999999999984 5778888864321100 11112 2366777665 68999999999999987
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
+ ..|+||||+++|+|.++++. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~--------------~~yivmEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~ 136 (320)
T d1xjda_ 76 E--------------NLFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136 (320)
T ss_dssp S--------------EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred C--------------ceeEEEeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee
Confidence 6 67999999999999999976 2468999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++....... ......||+.|+|||++.+ ..|+.++|||||||++|+
T Consensus 137 ~~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvilye 195 (320)
T d1xjda_ 137 DKD-------GHIKIADFGMCKENMLGDA----------KTNTFCGTPDYIAPEILLG----QKYNHSVDWWSFGVLLYE 195 (320)
T ss_dssp CTT-------SCEEECCCTTCBCCCCTTC----------CBCCCCSCGGGCCHHHHTT----CCBCTHHHHHHHHHHHHH
T ss_pred cCC-------Cceeccccchhhhcccccc----------cccccCCCCCcCCHHHHcC----CCCCchhhhhhhhHHHHH
Confidence 987 7899999999975543221 1123479999999999986 578999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
|++|+.||.+.+..++...+..+.. .++. ..++++.+|+.+||+.||.+|||
T Consensus 196 mltG~~PF~~~~~~~~~~~i~~~~~-~~p~---------------------------~~s~~~~dli~~~L~~dP~~R~s 247 (320)
T d1xjda_ 196 MLIGQSPFHGQDEEELFHSIRMDNP-FYPR---------------------------WLEKEAKDLLVKLFVREPEKRLG 247 (320)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCC-CCCT---------------------------TSCHHHHHHHHHHSCSSGGGSBT
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCC-CCCc---------------------------cCCHHHHHHHHHhcccCCCCCcC
Confidence 9999999999999888888866542 2221 33456999999999999999999
Q ss_pred HH-HHHHHHHhhc
Q 001152 1118 AG-DLYEMFVART 1129 (1137)
Q Consensus 1118 a~-EVL~~L~~~~ 1129 (1137)
+. |+++|+|++.
T Consensus 248 ~~~~l~~hpff~~ 260 (320)
T d1xjda_ 248 VRGDIRQHPLFRE 260 (320)
T ss_dssp TBSCGGGSGGGTT
T ss_pred HHHHHHhCchhcc
Confidence 95 8999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=401.75 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=201.1
Q ss_pred CCceEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~---~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
++|++.+.||+|+||.||+|++.. ..++||++.++... .....+. +.+|+.+|++++|||||++++++.+ +
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~----~~~E~~~l~~l~HpnIv~l~~~~~~-~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREK----FLQEALTMRQFDHPHIVKLIGVITE-N 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHH----HHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHH----HHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 579999999999999999999843 34566665554322 2333333 4899999999999999999999864 2
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++|+|.+++.. ....+++..++.++.||++||+|||+++|+||||||+||+++
T Consensus 81 --------------~~~iv~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~ 142 (273)
T d1mp8a_ 81 --------------PVWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 142 (273)
T ss_dssp --------------SCEEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred --------------eEEEEEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec
Confidence 35999999999999998765 234689999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 143 ~~-------~~~Kl~DfG~a~~~~~~~~~---------~~~~~~gt~~y~apE~l~~----~~~~~~~DiwSlGvil~e~ 202 (273)
T d1mp8a_ 143 SN-------DCVKLGDFGLSRYMEDSTYY---------KASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCMWEI 202 (273)
T ss_dssp ET-------TEEEECC----------------------------CCGGGCCHHHHHH----CCCSHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEccchhheeccCCcce---------eccceecCcccchhhHhcc----CCCCCccccccchHHHHHH
Confidence 88 78999999999765432211 1123468999999999986 5789999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
+| |.+||.+.+..++...+..+..+.++. .+++++.+||.+||+.||++|||
T Consensus 203 lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~dp~~Rps 255 (273)
T d1mp8a_ 203 LMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------------------NCPPTLYSLMTKCWAYDPSRRPR 255 (273)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------------CCCHHHHHHHHHHcCCCHhHCcC
Confidence 98 899999988888888887776544332 34556999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001152 1118 AGDLYEMFVAR 1128 (1137)
Q Consensus 1118 a~EVL~~L~~~ 1128 (1137)
++||+++|...
T Consensus 256 ~~ei~~~L~~i 266 (273)
T d1mp8a_ 256 FTELKAQLSTI 266 (273)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-44 Score=397.26 Aligned_cols=265 Identities=24% Similarity=0.283 Sum_probs=203.1
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.+.||+|+||+||+|++. ++.||+|+....... ..... .++.+|+.+|+.++|||||++++++...+.
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~----~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFY----LRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-CHHHH----HHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHH----HHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 46999999999999999999985 578899985433221 12222 345899999999999999999999886541
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
.....|+||||++|++|.+++.. ...+++.+++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 82 ----------~~~~~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~ 146 (277)
T d1o6ya_ 82 ----------AGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 146 (277)
T ss_dssp ----------SSEEEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred ----------CCceEEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc
Confidence 12257999999999999998876 246999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.++++|||.+......... .......+||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 147 ~-------~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~~DiwSlGvilyell 208 (277)
T d1o6ya_ 147 T-------NAVKVMDFGIARAIADSGNS-------VTQTAAVIGTAQYLSPEQARG----DSVDARSDVYSLGCVLYEVL 208 (277)
T ss_dssp T-------SCEEECCCTTCEECC-----------------------TTCCHHHHTT----CCCCHHHHHHHHHHHHHHHH
T ss_pred c-------ccceeehhhhhhhhcccccc-------ccccccccCcccccCHHHHcC----CCCCcceecccchHHHHHHH
Confidence 8 78999999988654432211 011234579999999999875 56899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC-CH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP-TA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP-Sa 1118 (1137)
||+.||.+.+..++...+........... ....++++.++|.+||+.||.+|| |+
T Consensus 209 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~s~~l~~li~~~L~~dp~~R~~sa 264 (277)
T d1o6ya_ 209 TGEPPFTGDSPVSVAYQHVREDPIPPSAR------------------------HEGLSADLDAVVLKALAKNPENRYQTA 264 (277)
T ss_dssp HSSCSCCCSSHHHHHHHHHHCCCCCGGGT------------------------SSSCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred hCCCCCCCcCHHHHHHHHHhcCCCCCchh------------------------ccCCCHHHHHHHHHHccCCHhHCHhHH
Confidence 99999999888877766654432211100 014456799999999999999999 78
Q ss_pred HHHHHHHHhh
Q 001152 1119 GDLYEMFVAR 1128 (1137)
Q Consensus 1119 ~EVL~~L~~~ 1128 (1137)
+++++.+...
T Consensus 265 ~~l~~~l~r~ 274 (277)
T d1o6ya_ 265 AEMRADLVRV 274 (277)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 8887776543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=405.67 Aligned_cols=255 Identities=19% Similarity=0.319 Sum_probs=204.5
Q ss_pred CCceEeeeecccCceEEEEEEECC--c----cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGS--A----DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~--~----~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
.+|++.++||+|+||+||+|.+.. + .||+|.. +... .....+ .+.+|+.+|++++|||||++++++.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~--~~~~-~~~~~~----~~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REAT-SPKANK----EILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEE--CC-----CTHH----HHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEe--cccc-CHHHHH----HHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 579999999999999999999853 2 3555543 2211 112223 3489999999999999999999998
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+. ..++||||+.+|+|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 82 ~~---------------~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NI 142 (317)
T d1xkka_ 82 TS---------------TVQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142 (317)
T ss_dssp SS---------------SEEEEEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred cC---------------CeeEEEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcc
Confidence 64 34889999999999998875 235799999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++
T Consensus 143 ll~~~-------~~~kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~----~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 143 LVKTP-------QHVKITDFGLAKLLGAEEKE--------YHAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVTV 203 (317)
T ss_dssp EEEET-------TEEEECCCSHHHHTTTTCC----------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHH
T ss_pred eeCCC-------CCeEeeccccceeccccccc--------ccccccccCccccChHHHhc----CCCChhhhhhhHHHHH
Confidence 99988 78999999999865432211 11123468999999999986 5689999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1036 LELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1036 ~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
|||+| |..||.+.+..++...+..+.++..+. .+++++.+|+.+||+.||.+
T Consensus 204 ~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~~~~li~~cl~~dP~~ 256 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASEISSILEKGERLPQPP---------------------------ICTIDVYMIMVKCWMIDADS 256 (317)
T ss_dssp HHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT---------------------------TBCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------ccCHHHHHHHHHhCCCChhh
Confidence 99998 899999888888888887766544332 34456999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001152 1115 RPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~ 1128 (1137)
|||+.||+++++..
T Consensus 257 RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 257 RPKFRELIIEFSKM 270 (317)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=404.42 Aligned_cols=265 Identities=25% Similarity=0.412 Sum_probs=212.0
Q ss_pred CCCCCCCCceEeeeecccCceEEEEEEECC--ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 796 LDPGSFPSLSSCDEAGKSVSSSLFRCKFGS--ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 796 ~~~~~~~~y~l~~~LG~GsfG~Vy~a~~~~--~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
.+..++++|++.++||+|+||+||+|++.+ ..++|||+.+..... ....+. +.+|+++|+++ +|||||++++
T Consensus 4 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~----~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRD----FAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CH----HHHHHHHHTTCCCCTTBCCEEE
T ss_pred CCccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHH----HHHHHHHHHhccCCCCEeeEEE
Confidence 345678899999999999999999999843 445566655443222 222333 48999999999 6999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhh-----------hcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLS-----------ETGEKHVSVKLALFIAQDVAAALVELH 941 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~-----------~~~~~~ls~~~i~~I~~QIa~gL~yLH 941 (1137)
++.+.+ ..++||||+++|+|.++++... ......+++..+..++.||+.||.|||
T Consensus 79 ~~~~~~--------------~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH 144 (309)
T d1fvra_ 79 ACEHRG--------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144 (309)
T ss_dssp EEEETT--------------EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCC--------------eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh
Confidence 998766 6799999999999999997521 122357999999999999999999999
Q ss_pred hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001152 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 942 s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1021 (1137)
+++|+||||||+|||++.+ +.+||+|||+++........ ....||..|+|||.+.+ ..
T Consensus 145 ~~~iiHrDlkp~NIL~~~~-------~~~kl~DfG~a~~~~~~~~~-----------~~~~gt~~y~aPE~l~~----~~ 202 (309)
T d1fvra_ 145 QKQFIHRDLAARNILVGEN-------YVAKIADFGLSRGQEVYVKK-----------TMGRLPVRWMAIESLNY----SV 202 (309)
T ss_dssp HTTEECSCCSGGGEEECGG-------GCEEECCTTCEESSCEECCC---------------CCTTTCCHHHHHH----CE
T ss_pred cCCccccccccceEEEcCC-------CceEEccccccccccccccc-----------cceecCCcccchHHhcc----CC
Confidence 9999999999999999988 78999999999754432211 13468999999999976 56
Q ss_pred CCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFL 1100 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLTG~-~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 1100 (1137)
++.++|||||||++|||++|. +||.+.+..++...+..+.++..+. .+++++
T Consensus 203 ~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~ 255 (309)
T d1fvra_ 203 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL---------------------------NCDDEV 255 (309)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCT---------------------------TBCHHH
T ss_pred CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCc---------------------------cCCHHH
Confidence 899999999999999999964 6788888888888877665544332 345569
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1101 VDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1101 ~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
.+|+.+||+.||++||||+||+++|...
T Consensus 256 ~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 256 YDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=400.31 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=205.5
Q ss_pred CCCCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+..+|++.++||+|+||.||+|++.++.||||+.+ .. ...+. +.+|++++++++|||||+++|++.+..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~--~~----~~~~~----~~~E~~~l~~l~HpnIv~~~g~~~~~~- 73 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--ND----ATAQA----FLAEASVMTQLRHSNLVQLLGVIVEEK- 73 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECC--CC----C--HH----HHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEEC--cH----HHHHH----HHHHHHHHHhCCCCCEeeEEEEEEecC-
Confidence 45679999999999999999999999999999743 21 12233 378999999999999999999986532
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
...++||||+++|+|.+++.... ...+++..+++|+.||+.||+|||+++|+||||||+|||++.
T Consensus 74 ------------~~~~lv~ey~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~ 138 (262)
T d1byga_ 74 ------------GGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 138 (262)
T ss_dssp -------------CCEEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred ------------CcEEEEEeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecC
Confidence 14599999999999999997632 235899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 139 ~-------~~~kl~dfg~s~~~~~~~-------------~~~~~~~~y~aPE~l~~----~~~t~~sDIwSfG~il~el~ 194 (262)
T d1byga_ 139 D-------NVAKVSDFGLTKEASSTQ-------------DTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIY 194 (262)
T ss_dssp T-------SCEEECCCCC-------------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHHH
T ss_pred C-------CCEeecccccceecCCCC-------------ccccccccCCChHHHhC----CCCChHHHHHhHHHHHHHHH
Confidence 8 789999999987544321 12358889999999986 56899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 T-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 T-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
| |.+||......++...+..+.++.++. ..++++.+|+.+||+.||.+||||
T Consensus 195 t~~~~p~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~li~~cl~~dP~~Rps~ 247 (262)
T d1byga_ 195 SFGRVPYPRIPLKDVVPRVEKGYKMDAPD---------------------------GCPPAVYEVMKNCWHLDAAMRPSF 247 (262)
T ss_dssp TTSCCSCTTSCGGGHHHHHTTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cCCHHHHHHHHHHcccCHhHCcCH
Confidence 8 799998888888888887766555432 234569999999999999999999
Q ss_pred HHHHHHHHhh
Q 001152 1119 GDLYEMFVAR 1128 (1137)
Q Consensus 1119 ~EVL~~L~~~ 1128 (1137)
.+|+++|...
T Consensus 248 ~~l~~~L~~i 257 (262)
T d1byga_ 248 LQLREQLEHI 257 (262)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-44 Score=401.53 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=211.7
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH 873 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~ 873 (1137)
-++|++.+.||+|+||+||+|++.+ +.||||+.. .. ......+ ++.+|+.+|++++||||++++++
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~--~~-~~~~~~~----~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EE-ASADMQA----DFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECC--TT-CCHHHHH----HHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEC--hh-cChHHHH----HHHHHHHHHHhcCCCCcccceee
Confidence 3469999999999999999999743 468888643 22 1233333 34899999999999999999999
Q ss_pred EecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------------------cCCCCCCHHHHHHHHHHHH
Q 001152 874 KISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------------TGEKHVSVKLALFIAQDVA 934 (1137)
Q Consensus 874 ~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-------------------~~~~~ls~~~i~~I~~QIa 934 (1137)
+.... ..++||||+++|+|.++++.... .....+++..++.|+.||+
T Consensus 85 ~~~~~--------------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 150 (301)
T d1lufa_ 85 CAVGK--------------PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 150 (301)
T ss_dssp ECSSS--------------SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred eccCC--------------ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHH
Confidence 98765 45999999999999999975321 1123589999999999999
Q ss_pred HHHHHHHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhc
Q 001152 935 AALVELHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLR 1014 (1137)
Q Consensus 935 ~gL~yLHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 1014 (1137)
.||+|||+++||||||||+|||++.+ +.+||+|||+++........ .......||+.|+|||.+.
T Consensus 151 ~gl~ylH~~~ivHrDlKp~NILld~~-------~~~Kl~DFGls~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~ 215 (301)
T d1lufa_ 151 AGMAYLSERKFVHRDLATRNCLVGEN-------MVVKIADFGLSRNIYSADYY--------KADGNDAIPIRWMPPESIF 215 (301)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGG-------GCEEECCCSCHHHHTGGGCB--------C----CCBCGGGCCHHHHH
T ss_pred HHhhhcccCCeEeeEEcccceEECCC-------CcEEEccchhheeccCCccc--------cccCCCCcCcCcCCHHHHc
Confidence 99999999999999999999999987 78999999999765433211 1112346889999999998
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhh
Q 001152 1015 AMHKPNLYGLEVDIWSYGCLLLELLTLQ-VPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAE 1093 (1137)
Q Consensus 1015 ~~~~~~~~s~ksDVWSLGviL~ELLTG~-~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1137)
+ ..|+.++|||||||++|||++|. +||.+.+..++...+..+..+..+.
T Consensus 216 ~----~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~-------------------------- 265 (301)
T d1lufa_ 216 Y----NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE-------------------------- 265 (301)
T ss_dssp H----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT--------------------------
T ss_pred c----CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCc--------------------------
Confidence 6 57899999999999999999985 6899889999888888776554332
Q ss_pred hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1094 LETLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1094 ~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
.+++++.+|+.+||+.||++||||.||++.|..+.
T Consensus 266 -~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 266 -NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 34456999999999999999999999999988653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=399.73 Aligned_cols=284 Identities=18% Similarity=0.255 Sum_probs=209.8
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+++|++.++||+|+||+||+|++. ++.||||+...... .. ....++.+|+.+|++++|||||++++++.+..
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~----~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TE----GVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--Ch----HHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 468999999999999999999985 57799998643321 11 11234588999999999999999999998766
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
+.|+||||+. +++.+++.. .....+++..+..|+.||+.||+|||++|||||||||+|||++
T Consensus 75 --------------~~~iv~e~~~-~~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~ 136 (298)
T d1gz8a_ 75 --------------KLYLVFEFLH-QDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 136 (298)
T ss_dssp --------------EEEEEEECCS-EEHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred --------------ceeEEEeecC-Cchhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec
Confidence 6799999997 556555543 2335699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+|+....... ......||+.|+|||++.. ...++.++|||||||++|+|
T Consensus 137 ~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~gt~~y~apE~~~~---~~~~~~~~DiwSlGvily~m 196 (298)
T d1gz8a_ 137 TE-------GAIKLADFGLARAFGVPVR----------TYTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEM 196 (298)
T ss_dssp TT-------SCEEECSTTHHHHHCCCSB----------CTTCCBCCCTTCCHHHHTT---CSSCCTHHHHHHHHHHHHHH
T ss_pred cc-------CcceeccCCcceeccCCcc----------cceeecccceeeehhhhcc---ccCCCccccccccchhhhHH
Confidence 77 7899999999976543221 1224479999999999875 24568999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcC--CCCCchh-HHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMG--KRPRLTD-ELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g--~~p~l~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
++|+.||.+.+..+....+... ....... ........ .... ...............++++.+|+.+||+.||.+|
T Consensus 197 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 274 (298)
T d1gz8a_ 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY-KPSF-PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 274 (298)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC-CTTS-CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTS
T ss_pred hhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc-cccc-ccccccchhhhccCCCHHHHHHHHHHccCChhHC
Confidence 9999999988877766655322 2111111 01100000 0000 0000000111122456789999999999999999
Q ss_pred CCHHHHHHHHHhhcC
Q 001152 1116 PTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~~ 1130 (1137)
||++|+++|+|++.-
T Consensus 275 ~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 275 ISAKAALAHPFFQDV 289 (298)
T ss_dssp CCHHHHHTSGGGTTC
T ss_pred cCHHHHhCCHhhccC
Confidence 999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-44 Score=399.25 Aligned_cols=283 Identities=19% Similarity=0.214 Sum_probs=208.4
Q ss_pred CCCceEeeeecccCceEEEEEEEC-CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
+++|++.++||+|+||+||+|++. +..||||+...+... . ....++.+|+.+|++++|||||++++++...+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 73 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--E----GIPSTTIREISILKELKHSNIVKLYDVIHTKK- 73 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG--G----CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC--h----HHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-
Confidence 468999999999999999999985 478999986443221 1 11234588999999999999999999999776
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
+.++||||+.++.+..+.+. ...+++..+..|+.||+.||+|||++|||||||||+|||++.
T Consensus 74 -------------~~~i~~e~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~ 135 (286)
T d1ob3a_ 74 -------------RLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (286)
T ss_dssp -------------CEEEEEECCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred -------------ceeEEEEeehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC
Confidence 56999999986655555433 357999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||.+......... .....+++.|+|||.+.+ ...++.++|||||||++|||+
T Consensus 136 ~-------~~~kl~DfG~a~~~~~~~~~----------~~~~~~~~~y~~pE~~~~---~~~~~~~~DiwslGv~l~el~ 195 (286)
T d1ob3a_ 136 E-------GELKIADFGLARAFGIPVRK----------YTHEIVTLWYRAPDVLMG---SKKYSTTIDIWSVGCIFAEMV 195 (286)
T ss_dssp T-------SCEEECCTTHHHHHCC-------------------CCCTTCCHHHHTT---CCSCCTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEecccccceecccCccc----------cceecccchhhhHHHHhC---CCCCCcceeehhcCcHHHHHH
Confidence 7 78999999998765432211 123468999999999875 356789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccc-ccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHE-HEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+|+.||.+.+..+....+...........+........ ...................++++.+|+.+||+.||++|||+
T Consensus 196 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~ 275 (286)
T d1ob3a_ 196 NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (286)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence 99999998887777666533211111100110000000 00000001111111223456789999999999999999999
Q ss_pred HHHHHHHHhh
Q 001152 1119 GDLYEMFVAR 1128 (1137)
Q Consensus 1119 ~EVL~~L~~~ 1128 (1137)
+|+++|+|++
T Consensus 276 ~ell~Hp~f~ 285 (286)
T d1ob3a_ 276 KQALEHAYFK 285 (286)
T ss_dssp HHHHTSGGGG
T ss_pred HHHhcCcccC
Confidence 9999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=410.67 Aligned_cols=264 Identities=23% Similarity=0.246 Sum_probs=201.7
Q ss_pred CCCceEee-eecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeeeeEec
Q 001152 801 FPSLSSCD-EAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYGHKIS 876 (1137)
Q Consensus 801 ~~~y~l~~-~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg~~~~ 876 (1137)
+++|++.. .||+|+||+||+|++. +..||||+.... +. +.+|+.++.++ +|||||+++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~----~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PK----ARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HH----HHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 57898875 5999999999999984 577899875311 12 36799987655 79999999999875
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
... ....+|+|||||+||+|.+++.+ .+...+++.+++.|+.||+.||+|||++||+||||||+|||
T Consensus 77 ~~~----------~~~~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIl 143 (335)
T d2ozaa1 77 LYA----------GRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 143 (335)
T ss_dssp EET----------TEEEEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred ccc----------CCCEEEEEEECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccc
Confidence 210 11268999999999999999975 33457999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+. ..+.+||+|||+|+....... .....||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 144 l~~~~----~~~~~Kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~----~~y~~~~DiwSlGvily 204 (335)
T d2ozaa1 144 YTSKR----PNAILKLTDFGFAKETTSHNS-----------LTTPCYTPYYVAPEVLGP----EKYDKSCDMWSLGVIMY 204 (335)
T ss_dssp ESCSS----TTCCEEECCCTTCEECCCCCC-----------CCCCSCCCSSCCCCCCCG----GGGSHHHHHHHHHHHHH
T ss_pred ccccc----ccccccccccceeeeccCCCc-----------cccccCCcccCCcHHHcC----CCCCHHHHHHhhchhHH
Confidence 98642 236799999999976543221 124479999999999876 46889999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCc-hhhhhhHHHHHHHHHHhcccCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKP-EAELETLSFLVDVFRRCTEENPTE 1114 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~L~dLl~~CL~~DP~~ 1114 (1137)
+|+||+.||.+.+..+....+.... ... ...+ ......++++.+||.+||+.||++
T Consensus 205 ~lltg~~Pf~~~~~~~~~~~~~~~i~~~~----------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 262 (335)
T d2ozaa1 205 ILLCGYPPFYSNHGLAISPGMKTRIRMGQ----------------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 262 (335)
T ss_dssp HHTTSSCSCEETTCC--------CCCSCS----------------------SSCCTTHHHHSCHHHHHHHHHHSCSSTTT
T ss_pred HHhhCCCCCCCCCHHHHHHHHHHHHhcCC----------------------CCCCCcccccCCHHHHHHHHHHccCChhH
Confidence 9999999998755443333332111 000 0001 111256678999999999999999
Q ss_pred CCCHHHHHHHHHhhcCC
Q 001152 1115 RPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1115 RPSa~EVL~~L~~~~~s 1131 (1137)
|||+.|+++|+|+....
T Consensus 263 R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 263 RMTITEFMNHPWIMQST 279 (335)
T ss_dssp SCCHHHHHHSHHHHTTT
T ss_pred CcCHHHHHcCHHhhCCC
Confidence 99999999999997543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=400.07 Aligned_cols=286 Identities=21% Similarity=0.207 Sum_probs=207.3
Q ss_pred CCceEeeeecccCceEEEEEEEC---CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC---CCCCcceeeeeEe
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG---SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL---RHSCIVEMYGHKI 875 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~---~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L---~HpNIVkllg~~~ 875 (1137)
.+|++.++||+|+||+||+|++. ++.||||+...+..... ... ++.+|+.+|+.+ +|||||++++++.
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~~----~~~~E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPL----STIREVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBC----THHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--HHH----HHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence 57999999999999999999984 34589998654432211 111 225677776665 7999999999986
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
.... ....+.++||||++++.+...... ....+++..++.++.||+.||+|||++|||||||||+||
T Consensus 81 ~~~~---------~~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NI 147 (305)
T d1blxa_ 81 VSRT---------DRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 147 (305)
T ss_dssp EEEC---------SSEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred cccc---------ccCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEE
Confidence 5321 112378999999987666544332 345699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||+++........ ....||+.|+|||++.+ ..|+.++||||+||++
T Consensus 148 Li~~~-------~~~kl~dfg~~~~~~~~~~~-----------~~~~gT~~Y~APE~~~~----~~y~~~~DiwSlG~il 205 (305)
T d1blxa_ 148 LVTSS-------GQIKLADFGLARIYSFQMAL-----------TSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCIF 205 (305)
T ss_dssp EECTT-------CCEEECSCCSCCCCCGGGGG-----------CCCCCCCTTCCHHHHTT----CCCCTHHHHHHHHHHH
T ss_pred EEcCC-------CCeeecchhhhhhhcccccC-----------CCcccChhhcCcchhcC----CCCChhehhhchHHHH
Confidence 99987 78999999998754432211 24579999999999976 5789999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1036 LELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1036 ~ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
|||++|+.||.+.+..+....+...........+........... ...............++.+.+|+.+||+.||++|
T Consensus 206 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 284 (305)
T d1blxa_ 206 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 284 (305)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS-CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhh-ccccccchhhccccCCHHHHHHHHHHCcCChhHC
Confidence 999999999999888877776643221111111111000000000 0000111111122456779999999999999999
Q ss_pred CCHHHHHHHHHhhc
Q 001152 1116 PTAGDLYEMFVART 1129 (1137)
Q Consensus 1116 PSa~EVL~~L~~~~ 1129 (1137)
|||+|+++|+|++.
T Consensus 285 ~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 285 ISAYSALSHPYFQD 298 (305)
T ss_dssp CCHHHHHTSGGGTT
T ss_pred cCHHHHhcChhhcC
Confidence 99999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=397.94 Aligned_cols=252 Identities=22% Similarity=0.247 Sum_probs=198.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC--CCCcceeeeeEecC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR--HSCIVEMYGHKISS 877 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~--HpNIVkllg~~~~~ 877 (1137)
++|++.+.||+|+||+||+|++. +..||||+.......... ... ...++.+|+.+|++++ |||||++++++.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-~~~-~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG-ELP-NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEE-ECT-TCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchh-hhh-HHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 47999999999999999999985 577899986543322111 000 0112367999999997 99999999999876
Q ss_pred CCCCCCCCCCccccceEEEEEeeccC-CCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeE
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKG-GSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENIL 956 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~g-gSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NIL 956 (1137)
+ ..++||||+.+ +++.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus 82 ~--------------~~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIl 142 (273)
T d1xwsa_ 82 D--------------SFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 142 (273)
T ss_dssp S--------------EEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred C--------------eEEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceE
Confidence 6 67999999976 588888865 246999999999999999999999999999999999999
Q ss_pred eccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHH
Q 001152 957 IDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLL 1036 (1137)
Q Consensus 957 ld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ 1036 (1137)
++.+. +.+||+|||+|+...... .....||+.|+|||++.+. ..++.++|||||||++|
T Consensus 143 l~~~~------~~vkl~DFG~a~~~~~~~------------~~~~~GT~~y~aPE~~~~~---~~~~~~~DiwSlGvily 201 (273)
T d1xwsa_ 143 IDLNR------GELKLIDFGSGALLKDTV------------YTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLY 201 (273)
T ss_dssp EETTT------TEEEECCCTTCEECCSSC------------BCCCCSCGGGSCHHHHHHS---CBCHHHHHHHHHHHHHH
T ss_pred EecCC------CeEEECccccceeccccc------------ccccccCCCcCCHHHHcCC---CCCCcccccccceeeeh
Confidence 98552 689999999997543321 1235799999999999762 34578899999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1037 ELLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1037 ELLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
||+||+.||.+.+ .+..+... ++ ...++++.+|+.+||+.||++||
T Consensus 202 ell~g~~Pf~~~~------~i~~~~~~-~~---------------------------~~~s~~~~~li~~~L~~dp~~R~ 247 (273)
T d1xwsa_ 202 DMVCGDIPFEHDE------EIIRGQVF-FR---------------------------QRVSSECQHLIRWCLALRPSDRP 247 (273)
T ss_dssp HHHHSSCSCCSHH------HHHHCCCC-CS---------------------------SCCCHHHHHHHHHHTCSSGGGSC
T ss_pred hHhhCCCCCCCch------HHhhcccC-CC---------------------------CCCCHHHHHHHHHHccCCHhHCc
Confidence 9999999997521 22222210 00 03455699999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
|++|+++|+|++.
T Consensus 248 s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 248 TFEEIQNHPWMQD 260 (273)
T ss_dssp CHHHHHTSGGGSS
T ss_pred CHHHHhcCHhhCC
Confidence 9999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=393.80 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=201.2
Q ss_pred CCCCceEeeeecccCceEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+..+|++.+.||+|+||+||+|++.+ ..||||+.. ..... .+. +.+|+.+|++++|||||++++++.++
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~--~~~~~---~~~----~~~E~~~l~~l~h~nIv~~~g~~~~~- 84 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMS---PEA----FLQEAQVMKKLRHEKLVQLYAVVSEE- 84 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECC--TTSSC---HHH----HHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEEC--cccCC---HHH----HHHHHHHHHhcccCCEeEEEEEEecC-
Confidence 45789999999999999999999965 568888743 32222 223 38899999999999999999998543
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+++|+|..++.... ...+++.+++.|+.||+.||+|||++||+||||||+||||+
T Consensus 85 --------------~~~lv~Ey~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~ 147 (285)
T d1fmka3 85 --------------PIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 147 (285)
T ss_dssp --------------SCEEEECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred --------------CeEEEEEecCCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC
Confidence 3489999999999999886521 23599999999999999999999999999999999999999
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||+++........ ......||+.|+|||++.. ..++.++|||||||++|||
T Consensus 148 ~~-------~~~kl~DfGla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~S~Giil~el 207 (285)
T d1fmka3 148 EN-------LVCKVADFGLARLIEDNEYT---------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTEL 207 (285)
T ss_dssp GG-------GCEEECCCCTTC-----------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHH
T ss_pred CC-------CcEEEcccchhhhccCCCce---------eeccccccccccChHHHhC----CCCCcHHhhhcchHHHHHH
Confidence 88 78999999999765432211 1123468999999999976 5688999999999999999
Q ss_pred HhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCC
Q 001152 1039 LTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPT 1117 (1137)
Q Consensus 1039 LTG-~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPS 1117 (1137)
++| .+|+.+....++...+..+..+..+. .+++++.+|+.+||+.||++|||
T Consensus 208 ~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dP~~Rps 260 (285)
T d1fmka3 208 TTKGRVPYPGMVNREVLDQVERGYRMPCPP---------------------------ECPESLHDLMCQCWRKEPEERPT 260 (285)
T ss_dssp HTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHhcCCCCCCc---------------------------ccCHHHHHHHHHHcccCHhHCcC
Confidence 996 55556677777888777665443332 34556999999999999999999
Q ss_pred HHHHHHHHHh
Q 001152 1118 AGDLYEMFVA 1127 (1137)
Q Consensus 1118 a~EVL~~L~~ 1127 (1137)
+++|++.+..
T Consensus 261 ~~~i~~~L~~ 270 (285)
T d1fmka3 261 FEYLQAFLED 270 (285)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHhh
Confidence 9999986643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=395.53 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=197.2
Q ss_pred CCCceEeeeecccCceEEEEEEECC-------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS-------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~-------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
.++|++.++||+|+||.||+|++.+ +.||||+. +... ...+.+. +.+|+.++.++ +|+|||.+++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l--~~~~-~~~~~~~----~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGA-THSEHRA----LMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHH----HHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEE--cccc-CcHHHHH----HHHHHHHHHhhcCCCeEEEeee
Confidence 3579999999999999999999732 35777763 2221 2333333 37788888777 5899999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSET-----------GEKHVSVKLALFIAQDVAAALVELH 941 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~-----------~~~~ls~~~i~~I~~QIa~gL~yLH 941 (1137)
++...+. ..++|||||++|+|.++++..... ....+++..++.|+.||++||+|||
T Consensus 85 ~~~~~~~-------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH 151 (299)
T d1ywna1 85 ACTKPGG-------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 151 (299)
T ss_dssp EECSTTS-------------CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH
T ss_pred eeccCCC-------------eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH
Confidence 8765431 469999999999999999763221 1235899999999999999999999
Q ss_pred hCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCC
Q 001152 942 SKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNL 1021 (1137)
Q Consensus 942 s~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 1021 (1137)
+++||||||||+|||++.+ +.+||+|||+|+........ .......||+.|+|||++.+ ..
T Consensus 152 ~~~ivHrDlKp~NILl~~~-------~~~Kl~DFGla~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~----~~ 212 (299)
T d1ywna1 152 SRKCIHRDLAARNILLSEK-------NVVKICDFGLARDIYKDPDY--------VRKGDARLPLKWMAPETIFD----RV 212 (299)
T ss_dssp HTTCCCSCCCGGGEEECGG-------GCEEECC------CCSCTTS--------CCTTSCCCGGGGCCHHHHHH----CC
T ss_pred hCCCcCCcCCccceeECCC-------CcEEEccCcchhhccccccc--------cccCceeeCccccchhHhhc----CC
Confidence 9999999999999999988 78999999999765432211 11224579999999999986 57
Q ss_pred CCchhhHHHHHHHHHHHHhC-CCCCCCCCH-HHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHH
Q 001152 1022 YGLEVDIWSYGCLLLELLTL-QVPYMGLSE-LEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSF 1099 (1137)
Q Consensus 1022 ~s~ksDVWSLGviL~ELLTG-~~Pf~~~~~-~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1137)
++.++|||||||++|||+|| ..||.+... ..+...+..+..+..+. .++++
T Consensus 213 ~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~ 265 (299)
T d1ywna1 213 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD---------------------------YTTPE 265 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT---------------------------TCCHH
T ss_pred CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCc---------------------------cCCHH
Confidence 89999999999999999997 567876543 34455556655444332 33456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1100 LVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1100 L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+.+++.+||+.||++|||++||++||...
T Consensus 266 l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 266 MYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999999754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=391.49 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=197.9
Q ss_pred CCCceEeeeecccCceEEEEEEECC---c--cEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEe
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS---A--DAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKI 875 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~---~--~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~ 875 (1137)
..+|++.+.||+|+||.||+|++.. . .||||+...... ......+ ++.+|+.+|++++|||||+++|++.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~----~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMD----DFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHH----HHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHH----HHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3579999999999999999998732 2 456665322211 1122223 3589999999999999999999996
Q ss_pred cCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCe
Q 001152 876 SSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENI 955 (1137)
Q Consensus 876 ~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NI 955 (1137)
+. ..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 82 ~~---------------~~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NI 142 (273)
T d1u46a_ 82 TP---------------PMKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 142 (273)
T ss_dssp SS---------------SCEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred ec---------------chheeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHh
Confidence 53 348999999999999987652 24699999999999999999999999999999999999
Q ss_pred EeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHH
Q 001152 956 LIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLL 1035 (1137)
Q Consensus 956 Lld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL 1035 (1137)
|++.+ +.+||+|||+++......... .......||+.|+|||++.+ ..++.++|||||||++
T Consensus 143 ll~~~-------~~vkl~DfGl~~~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~S~Gvil 204 (273)
T d1u46a_ 143 LLATR-------DLVKIGDFGLMRALPQNDDHY-------VMQEHRKVPFAWCAPESLKT----RTFSHASDTWMFGVTL 204 (273)
T ss_dssp EEEET-------TEEEECCCTTCEECCC-CCEE-------EC-----CCGGGCCHHHHHH----CEEEHHHHHHHHHHHH
T ss_pred ccccc-------cceeeccchhhhhcccCCCcc-------eecCccccCcccCCHHHHhC----CCCCcchhhhhhHHHH
Confidence 99988 789999999998764432211 11123457889999999986 5688999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCC
Q 001152 1036 LELLT-LQVPYMGLSELEIHDLIQMGK-RPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1036 ~ELLT-G~~Pf~~~~~~el~~~I~~g~-~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
|||+| |..||.+.+..++...+.... .+..+. .+++++.+|+.+||+.||+
T Consensus 205 ~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~~l~~li~~cl~~dp~ 257 (273)
T d1u46a_ 205 WEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE---------------------------DCPQDIYNVMVQCWAHKPE 257 (273)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred HHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcc---------------------------cccHHHHHHHHHHcCCChh
Confidence 99998 899999999988888875443 222111 3455699999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 001152 1114 ERPTAGDLYEMFVA 1127 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~ 1127 (1137)
+||||+||++.|..
T Consensus 258 ~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 258 DRPTFVALRDFLLE 271 (273)
T ss_dssp GSCCHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHh
Confidence 99999999987764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=394.72 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=207.4
Q ss_pred CCCceEeeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCccee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEM 870 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~~---------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkl 870 (1137)
.++|++.+.||+|+||.||+|++.+ ..||||+. +... ......++ .+|+..+.++ +|||||++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~--~~~~-~~~~~~~~----~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDA-TEKDLSDL----ISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECC--CTTC-CHHHHHHH----HHHHHHHHHHCCCTTBCCE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEE--Cccc-ChHHHHHH----HHHHHHHHHhcCCCeEEec
Confidence 4689999999999999999998632 24677653 3222 23333333 7898999888 79999999
Q ss_pred eeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----------cCCCCCCHHHHHHHHHHHHHHHHH
Q 001152 871 YGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----------TGEKHVSVKLALFIAQDVAAALVE 939 (1137)
Q Consensus 871 lg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-----------~~~~~ls~~~i~~I~~QIa~gL~y 939 (1137)
++++.+++ ..++||||+++|+|.+++..... .....+++.+++.|+.||+.||+|
T Consensus 85 ~~~~~~~~--------------~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~y 150 (299)
T d1fgka_ 85 LGACTQDG--------------PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150 (299)
T ss_dssp EEEECSSS--------------SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccCC--------------eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 99998766 45999999999999999975321 123468999999999999999999
Q ss_pred HHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 940 LHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
||+++||||||||+|||++.+ +.+||+|||+++........ .......+|+.|+|||.+.+
T Consensus 151 lH~~~ivHrDiKp~NiLl~~~-------~~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~---- 211 (299)
T d1fgka_ 151 LASKKCIHRDLAARNVLVTED-------NVMKIADFGLARDIHHIDYY--------KKTTNGRLPVKWMAPEALFD---- 211 (299)
T ss_dssp HHHTTCCCSCCSGGGEEECTT-------CCEEECSTTCCCCGGGCCTT--------CCCTTSCCGGGGSCHHHHHH----
T ss_pred hhhCCEEeeeecccceeecCC-------CCeEeccchhhccccccccc--------cccccCCCChhhhhhhHhcC----
Confidence 999999999999999999988 78999999999866543211 11224568999999999976
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHH
Q 001152 1020 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLS 1098 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1137)
..|+.++|||||||++|||++ |.+||.+....++...+..+..+..+. .+++
T Consensus 212 ~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~ 264 (299)
T d1fgka_ 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS---------------------------NCTN 264 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS---------------------------SCCH
T ss_pred CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCc---------------------------cchH
Confidence 578999999999999999998 799999888888888887766554332 3345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1099 FLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1099 ~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
++.+|+.+||+.||.+||||.||++.|....
T Consensus 265 ~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 265 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 6999999999999999999999999997653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-43 Score=399.29 Aligned_cols=285 Identities=22% Similarity=0.217 Sum_probs=206.0
Q ss_pred CceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCC
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~ 880 (1137)
+|+..++||+|+||+||+|++. ++.||||+...+.. .. .+|+++|++++|||||+++++|......
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~----~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FK----NRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SC----CHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HH----HHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 6999999999999999999985 56788987543321 11 4699999999999999999998754311
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEeccc
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLE 960 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~ 960 (1137)
....+++||||||+++ +...+.... .....+++..++.|+.||+.||+|||++||+||||||+|||++.+
T Consensus 89 --------~~~~~~~lv~Ey~~~~-~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~ 158 (350)
T d1q5ka_ 89 --------KDEVYLNLVLDYVPET-VYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 158 (350)
T ss_dssp --------CSCCEEEEEEECCSEE-HHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT
T ss_pred --------CCceEEEEEEeccCCc-cHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecC
Confidence 1123689999999754 444443322 234579999999999999999999999999999999999999876
Q ss_pred cccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHh
Q 001152 961 RKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLT 1040 (1137)
Q Consensus 961 ~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLT 1040 (1137)
. ..+||+|||+++....... .....||+.|+|||.+.+ ...++.++||||+||++|||++
T Consensus 159 ~------~~~kl~DFG~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~---~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 159 T------AVLKLCDFGSAKQLVRGEP-----------NVSYICSRYYRAPELIFG---ATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp T------CCEEECCCTTCEECCTTSC-----------CCSCCSCTTSCCHHHHTT---CSSCCTHHHHHHHHHHHHHHHH
T ss_pred C------CceeEecccchhhccCCcc-----------cccccccccccChHHhhc---ccCCCcceeecccceEEEehhh
Confidence 2 4799999999876543211 123479999999999875 2468999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccc-ccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHH
Q 001152 1041 LQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSC-HEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAG 1119 (1137)
Q Consensus 1041 G~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~ 1119 (1137)
|..||...+..+....+...........+...... ......+..............++++.+|+.+||+.||++||||.
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999988877766666432221212122111100 00000000000000001124567799999999999999999999
Q ss_pred HHHHHHHhhc
Q 001152 1120 DLYEMFVART 1129 (1137)
Q Consensus 1120 EVL~~L~~~~ 1129 (1137)
|+++|+|+..
T Consensus 299 e~L~Hp~f~~ 308 (350)
T d1q5ka_ 299 EACAHSFFDE 308 (350)
T ss_dssp HHHTSGGGGG
T ss_pred HHhcCHhhcc
Confidence 9999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-43 Score=398.01 Aligned_cols=284 Identities=19% Similarity=0.234 Sum_probs=206.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|+++++||+|+||+||+|.+. ++.||||++. .........+ ++.+|+.+|++++|||||+++++|...+.
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~--~~~~~~~~~~----~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAK----RAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECS--STTSSHHHHH----HHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEc--hhhcChHHHH----HHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 57999999999999999999985 5778888743 3222333333 34899999999999999999999987552
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ....+.|+||||+ +.+|..+++. ..+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 92 ~--------~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~ 156 (346)
T d1cm8a_ 92 L--------DDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 156 (346)
T ss_dssp T--------TTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c--------cccceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccc
Confidence 2 1223679999999 5788887765 36999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+|++|||+|+...... ....||+.|+|||++.+ ...++.++||||+||++|+|+
T Consensus 157 ~-------~~~kl~Dfg~a~~~~~~~-------------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~ell 213 (346)
T d1cm8a_ 157 D-------CELKILDFGLARQADSEM-------------TGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEMI 213 (346)
T ss_dssp T-------CCEEECCCTTCEECCSSC-------------CSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHHH
T ss_pred c-------cccccccccceeccCCcc-------------ccccccccccCHHHHcC---CCCCCccchhhcchHHHHHHH
Confidence 8 789999999997654321 23469999999999875 246789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|..||.+.+..+....+........................... ............++++.+||.+||+.||.+||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (346)
T d1cm8a_ 214 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293 (346)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc
Confidence 999999988777766555332221111111110000000000000 00011111224567799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
||+|+++|+|+..
T Consensus 294 ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 294 TAGEALAHPYFES 306 (346)
T ss_dssp CHHHHHHSGGGTT
T ss_pred CHHHHhcChhhCc
Confidence 9999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-43 Score=393.35 Aligned_cols=299 Identities=17% Similarity=0.198 Sum_probs=208.2
Q ss_pred CCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecC
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISS 877 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~ 877 (1137)
++++|++.++||+|+||+||+|++. ++.||||+...+... .. ...++.+|+.+|++++||||+++++++...
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~----~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EG----FPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--TS----SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hH----HHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 4789999999999999999999985 577999975433221 11 222347899999999999999999998764
Q ss_pred CCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEe
Q 001152 878 KWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILI 957 (1137)
Q Consensus 878 ~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILl 957 (1137)
..... ....+.|+||||+.++.+..+.. ....+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 82 ~~~~~------~~~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl 150 (318)
T d3blha1 82 ASPYN------RCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 150 (318)
T ss_dssp ---------------CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred ccccc------ccCceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee
Confidence 31100 11226799999998665554432 24579999999999999999999999999999999999999
Q ss_pred ccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHH
Q 001152 958 DLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLE 1037 (1137)
Q Consensus 958 d~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~E 1037 (1137)
+.+ +.+||+|||+++......... .......+||+.|+|||++.+ ...++.++|||||||++||
T Consensus 151 ~~~-------~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~gT~~Y~aPE~~~~---~~~~~~k~DiwSlGvil~e 214 (318)
T d3blha1 151 TRD-------GVLKLADFGLARAFSLAKNSQ------PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDLWGAGCIMAE 214 (318)
T ss_dssp CTT-------SCEEECCCTTCEECCC-----------CCCCCSCCSCGGGCCHHHHTT---CSSCCTHHHHHHHHHHHHH
T ss_pred cCC-------CcEEeeecceeeecccccccc------cccccceecCHHHhhHHHHcC---CCCCCcHHHcccCCceeee
Confidence 987 789999999997654322111 112234579999999999875 2468899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCch----hhhhhHHHHHHHHHHhcccCCC
Q 001152 1038 LLTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPE----AELETLSFLVDVFRRCTEENPT 1113 (1137)
Q Consensus 1038 LLTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~L~dLl~~CL~~DP~ 1113 (1137)
|++|+.||.+.+..+....+........+......................... ......+.+.+||.+||++||+
T Consensus 215 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~ 294 (318)
T d3blha1 215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294 (318)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChh
Confidence 999999999888777666653322111111101000000000000000000000 0123456788999999999999
Q ss_pred CCCCHHHHHHHHHhhcCC
Q 001152 1114 ERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1114 ~RPSa~EVL~~L~~~~~s 1131 (1137)
+||||+|+++|+||+..+
T Consensus 295 ~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 295 QRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp TSCCHHHHHHSGGGSSSS
T ss_pred HCcCHHHHHcChhhccCC
Confidence 999999999999998643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=388.35 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=200.4
Q ss_pred eEeeeecccCceEEEEEEECC---ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 805 SSCDEAGKSVSSSLFRCKFGS---ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 805 ~l~~~LG~GsfG~Vy~a~~~~---~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
.+.++||+|+||+||+|++.. +.++|+|+.++.. ......+.+ .+|+++|++++|||||+++|++.+.+.
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~----~~E~~~l~~l~HpnIv~~~g~~~~~~~-- 102 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSEG-- 102 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHH----HHHHHHHHTCCCTTBCCCCEEEEETTT--
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHH----HHHHHHHHhCCCCCEeEEeEEEEecCC--
Confidence 346789999999999999843 3333444334432 234444444 899999999999999999999875431
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecccc
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDLER 961 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~~~ 961 (1137)
..++|||||++|+|.++++. ....+++..+++|+.||+.||.|||+.+|+||||||+|||++.+
T Consensus 103 -----------~~~lv~E~~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~- 166 (311)
T d1r0pa_ 103 -----------SPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK- 166 (311)
T ss_dssp -----------EEEEEEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-
T ss_pred -----------ceEEEEEEeecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-
Confidence 67999999999999999875 23467889999999999999999999999999999999999877
Q ss_pred ccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHHhC
Q 001152 962 KKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELLTL 1041 (1137)
Q Consensus 962 ~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELLTG 1041 (1137)
+.+||+|||+++......... ........||+.|+|||.+.. ..++.++||||||+++|||+||
T Consensus 167 ------~~~kL~DFG~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDI~SfGivl~El~t~ 230 (311)
T d1r0pa_ 167 ------FTVKVADFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQT----QKFTTKSDVWSFGVLLWELMTR 230 (311)
T ss_dssp ------CCEEECSSGGGCCTTTTTCCC------TTCTTCSSCCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHHTT
T ss_pred ------CCEEEecccchhhcccccccc------ceecccccccccccChHHHhc----CCCCChhHhhhhHHHHHHHHHC
Confidence 789999999998665432211 011223468999999999876 5689999999999999999997
Q ss_pred CCCCCC-CCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCHHH
Q 001152 1042 QVPYMG-LSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTAGD 1120 (1137)
Q Consensus 1042 ~~Pf~~-~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~E 1120 (1137)
..||.. .+..++...+..+.++..+. .+++++.+|+.+||+.||++|||+.|
T Consensus 231 ~~p~~~~~~~~~~~~~i~~g~~~~~p~---------------------------~~~~~l~~li~~cl~~dP~~RPs~~e 283 (311)
T d1r0pa_ 231 GAPPYPDVNTFDITVYLLQGRRLLQPE---------------------------YCPDPLYEVMLKCWHPKAEMRPSFSE 283 (311)
T ss_dssp SCCSCC------CHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCcc---------------------------cCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence 777754 34455666666665543321 33456999999999999999999999
Q ss_pred HHHHHHhhcC
Q 001152 1121 LYEMFVARTS 1130 (1137)
Q Consensus 1121 VL~~L~~~~~ 1130 (1137)
|+++|.....
T Consensus 284 i~~~L~~i~~ 293 (311)
T d1r0pa_ 284 LVSRISAIFS 293 (311)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999887644
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=388.49 Aligned_cols=265 Identities=21% Similarity=0.345 Sum_probs=214.8
Q ss_pred CCCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 800 SFPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 800 ~~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
+.++|++.++||+|+||+||+|.+. ++.||||+. +.. ....+... +.+|+.++++++|||||++++
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~--~~~-~~~~~~~~----~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEA-ASMRERIE----FLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEEC--CTT-SCHHHHHH----HHHHHHHGGGCCCTTBCCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEE--Ccc-cChHHHHH----HHHHHHHHHHcCCCCEeeeee
Confidence 3578999999999999999999874 256888864 322 22333333 489999999999999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-----TGEKHVSVKLALFIAQDVAAALVELHSKHIMH 947 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-----~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIH 947 (1137)
++.... ..++||||+++|+|.+++..... .....+++..+.+|+.||+.||.|||+++|+|
T Consensus 91 ~~~~~~--------------~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivH 156 (308)
T d1p4oa_ 91 VVSQGQ--------------PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156 (308)
T ss_dssp EECSSS--------------SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred EEecCC--------------ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 997665 45999999999999999875321 12235789999999999999999999999999
Q ss_pred ccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhh
Q 001152 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1027 (1137)
Q Consensus 948 rDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1027 (1137)
|||||+|||++.+ +++||+|||+++.......... .....||+.|+|||.+.+ ..++.++|
T Consensus 157 rDlk~~NiLld~~-------~~~Kl~DFGla~~~~~~~~~~~--------~~~~~~t~~y~aPe~l~~----~~~~~~~D 217 (308)
T d1p4oa_ 157 RDLAARNCMVAED-------FTVKIGDFGMTRDIYETDYYRK--------GGKGLLPVRWMSPESLKD----GVFTTYSD 217 (308)
T ss_dssp SCCSGGGEEECTT-------CCEEECCTTCCCGGGGGGCEEG--------GGSSEECGGGCCHHHHHH----CCCCHHHH
T ss_pred ceEcCCceeecCC-------ceEEEeecccceeccCCcceee--------ccceecccccCCHHHHcc----CCCCcccc
Confidence 9999999999987 7899999999986654322111 113358999999999986 56889999
Q ss_pred HHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHH
Q 001152 1028 IWSYGCLLLELLTL-QVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRR 1106 (1137)
Q Consensus 1028 VWSLGviL~ELLTG-~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~ 1106 (1137)
||||||++|||+|| ..||.+.+..++...+..+..+..+. .+++.+.+++.+
T Consensus 218 v~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~---------------------------~~~~~l~~li~~ 270 (308)
T d1p4oa_ 218 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD---------------------------NCPDMLFELMRM 270 (308)
T ss_dssp HHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT---------------------------TCCHHHHHHHHH
T ss_pred cccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcc---------------------------cchHHHHHHHHH
Confidence 99999999999998 58899888888888887766544332 334569999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhcCC
Q 001152 1107 CTEENPTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1107 CL~~DP~~RPSa~EVL~~L~~~~~s 1131 (1137)
||+.||++|||++||+++|.....+
T Consensus 271 cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 271 CWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HcCCChhHCcCHHHHHHHHHHhcCC
Confidence 9999999999999999998776443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=387.68 Aligned_cols=268 Identities=24% Similarity=0.279 Sum_probs=198.1
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~~~ 881 (1137)
.+|.+.++||+|+||.||+|++.+..||||++..+ . .+.+ ...+|+..+..++|||||++++++.+.+.
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~-----~--~~~~--~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-- 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----E--ERSW--FREAEIYQTVMLRHENILGFIAADNKDNG-- 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG-----G--HHHH--HHHHHHHTSTTCCCTTBCCEEEEEEEECS--
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-----c--hhHH--HHHHHHHHHhhCCCCcCcceEEEEEeCCC--
Confidence 35889999999999999999999999999986422 1 1111 11345666678899999999999986431
Q ss_pred CCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCeeeccCCCC
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS--------KHIMHRDIKSE 953 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs--------~gIIHrDLKP~ 953 (1137)
....+|+||||+++|+|.+++++ ..+++..+.+++.|++.||+|||+ +||+||||||+
T Consensus 72 --------~~~~~~lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~ 137 (303)
T d1vjya_ 72 --------TWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp --------SSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGG
T ss_pred --------cceEEEEEEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCcc
Confidence 12368999999999999999986 358999999999999999999996 59999999999
Q ss_pred CeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC--CCCCchhhHHHH
Q 001152 954 NILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP--NLYGLEVDIWSY 1031 (1137)
Q Consensus 954 NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~--~~~s~ksDVWSL 1031 (1137)
||||+.+ +.+||+|||+++.......... .......||+.|+|||++.+.... ..++.++|||||
T Consensus 138 NILl~~~-------~~~Kl~DFGl~~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 138 NILVKKN-------GTCCIADLGLAVRHDSATDTID------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp GEEECTT-------SCEEECCCTTCEEEETTTTEEC------C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred ceEEcCC-------CCeEEEecCccccccCCCccee------ccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence 9999987 7899999999986654322211 112245799999999998752111 125789999999
Q ss_pred HHHHHHHHhCCCCCCCCCH---------------HHHHHHHH-cCCCCCchhHHhhhcccccccccccCCCCCCchhhhh
Q 001152 1032 GCLLLELLTLQVPYMGLSE---------------LEIHDLIQ-MGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELE 1095 (1137)
Q Consensus 1032 GviL~ELLTG~~Pf~~~~~---------------~el~~~I~-~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1137)
||++|||+||..||..... ......+. ...+|.++. ......
T Consensus 205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----------------------~~~~~~ 262 (303)
T d1vjya_ 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN----------------------RWQSCE 262 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG----------------------GGGGCH
T ss_pred HHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCc----------------------ccCChH
Confidence 9999999999887743211 11111111 111111111 111225
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1096 TLSFLVDVFRRCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1096 ~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
....+.+|+.+||+.||++|||+.||+++|....
T Consensus 263 ~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 263 ALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 5677999999999999999999999999987653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=388.86 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=205.5
Q ss_pred CCCceEeeeecccCceEEEEEEEC-------CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhC-CCCCcceeee
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG-------SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGAL-RHSCIVEMYG 872 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~-------~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L-~HpNIVkllg 872 (1137)
..+|++.++||+|+||.||+|++. +..||||+.. ... ...+... +.+|+.+++++ +|||||++++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~--~~~-~~~~~~~----~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSA-HLTEREA----LMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEEC--TTC-CHHHHHH----HHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEEC--ccc-CHHHHHH----HHHHHHHHHhccCCCCEEEEEE
Confidence 367999999999999999999862 2457787643 222 2333333 48899999999 5999999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhh-------------cCCCCCCHHHHHHHHHHHHHHHHH
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSE-------------TGEKHVSVKLALFIAQDVAAALVE 939 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~-------------~~~~~ls~~~i~~I~~QIa~gL~y 939 (1137)
++.+.. ..++|||||++|+|.++++.... .....+++..+..|+.||+.||+|
T Consensus 95 ~~~~~~--------------~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~ 160 (311)
T d1t46a_ 95 ACTIGG--------------PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160 (311)
T ss_dssp EECSSS--------------SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred EEeeCC--------------EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 998765 45999999999999999976321 123368999999999999999999
Q ss_pred HHhCCeeeccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCC
Q 001152 940 LHSKHIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKP 1019 (1137)
Q Consensus 940 LHs~gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 1019 (1137)
||+++||||||||+|||++.+ +.+|++|||.++......... ......||+.|+|||++.+
T Consensus 161 LH~~~ivHrDLKp~NIl~~~~-------~~~ki~DfG~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---- 221 (311)
T d1t46a_ 161 LASKNCIHRDLAARNILLTHG-------RITKICDFGLARDIKNDSNYV--------VKGNARLPVKWMAPESIFN---- 221 (311)
T ss_dssp HHHTTCCCSCCSGGGEEEETT-------TEEEECCCGGGSCTTSCTTSE--------ECSSSEECGGGCCHHHHHH----
T ss_pred HHhCCeeeccccccccccccc-------CcccccccchheeccCCCcce--------EeeecccChHHcCHHHhcC----
Confidence 999999999999999999987 789999999998655432211 1124578999999999986
Q ss_pred CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhH
Q 001152 1020 NLYGLEVDIWSYGCLLLELLT-LQVPYMGLSELEI-HDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETL 1097 (1137)
Q Consensus 1020 ~~~s~ksDVWSLGviL~ELLT-G~~Pf~~~~~~el-~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1137)
..++.++|||||||++|||+| |.+||.+.+..+. ...+..+.++..+. ..+
T Consensus 222 ~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~ 274 (311)
T d1t46a_ 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE---------------------------HAP 274 (311)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCT---------------------------TSC
T ss_pred CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc---------------------------ccc
Confidence 578999999999999999999 6666766555443 44445554443221 334
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 001152 1098 SFLVDVFRRCTEENPTERPTAGDLYEMFVAR 1128 (1137)
Q Consensus 1098 ~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~ 1128 (1137)
+++.+||.+||+.||.+||||+||++.|..+
T Consensus 275 ~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 275 AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 5699999999999999999999999999765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=379.83 Aligned_cols=284 Identities=19% Similarity=0.215 Sum_probs=210.0
Q ss_pred CCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCC
Q 001152 801 FPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSK 878 (1137)
Q Consensus 801 ~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~ 878 (1137)
+.+|++.++||+|+||+||+|++. ++.||||+.+.... .....+ ++.+|+.+|+.++|||||++++++.+..
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~----~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPS----SALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHH----HHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHH----HHHHHHHHHHhcCcCCEEeecccccccc
Confidence 368999999999999999999984 46789998654432 222233 3488999999999999999999998776
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++|||++.+++|..+++. ...+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 75 --------------~~~iv~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~ 135 (292)
T d1unla_ 75 --------------KLTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp --------------EEEEEEECCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred --------------ceeEEeeecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc
Confidence 67999999998888887764 35689999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+ +.+||+|||.++....... ......+++.|+|||++.+ ...++.++|||||||++|||
T Consensus 136 ~~-------~~~kl~DFG~a~~~~~~~~----------~~~~~~~~~~~~~pe~~~~---~~~~~~~~DiwSlG~il~el 195 (292)
T d1unla_ 136 RN-------GELKLANFGLARAFGIPVR----------CYSAEVVTLWYRPPDVLFG---AKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_dssp TT-------CCEEECCCTTCEECCSCCS----------CCCSCCSCGGGCCHHHHTT---CSCCCTHHHHHHHHHHHHHH
T ss_pred cC-------CceeeeecchhhcccCCCc----------cceeeccccchhhhhHhcc---CCCCCchhhccccchHHHHH
Confidence 77 7899999999976544321 1123457889999999875 24578999999999999999
Q ss_pred HhCCCCCC-CCCHHHHHHHHHcCCCCCchhHHhhhcc-cccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1039 LTLQVPYM-GLSELEIHDLIQMGKRPRLTDELEALGS-CHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1039 LTG~~Pf~-~~~~~el~~~I~~g~~p~l~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
++|..||. +.+..+....+.....+.....+..... ......................++++.+|+.+||+.||.+||
T Consensus 196 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 275 (292)
T d1unla_ 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc
Confidence 99998864 4555555555532221111111000000 000000000001111112235567799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
||+||++|+|+..
T Consensus 276 sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 276 SAEEALQHPYFSD 288 (292)
T ss_dssp CHHHHTTSGGGSS
T ss_pred CHHHHhcChhhcC
Confidence 9999999999964
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=387.00 Aligned_cols=289 Identities=18% Similarity=0.225 Sum_probs=205.0
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.++||+|+||+||+|++. ++.||||+.. ... .....+ ++++|+.+|++++|||||++++++.....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~--~~~-~~~~~~----~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--PFE-HQTYCQ----RTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEEC--CTT-CHHHHH----HHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEe--hhc-ChHHHH----HHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 36999999999999999999985 6778888753 221 222333 34899999999999999999999876542
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. .. ..+++|+|+.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 81 ~---------~~-~~~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 81 E---------QM-KDVYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144 (345)
T ss_dssp T---------TC-CCEEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred c---------cc-ceEEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC
Confidence 1 11 22444556678999999975 35999999999999999999999999999999999999997
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+||+|||+++......... ......+||+.|+|||++.. ...++.++||||+||++|+|+
T Consensus 145 ~-------~~~kl~DfG~a~~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~eml 207 (345)
T d1pmea_ 145 T-------CDLKICDFGLARVADPDHDHT-------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEML 207 (345)
T ss_dssp T-------CCEEECCCTTCEECCGGGCBC-------CTTCCCCSCGGGCCGGGTTT---BCSCSTHHHHHHHHHHHHHHH
T ss_pred C-------CCEEEcccCceeeccCCCccc-------eeeccccccceechHHHhhc---CCCCCchhhhhccCceehHHh
Confidence 7 789999999997654432211 11224579999999999864 256789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccc-cccc--CCCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHE-VAQS--GSGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||.+.+..+........................... .... .............++++++|+.+||+.||.+||
T Consensus 208 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 287 (345)
T d1pmea_ 208 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287 (345)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc
Confidence 9999999877766555442221111111100000000000 0000 000111111224456799999999999999999
Q ss_pred CHHHHHHHHHhhcC
Q 001152 1117 TAGDLYEMFVARTS 1130 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~~ 1130 (1137)
||+|+++|+|+...
T Consensus 288 ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 288 EVEQALAHPYLEQY 301 (345)
T ss_dssp CHHHHHTSGGGTTT
T ss_pred CHHHHhcCHhhccC
Confidence 99999999998743
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-41 Score=384.88 Aligned_cols=283 Identities=19% Similarity=0.207 Sum_probs=204.5
Q ss_pred CCCCCCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeE
Q 001152 798 PGSFPSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHK 874 (1137)
Q Consensus 798 ~~~~~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~ 874 (1137)
....++|++.++||+|+||+||+|++. ++.||+|+.+.. ..+ ++.+|+.+|++++ ||||+++++++
T Consensus 31 ~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~----~~~~Ei~il~~l~~hpnIv~~~~~~ 99 (328)
T d3bqca1 31 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKK----KIKREIKILENLRGGPNIITLADIV 99 (328)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHH----HHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHH----HHHHHHHHHHhccCCCCCcEEEEEE
Confidence 345578999999999999999999985 577888875321 112 2478999999996 99999999998
Q ss_pred ecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCC
Q 001152 875 ISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSEN 954 (1137)
Q Consensus 875 ~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~N 954 (1137)
..... ...++|||||++++|..+. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 100 ~~~~~------------~~~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~N 159 (328)
T d3bqca1 100 KDPVS------------RTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 159 (328)
T ss_dssp ECTTT------------CSEEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred EecCC------------CceeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccc
Confidence 75431 1579999999999987653 359999999999999999999999999999999999
Q ss_pred eEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHH
Q 001152 955 ILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCL 1034 (1137)
Q Consensus 955 ILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGvi 1034 (1137)
||++.++ ..+||+|||+|+....... .....+|+.|+|||.+.+ ...++.++||||+||+
T Consensus 160 ILi~~~~------~~vkl~DFG~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~~ 219 (328)
T d3bqca1 160 VMIDHEH------RKLRLIDWGLAEFYHPGQE-----------YNVRVASRYFKGPELLVD---YQMYDYSLDMWSLGCM 219 (328)
T ss_dssp EEEETTT------TEEEECCGGGCEECCTTCC-----------CCSCCSCGGGCCHHHHTT---CCCCCTHHHHHHHHHH
T ss_pred eEEcCCC------CeeeecccccceeccCCCc-----------ccccccCccccCcccccC---CCCCCcccchhhhhhh
Confidence 9998652 4699999999976543221 124568999999999875 2457899999999999
Q ss_pred HHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCchhH-Hhhhcccccccccc--------cCCCCCCchhhhhhHHHHHHHH
Q 001152 1035 LLELLTLQVPYMGLS-ELEIHDLIQMGKRPRLTDE-LEALGSCHEHEVAQ--------SGSGFEKPEAELETLSFLVDVF 1104 (1137)
Q Consensus 1035 L~ELLTG~~Pf~~~~-~~el~~~I~~g~~p~l~~~-l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~L~dLl 1104 (1137)
+|+|++|..||.... ..+....+........... .............. ..............++++.+||
T Consensus 220 l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 299 (328)
T d3bqca1 220 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299 (328)
T ss_dssp HHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHH
T ss_pred hHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHH
Confidence 999999999997543 3322222211110000000 00000000000000 0000111112234567899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhcCC
Q 001152 1105 RRCTEENPTERPTAGDLYEMFVARTSS 1131 (1137)
Q Consensus 1105 ~~CL~~DP~~RPSa~EVL~~L~~~~~s 1131 (1137)
.+||+.||.+|||++|+++|+||+...
T Consensus 300 ~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 300 DKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred HHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999998643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=388.17 Aligned_cols=284 Identities=17% Similarity=0.225 Sum_probs=202.3
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
.+|++.++||+|+||+||+|.+. +..||||+..... ....... ++.+|+.+|++++|||||+++++|...+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~----~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAK----RAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHH----HHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh--cCHHHHH----HHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 67999999999999999999985 6788998854332 2233333 34899999999999999999999976542
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. ....+.|+|||||. +++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 91 ~--------~~~~~~~iv~Ey~~-~~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~ 154 (355)
T d2b1pa1 91 L--------EEFQDVYLVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154 (355)
T ss_dssp T--------TTCCEEEEEEECCS-EEHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred c--------ccCceeEEEEeccc-hHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccc
Confidence 1 12348899999997 45555443 35899999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+|++|||+++....... .....+|+.|+|||++.+ ..++.++||||+||++|+|+
T Consensus 155 ~-------~~~kl~df~~~~~~~~~~~-----------~~~~~~t~~y~aPE~l~~----~~~~~~~DiwSlG~~l~ell 212 (355)
T d2b1pa1 155 D-------CTLKILDFGLARTAGTSFM-----------MTPYVVTRYYRAPEVILG----MGYKENVDIWSVGCIMGEMV 212 (355)
T ss_dssp T-------CCEEECCCCC--------------------------CCTTCCHHHHTT----CCCCTTHHHHHHHHHHHHHH
T ss_pred c-------cceeeechhhhhccccccc-----------cccccccccccChhhhcC----CCCCCCcccccccchHHHHh
Confidence 7 7899999998875543221 124469999999999976 57889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhccccccccccc--------------CCCCCCchhhhhhHHHHHHHHH
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQS--------------GSGFEKPEAELETLSFLVDVFR 1105 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~L~dLl~ 1105 (1137)
+|+.||.+.+.......+........+..+.............. .............++++.+|+.
T Consensus 213 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~ 292 (355)
T d2b1pa1 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292 (355)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHH
Confidence 99999998887776666533222222211111100000000000 0000111123356788999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhc
Q 001152 1106 RCTEENPTERPTAGDLYEMFVART 1129 (1137)
Q Consensus 1106 ~CL~~DP~~RPSa~EVL~~L~~~~ 1129 (1137)
+||+.||++||||+||++|+|+..
T Consensus 293 ~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 293 KMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=390.70 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=205.3
Q ss_pred CCCCCceEeeeecccCceEEEEEEE-----CCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC-CCcceeee
Q 001152 799 GSFPSLSSCDEAGKSVSSSLFRCKF-----GSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYG 872 (1137)
Q Consensus 799 ~~~~~y~l~~~LG~GsfG~Vy~a~~-----~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H-pNIVkllg 872 (1137)
..+++|++.+.||+|+||+||+|+. .++.||+|+++...........+. +.+|+++|++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~----~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH----TRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGG----CCCHHHHHHHHHTCTTBCCEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHH----HHHHHHHHHhccCCCeEEEeee
Confidence 4578899999999999999999986 246799998643322111122223 3789999999976 89999999
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
++.+.. ..++||||+.+|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||
T Consensus 97 ~~~~~~--------------~~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp 157 (322)
T d1vzoa_ 97 AFQTET--------------KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 157 (322)
T ss_dssp EEEETT--------------EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred eeccCC--------------ceeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCc
Confidence 998776 679999999999999999762 3578999999999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHH
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYG 1032 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLG 1032 (1137)
+|||++.+ +.+||+|||+++......... .....|++.|+|||.+.+ ....++.++||||||
T Consensus 158 ~Nill~~~-------~~vkL~DFG~a~~~~~~~~~~---------~~~~~g~~~~~~pe~~~~--~~~~~~~ksDIWSlG 219 (322)
T d1vzoa_ 158 ENILLDSN-------GHVVLTDFGLSKEFVADETER---------AYDFCGTIEYMAPDIVRG--GDSGHDKAVDWWSLG 219 (322)
T ss_dssp GGEEECTT-------SCEEESCSSEEEECCGGGGGG---------GCGGGSCCTTCCHHHHTT--CC---CTHHHHHHHH
T ss_pred cceeecCC-------CCEEEeeccchhhhccccccc---------ccccccccccchhHHhhc--CCcCCCchhhhHHHH
Confidence 99999987 789999999997654332211 123469999999999975 234678999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcC---CCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcc
Q 001152 1033 CLLLELLTLQVPYMGLSELEIHDLIQMG---KRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTE 1109 (1137)
Q Consensus 1033 viL~ELLTG~~Pf~~~~~~el~~~I~~g---~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~ 1109 (1137)
|++|+|++|+.||.+.+..+....+... ..+.++ ...++++.+|+.+||+
T Consensus 220 ~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~---------------------------~~~s~~~~~li~~~l~ 272 (322)
T d1vzoa_ 220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---------------------------QEMSALAKDLIQRLLM 272 (322)
T ss_dssp HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---------------------------TTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc---------------------------ccCCHHHHHHHHHHcc
Confidence 9999999999999775443333322111 011111 1455679999999999
Q ss_pred cCCCCCC-----CHHHHHHHHHhhc
Q 001152 1110 ENPTERP-----TAGDLYEMFVART 1129 (1137)
Q Consensus 1110 ~DP~~RP-----Sa~EVL~~L~~~~ 1129 (1137)
+||++|| |++|+++|+|++.
T Consensus 273 ~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 273 KDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp SSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999 5899999999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=385.18 Aligned_cols=284 Identities=19% Similarity=0.239 Sum_probs=207.2
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeeeEecCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGHKISSKW 879 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~~~~~~~ 879 (1137)
++|++.++||+|+||+||+|++. ++.||||+. +.........+. +.+|+.+|++++|||||++++++.....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i--~~~~~~~~~~~~----~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKR----TYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEEC--SCTTSSHHHHHH----HHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEE--CchhcChHHHHH----HHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 57999999999999999999985 577888874 333333333333 4899999999999999999999875432
Q ss_pred CCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEecc
Q 001152 880 LPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILIDL 959 (1137)
Q Consensus 880 ~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld~ 959 (1137)
. + ....++||+|+.+|+|.++++. ..+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 92 ~---~------~~~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~ 156 (348)
T d2gfsa1 92 L---E------EFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156 (348)
T ss_dssp T---T------TCCCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred c---c------cCceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc
Confidence 1 0 0123566777889999998854 36999999999999999999999999999999999999998
Q ss_pred ccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHHH
Q 001152 960 ERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLELL 1039 (1137)
Q Consensus 960 ~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~ELL 1039 (1137)
+ +.+|++|||.+....... ....||+.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 157 ~-------~~~kl~dfg~a~~~~~~~-------------~~~~g~~~y~apE~~~~---~~~~~~~~DiwSlGv~l~~ll 213 (348)
T d2gfsa1 157 D-------CELKILDFGLARHTDDEM-------------TGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELL 213 (348)
T ss_dssp T-------CCEEECCC----CCTGGG-------------SSSCHHHHTSCHHHHTT---CSCCCTTHHHHHHHHHHHHHH
T ss_pred c-------ccccccccchhcccCccc-------------ccccccccccCchhhcC---CccCCcccchhhhhHHHHHHH
Confidence 8 789999999987544321 13468999999999775 245789999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccC---CCCCCchhhhhhHHHHHHHHHHhcccCCCCCC
Q 001152 1040 TLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSG---SGFEKPEAELETLSFLVDVFRRCTEENPTERP 1116 (1137)
Q Consensus 1040 TG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RP 1116 (1137)
+|+.||.+.+.......+........................... ............++++++||.+||+.||.+||
T Consensus 214 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (348)
T d2gfsa1 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293 (348)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc
Confidence 999999998887777766433222111111100000000000000 00111111224567799999999999999999
Q ss_pred CHHHHHHHHHhhc
Q 001152 1117 TAGDLYEMFVART 1129 (1137)
Q Consensus 1117 Sa~EVL~~L~~~~ 1129 (1137)
||+|+++|+|+..
T Consensus 294 ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 294 TAAQALAHAYFAQ 306 (348)
T ss_dssp CHHHHHTSGGGTT
T ss_pred CHHHHhcCHhhCC
Confidence 9999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-39 Score=364.89 Aligned_cols=268 Identities=16% Similarity=0.178 Sum_probs=192.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcceeeee-EecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIVEMYGH-KISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg~-~~~~~ 878 (1137)
++|++.+.||+|+||+||+|++. +..||||+...+... + ++.+|+++++.++|+|+|..+.. +.+.+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~----~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------P----QLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------C----CHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------H----HHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 46999999999999999999985 578999986543211 1 23679999999997776655544 44443
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+ +++|...+.. ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 77 --------------~~~ivme~~-~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~ 137 (299)
T d1ckia_ 77 --------------YNVMVMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137 (299)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred --------------EEEEEEEEc-CCchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccc
Confidence 569999999 4777776654 235699999999999999999999999999999999999987
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
..+ ....+||+|||+|+.......... ..........||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 138 ~~~----~~~~vkl~DFG~a~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el 206 (299)
T d1ckia_ 138 LGK----KGNLVYIIDFGLAKKYRDARTHQH---IPYRENKNLTGTARYASINTHLG----IEQSRRDDLESLGYVLMYF 206 (299)
T ss_dssp CGG----GTTCEEECCCSSCEECBCTTTCCB---CCCCBCCSCCCCSSSCCHHHHTT----BCCCHHHHHHHHHHHHHHH
T ss_pred ccC----CCceeeeeccCcceeccccccccc---eeccccCCcCCCccccCHHHHhC----CCCCChhhEEecCHHHHHH
Confidence 542 125799999999987654322110 11112235679999999999876 5689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCCCCH
Q 001152 1039 LTLQVPYMGLSELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTERPTA 1118 (1137)
Q Consensus 1039 LTG~~Pf~~~~~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa 1118 (1137)
+||+.||......+....+...... .... ..+.....+++++.+++.+||+.||++||++
T Consensus 207 ~tg~~P~~~~~~~~~~~~~~~~~~~----~~~~----------------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~ 266 (299)
T d1ckia_ 207 NLGSLPWQGLKAATKRQKYERISEK----KMST----------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266 (299)
T ss_dssp HHSSCTTCCCC-------HHHHHHH----HHHS----------------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCH
T ss_pred HhCCCcccccchHHHHHHHHHhhcc----cCCC----------------ChhHhccCCCHHHHHHHHHHccCChhHCcCH
Confidence 9999999876554433322111000 0000 0000112456779999999999999999999
Q ss_pred HHH---HHHHHhhc
Q 001152 1119 GDL---YEMFVART 1129 (1137)
Q Consensus 1119 ~EV---L~~L~~~~ 1129 (1137)
+++ +++++.+.
T Consensus 267 ~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 267 SYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHc
Confidence 865 55665543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-38 Score=354.52 Aligned_cols=265 Identities=17% Similarity=0.173 Sum_probs=199.8
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC-CCcceeeeeEecCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH-SCIVEMYGHKISSK 878 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H-pNIVkllg~~~~~~ 878 (1137)
.+|++.++||+|+||+||+|++. ++.||||+...... .+ .+.+|+++++.+.| +||+.+++++....
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~----~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------AP----QLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SC----CHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cH----HHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 46999999999999999999985 57789997543221 11 23678899999975 89999999988765
Q ss_pred CCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCCeEec
Q 001152 879 WLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKSENILID 958 (1137)
Q Consensus 879 ~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP~NILld 958 (1137)
..++||||+ +++|.++++. ....+++.++..++.|++.||+|||++||+||||||+|||++
T Consensus 75 --------------~~~~vme~~-~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~ 135 (293)
T d1csna_ 75 --------------HNVLVIDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135 (293)
T ss_dssp --------------EEEEEEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred --------------ccEEEEEec-CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Confidence 669999999 6999998875 234699999999999999999999999999999999999998
Q ss_pred cccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhhHHHHHHHHHHH
Q 001152 959 LERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVDIWSYGCLLLEL 1038 (1137)
Q Consensus 959 ~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksDVWSLGviL~EL 1038 (1137)
.+. ....+.+||+|||+|+.......... ..........||+.|||||++.+ ..++.++|||||||++|||
T Consensus 136 ~~~--~~~~~~vkl~DFG~a~~~~~~~~~~~---~~~~~~~~~~GT~~y~aPE~~~~----~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 136 RPN--SKNANMIYVVDFGMVKFYRDPVTKQH---IPYREKKNLSGTARYMSINTHLG----REQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CSS--STTTTCEEECCCTTCEESBCTTTCCB---CCCCCCCCCCSCTTTCCHHHHTT----CCCCHHHHHHHHHHHHHHH
T ss_pred Ccc--cccCCceEEcccceeEEcccCccccc---eeecccCceEEchhhcCHHHhcC----CCCChHHHHHHhhHHHHHH
Confidence 642 12236799999999987654322111 11122335679999999999976 5689999999999999999
Q ss_pred HhCCCCCCCCC---HHHHHHHHHcCCCCCchhHHhhhcccccccccccCCCCCCchhhhhhHHHHHHHHHHhcccCCCCC
Q 001152 1039 LTLQVPYMGLS---ELEIHDLIQMGKRPRLTDELEALGSCHEHEVAQSGSGFEKPEAELETLSFLVDVFRRCTEENPTER 1115 (1137)
Q Consensus 1039 LTG~~Pf~~~~---~~el~~~I~~g~~p~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~dLl~~CL~~DP~~R 1115 (1137)
+||+.||.+.. ..+....+........... ....+++++.+++..|+..+|++|
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-----------------------l~~~~p~~l~~ii~~~~~~~~~~r 263 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE-----------------------LCAGFPEEFYKYMHYARNLAFDAT 263 (293)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-----------------------HTTTSCHHHHHHHHHHHHCCTTCC
T ss_pred HhCCCcCCCccchhHHHHHHHHHhccCCCChHH-----------------------hcCCCCHHHHHHHHHHhcCCcccC
Confidence 99999997543 2333333322111000111 111455679999999999999999
Q ss_pred CCHHHHHHHHHh
Q 001152 1116 PTAGDLYEMFVA 1127 (1137)
Q Consensus 1116 PSa~EVL~~L~~ 1127 (1137)
|+++.+.+.+..
T Consensus 264 P~y~~l~~~l~~ 275 (293)
T d1csna_ 264 PDYDYLQGLFSK 275 (293)
T ss_dssp CCHHHHHHHHHH
T ss_pred cCHHHHHHHHHH
Confidence 998887765543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-36 Score=342.99 Aligned_cols=286 Identities=19% Similarity=0.225 Sum_probs=191.9
Q ss_pred CCceEeeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-----------CCCcc
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-----------HSCIV 868 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-----------HpNIV 868 (1137)
.+|+++++||+|+||+||+|++. ++.||||+.+.+ ....+ .+.+|+.+++.++ |+|||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~----~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTE----AAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHH----HHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchH----HHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 35999999999999999999984 578899986422 11122 2367888887775 57899
Q ss_pred eeeeeEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeee
Q 001152 869 EMYGHKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHS-KHIMH 947 (1137)
Q Consensus 869 kllg~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs-~gIIH 947 (1137)
++++++...... ..++||+++..+......... .....+++..++.++.||+.||+|||+ .||+|
T Consensus 84 ~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvH 149 (362)
T d1q8ya_ 84 KLLDHFNHKGPN------------GVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH 149 (362)
T ss_dssp CCCEEEEEEETT------------EEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEEC
T ss_pred EEEEEeeecccc------------ceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcCccc
Confidence 999988754311 456777776554433333221 234578999999999999999999997 89999
Q ss_pred ccCCCCCeEeccccccCCCCCeEEEeecCccccccccccccccccCCCCCCCcccCCCcccchhhhccccCCCCCCchhh
Q 001152 948 RDIKSENILIDLERKKADGKPVVKLCDFDRAVPLRSFLHTCCIAHRGIPAPDVCVGTPRWMAPEVLRAMHKPNLYGLEVD 1027 (1137)
Q Consensus 948 rDLKP~NILld~~~~~~~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~s~ksD 1027 (1137)
|||||+|||++.++. ......++++|||.+....... ...+||+.|+|||++.+ ..++.++|
T Consensus 150 rDlKp~NIll~~~~~-~~~~~~~kl~dfg~s~~~~~~~-------------~~~~gt~~y~aPE~~~~----~~~~~~~D 211 (362)
T d1q8ya_ 150 TDIKPENVLMEIVDS-PENLIQIKIADLGNACWYDEHY-------------TNSIQTREYRSPEVLLG----APWGCGAD 211 (362)
T ss_dssp SCCSGGGEEEEEEET-TTTEEEEEECCCTTCEETTBCC-------------CSCCSCGGGCCHHHHHT----CCCCTHHH
T ss_pred ccCChhHeeeeccCc-ccccceeeEeeccccccccccc-------------ccccccccccChhhccc----cCCCcccc
Confidence 999999999987631 1111359999999987543321 23469999999999885 56889999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHH-HcCCCCCchhHHhhhcc----cccccccccCCCCC-------
Q 001152 1028 IWSYGCLLLELLTLQVPYMGLSEL------E-IHDLI-QMGKRPRLTDELEALGS----CHEHEVAQSGSGFE------- 1088 (1137)
Q Consensus 1028 VWSLGviL~ELLTG~~Pf~~~~~~------e-l~~~I-~~g~~p~l~~~l~~~~~----~~~~~~~~~~~~~~------- 1088 (1137)
|||+||++++|++|+.||...... + +...+ .-+..+. ........ ..............
T Consensus 212 iwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (362)
T d1q8ya_ 212 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS--YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289 (362)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCH--HHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHH
T ss_pred ccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCH--HHhhcccccccccccchhhhccccccCCchhhh
Confidence 999999999999999999753321 1 11111 1121111 00000000 00000000000000
Q ss_pred ---CchhhhhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 001152 1089 ---KPEAELETLSFLVDVFRRCTEENPTERPTAGDLYEMFVARTS 1130 (1137)
Q Consensus 1089 ---~~~~~~~~~~~L~dLl~~CL~~DP~~RPSa~EVL~~L~~~~~ 1130 (1137)
........++++.+|+.+||+.||.+||||+|+++|+|++..
T Consensus 290 ~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred cccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 000112567889999999999999999999999999999844
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.93 E-value=2.3e-26 Score=256.82 Aligned_cols=228 Identities=21% Similarity=0.252 Sum_probs=196.5
Q ss_pred CCCCEEEccCCCCCCC--CcccccCCCCCCCccEEEeec-CCCC-ccCccccCCCCCcEEEccCCCCCcc-cccccCCCC
Q 001152 41 DDDSVIDVSGKTVDFP--LIESYGNRGGDNSVEGLYLYK-NVLN-LIPKSVGRYEKLRNLKFFGNEINLF-PSEVGNLLG 115 (1137)
Q Consensus 41 ~~L~~LdLs~N~L~~~--~p~~~~~l~~L~~L~~L~Ls~-N~L~-~IP~~~~~L~~L~~L~Ls~N~L~~l-P~~l~~L~~ 115 (1137)
..++.|||++|+++|. +|..++++ ++|++|+|++ |.++ .||.+|++|++|++|+|++|+|..+ |..+.++.+
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L---~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~ 126 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANL---PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGC---TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTT
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcC---ccccccccccccccccccccccccccccchhhhccccccccccccccchhh
Confidence 3689999999999984 67777665 9999999986 7887 8999999999999999999999855 566889999
Q ss_pred CCEEEccCCC-CCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCC-cEEeccCCCCc-ccCccccCCCCCCEE
Q 001152 116 LECLQIKISS-PGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCL-TKLSVCHFSIR-YLPPEIGCLSNLEQL 192 (1137)
Q Consensus 116 L~~L~Ls~N~-~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L-~~L~Ls~N~L~-~IP~~l~~L~~L~~L 192 (1137)
|+.++++.|. ...+|..+.+++.|+.+++++| ...+.+|..+..+..| +.+++++|+++ ..|..+..+.. .++
T Consensus 127 L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n---~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l 202 (313)
T d1ogqa_ 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGN---RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFV 202 (313)
T ss_dssp CCEEECCSSEEESCCCGGGGGCTTCCEEECCSS---CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEE
T ss_pred hcccccccccccccCchhhccCcccceeecccc---cccccccccccccccccccccccccccccccccccccccc-ccc
Confidence 9999999988 6667888999999999999984 4456788888888776 88999999998 55667777654 479
Q ss_pred EccCCCCC-ccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 193 DLSFNKMK-YLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 193 ~Ls~N~L~-~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
++++|.+. .+|..++.+++|+.|++++|.++..|..++.+++|+.|+|++|+|+|.+|..|++|++|++|+|++|+|+|
T Consensus 203 ~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g 282 (313)
T d1ogqa_ 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccc
Confidence 99999887 77888899999999999999998666688899999999999999998888899999999999999999987
Q ss_pred CCCCCc
Q 001152 272 YCQVPS 277 (1137)
Q Consensus 272 ~~~iP~ 277 (1137)
.||.
T Consensus 283 --~iP~ 286 (313)
T d1ogqa_ 283 --EIPQ 286 (313)
T ss_dssp --ECCC
T ss_pred --cCCC
Confidence 4553
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.93 E-value=7.4e-27 Score=260.91 Aligned_cols=251 Identities=16% Similarity=0.176 Sum_probs=218.6
Q ss_pred CcccccCCCCCCccc--CCCCCCCCCCCCEEEccC-CCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCC
Q 001152 18 IKEKLPSEANKINNE--KNGSVNDDDDDSVIDVSG-KTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKL 93 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l--~~~~f~~l~~L~~LdLs~-N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L 93 (1137)
.+..|.+..|++++. .|..+.++++|++|||++ |+++|.+|..|+.+ ++|++|+|++|+|+.+ |..+..+..|
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L---~~L~~L~Ls~N~l~~~~~~~~~~~~~L 127 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL---TQLHYLYITHTNVSGAIPDFLSQIKTL 127 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGC---TTCSEEEEEEECCEEECCGGGGGCTTC
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccc---cccchhhhccccccccccccccchhhh
Confidence 367789999999874 367899999999999997 89999999988766 9999999999999966 5568999999
Q ss_pred cEEEccCCCCC-cccccccCCCCCCEEEccCCCCC-CCcccccCCCCC-CEEECCCCCCCCCcccchhhhcCCCCCcEEe
Q 001152 94 RNLKFFGNEIN-LFPSEVGNLLGLECLQIKISSPG-VNGFALNKLKGL-KELELSKVPPRPSVLTLLSEIAGLKCLTKLS 170 (1137)
Q Consensus 94 ~~L~Ls~N~L~-~lP~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~L~~L-~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~ 170 (1137)
++|++++|.+. .+|..++++++|+.+++++|.+. .+|..+..+..| +.++++.| ...+..|..+..+..+ .++
T Consensus 128 ~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n---~l~~~~~~~~~~l~~~-~l~ 203 (313)
T d1ogqa_ 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN---RLTGKIPPTFANLNLA-FVD 203 (313)
T ss_dssp CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSS---EEEEECCGGGGGCCCS-EEE
T ss_pred cccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccc---cccccccccccccccc-ccc
Confidence 99999999987 78999999999999999999955 677788888876 88999884 4455667777777655 799
Q ss_pred ccCCCCc-ccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccCCcCCCC
Q 001152 171 VCHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSL 248 (1137)
Q Consensus 171 Ls~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~N~Lsg~ 248 (1137)
+++|.+. .+|..++.+++|+.|++++|.++..|..++.+++|+.|+|++|+|+ .||.+|+++++|+.|+|++|+|+|.
T Consensus 204 l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~ 283 (313)
T d1ogqa_ 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCccccc
Confidence 9999877 6778889999999999999999966778999999999999999999 8999999999999999999999998
Q ss_pred CcccccCCCCCCEEEccCCcCCCCCCCC
Q 001152 249 GSLDLCLMHNLQNLNLQYNKLLSYCQVP 276 (1137)
Q Consensus 249 ~p~~l~~L~~L~~L~Ls~N~L~~~~~iP 276 (1137)
+| .+++|++|+.|++++|++-|..++|
T Consensus 284 iP-~~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 284 IP-QGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp CC-CSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred CC-CcccCCCCCHHHhCCCccccCCCCC
Confidence 88 6789999999999999854433455
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=5e-24 Score=236.68 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=199.7
Q ss_pred CCCcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcE
Q 001152 16 GPIKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRN 95 (1137)
Q Consensus 16 ~~~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~ 95 (1137)
++.++.|.+..|+|+.+++.+|.++++|++|++++|.+....|..|..+ ++|+.|+|++|+|+.||..+. ..|..
T Consensus 30 ~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l---~~L~~L~l~~n~l~~l~~~~~--~~l~~ 104 (305)
T d1xkua_ 30 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPL---VKLERLYLSKNQLKELPEKMP--KTLQE 104 (305)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTC---TTCCEEECCSSCCSBCCSSCC--TTCCE
T ss_pred CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCC---CccCEecccCCccCcCccchh--hhhhh
Confidence 3468888999999999988889999999999999999988877766544 889999999999998887544 47888
Q ss_pred EEccCCCCCccccc-ccCCCCCCEEEccCCCCCCC---cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEec
Q 001152 96 LKFFGNEINLFPSE-VGNLLGLECLQIKISSPGVN---GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSV 171 (1137)
Q Consensus 96 L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~~~~~---~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~L 171 (1137)
|++++|.+..++.. +.....+..+++..|..... +..+..+++|+.+++++|.+.. +|..+ +++|+.|++
T Consensus 105 L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~----l~~~~--~~~L~~L~l 178 (305)
T d1xkua_ 105 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT----IPQGL--PPSLTELHL 178 (305)
T ss_dssp EECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS----CCSSC--CTTCSEEEC
T ss_pred hhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc----cCccc--CCccCEEEC
Confidence 99999998877654 56677788888877764433 3467788889999998865533 33332 577888999
Q ss_pred cCCCCc-ccCccccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCC
Q 001152 172 CHFSIR-YLPPEIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLG 249 (1137)
Q Consensus 172 s~N~L~-~IP~~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~ 249 (1137)
++|.++ ..|..|..++.++.|++++|.++.+ |..+.++++|++|+|++|+|+.||.++.++++|+.|+|++|+|+.+.
T Consensus 179 ~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~i~ 258 (305)
T d1xkua_ 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIG 258 (305)
T ss_dssp TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCC
T ss_pred CCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccCccC
Confidence 998887 4456788888999999999999876 45678888999999999999999888888999999999999998876
Q ss_pred cccc------cCCCCCCEEEccCCcCCCCCCCCcchhh
Q 001152 250 SLDL------CLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1137)
Q Consensus 250 p~~l------~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1137)
...| ..+.+|+.|+|++|++..+.--|.++.|
T Consensus 259 ~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~ 296 (305)
T d1xkua_ 259 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296 (305)
T ss_dssp TTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred hhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcc
Confidence 5444 3567889999999988765434444443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.90 E-value=1.5e-22 Score=224.60 Aligned_cols=240 Identities=19% Similarity=0.238 Sum_probs=204.8
Q ss_pred ccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCcc-CccccCCCCCcEEEc
Q 001152 20 EKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLI-PKSVGRYEKLRNLKF 98 (1137)
Q Consensus 20 ~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~I-P~~~~~L~~L~~L~L 98 (1137)
..+.-..+++++++.+ + .+++++|||++|+|+.+.+.+|..+ ++|++|++++|.++.+ |..|.++++|++|+|
T Consensus 13 ~~~~C~~~~L~~lP~~-l--~~~l~~L~Ls~N~i~~l~~~~f~~l---~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 13 RVVQCSDLGLEKVPKD-L--PPDTALLDLQNNKITEIKDGDFKNL---KNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp TEEECTTSCCCSCCCS-C--CTTCCEEECCSSCCCCBCTTTTTTC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CEEEecCCCCCccCCC-C--CCCCCEEECcCCcCCCcChhHhhcc---ccccccccccccccccchhhhhCCCccCEecc
Confidence 3466677889988664 3 2589999999999998887766555 9999999999999988 567999999999999
Q ss_pred cCCCCCcccccccCCCCCCEEEccCCCCCCCc-ccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCc
Q 001152 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNG-FALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1137)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~-~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1137)
++|+|+.+|..+. ..|..|++..|.+..++ ..+.....+..++...|.. ......+..+..+++|+.+++++|.++
T Consensus 87 ~~n~l~~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~-~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 87 SKNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL-KSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp CSSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC-CGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred cCCccCcCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccc-cccCCCccccccccccCccccccCCcc
Confidence 9999999997653 58999999999977655 4577788889999988664 334445667888999999999999999
Q ss_pred ccCccccCCCCCCEEEccCCCCC-ccchhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeccCCcCCCCCcccccC
Q 001152 178 YLPPEIGCLSNLEQLDLSFNKMK-YLPTEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCL 255 (1137)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~-~LP~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~ 255 (1137)
.+|..+ +++|+.|++++|.++ ..|..+..++.++.|++++|.++.+ |..+.++++|+.|+|++|+|+.+++ .|..
T Consensus 164 ~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~-~l~~ 240 (305)
T d1xkua_ 164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG-GLAD 240 (305)
T ss_dssp SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCT-TTTT
T ss_pred ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccccc-cccc
Confidence 998754 689999999999998 5567889999999999999999977 4567789999999999999998854 8999
Q ss_pred CCCCCEEEccCCcCCC
Q 001152 256 MHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 256 L~~L~~L~Ls~N~L~~ 271 (1137)
+++|++|+|++|+|+.
T Consensus 241 l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISA 256 (305)
T ss_dssp CSSCCEEECCSSCCCC
T ss_pred ccCCCEEECCCCccCc
Confidence 9999999999999987
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=6.7e-23 Score=223.93 Aligned_cols=204 Identities=25% Similarity=0.249 Sum_probs=146.4
Q ss_pred CCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEccCCCCCcccccccCCCCCC
Q 001152 39 DDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPSEVGNLLGLE 117 (1137)
Q Consensus 39 ~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~ 117 (1137)
...++..+|.++++|+.+ |+.+. ++|++|+|++|+|+.+|. .|.++++|++|+|++|+|+.+|. ++.+++|+
T Consensus 8 ~~~~~~~v~C~~~~L~~i-P~~lp-----~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L~ 80 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTAL-PPDLP-----KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLG 80 (266)
T ss_dssp CSTTCCEEECTTSCCSSC-CSCCC-----TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCC
T ss_pred ccCCCeEEEccCCCCCee-CcCcC-----cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc-cccccccc
Confidence 344555566666666653 32221 356666666666666653 46666666666666666666653 34555666
Q ss_pred EEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccC
Q 001152 118 CLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSF 196 (1137)
Q Consensus 118 ~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~ 196 (1137)
.|+|++|.+... +..+.++++|+.|++++|.+..++. .+..+.+|++|++++
T Consensus 81 ~L~Ls~N~l~~~---------------------------~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~ 133 (266)
T d1p9ag_ 81 TLDLSHNQLQSL---------------------------PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (266)
T ss_dssp EEECCSSCCSSC---------------------------CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred cccccccccccc---------------------------ccccccccccccccccccccceeeccccccccccccccccc
Confidence 666555554333 3345566777788888888776655 567888999999999
Q ss_pred CCCCccchh-hcCCCCCCEEEccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCC
Q 001152 197 NKMKYLPTE-ICYLKALISLKVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQ 274 (1137)
Q Consensus 197 N~L~~LP~~-l~~L~~L~~L~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~ 274 (1137)
|.++.+|.. +..+++|+.|++++|+|+.+|.. +..+++|+.|+|++|+|+.+++ .+..+++|+.|+|++|+|.|.|.
T Consensus 134 n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~-~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPK-GFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCCCSEEECCSCCBCCSGG
T ss_pred cccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccCh-hHCCCCCCCEEEecCCCCCCCcc
Confidence 999988755 46688999999999999988654 6779999999999999997654 67789999999999999999887
Q ss_pred CCc
Q 001152 275 VPS 277 (1137)
Q Consensus 275 iP~ 277 (1137)
+-.
T Consensus 213 ~~~ 215 (266)
T d1p9ag_ 213 ILY 215 (266)
T ss_dssp GHH
T ss_pred hHH
Confidence 644
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=4.8e-23 Score=226.81 Aligned_cols=224 Identities=21% Similarity=0.226 Sum_probs=181.0
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEccCCCCCcccc-cccCCCCCCEEEc
Q 001152 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINLFPS-EVGNLLGLECLQI 121 (1137)
Q Consensus 44 ~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~L~~lP~-~l~~L~~L~~L~L 121 (1137)
..++.++++++.. |..+. +++++|+|++|+|+.||. .|.++++|++|++++|+|..++. .+.++..+..+..
T Consensus 14 ~~v~c~~~~L~~i-P~~ip-----~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~ 87 (284)
T d1ozna_ 14 VTTSCPQQGLQAV-PVGIP-----AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87 (284)
T ss_dssp CEEECCSSCCSSC-CTTCC-----TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred eEEEcCCCCCCcc-CCCCC-----CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccc
Confidence 4567777777754 33221 467888888888888875 58888888888888888886644 3566778888776
Q ss_pred cC-CCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCC
Q 001152 122 KI-SSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNK 198 (1137)
Q Consensus 122 s~-N~~~~~-~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~ 198 (1137)
.. |.+..+ +..|.++++|++|++++|.+... .+..+..+.+|+.+++++|+|+.||. .|..+++|+.|+|++|+
T Consensus 88 ~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~---~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL---GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp CSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCC---CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccccccccccchhhcccccCCEEecCCcccccc---cccccchhcccchhhhccccccccChhHhccccchhhcccccCc
Confidence 43 345444 46688888888888888654322 23456778899999999999998875 67889999999999999
Q ss_pred CCccc-hhhcCCCCCCEEEccCCCCCcc-CccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCC
Q 001152 199 MKYLP-TEICYLKALISLKVANNKLVEL-PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVP 276 (1137)
Q Consensus 199 L~~LP-~~l~~L~~L~~L~Ls~N~Ls~I-P~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP 276 (1137)
|+.+| ..|.++++|+.|+|++|+++.+ |..|..+++|+.|++++|+++++++..|..+++|++|+|++|+|.|.|++-
T Consensus 165 l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~ 244 (284)
T d1ozna_ 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (284)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch
Confidence 99875 5678899999999999999966 778899999999999999999999999999999999999999999988753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.7e-22 Score=220.59 Aligned_cols=195 Identities=19% Similarity=0.217 Sum_probs=161.5
Q ss_pred cccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEc
Q 001152 19 KEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKF 98 (1137)
Q Consensus 19 l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~L 98 (1137)
+.++....++|+.++++-. ++|++|||++|+|+++.+..|..+ ++|++|+|++|+|+.||. ++.+++|++|+|
T Consensus 12 ~~~v~C~~~~L~~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l---~~L~~L~L~~N~l~~l~~-~~~l~~L~~L~L 84 (266)
T d1p9ag_ 12 HLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPY---TRLTQLNLDRAELTKLQV-DGTLPVLGTLDL 84 (266)
T ss_dssp CCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSEEEGGGGTTC---TTCCEEECTTSCCCEEEC-CSCCTTCCEEEC
T ss_pred CeEEEccCCCCCeeCcCcC---cCCCEEECcCCcCCCcCHHHhhcc---cccccccccccccccccc-cccccccccccc
Confidence 4556788899999865332 579999999999998887777655 999999999999999974 678999999999
Q ss_pred cCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcc
Q 001152 99 FGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRY 178 (1137)
Q Consensus 99 s~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~ 178 (1137)
++|+|+.+|..+.++++|+.|++++|.+..++. ..+..+.+|+.|++++|.++.
T Consensus 85 s~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~--------------------------~~~~~l~~l~~L~l~~n~l~~ 138 (266)
T d1p9ag_ 85 SHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL--------------------------GALRGLGELQELYLKGNELKT 138 (266)
T ss_dssp CSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCS--------------------------STTTTCTTCCEEECTTSCCCC
T ss_pred ccccccccccccccccccccccccccccceeec--------------------------cccccccccccccccccccce
Confidence 999999999999999999999998877544321 234456677888888888887
Q ss_pred cCc-cccCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCC
Q 001152 179 LPP-EIGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246 (1137)
Q Consensus 179 IP~-~l~~L~~L~~L~Ls~N~L~~LP~-~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Ls 246 (1137)
+|. .+..+++|+.|++++|+|+.+|. .|..+++|++|+|++|+|+.||.+++.+++|+.|+|++|.+.
T Consensus 139 l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred eccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCC
Confidence 776 45678889999999999987764 477889999999999999999998888999999999999776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=7.8e-22 Score=223.89 Aligned_cols=236 Identities=20% Similarity=0.275 Sum_probs=180.6
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccC-------------
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIP------------- 84 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP------------- 84 (1137)
+++.|.+..|+|+.+.+ |.++++|++|+|++|.|.+..+ + +++++|+.|++++|.++.++
T Consensus 67 nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~--l---~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~ 139 (384)
T d2omza2 67 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--L---ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139 (384)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--G---TTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEE
T ss_pred CCCEEeCcCCcCCCCcc--ccCCcccccccccccccccccc--c---ccccccccccccccccccccccccccccccccc
Confidence 56666666666666643 6666666666666666655432 2 33466666666655554211
Q ss_pred ---------------------------------------------------ccccCCCCCcEEEccCCCCCcccccccCC
Q 001152 85 ---------------------------------------------------KSVGRYEKLRNLKFFGNEINLFPSEVGNL 113 (1137)
Q Consensus 85 ---------------------------------------------------~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L 113 (1137)
..+..+++++.|++++|.++.++. +...
T Consensus 140 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~-~~~~ 218 (384)
T d2omza2 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP-LGIL 218 (384)
T ss_dssp EEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG-GGGC
T ss_pred ccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCc-cccc
Confidence 123455778888999999998764 5667
Q ss_pred CCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEE
Q 001152 114 LGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLD 193 (1137)
Q Consensus 114 ~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~ 193 (1137)
++|+.|++++|.+..++ .+..+++|+.|++++|.+... + .+..+++|+.|++++|.++.+++ +..++.++.++
T Consensus 219 ~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~----~-~~~~~~~L~~L~l~~~~l~~~~~-~~~~~~l~~l~ 291 (384)
T d2omza2 219 TNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNL----A-PLSGLTKLTELKLGANQISNISP-LAGLTALTNLE 291 (384)
T ss_dssp TTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCC----G-GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEE
T ss_pred CCCCEEECCCCCCCCcc-hhhcccccchhccccCccCCC----C-cccccccCCEeeccCcccCCCCc-ccccccccccc
Confidence 89999999999987765 578899999999999766543 2 37788999999999999998765 67888999999
Q ss_pred ccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCC
Q 001152 194 LSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272 (1137)
Q Consensus 194 Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1137)
++.|+++.++ .+..+++|+.|+|++|+|+.++. +..+++|+.|+|++|+|++++ .|.++++|++|+|++|+|+++
T Consensus 292 ~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~~l~--~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 292 LNENQLEDIS-PISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDVS--SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCBC
T ss_pred cccccccccc-ccchhcccCeEECCCCCCCCCcc-cccCCCCCEEECCCCCCCCCh--hHcCCCCCCEEECCCCcCCCC
Confidence 9999998876 57888999999999999998864 788999999999999999863 588899999999999998873
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=1.2e-21 Score=222.37 Aligned_cols=236 Identities=22% Similarity=0.270 Sum_probs=199.9
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~ 97 (1137)
.+..|.+..+.|+.+. .+..+++|++|||++|+|++..+ + +++++|++|+|++|.++.+++ ++++++|+.|+
T Consensus 45 ~l~~L~l~~~~I~~l~--gl~~L~nL~~L~Ls~N~l~~l~~--l---~~L~~L~~L~L~~n~i~~i~~-l~~l~~L~~L~ 116 (384)
T d2omza2 45 QVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDITP--L---KNLTKLVDILMNNNQIADITP-LANLTNLTGLT 116 (384)
T ss_dssp TCCEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--G---TTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEE
T ss_pred CCCEEECCCCCCCCcc--ccccCCCCCEEeCcCCcCCCCcc--c---cCCcccccccccccccccccc-ccccccccccc
Confidence 5788999999999873 57889999999999999998653 4 556999999999999998864 88999999999
Q ss_pred ccCCCCCccc----------------------------------------------------------------ccccCC
Q 001152 98 FFGNEINLFP----------------------------------------------------------------SEVGNL 113 (1137)
Q Consensus 98 Ls~N~L~~lP----------------------------------------------------------------~~l~~L 113 (1137)
+++|.++.++ ..+..+
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 196 (384)
T d2omza2 117 LFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccc
Confidence 9998876321 124456
Q ss_pred CCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEE
Q 001152 114 LGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLD 193 (1137)
Q Consensus 114 ~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~ 193 (1137)
++++.|++++|.+..++. +....+|+.|++++|.+.. + ..+..+++|+.|++++|.++.+++ ++.+++|+.|+
T Consensus 197 ~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~----~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~ 269 (384)
T d2omza2 197 TNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKD----I-GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELK 269 (384)
T ss_dssp TTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC----C-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEE
T ss_pred cccceeeccCCccCCCCc-ccccCCCCEEECCCCCCCC----c-chhhcccccchhccccCccCCCCc-ccccccCCEee
Confidence 788889999888776553 5677899999999976543 2 357889999999999999998875 78899999999
Q ss_pred ccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCC
Q 001152 194 LSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272 (1137)
Q Consensus 194 Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1137)
+++|+++.++ .+..++.++.+.+++|.++.++ .+..+++|+.|+|++|+|+++++ +..+++|+.|+|++|+|+.+
T Consensus 270 l~~~~l~~~~-~~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~l 344 (384)
T d2omza2 270 LGANQISNIS-PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV 344 (384)
T ss_dssp CCSSCCCCCG-GGTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred ccCcccCCCC-cccccccccccccccccccccc-ccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCCC
Confidence 9999999887 5788999999999999999876 47789999999999999999864 88999999999999999873
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=5.3e-21 Score=210.27 Aligned_cols=247 Identities=20% Similarity=0.189 Sum_probs=186.3
Q ss_pred ccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEcc-
Q 001152 22 LPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFF- 99 (1137)
Q Consensus 22 L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls- 99 (1137)
+.....++++++..-. +++++|||++|+|+++.+.+|.++ ++|++|++++|.|..++. .+..+..+..|+..
T Consensus 16 v~c~~~~L~~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l---~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~ 89 (284)
T d1ozna_ 16 TSCPQQGLQAVPVGIP---AASQRIFLHGNRISHVPAASFRAC---RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (284)
T ss_dssp EECCSSCCSSCCTTCC---TTCSEEECTTSCCCEECTTTTTTC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEcCCCCCCccCCCCC---CCCCEEECcCCcCCCCCHHHhhcc---cccccccccccccccccccccccccccccccccc
Confidence 3445566777754322 467899999999988777666554 889999999999987764 46777888888764
Q ss_pred CCCCCcc-cccccCCCCCCEEEccCCCCCCC-cccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCc
Q 001152 100 GNEINLF-PSEVGNLLGLECLQIKISSPGVN-GFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1137)
Q Consensus 100 ~N~L~~l-P~~l~~L~~L~~L~Ls~N~~~~~-~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1137)
.|.++.+ |..|.++++|++|+|+.|.+..+ +..+..+.+|+.+++++|.+... .+..|..+++|+.|++++|+|+
T Consensus 90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i---~~~~f~~~~~L~~L~l~~N~l~ 166 (284)
T d1ozna_ 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL---PDDTFRDLGNLTHLFLHGNRIS 166 (284)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC---CTTTTTTCTTCCEEECCSSCCC
T ss_pred ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccccc---ChhHhccccchhhcccccCccc
Confidence 5667777 55688899999999998886554 45677888899999998655432 2345778889999999999999
Q ss_pred ccCc-cccCCCCCCEEEccCCCCCcc-chhhcCCCCCCEEEccCCCCCccC-ccccCCCCCCEEeccCCcCCCCCccccc
Q 001152 178 YLPP-EIGCLSNLEQLDLSFNKMKYL-PTEICYLKALISLKVANNKLVELP-SGLYLLQRLENLDLSNNRLTSLGSLDLC 254 (1137)
Q Consensus 178 ~IP~-~l~~L~~L~~L~Ls~N~L~~L-P~~l~~L~~L~~L~Ls~N~Ls~IP-~~l~~L~~L~~LdLS~N~Lsg~~p~~l~ 254 (1137)
.+|+ .|..+++|+.|+|++|+++.+ |..|.++++|++|++++|+++.+| ..+..+++|+.|+|++|.+...-+.. .
T Consensus 167 ~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~-~ 245 (284)
T d1ozna_ 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-P 245 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-H
T ss_pred ccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch-H
Confidence 8765 778899999999999999965 788899999999999999999776 45778999999999999988643311 1
Q ss_pred CCCCCCEEEccCCcCCCCCCCCcchh
Q 001152 255 LMHNLQNLNLQYNKLLSYCQVPSWIC 280 (1137)
Q Consensus 255 ~L~~L~~L~Ls~N~L~~~~~iP~~~~ 280 (1137)
-+..++.+....+.+.| ..|..+.
T Consensus 246 l~~~l~~~~~~~~~~~C--~~p~~l~ 269 (284)
T d1ozna_ 246 LWAWLQKFRGSSSEVPC--SLPQRLA 269 (284)
T ss_dssp HHHHHHHCCSEECCCBE--EESGGGT
T ss_pred HHHHHHhCcCCCCceEe--CCchHHc
Confidence 11234555566666665 5555543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=3.8e-21 Score=199.69 Aligned_cols=141 Identities=18% Similarity=0.212 Sum_probs=105.5
Q ss_pred ceEeeeecccCceEEEEEEE-CCccEEEEEEecccCCC----C------hHHHHHhHHhHHHHHHHHHhCCCCCcceeee
Q 001152 804 LSSCDEAGKSVSSSLFRCKF-GSADAAAKVRTLKVCGS----S------ADEIRNFEYSCLGEVRMLGALRHSCIVEMYG 872 (1137)
Q Consensus 804 y~l~~~LG~GsfG~Vy~a~~-~~~~vAVKi~~l~~~~~----~------~~~~e~~~~~~lrEi~iL~~L~HpNIVkllg 872 (1137)
+.+.++||+|+||+||+|++ .+..||||+.+...... . ..........+.+|+..+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46889999999999999987 46889999864322110 0 0011122234567899999999999998876
Q ss_pred eEecCCCCCCCCCCCccccceEEEEEeeccCCCHHHHHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001152 873 HKISSKWLPSADGNPEHHLLQSAIFMEYVKGGSVKNYIEKLSETGEKHVSVKLALFIAQDVAAALVELHSKHIMHRDIKS 952 (1137)
Q Consensus 873 ~~~~~~~~~~~~g~~~~~~~~l~LVmEy~~ggSL~~~L~~~~~~~~~~ls~~~i~~I~~QIa~gL~yLHs~gIIHrDLKP 952 (1137)
+.. .++||||+++..+. .++...+..++.||+.||+|||++||+||||||
T Consensus 82 ~~~------------------~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP 131 (191)
T d1zara2 82 WEG------------------NAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQ 131 (191)
T ss_dssp EET------------------TEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred ecC------------------CEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCCh
Confidence 531 17999999865432 244455678999999999999999999999999
Q ss_pred CCeEeccccccCCCCCeEEEeecCcccccc
Q 001152 953 ENILIDLERKKADGKPVVKLCDFDRAVPLR 982 (1137)
Q Consensus 953 ~NILld~~~~~~~~~~~vKL~DFGla~~~~ 982 (1137)
+|||++++ .++|+|||.|....
T Consensus 132 ~NILv~~~--------~~~liDFG~a~~~~ 153 (191)
T d1zara2 132 YNVLVSEE--------GIWIIDFPQSVEVG 153 (191)
T ss_dssp TSEEEETT--------EEEECCCTTCEETT
T ss_pred hheeeeCC--------CEEEEECCCcccCC
Confidence 99999854 48999999886543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=4.5e-19 Score=188.42 Aligned_cols=202 Identities=21% Similarity=0.278 Sum_probs=122.0
Q ss_pred cCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCC
Q 001152 23 PSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNE 102 (1137)
Q Consensus 23 ~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~ 102 (1137)
.+..++++.+ ..+.++.+|+.|+|++|+|+.. + .+ ..+++|++|+|++|.++.+++ +..+++|++|++++|.
T Consensus 25 ~l~~~~~~d~--~~~~~l~~L~~L~l~~~~i~~l-~-~l---~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 25 AAGKSNVTDT--VTQADLDGITTLSAFGTGVTTI-E-GV---QYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNP 96 (227)
T ss_dssp HTTCSSTTSE--ECHHHHHTCCEEECTTSCCCCC-T-TG---GGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCC
T ss_pred HhCCCCcCCc--CCHHHcCCcCEEECCCCCCCcc-h-hH---hcCCCCcEeecCCceeecccc-cccccccccccccccc
Confidence 3334444433 2344555555555555555532 1 12 233555555555555555432 5555555555555555
Q ss_pred CCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCcc
Q 001152 103 INLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182 (1137)
Q Consensus 103 L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~ 182 (1137)
++.++ .+.++++|+.|+++.+. .... ..+...+.+..+.++.+.+...+ .
T Consensus 97 ~~~i~-~l~~l~~L~~l~l~~~~-----------------------~~~~-----~~~~~~~~~~~l~~~~~~~~~~~-~ 146 (227)
T d1h6ua2 97 LKNVS-AIAGLQSIKTLDLTSTQ-----------------------ITDV-----TPLAGLSNLQVLYLDLNQITNIS-P 146 (227)
T ss_dssp CSCCG-GGTTCTTCCEEECTTSC-----------------------CCCC-----GGGTTCTTCCEEECCSSCCCCCG-G
T ss_pred ccccc-ccccccccccccccccc-----------------------cccc-----chhccccchhhhhchhhhhchhh-h
Confidence 55544 24455555555554433 2211 12344566677777777766433 3
Q ss_pred ccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEE
Q 001152 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNL 262 (1137)
Q Consensus 183 l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L 262 (1137)
+..+++|+.|++++|.++.++ .++++++|+.|+|++|+|+.+|. +.++++|+.|+|++|+|++++| +.++++|+.|
T Consensus 147 ~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L 222 (227)
T d1h6ua2 147 LAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222 (227)
T ss_dssp GGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEE
T ss_pred hccccccccccccccccccch-hhcccccceecccCCCccCCChh-hcCCCCCCEEECcCCcCCCCcc--cccCCCCCEE
Confidence 566777888888888777655 37778888888888888887764 7777888888888888887754 7788888888
Q ss_pred EccC
Q 001152 263 NLQY 266 (1137)
Q Consensus 263 ~Ls~ 266 (1137)
+|++
T Consensus 223 ~lsn 226 (227)
T d1h6ua2 223 TLTN 226 (227)
T ss_dssp EEEE
T ss_pred EeeC
Confidence 8764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.79 E-value=4.8e-18 Score=189.27 Aligned_cols=240 Identities=24% Similarity=0.215 Sum_probs=159.5
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~ 97 (1137)
.+..|++..|.|++++. .+++|++|+|++|+|+. +|+.+ .+|+.|++++|.++.|+.-. +.|++|+
T Consensus 39 ~l~~LdLs~~~L~~lp~----~~~~L~~L~Ls~N~l~~-lp~~~------~~L~~L~l~~n~l~~l~~lp---~~L~~L~ 104 (353)
T d1jl5a_ 39 QAHELELNNLGLSSLPE----LPPHLESLVASCNSLTE-LPELP------QSLKSLLVDNNNLKALSDLP---PLLEYLG 104 (353)
T ss_dssp TCSEEECTTSCCSCCCS----CCTTCSEEECCSSCCSS-CCCCC------TTCCEEECCSSCCSCCCSCC---TTCCEEE
T ss_pred CCCEEEeCCCCCCCCCC----CCCCCCEEECCCCCCcc-cccch------hhhhhhhhhhcccchhhhhc---ccccccc
Confidence 47789999999998863 35789999999999984 45432 57899999999999887421 3699999
Q ss_pred ccCCCCCcccccccCCCCCCEEEccCCCCCCCcc-------------------cccCCCCCCEEECCCCCCCCCcc----
Q 001152 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGF-------------------ALNKLKGLKELELSKVPPRPSVL---- 154 (1137)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~-------------------~~~~L~~L~~L~Ls~n~ln~~~~---- 154 (1137)
|++|.|+.+|. ++++++|+.|++++|.+...+. .+..+..++.|++.+|.......
T Consensus 105 L~~n~l~~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~ 183 (353)
T d1jl5a_ 105 VSNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLS 183 (353)
T ss_dssp CCSSCCSSCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTT
T ss_pred ccccccccccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccc
Confidence 99999999985 6889999999998887554432 23445667777777654322110
Q ss_pred -----------cchhhhcCCCCCcEEeccCCCCcccCccccC-----------------CCCCCEEEccCCCCCcc---c
Q 001152 155 -----------TLLSEIAGLKCLTKLSVCHFSIRYLPPEIGC-----------------LSNLEQLDLSFNKMKYL---P 203 (1137)
Q Consensus 155 -----------~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~-----------------L~~L~~L~Ls~N~L~~L---P 203 (1137)
.....+..++.|+.+++++|....+|..... ...+..+++..|.+..+ |
T Consensus 184 ~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~ 263 (353)
T d1jl5a_ 184 LESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263 (353)
T ss_dssp CCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0112345677788888888877665543211 12233333333332211 1
Q ss_pred hh--------------hcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcC
Q 001152 204 TE--------------ICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKL 269 (1137)
Q Consensus 204 ~~--------------l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L 269 (1137)
.. ...+++|++|+|++|+|+.||.. +++|+.|+|++|+|+.++. .+++|+.|+|++|+|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~L~~N~L~~l~~----~~~~L~~L~L~~N~L 336 (353)
T d1jl5a_ 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL---PPRLERLIASFNHLAEVPE----LPQNLKQLHVEYNPL 336 (353)
T ss_dssp TTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCC
T ss_pred chhcccccccCccccccccCCCCCEEECCCCccCccccc---cCCCCEEECCCCcCCcccc----ccCCCCEEECcCCcC
Confidence 10 11245788888888888888754 4677788888888876643 245788888888888
Q ss_pred CCCCCCCcch
Q 001152 270 LSYCQVPSWI 279 (1137)
Q Consensus 270 ~~~~~iP~~~ 279 (1137)
+.++.+|..+
T Consensus 337 ~~lp~~~~~L 346 (353)
T d1jl5a_ 337 REFPDIPESV 346 (353)
T ss_dssp SSCCCCCTTC
T ss_pred CCCCcccccc
Confidence 7765555543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=6.6e-19 Score=187.06 Aligned_cols=185 Identities=18% Similarity=0.226 Sum_probs=144.6
Q ss_pred CcccccCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEE
Q 001152 18 IKEKLPSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLK 97 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~ 97 (1137)
.++.|.+..|+|+.+. .+..+++|++|+|++|.|++..| + .++++|+.|++++|.++.++ .|.++++|+.|+
T Consensus 42 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~ls~n~i~~~~~--l---~~l~~l~~l~~~~n~~~~i~-~l~~l~~L~~l~ 113 (227)
T d1h6ua2 42 GITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP--L---KNLTKITELELSGNPLKNVS-AIAGLQSIKTLD 113 (227)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--G---TTCCSCCEEECCSCCCSCCG-GGTTCTTCCEEE
T ss_pred CcCEEECCCCCCCcch--hHhcCCCCcEeecCCceeecccc--c---cccccccccccccccccccc-cccccccccccc
Confidence 5778899999999983 58999999999999999998654 4 45599999999999999886 588999999999
Q ss_pred ccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCc
Q 001152 98 FFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIR 177 (1137)
Q Consensus 98 Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~ 177 (1137)
+++|.+..++. +.....+..+.++.+.+.... .+.++++|+.|++++|.++
T Consensus 114 l~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~----------------------------~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 114 LTSTQITDVTP-LAGLSNLQVLYLDLNQITNIS----------------------------PLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp CTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCG----------------------------GGGGCTTCCEEECCSSCCC
T ss_pred cccccccccch-hccccchhhhhchhhhhchhh----------------------------hhccccccccccccccccc
Confidence 99999886643 556667777776655432211 2445666777777777776
Q ss_pred ccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccC
Q 001152 178 YLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242 (1137)
Q Consensus 178 ~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~ 242 (1137)
.++. ++.+++|+.|+|++|+|+.+| .++++++|++|+|++|+|+.||+ +.++++|+.|+|++
T Consensus 165 ~~~~-l~~l~~L~~L~Ls~n~l~~l~-~l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 165 DLTP-LANLSKLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CCGG-GTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEE
T ss_pred cchh-hcccccceecccCCCccCCCh-hhcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEeeC
Confidence 5543 677888888888888888876 47788888888888888888874 77888888888863
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2.2e-18 Score=181.32 Aligned_cols=179 Identities=25% Similarity=0.299 Sum_probs=87.9
Q ss_pred EccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCC
Q 001152 47 DVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSP 126 (1137)
Q Consensus 47 dLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~ 126 (1137)
+|..+.+++.++. . .+.+|+.|++++|.++.++. |..+++|++|+|++|+|+.++. ++++++|++|++++|.+
T Consensus 30 ~l~~~~~~~~~~~--~---~L~~L~~L~l~~~~i~~l~~-l~~l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--N---ELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKV 102 (210)
T ss_dssp HTTCSCTTSEECH--H---HHHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred HhCcCccCCccCH--H---HhcCccEEECcCCCCCCchh-HhhCCCCCEEeCCCccccCccc-cccCccccccccccccc
Confidence 4455555544432 1 12455666666666665542 5556666666666666665553 45555666665555554
Q ss_pred CCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhh
Q 001152 127 GVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI 206 (1137)
Q Consensus 127 ~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l 206 (1137)
..++ .+. ++++|+.|++++|.+..++ .+..+++|+++++++|.++.++ .+
T Consensus 103 ~~l~-~l~---------------------------~l~~L~~L~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~~~-~~ 152 (210)
T d1h6ta2 103 KDLS-SLK---------------------------DLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDIT-VL 152 (210)
T ss_dssp CCGG-GGT---------------------------TCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCCG-GG
T ss_pred cccc-ccc---------------------------ccccccccccccccccccc-cccccccccccccccccccccc-cc
Confidence 4332 133 3334444444444443332 2344444455555555444332 33
Q ss_pred cCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEcc
Q 001152 207 CYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQ 265 (1137)
Q Consensus 207 ~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls 265 (1137)
..+++|+.|++++|+++.++. +.++++|+.|+|++|+|+.++ .+..|++|++|+|+
T Consensus 153 ~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i~~l~--~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 153 SRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELF 208 (210)
T ss_dssp GGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEE
T ss_pred ccccccccccccccccccccc-ccCCCCCCEEECCCCCCCCCh--hhcCCCCCCEEEcc
Confidence 444455555555555554432 444555555555555555432 24555555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2e-18 Score=184.34 Aligned_cols=215 Identities=20% Similarity=0.122 Sum_probs=153.1
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCc-cccCCCCCcEEEccCCCCCc-ccc-cccCCCCCCEEE
Q 001152 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPK-SVGRYEKLRNLKFFGNEINL-FPS-EVGNLLGLECLQ 120 (1137)
Q Consensus 44 ~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~-~~~~L~~L~~L~Ls~N~L~~-lP~-~l~~L~~L~~L~ 120 (1137)
++++.++++++..++..+ +++++|+|++|+|+.||. .|.++++|++|+|++|.+.. +|. .|.++++++.|.
T Consensus 11 ~~i~c~~~~l~~iP~~l~------~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~ 84 (242)
T d1xwdc1 11 RVFLCQESKVTEIPSDLP------RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84 (242)
T ss_dssp SEEEEESCSCSSCCSCSC------SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred CEEEEeCCCCCCcCCCCC------CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccc
Confidence 567777777774333222 467778888887877765 47777788888888877763 433 467777777777
Q ss_pred ccC-CCCC-CCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCC-CCCEEEccC
Q 001152 121 IKI-SSPG-VNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLS-NLEQLDLSF 196 (1137)
Q Consensus 121 Ls~-N~~~-~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~-~L~~L~Ls~ 196 (1137)
+.. |.+. ..+..|.++++|+.|++.+|.+.... ....+..+..|..+...++.+..++. .+..++ .++.|++++
T Consensus 85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~--~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~ 162 (242)
T d1xwdc1 85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLP--DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 162 (242)
T ss_dssp EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCC--CCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCS
T ss_pred ccccccccccccccccccccccccccchhhhcccc--cccccccccccccccccccccccccccccccccccceeeeccc
Confidence 643 3433 33355777788888888776543221 12234456667777778888887765 455554 788999999
Q ss_pred CCCCccchhhcCCCCCCEE-EccCCCCCccCcc-ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccC
Q 001152 197 NKMKYLPTEICYLKALISL-KVANNKLVELPSG-LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQY 266 (1137)
Q Consensus 197 N~L~~LP~~l~~L~~L~~L-~Ls~N~Ls~IP~~-l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~ 266 (1137)
|+++.++..+....++..+ ++++|+|+.||.. |.++++|+.|+|++|+|+.+++..|.++++|+.|++.+
T Consensus 163 n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 163 NGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp SCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 9999998877777777666 5688889999876 67799999999999999998887788888888777654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=9.6e-18 Score=174.82 Aligned_cols=178 Identities=23% Similarity=0.290 Sum_probs=102.2
Q ss_pred EEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCC
Q 001152 45 VIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKIS 124 (1137)
Q Consensus 45 ~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N 124 (1137)
.++|+.+.+++.++. .. +.+|+.|+|++|.++.++ .+..+++|++|+|++|+|+.++. ++++++|+.|+++.|
T Consensus 22 ~~~l~~~~~~~~~~~--~~---l~~l~~L~l~~~~i~~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 22 KTVLGKTNVTDTVSQ--TD---LDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHTTCSSTTSEECH--HH---HTTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred HHHhCCCCCCCccCH--HH---hcCCCEEECCCCCCCCcc-ccccCCCcCcCccccccccCccc-ccCCccccccccccc
Confidence 344555665554432 12 256666666666666663 35666667777777766666654 666666666666655
Q ss_pred CCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccch
Q 001152 125 SPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPT 204 (1137)
Q Consensus 125 ~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~ 204 (1137)
.+..++ .+.+++.|+.|++++|.+..++ .+..+++|+.|++++|++..+|
T Consensus 95 ~~~~~~----------------------------~l~~l~~L~~L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~~~- 144 (199)
T d2omxa2 95 QIADIT----------------------------PLANLTNLTGLTLFNNQITDID-PLKNLTNLNRLELSSNTISDIS- 144 (199)
T ss_dssp CCCCCG----------------------------GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG-
T ss_pred cccccc----------------------------cccccccccccccccccccccc-ccchhhhhHHhhhhhhhhcccc-
Confidence 533332 2334455555555555554432 2455566666666666666554
Q ss_pred hhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEE
Q 001152 205 EICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNL 262 (1137)
Q Consensus 205 ~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L 262 (1137)
.+..+++|+.|++++|+++.++. +.++++|+.|+|++|+++.++ .+..|++|+.|
T Consensus 145 ~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~i~~i~--~l~~L~~L~~L 199 (199)
T d2omxa2 145 ALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNKVSDIS--VLAKLTNLESL 199 (199)
T ss_dssp GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGGGCTTCSEE
T ss_pred cccccccccccccccccccCCcc-ccCCCCCCEEECCCCCCCCCc--cccCCCCCCcC
Confidence 45566666666666666666542 556666666666666666542 35566666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=2.7e-17 Score=172.88 Aligned_cols=180 Identities=18% Similarity=0.178 Sum_probs=127.6
Q ss_pred cCCCCCCcccCCCCCCCCCCCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCC
Q 001152 23 PSEANKINNEKNGSVNDDDDDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNE 102 (1137)
Q Consensus 23 ~~~~N~i~~l~~~~f~~l~~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~ 102 (1137)
.+..+.++.+.. ...+.+|+.|++++|.|+.... + ..+++|++|+|++|+|+.+++ ++.+++|++|+|++|+
T Consensus 30 ~l~~~~~~~~~~--~~~L~~L~~L~l~~~~i~~l~~--l---~~l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 30 NLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--I---QYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENK 101 (210)
T ss_dssp HTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCCTT--G---GGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred HhCcCccCCccC--HHHhcCccEEECcCCCCCCchh--H---hhCCCCCEEeCCCccccCccc-cccCcccccccccccc
Confidence 344555554432 2357789999999999987542 3 445999999999999999874 7899999999999999
Q ss_pred CCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCcc
Q 001152 103 INLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPE 182 (1137)
Q Consensus 103 L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~ 182 (1137)
|+.+| .+.++++|+.|++++|....++ .+..++.|+.++++.|.++.++ .
T Consensus 102 i~~l~-~l~~l~~L~~L~l~~~~~~~~~----------------------------~l~~l~~l~~l~~~~n~l~~~~-~ 151 (210)
T d1h6ta2 102 VKDLS-SLKDLKKLKSLSLEHNGISDIN----------------------------GLVHLPQLESLYLGNNKITDIT-V 151 (210)
T ss_dssp CCCGG-GGTTCTTCCEEECTTSCCCCCG----------------------------GGGGCTTCCEEECCSSCCCCCG-G
T ss_pred ccccc-cccccccccccccccccccccc----------------------------cccccccccccccccccccccc-c
Confidence 99998 5899999999999887644332 2344555566666666655433 3
Q ss_pred ccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccC
Q 001152 183 IGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSN 242 (1137)
Q Consensus 183 l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~ 242 (1137)
+..+++|+.|++++|+++.++ .+.++++|+.|+|++|+|+.|| .+..+++|+.|+|++
T Consensus 152 ~~~l~~L~~l~l~~n~l~~i~-~l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 152 LSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGGCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEE
T ss_pred ccccccccccccccccccccc-cccCCCCCCEEECCCCCCCCCh-hhcCCCCCCEEEccC
Confidence 455666666666666666665 3666666777777777666665 466666777776653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=3.8e-17 Score=170.24 Aligned_cols=167 Identities=21% Similarity=0.254 Sum_probs=125.5
Q ss_pred cEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCC
Q 001152 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPR 150 (1137)
Q Consensus 71 ~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln 150 (1137)
..+.++.+.++.++. ...+.+|++|++++|.|+.++ .+..+++| ++|++++|.+.
T Consensus 21 i~~~l~~~~~~~~~~-~~~l~~l~~L~l~~~~i~~l~-~l~~l~nL-----------------------~~L~Ls~N~l~ 75 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSID-GVEYLNNL-----------------------TQINFSNNQLT 75 (199)
T ss_dssp HHHHTTCSSTTSEEC-HHHHTTCCEEECTTSCCCCCT-TGGGCTTC-----------------------CEEECCSSCCC
T ss_pred HHHHhCCCCCCCccC-HHHhcCCCEEECCCCCCCCcc-ccccCCCc-----------------------CcCcccccccc
Confidence 344455555554321 234455666666666665553 24444444 45555544332
Q ss_pred CCcccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCcccc
Q 001152 151 PSVLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLY 230 (1137)
Q Consensus 151 ~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~ 230 (1137)
. ++ .+.++++|++|++++|.+..+|. +..+++|+.|++++|.+..++ .+..+++|+.|++++|++..+| .+.
T Consensus 76 ~----~~-~l~~l~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~~~-~l~ 147 (199)
T d2omxa2 76 D----IT-PLKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDID-PLKNLTNLNRLELSSNTISDIS-ALS 147 (199)
T ss_dssp C----CG-GGTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG-GGT
T ss_pred C----cc-cccCCcccccccccccccccccc-ccccccccccccccccccccc-ccchhhhhHHhhhhhhhhcccc-ccc
Confidence 2 22 26788899999999999988875 889999999999999998876 5888999999999999999886 588
Q ss_pred CCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCC
Q 001152 231 LLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSY 272 (1137)
Q Consensus 231 ~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~ 272 (1137)
.+++|+.|++++|+++++++ +.++++|+.|+|++|+++.+
T Consensus 148 ~~~~L~~L~l~~n~l~~l~~--l~~l~~L~~L~ls~N~i~~i 187 (199)
T d2omxa2 148 GLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSDI 187 (199)
T ss_dssp TCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred ccccccccccccccccCCcc--ccCCCCCCEEECCCCCCCCC
Confidence 89999999999999999854 89999999999999999873
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.72 E-value=3.8e-16 Score=173.66 Aligned_cols=217 Identities=24% Similarity=0.231 Sum_probs=151.0
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEc
Q 001152 42 DDSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQI 121 (1137)
Q Consensus 42 ~L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~L 121 (1137)
+++.|||++|+|+. +|+. +++|++|+|++|+|+.||..+ .+|+.|++++|+++.|+.- .+.|++|+|
T Consensus 39 ~l~~LdLs~~~L~~-lp~~------~~~L~~L~Ls~N~l~~lp~~~---~~L~~L~l~~n~l~~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL------PPHLESLVASCNSLTELPELP---QSLKSLLVDNNNLKALSDL---PPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC------CTTCSEEECCSSCCSSCCCCC---TTCCEEECCSSCCSCCCSC---CTTCCEEEC
T ss_pred CCCEEEeCCCCCCC-CCCC------CCCCCEEECCCCCCcccccch---hhhhhhhhhhcccchhhhh---ccccccccc
Confidence 68999999999986 4542 268999999999999999765 4789999999999988742 246999999
Q ss_pred cCCCCCCCcccccCCCCCCEEECCCCCCCCCccc---------------chhhhcCCCCCcEEeccCCCCcccCc-----
Q 001152 122 KISSPGVNGFALNKLKGLKELELSKVPPRPSVLT---------------LLSEIAGLKCLTKLSVCHFSIRYLPP----- 181 (1137)
Q Consensus 122 s~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~---------------lp~~l~~L~~L~~L~Ls~N~L~~IP~----- 181 (1137)
++|.+..+|. +..+++|+.|+++++.+...... .+..+..++.++.|.+.+|.+..+|.
T Consensus 106 ~~n~l~~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~ 184 (353)
T d1jl5a_ 106 SNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSL 184 (353)
T ss_dssp CSSCCSSCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred cccccccccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccc
Confidence 9999888875 67899999999998765432221 12335567778888888877654332
Q ss_pred --------------cccCCCCCCEEEccCCCCCccchhhcC-----------------CCCCCEEEccCCCCCcc---Cc
Q 001152 182 --------------EIGCLSNLEQLDLSFNKMKYLPTEICY-----------------LKALISLKVANNKLVEL---PS 227 (1137)
Q Consensus 182 --------------~l~~L~~L~~L~Ls~N~L~~LP~~l~~-----------------L~~L~~L~Ls~N~Ls~I---P~ 227 (1137)
.+..++.|+.|++++|....+|..... ...+..+++..|.+..+ |.
T Consensus 185 ~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~ 264 (353)
T d1jl5a_ 185 ESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264 (353)
T ss_dssp CEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 235567888888888887766533221 12344444444433321 11
Q ss_pred c--------------ccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCC
Q 001152 228 G--------------LYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVP 276 (1137)
Q Consensus 228 ~--------------l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP 276 (1137)
. ...+++|+.|+|++|+|+.++. .+++|+.|+|++|+|+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~lp~----~~~~L~~L~L~~N~L~~l~~~~ 323 (353)
T d1jl5a_ 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLAEVPELP 323 (353)
T ss_dssp TCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCCCC
T ss_pred hhcccccccCccccccccCCCCCEEECCCCccCcccc----ccCCCCEEECCCCcCCcccccc
Confidence 1 1124678888888888887653 2567888888888887654443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.4e-16 Score=169.91 Aligned_cols=197 Identities=16% Similarity=0.139 Sum_probs=163.4
Q ss_pred cEEEeecCCCCccCccccCCCCCcEEEccCCCCCccccc-ccCCCCCCEEEccCCCCCC-C-cccccCCCCCCEEECCCC
Q 001152 71 EGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSE-VGNLLGLECLQIKISSPGV-N-GFALNKLKGLKELELSKV 147 (1137)
Q Consensus 71 ~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~-l~~L~~L~~L~Ls~N~~~~-~-~~~~~~L~~L~~L~Ls~n 147 (1137)
+.++.+++.++.||..+. +++++|+|++|.|+.+|.. |.++++|++|+|++|.+.. + +..|.+++++++|.+...
T Consensus 11 ~~i~c~~~~l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 11 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp SEEEEESCSCSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred CEEEEeCCCCCCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 678999999999998764 4899999999999999874 8999999999999998553 3 457899999999998752
Q ss_pred CCCCCcccchhhhcCCCCCcEEeccCCCCcccCc--cccCCCCCCEEEccCCCCCccc-hhhcCC-CCCCEEEccCCCCC
Q 001152 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP--EIGCLSNLEQLDLSFNKMKYLP-TEICYL-KALISLKVANNKLV 223 (1137)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~--~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L-~~L~~L~Ls~N~Ls 223 (1137)
++.....+..|.++++|+.|++++|.+..+|. .+..+..|..+..+++.+..++ ..+..+ ..++.|++++|+++
T Consensus 89 --n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 89 --NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp --TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred --ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 23444555678899999999999999987665 3455667777788888999876 445554 48999999999999
Q ss_pred ccCccccCCCCCCEE-eccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 224 ELPSGLYLLQRLENL-DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 224 ~IP~~l~~L~~L~~L-dLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
.++..+++..++..+ ++++|+|+.+++..|..+++|++|+|++|+|+.
T Consensus 167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~ 215 (242)
T d1xwdc1 167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215 (242)
T ss_dssp EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCC
T ss_pred ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCc
Confidence 999888887776655 678899999988789999999999999999986
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.65 E-value=7.4e-17 Score=167.03 Aligned_cols=171 Identities=17% Similarity=0.120 Sum_probs=119.9
Q ss_pred ccEEEeecCCCCccCccccCCCCCcEEEccCCCCCc-cc-ccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCC
Q 001152 70 VEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINL-FP-SEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKV 147 (1137)
Q Consensus 70 L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~-lP-~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n 147 (1137)
.+.++.++|+|+.||..+. +++++|+|++|+|+. ++ ..|.++++|+.|+|++|.+..+
T Consensus 10 ~~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~------------------ 69 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI------------------ 69 (192)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCB------------------
T ss_pred CCEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccc------------------
Confidence 3567778888888877664 477778888888763 42 3356666666666665553322
Q ss_pred CCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCCCCccch-hhcCCCCCCEEEccCCCCCcc
Q 001152 148 PPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNKMKYLPT-EICYLKALISLKVANNKLVEL 225 (1137)
Q Consensus 148 ~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP~-~l~~L~~L~~L~Ls~N~Ls~I 225 (1137)
.+..+..+++|+.|+|++|+|+.||+ .|.++++|++|+|++|+|+.||. .|..+++|++|+|++|.+...
T Consensus 70 --------~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 70 --------EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp --------CTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred --------cccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 23456667788888888888887766 57888899999999999988764 467888899999999888744
Q ss_pred CccccCCCCCCEEeccCCcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 226 PSGLYLLQRLENLDLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 226 P~~l~~L~~L~~LdLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
+....-...|+.+.+..|.++...|. .+..++.++|+.|.|.|
T Consensus 142 ~~~~~~~~~l~~~~l~~~~~~c~~p~---~l~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 142 CHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKC 184 (192)
T ss_dssp GGGHHHHHHHHHHCCSGGGCBBCSST---TTTTSBGGGSCTTTCCC
T ss_pred cchHHHhhhhhhhcccCCCeEeCCCh---hhcCCEeeecCHhhCcC
Confidence 33221123456667778888765553 45667788889998887
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.60 E-value=6.3e-16 Score=159.93 Aligned_cols=173 Identities=17% Similarity=0.161 Sum_probs=131.1
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCc-cC-ccccCCCCCcEEEccCCCCCccc-ccccCCCCCCEE
Q 001152 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNL-IP-KSVGRYEKLRNLKFFGNEINLFP-SEVGNLLGLECL 119 (1137)
Q Consensus 43 L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~-IP-~~~~~L~~L~~L~Ls~N~L~~lP-~~l~~L~~L~~L 119 (1137)
.+++|+++|+|+.+++..+ +++++|+|++|+|+. ++ ..|.++++|+.|+|++|.+..++ ..+..+++|+.|
T Consensus 10 ~~~v~Cs~~~L~~iP~~lp------~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L 83 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRDIP------LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TTEEECTTSCCSSCCSCCC------TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCEEEEeCCCcCccCCCCC------CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccccee
Confidence 4689999999997654322 589999999999985 54 46899999999999999999764 557888889988
Q ss_pred EccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCCcEEeccCCCCcccCc-cccCCCCCCEEEccCCC
Q 001152 120 QIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCLTKLSVCHFSIRYLPP-EIGCLSNLEQLDLSFNK 198 (1137)
Q Consensus 120 ~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~-~l~~L~~L~~L~Ls~N~ 198 (1137)
+|++|++..++ |..|.++++|++|+|++|+|+.||+ .|..+++|++|+|++|.
T Consensus 84 ~Ls~N~l~~l~--------------------------~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~ 137 (192)
T d1w8aa_ 84 QLGENKIKEIS--------------------------NKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP 137 (192)
T ss_dssp ECCSCCCCEEC--------------------------SSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCC
T ss_pred eeccccccccC--------------------------HHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccc
Confidence 88888755443 2345667888888888999988866 67889999999999999
Q ss_pred CCccchhhcCCCCCCEEEccCCCCC-ccCccccCCCCCCEEeccCCcCCCCCc
Q 001152 199 MKYLPTEICYLKALISLKVANNKLV-ELPSGLYLLQRLENLDLSNNRLTSLGS 250 (1137)
Q Consensus 199 L~~LP~~l~~L~~L~~L~Ls~N~Ls-~IP~~l~~L~~L~~LdLS~N~Lsg~~p 250 (1137)
+...+....-...|+.+.+..|.++ ..|.. +..++.++|+.|.|+-..+
T Consensus 138 ~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 138 FNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp BCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCCCCCC
T ss_pred cccccchHHHhhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCcCCCC
Confidence 8844322111223556677788877 66754 4567778999999886544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=5.5e-15 Score=142.44 Aligned_cols=110 Identities=31% Similarity=0.362 Sum_probs=93.7
Q ss_pred cEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEeccCCcCC
Q 001152 167 TKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLLQRLENLDLSNNRLT 246 (1137)
Q Consensus 167 ~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~LdLS~N~Ls 246 (1137)
++|+|++|+|+.+|. +..+++|++|+|++|+|+.+|+.++.+++|+.|+|++|+|+.+| .+..+++|+.|++++|+|+
T Consensus 1 R~L~Ls~n~l~~l~~-l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~l~~N~i~ 78 (124)
T d1dcea3 1 RVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQ 78 (124)
T ss_dssp SEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCC
T ss_pred CEEEcCCCCCCCCcc-cccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccC-ccccccccCeEECCCCccC
Confidence 478999999998874 78899999999999999999988999999999999999999887 4888999999999999998
Q ss_pred CCCc-ccccCCCCCCEEEccCCcCCCCCCCCcc
Q 001152 247 SLGS-LDLCLMHNLQNLNLQYNKLLSYCQVPSW 278 (1137)
Q Consensus 247 g~~p-~~l~~L~~L~~L~Ls~N~L~~~~~iP~~ 278 (1137)
.++. ..+..+++|+.|++++|+++....++..
T Consensus 79 ~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~ 111 (124)
T d1dcea3 79 QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111 (124)
T ss_dssp SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred CCCCchhhcCCCCCCEEECCCCcCCcCccHHHH
Confidence 7754 4688899999999999998875544443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.8e-14 Score=145.26 Aligned_cols=125 Identities=19% Similarity=0.187 Sum_probs=62.5
Q ss_pred ccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccCCCCCCCcccccCCCCCCEEECCCCCCCCCcccchhhhcCCCCC
Q 001152 87 VGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKISSPGVNGFALNKLKGLKELELSKVPPRPSVLTLLSEIAGLKCL 166 (1137)
Q Consensus 87 ~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~N~~~~~~~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~~L~~L 166 (1137)
+.++.+|+.|+|++|+|+.||..+..+++|+.|+|++|.+..++ .+..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l~----------------------------~~~~l~~L 65 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD----------------------------GFPLLRRL 65 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEEC----------------------------CCCCCSSC
T ss_pred ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCccC----------------------------CcccCcch
Confidence 33445555566666665555543344444444444444322111 12334455
Q ss_pred cEEeccCCCCcccCccc-cCCCCCCEEEccCCCCCccch--hhcCCCCCCEEEccCCCCCccCc----cccCCCCCCEEe
Q 001152 167 TKLSVCHFSIRYLPPEI-GCLSNLEQLDLSFNKMKYLPT--EICYLKALISLKVANNKLVELPS----GLYLLQRLENLD 239 (1137)
Q Consensus 167 ~~L~Ls~N~L~~IP~~l-~~L~~L~~L~Ls~N~L~~LP~--~l~~L~~L~~L~Ls~N~Ls~IP~----~l~~L~~L~~Ld 239 (1137)
+.|++++|+|+.+|+.+ ..+++|+.|+|++|+|+.++. .+..+++|+.|+|++|.++.+|. .+..+++|+.||
T Consensus 66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred hhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 55555555555555432 345556666666666555542 34555555555555555555542 234455555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=9.8e-14 Score=133.54 Aligned_cols=99 Identities=20% Similarity=0.127 Sum_probs=71.3
Q ss_pred CEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCCccCccccCCCCCcEEEccCCCCCcccccccCCCCCCEEEccC
Q 001152 44 SVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLNLIPKSVGRYEKLRNLKFFGNEINLFPSEVGNLLGLECLQIKI 123 (1137)
Q Consensus 44 ~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~~IP~~~~~L~~L~~L~Ls~N~L~~lP~~l~~L~~L~~L~Ls~ 123 (1137)
++|||++|+|+.. +. + +++++|++|+|++|+|+.+|+.|+.+++|++|+|++|+|+.+|. ++++++|+.|++++
T Consensus 1 R~L~Ls~n~l~~l-~~-l---~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~~-~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CH-L---EQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG-VANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCSSC-CC-G---GGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCS
T ss_pred CEEEcCCCCCCCC-cc-c---ccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccCc-cccccccCeEECCC
Confidence 5788888888754 22 4 34488888888888888888888888888888888888888864 78888888888888
Q ss_pred CCCCCCc--ccccCCCCCCEEECCCCC
Q 001152 124 SSPGVNG--FALNKLKGLKELELSKVP 148 (1137)
Q Consensus 124 N~~~~~~--~~~~~L~~L~~L~Ls~n~ 148 (1137)
|.+..++ ..+..+++|+.|++++|+
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred CccCCCCCchhhcCCCCCCEEECCCCc
Confidence 8766544 234444444444444433
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=1.4e-14 Score=162.60 Aligned_cols=236 Identities=17% Similarity=0.134 Sum_probs=173.2
Q ss_pred CCCCCCCCCEEEccCCCCCCCCccccc-CCCCCCCccEEEeecCCCCcc----C-------ccccCCCCCcEEEccCCCC
Q 001152 36 SVNDDDDDSVIDVSGKTVDFPLIESYG-NRGGDNSVEGLYLYKNVLNLI----P-------KSVGRYEKLRNLKFFGNEI 103 (1137)
Q Consensus 36 ~f~~l~~L~~LdLs~N~L~~~~p~~~~-~l~~L~~L~~L~Ls~N~L~~I----P-------~~~~~L~~L~~L~Ls~N~L 103 (1137)
++.....|+.|+|++|.|...-...++ .+...++|+.|+|+++.+..+ | ..+...++|+.|+|++|.+
T Consensus 26 ~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i 105 (344)
T d2ca6a1 26 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 105 (344)
T ss_dssp HHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCC
T ss_pred HHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccc
Confidence 345578899999999988654333332 345668999999998866532 2 2345678999999999998
Q ss_pred Cc-----ccccccCCCCCCEEEccCCCCCCCcc--------------cccCCCCCCEEECCCCCCCCCc-ccchhhhcCC
Q 001152 104 NL-----FPSEVGNLLGLECLQIKISSPGVNGF--------------ALNKLKGLKELELSKVPPRPSV-LTLLSEIAGL 163 (1137)
Q Consensus 104 ~~-----lP~~l~~L~~L~~L~Ls~N~~~~~~~--------------~~~~L~~L~~L~Ls~n~ln~~~-~~lp~~l~~L 163 (1137)
+. +...+...++|+.|++++|.++.... .......|+.|.+++|.+.... ..+...+..+
T Consensus 106 ~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~ 185 (344)
T d2ca6a1 106 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185 (344)
T ss_dssp CTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred ccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhh
Confidence 73 44556678999999999887543210 1135678999999997764332 2344556778
Q ss_pred CCCcEEeccCCCCcc------cCccccCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCCc-----cCc
Q 001152 164 KCLTKLSVCHFSIRY------LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE-----LPS 227 (1137)
Q Consensus 164 ~~L~~L~Ls~N~L~~------IP~~l~~L~~L~~L~Ls~N~L~-----~LP~~l~~L~~L~~L~Ls~N~Ls~-----IP~ 227 (1137)
+.|+.|+|++|+|+. +...+..+++|+.|+|++|.|+ .+...+..+++|++|+|++|.|+. |-.
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 899999999999873 3345677899999999999997 355678889999999999999983 222
Q ss_pred cccC--CCCCCEEeccCCcCCCCC----cccc-cCCCCCCEEEccCCcCCC
Q 001152 228 GLYL--LQRLENLDLSNNRLTSLG----SLDL-CLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 228 ~l~~--L~~L~~LdLS~N~Lsg~~----p~~l-~~L~~L~~L~Ls~N~L~~ 271 (1137)
.+.. .+.|+.|+|++|+|+... ...+ .++++|+.|+|++|++..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 3333 367999999999987432 1223 257899999999999876
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.4e-13 Score=138.55 Aligned_cols=101 Identities=24% Similarity=0.243 Sum_probs=51.4
Q ss_pred CCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhh-cCCCCCCEEEccCCCCCccCc--cccCCCCCCEE
Q 001152 162 GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEI-CYLKALISLKVANNKLVELPS--GLYLLQRLENL 238 (1137)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l-~~L~~L~~L~Ls~N~Ls~IP~--~l~~L~~L~~L 238 (1137)
.+++|+.|+|++|+|+.++ .|..+++|++|+|++|+|+.+|..+ ..+++|+.|+|++|+|+.++. .+..+++|+.|
T Consensus 39 ~l~~L~~L~Ls~N~i~~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L 117 (162)
T d1a9na_ 39 TLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117 (162)
T ss_dssp GTTCCSEEECCSSCCCEEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEE
T ss_pred ccccCCEEECCCCCCCccC-CcccCcchhhhhcccccccCCCccccccccccccceeccccccccccccccccccccchh
Confidence 3444555555555555553 2455555555555555555554432 345555555555555554442 34455555555
Q ss_pred eccCCcCCCCCc---ccccCCCCCCEEE
Q 001152 239 DLSNNRLTSLGS---LDLCLMHNLQNLN 263 (1137)
Q Consensus 239 dLS~N~Lsg~~p---~~l~~L~~L~~L~ 263 (1137)
+|++|.++..+. ..+..+++|++||
T Consensus 118 ~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 118 CILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred hcCCCccccccchHHHHHHHCCCcCeeC
Confidence 555555554431 1244455555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=2.2e-13 Score=149.25 Aligned_cols=177 Identities=17% Similarity=0.161 Sum_probs=89.7
Q ss_pred CCCCCcEEEccCCCCC--cccccccCCCCCCEEEccCCCCCC-CcccccCCCCCCEEECCCCC-CCCCcccchhhhcCCC
Q 001152 89 RYEKLRNLKFFGNEIN--LFPSEVGNLLGLECLQIKISSPGV-NGFALNKLKGLKELELSKVP-PRPSVLTLLSEIAGLK 164 (1137)
Q Consensus 89 ~L~~L~~L~Ls~N~L~--~lP~~l~~L~~L~~L~Ls~N~~~~-~~~~~~~L~~L~~L~Ls~n~-ln~~~~~lp~~l~~L~ 164 (1137)
...+|++|+|+++.++ .++.-+.++++|++|+|+++.+.. ....+..+++|++|+++++. ++. ..+..-+.+++
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd--~~l~~l~~~~~ 121 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE--FALQTLLSSCS 121 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCH--HHHHHHHHHCT
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccc--cccchhhHHHH
Confidence 3345566666655554 234445555566666665554321 12334455566666665521 110 01111223456
Q ss_pred CCcEEeccCC-CCc--ccCcccc-CCCCCCEEEccCC--CCC--ccchhhcCCCCCCEEEccCCC-CC-ccCccccCCCC
Q 001152 165 CLTKLSVCHF-SIR--YLPPEIG-CLSNLEQLDLSFN--KMK--YLPTEICYLKALISLKVANNK-LV-ELPSGLYLLQR 234 (1137)
Q Consensus 165 ~L~~L~Ls~N-~L~--~IP~~l~-~L~~L~~L~Ls~N--~L~--~LP~~l~~L~~L~~L~Ls~N~-Ls-~IP~~l~~L~~ 234 (1137)
+|+.|+++++ .++ .++..+. ..++|+.|+|++. .++ .+..-+.++++|++|+|++|. ++ ..+..+.++++
T Consensus 122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~ 201 (284)
T d2astb2 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201 (284)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCc
Confidence 6666666653 333 2222222 2345666666653 333 233333456666666666643 55 44455666666
Q ss_pred CCEEeccC-CcCCCCCcccccCCCCCCEEEccCC
Q 001152 235 LENLDLSN-NRLTSLGSLDLCLMHNLQNLNLQYN 267 (1137)
Q Consensus 235 L~~LdLS~-N~Lsg~~p~~l~~L~~L~~L~Ls~N 267 (1137)
|+.|+|++ +.++......+.++++|+.|+++++
T Consensus 202 L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 66666666 3555444445666666666666655
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=2.9e-14 Score=163.39 Aligned_cols=87 Identities=7% Similarity=0.079 Sum_probs=44.4
Q ss_pred CcccccCCCCCCcccC----CCCCCCCCCCCEEEccCCCCCCCCcccc-cCCC-CCCCccEEEeecCCCCc-----cCcc
Q 001152 18 IKEKLPSEANKINNEK----NGSVNDDDDDSVIDVSGKTVDFPLIESY-GNRG-GDNSVEGLYLYKNVLNL-----IPKS 86 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~----~~~f~~l~~L~~LdLs~N~L~~~~p~~~-~~l~-~L~~L~~L~Ls~N~L~~-----IP~~ 86 (1137)
.++.|.+..|.|+... ..++...++|+.|||++|+|+......+ ..+. ...+|++|+|++|.++. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 4555666666555322 1234556666666666666542111111 1111 11356666666666652 3445
Q ss_pred ccCCCCCcEEEccCCCCC
Q 001152 87 VGRYEKLRNLKFFGNEIN 104 (1137)
Q Consensus 87 ~~~L~~L~~L~Ls~N~L~ 104 (1137)
+..+++|++|+|++|.|+
T Consensus 108 l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTSCTTCCEEECCSSBCH
T ss_pred hhccccccccccccccch
Confidence 556666666666666543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=1.5e-12 Score=130.01 Aligned_cols=119 Identities=21% Similarity=0.150 Sum_probs=102.1
Q ss_pred CCCCCcEEeccCCCCcccCccccCCCCCCEEEccCC-CCCccc-hhhcCCCCCCEEEccCCCCCccC-ccccCCCCCCEE
Q 001152 162 GLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFN-KMKYLP-TEICYLKALISLKVANNKLVELP-SGLYLLQRLENL 238 (1137)
Q Consensus 162 ~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N-~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP-~~l~~L~~L~~L 238 (1137)
.+...+.++.+++.+..+|..+..+++|+.|+|++| .|+.|+ ..|.++++|+.|+|++|+|+.|+ ..|..+++|+.|
T Consensus 6 ~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred CcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 345567789999999999999999999999999876 599886 46889999999999999999995 457889999999
Q ss_pred eccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCCCcchhh
Q 001152 239 DLSNNRLTSLGSLDLCLMHNLQNLNLQYNKLLSYCQVPSWICC 281 (1137)
Q Consensus 239 dLS~N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~~~~iP~~~~~ 281 (1137)
+|++|+|+.+++..|..+ +|+.|+|++|+|.|.|.+.....|
T Consensus 86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~ 127 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRW 127 (156)
T ss_dssp ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHH
T ss_pred eccCCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHH
Confidence 999999999988666554 799999999999998877655444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=8.7e-15 Score=152.45 Aligned_cols=81 Identities=31% Similarity=0.308 Sum_probs=32.5
Q ss_pred CCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccC--ccccCCCCCCEEeccC
Q 001152 165 CLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP--SGLYLLQRLENLDLSN 242 (1137)
Q Consensus 165 ~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP--~~l~~L~~L~~LdLS~ 242 (1137)
+|+.|++++|.|+.||..+..+++|++|+|++|+|+.++ .+..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++
T Consensus 71 ~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~ 149 (198)
T d1m9la_ 71 NLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149 (198)
T ss_dssp TCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECS
T ss_pred cccChhhcccccccccccccccccccccccccccccccc-cccccccccccccccchhccccccccccCCCccceeecCC
Confidence 333333333333333332222333444444444444432 2333444444444444444333 1234444444444444
Q ss_pred CcCC
Q 001152 243 NRLT 246 (1137)
Q Consensus 243 N~Ls 246 (1137)
|.++
T Consensus 150 N~l~ 153 (198)
T d1m9la_ 150 NPLY 153 (198)
T ss_dssp SHHH
T ss_pred Cccc
Confidence 4443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=8.3e-13 Score=144.63 Aligned_cols=220 Identities=20% Similarity=0.171 Sum_probs=147.1
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCCCccEEEeecCCCC--ccCccccCCCCCcEEEccCCCCC-cccccccCCCCCCEE
Q 001152 43 DSVIDVSGKTVDFPLIESYGNRGGDNSVEGLYLYKNVLN--LIPKSVGRYEKLRNLKFFGNEIN-LFPSEVGNLLGLECL 119 (1137)
Q Consensus 43 L~~LdLs~N~L~~~~p~~~~~l~~L~~L~~L~Ls~N~L~--~IP~~~~~L~~L~~L~Ls~N~L~-~lP~~l~~L~~L~~L 119 (1137)
+..+.++...+...+...+ ...+|++|+|+++.++ .++..+.++++|++|+|+++.++ ..+..++.+++|+.|
T Consensus 25 ~~~lrl~~~~~~~~~~~~~----~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 100 (284)
T d2astb2 25 VIAFRCPRSFMDQPLAEHF----SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100 (284)
T ss_dssp CSEEECTTCEECSCCCSCC----CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ceEeeccccccccchhhhc----cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCc
Confidence 4566666665554433322 3357889999888776 34555778888999999988887 556778888899999
Q ss_pred EccCCC-CCCCc--ccccCCCCCCEEECCCCCCCCCcccchhhhc-CCCCCcEEeccCC--CCc--ccCccccCCCCCCE
Q 001152 120 QIKISS-PGVNG--FALNKLKGLKELELSKVPPRPSVLTLLSEIA-GLKCLTKLSVCHF--SIR--YLPPEIGCLSNLEQ 191 (1137)
Q Consensus 120 ~Ls~N~-~~~~~--~~~~~L~~L~~L~Ls~n~ln~~~~~lp~~l~-~L~~L~~L~Ls~N--~L~--~IP~~l~~L~~L~~ 191 (1137)
+|+++. ++..+ ....++++|++|++++...-. ...+...+. ..++|+.|++++. .++ .+..-+..+++|++
T Consensus 101 ~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~-~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~ 179 (284)
T d2astb2 101 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT-EKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179 (284)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC-HHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSE
T ss_pred cccccccccccccchhhHHHHhccccccccccccc-cccchhhhcccccccchhhhcccccccccccccccccccccccc
Confidence 998743 44322 234578889999998732111 112222333 3468999999864 344 34444467889999
Q ss_pred EEccCC-CCC-ccchhhcCCCCCCEEEccCC-CCC-ccCccccCCCCCCEEeccCCcCC-CCCcccccCCCCCCEEEccC
Q 001152 192 LDLSFN-KMK-YLPTEICYLKALISLKVANN-KLV-ELPSGLYLLQRLENLDLSNNRLT-SLGSLDLCLMHNLQNLNLQY 266 (1137)
Q Consensus 192 L~Ls~N-~L~-~LP~~l~~L~~L~~L~Ls~N-~Ls-~IP~~l~~L~~L~~LdLS~N~Ls-g~~p~~l~~L~~L~~L~Ls~ 266 (1137)
|+|++| .++ ..+..+.++++|++|+|+++ .++ .....++++++|+.|+++++ ++ +........+++|+ +..
T Consensus 180 L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L~---i~~ 255 (284)
T d2astb2 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQ---INC 255 (284)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSE---ESC
T ss_pred cccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcccc---ccC
Confidence 999986 566 55678888999999999994 677 44566888999999999887 33 22221223455554 566
Q ss_pred CcCCC
Q 001152 267 NKLLS 271 (1137)
Q Consensus 267 N~L~~ 271 (1137)
++++.
T Consensus 256 ~~ls~ 260 (284)
T d2astb2 256 SHFTT 260 (284)
T ss_dssp CCSCC
T ss_pred ccCCC
Confidence 67665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.33 E-value=4.8e-13 Score=149.92 Aligned_cols=232 Identities=15% Similarity=0.111 Sum_probs=172.0
Q ss_pred CcccccCCCCCCcccC----CCCCCCCCCCCEEEccCCCCCCCCc---c----cccCCCCCCCccEEEeecCCCCc----
Q 001152 18 IKEKLPSEANKINNEK----NGSVNDDDDDSVIDVSGKTVDFPLI---E----SYGNRGGDNSVEGLYLYKNVLNL---- 82 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~----~~~f~~l~~L~~LdLs~N~L~~~~p---~----~~~~l~~L~~L~~L~Ls~N~L~~---- 82 (1137)
.++.|.+..|.|.... ...+...++|+.|+|+++.+..... . .+..+..+++|+.|+|++|.++.
T Consensus 32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 111 (344)
T d2ca6a1 32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111 (344)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred CCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccccc
Confidence 6888999999886543 2457888999999999987653321 1 12234456899999999999974
Q ss_pred -cCccccCCCCCcEEEccCCCCCc-----cccc---------ccCCCCCCEEEccCCCCCCCc-----ccccCCCCCCEE
Q 001152 83 -IPKSVGRYEKLRNLKFFGNEINL-----FPSE---------VGNLLGLECLQIKISSPGVNG-----FALNKLKGLKEL 142 (1137)
Q Consensus 83 -IP~~~~~L~~L~~L~Ls~N~L~~-----lP~~---------l~~L~~L~~L~Ls~N~~~~~~-----~~~~~L~~L~~L 142 (1137)
+...+...++|+.|+|++|.++. +... ......|+.|.++.|.++... ..+.....|+.|
T Consensus 112 ~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L 191 (344)
T d2ca6a1 112 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191 (344)
T ss_dssp HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE
T ss_pred chhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccc
Confidence 44456678899999999999852 1111 245778999999999866433 345678899999
Q ss_pred ECCCCCCCCC--cccchhhhcCCCCCcEEeccCCCCcc-----cCccccCCCCCCEEEccCCCCCc-----cchhhcC--
Q 001152 143 ELSKVPPRPS--VLTLLSEIAGLKCLTKLSVCHFSIRY-----LPPEIGCLSNLEQLDLSFNKMKY-----LPTEICY-- 208 (1137)
Q Consensus 143 ~Ls~n~ln~~--~~~lp~~l~~L~~L~~L~Ls~N~L~~-----IP~~l~~L~~L~~L~Ls~N~L~~-----LP~~l~~-- 208 (1137)
+|++|.+... ...+...+..+++|+.|+|++|.++. +...+..+++|++|+|++|.|+. +-..+..
T Consensus 192 ~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~ 271 (344)
T d2ca6a1 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 271 (344)
T ss_dssp ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCS
T ss_pred ccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhcc
Confidence 9999776432 11234456788999999999999862 44567788999999999999983 3334433
Q ss_pred CCCCCEEEccCCCCCc-----cCcccc-CCCCCCEEeccCCcCCCCC
Q 001152 209 LKALISLKVANNKLVE-----LPSGLY-LLQRLENLDLSNNRLTSLG 249 (1137)
Q Consensus 209 L~~L~~L~Ls~N~Ls~-----IP~~l~-~L~~L~~LdLS~N~Lsg~~ 249 (1137)
...|+.|+|++|+|+. +...+. ++++|+.|+|++|+|....
T Consensus 272 ~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~ 318 (344)
T d2ca6a1 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 318 (344)
T ss_dssp SCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcc
Confidence 4679999999999972 455554 5789999999999998643
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.25 E-value=1.1e-13 Score=143.87 Aligned_cols=117 Identities=25% Similarity=0.325 Sum_probs=104.1
Q ss_pred cccchhhhcCCCCCcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccCccccCC
Q 001152 153 VLTLLSEIAGLKCLTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELPSGLYLL 232 (1137)
Q Consensus 153 ~~~lp~~l~~L~~L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L 232 (1137)
+..++..+..|++|++|+|++|+|+.|+ .|..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+|+.++ .+..+
T Consensus 37 i~~l~~sl~~L~~L~~L~Ls~n~I~~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l~-~~~~l 114 (198)
T d1m9la_ 37 IEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLS-GIEKL 114 (198)
T ss_dssp CCCCHHHHHHTTTCCEEECSEEEESCCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCHH-HHHHH
T ss_pred hhhhhhHHhcccccceeECcccCCCCcc-cccCCccccChhhcccccccccccccccccccccccccccccccc-ccccc
Confidence 4456778899999999999999999996 588999999999999999999976677788999999999999885 47889
Q ss_pred CCCCEEeccCCcCCCCCc-ccccCCCCCCEEEccCCcCCC
Q 001152 233 QRLENLDLSNNRLTSLGS-LDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 233 ~~L~~LdLS~N~Lsg~~p-~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
++|+.|+|++|+|+.+.. ..+..+++|+.|+|++|++..
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 999999999999998754 368999999999999999865
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=4.3e-13 Score=153.49 Aligned_cols=107 Identities=12% Similarity=0.098 Sum_probs=81.5
Q ss_pred CcccccCCCCCCcccC-CCCCCCCCCCCEEEccCCCCCCC----CcccccCCCCCCCccEEEeecCCCCc-----cCccc
Q 001152 18 IKEKLPSEANKINNEK-NGSVNDDDDDSVIDVSGKTVDFP----LIESYGNRGGDNSVEGLYLYKNVLNL-----IPKSV 87 (1137)
Q Consensus 18 ~l~~L~~~~N~i~~l~-~~~f~~l~~L~~LdLs~N~L~~~----~p~~~~~l~~L~~L~~L~Ls~N~L~~-----IP~~~ 87 (1137)
++++|++..|+|+... ...+..++++++|+|++|+|+.. +...+ ..+++|++|+|++|.|+. +...+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L---~~~~~L~~LdLs~N~i~~~~~~~l~~~l 79 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSAL---RVNPALAELNLRSNELGDVGVHCVLQGL 79 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHH---HTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHH---hcCCCCCEEECcCCcCChHHHHHHHHHH
Confidence 5788999999998865 23466788999999999998732 23333 345899999999999973 23333
Q ss_pred c-CCCCCcEEEccCCCCCc-----ccccccCCCCCCEEEccCCCCC
Q 001152 88 G-RYEKLRNLKFFGNEINL-----FPSEVGNLLGLECLQIKISSPG 127 (1137)
Q Consensus 88 ~-~L~~L~~L~Ls~N~L~~-----lP~~l~~L~~L~~L~Ls~N~~~ 127 (1137)
. ...+|++|+|++|+|+. ++..+..+++|+.|+|++|.++
T Consensus 80 ~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 80 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred hcCCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 3 23479999999999973 4667888999999999988643
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=6.8e-11 Score=117.86 Aligned_cols=83 Identities=22% Similarity=0.256 Sum_probs=36.6
Q ss_pred CCCCcEEeccCC-CCcccCc-cccCCCCCCEEEccCCCCCccc-hhhcCCCCCCEEEccCCCCCccCccccCCCCCCEEe
Q 001152 163 LKCLTKLSVCHF-SIRYLPP-EIGCLSNLEQLDLSFNKMKYLP-TEICYLKALISLKVANNKLVELPSGLYLLQRLENLD 239 (1137)
Q Consensus 163 L~~L~~L~Ls~N-~L~~IP~-~l~~L~~L~~L~Ls~N~L~~LP-~~l~~L~~L~~L~Ls~N~Ls~IP~~l~~L~~L~~Ld 239 (1137)
+++|+.|++++| .|+.|+. .|..+++|+.|+|++|+|+.|+ ..|..+++|++|+|++|+|+.||..+....+|+.|+
T Consensus 30 l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~ 109 (156)
T d2ifga3 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELV 109 (156)
T ss_dssp CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEE
T ss_pred ccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccccccccc
Confidence 334444444332 2444433 3444444444444444444442 234444444444444444444444433333444444
Q ss_pred ccCCcC
Q 001152 240 LSNNRL 245 (1137)
Q Consensus 240 LS~N~L 245 (1137)
|++|.|
T Consensus 110 L~~Np~ 115 (156)
T d2ifga3 110 LSGNPL 115 (156)
T ss_dssp CCSSCC
T ss_pred cCCCcc
Confidence 444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.33 E-value=1.8e-08 Score=100.51 Aligned_cols=80 Identities=23% Similarity=0.129 Sum_probs=43.1
Q ss_pred cCCCCCCEEEccCCCCCccc---hhhcCCCCCCEEEccCCCCCccCc-cccCCCCCCEEeccCCcCCCCCcc-------c
Q 001152 184 GCLSNLEQLDLSFNKMKYLP---TEICYLKALISLKVANNKLVELPS-GLYLLQRLENLDLSNNRLTSLGSL-------D 252 (1137)
Q Consensus 184 ~~L~~L~~L~Ls~N~L~~LP---~~l~~L~~L~~L~Ls~N~Ls~IP~-~l~~L~~L~~LdLS~N~Lsg~~p~-------~ 252 (1137)
..+++|++|+|++|+|+.++ ..+..+++|+.|+|++|.|+.+++ ......+|+.|+|++|.++..... .
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 44556666666666665442 334556666666666666665543 122233566666666666554331 1
Q ss_pred ccCCCCCCEEE
Q 001152 253 LCLMHNLQNLN 263 (1137)
Q Consensus 253 l~~L~~L~~L~ 263 (1137)
+..+++|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 34556666554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.08 E-value=1e-07 Score=94.82 Aligned_cols=103 Identities=25% Similarity=0.168 Sum_probs=77.2
Q ss_pred CcEEeccCCCCcccCccccCCCCCCEEEccCCCCCccchhhcCCCCCCEEEccCCCCCccC---ccccCCCCCCEEeccC
Q 001152 166 LTKLSVCHFSIRYLPPEIGCLSNLEQLDLSFNKMKYLPTEICYLKALISLKVANNKLVELP---SGLYLLQRLENLDLSN 242 (1137)
Q Consensus 166 L~~L~Ls~N~L~~IP~~l~~L~~L~~L~Ls~N~L~~LP~~l~~L~~L~~L~Ls~N~Ls~IP---~~l~~L~~L~~LdLS~ 242 (1137)
.+.|+++++.. .| .+..+..+..|.+.+|....++..+..+++|+.|+|++|+|+.++ ..+..+++|+.|+|++
T Consensus 24 ~~~Ldls~l~~--~~-~l~~~~~~~~l~~~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~ 100 (162)
T d1koha1 24 QQALDLKGLRS--DP-DLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG 100 (162)
T ss_dssp SCCBCCCCCSS--CT-TTTTTTCCCCTTSHHHHHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTT
T ss_pred hCeeecccCCC--Cc-hhhhccchhhcchhhhHhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccccc
Confidence 45566665542 22 344455555566666555566655667999999999999999764 4466799999999999
Q ss_pred CcCCCCCcccccCCCCCCEEEccCCcCCC
Q 001152 243 NRLTSLGSLDLCLMHNLQNLNLQYNKLLS 271 (1137)
Q Consensus 243 N~Lsg~~p~~l~~L~~L~~L~Ls~N~L~~ 271 (1137)
|.|+.+.+..+.....|+.|+|++|+++.
T Consensus 101 N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 101 NELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp SCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred CccccchhhhhhhccccceeecCCCCcCc
Confidence 99999877566666789999999999976
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.96 E-value=2.2e-05 Score=82.52 Aligned_cols=85 Identities=9% Similarity=0.058 Sum_probs=55.9
Q ss_pred CCceEeeeecccCceEEEEEEECCccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-CCCcceeeeeEecCCCC
Q 001152 802 PSLSSCDEAGKSVSSSLFRCKFGSADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-HSCIVEMYGHKISSKWL 880 (1137)
Q Consensus 802 ~~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-HpNIVkllg~~~~~~~~ 880 (1137)
..|+..+..+-++.+.||+....+..+++|+........ . . .+.+|+..+..+. +--+.+++++...++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~-~---~----~~~~E~~~l~~l~~~vpvP~vl~~~~~~~-- 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT-T---Y----DVEREKDMMLWLEGKLPVPKVLHFERHDG-- 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS-T---T----CHHHHHHHHHHHTTTSCCCCEEEEEEETT--
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc-h---h----hHHHHHHHHHHHhccCCCCcEEEEEecCC--
Confidence 456777665555667899998877888888753222111 1 1 1256888887775 433557777766544
Q ss_pred CCCCCCCccccceEEEEEeeccCCCHHH
Q 001152 881 PSADGNPEHHLLQSAIFMEYVKGGSVKN 908 (1137)
Q Consensus 881 ~~~~g~~~~~~~~l~LVmEy~~ggSL~~ 908 (1137)
..++||++++|.++.+
T Consensus 84 ------------~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 84 ------------WSNLLMSEADGVLCSE 99 (263)
T ss_dssp ------------EEEEEEECCSSEEHHH
T ss_pred ------------ceEEEEEecccccccc
Confidence 5699999999877654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.43 E-value=4.9e-05 Score=75.24 Aligned_cols=106 Identities=17% Similarity=0.192 Sum_probs=61.9
Q ss_pred CCCCcEEeccCC-CCc--c---cCccccCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCCc-----cC
Q 001152 163 LKCLTKLSVCHF-SIR--Y---LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLVE-----LP 226 (1137)
Q Consensus 163 L~~L~~L~Ls~N-~L~--~---IP~~l~~L~~L~~L~Ls~N~L~-----~LP~~l~~L~~L~~L~Ls~N~Ls~-----IP 226 (1137)
.+.|+.|+|+++ .++ . +-..+...+.|+.|+|++|.|+ .+-..+...+.|+.|+|++|.|+. |-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 455666666653 343 1 1223455566777777777775 223445556677777777777762 22
Q ss_pred ccccCCCCCCEEeccCCcCCCCCc-------ccccCCCCCCEEEccCCc
Q 001152 227 SGLYLLQRLENLDLSNNRLTSLGS-------LDLCLMHNLQNLNLQYNK 268 (1137)
Q Consensus 227 ~~l~~L~~L~~LdLS~N~Lsg~~p-------~~l~~L~~L~~L~Ls~N~ 268 (1137)
..+...++|+.|+|++|.+..+.. ..+..-+.|+.|+++.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 345556677777777776664421 223345677777776653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.15 E-value=0.00017 Score=71.19 Aligned_cols=66 Identities=15% Similarity=0.158 Sum_probs=30.5
Q ss_pred CCCCCCEEEccCC-CCCCC-CcccccCCCCCCCccEEEeecCCCCc-----cCccccCCCCCcEEEccCCCCC
Q 001152 39 DDDDDSVIDVSGK-TVDFP-LIESYGNRGGDNSVEGLYLYKNVLNL-----IPKSVGRYEKLRNLKFFGNEIN 104 (1137)
Q Consensus 39 ~l~~L~~LdLs~N-~L~~~-~p~~~~~l~~L~~L~~L~Ls~N~L~~-----IP~~~~~L~~L~~L~Ls~N~L~ 104 (1137)
+.++|+.|+|+++ .++.. ....+..+...+.|++|+|++|.++. +-..+...+.|+.|+|++|.|+
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 3455666666653 34321 11112223333556666666665541 1123334455566666666554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.11 E-value=0.00032 Score=78.81 Aligned_cols=82 Identities=12% Similarity=-0.026 Sum_probs=44.9
Q ss_pred eeeecccCceEEEEEEEC--CccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCC-C--CCcceeeeeEecCCCCC
Q 001152 807 CDEAGKSVSSSLFRCKFG--SADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALR-H--SCIVEMYGHKISSKWLP 881 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~--~~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~-H--pNIVkllg~~~~~~~~~ 881 (1137)
.+.||.|....||+++.. +..++||.-.......+. .......+..+|++.|+.+. + ..+.+++.+..+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~-~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~----- 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-SWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE----- 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--C-CCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT-----
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCC-CCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC-----
Confidence 457899999999999864 356777753211111100 00000012255878777663 2 345566654322
Q ss_pred CCCCCCccccceEEEEEeeccCCC
Q 001152 882 SADGNPEHHLLQSAIFMEYVKGGS 905 (1137)
Q Consensus 882 ~~~g~~~~~~~~l~LVmEy~~ggS 905 (1137)
..++|||++++..
T Consensus 105 -----------~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 -----------MAVTVMEDLSHLK 117 (392)
T ss_dssp -----------TTEEEECCCTTSE
T ss_pred -----------CCEEEEeccCCcc
Confidence 2289999998654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.02 E-value=0.00046 Score=71.64 Aligned_cols=73 Identities=12% Similarity=0.061 Sum_probs=45.1
Q ss_pred eecccCc-eEEEEEEECC-ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCC--CCcceeeeeEecCCCCCCCC
Q 001152 809 EAGKSVS-SSLFRCKFGS-ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRH--SCIVEMYGHKISSKWLPSAD 884 (1137)
Q Consensus 809 ~LG~Gsf-G~Vy~a~~~~-~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~H--pNIVkllg~~~~~~~~~~~~ 884 (1137)
.+..|.. +.||+....+ ..+++|+..... . .. +.+|+..++.+.. -.+.+++++..+.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~---~~----l~~E~~~l~~L~~~gvpvP~v~~~~~~~~------ 79 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----L---NE----LQDEAARLSWLATTGVPCAAVLDVVTEAG------ 79 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----T---SC----HHHHHHHHHHHHTTTCCBCCEEEEEECSS------
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----H---hH----HHHHHHHHHHHHhcCCCCCceeeeccccc------
Confidence 4455554 6799998754 457777643221 1 11 2557777777653 23457777766544
Q ss_pred CCCccccceEEEEEeeccCCCH
Q 001152 885 GNPEHHLLQSAIFMEYVKGGSV 906 (1137)
Q Consensus 885 g~~~~~~~~l~LVmEy~~ggSL 906 (1137)
..++||+|++|.++
T Consensus 80 --------~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 80 --------RDWLLLGEVPGQDL 93 (255)
T ss_dssp --------CEEEEEECCSSEET
T ss_pred --------ceEEEEEeeecccc
Confidence 45999999987643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.69 E-value=0.00033 Score=68.70 Aligned_cols=109 Identities=14% Similarity=0.096 Sum_probs=66.4
Q ss_pred cCCCCCcEEeccC-CCCc--c---cCccccCCCCCCEEEccCCCCC-----ccchhhcCCCCCCEEEccCCCCC-----c
Q 001152 161 AGLKCLTKLSVCH-FSIR--Y---LPPEIGCLSNLEQLDLSFNKMK-----YLPTEICYLKALISLKVANNKLV-----E 224 (1137)
Q Consensus 161 ~~L~~L~~L~Ls~-N~L~--~---IP~~l~~L~~L~~L~Ls~N~L~-----~LP~~l~~L~~L~~L~Ls~N~Ls-----~ 224 (1137)
.+.+.|+.|+|++ +.++ . +-..+...++|+.|+|++|.|+ .|-..+...+.|+.|++++|.++ .
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4556677777776 4454 1 2223456677788888887776 23344555677888888888776 2
Q ss_pred cCccccCCCCCCEEec--cCCcCCCC----CcccccCCCCCCEEEccCCcC
Q 001152 225 LPSGLYLLQRLENLDL--SNNRLTSL----GSLDLCLMHNLQNLNLQYNKL 269 (1137)
Q Consensus 225 IP~~l~~L~~L~~LdL--S~N~Lsg~----~p~~l~~L~~L~~L~Ls~N~L 269 (1137)
|-..+...++|+.++| ++|.+... +...+...+.|+.|+++.|..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 3345666677776544 45666531 122345677888888876653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.40 E-value=0.00052 Score=67.23 Aligned_cols=85 Identities=15% Similarity=0.171 Sum_probs=49.0
Q ss_pred CCCCCCCEEEccC-CCCCCCCcc-cccCCCCCCCccEEEeecCCCCc-----cCccccCCCCCcEEEccCCCCC-----c
Q 001152 38 NDDDDDSVIDVSG-KTVDFPLIE-SYGNRGGDNSVEGLYLYKNVLNL-----IPKSVGRYEKLRNLKFFGNEIN-----L 105 (1137)
Q Consensus 38 ~~l~~L~~LdLs~-N~L~~~~p~-~~~~l~~L~~L~~L~Ls~N~L~~-----IP~~~~~L~~L~~L~Ls~N~L~-----~ 105 (1137)
.+.+.|+.|+|++ |.|+...-. .+..+...++|++|+|++|.++. |-..+...+.|+.|++++|.++ .
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4557777777776 445432211 22223445677777777777762 2234455667777777777775 2
Q ss_pred ccccccCCCCCCEEEcc
Q 001152 106 FPSEVGNLLGLECLQIK 122 (1137)
Q Consensus 106 lP~~l~~L~~L~~L~Ls 122 (1137)
|-..+...++|+.++|+
T Consensus 94 l~~~l~~~~~L~~l~L~ 110 (166)
T d1io0a_ 94 LVEALQSNTSLIELRID 110 (166)
T ss_dssp HHHGGGGCSSCCEEECC
T ss_pred HHHHHHhCccccEEeec
Confidence 33445556666665554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.59 E-value=0.038 Score=59.47 Aligned_cols=27 Identities=30% Similarity=0.288 Sum_probs=22.5
Q ss_pred CeeeccCCCCCeEeccccccCCCCCeEEEeecCccc
Q 001152 944 HIMHRDIKSENILIDLERKKADGKPVVKLCDFDRAV 979 (1137)
Q Consensus 944 gIIHrDLKP~NILld~~~~~~~~~~~vKL~DFGla~ 979 (1137)
++||+|+.+.|||++.+ ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~~---------~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG---------PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS---------EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC---------ceEEechhcc
Confidence 68999999999999743 4579999764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.10 E-value=0.069 Score=56.62 Aligned_cols=32 Identities=19% Similarity=0.113 Sum_probs=22.3
Q ss_pred CceEeeeecccCceEEEEEEECCccEEEEEEe
Q 001152 803 SLSSCDEAGKSVSSSLFRCKFGSADAAAKVRT 834 (1137)
Q Consensus 803 ~y~l~~~LG~GsfG~Vy~a~~~~~~vAVKi~~ 834 (1137)
...-.+.|..|---+.|+.+..+..+++|++.
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~ 50 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYE 50 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEEC
T ss_pred CceEeecCCCCcccCeEEEEECCCcEEEEEcC
Confidence 34445677888888999999888889999863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.68 E-value=0.082 Score=58.27 Aligned_cols=70 Identities=16% Similarity=0.264 Sum_probs=44.8
Q ss_pred eeeecccCceEEEEEEECC---------ccEEEEEEecccCCCChHHHHHhHHhHHHHHHHHHhCCCCCcc-eeeeeEec
Q 001152 807 CDEAGKSVSSSLFRCKFGS---------ADAAAKVRTLKVCGSSADEIRNFEYSCLGEVRMLGALRHSCIV-EMYGHKIS 876 (1137)
Q Consensus 807 ~~~LG~GsfG~Vy~a~~~~---------~~vAVKi~~l~~~~~~~~~~e~~~~~~lrEi~iL~~L~HpNIV-kllg~~~~ 876 (1137)
++.|+.|-.=.+|++.... ..+.+++.- . . ... .. . .+|..+++.+.-.+++ ++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~-~~~--id-r----~~E~~i~~~ls~~gl~Pkll~~~~- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-P-ETE--SH-L----VAESVIFTLLSERHLGPKLYGIFS- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-C-CCH--HH-H----HHHHHHHHHHHHTTSSSCEEEEET-
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-c-chh--hH-H----HHHHHHHHHHHhCCCCCeEEEEcC-
Confidence 3678889999999998642 345555542 2 1 111 11 1 4688888888633444 7777653
Q ss_pred CCCCCCCCCCCccccceEEEEEeeccCC
Q 001152 877 SKWLPSADGNPEHHLLQSAIFMEYVKGG 904 (1137)
Q Consensus 877 ~~~~~~~~g~~~~~~~~l~LVmEy~~gg 904 (1137)
+ ++||||++|.
T Consensus 116 -~----------------g~I~efi~g~ 126 (395)
T d1nw1a_ 116 -G----------------GRLEEYIPSR 126 (395)
T ss_dssp -T----------------EEEECCCCEE
T ss_pred -C----------------ceEEEEeccc
Confidence 2 6899999864
|